{"meta":{"query_hash":"640f9589c59b","filters":{"topic":"Melanoma and MAPK Pathways"},"cohort_total":749,"direct_labels_cover":2,"predictions_cover":749,"exported":749,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/640f9589c59b","api":"https://metacan.xera.ac/api/v1/cohort?topic=Melanoma+and+MAPK+Pathways"},"results":[{"id":"W143619609","doi":"10.1023/a:1020705210855","title":"Genetic Selection for Modulators of the MAP Kinase and β-Catenin Growth-Control Pathways in Mammalian Cells","year":2002,"lang":"en","type":"article","venue":"Biochemical Genetics","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Aptose Biosciences (Canada)","funders":"","keywords":"Biology; Genetic screen; Kinase; Mitogen-activated protein kinase; Cell biology; Phenotype; Protein kinase A; Signal transduction; Genetics; Gene","score_opus":0.00985745415457887,"score_gpt":0.18748154573564443,"score_spread":0.17762409158106557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W143619609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98154026,0.00085025816,0.01254802,0.0003522742,0.00009895554,0.00014068953,0.00050291215,0.00029112372,0.0036754892],"genre_scores_gemma":[0.982113,0.000974391,0.009455387,0.00017790974,0.00002815867,0.000118425545,0.0006348524,0.00022628214,0.006271496],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99970526,0.000058340203,0.000034236335,0.00005442045,0.000096918666,0.000050836043],"domain_scores_gemma":[0.9996257,0.00011574071,0.00010270235,0.000051704083,0.000023794144,0.000080321086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029732933,0.00053428404,0.0003382586,0.0005845978,0.00031784346,0.00050652464,0.0006062462,0.00047755765,0.0020669498],"category_scores_gemma":[0.00031540744,0.00046394073,0.00036689598,0.00041004602,0.0003833943,0.00021789712,0.00047150665,0.00092323427,0.0006138386],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004353153,0.000010042192,0.000050884784,0.0000062369454,0.0000025518814,0.00003144556,0.000006433669,0.000045421566,0.9992428,0.00025335152,0.000013623677,0.00029374557],"study_design_scores_gemma":[0.000026831956,0.000062935214,0.00093016576,0.0000025112363,0.000018424702,0.00017686914,0.000018926663,0.00071613153,0.9956969,0.00007003644,0.0022751617,0.000005168856],"about_ca_topic_score_codex":0.001054252,"about_ca_topic_score_gemma":0.0027754281,"teacher_disagreement_score":0.0020669498,"about_ca_system_score_codex":0.0005892512,"about_ca_system_score_gemma":0.00043601447,"threshold_uncertainty_score":0.0069146156},"labels":[],"label_agreement":null},{"id":"W1490756663","doi":"10.1684/ejd.2014.2300","title":"Dramatic response to radiotherapy combined with vemurafenib. Is vemurafenib a radiosensitizer?","year":2014,"lang":"en","type":"article","venue":"European Journal of Dermatology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Vemurafenib; Medicine; Radiosensitizer; Melanoma; Radiation therapy; Cancer research; Oncology; Internal medicine; Dermatology; Metastatic melanoma","score_opus":0.00578262844544919,"score_gpt":0.20826384239983944,"score_spread":0.20248121395439025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1490756663","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95730543,0.007546216,0.0069645243,0.0070905383,0.0012228874,0.0005636532,0.00091349013,0.0011327552,0.017260531],"genre_scores_gemma":[0.9898211,0.0011311902,0.0010239646,0.0023484032,0.00034324135,0.00005397383,0.00043868783,0.000057420333,0.0047820215],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9997545,0.000045542965,0.00002082899,0.000062931285,0.00004873041,0.000067447196],"domain_scores_gemma":[0.99947494,0.00013478601,0.00006527331,0.0000613754,0.000023831202,0.00023983677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020546422,0.00074150943,0.0009734339,0.00031202237,0.00045184937,0.00033148748,0.00038754594,0.0015637804,0.0012986987],"category_scores_gemma":[0.00068607565,0.00027362903,0.00083791674,0.00016170809,0.00032884313,0.00028119987,0.00035116432,0.002425355,0.0008768385],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005957322,0.0020692477,0.010780405,0.00046072257,0.00023804973,0.6513799,0.00054072705,0.0012672825,0.2422194,0.00062260486,0.0054971604,0.07896717],"study_design_scores_gemma":[0.0012641582,0.02047808,0.052210588,0.00004840272,0.00018914518,0.838734,0.00013995083,0.00250247,0.06944163,0.0003797965,0.0144951865,0.00011660445],"about_ca_topic_score_codex":0.00046048537,"about_ca_topic_score_gemma":0.0006555667,"teacher_disagreement_score":0.0015637804,"about_ca_system_score_codex":0.00037984707,"about_ca_system_score_gemma":0.00016752347,"threshold_uncertainty_score":0.0043445826},"labels":[],"label_agreement":null},{"id":"W1502027962","doi":"10.1212/wnl.84.14_supplement.p4.232","title":"Guillain-Barre Syndrome after Treatment with Dabrafenib for Metastatic Recurrent Melaloma. (P4.232)","year":2015,"lang":"en","type":"article","venue":"Neurology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Guillain-Barre syndrome; Medicine; Dabrafenib; Internal medicine; Pediatrics; Metastatic melanoma; Cancer","score_opus":0.0253450538833018,"score_gpt":0.2518534204863586,"score_spread":0.22650836660305682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1502027962","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95368665,0.008530072,0.0028470422,0.009335095,0.00084768404,0.0003582134,0.0005196889,0.00031950363,0.023555985],"genre_scores_gemma":[0.99454546,0.001137204,0.00060035154,0.0012742059,0.0004768357,0.000027017364,0.000098301745,0.000019278172,0.0018212555],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9995969,0.000049301987,0.00003344958,0.000105777595,0.00006237725,0.00015229578],"domain_scores_gemma":[0.99928325,0.00016600272,0.0001681629,0.00004614233,0.000044887012,0.000291549],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002706832,0.0018517765,0.0008487113,0.0013299354,0.0019153485,0.0009005676,0.0009392053,0.0036240004,0.002112768],"category_scores_gemma":[0.0016319467,0.00061357976,0.0010732327,0.0010001818,0.0012884149,0.0010490208,0.00088210695,0.002941038,0.000765425],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003562772,0.000013726307,0.0021360738,0.000013897847,0.0000056439017,0.9965283,0.000053635806,0.000028283337,0.00024727825,0.00006378619,0.00019421167,0.0006796104],"study_design_scores_gemma":[0.000017317183,0.000076718774,0.0038107564,0.00001344449,0.000011418507,0.99506336,0.00006125579,0.0001315962,0.00018306586,0.00012553994,0.00049848476,0.000007029279],"about_ca_topic_score_codex":0.004565548,"about_ca_topic_score_gemma":0.0048698685,"teacher_disagreement_score":0.004565548,"about_ca_system_score_codex":0.0015677842,"about_ca_system_score_gemma":0.0008321861,"threshold_uncertainty_score":0.011375129},"labels":[],"label_agreement":null},{"id":"W1522194210","doi":"10.5772/20002","title":"The Role of Cellular Differentiation and Cell Fate in Malignant Melanoma","year":2011,"lang":"en","type":"book-chapter","venue":"InTech eBooks","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute; National Institutes of Health","keywords":"Cell fate determination; Biology; Embryonic stem cell; Cellular differentiation; Progenitor cell; Carcinogenesis; Cell biology; Cell; Cell type; Cancer cell; Stem cell; Cancer; Genetics; Transcription factor; Gene","score_opus":0.009364464319599301,"score_gpt":0.1829541375553763,"score_spread":0.17358967323577698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1522194210","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009286602,0.99327034,0.0006270241,0.0014501628,0.0009615364,0.0000058070877,0.000019772524,0.0000073382294,0.0027293891],"genre_scores_gemma":[0.012439435,0.98160446,0.0005000305,0.0010387794,0.0015568339,0.000013601212,0.000047050748,0.000006491062,0.0027933544],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997472,0.000071866794,0.000027847991,0.000038224913,0.00008204205,0.000032803942],"domain_scores_gemma":[0.99985266,0.00006233647,0.00002285399,0.0000056283684,0.000039355593,0.00001711378],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005568704,0.00031206495,0.0006587439,0.0006892016,0.00034060545,0.0010276053,0.00047341906,0.0009865161,0.0013600062],"category_scores_gemma":[0.00046853817,0.00014783733,0.00029449686,0.00072666997,0.0011756053,0.0014641762,0.0007257115,0.0020228839,0.00066954637],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022790379,0.00007223008,0.0011445081,0.021194065,0.00006996214,0.0014845384,0.00156838,0.0010415599,0.03726144,0.17558107,0.040712837,0.71964145],"study_design_scores_gemma":[0.0000070119117,0.00013363898,0.0014705457,0.0016215573,0.00003442482,0.0022994925,0.0002477774,0.00011857577,0.003726926,0.018480787,0.9718403,0.000018995785],"about_ca_topic_score_codex":0.0007522994,"about_ca_topic_score_gemma":0.0012154758,"teacher_disagreement_score":0.0013600062,"about_ca_system_score_codex":0.00079897005,"about_ca_system_score_gemma":0.0007720021,"threshold_uncertainty_score":0.005796969},"labels":[],"label_agreement":null},{"id":"W1530286875","doi":"10.1158/1538-7445.mel2014-a33","title":"Abstract A33: Loss of tumor suppressors KAI1 and p27 identifies a unique subgroup of primary melanoma patients with poor survival","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Melanoma; Cohort; Oncology; Internal medicine; Proportional hazards model; Hazard ratio; Survival analysis; Cancer; Primary tumor; Metastasis; Cancer research","score_opus":0.04099922852141936,"score_gpt":0.31047052523955737,"score_spread":0.269471296718138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1530286875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994448,0.00010683147,0.00009399359,0.000018400637,0.000002526807,0.0000043900473,0.00013624021,0.0000052511573,0.00018764944],"genre_scores_gemma":[0.99957496,0.000029000923,0.00004432685,0.000008233432,0.000006219509,0.0000029322143,0.00020131608,0.0000016415464,0.00013146907],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99988997,0.000012684307,0.000010561459,0.000041456038,0.000020051228,0.000025208417],"domain_scores_gemma":[0.9995388,0.00007115205,0.00015754835,0.000039281607,0.000061270715,0.00013205905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001730641,0.00026458272,0.00028701877,0.0005250581,0.00033058107,0.00032203158,0.00018305144,0.00022459896,0.0025513347],"category_scores_gemma":[0.0007661822,0.00011743366,0.00024120173,0.0003560165,0.00019403991,0.00016243549,0.0002178348,0.00030359448,0.00044724956],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045033684,0.00005342741,0.98223096,0.000023873672,0.000052377396,0.0010018375,0.000078756944,0.00008190254,0.011845209,0.00002642862,0.00037353626,0.003781251],"study_design_scores_gemma":[0.000009741278,0.00016194637,0.9941374,0.0000033610288,0.000034062516,0.0039508445,0.00006996177,0.0002413307,0.0010636993,0.000037710382,0.00028715635,0.0000028564589],"about_ca_topic_score_codex":0.00084417657,"about_ca_topic_score_gemma":0.00078660983,"teacher_disagreement_score":0.0025513347,"about_ca_system_score_codex":0.00017632062,"about_ca_system_score_gemma":0.00016627675,"threshold_uncertainty_score":0.008535087},"labels":[],"label_agreement":null},{"id":"W1537901311","doi":"10.1186/ar479","title":"Overexpression of the autoantigen hnRNP-A2 (RA33), the tumour suppressor p53 and activated MAP-Kinase p38 in inflamed synovial tissue","year":2002,"lang":"en","type":"article","venue":"Arthritis Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Gigtforeningen; Univerzita Karlova v Praze","keywords":"Computer science","score_opus":0.02823179607658402,"score_gpt":0.29140622406857036,"score_spread":0.2631744279919863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1537901311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986386,0.0005608637,0.00046533346,0.000010307036,0.0000040246314,0.0000042274783,0.000078016354,0.000013743075,0.00022483147],"genre_scores_gemma":[0.99799097,0.00027059935,0.0005542104,0.000010083482,0.0000049066216,0.000009226187,0.00019341391,0.000004029919,0.0009626243],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998567,0.000025792418,0.000015089415,0.000033119064,0.000035558725,0.000033688004],"domain_scores_gemma":[0.999861,0.000017443745,0.000045204873,0.000015037419,0.00001546058,0.000045778448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014320688,0.00034615243,0.00014375111,0.0004264446,0.00018297379,0.00023641088,0.0000650642,0.00022259625,0.0010069064],"category_scores_gemma":[0.00014264442,0.00016934083,0.00022073659,0.00020077259,0.00018395884,0.00015548787,0.00020594634,0.00022576349,0.0002847424],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006821306,0.0000056546373,0.0009340668,0.000018558198,0.0000049868513,0.00018010386,0.00001615977,0.000011630258,0.99855727,0.000008904236,0.000004778022,0.00018958718],"study_design_scores_gemma":[0.000044801065,0.0011979016,0.1519262,0.000015203712,0.00006661285,0.009383326,0.00021910568,0.0009815993,0.8339713,0.00009360489,0.0020862375,0.00001401599],"about_ca_topic_score_codex":0.00048143513,"about_ca_topic_score_gemma":0.00060283084,"teacher_disagreement_score":0.0010069064,"about_ca_system_score_codex":0.00014515774,"about_ca_system_score_gemma":0.00011286527,"threshold_uncertainty_score":0.0033684373},"labels":[],"label_agreement":null},{"id":"W1557009112","doi":"","title":"Sustained activation of the extracellular signal-regulated kinase pathway protects cells from photofrin-mediated photodynamic therapy.","year":2002,"lang":"en","type":"article","venue":"PubMed","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"MAPK/ERK pathway; Kinase; Protein kinase A; Photodynamic therapy; Cell biology; Cancer research; Extracellular; Signal transduction; Photosensitizer; Biology; Mitogen-activated protein kinase; Chemistry","score_opus":0.010650561078665981,"score_gpt":0.17010030278792437,"score_spread":0.15944974170925838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1557009112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98143667,0.011486932,0.004501291,0.00016377542,0.00009747382,0.000062246436,0.0005552591,0.00015478671,0.0015414982],"genre_scores_gemma":[0.9891868,0.003906765,0.0028717492,0.000078513855,0.000018904215,0.00006720547,0.0011006491,0.000017416925,0.0027520168],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99992764,0.0000094837,0.0000053461117,0.0000137149345,0.000020667676,0.000023175857],"domain_scores_gemma":[0.9999405,0.0000110553065,0.000016604117,0.000009224378,0.000008472372,0.0000141923165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001653709,0.0003296561,0.00035609797,0.00016117177,0.00013180725,0.00020350167,0.00016261604,0.00036041357,0.0010543343],"category_scores_gemma":[0.00008472948,0.00009731388,0.0002821968,0.0001206593,0.00014259682,0.00025527814,0.0001406333,0.00059772003,0.00029044287],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000063937,0.000020571977,0.000044361244,0.000037800753,0.0000051353336,0.000019765092,0.000005362888,0.000025068046,0.99886143,0.000036929963,0.00003271751,0.0008469436],"study_design_scores_gemma":[0.000020925154,0.00042538572,0.0029893168,0.000009116189,0.000015833111,0.00024563566,0.000013475589,0.00041499312,0.9926898,0.00005453915,0.0031155741,0.0000053649856],"about_ca_topic_score_codex":0.00024214464,"about_ca_topic_score_gemma":0.0003924555,"teacher_disagreement_score":0.0010543343,"about_ca_system_score_codex":0.00021867781,"about_ca_system_score_gemma":0.00021207798,"threshold_uncertainty_score":0.0035271645},"labels":[],"label_agreement":null},{"id":"W1602852817","doi":"10.1158/1538-7445.am2014-3895","title":"Abstract 3895: Tumor suppressor activity of the ERK/MAPK signaling: inhibition of cell reprogramming by degradation of specific proteins","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"MAPK/ERK pathway; Cell biology; Biology; PI3K/AKT/mTOR pathway; Senescence; Cancer cell; Cancer research; Cell cycle; Signal transduction; Cell; Cancer; Genetics","score_opus":0.04364875536596474,"score_gpt":0.31197097774244864,"score_spread":0.2683222223764839,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1602852817","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882608,0.0034660853,0.0033601085,0.00019980784,0.00007130608,0.000050980765,0.00079839333,0.000105843945,0.003686711],"genre_scores_gemma":[0.990369,0.0013816073,0.0022043835,0.000058899484,0.000015504449,0.000057342753,0.0010430744,0.000021681159,0.0048484015],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990726,0.000010457068,0.000011489903,0.0000181897,0.00003198892,0.000020689875],"domain_scores_gemma":[0.99996567,0.0000060500047,0.0000076293463,0.0000058158416,0.00000346867,0.000011418804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009206998,0.00042477244,0.00020000528,0.00016130722,0.00011221837,0.00022092588,0.00019780945,0.00019441974,0.0025151381],"category_scores_gemma":[0.000055867185,0.0000822782,0.00026021595,0.00012189089,0.0001373849,0.00016143863,0.00013357901,0.0005033855,0.00051200844],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017858071,0.00006881965,0.000071660616,0.00004419158,0.0000060655766,0.00006473911,0.000006669838,0.00007912501,0.9968079,0.00022328061,0.000074433934,0.0023744523],"study_design_scores_gemma":[0.00003113693,0.00034201058,0.0008845234,0.0000045875804,0.000011129746,0.00024571267,0.000005952734,0.00054091803,0.99397606,0.00005951699,0.0038959566,0.0000024269143],"about_ca_topic_score_codex":0.00021811933,"about_ca_topic_score_gemma":0.00024809522,"teacher_disagreement_score":0.0025151381,"about_ca_system_score_codex":0.00020457107,"about_ca_system_score_gemma":0.00016911267,"threshold_uncertainty_score":0.0084139705},"labels":[],"label_agreement":null},{"id":"W167223770","doi":"10.1096/fasebj.21.5.a138-b","title":"VEGFR2 regulates p38 but not ERK1/2 in response to shear stress","year":2007,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University","funders":"Canadian Institutes of Health Research","keywords":"Phosphorylation; p38 mitogen-activated protein kinases; Shear stress; Kinase; Vascular endothelial growth factor; Chemistry; Internal medicine; Endocrinology; Cell biology; Biology; MAPK/ERK pathway; Medicine; VEGF receptors; Materials science","score_opus":0.01267770843528012,"score_gpt":0.24868531567213797,"score_spread":0.23600760723685785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W167223770","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881495,0.0045563653,0.0017249227,0.0005795145,0.00014052003,0.000028864048,0.0006748191,0.000113019065,0.004032464],"genre_scores_gemma":[0.9802004,0.0027868622,0.0017539338,0.00015193573,0.000063721614,0.00007137047,0.001395931,0.000021389204,0.013554437],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998424,0.00002477872,0.000009805928,0.000029433542,0.00002984102,0.00006376669],"domain_scores_gemma":[0.9999039,0.000008723007,0.000032840453,0.000010185428,0.000017171897,0.000027155234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018293175,0.00044212322,0.00017240644,0.00020539765,0.00019158541,0.00025034495,0.00017634282,0.00026435728,0.0042927954],"category_scores_gemma":[0.000120782366,0.00020362511,0.00029546823,0.000119505545,0.00018719102,0.00022322261,0.00019275426,0.00053928245,0.0010591424],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027665906,0.000050676732,0.00021663135,0.000075038704,0.000006075518,0.000101934245,0.000014855601,0.00003440959,0.99756217,0.000110174224,0.00020632643,0.001345012],"study_design_scores_gemma":[0.00023915626,0.0009947602,0.06912817,0.000044973305,0.000054815275,0.0011447485,0.00013667489,0.0031538825,0.91537637,0.0003244161,0.009386996,0.000014993539],"about_ca_topic_score_codex":0.0007948012,"about_ca_topic_score_gemma":0.0011616412,"teacher_disagreement_score":0.0042927954,"about_ca_system_score_codex":0.00027709047,"about_ca_system_score_gemma":0.00024733826,"threshold_uncertainty_score":0.0143607855},"labels":[],"label_agreement":null},{"id":"W1743462958","doi":"10.1016/j.celrep.2015.07.011","title":"Functional Redundancy of ERK1 and ERK2 MAP Kinases during Development","year":2015,"lang":"en","type":"article","venue":"Cell Reports","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":104,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"Canadian Institutes of Health Research","keywords":"Biology; Kinase; Effector; MAPK/ERK pathway; Cell biology; Mitogen-activated protein kinase; Embryonic stem cell; MAPK7; Signal transduction; Embryo; Embryogenesis; Genetics; MAP kinase kinase kinase; Gene","score_opus":0.01734037690953149,"score_gpt":0.20556685864015506,"score_spread":0.18822648173062356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1743462958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99517053,0.001335584,0.0021823861,0.000047508147,0.00000816972,0.0000071725203,0.00017869062,0.000054943644,0.0010149706],"genre_scores_gemma":[0.99638915,0.00053605536,0.001689494,0.000024473,0.0000051967963,0.000010796464,0.0002393744,0.000018785047,0.001086751],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99968994,0.0000565044,0.00003253357,0.00007019048,0.000079160294,0.00007169578],"domain_scores_gemma":[0.99973816,0.000038112892,0.00008987646,0.000043411626,0.000029240875,0.000061234925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002860836,0.0004913332,0.0002864335,0.000511804,0.00011230787,0.00039401045,0.00037523193,0.00023867503,0.00062935654],"category_scores_gemma":[0.00019277503,0.00027091766,0.00025928873,0.00015213004,0.00027067316,0.00033152633,0.00028106503,0.00034875516,0.00031168852],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007796024,0.0000062558597,0.0005503514,0.000023727012,0.000004652939,0.000117966156,0.000010740832,0.000074661395,0.99785644,0.0002751929,0.000012942531,0.0009891739],"study_design_scores_gemma":[0.000014171106,0.00017966337,0.03148032,0.000011226337,0.00004687608,0.002222634,0.00004909148,0.0013991544,0.9619946,0.00027830523,0.0023078807,0.00001602879],"about_ca_topic_score_codex":0.00014664451,"about_ca_topic_score_gemma":0.00025462013,"teacher_disagreement_score":0.00062935654,"about_ca_system_score_codex":0.00022969718,"about_ca_system_score_gemma":0.00018254928,"threshold_uncertainty_score":0.0021054149},"labels":[],"label_agreement":null},{"id":"W179471864","doi":"10.1096/fasebj.21.6.a1042-d","title":"p38 Stress Kinase Controls Late Apoptotic Events in L‐Glutamine‐deprived Sp2/0‐Ag14 Murine Hybridoma Cells","year":2007,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Laurentian University","funders":"","keywords":"Apoptosis; p38 mitogen-activated protein kinases; Programmed cell death; Glutamine; Cell biology; Oxidative stress; Mitochondrion; Caspase 3; Kinase; Biology; Caspase; Molecular biology; Protein kinase A; Biochemistry; Amino acid","score_opus":0.008247807202436298,"score_gpt":0.22498434136190795,"score_spread":0.21673653415947167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W179471864","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957359,0.00046294509,0.0018171902,0.00007076179,0.000027226572,0.000024591294,0.00053860544,0.00009363933,0.0012292998],"genre_scores_gemma":[0.9908365,0.0004457401,0.0023263425,0.00004474631,0.000016249836,0.00008280089,0.0012661653,0.00004292517,0.0049384315],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997892,0.000037594415,0.00001921692,0.000042378364,0.00004433728,0.000067311055],"domain_scores_gemma":[0.9998641,0.000017602557,0.000032287564,0.000021108226,0.000018564824,0.00004621461],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014581223,0.0005451143,0.00021538723,0.0003573336,0.00020224202,0.0002842479,0.00027559133,0.00027602076,0.0023637714],"category_scores_gemma":[0.000079332836,0.00016550894,0.00027192791,0.0002012408,0.00023866068,0.00026562533,0.00026980438,0.00084207486,0.0010986438],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013299899,0.000032075994,0.00008740156,0.000009337166,0.0000014242986,0.000035875273,0.000009375285,0.000016705317,0.9994061,0.000039446513,0.000021050622,0.00020819656],"study_design_scores_gemma":[0.000029245699,0.0003257795,0.0033322438,0.0000032150074,0.0000061496958,0.00017394451,0.00002669564,0.0006078111,0.9943393,0.00004650353,0.0011059802,0.0000030352173],"about_ca_topic_score_codex":0.00048055325,"about_ca_topic_score_gemma":0.00064233155,"teacher_disagreement_score":0.0023637714,"about_ca_system_score_codex":0.00032039144,"about_ca_system_score_gemma":0.00016070741,"threshold_uncertainty_score":0.007907629},"labels":[],"label_agreement":null},{"id":"W1807939285","doi":"10.1002/cncr.11644","title":"Use of tamoxifen in the treatment of malignant melanoma","year":2003,"lang":"en","type":"review","venue":"Cancer","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Tamoxifen; Oncology; Randomized controlled trial; Chemotherapy; Internal medicine; Regimen; Breast cancer; Cancer","score_opus":0.10515487838313409,"score_gpt":0.33695959819222127,"score_spread":0.23180471980908718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1807939285","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0033642997,0.99566156,0.000070069094,0.00049526716,0.00009668364,0.000023433326,0.00006058951,0.000003212701,0.00022485],"genre_scores_gemma":[0.14175294,0.8550822,0.0006859307,0.0014477216,0.0006102938,0.00013285843,0.00016362077,0.00000645572,0.00011792505],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99163604,0.0052424623,0.0015156278,0.00046022012,0.0010146828,0.00013098409],"domain_scores_gemma":[0.98326474,0.010972918,0.0047372747,0.00022209724,0.0006250156,0.0001779201],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009599769,0.0005963825,0.0033717009,0.0024309612,0.0002436711,0.0011612378,0.00082284457,0.0012729475,0.0016355071],"category_scores_gemma":[0.021434557,0.00045228263,0.005770283,0.002545995,0.00046069504,0.0006995065,0.00046879702,0.0012524364,0.00014568117],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015940767,0.00024875547,0.027340125,0.3978521,0.16585839,0.00053743686,0.00023436204,0.0020321282,0.0017905459,0.0008571591,0.00519895,0.38210922],"study_design_scores_gemma":[0.022736315,0.011358541,0.08631215,0.22305645,0.57258594,0.004011519,0.00041703825,0.0017428434,0.0029394235,0.0031109496,0.07157136,0.00015745954],"about_ca_topic_score_codex":0.0022242386,"about_ca_topic_score_gemma":0.0043416913,"teacher_disagreement_score":0.009599769,"about_ca_system_score_codex":0.0012541823,"about_ca_system_score_gemma":0.0015176573,"threshold_uncertainty_score":0.05076909},"labels":[],"label_agreement":null},{"id":"W1829588377","doi":"10.3389/fbioe.2015.00128","title":"Gαi3-Dependent Inhibition of JNK Activity on Intracellular Membranes","year":2015,"lang":"en","type":"article","venue":"Frontiers in Bioengineering and Biotechnology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Heart and Stroke Foundation","funders":"Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada","keywords":"Intracellular; Membrane; Chemistry; Cell biology; Biochemistry; Biology","score_opus":0.008850589721511273,"score_gpt":0.19570997048721087,"score_spread":0.18685938076569958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1829588377","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98581344,0.0029723395,0.0038458384,0.00040076236,0.00013946109,0.000070105314,0.0005992489,0.00012700439,0.0060317703],"genre_scores_gemma":[0.9916586,0.0021867207,0.002177888,0.00012922492,0.000019950308,0.00008316427,0.0006896681,0.000023021343,0.0030317775],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99983215,0.00002844525,0.000015198777,0.000024345645,0.00003642886,0.00006331254],"domain_scores_gemma":[0.9999373,0.000012744516,0.000015647272,0.000010993597,0.000008241822,0.000015178531],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017177568,0.0004834074,0.0002809241,0.00017182548,0.00022439989,0.0002832991,0.0003307327,0.00020877797,0.0016645701],"category_scores_gemma":[0.0001189258,0.00010483159,0.00040325295,0.00025041538,0.00030955454,0.00020447474,0.00027863865,0.00092881924,0.0005585462],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025389597,0.000042051128,0.00003938703,0.00005277513,0.0000052509918,0.000034243058,0.000013508415,0.000061389655,0.9980275,0.00018582426,0.00009074931,0.0011934421],"study_design_scores_gemma":[0.000029199136,0.00016274762,0.000973728,0.000005102704,0.000006415313,0.00008420285,0.000017520375,0.0004963905,0.99671966,0.000071583716,0.0014308739,0.0000025532859],"about_ca_topic_score_codex":0.0008174505,"about_ca_topic_score_gemma":0.001264696,"teacher_disagreement_score":0.0016645701,"about_ca_system_score_codex":0.00050559535,"about_ca_system_score_gemma":0.0003993231,"threshold_uncertainty_score":0.005568564},"labels":[],"label_agreement":null},{"id":"W1854678029","doi":"10.1177/1066896915592016","title":"Malignant Melanoma With Osteoclast-Like Differentiation","year":2015,"lang":"en","type":"article","venue":"International Journal of Surgical Pathology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Giant cell; Pathology; Biology; CD68; Osteoclast; Multinucleate; CD163; Giant Cell Tumors; Melanoma; Cellular differentiation; Immunohistochemistry; Macrophage; Cancer research; Medicine","score_opus":0.015585009566943664,"score_gpt":0.24835265553167113,"score_spread":0.23276764596472746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1854678029","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9801016,0.006486188,0.003738568,0.00027193068,0.000055194094,0.00012806567,0.00021637099,0.00016604569,0.00883617],"genre_scores_gemma":[0.9963238,0.00093813904,0.0014912778,0.000061036844,0.00003039711,0.000012688886,0.000083485174,0.000008277188,0.0010508387],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99984884,0.00001484318,0.000014589274,0.000029368706,0.000046243043,0.000046173463],"domain_scores_gemma":[0.99978215,0.000026931359,0.00007292481,0.000034313536,0.000028944427,0.00005470793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016139692,0.00043318464,0.00025709296,0.0004811092,0.00043569514,0.00031868028,0.00014409584,0.0006001522,0.0011679488],"category_scores_gemma":[0.00054050103,0.00021034849,0.00027221584,0.00037257536,0.00029860428,0.00020483418,0.00034118426,0.00033648236,0.00050082186],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005921038,0.00011040261,0.0750481,0.00054407096,0.000048905436,0.56855345,0.00042250872,0.00033338033,0.33077675,0.002744698,0.0012083787,0.019617299],"study_design_scores_gemma":[0.0000969076,0.00029193735,0.054947887,0.000059096743,0.00005928392,0.9068474,0.00022404353,0.0014514247,0.026019165,0.0013579592,0.00862326,0.000021654416],"about_ca_topic_score_codex":0.0010786466,"about_ca_topic_score_gemma":0.0024106475,"teacher_disagreement_score":0.0011679488,"about_ca_system_score_codex":0.00026537094,"about_ca_system_score_gemma":0.00022473284,"threshold_uncertainty_score":0.0039072037},"labels":[],"label_agreement":null},{"id":"W1886526654","doi":"10.4081/rt.2015.5698","title":"Amelanotic Melanoma Presenting with Plasmacytoid Morphology and <i>BRAF V600</i> Mutation","year":2015,"lang":"en","type":"article","venue":"Rare Tumors","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Melanoma; Pathology; Amelanotic melanoma; Malignancy; Vimentin; Plasmacytoid dendritic cell; Immunohistochemistry; Eosinophilic; Differential diagnosis; Dabrafenib; HMB-45; Cancer research; Metastatic melanoma; Antigen; Immunology; Vemurafenib","score_opus":0.013337626051979284,"score_gpt":0.22050675759663585,"score_spread":0.20716913154465658,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1886526654","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856801,0.0037233245,0.0020920045,0.00041795903,0.000093986986,0.0000672149,0.00013213398,0.00017630427,0.007617013],"genre_scores_gemma":[0.9975448,0.0009050699,0.0005345274,0.00012221975,0.00008621182,0.0000069157327,0.000043304157,0.00001544302,0.00074146496],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99983764,0.000013803988,0.000019629979,0.00003937666,0.00003080443,0.000058753198],"domain_scores_gemma":[0.99948764,0.00008902165,0.00022416179,0.000055099063,0.000034166533,0.000109881774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000103607716,0.0007870484,0.0004524478,0.0008292276,0.0006938008,0.00049375393,0.00032517128,0.0011885037,0.0015546697],"category_scores_gemma":[0.0007819005,0.00043555707,0.00034404552,0.0005896391,0.00040054866,0.00062406686,0.00049256673,0.0008658094,0.0007701577],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050205046,0.00002806451,0.02415961,0.000055381086,0.000010625545,0.9624522,0.0001102163,0.000048108854,0.009168244,0.00014152634,0.00029702234,0.0034788593],"study_design_scores_gemma":[0.000005376879,0.000039153736,0.008157189,0.0000076178544,0.000008153552,0.9898093,0.00006932661,0.00008049592,0.0010287297,0.00011124584,0.00067946536,0.0000039141623],"about_ca_topic_score_codex":0.00046337966,"about_ca_topic_score_gemma":0.00083518104,"teacher_disagreement_score":0.0015546697,"about_ca_system_score_codex":0.00018311586,"about_ca_system_score_gemma":0.00018959281,"threshold_uncertainty_score":0.005200863},"labels":[],"label_agreement":null},{"id":"W1887523814","doi":"10.1139/cjpp-2012-0258","title":"Involvement of mixed lineage kinase 3 in cancer","year":2012,"lang":"en","type":"review","venue":"Canadian Journal of Physiology and Pharmacology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of General Medical Sciences; National Institutes of Health","keywords":"MAP kinase kinase kinase; ASK1; Cyclin-dependent kinase 9; Mitogen-activated protein kinase kinase; Cyclin-dependent kinase 4; MAP2K7; Cell biology; MAPK/ERK pathway; Biology; Cyclin-dependent kinase 2; Cancer research; Protein kinase A; Signal transduction; Kinase; c-Raf; Mitogen-activated protein kinase","score_opus":0.05018907658177918,"score_gpt":0.3286900407316889,"score_spread":0.2785009641499097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1887523814","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020764068,0.99836737,0.000102002225,0.00020568028,0.00011721913,0.0000032903836,0.00001161488,0.000006282631,0.0009788559],"genre_scores_gemma":[0.0015567732,0.9969542,0.000191508,0.00014954852,0.00011880177,0.000005256172,0.000026960315,0.0000015491555,0.0009954734],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99991584,0.000012384215,0.000010910537,0.000016947439,0.000033766937,0.0000101007345],"domain_scores_gemma":[0.9999026,0.000028255123,0.00001681004,0.000003079173,0.00003114045,0.000018132736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031312052,0.0005734141,0.0007966517,0.0016240552,0.00025779865,0.0006473409,0.0005334665,0.00076059595,0.00270849],"category_scores_gemma":[0.000264123,0.00018349758,0.0002812382,0.0011569159,0.00034027034,0.0007926641,0.00048489572,0.0011856152,0.0020295978],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009730263,0.00006693969,0.00029086458,0.008787476,0.00005148858,0.00057298806,0.000051390467,0.00028846264,0.004427158,0.0033882102,0.022065708,0.95991194],"study_design_scores_gemma":[0.000020915306,0.000086578424,0.0010163254,0.0013414363,0.00006582866,0.0035591335,0.000045049925,0.000089297755,0.001527929,0.001812303,0.99041873,0.000016443686],"about_ca_topic_score_codex":0.0010802262,"about_ca_topic_score_gemma":0.0025572437,"teacher_disagreement_score":0.00270849,"about_ca_system_score_codex":0.0005939538,"about_ca_system_score_gemma":0.00074083207,"threshold_uncertainty_score":0.0090608},"labels":[],"label_agreement":null},{"id":"W1897773793","doi":"10.1002/cncr.28980","title":"Clinico‐morphological features of <scp>BRAF</scp> inhibition–induced proliferative skin lesions in cancer patients","year":2014,"lang":"en","type":"article","venue":"Cancer","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"","keywords":"Medicine; Keratoacanthoma; Dermatology; Biopsy; Dabrafenib; Cancer; Melanoma; Pathology; Skin biopsy; Hyperkeratosis; Skin cancer; Vemurafenib; Basal cell; Internal medicine; Metastatic melanoma","score_opus":0.023984977475985995,"score_gpt":0.2948491314484297,"score_spread":0.27086415397244373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1897773793","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993231,0.00018873894,0.000038247017,0.000008282019,0.0000014720761,0.000008343984,0.00005695491,0.000002498394,0.00037237984],"genre_scores_gemma":[0.99976534,0.00006471129,0.000047988564,0.000006354151,0.0000037518,0.0000047908243,0.000067707515,4.835124e-7,0.000038810434],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998299,0.000036880345,0.000019382453,0.000041697986,0.000035830606,0.00003620245],"domain_scores_gemma":[0.9994948,0.00010938812,0.00021575889,0.000018320117,0.0000446835,0.00011704146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020041704,0.00016983597,0.0001840894,0.00061614625,0.00034946576,0.00035792633,0.0001346404,0.00027845116,0.0010230518],"category_scores_gemma":[0.0008230328,0.0001274923,0.00018541058,0.0005908937,0.00020089457,0.00024203109,0.00016808732,0.00024293248,0.00016120113],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024725555,0.000050716204,0.9944575,0.000015986712,0.00002025842,0.00090047426,0.000059385042,0.000049986385,0.0015846246,0.000010615922,0.00007208665,0.0025311632],"study_design_scores_gemma":[0.0000068152517,0.00018007455,0.9941175,0.0000031027953,0.000018432143,0.004987284,0.00012374455,0.00014019475,0.0002688746,0.00001144551,0.0001393329,0.0000031391846],"about_ca_topic_score_codex":0.0009333782,"about_ca_topic_score_gemma":0.001288623,"teacher_disagreement_score":0.0010230518,"about_ca_system_score_codex":0.00023095684,"about_ca_system_score_gemma":0.00016834155,"threshold_uncertainty_score":0.003422439},"labels":[],"label_agreement":null},{"id":"W1907064528","doi":"10.18632/oncotarget.4854","title":"Loss of tumor suppressors KAI1 and p27 identifies a unique subgroup of primary melanoma patients with poor prognosis","year":2015,"lang":"en","type":"article","venue":"Oncotarget","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; Vancouver Coastal Health Research Institute; University of British Columbia; Vancouver Coastal Health","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Cancer Research Society; Canadian Dermatology Foundation","keywords":"Medicine; Melanoma; Subgroup analysis; Oncology; Survival analysis; Internal medicine; Cancer research; Meta-analysis","score_opus":0.008822382018303581,"score_gpt":0.20434775269320626,"score_spread":0.1955253706749027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1907064528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999255,0.00018931355,0.00009347386,0.000033774784,0.0000053649596,0.000006972594,0.000102923776,0.000004480459,0.0003085963],"genre_scores_gemma":[0.99960715,0.000053252712,0.00004556397,0.000014500147,0.000009338582,0.0000046633345,0.00016491202,0.0000024482604,0.00009835634],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99981457,0.000020094392,0.000020464395,0.000055461187,0.000029713567,0.00005972556],"domain_scores_gemma":[0.999549,0.00006309043,0.0001786324,0.000038256247,0.00005459345,0.000116513336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001838319,0.00031663186,0.0004876393,0.0009401526,0.0005156042,0.0006485123,0.00025822668,0.0003393922,0.0011645333],"category_scores_gemma":[0.00083716016,0.00016790247,0.00030173935,0.0008296244,0.00025406698,0.00033476367,0.0004884737,0.00035876178,0.0003007273],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031298437,0.000023827004,0.99152046,0.000011426611,0.00003977829,0.00040589122,0.00011833515,0.000049939,0.003919488,0.00003286794,0.0001755725,0.003389442],"study_design_scores_gemma":[0.0000167256,0.00012578307,0.9941953,0.000006557815,0.00007978775,0.0029549543,0.0005368131,0.00062617677,0.000600591,0.00024469572,0.00060444715,0.000008251805],"about_ca_topic_score_codex":0.0009364911,"about_ca_topic_score_gemma":0.0010750352,"teacher_disagreement_score":0.0011645333,"about_ca_system_score_codex":0.00019516321,"about_ca_system_score_gemma":0.000219958,"threshold_uncertainty_score":0.0038957},"labels":[],"label_agreement":null},{"id":"W1934017650","doi":"10.1111/pcmr.12423","title":"What's up <scp>NF</scp>1?","year":2015,"lang":"en","type":"letter","venue":"Pigment Cell & Melanoma Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Collège Lionel Groulx","funders":"","keywords":"Cell biology; Chemistry; Computational biology; Biology","score_opus":0.0715572374426514,"score_gpt":0.3262085447195253,"score_spread":0.2546513072768739,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1934017650","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009063618,0.0035817125,0.00013593338,0.9555349,0.027621437,0.000015671407,0.00005882243,0.0000559581,0.012089283],"genre_scores_gemma":[0.028477188,0.007705823,0.000804642,0.79054475,0.11102579,0.0000673266,0.0001520557,0.00007758369,0.06114486],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985582,0.00027086807,0.0001161344,0.0001410628,0.00065127946,0.00026239944],"domain_scores_gemma":[0.99560577,0.0013645502,0.00039221652,0.00022761922,0.0012804694,0.0011293018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016017015,0.00041255716,0.0008183167,0.00062140025,0.0032182105,0.002429878,0.00094343274,0.014732884,0.017450422],"category_scores_gemma":[0.012483843,0.0002912873,0.0006959116,0.0003204024,0.0021350628,0.001909169,0.0010133046,0.01187851,0.0084933145],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054169897,0.000020410787,0.00080366316,0.00007950409,0.000010907753,0.004318235,0.00007405298,0.00003047423,0.0006454776,0.002446071,0.96750915,0.024007875],"study_design_scores_gemma":[0.00006228212,0.000039713483,0.0009684563,0.00020563207,0.000022350663,0.0061478545,0.00030355286,0.00015531194,0.00069762813,0.010397455,0.98097056,0.000029195553],"about_ca_topic_score_codex":0.0031558825,"about_ca_topic_score_gemma":0.005911584,"teacher_disagreement_score":0.017450422,"about_ca_system_score_codex":0.003124572,"about_ca_system_score_gemma":0.0027233697,"threshold_uncertainty_score":0.058377504},"labels":[],"label_agreement":null},{"id":"W1937411730","doi":"10.1186/s12862-015-0450-x","title":"ERK1 and ERK2 present functional redundancy in tetrapods despite higher evolution rate of ERK1","year":2015,"lang":"en","type":"article","venue":"BMC Evolutionary Biology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bamfield Marine Sciences Centre; University of Alberta","funders":"Natural Sciences and Engineering Research Council of Canada; Association pour la Recherche sur le Cancer","keywords":"Biology; Gene isoform; Gene knockdown; Lizard; MAPK/ERK pathway; Gene; Cell biology; Genetics; Signal transduction; Zoology","score_opus":0.03876393534504356,"score_gpt":0.25976582142312726,"score_spread":0.2210018860780837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1937411730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973398,0.0007381471,0.00066020695,0.00004046495,0.000006200899,0.0000048062966,0.00040335208,0.000018486264,0.00078852393],"genre_scores_gemma":[0.9930434,0.0005186296,0.0020682071,0.00006233049,0.000010306904,0.000020233818,0.0020231998,0.00002322659,0.0022304535],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99992645,0.0000039183356,0.0000061991423,0.000036109057,0.000014887401,0.000012474909],"domain_scores_gemma":[0.99989414,0.000010317937,0.00004649034,0.00000913885,0.000014679649,0.000025250361],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007905688,0.00022636009,0.00015956724,0.00033807193,0.00027625664,0.00024593933,0.00015407646,0.00024279539,0.0011627991],"category_scores_gemma":[0.00009410362,0.00011988174,0.00024306895,0.00016396487,0.0001771629,0.00018333808,0.00023594609,0.00033952313,0.0003059008],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001980075,0.000010641943,0.009522888,0.0000882092,0.000018274312,0.00017580831,0.000078405,0.00006562431,0.9857431,0.00016439494,0.000056877398,0.0038776863],"study_design_scores_gemma":[0.000026452542,0.00036118313,0.7788395,0.00004356802,0.00011878555,0.004459619,0.00031878176,0.0015814989,0.20339884,0.00037018617,0.010455522,0.000026035184],"about_ca_topic_score_codex":0.00046436972,"about_ca_topic_score_gemma":0.00097624667,"teacher_disagreement_score":0.0011627991,"about_ca_system_score_codex":0.00017820724,"about_ca_system_score_gemma":0.00010656972,"threshold_uncertainty_score":0.0038899183},"labels":[],"label_agreement":null},{"id":"W1965097080","doi":"10.1158/1535-7163.mct-04-0297","title":"Raf kinase as a target for anticancer therapeutics","year":2005,"lang":"en","type":"review","venue":"Molecular Cancer Therapeutics","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":247,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"MAPK/ERK pathway; Receptor tyrosine kinase; Kinase; Tyrosine kinase; Cancer research; Signal transduction; Biology; Medicine; Cell biology","score_opus":0.055910670510332154,"score_gpt":0.36204434229330806,"score_spread":0.3061336717829759,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965097080","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003678441,0.99304765,0.00043412394,0.0005790961,0.0003264497,0.000012512174,0.000020745883,0.00002085433,0.005190707],"genre_scores_gemma":[0.0025842339,0.9908551,0.0006722364,0.00057366106,0.00026118252,0.000024246538,0.000043812375,0.000004314791,0.00498122],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99984896,0.000023264467,0.000013114961,0.000028604052,0.000069389454,0.000016613081],"domain_scores_gemma":[0.999913,0.00003211134,0.000012033165,0.0000048863767,0.00002675534,0.000011263908],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040862212,0.0007972847,0.0012011616,0.0018327003,0.00031401077,0.0007984849,0.0006603867,0.0012596041,0.0046002767],"category_scores_gemma":[0.00024167066,0.000309167,0.00040832974,0.0010389611,0.00045186337,0.0011572167,0.0005106917,0.002204577,0.0045649847],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010556317,0.00015580498,0.00015269019,0.0067802505,0.00006514633,0.00074951403,0.0000807338,0.0008187987,0.014444341,0.011973619,0.04159804,0.92307544],"study_design_scores_gemma":[0.00003225938,0.00010347248,0.00031731592,0.0007546347,0.000034033794,0.0016710596,0.000023977891,0.00014095467,0.0018600082,0.0023736928,0.99267596,0.000012691172],"about_ca_topic_score_codex":0.0005228252,"about_ca_topic_score_gemma":0.0013583713,"teacher_disagreement_score":0.0046002767,"about_ca_system_score_codex":0.00081028073,"about_ca_system_score_gemma":0.0005276783,"threshold_uncertainty_score":0.015389502},"labels":[],"label_agreement":null},{"id":"W1965301111","doi":"10.1517/14728222.2011.537656","title":"The promise and challenges of targeting RSK for the treatment of cancer","year":2010,"lang":"en","type":"article","venue":"Expert Opinion on Therapeutic Targets","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Kinase; Serine; Threonine; Protein-Serine-Threonine Kinases; Biology; Phosphorylation; Cancer; Cancer research; Ribosomal s6 kinase; Cell biology; Genetics; Protein kinase A; Protein kinase B","score_opus":0.03705129146068916,"score_gpt":0.315687583912151,"score_spread":0.2786362924514619,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965301111","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011075668,0.8701546,0.007837494,0.09535402,0.0037023397,0.000063792766,0.00018729079,0.00023091269,0.011393878],"genre_scores_gemma":[0.06686207,0.8885329,0.00819131,0.018623302,0.008026505,0.00016908326,0.0002700531,0.000059881713,0.009264973],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99950373,0.00014977848,0.00003607493,0.000069559464,0.00013950534,0.00010127795],"domain_scores_gemma":[0.9993617,0.00028979045,0.000059756836,0.000045136003,0.00015152855,0.000092010814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003011941,0.0007435516,0.0016587015,0.00054421584,0.00049864425,0.0017540376,0.00108071,0.0026248007,0.0051956913],"category_scores_gemma":[0.0012337074,0.00022976114,0.00091315917,0.00038494254,0.0014099039,0.0033344738,0.0007851278,0.0046686647,0.0030312552],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018855041,0.00050246075,0.0012110783,0.003880491,0.00029486808,0.0014651979,0.00023999448,0.003245353,0.048372183,0.039196815,0.09874678,0.8009592],"study_design_scores_gemma":[0.0008573178,0.002453142,0.0026122702,0.0011178398,0.00029956066,0.004553667,0.00069859554,0.0038561332,0.0140677905,0.067017026,0.9023269,0.00013986403],"about_ca_topic_score_codex":0.00053828006,"about_ca_topic_score_gemma":0.001712295,"teacher_disagreement_score":0.0051956913,"about_ca_system_score_codex":0.00083610625,"about_ca_system_score_gemma":0.001178053,"threshold_uncertainty_score":0.01738125},"labels":[],"label_agreement":null},{"id":"W1966894313","doi":"10.1038/sj.bjp.0706885","title":"Inhibitory effect of p38 mitogen‐activated protein kinase inhibitors on cytokine release from human macrophages","year":2006,"lang":"en","type":"article","venue":"British Journal of Pharmacology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Cytokine; p38 mitogen-activated protein kinases; Macrophage; Tumor necrosis factor alpha; MAPK/ERK pathway; Lipopolysaccharide; Immunology; Biology; Medicine; Pharmacology; Kinase; Cell biology; Biochemistry; In vitro","score_opus":0.004399314385054463,"score_gpt":0.23780940744026507,"score_spread":0.2334100930552106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966894313","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9835812,0.011607629,0.0014970119,0.00017780329,0.00008298751,0.00006909094,0.00026768394,0.00007270546,0.0026439382],"genre_scores_gemma":[0.98868805,0.006698824,0.0018954151,0.00011606109,0.00007659254,0.0001230592,0.00054735225,0.000014903043,0.00183971],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99983144,0.000041697138,0.000019138392,0.000019956691,0.000040835694,0.000046863694],"domain_scores_gemma":[0.9998989,0.000037603993,0.000022071024,0.000008833484,0.000017366952,0.000015196357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023659578,0.0005060681,0.0002770881,0.00018044234,0.0001604188,0.00021376909,0.00012540698,0.00014763827,0.0013335897],"category_scores_gemma":[0.00016442673,0.00011658212,0.00032795177,0.00010407212,0.000166951,0.00009482316,0.00017455049,0.00037825818,0.0004944123],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012054843,0.0002106955,0.00028931454,0.00014542918,0.000019383255,0.00009389963,0.00003059799,0.00014084396,0.989924,0.000028952776,0.00019310956,0.007718363],"study_design_scores_gemma":[0.00031520767,0.0035745413,0.0046037114,0.000019078305,0.000053995198,0.00045206177,0.000042990672,0.0008653617,0.98695,0.00004168961,0.0030741973,0.0000071781274],"about_ca_topic_score_codex":0.000288686,"about_ca_topic_score_gemma":0.00048418634,"teacher_disagreement_score":0.0013335897,"about_ca_system_score_codex":0.00014802268,"about_ca_system_score_gemma":0.0002600813,"threshold_uncertainty_score":0.0044612885},"labels":[],"label_agreement":null},{"id":"W1967035754","doi":"10.1038/ncomms1560","title":"P-Rex1 is required for efficient melanoblast migration and melanoma metastasis","year":2011,"lang":"en","type":"article","venue":"Nature Communications","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":180,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Biotechnology and Biological Sciences Research Council; Cancer Research UK; National Cancer Institute; National Institute of Environmental Health Sciences; Beatson Institute for Cancer Research; Medical Research Council","keywords":"Melanoma; Metastasis; Cancer research; Guanine nucleotide exchange factor; Biology; Cell migration; Cancer; Medicine; Cell culture; Cell biology; GTPase; Genetics","score_opus":0.035386974122916866,"score_gpt":0.28086873522232764,"score_spread":0.24548176109941078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967035754","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9826266,0.0031577877,0.007234189,0.00061825506,0.00013633155,0.000046027544,0.0011433047,0.0005150537,0.004522354],"genre_scores_gemma":[0.9885343,0.0005629316,0.0027751052,0.00009121579,0.00002272178,0.000028245235,0.0013072297,0.0001682004,0.006510133],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99972624,0.00003408209,0.000026539765,0.00007295384,0.00007791757,0.00006217536],"domain_scores_gemma":[0.9996867,0.00005429249,0.00010590278,0.00005996372,0.000022441083,0.00007073333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023735042,0.0005049163,0.00036229653,0.00033970765,0.0004470667,0.0007885161,0.00054735586,0.0007123068,0.0037444863],"category_scores_gemma":[0.00030158463,0.00044713955,0.00037957518,0.00014269081,0.0003930739,0.0004922433,0.00049868395,0.0012066098,0.0022895518],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000110650915,0.000017939594,0.00016834495,0.000022586817,0.000004506266,0.00017916725,0.0000066183834,0.00006985119,0.9983228,0.00019926457,0.00012335164,0.0007748456],"study_design_scores_gemma":[0.000022590932,0.00004313737,0.008214854,0.0000060547773,0.000007216131,0.0009520907,0.000030841915,0.0011817791,0.9858662,0.00013554766,0.0035331289,0.000006691292],"about_ca_topic_score_codex":0.0005769358,"about_ca_topic_score_gemma":0.0008954714,"teacher_disagreement_score":0.0037444863,"about_ca_system_score_codex":0.0005542659,"about_ca_system_score_gemma":0.00027041908,"threshold_uncertainty_score":0.012526572},"labels":[],"label_agreement":null},{"id":"W1967124582","doi":"10.1074/jbc.m109.083808","title":"Differential Regulation of Mitogen- and Stress-activated Protein Kinase-1 and -2 (MSK1 and MSK2) by CK2 following UV Radiation","year":2009,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; University of Toronto","funders":"Canadian Institutes of Health Research; Princess Margaret Hospital Foundation","keywords":"Kinase; Transactivation; p38 mitogen-activated protein kinases; Phosphorylation; Protein kinase A; Mitogen-activated protein kinase; Cell biology; Chemistry; MAPK/ERK pathway; Molecular biology; Biology; Biochemistry; Gene expression; Gene","score_opus":0.008920141025261714,"score_gpt":0.2205412476327776,"score_spread":0.2116211066075159,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967124582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978021,0.0010682055,0.00062213966,0.000018036035,0.000010777451,0.000008753237,0.00009240717,0.000018827388,0.00035869892],"genre_scores_gemma":[0.99786735,0.0005853637,0.00058515277,0.00001674558,0.000005899773,0.000021103773,0.00021176324,0.000007632689,0.00069894566],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99988985,0.000019326542,0.0000127177245,0.00003092708,0.000018368657,0.00002878776],"domain_scores_gemma":[0.9999205,0.000010480909,0.000032652773,0.000007210467,0.0000076246156,0.000021491669],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011768095,0.0003765388,0.00022007799,0.00014103012,0.00013664828,0.0002965822,0.00013950047,0.00016261371,0.0006737477],"category_scores_gemma":[0.000114815506,0.00012244517,0.00020496937,0.00010550097,0.00019950075,0.0002002772,0.00016620019,0.00025283845,0.0001758542],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016597759,0.000010578665,0.00019150638,0.000020805779,0.0000039317947,0.000024204392,0.000008794804,0.000047047215,0.9992016,0.000037833506,0.000009590124,0.00027819752],"study_design_scores_gemma":[0.00001375543,0.00011472477,0.0080999695,0.000004103443,0.000013325329,0.00020364496,0.000026745694,0.00076578057,0.98991805,0.00003790289,0.00079628243,0.0000056023964],"about_ca_topic_score_codex":0.00028890322,"about_ca_topic_score_gemma":0.00036735676,"teacher_disagreement_score":0.0006737477,"about_ca_system_score_codex":0.00027813754,"about_ca_system_score_gemma":0.000101374215,"threshold_uncertainty_score":0.00225389},"labels":[],"label_agreement":null},{"id":"W1967720595","doi":"10.1080/00498250110100720","title":"SB-242235, a selective inhibitor of p38 mitogenactivated protein kinase. I: Preclinical pharmacokinetics","year":2002,"lang":"en","type":"article","venue":"Xenobiotica","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Discovery Centre","funders":"","keywords":"Pharmacokinetics; Bioavailability; Pharmacology; Oral administration; Chemistry; Medicine","score_opus":0.023772721326301493,"score_gpt":0.2613691124793197,"score_spread":0.23759639115301823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967720595","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91648936,0.03214866,0.033392303,0.0008827233,0.00018998374,0.0017089441,0.0032109115,0.0014851445,0.010492045],"genre_scores_gemma":[0.9556869,0.014173332,0.016570628,0.00027318663,0.00013139666,0.0010811158,0.0039563635,0.00021673254,0.007910381],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997656,0.00008373755,0.000015256607,0.000040814703,0.00004716562,0.00004742162],"domain_scores_gemma":[0.9997578,0.00003890638,0.00006661854,0.000036656256,0.00003737831,0.000062585066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070921535,0.0009561399,0.0009075912,0.0004958416,0.00034492588,0.0005835145,0.00056917965,0.00051356695,0.0025964836],"category_scores_gemma":[0.0004631743,0.000334118,0.00045197536,0.0004071632,0.00036988957,0.00046367923,0.00017972494,0.0010827668,0.0014953221],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040291124,0.000997279,0.001013382,0.0005389162,0.0000862731,0.00035788992,0.00013391096,0.0012325548,0.94666684,0.0003867864,0.0012629092,0.04329423],"study_design_scores_gemma":[0.00074359414,0.030143378,0.009322415,0.000057848843,0.00038954892,0.0025512974,0.00012097773,0.0028624476,0.9265651,0.00029463926,0.026898231,0.00005047206],"about_ca_topic_score_codex":0.0021552767,"about_ca_topic_score_gemma":0.0032081143,"teacher_disagreement_score":0.0025964836,"about_ca_system_score_codex":0.0006745632,"about_ca_system_score_gemma":0.0010804202,"threshold_uncertainty_score":0.008686125},"labels":[],"label_agreement":null},{"id":"W1968020384","doi":"10.1074/jbc.m300847200","title":"Defining the Involvement of p38α MAPK in the Production of Anti- and Proinflammatory Cytokines Using an SB 203580-resistant Form of the Kinase","year":2003,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Proinflammatory cytokine; p38 mitogen-activated protein kinases; MAPK/ERK pathway; Cytokine; Tumor necrosis factor alpha; Biology; Cell biology; Kinase; Immunology; Inflammation","score_opus":0.0256076761310442,"score_gpt":0.24387958984122504,"score_spread":0.21827191371018084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968020384","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96491456,0.0042563486,0.026295839,0.0005697536,0.00021709206,0.00030946653,0.0006164954,0.00020371928,0.002616794],"genre_scores_gemma":[0.9501875,0.0055449368,0.036637925,0.00014026584,0.00007109011,0.0005096515,0.0014227,0.00006930146,0.005416682],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996458,0.000066880966,0.000057009278,0.00007410712,0.0000829519,0.00007332462],"domain_scores_gemma":[0.99985075,0.000026574959,0.000050507904,0.000027788397,0.00001855739,0.0000257692],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005286779,0.0014336755,0.00046622168,0.00034190042,0.00032016702,0.00045124354,0.000612728,0.00056344655,0.0020080425],"category_scores_gemma":[0.00022350693,0.0003948422,0.0005983599,0.00032210714,0.000547485,0.00052159425,0.00028782798,0.0017192544,0.0010111579],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014427044,0.00007074366,0.000048617007,0.000064628264,0.0000051004754,0.00005249037,0.000014955832,0.000036218684,0.9986625,0.00021100248,0.000024946494,0.00066445704],"study_design_scores_gemma":[0.00004590202,0.0005218677,0.0007718598,0.000009092177,0.000017961029,0.00053463766,0.000017760174,0.00063835946,0.9947619,0.000084186744,0.0025908775,0.000005644524],"about_ca_topic_score_codex":0.00041329776,"about_ca_topic_score_gemma":0.0004713019,"teacher_disagreement_score":0.0020080425,"about_ca_system_score_codex":0.00043667248,"about_ca_system_score_gemma":0.00045144488,"threshold_uncertainty_score":0.0067176223},"labels":[],"label_agreement":null},{"id":"W1968180930","doi":"10.1038/onc.2012.472","title":"RSK promotes G2 DNA damage checkpoint silencing and participates in melanoma chemoresistance","year":2012,"lang":"en","type":"article","venue":"Oncogene","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"Canadian Institutes of Health Research; Cancer Research Society; Dartmouth College","keywords":"Biology; DNA damage; Melanoma; MAPK/ERK pathway; CHEK1; Cancer research; Kinase; Protein kinase A; G2-M DNA damage checkpoint; Gene silencing; Ribosomal s6 kinase; Cell biology; Signal transduction; Cancer; DNA; Cell cycle checkpoint; Cell cycle; Genetics; PI3K/AKT/mTOR pathway; P70-S6 Kinase 1; Gene","score_opus":0.016287893807494763,"score_gpt":0.24759185748226198,"score_spread":0.23130396367476722,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968180930","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913926,0.0023639528,0.0021821347,0.00028865572,0.000053008458,0.00002072514,0.0003543801,0.00027109793,0.0030733338],"genre_scores_gemma":[0.9954763,0.0006498226,0.0004866378,0.000037866834,0.000009976624,0.000014549068,0.0002603504,0.000028275717,0.0030361945],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998939,0.000020619613,0.000009102082,0.00002009574,0.000022791139,0.00003350598],"domain_scores_gemma":[0.9999182,0.000007835967,0.00002927078,0.000016568205,0.000008177239,0.000019811607],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016331016,0.00043263254,0.00019620771,0.00034344665,0.00022544472,0.00047400227,0.00024194522,0.0002772805,0.0030606308],"category_scores_gemma":[0.00015952693,0.00020600899,0.0004020626,0.00016748896,0.00024397633,0.00024025154,0.0002916071,0.0006039085,0.0012783897],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004022076,0.000054061453,0.0007202624,0.000058611615,0.000013709346,0.000105908475,0.000010777391,0.00018032087,0.99554753,0.00058461004,0.00023547497,0.0020864403],"study_design_scores_gemma":[0.00006568225,0.00022148913,0.016881395,0.000010045456,0.00004079257,0.0006491521,0.000046221216,0.002287792,0.9740864,0.00034786528,0.005351594,0.000011670493],"about_ca_topic_score_codex":0.0004298888,"about_ca_topic_score_gemma":0.00055230386,"teacher_disagreement_score":0.0030606308,"about_ca_system_score_codex":0.0003432298,"about_ca_system_score_gemma":0.00022111322,"threshold_uncertainty_score":0.010238886},"labels":[],"label_agreement":null},{"id":"W1968772238","doi":"10.1016/j.cyto.2009.07.149","title":"Regulation of innate immunity and inflammation by the mitotic kinase PLK1 through inhibition of IKKε activity","year":2009,"lang":"en","type":"article","venue":"Cytokine","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Innate immune system; Inflammation; Kinase; PLK1; Immunity; Mitosis; Cell biology; IκB kinase; Biology; Immunology; Cancer research; NF-κB; Immune system; Apoptosis; Genetics; Cell cycle","score_opus":0.00971759616034402,"score_gpt":0.2276273172319846,"score_spread":0.21790972107164058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968772238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97664464,0.014031267,0.003896039,0.0007719736,0.0000995548,0.000025531996,0.00023881844,0.00010295745,0.004189198],"genre_scores_gemma":[0.9940666,0.0031199234,0.0009367436,0.000060356804,0.000020792695,0.000019383328,0.000110594054,0.000010198761,0.0016554632],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999941,0.00001009994,0.0000059096656,0.000010044553,0.000010977714,0.000021976952],"domain_scores_gemma":[0.99994075,0.0000097680995,0.00002628784,0.0000062811773,0.000004919144,0.000011984527],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001887161,0.0003459918,0.00014826508,0.00020550127,0.0002074093,0.00038621156,0.00023710639,0.00018103483,0.0014824288],"category_scores_gemma":[0.00016073805,0.00013629862,0.00015475246,0.000108004024,0.00023402601,0.0003665366,0.00023663616,0.00068927085,0.00030094525],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010945634,0.0000701232,0.00037819796,0.00016359269,0.0000118901235,0.000113785594,0.000022783111,0.00024149226,0.9888072,0.0012103656,0.00018192547,0.0077040363],"study_design_scores_gemma":[0.000106692176,0.00029025157,0.0027941703,0.000015963684,0.000019148803,0.0002826944,0.00003056887,0.00093655445,0.99117434,0.00045848126,0.0038853993,0.00000571035],"about_ca_topic_score_codex":0.0001591081,"about_ca_topic_score_gemma":0.00035992736,"teacher_disagreement_score":0.0014824288,"about_ca_system_score_codex":0.00041944196,"about_ca_system_score_gemma":0.00026569373,"threshold_uncertainty_score":0.0049592257},"labels":[],"label_agreement":null},{"id":"W1971380103","doi":"10.1186/1471-2407-10-515","title":"Antitumour activity of a potent MEK inhibitor RDEA119/BAY 869766 combined with rapamycin in human orthotopic primary pancreatic cancer xenografts","year":2010,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute","keywords":"Surgical oncology; Medicine; Pancreatic cancer; Cancer research; Discovery and development of mTOR inhibitors; Bay; Oncology; Pharmacology; Cancer; Internal medicine; Apoptosis; PI3K/AKT/mTOR pathway; Biology","score_opus":0.010368641812603016,"score_gpt":0.2491032595514882,"score_spread":0.23873461773888519,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971380103","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995207,0.0015454263,0.00090367236,0.00006931409,0.0000369377,0.000065102206,0.0006279352,0.00016590426,0.0013787233],"genre_scores_gemma":[0.99418736,0.0014536662,0.0015530182,0.000025141544,0.0000128525,0.00004175794,0.0010005032,0.00003102565,0.0016947035],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999012,0.00001703872,0.000009857587,0.000017183724,0.000027667389,0.000027045759],"domain_scores_gemma":[0.9999125,0.000016093181,0.000020363193,0.000013587404,0.000010024324,0.000027447259],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014404503,0.00047032023,0.00048367478,0.00036148526,0.00013993372,0.00027758148,0.00023907518,0.00019564353,0.0011696807],"category_scores_gemma":[0.00007982579,0.00017740141,0.00034496564,0.0003413925,0.00013302088,0.00014189641,0.0001264448,0.0007722246,0.00041388843],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011015215,0.00048538714,0.00026464742,0.00009373037,0.000025560315,0.000051378567,0.000020841737,0.0005972152,0.9922464,0.00003056524,0.00016708112,0.004915691],"study_design_scores_gemma":[0.00020991276,0.005883299,0.0046932613,0.000007139562,0.00006561619,0.0002077012,0.000017094706,0.0012006502,0.98638374,0.0000112982425,0.0013146438,0.000005672673],"about_ca_topic_score_codex":0.0014831722,"about_ca_topic_score_gemma":0.0023402816,"teacher_disagreement_score":0.0014831722,"about_ca_system_score_codex":0.00033076896,"about_ca_system_score_gemma":0.00034536395,"threshold_uncertainty_score":0.0039129853},"labels":[],"label_agreement":null},{"id":"W1972089204","doi":"10.1186/1755-8794-6-40","title":"Intratumoral genetic heterogeneity in metastatic melanoma is accompanied by variation in malignant behaviors","year":2013,"lang":"en","type":"article","venue":"BMC Medical Genomics","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Cancer Council Victoria; National Health and Medical Research Council; Natural Sciences and Engineering Research Council of Canada; Cure Cancer Australia Foundation; Cancer Australia; Melanoma Research Alliance","keywords":"Human genetics; Melanoma; Metastatic melanoma; Variation (astronomy); Biology; DNA microarray; Genetic variation; Cancer research; Oncology; Genetics; Internal medicine; Bioinformatics; Medicine; Gene; Gene expression","score_opus":0.014045152595532285,"score_gpt":0.2463499973945595,"score_spread":0.23230484479902722,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972089204","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982651,0.00025273944,0.0010096764,0.000014524203,0.0000015368563,0.00000682746,0.00012145772,0.000017497843,0.0003106952],"genre_scores_gemma":[0.9992274,0.000079316385,0.0003881118,0.00000777258,0.0000021418693,0.0000071537065,0.000113700895,0.000007196556,0.00016715658],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99985397,0.000019298386,0.000009680896,0.000052832245,0.000043946497,0.000020193913],"domain_scores_gemma":[0.9996797,0.00007138162,0.00013195215,0.000035667726,0.000039049388,0.000042321262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016623951,0.00013330072,0.00016302358,0.0005247824,0.00014797851,0.00022325922,0.00011310024,0.0002056069,0.00087316666],"category_scores_gemma":[0.00035854295,0.000115363575,0.000109104796,0.0002880303,0.00016721562,0.000115939125,0.00018847693,0.00022631825,0.00017063117],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013018918,0.000016212372,0.021950949,0.000023153538,0.000017762237,0.00016117633,0.00003931464,0.00013463758,0.97517246,0.00006918701,0.000027741908,0.0022571927],"study_design_scores_gemma":[0.000013676837,0.00038956187,0.75635964,0.000010103824,0.00007164169,0.0042736903,0.00012714686,0.0027825057,0.23408104,0.0005802094,0.001297827,0.000012981501],"about_ca_topic_score_codex":0.00035695534,"about_ca_topic_score_gemma":0.0005373529,"teacher_disagreement_score":0.00087316666,"about_ca_system_score_codex":0.00015541937,"about_ca_system_score_gemma":0.00008854602,"threshold_uncertainty_score":0.0029210448},"labels":[],"label_agreement":null},{"id":"W1973460380","doi":"10.1016/j.bbamcr.2006.11.001","title":"Atypical mitogen-activated protein kinases: Structure, regulation and functions","year":2006,"lang":"en","type":"review","venue":"Biochimica et Biophysica Acta (BBA) - Molecular Cell Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":299,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"National Cancer Institute; Canada Research Chairs","keywords":"MAPK7; MAPKAPK2; Mitogen-activated protein kinase; MAPK14; Kinase; MAP kinase kinase kinase; MAP2K7; c-Raf; Biology; Cell biology; ASK1; Protein-Serine-Threonine Kinases; p38 mitogen-activated protein kinases; Mitogen-activated protein kinase kinase; MAPK/ERK pathway; Protein kinase A; Cyclin-dependent kinase 2","score_opus":0.046034078759945224,"score_gpt":0.3393542111267232,"score_spread":0.293320132366778,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973460380","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022519597,0.9980878,0.00035341235,0.00018020745,0.00029657455,0.00000502477,0.000025766583,0.000013060932,0.00081293203],"genre_scores_gemma":[0.0010885155,0.99672663,0.0005178134,0.00014809088,0.0002950146,0.0000108891045,0.000065873945,0.0000018135722,0.0011452782],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99985635,0.00001360565,0.0000209132,0.00003009692,0.000061031795,0.000018052357],"domain_scores_gemma":[0.999782,0.00007165864,0.00003922456,0.00001120828,0.000063377505,0.00003245463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058556645,0.001296071,0.0015976044,0.0016134621,0.00033695504,0.0011178268,0.0013986137,0.0010766053,0.0021107853],"category_scores_gemma":[0.0005221743,0.0004079358,0.0003170744,0.0027065405,0.00068633165,0.0017264754,0.00057174196,0.0020111192,0.0029013474],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018910244,0.000068321235,0.00018125187,0.00752364,0.000051592528,0.00034043114,0.000052776337,0.00037119974,0.0077080033,0.0027113173,0.026887313,0.9539152],"study_design_scores_gemma":[0.000031008218,0.00005307631,0.00070602016,0.00055152643,0.000073485215,0.0016043815,0.000053066542,0.000082434264,0.0017286454,0.0016597876,0.99343914,0.000017408604],"about_ca_topic_score_codex":0.0007330899,"about_ca_topic_score_gemma":0.0017160214,"teacher_disagreement_score":0.0021107853,"about_ca_system_score_codex":0.000782212,"about_ca_system_score_gemma":0.0009632464,"threshold_uncertainty_score":0.007061243},"labels":[],"label_agreement":null},{"id":"W1974404622","doi":"10.2741/3086","title":"The Mnks: MAP kinase-interacting kinases (MAP kinase signal-integrating kinases)","year":2008,"lang":"en","type":"review","venue":"Frontiers in bioscience","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":198,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; Canadian Institutes of Health Research; European Commission","keywords":"Kinase; EIF4E; MAPK7; Mitogen-activated protein kinase; Cell biology; Translation (biology); Receptor tyrosine kinase; MAP2K7; Alternative splicing; Biology; Scaffold protein; MAPK14; Signal transduction; MAP kinase kinase kinase; Cyclin-dependent kinase 2; Biochemistry; Protein kinase A; Gene isoform; Gene; Messenger RNA","score_opus":0.02210076121847201,"score_gpt":0.2857966600787956,"score_spread":0.26369589886032363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974404622","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00030362414,0.9937171,0.00061466766,0.00024774298,0.00058655866,0.000011418837,0.000047116027,0.000053703097,0.0044180932],"genre_scores_gemma":[0.0022068133,0.9892347,0.0011384054,0.00029642627,0.00043297908,0.000024199662,0.00020860409,0.000007323317,0.00645061],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99987495,0.0000123867685,0.000017187815,0.000028223423,0.00005136117,0.000015900892],"domain_scores_gemma":[0.9998629,0.000028348144,0.000030120864,0.0000075407365,0.000039394672,0.00003158594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032377648,0.001515191,0.0010467457,0.0018690474,0.00026369878,0.0010271594,0.00095636444,0.00084649393,0.0034834624],"category_scores_gemma":[0.00027684832,0.00025128212,0.0002435575,0.002320824,0.0006819662,0.0017850905,0.0006306653,0.001690153,0.00950327],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000077836536,0.000058074027,0.00015353248,0.0035477316,0.000032063694,0.00019131003,0.000040777806,0.00030868614,0.0056323335,0.0037462222,0.03504142,0.9511701],"study_design_scores_gemma":[0.000010203418,0.000021828262,0.0002897267,0.00023406396,0.000011921988,0.00067256915,0.000017634833,0.000038244198,0.00074614293,0.0009140896,0.9970372,0.000006414499],"about_ca_topic_score_codex":0.0005154263,"about_ca_topic_score_gemma":0.0007126976,"teacher_disagreement_score":0.0034834624,"about_ca_system_score_codex":0.0006354628,"about_ca_system_score_gemma":0.0005904017,"threshold_uncertainty_score":0.011653364},"labels":[],"label_agreement":null},{"id":"W1974646396","doi":"10.1038/sj.onc.1210408","title":"KSR and CNK: two scaffolds regulating RAS-mediated RAF activation","year":2007,"lang":"en","type":"review","venue":"Oncogene","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":140,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal; Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Scaffold protein; Biology; Cell biology; MAPK/ERK pathway; Kinase; Protein kinase A; Enhancer; Signal transduction; Suppressor; Intracellular; Biochemistry; Transcription factor","score_opus":0.050090262301154785,"score_gpt":0.3462977213887031,"score_spread":0.2962074590875483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974646396","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00065750256,0.9948776,0.0010459045,0.0003991695,0.00036257872,0.000009531655,0.000041817468,0.00003700049,0.0025689248],"genre_scores_gemma":[0.002609752,0.99318564,0.00090591074,0.0002462801,0.0002053419,0.000017109189,0.00009212466,0.000004094755,0.002733625],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99986947,0.0000129384,0.000014948209,0.000027354932,0.000055811506,0.000019569125],"domain_scores_gemma":[0.99986744,0.00004280204,0.000028316712,0.0000062913755,0.000035611774,0.000019434101],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043752542,0.0013080586,0.0012712204,0.0013423503,0.00026399887,0.0013334239,0.0012595245,0.0012714433,0.0018975874],"category_scores_gemma":[0.00033146437,0.0003353319,0.00023850666,0.0016093848,0.00077220367,0.0014277542,0.0006168252,0.0018203581,0.0028697895],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018399979,0.000075886375,0.00015865419,0.0058196206,0.00005546319,0.0004790233,0.0000499621,0.0006746404,0.019019574,0.0070051393,0.02148629,0.9449917],"study_design_scores_gemma":[0.000037501784,0.00006554083,0.00073547784,0.00061692164,0.000073853524,0.0017155968,0.00006934688,0.00017714716,0.008690478,0.0029780548,0.984812,0.000027993594],"about_ca_topic_score_codex":0.00063204893,"about_ca_topic_score_gemma":0.0015882371,"teacher_disagreement_score":0.0018975874,"about_ca_system_score_codex":0.00094734464,"about_ca_system_score_gemma":0.0008506192,"threshold_uncertainty_score":0.0068734884},"labels":[],"label_agreement":null},{"id":"W1976276721","doi":"10.1074/jbc.m203428200","title":"K252a and CEP1347 Are Neuroprotective Compounds That Inhibit Mixed-lineage Kinase-3 and Induce Activation of Akt and ERK","year":2002,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Aegera Therapeutics (Canada); McGill University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Trk receptor; Protein kinase B; Neuroprotection; MAPK/ERK pathway; Tropomyosin receptor kinase A; Neurotrophin; Kinase; Neurotrophic factors; PI3K/AKT/mTOR pathway; Neurite; Cell biology; Signal transduction; Biology; Pharmacology; Chemistry; Biochemistry; Receptor; In vitro","score_opus":0.03488339305626582,"score_gpt":0.22233951177399183,"score_spread":0.18745611871772602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976276721","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9747353,0.009916097,0.0032283813,0.00024714114,0.00009361929,0.00018460443,0.001201531,0.00022129621,0.0101720765],"genre_scores_gemma":[0.9857531,0.004339473,0.0037554342,0.00009505876,0.000017780063,0.00011826576,0.0012683654,0.000017663835,0.00463486],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989426,0.000010924524,0.000008630068,0.000015896605,0.000034523593,0.00003571187],"domain_scores_gemma":[0.9999517,0.000003831988,0.000011160229,0.000004426697,0.00000582217,0.000023009017],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000066853834,0.00069963513,0.00028022382,0.00042403207,0.0002659208,0.00023445816,0.00028682893,0.0003394511,0.0027290948],"category_scores_gemma":[0.00007617443,0.00013363545,0.00031914853,0.00023084984,0.0002580273,0.00022115455,0.00014045695,0.00059805624,0.0007635927],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004192056,0.000121959216,0.00012072217,0.00011095916,0.000025092235,0.00014468408,0.000011199682,0.00018858236,0.99278754,0.00021527377,0.00027359818,0.005581261],"study_design_scores_gemma":[0.00014840801,0.0017422127,0.004598696,0.000011204331,0.000047396927,0.00074860285,0.000033379878,0.0004485254,0.9843762,0.00013576851,0.007692554,0.000016998007],"about_ca_topic_score_codex":0.0014246542,"about_ca_topic_score_gemma":0.003831246,"teacher_disagreement_score":0.0027290948,"about_ca_system_score_codex":0.00040958895,"about_ca_system_score_gemma":0.0002955976,"threshold_uncertainty_score":0.009129703},"labels":[],"label_agreement":null},{"id":"W1977852460","doi":"10.1073/pnas.0905139106","title":"Immune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survival","year":2009,"lang":"en","type":"article","venue":"Proceedings of the National Academy of Sciences","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":381,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Allergy and Infectious Diseases; York University; Emerald Foundation; National Cancer Institute; National Science Foundation; National Institutes of Health; Cancer Research Institute","keywords":"Melanoma; Immune system; Tumor-infiltrating lymphocytes; Gene expression profiling; Mitotic index; Oncology; Metastasis; Survival analysis; Medicine; Cancer research; Immunology; Internal medicine; Biology; Gene expression; Cancer; Immunotherapy; Gene; Mitosis","score_opus":0.0371327176768018,"score_gpt":0.3280444458010932,"score_spread":0.2909117281242914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977852460","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99803644,0.00064401043,0.0004263251,0.000058063793,0.0000076076367,0.000010098224,0.00012886059,0.000011590673,0.0006771202],"genre_scores_gemma":[0.99894184,0.00017701439,0.0004505493,0.000016851258,0.000014360477,0.000005939389,0.00016890219,0.0000018278187,0.00022265532],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998772,0.000044744098,0.000010626043,0.00002079193,0.000027366938,0.00001921601],"domain_scores_gemma":[0.9996389,0.00009546436,0.00010010058,0.000018877256,0.000038514227,0.00010809599],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049307925,0.00026453758,0.00027286442,0.0006383963,0.00013773565,0.0003733659,0.00009165756,0.00024636037,0.00087943353],"category_scores_gemma":[0.0008936678,0.00009189262,0.00018807662,0.00030743924,0.00014672648,0.00019071331,0.00021679093,0.0003284859,0.00029568523],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057087216,0.00004187336,0.9783981,0.000015481359,0.000033885288,0.000054548247,0.000022561791,0.00032817776,0.009076354,0.000019559597,0.00012886236,0.011309831],"study_design_scores_gemma":[0.000008148329,0.00018908853,0.99566585,0.000006447592,0.00004382874,0.00023253296,0.00003830186,0.0018530509,0.0015458963,0.000065874716,0.00034693335,0.0000040715286],"about_ca_topic_score_codex":0.00039192426,"about_ca_topic_score_gemma":0.0011881691,"teacher_disagreement_score":0.00087943353,"about_ca_system_score_codex":0.00012344848,"about_ca_system_score_gemma":0.00012442832,"threshold_uncertainty_score":0.0029420257},"labels":[],"label_agreement":null},{"id":"W1979285069","doi":"10.1016/j.cellsig.2010.06.002","title":"Effect of pressure overload-induced hypertrophy on the expression and localization of p38 MAP kinase isoforms in the mouse heart","year":2010,"lang":"en","type":"article","venue":"Cellular Signalling","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":52,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Heart Institute; Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"Pressure overload; Gene isoform; Biology; Kinase; p38 mitogen-activated protein kinases; Protein kinase A; Muscle hypertrophy; Messenger RNA; Cell biology; Molecular biology; Endocrinology; Biochemistry; Gene; Cardiac hypertrophy","score_opus":0.007122410124129442,"score_gpt":0.21061510997966376,"score_spread":0.2034926998555343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979285069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997106,0.0010200104,0.0006813943,0.00012984747,0.0000473723,0.000014075458,0.00023039302,0.000066660934,0.0007041651],"genre_scores_gemma":[0.9942854,0.0009217212,0.0008482358,0.00010894944,0.000048754115,0.00004577886,0.00032660356,0.000049606824,0.0033649807],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99972624,0.00005909504,0.000022877377,0.00004652675,0.000055786433,0.00008944461],"domain_scores_gemma":[0.99945825,0.00013107319,0.00012229488,0.00006127267,0.00002825663,0.00019892259],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034832355,0.00062508,0.0003524277,0.0005608353,0.00025444638,0.00032468836,0.0002668005,0.00044496957,0.0018532103],"category_scores_gemma":[0.00026660136,0.00043832295,0.000397616,0.00024152624,0.000742233,0.0005918361,0.00032959608,0.0012497867,0.00029200772],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012371669,0.00008496503,0.00023870384,0.0000290152,0.000008002813,0.00011001114,0.00003270519,0.000053040316,0.9972813,0.00008959508,0.000032728272,0.0008028096],"study_design_scores_gemma":[0.000102223006,0.0017252862,0.010043904,0.000010355721,0.000051474683,0.00020552559,0.00007865317,0.0005809025,0.9862883,0.00015669044,0.00074255816,0.000014140102],"about_ca_topic_score_codex":0.00048096981,"about_ca_topic_score_gemma":0.0007511027,"teacher_disagreement_score":0.0018532103,"about_ca_system_score_codex":0.00028417067,"about_ca_system_score_gemma":0.00023012397,"threshold_uncertainty_score":0.0061995387},"labels":[],"label_agreement":null},{"id":"W1980423706","doi":"10.1016/j.ddmec.2006.02.007","title":"New aspects of p38 mitogen activated protein kinase (MAPK) biology in lung inflammation","year":2006,"lang":"en","type":"review","venue":"Drug Discovery Today Disease Mechanisms","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Canadian Institutes of Health Research; Fondation pour la Recherche Médicale","keywords":"ARDS; Inflammation; COPD; Medicine; Lung; Cystic fibrosis; Asthma; p38 mitogen-activated protein kinases; Immunology; Protein kinase A; Mitogen-activated protein kinase; MAPK/ERK pathway; Kinase; Biology; Internal medicine; Cell biology","score_opus":0.010986314552388928,"score_gpt":0.2608264003285251,"score_spread":0.24984008577613617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980423706","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016082695,0.99722326,0.0004907755,0.0006858911,0.00046332652,0.0000046526297,0.000009893083,0.00001052323,0.0009509436],"genre_scores_gemma":[0.0007287967,0.99712557,0.0004917825,0.00030897238,0.00052423583,0.000006744414,0.000016498881,0.0000015017166,0.00079587393],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99980944,0.000028891493,0.000025288444,0.000028868633,0.00008529781,0.000022171447],"domain_scores_gemma":[0.9996841,0.00013976531,0.000030269955,0.0000113815195,0.00009297272,0.00004157133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011072034,0.0011360949,0.0016255705,0.0015244554,0.00043026006,0.0014982197,0.00131026,0.0016423763,0.002598218],"category_scores_gemma":[0.00064411334,0.0003929186,0.0004540382,0.0018982975,0.0009967809,0.002458793,0.0007210919,0.0028714982,0.0023720057],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002647558,0.00014261504,0.00019807862,0.00913192,0.00007061774,0.0007069163,0.0000785748,0.0005909445,0.009291611,0.0066495305,0.04694136,0.92593294],"study_design_scores_gemma":[0.00006118357,0.00012846582,0.0006341317,0.0010618056,0.00008057,0.0018144827,0.0000848174,0.00019177127,0.0016906745,0.0052362643,0.9889887,0.00002706716],"about_ca_topic_score_codex":0.00079438474,"about_ca_topic_score_gemma":0.0018048382,"teacher_disagreement_score":0.002598218,"about_ca_system_score_codex":0.0008885442,"about_ca_system_score_gemma":0.0010940431,"threshold_uncertainty_score":0.008691907},"labels":[],"label_agreement":null},{"id":"W1980968474","doi":"10.2174/1381612023393107","title":"Rationale for Ras and Raf-kinase as a Target for Cancer Therapeutics","year":2002,"lang":"en","type":"review","venue":"Current Pharmaceutical Design","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"MAPK/ERK pathway; Signal transduction; Anti-apoptotic Ras signalling cascade; Kinase; Protein kinase A; Cell biology; Biology; Cancer research; Signalling pathways; Computational biology","score_opus":0.2988579203544697,"score_gpt":0.45575172331042946,"score_spread":0.15689380295595978,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980968474","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007318607,0.9718488,0.0024643652,0.008576105,0.0028576877,0.00005595854,0.000044466855,0.00003866292,0.013382081],"genre_scores_gemma":[0.009279015,0.95654684,0.004007999,0.009058411,0.0020976162,0.00020627583,0.000053299274,0.00001599962,0.01873442],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995455,0.00012551618,0.0000435913,0.00010572214,0.00015053412,0.000029064302],"domain_scores_gemma":[0.99969554,0.0001357418,0.00003092647,0.00001776708,0.00008716206,0.000032927113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014477975,0.00096633617,0.001066158,0.0017254929,0.0005528234,0.0012329632,0.0011148985,0.0031008315,0.0038438363],"category_scores_gemma":[0.0008221317,0.0003579676,0.0005863841,0.0010085419,0.0021299964,0.0021374759,0.00092814385,0.0049440125,0.0035494787],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038503876,0.00032148065,0.0002761651,0.009537615,0.00009179884,0.0017499425,0.00028177077,0.0014542537,0.016431767,0.26325092,0.10195477,0.6042645],"study_design_scores_gemma":[0.00007893478,0.00013453484,0.00017854427,0.00092987734,0.000024545141,0.00096617185,0.00004029849,0.00015181176,0.0014063752,0.013986623,0.98208594,0.00001636332],"about_ca_topic_score_codex":0.00072228553,"about_ca_topic_score_gemma":0.001055183,"teacher_disagreement_score":0.0038438363,"about_ca_system_score_codex":0.001834623,"about_ca_system_score_gemma":0.0016056349,"threshold_uncertainty_score":0.013311148},"labels":[],"label_agreement":null},{"id":"W1981578404","doi":"10.1139/y10-088","title":"Regulation of stress-associated scaffold proteins JIP1 and JIP3 on the c-Jun NH<sub>2</sub>-terminal kinase in ischemia–reperfusion","year":2010,"lang":"en","type":"article","venue":"Canadian Journal of Physiology and Pharmacology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Manitoba; St. Boniface Hospital; Agriculture and Agri-Food Canada","funders":"","keywords":"c-jun; Kinase; Ischemia; Chemistry; Scaffold protein; Terminal (telecommunication); Medicine; Cell biology; Internal medicine; Biology; Biochemistry; Signal transduction; Transcription factor; Gene; Computer science; Telecommunications","score_opus":0.007175286583832578,"score_gpt":0.2225109878749075,"score_spread":0.21533570129107493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981578404","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970283,0.0011970095,0.0010254581,0.00006973493,0.000012716387,0.000008284153,0.00012049231,0.000030031604,0.0005080289],"genre_scores_gemma":[0.99729425,0.0006724353,0.0010105988,0.000032119613,0.0000047741637,0.000020811683,0.00019164222,0.000010400758,0.000763015],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99993193,0.000012769693,0.0000048862407,0.000012542831,0.000016140004,0.000021741336],"domain_scores_gemma":[0.9999323,0.000010651283,0.000020646457,0.000005965776,0.000011566756,0.000018913759],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000115317715,0.0003289651,0.00019006341,0.00013330759,0.00027782322,0.00022669336,0.000114990595,0.0002105688,0.000717312],"category_scores_gemma":[0.00009443073,0.00013482862,0.0002329972,0.00011393037,0.00025505747,0.00022941898,0.0001997579,0.0004429038,0.00022246958],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013723753,0.000009967455,0.00012615175,0.000019310535,0.0000023288342,0.000031271327,0.0000090092335,0.000033686843,0.9992084,0.00004136075,0.000021640783,0.00035966522],"study_design_scores_gemma":[0.000022697086,0.00011964352,0.014512185,0.0000039999823,0.000015860027,0.00017624488,0.00004194315,0.001284713,0.98288065,0.00006333595,0.0008732641,0.0000055916357],"about_ca_topic_score_codex":0.00073609734,"about_ca_topic_score_gemma":0.0012729779,"teacher_disagreement_score":0.00073609734,"about_ca_system_score_codex":0.0003804354,"about_ca_system_score_gemma":0.00025366497,"threshold_uncertainty_score":0.002760291},"labels":[],"label_agreement":null},{"id":"W1983590366","doi":"10.1371/journal.pgen.1004669","title":"Germline Mutations in MAP3K6 Are Associated with Familial Gastric Cancer","year":2014,"lang":"en","type":"article","venue":"PLoS Genetics","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Nova Scotia Health Authority; McGill University; Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal; Queen Elizabeth II Health Sciences Centre; University of British Columbia; Princess Margaret Cancer Centre; Izaak Walton Killam Health Centre; Dalhousie University","funders":"Fundação para a Ciência e a Tecnologia; Health Canada; IWK Health Centre; Dalhousie University; Genome Atlantic; Nova Scotia Health Research Foundation; Genome Canada","keywords":"Biology; Germline mutation; Cancer; Genetics; Germline; CDH1; Cancer research; Gene; Point mutation; Mutation; DNA methylation; Somatic cell; Gene expression; Cell; Cadherin","score_opus":0.014706777808818714,"score_gpt":0.22640668497869218,"score_spread":0.21169990716987347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983590366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960569,0.0010128438,0.00042757948,0.00012789914,0.000020134285,0.00002000227,0.00043639232,0.000059676804,0.0018385204],"genre_scores_gemma":[0.99876785,0.00027008244,0.00023226939,0.000039201255,0.0000150790065,0.000002891433,0.00020970286,0.0000065275135,0.00045630927],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997942,0.000016118984,0.000017041446,0.000047738984,0.00008292916,0.000041998086],"domain_scores_gemma":[0.9996847,0.00004297753,0.0001257792,0.0000184871,0.000051043797,0.000077142366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000109468914,0.00091159256,0.0003256506,0.0010583381,0.0009218169,0.0002948191,0.00040398823,0.000647117,0.0034053754],"category_scores_gemma":[0.0006701653,0.00023396019,0.0003696106,0.0011700835,0.0005462663,0.00010720799,0.00043249913,0.00043972806,0.00042975054],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010966547,0.00010805379,0.75199634,0.00021673265,0.00029540138,0.14727226,0.0010738426,0.0005036783,0.080548346,0.00039857952,0.001501798,0.014988291],"study_design_scores_gemma":[0.000031143958,0.000097033175,0.85946643,0.000038200975,0.00017325622,0.12775183,0.00035016728,0.0006813179,0.007995635,0.00022521487,0.0031697357,0.000020126738],"about_ca_topic_score_codex":0.019187814,"about_ca_topic_score_gemma":0.015523545,"teacher_disagreement_score":0.019187814,"about_ca_system_score_codex":0.0005763892,"about_ca_system_score_gemma":0.0003744699,"threshold_uncertainty_score":0.038152218},"labels":[],"label_agreement":null},{"id":"W1983833034","doi":"10.1038/sj.onc.1210414","title":"The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition","year":2007,"lang":"en","type":"review","venue":"Oncogene","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1104,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer","funders":"","keywords":"Biology; Cell biology; Cell cycle; MAPK/ERK pathway; Kinase; Protein kinase A; Cyclin-dependent kinase 2; Mitogen-activated protein kinase; Signal transduction; Cyclin; Cyclin-dependent kinase 4; Anti-apoptotic Ras signalling cascade; ASK1; Cell growth; Mitogen-Activated Protein Kinase 3; Mitogen-activated protein kinase kinase; Cell; Biochemistry","score_opus":0.04216164765805923,"score_gpt":0.32391421387175706,"score_spread":0.2817525662136978,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983833034","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014166086,0.99722606,0.0003419827,0.00037871837,0.00052537484,0.0000055908395,0.000018932891,0.000012158699,0.0013495128],"genre_scores_gemma":[0.000752504,0.99677426,0.00042054013,0.00024333983,0.00033783537,0.000007667034,0.00004249679,0.000002206792,0.0014191404],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99988115,0.000013063068,0.000014558987,0.000023923063,0.0000526743,0.00001464439],"domain_scores_gemma":[0.99980634,0.00005752266,0.00003233444,0.000006412293,0.00006737611,0.00003009134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005172964,0.0013353168,0.001311521,0.0014587784,0.00030345735,0.0010563019,0.0012052481,0.0012786984,0.0024091043],"category_scores_gemma":[0.00039859553,0.0003390591,0.000291524,0.0020778042,0.00062085025,0.0015120194,0.0006127558,0.0023945053,0.0031644457],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017949055,0.000080481484,0.00015086595,0.007593885,0.00006647881,0.000385312,0.000038485734,0.00057286787,0.0076527954,0.0053413403,0.051910788,0.9260273],"study_design_scores_gemma":[0.000025278907,0.000045846227,0.00043088823,0.0007211462,0.000057454883,0.00087563426,0.000028538958,0.00011283458,0.0014083605,0.0017677775,0.99451303,0.000013309365],"about_ca_topic_score_codex":0.00094724214,"about_ca_topic_score_gemma":0.0023743403,"teacher_disagreement_score":0.0024091043,"about_ca_system_score_codex":0.0009445853,"about_ca_system_score_gemma":0.0011553653,"threshold_uncertainty_score":0.008059263},"labels":[],"label_agreement":null},{"id":"W1983899867","doi":"10.1186/2044-5040-2-5","title":"A novel whole-cell lysate kinase assay identifies substrates of the p38 MAPK in differentiating myoblasts","year":2012,"lang":"en","type":"article","venue":"Skeletal Muscle","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; University of Toronto; Canada Research Chairs; Ottawa Hospital; University of Ottawa","funders":"Natural Sciences and Engineering Research Council of Canada; Multiple Sclerosis Society of Canada; Canadian Institutes of Health Research; Multiple Sclerosis Society; University of Ottawa","keywords":"Cell biology; Myogenesis; Kinase; Biology; p38 mitogen-activated protein kinases; Phosphorylation; Protein kinase A; Gene isoform; Myocyte; Biochemistry; Gene","score_opus":0.011473661751050239,"score_gpt":0.21856785002176285,"score_spread":0.2070941882707126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983899867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8763631,0.0047135325,0.11350152,0.00026304743,0.00015593668,0.00037882643,0.0018626442,0.00036901023,0.0023922767],"genre_scores_gemma":[0.72247267,0.0038303467,0.2585802,0.00022862219,0.00009661768,0.0007294835,0.007048208,0.00014429793,0.0068695694],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99941576,0.000105110084,0.00007280215,0.00016047379,0.00017262754,0.000073213494],"domain_scores_gemma":[0.9996184,0.00011199955,0.00007552051,0.00004514622,0.00007607073,0.000072879215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000495927,0.0012313202,0.0005199386,0.0008782943,0.00039093802,0.0004119883,0.00074053736,0.00060941296,0.0016228195],"category_scores_gemma":[0.00034359662,0.00041452213,0.0005569652,0.0004946942,0.00036011616,0.00042077573,0.00042228802,0.0010560851,0.0012064438],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003311918,0.000018039947,0.00013596368,0.000035626395,0.0000037977136,0.000014944707,0.0000068654676,0.00000996961,0.9992405,0.000016142492,0.000013238598,0.0004717829],"study_design_scores_gemma":[0.000028141372,0.00026827844,0.007719547,0.000010455523,0.000031826225,0.0006507153,0.000025897814,0.000989888,0.9889643,0.00007316636,0.0012275445,0.0000101235055],"about_ca_topic_score_codex":0.00020488848,"about_ca_topic_score_gemma":0.00068649225,"teacher_disagreement_score":0.0016228195,"about_ca_system_score_codex":0.0003054648,"about_ca_system_score_gemma":0.00033443415,"threshold_uncertainty_score":0.0054289103},"labels":[],"label_agreement":null},{"id":"W1984912202","doi":"10.1021/jm900607f","title":"Development of Novel, Highly Potent Inhibitors of V-RAF Murine Sarcoma Viral Oncogene Homologue B1 (BRAF): Increasing Cellular Potency through Optimization of a Distal Heteroaromatic Group","year":2010,"lang":"en","type":"article","venue":"Journal of Medicinal Chemistry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"Cancer Research UK; Wellcome Trust","keywords":"Chemistry; Viral Oncogene; Kinase; Potency; In vivo; Melanoma; Oncogene; In vitro; MAPK/ERK pathway; V600E; Mutant; Cancer research; Pharmacology; Biochemistry; Biology; Cell; Cell cycle","score_opus":0.008721649390379867,"score_gpt":0.22202580823373122,"score_spread":0.21330415884335135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984912202","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.975517,0.007350327,0.012202453,0.00015239428,0.00004281201,0.0002574742,0.0003503835,0.00014144958,0.0039857337],"genre_scores_gemma":[0.97628206,0.00690007,0.012492273,0.000104134,0.00003272537,0.00010964903,0.0005857281,0.000019645326,0.003473733],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999434,0.000007909081,0.000004671973,0.000011093761,0.000018593868,0.000014354888],"domain_scores_gemma":[0.9999577,0.0000049778973,0.000014170408,0.0000036715423,0.000007076084,0.000012454425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013083316,0.00034950208,0.00025338723,0.00016408341,0.000113674374,0.0001964801,0.0003268353,0.00024157898,0.0008617969],"category_scores_gemma":[0.00006874458,0.00012565032,0.00018106349,0.00013580563,0.00013464515,0.00019433894,0.00013931423,0.00045882084,0.00035367842],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000112877715,0.00015491777,0.0001371,0.00010460071,0.000010875254,0.00010945566,0.00003110126,0.0008877847,0.9887205,0.00025015327,0.000101219215,0.00937947],"study_design_scores_gemma":[0.00018663079,0.004012041,0.0021070202,0.000011630756,0.000053030475,0.00069812994,0.000021963559,0.0015271722,0.97987753,0.00009076447,0.011393681,0.000020324327],"about_ca_topic_score_codex":0.0003302053,"about_ca_topic_score_gemma":0.0014309325,"teacher_disagreement_score":0.0008617969,"about_ca_system_score_codex":0.00019156148,"about_ca_system_score_gemma":0.00022318303,"threshold_uncertainty_score":0.002883017},"labels":[],"label_agreement":null},{"id":"W1985309852","doi":"10.1038/nature08314","title":"A dimerization-dependent mechanism drives RAF catalytic activation","year":2009,"lang":"en","type":"article","venue":"Nature","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":498,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Institute for Research in Immunology and Cancer; Université de Montréal; Lunenfeld-Tanenbaum Research Institute","funders":"Canadian Institutes of Health Research","keywords":"MAPK/ERK pathway; Cell biology; Kinase; Receptor tyrosine kinase; Signal transduction; Tyrosine kinase; Chemistry; Phosphorylation; Biology","score_opus":0.0041429794295503005,"score_gpt":0.22573165602047665,"score_spread":0.22158867659092635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985309852","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96212167,0.0015054784,0.021866044,0.001820298,0.0002824027,0.000067931425,0.00035226182,0.0006011795,0.011382776],"genre_scores_gemma":[0.99345255,0.00022656059,0.0022926466,0.00014852411,0.000019657726,0.000015800159,0.00018407076,0.000019132309,0.0036410734],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999762,0.00002690086,0.000012641542,0.00007396492,0.000059170463,0.00006537056],"domain_scores_gemma":[0.9998337,0.000027950713,0.000022722295,0.000040431307,0.000020437461,0.000054689157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003069124,0.000247493,0.00015135479,0.0001632678,0.0005426345,0.0005361256,0.00031276816,0.0005647608,0.0026150106],"category_scores_gemma":[0.00030433928,0.00027560449,0.00030190425,0.00010488228,0.0002906132,0.00061482727,0.00044647898,0.0013095851,0.0013344447],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008938211,0.000035845995,0.00020239019,0.000021138834,0.000004762263,0.00012565627,0.00001996436,0.00009669765,0.9937937,0.0029706045,0.00045328218,0.0021866234],"study_design_scores_gemma":[0.000031790078,0.00006205342,0.002860916,0.0000049814143,0.000006437392,0.00086312427,0.00004772934,0.005516906,0.98338103,0.001593099,0.0056197383,0.000012251187],"about_ca_topic_score_codex":0.0002090391,"about_ca_topic_score_gemma":0.00040902727,"teacher_disagreement_score":0.0026150106,"about_ca_system_score_codex":0.00056232116,"about_ca_system_score_gemma":0.00023533632,"threshold_uncertainty_score":0.0087480545},"labels":[],"label_agreement":null},{"id":"W1985928174","doi":"10.1038/nature13121","title":"Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma","year":2014,"lang":"en","type":"article","venue":"Nature","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":910,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Melanoma; Cancer research; Vemurafenib; V600E; MEK inhibitor; Epidermal growth factor receptor; MAPK/ERK pathway; EGFR inhibitors; Selumetinib; Biology; Medicine; Oncogene; Kinase; Cancer; Mutation; Internal medicine; Cell cycle; Cell biology","score_opus":0.004767629710370415,"score_gpt":0.21284127473919862,"score_spread":0.2080736450288282,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985928174","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861487,0.0043317955,0.0027257586,0.00030095672,0.00006782478,0.000031349584,0.00016980509,0.00019709968,0.006026688],"genre_scores_gemma":[0.99670047,0.00094064284,0.00038363773,0.000038959384,0.000009349886,0.000008832747,0.00006327955,0.000011991051,0.0018428348],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998883,0.000019290585,0.0000067737055,0.000017893306,0.00003737246,0.000030272733],"domain_scores_gemma":[0.9999443,0.000009925309,0.000014044533,0.000017528864,0.0000061929663,0.000007947975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019566836,0.00018355656,0.00015759727,0.00017040013,0.000102033686,0.00026565496,0.00030436568,0.00025850305,0.0015904558],"category_scores_gemma":[0.00017605518,0.00014668227,0.00020288478,0.00009334991,0.00020599405,0.00021565602,0.00018512881,0.0006348835,0.00024303953],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018569715,0.000053258562,0.0003082888,0.00004710341,0.000009230526,0.0001306357,0.000014670653,0.0004856201,0.9889825,0.0015542837,0.00017450059,0.00805434],"study_design_scores_gemma":[0.000050084967,0.0008515451,0.00741089,0.000009434031,0.000018106526,0.0008915206,0.000030149025,0.0017910732,0.98226917,0.0010355795,0.0056326063,0.000009861421],"about_ca_topic_score_codex":0.00035675566,"about_ca_topic_score_gemma":0.000524926,"teacher_disagreement_score":0.0015904558,"about_ca_system_score_codex":0.0003666668,"about_ca_system_score_gemma":0.00014393147,"threshold_uncertainty_score":0.0053206086},"labels":[],"label_agreement":null},{"id":"W1986023178","doi":"10.1128/mcb.01701-13","title":"The Catalytic Activity of the Mitogen-Activated Protein Kinase Extracellular Signal-Regulated Kinase 3 Is Required To Sustain CD4<sup>+</sup> CD8<sup>+</sup> Thymocyte Survival","year":2014,"lang":"en","type":"article","venue":"Molecular and Cellular Biology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Biology; Protein kinase A; Kinase; Cell biology; Extracellular; CD8; Thymocyte; Mitogen-activated protein kinase; Molecular biology; Signal transduction; Biochemistry; Antigen; Immunology","score_opus":0.008446801582782744,"score_gpt":0.21464563771381237,"score_spread":0.20619883613102963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986023178","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99189395,0.0018802303,0.0037108716,0.00010117813,0.000021756952,0.000011004237,0.0002958594,0.00012375259,0.0019612657],"genre_scores_gemma":[0.99676967,0.0005323782,0.0011840357,0.000021674647,0.0000064138544,0.000010731631,0.00025933352,0.0000146523225,0.0012011776],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999923,0.000010140738,0.0000059023946,0.000013919214,0.0000207817,0.00002624101],"domain_scores_gemma":[0.99990547,0.0000090006915,0.000036741196,0.000010496165,0.000011680153,0.000026691401],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006662561,0.0003092858,0.00013960492,0.00012278353,0.00015041702,0.00026303937,0.00017041832,0.00018885291,0.00080317614],"category_scores_gemma":[0.00010370528,0.000097752025,0.00017395634,0.00008321045,0.00018186978,0.00016397939,0.00021885574,0.00040665315,0.0005306686],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051195762,0.000008857082,0.00025417822,0.000017830664,0.0000021600479,0.000062551335,0.0000035565315,0.000047128047,0.9983473,0.00011752807,0.000029605175,0.0010582086],"study_design_scores_gemma":[0.000013059546,0.00011874359,0.016267734,0.000009124436,0.000010960292,0.001134288,0.000036443933,0.0015396421,0.97650594,0.0003303385,0.004028703,0.000005040616],"about_ca_topic_score_codex":0.00023982309,"about_ca_topic_score_gemma":0.0002986524,"teacher_disagreement_score":0.00080317614,"about_ca_system_score_codex":0.00020163608,"about_ca_system_score_gemma":0.00017336188,"threshold_uncertainty_score":0.0026868582},"labels":[],"label_agreement":null},{"id":"W1986193009","doi":"10.1016/j.ejmech.2013.10.052","title":"Structural determinants for ERK5 (MAPK7) and leucine rich repeat kinase 2 activities of benzo[e]pyrimido-[5,4-b]diazepine-6(11H)-ones","year":2013,"lang":"en","type":"article","venue":"European Journal of Medicinal Chemistry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of General Medical Sciences; National Human Genome Research Institute; Wellcome Trust; Canadian Institutes of Health Research; Genome Canada; Novartis Foundation; Medical Research Council; Merck KGaA; National Cancer Institute; AbbVie; Life Technologies Corporation; GlaxoSmithKline; University of California; Pfizer","keywords":"Chemistry; Diazepine; Kinase; Stereochemistry; Biochemistry; Ring (chemistry); Organic chemistry","score_opus":0.011960522515839948,"score_gpt":0.23079304400279935,"score_spread":0.2188325214869594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986193009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99514055,0.0006460568,0.0012116726,0.00003727657,0.000005914559,0.000018188404,0.00009944857,0.000014996945,0.0028258313],"genre_scores_gemma":[0.9979792,0.00040472846,0.0006239243,0.000015657104,0.0000024940564,0.0000071228505,0.000113758855,0.0000024816927,0.00085064967],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999609,0.000008544732,0.0000024083163,0.0000054333254,0.000010846767,0.0000119435],"domain_scores_gemma":[0.9999646,0.000006326669,0.000012502004,0.0000017939259,0.000003791676,0.00001096527],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007727577,0.00014158648,0.000106426545,0.00006867918,0.00007163592,0.00010834412,0.0001326352,0.000089347464,0.0015812712],"category_scores_gemma":[0.000098305136,0.00008215331,0.00009911057,0.000045980927,0.00010926711,0.000104204584,0.000094557516,0.00016729871,0.00028950733],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035487124,0.00005199591,0.0003391085,0.000058786518,0.000005096477,0.00015108206,0.000021135957,0.00093238126,0.9948607,0.0006631003,0.000050821658,0.0025108978],"study_design_scores_gemma":[0.000101249316,0.001640005,0.008423888,0.000009509528,0.000020246365,0.0004970698,0.000040143434,0.002973453,0.98180836,0.00023615667,0.0042343265,0.00001558927],"about_ca_topic_score_codex":0.00035057394,"about_ca_topic_score_gemma":0.0005683175,"teacher_disagreement_score":0.0015812712,"about_ca_system_score_codex":0.00013508728,"about_ca_system_score_gemma":0.0001605668,"threshold_uncertainty_score":0.005289912},"labels":[],"label_agreement":null},{"id":"W1986408860","doi":"10.1309/5d7mm22davgdt1r8","title":"Loss of Raf-1 Kinase Inhibitor Protein Expression Is Associated With Tumor Progression and Metastasis in Colorectal Cancer","year":2007,"lang":"en","type":"article","venue":"American Journal of Clinical Pathology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":129,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Colorectal cancer; Cancer research; Metastasis; Protein kinase A; Regulator; Kinase; Medicine; Cancer; Biology; Oncology; Internal medicine; Gene; Cell biology; Genetics","score_opus":0.01717962287403015,"score_gpt":0.3443092566142189,"score_spread":0.3271296337401888,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986408860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999281,0.0004230608,0.000117001924,0.000022711705,0.0000013121837,0.000001815936,0.000039225808,0.000005456426,0.00010846532],"genre_scores_gemma":[0.9995579,0.00014275068,0.00010770044,0.000005667791,0.0000034456023,0.0000021896758,0.000077636854,0.000001291979,0.00010141111],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998838,0.000026539798,0.000012040596,0.000025465719,0.000030796393,0.00002146415],"domain_scores_gemma":[0.9995302,0.0000643251,0.0002602738,0.000025361385,0.000039691724,0.000080185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017138041,0.00017724045,0.00018040107,0.00060423266,0.00020653904,0.00019208567,0.0001215011,0.00020509702,0.00074135396],"category_scores_gemma":[0.0005250616,0.00014347436,0.000104785504,0.00033418107,0.0002537281,0.00015993342,0.00017069577,0.00030411943,0.00016602517],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018431804,0.000081697246,0.7276943,0.00009703009,0.00008009507,0.0012708778,0.00009829452,0.00021355224,0.2589059,0.000101735845,0.00022700346,0.009386398],"study_design_scores_gemma":[0.000011446018,0.00018275542,0.98765624,0.0000028095453,0.000027930528,0.003016372,0.00005570282,0.00040370022,0.008274675,0.000061789135,0.00030214348,0.000004480581],"about_ca_topic_score_codex":0.00049508765,"about_ca_topic_score_gemma":0.0006610627,"teacher_disagreement_score":0.00074135396,"about_ca_system_score_codex":0.000144212,"about_ca_system_score_gemma":0.00012918389,"threshold_uncertainty_score":0.0024800897},"labels":[],"label_agreement":null},{"id":"W1986449091","doi":"10.4161/cc.7.7.5610","title":"Mice lacking both mixed-lineage kinase genes Mlk1 and Mlk2 retain a wild type phenotype","year":2008,"lang":"en","type":"article","venue":"Cell Cycle","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"National Cancer Institute; Natural Sciences and Engineering Research Council of Canada; Terry Fox Foundation","keywords":"Biology; Kinase; MAP kinase kinase kinase; Mitogen-activated protein kinase kinase; Cell biology; ASK1; MAP2K7; Cyclin-dependent kinase 4; MAPK/ERK pathway; c-Raf; Protein kinase A; Mitogen-activated protein kinase; p38 mitogen-activated protein kinases; Cyclin-dependent kinase 2; Molecular biology","score_opus":0.012821056384172429,"score_gpt":0.21099434865069613,"score_spread":0.1981732922665237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986449091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98096734,0.0016142465,0.009795032,0.00019628933,0.00007837199,0.00006720179,0.0028830592,0.00087021955,0.0035281542],"genre_scores_gemma":[0.9604861,0.0014738867,0.008993283,0.00013569354,0.000044244818,0.00017409743,0.0033274693,0.0003685787,0.02499675],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996773,0.000029456814,0.000037279937,0.00010380177,0.00009808671,0.000054085314],"domain_scores_gemma":[0.99927336,0.00007164937,0.0003748427,0.00006318405,0.000029996127,0.00018691184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023300962,0.0013435956,0.00042281632,0.0011518357,0.00028391424,0.00048645173,0.0005716774,0.00084487296,0.0054463837],"category_scores_gemma":[0.00018783986,0.00040676945,0.00033939577,0.00035471117,0.0006052655,0.00045070337,0.00046302006,0.0011298292,0.0020013095],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001443484,0.000033201937,0.0003356558,0.00002920932,0.000010304567,0.00017819687,0.000019389101,0.000049520684,0.9974705,0.00034698026,0.00007467666,0.0013080433],"study_design_scores_gemma":[0.00013213829,0.00062956626,0.014739616,0.000030876912,0.000084219035,0.004597542,0.00008029326,0.0011780588,0.96614367,0.00044362014,0.011913761,0.000026700242],"about_ca_topic_score_codex":0.00025420243,"about_ca_topic_score_gemma":0.00072498224,"teacher_disagreement_score":0.0054463837,"about_ca_system_score_codex":0.00032863376,"about_ca_system_score_gemma":0.00022538003,"threshold_uncertainty_score":0.018219948},"labels":[],"label_agreement":null},{"id":"W1986755577","doi":"10.3892/or.2013.2645","title":"Expression and activation of P38 MAP kinase in invasive ductal breast cancers: Correlation with expression of the estrogen receptor, HER2 and downstream signaling phosphorylated proteins","year":2013,"lang":"en","type":"article","venue":"Oncology Reports","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre d'expertise et de recherche en infrastructures urbaines","funders":"Ligue Contre le Cancer","keywords":"Cancer research; MAPK/ERK pathway; Protein kinase B; Biology; Oncogene; Estrogen receptor; Carcinogenesis; Phosphorylation; Kinase; Breast cancer; Cell cycle; Cancer; Cell biology","score_opus":0.005277762863721409,"score_gpt":0.20642384940840297,"score_spread":0.20114608654468155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986755577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983746,0.00086350576,0.00032895195,0.00001984239,0.000003281204,0.0000044438993,0.00007950463,0.00000747304,0.00031835173],"genre_scores_gemma":[0.99799323,0.00062076724,0.00047792713,0.0000093760145,0.000008273561,0.000013763092,0.00013913919,0.0000022225938,0.0007352195],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99987507,0.000016474405,0.000012884269,0.000031163836,0.000040357932,0.000024042558],"domain_scores_gemma":[0.9997967,0.000040449937,0.00008636565,0.000010498677,0.00003121618,0.00003470541],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020039295,0.0001856678,0.0001159796,0.000440257,0.00014736233,0.00023377824,0.00008676475,0.00017158169,0.0010457798],"category_scores_gemma":[0.00031500147,0.00014603473,0.0000951291,0.00036906308,0.00019443697,0.0002207347,0.00016499731,0.00030173536,0.00025132764],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011812773,0.00021430812,0.385233,0.00021552476,0.000064526655,0.00097322435,0.000434709,0.00012845048,0.5931858,0.00009708174,0.00018464723,0.018087398],"study_design_scores_gemma":[0.000009615213,0.0004937082,0.9271414,0.000007639657,0.0000362847,0.004082144,0.00038093788,0.0004227647,0.066159956,0.0001501056,0.0011074328,0.000007811829],"about_ca_topic_score_codex":0.00020373658,"about_ca_topic_score_gemma":0.0003037789,"teacher_disagreement_score":0.0010457798,"about_ca_system_score_codex":0.00010312611,"about_ca_system_score_gemma":0.00010088759,"threshold_uncertainty_score":0.0034985542},"labels":[],"label_agreement":null},{"id":"W1987490886","doi":"10.1002/cyto.b.20092","title":"Pharmacodynamic monitoring of BAY 43‐9006 (Sorafenib) in phase I clinical trials involving solid tumor and AML/MDS patients, using flow cytometry to monitor activation of the ERK pathway in peripheral blood cells","year":2006,"lang":"en","type":"article","venue":"Cytometry Part B Clinical Cytometry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"National Cancer Institute; Case Western Reserve University; Northwestern University","keywords":"Flow cytometry; MAPK/ERK pathway; Medicine; Pharmacology; Cancer research; Kinase; Chemistry; Immunology; Biochemistry","score_opus":0.06673508492901951,"score_gpt":0.4023568401769417,"score_spread":0.33562175524792215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987490886","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905968,0.0029074894,0.0034675421,0.00024989338,0.000046539593,0.00064621103,0.0003815015,0.00015985823,0.001544284],"genre_scores_gemma":[0.9928267,0.00083997694,0.004116404,0.0001693645,0.000059177393,0.0005569207,0.00070142554,0.00002203996,0.00070797495],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99944896,0.00023523081,0.000047564423,0.00007734138,0.00013120378,0.000059730373],"domain_scores_gemma":[0.99951196,0.00012132446,0.00016074211,0.00002627356,0.000059673785,0.00011998042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015043067,0.00049160444,0.0008060214,0.00043619238,0.00020526607,0.00059243885,0.0002514204,0.00039762247,0.0010120354],"category_scores_gemma":[0.000960217,0.00018746287,0.00028091957,0.0003921141,0.00027596,0.00033990285,0.00015237088,0.0010430437,0.000346298],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.044306044,0.0047835717,0.028043235,0.00053384475,0.00033523448,0.00021999096,0.00026807966,0.0039977273,0.7306971,0.00031296795,0.0023968904,0.18410528],"study_design_scores_gemma":[0.021725176,0.16740035,0.14027214,0.000047937894,0.00078330573,0.0021623548,0.00008519074,0.015311461,0.63589644,0.00052023167,0.015702132,0.0000932483],"about_ca_topic_score_codex":0.00015540159,"about_ca_topic_score_gemma":0.00045788492,"teacher_disagreement_score":0.0015043067,"about_ca_system_score_codex":0.00047262775,"about_ca_system_score_gemma":0.0003828676,"threshold_uncertainty_score":0.007955611},"labels":[],"label_agreement":null},{"id":"W1989595797","doi":"10.1186/1479-5876-12-s1-p5","title":"Phase Ib/II, open-label, dose-escalation study of LGX818, an oral selective BRAF inhibitor, in combination with MEK162, an oral MEK1/2 inhibitor, in patients with BRAF V600-dependent advanced solid tumors: preliminary results","year":2014,"lang":"en","type":"article","venue":"Journal of Translational Medicine","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Maximum tolerated dose; Cancer research; Open label; Pharmacology; MEK inhibitor; Medicine; Oncology; Chemistry; Internal medicine; Adverse effect; MAPK/ERK pathway; Phosphorylation; Biochemistry","score_opus":0.018603095485809525,"score_gpt":0.30734829191077545,"score_spread":0.28874519642496593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989595797","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877701,0.002371532,0.0012984702,0.0008254146,0.00018588705,0.0027763855,0.001620094,0.00024280361,0.002909291],"genre_scores_gemma":[0.977805,0.0028498464,0.0040431465,0.0013698015,0.00019138465,0.003720156,0.0036708182,0.00012594237,0.0062238504],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9994691,0.00021958946,0.000019333134,0.0000875808,0.00005794846,0.00014647857],"domain_scores_gemma":[0.9992957,0.00009574929,0.00010286143,0.000066855886,0.00004216902,0.00039663934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014557733,0.0023829353,0.0024477595,0.0006098917,0.0006306806,0.0012724972,0.0012959926,0.0018516022,0.003520669],"category_scores_gemma":[0.0007800856,0.0009826795,0.0019282089,0.00047963613,0.0013400747,0.0011313597,0.00040485605,0.0056728953,0.0011400535],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.54108065,0.18402553,0.004097962,0.00092282565,0.0016687424,0.00040881033,0.00069010805,0.0060519604,0.10607531,0.0005910439,0.0111215105,0.14326562],"study_design_scores_gemma":[0.49712345,0.47697866,0.01002579,0.000045205186,0.00046618207,0.00036422093,0.00015357492,0.002300525,0.007842781,0.0005082951,0.0041299495,0.00006145197],"about_ca_topic_score_codex":0.0017477284,"about_ca_topic_score_gemma":0.0043170527,"teacher_disagreement_score":0.003520669,"about_ca_system_score_codex":0.0011724343,"about_ca_system_score_gemma":0.0016204756,"threshold_uncertainty_score":0.011777818},"labels":[],"label_agreement":null},{"id":"W1989836805","doi":"10.1016/j.cellsig.2003.07.003","title":"Calcium pyrophosphate dihydrate crystal associated induction of neutrophil activation and repression of TNF-α-induced apoptosis is mediated by the p38 MAP kinase","year":2003,"lang":"en","type":"article","venue":"Cellular Signalling","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"p38 mitogen-activated protein kinases; Psychological repression; Apoptosis; Chemistry; Cell biology; Tumor necrosis factor alpha; Kinase; Calcium; Protein kinase A; Biochemistry; Biology; Endocrinology; Gene expression; Gene","score_opus":0.017237330287706753,"score_gpt":0.2206108905607344,"score_spread":0.20337356027302766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989836805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989786,0.001765255,0.003976918,0.00023471132,0.00008305046,0.000070746784,0.00038648635,0.00012970819,0.0035669876],"genre_scores_gemma":[0.9934796,0.0006101333,0.0012414679,0.00003117155,0.000012921819,0.000043958004,0.00034640075,0.000009817136,0.0042245593],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998604,0.000018097835,0.000009566365,0.000016071113,0.000043214688,0.00005256401],"domain_scores_gemma":[0.9999201,0.000010516107,0.00002654866,0.000013420234,0.000010606675,0.000018746918],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009337965,0.00024246551,0.00020983587,0.00018527203,0.00017801329,0.00024304925,0.00017963345,0.00020198956,0.0023645621],"category_scores_gemma":[0.00013430559,0.00014449652,0.00025015505,0.00012634741,0.000206153,0.00016188133,0.00019343973,0.00054213824,0.00041245788],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005173777,0.000055215016,0.00010305975,0.000036144025,0.0000027040912,0.00009069466,0.000007178846,0.000038416452,0.997729,0.0001955115,0.000072806084,0.0011518326],"study_design_scores_gemma":[0.000034324577,0.00018360125,0.0022822157,0.000002398879,0.0000035441333,0.00014526631,0.000011832687,0.0002537058,0.99597114,0.000051731873,0.0010578897,0.0000023400105],"about_ca_topic_score_codex":0.0008754514,"about_ca_topic_score_gemma":0.0016960711,"teacher_disagreement_score":0.0023645621,"about_ca_system_score_codex":0.00041474824,"about_ca_system_score_gemma":0.00036791735,"threshold_uncertainty_score":0.007910311},"labels":[],"label_agreement":null},{"id":"W1989841664","doi":"10.1074/jbc.m709682200","title":"Determinants That Control the Distinct Subcellular Localization of p38α-PRAK and p38β-PRAK Complexes","year":2008,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Project 211; Canadian Institutes of Health Research; National Natural Science Foundation of China","keywords":"Subcellular localization; Nuclear localization sequence; p38 mitogen-activated protein kinases; Biology; Protein kinase A; Cell biology; Kinase; Biochemistry; Nucleus; Cytoplasm","score_opus":0.027114566436126145,"score_gpt":0.23462396677771138,"score_spread":0.20750940034158524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989841664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930561,0.00081149285,0.004349959,0.000053701275,0.000030073164,0.00004095852,0.00017010528,0.0000644521,0.0014232041],"genre_scores_gemma":[0.99487984,0.00037468458,0.002875154,0.00004815725,0.000010554206,0.000034192464,0.00041133122,0.00004971522,0.0013163628],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997706,0.00003921801,0.00002777316,0.000061123596,0.000047258785,0.000053948123],"domain_scores_gemma":[0.9995883,0.00006893445,0.00015566727,0.00003926089,0.00003309319,0.00011471072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017067477,0.00045346032,0.00019793058,0.00018096199,0.00013413832,0.00033258685,0.00021088708,0.00019710326,0.0018420016],"category_scores_gemma":[0.0003126686,0.00022431367,0.00025635987,0.00012650799,0.00033017507,0.0003092675,0.00028297704,0.00065278605,0.0009777597],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052459487,0.000015972453,0.00018644372,0.000014610925,0.0000024118706,0.000038852482,0.000013573031,0.000029305194,0.9989862,0.00012337771,0.000012852869,0.0005239147],"study_design_scores_gemma":[0.000031752115,0.00015707884,0.012775103,0.000011074755,0.000021547225,0.0006067739,0.000060536473,0.0013502993,0.9827204,0.00018025174,0.0020757772,0.0000095290525],"about_ca_topic_score_codex":0.0002638776,"about_ca_topic_score_gemma":0.0002805475,"teacher_disagreement_score":0.0018420016,"about_ca_system_score_codex":0.00035557096,"about_ca_system_score_gemma":0.00016158355,"threshold_uncertainty_score":0.006162107},"labels":[],"label_agreement":null},{"id":"W1989876648","doi":"10.1038/sj.emboj.7600489","title":"Activation of MK5/PRAK by the atypical MAP kinase ERK3 defines a novel signal transduction pathway","year":2004,"lang":"en","type":"article","venue":"The EMBO Journal","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":138,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"Canadian Institutes of Health Research; Cancer Research UK; University of Dundee","keywords":"Biology; Signal transduction; Kinase; Cell biology; Genetics; Transduction (biophysics); Computational biology; Biochemistry","score_opus":0.013641739331838038,"score_gpt":0.22117470917641413,"score_spread":0.2075329698445761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989876648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98211896,0.0028358703,0.009564772,0.00016704602,0.000034316192,0.000022915825,0.00030179406,0.00006540724,0.004888952],"genre_scores_gemma":[0.992597,0.0008575615,0.0041946624,0.00006329524,0.000011364348,0.000013757592,0.0004242384,0.000009289307,0.0018288355],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998609,0.000016921605,0.000007914872,0.00002348109,0.000039518847,0.00005126106],"domain_scores_gemma":[0.9999471,0.000004920845,0.000015544265,0.0000070893966,0.000009708963,0.000015720776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013552143,0.0003259258,0.0001554969,0.00016032768,0.0002287157,0.00060476933,0.0002960827,0.00025785272,0.0008612071],"category_scores_gemma":[0.00009413539,0.00017810531,0.00029742517,0.00012559353,0.00020852093,0.0005119048,0.0004288439,0.00058198656,0.00058388506],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001082337,0.000009613196,0.0003001853,0.000025440644,0.0000034169366,0.00010434145,0.0000149004745,0.000055814973,0.99683326,0.0011175048,0.00003554182,0.001391632],"study_design_scores_gemma":[0.00003209715,0.00020708806,0.020706058,0.0000174673,0.000026724498,0.0017624574,0.00011795878,0.0026265425,0.9659282,0.0015727386,0.0069833766,0.000019389769],"about_ca_topic_score_codex":0.00035793742,"about_ca_topic_score_gemma":0.0006811039,"teacher_disagreement_score":0.0008612071,"about_ca_system_score_codex":0.00047898092,"about_ca_system_score_gemma":0.00019679191,"threshold_uncertainty_score":0.0034753084},"labels":[],"label_agreement":null},{"id":"W1990899207","doi":"10.1016/j.bmc.2014.06.027","title":"Discovery of inhibitors of the mitotic kinase TTK based on N-(3-(3-sulfamoylphenyl)-1H-indazol-5-yl)-acetamides and carboxamides","year":2014,"lang":"en","type":"article","venue":"Bioorganic & Medicinal Chemistry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; University Health Network","funders":"Argonne National Laboratory; Shionogi","keywords":"Chemistry; Kinase; Mitosis; Stereochemistry; Pharmacology; Biochemistry; Cell biology","score_opus":0.005042545180360394,"score_gpt":0.18944833312156176,"score_spread":0.18440578794120135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990899207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9432535,0.020678515,0.01584073,0.00053096603,0.00026945048,0.00056463445,0.00066620286,0.0005401608,0.017655836],"genre_scores_gemma":[0.97531575,0.012146411,0.0051647187,0.00021995137,0.00005770425,0.00019106061,0.00065892906,0.000030898733,0.00621453],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99993336,0.0000094510515,0.0000043207265,0.000009913973,0.000016235152,0.000026795105],"domain_scores_gemma":[0.99993944,0.000010100973,0.000015991569,0.0000035801309,0.000011107362,0.000019774314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022727101,0.0005650535,0.00033586734,0.0003481275,0.00014404337,0.00030535215,0.0004209364,0.00025523725,0.0012282003],"category_scores_gemma":[0.0001885492,0.00024266998,0.00029072657,0.00016663769,0.00016713991,0.00025359195,0.00019673957,0.00063420134,0.00035186217],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008818494,0.00041911256,0.0004922043,0.0002737304,0.000061400475,0.0004182212,0.00008991599,0.0027580366,0.94554704,0.0025116866,0.0013224101,0.045224305],"study_design_scores_gemma":[0.0015874023,0.0068551777,0.0052861306,0.00008871877,0.00019080589,0.0011955956,0.000049734645,0.009409066,0.9387915,0.00059633586,0.035891924,0.000057562287],"about_ca_topic_score_codex":0.00088968145,"about_ca_topic_score_gemma":0.0024109695,"teacher_disagreement_score":0.0012282003,"about_ca_system_score_codex":0.00041005015,"about_ca_system_score_gemma":0.00027825186,"threshold_uncertainty_score":0.0041087866},"labels":[],"label_agreement":null},{"id":"W1991605733","doi":"10.1016/s0006-291x(02)02562-7","title":"Activation of p38 MAPK induces cell cycle arrest via inhibition of Raf/ERK pathway during muscle differentiation","year":2002,"lang":"en","type":"article","venue":"Biochemical and Biophysical Research Communications","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":84,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Toronto","keywords":"Myogenesis; MAPK/ERK pathway; Cell biology; p38 mitogen-activated protein kinases; Cell cycle; Cellular differentiation; Cell cycle checkpoint; Cell growth; Chemistry; Myocyte; Biology; Cell; Signal transduction; Biochemistry","score_opus":0.04357955398602212,"score_gpt":0.28487098288375967,"score_spread":0.24129142889773755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991605733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933662,0.0013153054,0.0018705806,0.00014062313,0.000041333584,0.000039269147,0.00027008462,0.00006679583,0.0028898444],"genre_scores_gemma":[0.9944372,0.0008177485,0.0011109496,0.000046020356,0.000016129203,0.000071036884,0.00037242734,0.000013557382,0.0031149536],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998636,0.000019174486,0.000010082105,0.000015465486,0.000022123984,0.000069385846],"domain_scores_gemma":[0.9999174,0.00002130685,0.000015019004,0.00001110858,0.0000097054535,0.000025515217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016810624,0.0003236771,0.00020199822,0.0002655795,0.00030772047,0.00022962292,0.00026172952,0.00018866843,0.0015186078],"category_scores_gemma":[0.00012580845,0.00022418005,0.00031265398,0.00019382244,0.00019595065,0.00022945201,0.00024507,0.00074012956,0.0005079168],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034428405,0.000047609963,0.000086822474,0.000030466921,0.000003947383,0.000059981794,0.00001557737,0.000046370365,0.9982634,0.00016984204,0.00006618043,0.0008655268],"study_design_scores_gemma":[0.00003156759,0.00021580169,0.0020232308,0.0000036994472,0.000008270843,0.000090526504,0.000016587079,0.0004448277,0.9958507,0.00004707062,0.0012654101,0.0000022511138],"about_ca_topic_score_codex":0.00089936843,"about_ca_topic_score_gemma":0.0018747885,"teacher_disagreement_score":0.0015186078,"about_ca_system_score_codex":0.00036505106,"about_ca_system_score_gemma":0.00031310917,"threshold_uncertainty_score":0.005080223},"labels":[],"label_agreement":null},{"id":"W1993341051","doi":"10.1517/13543776.12.12.1795","title":"Developments in mitogen-induced extracellular kinase 1 inhibitors and their use in the treatment of disease","year":2002,"lang":"en","type":"article","venue":"Expert Opinion on Therapeutic Patents","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University; St. Joseph's Hospital; University of Toronto","funders":"","keywords":"MAPK/ERK pathway; Kinase; Signal transduction; Cancer research; Extracellular; Protein kinase A; Mitogen-activated protein kinase; Immune system; ASK1; Biology; Cell biology; Medicine; Immunology; Mitogen-activated protein kinase kinase","score_opus":0.08536307861861339,"score_gpt":0.27448759424772895,"score_spread":0.18912451562911556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993341051","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014300221,0.94331086,0.007727202,0.008023686,0.0014236999,0.00010466212,0.00009344928,0.000103040955,0.024913149],"genre_scores_gemma":[0.08469233,0.8829606,0.011015098,0.004334831,0.003059758,0.00019634052,0.00021288959,0.000031885706,0.013496347],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99973875,0.00008220606,0.000020197516,0.000035733636,0.00008392109,0.0000392901],"domain_scores_gemma":[0.9997248,0.00013904498,0.000040368188,0.000014062248,0.000050313338,0.000031382697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011941828,0.00061758194,0.00083230063,0.00094062736,0.00025863913,0.000806969,0.00060291355,0.0012507912,0.0035570087],"category_scores_gemma":[0.00050958036,0.00019366949,0.00044376912,0.0006286956,0.00057464046,0.0009399636,0.00039033752,0.0019682467,0.0017337252],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008208301,0.0006001319,0.000485331,0.002344545,0.000081732855,0.0012457658,0.00013953344,0.00085457246,0.054280914,0.016967217,0.014295707,0.90788376],"study_design_scores_gemma":[0.00076100783,0.0027133792,0.0026322324,0.0004896488,0.0001466248,0.005042769,0.00007140132,0.0008878004,0.030434951,0.008049482,0.9487237,0.000047137342],"about_ca_topic_score_codex":0.00037868755,"about_ca_topic_score_gemma":0.0009935867,"teacher_disagreement_score":0.0035570087,"about_ca_system_score_codex":0.00051016745,"about_ca_system_score_gemma":0.0004758575,"threshold_uncertainty_score":0.011899352},"labels":[],"label_agreement":null},{"id":"W1993628564","doi":"10.1074/jbc.m508356200","title":"Features of the Catalytic Domains and C Termini of the MAPK Signal-integrating Kinases Mnk1 and Mnk2 Determine Their Differing Activities and Regulatory Properties","year":2005,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Kinase; MAPK/ERK pathway; Computational biology; Cell biology; Biology","score_opus":0.013640276647355879,"score_gpt":0.20152278505922486,"score_spread":0.187882508411869,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993628564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966118,0.0007610457,0.0019851883,0.00002894298,0.000005935665,0.000007923376,0.00013674598,0.00001918133,0.00044311103],"genre_scores_gemma":[0.99678963,0.00024535484,0.0018226549,0.000019938183,0.0000049082128,0.000015913489,0.00052197604,0.00001331454,0.00056625524],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99979323,0.000024521692,0.000022640652,0.00005644711,0.000057616064,0.00004558219],"domain_scores_gemma":[0.99973434,0.00005036432,0.00008474921,0.000031807787,0.000026125075,0.00007265283],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020124331,0.00034221646,0.00018857598,0.00014115822,0.00011627437,0.00043477057,0.00022072546,0.0002239049,0.0005280408],"category_scores_gemma":[0.00036033697,0.0001736981,0.00025497068,0.00011532706,0.0002257284,0.00026785975,0.00021602315,0.00049339165,0.00034397043],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009776678,0.000010406808,0.0008811585,0.000016494132,0.0000031382424,0.000023227181,0.0000073129336,0.00006350307,0.99831414,0.00004817923,0.0000062145673,0.00052846194],"study_design_scores_gemma":[0.000017492162,0.0001239326,0.05298031,0.0000055508785,0.000023732255,0.0007713382,0.00003991209,0.0016744477,0.9427451,0.000093627496,0.0015158026,0.000008754037],"about_ca_topic_score_codex":0.00027354428,"about_ca_topic_score_gemma":0.00027905472,"teacher_disagreement_score":0.0005280408,"about_ca_system_score_codex":0.00024288753,"about_ca_system_score_gemma":0.00016436748,"threshold_uncertainty_score":0.0017664433},"labels":[],"label_agreement":null},{"id":"W1995930415","doi":"10.1038/oncsis.2012.11","title":"Constitutive activation of breast tumor kinase accelerates cell migration and tumor growth in vivo","year":2012,"lang":"en","type":"article","venue":"Oncogenesis","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"Canadian Institutes of Health Research","keywords":"Cancer research; Tyrosine kinase; Kinase; Cell growth; Metastasis; Proto-oncogene tyrosine-protein kinase Src; Chemistry; Cancer; Biology; Signal transduction; Internal medicine; Medicine; Cell biology; Biochemistry","score_opus":0.009962973943617767,"score_gpt":0.21883716067176134,"score_spread":0.20887418672814356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995930415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994885,0.0015074415,0.0015861073,0.00009374662,0.0000429218,0.000017825483,0.00024548863,0.00011241872,0.0015089072],"genre_scores_gemma":[0.99280095,0.0009908518,0.0015620393,0.00004746849,0.000011232041,0.000030498679,0.0005607257,0.000025378844,0.0039709643],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99987984,0.00002387421,0.000007326911,0.000016545953,0.000027266973,0.000045200424],"domain_scores_gemma":[0.9999143,0.000013683591,0.0000143529915,0.000015030033,0.000008682049,0.000033978275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012841591,0.00032736326,0.00018497196,0.00018141947,0.00008758489,0.00018065961,0.00011443546,0.00017121201,0.0011250441],"category_scores_gemma":[0.00007290855,0.00012688455,0.00017481182,0.00012816513,0.000090164154,0.00010320335,0.00013289548,0.0005251857,0.0006346875],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000114423005,0.00007075766,0.00009266682,0.000012243965,0.00000230221,0.000016297075,0.00000514077,0.000020980973,0.9987676,0.00003920143,0.000055056167,0.00080335804],"study_design_scores_gemma":[0.000025296253,0.0009021218,0.0041243145,0.00000414111,0.000008672763,0.00017126073,0.000013959955,0.0009534751,0.9917354,0.000038972667,0.0020195437,0.0000028846514],"about_ca_topic_score_codex":0.0005772639,"about_ca_topic_score_gemma":0.0007796732,"teacher_disagreement_score":0.0011250441,"about_ca_system_score_codex":0.00018070181,"about_ca_system_score_gemma":0.00017764905,"threshold_uncertainty_score":0.003763616},"labels":[],"label_agreement":null},{"id":"W1997225815","doi":"10.1089/omi.2006.10.66","title":"Genetic Variation and the Mitogen-Activated Protein Kinase (MAPK) Signaling Pathway","year":2006,"lang":"en","type":"article","venue":"OMICS A Journal of Integrative Biology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"Canadian Institutes of Health Research","keywords":"Biology; MAPK/ERK pathway; Protein kinase A; Epistasis; Genetics; dbSNP; Signal transduction; Gene; Phosphorylation; Single-nucleotide polymorphism; Allele; Kinase; Function (biology); Computational biology; Genotype","score_opus":0.006539377973044277,"score_gpt":0.21390299772629967,"score_spread":0.2073636197532554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997225815","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99748933,0.00039781912,0.0013182097,0.000058039597,0.0000071320073,0.0000040210234,0.00013867968,0.000012504105,0.00057417084],"genre_scores_gemma":[0.99904925,0.00016201404,0.0005674047,0.000013276087,0.0000050042136,0.0000026197397,0.00009732182,0.0000036578595,0.00009939097],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996816,0.00013071907,0.000027572503,0.00007483655,0.000054419004,0.00003084336],"domain_scores_gemma":[0.99969697,0.00015941064,0.00009331653,0.00001479813,0.000012870394,0.00002265992],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029244486,0.00023910709,0.00017763789,0.0005566444,0.00022179312,0.00022080584,0.00014580166,0.000260647,0.0011286149],"category_scores_gemma":[0.00087842444,0.00007823075,0.00022113367,0.00054285256,0.00020205523,0.0001324095,0.00018065357,0.00022898606,0.00010942257],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016623595,0.00016546258,0.6169257,0.00022754906,0.0011760019,0.004495072,0.00045785305,0.0067088027,0.30749336,0.003901277,0.00048425863,0.05630231],"study_design_scores_gemma":[0.00004484394,0.0002353148,0.96139383,0.000034812863,0.0003119529,0.006954679,0.00023791022,0.009798849,0.013846716,0.0042598145,0.002844038,0.00003728256],"about_ca_topic_score_codex":0.0006903477,"about_ca_topic_score_gemma":0.001290858,"teacher_disagreement_score":0.0011286149,"about_ca_system_score_codex":0.000133194,"about_ca_system_score_gemma":0.00014115956,"threshold_uncertainty_score":0.0037755966},"labels":[],"label_agreement":null},{"id":"W1997245211","doi":"10.1038/jid.2014.26","title":"Loss of AMPKα1 Expression Is Associated with Poor Survival in Melanoma Patients","year":2014,"lang":"en","type":"letter","venue":"Journal of Investigative Dermatology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; Quest University Canada; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Melanoma; Medicine; AMPK; Cancer research; Scopus; Oncology; Chemotherapy; Internal medicine; Protein kinase A; Kinase; MEDLINE; Biology","score_opus":0.01610958565522716,"score_gpt":0.22609428986185692,"score_spread":0.20998470420662976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997245211","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9732337,0.003512168,0.00045719647,0.0147495,0.0005582085,0.00001737827,0.0005437237,0.000042427742,0.006885718],"genre_scores_gemma":[0.9945775,0.00083025626,0.00025622942,0.0018757477,0.00060640747,0.000009095435,0.0001642338,0.0000058592295,0.0016747199],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998628,0.000030492982,0.00001719618,0.000026087477,0.00003168217,0.000031708045],"domain_scores_gemma":[0.9994831,0.00017696255,0.00013644424,0.000041793824,0.00007671359,0.00008498987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019684988,0.00017184447,0.0003222177,0.00029089014,0.00033550555,0.0004420086,0.00020332362,0.0007618781,0.0016003874],"category_scores_gemma":[0.0013365014,0.00013553578,0.00023276827,0.00042212062,0.00018203097,0.00025391346,0.00014963694,0.0007862302,0.00032036455],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001794061,0.00010532387,0.91970146,0.00013128635,0.00010691791,0.028103594,0.0001821667,0.00017787487,0.015857097,0.00038631205,0.0076701185,0.025783723],"study_design_scores_gemma":[0.00006721594,0.00027608857,0.9272494,0.00006137388,0.00017846028,0.053762425,0.00042910973,0.0010934942,0.0028288283,0.0010907628,0.012934724,0.00002828139],"about_ca_topic_score_codex":0.0005064585,"about_ca_topic_score_gemma":0.000774675,"teacher_disagreement_score":0.0016003874,"about_ca_system_score_codex":0.00022355784,"about_ca_system_score_gemma":0.00012339433,"threshold_uncertainty_score":0.0053538084},"labels":[],"label_agreement":null},{"id":"W1997686190","doi":"10.1152/ajpgi.00453.2003","title":"Dual role of MEK/ERK signaling in senescence and transformation of intestinal epithelial cells","year":2004,"lang":"en","type":"article","venue":"American Journal of Physiology-Gastrointestinal and Liver Physiology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Institutes of Health Research; Université de Sherbrooke","funders":"","keywords":"Cell biology; MAPK/ERK pathway; Biology; Cell growth; Cell cycle; Kinase; Cell; Biochemistry","score_opus":0.004859156115739771,"score_gpt":0.1987681788471937,"score_spread":0.1939090227314539,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997686190","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98680216,0.0063932207,0.0036436715,0.00014669915,0.000043987133,0.00003793573,0.00033632046,0.000101076024,0.0024948942],"genre_scores_gemma":[0.99433327,0.0016923696,0.0017353438,0.000043805285,0.000016120535,0.000028646979,0.00026466534,0.000009339019,0.0018764479],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998511,0.000029209143,0.000017364764,0.00002916099,0.000032064185,0.000041012983],"domain_scores_gemma":[0.9999167,0.000010498976,0.000015698575,0.000011590459,0.00001446226,0.000031060863],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015773423,0.00043494033,0.00026622746,0.00033101943,0.0002055336,0.00033529673,0.00016694303,0.00022851976,0.00086767995],"category_scores_gemma":[0.000096798554,0.00016505978,0.000330154,0.00013871177,0.00018527803,0.00029765777,0.00031537315,0.00051221374,0.00039024008],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032715118,0.000037665915,0.00033250594,0.00010210564,0.00000599746,0.00015090595,0.000021590515,0.000043803913,0.99587077,0.00035721855,0.000031458265,0.0027186358],"study_design_scores_gemma":[0.000043356846,0.0003924632,0.009427314,0.000012010942,0.000030118717,0.0015809375,0.00005432802,0.0012546659,0.98115635,0.00027869543,0.0057581146,0.000011502311],"about_ca_topic_score_codex":0.00014118163,"about_ca_topic_score_gemma":0.00017405073,"teacher_disagreement_score":0.00086767995,"about_ca_system_score_codex":0.00021004525,"about_ca_system_score_gemma":0.00016681796,"threshold_uncertainty_score":0.0029027462},"labels":[],"label_agreement":null},{"id":"W1998192314","doi":"10.4161/23723548.2014.964037","title":"Key regulators of apoptosis execution as biomarker candidates in melanoma","year":2014,"lang":"en","type":"review","venue":"Molecular & Cellular Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal College of Physicians and Surgeons of Canada","funders":"","keywords":"Apoptosis; Melanoma; Biomarker; Cancer research; Programmed cell death; Biology; Cancer; Disease; Bioinformatics; Medicine; Internal medicine; Genetics","score_opus":0.01703241044668241,"score_gpt":0.29647840818239896,"score_spread":0.27944599773571654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998192314","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014805507,0.9988317,0.00020920888,0.00021431479,0.000108913766,0.0000055488226,0.000014883673,0.000007777183,0.0004596301],"genre_scores_gemma":[0.0010864905,0.99791604,0.0003461853,0.0001364382,0.00011985078,0.000007916219,0.000029373077,0.0000015530296,0.00035611403],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997837,0.00003994714,0.000034469445,0.000042703625,0.00007740285,0.000021910551],"domain_scores_gemma":[0.9996136,0.00017533507,0.000068037356,0.000011082891,0.00010036617,0.000031643056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080172863,0.00092516706,0.001418849,0.002864184,0.00024434857,0.0010937284,0.0008320989,0.0011021764,0.0018321327],"category_scores_gemma":[0.0007758877,0.00035266866,0.00048026472,0.0019741238,0.0005422651,0.0014675139,0.0006604588,0.0017490176,0.0016114364],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011215035,0.000076497694,0.00048943126,0.014694613,0.0000976815,0.00031710227,0.000055764187,0.000393896,0.0051468154,0.0038698833,0.013777461,0.9609688],"study_design_scores_gemma":[0.000029378834,0.00023369622,0.0020094023,0.0039005207,0.00025466917,0.003010258,0.000089484885,0.00034785838,0.0040157833,0.004111363,0.9819516,0.000046045],"about_ca_topic_score_codex":0.00062343496,"about_ca_topic_score_gemma":0.001220193,"teacher_disagreement_score":0.002864184,"about_ca_system_score_codex":0.00069665414,"about_ca_system_score_gemma":0.001033591,"threshold_uncertainty_score":0.006129086},"labels":[],"label_agreement":null},{"id":"W1998796741","doi":"10.1038/sj.onc.1207226","title":"Expression of activated M-Ras in a murine mammary epithelial cell line induces epithelial–mesenchymal transition and tumorigenesis","year":2004,"lang":"en","type":"article","venue":"Oncogene","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Hospital and Health Sciences Centre; University of British Columbia","funders":"Cancer Research Institute","keywords":"Biology; Carcinogenesis; Epithelial–mesenchymal transition; Matrigel; Vimentin; Cell culture; Cancer research; Cell growth; Mammary tumor; Mesenchymal stem cell; Molecular biology; Cell biology; Downregulation and upregulation; Angiogenesis; Cancer; Immunology; Immunohistochemistry; Genetics; Gene","score_opus":0.009136337901732848,"score_gpt":0.22274327986932932,"score_spread":0.21360694196759647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998796741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932769,0.0010069793,0.002664489,0.00014790015,0.000060443588,0.000053176005,0.00054613245,0.00014536118,0.0020986788],"genre_scores_gemma":[0.9932399,0.0005024897,0.0018318701,0.000035698842,0.00001582947,0.000043832333,0.00066958886,0.000031806696,0.0036289662],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99952877,0.00009858357,0.00006108516,0.000052618085,0.000105814484,0.00015307954],"domain_scores_gemma":[0.99959713,0.00010679306,0.0000810872,0.00009204793,0.000034307508,0.00008868481],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031816238,0.00052701734,0.00030705496,0.0008388162,0.00032004065,0.00045242,0.00033734445,0.00051917246,0.0016490449],"category_scores_gemma":[0.00019494357,0.00038642887,0.0005645461,0.0004365907,0.00029844718,0.0003342244,0.00028094713,0.0010956523,0.0008142107],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001671099,0.00005592273,0.000119172066,0.000013311649,0.0000037191776,0.00006868308,0.000014084396,0.000040855535,0.9990416,0.00019731901,0.000021283562,0.0002568685],"study_design_scores_gemma":[0.000009416979,0.00014356217,0.00083597755,0.000002309606,0.0000092502105,0.00011167013,0.000021580898,0.0004102299,0.9975731,0.000034332406,0.00084695296,0.0000016892878],"about_ca_topic_score_codex":0.0012319988,"about_ca_topic_score_gemma":0.0019020414,"teacher_disagreement_score":0.0016490449,"about_ca_system_score_codex":0.0006039476,"about_ca_system_score_gemma":0.0003336657,"threshold_uncertainty_score":0.0055166483},"labels":[],"label_agreement":null},{"id":"W1999513735","doi":"10.1080/00498250110100711","title":"SB-242235, a selective inhibitor of p38 mitogen-activated protein kinase. II: In vitro and in vivo metabolism studies and pharmacokinetic extrapolation to man","year":2002,"lang":"en","type":"article","venue":"Xenobiotica","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Discovery Centre","funders":"","keywords":"Pharmacokinetics; In vivo; Pharmacology; In vitro; Microsome; Metabolism; Kinase; Chemistry; Biology; Biochemistry","score_opus":0.016617292182223586,"score_gpt":0.2516120641375673,"score_spread":0.23499477195534374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999513735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87713337,0.027529435,0.086659096,0.00039375573,0.00016213986,0.0005992763,0.0020901125,0.00090866693,0.0045241746],"genre_scores_gemma":[0.9468673,0.018930301,0.026571164,0.00017183,0.00010653855,0.00036795798,0.003481101,0.00018488154,0.0033188497],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99971706,0.000109760666,0.000017874518,0.000056976107,0.000059418304,0.00003889322],"domain_scores_gemma":[0.99980396,0.000051638737,0.00005339079,0.000026808942,0.000028371975,0.000035797777],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081439764,0.0010740351,0.00076235423,0.00056005805,0.0002813602,0.00048382118,0.0004331502,0.00040714827,0.0011323484],"category_scores_gemma":[0.0006076162,0.00040998386,0.0004811461,0.0003948586,0.00033327178,0.0003746445,0.00014057901,0.00092155737,0.0008954863],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031610595,0.00043219604,0.0014898852,0.00031905345,0.00008280341,0.00028164824,0.00008069543,0.0029648573,0.9651406,0.00029446476,0.00061191904,0.025140878],"study_design_scores_gemma":[0.0001840629,0.009922553,0.0076067643,0.000026165964,0.00030665583,0.0015021086,0.00006195991,0.012531486,0.956117,0.00024352536,0.011447876,0.000049925737],"about_ca_topic_score_codex":0.0052748974,"about_ca_topic_score_gemma":0.0033565513,"teacher_disagreement_score":0.0052748974,"about_ca_system_score_codex":0.0008244314,"about_ca_system_score_gemma":0.00076701347,"threshold_uncertainty_score":0.010488391},"labels":[],"label_agreement":null},{"id":"W2000123112","doi":"10.1023/b:drug.0000026258.02846.1c","title":"Phase II trial of flavopiridol, a cyclin dependent kinase inhibitor, in untreated metastatic malignant melanoma","year":2004,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":89,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ottawa Regional Cancer Foundation; Hamilton Regional Laboratory Medicine Program; McGill University","funders":"National Cancer Institute; McGill University","keywords":"Nausea; Medicine; Gastroenterology; Internal medicine; Vomiting; Diarrhea; Melanoma; Progressive disease; Anorexia; Toxicity; Regimen; Phases of clinical research; Surgery; Chemotherapy; Cancer research","score_opus":0.021077545427093294,"score_gpt":0.2726131858557945,"score_spread":0.25153564042870125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000123112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99131244,0.003414681,0.00047396348,0.00068380457,0.00023075708,0.00091064797,0.0006205802,0.00007181702,0.0022812635],"genre_scores_gemma":[0.9884322,0.0031430451,0.00082257675,0.0005568094,0.00020184636,0.0010595034,0.001235714,0.000027116504,0.0045210924],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99976486,0.00009641721,0.0000071964173,0.000032153584,0.000019451445,0.000079964615],"domain_scores_gemma":[0.9995629,0.00008820092,0.000052606385,0.000034921104,0.000020486501,0.00024091013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009792295,0.0012901317,0.0018317263,0.0004425451,0.0004952002,0.00076721126,0.00081089785,0.0011282499,0.002803592],"category_scores_gemma":[0.0007221702,0.0004698168,0.0009505878,0.0003532533,0.0009513634,0.0007432466,0.00023667135,0.0027637463,0.0005181325],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.72720486,0.05093186,0.004622452,0.0010118576,0.0011736153,0.00059143885,0.00043975585,0.0045439834,0.07544234,0.00091304205,0.0064801304,0.12664461],"study_design_scores_gemma":[0.47452325,0.4989129,0.011687991,0.000060815128,0.0004068326,0.0004321541,0.0001515262,0.0020079294,0.007267707,0.0004853298,0.0040230653,0.000040459752],"about_ca_topic_score_codex":0.0020406311,"about_ca_topic_score_gemma":0.0049794125,"teacher_disagreement_score":0.002803592,"about_ca_system_score_codex":0.0008702683,"about_ca_system_score_gemma":0.0009450795,"threshold_uncertainty_score":0.00937897},"labels":[],"label_agreement":null},{"id":"W2001789499","doi":"10.1074/jbc.m205277200","title":"A Dominant-negative p38 MAPK Mutant and Novel Selective Inhibitors of p38 MAPK Reduce Insulin-stimulated Glucose Uptake in 3T3-L1 Adipocytes without Affecting GLUT4 Translocation","year":2002,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":135,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"GLUT4; 3T3-L1; Glucose uptake; MAPK/ERK pathway; Chromosomal translocation; Glucose transporter; Insulin; Mutant; p38 mitogen-activated protein kinases; Chemistry; Internal medicine; Endocrinology; Cell biology; Adipocyte; Biology; Kinase; Biochemistry; Medicine; Adipose tissue; Gene","score_opus":0.022527578704434878,"score_gpt":0.2450945455803939,"score_spread":0.222566966875959,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001789499","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928161,0.002445535,0.0027897474,0.00016459497,0.00006076236,0.000053277345,0.00036982552,0.0001429899,0.0011572791],"genre_scores_gemma":[0.98680615,0.0023534137,0.006273116,0.00009805619,0.000028153538,0.0001335207,0.0009027034,0.0000339524,0.0033710096],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998652,0.000021982936,0.000014123955,0.000029545412,0.000035745794,0.0000334711],"domain_scores_gemma":[0.99993896,0.000011001021,0.000017227809,0.0000070675214,0.000005375169,0.000020255346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017393296,0.0006963441,0.000351965,0.00015033715,0.00016405557,0.00021651598,0.00029517486,0.00029561223,0.0013115829],"category_scores_gemma":[0.000071728886,0.00018883958,0.00040120672,0.00019265835,0.00029403254,0.00023517237,0.00013733434,0.0006985974,0.0005317602],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021241051,0.00007480398,0.00003411414,0.000034721987,0.0000071153386,0.000029096811,0.000006907975,0.000042339165,0.9987853,0.000054557095,0.00003351368,0.0006851182],"study_design_scores_gemma":[0.0000850049,0.000872835,0.0009969273,0.000004248474,0.000026800833,0.0002344347,0.000017805221,0.0007151536,0.99592775,0.00003365308,0.0010810532,0.000004222115],"about_ca_topic_score_codex":0.00047272735,"about_ca_topic_score_gemma":0.00096488546,"teacher_disagreement_score":0.0013115829,"about_ca_system_score_codex":0.00038716706,"about_ca_system_score_gemma":0.0003116891,"threshold_uncertainty_score":0.004387617},"labels":[],"label_agreement":null},{"id":"W2002965548","doi":"10.1002/jcp.10432","title":"Down‐regulation of MEK/ERK signaling by E‐cadherin‐dependent PI3K/Akt pathway in differentiating intestinal epithelial cells","year":2003,"lang":"en","type":"article","venue":"Journal of Cellular Physiology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":99,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"Canada Research Chairs","keywords":"PI3K/AKT/mTOR pathway; Protein kinase B; Cell biology; MAPK/ERK pathway; Adherens junction; LY294002; Cadherin; Phosphorylation; Chemistry; MEK inhibitor; Biology; Signal transduction; Cell; Biochemistry","score_opus":0.007240307943950578,"score_gpt":0.2010914502718976,"score_spread":0.193851142327947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002965548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993353,0.0017393919,0.002240317,0.000096934105,0.000043822238,0.00004562849,0.0005435857,0.00013165611,0.0018056836],"genre_scores_gemma":[0.9887018,0.0020344644,0.0046807877,0.00006455312,0.000015707932,0.00009384588,0.0008205302,0.00002414291,0.003564134],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998549,0.000017225557,0.000024143608,0.000024659696,0.00003662407,0.000042372136],"domain_scores_gemma":[0.9999449,0.000010179379,0.0000123146765,0.000007937883,0.000007839436,0.000016805685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013323555,0.00031963905,0.00023439202,0.00017580978,0.00016876712,0.00035751468,0.00022215271,0.00016154611,0.0008418426],"category_scores_gemma":[0.00007776135,0.00018308652,0.00025187412,0.00020691373,0.0001749102,0.000201753,0.00018024407,0.0006952821,0.00031932353],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013858153,0.000050681225,0.00010431623,0.000051805524,0.000004579189,0.000033671648,0.000013552881,0.00006568415,0.9982607,0.00011716917,0.000032163807,0.0011271429],"study_design_scores_gemma":[0.00003118024,0.00014474895,0.0028851617,0.0000045827896,0.000015337597,0.00008992846,0.000017123957,0.0011341622,0.99332833,0.000029518831,0.0023164738,0.0000034762695],"about_ca_topic_score_codex":0.0012428055,"about_ca_topic_score_gemma":0.0018217198,"teacher_disagreement_score":0.0012428055,"about_ca_system_score_codex":0.00037586814,"about_ca_system_score_gemma":0.0004297659,"threshold_uncertainty_score":0.0028162599},"labels":[],"label_agreement":null},{"id":"W2003463518","doi":"10.1158/1538-7445.am2012-4166","title":"Abstract 4166: Tumor suppressor activity of the ERK/MAPK pathway by promoting selective protein degradation","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame; Université de Montréal","funders":"","keywords":"MAPK/ERK pathway; Protein kinase B; PI3K/AKT/mTOR pathway; Cancer research; Signal transduction; Cell biology; Kinase; Biology; Senescence","score_opus":0.04202752112323867,"score_gpt":0.3331159407019406,"score_spread":0.29108841957870196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003463518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95420337,0.013857034,0.009866712,0.00088234514,0.00056241325,0.00016417394,0.002711712,0.0006860727,0.017066117],"genre_scores_gemma":[0.96070445,0.0072045233,0.005650151,0.00020967665,0.00013252017,0.00014828765,0.00380581,0.00007671786,0.022067886],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999242,0.000009417809,0.000009622665,0.0000130858125,0.000024520134,0.000019126228],"domain_scores_gemma":[0.99995553,0.000005222494,0.000012396926,0.0000062299882,0.0000049855444,0.000015608179],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011379953,0.00064609735,0.00019705138,0.00021511425,0.00016024621,0.00027731273,0.0001833561,0.0002246975,0.006005266],"category_scores_gemma":[0.00007529745,0.00015718726,0.00028389014,0.00015259844,0.00012957361,0.0001861892,0.00020612922,0.0006508143,0.0016706137],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003367136,0.00012470933,0.000096147494,0.00016791208,0.000009493463,0.000108487475,0.0000054820325,0.00015379675,0.9927897,0.00050296483,0.00052884605,0.005175818],"study_design_scores_gemma":[0.00012536578,0.00085253234,0.0027845728,0.00002216836,0.00002129009,0.0009281059,0.000008444757,0.0012062762,0.9750835,0.00022613602,0.018732717,0.000008926674],"about_ca_topic_score_codex":0.00008840293,"about_ca_topic_score_gemma":0.00013429216,"teacher_disagreement_score":0.006005266,"about_ca_system_score_codex":0.00015389691,"about_ca_system_score_gemma":0.00019462765,"threshold_uncertainty_score":0.020089567},"labels":[],"label_agreement":null},{"id":"W2003509083","doi":"10.1042/bj20040948","title":"p90 ribosomal S6 kinase 2 is associated with and dephosphorylated by protein phosphatase 2Cδ","year":2004,"lang":"en","type":"article","venue":"Biochemical Journal","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Biotechnology Research Institute","funders":"Medical Research Council; Sundhed og Sygdom, Det Frie Forskningsråd; Kræftens Bekæmpelse","keywords":"Mitogen-activated protein kinase kinase; Cyclin-dependent kinase 9; Protein kinase domain; Kinase; MAP kinase kinase kinase; Cyclin-dependent kinase 2; c-Raf; MAP2K7; P70-S6 Kinase 1; Phosphatase; Protein kinase A; Ribosomal s6 kinase; Phosphorylation; Biochemistry; Biology; Molecular biology; Chemistry; Cell biology; Mutant; Protein kinase B","score_opus":0.005100390114667312,"score_gpt":0.19925649189488318,"score_spread":0.19415610178021586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003509083","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951711,0.0017797593,0.0018367952,0.000066431014,0.000022957202,0.000011785223,0.00024159845,0.000093603805,0.00077601545],"genre_scores_gemma":[0.99376136,0.00092301884,0.0012263082,0.000034193883,0.00001549278,0.000027613232,0.0012162476,0.0000226568,0.0027731846],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997497,0.00002819283,0.000018398969,0.00007232708,0.000078367215,0.000053004216],"domain_scores_gemma":[0.99991536,0.000006387746,0.00003806167,0.000010130037,0.0000074361365,0.000022713122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012429195,0.0006491461,0.0002774976,0.00026992967,0.00018336692,0.0003198799,0.00023585928,0.00021530548,0.0012660042],"category_scores_gemma":[0.00011497601,0.00026530036,0.00048714687,0.00023073275,0.0002639727,0.00017032718,0.00029022145,0.00033788633,0.0007333663],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013589457,0.000015020992,0.0005145715,0.000041209067,0.000011702488,0.00007086896,0.0000082779925,0.000061867395,0.99843544,0.00006470021,0.00004061807,0.00059980835],"study_design_scores_gemma":[0.000041814128,0.00015178276,0.028206125,0.000007977565,0.000018659459,0.0012290482,0.000029365785,0.0015875048,0.9641049,0.00011295802,0.0045000683,0.000009807174],"about_ca_topic_score_codex":0.00070837984,"about_ca_topic_score_gemma":0.000935348,"teacher_disagreement_score":0.0012660042,"about_ca_system_score_codex":0.00050325785,"about_ca_system_score_gemma":0.00020277145,"threshold_uncertainty_score":0.004235208},"labels":[],"label_agreement":null},{"id":"W2003701881","doi":"10.1158/0008-5472.can-04-2369","title":"Mitogen- and Stress-Activated Protein Kinase 1 Activity and Histone H3 Phosphorylation in Oncogene-Transformed Mouse Fibroblasts","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Histone H3; Protein kinase A; c-Raf; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; MAPK/ERK pathway; Cell biology; Kinase; Signal transduction; MAP kinase kinase kinase; Mitogen-Activated Protein Kinase 3; Molecular biology; MAP2K7; ASK1; Biology; Chemistry; Chromatin; Cyclin-dependent kinase 2; Biochemistry","score_opus":0.031506656332913,"score_gpt":0.3431884818826738,"score_spread":0.3116818255497608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003701881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945215,0.0013215442,0.0014375532,0.00007420919,0.000031567488,0.000030566804,0.0010357198,0.00011282082,0.0014345602],"genre_scores_gemma":[0.9899525,0.0011301067,0.0023787285,0.000036608995,0.000011681114,0.000077325094,0.0016748997,0.000025319887,0.0047129313],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99976724,0.000029979828,0.000030306039,0.000044983466,0.0000750647,0.000052432704],"domain_scores_gemma":[0.99981254,0.000026654683,0.00004930115,0.000025569345,0.000018166014,0.0000677876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017522101,0.0005430246,0.00021511385,0.0005793535,0.00023240523,0.00028697334,0.00031375012,0.00036448095,0.0016960754],"category_scores_gemma":[0.00010730443,0.00031493476,0.00042352793,0.00031470397,0.00023486001,0.0001961819,0.00017102697,0.000767008,0.0006215703],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010509219,0.000029171582,0.0001860005,0.000010750166,0.000002829021,0.000052972187,0.000013043192,0.00002412006,0.9992218,0.000053582244,0.0000145582835,0.0002861187],"study_design_scores_gemma":[0.00002828007,0.0003145795,0.010851514,0.0000041511344,0.0000123508535,0.00040130405,0.00003855413,0.0008038494,0.98618525,0.00006145534,0.001291525,0.000007143921],"about_ca_topic_score_codex":0.0022886405,"about_ca_topic_score_gemma":0.0028665697,"teacher_disagreement_score":0.0022886405,"about_ca_system_score_codex":0.0004879859,"about_ca_system_score_gemma":0.00024211647,"threshold_uncertainty_score":0.005673945},"labels":[],"label_agreement":null},{"id":"W2004474495","doi":"10.1038/nsmb.2924","title":"Crystal structure of a BRAF kinase domain monomer explains basis for allosteric regulation","year":2014,"lang":"en","type":"article","venue":"Nature Structural & Molecular Biology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":163,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer; Université de Montréal; Lunenfeld-Tanenbaum Research Institute","funders":"Canadian Institutes of Health Research","keywords":"Allosteric regulation; Dimer; Protein kinase domain; Monomer; Helix (gastropod); Transferase; Chemistry; Kinase; Crystal structure; Active site; Stereochemistry; Crystallography; Enzyme; Biophysics; Biochemistry; Biology; Mutant; Gene","score_opus":0.003948953721555673,"score_gpt":0.25018331247628256,"score_spread":0.24623435875472688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004474495","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98648524,0.0009969086,0.0042050024,0.0010820443,0.00015348497,0.000025990605,0.00036537615,0.00021437691,0.0064716903],"genre_scores_gemma":[0.9947761,0.00042346836,0.0022561352,0.00013598947,0.0000180234,0.000012235457,0.00043145273,0.000025697678,0.0019207578],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99993396,0.0000061915907,0.0000028234097,0.0000156747,0.000026764372,0.00001449131],"domain_scores_gemma":[0.9999157,0.00002232041,0.000013786987,0.0000075565986,0.000013885888,0.000026700533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014255455,0.00023525422,0.0002406307,0.00009478239,0.0006115043,0.00035355857,0.00064152275,0.0005095182,0.0030914843],"category_scores_gemma":[0.00025072333,0.00018777272,0.00018255015,0.000112602225,0.00026133357,0.00030994345,0.00023296296,0.0012217736,0.0005046709],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00081032823,0.0003263672,0.003111159,0.00032613822,0.000052616717,0.0019287609,0.00029310133,0.006031179,0.9595162,0.011315446,0.0063637705,0.009925008],"study_design_scores_gemma":[0.0006080106,0.0007369762,0.014888827,0.00009166697,0.00017177497,0.004037413,0.0008676798,0.11185249,0.814091,0.015074877,0.03741618,0.00016315866],"about_ca_topic_score_codex":0.0012524149,"about_ca_topic_score_gemma":0.0018054894,"teacher_disagreement_score":0.0030914843,"about_ca_system_score_codex":0.0004326781,"about_ca_system_score_gemma":0.0004101692,"threshold_uncertainty_score":0.0103420615},"labels":[],"label_agreement":null},{"id":"W2006002450","doi":"10.1074/jbc.m004092200","title":"The Kinase Activation Loop Is the Key to Mixed Lineage Kinase-3 Activation via Both Autophosphorylation and Hematopoetic Progenitor Kinase 1 Phosphorylation","year":2001,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Autophosphorylation; Phosphorylation; Cell biology; Chemistry; Biochemistry; Biology; Protein kinase A","score_opus":0.01679816095871574,"score_gpt":0.24141081760315425,"score_spread":0.2246126566444385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006002450","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945082,0.0003886281,0.0040145963,0.00006865139,0.00001153442,0.000015236692,0.00006187591,0.00004869171,0.0008826744],"genre_scores_gemma":[0.997649,0.00015631523,0.0014762493,0.000019828614,0.0000037392192,0.000008821991,0.00008759498,0.000008055175,0.0005905242],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999211,0.000011530303,0.000006247652,0.000018672245,0.000024015912,0.000018522165],"domain_scores_gemma":[0.9999286,0.000012654131,0.000022426188,0.0000070438973,0.0000074409454,0.00002186886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008554564,0.0003234075,0.00015111915,0.00008586602,0.00017092476,0.00025939505,0.00020990412,0.00021713888,0.0013610311],"category_scores_gemma":[0.00011687531,0.00012002198,0.00021688294,0.000060420665,0.00022685553,0.00024400702,0.00022475793,0.0005029699,0.0005246421],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012882915,0.000012608814,0.00022478684,0.000024305009,0.000002836522,0.00008030453,0.000014244449,0.000169041,0.9979796,0.00031304604,0.000014436776,0.0010358907],"study_design_scores_gemma":[0.000019115285,0.00006778553,0.0026933667,0.0000044042827,0.0000059316035,0.00030346995,0.000017144359,0.0019513913,0.99388134,0.00018304067,0.0008685083,0.000004495409],"about_ca_topic_score_codex":0.00028494524,"about_ca_topic_score_gemma":0.0002993003,"teacher_disagreement_score":0.0013610311,"about_ca_system_score_codex":0.00028880185,"about_ca_system_score_gemma":0.00024313015,"threshold_uncertainty_score":0.004553139},"labels":[],"label_agreement":null},{"id":"W2007010482","doi":"10.1159/000330206","title":"Outcomes of Patients with Metastatic Melanoma Treated with Molecularly Targeted Agents in Phase I Clinical Trials","year":2011,"lang":"en","type":"article","venue":"Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Medicine; Dacarbazine; Internal medicine; Clinical trial; Chemotherapy; Temozolomide; Phases of clinical research; Oncology; Melanoma; Cytokine; Gastroenterology; Surgery; Cancer research","score_opus":0.11932805219443275,"score_gpt":0.3919691157399389,"score_spread":0.27264106354550616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007010482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925648,0.004048449,0.00048646034,0.00025720822,0.000035863384,0.00036317986,0.0008044559,0.000016257332,0.0014232857],"genre_scores_gemma":[0.99541676,0.0007370429,0.0004073551,0.00027977035,0.000083345716,0.00048187148,0.0022560104,0.0000062476693,0.00033166917],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99819547,0.0010698593,0.00024083143,0.00019138893,0.00016193566,0.00014054758],"domain_scores_gemma":[0.99446553,0.0015715007,0.0025541736,0.00025464696,0.00038260082,0.00077160413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004506923,0.0003445855,0.0011159393,0.00032270653,0.00052128563,0.0009021329,0.00026153296,0.0006319733,0.0013473596],"category_scores_gemma":[0.0058247843,0.00015102034,0.000937918,0.00044841008,0.00034555732,0.00061576586,0.00038300833,0.0008447063,0.0002464997],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11553952,0.0034216058,0.80617183,0.0007350143,0.002289542,0.0007060152,0.00026908368,0.002248657,0.0070243995,0.00027868454,0.0026641013,0.058651555],"study_design_scores_gemma":[0.030465404,0.16176155,0.78207123,0.00025346983,0.0029695835,0.0034567742,0.00024733433,0.0032594951,0.007145219,0.00091228995,0.007386322,0.00007125437],"about_ca_topic_score_codex":0.00015011383,"about_ca_topic_score_gemma":0.000161623,"teacher_disagreement_score":0.004506923,"about_ca_system_score_codex":0.0004260078,"about_ca_system_score_gemma":0.00045407587,"threshold_uncertainty_score":0.023835123},"labels":[],"label_agreement":null},{"id":"W2008413774","doi":"10.1158/1078-0432.mechres-ia11","title":"Abstract IA11: Using Molecular Profiling Strategies in Clinical Trials to Understand Resistance Mechanisms in the Era of Personalized Cancer Medicine","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Vemurafenib; Medicine; Acquired resistance; Druggability; Drug resistance; Clinical trial; Melanoma; Oncology; Precision medicine; Cancer; Cancer research; Ipilimumab; Internal medicine; Bioinformatics; Biology; Metastatic melanoma; Pathology; Immunotherapy; Gene; Genetics","score_opus":0.5070920791879917,"score_gpt":0.5937702580808246,"score_spread":0.08667817889283291,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008413774","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4976553,0.106328785,0.12949048,0.112240806,0.008174869,0.02289899,0.018254243,0.0042971214,0.10065939],"genre_scores_gemma":[0.7932592,0.02487186,0.11646726,0.030990586,0.0024948437,0.0132798655,0.0062924186,0.00034040783,0.012003596],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9831844,0.01338299,0.0007208866,0.0008436212,0.001213821,0.000654321],"domain_scores_gemma":[0.9827811,0.0060837185,0.0046625873,0.0017159245,0.002760269,0.0019964464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03040442,0.001152672,0.0023412816,0.0010708332,0.00042726414,0.003961286,0.0010652026,0.0020899375,0.01053836],"category_scores_gemma":[0.019922825,0.0005399668,0.001552677,0.0014159051,0.0013509375,0.0026296822,0.001336877,0.0042122784,0.002579676],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.050273877,0.0044962913,0.03342643,0.003200856,0.002335666,0.00015337433,0.00028873244,0.0064596324,0.035312578,0.0128993755,0.051064566,0.8000886],"study_design_scores_gemma":[0.059512805,0.2299921,0.1613565,0.004605367,0.0066834455,0.0013757413,0.0008154723,0.05153672,0.039611604,0.044834703,0.39898518,0.00069041713],"about_ca_topic_score_codex":0.0005979958,"about_ca_topic_score_gemma":0.0011044671,"teacher_disagreement_score":0.03040442,"about_ca_system_score_codex":0.0022284384,"about_ca_system_score_gemma":0.00336668,"threshold_uncertainty_score":0.16079587},"labels":[],"label_agreement":null},{"id":"W2010317482","doi":"10.1016/j.mpdhp.2014.10.001","title":"Targeted therapy in melanoma: the era of personalized medicine","year":2014,"lang":"en","type":"article","venue":"Diagnostic histopathology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Melanoma; Cancer; Incidence (geometry); Targeted therapy; Disease; Skin cancer; Oncology; Internal medicine; Cancer research","score_opus":0.008976732925360364,"score_gpt":0.23100024290482418,"score_spread":0.22202350997946382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010317482","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.061222594,0.70166814,0.038831897,0.17018582,0.0026026024,0.00007214133,0.00035175096,0.00039690392,0.024668172],"genre_scores_gemma":[0.51838833,0.42514434,0.0194092,0.023878776,0.0068375226,0.00008175193,0.00016041062,0.000077995006,0.0060216733],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99951077,0.00018624851,0.000025845507,0.000079656165,0.00014112562,0.000056451405],"domain_scores_gemma":[0.9989986,0.0005587802,0.00012934707,0.00008085245,0.00014652836,0.000085940024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016813132,0.00042940327,0.001108607,0.0007725441,0.00048882863,0.0020927337,0.000543037,0.0014831757,0.002257553],"category_scores_gemma":[0.0017178695,0.00020157824,0.00042687551,0.0005447927,0.0014807308,0.0030680145,0.0012001153,0.0036840057,0.00049296976],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009824458,0.0006546204,0.013422867,0.0021499167,0.00031844364,0.001531555,0.0003522951,0.0049588033,0.048277304,0.12787116,0.032220494,0.7672601],"study_design_scores_gemma":[0.0003482257,0.0013113595,0.031446286,0.0023987151,0.00058644096,0.009718865,0.0013374557,0.017549785,0.027577465,0.47964066,0.42786703,0.00021767875],"about_ca_topic_score_codex":0.0005475487,"about_ca_topic_score_gemma":0.0012958964,"teacher_disagreement_score":0.002257553,"about_ca_system_score_codex":0.0016023071,"about_ca_system_score_gemma":0.001002564,"threshold_uncertainty_score":0.011625588},"labels":[],"label_agreement":null},{"id":"W2010789517","doi":"10.1074/jbc.m600497200","title":"Transgenic Drak2 Overexpression in Mice Leads to Increased T Cell Apoptosis and Compromised Memory T Cell Development","year":2006,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Notre-Dame; Centre Hospitalier de l’Université de Montréal","funders":"Canadian Institutes of Health Research; Heart And Stroke Foundation Of Quebec; Kidney Foundation of Canada; Heart and Stroke Foundation of Canada","keywords":"Biology; T cell; Apoptosis; CD8; IL-2 receptor; Cell biology; Programmed cell death; Molecular biology; Cancer research; Immune system; Immunology; Biochemistry","score_opus":0.01039291454899875,"score_gpt":0.21001622511550955,"score_spread":0.1996233105665108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010789517","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920399,0.0012211173,0.0040582824,0.000120432625,0.00006290303,0.00003700708,0.00088634697,0.00031405003,0.0012599399],"genre_scores_gemma":[0.9876956,0.0011853967,0.003100769,0.000109727545,0.00002919533,0.000084692765,0.0010680496,0.00013745327,0.006589259],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996265,0.00004384061,0.00004726099,0.00013008957,0.00006338481,0.00008885351],"domain_scores_gemma":[0.9996526,0.00003527995,0.00015706386,0.00003084706,0.000019577425,0.00010469626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017907782,0.0008237455,0.00037816912,0.00081760826,0.0001943467,0.0004927811,0.00037530102,0.0007347693,0.002461063],"category_scores_gemma":[0.0001515184,0.0004562,0.0003657495,0.00030107098,0.00038048782,0.0003789069,0.0003179865,0.0012416022,0.00078950473],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011096883,0.000021639698,0.00013502954,0.000025495656,0.0000051454695,0.00016378217,0.000014597091,0.00003926643,0.99888974,0.00006393161,0.000022364038,0.0005080654],"study_design_scores_gemma":[0.000080183854,0.00067795475,0.0056817755,0.000021235544,0.00006462991,0.0022123177,0.00007915738,0.0010488139,0.9862897,0.00016044197,0.0036670621,0.000016694887],"about_ca_topic_score_codex":0.0002596165,"about_ca_topic_score_gemma":0.00041559618,"teacher_disagreement_score":0.002461063,"about_ca_system_score_codex":0.0002862765,"about_ca_system_score_gemma":0.00015744468,"threshold_uncertainty_score":0.00823313},"labels":[],"label_agreement":null},{"id":"W2011089118","doi":"10.1016/s1359-6446(04)03251-9","title":"Targeting JNK3 for the treatment of neurodegenerative disorders","year":2004,"lang":"en","type":"review","venue":"Drug Discovery Today","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":126,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Disease; Neuroscience; Neurotoxin; Neurodegeneration; Apoptosis; Kinase; Parkinson's disease; Biology; Medicine; Cell biology; Pathology; Endocrinology; Genetics","score_opus":0.019338972808985853,"score_gpt":0.2857150262731281,"score_spread":0.2663760534641423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011089118","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00060420047,0.9943587,0.0009714433,0.0007468286,0.00049857236,0.000016151602,0.0000369347,0.00003386963,0.0027333011],"genre_scores_gemma":[0.0022732639,0.9933704,0.00094070454,0.00043210835,0.0002070543,0.000019071524,0.00006708473,0.0000044432427,0.0026857639],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99987876,0.000016469095,0.0000127493995,0.000019124116,0.000052492334,0.000020458136],"domain_scores_gemma":[0.9998673,0.000046249854,0.00001807333,0.000005917644,0.00003928972,0.000023008022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062960945,0.0011975813,0.0014915798,0.0013381566,0.00032838038,0.00092846935,0.001240682,0.0011773215,0.002779451],"category_scores_gemma":[0.00030583635,0.00026331012,0.00047495952,0.001304475,0.00060344156,0.0011902183,0.0004588893,0.002320262,0.0023277923],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002969812,0.0001664408,0.00013601394,0.0054002893,0.00009536668,0.00057232694,0.00004687762,0.000721376,0.011924406,0.00396779,0.037280675,0.9393914],"study_design_scores_gemma":[0.00015508596,0.0002182021,0.0007226547,0.0007771415,0.00013033046,0.0020921815,0.00005129951,0.00024372285,0.004951708,0.0027644678,0.9878627,0.000030375526],"about_ca_topic_score_codex":0.0014098482,"about_ca_topic_score_gemma":0.0045717913,"teacher_disagreement_score":0.002779451,"about_ca_system_score_codex":0.0007885401,"about_ca_system_score_gemma":0.00079089485,"threshold_uncertainty_score":0.009298205},"labels":[],"label_agreement":null},{"id":"W2011113518","doi":"10.1038/onc.2012.312","title":"RSK regulates activated BRAF signalling to mTORC1 and promotes melanoma growth","year":2012,"lang":"en","type":"article","venue":"Oncogene","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":66,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"National Cancer Institute","keywords":"Biology; MAPK/ERK pathway; mTORC1; PI3K/AKT/mTOR pathway; Ribosomal s6 kinase; Neuroblastoma RAS viral oncogene homolog; Cell biology; Protein kinase A; Kinase; Melanoma; Cancer research; HRAS; Cell growth; MAPK cascade; RNA interference; Signal transduction; P70-S6 Kinase 1; Genetics; RNA; Mutation; Gene; KRAS","score_opus":0.012035427890848702,"score_gpt":0.23018064391079834,"score_spread":0.21814521601994963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011113518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9852207,0.0037322338,0.0019845928,0.00050395564,0.00014185307,0.000027752922,0.0007964582,0.00041465726,0.00717778],"genre_scores_gemma":[0.9926898,0.0011013147,0.0007633561,0.00007999781,0.00002239226,0.000024744686,0.0005228109,0.000059938735,0.0047356314],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998178,0.000028103797,0.000014713188,0.00002896407,0.00004937199,0.000061112434],"domain_scores_gemma":[0.9998987,0.000010503113,0.000036971378,0.000013105899,0.0000116303545,0.000029027582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001696196,0.00044783935,0.0001953086,0.00043498073,0.0003118951,0.00058161,0.00034207618,0.00027651832,0.00402074],"category_scores_gemma":[0.00020588368,0.00026963462,0.00047407436,0.00018852852,0.00030892243,0.00025787164,0.0003683731,0.0007744008,0.0019097741],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000809259,0.00008033585,0.0005384502,0.00008347856,0.000020029238,0.00012491703,0.00001727361,0.00021957164,0.99409616,0.00068113435,0.0004966905,0.0028326127],"study_design_scores_gemma":[0.00011937953,0.00034274533,0.016722202,0.000017027121,0.000061799474,0.00057345064,0.00008152553,0.0024228052,0.96832824,0.00041426372,0.010895218,0.000021491935],"about_ca_topic_score_codex":0.00091882015,"about_ca_topic_score_gemma":0.002349887,"teacher_disagreement_score":0.00402074,"about_ca_system_score_codex":0.0006062187,"about_ca_system_score_gemma":0.00033612727,"threshold_uncertainty_score":0.013450742},"labels":[],"label_agreement":null},{"id":"W2011780255","doi":"10.1038/nchembio.1257","title":"Inhibitors that stabilize a closed RAF kinase domain conformation induce dimerization","year":2013,"lang":"en","type":"article","venue":"Nature Chemical Biology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":178,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Metropolitan University; University of Toronto; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; Université de Montréal; Institute for Research in Immunology and Cancer","funders":"Canadian Institutes of Health Research","keywords":"Kinase; Protein kinase domain; Transactivation; Chemistry; Cell biology; Protein kinase A; Biochemistry; Förster resonance energy transfer; Allosteric regulation; Enzyme; Biology; Transcription factor; Gene; Mutant","score_opus":0.006135531041005006,"score_gpt":0.22668901362892158,"score_spread":0.22055348258791657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011780255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98314947,0.0016228734,0.0066740625,0.00033550797,0.00016080673,0.00010570753,0.00029395282,0.000297305,0.007360278],"genre_scores_gemma":[0.996075,0.00040380558,0.0011425043,0.00015917837,0.000015709113,0.00003374017,0.0002442268,0.000038501883,0.0018872675],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997218,0.000046878446,0.000024967097,0.000050535935,0.000078643454,0.000077153396],"domain_scores_gemma":[0.9997484,0.00007176797,0.000057311914,0.0000360647,0.000024900704,0.00006157566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031301306,0.00040966843,0.00037083105,0.00025907325,0.0003905132,0.00056051224,0.0003163485,0.00038765956,0.0031130586],"category_scores_gemma":[0.0003341094,0.00028119987,0.00043065374,0.00015204462,0.00036734276,0.00030706375,0.00025152948,0.0012603014,0.0007081571],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014545937,0.00009389368,0.000086945096,0.00003406216,0.000023432087,0.00003826937,0.000012925344,0.0001915568,0.99746406,0.00042762305,0.00021066327,0.0012710673],"study_design_scores_gemma":[0.000051768926,0.000116472416,0.0006022521,0.0000035184169,0.0000137081015,0.00012874998,0.000009504792,0.0009678338,0.9961732,0.00010587603,0.0018211473,0.0000060661446],"about_ca_topic_score_codex":0.00037186142,"about_ca_topic_score_gemma":0.00065239856,"teacher_disagreement_score":0.0031130586,"about_ca_system_score_codex":0.00050050404,"about_ca_system_score_gemma":0.00022159485,"threshold_uncertainty_score":0.010414243},"labels":[],"label_agreement":null},{"id":"W2012074445","doi":"10.1074/jbc.m110.181529","title":"Activation Loop Phosphorylation of ERK3/ERK4 by Group I p21-activated Kinases (PAKs) Defines a Novel PAK-ERK3/4-MAPK-activated Protein Kinase 5 Signaling Pathway","year":2010,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"National Cancer Institute; Canadian Institutes of Health Research; U.S. Public Health Service; National Institutes of Health; Leukemia and Lymphoma Society","keywords":"Kinase; PAK1; MAP2K7; Phosphorylation; MAP kinase kinase kinase; c-Raf; Mitogen-activated protein kinase kinase; ASK1; Cell biology; Cyclin-dependent kinase 2; MAPK14; Mitogen-activated protein kinase; Biology; Protein kinase A; Cyclin-dependent kinase 9; Chemistry; Biochemistry","score_opus":0.017491604067583152,"score_gpt":0.2283205964808308,"score_spread":0.21082899241324765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012074445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99030894,0.0010673341,0.0060255025,0.00006616082,0.000012665076,0.000034834324,0.0002796849,0.00006958362,0.0021353513],"genre_scores_gemma":[0.9882448,0.0010153739,0.0068556373,0.00003452233,0.000011398488,0.000032510186,0.0009354393,0.0000119950455,0.0028582867],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99993217,0.000007778641,0.00000483956,0.000016590271,0.000018748502,0.000019807614],"domain_scores_gemma":[0.99995995,0.0000024440963,0.000019170977,0.0000038939397,0.0000046456503,0.000009882377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005859864,0.00037947609,0.00016702838,0.00022857773,0.00021629952,0.00026588835,0.0001771597,0.00014668576,0.0005638003],"category_scores_gemma":[0.00005035634,0.00014259425,0.00031444128,0.00016982527,0.0001882991,0.0002473444,0.0002669692,0.0003442849,0.00045476411],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000080839985,0.000021574942,0.0006742897,0.000027283115,0.0000046084406,0.00014692215,0.00001532875,0.00008790534,0.9966474,0.00035487494,0.000043024826,0.0018959227],"study_design_scores_gemma":[0.000017444072,0.00019003573,0.018329594,0.000004971015,0.000019197065,0.001465112,0.00004239494,0.0016748977,0.971419,0.00041266403,0.0064145997,0.000009982479],"about_ca_topic_score_codex":0.00016445134,"about_ca_topic_score_gemma":0.00026711074,"teacher_disagreement_score":0.0005638003,"about_ca_system_score_codex":0.00026066665,"about_ca_system_score_gemma":0.00014967704,"threshold_uncertainty_score":0.0018912554},"labels":[],"label_agreement":null},{"id":"W2012440244","doi":"10.1074/jbc.c000917200","title":"Stress-induced Inhibition of ERK1 and ERK2 by Direct Interaction with p38 MAP Kinase","year":2001,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":166,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kinexus Bioinformatics Corporation (Canada); University of British Columbia","funders":"","keywords":"ASK1; Mitogen-activated protein kinase kinase; MAP2K7; MAP kinase kinase kinase; MAPK14; Kinase; Protein kinase A; c-Raf; Mitogen-activated protein kinase; Cyclin-dependent kinase 9; MAPK/ERK pathway; p38 mitogen-activated protein kinases; Phosphorylation; Activator (genetics); Cyclin-dependent kinase 2; Molecular biology; Cell biology; Biology; Chemistry; Biochemistry","score_opus":0.015280036115688662,"score_gpt":0.23800218362280454,"score_spread":0.2227221475071159,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012440244","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9776227,0.007690117,0.009693478,0.00029153647,0.000111877576,0.00008686401,0.00069532555,0.00017829936,0.0036298065],"genre_scores_gemma":[0.97694063,0.0042405995,0.008815007,0.00010018147,0.0000483049,0.00025318167,0.0020495886,0.000033413686,0.0075191986],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99982613,0.000023456865,0.000016248174,0.000033646775,0.00004537593,0.000055170578],"domain_scores_gemma":[0.99995124,0.000008167587,0.000011479106,0.000006914898,0.000009394919,0.000012758886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014311432,0.0007082546,0.00025617564,0.00016686473,0.0002255791,0.00022726145,0.00025917974,0.0001236543,0.002421977],"category_scores_gemma":[0.00007705626,0.00016887546,0.00033325274,0.00016384265,0.00016564109,0.00020376629,0.0002679121,0.0006019644,0.00062023546],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009548885,0.00004983465,0.0000580987,0.0000975849,0.000008010195,0.000027161945,0.000016556234,0.000030466852,0.99795294,0.00010277633,0.000093054114,0.0014679984],"study_design_scores_gemma":[0.000021576594,0.00019401811,0.0022791575,0.000008143701,0.000008242133,0.00014868352,0.0000138554915,0.0006695042,0.9929656,0.000074217554,0.0036136922,0.000003343067],"about_ca_topic_score_codex":0.00033276255,"about_ca_topic_score_gemma":0.000703448,"teacher_disagreement_score":0.002421977,"about_ca_system_score_codex":0.00024669484,"about_ca_system_score_gemma":0.00023089343,"threshold_uncertainty_score":0.008102298},"labels":[],"label_agreement":null},{"id":"W2012445850","doi":"10.1097/00004872-200206000-00024","title":"Inhibition of mitogen-activated protein/extracellular signal-regulated kinase improves endothelial function and attenuates Ang II-induced contractility of mesenteric resistance arteries from spontaneously hypertensive rats","year":2002,"lang":"en","type":"article","venue":"Journal of Hypertension","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute; Université de Montréal","funders":"","keywords":"Contractility; Mesenteric arteries; Endocrinology; Medicine; Internal medicine; Vascular smooth muscle; Contraction (grammar); Angiotensin II; Spontaneously hypertensive rat; Kinase; Electrical impedance myography; Extracellular; Blood pressure; Vasodilation; Biology; Artery; Cell biology; Smooth muscle","score_opus":0.017230605372918272,"score_gpt":0.19153413741768474,"score_spread":0.17430353204476648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012445850","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968418,0.0008771696,0.0011792029,0.00009616594,0.000045821813,0.000023104554,0.00020651413,0.00010069937,0.0006294245],"genre_scores_gemma":[0.99273723,0.0017056561,0.0020880634,0.00009025957,0.000041364812,0.00006901599,0.0005739092,0.000021817064,0.0026725323],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990845,0.0000126832465,0.000011880269,0.000015597967,0.000020080206,0.00003135669],"domain_scores_gemma":[0.9998758,0.000008465412,0.00004582442,0.000010811948,0.000011293186,0.000047783236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013577029,0.00074777205,0.0005377431,0.0002617365,0.0001270285,0.00015966145,0.00021249008,0.0002008017,0.0014604944],"category_scores_gemma":[0.00010594709,0.00019775458,0.00033504877,0.00011658847,0.00018800293,0.00021231553,0.00015731172,0.0008316368,0.00036586527],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012651212,0.00045487285,0.0002951376,0.00008393319,0.000025291944,0.000059096237,0.00001618834,0.00008009961,0.9925569,0.000032234973,0.00009710558,0.0050339727],"study_design_scores_gemma":[0.0004606907,0.009559681,0.029154737,0.000026831889,0.00015976088,0.0004903782,0.00008756989,0.002109723,0.95541734,0.00007974972,0.002437257,0.00001629805],"about_ca_topic_score_codex":0.0003702309,"about_ca_topic_score_gemma":0.00066737965,"teacher_disagreement_score":0.0014604944,"about_ca_system_score_codex":0.00014204395,"about_ca_system_score_gemma":0.00015984804,"threshold_uncertainty_score":0.0048858523},"labels":[],"label_agreement":null},{"id":"W2012871013","doi":"10.1186/1471-2407-8-337","title":"Activation of MEK1 or MEK2 isoform is sufficient to fully transform intestinal epithelial cells and induce the formation of metastatic tumors","year":2008,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Université de Montréal; McGill University; Institute for Research in Immunology and Cancer","funders":"National Cancer Institute; Canada Research Chairs; Cancer Research Society","keywords":"Cancer research; Cell growth; Biology; Gene silencing; Cell biology; Carcinogenesis; Colorectal cancer; Cancer; Gene","score_opus":0.03504055605425711,"score_gpt":0.26620816107535067,"score_spread":0.23116760502109357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012871013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943541,0.00093227887,0.0022085155,0.00007136406,0.000027280683,0.000039792274,0.00057157245,0.00012633987,0.0016688264],"genre_scores_gemma":[0.9931833,0.0005844096,0.0023819124,0.000030228935,0.000008938238,0.0000450144,0.0010996282,0.00003685345,0.0026297113],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998574,0.000015995776,0.000017735674,0.000027070175,0.00004289462,0.000038816193],"domain_scores_gemma":[0.99982977,0.000039375715,0.000035211742,0.000022616576,0.000012162808,0.000060911436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012513343,0.0004743148,0.00023753605,0.00018876199,0.0001230239,0.00024347463,0.00017387392,0.00020087484,0.002013148],"category_scores_gemma":[0.00010163351,0.00015806186,0.00024803044,0.00010095563,0.00019808124,0.00013957218,0.00018192756,0.00056489196,0.00053601444],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006148508,0.000024613235,0.00008584033,0.000028147397,0.0000034687507,0.00002467448,0.0000045495613,0.000030417588,0.9993387,0.00004008059,0.000023563582,0.00033446602],"study_design_scores_gemma":[0.00001533503,0.00023969087,0.0018683475,0.0000036508115,0.000012166274,0.00026518386,0.000011552559,0.0006198191,0.9951749,0.000017755046,0.0017692138,0.000002455798],"about_ca_topic_score_codex":0.0005109164,"about_ca_topic_score_gemma":0.0008787036,"teacher_disagreement_score":0.002013148,"about_ca_system_score_codex":0.00028761046,"about_ca_system_score_gemma":0.00030201479,"threshold_uncertainty_score":0.006734669},"labels":[],"label_agreement":null},{"id":"W2014431943","doi":"10.1016/j.ahj.2015.02.012","title":"Rationale and design of the LosmApimod To Inhibit p38 MAP kinase as a TherapeUtic target and moDify outcomes after an acute coronary syndromE trial","year":2015,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"Agence Nationale de la Recherche","keywords":"Medicine; TIMI; Myocardial infarction; Clinical endpoint; Acute coronary syndrome; Placebo; Clinical trial; Internal medicine; Revascularization; Percutaneous coronary intervention; Randomized controlled trial; Cardiology; Pathology","score_opus":0.03182720917543021,"score_gpt":0.28484970855990366,"score_spread":0.25302249938447346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014431943","genre_codex":"protocol","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.35193098,0.034780167,0.04226196,0.02790428,0.010295991,0.4793675,0.007769712,0.0005761344,0.04511331],"genre_scores_gemma":[0.6256144,0.0068038637,0.048475683,0.015782895,0.00366001,0.2905008,0.0014595889,0.00010398023,0.0075986777],"study_design_codex":"randomized_trial","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9895281,0.0069680545,0.00081437425,0.0010523198,0.00079999067,0.00083708763],"domain_scores_gemma":[0.9959227,0.0014135852,0.00074122736,0.00048943434,0.0004088636,0.0010242555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02615942,0.0029312717,0.004062269,0.00090692256,0.0013569961,0.0029601224,0.0014746618,0.0033893695,0.006692179],"category_scores_gemma":[0.011805129,0.0018027484,0.0029989902,0.0006694672,0.0035632825,0.001377877,0.0013400658,0.0058349823,0.002087693],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8337207,0.010728696,0.0071241986,0.0057418547,0.006811037,0.0003849295,0.0003804685,0.0050487863,0.011543486,0.029413262,0.006636137,0.08246643],"study_design_scores_gemma":[0.8108964,0.093534924,0.008857407,0.0016016817,0.0072963513,0.00023394704,0.00016313425,0.0044229752,0.0037378126,0.020679664,0.048366647,0.00020908851],"about_ca_topic_score_codex":0.00044315762,"about_ca_topic_score_gemma":0.0011382977,"teacher_disagreement_score":0.02615942,"about_ca_system_score_codex":0.0016467527,"about_ca_system_score_gemma":0.0050792806,"threshold_uncertainty_score":0.1383459},"labels":[],"label_agreement":null},{"id":"W2018807996","doi":"10.1038/jid.2015.11","title":"The Role of eIF4E in Response and Acquired Resistance to Vemurafenib in Melanoma","year":2015,"lang":"en","type":"article","venue":"Journal of Investigative Dermatology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"Canadian Institutes of Health Research; Plexxikon","keywords":"Vemurafenib; EIF4E; Melanoma; Cancer research; Cell culture; Cell growth; Biology; Translation (biology); Medicine; Messenger RNA; Genetics; Gene; Metastatic melanoma","score_opus":0.015278052005459864,"score_gpt":0.24610327934321893,"score_spread":0.23082522733775906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018807996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871393,0.009897452,0.0003623786,0.00039608913,0.00005136353,0.000011674364,0.00018818985,0.000027591599,0.0019260288],"genre_scores_gemma":[0.9982278,0.00090629,0.00012158947,0.000024590187,0.000011625401,0.0000047246353,0.000065000524,0.0000026126875,0.00063580385],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998956,0.000029192117,0.000011427557,0.000011775553,0.000019773466,0.00003219068],"domain_scores_gemma":[0.99991524,0.000019037869,0.000023788076,0.000007827191,0.000013024664,0.000021106263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028210424,0.00016368057,0.00020314321,0.00034050658,0.00018910626,0.00043363377,0.00015143563,0.00025957738,0.0012258558],"category_scores_gemma":[0.00042233092,0.00012849602,0.00021686473,0.00015735041,0.00015212497,0.0002661072,0.00020029666,0.0003565783,0.00015185612],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011105603,0.00045353975,0.05725999,0.00043172963,0.00020640712,0.0023761222,0.0002037205,0.0034647926,0.8561644,0.0017496182,0.0012457692,0.06533829],"study_design_scores_gemma":[0.00038363316,0.0024257994,0.6361329,0.00007839865,0.0002547843,0.0063397433,0.000795124,0.009833919,0.31805277,0.002102421,0.02355345,0.000047131303],"about_ca_topic_score_codex":0.00043537794,"about_ca_topic_score_gemma":0.00047721,"teacher_disagreement_score":0.0012258558,"about_ca_system_score_codex":0.00042242734,"about_ca_system_score_gemma":0.0001890866,"threshold_uncertainty_score":0.004100919},"labels":[],"label_agreement":null},{"id":"W2020620262","doi":"10.1016/j.ajpath.2014.11.021","title":"RSK1 Activation Promotes Invasion in Nodular Melanoma","year":2015,"lang":"en","type":"article","venue":"American Journal Of Pathology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; School of Medicine, New York University; National Institutes of Health; Melanoma Research Alliance; Chemotherapy Foundation; York University; American Skin Association","keywords":"Melanoma; Metastasis; Cancer research; Biology; Motility; Matrix metalloproteinase; Pathology; Tissue microarray; Nodular melanoma; Cancer; Immunohistochemistry; Medicine; Immunology; Cell biology","score_opus":0.017687117629509887,"score_gpt":0.251575593199775,"score_spread":0.23388847557026513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020620262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99637824,0.001200061,0.00042609926,0.00010376197,0.00003762808,0.000010079735,0.00021760864,0.00005757461,0.0015689712],"genre_scores_gemma":[0.9972601,0.0005347297,0.00020434421,0.000023325303,0.0000061165997,0.0000131202205,0.00023142008,0.000007479064,0.0017195524],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998909,0.000022572964,0.000007490817,0.000014933684,0.000023043918,0.000041092608],"domain_scores_gemma":[0.9999342,0.00000791953,0.00001751714,0.000009513501,0.0000046312734,0.000026244883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012759093,0.00029876374,0.00015563783,0.00018685558,0.0001609187,0.00030526132,0.00012475456,0.00017529905,0.002570165],"category_scores_gemma":[0.00010313566,0.00016246088,0.00029614367,0.0001039993,0.00014255849,0.00015775363,0.00021368636,0.00068899343,0.0007845044],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005666263,0.00010905225,0.00085651013,0.000067542074,0.000009660191,0.00012804406,0.000013947031,0.000098170385,0.9961951,0.00014824727,0.00021926376,0.0015880088],"study_design_scores_gemma":[0.00008531978,0.0011815309,0.04951716,0.000019929419,0.000055975695,0.0014270202,0.00022308475,0.0025265582,0.93840146,0.00020632577,0.0063427566,0.000012954389],"about_ca_topic_score_codex":0.00044061177,"about_ca_topic_score_gemma":0.0009190868,"teacher_disagreement_score":0.002570165,"about_ca_system_score_codex":0.00023778192,"about_ca_system_score_gemma":0.00018173596,"threshold_uncertainty_score":0.00859803},"labels":[],"label_agreement":null},{"id":"W2021563552","doi":"10.1007/s00018-010-0520-6","title":"Mechanistic principles of RAF kinase signaling","year":2010,"lang":"en","type":"review","venue":"Cellular and Molecular Life Sciences","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":72,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Lunenfeld-Tanenbaum Research Institute; Université de Montréal; Institute for Research in Immunology and Cancer","funders":"Canadian Institutes of Health Research","keywords":"Kinase; Cell biology; Receptor tyrosine kinase; Function (biology); Chemistry; Tyrosine kinase; Protein kinase domain; SH3 domain; Biology; Signal transduction; Biochemistry; Mutant; Gene","score_opus":0.04140567237559033,"score_gpt":0.28504004498691426,"score_spread":0.24363437261132392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021563552","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000380953,0.9895188,0.0030337656,0.0015969351,0.000904492,0.000014095953,0.00003053691,0.000033136443,0.004487298],"genre_scores_gemma":[0.0032251105,0.9914989,0.0016589443,0.00076576835,0.00059344777,0.000031599182,0.000043304135,0.000004280287,0.0021787337],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997528,0.00004080749,0.000024887471,0.000057955567,0.000083066305,0.000040479306],"domain_scores_gemma":[0.99986494,0.000057915764,0.000012886547,0.000010133546,0.000037039514,0.00001705631],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012360981,0.0016552048,0.0014728339,0.0015170124,0.0005759482,0.001968239,0.0022534162,0.0017595297,0.0017266269],"category_scores_gemma":[0.0006256117,0.00059683487,0.00053082366,0.0012783739,0.0024209332,0.002769706,0.0013799472,0.00454285,0.0018783227],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022222055,0.0002027695,0.00022698804,0.011049218,0.00011880415,0.0011704703,0.0001981107,0.0039507644,0.01906972,0.1290093,0.0434627,0.7913189],"study_design_scores_gemma":[0.00003440081,0.000047755057,0.00026037285,0.0011349459,0.00004765651,0.0012166133,0.000072836796,0.0005750323,0.003309261,0.047030427,0.94623864,0.000032024862],"about_ca_topic_score_codex":0.0009998112,"about_ca_topic_score_gemma":0.0012762023,"teacher_disagreement_score":0.0022534162,"about_ca_system_score_codex":0.001880039,"about_ca_system_score_gemma":0.0015176631,"threshold_uncertainty_score":0.013640642},"labels":[],"label_agreement":null},{"id":"W2021643794","doi":"10.1158/0008-5472.can-07-2976","title":"3′-Deoxy-3′-[18F]Fluorothymidine Positron Emission Tomography Is a Sensitive Method for Imaging the Response of BRAF-Dependent Tumors to MEK Inhibition","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institutes of Health; Golfers Against Cancer; National Cancer Institute; Samuel Waxman Cancer Research Foundation","keywords":"Cancer research; Cancer; Kinase; MEK inhibitor; Growth inhibition; Apoptosis; Positron emission tomography; Biology; MAPK/ERK pathway; Medicine; Internal medicine; Cell biology; Nuclear medicine; Biochemistry","score_opus":0.03009618755797126,"score_gpt":0.3947596411696007,"score_spread":0.36466345361162944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021643794","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6376494,0.052121792,0.28383267,0.001069034,0.00018824292,0.00029784345,0.00211751,0.0031670171,0.019556547],"genre_scores_gemma":[0.79368734,0.023649858,0.1669234,0.00058758346,0.00012814329,0.00046753715,0.0022210728,0.0002794986,0.0120555395],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997985,0.000057570996,0.000006720754,0.00006320592,0.00004198249,0.000032128],"domain_scores_gemma":[0.9998332,0.0000651688,0.000042717023,0.000016958164,0.00001944697,0.000022463902],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044654985,0.0007787889,0.0004977925,0.0008363564,0.00020622574,0.00044736703,0.000573598,0.0011534024,0.001369752],"category_scores_gemma":[0.00039968165,0.00059580815,0.00033593283,0.0004846356,0.00042860868,0.0004756838,0.0002162688,0.0007381861,0.0008643508],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012567188,0.00001623528,0.00050228596,0.00008470807,0.000012063861,0.00010256375,0.000015975467,0.00010919957,0.9937371,0.00014701851,0.00021067525,0.0049364986],"study_design_scores_gemma":[0.000051840565,0.0007080804,0.012900134,0.000025605883,0.00006101727,0.0034013363,0.000042751,0.0029580563,0.9670642,0.00021981819,0.012528519,0.000038535884],"about_ca_topic_score_codex":0.0018287766,"about_ca_topic_score_gemma":0.0025724606,"teacher_disagreement_score":0.0018287766,"about_ca_system_score_codex":0.0005788082,"about_ca_system_score_gemma":0.000266683,"threshold_uncertainty_score":0.0045822263},"labels":[],"label_agreement":null},{"id":"W2022204925","doi":"10.1074/jbc.m115.648097","title":"The Crystal Structure of Cancer Osaka Thyroid Kinase Reveals an Unexpected Kinase Domain Fold","year":2015,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Discovery Centre","funders":"Paul Scherrer Institut","keywords":"Kinase; Cyclin-dependent kinase 9; MAP2K7; Protein kinase domain; Mitogen-activated protein kinase kinase; MAP kinase kinase kinase; Protein kinase A; Biochemistry; Biology; ASK1; Cyclin-dependent kinase 2; Cell biology; Chemistry","score_opus":0.019906932317673185,"score_gpt":0.2682185433530814,"score_spread":0.2483116110354082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022204925","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9626419,0.015006247,0.0065340726,0.001667313,0.00030394242,0.00009322701,0.0021598455,0.0004265857,0.011166733],"genre_scores_gemma":[0.9739458,0.0069340966,0.0069221803,0.00040108053,0.00003342929,0.00005181231,0.0051160743,0.000058527057,0.0065369126],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99992085,0.000005844888,0.0000035795524,0.000019338442,0.00003414423,0.000016353233],"domain_scores_gemma":[0.99996305,0.000005213755,0.0000074495097,0.0000018873914,0.0000073198166,0.00001518971],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012191356,0.00037395727,0.0004483784,0.00011621141,0.00026058612,0.0005012521,0.00045849907,0.0004979567,0.0012967174],"category_scores_gemma":[0.00019231018,0.00021390468,0.00019310304,0.00032387525,0.0002544044,0.00034586168,0.0002790095,0.0010050117,0.0003492897],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010419119,0.0001621989,0.0044870637,0.0007442935,0.00012960107,0.002114424,0.000498057,0.006226446,0.9436084,0.0038915637,0.010634151,0.026461883],"study_design_scores_gemma":[0.0013999286,0.001517904,0.07192959,0.00021878557,0.0005627585,0.007946584,0.0014303817,0.09939419,0.5214058,0.00436748,0.28955123,0.0002753361],"about_ca_topic_score_codex":0.0051071104,"about_ca_topic_score_gemma":0.005671618,"teacher_disagreement_score":0.0051071104,"about_ca_system_score_codex":0.00074823183,"about_ca_system_score_gemma":0.0008476477,"threshold_uncertainty_score":0.010154784},"labels":[],"label_agreement":null},{"id":"W2022371765","doi":"10.2741/3003","title":"The RSK factors of activating the Ras/MAPK signaling cascade","year":2008,"lang":"en","type":"review","venue":"Frontiers in bioscience","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":222,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer","funders":"National Cancer Institute; Terry Fox Foundation","keywords":"MAPK/ERK pathway; Gene isoform; Ribosomal s6 kinase; Kinase; Cell biology; Biology; Signal transduction; Effector; Protein kinase A; MAPK cascade; Gene; Biochemistry; PI3K/AKT/mTOR pathway; P70-S6 Kinase 1","score_opus":0.030618619885792297,"score_gpt":0.28175283828594966,"score_spread":0.25113421840015737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022371765","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005976688,0.9926138,0.0010045553,0.0002512195,0.00023601532,0.000014016095,0.00003323574,0.000047618898,0.0052019428],"genre_scores_gemma":[0.0034941216,0.9917858,0.0008828505,0.00015701407,0.00020059913,0.00002384707,0.00007622036,0.0000047300014,0.003374735],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99986756,0.000017319075,0.000013539917,0.0000329488,0.000054506938,0.000014097908],"domain_scores_gemma":[0.9999298,0.000016792117,0.00001582227,0.000003822276,0.000020988027,0.000012762531],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025377044,0.0012336945,0.00076850347,0.0016754757,0.00027100186,0.00082203536,0.00075621513,0.00074448466,0.0028260883],"category_scores_gemma":[0.00022960236,0.00026623992,0.00030535823,0.0012009523,0.0005380074,0.0011251647,0.0005613862,0.0013590591,0.00453927],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008633872,0.00005622053,0.00017806514,0.0046590352,0.000042474774,0.00035441061,0.000052277217,0.0004150702,0.010209776,0.0061045703,0.0148068,0.9630349],"study_design_scores_gemma":[0.000020792517,0.000052832846,0.0007872675,0.00045692048,0.00003142122,0.0018564353,0.000035433444,0.000113652255,0.0050561177,0.002296721,0.9892755,0.000016950253],"about_ca_topic_score_codex":0.00059977674,"about_ca_topic_score_gemma":0.0009038829,"teacher_disagreement_score":0.0028260883,"about_ca_system_score_codex":0.00060003146,"about_ca_system_score_gemma":0.0005792069,"threshold_uncertainty_score":0.00945425},"labels":[],"label_agreement":null},{"id":"W2023276278","doi":"10.1007/s12032-015-0490-5","title":"ERK1/2 promoted proliferation and inhibited apoptosis of human cervical cancer cells and regulated the expression of c-Fos and c-Jun proteins","year":2015,"lang":"en","type":"article","venue":"Medical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":56,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"HeLa; Apoptosis; Cell cycle; Cell growth; MAPK/ERK pathway; Flow cytometry; Cancer research; Cell; Kinase; Western blot; Biology; Cancer; Cancer cell; Molecular biology; Chemistry; Cell biology; Biochemistry; Gene; Genetics","score_opus":0.019487647846426464,"score_gpt":0.285930108448547,"score_spread":0.2664424606021205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023276278","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866214,0.0037170425,0.001840517,0.00025409053,0.00008151017,0.000057530775,0.0005545507,0.00008736212,0.006785991],"genre_scores_gemma":[0.98864204,0.0024201293,0.00073903165,0.000071786526,0.000022803824,0.00004022111,0.00053696014,0.000009874597,0.0075171357],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999356,0.000008642532,0.0000034188672,0.00000754381,0.00001571622,0.00002901393],"domain_scores_gemma":[0.9999746,0.0000033474555,0.0000040150967,0.0000033991066,0.0000074520967,0.0000071329687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009061201,0.00040508673,0.00018053579,0.000408369,0.0002434203,0.00015655886,0.00012669594,0.00014496021,0.0025448133],"category_scores_gemma":[0.000064269516,0.00010810088,0.00026224655,0.00019559542,0.0001332504,0.00013451939,0.0001275767,0.0005265566,0.00043326296],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035435654,0.00016056596,0.00040008777,0.00013474179,0.000010902014,0.000120119315,0.000031860247,0.000103468075,0.9923119,0.00030669942,0.0002533969,0.005811788],"study_design_scores_gemma":[0.00006858732,0.00047948473,0.008671366,0.00001173441,0.000037678674,0.00060781714,0.00006707937,0.00092722866,0.98096174,0.00020227896,0.007957733,0.0000072121998],"about_ca_topic_score_codex":0.0008087264,"about_ca_topic_score_gemma":0.0016520134,"teacher_disagreement_score":0.0025448133,"about_ca_system_score_codex":0.00021923333,"about_ca_system_score_gemma":0.0003164324,"threshold_uncertainty_score":0.008513272},"labels":[],"label_agreement":null},{"id":"W2023821657","doi":"10.1371/journal.pone.0017578","title":"Cytoplasmic Skp2 Expression Is Increased in Human Melanoma and Correlated with Patient Survival","year":2011,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health; University of British Columbia; Vancouver Coastal Health Research Institute","funders":"CIHR Skin Research Training Centre; Canadian Institutes of Health Research; Michael Smith Health Research BC; Canadian Dermatology Foundation","keywords":"Melanoma; SKP2; Tissue microarray; Immunohistochemistry; Cancer research; Medicine; Cancer; Biomarker; Cell cycle; Pathology; Metastasis; Clinical significance; Oncology; Biology; Internal medicine; Ubiquitin; Gene; Ubiquitin ligase","score_opus":0.02843053325261224,"score_gpt":0.18975454579113782,"score_spread":0.16132401253852557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023821657","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986449,0.0006484008,0.00017835326,0.000019305959,0.000003463157,0.0000029958126,0.00018545857,0.000011722058,0.00030549432],"genre_scores_gemma":[0.99949396,0.00011862684,0.00007216302,0.0000052406144,0.0000038847047,0.0000035978837,0.00019520227,0.0000014156535,0.000105835716],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99989426,0.00002101949,0.000011386193,0.000030676765,0.000025858064,0.000016725913],"domain_scores_gemma":[0.99935406,0.00013656786,0.00033346313,0.000034183573,0.000067864254,0.00007384884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002300779,0.00016409594,0.00018007212,0.00040069586,0.00015424316,0.00024242622,0.000099303645,0.00019946783,0.0011829721],"category_scores_gemma":[0.00070451206,0.00010860199,0.00014177414,0.00041024643,0.00018238416,0.0001466743,0.00016979355,0.00020122931,0.00014916682],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065982516,0.000017825527,0.9787442,0.00004784268,0.000052265576,0.00039053624,0.000061607694,0.00014379363,0.016134422,0.000027286987,0.00014877823,0.003571631],"study_design_scores_gemma":[0.000007856373,0.0001053643,0.9952878,0.000005024972,0.000045980854,0.0018864172,0.000054583048,0.0002509403,0.0018903972,0.000041439736,0.00042122655,0.0000029391913],"about_ca_topic_score_codex":0.0003607702,"about_ca_topic_score_gemma":0.00045097884,"teacher_disagreement_score":0.0011829721,"about_ca_system_score_codex":0.00013042535,"about_ca_system_score_gemma":0.00009862372,"threshold_uncertainty_score":0.0039574504},"labels":[],"label_agreement":null},{"id":"W2025085818","doi":"10.1126/science.1158739","title":"Phosphorylation Networks Regulating JNK Activity in Diverse Genetic Backgrounds","year":2008,"lang":"en","type":"article","venue":"Science","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":123,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"Howard Hughes Medical Institute","keywords":"Phosphoproteomics; RNA interference; Computational biology; Phosphorylation; Biology; Gene; Kinase; Signal transduction; Genetics; Computer science; RNA; Protein phosphorylation; Protein kinase A","score_opus":0.019924909245367644,"score_gpt":0.2414477783580355,"score_spread":0.22152286911266786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025085818","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9808637,0.000063575586,0.017653346,0.00003353814,0.0000037165432,0.000026678974,0.00012818762,0.00014268077,0.0010846107],"genre_scores_gemma":[0.9868176,0.00017705548,0.012090948,0.000015256682,0.0000018057565,0.000054127926,0.0003471024,0.000029520845,0.0004664989],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998511,0.000028034385,0.00000942235,0.000040995856,0.000042709966,0.000027716735],"domain_scores_gemma":[0.9998425,0.00005825758,0.000044590983,0.000012914037,0.000018312148,0.000023356062],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030393244,0.00052231865,0.0002520711,0.00035318767,0.0002645474,0.00034242988,0.0003579642,0.00018501394,0.00053784816],"category_scores_gemma":[0.00057891797,0.00018535595,0.00028110578,0.00027159654,0.00029603048,0.0003467812,0.00032842017,0.0002938756,0.00010282642],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040555917,0.00012231962,0.0038487997,0.000072957744,0.000047654685,0.00021956304,0.00004174897,0.114391126,0.8658497,0.004296549,0.000119238044,0.010584827],"study_design_scores_gemma":[0.00007759932,0.00026828836,0.0101369815,0.0000067318297,0.00009685263,0.00018587612,0.00005929032,0.61879265,0.36382803,0.0054714833,0.0010369265,0.000039312858],"about_ca_topic_score_codex":0.0006785063,"about_ca_topic_score_gemma":0.0015644178,"teacher_disagreement_score":0.00070846826,"about_ca_system_score_codex":0.00070846826,"about_ca_system_score_gemma":0.00024501927,"threshold_uncertainty_score":0.005140364},"labels":[],"label_agreement":null},{"id":"W2025194227","doi":"10.1006/bbrc.2000.3009","title":"Stress-Activated Protein Kinase-Dependent Induction of c-fos by Cd2+ Is Mediated by MKK7","year":2000,"lang":"en","type":"article","venue":"Biochemical and Biophysical Research Communications","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University of Toronto","funders":"","keywords":"MAPK/ERK pathway; Kinase; Chemistry; c-Fos; Protein kinase A; Mitogen-activated protein kinase; p38 mitogen-activated protein kinases; Cell biology; MAP kinase kinase kinase; Signal transduction; Mitogen-activated protein kinase kinase; Molecular biology; Biology; Gene expression; Biochemistry; Gene","score_opus":0.03948262302550619,"score_gpt":0.3209071248978224,"score_spread":0.2814245018723162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025194227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932688,0.0014951645,0.0016837188,0.00026232484,0.000096852054,0.000031594664,0.0004115437,0.000093330666,0.0026566864],"genre_scores_gemma":[0.99266547,0.0007186655,0.0016171609,0.00008876276,0.000029082226,0.00006799132,0.00097574305,0.000024715568,0.0038122416],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99985766,0.00001827455,0.000009815181,0.000019035027,0.000026331394,0.000068877576],"domain_scores_gemma":[0.9998939,0.000014177072,0.000021213047,0.000010941599,0.000015111434,0.00004464021],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011803585,0.00047577653,0.00022887517,0.00022586704,0.00036294176,0.0003621047,0.00021757596,0.00021513866,0.0024304178],"category_scores_gemma":[0.00011279405,0.00017712846,0.00033742213,0.00015035708,0.00032428929,0.00026421796,0.00026615948,0.0006885756,0.00065433356],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004930593,0.000034080596,0.00012098325,0.00003543686,0.000004177145,0.0000389994,0.000011958396,0.000021096443,0.9984534,0.00011009674,0.00009629596,0.00058050564],"study_design_scores_gemma":[0.00006198693,0.00015770816,0.008253877,0.000007921926,0.000010542727,0.0001649591,0.000046807145,0.0005405325,0.9885516,0.00009744819,0.0021010723,0.0000055499872],"about_ca_topic_score_codex":0.0007808305,"about_ca_topic_score_gemma":0.0022137044,"teacher_disagreement_score":0.0024304178,"about_ca_system_score_codex":0.00054782664,"about_ca_system_score_gemma":0.00030953946,"threshold_uncertainty_score":0.00813055},"labels":[],"label_agreement":null},{"id":"W2025207475","doi":"10.1016/s0006-2952(01)00839-5","title":"Potentiation of cyclic AMP and cyclic GMP accumulation by p38 mitogen-activated protein kinase (p38MAPK) inhibitors in rat pinealocytes11Abbreviations: MAPK, mitogen-activated protein kinase; cAMP and cGMP, cyclic AMP and cyclic GMP, respectively; PKC, protein kinase C; IL-1β, interleukin-1β; IBMX, isobutylmethylxanthine; ISO, isoproterenol; PMA, 4β-phorbol 12-myristate 13-acetate; NE, norepinephrine; RIA, radioimmunoassay; DMEM, Dulbecco’s modified Eagle’s medium; PDE, phosphodiesterase; and CM, calmodulin.","year":2001,"lang":"en","type":"article","venue":"Biochemical Pharmacology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Medical Research Council Canada","keywords":"Protein kinase A; Pinealocyte; PDE10A; Phosphodiesterase; Phosphodiesterase 3; Rolipram; Cyclic nucleotide; Kinase; Phosphodiesterase inhibitor; Chemistry; Second messenger system; Endocrinology; Internal medicine; Biology; Biochemistry; Intracellular; Melatonin; Nucleotide; Enzyme; Pineal gland; Medicine","score_opus":0.01868846822094202,"score_gpt":0.27305437757822787,"score_spread":0.25436590935728587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025207475","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9707628,0.012358847,0.0026649602,0.00042194795,0.00026121206,0.00012610086,0.002395578,0.0001694906,0.010839197],"genre_scores_gemma":[0.9743627,0.0068030097,0.003747553,0.00017295589,0.000117626536,0.00019918171,0.0037004044,0.000045715336,0.010850731],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99975866,0.000025551026,0.000018825758,0.00003815037,0.00004386518,0.000114967945],"domain_scores_gemma":[0.99978286,0.00004306455,0.000036945985,0.00004159693,0.00003097182,0.00006459652],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023181965,0.0006165019,0.0003647411,0.00033333563,0.00037218432,0.00029958607,0.00034345518,0.00029544657,0.002977731],"category_scores_gemma":[0.0002638791,0.0002411861,0.0004890339,0.00028804183,0.00033903212,0.0003359618,0.0003087955,0.001050595,0.0010405087],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040903912,0.000115284696,0.000065673834,0.000086337,0.000004338195,0.00014969372,0.00005336481,0.0000277216,0.997532,0.00013042155,0.00011235292,0.0013137117],"study_design_scores_gemma":[0.000064762055,0.0011378974,0.009232211,0.000024500652,0.000022265971,0.00022099155,0.00007769424,0.000286082,0.9846683,0.00009081089,0.0041668806,0.0000075419152],"about_ca_topic_score_codex":0.0025973434,"about_ca_topic_score_gemma":0.0066114427,"teacher_disagreement_score":0.002977731,"about_ca_system_score_codex":0.0006092576,"about_ca_system_score_gemma":0.00047718384,"threshold_uncertainty_score":0.009961486},"labels":[],"label_agreement":null},{"id":"W2026319826","doi":"10.1074/jbc.m103883200","title":"Inhibition of Anti-IgM-induced Translocation of Protein Kinase C βI Inhibits ERK2 Activation and Increases Apoptosis","year":2001,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"National Cancer Institute; University of Toronto; Cancer Research Society","keywords":"Chromosomal translocation; Apoptosis; ASK1; Cell biology; Protein kinase A; Chemistry; Kinase; Cancer research; Mitogen-activated protein kinase kinase; Molecular biology; Biology; Biochemistry; Gene","score_opus":0.021906699576330194,"score_gpt":0.23843381210151635,"score_spread":0.21652711252518614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026319826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948147,0.0015733745,0.0012260742,0.00011130476,0.000040981427,0.000045267832,0.00045338535,0.00009976362,0.0016349737],"genre_scores_gemma":[0.9891201,0.002524606,0.0020166212,0.000105574814,0.000016358259,0.000114539194,0.0019956538,0.000030237019,0.0040761763],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99987614,0.000011786075,0.0000112046755,0.000020872847,0.000027727712,0.0000522407],"domain_scores_gemma":[0.99993455,0.000007858816,0.00002110641,0.0000068960207,0.000006711017,0.000022961649],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008964711,0.00058420515,0.00030377024,0.0002309912,0.00014126068,0.0002631909,0.0002576807,0.00022605149,0.0020173178],"category_scores_gemma":[0.000076180026,0.00014497666,0.0003081629,0.00020794732,0.00022909984,0.00016763531,0.00018777772,0.00093674415,0.0007569351],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021805472,0.000074965246,0.0000783966,0.000053127813,0.000007249861,0.000034325978,0.000007787361,0.00005136538,0.9982161,0.00004679936,0.000053080206,0.0011587521],"study_design_scores_gemma":[0.000033988224,0.0002885285,0.0021962938,0.0000059706663,0.000008587278,0.00015062527,0.000014903515,0.00040909208,0.99501824,0.000019916499,0.0018508103,0.0000030443862],"about_ca_topic_score_codex":0.0005106576,"about_ca_topic_score_gemma":0.000559219,"teacher_disagreement_score":0.0020173178,"about_ca_system_score_codex":0.00042765427,"about_ca_system_score_gemma":0.00030314416,"threshold_uncertainty_score":0.0067486167},"labels":[],"label_agreement":null},{"id":"W2029014360","doi":"10.1016/j.ahj.2012.07.030","title":"The Study Of LoSmapimod treatment on inflammation and InfarCtSizE (SOLSTICE): Design and rationale","year":2012,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Medicine; Solstice; Inflammation; Intensive care medicine; Internal medicine; Astronomy","score_opus":0.026097173621825946,"score_gpt":0.2767630739857006,"score_spread":0.25066590036387465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029014360","genre_codex":"empirical","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"protocol","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8924328,0.016742012,0.021404406,0.004959792,0.0018536012,0.040834248,0.004798815,0.00042701166,0.016547285],"genre_scores_gemma":[0.85653645,0.014630598,0.038284462,0.0029628046,0.0013214062,0.069424585,0.0018457875,0.00013140579,0.014862483],"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983557,0.0008230662,0.00012900177,0.00023659317,0.00017544057,0.00028019818],"domain_scores_gemma":[0.9993024,0.00015944653,0.000102763086,0.00009850956,0.00006693072,0.0002698427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046088784,0.002256246,0.002487256,0.0010562445,0.0012787714,0.0012229955,0.0015549717,0.0016105054,0.004971294],"category_scores_gemma":[0.0015403909,0.0009682033,0.0016506464,0.00077177444,0.002630674,0.0008253888,0.00086039095,0.0033552388,0.00090378046],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4500148,0.048604377,0.005973624,0.005134328,0.0015113637,0.0008531919,0.0006759452,0.0049451985,0.23588884,0.030797513,0.009646125,0.20595469],"study_design_scores_gemma":[0.33417845,0.46525237,0.0060653263,0.0006277843,0.0026340308,0.0005449618,0.0003168776,0.00388112,0.11398617,0.007119545,0.06512929,0.00026406115],"about_ca_topic_score_codex":0.0008849305,"about_ca_topic_score_gemma":0.0024517097,"teacher_disagreement_score":0.004971294,"about_ca_system_score_codex":0.0012768102,"about_ca_system_score_gemma":0.005127666,"threshold_uncertainty_score":0.024374425},"labels":[],"label_agreement":null},{"id":"W2029575024","doi":"10.1038/nm.2166","title":"Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma","year":2010,"lang":"en","type":"article","venue":"Nature Medicine","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":472,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of Calgary","funders":"National Cancer Institute; National Institute on Drug Abuse; Canadian Institutes of Health Research; Weill Cornell Medical College; Howard Hughes Medical Institute","keywords":"Cancer research; Fusion gene; Prostate cancer; Chromoplexy; Cancer; Biology; Anaplastic lymphoma kinase; Oncogene; Oncogene Proteins; Melanoma; Viral Oncogene; Gene; Medicine; Lung cancer; Regulation of gene expression; Genetics; PCA3; Cell cycle; Internal medicine","score_opus":0.005012724505159081,"score_gpt":0.25060741129418523,"score_spread":0.24559468678902616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029575024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98670924,0.0062287934,0.0007078758,0.0004426469,0.0000165112,0.0000068937047,0.00015586216,0.000042829284,0.0056894063],"genre_scores_gemma":[0.9970291,0.0015864832,0.00016619328,0.000025317884,0.000008400787,0.0000042568568,0.00006959414,0.00000514923,0.0011054376],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999294,0.000019706678,0.000004273134,0.000008693631,0.000016805152,0.000021086888],"domain_scores_gemma":[0.9999341,0.000015571926,0.000017857728,0.000008921445,0.00000692141,0.00001666369],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012913758,0.00014461961,0.00007991666,0.00059993885,0.00022765271,0.00029638602,0.00015987213,0.00024046443,0.001397595],"category_scores_gemma":[0.00020489864,0.00015818758,0.00010855415,0.00023331151,0.00025810336,0.00020355349,0.0002190309,0.00031406854,0.00019082571],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018389225,0.00007558296,0.021778626,0.00012420352,0.00004407647,0.0046866303,0.00018543196,0.00097117195,0.93435466,0.010644689,0.00082512625,0.024470791],"study_design_scores_gemma":[0.0002407488,0.0007835983,0.41477516,0.000052382693,0.00020328425,0.0562164,0.0011122933,0.0034883118,0.4636798,0.013531898,0.045856997,0.000059133738],"about_ca_topic_score_codex":0.0012101948,"about_ca_topic_score_gemma":0.0014372009,"teacher_disagreement_score":0.001397595,"about_ca_system_score_codex":0.0004036177,"about_ca_system_score_gemma":0.00023363119,"threshold_uncertainty_score":0.004675448},"labels":[],"label_agreement":null},{"id":"W2032490154","doi":"10.2174/157488406778249325","title":"Sorafenib (BAY 43-9006): Review of Clinical Development","year":2006,"lang":"en","type":"review","venue":"Current Clinical Pharmacology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Sorafenib; Medicine; Hepatocellular carcinoma; Rash; Pharmacology; Tyrosine-kinase inhibitor; Renal cell carcinoma; Internal medicine; Platelet-derived growth factor receptor; Oncology; Toxicity; Cancer; Receptor","score_opus":0.2477982877687997,"score_gpt":0.5447069939674991,"score_spread":0.2969087061986994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032490154","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00030770365,0.9976463,0.00022459993,0.0004155168,0.00020685433,0.00001015996,0.00003110671,0.000018848827,0.0011390396],"genre_scores_gemma":[0.0011143121,0.9969645,0.00043275047,0.00030140328,0.00018881819,0.000011712661,0.00007200216,0.000003079911,0.00091136387],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998393,0.00002445127,0.000024530402,0.0000321803,0.000063138854,0.000016319542],"domain_scores_gemma":[0.9997166,0.00008139683,0.00004607398,0.00000899489,0.00008708454,0.000059802805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007571364,0.0008953222,0.0015147467,0.0020433385,0.00023103655,0.0010568162,0.001219126,0.00084799435,0.0052628713],"category_scores_gemma":[0.0006768894,0.00034607554,0.0004201076,0.0024396714,0.0004125627,0.0015027133,0.0005687591,0.0014975857,0.0038057829],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000156449,0.0001123513,0.00012646303,0.0052346885,0.000041325347,0.00020248766,0.000022525377,0.00027983217,0.0015564983,0.0009533799,0.026435817,0.96487814],"study_design_scores_gemma":[0.00012139239,0.0003267941,0.0010293782,0.0018535921,0.00010454494,0.0015444913,0.00004241545,0.00014596246,0.0006323992,0.0010134791,0.9931666,0.000019049474],"about_ca_topic_score_codex":0.00074279064,"about_ca_topic_score_gemma":0.0018272775,"teacher_disagreement_score":0.0052628713,"about_ca_system_score_codex":0.0006362658,"about_ca_system_score_gemma":0.000971664,"threshold_uncertainty_score":0.01760608},"labels":[],"label_agreement":null},{"id":"W2033587656","doi":"10.2174/1381612023393053","title":"BAY 43-9006: Early Clinical Data in Patients with Advanced Solid Malignancies","year":2002,"lang":"en","type":"review","venue":"Current Pharmaceutical Design","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario; McMaster University Medical Centre","funders":"","keywords":"Medicine; Pharmacokinetics; Toxicity; Pharmacology; Bioavailability; Rash; Bay; Clinical trial; Diarrhea; Nausea; Refractory (planetary science); Gastrointestinal tract; Internal medicine; Oncology; Gastroenterology; Biology","score_opus":0.25302331392296024,"score_gpt":0.4456181802779548,"score_spread":0.19259486635499456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033587656","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018589265,0.9941208,0.0004394208,0.00039101127,0.00013114884,0.000016017475,0.000046737332,0.000039928622,0.0029560206],"genre_scores_gemma":[0.010026967,0.98613524,0.00054923625,0.0005560556,0.00020628775,0.000021909504,0.00010694527,0.0000067980395,0.0023905302],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99985874,0.00003025504,0.000017773134,0.00002858982,0.00005524556,0.00000949424],"domain_scores_gemma":[0.9997576,0.00010633404,0.00004164756,0.000008481251,0.0000548172,0.000031127056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064200413,0.000761561,0.0012527126,0.000644526,0.00012364534,0.00048787316,0.00059589813,0.00070193154,0.0027926592],"category_scores_gemma":[0.0006077981,0.00012729745,0.00028209566,0.0013255519,0.00021232442,0.00050905725,0.00024299805,0.0009274631,0.0024040556],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030636045,0.00006570596,0.00040921613,0.0038229376,0.000056791578,0.0002561652,0.00003809771,0.0002776264,0.0030187322,0.00042929922,0.009240615,0.9820786],"study_design_scores_gemma":[0.0003646646,0.0017794364,0.009343474,0.0017166049,0.0003912116,0.006301894,0.000062683815,0.0003317413,0.0040252213,0.00080710405,0.97484076,0.00003522338],"about_ca_topic_score_codex":0.00044120036,"about_ca_topic_score_gemma":0.0008954202,"teacher_disagreement_score":0.0027926592,"about_ca_system_score_codex":0.00033280792,"about_ca_system_score_gemma":0.00033430473,"threshold_uncertainty_score":0.009342372},"labels":[],"label_agreement":null},{"id":"W2034611095","doi":"10.1016/s0969-2126(03)00092-3","title":"Catalytically Active MAP KAP Kinase 2 Structures in Complex with Staurosporine and ADP Reveal Differences with the Autoinhibited Enzyme","year":2003,"lang":"en","type":"article","venue":"Structure","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":64,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Staurosporine; Kinase; Enzyme; Phosphorylation; p38 mitogen-activated protein kinases; Substrate (aquarium); Chemistry; Protein kinase A; Biochemistry; Binding site; Active site; Mitogen-activated protein kinase; Stereochemistry; Cell biology; Biophysics; Biology","score_opus":0.00728327123550606,"score_gpt":0.20553663548692255,"score_spread":0.1982533642514165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034611095","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956701,0.0009979443,0.0009988903,0.0002235091,0.000032203126,0.0000060871944,0.00027379816,0.000048528036,0.0017488897],"genre_scores_gemma":[0.99619824,0.00049608113,0.0007297991,0.000056336154,0.0000083697405,0.00000806793,0.0008374345,0.000020171816,0.0016455526],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999075,0.000009112073,0.0000053787744,0.000021657532,0.000029671812,0.000026724872],"domain_scores_gemma":[0.99983156,0.00004245585,0.00004326911,0.000015676054,0.000019721107,0.00004736622],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014868287,0.00046777213,0.00032858585,0.0002125225,0.00041720518,0.0007580012,0.00078390853,0.00058300555,0.0020354476],"category_scores_gemma":[0.00031945235,0.00044438167,0.0002550227,0.0003244631,0.00038040767,0.00063560065,0.00016664133,0.0015594956,0.00032484566],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013918311,0.000211353,0.0013514131,0.00022625964,0.00010960709,0.00089250994,0.00037188394,0.0034594522,0.9852555,0.0031109424,0.000991059,0.002628321],"study_design_scores_gemma":[0.0002360975,0.00038362227,0.018710295,0.000037480768,0.00009579094,0.0016840614,0.0003773313,0.0227653,0.9474858,0.001214454,0.00691658,0.000093336566],"about_ca_topic_score_codex":0.0036841827,"about_ca_topic_score_gemma":0.003823637,"teacher_disagreement_score":0.0036841827,"about_ca_system_score_codex":0.0013849918,"about_ca_system_score_gemma":0.0004602289,"threshold_uncertainty_score":0.010048866},"labels":[],"label_agreement":null},{"id":"W2035166330","doi":"10.1371/journal.pone.0075405","title":"Decreased Expression of Nuclear p300 Is Associated with Disease Progression and Worse Prognosis of Melanoma Patients","year":2013,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Melanoma; Tissue microarray; Cancer research; Cancer; Medicine; Metastasis; Oncology; Pathology; Nodular melanoma; Biology; Internal medicine","score_opus":0.012477188321729086,"score_gpt":0.19407130926080657,"score_spread":0.18159412093907748,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035166330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986557,0.0005130079,0.00021104631,0.00004324217,0.000005234971,0.000004093089,0.00016890887,0.000008850749,0.00038993766],"genre_scores_gemma":[0.9995221,0.00009311043,0.00009268315,0.000006878598,0.0000058496717,0.0000032060402,0.00012796132,0.0000015413734,0.00014667143],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999232,0.000012822202,0.000007297215,0.000024126659,0.000017468537,0.000014970928],"domain_scores_gemma":[0.99950397,0.000077219534,0.00023612552,0.00001938486,0.00006531306,0.000098005476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016727638,0.0001461615,0.00018120166,0.0003700866,0.00020732054,0.00024684236,0.00013748372,0.00018295094,0.0019590482],"category_scores_gemma":[0.0006751376,0.00007412386,0.00017939245,0.00031615075,0.00014187205,0.00015060876,0.00013295938,0.0003750898,0.00027113935],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007229461,0.000039656923,0.97993886,0.000035777095,0.0000491364,0.00035768998,0.000055959856,0.00009400711,0.011818728,0.00003657045,0.0002538381,0.006596758],"study_design_scores_gemma":[0.00000918858,0.00010830837,0.9966719,0.0000057090856,0.000045078486,0.0011967163,0.00005933666,0.0003730943,0.0010587319,0.000058335947,0.0004098734,0.0000036516828],"about_ca_topic_score_codex":0.00062741106,"about_ca_topic_score_gemma":0.00068561255,"teacher_disagreement_score":0.0019590482,"about_ca_system_score_codex":0.00014545368,"about_ca_system_score_gemma":0.00012358322,"threshold_uncertainty_score":0.0065537095},"labels":[],"label_agreement":null},{"id":"W2036442353","doi":"10.1016/j.ejmech.2014.07.018","title":"Towards the development of chromone-based MEK1/2 modulators","year":2014,"lang":"en","type":"article","venue":"European Journal of Medicinal Chemistry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"Vetenskapsrådet; Knut och Alice Wallenbergs Stiftelse; Svenska Forskningsrådet Formas; Cancer Research Society","keywords":"Chromone; Chemistry; Allosteric regulation; Kinase; Structure–activity relationship; In vitro; Lead compound; Protein kinase A; IC50; MAPK/ERK pathway; Drug discovery; Biochemistry; Stereochemistry; Enzyme","score_opus":0.014596002274801767,"score_gpt":0.21871213868301803,"score_spread":0.20411613640821627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036442353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.67220175,0.12054243,0.1335755,0.0045049055,0.0013036842,0.001305164,0.0018996715,0.0012263412,0.063440576],"genre_scores_gemma":[0.904594,0.053256694,0.022481171,0.0012534758,0.00014217259,0.00027604593,0.0007978134,0.000046787558,0.017151888],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99993443,0.0000127745725,0.000003334729,0.000012903455,0.000014549338,0.000022036202],"domain_scores_gemma":[0.99994874,0.000009445188,0.000010263395,0.000004453649,0.000010756663,0.000016399701],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036334113,0.00056635996,0.00025880663,0.00032416006,0.00021359509,0.00044516686,0.00053216994,0.00037524142,0.0032518033],"category_scores_gemma":[0.00019419611,0.00018487198,0.00021643651,0.00019650595,0.00031440318,0.0005787803,0.0004983409,0.001059539,0.0007465008],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012734977,0.00078833755,0.000624324,0.0019531331,0.000108274355,0.0010077242,0.00035422825,0.006830468,0.7873726,0.031992044,0.006905134,0.16079016],"study_design_scores_gemma":[0.0007407422,0.0054830695,0.0024391215,0.00034479494,0.00016979132,0.0013173397,0.00014929386,0.008232314,0.78995186,0.0072458046,0.18380356,0.00012233914],"about_ca_topic_score_codex":0.0006048667,"about_ca_topic_score_gemma":0.0021005275,"teacher_disagreement_score":0.0032518033,"about_ca_system_score_codex":0.00050238223,"about_ca_system_score_gemma":0.00048285574,"threshold_uncertainty_score":0.0108783245},"labels":[],"label_agreement":null},{"id":"W2036553455","doi":"10.1006/geno.2002.7013","title":"The Protein Kinase ERK3 Is Encoded by a Single Functional Gene: Genomic Analysis of the ERK3 Gene Family","year":2002,"lang":"en","type":"article","venue":"Genomics","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Institute for Advanced Research; Université de Montréal; Montreal Clinical Research Institute","funders":"","keywords":"Pseudogene; Biology; Genetics; Gene; Gene family; Cyclin-dependent kinase 4; Gene duplication; Exon; c-Raf; Protein kinase A; MAP2K7; Subfamily; Kinase; Molecular biology; Cyclin-dependent kinase 2; Gene expression; Genome","score_opus":0.015178651131607991,"score_gpt":0.18267258542509543,"score_spread":0.16749393429348744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036553455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898908,0.0010599068,0.006523886,0.0002862967,0.000017918166,0.000011295502,0.00083059847,0.000063185376,0.001316116],"genre_scores_gemma":[0.98513305,0.0011974714,0.0074427146,0.00011393767,0.00001231062,0.000019920575,0.0030267062,0.000040175903,0.003013693],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99996185,0.0000028800637,0.000001647267,0.000010302727,0.000010490062,0.000012855169],"domain_scores_gemma":[0.9999291,0.000014485989,0.0000166838,0.0000058845685,0.000012162878,0.00002165164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000668356,0.00028062752,0.00019429559,0.00022832154,0.00025051067,0.00020891038,0.0001923476,0.00020256278,0.00097439374],"category_scores_gemma":[0.00010718887,0.00010308639,0.00028733417,0.00022934134,0.00024370874,0.00021700787,0.00017795271,0.00058902265,0.0005081812],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017983277,0.00001148241,0.00035145626,0.000019034575,0.000002907877,0.00010333371,0.000010802394,0.000052604486,0.99705243,0.00030083975,0.00004835437,0.0018669672],"study_design_scores_gemma":[0.00002753888,0.00016241905,0.037027646,0.000012101984,0.000051534353,0.002593127,0.0001021462,0.0014421644,0.95014817,0.0012616807,0.007156976,0.000014589024],"about_ca_topic_score_codex":0.0013100498,"about_ca_topic_score_gemma":0.0014202821,"teacher_disagreement_score":0.0013100498,"about_ca_system_score_codex":0.000352111,"about_ca_system_score_gemma":0.00032257795,"threshold_uncertainty_score":0.0032596588},"labels":[],"label_agreement":null},{"id":"W2036813543","doi":"10.1016/j.coph.2014.07.015","title":"Recently targeted kinases and their inhibitors—the path to clinical trials","year":2014,"lang":"en","type":"review","venue":"Current Opinion in Pharmacology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":51,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health; Ontario Ministry of Economic Development and Innovation; Wellcome Trust","keywords":"Kinase; Clinical trial; Medicine; Drug development; Pharmacology; Computational biology; Drug; Bioinformatics; Biology; Internal medicine; Biochemistry","score_opus":0.22630475708816697,"score_gpt":0.5048450191155313,"score_spread":0.27854026202736426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036813543","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024019477,0.99356854,0.00052919734,0.002593296,0.0010786337,0.000016151056,0.000053470947,0.00002169179,0.0018988472],"genre_scores_gemma":[0.0023377992,0.9903536,0.00069773296,0.003375107,0.0010717171,0.000031234173,0.00011610304,0.0000074140335,0.0020091988],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997476,0.000056382556,0.000023919227,0.0000481454,0.00008634881,0.000037553076],"domain_scores_gemma":[0.9994797,0.00026505184,0.00005988987,0.000015622118,0.000098704135,0.000081053324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011709064,0.00089516514,0.0018598675,0.0008858737,0.00024025864,0.0014951655,0.0010891727,0.001567232,0.005418801],"category_scores_gemma":[0.0013213035,0.00028432813,0.0006269427,0.0009638729,0.00082694844,0.0020055454,0.0007650258,0.00552809,0.0026104667],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042541805,0.00017490436,0.00015375123,0.0063195257,0.00010643112,0.00021820283,0.000036289326,0.0006228312,0.0027302394,0.008681347,0.09443341,0.88609767],"study_design_scores_gemma":[0.0002740593,0.00030459618,0.0005520047,0.002773823,0.00014495337,0.00070936856,0.000041733518,0.00027706992,0.00061500876,0.00720046,0.9870777,0.000029115412],"about_ca_topic_score_codex":0.00061487267,"about_ca_topic_score_gemma":0.0023405745,"teacher_disagreement_score":0.005418801,"about_ca_system_score_codex":0.00088170316,"about_ca_system_score_gemma":0.001218553,"threshold_uncertainty_score":0.01812774},"labels":[],"label_agreement":null},{"id":"W2037838528","doi":"10.1016/j.devcel.2007.03.009","title":"Mek1/2 MAPK Kinases Are Essential for Mammalian Development, Homeostasis, and Raf-Induced Hyperplasia","year":2007,"lang":"en","type":"article","venue":"Developmental Cell","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":144,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; Canadian Institutes of Health Research; National Institutes of Health; Office of Research and Development","keywords":"Biology; MAPK/ERK pathway; Cell biology; Kinase; Phenotype; Phosphorylation; Gene isoform; Protein kinase A; Genetics; Gene","score_opus":0.013692200700371183,"score_gpt":0.2335265452977893,"score_spread":0.2198343445974181,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037838528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9682844,0.007873511,0.010430209,0.0006038773,0.00009428459,0.000041815958,0.001138938,0.0004277799,0.011105124],"genre_scores_gemma":[0.98692256,0.0017815917,0.0035293705,0.000043982425,0.0000182641,0.000017083717,0.0005898021,0.000035174635,0.007062225],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991024,0.000010993699,0.00000555722,0.00001571594,0.00002717046,0.000030311501],"domain_scores_gemma":[0.99989283,0.000009794926,0.000025513229,0.000013333046,0.00002157132,0.000036939095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011840313,0.0005089534,0.00013234172,0.0004884888,0.00037315174,0.00035785226,0.00020510524,0.00018949813,0.0015906049],"category_scores_gemma":[0.0001751228,0.00018521868,0.00016569212,0.00016380718,0.00022621878,0.00034023856,0.00028624732,0.0005897799,0.00063519424],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004717939,0.000028807719,0.00097154273,0.00007750583,0.0000075524895,0.0002858104,0.00003141072,0.00012542788,0.9887279,0.0021639268,0.00024511607,0.006863108],"study_design_scores_gemma":[0.00003027231,0.00015769369,0.021382011,0.000012102832,0.000028387125,0.00245321,0.00007011924,0.00097198744,0.95784825,0.0012750581,0.01575784,0.000013008241],"about_ca_topic_score_codex":0.0010443884,"about_ca_topic_score_gemma":0.0022125347,"teacher_disagreement_score":0.0015906049,"about_ca_system_score_codex":0.0005213572,"about_ca_system_score_gemma":0.00037248977,"threshold_uncertainty_score":0.005321145},"labels":[],"label_agreement":null},{"id":"W2038264590","doi":"10.1158/2159-8290.cd-12-0386","title":"Inhibiting EGF Receptor or SRC Family Kinase Signaling Overcomes BRAF Inhibitor Resistance in Melanoma","year":2012,"lang":"en","type":"article","venue":"Cancer Discovery","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":373,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"Cancer Research UK; Wellcome Trust","keywords":"Vemurafenib; Dasatinib; Cancer research; Src family kinase; Melanoma; Tyrosine kinase; EGFR inhibitors; Metastasis; Epidermal growth factor receptor; Gefitinib; Medicine; Signal transduction; Kinase; Proto-oncogene tyrosine-protein kinase Src; Biology; Cancer; Oncogene; Internal medicine; Cell cycle; Cell biology","score_opus":0.020317167747091056,"score_gpt":0.2606265288370754,"score_spread":0.24030936108998432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038264590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904108,0.0041812565,0.0022842444,0.00016269236,0.000074247044,0.00009887524,0.00035063495,0.00014428733,0.0022929627],"genre_scores_gemma":[0.99350387,0.0019130881,0.002044173,0.000053935913,0.00001582323,0.000045302357,0.00053111615,0.000021002998,0.001871793],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999006,0.000011454095,0.000010748803,0.0000141177225,0.000032819302,0.000030330293],"domain_scores_gemma":[0.9999553,0.000008044199,0.000011572748,0.0000074416334,0.0000071536765,0.000010497579],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014163267,0.0003083551,0.00031921818,0.00017114003,0.0001242403,0.00022684992,0.00023148947,0.00026018222,0.0013094548],"category_scores_gemma":[0.00007853212,0.0000939142,0.0003435847,0.00010472149,0.0001256357,0.000116784075,0.00013444707,0.00049474824,0.00039165758],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013715749,0.000112647,0.00031048956,0.000066296445,0.0000100454035,0.0000719567,0.000011301624,0.00015936971,0.99202675,0.00010899261,0.00011541593,0.0068695787],"study_design_scores_gemma":[0.00009007537,0.002171323,0.0038559167,0.000008117049,0.00003162272,0.0009807221,0.000015260832,0.0010842422,0.985254,0.000041313793,0.006461563,0.0000058427067],"about_ca_topic_score_codex":0.00040465756,"about_ca_topic_score_gemma":0.0007895913,"teacher_disagreement_score":0.0013094548,"about_ca_system_score_codex":0.0002102823,"about_ca_system_score_gemma":0.0001835464,"threshold_uncertainty_score":0.0043805838},"labels":[],"label_agreement":null},{"id":"W2038472314","doi":"10.1016/s0140-6736(14)60417-7","title":"Losmapimod, a novel p38 mitogen-activated protein kinase inhibitor, in non-ST-segment elevation myocardial infarction: a randomised phase 2 trial","year":2014,"lang":"en","type":"article","venue":"The Lancet","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":155,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"Agency for Healthcare Research and Quality; National Institutes of Health; Duke Clinical Research Institute; King's College London; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; Guy's and St Thomas' NHS Foundation Trust; Abbott Vascular; GlaxoSmithKline; AstraZeneca","keywords":"Medicine; Myocardial infarction; Placebo; Internal medicine; Adverse effect; Cardiology; Gastroenterology; ST segment; Heart failure; Natriuretic peptide; Pathology","score_opus":0.019417503229661348,"score_gpt":0.26140549362228505,"score_spread":0.2419879903926237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038472314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9606624,0.020977627,0.0013692093,0.0037424713,0.0016222188,0.0023294925,0.0026127722,0.000299112,0.0063847206],"genre_scores_gemma":[0.9618538,0.014382826,0.0017354279,0.004035512,0.0010672769,0.0036320996,0.0031994376,0.000054194898,0.010039487],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9997477,0.000100256984,0.000011676561,0.000041418687,0.000022676097,0.00007628749],"domain_scores_gemma":[0.9997085,0.00007178304,0.000047076737,0.000018234816,0.000018763767,0.0001356712],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010049825,0.0018138472,0.0022696434,0.00029497285,0.00026464983,0.0010078927,0.00065417145,0.0012411086,0.0064199455],"category_scores_gemma":[0.0009090915,0.00047590304,0.0014175255,0.00036735553,0.0007029357,0.0009880889,0.00031012375,0.0033228635,0.0010672229],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.93845826,0.003594218,0.0008326553,0.0014129292,0.0015407292,0.00010306002,0.000060397793,0.0007232614,0.007127457,0.00040105823,0.0046566697,0.041089438],"study_design_scores_gemma":[0.96969384,0.025901405,0.0018943431,0.00004387352,0.00039563255,0.000045641435,0.000026166837,0.00025503527,0.00028954784,0.00025565157,0.0011840936,0.000014765411],"about_ca_topic_score_codex":0.0010785984,"about_ca_topic_score_gemma":0.0030906205,"teacher_disagreement_score":0.0064199455,"about_ca_system_score_codex":0.00074345805,"about_ca_system_score_gemma":0.0007787243,"threshold_uncertainty_score":0.021476924},"labels":[],"label_agreement":null},{"id":"W2038496625","doi":"10.1139/o04-114","title":"Wiring diagrams of MAPK regulation by MEKK1, 2, and 3","year":2004,"lang":"en","type":"review","venue":"Biochemistry and Cell Biology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":101,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of General Medical Sciences","keywords":"MAPK/ERK pathway; Signal transduction; Cell biology; Kinase; Biology; MAP kinase kinase kinase; Phenotype; Protein kinase A; Neuroscience; Mitogen-activated protein kinase; Computational biology; Genetics; Gene","score_opus":0.01161571582897742,"score_gpt":0.24610419855307025,"score_spread":0.23448848272409284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038496625","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0053608143,0.9048896,0.039388947,0.0012389102,0.0007746804,0.00005797276,0.00022874617,0.00047110606,0.047589283],"genre_scores_gemma":[0.028766584,0.9312937,0.024752978,0.00040065957,0.00026883415,0.000109721266,0.00035140367,0.00004246453,0.014013671],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998809,0.000019970015,0.000013850066,0.000027646889,0.00005067274,0.0000069853827],"domain_scores_gemma":[0.9998882,0.000039963663,0.000022924745,0.00000807297,0.000032038042,0.000008863091],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023173967,0.00082085613,0.0005835123,0.0016962924,0.0003235506,0.0008299003,0.00074057124,0.0005452052,0.0031672493],"category_scores_gemma":[0.0003568451,0.0003159606,0.0002901094,0.0013936622,0.0006194864,0.0013905532,0.00032939063,0.00063945743,0.0020371045],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007401138,0.00003181994,0.00032088187,0.0071782963,0.00006320467,0.00061052176,0.00029161177,0.0049959123,0.027395563,0.14901482,0.018316729,0.7917066],"study_design_scores_gemma":[0.000011668763,0.000037782862,0.0006597925,0.0009526258,0.00005146193,0.0017424554,0.000076025346,0.0011238471,0.0069399746,0.05710308,0.93126726,0.000034012894],"about_ca_topic_score_codex":0.000729261,"about_ca_topic_score_gemma":0.0008974039,"teacher_disagreement_score":0.0031672493,"about_ca_system_score_codex":0.00081806927,"about_ca_system_score_gemma":0.00069221243,"threshold_uncertainty_score":0.0105955005},"labels":[],"label_agreement":null},{"id":"W2039322311","doi":"10.1371/journal.pone.0086681","title":"The Non-Classical MAP Kinase ERK3 Controls T Cell Activation","year":2014,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"Canadian Institutes of Health Research","keywords":"MAPK/ERK pathway; T cell; Cell biology; Kinase; T-cell receptor; CD8; Mitogen-activated protein kinase; Cytotoxic T cell; Protein kinase A; Biology; Molecular biology; Chemistry; Immune system; Immunology; In vitro; Biochemistry","score_opus":0.013894357291389702,"score_gpt":0.19432496822272616,"score_spread":0.18043061093133644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039322311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987189,0.002156933,0.0064047333,0.00012594144,0.00003814309,0.000020924783,0.00054127676,0.00016084667,0.0033622342],"genre_scores_gemma":[0.9961235,0.0007219672,0.0011807769,0.000024788707,0.000009092543,0.000011755499,0.00024524867,0.000019640269,0.0016631285],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998745,0.0000155221,0.000007902437,0.00002752845,0.000027734595,0.000046767174],"domain_scores_gemma":[0.9999229,0.000009160964,0.000024371271,0.000007466977,0.0000151511085,0.000020980395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009935129,0.0003595208,0.00014152142,0.00019696311,0.00021948222,0.00036194926,0.00022547222,0.00019270758,0.00160195],"category_scores_gemma":[0.0001319438,0.00011245339,0.0002294962,0.00017240808,0.00020875428,0.00031850353,0.00027853588,0.00044430266,0.0007045164],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022098563,0.000016298847,0.00052387145,0.00004303838,0.000004242376,0.0001108179,0.000015005754,0.00009230703,0.99643576,0.00027796507,0.00006929644,0.002190379],"study_design_scores_gemma":[0.000026010337,0.00013943118,0.023734037,0.000012262861,0.000016695902,0.0008557804,0.0000793342,0.0029742566,0.9670505,0.00096227066,0.004136323,0.000013020464],"about_ca_topic_score_codex":0.00022377924,"about_ca_topic_score_gemma":0.00030461999,"teacher_disagreement_score":0.00160195,"about_ca_system_score_codex":0.00028410403,"about_ca_system_score_gemma":0.00019148114,"threshold_uncertainty_score":0.005359113},"labels":[],"label_agreement":null},{"id":"W2040110061","doi":"10.1517/14728220802607363","title":"Melanoma: targeting signaling pathways and RaLP","year":2008,"lang":"en","type":"article","venue":"Expert Opinion on Therapeutic Targets","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Waterloo","keywords":"Melanoma; Metastatic melanoma; Medicine; Cancer research; Signal transduction; Disease; Cancer; Biology; Internal medicine; Genetics","score_opus":0.03357481669340083,"score_gpt":0.26063119984644734,"score_spread":0.2270563831530465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040110061","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16361687,0.7570295,0.019061245,0.014490854,0.0007790087,0.00021353716,0.0005387793,0.00059786,0.043672435],"genre_scores_gemma":[0.48044166,0.48859197,0.0107729025,0.0023496985,0.0005576128,0.00012346324,0.00048287012,0.000057281195,0.016622595],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99993646,0.000016309037,0.000003254425,0.000010937641,0.000017855964,0.000015245672],"domain_scores_gemma":[0.999977,0.0000051466664,0.0000069148186,0.0000014917496,0.0000042504457,0.0000051675293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018873482,0.00049978105,0.0002901614,0.00034102463,0.00016505914,0.00040782848,0.00021855129,0.00042895792,0.0016645335],"category_scores_gemma":[0.0000821302,0.00011750053,0.00019950604,0.00020937381,0.00028443412,0.0003147739,0.00026176596,0.0006574434,0.0008516691],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060874486,0.00018491244,0.0007562656,0.0028120656,0.000055370292,0.0026108387,0.00010922296,0.0011022337,0.78641856,0.010280657,0.008656714,0.18640442],"study_design_scores_gemma":[0.0002560825,0.0013670224,0.0073960884,0.00039404258,0.00020001107,0.016686136,0.00018504563,0.0029436012,0.5241778,0.009616637,0.43672952,0.00004804939],"about_ca_topic_score_codex":0.0005107601,"about_ca_topic_score_gemma":0.00080676837,"teacher_disagreement_score":0.0016645335,"about_ca_system_score_codex":0.0004724176,"about_ca_system_score_gemma":0.00031642907,"threshold_uncertainty_score":0.005568385},"labels":[],"label_agreement":null},{"id":"W2041648860","doi":"10.1016/s0014-4886(03)00101-8","title":"Inhibition of p38 mitogen-activated protein kinase interferes with cell shape changes and gene expression associated with Schwann cell myelination","year":2003,"lang":"en","type":"article","venue":"Experimental Neurology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":56,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Canadian Institutes of Health Research; Multiple Sclerosis Society; Multiple Sclerosis Society of Canada; ALS Association","keywords":"Protein kinase A; Schwann cell; Mitogen-activated protein kinase; Cell biology; Neuroscience; Gene expression; Gene; Cell; p38 mitogen-activated protein kinases; Kinase; Biology; Genetics","score_opus":0.00882924632211903,"score_gpt":0.2068816712628207,"score_spread":0.19805242494070166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041648860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934802,0.001448355,0.0017574312,0.000252531,0.000092390284,0.000041036077,0.00025134574,0.000101991085,0.0025748878],"genre_scores_gemma":[0.9942251,0.0009803574,0.0015014389,0.000039101706,0.000023194625,0.000072693,0.00021452659,0.000019471981,0.0029241103],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997317,0.0000417135,0.00001765742,0.00003205088,0.000048265727,0.00012859548],"domain_scores_gemma":[0.9998877,0.000028030277,0.000025178855,0.000016584123,0.000008313184,0.000034191842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001905439,0.00078624184,0.00031016485,0.00041390376,0.0004553072,0.00027807814,0.00042592624,0.0003593034,0.002339301],"category_scores_gemma":[0.00017966618,0.00026017727,0.0003597874,0.00030222215,0.00054486183,0.00025331043,0.00024536642,0.0009152893,0.00046066847],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010698435,0.00017198657,0.00011360075,0.000046197343,0.0000085516085,0.0001366403,0.000028395503,0.00011499993,0.99640024,0.00035398258,0.00008816762,0.0014673828],"study_design_scores_gemma":[0.000062018546,0.0005393527,0.0011891514,0.0000031098916,0.0000111418585,0.00017366977,0.00002909746,0.0004071267,0.9964348,0.00010336547,0.0010439702,0.000003156679],"about_ca_topic_score_codex":0.0011968976,"about_ca_topic_score_gemma":0.002076808,"teacher_disagreement_score":0.002339301,"about_ca_system_score_codex":0.0005217927,"about_ca_system_score_gemma":0.0005645264,"threshold_uncertainty_score":0.007825732},"labels":[],"label_agreement":null},{"id":"W2044257846","doi":"10.1615/critrevoncog.2014011899","title":"Raf Kinase Inhibitory Protein (RKIP): Functional Pleiotropy in the Mammalian Brain","year":2014,"lang":"en","type":"review","venue":"Critical Reviews™ in Oncogenesis","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Neuroscience; Protein kinase A; Context (archaeology); Biology; Kinase; Cell biology","score_opus":0.06036767630130355,"score_gpt":0.3526379026840249,"score_spread":0.2922702263827214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044257846","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00046077475,0.99736065,0.0002680416,0.00024981747,0.00012228693,0.000002756307,0.0000150335545,0.000012086184,0.0015085898],"genre_scores_gemma":[0.003109692,0.9952496,0.00043983146,0.00013458701,0.00015545198,0.0000061357446,0.000033941742,0.000002677205,0.00086798216],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999248,0.000008551825,0.000012041342,0.000019667199,0.000025485106,0.000009451736],"domain_scores_gemma":[0.99993026,0.000021097083,0.000015295209,0.0000027547644,0.000016952969,0.000013735009],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002504001,0.0006482954,0.00067919336,0.0012550104,0.00020330578,0.0005437842,0.0004025827,0.0005525308,0.0011787978],"category_scores_gemma":[0.00017998459,0.00017132616,0.00020428804,0.0010973185,0.0005806081,0.00078490603,0.00053948554,0.001176613,0.00136957],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011835318,0.000035780577,0.00035446192,0.007139364,0.000054662607,0.0006844654,0.00009848855,0.00031188305,0.020976374,0.007880091,0.011612471,0.9507336],"study_design_scores_gemma":[0.00001649548,0.00008433937,0.001842897,0.00067808875,0.000063824584,0.0050950563,0.00006635758,0.000078377736,0.0038546661,0.0027109492,0.985485,0.000023916788],"about_ca_topic_score_codex":0.00046070426,"about_ca_topic_score_gemma":0.0007667489,"teacher_disagreement_score":0.0012550104,"about_ca_system_score_codex":0.0004249172,"about_ca_system_score_gemma":0.00054473145,"threshold_uncertainty_score":0.003943503},"labels":[],"label_agreement":null},{"id":"W2045506400","doi":"10.1038/ncb2130","title":"AKAP-Lbc enhances cyclic AMP control of the ERK1/2 cascade","year":2010,"lang":"en","type":"article","venue":"Nature Cell Biology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":125,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health; Howard Hughes Medical Institute","keywords":"MAPK/ERK pathway; Protein kinase A; Cell biology; Scaffold protein; Kinase; MAPK cascade; Phosphorylation; IQGAP1; Signal transduction; Second messenger system; Mitogen-activated protein kinase kinase; Chemistry; c-Raf; Biology","score_opus":0.003011618706480639,"score_gpt":0.22528188726650886,"score_spread":0.2222702685600282,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045506400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99097085,0.0018296585,0.0016278932,0.0004455438,0.00014830139,0.0000373806,0.00046804495,0.00013372804,0.0043386747],"genre_scores_gemma":[0.99463487,0.00070949306,0.0012337657,0.00009037581,0.0000415413,0.000034304132,0.00033607826,0.0000246381,0.002895013],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997713,0.00004343924,0.000018736442,0.000027770162,0.000043986925,0.00009477954],"domain_scores_gemma":[0.99982685,0.000042785407,0.000024247918,0.000030704963,0.000020310577,0.00005521267],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024543944,0.00037724499,0.00027947273,0.0003401406,0.0002940813,0.0005386524,0.0003596113,0.00031759447,0.0029415258],"category_scores_gemma":[0.0003109957,0.00015835889,0.00030458948,0.00023968253,0.0002848662,0.0003730774,0.0003816716,0.0012723458,0.0008203287],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007265714,0.00010095929,0.000074381824,0.0000559017,0.000004656709,0.000073469826,0.00000860277,0.00009702773,0.9970643,0.00021769326,0.00011774364,0.0014586202],"study_design_scores_gemma":[0.000050749954,0.00018816789,0.0016509421,0.000005178702,0.0000078893445,0.00009617644,0.000015146724,0.0008144939,0.9957753,0.00007274243,0.0013183457,0.000004952861],"about_ca_topic_score_codex":0.0011409732,"about_ca_topic_score_gemma":0.0012717575,"teacher_disagreement_score":0.0029415258,"about_ca_system_score_codex":0.0006412629,"about_ca_system_score_gemma":0.00044247127,"threshold_uncertainty_score":0.009840369},"labels":[],"label_agreement":null},{"id":"W2046576482","doi":"10.1503/cmaj.130989","title":"New treatments for metastatic melanoma","year":2014,"lang":"en","type":"review","venue":"Canadian Medical Association Journal","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Dacarbazine; Medicine; Metastatic melanoma; Melanoma; Randomized controlled trial; Chemotherapy; Overall survival; Standard of care; Surgery; Oncology; Internal medicine; Cancer research","score_opus":0.019768470485664918,"score_gpt":0.29344630586354686,"score_spread":0.27367783537788193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046576482","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009122476,0.99708027,0.00012412343,0.0006388976,0.00047657936,0.000008882057,0.000031861786,0.000008694725,0.001539392],"genre_scores_gemma":[0.00086876756,0.99616635,0.00020897042,0.0009162032,0.00044904344,0.000011816252,0.00005336407,0.0000025678905,0.0013228427],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99974924,0.000041899668,0.000024415864,0.000045697176,0.00011469866,0.000024111512],"domain_scores_gemma":[0.9997925,0.0000820784,0.000034055334,0.0000077651475,0.00005536072,0.000028306922],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048875686,0.000820769,0.00095449743,0.0019586382,0.00032043023,0.00060105947,0.0008878807,0.0009701212,0.006841869],"category_scores_gemma":[0.00071150187,0.00021590783,0.00063721463,0.0009590773,0.000463931,0.0012081446,0.0006677725,0.0029254532,0.0025219363],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008893856,0.00007693152,0.00011296787,0.010063077,0.000070805756,0.0001767478,0.00003574204,0.0002214203,0.0012995531,0.0034007223,0.05621069,0.9282424],"study_design_scores_gemma":[0.000056105568,0.00012632545,0.00063255895,0.003636276,0.00008286379,0.0013076738,0.000029529068,0.000054838354,0.00025427467,0.0019744125,0.99182945,0.00001566655],"about_ca_topic_score_codex":0.0015865647,"about_ca_topic_score_gemma":0.0059594726,"teacher_disagreement_score":0.006841869,"about_ca_system_score_codex":0.00063496217,"about_ca_system_score_gemma":0.00072373694,"threshold_uncertainty_score":0.022888303},"labels":[],"label_agreement":null},{"id":"W2049211399","doi":"10.1161/01.cir.0000147773.86866.cd","title":"Inhibition of Vascular Smooth Muscle Cell Proliferation and Neointimal Formation in Injured Arteries by a Novel, Oral Mitogen-Activated Protein Kinase/Extracellular Signal–Regulated Kinase Inhibitor","year":2004,"lang":"en","type":"article","venue":"Circulation","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"MAPK/ERK pathway; Medicine; Vascular smooth muscle; Kinase; Neointima; Cell growth; Protein kinase A; Mitogen-activated protein kinase; Endocrinology; Cell biology; Internal medicine; Biology; Biochemistry; Restenosis; Smooth muscle","score_opus":0.00825379092483082,"score_gpt":0.19667467730987961,"score_spread":0.18842088638504878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049211399","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928697,0.0030813387,0.0024657915,0.000051320316,0.00004366803,0.00009995893,0.00027437546,0.00007374708,0.0010401839],"genre_scores_gemma":[0.9910348,0.003179187,0.0036127432,0.000045505385,0.00003501005,0.0001446812,0.0005052004,0.0000087644985,0.001434233],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999366,0.000007732567,0.0000090934645,0.000015760872,0.000014487202,0.000016261672],"domain_scores_gemma":[0.99996185,0.000004560207,0.000015033673,0.0000035571773,0.0000036114513,0.000011415668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000105613915,0.00062327634,0.00044620223,0.00029340977,0.0001227263,0.0002149734,0.00026478787,0.00026040955,0.0009520289],"category_scores_gemma":[0.00007966724,0.00015076595,0.00039020542,0.00016255729,0.00020276663,0.00020473068,0.00015346211,0.0007206241,0.00025208504],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001681617,0.00073450676,0.00029968715,0.00032395596,0.00003611497,0.00011157088,0.000018853423,0.00029873752,0.9842924,0.00011879761,0.00012713208,0.011956579],"study_design_scores_gemma":[0.0011229395,0.010227431,0.005786357,0.000023298422,0.00017708192,0.00064240023,0.00002300087,0.0013429283,0.97724026,0.000051485393,0.0033504262,0.000012437431],"about_ca_topic_score_codex":0.00018840721,"about_ca_topic_score_gemma":0.00045154666,"teacher_disagreement_score":0.0009520289,"about_ca_system_score_codex":0.0002066131,"about_ca_system_score_gemma":0.00023389753,"threshold_uncertainty_score":0.003184855},"labels":[],"label_agreement":null},{"id":"W2049723387","doi":"10.1021/bi0487692","title":"Identification of Key Residues in the A-Raf Kinase Important for Phosphoinositide Lipid Binding Specificity","year":2005,"lang":"en","type":"article","venue":"Biochemistry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency; University of Saskatchewan","funders":"","keywords":"Kinase; Phosphatidylinositol; Biochemistry; c-Raf; Cell biology; C2 domain; Phosphatidic acid; Signal transduction; Protein kinase domain; Mutant; Chemistry; Biology; Protein kinase A; Mitogen-activated protein kinase kinase; Membrane; Phospholipid","score_opus":0.01182483567150565,"score_gpt":0.24724713045454272,"score_spread":0.23542229478303706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049723387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892958,0.002862312,0.00494862,0.00015218153,0.00005970277,0.00007624384,0.00055318576,0.00006321307,0.001988717],"genre_scores_gemma":[0.9910546,0.0013069093,0.0048768083,0.000081893915,0.000022469447,0.00002945323,0.0009391687,0.000013138926,0.0016756365],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999325,0.000010087629,0.0000061216897,0.000016494927,0.000017836288,0.000016922993],"domain_scores_gemma":[0.99988747,0.000020236135,0.000027779852,0.000010334758,0.000018271749,0.00003588848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000096666095,0.00028972383,0.00017072931,0.00018193015,0.00016483974,0.00022592975,0.00030554374,0.00036150045,0.0012500004],"category_scores_gemma":[0.00019777929,0.00012266113,0.00023121813,0.000119510456,0.00019201482,0.00021278183,0.00015533301,0.00044366697,0.00080275413],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016562047,0.000036390073,0.00036454236,0.00002964494,0.000003650337,0.00012299407,0.000008856561,0.00010864433,0.99719244,0.00019145534,0.00004458937,0.0017311722],"study_design_scores_gemma":[0.00005392366,0.00038132744,0.024984155,0.000018005408,0.000033077245,0.001671332,0.000041057403,0.0027208317,0.9633657,0.00040065232,0.006313337,0.000016470462],"about_ca_topic_score_codex":0.00060139754,"about_ca_topic_score_gemma":0.0006608649,"teacher_disagreement_score":0.0012500004,"about_ca_system_score_codex":0.00023215033,"about_ca_system_score_gemma":0.00018423478,"threshold_uncertainty_score":0.004181683},"labels":[],"label_agreement":null},{"id":"W2051269487","doi":"10.1186/1471-2407-14-2","title":"Mitogen activated protein kinase kinase kinase 3 (MAP3K3/MEKK3) overexpression is an early event in esophageal tumorigenesis and is a predictor of poor disease prognosis","year":2014,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Surgical oncology; Hazard ratio; Internal medicine; Proportional hazards model; Survival analysis; Oncology; Esophageal cancer; Gastroenterology; Cancer; Confidence interval","score_opus":0.012966461517297384,"score_gpt":0.25176702367209697,"score_spread":0.23880056215479958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051269487","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979972,0.0011610969,0.00035266936,0.000053354423,0.000005501136,0.000004754357,0.00019366502,0.0000132487585,0.00021849666],"genre_scores_gemma":[0.9990163,0.00036441325,0.00025752152,0.000010968608,0.000006451569,0.0000037575937,0.00018080564,0.0000018328391,0.00015788026],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99992144,0.000012246683,0.0000070698648,0.000015259378,0.000024914492,0.00001910306],"domain_scores_gemma":[0.9997569,0.000054200227,0.00010556091,0.000009206865,0.00003414781,0.000039940696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017698984,0.00022554984,0.00016930692,0.0002482185,0.00015510773,0.00020783592,0.00011738394,0.00017086724,0.0012571567],"category_scores_gemma":[0.00029703553,0.000089822184,0.00017707204,0.00026270404,0.00017931139,0.00011681458,0.00018656398,0.00033477164,0.00024105115],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016357205,0.00007909242,0.8672252,0.0001884437,0.00014169683,0.00059326336,0.00005260487,0.00036990823,0.11639583,0.000058414505,0.00036169201,0.012897947],"study_design_scores_gemma":[0.000011122842,0.0001482022,0.97866994,0.000007890022,0.000060794693,0.0014844304,0.000049402082,0.00051327556,0.018266361,0.00006232495,0.00072194694,0.000004446178],"about_ca_topic_score_codex":0.00068304787,"about_ca_topic_score_gemma":0.00094311143,"teacher_disagreement_score":0.0012571567,"about_ca_system_score_codex":0.00024143734,"about_ca_system_score_gemma":0.00018648287,"threshold_uncertainty_score":0.0042055845},"labels":[],"label_agreement":null},{"id":"W2051557275","doi":"10.1074/jbc.m111.235275","title":"Distinct Functions of the Mitogen-activated Protein Kinase-activated Protein (MAPKAP) Kinases MK2 and MK3","year":2011,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Deutsche Forschungsgemeinschaft","keywords":"Kinase; Cell biology; STAT3; MAPK/ERK pathway; Gene expression; Signal transduction; Phosphorylation; Protein kinase A; Chemistry; Regulation of gene expression; Interferon; Biology; Molecular biology; Gene; Immunology; Biochemistry","score_opus":0.03176602623745515,"score_gpt":0.2213487305174324,"score_spread":0.18958270427997725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051557275","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97516555,0.007419435,0.013030887,0.0002715142,0.000077855286,0.00003838915,0.0008592748,0.00013042199,0.0030066741],"genre_scores_gemma":[0.9927771,0.0014585732,0.0031482324,0.00007564875,0.00002339081,0.000051518487,0.00059275544,0.000027859385,0.0018449366],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999851,0.000021836948,0.00001349343,0.000026231764,0.00003646928,0.000050942806],"domain_scores_gemma":[0.9998703,0.000015038963,0.000037049253,0.000013822895,0.000019947764,0.000043789034],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019987945,0.00068001944,0.00028176987,0.000227557,0.00022643222,0.00046904112,0.00022210465,0.00029673803,0.0012694962],"category_scores_gemma":[0.00013928527,0.00014392709,0.00057279767,0.00013304486,0.00026565345,0.00039646841,0.0005097521,0.0007273261,0.0005359353],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044280177,0.000018687435,0.00060914084,0.00010427081,0.000008728981,0.000101403624,0.00002982703,0.000121677156,0.99659926,0.000565806,0.000050047813,0.0013483677],"study_design_scores_gemma":[0.00004313328,0.00021971943,0.017694397,0.000015687858,0.00004844294,0.0012698105,0.000084919855,0.0019984718,0.9729307,0.0007388918,0.004939491,0.000016208829],"about_ca_topic_score_codex":0.00025347082,"about_ca_topic_score_gemma":0.0003274029,"teacher_disagreement_score":0.0012694962,"about_ca_system_score_codex":0.00035787976,"about_ca_system_score_gemma":0.00039157542,"threshold_uncertainty_score":0.0042468905},"labels":[],"label_agreement":null},{"id":"W2051858387","doi":"10.1016/j.jmb.2010.03.064","title":"The Crystal Structure of the Active Form of the C-Terminal Kinase Domain of Mitogen- and Stress-Activated Protein Kinase 1","year":2010,"lang":"en","type":"article","venue":"Journal of Molecular Biology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Zymeworks (Canada)","funders":"National Center for Research Resources; National Institute of Environmental Health Sciences; Hormel Foundation; National Cancer Institute; Basic Energy Sciences; Foundation for the National Institutes of Health","keywords":"Protein kinase A; Protein kinase R; Terminal (telecommunication); Chemistry; Mitogen-activated protein kinase kinase; Mitogen-activated protein kinase; Kinase; ASK1; Cell biology; Biochemistry; Biology; Computer science","score_opus":0.0037508788368404316,"score_gpt":0.22478102683772314,"score_spread":0.2210301480008827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051858387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9455463,0.0155821815,0.006388112,0.0045017367,0.0016509043,0.0001346992,0.0072334353,0.000400973,0.018561736],"genre_scores_gemma":[0.948944,0.009037532,0.008744114,0.0008524728,0.0001772676,0.000105828214,0.019460648,0.00008150745,0.012596636],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991095,0.000008257528,0.0000043377713,0.00001579827,0.000037915248,0.000022778837],"domain_scores_gemma":[0.9998354,0.000046452686,0.000027583636,0.000007065192,0.00003706633,0.00004653556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002980454,0.0004433226,0.00054392364,0.00016574094,0.0005097684,0.0009735438,0.0009373789,0.00062489806,0.002048786],"category_scores_gemma":[0.0005788664,0.00029705052,0.00018773673,0.0004041244,0.00032742816,0.0005468678,0.00020056959,0.0021507822,0.0005327279],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005060377,0.0015104655,0.011379416,0.0027383491,0.00031793574,0.0049496703,0.0014310426,0.023449812,0.73428386,0.028893407,0.10516988,0.080815814],"study_design_scores_gemma":[0.0034864384,0.0013628859,0.06933232,0.00048821277,0.0005682923,0.0057925885,0.0023428802,0.10831501,0.47357562,0.013109234,0.32114258,0.00048401562],"about_ca_topic_score_codex":0.0048376396,"about_ca_topic_score_gemma":0.0062721013,"teacher_disagreement_score":0.0048376396,"about_ca_system_score_codex":0.0013276404,"about_ca_system_score_gemma":0.0013987861,"threshold_uncertainty_score":0.009632707},"labels":[],"label_agreement":null},{"id":"W2052341771","doi":"10.1002/eji.200636620","title":"Pathologic expression of MHC class II is driven by mitogen‐activated protein kinases","year":2007,"lang":"en","type":"article","venue":"European Journal of Immunology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Institut National de la Santé et de la Recherche Médicale; Canadian Institutes of Health Research; Cancer Research Society; Association pour la Recherche sur le Cancer","keywords":"CIITA; MAPK/ERK pathway; Biology; Enhancer; Kinase; Transcription factor; Cancer research; Microphthalmia-associated transcription factor; Cell biology; Protein kinase A; MHC class I; MHC class II; Transactivation; Mitogen-activated protein kinase; Molecular biology; Major histocompatibility complex; Genetics; Gene","score_opus":0.009438724971073143,"score_gpt":0.2166225842017941,"score_spread":0.20718385923072094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052341771","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870417,0.0016913584,0.0072640367,0.00011290184,0.00006465476,0.00004052912,0.00031589722,0.00011970205,0.0033492572],"genre_scores_gemma":[0.99237704,0.00095071224,0.0028207733,0.00003386305,0.000015747059,0.000032490705,0.0005297577,0.000018710905,0.0032210248],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99987006,0.00001968697,0.0000072555463,0.000025845406,0.000041089163,0.000036004032],"domain_scores_gemma":[0.99991846,0.000012669882,0.000025761903,0.000010237414,0.000012133601,0.000020661693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011123555,0.00039729697,0.00012822833,0.000171922,0.000119397344,0.00020800425,0.00013402135,0.0001232101,0.0013934014],"category_scores_gemma":[0.000086625856,0.00010857175,0.0001644272,0.000077790064,0.00016506134,0.00011063228,0.00017886759,0.00047249172,0.00062566384],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014751088,0.000004758625,0.00005849551,0.00000932578,5.1191955e-7,0.000016456013,0.0000024098063,0.000007988311,0.9995772,0.000055201093,0.0000115163175,0.00024135371],"study_design_scores_gemma":[0.000009455573,0.0001106565,0.0036864681,0.0000065004,0.0000046327696,0.00033069844,0.000019921408,0.00057166547,0.99275523,0.000076024015,0.002426626,0.0000021186488],"about_ca_topic_score_codex":0.00023471584,"about_ca_topic_score_gemma":0.0002539505,"teacher_disagreement_score":0.0013934014,"about_ca_system_score_codex":0.0002818201,"about_ca_system_score_gemma":0.00015056784,"threshold_uncertainty_score":0.004661441},"labels":[],"label_agreement":null},{"id":"W2053089175","doi":"10.1007/s00403-012-1294-5","title":"Role of translocator protein in melanoma growth and progression","year":2012,"lang":"en","type":"article","venue":"Archives of Dermatological Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"Canadian Institutes of Health Research; Health Canada; National Institutes of Health","keywords":"Translocator protein; Immunohistochemistry; Melanoma; Carcinogenesis; Biology; Cytoplasm; Mitochondrion; Cancer research; Pathology; Tumor progression; Cell growth; Cancer; Medicine; Cell biology; Immunology; Inflammation; Biochemistry","score_opus":0.02712453352296963,"score_gpt":0.3214395937405405,"score_spread":0.29431506021757087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053089175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9721318,0.018082881,0.0041590068,0.0013970202,0.00013111637,0.000031717846,0.000516654,0.00025899487,0.003290801],"genre_scores_gemma":[0.9872729,0.004145232,0.0017252219,0.000069204114,0.00003097539,0.00002716624,0.00037106662,0.000039478837,0.006318753],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998678,0.000023918155,0.000012459542,0.000033088116,0.000028447077,0.000034228095],"domain_scores_gemma":[0.9998271,0.000028552186,0.000043954995,0.000022924436,0.000025697424,0.00005175708],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026477603,0.00040286276,0.00025104362,0.0004581517,0.000541073,0.00075851387,0.000244213,0.00070135953,0.0027025996],"category_scores_gemma":[0.0002736139,0.00024426077,0.00030013925,0.00017116859,0.00037765503,0.0010852809,0.0005115102,0.0007721099,0.001155248],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069372513,0.00004203378,0.00073800114,0.00006456237,0.000007689543,0.00057606935,0.00004125223,0.00008880603,0.9935975,0.0012112593,0.00019584758,0.0027432689],"study_design_scores_gemma":[0.00012086331,0.0005386752,0.027422698,0.000041331892,0.000054980974,0.0058315676,0.00038371194,0.004174579,0.9428613,0.0023442605,0.016188577,0.000037499703],"about_ca_topic_score_codex":0.0004862297,"about_ca_topic_score_gemma":0.00039768787,"teacher_disagreement_score":0.0027025996,"about_ca_system_score_codex":0.00061509537,"about_ca_system_score_gemma":0.00037000526,"threshold_uncertainty_score":0.009041071},"labels":[],"label_agreement":null},{"id":"W2053283364","doi":"10.1016/j.cellsig.2010.05.019","title":"Characterization of a novel MK3 splice variant from murine ventricular myocardium","year":2010,"lang":"en","type":"article","venue":"Cellular Signalling","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal; Montreal Heart Institute","funders":"Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada","keywords":"Messenger RNA; p38 mitogen-activated protein kinases; Biology; Cytoplasm; Molecular biology; Phosphorylation; Chemistry; Protein kinase A; Cell biology; Biochemistry; Gene","score_opus":0.008698175824077156,"score_gpt":0.19309891340231303,"score_spread":0.18440073757823588,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053283364","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917225,0.000500038,0.0059693176,0.00012568136,0.000064271335,0.000033620367,0.0007672032,0.0000566427,0.00076065114],"genre_scores_gemma":[0.98924154,0.00042873897,0.005330283,0.00010809657,0.000036327656,0.00003926743,0.0025996026,0.000059149672,0.0021570474],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999064,0.000009269893,0.000016785832,0.000023515551,0.000022953514,0.000020920472],"domain_scores_gemma":[0.99967194,0.000064408996,0.00010691845,0.000040646268,0.00004171976,0.00007444617],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013300325,0.00039824497,0.0002238394,0.00031029794,0.00018978056,0.00040607032,0.00036055225,0.000371776,0.0015415892],"category_scores_gemma":[0.00028509984,0.00021067384,0.00046572552,0.00012822406,0.00025297396,0.00018807751,0.00031672788,0.00063817337,0.0009805518],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000101838574,0.000008230909,0.00032039263,0.000017151482,0.00000652824,0.00044105126,0.000016461936,0.00002796368,0.9984486,0.00011740847,0.000020685146,0.00047354255],"study_design_scores_gemma":[0.00005842243,0.0003705923,0.021474428,0.00001623662,0.00011500148,0.007663798,0.00013143994,0.0013490136,0.9618491,0.00041944216,0.0065341694,0.00001830244],"about_ca_topic_score_codex":0.0003335181,"about_ca_topic_score_gemma":0.00039489756,"teacher_disagreement_score":0.0015415892,"about_ca_system_score_codex":0.00020975085,"about_ca_system_score_gemma":0.0001627049,"threshold_uncertainty_score":0.005157113},"labels":[],"label_agreement":null},{"id":"W2054151334","doi":"10.2310/7750.2013.13120","title":"Cutaneous Adverse Events during Vemurafenib Therapy","year":2014,"lang":"en","type":"review","venue":"Journal of Cutaneous Medicine and Surgery","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Women's College Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Vemurafenib; Medicine; Adverse effect; Keratoacanthoma; Discontinuation; Dermatology; Melanoma; Basal cell; Internal medicine; Metastatic melanoma; Cancer research","score_opus":0.03353372408600606,"score_gpt":0.29355354859090155,"score_spread":0.26001982450489547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054151334","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0030358708,0.99147546,0.0007529475,0.0003855709,0.00019984468,0.000020159663,0.00003554504,0.00003340963,0.0040611313],"genre_scores_gemma":[0.039816763,0.9549802,0.0006750863,0.0006976014,0.0005310109,0.000033441174,0.00012241365,0.0000082833285,0.003135121],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99967396,0.0000872504,0.000056403787,0.000044280874,0.00010569994,0.000032419328],"domain_scores_gemma":[0.99942005,0.00025491035,0.00016481592,0.000014078811,0.00010623794,0.00003992477],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047257802,0.0005308464,0.00090305216,0.00094717403,0.0002526777,0.0007152962,0.0004923654,0.00085300714,0.0018611541],"category_scores_gemma":[0.0012038024,0.00014186827,0.0004852992,0.00067132903,0.0002595123,0.00062235445,0.00035288036,0.0009885922,0.0007134414],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001655329,0.000057779762,0.0014386637,0.008935789,0.00014458799,0.006391653,0.00010944917,0.00058324146,0.0032111278,0.0010018486,0.012709009,0.96525127],"study_design_scores_gemma":[0.00016554495,0.000613276,0.016342297,0.008421543,0.00065698783,0.2035918,0.00031829916,0.0008353081,0.0065462217,0.001845086,0.76058406,0.00007959046],"about_ca_topic_score_codex":0.00054776715,"about_ca_topic_score_gemma":0.0011564431,"teacher_disagreement_score":0.0018611541,"about_ca_system_score_codex":0.00038598393,"about_ca_system_score_gemma":0.00042965243,"threshold_uncertainty_score":0.006226182},"labels":[],"label_agreement":null},{"id":"W2054312364","doi":"10.1158/0008-5472.can-13-1310","title":"MAPK Kinase 3 Is a Tumor Suppressor with Reduced Copy Number in Breast Cancer","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Beatrice Hunter Cancer Research Institute; Dalhousie University","funders":"Canadian Institutes of Health Research","keywords":"Suppressor; Breast cancer; Cancer research; Cancer; Cell cycle; Kinase; Cyclin-dependent kinase 4; MAPK/ERK pathway; Biology; Cell growth; Protein kinase A; Cyclin-dependent kinase 2; Cell biology; Genetics","score_opus":0.02897470359871875,"score_gpt":0.34534608945878104,"score_spread":0.3163713858600623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054312364","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99128926,0.002619991,0.0030275774,0.00032990606,0.00003917281,0.000014817476,0.0005776637,0.00023387953,0.0018677016],"genre_scores_gemma":[0.99631554,0.0006402727,0.00090826396,0.000033890487,0.000008494385,0.000009447756,0.00033694258,0.00001957193,0.0017275389],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999486,0.000006959185,0.0000042265174,0.000011373462,0.000021708383,0.000007167457],"domain_scores_gemma":[0.9999392,0.000011323118,0.000019956407,0.0000070572987,0.0000062502622,0.000016250244],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007515025,0.00020448683,0.00013280605,0.00039064893,0.00016916024,0.00016234693,0.0002037896,0.00019106787,0.0019503912],"category_scores_gemma":[0.00017309017,0.000101275655,0.00015634032,0.0002258662,0.00016559039,0.00010850241,0.00013484109,0.00030727987,0.0005926184],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014028496,0.000016220543,0.0010158857,0.000023687655,0.000007267772,0.0002247988,0.000010007951,0.00007973013,0.99515295,0.00019866085,0.00010585408,0.003024609],"study_design_scores_gemma":[0.00005730818,0.00033068733,0.05071915,0.000010317839,0.00008087671,0.011266193,0.000059234066,0.0027470991,0.92073363,0.0012789369,0.012701348,0.000015280382],"about_ca_topic_score_codex":0.00037252085,"about_ca_topic_score_gemma":0.00040592597,"teacher_disagreement_score":0.0019503912,"about_ca_system_score_codex":0.00024547923,"about_ca_system_score_gemma":0.00015682138,"threshold_uncertainty_score":0.006524682},"labels":[],"label_agreement":null},{"id":"W2054828913","doi":"10.1007/s40265-013-0014-6","title":"Mitogen-Activated Protein Kinases as Therapeutic Targets for Rheumatoid Arthritis","year":2013,"lang":"en","type":"review","venue":"Drugs","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":61,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Medicine; Rheumatoid arthritis; Druggability; Context (archaeology); Kinase; Immunology; Inflammation; Proinflammatory cytokine; Arthritis; MAPK/ERK pathway; Methotrexate; p38 mitogen-activated protein kinases; Pharmacology","score_opus":0.026024606140518408,"score_gpt":0.2893558393361413,"score_spread":0.2633312331956229,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054828913","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013740799,0.9977825,0.0002476405,0.00029575892,0.00028040615,0.000006973602,0.000025316049,0.000015004213,0.0012089009],"genre_scores_gemma":[0.0011830498,0.9966181,0.00035475875,0.00031705844,0.00027137867,0.000011382564,0.0000422479,0.0000030303652,0.0011990134],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998617,0.000020121995,0.000017165916,0.000021692094,0.000060161652,0.000019036359],"domain_scores_gemma":[0.99980325,0.00007769673,0.000037573045,0.0000071102186,0.000052138497,0.000022345883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050201867,0.0010598333,0.0014400629,0.0018978539,0.0002489041,0.00087798515,0.00085414003,0.0010235201,0.0032574248],"category_scores_gemma":[0.0005856753,0.00032525408,0.00039127024,0.001806712,0.00049120584,0.00094085146,0.00058275193,0.0024056002,0.0020014418],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016061959,0.0001165055,0.000107691216,0.008545343,0.000077820994,0.00024009885,0.000026659665,0.00048675435,0.0040642535,0.002956793,0.040129904,0.9430875],"study_design_scores_gemma":[0.000069838956,0.00013514151,0.0004933278,0.0012138814,0.00015563448,0.0010247675,0.000029875637,0.00020219466,0.0011475356,0.0017896345,0.9937192,0.000019105077],"about_ca_topic_score_codex":0.0008130016,"about_ca_topic_score_gemma":0.0030332967,"teacher_disagreement_score":0.0032574248,"about_ca_system_score_codex":0.0005708174,"about_ca_system_score_gemma":0.0007370176,"threshold_uncertainty_score":0.01089716},"labels":[],"label_agreement":null},{"id":"W2054913636","doi":"10.1158/1078-0432.ccr-14-0341","title":"Phase I Expansion and Pharmacodynamic Study of the Oral MEK Inhibitor RO4987655 (CH4987655) in Selected Patients with Advanced Cancer with <i>RAS–RAF</i> Mutations","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"KRAS; Medicine; MEK inhibitor; Colorectal cancer; Neuroblastoma RAS viral oncogene homolog; Melanoma; Cancer; Oncology; Internal medicine; Pharmacodynamics; Lung cancer; Adverse effect; Progressive disease; Cancer research; MAPK/ERK pathway; Pharmacokinetics; Kinase; Disease; Biology","score_opus":0.04652522395130103,"score_gpt":0.44238819226232884,"score_spread":0.3958629683110278,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054913636","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99724704,0.00033983777,0.00046955657,0.00007908818,0.000018643952,0.0012019994,0.00025790746,0.000035215664,0.0003507548],"genre_scores_gemma":[0.9950734,0.00030639305,0.0014737474,0.00028366927,0.000069399364,0.0012557874,0.00093918067,0.000018488916,0.0005799856],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9993555,0.00032562992,0.000031282583,0.00010518557,0.00007215172,0.00011013613],"domain_scores_gemma":[0.99911505,0.00014148808,0.00021649028,0.00012581667,0.00006054658,0.00034055876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018184485,0.0014567025,0.0014987035,0.00036908188,0.00037260962,0.0006195475,0.00074108806,0.0006738626,0.0018169509],"category_scores_gemma":[0.0010459024,0.00053686375,0.0009771758,0.00030844685,0.0007919008,0.00064485596,0.00037389345,0.0022813058,0.0005123255],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4257371,0.1581893,0.053967126,0.00053083966,0.0014033964,0.00072829076,0.00087085355,0.006542593,0.19105731,0.00028930878,0.0033949025,0.15728907],"study_design_scores_gemma":[0.15139188,0.7847955,0.046973206,0.00001829746,0.00038843317,0.0005912097,0.00009152273,0.0015093052,0.012070596,0.000108913366,0.0020251088,0.000036056077],"about_ca_topic_score_codex":0.0006457212,"about_ca_topic_score_gemma":0.0014026319,"teacher_disagreement_score":0.0018184485,"about_ca_system_score_codex":0.0008378141,"about_ca_system_score_gemma":0.0012769579,"threshold_uncertainty_score":0.009616971},"labels":[],"label_agreement":null},{"id":"W2054946171","doi":"10.1038/nrm3979","title":"Regulation of RAF protein kinases in ERK signalling","year":2015,"lang":"en","type":"review","venue":"Nature Reviews Molecular Cell Biology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":702,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal; Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Kinase; Allosteric regulation; MAPK/ERK pathway; Signalling; Cell biology; Function (biology); Suppressor; Phosphorylation; Chemistry; Biology; Biochemistry; Enzyme; Cancer; Genetics","score_opus":0.028283402185940106,"score_gpt":0.317174288496513,"score_spread":0.2888908863105729,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054946171","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018500292,0.99761546,0.00032345674,0.00038005813,0.000289424,0.0000038254025,0.0000161112,0.000009832418,0.001176887],"genre_scores_gemma":[0.0015498546,0.9969272,0.00023069422,0.00023746585,0.00021201756,0.0000055865366,0.000024809227,0.0000015049214,0.00081090064],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99982685,0.00002196824,0.000018266845,0.000028818245,0.000075748336,0.000028322962],"domain_scores_gemma":[0.99984574,0.000053982494,0.000025924806,0.0000069610173,0.00004570638,0.000021656155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000679295,0.0009460124,0.0010225758,0.0012775242,0.00027489255,0.0011452679,0.00094489305,0.0011354467,0.0020652686],"category_scores_gemma":[0.00047628244,0.00036939397,0.00034143517,0.0013005382,0.0008526946,0.0015560093,0.0010726603,0.0023011544,0.0018660314],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016726556,0.000061234074,0.00016656613,0.010099602,0.000088086126,0.00041727818,0.00007730591,0.0009038386,0.014086794,0.01498908,0.031906724,0.9270361],"study_design_scores_gemma":[0.000029541288,0.00004400527,0.0007338623,0.0014653463,0.000071524395,0.00080717506,0.000052352974,0.0001856343,0.0032024945,0.006211831,0.9871705,0.000025722326],"about_ca_topic_score_codex":0.0006163022,"about_ca_topic_score_gemma":0.0014664801,"teacher_disagreement_score":0.0020652686,"about_ca_system_score_codex":0.00080096733,"about_ca_system_score_gemma":0.00080319797,"threshold_uncertainty_score":0.006909013},"labels":[],"label_agreement":null},{"id":"W2056148985","doi":"10.1074/jbc.m705895200","title":"Glycogen Synthase Kinase-3β Induces Neuronal Cell Death via Direct Phosphorylation of Mixed Lineage Kinase 3","year":2007,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute","funders":"National Institute of General Medical Sciences; Canadian Institutes of Health Research","keywords":"GSK-3; Phosphorylation; Cell biology; Glycogen synthase; GSK3B; Kinase; Lineage (genetic); Protein kinase A; Biology; Chemistry; Biochemistry; Gene","score_opus":0.019935758585784908,"score_gpt":0.24206113815783603,"score_spread":0.2221253795720511,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056148985","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947619,0.0013857518,0.0011988776,0.000091977075,0.00003965676,0.00003341269,0.0003658252,0.000078001816,0.0020446195],"genre_scores_gemma":[0.99583364,0.0009888733,0.0007923414,0.00006584336,0.0000072652424,0.00006165606,0.0005270733,0.000010702543,0.0017126772],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99986124,0.000016126247,0.000017248187,0.000019893212,0.000041837196,0.000043625034],"domain_scores_gemma":[0.99994564,0.0000061009628,0.000016717171,0.0000068538866,0.0000054397597,0.00001920721],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001030743,0.00042852634,0.0002165585,0.00022590454,0.00014601203,0.00018707932,0.00019611644,0.00019501572,0.0011443949],"category_scores_gemma":[0.00008051092,0.00013792845,0.00035818046,0.00015872307,0.00018357196,0.00014876782,0.00023065138,0.0005911565,0.000365765],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018054608,0.000033673477,0.00017011631,0.00005198626,0.000008837845,0.00009847662,0.000014072351,0.000034103112,0.998412,0.00007951619,0.00004876839,0.00086797104],"study_design_scores_gemma":[0.00006123681,0.00048136245,0.008289589,0.000013278243,0.000022847744,0.0003975987,0.000041583546,0.0008006843,0.9880884,0.00012960001,0.0016682954,0.0000054626116],"about_ca_topic_score_codex":0.0006630234,"about_ca_topic_score_gemma":0.0011076011,"teacher_disagreement_score":0.0011443949,"about_ca_system_score_codex":0.00027274998,"about_ca_system_score_gemma":0.00027217768,"threshold_uncertainty_score":0.0038284063},"labels":[],"label_agreement":null},{"id":"W2056469580","doi":"10.1016/j.cellsig.2004.11.006","title":"A-Raf associates with and regulates platelet-derived growth factor receptor signalling","year":2004,"lang":"en","type":"article","venue":"Cellular Signalling","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency; University of Saskatchewan","funders":"National Cancer Institute; Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Terry Fox Foundation; Saskatchewan Cancer Agency","keywords":"Autophosphorylation; Platelet-derived growth factor receptor; GRB2; Cell biology; Receptor tyrosine kinase; Growth factor receptor; Tyrosine kinase; Chemistry; Tyrosine phosphorylation; Tropomyosin receptor kinase C; MAPK/ERK pathway; Cancer research; Signal transduction; Biology; Phosphorylation; Growth factor; Biochemistry; Receptor; Protein kinase A","score_opus":0.00993843304290545,"score_gpt":0.1904841164186484,"score_spread":0.18054568337574295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056469580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98545754,0.0039509465,0.002882649,0.00035078183,0.000059966962,0.000020247218,0.00019955027,0.00012152746,0.006956797],"genre_scores_gemma":[0.99095577,0.0014590175,0.0012709417,0.00008487287,0.00003243251,0.000019852178,0.0004701702,0.000033726756,0.0056731123],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99970454,0.000038643986,0.0000111670715,0.00004760904,0.000076859185,0.0001211397],"domain_scores_gemma":[0.9998865,0.000018924457,0.000027739688,0.000013823198,0.000019072939,0.000033902303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017309496,0.00043324064,0.00016754311,0.000495364,0.0007017968,0.0008065189,0.0004282827,0.00043802656,0.0020751858],"category_scores_gemma":[0.00028959787,0.00039798178,0.00042799846,0.00025162112,0.00030142625,0.0006858603,0.0006593723,0.00072609197,0.0020655969],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036174775,0.00004416728,0.0006519976,0.000057532958,0.00001428705,0.0003019705,0.00003227531,0.00012342857,0.9948573,0.001000955,0.00020486432,0.0023495136],"study_design_scores_gemma":[0.000061206156,0.00020104105,0.040682476,0.00002207066,0.000042428946,0.0027750956,0.0002234025,0.0043923804,0.9340626,0.0012047858,0.016295994,0.00003653347],"about_ca_topic_score_codex":0.0006365424,"about_ca_topic_score_gemma":0.0008079711,"teacher_disagreement_score":0.0020751858,"about_ca_system_score_codex":0.00053433754,"about_ca_system_score_gemma":0.0001664887,"threshold_uncertainty_score":0.0069422126},"labels":[],"label_agreement":null},{"id":"W2057255923","doi":"10.1016/s0960-9822(02)00831-x","title":"MAP Kinase Module: The Ksr Connection","year":2002,"lang":"en","type":"article","venue":"Current Biology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"","keywords":"Biology; Kinase; Cell biology; Mitogen-activated protein kinase; Computational biology; Connection (principal bundle); MAP kinase kinase kinase; MAPK/ERK pathway","score_opus":0.0330297781244277,"score_gpt":0.2636431814857027,"score_spread":0.230613403361275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057255923","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7281133,0.01789675,0.07398837,0.0067981947,0.001721847,0.00013948603,0.001456652,0.0033690433,0.16651632],"genre_scores_gemma":[0.95826566,0.004843289,0.0071091396,0.00051008404,0.00035135797,0.000032894983,0.00060671364,0.000077836026,0.02820307],"study_design_codex":"bench_or_experimental","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.999887,0.00001366143,0.0000052281066,0.00003947603,0.000027426071,0.00002718289],"domain_scores_gemma":[0.99991214,0.000010221984,0.000018414,0.00001615898,0.00001595197,0.000027159318],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012787765,0.00041668807,0.00030858745,0.00026221908,0.00030302224,0.0008510834,0.000610978,0.0006071511,0.00896793],"category_scores_gemma":[0.0002528992,0.00014215913,0.00020300243,0.00022682892,0.00035907587,0.0014998771,0.0006038731,0.00064848235,0.0054730703],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008789395,0.00018109518,0.001507724,0.00088789896,0.0000760687,0.0018317284,0.00014991529,0.0017555302,0.6396972,0.23243739,0.007901763,0.11269477],"study_design_scores_gemma":[0.00020383293,0.0007021105,0.013072781,0.00013740052,0.00013551643,0.007490933,0.00022053735,0.015631558,0.6055494,0.12966745,0.22705036,0.00013810913],"about_ca_topic_score_codex":0.0001369662,"about_ca_topic_score_gemma":0.0001185457,"teacher_disagreement_score":0.00896793,"about_ca_system_score_codex":0.00033035077,"about_ca_system_score_gemma":0.0002204993,"threshold_uncertainty_score":0.030000746},"labels":[],"label_agreement":null},{"id":"W2057923468","doi":"10.1074/jbc.m606225200","title":"Regulation of MAPK-activated Protein Kinase 5 Activity and Subcellular Localization by the Atypical MAPK ERK4/MAPK4","year":2006,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer","funders":"","keywords":"Protein kinase A; MAPK/ERK pathway; Kinase; HeLa; Phosphorylation; Cell biology; p38 mitogen-activated protein kinases; Cytoplasm; Chemistry; Biology; Biochemistry; Cell","score_opus":0.00992572397851768,"score_gpt":0.20629523351490142,"score_spread":0.19636950953638374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057923468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942227,0.0012668711,0.00307144,0.000043994747,0.000012152163,0.000007907723,0.000095674644,0.00003273755,0.0012464963],"genre_scores_gemma":[0.99628866,0.0004749295,0.0017532905,0.000013833882,0.000002441199,0.000009186483,0.00015278265,0.0000061515,0.0012987392],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999074,0.00002146773,0.0000075198145,0.000016887197,0.000022793141,0.00002393026],"domain_scores_gemma":[0.9999567,0.000006190238,0.000014291289,0.000004915438,0.0000071748395,0.000010699639],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008910464,0.00024034662,0.00007749286,0.00016983887,0.00011496307,0.00018400463,0.00012016545,0.00010539148,0.00089161727],"category_scores_gemma":[0.00008825351,0.00009831217,0.00014314968,0.00007496359,0.00013367164,0.00014284138,0.000180506,0.00022205953,0.00023860334],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005823644,0.000006344344,0.0002731384,0.000013216974,0.0000020830603,0.00002642519,0.0000038806024,0.000043041673,0.99867934,0.00012257633,0.000012532736,0.0007593179],"study_design_scores_gemma":[0.000006917559,0.00005040011,0.0074648606,0.0000022075292,0.000006310895,0.00016971667,0.000015557207,0.0010376284,0.9899753,0.00009729127,0.001171302,0.0000025064062],"about_ca_topic_score_codex":0.00028257264,"about_ca_topic_score_gemma":0.00049174903,"teacher_disagreement_score":0.00089161727,"about_ca_system_score_codex":0.0002732935,"about_ca_system_score_gemma":0.00009607007,"threshold_uncertainty_score":0.0029827952},"labels":[],"label_agreement":null},{"id":"W2059719338","doi":"10.1001/jamadermatol.2013.4200","title":"Vemurafenib and Radiosensitization","year":2013,"lang":"en","type":"article","venue":"JAMA Dermatology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":90,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec","funders":"","keywords":"Medicine; Vemurafenib; Dermatology; Medical physics; Cancer research; Melanoma; Metastatic melanoma","score_opus":0.004179907464712682,"score_gpt":0.1903157000028476,"score_spread":0.1861357925381349,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059719338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5023871,0.4431794,0.002917334,0.009134937,0.0006383176,0.00007226222,0.00024217754,0.000121463454,0.041306987],"genre_scores_gemma":[0.96512955,0.027489934,0.00037537116,0.0004567824,0.0003132368,0.000011098008,0.000083058236,0.0000044402254,0.0061364123],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998641,0.00005058604,0.000011774777,0.000019931249,0.00002997507,0.000023668536],"domain_scores_gemma":[0.9997594,0.00007016912,0.00012222769,0.000009498902,0.000015176076,0.00002353134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019889655,0.00018657181,0.00015548474,0.00023157599,0.0001769345,0.00039812486,0.0001624953,0.00047157696,0.0037978184],"category_scores_gemma":[0.00052474387,0.000063695974,0.00021012798,0.00017242154,0.00021414467,0.0002065853,0.00021061861,0.00043531548,0.00032901997],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056478,0.0013271319,0.11412617,0.0028774843,0.0005581192,0.046854798,0.00045757936,0.0036141078,0.12783825,0.026880281,0.016758505,0.6530598],"study_design_scores_gemma":[0.00059601356,0.0035366174,0.3129447,0.000622063,0.00038371002,0.22647166,0.000505281,0.007414662,0.09806589,0.022434391,0.32694957,0.000075496406],"about_ca_topic_score_codex":0.00061261066,"about_ca_topic_score_gemma":0.00066533155,"teacher_disagreement_score":0.0037978184,"about_ca_system_score_codex":0.0004236797,"about_ca_system_score_gemma":0.00020259984,"threshold_uncertainty_score":0.012705028},"labels":[],"label_agreement":null},{"id":"W2060163314","doi":"10.1074/jbc.m000312200","title":"Stress-induced Activation of Protein Kinase CK2 by Direct Interaction with p38 Mitogen-activated Protein Kinase","year":2000,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":144,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Mitogen-activated protein kinase kinase; ASK1; Protein kinase A; Protein kinase R; MAP kinase kinase kinase; MAP2K7; Cyclin-dependent kinase 9; Cyclin-dependent kinase 2; c-Raf; p38 mitogen-activated protein kinases; Cell biology; Chemistry; Mitogen-activated protein kinase; Kinase; Biology","score_opus":0.015578738641299661,"score_gpt":0.23696449889511084,"score_spread":0.22138576025381118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060163314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99058014,0.0037277704,0.0025223258,0.00016349029,0.000051767103,0.000029716406,0.00015027184,0.00004794263,0.0027265577],"genre_scores_gemma":[0.9960884,0.001129776,0.00096346013,0.000026813772,0.000019069836,0.000025250587,0.00016350238,0.000004682847,0.0015789854],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999915,0.000017011322,0.000005137158,0.000016624039,0.000019983654,0.000026184876],"domain_scores_gemma":[0.99995947,0.0000068558966,0.000010653584,0.0000057072625,0.000004711656,0.0000125975075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009430933,0.00050189276,0.00013666379,0.00012077534,0.00019808786,0.00020955017,0.000097211116,0.00013500577,0.0017131796],"category_scores_gemma":[0.00008979999,0.00009688749,0.00018385977,0.000101622565,0.00013773997,0.00020750762,0.00020360686,0.0002825651,0.0003186338],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008111762,0.000017885832,0.0001897275,0.00003602334,0.0000040191285,0.00004429091,0.000009592202,0.000022528837,0.9987913,0.00007831195,0.000036419337,0.0006888018],"study_design_scores_gemma":[0.000012695141,0.000121998535,0.005171964,0.0000036066772,0.000006098147,0.00023275004,0.000016192489,0.00046796177,0.99193305,0.00006510469,0.0019658534,0.0000027213907],"about_ca_topic_score_codex":0.00024133171,"about_ca_topic_score_gemma":0.0005369137,"teacher_disagreement_score":0.0017131796,"about_ca_system_score_codex":0.00023443693,"about_ca_system_score_gemma":0.00011805219,"threshold_uncertainty_score":0.0057311654},"labels":[],"label_agreement":null},{"id":"W2061091085","doi":"10.1371/journal.pone.0057185","title":"GADD45α Induction by Nickel Negatively Regulates JNKs/p38 Activation via Promoting PP2Cα Expression","year":2013,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Environmental Health Sciences; National Cancer Institute; National Institutes of Health; Queen's University; National Natural Science Foundation of China","keywords":"Gadd45; p38 mitogen-activated protein kinases; Cell biology; Ectopic expression; Downregulation and upregulation; DNA damage; MAPK/ERK pathway; Phosphorylation; Biology; Chemistry; Cell culture; Cell; Gene; Biochemistry; Cell cycle; Genetics; Cell cycle checkpoint; DNA","score_opus":0.02141665828696358,"score_gpt":0.20177932232774276,"score_spread":0.1803626640407792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061091085","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98641765,0.0036895636,0.0054475353,0.00021942891,0.0001198926,0.000044702683,0.0009451599,0.0002617374,0.0028543004],"genre_scores_gemma":[0.991987,0.0012296442,0.0020546878,0.0000845922,0.00001996946,0.00004004283,0.0008860191,0.000030034285,0.0036679478],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99980444,0.000015431839,0.00002361806,0.00005742214,0.000042827025,0.00005636737],"domain_scores_gemma":[0.99994123,0.0000027218616,0.000015831414,0.000007867929,0.0000097320635,0.000022505657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009088808,0.00042012925,0.00025074987,0.00018444043,0.00024379496,0.00037615243,0.00016511393,0.00015960421,0.0008842845],"category_scores_gemma":[0.000071234346,0.00016819121,0.00041235858,0.00015290227,0.000248633,0.000177746,0.0003300158,0.00047504352,0.00036277782],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000094025505,0.000017260052,0.0003257683,0.000075449505,0.0000058469154,0.000065826,0.000020390056,0.000022178077,0.99858725,0.00007124992,0.000062684325,0.00065219344],"study_design_scores_gemma":[0.000014984487,0.00009099943,0.011459072,0.000007407022,0.000016553258,0.00032758812,0.00004311692,0.0004142212,0.9835231,0.00007308203,0.0040248614,0.000005055849],"about_ca_topic_score_codex":0.00079777645,"about_ca_topic_score_gemma":0.0012271415,"teacher_disagreement_score":0.0008842845,"about_ca_system_score_codex":0.00029582958,"about_ca_system_score_gemma":0.00020652366,"threshold_uncertainty_score":0.0029582381},"labels":[],"label_agreement":null},{"id":"W2061339803","doi":"10.1007/s10555-013-9433-9","title":"Targeting MAPK pathway in melanoma therapy","year":2013,"lang":"en","type":"review","venue":"Cancer and Metastasis Reviews","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":96,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health Research Institute; University of British Columbia; Vancouver Coastal Health","funders":"Canadian Institutes of Health Research","keywords":"Vemurafenib; Melanoma; MAPK/ERK pathway; Medicine; Dabrafenib; Targeted therapy; Cancer research; Trametinib; Pharmacology; Drug resistance; Metastatic melanoma; Kinase; Cancer; Internal medicine; Biology","score_opus":0.0835042255553753,"score_gpt":0.34484216514126104,"score_spread":0.26133793958588575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061339803","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011286023,0.99796116,0.00024521886,0.00032853303,0.0003672134,0.0000063618886,0.000017152512,0.000014032648,0.00094743015],"genre_scores_gemma":[0.0008299344,0.9971445,0.0002946818,0.0003229577,0.0002898762,0.000010856085,0.000033561268,0.0000023058985,0.00107135],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99988365,0.000016946797,0.000012325142,0.000020370238,0.000049368646,0.000017355496],"domain_scores_gemma":[0.9998568,0.000052697837,0.00002099374,0.000004343879,0.00004271889,0.000022421198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044605826,0.0009504022,0.0012715093,0.0015028199,0.0002453103,0.00075030787,0.0007603452,0.00092508557,0.002947177],"category_scores_gemma":[0.0004977216,0.00030869633,0.00043805852,0.0011767149,0.00041018968,0.0009628852,0.0006451722,0.0025305746,0.0017129561],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001232724,0.000119079625,0.00010398055,0.0074701286,0.000065572895,0.00018418366,0.000024676001,0.00050935824,0.0041331504,0.0025865582,0.06726925,0.9174109],"study_design_scores_gemma":[0.000056589914,0.000116807576,0.0004921348,0.0014238424,0.00013371954,0.00081663707,0.000027550568,0.00028668076,0.0010663588,0.002006992,0.9935508,0.000021815235],"about_ca_topic_score_codex":0.001051977,"about_ca_topic_score_gemma":0.0033208919,"teacher_disagreement_score":0.002947177,"about_ca_system_score_codex":0.0006112407,"about_ca_system_score_gemma":0.0007830163,"threshold_uncertainty_score":0.0098593235},"labels":[],"label_agreement":null},{"id":"W2064854415","doi":"10.1042/bj20110289","title":"Regulation and function of the RSK family of protein kinases","year":2011,"lang":"en","type":"review","venue":"Biochemical Journal","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":376,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Biology; Gene isoform; Kinase; Effector; Cell biology; Ribosomal s6 kinase; Caenorhabditis elegans; Function (biology); Signal transduction; MAPK/ERK pathway; SH3 domain; Genetics; Receptor tyrosine kinase; Gene; PI3K/AKT/mTOR pathway; P70-S6 Kinase 1","score_opus":0.033976305682259504,"score_gpt":0.25459849156119935,"score_spread":0.22062218587893984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064854415","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018160518,0.995355,0.0004964383,0.00021143848,0.00010278463,0.000004969157,0.000030425354,0.0000135879845,0.0019693775],"genre_scores_gemma":[0.00929012,0.98807704,0.00056006206,0.00011152663,0.0001235764,0.0000116446945,0.00007726771,0.000003376689,0.0017453122],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998292,0.000023363813,0.000022618373,0.000040247614,0.000062350875,0.000022166134],"domain_scores_gemma":[0.9999138,0.000024963176,0.000019443642,0.0000047997223,0.000024165509,0.000012751682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035396797,0.00075514615,0.0007489288,0.0010557919,0.0001929166,0.0006982699,0.0006069289,0.00057086145,0.001008432],"category_scores_gemma":[0.00027937762,0.00024686754,0.00030506085,0.0008762472,0.00049255526,0.00084503926,0.00045037418,0.0010930956,0.0016854046],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026044642,0.00006746153,0.0007287952,0.009029737,0.00013818269,0.00077240437,0.0001217551,0.0013962872,0.052807055,0.009249527,0.0125169195,0.9129114],"study_design_scores_gemma":[0.000035875546,0.0000966206,0.003623055,0.00063336606,0.00008298065,0.0037462015,0.00005909403,0.000359024,0.01916554,0.0033628424,0.9688035,0.00003186978],"about_ca_topic_score_codex":0.00048397432,"about_ca_topic_score_gemma":0.000653477,"teacher_disagreement_score":0.0010557919,"about_ca_system_score_codex":0.0008020878,"about_ca_system_score_gemma":0.00056649436,"threshold_uncertainty_score":0.005819559},"labels":[],"label_agreement":null},{"id":"W2065973638","doi":"10.1038/modpathol.3800206","title":"Ets-1 transcription factor is widely expressed in benign and malignant melanocytes and its expression has no significant association with prognosis","year":2004,"lang":"en","type":"article","venue":"Modern Pathology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Royal University Hospital","funders":"","keywords":"Immunohistochemistry; Melanoma; Medicine; Pathology; Breslow Thickness; Correlation; Exact test; Mann–Whitney U test; Spearman's rank correlation coefficient; Oncology; Internal medicine; Cancer; Cancer research","score_opus":0.02021665198394415,"score_gpt":0.21697667410773983,"score_spread":0.19676002212379567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065973638","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934823,0.0038189027,0.0007400425,0.00008347444,0.000021400529,0.000004676884,0.00027027825,0.00001998833,0.001558818],"genre_scores_gemma":[0.9975331,0.00090800074,0.00014740191,0.00001201284,0.00001910815,0.0000039514903,0.0002536577,0.0000043873324,0.0011183324],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998535,0.000029185432,0.000016939708,0.000027225356,0.00004639265,0.000026732147],"domain_scores_gemma":[0.99944955,0.00019720389,0.00015494545,0.000039400213,0.00008253172,0.00007644417],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029405722,0.00021562948,0.00024009902,0.00052060385,0.00019248831,0.00026464072,0.00019252741,0.00023970584,0.0026415475],"category_scores_gemma":[0.00061299145,0.00010132791,0.00019706566,0.00046142968,0.00026040408,0.00028168794,0.00023148525,0.00025618126,0.00044671865],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017514179,0.0000729557,0.71875894,0.00020157821,0.00019704353,0.0015464051,0.0003115243,0.00018301644,0.23898731,0.00059249584,0.00035998394,0.037037387],"study_design_scores_gemma":[0.00001682433,0.0003013975,0.95926595,0.000021482843,0.00013975614,0.006491822,0.00029067716,0.0003959616,0.028367853,0.00080613623,0.003886924,0.000015256764],"about_ca_topic_score_codex":0.00033831774,"about_ca_topic_score_gemma":0.00033769585,"teacher_disagreement_score":0.0026415475,"about_ca_system_score_codex":0.00013920401,"about_ca_system_score_gemma":0.00012260172,"threshold_uncertainty_score":0.008836865},"labels":[],"label_agreement":null},{"id":"W2066436694","doi":"10.1016/s1056-8719(00)00118-0","title":"Simultaneous measurement of ERK, p38, and JNK MAP kinase cascades in vascular smooth muscle cells","year":2000,"lang":"en","type":"article","venue":"Journal of Pharmacological and Toxicological Methods","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute; Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"Kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; MAP2K7; MAPK14; p38 mitogen-activated protein kinases; Chemistry; Protein kinase C; MAP kinase kinase kinase; Protein kinase A; Cyclin-dependent kinase 9; Molecular biology; MAPK/ERK pathway; cGMP-dependent protein kinase; Cyclin-dependent kinase 2; Mitogen-Activated Protein Kinase 3; Phosphorylation; Cell biology; Biochemistry; Biology","score_opus":0.03474266798551937,"score_gpt":0.3323664458268894,"score_spread":0.29762377784137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066436694","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94437605,0.0032943303,0.04604868,0.00031379593,0.00021971515,0.00011941093,0.0006508982,0.00016997647,0.0048071644],"genre_scores_gemma":[0.93917626,0.0031152684,0.046539057,0.00016869305,0.00010065392,0.0006541504,0.0013041227,0.000038179987,0.008903621],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997036,0.000038482205,0.0000216855,0.00006995499,0.0000897935,0.000076479344],"domain_scores_gemma":[0.9998691,0.000024513265,0.0000141750315,0.000020258123,0.000033142733,0.000038829086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034156765,0.00040559735,0.00022169924,0.00035495323,0.00049952505,0.0002655309,0.0003000474,0.00028334634,0.0012250539],"category_scores_gemma":[0.00016400755,0.00025078093,0.00030333237,0.00043908617,0.000266888,0.00043440395,0.00031154236,0.0012730719,0.00030166053],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014981792,0.00003589603,0.000097823184,0.000027473901,0.0000040951863,0.000020170444,0.000022229084,0.00001847253,0.9986644,0.0001398685,0.000029078643,0.00079077954],"study_design_scores_gemma":[0.000043032738,0.00031831962,0.0052292557,0.000007683514,0.000038017784,0.00014416396,0.000057055833,0.0010864801,0.9913463,0.00017213653,0.0015507424,0.0000068175],"about_ca_topic_score_codex":0.0005510658,"about_ca_topic_score_gemma":0.0016452334,"teacher_disagreement_score":0.0012250539,"about_ca_system_score_codex":0.00027907893,"about_ca_system_score_gemma":0.0003829503,"threshold_uncertainty_score":0.0040982366},"labels":[],"label_agreement":null},{"id":"W2068645642","doi":"10.1016/s0960-894x(01)00238-4","title":"MEK (MAPKK) inhibitors. Part 2: structure–activity relationships of 4-anilino-3-cyano-6,7-dialkoxyquinolines","year":2001,"lang":"en","type":"article","venue":"Bioorganic & Medicinal Chemistry Letters","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Chemistry; Linker; Kinase; Structure–activity relationship; Stereochemistry; Methylene; Aniline; Enzyme inhibitor; Protein kinase A; Enzyme; Biochemistry; In vitro; Medicinal chemistry; Organic chemistry","score_opus":0.016883754146990112,"score_gpt":0.2186558177986337,"score_spread":0.20177206365164357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068645642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86312175,0.10633854,0.0077102934,0.0006660362,0.00032899977,0.00041317384,0.0024282786,0.00041066066,0.018582217],"genre_scores_gemma":[0.9454603,0.035881758,0.0036778199,0.00036177196,0.00010546162,0.00021944988,0.0025004917,0.000034218887,0.011758713],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999329,0.000014160707,0.000006367932,0.000008781253,0.000015973264,0.000021854195],"domain_scores_gemma":[0.99994886,0.000014490088,0.000009794709,0.0000041033095,0.000009438884,0.000013325975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023027057,0.0004984055,0.00030493407,0.00034195947,0.00012113727,0.00016009256,0.00037628133,0.00018753223,0.0022065674],"category_scores_gemma":[0.00017693163,0.00019262143,0.00032998028,0.00018492575,0.00011033855,0.00019140428,0.0001287002,0.00048591627,0.00073824776],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001607206,0.00066979113,0.00038857202,0.0005057896,0.00009407815,0.00016802445,0.00006179784,0.0021693993,0.94539744,0.0007781767,0.002262674,0.045897033],"study_design_scores_gemma":[0.0016878579,0.009297324,0.009152206,0.00006527861,0.00031148116,0.0014848483,0.00003799086,0.0025392321,0.9253301,0.0004313931,0.04959954,0.0000627925],"about_ca_topic_score_codex":0.00066297915,"about_ca_topic_score_gemma":0.0016919377,"teacher_disagreement_score":0.0022065674,"about_ca_system_score_codex":0.00032826833,"about_ca_system_score_gemma":0.00017353438,"threshold_uncertainty_score":0.0073816776},"labels":[],"label_agreement":null},{"id":"W2070028004","doi":"10.1016/j.jval.2014.03.485","title":"Cost Effectiveness of Trametinib as First-Line (1l) Treatment for Braf V600 Positive Advanced or Metastatic Melanoma — A Canadian Societal Perspective","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Trametinib; Dacarbazine; Vemurafenib; Medicine; Internal medicine; Oncology; Melanoma; Metastatic melanoma; Chemotherapy; Cancer research; Biology","score_opus":0.0471651896086674,"score_gpt":0.34261534361423285,"score_spread":0.29545015400556546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070028004","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24846071,0.17080727,0.0021808203,0.40648997,0.00269244,0.00025917476,0.029111017,0.0001484529,0.13985017],"genre_scores_gemma":[0.9309218,0.047061935,0.0016658161,0.010436781,0.0011907321,0.00004699826,0.0038210433,0.000038393704,0.0048164236],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99691015,0.0007930323,0.00012618503,0.0001613754,0.0012263283,0.000782958],"domain_scores_gemma":[0.9929361,0.0012316144,0.00078947336,0.0000625152,0.0031681813,0.0018120478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002511559,0.0007910132,0.0010054135,0.0022930915,0.0014966968,0.0047225766,0.0015153872,0.0025054098,0.007076392],"category_scores_gemma":[0.011447814,0.0003050507,0.0020959107,0.0039337627,0.0011224289,0.0011443883,0.00093813345,0.00288993,0.00027532506],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008820375,0.00087822764,0.14283627,0.0037640869,0.005655734,0.0015782332,0.001038158,0.0714494,0.0026111675,0.10467522,0.239463,0.4172302],"study_design_scores_gemma":[0.0027254717,0.0025383944,0.5754866,0.0085776765,0.010604979,0.00241308,0.0065323887,0.07169677,0.0014859836,0.035733428,0.28119186,0.001013419],"about_ca_topic_score_codex":0.9508193,"about_ca_topic_score_gemma":0.9606139,"teacher_disagreement_score":0.08935536,"about_ca_system_score_codex":0.08935536,"about_ca_system_score_gemma":0.09236475,"threshold_uncertainty_score":0.6483215},"labels":[],"label_agreement":null},{"id":"W2074141001","doi":"10.1016/s0090-8258(02)00144-0","title":"Phase II study of CGP 69846A (ISIS 5132) in recurrent epithelial ovarian cancer: an NCIC clinical trials group study (NCIC IND.116)☆","year":2003,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":75,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Hamilton Regional Laboratory Medicine Program; Ottawa Regional Cancer Foundation; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Ovarian cancer; Toxicity; Internal medicine; Cancer; Phases of clinical research; Oncology; Gastroenterology; Ovary","score_opus":0.14226297164992605,"score_gpt":0.46476003455572107,"score_spread":0.32249706290579505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074141001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98393077,0.0033765025,0.000475592,0.0013647899,0.0002640752,0.0024036,0.0033544975,0.00028389474,0.004546279],"genre_scores_gemma":[0.9727683,0.003812475,0.0021304681,0.0017492394,0.00022853762,0.0024322972,0.0072688875,0.000057455036,0.009552318],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997075,0.00013089598,0.000011186132,0.0000405273,0.000029060586,0.00008069129],"domain_scores_gemma":[0.9996068,0.000050837436,0.00008459185,0.00003149826,0.000016318409,0.00020993105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011037171,0.0014919029,0.00156609,0.00057689095,0.00036036927,0.00073714403,0.0007723855,0.0014878481,0.004851272],"category_scores_gemma":[0.0006519666,0.0004759854,0.0011783172,0.0006103241,0.000732294,0.0005251049,0.00031949254,0.0030736919,0.0011309799],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6633937,0.044208147,0.0076477546,0.0013310086,0.00205036,0.00034830876,0.00026897475,0.004260759,0.06315832,0.0006434993,0.026939485,0.18574968],"study_design_scores_gemma":[0.66249,0.30808687,0.016644023,0.00005700654,0.0007674964,0.00027809953,0.00006260018,0.0012592794,0.0040762774,0.00028130817,0.0059470567,0.00005005536],"about_ca_topic_score_codex":0.0030654415,"about_ca_topic_score_gemma":0.007848018,"teacher_disagreement_score":0.004851272,"about_ca_system_score_codex":0.00081859244,"about_ca_system_score_gemma":0.0014465082,"threshold_uncertainty_score":0.016229153},"labels":[],"label_agreement":null},{"id":"W2075525534","doi":"10.1016/s0960-894x(00)00580-1","title":"Synthesis and Structure–Activity Relationships of 3-Cyano-4-(phenoxyanilino)quinolines as MEK (MAPKK) Inhibitors","year":2000,"lang":"en","type":"article","venue":"Bioorganic & Medicinal Chemistry Letters","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Chemistry; Kinase; Enzyme inhibitor; Alkoxy group; Mitogen-activated protein kinase; Structure–activity relationship; IC50; Inhibitory postsynaptic potential; Stereochemistry; Mitogen-activated protein kinase kinase; Enzyme; Protein kinase A; Biochemistry; In vitro; Organic chemistry; Endocrinology; Biology","score_opus":0.008896503226833899,"score_gpt":0.20487395553096968,"score_spread":0.19597745230413577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075525534","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9454013,0.025358183,0.0151073085,0.0004469911,0.00017716907,0.0004920861,0.0009760009,0.0002811743,0.011759908],"genre_scores_gemma":[0.98488945,0.006989844,0.004191703,0.00009236467,0.00002903533,0.00008734801,0.0004916193,0.000021604961,0.0032071606],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989367,0.000028070197,0.000009184831,0.000015334826,0.000020095255,0.000033654247],"domain_scores_gemma":[0.9999039,0.0000202389,0.000020087911,0.000008946489,0.000020776746,0.000026059928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034991794,0.0003702911,0.0003146965,0.00035650947,0.0001960796,0.0002319271,0.0006800499,0.00030372565,0.0018760291],"category_scores_gemma":[0.0002280159,0.00023244688,0.00026598418,0.00020434141,0.00016969998,0.00025687684,0.00020199957,0.00042900065,0.00056848646],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00086583674,0.00041766776,0.00029652083,0.00033912444,0.00004009006,0.0003832689,0.00011278847,0.0026474409,0.97448653,0.0012705402,0.00061180553,0.018528415],"study_design_scores_gemma":[0.00057210587,0.004796275,0.0034661707,0.00004289657,0.000100757774,0.00065912626,0.000054727112,0.003846329,0.9684683,0.0003379322,0.017605975,0.000049492442],"about_ca_topic_score_codex":0.00095307577,"about_ca_topic_score_gemma":0.0020480684,"teacher_disagreement_score":0.0018760291,"about_ca_system_score_codex":0.0002923961,"about_ca_system_score_gemma":0.00023443559,"threshold_uncertainty_score":0.006275952},"labels":[],"label_agreement":null},{"id":"W2075925391","doi":"10.1016/j.cell.2014.11.053","title":"Pathological Axonal Death through a MAPK Cascade that Triggers a Local Energy Deficit","year":2015,"lang":"en","type":"article","venue":"Cell","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":306,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; University of Ottawa","funders":"National Institute of Neurological Disorders and Stroke","keywords":"MAPK/ERK pathway; Biology; Cell biology; Neuroscience; Axon; Protein kinase A; Signal transduction; Programmed cell death; Autophagy; Kinase; Apoptosis; Genetics","score_opus":0.04483218265073828,"score_gpt":0.24115619216840908,"score_spread":0.19632400951767082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075925391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897259,0.0018186662,0.003852131,0.0004259766,0.000062634455,0.000030552856,0.00017304356,0.00009544313,0.0038156363],"genre_scores_gemma":[0.99686784,0.00060105056,0.00077577884,0.000056871733,0.0000072539187,0.000018463319,0.00005358127,0.0000059411323,0.0016131416],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999305,0.000011216788,0.00000491179,0.000012514067,0.000015109696,0.000025720015],"domain_scores_gemma":[0.9999591,0.000004475939,0.00001114795,0.0000070164156,0.0000061730857,0.00001194497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012525926,0.0003901943,0.00015469507,0.00026353917,0.00028840755,0.0002901683,0.0002164976,0.0004020088,0.0016828906],"category_scores_gemma":[0.00007891294,0.00011991924,0.0002575768,0.00014207592,0.00023619864,0.0003836952,0.00028585023,0.00059626484,0.0002494377],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037660653,0.00004126409,0.0005135529,0.000059941296,0.000012886029,0.00094898173,0.00002222145,0.0001410288,0.9951009,0.0010567805,0.00013393379,0.0015917976],"study_design_scores_gemma":[0.00006561452,0.0005643613,0.012389807,0.00002539714,0.00004857284,0.0035544243,0.00017652966,0.0018101304,0.9766967,0.0017894477,0.0028664973,0.000012401989],"about_ca_topic_score_codex":0.0004763851,"about_ca_topic_score_gemma":0.0007451189,"teacher_disagreement_score":0.0016828906,"about_ca_system_score_codex":0.0003662343,"about_ca_system_score_gemma":0.0002121081,"threshold_uncertainty_score":0.005629778},"labels":[],"label_agreement":null},{"id":"W2076242481","doi":"10.1073/pnas.0709705105","title":"CNK and HYP form a discrete dimer by their SAM domains to mediate RAF kinase signaling","year":2008,"lang":"en","type":"article","venue":"Proceedings of the National Academy of Sciences","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer; Université de Montréal; Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"Argonne National Laboratory; National Cancer Institute; University of Toronto; Cancer Research Society","keywords":"Kinase; MAPK/ERK pathway; Cell biology; Protein kinase A; Protein kinase domain; Signal transduction; Chemistry; Dimer; Biology; Biochemistry; Gene","score_opus":0.02543315918479728,"score_gpt":0.2641857467895435,"score_spread":0.2387525876047462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076242481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950611,0.0005606682,0.0026413654,0.00007470301,0.000013197126,0.000011499721,0.000053274165,0.00003383097,0.0015505131],"genre_scores_gemma":[0.99656004,0.00013622968,0.00205017,0.0000280481,0.0000033404058,0.0000052779687,0.00013280605,0.000005315064,0.0010788372],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989736,0.00001810729,0.0000047123563,0.000021323562,0.000036752004,0.00002173105],"domain_scores_gemma":[0.9999368,0.0000052875153,0.000016193428,0.000006312836,0.0000061611267,0.000029139332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013779372,0.00021603325,0.00014118191,0.000069795984,0.00021624756,0.00026491945,0.0002494653,0.00018996975,0.0013902428],"category_scores_gemma":[0.000120487864,0.00014535912,0.00015477695,0.00007547955,0.00015313484,0.00023290036,0.00031756633,0.00039094867,0.00051236316],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015739597,0.00003157547,0.0008136003,0.000035092435,0.000009888285,0.000167636,0.000026916725,0.00039216375,0.99570304,0.0007912559,0.00010488402,0.0017666153],"study_design_scores_gemma":[0.00010899024,0.00021184521,0.016465498,0.000011438478,0.000018729366,0.0018979226,0.000106884116,0.013341665,0.9580155,0.0005572934,0.009242462,0.000021757318],"about_ca_topic_score_codex":0.00032574346,"about_ca_topic_score_gemma":0.00073194865,"teacher_disagreement_score":0.0013902428,"about_ca_system_score_codex":0.0003909121,"about_ca_system_score_gemma":0.00020343046,"threshold_uncertainty_score":0.004650831},"labels":[],"label_agreement":null},{"id":"W2076869933","doi":"10.1007/s40273-014-0241-z","title":"Cost Effectiveness of Dabrafenib as a First-Line Treatment in Patients with BRAF V600 Mutation-Positive Unresectable or Metastatic Melanoma in Canada","year":2014,"lang":"en","type":"article","venue":"PharmacoEconomics","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"GlaxoSmithKline; Eli Lilly and Company","keywords":"Dabrafenib; Dacarbazine; Vemurafenib; Medicine; Oncology; Progression-free survival; Internal medicine; Hazard ratio; Metastatic melanoma; Melanoma; Cancer research; Overall survival; Confidence interval","score_opus":0.013149909881605824,"score_gpt":0.26533107913349996,"score_spread":0.25218116925189416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076869933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96561897,0.0092356065,0.00017353246,0.01023829,0.00013173293,0.00009654115,0.004725686,0.000028374334,0.009751325],"genre_scores_gemma":[0.99483585,0.0024184678,0.00013677047,0.0005480683,0.000031974716,0.000013491334,0.00088935037,0.0000058747355,0.0011201608],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99942076,0.00010781484,0.000034816483,0.00004785678,0.00016066861,0.0002281054],"domain_scores_gemma":[0.9983688,0.00022816299,0.00026184774,0.000016732185,0.00037826534,0.00074629846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031985308,0.00024774185,0.0005120258,0.0006260277,0.00076494954,0.0013354168,0.00074524706,0.00055207097,0.0029165875],"category_scores_gemma":[0.0031739378,0.00018171726,0.0010242512,0.0015666225,0.00043376506,0.00026955162,0.00043855282,0.0009010749,0.00009284965],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011788206,0.0008655529,0.79027575,0.0007731606,0.001583427,0.001452455,0.0003503521,0.028193293,0.0012346143,0.0043817614,0.029973475,0.129128],"study_design_scores_gemma":[0.0022135968,0.0010329969,0.9557512,0.00037364123,0.0014905062,0.00086633314,0.0015140915,0.024763554,0.00054917095,0.00075548136,0.01059549,0.00009400939],"about_ca_topic_score_codex":0.97865456,"about_ca_topic_score_gemma":0.9876293,"teacher_disagreement_score":0.06315782,"about_ca_system_score_codex":0.06315782,"about_ca_system_score_gemma":0.045615,"threshold_uncertainty_score":0.4582442},"labels":[],"label_agreement":null},{"id":"W2077996667","doi":"10.1177/1087057113497401","title":"Perspective on the Discovery and Scientific Impact of p38 MAP Kinase","year":2013,"lang":"en","type":"review","venue":"SLAS DISCOVERY","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Resverlogix (Canada)","funders":"","keywords":"Drug discovery; Computational biology; Perspective (graphical); p38 mitogen-activated protein kinases; Mitogen-activated protein kinase; Data science; Field (mathematics); Biology; Computer science; Kinase; Bioinformatics; Protein kinase A; Cell biology; Artificial intelligence","score_opus":0.030433995127690034,"score_gpt":0.3169229605518093,"score_spread":0.2864889654241193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077996667","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000646573,0.9970381,0.00018952077,0.0012868326,0.0006206906,0.0000024049189,0.000016861122,0.0000073175024,0.00077372964],"genre_scores_gemma":[0.0005982956,0.9968329,0.00024397622,0.000997555,0.00069572526,0.00000402441,0.000021906448,0.0000016866169,0.00060394086],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99972147,0.000044099994,0.000026758482,0.00005037131,0.00011228779,0.00004495666],"domain_scores_gemma":[0.9993248,0.0003131405,0.00006206356,0.000020247906,0.00019663095,0.00008307383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014883747,0.0011474747,0.0014655929,0.002211863,0.00039315503,0.0016517831,0.0012885648,0.002231308,0.0035993236],"category_scores_gemma":[0.0013710924,0.00037417604,0.0006002428,0.0022467,0.0012841626,0.0027371934,0.0012268224,0.0045761294,0.0022696469],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027330362,0.00010755263,0.00018360848,0.0145571185,0.00013141356,0.0006310787,0.00007392612,0.00061255385,0.006562443,0.016586866,0.13259932,0.8276808],"study_design_scores_gemma":[0.000033400407,0.000076790355,0.00026683797,0.0013020118,0.00006506096,0.0005996063,0.000042729018,0.000105099396,0.0007115597,0.0042341365,0.99254215,0.000020633577],"about_ca_topic_score_codex":0.0012250872,"about_ca_topic_score_gemma":0.0029740287,"teacher_disagreement_score":0.0035993236,"about_ca_system_score_codex":0.0012372755,"about_ca_system_score_gemma":0.0018739473,"threshold_uncertainty_score":0.012040913},"labels":[],"label_agreement":null},{"id":"W2078902726","doi":"10.1038/nchembio.1629","title":"A unique inhibitor binding site in ERK1/2 is associated with slow binding kinetics","year":2014,"lang":"en","type":"article","venue":"Nature Chemical Biology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":248,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; Cancer Research UK; Wellcome Trust","keywords":"Binding site; Receptor–ligand kinetics; Kinase; Kinetics; Chemistry; Plasma protein binding; Biophysics; MAPK/ERK pathway; Pyrimidine; Biochemistry; Stereochemistry; Biology; Receptor","score_opus":0.005112793602613707,"score_gpt":0.2249571127614532,"score_spread":0.21984431915883948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078902726","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95607054,0.00082074595,0.03744656,0.00032231546,0.0000843499,0.00006839167,0.00050218846,0.00054048665,0.0041443887],"genre_scores_gemma":[0.9891048,0.00019862027,0.007930376,0.00012596883,0.000013831385,0.000054152682,0.0004685825,0.00014497593,0.0019585898],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99962914,0.00004068688,0.000019209996,0.000117222975,0.00010306448,0.00009061996],"domain_scores_gemma":[0.9991266,0.0003126765,0.00021642922,0.00010265754,0.00009443521,0.00014725095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044293527,0.0005262523,0.00064839615,0.00036857085,0.0005559347,0.0007250271,0.0009833673,0.0005955969,0.003994131],"category_scores_gemma":[0.0009140382,0.0006622573,0.00068325526,0.0002543113,0.00050201867,0.0007800166,0.00036593294,0.0015477829,0.0012987439],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005649026,0.00007772339,0.00048414324,0.0000667105,0.000035366218,0.00019243402,0.000036239304,0.00072727806,0.9928999,0.0015061958,0.00026027783,0.0031488845],"study_design_scores_gemma":[0.0000693107,0.00015532628,0.004656488,0.000008055144,0.000046762376,0.0008294033,0.000022966935,0.010335645,0.9817145,0.0006791675,0.0014361409,0.000046234152],"about_ca_topic_score_codex":0.0014150005,"about_ca_topic_score_gemma":0.0012921995,"teacher_disagreement_score":0.003994131,"about_ca_system_score_codex":0.0007147241,"about_ca_system_score_gemma":0.00039135118,"threshold_uncertainty_score":0.013361692},"labels":[],"label_agreement":null},{"id":"W2079421845","doi":"10.1371/journal.pone.0029336","title":"Intra- and Inter-Tumor Heterogeneity of BRAFV600EMutations in Primary and Metastatic Melanoma","year":2012,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":286,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; National Institute of Arthritis and Musculoskeletal and Skin Diseases; York University; U.S. Department of Veterans Affairs","keywords":"Tumor heterogeneity; Metastatic melanoma; Melanoma; Primary (astronomy); Primary tumor; Medicine; Cancer research; Oncology; Metastasis; Biology; Pathology; Internal medicine; Cancer","score_opus":0.029787512688763756,"score_gpt":0.23192001735446996,"score_spread":0.2021325046657062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079421845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99925,0.00024507774,0.000285968,0.0000065731783,0.0000011285691,0.00000616692,0.000027057986,0.0000058867167,0.0001721342],"genre_scores_gemma":[0.99962103,0.00004925421,0.00022050177,0.0000055301866,0.0000023970165,0.0000048490565,0.000036987276,0.0000020204934,0.000057441728],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9997763,0.000039836217,0.000020467553,0.00007040344,0.00005919135,0.000033677396],"domain_scores_gemma":[0.9996935,0.00011599764,0.000069239606,0.00003723509,0.00003368809,0.00005031877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002506717,0.00009312328,0.00020771073,0.00046682847,0.00014514306,0.00024887372,0.00009254513,0.00018583465,0.0006930402],"category_scores_gemma":[0.00085129216,0.00015465701,0.00009802188,0.00014844206,0.00023027827,0.00012210588,0.00015066865,0.00017404342,0.00014047316],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009624876,0.00008108981,0.36685774,0.00006041303,0.000056082776,0.001971008,0.00036953902,0.0005575154,0.61107284,0.00013598858,0.00009756639,0.017777745],"study_design_scores_gemma":[0.000026928965,0.0006440039,0.9014163,0.000008666829,0.00006832909,0.013515132,0.00019756488,0.0017135057,0.08104222,0.0003218549,0.0010307978,0.000014643955],"about_ca_topic_score_codex":0.00038227023,"about_ca_topic_score_gemma":0.00067589345,"teacher_disagreement_score":0.0006930402,"about_ca_system_score_codex":0.0001928962,"about_ca_system_score_gemma":0.000070717586,"threshold_uncertainty_score":0.0023185015},"labels":[],"label_agreement":null},{"id":"W2080087856","doi":"10.1016/j.bbrc.2008.05.135","title":"Major contribution of MEK1 to the activation of ERK1/ERK2 and to the growth of LS174T colon carcinoma cells","year":2008,"lang":"en","type":"article","venue":"Biochemical and Biophysical Research Communications","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Institut National Du Cancer; Canceropôle PACA; Centre National de la Recherche Scientifique","keywords":"Cell growth; Activator (genetics); MAPK/ERK pathway; In vivo; Small hairpin RNA; Gene isoform; Cell biology; Cancer research; Biology; Kinase; Chemistry; Cell culture; Gene knockdown; Biochemistry; Gene; Genetics","score_opus":0.04567662822636049,"score_gpt":0.31434466776609543,"score_spread":0.26866803953973495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080087856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908896,0.0039012916,0.00081627123,0.00025562575,0.00004918046,0.000020346812,0.00068772765,0.0000709134,0.0033091397],"genre_scores_gemma":[0.9918743,0.0013181659,0.00057720067,0.0000589642,0.000015648757,0.000025388741,0.0007280083,0.00001979832,0.0053825937],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991405,0.000010804921,0.000004429884,0.00001183561,0.000018012195,0.000040833926],"domain_scores_gemma":[0.9998857,0.00001991851,0.000009181167,0.000012349839,0.00002457624,0.000048298996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010665929,0.00047932647,0.00025233897,0.00035411448,0.00030240836,0.0003099807,0.0001717624,0.00017550727,0.002362037],"category_scores_gemma":[0.00014554163,0.00019002137,0.00029448705,0.0001238392,0.00016865373,0.00019012883,0.00023673479,0.0007749271,0.0005375097],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005616979,0.000042106036,0.00029078775,0.00007801646,0.000004869894,0.000066483975,0.00002318613,0.00010325236,0.99614775,0.00026766633,0.00011386586,0.0023002985],"study_design_scores_gemma":[0.000021629012,0.00016227964,0.00827455,0.0000070368346,0.000014973094,0.00016980749,0.00004201283,0.0005458393,0.9882471,0.0000594285,0.002450191,0.0000051973084],"about_ca_topic_score_codex":0.0029069285,"about_ca_topic_score_gemma":0.002218221,"teacher_disagreement_score":0.0029069285,"about_ca_system_score_codex":0.0005775966,"about_ca_system_score_gemma":0.0005918615,"threshold_uncertainty_score":0.007901847},"labels":[],"label_agreement":null},{"id":"W2081113836","doi":"10.1038/sj.onc.1207422","title":"p38 MAP kinase signaling is necessary for rat chondrosarcoma cell proliferation","year":2004,"lang":"en","type":"article","venue":"Oncogene","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Shriners Hospitals for Children - Canada; Canadian Institutes of Health Research; Western University","funders":"","keywords":"Biology; Cell cycle; Cancer research; Cyclin-dependent kinase; Cell growth; Cell biology; Cyclin; Cyclin E; Mitogen-activated protein kinase; Cyclin A; Kinase; Cyclin-dependent kinase 2; Protein kinase A; Cell; Biochemistry","score_opus":0.012647482756312597,"score_gpt":0.2419429090879394,"score_spread":0.2292954263316268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081113836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99004805,0.0021859964,0.0030191876,0.00016600148,0.000031392905,0.000027835125,0.0008239772,0.00020179071,0.0034957603],"genre_scores_gemma":[0.9916045,0.0006329359,0.0017521662,0.000024937382,0.0000092582195,0.000033263208,0.0009143372,0.000024841109,0.0050037582],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997999,0.00002194152,0.000016395257,0.00003057784,0.00005878887,0.00007239462],"domain_scores_gemma":[0.99975806,0.000039323997,0.000053529413,0.00004564975,0.00003340253,0.00007010614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012337457,0.0004177976,0.00025308446,0.00053945184,0.00046469472,0.00027435317,0.00025638356,0.00025130584,0.0024424316],"category_scores_gemma":[0.00017373869,0.0003084595,0.000332293,0.0002513732,0.00027773585,0.0003557707,0.00025579977,0.0005620313,0.00090047973],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011715703,0.000020563532,0.00018026469,0.000023250235,0.0000019850288,0.000107876614,0.000012032066,0.000020971733,0.9987686,0.00019542278,0.000038416347,0.00051331014],"study_design_scores_gemma":[0.000011045844,0.00011344312,0.006179118,0.000003989529,0.000008321302,0.00039052925,0.00003344564,0.00029439927,0.99130964,0.00007272812,0.0015808799,0.0000025309166],"about_ca_topic_score_codex":0.0031887507,"about_ca_topic_score_gemma":0.006326544,"teacher_disagreement_score":0.0031887507,"about_ca_system_score_codex":0.0006262876,"about_ca_system_score_gemma":0.0005527146,"threshold_uncertainty_score":0.008170724},"labels":[],"label_agreement":null},{"id":"W2082339380","doi":"10.1038/480329a","title":"A drug-resistant duo","year":2011,"lang":"en","type":"letter","venue":"Nature","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Vemurafenib; Acquired resistance; Drug resistance; Cancer research; Melanoma; Drug; Medicine; Kinase; Mutant; Pharmacology; Metastatic melanoma; Biology; Genetics; Gene","score_opus":0.006980386219293363,"score_gpt":0.2142752218983333,"score_spread":0.20729483567903995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082339380","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03762839,0.00867808,0.0022875592,0.85538983,0.039449926,0.00015518426,0.00068636134,0.00032044566,0.055404134],"genre_scores_gemma":[0.29269758,0.010022281,0.004538233,0.5508073,0.032353632,0.00019782074,0.0004749697,0.00015910222,0.108749025],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997166,0.000056970865,0.000027189015,0.0000641054,0.00005858004,0.00007651988],"domain_scores_gemma":[0.99958307,0.00015794182,0.00003704532,0.00005003234,0.00004797066,0.0001238767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005201842,0.00048769952,0.00042574658,0.00033959854,0.001379808,0.0014252653,0.00047121977,0.00942664,0.0042611654],"category_scores_gemma":[0.002189165,0.00023491397,0.0007778273,0.00020381293,0.00080156635,0.0010414043,0.0005872734,0.006645411,0.0018931023],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007911768,0.00022043535,0.0033156106,0.00018356585,0.00007931625,0.19669408,0.00027506624,0.00026405288,0.0146271745,0.03568199,0.6970751,0.050792422],"study_design_scores_gemma":[0.00031417146,0.0002718524,0.0029120885,0.000102072096,0.000075132506,0.11825204,0.00028228926,0.002071329,0.005078843,0.020383975,0.850206,0.000050212642],"about_ca_topic_score_codex":0.0010579035,"about_ca_topic_score_gemma":0.0016911147,"teacher_disagreement_score":0.00942664,"about_ca_system_score_codex":0.001240438,"about_ca_system_score_gemma":0.0004666761,"threshold_uncertainty_score":0.014255047},"labels":[],"label_agreement":null},{"id":"W2082700617","doi":"10.1016/j.clinbiochem.2008.03.011","title":"Prognostic significance of BP1 mRNA expression level in patients with non-small cell lung cancer","year":2008,"lang":"en","type":"article","venue":"Clinical Biochemistry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Genomics; University of Ottawa","funders":"University of Ottawa","keywords":"Lung cancer; Messenger RNA; Medicine; Cancer; Oncology; Expression (computer science); Internal medicine; Clinical significance; Biology; Cancer research; Genetics; Gene; Computer science","score_opus":0.0259217992379839,"score_gpt":0.2769537409259857,"score_spread":0.2510319416880018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082700617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975464,0.00083119574,0.000113986374,0.000111909256,0.000019792304,0.000004377761,0.00032268383,0.000014332336,0.0010353843],"genre_scores_gemma":[0.99914217,0.00017820211,0.000071262184,0.00002673117,0.000030637122,0.000006355328,0.0002414121,0.000003225814,0.00030003817],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99986565,0.000025917117,0.000012631186,0.000028159016,0.000028439095,0.000039191604],"domain_scores_gemma":[0.9993358,0.00023088932,0.00016645882,0.000024081186,0.000072992436,0.0001697379],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017983018,0.00025651266,0.0003510818,0.0008153959,0.00042578002,0.0005166634,0.00020660638,0.0004412988,0.0016587734],"category_scores_gemma":[0.001050602,0.00019644246,0.00018804935,0.0007975115,0.00029908124,0.00031141762,0.00021040946,0.0005049834,0.00034220633],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007231507,0.00003200137,0.9909079,0.00002153917,0.000037226466,0.00042994064,0.000035127396,0.00007934734,0.004913114,0.000031287527,0.00017732523,0.0026122073],"study_design_scores_gemma":[0.0000110001065,0.00011934588,0.99717426,0.0000037785323,0.000056851575,0.0008728176,0.000073319046,0.00032172815,0.0010040686,0.00006182337,0.0002961141,0.000004933976],"about_ca_topic_score_codex":0.0009471221,"about_ca_topic_score_gemma":0.0012398361,"teacher_disagreement_score":0.0016587734,"about_ca_system_score_codex":0.0002602733,"about_ca_system_score_gemma":0.00023750526,"threshold_uncertainty_score":0.005549133},"labels":[],"label_agreement":null},{"id":"W2083246985","doi":"10.1111/j.1471-4159.2009.06300.x","title":"Serine 209 resides within a putative p38(MAPK) consensus motif and regulates monoamine oxidase‐A activity","year":2009,"lang":"en","type":"article","venue":"Journal of Neurochemistry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; University of Saskatchewan","funders":"Canadian Institutes of Health Research; Saskatchewan Health Research Foundation","keywords":"Monoamine oxidase; MAPK/ERK pathway; Phosphorylation; Biology; p38 mitogen-activated protein kinases; Protein kinase A; Cell biology; Biochemistry; Enzyme","score_opus":0.00892688236097565,"score_gpt":0.23556422702461746,"score_spread":0.22663734466364183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083246985","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99228173,0.000935212,0.0040692366,0.00013344956,0.000057592562,0.000037429014,0.0005273389,0.000112047484,0.001845861],"genre_scores_gemma":[0.99341327,0.0006282895,0.0032822753,0.000050146402,0.000025876894,0.000039504543,0.000736896,0.000015662055,0.0018079755],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99992824,0.000011354016,0.000007793669,0.000019998331,0.00001691124,0.000015726178],"domain_scores_gemma":[0.999912,0.000009378323,0.00004419703,0.0000053627,0.000007323521,0.000021738313],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000083478364,0.00047095882,0.00019042839,0.00012325933,0.00020884247,0.00016352472,0.00018933628,0.00027254358,0.0023614932],"category_scores_gemma":[0.000110081804,0.00012456924,0.00034735608,0.00009925679,0.00015033098,0.0001500028,0.00014993745,0.00026564003,0.0013195839],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027599253,0.00003648426,0.0004725309,0.00006896287,0.000008373618,0.00044852175,0.000012406885,0.00007958946,0.9963431,0.00024503664,0.00010052439,0.0019084283],"study_design_scores_gemma":[0.00007264144,0.00069330283,0.022946928,0.00002510397,0.000037038546,0.0033395328,0.000050629264,0.0016059264,0.96269906,0.00035934974,0.008153449,0.000017108567],"about_ca_topic_score_codex":0.0002901116,"about_ca_topic_score_gemma":0.00033605777,"teacher_disagreement_score":0.0023614932,"about_ca_system_score_codex":0.00023872669,"about_ca_system_score_gemma":0.00022374807,"threshold_uncertainty_score":0.0079},"labels":[],"label_agreement":null},{"id":"W2085079049","doi":"10.3892/ijo.24.1.65","title":"Involvement of the mitogen-activated protein kinase kinase 2 in the induction of cell dissociation in pancreatic cancer","year":2004,"lang":"en","type":"article","venue":"International Journal of Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Public Health Agency of Canada","keywords":"Pancreatic cancer; Cancer research; Protein kinase A; Kinase; Oncogene; Biology; Cancer cell; Cell; Internal medicine; Cell biology; Cell cycle; Cancer; Endocrinology; Medicine; Biochemistry","score_opus":0.017386830262002453,"score_gpt":0.2875466202597049,"score_spread":0.27015978999770246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085079049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99216545,0.004288953,0.0017789765,0.0000745019,0.000031808246,0.000029545465,0.00019117081,0.00005235868,0.0013872605],"genre_scores_gemma":[0.9939481,0.0017568594,0.001191388,0.00003775469,0.0000074350273,0.00004123622,0.0003629099,0.00000586103,0.0026484646],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99993014,0.000010945126,0.000005651094,0.000014799083,0.000017712488,0.000020749887],"domain_scores_gemma":[0.9999682,0.0000036241022,0.0000072405733,0.0000037053353,0.0000053950835,0.000011827032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007684375,0.00032716047,0.00016744681,0.0002539222,0.000234369,0.00030600026,0.000102726255,0.00017692723,0.00079996814],"category_scores_gemma":[0.000059895126,0.00014378305,0.00020958274,0.00013622885,0.00013418245,0.00019734545,0.00021174196,0.00047347345,0.00021262445],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022451248,0.000054111784,0.0014093769,0.00007215328,0.0000073991214,0.00024344929,0.00002774545,0.00007306627,0.99548376,0.00010228667,0.000058628597,0.002243555],"study_design_scores_gemma":[0.000023387653,0.00031021168,0.03629334,0.0000074321515,0.00001989315,0.0010860297,0.00011569091,0.0010315594,0.9560696,0.000102054044,0.0049338536,0.0000068650475],"about_ca_topic_score_codex":0.000514149,"about_ca_topic_score_gemma":0.0006737033,"teacher_disagreement_score":0.00079996814,"about_ca_system_score_codex":0.00024234719,"about_ca_system_score_gemma":0.00020818003,"threshold_uncertainty_score":0.0026761293},"labels":[],"label_agreement":null},{"id":"W2085362455","doi":"10.1002/jcp.21560","title":"Activation loop phosphorylation of the atypical MAP kinases ERK3 and ERK4 is required for binding, activation and cytoplasmic relocalization of MK5","year":2008,"lang":"en","type":"article","venue":"Journal of Cellular Physiology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Kinase; Phosphorylation; Mitogen-activated protein kinase; MAPK14; p38 mitogen-activated protein kinases; Cell biology; Protein-Serine-Threonine Kinases; MAP2K7; Biology; Chemistry; MAP kinase kinase kinase; Protein kinase A; Biochemistry; Cyclin-dependent kinase 2","score_opus":0.015389080973899297,"score_gpt":0.22366006093259788,"score_spread":0.2082709799586986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085362455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953242,0.0007082167,0.0025288465,0.000043327174,0.000018621888,0.000009763887,0.00020557593,0.000043098495,0.001118276],"genre_scores_gemma":[0.99593,0.00026212243,0.0013174557,0.000025281919,0.000005629615,0.00001589167,0.0006181696,0.000024709267,0.0018006505],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998553,0.00002225124,0.000015686386,0.000024379106,0.00003372714,0.00004866361],"domain_scores_gemma":[0.9998604,0.000019114941,0.000038705857,0.000020259724,0.000017779028,0.000043736265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011760904,0.00029510056,0.0001737006,0.00012470782,0.00016245828,0.0002621146,0.000228042,0.00013898133,0.0020843728],"category_scores_gemma":[0.00016055255,0.00017057602,0.00027007097,0.000081041944,0.00015435602,0.00021555013,0.00031746188,0.0003638798,0.000847284],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000119974626,0.00001529783,0.00017380342,0.000024990662,0.000003103716,0.000032502307,0.000008186893,0.000037476417,0.9989825,0.00011379039,0.000022933049,0.0004654145],"study_design_scores_gemma":[0.000011443744,0.000066795,0.013071929,0.000004806878,0.000008972598,0.00019926854,0.000027654341,0.0011035895,0.9834509,0.00007361492,0.0019765762,0.000004331774],"about_ca_topic_score_codex":0.0005000355,"about_ca_topic_score_gemma":0.000661345,"teacher_disagreement_score":0.0020843728,"about_ca_system_score_codex":0.0003015458,"about_ca_system_score_gemma":0.00025524164,"threshold_uncertainty_score":0.006972909},"labels":[],"label_agreement":null},{"id":"W2085971293","doi":"10.1002/cbic.201402512","title":"Identification and Characterization of a Small‐Molecule Inhibitor of Death‐Associated Protein Kinase 1","year":2014,"lang":"en","type":"article","venue":"ChemBioChem","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Ministero dello Sviluppo Economico; Strategic Research Council; Novo Nordisk; Ontario Ministry of Economic Development and Innovation; Genome Canada; Wellcome Trust; GlaxoSmithKline; Pfizer; Eli Lilly and Company","keywords":"Identification (biology); Small molecule; Chemistry; Kinase; Protein kinase A; Computational biology; Molecule; Biochemistry; Cell biology; Biology","score_opus":0.00832888224529081,"score_gpt":0.2011807604510626,"score_spread":0.1928518782057718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085971293","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9673459,0.008587926,0.018676097,0.00027260516,0.000049976137,0.0003239221,0.0012715714,0.00015413536,0.0033179447],"genre_scores_gemma":[0.97440624,0.00371687,0.012773123,0.0001428692,0.000027839778,0.00012647158,0.004169568,0.000020565976,0.004616363],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990785,0.0000064349006,0.000006634748,0.000019340221,0.00004178145,0.000017898108],"domain_scores_gemma":[0.99995255,0.0000063419725,0.000010836554,0.000003526932,0.000011599423,0.000015158698],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012408283,0.0003488619,0.00035568827,0.00016486442,0.0000963171,0.00026706848,0.00033545756,0.00023734341,0.0005895779],"category_scores_gemma":[0.00015330958,0.000098078825,0.00019380118,0.00014651593,0.000112912414,0.00019414502,0.00013614599,0.0003584978,0.00033964208],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006744308,0.00006137981,0.00019615873,0.00005166678,0.000007293827,0.00007459866,0.00000741249,0.0004936858,0.9946808,0.000068356814,0.00007877101,0.004212317],"study_design_scores_gemma":[0.00006354744,0.0011654187,0.002968202,0.00000558901,0.000028917515,0.0005055789,0.000006595117,0.0042923787,0.98500466,0.00004137091,0.005907877,0.000009854944],"about_ca_topic_score_codex":0.00040694207,"about_ca_topic_score_gemma":0.0004705072,"teacher_disagreement_score":0.0005895779,"about_ca_system_score_codex":0.00035401003,"about_ca_system_score_gemma":0.00027930306,"threshold_uncertainty_score":0.0025684834},"labels":[],"label_agreement":null},{"id":"W2086921761","doi":"10.1158/1535-7163.targ-11-a229","title":"Abstract A229: BRAF inhibitors upregulate EGFR ligands: A molecular link to RAF inhibitor-induced cutaneous squamous cell carcinomas.","year":2011,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Workplace Health, Safety and Compensation Commission","funders":"","keywords":"Vemurafenib; Cancer research; HRAS; Melanoma; Cancer; Downregulation and upregulation; Neuroblastoma RAS viral oncogene homolog; EGFR inhibitors; MAPK/ERK pathway; Skin cancer; Kinase; Cell growth; Medicine; Biology; KRAS; Epidermal growth factor receptor; Internal medicine; Colorectal cancer; Cell biology","score_opus":0.022563827664879663,"score_gpt":0.2431232919268744,"score_spread":0.22055946426199474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086921761","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89732903,0.011444605,0.0088210255,0.002682778,0.0026497305,0.0004203322,0.0041710036,0.0015021799,0.07097931],"genre_scores_gemma":[0.91646737,0.0025480972,0.0023020061,0.00045130317,0.0003160366,0.000092030336,0.0014413928,0.00010834282,0.07627346],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999008,0.000014882449,0.000009479964,0.00002347558,0.000034451037,0.000016835631],"domain_scores_gemma":[0.9999013,0.000018908087,0.000021013664,0.000011362561,0.000018068273,0.000029327284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016777588,0.00037512966,0.00024118059,0.00041014043,0.0001882072,0.00046655646,0.00044047838,0.00051911286,0.020211212],"category_scores_gemma":[0.00016041208,0.00017610202,0.00022724218,0.00016589415,0.00014350883,0.0003485082,0.00016814518,0.0005188217,0.0031183863],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016015149,0.0003862121,0.001328247,0.00036151477,0.00003266439,0.0017111546,0.00003237602,0.00019528445,0.94801563,0.0017319361,0.007983708,0.036619887],"study_design_scores_gemma":[0.0002363973,0.0029279916,0.021451913,0.000026207988,0.00006105953,0.0053509236,0.000055065353,0.0013576418,0.92059845,0.00078356516,0.04713218,0.000018639716],"about_ca_topic_score_codex":0.00075079245,"about_ca_topic_score_gemma":0.0007251066,"teacher_disagreement_score":0.020211212,"about_ca_system_score_codex":0.00034944495,"about_ca_system_score_gemma":0.0002657748,"threshold_uncertainty_score":0.067613244},"labels":[],"label_agreement":null},{"id":"W2087731919","doi":"10.1002/1521-4141(200111)31:11<3218::aid-immu3218>3.0.co;2-9","title":"The p38 mitogen-activated protein kinases can have opposing roles in the antigen-dependent or endotoxin-stimulated production of IL-12 and IFN-γ","year":2001,"lang":"en","type":"article","venue":"European Journal of Immunology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Arthritis Network; Canadian Institutes of Health Research; Arthritis Society","keywords":"p38 mitogen-activated protein kinases; Biology; Mitogen-activated protein kinase; Kinase; Cell biology; Antigen; Protein kinase A; Immunology","score_opus":0.018310708027950876,"score_gpt":0.22976537209561998,"score_spread":0.2114546640676691,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087731919","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95009273,0.029811943,0.011162236,0.0009904223,0.00026340567,0.00014261056,0.0003730365,0.00015572387,0.0070077954],"genre_scores_gemma":[0.97840047,0.010486318,0.005947734,0.0001585691,0.00012302332,0.00018058802,0.00022895442,0.000015686132,0.004458623],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997441,0.00003712606,0.00001963052,0.00004828124,0.00005791324,0.0000928739],"domain_scores_gemma":[0.99989593,0.000022227016,0.000027420954,0.000008690471,0.000013628433,0.000032178905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040317472,0.0010413958,0.00040200437,0.0002974195,0.00025810802,0.0004817585,0.00027020698,0.0004948687,0.0025206017],"category_scores_gemma":[0.000325242,0.00033173183,0.00041347512,0.00020925267,0.00049871695,0.0008055473,0.00041190482,0.00088065333,0.0009230016],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008565915,0.00009196521,0.0005809781,0.00022905678,0.000017755583,0.00024295809,0.000058427217,0.00013400118,0.9874657,0.0004929282,0.0000922214,0.009737356],"study_design_scores_gemma":[0.00016048038,0.0019278273,0.021724982,0.00007065276,0.00009473283,0.002639819,0.00027161313,0.0021525335,0.9578502,0.0018184317,0.01125999,0.000028706687],"about_ca_topic_score_codex":0.0001771815,"about_ca_topic_score_gemma":0.00032528228,"teacher_disagreement_score":0.0025206017,"about_ca_system_score_codex":0.0002862192,"about_ca_system_score_gemma":0.00036921987,"threshold_uncertainty_score":0.0084322095},"labels":[],"label_agreement":null},{"id":"W2089686819","doi":"10.1016/j.celrep.2014.02.045","title":"Intrinsic Resistance to MEK Inhibition in KRAS Mutant Lung and Colon Cancer through Transcriptional Induction of ERBB3","year":2014,"lang":"en","type":"article","venue":"Cell Reports","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":316,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Associazione Italiana per la Ricerca sul Cancro; Ministero dell’Istruzione, dell’Università e della Ricerca; Nederlandse Organisatie voor Wetenschappelijk Onderzoek","keywords":"KRAS; ERBB3; Kinome; Downregulation and upregulation; Cancer research; Receptor tyrosine kinase; Mutant; Cetuximab; ErbB; MEK inhibitor; Kinase; Colorectal cancer; Biology; Cancer; MAPK/ERK pathway; Signal transduction; Medicine; Cell biology; Internal medicine; Gene; Biochemistry","score_opus":0.008725670807022873,"score_gpt":0.2299171364603361,"score_spread":0.2211914656533132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089686819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972332,0.00062736607,0.00077103014,0.00006554249,0.0000054504035,0.000008974018,0.0001411734,0.00004734673,0.0010999524],"genre_scores_gemma":[0.99826103,0.00032373492,0.00046661508,0.000015490403,0.000001915386,0.0000076583965,0.00011918313,0.0000067766596,0.00079752144],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999925,0.000011263355,0.0000066765515,0.000009217956,0.000025786332,0.000022014357],"domain_scores_gemma":[0.9999553,0.000007924925,0.000011500717,0.000007060503,0.0000050939057,0.000013095546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008346912,0.00017396099,0.00015310534,0.00014853565,0.00009882838,0.0002249468,0.00009439931,0.00012159916,0.00095522666],"category_scores_gemma":[0.00007456654,0.000093602794,0.00015355508,0.00011102807,0.00011311945,0.00009236369,0.000119964425,0.00038065942,0.00024853344],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052461546,0.00001582164,0.0004717023,0.000014532024,0.000003765639,0.000034209144,0.0000053454414,0.000136663,0.99785525,0.00010148776,0.00003881309,0.0012698318],"study_design_scores_gemma":[0.00001143642,0.00033976184,0.0071521555,0.0000028992315,0.000010926007,0.0005000993,0.000016971711,0.0009707881,0.98967534,0.000056775432,0.0012599179,0.0000028289232],"about_ca_topic_score_codex":0.00046101506,"about_ca_topic_score_gemma":0.0013685739,"teacher_disagreement_score":0.00095522666,"about_ca_system_score_codex":0.00021040565,"about_ca_system_score_gemma":0.00016762428,"threshold_uncertainty_score":0.0031955242},"labels":[],"label_agreement":null},{"id":"W2091567174","doi":"10.1586/14737140.2015.1014343","title":"Dabrafenib in the treatment of metastatic or unresectable melanoma","year":2015,"lang":"en","type":"review","venue":"Expert Review of Anticancer Therapy","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Dabrafenib; Medicine; Trametinib; Melanoma; Metastatic melanoma; Oncology; Vemurafenib; Internal medicine; Clinical trial; Immunotherapy; Progression-free survival; Overall survival; Cancer research; Cancer; MAPK/ERK pathway; Kinase","score_opus":0.11361302437224512,"score_gpt":0.4255522667774826,"score_spread":0.31193924240523746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091567174","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001008858,0.9986759,0.000079605656,0.00019109155,0.00013295238,0.0000033493213,0.00001363817,0.0000055889914,0.00079703797],"genre_scores_gemma":[0.00068947766,0.9983735,0.00008654921,0.0001482892,0.0001020374,0.0000034148254,0.000027410555,0.0000010668541,0.00056822866],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99988174,0.000021446469,0.00001566472,0.00002056273,0.00004707134,0.000013537733],"domain_scores_gemma":[0.99988484,0.000041236628,0.000022458613,0.0000031873572,0.000031452262,0.000016866039],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041980494,0.0006559757,0.0010125538,0.0017020702,0.00019699933,0.00066012936,0.00063453143,0.00069394795,0.004131613],"category_scores_gemma":[0.00035511077,0.00019392652,0.0004465226,0.0015249185,0.00026635441,0.0008368595,0.0006287025,0.001463581,0.0023089324],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007831876,0.000055012766,0.000098677665,0.012296913,0.0000872222,0.00018066828,0.0000315532,0.000340368,0.0015471154,0.0019335761,0.034022693,0.94932795],"study_design_scores_gemma":[0.000028459162,0.000095384676,0.0005473615,0.00232763,0.00009940615,0.001416595,0.000030220634,0.000093112285,0.00036785295,0.001471741,0.9935082,0.0000139233625],"about_ca_topic_score_codex":0.0007101515,"about_ca_topic_score_gemma":0.0020090777,"teacher_disagreement_score":0.004131613,"about_ca_system_score_codex":0.0004136265,"about_ca_system_score_gemma":0.00062683603,"threshold_uncertainty_score":0.013821602},"labels":[],"label_agreement":null},{"id":"W2091983242","doi":"10.3129/i09-109","title":"p38 mitogen-activated protein kinase protects human retinal pigment epithelial cells exposed to oxidative stress","year":2009,"lang":"en","type":"article","venue":"Canadian Journal of Ophthalmology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"MAPK/ERK pathway; p38 mitogen-activated protein kinases; Protein kinase A; Cell biology; Viability assay; Kinase; Oxidative stress; Molecular biology; Programmed cell death; Chemistry; Transfection; Cell culture; Biology; Cell; Biochemistry; Apoptosis","score_opus":0.019591576888704606,"score_gpt":0.25132677276944765,"score_spread":0.23173519588074304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091983242","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944108,0.0032240788,0.0005896407,0.00023499962,0.00010226172,0.00003171357,0.00021636752,0.00004811151,0.0011420709],"genre_scores_gemma":[0.99446625,0.0017604199,0.00036875444,0.000058100257,0.00001990735,0.00003052715,0.00031036593,0.000005935558,0.0029797175],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998449,0.000021949014,0.000010096387,0.000020142816,0.000027655333,0.00007522088],"domain_scores_gemma":[0.99993944,0.0000066466173,0.000010195168,0.00001263383,0.000015202292,0.0000157939],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018885145,0.0005097715,0.00037139692,0.00027896825,0.00046710315,0.0003452142,0.0002790739,0.00036930537,0.0025540944],"category_scores_gemma":[0.00015452344,0.00023487098,0.0003537909,0.00023345038,0.00021857004,0.00027938536,0.00024534212,0.000687531,0.00035336954],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002671243,0.00032834485,0.00066208036,0.00014512746,0.00003459086,0.00025120054,0.00010935703,0.00007322605,0.99168265,0.00018435856,0.0002619164,0.0035958877],"study_design_scores_gemma":[0.0002728948,0.0022178872,0.022668071,0.00003097526,0.00009847908,0.00053148385,0.00045451426,0.00077748654,0.96819365,0.00021891693,0.0045180544,0.000017624781],"about_ca_topic_score_codex":0.005936388,"about_ca_topic_score_gemma":0.00564848,"teacher_disagreement_score":0.005936388,"about_ca_system_score_codex":0.00033695344,"about_ca_system_score_gemma":0.0007705637,"threshold_uncertainty_score":0.011803687},"labels":[],"label_agreement":null},{"id":"W2092096790","doi":"10.1038/jid.2013.378","title":"Is a Single BRAF Wild-Type Test Sufficient to Exclude Melanoma Patients from Vemurafenib Therapy?","year":2013,"lang":"en","type":"letter","venue":"Journal of Investigative Dermatology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Institut National Du Cancer","keywords":"Vemurafenib; Medicine; Melanoma; Dermatology; Test (biology); Oncology; Internal medicine; Cancer research; Metastatic melanoma; Biology","score_opus":0.03078801824767424,"score_gpt":0.23806569278434192,"score_spread":0.20727767453666768,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092096790","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.023121411,0.0037991551,0.00084934424,0.9519466,0.010677204,0.000035142668,0.00016324874,0.0000850836,0.009322778],"genre_scores_gemma":[0.33996716,0.00584025,0.0036395877,0.55318964,0.090616494,0.00007753812,0.00021499621,0.000068723406,0.006385604],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990282,0.00027772196,0.00017126034,0.000119748416,0.00021035611,0.00019275032],"domain_scores_gemma":[0.99660206,0.0020022236,0.00021116137,0.00013269731,0.0004888142,0.00056308997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001219655,0.0004249806,0.0011182427,0.00056881085,0.0011509142,0.0011724712,0.00091509614,0.013138251,0.0025249622],"category_scores_gemma":[0.0130982725,0.0003845827,0.00094575825,0.00037167958,0.0012492298,0.0018373214,0.00045794345,0.008520845,0.00222693],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001542029,0.0004044968,0.06476805,0.00036957202,0.00021121779,0.22014186,0.00039904815,0.0008496672,0.0051233424,0.006122532,0.58942807,0.11064018],"study_design_scores_gemma":[0.0011571051,0.0011276016,0.047044996,0.0010417249,0.0005234267,0.47036627,0.001954822,0.0072049224,0.004995485,0.04829197,0.41599396,0.0002977131],"about_ca_topic_score_codex":0.0017195,"about_ca_topic_score_gemma":0.0027094148,"teacher_disagreement_score":0.013138251,"about_ca_system_score_codex":0.001418549,"about_ca_system_score_gemma":0.0009958924,"threshold_uncertainty_score":0.010292292},"labels":[],"label_agreement":null},{"id":"W2092363432","doi":"10.1074/jbc.m211598200","title":"Negative Regulation of Mixed Lineage Kinase 3 by Protein Kinase B/AKT Leads to Cell Survival","year":2003,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":139,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"National Institute of General Medical Sciences; National Institutes of Health","keywords":"AKT1; MAP kinase kinase kinase; MAP2K7; ASK1; Cyclin-dependent kinase 9; Protein kinase B; Mitogen-activated protein kinase kinase; Cyclin-dependent kinase 2; Cyclin-dependent kinase 4; c-Raf; Cell biology; Biology; Protein kinase A; Kinase; Signal transduction","score_opus":0.01605063107311191,"score_gpt":0.2330801445419591,"score_spread":0.2170295134688472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092363432","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932742,0.0013275114,0.00220473,0.00013530083,0.000054382042,0.000014942332,0.00026128313,0.00009119916,0.002636577],"genre_scores_gemma":[0.99639076,0.0005082491,0.00072244613,0.000037816735,0.0000052535615,0.000017854249,0.0002356016,0.000010376143,0.0020716707],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999051,0.000014749808,0.000007654917,0.000013671036,0.000027726266,0.000031048246],"domain_scores_gemma":[0.9999443,0.00000888202,0.000014487079,0.000007916333,0.0000063028256,0.000017963848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000106077285,0.0002502044,0.000108869506,0.00012653237,0.00017410783,0.0002247245,0.000117025644,0.00013190103,0.0017500018],"category_scores_gemma":[0.00007705376,0.00010460402,0.00019882982,0.00010817337,0.00017057733,0.00013977395,0.00012815438,0.0004572416,0.0004457845],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001609221,0.000028097516,0.0002104201,0.000024347235,0.0000034671073,0.000049510494,0.0000088174875,0.00005212442,0.9981111,0.00028730533,0.00009192416,0.0009720119],"study_design_scores_gemma":[0.000030079955,0.00015836812,0.0034596059,0.00000535757,0.000010960391,0.00022434798,0.000021353248,0.0013243046,0.9913271,0.00013731104,0.0032982097,0.0000029947098],"about_ca_topic_score_codex":0.0005220787,"about_ca_topic_score_gemma":0.00060499733,"teacher_disagreement_score":0.0017500018,"about_ca_system_score_codex":0.0002883578,"about_ca_system_score_gemma":0.00025332393,"threshold_uncertainty_score":0.0058543086},"labels":[],"label_agreement":null},{"id":"W2096376623","doi":"10.1093/carcin/bgu016","title":"Targeted deletion of RasGRP1 impairs skin tumorigenesis","year":2014,"lang":"en","type":"article","venue":"Carcinogenesis","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute","keywords":"Carcinogenesis; Cancer research; Keratinocyte; Activator (genetics); Biology; Cell culture; Cancer; Genetics; Receptor","score_opus":0.006008155161474483,"score_gpt":0.2019179562737574,"score_spread":0.1959098011122829,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096376623","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963977,0.00041531335,0.0013224623,0.00006731824,0.00003582569,0.000025015303,0.0003992327,0.00019514172,0.0011419789],"genre_scores_gemma":[0.99494284,0.00037527192,0.00076612213,0.000023734092,0.0000064534993,0.000022533586,0.0002794865,0.00003805893,0.0035454738],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997558,0.000036816993,0.000027577336,0.000048963062,0.00006538418,0.0000655057],"domain_scores_gemma":[0.99969554,0.000049123995,0.00007477895,0.000039628165,0.000013631265,0.000127478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001389678,0.00057898724,0.0003211979,0.0005988314,0.00019276528,0.0003282946,0.00033494402,0.0005114955,0.002976832],"category_scores_gemma":[0.00013023558,0.00031895447,0.00033798296,0.00022747023,0.00032460882,0.00029440928,0.00032369405,0.00095415156,0.00074125716],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013985747,0.00007572923,0.000089697365,0.000015427377,0.0000058405585,0.00006917922,0.00001303715,0.0000918625,0.99870753,0.00010641114,0.00002518348,0.00066020596],"study_design_scores_gemma":[0.000019171468,0.00051769946,0.0030562496,0.000006587603,0.000022518785,0.0002715133,0.000042518022,0.0012546467,0.99363434,0.000087019944,0.0010810331,0.0000066795537],"about_ca_topic_score_codex":0.00051307987,"about_ca_topic_score_gemma":0.00063621305,"teacher_disagreement_score":0.002976832,"about_ca_system_score_codex":0.00028626996,"about_ca_system_score_gemma":0.0002240636,"threshold_uncertainty_score":0.009958506},"labels":[],"label_agreement":null},{"id":"W2096440522","doi":"10.1042/bj3460169","title":"Cloning and characterization of mouse extracellular-signal-regulated protein kinase 3 as a unique gene product of 100 kDa","year":2000,"lang":"en","type":"article","venue":"Biochemical Journal","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôtel-Dieu de Montréal","funders":"Medical Research Council; Medical Research Council Canada; Heart and Stroke Foundation of Canada","keywords":"Biology; Molecular biology; Complementary DNA; Gene product; Kinase; Protein kinase A; Gene; c-Raf; Gene expression; Signal transduction; Mitogen-activated protein kinase kinase; Genetics","score_opus":0.006976926530902134,"score_gpt":0.2075050572245967,"score_spread":0.20052813069369457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096440522","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9780368,0.0018795037,0.015228468,0.00028420947,0.000050004222,0.00008189746,0.0016532458,0.000104159226,0.0026816751],"genre_scores_gemma":[0.9323199,0.003606919,0.034368984,0.00018807063,0.00003700848,0.00015130949,0.01618637,0.000084769265,0.0130566005],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999449,0.0000050460685,0.0000049636787,0.000012746304,0.000020024296,0.000012237793],"domain_scores_gemma":[0.9999125,0.000013750348,0.000017448985,0.000010873086,0.000011653054,0.000033823224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000119289,0.00028697253,0.00011768802,0.00027687394,0.00013853186,0.00018351123,0.0001917466,0.00022973922,0.0007836628],"category_scores_gemma":[0.00013164057,0.0001460286,0.0002508197,0.00019007684,0.00014676538,0.00018476519,0.00017531426,0.00041622244,0.0007987748],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037286027,0.000011919477,0.00018550169,0.000013899365,0.0000017110302,0.0000875634,0.000010137833,0.000019265288,0.9980477,0.0001536831,0.000029659217,0.001401722],"study_design_scores_gemma":[0.000050692455,0.00037889692,0.0219169,0.000019879697,0.000044684726,0.0026832041,0.000044224234,0.0009944842,0.9501204,0.00051151984,0.023222422,0.000012708164],"about_ca_topic_score_codex":0.0002720075,"about_ca_topic_score_gemma":0.00043283196,"teacher_disagreement_score":0.0007836628,"about_ca_system_score_codex":0.00017084525,"about_ca_system_score_gemma":0.00021373872,"threshold_uncertainty_score":0.002621591},"labels":[],"label_agreement":null},{"id":"W2098106638","doi":"10.1016/j.molonc.2011.03.005","title":"Melanoma — The pieces of the puzzle finally start coming together!","year":2011,"lang":"en","type":"article","venue":"Molecular Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Melanoma; Biology; Medicine; Computer science; Computational biology; Cancer research","score_opus":0.02541976603476033,"score_gpt":0.24011855738211163,"score_spread":0.21469879134735131,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098106638","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026298796,0.21024005,0.0017859114,0.70462483,0.06915881,0.000032155822,0.00028916678,0.00033164423,0.010907573],"genre_scores_gemma":[0.043088533,0.26101667,0.0075254506,0.5407302,0.07560058,0.00012664132,0.0008517252,0.00062346156,0.07043677],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.998323,0.000498581,0.00012073177,0.0002554695,0.00048672053,0.0003154483],"domain_scores_gemma":[0.9956773,0.0008581726,0.0002692952,0.0002769404,0.0011766044,0.0017416347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034065845,0.0015710128,0.0019290036,0.0011118662,0.0035451103,0.0060985275,0.0013255689,0.0075583206,0.021018824],"category_scores_gemma":[0.006265685,0.00046566647,0.0015675431,0.0008333403,0.0043243454,0.015039394,0.0046255453,0.02140147,0.014382728],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028113404,0.0001087289,0.0012282721,0.0008632175,0.00009982863,0.00090777536,0.00067752367,0.000113691916,0.0018889555,0.0125060165,0.8065365,0.17478828],"study_design_scores_gemma":[0.00002856995,0.00014778262,0.0010439507,0.0008124704,0.000038565664,0.0015346076,0.0023565018,0.00008651643,0.0002230823,0.019983387,0.97369766,0.000046908925],"about_ca_topic_score_codex":0.0018237403,"about_ca_topic_score_gemma":0.0041816207,"teacher_disagreement_score":0.021018824,"about_ca_system_score_codex":0.0018317142,"about_ca_system_score_gemma":0.0025041765,"threshold_uncertainty_score":0.070315},"labels":[],"label_agreement":null},{"id":"W2099259685","doi":"10.1093/annonc/mdi310","title":"Phase I study to determine the safety and pharmacokinetics of the novel Raf kinase and VEGFR inhibitor BAY 43-9006, administered for 28 days on/7 days off in patients with advanced, refractory solid tumors","year":2005,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":301,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bayer (Canada); Juravinski Cancer Centre","funders":"","keywords":"Medicine; Pharmacokinetics; Dosing; Toxicity; Adverse effect; Kinase; Internal medicine; Bay; Pharmacology; Refractory (planetary science); Tyrosine-kinase inhibitor; Cancer; Gastroenterology; Oncology","score_opus":0.03243005053116366,"score_gpt":0.3398462573339467,"score_spread":0.30741620680278303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099259685","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995596,0.00087682647,0.0005456453,0.0002938801,0.00008081156,0.00078112754,0.0005781588,0.00008269568,0.0011649445],"genre_scores_gemma":[0.99277663,0.0009097505,0.0012365351,0.00045296253,0.0001626886,0.0011046651,0.0011617043,0.000037865695,0.0021572178],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99974936,0.000098312936,0.000008405795,0.000049727158,0.000023931752,0.00007020917],"domain_scores_gemma":[0.99926096,0.00011571592,0.00014732093,0.00006737437,0.00003300767,0.00037553796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007216412,0.0013465534,0.002069103,0.00036292762,0.00044669522,0.00084267964,0.000663846,0.0009903872,0.0028938542],"category_scores_gemma":[0.00083522557,0.0006437227,0.001028204,0.00039896864,0.0010159203,0.00080566667,0.00022525091,0.003881328,0.0007625729],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.75130653,0.07048776,0.006813663,0.00032739472,0.00096299924,0.00033732652,0.00027488905,0.0039672437,0.081324756,0.00049592514,0.003961244,0.079740256],"study_design_scores_gemma":[0.4222872,0.5510301,0.014494086,0.000018638693,0.00042780742,0.00045070902,0.000063837986,0.0023178663,0.005918814,0.0003763704,0.0025791195,0.000035506568],"about_ca_topic_score_codex":0.0013547835,"about_ca_topic_score_gemma":0.0026814933,"teacher_disagreement_score":0.0028938542,"about_ca_system_score_codex":0.0009018059,"about_ca_system_score_gemma":0.0017842123,"threshold_uncertainty_score":0.009680927},"labels":[],"label_agreement":null},{"id":"W2099267053","doi":"10.1101/gad.962902","title":"KSR is a scaffold required for activation of the ERK/MAPK module","year":2002,"lang":"en","type":"article","venue":"Genes & Development","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":220,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"National Cancer Institute","keywords":"MAPK/ERK pathway; Cell biology; Scaffold protein; Biology; Caenorhabditis elegans; Kinase; Phosphorylation; Scaffold; Suppressor; MEK inhibitor; Signal transduction; Genetics; Cancer; Computer science; Gene","score_opus":0.026683812078635235,"score_gpt":0.2261812319709946,"score_spread":0.19949741989235936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099267053","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98734576,0.0013096512,0.0067878687,0.0001319989,0.000033887773,0.000015794049,0.0006233507,0.0005461641,0.0032055199],"genre_scores_gemma":[0.9922621,0.0003261112,0.0030500023,0.00002151704,0.0000103212515,0.0000066917373,0.0010175671,0.000053637512,0.0032520483],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99983776,0.000015368403,0.000014154447,0.000042452302,0.00005879536,0.000031478212],"domain_scores_gemma":[0.9998053,0.000018973209,0.00006782823,0.00003070705,0.00002147606,0.000055752706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011473113,0.0004228943,0.00023539513,0.00027928068,0.00037875216,0.00040135378,0.00025266904,0.00027852922,0.002276528],"category_scores_gemma":[0.00017129889,0.00023251938,0.0003067407,0.00012469188,0.00024902468,0.0003266783,0.00046547988,0.0003402765,0.002896785],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004776948,0.000008124625,0.0002831583,0.00002710436,0.0000030437402,0.0002539902,0.000011524317,0.000045170676,0.9974101,0.00032003282,0.000048504295,0.0015413773],"study_design_scores_gemma":[0.000014517393,0.000093031675,0.012608036,0.000008229821,0.000012619329,0.0022819752,0.000034517016,0.0011021413,0.9760885,0.00018324588,0.0075622285,0.000011039152],"about_ca_topic_score_codex":0.00038551452,"about_ca_topic_score_gemma":0.00065021886,"teacher_disagreement_score":0.002276528,"about_ca_system_score_codex":0.00043936502,"about_ca_system_score_gemma":0.00020324608,"threshold_uncertainty_score":0.0076158047},"labels":[],"label_agreement":null},{"id":"W2100743480","doi":"10.1158/0008-5472.can-13-2775","title":"A Meta-analysis of Lung Cancer Gene Expression Identifies <i>PTK7</i> as a Survival Gene in Lung Adenocarcinoma","year":2014,"lang":"en","type":"review","venue":"Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":158,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"National Cancer Institute","keywords":"Adenocarcinoma; Lung cancer; Cancer research; Gene signature; Biology; Cancer; Gene; Gene expression; Pathology; Medicine; Genetics","score_opus":0.19682232174945372,"score_gpt":0.4574054528975547,"score_spread":0.26058313114810094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100743480","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0041563762,0.9946104,0.00030728616,0.00026201914,0.000070859445,0.0000062236454,0.00032643377,0.000010826267,0.0002495809],"genre_scores_gemma":[0.07375924,0.9234442,0.0011137862,0.0003502594,0.0001762023,0.000022242226,0.0008639613,0.000015155547,0.00025500025],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9995024,0.00015107499,0.00008056718,0.00012234869,0.00011385373,0.00002974891],"domain_scores_gemma":[0.99885714,0.000738923,0.00016375934,0.000055745804,0.00013903828,0.000045369456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001728305,0.00055273174,0.0025125807,0.0018559679,0.00011378445,0.0007452711,0.0005492585,0.00041981714,0.0010412565],"category_scores_gemma":[0.0017257772,0.0002183145,0.003540486,0.0032583678,0.00017100398,0.00036223818,0.00038381666,0.0005911731,0.00019080097],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023589747,0.000044182565,0.063999176,0.08439435,0.08773806,0.00068553677,0.00010369283,0.0020110018,0.0061754617,0.0011790836,0.013172597,0.7381379],"study_design_scores_gemma":[0.0004769147,0.0011981706,0.3717469,0.019152554,0.3513075,0.0059935306,0.00029195932,0.0029657779,0.007721893,0.0047245766,0.23422305,0.00019714951],"about_ca_topic_score_codex":0.0014407076,"about_ca_topic_score_gemma":0.003910826,"teacher_disagreement_score":0.0025125807,"about_ca_system_score_codex":0.00055724103,"about_ca_system_score_gemma":0.00091535336,"threshold_uncertainty_score":0.009140313},"labels":[],"label_agreement":null},{"id":"W2101417059","doi":"10.1074/jbc.m008096200","title":"Kinase Suppressor of Ras Signals through Thr269 of c-Raf-1","year":2001,"lang":"en","type":"retraction","venue":"Journal of Biological Chemistry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":71,"is_retracted":true,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Medical Research Council; National Institutes of Health; Medical Research Council Canada","keywords":"Autophosphorylation; Phosphorylation; Kinase; Serine; Tyrosine phosphorylation; Cell biology; Substrate-level phosphorylation; Biochemistry; Chemistry; Tyrosine kinase; Signal transduction; Protein kinase A; Biology","score_opus":0.03792983156927502,"score_gpt":0.2859136230190474,"score_spread":0.24798379144977237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101417059","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99560106,0.0008830707,0.0017762254,0.00008481105,0.00003233467,0.00003931518,0.0003309179,0.00006859908,0.0011837404],"genre_scores_gemma":[0.99319154,0.00065673457,0.0018721692,0.000022927754,0.000014781913,0.000030081052,0.000925009,0.000014367019,0.0032724233],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99987435,0.00002538258,0.00001319803,0.000019132898,0.0000394405,0.000028454697],"domain_scores_gemma":[0.9998946,0.000014930492,0.000031733074,0.00001421213,0.000008798856,0.00003564356],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0001473865,0.0007193636,0.00026357232,0.00021385045,0.00015869734,0.000320225,0.00026982365,0.00018931337,0.001954541],"category_scores_gemma":[0.00009868873,0.00014494528,0.00025831754,0.00011816367,0.0002259181,0.00016235684,0.00022852476,0.00058085547,0.0011000957],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001171401,0.000030334537,0.000083179395,0.000020681682,0.0000022407862,0.00004702599,0.0000037003447,0.000034549827,0.9991358,0.000077468605,0.000021652191,0.00042636957],"study_design_scores_gemma":[0.000025081397,0.00035948795,0.0016930065,0.000002877024,0.000005608218,0.000460084,0.000009336211,0.0008567937,0.994921,0.000035112662,0.0016271698,0.0000044729845],"about_ca_topic_score_codex":0.00030262928,"about_ca_topic_score_gemma":0.00051410496,"teacher_disagreement_score":0.9998107,"about_ca_system_score_codex":0.0002402259,"about_ca_system_score_gemma":0.00021923981,"threshold_uncertainty_score":0.0065386295},"labels":[],"label_agreement":null},{"id":"W2101666731","doi":"10.1136/jclinpath-2013-201471","title":"Molecular biology of normal melanocytes and melanoma cells","year":2013,"lang":"en","type":"review","venue":"Journal of Clinical Pathology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":136,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Melanoma; Melanocyte; Cancer research; Malignant transformation; Skin cancer; Biology; Population; Cell; Cancer; Cell growth; Medicine; Immunology; Internal medicine; Genetics","score_opus":0.0628149022130208,"score_gpt":0.400415545993399,"score_spread":0.33760064378037824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101666731","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00043134645,0.9961533,0.00039569233,0.0004550672,0.00037190964,0.000007418679,0.000017581973,0.000012880961,0.0021548346],"genre_scores_gemma":[0.0036121157,0.993091,0.00040735555,0.00024077177,0.00032005252,0.000014330671,0.00004493079,0.0000029129078,0.0022665672],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997886,0.00003326076,0.000021005324,0.000036053872,0.00009337494,0.000027861523],"domain_scores_gemma":[0.999851,0.000043434335,0.000022695249,0.000007998626,0.00005072838,0.000024189512],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034868286,0.00073914207,0.000804869,0.0011841395,0.00035573507,0.0009175049,0.00067627133,0.0010165524,0.0019708888],"category_scores_gemma":[0.00037665368,0.00023682193,0.00031410178,0.00083785487,0.0007310678,0.0011792762,0.0006943968,0.0015453736,0.0019008061],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014440481,0.000097666794,0.00044364965,0.011321328,0.0000502308,0.00093706313,0.00014028186,0.00037641,0.029472273,0.012487605,0.026525596,0.9180033],"study_design_scores_gemma":[0.000010581851,0.00006770288,0.0012308419,0.0007717506,0.000029565581,0.003368657,0.00006261135,0.00008013278,0.0061400277,0.003361504,0.98485905,0.00001763614],"about_ca_topic_score_codex":0.0005103902,"about_ca_topic_score_gemma":0.0006906507,"teacher_disagreement_score":0.0019708888,"about_ca_system_score_codex":0.0007602311,"about_ca_system_score_gemma":0.000831085,"threshold_uncertainty_score":0.006593287},"labels":[],"label_agreement":null},{"id":"W2102646127","doi":"10.1016/j.molcel.2005.10.022","title":"Wild-Type and Mutant B-RAF Activate C-RAF through Distinct Mechanisms Involving Heterodimerization","year":2005,"lang":"en","type":"article","venue":"Molecular Cell","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":421,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Cancer Research UK; Cancer Research Institute","keywords":"Biology; Mutant; Genetics; Wild type; Cell biology; Mutation; Gene","score_opus":0.007918534931107038,"score_gpt":0.20997684267740618,"score_spread":0.20205830774629915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102646127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98676306,0.0020219071,0.005545235,0.00017854884,0.000085879234,0.000054321747,0.0003465099,0.00013630227,0.0048681446],"genre_scores_gemma":[0.9906493,0.00074173976,0.002839806,0.00009754979,0.000022328932,0.00006820387,0.00079552544,0.000043685293,0.004741953],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99956244,0.000066779154,0.000036099453,0.000078699486,0.00010548444,0.00015054773],"domain_scores_gemma":[0.9998185,0.000043130323,0.000025751762,0.000034083543,0.000029845403,0.000048808175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040521167,0.00047762776,0.00022768763,0.00035842092,0.00032176,0.00066318235,0.00033575177,0.00037589448,0.0024100407],"category_scores_gemma":[0.0002473239,0.0003406019,0.00056738354,0.00021302339,0.00022434277,0.00058519264,0.0004509578,0.0010974476,0.0011207034],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011650204,0.000042089145,0.00016107329,0.000020839017,0.0000074180184,0.000039839284,0.000012458638,0.00001992351,0.9983165,0.0005851483,0.000070399736,0.0006078353],"study_design_scores_gemma":[0.00004290606,0.00011218324,0.00511124,0.0000066194452,0.000020175938,0.0006515457,0.000058109497,0.001153842,0.9896702,0.00022953028,0.0029339723,0.000009596159],"about_ca_topic_score_codex":0.00025911353,"about_ca_topic_score_gemma":0.00039816505,"teacher_disagreement_score":0.0024100407,"about_ca_system_score_codex":0.0003903085,"about_ca_system_score_gemma":0.00016187207,"threshold_uncertainty_score":0.008062422},"labels":[],"label_agreement":null},{"id":"W2103845135","doi":"10.1200/jco.2012.30.15_suppl.8502","title":"Updated overall survival (OS) results for BRIM-3, a phase III randomized, open-label, multicenter trial comparing BRAF inhibitor vemurafenib (vem) with dacarbazine (DTIC) in previously untreated patients with <i>BRAF<sup>V600E</sup></i>-mutated melanoma.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":140,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Vemurafenib; Dacarbazine; Hazard ratio; Internal medicine; Interim analysis; Temozolomide; Metastatic melanoma; Gastroenterology; Oncology; Surgery; Randomized controlled trial; Confidence interval; Chemotherapy; Cancer","score_opus":0.07959961057608907,"score_gpt":0.3936601599823536,"score_spread":0.31406054940626454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103845135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.916797,0.012188907,0.004437633,0.0011963359,0.00032987157,0.0019808356,0.05475004,0.0005190863,0.007800257],"genre_scores_gemma":[0.8974792,0.0017660161,0.0045447466,0.001634532,0.00025239843,0.0018674688,0.089290954,0.00015537674,0.003009269],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99772304,0.0013381045,0.00013581471,0.00024003067,0.00039470562,0.00016817197],"domain_scores_gemma":[0.99486536,0.0015143857,0.0020390728,0.00049314275,0.0004093978,0.0006786737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009375856,0.0008389901,0.0013167572,0.0007374107,0.00029962376,0.0012287701,0.0010616776,0.00075978314,0.0024841842],"category_scores_gemma":[0.0067664655,0.00048150212,0.0025463947,0.00081437634,0.00027773107,0.0008749365,0.0007625831,0.0022635336,0.00055442227],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6484267,0.0047644703,0.12801746,0.0029243552,0.02366746,0.0005264032,0.00044612802,0.010890496,0.027438238,0.0007609897,0.04048409,0.11165316],"study_design_scores_gemma":[0.17965773,0.09965728,0.6247171,0.00038700268,0.03665255,0.0012835186,0.00012500817,0.005869832,0.014887692,0.00076838315,0.035772707,0.00022105135],"about_ca_topic_score_codex":0.0010196349,"about_ca_topic_score_gemma":0.002723147,"teacher_disagreement_score":0.009375856,"about_ca_system_score_codex":0.0008625141,"about_ca_system_score_gemma":0.0009475075,"threshold_uncertainty_score":0.049584866},"labels":[],"label_agreement":null},{"id":"W2104902103","doi":"10.1186/1471-2407-14-398","title":"A combination of p300 and Braf expression in the diagnosis and prognosis of melanoma","year":2014,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; University of British Columbia","funders":"Canadian Institutes of Health Research; Canadian Dermatology Foundation","keywords":"Melanoma; Vemurafenib; Medicine; Surgical oncology; Oncology; Proportional hazards model; Nodular melanoma; Internal medicine; Cancer research; Metastatic melanoma","score_opus":0.017481146146583547,"score_gpt":0.25760253572705977,"score_spread":0.2401213895804762,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104902103","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974842,0.0010900921,0.00056448404,0.00007244694,0.000010111924,0.000009181417,0.00013629855,0.000014691745,0.00061854185],"genre_scores_gemma":[0.9994661,0.00011446198,0.00022693515,0.0000044845997,0.000012348767,0.0000030156195,0.00008289389,0.0000014831463,0.00008827273],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99969625,0.000090963214,0.000029057044,0.000055228364,0.000086733584,0.000041710267],"domain_scores_gemma":[0.9989152,0.00032408178,0.00042655363,0.000048520586,0.00014045429,0.000145272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000696161,0.00023935734,0.0002153515,0.000898803,0.000213239,0.0003266699,0.00024280213,0.00032435977,0.0015617202],"category_scores_gemma":[0.0015351226,0.000105132814,0.0002737812,0.00061409693,0.00024473117,0.00022877175,0.00020200631,0.00035652716,0.00042123828],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005306541,0.00002516881,0.9888115,0.000020229882,0.000037206315,0.0002787721,0.000018766586,0.0001445572,0.0033346312,0.000021207832,0.0001336928,0.0066436925],"study_design_scores_gemma":[0.000007150383,0.00019171485,0.9945089,0.0000076222364,0.00006269943,0.002416123,0.000049547045,0.0011711132,0.0010947883,0.00010317336,0.000381192,0.00000600887],"about_ca_topic_score_codex":0.0005344896,"about_ca_topic_score_gemma":0.0007438996,"teacher_disagreement_score":0.0015617202,"about_ca_system_score_codex":0.00020254268,"about_ca_system_score_gemma":0.00022493907,"threshold_uncertainty_score":0.005224526},"labels":[],"label_agreement":null},{"id":"W2105061758","doi":"10.1016/j.jcjo.2013.12.012","title":"Regression of orbital and choroidal metastases from melanoma after treatment with vemurafenib","year":2014,"lang":"en","type":"letter","venue":"Canadian Journal of Ophthalmology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Vemurafenib; Choroidal melanoma; Melanoma; Medicine; Regression; Oncology; Dermatology; Internal medicine; Cancer research; Metastatic melanoma; Mathematics; Statistics","score_opus":0.015344114267266298,"score_gpt":0.22849415541181825,"score_spread":0.21315004114455194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105061758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9525761,0.010212726,0.0020166698,0.013217005,0.0011197835,0.00014232403,0.00023431031,0.0003319584,0.02014917],"genre_scores_gemma":[0.9931375,0.0010350085,0.0003386443,0.0008901805,0.00032435035,0.0000146422935,0.000110293404,0.000014635607,0.004134745],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9998679,0.000018367971,0.000011097368,0.000014650621,0.00003571243,0.000052157382],"domain_scores_gemma":[0.9995982,0.00014709991,0.00005688546,0.000045120258,0.000033662596,0.00011919275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019356074,0.00029947326,0.0005927947,0.00032812628,0.00045875393,0.0003502447,0.00041220218,0.00080608245,0.0012126802],"category_scores_gemma":[0.0010971287,0.00015986939,0.0005299243,0.00021565106,0.0003556686,0.00030766855,0.00017384441,0.0016653785,0.00025915206],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008055388,0.00071224954,0.032631528,0.00042523726,0.00024135348,0.72387344,0.00048252073,0.0013282932,0.07898101,0.0015732956,0.010686912,0.14100876],"study_design_scores_gemma":[0.0011307608,0.0036152215,0.19118954,0.00006390629,0.00039057442,0.7280658,0.00029299132,0.009189562,0.025907056,0.0016366588,0.03842641,0.000091565555],"about_ca_topic_score_codex":0.004048577,"about_ca_topic_score_gemma":0.0065958896,"teacher_disagreement_score":0.004048577,"about_ca_system_score_codex":0.00087030896,"about_ca_system_score_gemma":0.00049120025,"threshold_uncertainty_score":0.0080500245},"labels":[],"label_agreement":null},{"id":"W2105195683","doi":"10.1002/cyto.1067","title":"Measurement of MAP kinase activation by flow cytometry using phospho‐specific antibodies to MEK and ERK: Potential for pharmacodynamic monitoring of signal transduction inhibitors","year":2001,"lang":"en","type":"article","venue":"Cytometry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":178,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"MAPK/ERK pathway; Signal transduction; Flow cytometry; Kinase; Mitogen-activated protein kinase; MEK inhibitor; Mitogen-activated protein kinase kinase; Protein kinase A; Biology; Cell biology; Cancer research; Protein kinase C; Chemistry; Pharmacology; Molecular biology","score_opus":0.02178551514584201,"score_gpt":0.26953978126859096,"score_spread":0.24775426612274895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105195683","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.47364378,0.0068820263,0.5077401,0.0010498121,0.00040181229,0.000531457,0.0012359432,0.0024814513,0.006033637],"genre_scores_gemma":[0.66541034,0.0077819494,0.31888726,0.0004962374,0.00023562757,0.0013806166,0.0009832443,0.00014453505,0.0046802503],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994356,0.00016249812,0.000050022667,0.00014827661,0.00014249152,0.000061018443],"domain_scores_gemma":[0.99940383,0.00029379598,0.000088587185,0.000059415892,0.00008974826,0.000064642874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014838906,0.00071486074,0.00065786805,0.0012425168,0.00034784368,0.00068656984,0.000846997,0.0008787112,0.0017798584],"category_scores_gemma":[0.0010046508,0.00034323309,0.00022402899,0.0006022413,0.0004897,0.0009963386,0.0003747801,0.0016091955,0.00057700643],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015686362,0.000077439254,0.0002394007,0.00006556396,0.000008418286,0.000018016131,0.000019686508,0.000117355754,0.99158233,0.00030051867,0.00014244535,0.007272033],"study_design_scores_gemma":[0.00003281377,0.00020357392,0.001628562,0.000007053179,0.000018190292,0.00014539243,0.000012753766,0.004283937,0.9917789,0.00048447694,0.0013918016,0.000012386332],"about_ca_topic_score_codex":0.00019167768,"about_ca_topic_score_gemma":0.00036891413,"teacher_disagreement_score":0.0017798584,"about_ca_system_score_codex":0.0004681984,"about_ca_system_score_gemma":0.0002731601,"threshold_uncertainty_score":0.007847667},"labels":[],"label_agreement":null},{"id":"W2106773063","doi":"10.1093/jnci/93.19.1473","title":"In Vitro Evidence for Homologous Recombinational Repair in Resistance to Melphalan","year":2001,"lang":"en","type":"article","venue":"JNCI Journal of the National Cancer Institute","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Melphalan; XRCC3; RAD51; Ku80; DNA repair; Ku70; Homologous recombination; Nitrogen mustard; DNA damage; Biology; Non-homologous end joining; RAD52; ERCC1; DNA; Molecular biology; Cancer research; Genetics; Nucleotide excision repair; DNA-binding protein; Gene; Transcription factor; Chemotherapy","score_opus":0.07110099166967875,"score_gpt":0.359029660498361,"score_spread":0.28792866882868223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106773063","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96378374,0.011236465,0.015780158,0.00034780888,0.000094134884,0.00009200821,0.0012437253,0.0002856307,0.007136442],"genre_scores_gemma":[0.9924838,0.0010682616,0.0032396917,0.000058778205,0.00001793323,0.000038712253,0.0014312222,0.00002137225,0.0016401864],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99943036,0.00016362299,0.00008141334,0.00007339325,0.00019096983,0.00006023551],"domain_scores_gemma":[0.99794227,0.0008766548,0.00048985373,0.00030672952,0.00027673124,0.00010775025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068746024,0.00039014223,0.00021594943,0.0003427078,0.000112528585,0.0003630631,0.00036613204,0.00036318888,0.0044107265],"category_scores_gemma":[0.0011408993,0.00015034877,0.00032028393,0.0002272465,0.00022412853,0.0001834862,0.00022389572,0.00057928945,0.0015418417],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023182009,0.00009494671,0.002779864,0.00013799692,0.00004290093,0.00014870269,0.000032011358,0.00013821898,0.99415004,0.0002542304,0.0001059203,0.0018834271],"study_design_scores_gemma":[0.000022921082,0.00046443866,0.017395377,0.000017457125,0.000058191523,0.0014685673,0.000040620394,0.0011540254,0.9758985,0.000153887,0.0033193186,0.0000067323494],"about_ca_topic_score_codex":0.00048099912,"about_ca_topic_score_gemma":0.0003964518,"teacher_disagreement_score":0.0044107265,"about_ca_system_score_codex":0.00034509474,"about_ca_system_score_gemma":0.00018530294,"threshold_uncertainty_score":0.014755309},"labels":[],"label_agreement":null},{"id":"W2106971217","doi":"10.1371/journal.pone.0008044","title":"Structural Diversity of the Active N-Terminal Kinase Domain of p90 Ribosomal S6 Kinase 2","year":2009,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Light Source (Canada)","funders":"National Cancer Institute; National Institutes of Health; National Institute of Environmental Health Sciences; Hormel Foundation","keywords":"Protein kinase domain; Kinase; Biology; Biochemistry; Molecular biology; Protein kinase A; Cell biology; Chemistry; Biophysics; Mutant; Gene","score_opus":0.02097129361313658,"score_gpt":0.20939129152658667,"score_spread":0.1884199979134501,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106971217","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99583995,0.0009649318,0.0016413471,0.000060826875,0.00001061838,0.000008719793,0.0001612183,0.00003405408,0.0012784208],"genre_scores_gemma":[0.9975313,0.0002907407,0.0008801129,0.000045601104,0.000009088772,0.0000072524917,0.00073387165,0.0000069815737,0.0004950586],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999137,0.000015184137,0.000006957853,0.000020888925,0.000027531683,0.000015756963],"domain_scores_gemma":[0.9999261,0.000009097533,0.000019956735,0.0000071682252,0.000012663891,0.000025122305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000750726,0.00025269095,0.00020487812,0.0001476342,0.00013845091,0.000311214,0.00023943059,0.00017903582,0.0006236985],"category_scores_gemma":[0.00017402519,0.00012899716,0.00018818586,0.00014236776,0.00014404955,0.00021740321,0.00017818327,0.0002794903,0.00036696423],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033163233,0.00002963238,0.0016041481,0.00006980162,0.000015110856,0.00034437556,0.000054977238,0.00085618836,0.99297583,0.0003728847,0.00014443949,0.0032009247],"study_design_scores_gemma":[0.00018063237,0.00098639,0.1054853,0.000058426547,0.00012797996,0.00733638,0.00031343958,0.017254021,0.83958626,0.002006835,0.026581462,0.00008284319],"about_ca_topic_score_codex":0.00025116093,"about_ca_topic_score_gemma":0.00023526434,"teacher_disagreement_score":0.0006236985,"about_ca_system_score_codex":0.00020412488,"about_ca_system_score_gemma":0.00016070448,"threshold_uncertainty_score":0.0020865202},"labels":[],"label_agreement":null},{"id":"W2107233903","doi":"10.1093/annonc/mdp254","title":"Small molecules and targeted therapies in distant metastatic disease","year":2009,"lang":"en","type":"review","venue":"Annals of Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":85,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Sunitinib; Everolimus; Targeted therapy; Sorafenib; Cancer research; Imatinib; Temsirolimus; Axitinib; Melanoma; Trametinib; Pazopanib; Pharmacology; Tyrosine kinase; Oncology; PI3K/AKT/mTOR pathway; Internal medicine; Cancer; Kinase; MAPK/ERK pathway; Signal transduction; Biology; Receptor; Discovery and development of mTOR inhibitors","score_opus":0.12445407943585476,"score_gpt":0.377092111462753,"score_spread":0.2526380320268983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107233903","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023441343,0.9962107,0.0003977359,0.00045552698,0.0007099123,0.000008788788,0.000021633692,0.00001550535,0.0019458474],"genre_scores_gemma":[0.0016677605,0.9940124,0.00048821542,0.00045015514,0.0005326227,0.000019492454,0.000046431618,0.000003117231,0.0027798475],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99988353,0.000018420746,0.000012185986,0.000017891325,0.000053761458,0.000014219145],"domain_scores_gemma":[0.9998554,0.00006799148,0.000021871558,0.000005866569,0.00003317934,0.000015804744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052957336,0.00093850534,0.0012094335,0.0012200106,0.00023641335,0.0006307151,0.0008859509,0.0010334477,0.0033565513],"category_scores_gemma":[0.000515249,0.00028235046,0.00039236987,0.0012595088,0.000471695,0.000855643,0.0004944995,0.0021001066,0.0021699953],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001598814,0.0001267084,0.00010943477,0.004323992,0.00006189897,0.00026307648,0.00002445763,0.0006563851,0.0038523301,0.0033538367,0.05938785,0.92768013],"study_design_scores_gemma":[0.00006826387,0.00013439024,0.00047597883,0.00073042285,0.000091769056,0.0010714933,0.000018602048,0.00021411061,0.0009893933,0.0016567204,0.9945359,0.000012957263],"about_ca_topic_score_codex":0.00064980314,"about_ca_topic_score_gemma":0.0023560645,"teacher_disagreement_score":0.0033565513,"about_ca_system_score_codex":0.0006060269,"about_ca_system_score_gemma":0.00055664696,"threshold_uncertainty_score":0.01122874},"labels":[],"label_agreement":null},{"id":"W2107400826","doi":"10.1158/0008-5472.can-11-2126","title":"Sef Downregulation by Ras Causes MEK1/2 to Become Aberrantly Nuclear Localized Leading to Polyploidy and Neoplastic Transformation","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Institute for Research in Immunology and Cancer; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Downregulation and upregulation; Neoplastic transformation; Carcinogenesis; MAPK/ERK pathway; Nuclear localization sequence; Cell biology; Biology; Phosphorylation; Cancer research; Nuclear export signal; Signal transduction; Kinase; Subcellular localization; Malignant transformation; Cancer; Cell growth; Cell nucleus; Nucleus; Genetics; Cytoplasm; Gene","score_opus":0.04321457610070474,"score_gpt":0.3559262528742646,"score_spread":0.3127116767735599,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107400826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972736,0.0004242288,0.0013625128,0.00006200555,0.00001234393,0.0000108308195,0.00009186156,0.000053919466,0.0007086097],"genre_scores_gemma":[0.99734855,0.0002799924,0.00076929916,0.000017891978,0.0000026415796,0.000012605181,0.00012340826,0.000010718712,0.001434881],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999014,0.000014330731,0.000012410781,0.00001779333,0.0000280208,0.000026035943],"domain_scores_gemma":[0.99991477,0.000019261499,0.000022843384,0.000014041627,0.000006026272,0.000023015542],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000078680234,0.0003187742,0.00019442067,0.00020135789,0.00013886303,0.00024728474,0.00016501037,0.00022260347,0.00097163726],"category_scores_gemma":[0.000080417,0.000165259,0.00019289179,0.000102650665,0.00024957923,0.0001598511,0.00019876745,0.0005701434,0.00025009614],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002386377,0.000009885953,0.00006610126,0.0000069692346,0.0000016219934,0.000039148243,0.000006686217,0.000032756092,0.99947685,0.000062778534,0.0000079124575,0.00026548546],"study_design_scores_gemma":[0.0000062236554,0.000111903064,0.0018072102,0.0000016219111,0.00000446525,0.0002524118,0.000022097836,0.00061664014,0.9962572,0.000035809404,0.0008821862,0.000002273198],"about_ca_topic_score_codex":0.0008989816,"about_ca_topic_score_gemma":0.0019163149,"teacher_disagreement_score":0.00097163726,"about_ca_system_score_codex":0.00029074735,"about_ca_system_score_gemma":0.00019459277,"threshold_uncertainty_score":0.0032504797},"labels":[],"label_agreement":null},{"id":"W2107495112","doi":"10.1128/mmbr.00031-10","title":"Activation and Function of the MAPKs and Their Substrates, the MAPK-Activated Protein Kinases","year":2011,"lang":"en","type":"review","venue":"Microbiology and Molecular Biology Reviews","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3257,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Kinase; Biology; Cell biology; MAPK/ERK pathway; p38 mitogen-activated protein kinases; Ribosomal s6 kinase; Mitogen-activated protein kinase; Protein kinase A; Mitogen-activated protein kinase kinase; MAP2K7; MAP kinase kinase kinase; ASK1; Signal transduction; Cyclin-dependent kinase 2; P70-S6 Kinase 1; Protein kinase B","score_opus":0.029848210072261107,"score_gpt":0.2585359077245694,"score_spread":0.2286876976523083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107495112","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22157092,0.62410945,0.060916804,0.006526245,0.00296879,0.00052021863,0.006723506,0.0010028256,0.075661264],"genre_scores_gemma":[0.6988566,0.23553574,0.021792153,0.0014346422,0.0014953827,0.00033034128,0.0037963877,0.00011982833,0.03663882],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99955124,0.000054952427,0.000044002416,0.00012613356,0.00015942677,0.000064235166],"domain_scores_gemma":[0.9997538,0.00002035167,0.00007937815,0.000014405494,0.000087632565,0.00004450941],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005619389,0.00085132907,0.000410203,0.0006948559,0.0007600521,0.0016750857,0.00043900768,0.0006760081,0.0039428743],"category_scores_gemma":[0.0007370327,0.00025429772,0.00047523124,0.0007170089,0.0005439934,0.0014813247,0.000711845,0.0011056361,0.002616903],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001017717,0.00039283658,0.009639783,0.0057886345,0.0002376343,0.0019373933,0.00049350667,0.001974556,0.6377046,0.040553086,0.023914615,0.27634567],"study_design_scores_gemma":[0.0001008302,0.00070307776,0.045714054,0.00091262977,0.00024008994,0.009832817,0.00082895235,0.0035224194,0.28578213,0.026966134,0.62520516,0.00019174744],"about_ca_topic_score_codex":0.00065545016,"about_ca_topic_score_gemma":0.00042870737,"teacher_disagreement_score":0.0039428743,"about_ca_system_score_codex":0.0007503229,"about_ca_system_score_gemma":0.000966107,"threshold_uncertainty_score":0.01319021},"labels":[],"label_agreement":null},{"id":"W2110962636","doi":"10.1186/1476-4598-9-271","title":"The serine protease inhibitor serpinE2 is a novel target of ERK signaling involved in human colorectal tumorigenesis","year":2010,"lang":"en","type":"article","venue":"Molecular Cancer","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Université de Sherbrooke","funders":"Canadian Institutes of Health Research; Canadian Association of Gastroenterology; Crohn's and Colitis Foundation of Canada","keywords":"Biology; KRAS; Carcinogenesis; Cancer research; MAPK/ERK pathway; Kinase; MEK inhibitor; Colorectal cancer; Molecular biology; Cancer; Cell biology; Genetics","score_opus":0.007997924231554338,"score_gpt":0.2428362163992162,"score_spread":0.23483829216766186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110962636","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9718066,0.014766077,0.0067010405,0.0004520201,0.00014857574,0.000060919967,0.0016690536,0.00036434192,0.004031379],"genre_scores_gemma":[0.98836386,0.0035879128,0.0025026451,0.00008575268,0.00006638218,0.000023913293,0.0015648449,0.000028303915,0.0037763957],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999372,0.0000073788233,0.0000049350833,0.000017176726,0.000021571825,0.000011839102],"domain_scores_gemma":[0.99992585,0.000009302958,0.000028404105,0.0000055342316,0.000011797626,0.00001909291],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007219325,0.00042214774,0.00021477159,0.0002622283,0.0001537662,0.0003054919,0.00013311452,0.00020409278,0.0013153884],"category_scores_gemma":[0.0001111057,0.00008411531,0.00029968805,0.0001473091,0.00015128696,0.00012769025,0.000118299526,0.00035811387,0.00054966466],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004301308,0.000029636161,0.0011468114,0.00013474631,0.000017162532,0.00080602046,0.000014928981,0.00009744801,0.99251735,0.00010085221,0.00020233759,0.004502551],"study_design_scores_gemma":[0.000051988765,0.00040831734,0.029535362,0.000018667683,0.00008925869,0.006458511,0.000049314112,0.0013306141,0.94792753,0.0001747157,0.013941991,0.000013647882],"about_ca_topic_score_codex":0.00033023898,"about_ca_topic_score_gemma":0.00042143324,"teacher_disagreement_score":0.0013153884,"about_ca_system_score_codex":0.00024176078,"about_ca_system_score_gemma":0.0001449797,"threshold_uncertainty_score":0.0044003725},"labels":[],"label_agreement":null},{"id":"W2111404068","doi":"10.1016/s1470-2045(14)70012-9","title":"Safety and efficacy of vemurafenib in BRAFV600E and BRAFV600K mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study","year":2014,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":978,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"National Medical Research Council; National Health and Medical Research Council; National Cancer Institute; National Institutes of Health; National Institute for Health and Care Research; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; Genentech; F. Hoffmann-La Roche","keywords":"Vemurafenib; Dacarbazine; Medicine; Internal medicine; Melanoma; Population; Oncology; Progression-free survival; Metastatic melanoma; Chemotherapy; Cancer research; Cancer","score_opus":0.0286159142605539,"score_gpt":0.3339014764236995,"score_spread":0.3052855621631456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111404068","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99167293,0.0047524567,0.0004626338,0.00040933606,0.00019128175,0.00046462347,0.000985936,0.00008585576,0.00097488693],"genre_scores_gemma":[0.99372286,0.0015021666,0.0004907216,0.00062032195,0.00023301839,0.0006096335,0.0013580752,0.00003562452,0.0014275884],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99872833,0.0006131897,0.00006362491,0.00016202425,0.00012748309,0.0003054112],"domain_scores_gemma":[0.9979856,0.0005695259,0.00049975276,0.0002264808,0.00013192705,0.0005866196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003949154,0.0018262627,0.0036587354,0.00041765007,0.00046277163,0.0018103584,0.0011022305,0.0020356025,0.0035823206],"category_scores_gemma":[0.0029276935,0.00085706316,0.003841465,0.0004780108,0.001255677,0.0021236553,0.0004808018,0.004416535,0.0011533354],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95676416,0.003857563,0.0020382584,0.00048029487,0.0018548663,0.000079259764,0.00008827834,0.0008627842,0.005060294,0.00008658344,0.0011240011,0.027703583],"study_design_scores_gemma":[0.8063305,0.16647942,0.020687902,0.00007640621,0.0016794241,0.00022631006,0.000078332196,0.0009554772,0.0013807025,0.0004578911,0.0015756332,0.00007200619],"about_ca_topic_score_codex":0.0009440455,"about_ca_topic_score_gemma":0.0015214767,"teacher_disagreement_score":0.003949154,"about_ca_system_score_codex":0.0013212564,"about_ca_system_score_gemma":0.00095832883,"threshold_uncertainty_score":0.020885348},"labels":[],"label_agreement":null},{"id":"W2111650683","doi":"10.1007/s12012-009-9056-0","title":"Mechanisms of Myocyte Cytotoxicity Induced by the Multikinase Inhibitor Sorafenib","year":2009,"lang":"en","type":"article","venue":"Cardiovascular Toxicology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":48,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Apotex (Canada); University of Manitoba","funders":"Canadian Institutes of Health Research","keywords":"Cytotoxicity; Sorafenib; Chemistry; Pharmacology; Myocyte; Cancer research; Internal medicine; Medicine; Biochemistry; In vitro; Hepatocellular carcinoma","score_opus":0.012619230312792003,"score_gpt":0.22452430043128604,"score_spread":0.21190507011849405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111650683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9713472,0.01276903,0.008457861,0.00062321435,0.000104055995,0.000086117,0.00039714933,0.00014411984,0.0060712956],"genre_scores_gemma":[0.9949403,0.0024492033,0.0005942175,0.000052382078,0.00001303617,0.00002812863,0.00012254382,0.0000050944936,0.0017951123],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99984777,0.0000404974,0.0000102018585,0.00001706054,0.00003524554,0.000049103084],"domain_scores_gemma":[0.9999051,0.000017028391,0.000029355211,0.000014785819,0.00001874499,0.000015022931],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021627643,0.00037157722,0.00027792918,0.0002400427,0.00025543445,0.0003585978,0.0002637312,0.00030812796,0.0014408735],"category_scores_gemma":[0.0001303326,0.00014232134,0.0003464925,0.000095030366,0.00017140557,0.0002917303,0.00027091455,0.00046620725,0.00030737536],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005590547,0.00006792657,0.0006715349,0.00015349663,0.000024989768,0.0003180567,0.000049473558,0.00056175067,0.9898532,0.0021256846,0.00018078857,0.0054340847],"study_design_scores_gemma":[0.00007427207,0.00096870924,0.01700304,0.000030889063,0.000046053683,0.0010343178,0.00014449998,0.0030199317,0.9718366,0.0012650857,0.00456162,0.000014887824],"about_ca_topic_score_codex":0.00035830186,"about_ca_topic_score_gemma":0.0006022976,"teacher_disagreement_score":0.0014408735,"about_ca_system_score_codex":0.00045391812,"about_ca_system_score_gemma":0.00021674628,"threshold_uncertainty_score":0.0048202276},"labels":[],"label_agreement":null},{"id":"W2112967018","doi":"10.1158/1078-0432.ccr-11-1344","title":"Skin Tumors Induced by Sorafenib; Paradoxic RAS–RAF Pathway Activation and Oncogenic Mutations of <i>HRAS</i> , <i>TP53</i> , and <i>TGFBR1</i>","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":120,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"HRAS; Sorafenib; Neuroblastoma RAS viral oncogene homolog; Cancer research; Keratinocyte; MAPK/ERK pathway; In vivo; Kinase; Malignant transformation; Medicine; Pathology; Biology; Cancer; KRAS; In vitro; Internal medicine; Hepatocellular carcinoma","score_opus":0.15463426291045915,"score_gpt":0.41440380203132415,"score_spread":0.259769539120865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112967018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992105,0.00023083879,0.00015815148,0.0000057941725,0.000002444702,0.000010157962,0.0000306181,0.000014045593,0.0003373229],"genre_scores_gemma":[0.9997229,0.000051016155,0.00009017266,0.000006663651,0.0000023534196,0.000002992923,0.00004737291,0.0000012926962,0.00007520791],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998529,0.000037788766,0.0000105666695,0.00003067839,0.00003445704,0.000033580356],"domain_scores_gemma":[0.99974257,0.000042622774,0.00010199623,0.000027781336,0.000018422998,0.000066565895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013626328,0.00020761095,0.00020625346,0.0003007898,0.00022100743,0.00021943828,0.00009202083,0.00015481842,0.0011357074],"category_scores_gemma":[0.00023333913,0.00014137334,0.0002895791,0.00016040352,0.00016135752,0.000115864525,0.00015327538,0.0002701905,0.00022961354],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026875802,0.00026060457,0.12952626,0.00016044822,0.00007884838,0.0076694265,0.00010631096,0.00021808765,0.85003775,0.000072296374,0.00012146257,0.009060966],"study_design_scores_gemma":[0.00016224345,0.004696692,0.5948448,0.000012123478,0.0001370409,0.048834536,0.00022511376,0.0010952869,0.3482426,0.00009299166,0.0016393517,0.000017234222],"about_ca_topic_score_codex":0.00020826302,"about_ca_topic_score_gemma":0.00026457716,"teacher_disagreement_score":0.0011357074,"about_ca_system_score_codex":0.00015399158,"about_ca_system_score_gemma":0.000111611254,"threshold_uncertainty_score":0.0037993193},"labels":[],"label_agreement":null},{"id":"W2114067189","doi":"10.1158/0008-5472.can-13-2381","title":"ERKs in Cancer: Friends or Foes?","year":2014,"lang":"en","type":"review","venue":"Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":211,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"Canadian Institutes of Health Research","keywords":"Cancer; Medicine; Internal medicine","score_opus":0.207352210794642,"score_gpt":0.5086070552722703,"score_spread":0.30125484447762835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114067189","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000051499745,0.9973953,0.00005214096,0.0013444792,0.000525021,0.0000010213388,0.0000047834524,0.000004616291,0.0006210616],"genre_scores_gemma":[0.00068676495,0.9966149,0.00010081038,0.0007774107,0.0007500942,0.0000029487292,0.000010333728,0.0000020657976,0.0010546455],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998084,0.000050698167,0.000021442811,0.00003013235,0.000066168606,0.000023212418],"domain_scores_gemma":[0.9995919,0.00019654926,0.000034600816,0.000018216213,0.00009817463,0.000060645994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007373323,0.0007365219,0.0010626009,0.0014473654,0.0004440067,0.0013902878,0.0008923448,0.0015472628,0.0029113088],"category_scores_gemma":[0.0009881053,0.00022765684,0.00040530498,0.0017023254,0.00109327,0.0031885977,0.00092826807,0.0032369723,0.0022902233],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006981748,0.000042436186,0.00017647311,0.006344677,0.00006192757,0.00024332094,0.00014629075,0.00022077704,0.0008132071,0.009189934,0.10377084,0.8789203],"study_design_scores_gemma":[0.0000070663787,0.000027787177,0.0003140565,0.0013980989,0.00002112744,0.00069395814,0.00008116712,0.00003295727,0.000093136965,0.0046258224,0.99269545,0.0000094129255],"about_ca_topic_score_codex":0.00074076606,"about_ca_topic_score_gemma":0.0014715903,"teacher_disagreement_score":0.0029113088,"about_ca_system_score_codex":0.00072580244,"about_ca_system_score_gemma":0.0008764351,"threshold_uncertainty_score":0.00973928},"labels":[],"label_agreement":null},{"id":"W2115142313","doi":"10.1074/jbc.m306002200","title":"Identification of a Novel Human Kinase Supporter of Ras (hKSR-2) That Functions as a Negative Regulator of Cot (Tpl2) Signaling","year":2003,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"MAP kinase kinase kinase; Cell biology; c-Raf; MAPK/ERK pathway; Kinase; MAP2K7; Mitogen-activated protein kinase kinase; Protein kinase A; ASK1; Signal transduction; Biology; Chemistry; Cyclin-dependent kinase 2","score_opus":0.03380380386447431,"score_gpt":0.2681899655970171,"score_spread":0.23438616173254276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115142313","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99527884,0.00087383325,0.0022322042,0.00008500283,0.000027836943,0.000020418393,0.00092458,0.00007454669,0.00048268886],"genre_scores_gemma":[0.9894303,0.00071206974,0.0043797963,0.00007301063,0.000023555549,0.000017382843,0.0038358169,0.00001883806,0.001509129],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999428,0.000005797595,0.000005845535,0.000018142495,0.000018903298,0.000008513618],"domain_scores_gemma":[0.99991536,0.000010448121,0.000036183523,0.000008200371,0.000009412096,0.000020346926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000545113,0.00038194604,0.0002718634,0.00020517761,0.00011205723,0.00023478185,0.00017610338,0.00023569808,0.00070107984],"category_scores_gemma":[0.000115769006,0.00011330902,0.0003841474,0.00018468892,0.00010506005,0.00010832264,0.00011511512,0.00024622158,0.0005394948],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017455309,0.000020888368,0.0019148067,0.00006216781,0.0000191409,0.00073835475,0.000019810048,0.00011277197,0.99484974,0.000067731264,0.00010242567,0.0019176803],"study_design_scores_gemma":[0.000062583116,0.0005557672,0.061489273,0.000018287634,0.00013113124,0.010979981,0.00010053193,0.0070837177,0.90771616,0.00011252247,0.011724077,0.000025994943],"about_ca_topic_score_codex":0.0003418506,"about_ca_topic_score_gemma":0.0004796057,"teacher_disagreement_score":0.00070107984,"about_ca_system_score_codex":0.00023528474,"about_ca_system_score_gemma":0.00014203989,"threshold_uncertainty_score":0.0023453236},"labels":[],"label_agreement":null},{"id":"W2116155140","doi":"10.1017/s146239941100202x","title":"Towards new therapeutic approaches for malignant melanoma","year":2011,"lang":"en","type":"review","venue":"Expert Reviews in Molecular Medicine","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Canadian Institutes of Health Research; Melanoma Research Alliance","keywords":"Melanoma; Cancer research; Cancer; Disease; Medicine; Computational biology; Biology; Pathology; Internal medicine","score_opus":0.1497417081651183,"score_gpt":0.3551992918440242,"score_spread":0.2054575836789059,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116155140","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024654184,0.995937,0.00063477166,0.0006505093,0.00034770212,0.000013861639,0.000013189381,0.000019484467,0.0021369378],"genre_scores_gemma":[0.0016418016,0.9941497,0.0011418755,0.0007406343,0.0003217164,0.000027814564,0.000040326096,0.0000049917585,0.0019310395],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997769,0.000050185226,0.000021069922,0.000033956178,0.00009303688,0.00002484728],"domain_scores_gemma":[0.99983025,0.00007506828,0.000023962075,0.000008454619,0.00004210644,0.000020153973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008289784,0.00089839724,0.0012201883,0.0021124682,0.0003935062,0.0009991475,0.0009138924,0.0018204544,0.004463127],"category_scores_gemma":[0.0004904566,0.00038534365,0.0006730555,0.000938996,0.00084030465,0.0016953882,0.00083696115,0.004489561,0.0035535928],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009282237,0.00019973941,0.000117677904,0.009378621,0.00008176138,0.0005117434,0.00011646608,0.00063170935,0.00877713,0.012744844,0.027645322,0.9397021],"study_design_scores_gemma":[0.000047212554,0.00014407664,0.00037469697,0.0014127519,0.000044431003,0.0014688235,0.000044993125,0.00013519975,0.001088569,0.004267958,0.9909537,0.000017564686],"about_ca_topic_score_codex":0.000738049,"about_ca_topic_score_gemma":0.0017934676,"teacher_disagreement_score":0.004463127,"about_ca_system_score_codex":0.00070983206,"about_ca_system_score_gemma":0.00063398224,"threshold_uncertainty_score":0.0149306655},"labels":[],"label_agreement":null},{"id":"W2116254970","doi":"10.1038/ncb1098","title":"MKK7 couples stress signalling to G2/M cell-cycle progression and cellular senescence","year":2004,"lang":"en","type":"article","venue":"Nature Cell Biology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":146,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Cell biology; Cyclin-dependent kinase 1; Cell cycle; Senescence; Cell cycle checkpoint; Biology; Embryonic stem cell; Cell growth; Kinase; Cell; Genetics; Gene","score_opus":0.0041888761731188025,"score_gpt":0.23464169549599076,"score_spread":0.23045281932287195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116254970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97656655,0.008231854,0.004522072,0.000989404,0.00027958624,0.00006891451,0.00076076103,0.00029954858,0.008281279],"genre_scores_gemma":[0.988865,0.0027519034,0.0014392928,0.00024057586,0.000056954672,0.000058608977,0.00073850644,0.000060629663,0.0057885963],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997898,0.000034842662,0.000011539712,0.00002530522,0.000042884025,0.000095583],"domain_scores_gemma":[0.99988663,0.000011660968,0.000019785793,0.000012828141,0.000023853116,0.00004525965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018527928,0.00066244294,0.00029501645,0.00046440514,0.000453308,0.00075015135,0.0003883603,0.00047289458,0.002312984],"category_scores_gemma":[0.00019128917,0.0003093008,0.00039198762,0.00023955254,0.00032329405,0.0005321126,0.00063935807,0.0009860224,0.0014041307],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004886556,0.00003602106,0.000399138,0.0000851686,0.000011349327,0.00009696135,0.000022698297,0.00009287115,0.99510115,0.0006466473,0.00030671502,0.0027126323],"study_design_scores_gemma":[0.000044792665,0.00026632802,0.0078250095,0.0000130084845,0.000024414041,0.00024900588,0.00009064466,0.0009278964,0.9843911,0.0005142314,0.0056417175,0.000011756065],"about_ca_topic_score_codex":0.0009073132,"about_ca_topic_score_gemma":0.0016573154,"teacher_disagreement_score":0.002312984,"about_ca_system_score_codex":0.00065249833,"about_ca_system_score_gemma":0.00046622838,"threshold_uncertainty_score":0.007737696},"labels":[],"label_agreement":null},{"id":"W2116344367","doi":"10.1517/14728222.2010.531014","title":"Paving the way for targeting RSK in cancer","year":2010,"lang":"en","type":"article","venue":"Expert Opinion on Therapeutic Targets","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Kinase; Ribosomal s6 kinase; MAPK/ERK pathway; Biology; Cell biology; Motility; Cancer cell; Cancer; Signal transduction; Phosphorylation; Cell growth; Protein kinase A; p38 mitogen-activated protein kinases; Cancer research; PI3K/AKT/mTOR pathway; Biochemistry; Genetics; P70-S6 Kinase 1","score_opus":0.02663451962857396,"score_gpt":0.31911428966363176,"score_spread":0.2924797700350578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116344367","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.047681175,0.8188811,0.033478517,0.06881848,0.003547285,0.0002754012,0.00031609688,0.00059262034,0.026409471],"genre_scores_gemma":[0.1898826,0.74166054,0.030086625,0.015816279,0.0029146862,0.00029366824,0.0004376172,0.000081995735,0.018825924],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997979,0.00006720517,0.000013907469,0.000028124472,0.00004392061,0.000048934406],"domain_scores_gemma":[0.9998666,0.000040149564,0.000020595957,0.000009648335,0.000027812619,0.00003516327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070777786,0.0005319881,0.00069256313,0.0004789805,0.00035033506,0.0010222899,0.0006156344,0.001870084,0.0042698137],"category_scores_gemma":[0.00030999488,0.0002601118,0.00043015834,0.00035733974,0.0007247018,0.0016738048,0.000590319,0.0021413432,0.00199711],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012277951,0.00063906243,0.0012533683,0.003877709,0.00013393929,0.002214296,0.0002867751,0.0038030515,0.21059068,0.034371153,0.05447247,0.6871297],"study_design_scores_gemma":[0.0005876507,0.001859485,0.0023929994,0.0005080162,0.0001699348,0.004193451,0.0003541394,0.0033287553,0.060629115,0.033189226,0.89270455,0.00008270248],"about_ca_topic_score_codex":0.0005366944,"about_ca_topic_score_gemma":0.0015521736,"teacher_disagreement_score":0.0042698137,"about_ca_system_score_codex":0.0007507342,"about_ca_system_score_gemma":0.000798227,"threshold_uncertainty_score":0.014283955},"labels":[],"label_agreement":null},{"id":"W2117514750","doi":"10.1158/1535-7163.mct-07-2376","title":"Transient exposure of carcinoma cells to RAS/MEK inhibitors and UCN-01 causes cell death<i>in vitro</i>and<i>in vivo</i>","year":2008,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute","keywords":"In vivo; In vitro; Programmed cell death; Cancer research; Chemistry; Transient (computer programming); Cell culture; Cell biology; Biology; Apoptosis; Pharmacology; Biochemistry; Genetics","score_opus":0.014835812172876427,"score_gpt":0.22654438564568544,"score_spread":0.211708573472809,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117514750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99316025,0.0014947053,0.0020326674,0.000102800834,0.00007057512,0.000054415177,0.0005882245,0.00010615475,0.002390223],"genre_scores_gemma":[0.9891726,0.0014939562,0.0028786147,0.000067890425,0.000011787082,0.00014009692,0.0019508755,0.000023723185,0.004260458],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99979526,0.000033479868,0.000017255998,0.00004135817,0.000048352507,0.00006430333],"domain_scores_gemma":[0.9999248,0.000015198199,0.00001587146,0.000015784512,0.000007327317,0.000021142952],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001214228,0.00042681326,0.00036839378,0.00015626998,0.0002102318,0.0002804419,0.00023526185,0.0002387631,0.0016604419],"category_scores_gemma":[0.000062009385,0.00015981331,0.0004225981,0.00021818465,0.00022246534,0.0001701011,0.0001538017,0.0009015893,0.00045792444],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032916863,0.00011923039,0.00017902153,0.000030373652,0.00001194934,0.000043912256,0.000018822002,0.000098642435,0.9980551,0.000097861164,0.00008163261,0.00093433855],"study_design_scores_gemma":[0.000008537771,0.00047333256,0.001122111,0.000001843948,0.000009494307,0.00007085223,0.000015433652,0.0003005222,0.99720424,0.0000082541565,0.0007834463,0.0000017732433],"about_ca_topic_score_codex":0.0016511242,"about_ca_topic_score_gemma":0.0031368956,"teacher_disagreement_score":0.0016604419,"about_ca_system_score_codex":0.0004540438,"about_ca_system_score_gemma":0.0003632057,"threshold_uncertainty_score":0.0055547357},"labels":[],"label_agreement":null},{"id":"W2119081353","doi":"10.1158/1078-0432.ccr-11-1122","title":"RAF265 Inhibits the Growth of Advanced Human Melanoma Tumors","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"National Center for Advancing Translational Sciences; National Institute of General Medical Sciences; National Cancer Institute; National Heart, Lung, and Blood Institute; U.S. Public Health Service; U.S. Food and Drug Administration; Vanderbilt University Medical Center; Vanderbilt University; U.S. Department of Veterans Affairs","keywords":"Cancer research; Melanoma; MAPK/ERK pathway; Cell growth; V600E; Kinase; Cancer; Medicine; Apoptosis; Signal transduction; Mutation; Biology; Internal medicine; Gene; Cell biology","score_opus":0.15127478355897447,"score_gpt":0.4782351862684745,"score_spread":0.3269604027095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119081353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973531,0.0013716009,0.00035106504,0.00004900169,0.000013573761,0.00004050445,0.00014554682,0.00004858374,0.000627032],"genre_scores_gemma":[0.99715084,0.00084277656,0.00052301545,0.000024670455,0.000013167266,0.000023573759,0.00041160092,0.0000089715995,0.0010013576],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999261,0.000012867317,0.0000033336582,0.000010108653,0.00002397946,0.000023644647],"domain_scores_gemma":[0.9999391,0.000011554276,0.000013130149,0.0000059191184,0.000008042074,0.000022335582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013958056,0.00051569263,0.0003082593,0.00018338407,0.00012130997,0.00016849139,0.00013884343,0.00014449927,0.0011807532],"category_scores_gemma":[0.000072253584,0.00007863111,0.0001987487,0.00007627634,0.00014397553,0.00009529579,0.0001080373,0.0005043898,0.0003400022],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010298664,0.0007610641,0.0008344194,0.00008972129,0.000018200019,0.000113941314,0.000019191855,0.00042883266,0.98672545,0.000042770476,0.00023942611,0.009697142],"study_design_scores_gemma":[0.00069627,0.032280378,0.020790214,0.000025820236,0.00008881901,0.0019489431,0.000053219006,0.0029173254,0.9353109,0.00006600317,0.005810856,0.000011090847],"about_ca_topic_score_codex":0.00042066845,"about_ca_topic_score_gemma":0.00080897426,"teacher_disagreement_score":0.0011807532,"about_ca_system_score_codex":0.00019310783,"about_ca_system_score_gemma":0.00020312809,"threshold_uncertainty_score":0.0039500594},"labels":[],"label_agreement":null},{"id":"W2120136426","doi":"10.1139/o04-121","title":"The Ras-MAPK signal transduction pathway, cancer and chromatin remodeling","year":2005,"lang":"en","type":"review","venue":"Biochemistry and Cell Biology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":217,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"National Cancer Institute; Canadian Institutes of Health Research; Canada Research Chairs; CancerCare Manitoba Foundation","keywords":"Chromatin remodeling; MAPK/ERK pathway; Cell biology; Histone H3; Chromatin; Biology; Signal transduction; Histone; Kinase; Mitogen-activated protein kinase; Phosphorylation; Protein kinase A; Chromatin immunoprecipitation; Cancer research; Gene expression; Gene; Genetics; Promoter","score_opus":0.020777105371813827,"score_gpt":0.2729986952507849,"score_spread":0.2522215898789711,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120136426","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017817308,0.9971928,0.00016363294,0.00022131407,0.000259603,0.000005489421,0.000015015236,0.000011419308,0.0019525657],"genre_scores_gemma":[0.0007041631,0.9971322,0.0001882237,0.00014488233,0.00015073152,0.000007411642,0.00003241134,0.0000012858038,0.0016386512],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999002,0.00001458834,0.000011409131,0.000020256242,0.00004133034,0.000012170929],"domain_scores_gemma":[0.9998971,0.00003328881,0.000014653801,0.0000047679623,0.000031962314,0.000018196179],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002802374,0.0008667005,0.0011130833,0.0017212321,0.00034240735,0.0008423971,0.0007455645,0.0011213227,0.0031724744],"category_scores_gemma":[0.0002581036,0.0002896752,0.00025723883,0.0019718711,0.00047976073,0.0011771214,0.00050171197,0.0011441965,0.0038696867],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007555891,0.00007524798,0.00018550102,0.008611802,0.000051710223,0.0003955157,0.00006720849,0.0003929801,0.0046718996,0.0038728598,0.031123208,0.9504766],"study_design_scores_gemma":[0.000011755862,0.000051214178,0.00069909386,0.0006986333,0.000026587031,0.0013524627,0.000047403017,0.000051394327,0.0006271321,0.0017159829,0.9947084,0.000009842598],"about_ca_topic_score_codex":0.0009484496,"about_ca_topic_score_gemma":0.002025583,"teacher_disagreement_score":0.0031724744,"about_ca_system_score_codex":0.00074781984,"about_ca_system_score_gemma":0.0007663443,"threshold_uncertainty_score":0.010613024},"labels":[],"label_agreement":null},{"id":"W2120707752","doi":"10.1158/1055-9965.epi-11-0472","title":"Prognostic Significance of Cytoplasmic p27 Expression in Human Melanoma","year":2011,"lang":"en","type":"article","venue":"Cancer Epidemiology Biomarkers & Prevention","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; Vancouver Coastal Health Research Institute; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Melanoma; Tissue microarray; Medicine; Cancer research; Biomarker; Pathology; Oncology; Proportional hazards model; Cytoplasm; Cancer; Internal medicine; Immunohistochemistry; Biology","score_opus":0.06269212030114905,"score_gpt":0.324242944876315,"score_spread":0.26155082457516593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120707752","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986148,0.0007310847,0.00022425372,0.000019137264,0.0000033226258,0.0000034186878,0.00013145032,0.000007442658,0.00026509134],"genre_scores_gemma":[0.99960035,0.00010341171,0.000101221674,0.0000038029636,0.0000041246863,0.0000039677993,0.0001319072,0.0000015236994,0.0000497418],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999105,0.000019139614,0.000007372485,0.0000250499,0.000020972195,0.000016900993],"domain_scores_gemma":[0.9995733,0.000116034804,0.00015590056,0.000027026657,0.00005842091,0.00006940163],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020224009,0.00018069216,0.00014707414,0.00044638448,0.00018014545,0.00018134079,0.000098487544,0.00019787019,0.0009488943],"category_scores_gemma":[0.0007798783,0.00010281299,0.000101075755,0.0003095191,0.00021630304,0.00011605184,0.00014861852,0.00018900044,0.00015857346],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009305171,0.000018326733,0.96287507,0.000044072443,0.000044608372,0.00043310903,0.00003997803,0.00027622064,0.029930638,0.000041153595,0.00020413962,0.0051622605],"study_design_scores_gemma":[0.000016544573,0.00014349486,0.9902446,0.000007766705,0.00006197016,0.002809713,0.00006573089,0.0006264395,0.0054402067,0.00006408986,0.00051529857,0.0000041364233],"about_ca_topic_score_codex":0.00057293853,"about_ca_topic_score_gemma":0.0006939155,"teacher_disagreement_score":0.0009488943,"about_ca_system_score_codex":0.00015935194,"about_ca_system_score_gemma":0.00013505714,"threshold_uncertainty_score":0.0031744242},"labels":[],"label_agreement":null},{"id":"W2125048552","doi":"10.1084/jem.194.6.757","title":"The Stress Kinase Mitogen-Activated Protein Kinase Kinase (Mkk)7 Is a Negative Regulator of Antigen Receptor and Growth Factor Receptor–Induced Proliferation in Hematopoietic Cells","year":2001,"lang":"en","type":"article","venue":"The Journal of Experimental Medicine","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Amgen (Canada); University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Cell biology; Interleukin 33; Mitogen-activated protein kinase kinase; MAP kinase kinase kinase; ASK1; Cancer research; MAPK/ERK pathway; Biology; Mitogen-activated protein kinase; Kinase; Protein kinase A; Chemistry; Cytokine; Immunology; Interleukin","score_opus":0.015903587272496612,"score_gpt":0.26223208883878774,"score_spread":0.24632850156629113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125048552","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93303907,0.038405947,0.01621173,0.00050583493,0.00035949063,0.00012850652,0.0015598416,0.0008884633,0.008901015],"genre_scores_gemma":[0.97337794,0.012430982,0.0046307347,0.00013476945,0.00007802431,0.00009294326,0.001847697,0.00005542068,0.0073515624],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998511,0.0000144845,0.000010762508,0.000026752487,0.00006938855,0.00002753668],"domain_scores_gemma":[0.9998946,0.000005904755,0.000038136382,0.000007259573,0.000025852944,0.0000282445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010374662,0.00061249186,0.0002558256,0.00036071177,0.00030309128,0.0002858227,0.00020925966,0.00020172511,0.00097246474],"category_scores_gemma":[0.00008357092,0.00018491005,0.00027697004,0.00018816181,0.00022763164,0.00021004646,0.0003200669,0.00043259768,0.00079276453],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000093171075,0.000016341784,0.00053385453,0.00011804297,0.000009694261,0.00014362752,0.000014298975,0.00007387489,0.9932863,0.00028983995,0.00026797864,0.005152968],"study_design_scores_gemma":[0.000028750572,0.00028684203,0.0142146405,0.000025830284,0.000038024264,0.0013361273,0.000051079725,0.0011094428,0.96020335,0.00031084722,0.022381041,0.000014199256],"about_ca_topic_score_codex":0.00027182786,"about_ca_topic_score_gemma":0.00034412427,"teacher_disagreement_score":0.00097246474,"about_ca_system_score_codex":0.0003292007,"about_ca_system_score_gemma":0.00025943093,"threshold_uncertainty_score":0.0032532811},"labels":[],"label_agreement":null},{"id":"W2126281471","doi":"10.1128/mcb.01265-06","title":"Differential Regulation of B-Raf Isoforms by Phosphorylation and AutoinhibitoryMechanisms","year":2006,"lang":"en","type":"article","venue":"Molecular and Cellular Biology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Nautical Research Society","funders":"Institut National de la Santé et de la Recherche Médicale; Institut National Du Cancer; Centre National de la Recherche Scientifique; Association pour la Recherche sur le Cancer","keywords":"Gene isoform; Phosphorylation; Biology; Exon; Alternative splicing; RNA splicing; Kinase; Protein kinase domain; Mutation; Molecular biology; Cell biology; Biochemistry; Gene; Mutant","score_opus":0.002355465144577604,"score_gpt":0.17373805012107998,"score_spread":0.17138258497650238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126281471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978388,0.00062543515,0.00081389386,0.00002383966,0.0000073870415,0.000008743497,0.000058064084,0.000014795041,0.0006091809],"genre_scores_gemma":[0.99779177,0.00046200948,0.0008906553,0.000023066792,0.0000036496756,0.000018502864,0.00012378817,0.000006598576,0.00067983964],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998103,0.000038289752,0.000015997219,0.000036387824,0.000049160284,0.00004993397],"domain_scores_gemma":[0.9999144,0.000016333288,0.000027585658,0.0000125043225,0.0000110086,0.000018285926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001610581,0.000281536,0.00013587662,0.00015930332,0.00015603502,0.00028676138,0.00015933628,0.00022943561,0.0007393675],"category_scores_gemma":[0.00010377808,0.0001749519,0.00027458396,0.000083709776,0.00021813701,0.00018943886,0.00020185404,0.00043996834,0.00027505952],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004209629,0.000011096179,0.00012981094,0.000008627797,0.0000023617786,0.00002283965,0.0000074604222,0.000023689487,0.9994215,0.000050606057,0.000005336179,0.0002746898],"study_design_scores_gemma":[0.000015682459,0.0001521289,0.009367993,0.000004925071,0.000011265485,0.0003514656,0.000027561027,0.0009402766,0.9882089,0.00006852463,0.0008455584,0.000005628203],"about_ca_topic_score_codex":0.00028212066,"about_ca_topic_score_gemma":0.00044459495,"teacher_disagreement_score":0.0007393675,"about_ca_system_score_codex":0.00016780292,"about_ca_system_score_gemma":0.000105702165,"threshold_uncertainty_score":0.002473414},"labels":[],"label_agreement":null},{"id":"W2128035403","doi":"10.1056/nejmoa1412082","title":"Nivolumab in Previously Untreated Melanoma without <i>BRAF</i> Mutation","year":2014,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5352,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; BC Cancer Agency","funders":"","keywords":"Nivolumab; Melanoma; Mutation; Medicine; Cancer research; Biology; Genetics; Internal medicine; Cancer; Immunotherapy; Gene","score_opus":0.007510965650476341,"score_gpt":0.2337536327064622,"score_spread":0.22624266705598586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128035403","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958852,0.0030351523,0.00012905592,0.00012288429,0.00005674901,0.00011188347,0.000039328315,0.000008558362,0.00061111385],"genre_scores_gemma":[0.99787676,0.0011756319,0.00023449284,0.00017503093,0.00007036557,0.00008517702,0.00007548735,0.0000041798085,0.00030282058],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.999634,0.00019063204,0.000024480873,0.00006098332,0.000041657426,0.000048169142],"domain_scores_gemma":[0.9995321,0.00018346793,0.00011466183,0.000020764644,0.00002023998,0.00012883726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073763664,0.00027776603,0.0007465404,0.00018367752,0.00024396818,0.00028241347,0.00023324859,0.00030663106,0.00094153744],"category_scores_gemma":[0.0010898235,0.00016033684,0.0004362279,0.00015046781,0.00029414947,0.00020283277,0.00014532031,0.0007969536,0.00018080419],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.46286678,0.013443679,0.091395706,0.0018210295,0.002335471,0.0015859626,0.0006070859,0.007129424,0.07233088,0.00049689115,0.003152635,0.3428344],"study_design_scores_gemma":[0.19114488,0.54144603,0.2156497,0.00056697044,0.002224719,0.00368156,0.0003495796,0.00755629,0.018200433,0.00115424,0.017939353,0.00008628311],"about_ca_topic_score_codex":0.0008822759,"about_ca_topic_score_gemma":0.002663008,"teacher_disagreement_score":0.00094153744,"about_ca_system_score_codex":0.0005873333,"about_ca_system_score_gemma":0.00053787103,"threshold_uncertainty_score":0.0042613745},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"nonrandomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"split"},{"id":"W2128463141","doi":"10.1074/jbc.m011780200","title":"Impaired Synergistic Activation of Stress-activated Protein Kinase SAPK/JNK in Mouse Embryonic Stem Cells Lacking SEK1/MKK4","year":2001,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Amgen (Canada); University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Phosphorylation; Kinase; MAPK/ERK pathway; Cell biology; p38 mitogen-activated protein kinases; Protein kinase A; Chemistry; Mitogen-activated protein kinase; Molecular biology; Biology","score_opus":0.02437249285869776,"score_gpt":0.24042394110580628,"score_spread":0.21605144824710854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128463141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99344105,0.00075528614,0.0035823828,0.00005421619,0.00005539972,0.000041776686,0.000800469,0.00016032765,0.0011090203],"genre_scores_gemma":[0.9908496,0.0005947042,0.0027571253,0.00004401197,0.000012087824,0.00010001877,0.0014552256,0.00006933471,0.004117954],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99957234,0.0000583399,0.00009387863,0.000077422366,0.00013357321,0.00006442365],"domain_scores_gemma":[0.9995289,0.00006396538,0.0001502468,0.00005422126,0.000034556626,0.00016818962],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025775933,0.0008277371,0.00048637151,0.00047463726,0.00014144763,0.00043116393,0.0004286332,0.0004176791,0.0013359375],"category_scores_gemma":[0.0001635096,0.00037866697,0.00043306535,0.00022473991,0.00037106886,0.00030308348,0.00044098674,0.000952405,0.0006766114],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000074009615,0.000015875861,0.00008140756,0.000022828692,0.000006332144,0.00007076948,0.000016252765,0.00005903995,0.99920875,0.000090219066,0.000013931096,0.00034061164],"study_design_scores_gemma":[0.000016901524,0.00018905709,0.002552315,0.000005720889,0.000022979935,0.00031522365,0.000029967683,0.0010894088,0.9944945,0.000039277664,0.0012381321,0.0000064294027],"about_ca_topic_score_codex":0.00037899974,"about_ca_topic_score_gemma":0.0004970154,"teacher_disagreement_score":0.0013359375,"about_ca_system_score_codex":0.00029039194,"about_ca_system_score_gemma":0.00024559977,"threshold_uncertainty_score":0.004469216},"labels":[],"label_agreement":null},{"id":"W2128542677","doi":"10.1056/nejmoa1103782","title":"Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation","year":2011,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7688,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"National Center for Advancing Translational Sciences; National Cancer Institute","keywords":"Vemurafenib; Medicine; Dacarbazine; Interim analysis; Internal medicine; Adverse effect; Melanoma; Oncology; Rash; Dabrafenib; Progression-free survival; Nausea; Clinical trial; Cancer research; Metastatic melanoma; Chemotherapy; Cancer","score_opus":0.015999499600173304,"score_gpt":0.22066546399615003,"score_spread":0.20466596439597673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128542677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99702245,0.0020135595,0.00040959584,0.00009229236,0.000019061048,0.000027708178,0.000053986143,0.000017065238,0.0003443662],"genre_scores_gemma":[0.9988675,0.00054986717,0.00023665644,0.00005676489,0.00002564824,0.00002587409,0.000121983176,0.0000020773102,0.00011375374],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9997167,0.00014306995,0.000014864789,0.0000368608,0.000038648323,0.00004982441],"domain_scores_gemma":[0.99973387,0.00009326206,0.000081005695,0.000016251184,0.000012286612,0.00006329297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008445873,0.00023721649,0.00044980418,0.00017821504,0.00010145119,0.00022114802,0.00018821888,0.0001800431,0.0012320405],"category_scores_gemma":[0.0009019055,0.000069181384,0.00048085264,0.00012137476,0.00019568963,0.00018768912,0.00021034587,0.00049634406,0.00012064848],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.24257404,0.010005319,0.08966987,0.0011131347,0.0015353804,0.0008762745,0.0002969125,0.009980792,0.09372028,0.00036826552,0.0022288207,0.54763097],"study_design_scores_gemma":[0.049445644,0.38878214,0.50955874,0.0001930126,0.0017112915,0.0044207284,0.00015529542,0.008731132,0.024969473,0.0013503815,0.010622909,0.00005916296],"about_ca_topic_score_codex":0.00018359261,"about_ca_topic_score_gemma":0.0004021598,"teacher_disagreement_score":0.0012320405,"about_ca_system_score_codex":0.00023414007,"about_ca_system_score_gemma":0.00023326192,"threshold_uncertainty_score":0.004466653},"labels":[],"label_agreement":null},{"id":"W2130044807","doi":"10.1038/sj.embor.embor939","title":"An essential function of the mitogen‐activated protein kinase Erk2 in mouse trophoblast development","year":2003,"lang":"en","type":"article","venue":"EMBO Reports","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":359,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"Canadian Institutes of Health Research; Centre National de la Recherche Scientifique; Cancer Research Society","keywords":"Trophoblast; Cell biology; Biology; MAPK/ERK pathway; Protein kinase A; Kinase; Embryonic stem cell; Embryogenesis; Embryo; Cell growth; Placenta; Fetus; Genetics; Gene","score_opus":0.006149139100158751,"score_gpt":0.20613872026186705,"score_spread":0.1999895811617083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130044807","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98051536,0.004298249,0.0071389056,0.00032509194,0.00006528936,0.000019708546,0.0006347291,0.00018261919,0.0068200254],"genre_scores_gemma":[0.9916053,0.0008434553,0.0022728338,0.000038049882,0.000009249402,0.000017914708,0.00043020074,0.00003307089,0.0047498643],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998895,0.00001975817,0.000010788901,0.000021366774,0.000028974988,0.00002960796],"domain_scores_gemma":[0.9998424,0.000027255812,0.000031821786,0.00002914703,0.000019708159,0.00004973359],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020364841,0.00040840855,0.00012647723,0.00030353776,0.00025400476,0.00036607633,0.00021506853,0.00027121097,0.0014585276],"category_scores_gemma":[0.00018446945,0.0002783535,0.00020051641,0.000114896226,0.00024660197,0.00032134986,0.00033970719,0.0005182331,0.0005219695],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017293263,0.000006044934,0.00021112087,0.000028213868,0.000002481934,0.00020457366,0.000012041431,0.000047703285,0.99765176,0.0006745519,0.00005548072,0.0009330987],"study_design_scores_gemma":[0.00001657818,0.000049916416,0.004637001,0.0000064027327,0.00001170862,0.0010937867,0.000025299134,0.00046121268,0.98936474,0.00027278438,0.0040572146,0.0000033698773],"about_ca_topic_score_codex":0.0004607082,"about_ca_topic_score_gemma":0.0007600044,"teacher_disagreement_score":0.0014585276,"about_ca_system_score_codex":0.0003914855,"about_ca_system_score_gemma":0.0003094424,"threshold_uncertainty_score":0.004879236},"labels":[],"label_agreement":null},{"id":"W2131375222","doi":"10.1128/mcb.24.10.4255-4266.2004","title":"Characterization of Mouse <i>Rsk4</i> as an Inhibitor of Fibroblast Growth Factor-RAS-Extracellular Signal-Regulated Kinase Signaling","year":2004,"lang":"en","type":"article","venue":"Molecular and Cellular Biology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Lunenfeld-Tanenbaum Research Institute","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of General Medical Sciences","keywords":"Biology; Ribosomal s6 kinase; Cell biology; MAPK/ERK pathway; Signal transduction; Kinase; Receptor tyrosine kinase; Extracellular; Fibroblast growth factor; Receptor; Genetics; Protein kinase B","score_opus":0.005645776628842951,"score_gpt":0.1981594532899964,"score_spread":0.19251367666115346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131375222","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9844844,0.0017140834,0.008326982,0.0002510214,0.000051194133,0.000087741384,0.0016614749,0.00023421143,0.0031888667],"genre_scores_gemma":[0.96212894,0.002178071,0.013503949,0.00015922294,0.000041208583,0.0002079943,0.008298187,0.00016715217,0.013315412],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99983716,0.000020903706,0.00001714962,0.00002889246,0.000052246483,0.000043675103],"domain_scores_gemma":[0.999803,0.000028290811,0.00006675447,0.000025239082,0.00003145539,0.000045326877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017284279,0.0005066366,0.0002311302,0.0005031552,0.00019073441,0.00033469123,0.00040025474,0.00029604937,0.0016252177],"category_scores_gemma":[0.00016515407,0.00021865405,0.00044835985,0.00019240721,0.0002068289,0.00020562435,0.00013478247,0.00059340324,0.0011266994],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056729707,0.000018356102,0.0001292242,0.0000138355,0.0000046675154,0.000029375407,0.0000028780917,0.000043371543,0.9990465,0.000099895195,0.000031741285,0.00052346586],"study_design_scores_gemma":[0.00001641327,0.00015985659,0.0020229246,0.0000027346166,0.000017164482,0.0002748175,0.0000070233073,0.00046385406,0.9937156,0.000037763504,0.0032787998,0.000002913984],"about_ca_topic_score_codex":0.00053478463,"about_ca_topic_score_gemma":0.0006249052,"teacher_disagreement_score":0.0016252177,"about_ca_system_score_codex":0.0005109025,"about_ca_system_score_gemma":0.00022797612,"threshold_uncertainty_score":0.0054368973},"labels":[],"label_agreement":null},{"id":"W2132230514","doi":"10.1523/jneurosci.4216-06.2006","title":"JNK Gives Axons a Second Chance: Figure 1.","year":2006,"lang":"en","type":"review","venue":"Journal of Neuroscience","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Michael Smith Health Research BC","keywords":"Neuroscience; Neurite; Axon; Polarity (international relations); Cell polarity; Biology; In vitro; Cell","score_opus":0.04241066476734407,"score_gpt":0.3122661441583711,"score_spread":0.26985547939102705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132230514","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0073385467,0.82257503,0.013007623,0.010653685,0.012049749,0.00011335155,0.00096983946,0.0006407402,0.13265142],"genre_scores_gemma":[0.042893395,0.8128063,0.0050675087,0.0027147026,0.0015623509,0.000093093106,0.00091810443,0.00006254626,0.13388197],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998503,0.000019397992,0.000008796335,0.000033317163,0.000060668383,0.000027488928],"domain_scores_gemma":[0.9999254,0.00001057541,0.000009252414,0.000006153158,0.00003261114,0.000015894946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002659824,0.0011210227,0.00058645254,0.00057589385,0.00041515095,0.0012404373,0.0006475337,0.0011052244,0.0125966985],"category_scores_gemma":[0.00020377991,0.00025755467,0.00031880033,0.0005115894,0.00056298834,0.0013575171,0.00054247,0.001659443,0.0100902915],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041602438,0.00004941069,0.00040078498,0.008198759,0.00007496659,0.0009177885,0.00015621848,0.0006921171,0.112839565,0.053586982,0.16671024,0.6559571],"study_design_scores_gemma":[0.000018557921,0.000046684385,0.00054884824,0.00040261287,0.000031429547,0.0014283895,0.00007877941,0.00013318435,0.02067817,0.0040063476,0.9726106,0.000016359389],"about_ca_topic_score_codex":0.00057126646,"about_ca_topic_score_gemma":0.0011483064,"teacher_disagreement_score":0.0125966985,"about_ca_system_score_codex":0.0006680596,"about_ca_system_score_gemma":0.0005600663,"threshold_uncertainty_score":0.042140126},"labels":[],"label_agreement":null},{"id":"W2134846340","doi":"10.1111/ijd.12724","title":"Bench to bedside: mechanistic principles of targeting the RAF kinase in melanoma","year":2014,"lang":"en","type":"review","venue":"International Journal of Dermatology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Vemurafenib; Medicine; Melanoma; Kinase; Cancer research; Metastatic melanoma; Bench to bedside; Disease; Bioinformatics; Internal medicine; Biology; Genetics","score_opus":0.026478632058435154,"score_gpt":0.3195187637903334,"score_spread":0.29304013173189825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134846340","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020436174,0.99491656,0.000533228,0.0011087859,0.00063466426,0.000009565559,0.000015330053,0.0000132059085,0.0025642707],"genre_scores_gemma":[0.0017610698,0.9952035,0.0006048542,0.0006172064,0.00048430925,0.0000121915955,0.000021846377,0.0000024130948,0.0012925135],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998487,0.000030101453,0.000015669926,0.000022080021,0.00006610877,0.000017345723],"domain_scores_gemma":[0.99983346,0.00007396139,0.000015662008,0.0000071885906,0.000046570232,0.000023094646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000610115,0.0006792957,0.000767235,0.0014537077,0.00033527054,0.000952567,0.0007178974,0.0012433034,0.0030546116],"category_scores_gemma":[0.0005167521,0.00026177344,0.00054806826,0.00080430007,0.0006290037,0.001747814,0.00069201685,0.002837087,0.0021509],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013075492,0.0001592006,0.00021385854,0.013522335,0.00008153798,0.0007313881,0.0001494851,0.0007296416,0.009960923,0.020285951,0.061293356,0.8927416],"study_design_scores_gemma":[0.000018118242,0.00011378993,0.0003152255,0.0012767535,0.000035288485,0.0014435716,0.00004939343,0.00011770998,0.0011910779,0.005700114,0.9897223,0.000016616294],"about_ca_topic_score_codex":0.0003388056,"about_ca_topic_score_gemma":0.0008540949,"teacher_disagreement_score":0.0030546116,"about_ca_system_score_codex":0.0005465858,"about_ca_system_score_gemma":0.00062258734,"threshold_uncertainty_score":0.0102187395},"labels":[],"label_agreement":null},{"id":"W2135344663","doi":"10.1080/00498250110065621","title":"Preclinical pharmacokinetics of SB-203580, a potent inhibitor of p38 mitogen-activated protein kinase","year":2001,"lang":"en","type":"article","venue":"Xenobiotica","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Discovery Centre","funders":"","keywords":"In vivo; Pharmacokinetics; Bioavailability; Pharmacology; In vitro; Mitogen-activated protein kinase; Chemistry; p38 mitogen-activated protein kinases; Protein kinase A; Kinase; Biology; Biochemistry; Biotechnology","score_opus":0.0216553931093105,"score_gpt":0.27896684578753567,"score_spread":0.2573114526782252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135344663","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97267014,0.0070223445,0.00979923,0.00058938004,0.0001913131,0.00092160876,0.003169301,0.00055059936,0.0050859335],"genre_scores_gemma":[0.9825875,0.004623972,0.004412153,0.0003069618,0.00012899247,0.00066262786,0.0030127116,0.000112579866,0.0041525452],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999788,0.00008450324,0.000011469091,0.000036194928,0.00003987849,0.00003992606],"domain_scores_gemma":[0.99962103,0.00007628292,0.000103571074,0.000040698036,0.00006159924,0.00009684759],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006952891,0.0006362958,0.000622194,0.0004127548,0.00030382728,0.0006704125,0.00044954658,0.00046008898,0.0021798168],"category_scores_gemma":[0.0009313178,0.0003663885,0.00036843997,0.00031711947,0.000366183,0.0006488285,0.00015841749,0.0014187268,0.000838694],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032382715,0.009088261,0.0033396955,0.0004435095,0.0002223209,0.00041438255,0.00028983282,0.0035710153,0.8803531,0.00071332464,0.0046944525,0.064487346],"study_design_scores_gemma":[0.00431605,0.24039134,0.028784124,0.0000980593,0.0008729739,0.002114189,0.00032396673,0.013347485,0.68117476,0.00090890686,0.027572002,0.00009604635],"about_ca_topic_score_codex":0.0019824537,"about_ca_topic_score_gemma":0.00242498,"teacher_disagreement_score":0.0021798168,"about_ca_system_score_codex":0.0008375942,"about_ca_system_score_gemma":0.0008740287,"threshold_uncertainty_score":0.0072922707},"labels":[],"label_agreement":null},{"id":"W2136128469","doi":"10.1016/j.bmcl.2006.05.019","title":"Discovery of 3-hydroxy-4-carboxyalkylamidino-5-arylamino-isothiazoles as potent MEK1 inhibitors","year":2006,"lang":"en","type":"article","venue":"Bioorganic & Medicinal Chemistry Letters","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Valeant Pharmaceuticals International","keywords":"Chemistry; Stereochemistry; Combinatorial chemistry","score_opus":0.0036186011745197714,"score_gpt":0.18667245101142793,"score_spread":0.18305384983690817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136128469","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9705244,0.0073951134,0.00964179,0.000430763,0.00014080553,0.00022826392,0.0005090083,0.00028602383,0.010843876],"genre_scores_gemma":[0.9876835,0.0035278634,0.0038071922,0.00010072423,0.00002970035,0.00006732236,0.00036156335,0.0000190164,0.0044031413],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998894,0.000021918342,0.00000688356,0.000011018104,0.000027719989,0.000042945678],"domain_scores_gemma":[0.9999157,0.000014827195,0.000017588194,0.000008022446,0.000019771505,0.000024054429],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027401306,0.0003729364,0.00028035475,0.00024314706,0.00015484943,0.00020666866,0.00045913717,0.00028541396,0.0017003963],"category_scores_gemma":[0.0002330163,0.00019419908,0.00019525367,0.00017193133,0.00016275085,0.0001525545,0.00020967047,0.0005611326,0.00052809744],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031871616,0.000113673945,0.00023343762,0.00011034397,0.000014738284,0.00027193702,0.000067456094,0.00084231637,0.98551846,0.0006170319,0.00036730865,0.011524612],"study_design_scores_gemma":[0.00024439473,0.0019667798,0.0028517297,0.000020233569,0.000054239677,0.0005097259,0.000034395325,0.002202,0.9799178,0.00011818721,0.01205988,0.000020580701],"about_ca_topic_score_codex":0.0011553108,"about_ca_topic_score_gemma":0.004555638,"teacher_disagreement_score":0.0017003963,"about_ca_system_score_codex":0.0004323903,"about_ca_system_score_gemma":0.00028544528,"threshold_uncertainty_score":0.005688429},"labels":[],"label_agreement":null},{"id":"W2136718845","doi":"10.1074/jbc.m213182200","title":"Different Properties of SEK1 and MKK7 in Dual Phosphorylation of Stress-induced Activated Protein Kinase SAPK/JNK in Embryonic Stem Cells","year":2003,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"Japan Society for the Promotion of Science; Mitsubishi Foundation; Ministry of Education, Culture, Sports, Science and Technology","keywords":"Embryonic stem cell; Cell biology; Phosphorylation; Protein kinase A; Dual (grammatical number); Kinase; Chemistry; Biology; Biochemistry","score_opus":0.02484527172999496,"score_gpt":0.21715186338599832,"score_spread":0.19230659165600336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136718845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922695,0.0025807975,0.00354702,0.00007207528,0.00005572776,0.000027425942,0.00041977357,0.0000394022,0.0009882369],"genre_scores_gemma":[0.99065804,0.0014583135,0.0032971974,0.00006990919,0.000015181975,0.00006942882,0.001700531,0.00002332117,0.002708038],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997881,0.000027302773,0.000034086795,0.000035429253,0.00008205229,0.000033056556],"domain_scores_gemma":[0.9999012,0.000010729678,0.000021926275,0.000010145295,0.000015720416,0.000040273324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001638639,0.00039825463,0.00025748493,0.00022543526,0.00012995893,0.0002989068,0.00023572934,0.0002452752,0.0007666663],"category_scores_gemma":[0.00011004066,0.0001780284,0.0003296577,0.0001354872,0.00017403597,0.00022562468,0.00023103987,0.0005903777,0.00038009993],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000076884266,0.000011208792,0.00013840105,0.00004317661,0.000004210687,0.00004034024,0.0000125735,0.000028626748,0.9989794,0.000104413935,0.000015472498,0.00054524187],"study_design_scores_gemma":[0.000012231448,0.00013991025,0.0039132144,0.0000044097296,0.000019592864,0.0003367269,0.0000221638,0.0006126264,0.9932238,0.000044177254,0.0016657137,0.0000055373525],"about_ca_topic_score_codex":0.00016369524,"about_ca_topic_score_gemma":0.00022101057,"teacher_disagreement_score":0.0007666663,"about_ca_system_score_codex":0.00019831577,"about_ca_system_score_gemma":0.00012647506,"threshold_uncertainty_score":0.0025647283},"labels":[],"label_agreement":null},{"id":"W2136742446","doi":"10.1016/j.cellsig.2010.02.009","title":"Characterization of the expression and regulation of MK5 in the murine ventricular myocardium","year":2010,"lang":"en","type":"article","venue":"Cellular Signalling","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal; Montreal Heart Institute","funders":"Canadian Institutes of Health Research","keywords":"Exon; Messenger RNA; Protein kinase A; Biology; Kinase; Cell biology; Genetics; Gene","score_opus":0.005594686090634668,"score_gpt":0.1824374679987618,"score_spread":0.17684278190812713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136742446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98834443,0.0029333998,0.0055118534,0.00008089943,0.000016676273,0.000021423828,0.000592504,0.000047858517,0.0024509311],"genre_scores_gemma":[0.9907851,0.0008812186,0.003156805,0.000051595336,0.000011702829,0.00003599799,0.0006535727,0.000026042624,0.0043980116],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990094,0.00001063035,0.000009509847,0.00002361561,0.00002445856,0.000030800267],"domain_scores_gemma":[0.9998447,0.000020217578,0.000057758112,0.000015825026,0.000017516273,0.00004391366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012779426,0.00022626497,0.00013586303,0.0004271342,0.00017479848,0.00039886654,0.00020426293,0.00019544478,0.0010554509],"category_scores_gemma":[0.00013139026,0.0002172679,0.00021171331,0.00013583127,0.00018748932,0.00026020952,0.0002260825,0.00045487538,0.00053464086],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007640533,0.000007016849,0.00034154239,0.000020649408,0.0000023856012,0.00005751783,0.00001676294,0.000032836553,0.9985637,0.0003086635,0.000011713963,0.0005608126],"study_design_scores_gemma":[0.000013454932,0.00017216531,0.027673058,0.000014735611,0.000029283417,0.0004754147,0.00011401115,0.0008610015,0.96724963,0.00023780415,0.0031540461,0.00000538217],"about_ca_topic_score_codex":0.00050432154,"about_ca_topic_score_gemma":0.0007212486,"teacher_disagreement_score":0.0010554509,"about_ca_system_score_codex":0.00030752135,"about_ca_system_score_gemma":0.0001328006,"threshold_uncertainty_score":0.0035308003},"labels":[],"label_agreement":null},{"id":"W2137723371","doi":"10.1200/jco.2007.12.7837","title":"Meta-Analysis of Phase II Cooperative Group Trials in Metastatic Stage IV Melanoma to Determine Progression-Free and Overall Survival Benchmarks for Future Phase II Trials","year":2008,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":700,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences","keywords":"Medicine; Internal medicine; Clinical trial; Oncology; Multivariate analysis; Progression-free survival; Clinical endpoint; Cancer; Randomized controlled trial; Overall survival","score_opus":0.3381739698257792,"score_gpt":0.5079362980495256,"score_spread":0.16976232822374637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137723371","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08072662,0.87279564,0.035336953,0.0016213014,0.001331421,0.0025155407,0.0030006324,0.00048897933,0.002182992],"genre_scores_gemma":[0.91934264,0.048469864,0.020680519,0.0019195913,0.0009615979,0.004510328,0.003126444,0.00031266603,0.0006764221],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.8516355,0.12457353,0.010274407,0.0063578966,0.0064795925,0.0006790564],"domain_scores_gemma":[0.74064493,0.21803325,0.021749966,0.013483586,0.0047762655,0.0013120765],"candidate_categories":["metaresearch","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.15465574,0.003967302,0.018056596,0.006574961,0.00062827964,0.004705305,0.0028839756,0.0022311807,0.0016023153],"category_scores_gemma":[0.19531094,0.0012683837,0.038797595,0.0064625805,0.0008322761,0.002644974,0.0016235798,0.002842288,0.00017711596],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005643854,0.000026043124,0.019456591,0.012395196,0.94776016,0.000079154335,0.000042783387,0.004632857,0.00020596887,0.00030905617,0.0008795782,0.008568695],"study_design_scores_gemma":[0.0035140761,0.0011330268,0.020954033,0.0036458722,0.9569032,0.00016346444,0.00005915211,0.007628096,0.00043315237,0.00232062,0.0031854133,0.00005983716],"about_ca_topic_score_codex":0.0023403808,"about_ca_topic_score_gemma":0.0035411587,"teacher_disagreement_score":0.9819434,"about_ca_system_score_codex":0.001983556,"about_ca_system_score_gemma":0.0023329584,"threshold_uncertainty_score":0.8179075},"labels":[],"label_agreement":null},{"id":"W2137990944","doi":"10.1186/1756-8722-3-8","title":"From basic research to clinical development of MEK1/2 inhibitors for cancer therapy","year":2010,"lang":"en","type":"review","venue":"Journal of Hematology & Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":244,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"National Cancer Institute; Canadian Institutes of Health Research; Cancer Research Society","keywords":"Cancer research; Regulator; Cancer; Kinase; Receptor tyrosine kinase; MAPK/ERK pathway; Hematology; Tyrosine kinase; Signal transduction; Function (biology); Hyperactivation; Medicine; Biology; Internal medicine; Cell biology; Gene; Biochemistry","score_opus":0.23335411210150298,"score_gpt":0.5308665528212848,"score_spread":0.29751244071978183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137990944","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00044982668,0.99350923,0.00083188503,0.0013256556,0.00038621738,0.00002323323,0.000030685067,0.00003067518,0.0034126008],"genre_scores_gemma":[0.0021255885,0.99402505,0.0009546238,0.0007599545,0.00040653232,0.000027747099,0.000043488766,0.0000050566264,0.0016519687],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99977773,0.000046802536,0.000026789276,0.000038714912,0.000083732346,0.000026102776],"domain_scores_gemma":[0.999726,0.00010787256,0.00003426426,0.00001342856,0.00007500208,0.000043373355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010493726,0.0009451835,0.0012636537,0.0017012439,0.00028132563,0.0011160792,0.00094657455,0.0013416314,0.004546742],"category_scores_gemma":[0.0006772407,0.00038500456,0.00045053175,0.0012159529,0.00081296795,0.0014620731,0.00067895226,0.0029055204,0.0039604283],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015034396,0.00019627894,0.00014745614,0.0057681943,0.00005409776,0.0004109926,0.000060227372,0.00054437964,0.007499758,0.0069809332,0.032861717,0.94532555],"study_design_scores_gemma":[0.00007705846,0.00023355971,0.0006099435,0.0014217849,0.000052064293,0.0015866028,0.000029455683,0.00017882831,0.0024345343,0.0033622547,0.9899961,0.00001784517],"about_ca_topic_score_codex":0.00054612494,"about_ca_topic_score_gemma":0.0011022823,"teacher_disagreement_score":0.004546742,"about_ca_system_score_codex":0.0010466529,"about_ca_system_score_gemma":0.001000258,"threshold_uncertainty_score":0.0152103305},"labels":[],"label_agreement":null},{"id":"W2138718238","doi":"10.1523/jneurosci.5227-03.2004","title":"Mitogen- and Stress-Activated Protein Kinase 1 Mediates cAMP Response Element-Binding Protein Phosphorylation and Activation by Neurotrophins","year":2004,"lang":"en","type":"article","venue":"Journal of Neuroscience","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":222,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"National Institute of Mental Health; Medical Research Council; Merck KGaA; GlaxoSmithKline; National Institutes of Health; Pfizer","keywords":"CREB; Protein kinase A; Ribosomal s6 kinase; Cell biology; Mitogen-activated protein kinase kinase; Phosphorylation; Neurotrophin; Kinase; MAP kinase kinase kinase; Biology; Molecular biology; Transcription factor; Biochemistry; Protein kinase B; P70-S6 Kinase 1; Receptor; Gene","score_opus":0.012715642609635452,"score_gpt":0.23927841705704953,"score_spread":0.22656277444741407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138718238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99025047,0.003897829,0.0024408258,0.00018206681,0.0000430373,0.000017459162,0.00023083435,0.000109939756,0.002827453],"genre_scores_gemma":[0.9930862,0.002716175,0.0010274113,0.00003373087,0.000019975732,0.000029133815,0.00031277954,0.000009670714,0.0027648604],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99993026,0.000008463492,0.0000034920397,0.000012895995,0.000019017722,0.000025821388],"domain_scores_gemma":[0.9999516,0.000004652102,0.000015674259,0.0000036185647,0.000006469518,0.000018056178],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008972056,0.000650283,0.00019452728,0.00019570604,0.00025737425,0.00022650843,0.00017133793,0.00016656477,0.0012431726],"category_scores_gemma":[0.00013239714,0.000121844176,0.00020413152,0.00007510984,0.00021425862,0.00023852306,0.00020084095,0.00046411215,0.0004921704],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010425152,0.000012819408,0.00009193174,0.000047265934,0.0000020997877,0.000044399574,0.000010138588,0.00007132697,0.99811447,0.00020159771,0.000048839574,0.0012509025],"study_design_scores_gemma":[0.000032946697,0.0002448392,0.014195019,0.000020684003,0.000015890313,0.00039456994,0.00003684131,0.001678019,0.9781925,0.0004801346,0.0046980106,0.000010577925],"about_ca_topic_score_codex":0.00092086405,"about_ca_topic_score_gemma":0.0014036254,"teacher_disagreement_score":0.0012431726,"about_ca_system_score_codex":0.00046211653,"about_ca_system_score_gemma":0.00027834924,"threshold_uncertainty_score":0.0041588545},"labels":[],"label_agreement":null},{"id":"W2140777372","doi":"10.1158/1541-7786.mcr-07-2001","title":"BRAF Silencing by Short Hairpin RNA or Chemical Blockade by PLX4032 Leads to Different Responses in Melanoma and Thyroid Carcinoma Cells","year":2008,"lang":"en","type":"article","venue":"Molecular Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":187,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University","funders":"Plexxikon","keywords":"Cancer research; Gene silencing; Thyroid cancer; Small hairpin RNA; Melanoma; Thyroid carcinoma; Cancer; Biology; Anaplastic thyroid cancer; Gene knockdown; Cell growth; RNA interference; Cell culture; Medicine; Thyroid; Internal medicine; Endocrinology; RNA","score_opus":0.03724670571200836,"score_gpt":0.31836257568427995,"score_spread":0.28111586997227156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140777372","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958763,0.00078364747,0.0012189919,0.00006119357,0.00003732029,0.000047756963,0.0005341217,0.00007725359,0.0013635237],"genre_scores_gemma":[0.9904861,0.0006767013,0.0018166773,0.00006877594,0.000008537231,0.00013691289,0.0012603464,0.000025327543,0.0055206344],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998292,0.000018548355,0.000023916344,0.00003839729,0.000051970663,0.000037981197],"domain_scores_gemma":[0.99991465,0.000017332613,0.000013144585,0.000012840055,0.000014800506,0.000027239332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013419411,0.00028580663,0.00027453317,0.00020522262,0.00016577159,0.00020559279,0.0001531128,0.00028517487,0.0009872039],"category_scores_gemma":[0.00009645855,0.00011412511,0.00035613886,0.0001956941,0.00017600517,0.0001348056,0.00013199943,0.0005769688,0.0003247224],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045229597,0.000015420326,0.00004655275,0.000012003271,0.0000019298043,0.000021288393,0.000014573687,0.000018023806,0.99956197,0.000033049837,0.000017200698,0.00021277505],"study_design_scores_gemma":[0.000014309934,0.00041331892,0.0022027055,0.0000021616725,0.000009858343,0.00010853133,0.000027931346,0.0005073235,0.99574786,0.000020501242,0.00094192725,0.0000035207804],"about_ca_topic_score_codex":0.0018867484,"about_ca_topic_score_gemma":0.0018720127,"teacher_disagreement_score":0.0018867484,"about_ca_system_score_codex":0.00034578287,"about_ca_system_score_gemma":0.00023380297,"threshold_uncertainty_score":0.0037515163},"labels":[],"label_agreement":null},{"id":"W2142308379","doi":"10.1158/1078-0432.ccr-07-4496","title":"Inverse Association between Raf Kinase Inhibitory Protein and Signal Transducers and Activators of Transcription 3 Expression in Gastric Adenocarcinoma Patients: Implications for Clinical Outcome","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Center for Research Resources","keywords":"STAT3; Tissue microarray; Cancer research; Immunohistochemistry; STAT protein; Adenocarcinoma; Medicine; Cancer; Metastasis; Transcription factor; Pathology; Signal transduction; Biology; Internal medicine; Gene","score_opus":0.23121385549468268,"score_gpt":0.45240654009255904,"score_spread":0.22119268459787636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142308379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990996,0.0003530524,0.00007202718,0.000056305456,0.0000040791074,0.0000029465928,0.000121822115,0.000004461332,0.00028573498],"genre_scores_gemma":[0.9996661,0.00007085489,0.000050054347,0.000012465953,0.000007176682,0.0000032716787,0.00012121132,0.0000010168472,0.00006794069],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998826,0.000026202513,0.000011868751,0.00003002031,0.00002638255,0.000022943732],"domain_scores_gemma":[0.9994554,0.000120835626,0.00021644036,0.000025312345,0.000053510754,0.00012845037],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026164768,0.0001882526,0.00022362288,0.00036897513,0.00021103512,0.00027382374,0.00017171525,0.0003393979,0.0014035217],"category_scores_gemma":[0.00093166396,0.000104908286,0.00024665345,0.000449783,0.00027759315,0.00020779471,0.00018412521,0.0004781254,0.00021172703],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005554859,0.000020568577,0.9959496,0.000013236059,0.00003101092,0.000123707,0.00002145478,0.000079756464,0.0016147412,0.000019011435,0.00008032866,0.0014909601],"study_design_scores_gemma":[0.000014668062,0.00009141924,0.9981754,0.0000039995375,0.000039317834,0.0006435414,0.000053620293,0.00045913932,0.0003199688,0.00006406508,0.0001311311,0.000003668138],"about_ca_topic_score_codex":0.00058105896,"about_ca_topic_score_gemma":0.0009030298,"teacher_disagreement_score":0.0014035217,"about_ca_system_score_codex":0.00020491153,"about_ca_system_score_gemma":0.00019066314,"threshold_uncertainty_score":0.0046952367},"labels":[],"label_agreement":null},{"id":"W2142663890","doi":"10.1128/mcb.06633-11","title":"The Extracellular Signal-Regulated Kinase 3 (Mitogen-Activated Protein Kinase 6 [MAPK6])–MAPK-Activated Protein Kinase 5 Signaling Complex Regulates Septin Function and Dendrite Morphology","year":2012,"lang":"en","type":"article","venue":"Molecular and Cellular Biology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"Canadian Institutes of Health Research; National Institutes of Health","keywords":"Cell biology; ASK1; Protein kinase A; MAP kinase kinase kinase; Kinase; MAPK/ERK pathway; Biology; Mitogen-activated protein kinase kinase; Signal transduction; c-Raf; Cyclin-dependent kinase 9","score_opus":0.013267015536219458,"score_gpt":0.2182804152633671,"score_spread":0.20501339972714766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142663890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930987,0.00047680593,0.0044684513,0.00006669675,0.000010523512,0.000015084201,0.0004344022,0.000065951535,0.0013634728],"genre_scores_gemma":[0.9948507,0.00026606955,0.0028785497,0.000022215609,0.00000247159,0.000014525207,0.00045192754,0.000013231533,0.0015002073],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998766,0.000021094342,0.00001145358,0.000027685051,0.000035160137,0.000027955033],"domain_scores_gemma":[0.99990845,0.000006454486,0.000041871943,0.00000596923,0.000007551062,0.000029785302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000093019364,0.00035830511,0.00011144301,0.00023136192,0.00020493282,0.0002579019,0.00020299065,0.00024708913,0.0010687618],"category_scores_gemma":[0.00009545969,0.0001540775,0.0002087463,0.000096010626,0.0002299908,0.00022215926,0.00032849656,0.00038689107,0.00045951412],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000065904125,0.000008773099,0.0004060898,0.00001661953,0.000004378389,0.00006098548,0.0000060980224,0.000088398294,0.99841475,0.00025598612,0.00003085461,0.0006410795],"study_design_scores_gemma":[0.000012734727,0.00007258227,0.013657459,0.0000056972344,0.000014355775,0.00047995482,0.00002202316,0.0021841703,0.98152417,0.00016775768,0.0018543584,0.0000047051585],"about_ca_topic_score_codex":0.00030719375,"about_ca_topic_score_gemma":0.0007376014,"teacher_disagreement_score":0.0010687618,"about_ca_system_score_codex":0.00036036788,"about_ca_system_score_gemma":0.00014927483,"threshold_uncertainty_score":0.0035753846},"labels":[],"label_agreement":null},{"id":"W2142850270","doi":"10.1186/jbiol45","title":"Dimerization in protein kinase signaling.","year":2006,"lang":"en","type":"article","venue":"Journal of Biology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Kinase; Cell biology; Phosphorylation; Protein kinase A; Mitogen-activated protein kinase; Biology; Protein phosphorylation; Chemistry; Biochemistry","score_opus":0.006039574453730711,"score_gpt":0.22297198972135182,"score_spread":0.2169324152676211,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142850270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4022474,0.34952158,0.11213811,0.030706313,0.006591526,0.00016955647,0.00044035754,0.0005223136,0.097662866],"genre_scores_gemma":[0.93074536,0.0439776,0.0070751538,0.003209502,0.0012462774,0.00006997008,0.00027648907,0.000017815564,0.013381906],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9995944,0.00012891804,0.000016381591,0.000089136236,0.00008938421,0.00008189366],"domain_scores_gemma":[0.9998497,0.00003223381,0.000030181855,0.00001336961,0.00001246218,0.00006199876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007878183,0.00043837243,0.0003934278,0.0002462878,0.0013048459,0.0008972603,0.0004482421,0.0011947375,0.0019491978],"category_scores_gemma":[0.00033357315,0.00023811926,0.0002688394,0.00027601366,0.0009640318,0.0012578215,0.00085105334,0.0013277903,0.0017599628],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007177483,0.0002606858,0.0017028609,0.0012269634,0.00006530876,0.0015425973,0.00096845353,0.0026807855,0.42901254,0.43839762,0.017897489,0.105526924],"study_design_scores_gemma":[0.00018388283,0.00075124885,0.004866336,0.00023361084,0.0000943165,0.010768397,0.0010392427,0.012932,0.19213337,0.35060576,0.4262631,0.00012870297],"about_ca_topic_score_codex":0.00014353484,"about_ca_topic_score_gemma":0.00019412335,"teacher_disagreement_score":0.0019491978,"about_ca_system_score_codex":0.0005270666,"about_ca_system_score_gemma":0.00025651243,"threshold_uncertainty_score":0.0065206885},"labels":[],"label_agreement":null},{"id":"W2143918464","doi":"10.1158/1078-0432.ccr-09-1180","title":"c-Jun-NH2-kinase-1 Inhibition Leads to Antitumor Activity in Ovarian Cancer","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Center for Research Resources; National Cancer Institute","keywords":"Ovarian cancer; Cancer research; Debulking; Ovarian carcinoma; In vivo; Cancer; Medicine; Kinase; Apoptosis; Docetaxel; Cell growth; Internal medicine; Biology","score_opus":0.15785474597755314,"score_gpt":0.4952506165954008,"score_spread":0.3373958706178477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143918464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99624985,0.0021346693,0.00062039925,0.00006575257,0.000021619011,0.00003413356,0.00015450802,0.00004364787,0.0006754238],"genre_scores_gemma":[0.9965971,0.0012272171,0.0007969218,0.000024178027,0.00000715884,0.00003517299,0.0003380752,0.000006655169,0.0009675926],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99993634,0.000008495493,0.0000064604055,0.000010634985,0.000019531706,0.00001859354],"domain_scores_gemma":[0.99995625,0.000008422888,0.000014620595,0.000004731548,0.000005131063,0.000010762204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013382928,0.00032673593,0.00032496676,0.00014512106,0.000112374175,0.00018733207,0.00015419228,0.00014751502,0.0009317922],"category_scores_gemma":[0.000081972226,0.00008782434,0.00015633556,0.00013833558,0.00015638892,0.00010996787,0.00010211906,0.00046987412,0.00016635923],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003055604,0.00013566417,0.00025360784,0.00009821348,0.0000069751964,0.00002752552,0.000009128039,0.00012807571,0.995445,0.00004056158,0.00005196511,0.0034976993],"study_design_scores_gemma":[0.00007353784,0.0015528986,0.00417347,0.000004755117,0.00002410768,0.00023527666,0.000014386377,0.00059092866,0.9919373,0.000018692486,0.0013721035,0.0000025902727],"about_ca_topic_score_codex":0.00024278523,"about_ca_topic_score_gemma":0.00064813596,"teacher_disagreement_score":0.0009317922,"about_ca_system_score_codex":0.00023469815,"about_ca_system_score_gemma":0.00022934702,"threshold_uncertainty_score":0.0031172037},"labels":[],"label_agreement":null},{"id":"W2144547786","doi":"10.1158/1078-0432.ccr-11-2436","title":"Phase I Study of the Combination of Sorafenib and Temsirolimus in Patients with Metastatic Melanoma","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"National Cancer Institute","keywords":"Temsirolimus; Sorafenib; Medicine; Internal medicine; Oncology; Response Evaluation Criteria in Solid Tumors; Neuroblastoma RAS viral oncogene homolog; Cancer; Gastroenterology; Phases of clinical research; Toxicity; Surgery; Hepatocellular carcinoma; KRAS; Biology","score_opus":0.1270920474656933,"score_gpt":0.4640427284017923,"score_spread":0.336950680936099,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144547786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904979,0.0034303628,0.00075796235,0.0006409021,0.00017420253,0.0021490874,0.000525458,0.00013267616,0.0016915234],"genre_scores_gemma":[0.9905075,0.0018963679,0.0018418181,0.000568461,0.0003119876,0.0017452191,0.001226844,0.000025882975,0.0018759259],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995833,0.00018669471,0.000023982078,0.00006126468,0.000058477846,0.00008628112],"domain_scores_gemma":[0.9994112,0.00006211843,0.00010166501,0.000030296058,0.000034395274,0.00036033892],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001393367,0.0016757287,0.0022686536,0.00041891448,0.0004272582,0.0006827973,0.0008624401,0.00088064733,0.0031117585],"category_scores_gemma":[0.0007115402,0.00068482565,0.0009562219,0.0003586908,0.0007462476,0.0005737744,0.00032478495,0.0027531297,0.00095273263],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5766771,0.11325663,0.012919645,0.0017156561,0.001947725,0.0010419685,0.00042673916,0.0055954386,0.12005364,0.00044139542,0.0097816875,0.15614243],"study_design_scores_gemma":[0.5165944,0.4595424,0.012191145,0.000048035385,0.00037719068,0.00071854325,0.000040282353,0.0016492973,0.005019741,0.00014804649,0.0036380035,0.000033015527],"about_ca_topic_score_codex":0.0005789191,"about_ca_topic_score_gemma":0.001537505,"teacher_disagreement_score":0.0031117585,"about_ca_system_score_codex":0.0007429141,"about_ca_system_score_gemma":0.0017155331,"threshold_uncertainty_score":0.010409832},"labels":[],"label_agreement":null},{"id":"W2144669213","doi":"10.1017/s0317167100012191","title":"ERK5: A Novel IKKα-Kinase in Rat Hippocampal Neurons","year":2011,"lang":"en","type":"article","venue":"Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"U.S. Department of Veterans Affairs","keywords":"Hippocampal formation; Wortmannin; Phosphorylation; Endocrinology; Pathogenesis; Neurodegeneration; Internal medicine; Insulin receptor; Insulin; Insulin resistance; IκB kinase; Biology; Neuroscience; Cell biology; Medicine; Phosphatidylinositol; Signal transduction; NF-κB; Disease","score_opus":0.04512972583174145,"score_gpt":0.24745740982582876,"score_spread":0.2023276839940873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144669213","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9811375,0.00820712,0.0055113346,0.00021565525,0.00012301526,0.00009401982,0.0011463412,0.000107022235,0.003457906],"genre_scores_gemma":[0.98254526,0.004945334,0.0048558144,0.000081803904,0.000024346358,0.00010944954,0.0028093988,0.000013877549,0.004614588],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99992335,0.000006401476,0.000010890701,0.000016028107,0.0000191012,0.000024339366],"domain_scores_gemma":[0.9999658,0.0000024420372,0.000010521402,0.0000043174146,0.0000066849916,0.000010254726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014163456,0.000601733,0.00015626728,0.00023340476,0.00025502392,0.00020717175,0.000316868,0.00018381981,0.0013754515],"category_scores_gemma":[0.00006248187,0.000121978555,0.00036151716,0.0001611581,0.00017451521,0.00022430385,0.00015145903,0.00043282125,0.00061642675],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039065036,0.000094541225,0.00025102097,0.00015771025,0.0000092794935,0.00010586388,0.00001535663,0.00007940825,0.99673444,0.00018337941,0.00007319282,0.0019050492],"study_design_scores_gemma":[0.0000732486,0.00067410467,0.004945507,0.000020100668,0.00005256879,0.0006981027,0.00004526301,0.0006023235,0.98952186,0.00011724096,0.0032444177,0.000005249637],"about_ca_topic_score_codex":0.000763803,"about_ca_topic_score_gemma":0.0009197714,"teacher_disagreement_score":0.0013754515,"about_ca_system_score_codex":0.0004521441,"about_ca_system_score_gemma":0.00030885087,"threshold_uncertainty_score":0.0046012998},"labels":[],"label_agreement":null},{"id":"W2144708319","doi":"10.1016/j.ccr.2011.04.002","title":"c-Raf, but Not B-Raf, Is Essential for Development of K-Ras Oncogene-Driven Non-Small Cell Lung Carcinoma","year":2011,"lang":"en","type":"article","venue":"Cancer Cell","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":297,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôtel-Dieu de Québec","funders":"","keywords":"Oncogene; MAPK/ERK pathway; Cancer research; Kinase; Biology; Concomitant; Anti-apoptotic Ras signalling cascade; Lung; Carcinoma; clone (Java method); Cell; Medicine; Cell biology; Internal medicine; Cell cycle; Gene; Genetics","score_opus":0.025568695649902887,"score_gpt":0.2407732591841122,"score_spread":0.2152045635342093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144708319","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930126,0.00082608475,0.0021161113,0.00016157828,0.000026981434,0.000021974256,0.00040271832,0.000113149326,0.0033188034],"genre_scores_gemma":[0.9944465,0.00031502426,0.0010161482,0.00002507503,0.0000047484245,0.000014805616,0.00046117138,0.00003247758,0.003683946],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997818,0.00003245178,0.000026644408,0.000031176503,0.00007893265,0.000048991707],"domain_scores_gemma":[0.9996923,0.00007211253,0.000052375548,0.000051160416,0.000037332546,0.00009483643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001548989,0.00028943588,0.00015872171,0.00051908934,0.00037091164,0.00036083677,0.00026429177,0.00027334483,0.0018295986],"category_scores_gemma":[0.00021302929,0.0002764337,0.00021736031,0.00014359261,0.00024205323,0.0002470538,0.0002807343,0.0008062031,0.00085498614],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006931376,0.000019320805,0.00016868942,0.000008153806,0.0000017274626,0.00010972121,0.0000065424333,0.000028955075,0.99893457,0.00019908856,0.00003726254,0.0004167088],"study_design_scores_gemma":[0.000011095985,0.000075135744,0.0047045886,0.000002803119,0.0000081923245,0.000835394,0.000025124638,0.0011109492,0.99049056,0.00009643914,0.0026360645,0.0000036912954],"about_ca_topic_score_codex":0.00157305,"about_ca_topic_score_gemma":0.0027576238,"teacher_disagreement_score":0.0018295986,"about_ca_system_score_codex":0.0005533184,"about_ca_system_score_gemma":0.00042515362,"threshold_uncertainty_score":0.006120622},"labels":[],"label_agreement":null},{"id":"W2144906866","doi":"10.1093/annonc/mdu049","title":"Whole-genome sequencing reveals complex mechanisms of intrinsic resistance to BRAF inhibition","year":2014,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":65,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"University College London; Cancer Research UK; Wellcome Trust; Harry J. Lloyd Charitable Trust","keywords":"Vemurafenib; Dabrafenib; Sanger sequencing; Cancer research; PTEN; Medicine; GNAQ; Melanoma; MEK inhibitor; Mutation; Biology; MAPK/ERK pathway; Genetics; PI3K/AKT/mTOR pathway; Kinase; Signal transduction; Gene","score_opus":0.06010748525716944,"score_gpt":0.3109945371453774,"score_spread":0.2508870518882079,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144906866","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99068415,0.002246878,0.0032606074,0.0004067688,0.000019302823,0.000008516378,0.00187773,0.0001817296,0.0013143187],"genre_scores_gemma":[0.99365413,0.0015634414,0.0018306593,0.00014297718,0.0000133337835,0.000008716807,0.0016963836,0.00005152178,0.0010388457],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99988043,0.000013620765,0.00000588673,0.000039522933,0.000043496962,0.000017043145],"domain_scores_gemma":[0.9998692,0.00004162386,0.00003985215,0.000019940915,0.000016767433,0.00001258321],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022422621,0.00025591516,0.00029407235,0.00029123508,0.00012335835,0.00060864096,0.00022270877,0.0003685733,0.0009438188],"category_scores_gemma":[0.0003356111,0.00021018428,0.00030022397,0.00031538308,0.00018231984,0.00027208458,0.00021039501,0.00057866477,0.00024923251],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025455974,0.000028411801,0.011787051,0.000110334004,0.00017748082,0.00013899471,0.000059689617,0.0013211279,0.96330917,0.00087360456,0.0006758146,0.021263644],"study_design_scores_gemma":[0.000056192603,0.00037238564,0.6376208,0.000048098427,0.0004686897,0.0018357137,0.00024857442,0.017923094,0.3158923,0.0057103205,0.019767594,0.000056240744],"about_ca_topic_score_codex":0.00071236014,"about_ca_topic_score_gemma":0.0020488757,"teacher_disagreement_score":0.0009438188,"about_ca_system_score_codex":0.00027955082,"about_ca_system_score_gemma":0.0002177644,"threshold_uncertainty_score":0.0031573772},"labels":[],"label_agreement":null},{"id":"W2146021917","doi":"10.1074/jbc.m310335200","title":"Stress Induces Mitochondria-mediated Apoptosis Independent of SAPK/JNK Activation in Embryonic Stem Cells","year":2004,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Cell biology; Apoptosis; Embryonic stem cell; p38 mitogen-activated protein kinases; MAPK/ERK pathway; Kinase; Protein kinase A; Biology; Mitogen-activated protein kinase; Chemistry; Gene; Biochemistry","score_opus":0.01836099353921242,"score_gpt":0.23232319991421696,"score_spread":0.21396220637500454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146021917","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864178,0.0032040146,0.0060433815,0.00013722204,0.000080741185,0.00008036346,0.0012123446,0.00020928575,0.0026148995],"genre_scores_gemma":[0.9889283,0.0019322016,0.002903168,0.0001264938,0.00002106668,0.00010641326,0.0022608754,0.000040301384,0.0036811638],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997745,0.000024544865,0.000041971234,0.00003850006,0.000089918736,0.00003058955],"domain_scores_gemma":[0.9998307,0.000032125605,0.000051097133,0.00002639457,0.000022871762,0.00003675842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018142295,0.0004794622,0.00033551178,0.00031174524,0.00014763827,0.00029988785,0.00022939513,0.00027383026,0.0012631936],"category_scores_gemma":[0.00012851636,0.00022970133,0.00038842272,0.00019309824,0.00021043494,0.00026706414,0.00028510665,0.00088456424,0.0006202432],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000862333,0.00001750496,0.00013716098,0.000053146807,0.0000059221425,0.00009093704,0.000021022164,0.00003439269,0.9983588,0.000131974,0.00004680989,0.0010160528],"study_design_scores_gemma":[0.000050563704,0.00030688054,0.0083205495,0.000014501589,0.00002987264,0.00080473244,0.000043860513,0.0011700013,0.9844892,0.00016735609,0.0045926385,0.0000097456505],"about_ca_topic_score_codex":0.00026925086,"about_ca_topic_score_gemma":0.00035618723,"teacher_disagreement_score":0.0012631936,"about_ca_system_score_codex":0.00028107173,"about_ca_system_score_gemma":0.00018739265,"threshold_uncertainty_score":0.00422585},"labels":[],"label_agreement":null},{"id":"W2146211196","doi":"10.3747/co.v15i2.173","title":"Biochemotherapy for the Treatment of Metastatic Malignant Melanoma: A Clinical Practice Guideline","year":2008,"lang":"en","type":"article","venue":"Current Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Cancer Care Ontario","funders":"","keywords":"Medicine; Guideline; Melanoma; Quality of life (healthcare); Oncology; Disease; Cancer; Internal medicine; Intensive care medicine; Radiation therapy; Regimen; Adverse effect; Pathology; Nursing","score_opus":0.17885961851759366,"score_gpt":0.4605014070652123,"score_spread":0.2816417885476187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146211196","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006988181,0.22155297,0.035057817,0.61293066,0.0096696,0.013306654,0.006298069,0.0011007563,0.09309527],"genre_scores_gemma":[0.03292357,0.39717844,0.3268412,0.17312965,0.007871957,0.012756347,0.014989603,0.00024702805,0.034062233],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9937737,0.0016724172,0.0018602689,0.00033363805,0.0020449536,0.00031492847],"domain_scores_gemma":[0.9801759,0.0028298819,0.0024424088,0.00043931633,0.012384173,0.0017283467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008465608,0.0013438873,0.0018759507,0.0036869156,0.0015118646,0.00195076,0.0050487667,0.008337311,0.0031941466],"category_scores_gemma":[0.014165093,0.00081021787,0.0023606813,0.004267124,0.0013713979,0.0022784944,0.001585337,0.006507848,0.0033708964],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000074571806,0.000406933,0.0028627024,0.008908753,0.00015314893,0.0010100881,0.0005857541,0.0011264517,0.0016762703,0.0031601642,0.722079,0.25795615],"study_design_scores_gemma":[0.0003445948,0.00021656313,0.0127578,0.044369627,0.00042150434,0.0015324242,0.0005366682,0.0018615875,0.0005574288,0.0058750557,0.93142664,0.00010014155],"about_ca_topic_score_codex":0.055481408,"about_ca_topic_score_gemma":0.115989685,"teacher_disagreement_score":0.055481408,"about_ca_system_score_codex":0.007372585,"about_ca_system_score_gemma":0.02749715,"threshold_uncertainty_score":0.11031693},"labels":[],"label_agreement":null},{"id":"W2148291345","doi":"10.1111/pcmr.12424","title":"Extrinsic factors can mediate resistance to <scp>BRAF</scp> inhibition in central nervous system melanoma metastases","year":2015,"lang":"en","type":"article","venue":"Pigment Cell & Melanoma Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Cancer Research UK; National Institute for Health and Care Research; Novartis; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; Pfizer; Royal Marsden NHS Foundation Trust; Francis Crick Institute","keywords":"Vemurafenib; Dabrafenib; Melanoma; Medicine; Cancer research; Central nervous system; Cerebrospinal fluid; MAPK/ERK pathway; MEK inhibitor; Pathology; Kinase; Internal medicine; Biology; Metastatic melanoma","score_opus":0.04991186967412619,"score_gpt":0.28753509411835854,"score_spread":0.23762322444423234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148291345","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99567765,0.0024331263,0.00026987813,0.000031309177,0.0000037841835,0.000009149122,0.00011036164,0.000010839185,0.001453862],"genre_scores_gemma":[0.99888724,0.0005837343,0.00014916567,0.000012733501,0.000010252705,0.0000033806255,0.00013560618,0.000003996158,0.00021393462],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99988604,0.000018971412,0.0000188545,0.000021638818,0.00002805687,0.000026437545],"domain_scores_gemma":[0.9996296,0.000081133614,0.00015758476,0.00001863219,0.0000622308,0.000050888415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016577113,0.00017454517,0.00021436509,0.00060516974,0.00017704081,0.0003370696,0.00013705804,0.00016651269,0.0011854119],"category_scores_gemma":[0.0007841259,0.00009349709,0.00018014562,0.00030678516,0.00021807398,0.00022013654,0.00023300873,0.00010941298,0.00029979664],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000674548,0.00002870567,0.9045535,0.00022841796,0.000085612475,0.022873668,0.00019563391,0.00021258088,0.030025693,0.00014484141,0.00037577617,0.04060116],"study_design_scores_gemma":[0.000020623314,0.00031363047,0.8442274,0.000042048014,0.00011643659,0.13865936,0.00027306462,0.00040290598,0.012451681,0.00012247066,0.003359151,0.000011265566],"about_ca_topic_score_codex":0.0008091835,"about_ca_topic_score_gemma":0.0014402199,"teacher_disagreement_score":0.0011854119,"about_ca_system_score_codex":0.0002377241,"about_ca_system_score_gemma":0.0001925375,"threshold_uncertainty_score":0.003965616},"labels":[],"label_agreement":null},{"id":"W2150153870","doi":"10.1093/annonc/mdu154","title":"Patient perception of the benefit of a BRAF inhibitor in metastatic melanoma: quality-of-life analyses of the BREAK-3 study comparing dabrafenib with dacarbazine","year":2014,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Dabrafenib; Medicine; Dacarbazine; Nausea; Vomiting; Quality of life (healthcare); Internal medicine; Oncology; Chemotherapy; Vemurafenib; Cancer; Metastatic melanoma","score_opus":0.10730208951411321,"score_gpt":0.37843127100091906,"score_spread":0.27112918148680587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150153870","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971836,0.0013021523,0.00009357822,0.00017848233,0.00001589963,0.00003072565,0.00066841225,0.0000034533175,0.00052362605],"genre_scores_gemma":[0.99901044,0.0002005455,0.00008002447,0.000089525245,0.000016288062,0.00001819718,0.00045242207,0.0000015999757,0.00013087159],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99875677,0.0006790161,0.00010544787,0.00014372126,0.00017321402,0.00014181824],"domain_scores_gemma":[0.9972529,0.00092819706,0.001032069,0.00011344884,0.00014646159,0.00052698696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025999374,0.00044053717,0.0009774999,0.00036254482,0.00027464994,0.00080289645,0.00038330257,0.00062739314,0.002329946],"category_scores_gemma":[0.003424279,0.00019942313,0.0027085068,0.00055073417,0.00033737952,0.0006993145,0.00049905817,0.0013094054,0.00015583147],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.21675369,0.0024481188,0.7173921,0.00047357712,0.014413531,0.0001409725,0.00029028783,0.0028891743,0.003156761,0.00018875072,0.0012538288,0.04059923],"study_design_scores_gemma":[0.009715705,0.028155182,0.9528138,0.000046962527,0.0042906804,0.00019192851,0.0003087387,0.0020865318,0.0006563022,0.0002476646,0.0014172113,0.000069303795],"about_ca_topic_score_codex":0.0016376536,"about_ca_topic_score_gemma":0.002769817,"teacher_disagreement_score":0.0025999374,"about_ca_system_score_codex":0.0007080397,"about_ca_system_score_gemma":0.00029183546,"threshold_uncertainty_score":0.013749957},"labels":[],"label_agreement":null},{"id":"W2151507583","doi":"10.1634/theoncologist.12-4-426","title":"Safety, Pharmacokinetics, and Preliminary Antitumor Activity of Sorafenib: A Review of Four Phase I Trials in Patients with Advanced Refractory Solid Tumors","year":2007,"lang":"en","type":"review","venue":"The Oncologist","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":418,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; Princess Margaret Cancer Centre","funders":"","keywords":"Sorafenib; Medicine; Clinical trial; Pharmacokinetics; Refractory (planetary science); Pharmacology; Oncology; Drug; Toxicity; Safety profile; Phases of clinical research; Internal medicine; Medical physics; Adverse effect; Hepatocellular carcinoma","score_opus":0.07306418962376841,"score_gpt":0.4061245175451803,"score_spread":0.3330603279214119,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151507583","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010373872,0.9981744,0.00017410342,0.00019897956,0.0000398906,0.000029198674,0.000069125024,0.000009042171,0.00026787503],"genre_scores_gemma":[0.0075883204,0.9911885,0.00045344414,0.0003870451,0.00005733298,0.000050658222,0.00012781504,0.0000070095634,0.00013985597],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9989202,0.0003125216,0.00036993297,0.00013422071,0.0002302259,0.00003291683],"domain_scores_gemma":[0.9960336,0.0022419165,0.0010265055,0.00007221165,0.00050943345,0.000116451214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033290773,0.00069807365,0.002896372,0.00193218,0.00025410793,0.0010625968,0.0011550158,0.0006359826,0.0010873388],"category_scores_gemma":[0.0045810994,0.00035454906,0.0021934635,0.0030315307,0.00049213733,0.0010811177,0.00040789865,0.0008342118,0.00029752613],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012524985,0.00009750547,0.001475196,0.1760388,0.002715233,0.00026871567,0.00023341502,0.00053426024,0.0043726815,0.00049665157,0.010438369,0.8020767],"study_design_scores_gemma":[0.0022726925,0.0071587716,0.031882904,0.16761757,0.044318452,0.0067443606,0.00082032377,0.0009174586,0.0068785218,0.0020648648,0.7291472,0.00017680085],"about_ca_topic_score_codex":0.0006792542,"about_ca_topic_score_gemma":0.0017828065,"teacher_disagreement_score":0.0033290773,"about_ca_system_score_codex":0.0007506566,"about_ca_system_score_gemma":0.0015667262,"threshold_uncertainty_score":0.01760608},"labels":[],"label_agreement":null},{"id":"W2155321348","doi":"10.1158/1535-7163.mct-05-0099","title":"Combined inhibition of the phosphatidylinositol 3-kinase/Akt and Ras/mitogen-activated protein kinase pathways results in synergistic effects in glioblastoma cells","year":2006,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Protein kinase B; Kinase; Integrin-linked kinase; MAPK/ERK pathway; Cancer research; Wortmannin; PI3K/AKT/mTOR pathway; Protein kinase A; Phosphatidylinositol; Chemistry; Biology; Cell biology; Molecular biology; Signal transduction; Cyclin-dependent kinase 2","score_opus":0.0073327816817469645,"score_gpt":0.21447004087722632,"score_spread":0.20713725919547935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155321348","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922127,0.0029685993,0.002244437,0.00010273646,0.0000500772,0.000072628514,0.00029257932,0.00010500301,0.0019513143],"genre_scores_gemma":[0.9918481,0.0016445385,0.0042415285,0.00005023958,0.000012733532,0.000108445485,0.0004972746,0.000011079598,0.0015859158],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996921,0.000046550504,0.00003739361,0.000035962283,0.000118952295,0.00006911732],"domain_scores_gemma":[0.9999268,0.000011935782,0.000014683656,0.000009681122,0.00001241009,0.000024480196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023378739,0.0006160966,0.00069995795,0.00042886043,0.00018023874,0.00030670327,0.00022454523,0.00022177768,0.0007216102],"category_scores_gemma":[0.00007264642,0.00020792315,0.0005229351,0.0003648232,0.00014271164,0.00016656684,0.00025243594,0.00053109945,0.00029709982],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022684128,0.00018204574,0.00039069846,0.000086980406,0.00003788426,0.000051283172,0.00002840026,0.00014263719,0.99461985,0.000083117375,0.00012688688,0.0040233587],"study_design_scores_gemma":[0.000038035352,0.0011680828,0.003325734,0.0000051418633,0.00007105933,0.00018029888,0.00002749716,0.0007724353,0.9927025,0.00002242815,0.0016820384,0.0000049148207],"about_ca_topic_score_codex":0.0011263894,"about_ca_topic_score_gemma":0.0033973872,"teacher_disagreement_score":0.0011263894,"about_ca_system_score_codex":0.0002998461,"about_ca_system_score_gemma":0.0003480009,"threshold_uncertainty_score":0.002413988},"labels":[],"label_agreement":null},{"id":"W2155461614","doi":"10.1056/nejmoa1105358","title":"<i>RAS</i> Mutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF Inhibitors","year":2012,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1028,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"University of California, San Francisco; Plexxikon; European Organisation for Research and Treatment of Cancer; Jonsson Cancer Center Foundation; National Cancer Institute; University of California, Los Angeles; Cancer Research UK; Wellcome Trust; California Institute of Technology","keywords":"HRAS; Vemurafenib; Neuroblastoma RAS viral oncogene homolog; KRAS; Cancer research; MAPK/ERK pathway; Carcinogenesis; V600E; Cell growth; Mutation; Biology; Medicine; Kinase; Melanoma; Cancer; Internal medicine; Gene; Genetics","score_opus":0.006657930907524172,"score_gpt":0.2093037642751884,"score_spread":0.20264583336766423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155461614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989256,0.0003773279,0.000047552036,0.000028363034,0.0000044017943,0.000007079899,0.00006995678,0.0000051960824,0.0005344561],"genre_scores_gemma":[0.9997713,0.000071550174,0.000039448732,0.000014151022,0.000005494788,0.0000030514202,0.00005427839,0.00000105745,0.000039700695],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99977595,0.000038966093,0.00002995951,0.000054303913,0.000059227637,0.00004165865],"domain_scores_gemma":[0.99943,0.00012132076,0.00023949344,0.000025801332,0.00006852355,0.000114915674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024109527,0.00016307613,0.0003192322,0.0006626778,0.00035703325,0.00046714477,0.0001600045,0.0004098856,0.0013774558],"category_scores_gemma":[0.0010837767,0.0001678807,0.00030900433,0.00051592937,0.00018099512,0.00025724375,0.00018501322,0.00034278195,0.0001936499],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039871177,0.000039580013,0.9922442,0.000014924417,0.00004059869,0.00085456343,0.000037680336,0.000057530495,0.0031359494,0.000010698058,0.000080273785,0.0030852177],"study_design_scores_gemma":[0.000015539872,0.00021430966,0.9940394,0.000007164177,0.000051789448,0.0044120494,0.00009371947,0.00021942117,0.00067271513,0.000018797346,0.0002512662,0.0000038473454],"about_ca_topic_score_codex":0.000807571,"about_ca_topic_score_gemma":0.001003079,"teacher_disagreement_score":0.0013774558,"about_ca_system_score_codex":0.00020282193,"about_ca_system_score_gemma":0.00018371484,"threshold_uncertainty_score":0.0046080947},"labels":[],"label_agreement":null},{"id":"W2157745333","doi":"10.1101/gad.1390406","title":"A KSR/CNK complex mediated by HYP, a novel SAM domain-containing protein, regulates RAS-dependent RAF activation in <i>Drosophila</i>","year":2006,"lang":"en","type":"article","venue":"Genes & Development","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Scaffold protein; Biology; Cell biology; MAPK/ERK pathway; Protein kinase A; Kinase; Effector; Small GTPase; Activator (genetics); Signal transduction; Biochemistry; Receptor","score_opus":0.012085240826816092,"score_gpt":0.21021876128880218,"score_spread":0.1981335204619861,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157745333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99665326,0.0005573179,0.0016645987,0.000044097924,0.000008898715,0.000008946622,0.00007831643,0.000073080846,0.00091156695],"genre_scores_gemma":[0.9963341,0.00018175929,0.0018924638,0.000027888707,0.0000061186875,0.000009943827,0.00020759876,0.000018626548,0.001321411],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999176,0.000012714488,0.0000037644863,0.000022186876,0.000026145348,0.000017549106],"domain_scores_gemma":[0.9999269,0.0000068369545,0.000028641849,0.000007382605,0.000004754328,0.000025461013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007958607,0.0002750215,0.000108826636,0.00012606508,0.00017764654,0.00019594355,0.00017791809,0.00012819924,0.0009647484],"category_scores_gemma":[0.000062634834,0.0001360523,0.00013342459,0.00006344743,0.00019495231,0.00015082894,0.0002924273,0.00027791198,0.0003898197],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028174874,0.0000035836356,0.0001319926,0.000009951942,0.0000019241163,0.000040539755,0.000005025495,0.000021075497,0.99939024,0.000078515615,0.000020706822,0.0002682957],"study_design_scores_gemma":[0.000019272344,0.00009388994,0.014652142,0.0000033191711,0.000008439045,0.00053593214,0.000024237152,0.0018425339,0.9802868,0.00006726022,0.0024620737,0.0000041689736],"about_ca_topic_score_codex":0.00032102433,"about_ca_topic_score_gemma":0.00074429566,"teacher_disagreement_score":0.0009647484,"about_ca_system_score_codex":0.00031274726,"about_ca_system_score_gemma":0.00008725702,"threshold_uncertainty_score":0.0032274723},"labels":[],"label_agreement":null},{"id":"W2158791991","doi":"10.1016/j.bmcl.2009.10.049","title":"Non-hinge-binding pyrazolo[1,5-a]pyrimidines as potent B-Raf kinase inhibitors","year":2009,"lang":"en","type":"article","venue":"Bioorganic & Medicinal Chemistry Letters","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Chemistry; Trifluoromethyl; Stereochemistry; Kinase; Hydrogen bond; Amine gas treating; Aryl; Protein kinase A; Chemical synthesis; Structure–activity relationship; In vitro; Combinatorial chemistry; Biochemistry; Molecule; Organic chemistry","score_opus":0.006420254641340049,"score_gpt":0.2185084930702599,"score_spread":0.21208823842891986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158791991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9577779,0.023779156,0.0046076854,0.0003703523,0.00019802095,0.00015806664,0.00066457025,0.00034512105,0.012099106],"genre_scores_gemma":[0.9850707,0.007923511,0.0016961591,0.000090514885,0.000026296106,0.00005326528,0.00041654878,0.000016845452,0.0047061983],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999143,0.000018903393,0.00000511083,0.000010479943,0.00002224494,0.000028926837],"domain_scores_gemma":[0.99995875,0.000008272072,0.000008280508,0.000004382121,0.0000053958715,0.00001496418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023168398,0.00035969994,0.0003711131,0.0003100191,0.0002261804,0.0002957577,0.000483563,0.0002888776,0.0020687073],"category_scores_gemma":[0.00012947863,0.00019452117,0.00017593185,0.00021850587,0.00017609213,0.00028400653,0.00028895857,0.0005494352,0.0004346419],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00205451,0.00045595356,0.00040238164,0.0005260142,0.000038356964,0.00052843237,0.00012378392,0.0038129205,0.9336924,0.0029588046,0.0020495167,0.05335689],"study_design_scores_gemma":[0.0019319892,0.010847972,0.0076220315,0.000083946674,0.0001438171,0.0023695843,0.000095432064,0.009469538,0.9157034,0.0013047445,0.050322313,0.00010515031],"about_ca_topic_score_codex":0.000689373,"about_ca_topic_score_gemma":0.0028292171,"teacher_disagreement_score":0.0020687073,"about_ca_system_score_codex":0.00037349234,"about_ca_system_score_gemma":0.00022452167,"threshold_uncertainty_score":0.006920457},"labels":[],"label_agreement":null},{"id":"W2159246510","doi":"10.1158/1541-7786.mcr-13-0294","title":"Hematopoietic Expression of Oncogenic <i>BRAF</i> Promotes Aberrant Growth of Monocyte-Lineage Cells Resistant to PLX4720","year":2013,"lang":"en","type":"article","venue":"Molecular Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute; Home Office; Cancer Research UK","keywords":"Cancer research; Biology; Haematopoiesis; Monocyte; Myeloid; Cytokine; Bone marrow; PI3K/AKT/mTOR pathway; Macrophage; Immunology; Cell biology; Stem cell; Signal transduction; In vitro","score_opus":0.030141430433383107,"score_gpt":0.31480745100598573,"score_spread":0.2846660205726026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159246510","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952863,0.0006303788,0.0014104674,0.00008056675,0.000018409712,0.000029574081,0.00033521975,0.000084498075,0.0021245682],"genre_scores_gemma":[0.9960699,0.00037664376,0.0011220216,0.0000479143,0.0000082407505,0.000029040766,0.0004471235,0.000013535357,0.0018856323],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999861,0.00002720812,0.000012382071,0.00001656345,0.00003127105,0.00005160166],"domain_scores_gemma":[0.9999237,0.000013316606,0.000018329833,0.000009741476,0.000009276864,0.000025560827],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010935186,0.00029334179,0.00014227697,0.0001186166,0.000119296405,0.00022969431,0.00010389472,0.00014344632,0.0015280938],"category_scores_gemma":[0.000052487794,0.00008201766,0.00014759634,0.00010447492,0.00015221217,0.00007843086,0.00014048949,0.00044079823,0.00073810987],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000119306605,0.000039429648,0.00021611342,0.000017663533,0.0000016793379,0.000070682305,0.0000093541685,0.000024825766,0.99876547,0.000062723855,0.00005976825,0.0006130277],"study_design_scores_gemma":[0.000018328525,0.00051560975,0.004315666,0.0000045351485,0.000007978342,0.0004097777,0.000029943745,0.0006403,0.9923137,0.00002192144,0.0017202415,0.000002046422],"about_ca_topic_score_codex":0.00071083393,"about_ca_topic_score_gemma":0.0008931184,"teacher_disagreement_score":0.0015280938,"about_ca_system_score_codex":0.00020737432,"about_ca_system_score_gemma":0.00018429487,"threshold_uncertainty_score":0.0051119328},"labels":[],"label_agreement":null},{"id":"W2159381901","doi":"10.1161/hypertensionaha.110.159889","title":"Mitogen-Activated Protein Kinase–Activated Protein Kinase 2 in Angiotensin II–Induced Inflammation and Hypertension","year":2010,"lang":"en","type":"article","venue":"Hypertension","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research; Institut de Cardiologie de Montréal","keywords":"Angiotensin II; Nicotinamide adenine dinucleotide phosphate; Protein kinase A; Chemistry; Internal medicine; Endocrinology; Kinase; Biology; Oxidase test; Biochemistry; Medicine; Receptor; Enzyme","score_opus":0.015745438883132932,"score_gpt":0.21187925238870184,"score_spread":0.1961338135055689,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159381901","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85506165,0.124427095,0.007228938,0.0029388005,0.0011781773,0.00010742316,0.00031378696,0.00024628904,0.008497828],"genre_scores_gemma":[0.9654678,0.026028514,0.0017608565,0.00046288912,0.0003478039,0.00009666395,0.00021886529,0.0000117567,0.0056049367],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998766,0.000033332406,0.00000990807,0.000015955695,0.000028473763,0.000035663863],"domain_scores_gemma":[0.99993944,0.000006267442,0.000017662436,0.0000047204626,0.000007822723,0.000024108187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027133746,0.0005231709,0.00030888975,0.00022787965,0.0001883713,0.00034778583,0.00018016744,0.0004367093,0.0010410859],"category_scores_gemma":[0.000086507156,0.00017821709,0.0003684377,0.00014748561,0.00024003517,0.0002457422,0.00019766825,0.001238536,0.00022761081],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002313356,0.000539662,0.0018049376,0.0006897305,0.00008322011,0.001419363,0.00007951497,0.00041879795,0.9728565,0.0017279645,0.0013682412,0.016698685],"study_design_scores_gemma":[0.0011733848,0.005033661,0.21769218,0.00026938648,0.00060838833,0.011418378,0.00037954512,0.010824831,0.672894,0.0055969106,0.07398957,0.00011985865],"about_ca_topic_score_codex":0.00033024023,"about_ca_topic_score_gemma":0.0005169875,"teacher_disagreement_score":0.0010410859,"about_ca_system_score_codex":0.000264017,"about_ca_system_score_gemma":0.0002531221,"threshold_uncertainty_score":0.003482759},"labels":[],"label_agreement":null},{"id":"W2159631216","doi":"10.5430/jst.v2n5p13","title":"Combinatorial treatment with carboxyamidotriazole- orotate and temozolomide in sc-implanted human LOX IMVI melanoma xenografts","year":2012,"lang":"en","type":"article","venue":"Journal of Solid Tumors","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Temozolomide; Medicine; Pharmacology; Melanoma; Cancer research; Glioma","score_opus":0.011171134092234549,"score_gpt":0.2529653365666711,"score_spread":0.24179420247443653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159631216","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975727,0.0004705243,0.00042246544,0.000026386797,0.000025977808,0.00005789143,0.00022344617,0.000045156936,0.0011555909],"genre_scores_gemma":[0.9971398,0.00034196273,0.00084732537,0.0000137928,0.0000072717066,0.000044729008,0.0002887992,0.000008251781,0.0013079756],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999114,0.000013713796,0.0000072288817,0.000015809612,0.000020638152,0.000031164105],"domain_scores_gemma":[0.99995005,0.000007189134,0.000010663404,0.0000061853107,0.0000048274587,0.000021241975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000117339296,0.00026345527,0.0003739284,0.00020233441,0.00010170274,0.00022143518,0.0002118789,0.00017916766,0.0009123316],"category_scores_gemma":[0.000065005974,0.00009409635,0.00018265427,0.00017908806,0.00012353326,0.00011609313,0.00011623825,0.00042904034,0.00018427626],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008574384,0.00033662483,0.00035155256,0.000050460334,0.000015987998,0.00007353842,0.000032939734,0.00026814404,0.9945404,0.00008568649,0.0001366145,0.0032506245],"study_design_scores_gemma":[0.00017074187,0.006858583,0.0059965737,0.000008275287,0.00005105567,0.00025914932,0.0000408846,0.0017815762,0.98253167,0.00001902063,0.0022763922,0.000005951536],"about_ca_topic_score_codex":0.0012855148,"about_ca_topic_score_gemma":0.0027167045,"teacher_disagreement_score":0.0012855148,"about_ca_system_score_codex":0.00022436332,"about_ca_system_score_gemma":0.00026175697,"threshold_uncertainty_score":0.0030520558},"labels":[],"label_agreement":null},{"id":"W2159793198","doi":"10.1021/jm4000837","title":"X-ray Crystal Structure of ERK5 (MAPK7) in Complex with a Specific Inhibitor","year":2013,"lang":"en","type":"article","venue":"Journal of Medicinal Chemistry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; Wellcome Trust","keywords":"Chemistry; Kinase; MAPK7; Protein kinase domain; Binding site; Angiogenesis; Structure–activity relationship; Computational biology; Protein kinase A; Biochemistry; Cancer research; Cyclin-dependent kinase 2; Biology; Gene","score_opus":0.007936707667701498,"score_gpt":0.20800692326045764,"score_spread":0.20007021559275615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159793198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97897696,0.006304002,0.0022030089,0.00077943684,0.00011211614,0.00004027303,0.0022872977,0.00016999603,0.0091269305],"genre_scores_gemma":[0.97300774,0.0047812723,0.004720636,0.00030745068,0.000034109555,0.000048064074,0.011736617,0.000057791414,0.0053063296],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99980325,0.000027653019,0.000008884223,0.000025517658,0.0000956214,0.000039060695],"domain_scores_gemma":[0.99989665,0.000031288095,0.000017317827,0.0000043640166,0.000026794607,0.000023543393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022887801,0.00038653976,0.0005362125,0.00015632289,0.0003742383,0.00041004055,0.00087266933,0.0005048265,0.0022049765],"category_scores_gemma":[0.00025391806,0.00023571,0.00018556161,0.00033147956,0.00022923246,0.00028396051,0.00018987487,0.001139326,0.0003988031],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004467017,0.0012057357,0.008511535,0.001610134,0.00049702125,0.002165823,0.000814778,0.023672234,0.8965325,0.0069384975,0.021664733,0.031919964],"study_design_scores_gemma":[0.0016583073,0.0019945458,0.062215455,0.00022870033,0.00041129845,0.0024996772,0.0014757959,0.120068386,0.72617334,0.0022393097,0.080787055,0.00024819412],"about_ca_topic_score_codex":0.0050173565,"about_ca_topic_score_gemma":0.004450196,"teacher_disagreement_score":0.0050173565,"about_ca_system_score_codex":0.0006355016,"about_ca_system_score_gemma":0.00062125956,"threshold_uncertainty_score":0.009976327},"labels":[],"label_agreement":null},{"id":"W2161028192","doi":"10.1038/msb.2013.25","title":"Phosphoproteome dynamics reveal novel ERK1/2 MAP kinase substrates with broad spectrum of functions","year":2013,"lang":"en","type":"article","venue":"Molecular Systems Biology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":156,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"Canada Research Chairs; Canadian Institutes of Health Research; Fondation de France; Cancer Research Society","keywords":"Biology; Phosphoproteomics; Kinase; Cell biology; Phosphorylation; Alternative splicing; Chromatin; Computational biology; Protein phosphorylation; Genetics; Protein kinase A; Gene; Gene isoform","score_opus":0.005699035251137267,"score_gpt":0.1940205345149684,"score_spread":0.18832149926383113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161028192","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996743,0.0007001962,0.0016886505,0.000027974811,0.0000029100063,0.000005599713,0.00047533578,0.0000226984,0.00033372777],"genre_scores_gemma":[0.9952454,0.00054476404,0.002607811,0.000019417532,0.00000445061,0.000011769635,0.0010628384,0.000010454234,0.0004929225],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99994445,0.000005751379,0.0000041731587,0.00001692021,0.000017047225,0.000011691887],"domain_scores_gemma":[0.9999424,0.000008776531,0.000020750022,0.000005441174,0.00001053653,0.000012155399],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011968334,0.00028446966,0.00022912365,0.00051269657,0.00013311514,0.00024177459,0.00012137881,0.0001683393,0.00081440114],"category_scores_gemma":[0.00011193996,0.00011796981,0.00024691768,0.00037376498,0.00011163158,0.00026043886,0.0001681561,0.0002234398,0.00021526977],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003125388,0.000023765806,0.0062065283,0.0000637307,0.000022422568,0.00012085638,0.000033643762,0.00028867536,0.9892944,0.000116013936,0.00006747558,0.003449994],"study_design_scores_gemma":[0.00003277221,0.00023272166,0.39369068,0.000012890918,0.000116753494,0.0021971734,0.00017190499,0.016727094,0.5832704,0.00075776567,0.0027584103,0.00003149371],"about_ca_topic_score_codex":0.00025768683,"about_ca_topic_score_gemma":0.00035197425,"teacher_disagreement_score":0.00081440114,"about_ca_system_score_codex":0.0001314904,"about_ca_system_score_gemma":0.00007875447,"threshold_uncertainty_score":0.0027244687},"labels":[],"label_agreement":null},{"id":"W2162808671","doi":"10.1158/0008-5472.can-09-3669","title":"The Mitogen-Activated Protein Kinase Kinase 4 Has a Pro-Oncogenic Role in Skin Cancer","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Centre National de la Recherche Scientifique; Institute of Genetics; Wellcome Trust","keywords":"Carcinogenesis; Protein kinase A; MAPK/ERK pathway; Kinase; Cancer; Cancer research; Biology; Cell biology; Mitogen-activated protein kinase; Signal transduction; Cancer cell; Genetics","score_opus":0.043867190907508596,"score_gpt":0.35013322029543975,"score_spread":0.3062660293879311,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162808671","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9276433,0.05767841,0.0049524717,0.001289039,0.00018267028,0.000039722905,0.00025026692,0.00018889408,0.007775157],"genre_scores_gemma":[0.9822192,0.012377368,0.0016242529,0.00008147216,0.000037754577,0.000017147537,0.00012815585,0.0000065898457,0.0035081233],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99994016,0.000015042625,0.0000036533922,0.000010537239,0.000014132803,0.000016413236],"domain_scores_gemma":[0.99994564,0.000007822354,0.000014785361,0.000005646861,0.000008937636,0.000017204102],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016918396,0.00045382034,0.00017319946,0.00037719338,0.00028516917,0.0002688881,0.00016645141,0.00031249426,0.0010615147],"category_scores_gemma":[0.00012715017,0.00012146599,0.00017536125,0.00016708158,0.00030541822,0.00027315336,0.0002879674,0.0003892508,0.00036869472],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00079862366,0.000097323835,0.002294037,0.00026107178,0.000018633269,0.0004188841,0.000024276444,0.000419173,0.9727903,0.0021440925,0.00033149196,0.020402012],"study_design_scores_gemma":[0.00007347194,0.001047532,0.027753696,0.000036369616,0.00009077282,0.00331068,0.00010049475,0.0014263345,0.93130213,0.0030248084,0.031810008,0.00002365628],"about_ca_topic_score_codex":0.00029173782,"about_ca_topic_score_gemma":0.00033455182,"teacher_disagreement_score":0.0010615147,"about_ca_system_score_codex":0.00039362494,"about_ca_system_score_gemma":0.00030673546,"threshold_uncertainty_score":0.0035511851},"labels":[],"label_agreement":null},{"id":"W2162845412","doi":"10.1517/14728222.11.10.1339","title":"c-Jun N-terminal kinases as potential therapeutic targets","year":2007,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Targets","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"University of Otago","keywords":"Kinase; Disease; Signal transduction; Inflammation; Pathogenesis; p38 mitogen-activated protein kinases; Diabetes mellitus; c-jun; Cancer; Bioinformatics; Medicine; Immunology; Biology; Cancer research; Neuroscience; Cell biology; Gene; Protein kinase A; Genetics; Transcription factor; Pathology; Endocrinology","score_opus":0.0574021792479626,"score_gpt":0.36577426696190085,"score_spread":0.30837208771393826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162845412","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020168432,0.99650747,0.00024703247,0.0006140304,0.00043583094,0.000009705777,0.00001872521,0.000014544512,0.0019510043],"genre_scores_gemma":[0.0011060791,0.9958003,0.00044638963,0.00054453814,0.00035631924,0.00002071359,0.000057827387,0.000002776882,0.0016650507],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998266,0.000033075776,0.000015989519,0.000029567442,0.000070134425,0.000024747485],"domain_scores_gemma":[0.99981576,0.00007111308,0.000026380132,0.000006517645,0.000055178054,0.00002515494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070811086,0.0010499661,0.0015850624,0.0015067455,0.00025882194,0.00090359786,0.0011303697,0.0015370717,0.0042560236],"category_scores_gemma":[0.0004475656,0.00028733912,0.00045171217,0.0012708555,0.0004665609,0.0013742801,0.00057484396,0.0029745672,0.004455614],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018638949,0.00019134606,0.00012884266,0.008281086,0.00007797223,0.0005450453,0.000049450933,0.0006596115,0.007713842,0.0059333285,0.059861694,0.91637146],"study_design_scores_gemma":[0.00008153555,0.00013709531,0.00047402713,0.0013296055,0.00006122068,0.0014665481,0.00003980018,0.00018343034,0.0012540343,0.0026799128,0.99227226,0.000020659936],"about_ca_topic_score_codex":0.00046376674,"about_ca_topic_score_gemma":0.0013724008,"teacher_disagreement_score":0.0042560236,"about_ca_system_score_codex":0.000688261,"about_ca_system_score_gemma":0.00060584355,"threshold_uncertainty_score":0.0142377615},"labels":[],"label_agreement":null},{"id":"W2163563579","doi":"10.1016/s1470-2045(14)70051-8","title":"Vemurafenib in patients with BRAFV600 mutated metastatic melanoma: an open-label, multicentre, safety study","year":2014,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":292,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Vemurafenib; Rash; Adverse effect; Internal medicine; Nausea; Clinical endpoint; Population; Dacarbazine; Expanded access; Interim analysis; Dermatology; Surgery; Oncology; Gastroenterology; Clinical trial; Metastatic melanoma; Chemotherapy; Cancer","score_opus":0.03517410555670822,"score_gpt":0.3139019102081614,"score_spread":0.2787278046514532,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163563579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99446577,0.0032750648,0.00045629122,0.00026175205,0.00008114633,0.00021216701,0.0005488306,0.000032200944,0.0006670152],"genre_scores_gemma":[0.996393,0.0012186145,0.00036934932,0.00037200665,0.00013812412,0.00020627338,0.0006499981,0.000013971505,0.0006385967],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99919933,0.00040439868,0.000046614347,0.00014577371,0.00009404312,0.00010985155],"domain_scores_gemma":[0.9986965,0.00040651576,0.00037984783,0.00014155958,0.00009365274,0.00028182488],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016478985,0.0012129662,0.0021350547,0.00023225395,0.0002774341,0.0012590404,0.0004963301,0.0011959592,0.0018338977],"category_scores_gemma":[0.002178786,0.00050480897,0.0022827706,0.0003805183,0.0007063817,0.0012460188,0.00033423209,0.002149305,0.00040505064],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.905978,0.005380731,0.015581419,0.0011987718,0.0058677755,0.0002744225,0.00017370413,0.001510097,0.011504664,0.00023806977,0.0016623174,0.05063002],"study_design_scores_gemma":[0.68890005,0.21032266,0.082126245,0.00017177021,0.006042107,0.0010046916,0.00020485536,0.0027433508,0.0026178206,0.0009312122,0.0047943173,0.00014083342],"about_ca_topic_score_codex":0.00040361233,"about_ca_topic_score_gemma":0.0008681738,"teacher_disagreement_score":0.0021350547,"about_ca_system_score_codex":0.0007314818,"about_ca_system_score_gemma":0.0006434712,"threshold_uncertainty_score":0.0087150335},"labels":[],"label_agreement":null},{"id":"W2164670208","doi":"10.1002/9783527683031.ch1","title":"Global Approaches to Understanding Protein Kinase Functions","year":2015,"lang":"en","type":"other","venue":"","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"","keywords":"Kinase; Function (biology); Gene knockdown; Computational biology; Protein kinase A; Biology; Cell biology; ASK1; RNA interference; Disease; Mitogen-activated protein kinase kinase; Genetics; Medicine; Cell culture; Gene; Pathology","score_opus":0.14767627515741125,"score_gpt":0.2495025798191389,"score_spread":0.10182630466172765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164670208","genre_codex":"methods","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07625318,0.024067735,0.83442533,0.0016427438,0.0003704733,0.00014808132,0.0023807257,0.0028897775,0.057821903],"genre_scores_gemma":[0.50238836,0.05016503,0.41824475,0.0012399378,0.00030925442,0.00086873106,0.004612606,0.0011064818,0.021064907],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.999782,0.00002414438,0.0000131280985,0.000111199486,0.000041644922,0.00002792409],"domain_scores_gemma":[0.99988115,0.000027245096,0.000021087719,0.000041075516,0.000015775066,0.000013695867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005073732,0.0013213368,0.0009411092,0.0010191469,0.000589313,0.0013305873,0.0010910445,0.00065572787,0.003962052],"category_scores_gemma":[0.00044819148,0.0005199423,0.0008072447,0.0009280806,0.001372325,0.0027149052,0.0014151738,0.0027897272,0.0015437771],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002157001,0.00008778468,0.0019434051,0.0010671746,0.0001394573,0.0001670442,0.00029182705,0.022031728,0.50640446,0.3258634,0.003598394,0.13818967],"study_design_scores_gemma":[0.00007467005,0.00032482677,0.013069452,0.00021370684,0.00028732972,0.0010401021,0.0006368691,0.06425291,0.27034196,0.35461566,0.29501662,0.00012593766],"about_ca_topic_score_codex":0.0013307881,"about_ca_topic_score_gemma":0.0018497187,"teacher_disagreement_score":0.003962052,"about_ca_system_score_codex":0.0013144767,"about_ca_system_score_gemma":0.00069649814,"threshold_uncertainty_score":0.013254344},"labels":[],"label_agreement":null},{"id":"W2165575701","doi":"10.1016/j.cell.2012.02.053","title":"Dynamic Reprogramming of the Kinome in Response to Targeted MEK Inhibition in Triple-Negative Breast Cancer","year":2012,"lang":"en","type":"article","venue":"Cell","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":744,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of General Medical Sciences; National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; National Institute of Environmental Health Sciences; Canadian Institutes of Health Research","keywords":"Kinome; Triple-negative breast cancer; MEK inhibitor; Biology; Cancer research; MAPK/ERK pathway; Reprogramming; Receptor tyrosine kinase; Kinase; Trametinib; Gene knockdown; Cancer; Cell biology; Breast cancer; Apoptosis; Biochemistry; Cell; Genetics","score_opus":0.007236532849522338,"score_gpt":0.23873211960605845,"score_spread":0.23149558675653611,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165575701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968771,0.0008420456,0.00040407528,0.00008237952,0.000018916378,0.0000070167443,0.00024558918,0.00003024057,0.001492708],"genre_scores_gemma":[0.99849844,0.0002640329,0.000158439,0.00002768111,0.0000019972108,0.000008092044,0.000100450205,0.000004753081,0.0009360185],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999286,0.000008146026,0.0000043016453,0.000011341434,0.000020907552,0.000026819342],"domain_scores_gemma":[0.99996936,0.0000054977745,0.0000063317507,0.000004708366,0.0000037779525,0.000010356393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007144449,0.000111378744,0.0001925654,0.0001389078,0.00015908232,0.00033291802,0.00012400794,0.00014316701,0.0013737489],"category_scores_gemma":[0.000094707946,0.000096350166,0.000112446956,0.00012899814,0.00012231353,0.00017104964,0.00012978433,0.00033785962,0.00020508979],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021543601,0.00001726756,0.00028263568,0.000017948027,0.0000034411441,0.00007524567,0.00002049639,0.000091199596,0.99752134,0.00012769422,0.00009616223,0.0015310071],"study_design_scores_gemma":[0.000024392744,0.00022361374,0.022647943,0.000005482056,0.000019399706,0.0005328966,0.00019465302,0.0016952725,0.97116673,0.00020189336,0.0032776138,0.000010134535],"about_ca_topic_score_codex":0.0012345643,"about_ca_topic_score_gemma":0.002290696,"teacher_disagreement_score":0.0013737489,"about_ca_system_score_codex":0.00036261496,"about_ca_system_score_gemma":0.00016918685,"threshold_uncertainty_score":0.0045956373},"labels":[],"label_agreement":null},{"id":"W2166039202","doi":"10.1007/s12031-007-9011-0","title":"p38 Mitogen-Activated Protein Kinase Regulates Myelination","year":2007,"lang":"en","type":"review","venue":"Journal of Molecular Neuroscience","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":52,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Multiple Sclerosis Society","keywords":"Protein kinase A; Neurochemistry; Mitogen-activated protein kinase; p38 mitogen-activated protein kinases; Cell biology; Kinase; Chemistry; Neurology; Biology; Neuroscience","score_opus":0.04326119599476313,"score_gpt":0.32450406353456246,"score_spread":0.2812428675397993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166039202","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00074945745,0.99358374,0.0010697383,0.00074752484,0.00075274386,0.000011025034,0.000035595218,0.00003086838,0.0030192353],"genre_scores_gemma":[0.0036048274,0.99105835,0.0010019973,0.00036322343,0.00050605775,0.000021503361,0.00005801214,0.000003853179,0.0033822036],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999031,0.000009554593,0.000011478968,0.000020128087,0.000041302523,0.000014479507],"domain_scores_gemma":[0.99988484,0.00003242227,0.000021542019,0.0000055718738,0.00004005082,0.000015524096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041353505,0.0010513625,0.00083529326,0.0010313551,0.00026506017,0.0007316111,0.00080014917,0.0009490037,0.001851841],"category_scores_gemma":[0.0002636118,0.00028363717,0.00025343723,0.0011149963,0.0005591084,0.0009427853,0.0004871543,0.0016583563,0.0019801727],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021883853,0.00009733858,0.00021735305,0.0055517973,0.000061738014,0.0005770226,0.00004370939,0.0004571257,0.022351054,0.0047734724,0.02844312,0.9372074],"study_design_scores_gemma":[0.00004877608,0.00010134715,0.0015661418,0.00076982816,0.00009592876,0.0021630647,0.00007259163,0.0001924853,0.010434776,0.0033524365,0.9811782,0.000024298508],"about_ca_topic_score_codex":0.00053758017,"about_ca_topic_score_gemma":0.0016427563,"teacher_disagreement_score":0.001851841,"about_ca_system_score_codex":0.00070766226,"about_ca_system_score_gemma":0.00077929656,"threshold_uncertainty_score":0.006194949},"labels":[],"label_agreement":null},{"id":"W2166262263","doi":"10.1016/s0140-6736(12)60868-x","title":"Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial","year":2012,"lang":"en","type":"article","venue":"The Lancet","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2960,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"GlaxoSmithKline","keywords":"Dabrafenib; Dacarbazine; Medicine; Internal medicine; Melanoma; Hazard ratio; Clinical endpoint; Adverse effect; Oncology; Phases of clinical research; Progression-free survival; Clinical trial; Randomized controlled trial; Gastroenterology; Surgery; Metastatic melanoma; Chemotherapy; Cancer; Vemurafenib; Confidence interval; Cancer research","score_opus":0.057439172744314745,"score_gpt":0.33927841828956995,"score_spread":0.2818392455452552,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166262263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95219874,0.029633304,0.001939182,0.0034992367,0.0019682012,0.0040198416,0.003185037,0.00026249883,0.0032940244],"genre_scores_gemma":[0.9695686,0.0119523,0.0023148172,0.0030668466,0.00071371696,0.0039372314,0.0022794607,0.000059047485,0.0061078696],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9992804,0.00037641457,0.00003670713,0.000116428615,0.00005032648,0.00013984884],"domain_scores_gemma":[0.9992912,0.0002016753,0.00015708734,0.000056955912,0.000053379445,0.00023967882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001910806,0.0023383608,0.0039071795,0.00037883813,0.00040198618,0.0013591141,0.00079506217,0.0017603072,0.0069190306],"category_scores_gemma":[0.0019283638,0.0006765875,0.003014379,0.0005694974,0.0010278627,0.001218253,0.0004155621,0.0030913786,0.0010622876],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98052555,0.0010411525,0.00046202456,0.0010603887,0.0018959353,0.000059187605,0.000036444577,0.0003910434,0.0018738111,0.000132373,0.0015765023,0.010945554],"study_design_scores_gemma":[0.9840518,0.013104175,0.0009076378,0.00004604607,0.0006189765,0.00004051625,0.00001977099,0.00021024796,0.00012181421,0.00018947969,0.0006753111,0.000014227207],"about_ca_topic_score_codex":0.0018320751,"about_ca_topic_score_gemma":0.0042880857,"teacher_disagreement_score":0.0069190306,"about_ca_system_score_codex":0.001146219,"about_ca_system_score_gemma":0.0010231488,"threshold_uncertainty_score":0.02314645},"labels":[],"label_agreement":null},{"id":"W2167229341","doi":"10.1161/01.atv.0000053182.58636.be","title":"Role of p44/p42 MAP Kinase in the Age-Dependent Increase in Vascular Smooth Muscle Cell Proliferation and Neointimal Formation","year":2003,"lang":"en","type":"article","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"Canadian Institutes of Health Research","keywords":"MAPK/ERK pathway; Vascular smooth muscle; Cell growth; Mitogen-activated protein kinase; Neointima; Medicine; Cell biology; Endocrinology; Internal medicine; Kinase; Cancer research; Biology; Restenosis; Smooth muscle; Stent; Biochemistry","score_opus":0.013210116697113148,"score_gpt":0.2244197281662989,"score_spread":0.21120961146918577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167229341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97903836,0.015562115,0.003609854,0.00014366944,0.00005925732,0.000030718613,0.00013374939,0.00006201615,0.0013603122],"genre_scores_gemma":[0.99061805,0.0054560085,0.0020827418,0.000043856566,0.00006201056,0.00003998902,0.000095809264,0.0000050959065,0.0015964641],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990785,0.00001661086,0.0000082857105,0.000021612519,0.000024348323,0.000021298014],"domain_scores_gemma":[0.9998989,0.000009165174,0.000039728755,0.000007486007,0.000016493916,0.00002824858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024740596,0.0005849693,0.00019246849,0.00028677203,0.00019621819,0.00021186697,0.00011404069,0.0002800171,0.0007290578],"category_scores_gemma":[0.0001245342,0.00013417222,0.00025647818,0.000103338156,0.00019342921,0.00034771158,0.00019526616,0.00037151892,0.0001841554],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028806852,0.000099776895,0.0023327174,0.00012199414,0.000013014421,0.00033415164,0.000043427848,0.000044697434,0.9912156,0.00015162898,0.000059435584,0.0052955467],"study_design_scores_gemma":[0.00003947894,0.0023759762,0.18385702,0.0000368545,0.000110517925,0.002835052,0.00014126764,0.0014355223,0.8030741,0.00046832822,0.0056091007,0.00001685373],"about_ca_topic_score_codex":0.00013079736,"about_ca_topic_score_gemma":0.00015108529,"teacher_disagreement_score":0.0007290578,"about_ca_system_score_codex":0.00011813225,"about_ca_system_score_gemma":0.00016998324,"threshold_uncertainty_score":0.0024389029},"labels":[],"label_agreement":null},{"id":"W2167689405","doi":"10.1158/1078-0432.ccr-07-1380","title":"Node-Negative Colorectal Cancer at High Risk of Distant Metastasis Identified by Combined Analysis of Lymph Node Status, Vascular Invasion, and Raf-1 Kinase Inhibitor Protein Expression","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Colorectal cancer; Medicine; Univariate analysis; Oncology; Internal medicine; Stage (stratigraphy); Metastasis; Cancer; Immunohistochemistry; Multivariate analysis; Lymph node; Tissue microarray; Pathology; Cancer research; Biology","score_opus":0.056547800871899354,"score_gpt":0.3718547099314861,"score_spread":0.31530690905958675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167689405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9997063,0.00008568629,0.000059841495,0.000013413948,0.0000016672092,0.0000024703938,0.000040513227,0.00000134859,0.00008869398],"genre_scores_gemma":[0.99967515,0.000039861785,0.00010028546,0.000008608533,0.000004611548,0.0000033678334,0.00010119846,5.3194964e-7,0.00006639916],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99991596,0.000019765157,0.0000051945613,0.000022312115,0.000019728886,0.000016890743],"domain_scores_gemma":[0.9997805,0.00004857878,0.00007391009,0.000009726826,0.00001784833,0.00006950034],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014380788,0.00025511245,0.0002609367,0.0003015412,0.0002054756,0.00020534945,0.000117895135,0.00020105766,0.00117489],"category_scores_gemma":[0.0004575165,0.000114184324,0.00013892553,0.00025841015,0.0001712455,0.00012639609,0.00014431257,0.00018793982,0.00015837459],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044137906,0.000041883988,0.98541,0.000014589178,0.00004325814,0.0004597085,0.000024825998,0.00012302889,0.011481221,0.00001537161,0.000089029025,0.0018557339],"study_design_scores_gemma":[0.000018504348,0.00019013965,0.9967325,0.0000031280695,0.00004718613,0.0015462858,0.00005238833,0.0004686311,0.0007390691,0.0000281577,0.00017092383,0.0000030025255],"about_ca_topic_score_codex":0.00085895625,"about_ca_topic_score_gemma":0.0023286685,"teacher_disagreement_score":0.00117489,"about_ca_system_score_codex":0.00013854692,"about_ca_system_score_gemma":0.00024013543,"threshold_uncertainty_score":0.0039304495},"labels":[],"label_agreement":null},{"id":"W2169278779","doi":"10.1093/annonc/mdv188","title":"Titration of signalling output: insights into clinical combinations of MEK and AKT inhibitors","year":2015,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"Institute of Cancer Research; Cancer Research UK; National Institute for Health and Care Research; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research","keywords":"Protein kinase B; PI3K/AKT/mTOR pathway; MAPK/ERK pathway; MEK inhibitor; Medicine; Growth inhibition; Cell growth; Cancer research; Pharmacology; Cell biology; Biology; Signal transduction; Biochemistry","score_opus":0.13088846515186378,"score_gpt":0.3920301638741505,"score_spread":0.26114169872228676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169278779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94650084,0.024004098,0.009234559,0.0024846634,0.00041767498,0.00036751776,0.0005318053,0.00038469202,0.01607413],"genre_scores_gemma":[0.98987204,0.005016209,0.0027566438,0.00023361109,0.000068167916,0.00010325286,0.00018542228,0.00004551376,0.0017191792],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99969625,0.000081652746,0.000025512009,0.000049166494,0.00007628153,0.00007122627],"domain_scores_gemma":[0.9998061,0.00007271682,0.000029676243,0.00002543071,0.00002365507,0.000042458898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009300312,0.0006032044,0.0007350581,0.00054019666,0.00026321472,0.0013808951,0.0005455264,0.00041203032,0.0037870475],"category_scores_gemma":[0.00096737896,0.0002617058,0.00044553235,0.00043215562,0.00039030032,0.00096716377,0.00036221798,0.001981967,0.00067245663],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019713476,0.0037311958,0.005427667,0.00076968723,0.0003105612,0.0004777042,0.0002651481,0.0087756105,0.5900703,0.0049607074,0.0039762,0.3615218],"study_design_scores_gemma":[0.008339379,0.07000819,0.035002377,0.00035083952,0.0013141322,0.0034048683,0.0007780211,0.031950854,0.75540674,0.010398066,0.08278811,0.00025849405],"about_ca_topic_score_codex":0.00027858713,"about_ca_topic_score_gemma":0.0011622311,"teacher_disagreement_score":0.0037870475,"about_ca_system_score_codex":0.00048603993,"about_ca_system_score_gemma":0.0006129725,"threshold_uncertainty_score":0.012668908},"labels":[],"label_agreement":null},{"id":"W2170022976","doi":"10.1016/j.ajhg.2014.11.009","title":"Fine-Scale Mapping of the 5q11.2 Breast Cancer Locus Reveals at Least Three Independent Risk Variants Regulating MAP3K1","year":2014,"lang":"en","type":"article","venue":"The American Journal of Human Genetics","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":90,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University and Génome Québec Innovation Centre; Public Health Ontario; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; McGill University Health Centre; McGill University; University of Toronto; Centre hospitalier universitaire de Québec; Royal Victoria Hospital; Université de Montréal; Royal Victoria Regional Health Centre; Université Laval","funders":"Medical Research Council; Canadian Institutes of Health Research; National Institute for Health and Care Research; National Cancer Institute; Cancer Research UK; National Institutes of Health; Francis Crick Institute; World Health Organization","keywords":"Locus (genetics); Breast cancer; Genetics; Biology; Scale (ratio); Cancer; Geography; Gene; Cartography","score_opus":0.010677906471367026,"score_gpt":0.23363551846775227,"score_spread":0.22295761199638525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170022976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950523,0.00042247324,0.0025351634,0.00019883561,0.000019054578,0.000016059954,0.00056843,0.000050737635,0.0011370069],"genre_scores_gemma":[0.99778795,0.000114097085,0.0008916833,0.00006473209,0.000007732179,0.000009190452,0.00048433812,0.000013989648,0.00062637165],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99974996,0.000030564242,0.000021394679,0.00009173274,0.000057598023,0.00004873302],"domain_scores_gemma":[0.99977726,0.00007016522,0.000074877484,0.000024031197,0.000013609791,0.000040140807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021739534,0.0007646781,0.0002479531,0.00094609574,0.00039271713,0.0004655411,0.00045423408,0.0006768074,0.0031444721],"category_scores_gemma":[0.0004583057,0.00030398316,0.00070743397,0.00045478583,0.00030990268,0.00009469621,0.00041683848,0.00055597094,0.00044378816],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014132275,0.00014413455,0.09627434,0.000097536366,0.00032969564,0.006727616,0.00037782633,0.0012421675,0.8777492,0.0015543991,0.0005848611,0.013504957],"study_design_scores_gemma":[0.0002574913,0.00030713194,0.8831258,0.00006029686,0.00058746967,0.010795482,0.0002358193,0.0025516415,0.09693958,0.0009808026,0.0041092113,0.00004927824],"about_ca_topic_score_codex":0.004894873,"about_ca_topic_score_gemma":0.007524345,"teacher_disagreement_score":0.004894873,"about_ca_system_score_codex":0.00030392405,"about_ca_system_score_gemma":0.0002676318,"threshold_uncertainty_score":0.010519326},"labels":[],"label_agreement":null},{"id":"W2171367970","doi":"10.1200/jco.2012.44.7888","title":"Pharmacodynamic Effects and Mechanisms of Resistance to Vemurafenib in Patients With Metastatic Melanoma","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":363,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Jonsson Comprehensive Cancer Center; University of Texas MD Anderson Cancer Center; University of California, Los Angeles; Peter MacCallum Cancer Centre; Plexxikon; Vanderbilt University; Moffitt Cancer Center; Genentech; University of Pittsburgh; F. Hoffmann-La Roche; Vanderbilt-Ingram Cancer Center; York University; University of Pennsylvania; Massachusetts General Hospital; GlaxoSmithKline","keywords":"Vemurafenib; Medicine; Neuroblastoma RAS viral oncogene homolog; MAPK/ERK pathway; Cancer research; Melanoma; Kinase; Phosphorylation; Internal medicine; Cancer; Metastatic melanoma; KRAS; Biology; Colorectal cancer; Cell biology","score_opus":0.019358797503458477,"score_gpt":0.34063784778405976,"score_spread":0.3212790502806013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171367970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996548,0.0022113079,0.00023573208,0.00015181983,0.000007196614,0.00002278758,0.00011145255,0.000013174386,0.0006984993],"genre_scores_gemma":[0.9994136,0.00017559029,0.00012001313,0.00006155516,0.000021939735,0.000011897719,0.000098506054,0.0000018830222,0.000095122894],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99965465,0.00012918194,0.000028981061,0.00006413867,0.00008335818,0.000039612223],"domain_scores_gemma":[0.9993561,0.00021349195,0.00023518407,0.000022721451,0.000048714934,0.00012385697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042044255,0.00025165375,0.00058787374,0.00024245326,0.00017290494,0.00028970282,0.00013719403,0.00032872809,0.00064521685],"category_scores_gemma":[0.001868151,0.00011765929,0.00026062166,0.00021380723,0.0001560508,0.00024248124,0.00012648218,0.00037820553,0.00012552219],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010137181,0.00047489608,0.8759732,0.00017788421,0.00040001186,0.001288667,0.00015539327,0.0014521872,0.034446746,0.00015321831,0.00066057564,0.07467996],"study_design_scores_gemma":[0.00045756,0.0063439286,0.98089576,0.000018811385,0.0002059504,0.00446924,0.00006877106,0.0021911175,0.0035837863,0.00022167775,0.0015252022,0.000018157085],"about_ca_topic_score_codex":0.00023964024,"about_ca_topic_score_gemma":0.00042561832,"teacher_disagreement_score":0.00064521685,"about_ca_system_score_codex":0.0002794149,"about_ca_system_score_gemma":0.00014803087,"threshold_uncertainty_score":0.0022234917},"labels":[],"label_agreement":null},{"id":"W2172224626","doi":"","title":"Activated mitogen-activated protein kinase expression during human breast tumorigenesis and breast cancer progression.","year":2002,"lang":"en","type":"article","venue":"PubMed","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":196,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Breast cancer; Tamoxifen; Medicine; MAPK/ERK pathway; Immunohistochemistry; Carcinogenesis; Kinase; Cancer research; Cancer; Lymph node; Internal medicine; Metastasis; Oncology; Mammary gland; Pathology; Biology","score_opus":0.014394704781926521,"score_gpt":0.22121279831514729,"score_spread":0.20681809353322075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2172224626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99416924,0.0037773775,0.00072045735,0.00005475274,0.000013133065,0.000024671604,0.00030949007,0.000037891845,0.00089297857],"genre_scores_gemma":[0.9953052,0.0017237746,0.00064448384,0.000031520434,0.000015066433,0.000036430203,0.00065941515,0.0000042830297,0.0015799851],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99987984,0.000019439347,0.000008786249,0.000024943576,0.00003415462,0.000032730262],"domain_scores_gemma":[0.9998592,0.000023133287,0.00005159596,0.000013034495,0.00003103098,0.000022049615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018184638,0.00024972943,0.00013740626,0.00030873928,0.00012272735,0.00023374126,0.00010622204,0.0001969768,0.0018425769],"category_scores_gemma":[0.00025883946,0.000083268715,0.00013907,0.00022474014,0.0001512117,0.00014615453,0.0001393719,0.00025138157,0.0005315064],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013934259,0.00011509442,0.019009648,0.00028481687,0.00002196848,0.00048224095,0.000094727104,0.000104222876,0.9643989,0.00016394183,0.00024066446,0.013690357],"study_design_scores_gemma":[0.000057512927,0.0015521599,0.37601432,0.000038233247,0.0000989308,0.006921708,0.00021145631,0.0010445693,0.6048148,0.0003079072,0.008926269,0.0000121492785],"about_ca_topic_score_codex":0.00030959467,"about_ca_topic_score_gemma":0.0002941248,"teacher_disagreement_score":0.0018425769,"about_ca_system_score_codex":0.00024302931,"about_ca_system_score_gemma":0.00018228195,"threshold_uncertainty_score":0.006164074},"labels":[],"label_agreement":null},{"id":"W2172450144","doi":"10.1016/s0960-894x(03)00640-1","title":"Synthesis and evaluation of 4-Anilino-6,7-dialkoxy-3-quinolinecarbonitriles as inhibitors of kinases of the Ras-MAPK signaling cascade","year":2003,"lang":"en","type":"article","venue":"Bioorganic & Medicinal Chemistry Letters","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Chemistry; Aniline; Kinase; MAPK/ERK pathway; Phosphorylation; Mitogen-activated protein kinase; Structure–activity relationship; Stereochemistry; Biochemistry; In vitro; Organic chemistry","score_opus":0.013331390779175218,"score_gpt":0.2330483175607817,"score_spread":0.21971692678160648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2172450144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9658689,0.009928187,0.01157899,0.0003046956,0.00013453554,0.0006450175,0.0007350426,0.00023743548,0.010567206],"genre_scores_gemma":[0.9850134,0.004860349,0.0047517903,0.000110945264,0.00003476582,0.00015125307,0.0006582125,0.000026813086,0.004392428],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998497,0.000040811323,0.000012047754,0.000020985563,0.000029287536,0.00004709767],"domain_scores_gemma":[0.99987686,0.000023124387,0.000028917479,0.000012964557,0.000027797338,0.00003035142],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005196267,0.00042046857,0.00039667916,0.00036311694,0.00021814367,0.00025860412,0.00065094803,0.00045127448,0.0017701758],"category_scores_gemma":[0.00026627217,0.000192926,0.0003020102,0.00015600823,0.00020698477,0.00025460872,0.00020478554,0.00039708114,0.0005281337],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094525027,0.00039101613,0.00024081099,0.00031943372,0.0000412227,0.00056922034,0.0001306818,0.0026327383,0.9759635,0.0011959171,0.00043034466,0.0171399],"study_design_scores_gemma":[0.00061146216,0.0049418863,0.0021505824,0.000029818864,0.00008345825,0.0006809878,0.000043835364,0.0022383279,0.97722536,0.0001673993,0.011786372,0.000040500974],"about_ca_topic_score_codex":0.00064076413,"about_ca_topic_score_gemma":0.0010439871,"teacher_disagreement_score":0.0017701758,"about_ca_system_score_codex":0.0002693294,"about_ca_system_score_gemma":0.0002725085,"threshold_uncertainty_score":0.005921781},"labels":[],"label_agreement":null},{"id":"W2192572578","doi":"10.1158/1078-0432.ccr-15-1681","title":"A Phase I Study of the Safety, Pharmacokinetics, and Pharmacodynamics of Combination Therapy with Refametinib plus Sorafenib in Patients with Advanced Cancer","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"National Cancer Institute; Bayer HealthCare","keywords":"Sorafenib; Pharmacokinetics; Medicine; Tolerability; Pharmacodynamics; Dosing; Pharmacology; Internal medicine; Hepatocellular carcinoma; Adverse effect; Cancer; Oncology; Gastroenterology","score_opus":0.11807690024990147,"score_gpt":0.47949471591080817,"score_spread":0.3614178156609067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2192572578","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99733424,0.0006619161,0.00044164495,0.00011813549,0.000035614088,0.0006496374,0.00022302789,0.000034795325,0.0005008322],"genre_scores_gemma":[0.99507624,0.0006422357,0.0016954837,0.00021068854,0.000102625396,0.00072086614,0.00085754495,0.00001677811,0.0006775124],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99934834,0.000299126,0.000039384766,0.000124707,0.00009631382,0.00009215228],"domain_scores_gemma":[0.9991999,0.00013047142,0.00020461364,0.000106784624,0.000049401933,0.00030881775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013187319,0.0015351307,0.0020287654,0.00037437887,0.00034212836,0.00067641377,0.00080979057,0.00065791915,0.0018297902],"category_scores_gemma":[0.00088905945,0.00070258474,0.0011339745,0.00042449514,0.0007450155,0.00071143307,0.00030187517,0.0024074719,0.0005214419],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5130092,0.13258411,0.018751293,0.0008086016,0.0017547872,0.00058708206,0.00044125106,0.005850504,0.1561683,0.0002552259,0.002383158,0.16740653],"study_design_scores_gemma":[0.23054376,0.7365344,0.018129667,0.000020077394,0.00040190155,0.00065499503,0.00004177371,0.0021344402,0.009396119,0.00009428811,0.0020072132,0.00004135391],"about_ca_topic_score_codex":0.00045997163,"about_ca_topic_score_gemma":0.001079156,"teacher_disagreement_score":0.0020287654,"about_ca_system_score_codex":0.00076611247,"about_ca_system_score_gemma":0.0013671364,"threshold_uncertainty_score":0.0069742203},"labels":[],"label_agreement":null},{"id":"W2209218670","doi":"10.1007/s10198-015-0757-y","title":"Economic burden of toxicities associated with treating metastatic melanoma in eight countries","year":2015,"lang":"en","type":"article","venue":"The European Journal of Health Economics","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Amgen","keywords":"Medicine; Diarrhea; Adverse effect; Internal medicine","score_opus":0.0288019819752227,"score_gpt":0.24471893674072437,"score_spread":0.21591695476550166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2209218670","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92629266,0.045120407,0.001122069,0.002753665,0.00007455173,0.00023146572,0.0070177023,0.000027357035,0.017360153],"genre_scores_gemma":[0.986702,0.010127674,0.0008984626,0.000301202,0.0000309285,0.00008708793,0.0015117961,0.00000569592,0.0003351101],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99766076,0.0014666178,0.00026033484,0.00011127203,0.00033432568,0.00016667724],"domain_scores_gemma":[0.99436367,0.0018606863,0.0027561462,0.00008596427,0.00059288536,0.00034061383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023583241,0.00030023084,0.0003614293,0.0020207076,0.00025812478,0.0014169707,0.00022825887,0.00032886694,0.0015611389],"category_scores_gemma":[0.009849144,0.00016645665,0.0013442585,0.002957051,0.0003410568,0.00049755676,0.0008819775,0.0004718751,0.0001082132],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010861395,0.00014621604,0.84834915,0.0031638904,0.0029282111,0.001275347,0.0006292699,0.023607325,0.00029176116,0.0029741833,0.007906208,0.10764234],"study_design_scores_gemma":[0.00029418292,0.0010785987,0.945138,0.0046799495,0.0022153042,0.0035077168,0.002850363,0.009077018,0.0004416954,0.001670525,0.028980758,0.000065891836],"about_ca_topic_score_codex":0.022572588,"about_ca_topic_score_gemma":0.017792111,"teacher_disagreement_score":0.022572588,"about_ca_system_score_codex":0.0033781996,"about_ca_system_score_gemma":0.0017994872,"threshold_uncertainty_score":0.044882357},"labels":[],"label_agreement":null},{"id":"W2214943066","doi":"10.14740/jocmr2424w","title":"Novel Drugs and Combination Therapies for the Treatment of Metastatic Melanoma","year":2015,"lang":"en","type":"review","venue":"Journal of Clinical Medicine Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Dabrafenib; Vemurafenib; Medicine; Ipilimumab; Trametinib; Nivolumab; Pembrolizumab; Targeted therapy; Melanoma; Metastatic melanoma; MAPK/ERK pathway; Adverse effect; Combination therapy; Oncology; Immune checkpoint; Cancer research; Immunotherapy; Cancer; Pharmacology; Internal medicine; Kinase","score_opus":0.4573143908375632,"score_gpt":0.5752513556841012,"score_spread":0.11793696484653804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2214943066","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002584002,0.99711895,0.0001777887,0.00030136955,0.00023655419,0.000010597883,0.000027063312,0.000010341203,0.0018590164],"genre_scores_gemma":[0.0014253682,0.99614525,0.00035258458,0.00032597178,0.00021394802,0.000013445432,0.0000549313,0.000002578592,0.0014658703],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998399,0.00002900518,0.000020269184,0.000025364234,0.00007024219,0.000015209204],"domain_scores_gemma":[0.9998549,0.000060565762,0.00002271136,0.0000049650116,0.000039158793,0.000017492215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003425755,0.0006296065,0.0009800027,0.0019719773,0.00026449494,0.00062285084,0.00062741135,0.0007890128,0.0049552196],"category_scores_gemma":[0.00045497125,0.00020461202,0.00058920094,0.0010635498,0.00030150442,0.0009116729,0.00049926253,0.002335878,0.002160001],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008403503,0.00013866917,0.00014512074,0.008364696,0.00009603813,0.00030159779,0.000046182235,0.00027386728,0.0023296461,0.002706671,0.02941878,0.9560946],"study_design_scores_gemma":[0.000038946593,0.00016821775,0.00062275573,0.0017537271,0.00010245718,0.0021476406,0.000028250579,0.00010910078,0.0006990755,0.0013325972,0.992983,0.0000142317385],"about_ca_topic_score_codex":0.0005749478,"about_ca_topic_score_gemma":0.0020246145,"teacher_disagreement_score":0.0049552196,"about_ca_system_score_codex":0.00043016675,"about_ca_system_score_gemma":0.00045085722,"threshold_uncertainty_score":0.016576886},"labels":[],"label_agreement":null},{"id":"W222191070","doi":"10.1023/a:1020694425356","title":"A Randomized Phase II Study of Two Schedules of Bryostatin-1 (NSC339555) in Patients with Advanced Malignant Melanoma – A National Cancer Institute of Canada Clinical Trials Group Study","year":2002,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Nova Scotia Cancer Centre; Université de Montréal; Cancer Care Ontario; Hôpital Notre-Dame; Centre Hospitalier de l’Université de Montréal; McGill University","funders":"National Cancer Institute","keywords":"Medicine; Nausea; myalgia; Adverse effect; Toxicity; Internal medicine; Lethargy; Phases of clinical research; Chemotherapy; Surgery; Clinical endpoint; Randomized controlled trial; Bryostatin 1; Gastroenterology","score_opus":0.05453415470042501,"score_gpt":0.34755567791445957,"score_spread":0.2930215232140346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W222191070","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99125403,0.0011111351,0.00050875056,0.00074210303,0.00038066762,0.0032236683,0.0012126884,0.00008901207,0.0014780277],"genre_scores_gemma":[0.98283654,0.001557415,0.0018592131,0.001252119,0.0005111734,0.005580193,0.0023236463,0.000050544335,0.0040291483],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9992161,0.00037728666,0.000032098076,0.0001299495,0.000046124354,0.0001985227],"domain_scores_gemma":[0.9986659,0.00023103619,0.00021393455,0.00017235447,0.000055329783,0.0006614007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002136332,0.0025145162,0.0042958884,0.00059181324,0.0006333128,0.001009724,0.0016167792,0.0019135108,0.0072456077],"category_scores_gemma":[0.0013807748,0.0010510444,0.0020019095,0.00070066773,0.002018472,0.0014339419,0.0005134837,0.004997739,0.0013034013],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9628806,0.018223712,0.00067654264,0.00014804158,0.0005112707,0.00003337586,0.000052777297,0.0007200553,0.004001828,0.00014275359,0.0010626415,0.011546425],"study_design_scores_gemma":[0.9031536,0.094057955,0.0014187022,0.0000055971072,0.00019792732,0.000019710258,0.000018954264,0.00027142253,0.00031978494,0.00011205709,0.0004113347,0.000013041744],"about_ca_topic_score_codex":0.003735674,"about_ca_topic_score_gemma":0.008606678,"teacher_disagreement_score":0.0072456077,"about_ca_system_score_codex":0.0016569392,"about_ca_system_score_gemma":0.002620343,"threshold_uncertainty_score":0.024238944},"labels":[],"label_agreement":null},{"id":"W2223807461","doi":"10.1016/j.coi.2015.12.006","title":"Melanoma: the intersection of molecular targeted therapy and immune checkpoint inhibition","year":2016,"lang":"en","type":"review","venue":"Current Opinion in Immunology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Bristol-Myers Squibb Canada","keywords":"Melanoma; Immune checkpoint; Targeted therapy; Blockade; Immune system; Medicine; Cancer research; Immunotherapy; Immunology; Cancer; Internal medicine; Receptor","score_opus":0.04236795058960134,"score_gpt":0.3149179662027996,"score_spread":0.27255001561319825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2223807461","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001422343,0.99704367,0.0002791681,0.0010948136,0.00048342696,0.000004771025,0.000013469088,0.000011233149,0.00092723133],"genre_scores_gemma":[0.0015917907,0.99581677,0.00028277683,0.0008400179,0.00055402465,0.000009544784,0.000029854133,0.0000022246502,0.0008731057],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99982005,0.000031074575,0.000017475899,0.00003193965,0.000073283,0.000026150228],"domain_scores_gemma":[0.99978274,0.00009307078,0.000032034914,0.000007964703,0.000051087663,0.0000330186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071337,0.00070064433,0.0013549112,0.0009430256,0.00021270048,0.0011621105,0.00089898077,0.001430158,0.002557835],"category_scores_gemma":[0.00054181303,0.00021417101,0.0004138308,0.0007924323,0.0006588566,0.0014583395,0.00072279334,0.0035969473,0.0014302289],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020204386,0.000112760295,0.00016857682,0.007402135,0.000070567294,0.0002750625,0.00003374528,0.0005054585,0.0058738934,0.009259713,0.047978986,0.9281171],"study_design_scores_gemma":[0.00005656253,0.00014311732,0.0006375671,0.0015129651,0.000087924236,0.0011835874,0.000041524865,0.00024153964,0.0013456482,0.00520586,0.989521,0.000022675415],"about_ca_topic_score_codex":0.00050011225,"about_ca_topic_score_gemma":0.001552702,"teacher_disagreement_score":0.002557835,"about_ca_system_score_codex":0.0007553811,"about_ca_system_score_gemma":0.0007499529,"threshold_uncertainty_score":0.008556843},"labels":[],"label_agreement":null},{"id":"W2224326414","doi":"10.1016/j.ejca.2015.09.025","title":"Small data sets to develop and validate prognostic models are problematic","year":2015,"lang":"en","type":"letter","venue":"European Journal of Cancer","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"","keywords":"Ipilimumab; Medicine; Nomogram; Prognostic model; Internal medicine; Oncology; Metastatic melanoma; Melanoma; Overall survival; Cancer; Immunotherapy; Cancer research","score_opus":0.13992624113722474,"score_gpt":0.2838337292900866,"score_spread":0.14390748815286186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2224326414","genre_codex":"methods","genre_gemma":"commentary","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19726561,0.025523288,0.49125433,0.14461806,0.01631408,0.004963302,0.0834682,0.005989447,0.030603679],"genre_scores_gemma":[0.6494492,0.003518167,0.260899,0.02953067,0.0034236817,0.006381632,0.042909563,0.0011210591,0.0027670087],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9605754,0.02814925,0.0028888138,0.0031815616,0.004801619,0.0004033261],"domain_scores_gemma":[0.5427796,0.39810738,0.0055547683,0.03639161,0.014977829,0.002188782],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.08454633,0.0014285144,0.0036086095,0.0023742896,0.0019090136,0.0047704247,0.004302927,0.0024920828,0.006051212],"category_scores_gemma":[0.30954224,0.0014177954,0.0024167704,0.0022369493,0.003225446,0.0058082347,0.003817595,0.0076971874,0.003307686],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036421237,0.0015796992,0.16493276,0.0050605214,0.009310121,0.0022335714,0.00069663546,0.05652279,0.0056786034,0.022475353,0.29388496,0.4339828],"study_design_scores_gemma":[0.0026800022,0.0013030817,0.121169664,0.0039030225,0.0033914899,0.0032288514,0.0016828992,0.18123952,0.008944352,0.389221,0.28281966,0.00041649787],"about_ca_topic_score_codex":0.0036926512,"about_ca_topic_score_gemma":0.00510611,"teacher_disagreement_score":0.9154537,"about_ca_system_score_codex":0.0018288029,"about_ca_system_score_gemma":0.0021413257,"threshold_uncertainty_score":0.44712907},"labels":[],"label_agreement":null},{"id":"W2242926713","doi":"10.1200/jco.2004.22.90140.7529","title":"A meta-analysis of biochemotherapy (BCT) for the treatment of metastatic malignant melanoma (MM)","year":2004,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Chemotherapy; Randomized controlled trial; Meta-analysis; Oncology; Cochrane Library; Clinical trial; Immunotherapy; Relative risk; Surgery; Cancer; Confidence interval","score_opus":0.2551563295747263,"score_gpt":0.4505082426026526,"score_spread":0.19535191302792632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2242926713","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01772086,0.97955495,0.0008274651,0.0003534419,0.00042822296,0.00023605165,0.0004163193,0.000042165575,0.0004205191],"genre_scores_gemma":[0.5572926,0.43469903,0.0034510933,0.0013504375,0.00053153414,0.000988028,0.00094780885,0.00006146374,0.0006779326],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98768926,0.008328843,0.001723128,0.001075054,0.0008836755,0.00030003185],"domain_scores_gemma":[0.98657775,0.010057469,0.001781309,0.0005057792,0.0007765149,0.00030121804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013933451,0.0026308817,0.015860492,0.0045236577,0.00068102474,0.0029390918,0.0013933948,0.0023616843,0.0038289845],"category_scores_gemma":[0.023445606,0.0012939656,0.05147975,0.0049620946,0.0005896105,0.0014687001,0.0012088363,0.0023586194,0.00033918166],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007793414,0.000036922207,0.0029636838,0.07647945,0.90482867,0.00009619584,0.000035225235,0.00059305737,0.00027323217,0.00008185607,0.0003966295,0.0064217043],"study_design_scores_gemma":[0.0015763142,0.0004099815,0.0033333802,0.0036983872,0.98975974,0.0000542103,0.000018887567,0.0002682104,0.00007980353,0.00013496849,0.0006523044,0.000013856776],"about_ca_topic_score_codex":0.0062717535,"about_ca_topic_score_gemma":0.011701184,"teacher_disagreement_score":0.015860492,"about_ca_system_score_codex":0.0020159935,"about_ca_system_score_gemma":0.0023903933,"threshold_uncertainty_score":0.07368803},"labels":[],"label_agreement":null},{"id":"W2256206968","doi":"10.1021/jm100095x","title":"Discovery and Evaluation of 7-Alkyl-1,5-bis-aryl-pyrazolopyridinones as Highly Potent, Selective, and Orally Efficacious Inhibitors of p38α Mitogen-Activated Protein Kinase<sup>⊥</sup>⊥ Atomic coordinates and structure factors for crystal structure of compound<b>3d</b>with p38α can be accessed using PDB code 3LHJ.","year":2010,"lang":"en","type":"article","venue":"Journal of Medicinal Chemistry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Discovery Centre","funders":"","keywords":"Chemistry; Proinflammatory cytokine; Protein kinase A; Kinase; Arthritis; Tumor necrosis factor alpha; p38 mitogen-activated protein kinases; Signal transduction; Mitogen-activated protein kinase; Biochemistry; Pharmacology; Immunology; Inflammation; Biology","score_opus":0.011735952853591716,"score_gpt":0.2564363059530085,"score_spread":0.24470035309941676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2256206968","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96462804,0.017636491,0.007399209,0.00047942344,0.00011047274,0.00068085565,0.0013668487,0.00027778803,0.007420911],"genre_scores_gemma":[0.968628,0.013708669,0.010058591,0.00020293756,0.000042580315,0.000205646,0.0019997067,0.00002866269,0.0051251748],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998913,0.00001706592,0.0000065528347,0.000015446578,0.000033950608,0.000035628967],"domain_scores_gemma":[0.9999336,0.0000066322245,0.000018374732,0.000005193177,0.0000133297235,0.000022887074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023982194,0.0005390317,0.0003999843,0.00026612473,0.00017855575,0.00029483341,0.0004078658,0.00030363587,0.0012710782],"category_scores_gemma":[0.0001610538,0.00015530604,0.00023281932,0.00021911759,0.00026496922,0.00024402377,0.0001605968,0.00047409738,0.00045358785],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001268936,0.0014015033,0.00075788726,0.0003953461,0.000043237524,0.00062726013,0.000118515076,0.0032476226,0.9138219,0.001396855,0.0020835036,0.07483751],"study_design_scores_gemma":[0.0023103051,0.02233852,0.006356782,0.000063714484,0.00013327906,0.0025189403,0.000056190842,0.004471107,0.929982,0.00035735965,0.031343024,0.00006879113],"about_ca_topic_score_codex":0.0011874813,"about_ca_topic_score_gemma":0.0029271662,"teacher_disagreement_score":0.0012710782,"about_ca_system_score_codex":0.0003817178,"about_ca_system_score_gemma":0.00046738927,"threshold_uncertainty_score":0.0042521358},"labels":[],"label_agreement":null},{"id":"W2258535515","doi":"10.1158/2159-8290.cd-15-1336","title":"Application of Sequencing, Liquid Biopsies, and Patient-Derived Xenografts for Personalized Medicine in Melanoma","year":2015,"lang":"en","type":"article","venue":"Cancer Discovery","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":230,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"National Institute for Health and Care Research; Cancer Research UK; Wellcome Trust; Wellcome","keywords":"Melanoma; Precision medicine; Medicine; Personalized medicine; Liquid biopsy; Targeted therapy; Exome sequencing; Biopsy; Oncology; Cancer research; Exome; Internal medicine; Mutation; Bioinformatics; Pathology; Cancer; Biology; Gene","score_opus":0.024170638168393165,"score_gpt":0.27138030036339983,"score_spread":0.24720966219500667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2258535515","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7704568,0.008858498,0.20920423,0.0012885991,0.0002687676,0.00054216146,0.0032239028,0.0011341522,0.0050229137],"genre_scores_gemma":[0.8560982,0.0024896772,0.13706493,0.00037523787,0.0000690871,0.00025322998,0.002381434,0.00014274962,0.0011254102],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9993749,0.00022801664,0.00005303116,0.00015144402,0.0001536338,0.00003889252],"domain_scores_gemma":[0.9990397,0.0003268703,0.00018343824,0.00024931165,0.000146352,0.00005434222],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024742573,0.00037713227,0.0002708105,0.0005600925,0.0002617989,0.00088050764,0.0003580973,0.00061894546,0.0012138971],"category_scores_gemma":[0.002018889,0.00023241364,0.00029938933,0.0004263891,0.0006665324,0.0004846234,0.00068161625,0.0007319761,0.00043582058],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008114445,0.00023345498,0.042862315,0.00027369527,0.000117557145,0.0004212891,0.00023204151,0.0067581465,0.86250365,0.0021915133,0.0012205464,0.0823744],"study_design_scores_gemma":[0.00009882393,0.001490525,0.043122347,0.000091164424,0.00018898536,0.0035062602,0.0002201869,0.031091366,0.89571583,0.0047497232,0.019672416,0.000052311443],"about_ca_topic_score_codex":0.00052930333,"about_ca_topic_score_gemma":0.0009621195,"teacher_disagreement_score":0.0024742573,"about_ca_system_score_codex":0.00040357522,"about_ca_system_score_gemma":0.00049618655,"threshold_uncertainty_score":0.013085306},"labels":[],"label_agreement":null},{"id":"W2258872553","doi":"10.1016/j.ejca.2015.12.002","title":"p53 Reactivation by PRIMA-1Met (APR-246) sensitises V600E/KBRAF melanoma to vemurafenib","year":2016,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":56,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Amis de l'Institut Bordet","keywords":"Vemurafenib; Melanoma; Cancer research; PI3K/AKT/mTOR pathway; Medicine; MAPK/ERK pathway; Protein kinase B; V600E; MEK inhibitor; Pharmacology; Apoptosis; Biology; Signal transduction; Mutation; Metastatic melanoma","score_opus":0.0087270120395586,"score_gpt":0.23768664893815036,"score_spread":0.22895963689859175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2258872553","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99721116,0.00053189683,0.00047776417,0.00009583793,0.000069004134,0.000027092981,0.00020853945,0.00007432923,0.001304456],"genre_scores_gemma":[0.99755764,0.0002288498,0.0003125534,0.000025886677,0.000010154562,0.000019397417,0.0002662996,0.000013872681,0.0015653595],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998343,0.000038629394,0.000015955307,0.000020725787,0.00003083013,0.000059480044],"domain_scores_gemma":[0.9999131,0.000019846755,0.000013956573,0.000021073676,0.0000055252326,0.00002652251],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012479359,0.00026389342,0.0002916085,0.00018085972,0.00014125825,0.00032894724,0.00024030905,0.0002784907,0.0033241494],"category_scores_gemma":[0.00022739758,0.00019931783,0.00025741695,0.0001004692,0.00018504712,0.00022375234,0.00022133111,0.00073610124,0.00075574766],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007278482,0.00014985574,0.00027578435,0.000036249254,0.00001212483,0.00012181755,0.000026488064,0.00018896644,0.99526405,0.00012688337,0.00018450069,0.0028853677],"study_design_scores_gemma":[0.00012900328,0.0016313604,0.0062130415,0.0000065616564,0.000014931306,0.0005887584,0.000047661622,0.001274868,0.98679626,0.00009944853,0.0031891647,0.000008844043],"about_ca_topic_score_codex":0.0006872234,"about_ca_topic_score_gemma":0.0009777392,"teacher_disagreement_score":0.0033241494,"about_ca_system_score_codex":0.00019924562,"about_ca_system_score_gemma":0.00017649254,"threshold_uncertainty_score":0.011120379},"labels":[],"label_agreement":null},{"id":"W2265121903","doi":"10.1007/s10637-016-0324-0","title":"A phase II study of cediranib, an oral VEGF inhibitor, in previously untreated patients with metastatic or recurrent malignant melanoma","year":2016,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Health Sciences Centre; Ontario Clinical Oncology Group; Juravinski Cancer Centre; Princess Margaret Cancer Centre; Hamilton Health Sciences","funders":"National Cancer Institute; U.S. Public Health Service","keywords":"Medicine; Nausea; Internal medicine; Progressive disease; Melanoma; Adverse effect; Gastroenterology; Phases of clinical research; Response Evaluation Criteria in Solid Tumors; Oncology; Toxicity; Chemotherapy; Surgery; Cancer research","score_opus":0.024027290171344008,"score_gpt":0.27115774109121094,"score_spread":0.24713045091986693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2265121903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923091,0.003380069,0.00050409127,0.00039718993,0.0001650932,0.0010794307,0.000537573,0.000054197295,0.0015731821],"genre_scores_gemma":[0.98962003,0.0032415076,0.001261879,0.0007225273,0.00020534969,0.0010751656,0.0014467009,0.000030416097,0.0023963642],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99958473,0.00019470423,0.000016888658,0.000065248605,0.000036079506,0.00010232246],"domain_scores_gemma":[0.99936134,0.00011972906,0.00008449175,0.000063851054,0.00003322528,0.0003373407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014292315,0.0012875176,0.002851775,0.00044517027,0.0005216651,0.0009441022,0.00081037416,0.001127123,0.0021378319],"category_scores_gemma":[0.0009223146,0.0006351198,0.0015447926,0.00038387722,0.0009131925,0.00067085953,0.0002573188,0.0029772795,0.0005734261],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.71797967,0.06643746,0.01356006,0.00104321,0.0030393656,0.0007653118,0.00050157646,0.00346812,0.07973911,0.00046302142,0.003733934,0.109269165],"study_design_scores_gemma":[0.53514725,0.43499735,0.019320846,0.00003569509,0.0009793811,0.00055245194,0.00010223699,0.0013335694,0.0036481305,0.00017107699,0.0036686365,0.000043354816],"about_ca_topic_score_codex":0.0021370435,"about_ca_topic_score_gemma":0.005294906,"teacher_disagreement_score":0.002851775,"about_ca_system_score_codex":0.0008550208,"about_ca_system_score_gemma":0.001233049,"threshold_uncertainty_score":0.007558584},"labels":[],"label_agreement":null},{"id":"W2266830739","doi":"10.1684/ejd.2015.2628","title":"Phototoxicity of B-RAF inhibitors: Exclusively due to UVA radiation and rapidly regressive","year":2015,"lang":"en","type":"article","venue":"European Journal of Dermatology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Phototoxicity; Medicine; Dermatology; Photosensitivity; Sunscreening Agents; Internal medicine; Cancer; Skin cancer; Genetics; Optics; In vitro","score_opus":0.0147695089208061,"score_gpt":0.23579492478913247,"score_spread":0.22102541586832636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2266830739","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973623,0.0016448624,0.00022016095,0.000017980472,0.0000039432257,0.000025501015,0.000077990175,0.0000057808634,0.0006414884],"genre_scores_gemma":[0.9994816,0.00022819915,0.000060183935,0.000019082168,0.000008816839,0.00000853983,0.00009190547,0.0000022772367,0.00009950304],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99954873,0.00013235111,0.0000488698,0.00012213204,0.00008469502,0.00006318049],"domain_scores_gemma":[0.9984863,0.00026014904,0.00096060795,0.0000835099,0.00006877282,0.00014071111],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005186591,0.0002625603,0.0004642887,0.00033425726,0.00034144995,0.00044985802,0.00014472072,0.00029170443,0.0021840003],"category_scores_gemma":[0.0009880404,0.00020616852,0.0006865312,0.00032433998,0.0002762614,0.00026165016,0.00030773514,0.0005385736,0.0002548149],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063259806,0.0006238081,0.9462725,0.00022492395,0.00044899178,0.0021854239,0.00011473681,0.00028277235,0.018473653,0.00009422093,0.0002460577,0.024707105],"study_design_scores_gemma":[0.0001455045,0.0025562835,0.98360944,0.000018768824,0.0001865041,0.010039318,0.000056886613,0.00021633225,0.0024623333,0.000069054906,0.00063069636,0.000008898461],"about_ca_topic_score_codex":0.0003994902,"about_ca_topic_score_gemma":0.00042971983,"teacher_disagreement_score":0.0021840003,"about_ca_system_score_codex":0.00038781165,"about_ca_system_score_gemma":0.00023675711,"threshold_uncertainty_score":0.007306218},"labels":[],"label_agreement":null},{"id":"W2277864649","doi":"10.1091/mbc.e15-07-0527","title":"Regulatory roles of conserved phosphorylation sites in the activation T-loop of the MAP kinase ERK1","year":2016,"lang":"en","type":"article","venue":"Molecular Biology of the Cell","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kinexus Bioinformatics Corporation (Canada); University of British Columbia","funders":"University of British Columbia; Johns Hopkins University","keywords":"Autophosphorylation; Biology; MAP2K7; MAPK14; Cyclin-dependent kinase 2; Kinase; Mitogen-activated protein kinase kinase; MAP kinase kinase kinase; Phosphorylation; c-Raf; Protein kinase A; Cyclin-dependent kinase 9; Cell biology; ASK1; Biochemistry","score_opus":0.007934838574307714,"score_gpt":0.21206488047174882,"score_spread":0.2041300418974411,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2277864649","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963553,0.00052762096,0.0023403475,0.000030878742,0.000012793653,0.000012782982,0.00005274331,0.000047524853,0.0006199772],"genre_scores_gemma":[0.99870133,0.00012443564,0.0008225906,0.000019698571,0.000004660264,0.0000069540188,0.00007732496,0.0000065767344,0.00023639986],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999176,0.00001891772,0.0000052661776,0.000024418649,0.000015402968,0.00001836011],"domain_scores_gemma":[0.99986863,0.000024434923,0.000048967373,0.0000062707763,0.000013705874,0.000037891452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001278496,0.00022437656,0.00012194657,0.00012455106,0.00014654834,0.00022051783,0.00017045684,0.00016845202,0.0010010226],"category_scores_gemma":[0.00019683714,0.00010186152,0.00018898891,0.00008045183,0.00019351259,0.00016832855,0.00016603072,0.00020437417,0.0003578226],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010354152,0.000063268046,0.0017497144,0.000049363836,0.000008899598,0.0002908343,0.000045840465,0.0007004944,0.99097604,0.00035629925,0.0000894393,0.0046345247],"study_design_scores_gemma":[0.0001682399,0.00084836694,0.059193093,0.00002460293,0.000044679797,0.0014041287,0.0001424379,0.015141945,0.91918194,0.0009739157,0.0028311901,0.000045402012],"about_ca_topic_score_codex":0.00022842456,"about_ca_topic_score_gemma":0.00025147625,"teacher_disagreement_score":0.0010010226,"about_ca_system_score_codex":0.00017424901,"about_ca_system_score_gemma":0.000136567,"threshold_uncertainty_score":0.0033487678},"labels":[],"label_agreement":null},{"id":"W2278622931","doi":"10.69645/wzqs6265","title":"RAS and RAF signaling in melanoma: biology and therapies","year":2010,"lang":"en","type":"article","venue":"˜The œbiomedical & life sciences collection.","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Melanoma; Cancer research; Biology; Computational biology; Cell biology","score_opus":0.011145501380478644,"score_gpt":0.26192180965292516,"score_spread":0.2507763082724465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2278622931","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11238556,0.7728215,0.0035252483,0.042911567,0.0015547205,0.00021026224,0.0014029753,0.0002935329,0.06489458],"genre_scores_gemma":[0.24515992,0.6874205,0.004728772,0.0016605853,0.0025295753,0.00017356832,0.0013661558,0.0000466606,0.05691427],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99981946,0.00004109602,0.000011712164,0.00001516534,0.00008143323,0.000031237974],"domain_scores_gemma":[0.99985445,0.000023748755,0.000011596161,0.000016761798,0.00003991299,0.000053572367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009084468,0.00044445365,0.00043458163,0.0017059605,0.00041492181,0.0007279647,0.0003163989,0.00048015694,0.003964689],"category_scores_gemma":[0.00031129443,0.00022061836,0.00021547513,0.0005890903,0.00050377497,0.0004855442,0.0005220588,0.0015894776,0.001641772],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024800343,0.0008519254,0.0042556585,0.0012075454,0.00007063498,0.001066856,0.00019235199,0.0008962743,0.15764311,0.020184802,0.073148794,0.73800194],"study_design_scores_gemma":[0.00058993563,0.0015470197,0.026069686,0.00051972584,0.00011362358,0.006055048,0.0002397647,0.0012271416,0.10502537,0.012783305,0.84576505,0.00006434529],"about_ca_topic_score_codex":0.0010470169,"about_ca_topic_score_gemma":0.0041894848,"teacher_disagreement_score":0.003964689,"about_ca_system_score_codex":0.0007167144,"about_ca_system_score_gemma":0.0009914705,"threshold_uncertainty_score":0.013263226},"labels":[],"label_agreement":null},{"id":"W2293149121","doi":"10.7554/elife.09976","title":"Registered report: RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth","year":2016,"lang":"en","type":"article","venue":"eLife","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kinexus Bioinformatics Corporation (Canada)","funders":"Laura and John Arnold Foundation","keywords":"MAPK/ERK pathway; Kinase; Cancer research; p38 mitogen-activated protein kinases; Chemistry; Biology; Cell biology","score_opus":0.011194078382118252,"score_gpt":0.240807449064828,"score_spread":0.22961337068270976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2293149121","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11687351,0.017104259,0.105707645,0.17829315,0.15030482,0.026724542,0.09840704,0.013599651,0.29298535],"genre_scores_gemma":[0.25973997,0.015673531,0.14530204,0.026619356,0.023346262,0.016182061,0.10036595,0.007697791,0.405073],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9754836,0.003974313,0.002079088,0.0022071507,0.015246089,0.001009764],"domain_scores_gemma":[0.9180388,0.013446788,0.007878162,0.018970395,0.03156676,0.010099079],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.045994718,0.0010486471,0.0010170349,0.0023810056,0.0025266635,0.0055047325,0.0031571004,0.003338222,0.050871983],"category_scores_gemma":[0.045008022,0.000710213,0.0018898814,0.001977374,0.00199318,0.0029870833,0.0041824724,0.0036786539,0.023881592],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005265829,0.001210905,0.0056149163,0.0019928345,0.0003562158,0.00062762777,0.00054059253,0.0006639162,0.07289446,0.017953016,0.7302958,0.16258389],"study_design_scores_gemma":[0.0017259009,0.0048832158,0.008839495,0.00041394943,0.00037728195,0.0006331883,0.00028116925,0.00079144805,0.10334502,0.0063082357,0.87223977,0.00016133802],"about_ca_topic_score_codex":0.0014150142,"about_ca_topic_score_gemma":0.002836132,"teacher_disagreement_score":0.050871983,"about_ca_system_score_codex":0.0031220054,"about_ca_system_score_gemma":0.014261078,"threshold_uncertainty_score":0.2432462},"labels":[],"label_agreement":null},{"id":"W2293555343","doi":"10.1016/j.str.2015.12.015","title":"Family-wide Structural Analysis of Human Numb-Associated Protein Kinases","year":2016,"lang":"en","type":"article","venue":"Structure","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":149,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canada Foundation for Innovation; Novartis Foundation; Ontario Ministry of Economic Development and Innovation; Wellcome Trust; Genome Canada; AbbVie; Janssen Biotech; Canadian Institutes of Health Research; Wellcome; GlaxoSmithKline; Bayer; Pfizer; Diamond Light Source; Boehringer Ingelheim","keywords":"NUMB; Kinase; Protein-Serine-Threonine Kinases; Cell biology; SH3 domain; Computational biology; Biology; Chemistry; Protein kinase A; Proto-oncogene tyrosine-protein kinase Src","score_opus":0.007312482021153567,"score_gpt":0.2382263931156565,"score_spread":0.23091391109450293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2293555343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99369967,0.0024261666,0.0016542936,0.00011319112,0.000012952975,0.000019474837,0.0009609902,0.00004620797,0.0010671169],"genre_scores_gemma":[0.99139905,0.0012282868,0.0035221595,0.000040941406,0.0000056774197,0.000015362884,0.0028676423,0.000024215884,0.0008966862],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999392,0.000012721093,0.0000043888604,0.000015463176,0.000019705238,0.000008587107],"domain_scores_gemma":[0.99994504,0.0000091536995,0.00001639509,0.0000043982213,0.0000089004425,0.000016018857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013606306,0.00032624195,0.0002798823,0.00021172703,0.00021633419,0.00022263617,0.00025255393,0.00019991375,0.00090039265],"category_scores_gemma":[0.00017417708,0.0001287224,0.00023230512,0.00022767592,0.000110107314,0.0001759394,0.00018432211,0.00034001385,0.00023640004],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007115951,0.00010270777,0.0035936625,0.00019308427,0.000083535706,0.00055279594,0.00016595198,0.0041981754,0.9803269,0.0007672371,0.0008052294,0.008499193],"study_design_scores_gemma":[0.00017396346,0.0007724991,0.10411705,0.00006337848,0.0002520033,0.0058175568,0.0005179636,0.054164734,0.7970024,0.0012349457,0.035807405,0.00007621639],"about_ca_topic_score_codex":0.0015579684,"about_ca_topic_score_gemma":0.002352878,"teacher_disagreement_score":0.0015579684,"about_ca_system_score_codex":0.00045267798,"about_ca_system_score_gemma":0.00023135089,"threshold_uncertainty_score":0.0032844543},"labels":[],"label_agreement":null},{"id":"W2294989188","doi":"10.1093/annonc/mdw100","title":"Ocular toxicities of MEK inhibitors and other targeted therapies","year":2016,"lang":"en","type":"review","venue":"Annals of Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":106,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Toxicity; Retinopathy; Targeted therapy; Pharmacology; Bioinformatics; Cancer; Internal medicine","score_opus":0.07494947418798979,"score_gpt":0.367025249348498,"score_spread":0.2920757751605082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2294989188","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027174255,0.99746156,0.00015647587,0.0002894594,0.00017512304,0.0000049828946,0.000022460597,0.000009714774,0.0016084692],"genre_scores_gemma":[0.0026091659,0.99477345,0.00023625403,0.0004607503,0.00036149172,0.000008741377,0.000048090787,0.000002812658,0.0014992156],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998629,0.000021326445,0.000020558458,0.000021587037,0.00005658342,0.00001708835],"domain_scores_gemma":[0.99981433,0.00008887173,0.000039912873,0.000006143399,0.000036086865,0.000014696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037295202,0.0006158363,0.0009686997,0.0010338657,0.00018156155,0.00067872973,0.0005863279,0.0006408201,0.0037575585],"category_scores_gemma":[0.00045689172,0.00019150543,0.0005231076,0.00082995335,0.00028979813,0.0006121989,0.00044073752,0.0015551732,0.0008894997],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001241556,0.00006898553,0.0001783197,0.005606874,0.0000756341,0.00027569247,0.000018046425,0.00037944035,0.0014472955,0.0014485072,0.028818706,0.96155834],"study_design_scores_gemma":[0.000101533726,0.0002182446,0.0016429605,0.002638274,0.0002791836,0.0035940919,0.000039653863,0.00023240637,0.0012408885,0.0019092403,0.98807865,0.00002490812],"about_ca_topic_score_codex":0.0007781112,"about_ca_topic_score_gemma":0.0028676265,"teacher_disagreement_score":0.0037575585,"about_ca_system_score_codex":0.00045164328,"about_ca_system_score_gemma":0.0005907383,"threshold_uncertainty_score":0.012570322},"labels":[],"label_agreement":null},{"id":"W2308664614","doi":"10.1021/acschembio.6b00043","title":"Structure of the Human Protein Kinase ZAK in Complex with Vemurafenib","year":2016,"lang":"en","type":"article","venue":"ACS Chemical Biology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Structural Genomics Consortium; John Fell Fund, University of Oxford; Boehringer Ingelheim; Wellcome; National Institute of General Medical Sciences; Wellcome Trust","keywords":"Vemurafenib; Kinase; Cancer research; Protein kinase A; Computational biology; Medicine; Biology; Cell biology; Metastatic melanoma; Melanoma","score_opus":0.010833529963615156,"score_gpt":0.2312153847882892,"score_spread":0.22038185482467404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2308664614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889675,0.0024143192,0.0016336686,0.00066523964,0.000079686666,0.000024104918,0.0015102034,0.00017786089,0.0045273644],"genre_scores_gemma":[0.9890666,0.0012985109,0.0015165374,0.00014866277,0.000017661761,0.000016691434,0.005238592,0.00004566761,0.0026509436],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999788,0.000018311865,0.000007684167,0.00004177254,0.000080328304,0.00006403781],"domain_scores_gemma":[0.9998171,0.000048684447,0.000043305798,0.000008515562,0.000023649847,0.000058834637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014162633,0.0004181973,0.00055111095,0.0003274313,0.00065767154,0.0006329957,0.0011876035,0.00056086155,0.0034135445],"category_scores_gemma":[0.00039089256,0.00031936492,0.00033097432,0.00042054817,0.0002843143,0.00041514737,0.00035748267,0.0011764494,0.00040460008],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005859311,0.001057657,0.014111819,0.0011512438,0.0006036992,0.0059025576,0.0012192198,0.024834575,0.90533954,0.006458724,0.015155598,0.018305983],"study_design_scores_gemma":[0.0011126508,0.0018280603,0.11272881,0.00018466204,0.0004104474,0.005691863,0.0019690543,0.25655833,0.5506221,0.0021328353,0.066308185,0.00045294594],"about_ca_topic_score_codex":0.01141151,"about_ca_topic_score_gemma":0.010602549,"teacher_disagreement_score":0.01141151,"about_ca_system_score_codex":0.0016706763,"about_ca_system_score_gemma":0.00091042253,"threshold_uncertainty_score":0.022690177},"labels":[],"label_agreement":null},{"id":"W2308813726","doi":"10.1096/fasebj.24.1_supplement.521.1","title":"ERK3‐MK5 regulates interstitial fibrosis during pressure‐overload hypertrophy","year":2010,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Pressure overload; Internal medicine; Muscle hypertrophy; Fibrosis; Endocrinology; Medicine; Myocardial fibrosis; Cardiology; Cardiac hypertrophy","score_opus":0.005406856677841136,"score_gpt":0.1998973593376913,"score_spread":0.19449050265985016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2308813726","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99693286,0.0008677123,0.0010669284,0.000093993534,0.000024552459,0.00000964609,0.00025019897,0.00003708916,0.00071703823],"genre_scores_gemma":[0.9970822,0.00033939525,0.00053240603,0.000061619365,0.000009819733,0.000020355792,0.0003092785,0.000008640179,0.0016362884],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99986553,0.000015823063,0.000011021319,0.000026628222,0.00003024633,0.000050714072],"domain_scores_gemma":[0.9998987,0.000004679782,0.000040253333,0.000005279715,0.0000087453855,0.000042318097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011103536,0.00037192274,0.00020407682,0.00021145244,0.00020285811,0.00026040632,0.00022300541,0.00024154256,0.0013848711],"category_scores_gemma":[0.00007940701,0.00017768871,0.00031684476,0.00009487173,0.00029458813,0.00026089314,0.00026614324,0.00061344996,0.00036989065],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033625745,0.000041669005,0.0005515492,0.000041644293,0.000006013888,0.000055858494,0.000020516844,0.000038905324,0.99820447,0.00008794181,0.000040959345,0.0005740936],"study_design_scores_gemma":[0.000077859324,0.0007328196,0.09203318,0.000024317447,0.000057246834,0.000489166,0.00015304713,0.0020351373,0.90195847,0.00014240688,0.0022829405,0.000013363981],"about_ca_topic_score_codex":0.0005018892,"about_ca_topic_score_gemma":0.0009880988,"teacher_disagreement_score":0.0013848711,"about_ca_system_score_codex":0.0002931838,"about_ca_system_score_gemma":0.00017056464,"threshold_uncertainty_score":0.00463289},"labels":[],"label_agreement":null},{"id":"W2313564723","doi":"10.1158/1538-7445.am10-2521","title":"Abstract 2521: The pan-RAF inhibitor PLX4032 inhibits ERK signaling and tumor cell proliferation in a V600E BRAF mutant-selective manner","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Workplace Health, Safety and Compensation Commission","funders":"","keywords":"MAPK/ERK pathway; MEK inhibitor; Cancer research; Kinase; V600E; Mutant; Phosphorylation; Cell growth; Signal transduction; Protein kinase A; Biology; Chemistry; Cell biology; Biochemistry; Gene","score_opus":0.02505307162938562,"score_gpt":0.31663698929806644,"score_spread":0.2915839176686808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313564723","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98422223,0.004332203,0.0014107785,0.00025533428,0.00008101759,0.00013120449,0.0008762221,0.00028541128,0.008405513],"genre_scores_gemma":[0.98773044,0.0024501057,0.0011831718,0.00010647246,0.000026879767,0.00011875437,0.0016121024,0.000028753608,0.00674331],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999212,0.000012356463,0.0000057891825,0.000012788092,0.000020605077,0.000027158787],"domain_scores_gemma":[0.9999591,0.0000077475925,0.000008334504,0.000005021685,0.0000045107945,0.00001520845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011397916,0.00072877406,0.00035872994,0.00024477832,0.0001474506,0.00019477599,0.0002254273,0.0003260442,0.0043487777],"category_scores_gemma":[0.000084916086,0.00017101965,0.00019636792,0.00017099666,0.00016382046,0.00014815216,0.0001670996,0.0006029245,0.0011279763],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070424343,0.00033457336,0.00017681712,0.00012852118,0.000013660457,0.00014943964,0.000012105322,0.00029765375,0.9892603,0.00017919338,0.00072979124,0.008013649],"study_design_scores_gemma":[0.00049773057,0.0040318463,0.004565507,0.000021014393,0.00003088265,0.001010969,0.000018701716,0.0016279299,0.9817446,0.00010790932,0.006334017,0.000008902043],"about_ca_topic_score_codex":0.00031837448,"about_ca_topic_score_gemma":0.0004453863,"teacher_disagreement_score":0.0043487777,"about_ca_system_score_codex":0.00016764778,"about_ca_system_score_gemma":0.0002820682,"threshold_uncertainty_score":0.014548123},"labels":[],"label_agreement":null},{"id":"W2315879546","doi":"10.1038/sj.onc.1205643","title":"Dominant negative MEKK1 inhibits survival of pancreatic cancer cells","year":2002,"lang":"en","type":"article","venue":"Oncogene","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":62,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Public Health Agency of Canada","keywords":"Pancreatic cancer; Biology; Cancer research; MAPK/ERK pathway; Transfection; Kinase; Cancer cell; Cancer; Cell culture; Molecular biology; Cell biology; Genetics","score_opus":0.019804603529525937,"score_gpt":0.2428662086793078,"score_spread":0.22306160514978188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2315879546","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921409,0.0024800655,0.0012747002,0.00024555434,0.000085621316,0.000020768393,0.00065698463,0.00015924858,0.0029360882],"genre_scores_gemma":[0.9922339,0.001625515,0.0008077022,0.00005224806,0.000010194112,0.000028372067,0.0007298289,0.000022482029,0.004489764],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99984217,0.000021466738,0.000014956144,0.000021281978,0.000036961745,0.00006315523],"domain_scores_gemma":[0.99989855,0.000028647977,0.00001222801,0.000017498183,0.0000101763435,0.000032872424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013731758,0.0004160003,0.00035569115,0.00033748196,0.00029472072,0.00036869664,0.00030467342,0.00023122541,0.0015579825],"category_scores_gemma":[0.00011003091,0.00019306898,0.0003123885,0.00027370342,0.00022201148,0.00016934471,0.00018237391,0.0008977696,0.00057817827],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003908803,0.00011148729,0.00019723327,0.000064622356,0.000011805218,0.00006859355,0.000031128035,0.00018783729,0.99575067,0.00024294232,0.00027329486,0.00266957],"study_design_scores_gemma":[0.000038122373,0.00030503588,0.0017063875,0.0000049868895,0.00001969637,0.00017573709,0.000037769794,0.00088402745,0.9940414,0.000046558325,0.0027364278,0.000003922472],"about_ca_topic_score_codex":0.0028005622,"about_ca_topic_score_gemma":0.0031846627,"teacher_disagreement_score":0.0028005622,"about_ca_system_score_codex":0.00056982774,"about_ca_system_score_gemma":0.00054842304,"threshold_uncertainty_score":0.005568564},"labels":[],"label_agreement":null},{"id":"W2319234722","doi":"10.1158/0008-5472.fbcr09-b59","title":"Abstract B59: Role of Nf1 signaling in regulating pigmentation in the mouse","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Neurofibromin 1; Microphthalmia-associated transcription factor; Melanocyte; Dermis; Biology; Melanocortin 1 receptor; Knockout mouse; Gene knockin; Allele; Neurofibromatosis; Cancer research; Genetics; Cell biology; Gene; Anatomy; Melanoma; Transcription factor","score_opus":0.05199039787244116,"score_gpt":0.37962530007676654,"score_spread":0.3276349022043254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2319234722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96993536,0.0028683632,0.009567505,0.0010808079,0.00019252284,0.00017027032,0.0045017265,0.00092384533,0.010759513],"genre_scores_gemma":[0.94676536,0.0018819376,0.010671922,0.00041523052,0.000042825708,0.00032421932,0.0032604563,0.00039899704,0.03623909],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995122,0.00005269289,0.00006295384,0.0001421593,0.00013659665,0.00009352333],"domain_scores_gemma":[0.9994548,0.000051790234,0.00017231173,0.000056858855,0.00003628183,0.00022787617],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002937927,0.0008408521,0.00031322322,0.0018145631,0.00057558273,0.00050212105,0.0007267766,0.0011700245,0.008094832],"category_scores_gemma":[0.00017618937,0.0004467849,0.0005525735,0.00027853932,0.0006886799,0.00053146813,0.0005219138,0.0014602337,0.0027338814],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021814252,0.00008860191,0.00026006825,0.000040178897,0.0000056089148,0.00014230072,0.00002540318,0.0000502841,0.99694234,0.0005323928,0.0001337928,0.0015608197],"study_design_scores_gemma":[0.00014079837,0.0006769067,0.009480227,0.00009500047,0.000035082594,0.0014716663,0.00008852459,0.0014031626,0.97329354,0.00060967496,0.012685431,0.000019931782],"about_ca_topic_score_codex":0.00085410953,"about_ca_topic_score_gemma":0.00094221457,"teacher_disagreement_score":0.008094832,"about_ca_system_score_codex":0.0008021104,"about_ca_system_score_gemma":0.00027236255,"threshold_uncertainty_score":0.02707988},"labels":[],"label_agreement":null},{"id":"W2319418820","doi":"10.1016/s1470-2045(16)00117-0","title":"Targeted therapy in BRAF-mutated lung adenocarcinoma","year":2016,"lang":"en","type":"letter","venue":"The Lancet Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Adenocarcinoma; Targeted therapy; Cancer research; Lung; Oncology; Medicine; Adenocarcinoma of the lung; Internal medicine; Cancer","score_opus":0.031531213826955166,"score_gpt":0.2888015405649193,"score_spread":0.25727032673796413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2319418820","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003187043,0.020671422,0.0002708564,0.9419796,0.026915956,0.000027016667,0.00008193852,0.000044874378,0.0068211844],"genre_scores_gemma":[0.06270695,0.027549885,0.00094887684,0.7284988,0.15918942,0.00012401922,0.00012964632,0.000044246906,0.020808175],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994307,0.00015335134,0.00006311594,0.000057209072,0.00019084263,0.000104710656],"domain_scores_gemma":[0.9989203,0.0005874822,0.00009303716,0.00004944551,0.00010847426,0.00024129427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086625,0.00044996952,0.0009830203,0.0003981565,0.0009180103,0.0013947502,0.00067064253,0.013831344,0.0030617833],"category_scores_gemma":[0.0050768903,0.00038221432,0.0007884661,0.00025680044,0.0011817028,0.0013415572,0.00079574354,0.013373502,0.0018047609],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005825447,0.00015981754,0.0020293135,0.00027932596,0.00006274064,0.013044979,0.00009280499,0.00057850574,0.0024084907,0.007936031,0.8940492,0.07877627],"study_design_scores_gemma":[0.0010487004,0.00060228806,0.002684065,0.0004948405,0.00012883211,0.016368976,0.00016972348,0.0023914026,0.0021929212,0.03107492,0.9427843,0.000059137627],"about_ca_topic_score_codex":0.0010097125,"about_ca_topic_score_gemma":0.0031435995,"teacher_disagreement_score":0.013831344,"about_ca_system_score_codex":0.002125118,"about_ca_system_score_gemma":0.0009018913,"threshold_uncertainty_score":0.0154188275},"labels":[],"label_agreement":null},{"id":"W2320148628","doi":"10.1097/cmr.0000000000000034","title":"Vemurafenib in the French temporary authorization for use metastatic melanoma cohort","year":2013,"lang":"en","type":"article","venue":"Melanoma Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Vemurafenib; Medicine; Discontinuation; Internal medicine; Melanoma; Confidence interval; Adverse effect; Oncology; Brain metastasis; Cohort; Surgery; Metastasis; Metastatic melanoma; Cancer; Cancer research","score_opus":0.0817002284918776,"score_gpt":0.3392314328487025,"score_spread":0.2575312043568249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320148628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9769472,0.0012677497,0.0004881173,0.00063947606,0.000035897603,0.00020322854,0.015885811,0.000044683296,0.0044878577],"genre_scores_gemma":[0.9830524,0.0003094549,0.00020921718,0.00051598024,0.000072323586,0.00020331237,0.013292055,0.000023246397,0.0023220696],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99932206,0.00014747119,0.000029854376,0.00016088411,0.00013019155,0.00020951989],"domain_scores_gemma":[0.99912685,0.00008715975,0.0002681677,0.000121490484,0.00017794449,0.00021831946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010431568,0.00033015496,0.0005429547,0.00064227433,0.0007298862,0.000846054,0.00033154374,0.00043073975,0.0043321005],"category_scores_gemma":[0.0015863026,0.00022859253,0.0007745731,0.0006668939,0.0001970033,0.0004087624,0.00046851696,0.0006558401,0.00078227505],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005125783,0.0002788459,0.95060843,0.000079789796,0.0004822833,0.0011826089,0.00030907252,0.000708247,0.003257138,0.00063889264,0.01683221,0.02049676],"study_design_scores_gemma":[0.00047148144,0.00088718685,0.9755103,0.000025946345,0.00013512034,0.0013982703,0.000161334,0.0006776557,0.0003060618,0.00016253424,0.020229379,0.0000348358],"about_ca_topic_score_codex":0.049927175,"about_ca_topic_score_gemma":0.039939996,"teacher_disagreement_score":0.049927175,"about_ca_system_score_codex":0.0013996196,"about_ca_system_score_gemma":0.001305074,"threshold_uncertainty_score":0.099273145},"labels":[],"label_agreement":null},{"id":"W2321350289","doi":"10.1158/1538-7445.am10-2680","title":"Abstract 2680: Nonautoinhibitory properties of the C-terminal helix of the mitogen- and stress-activated protein kinase 1","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Light Source (Canada)","funders":"","keywords":"Autophosphorylation; Mitogen-activated protein kinase kinase; MAP2K7; Cyclin-dependent kinase 9; c-Raf; MAP kinase kinase kinase; Protein kinase A; Cyclin-dependent kinase 2; MAPK14; Protein kinase domain; Protein kinase R; Chemistry; Kinase; Cell biology; Biochemistry; Molecular biology; Biology; Mutant; Gene","score_opus":0.0380924380102597,"score_gpt":0.30561936430842024,"score_spread":0.26752692629816055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321350289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98288697,0.004376592,0.0036289694,0.00026561265,0.00022109174,0.000067968074,0.0012594492,0.00022467732,0.007068718],"genre_scores_gemma":[0.9820932,0.0012215173,0.003085234,0.00013464302,0.000109109526,0.00006538307,0.005433223,0.000053789525,0.007803878],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99992156,0.000010086643,0.000005199844,0.000016549973,0.000032575084,0.000013984045],"domain_scores_gemma":[0.99984837,0.000023890314,0.000039607054,0.000008972625,0.00002402704,0.00005507749],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009439535,0.00069318217,0.0002746887,0.00013532193,0.00018444516,0.00025575003,0.0004122898,0.00024312784,0.004499691],"category_scores_gemma":[0.00017508057,0.00014277833,0.00022949204,0.00012626275,0.00021060355,0.0001445311,0.00015756587,0.00046796282,0.0023245995],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007035832,0.00007015634,0.00047301996,0.00016336107,0.000018670828,0.00039343126,0.000017714076,0.00043858297,0.99401337,0.0003998158,0.00064305414,0.0026652329],"study_design_scores_gemma":[0.00047350986,0.00081390265,0.018260127,0.000055265784,0.0000571451,0.003306387,0.00006449841,0.0073570833,0.9410088,0.0008497491,0.027696986,0.000056638673],"about_ca_topic_score_codex":0.0005948058,"about_ca_topic_score_gemma":0.0003727622,"teacher_disagreement_score":0.004499691,"about_ca_system_score_codex":0.000377778,"about_ca_system_score_gemma":0.00019491924,"threshold_uncertainty_score":0.015053034},"labels":[],"label_agreement":null},{"id":"W2324097249","doi":"10.1007/s10555-016-9623-3","title":"Understanding the cellular roles of Fyn-related kinase (FRK): implications in cancer biology","year":2016,"lang":"en","type":"review","venue":"Cancer and Metastasis Reviews","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":59,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"FYN; Biology; Kinase; Tyrosine kinase; Context (archaeology); Proto-oncogene tyrosine-protein kinase Src; Cell biology; Receptor tyrosine kinase; Cancer research; Ectopic expression; Signal transduction; Genetics; Cell culture","score_opus":0.18372154927041917,"score_gpt":0.38480153723194815,"score_spread":0.20107998796152898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2324097249","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007719821,0.9988325,0.00012590543,0.00033051666,0.00017195582,0.0000014903165,0.00000932558,0.0000039680535,0.00044709884],"genre_scores_gemma":[0.00048666072,0.99862313,0.0001376665,0.00016389576,0.00016531849,0.0000024573465,0.000016208127,7.185111e-7,0.0004038441],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998605,0.000015660102,0.000016843944,0.000026891788,0.000058776008,0.00002133321],"domain_scores_gemma":[0.99975115,0.000088537134,0.000043766904,0.00000765392,0.00007167337,0.000037281585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065990887,0.0008171316,0.0010491612,0.0013734148,0.00024471834,0.0010596738,0.00080867286,0.0013986276,0.002286577],"category_scores_gemma":[0.00066528184,0.00025777653,0.00037367624,0.0014297094,0.000638791,0.0016922912,0.00080177485,0.0020861905,0.001528585],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000107792075,0.000046049172,0.00016580445,0.010307825,0.00006623401,0.00019133452,0.00004838562,0.0003713238,0.006966111,0.0062755356,0.042581033,0.93287265],"study_design_scores_gemma":[0.000015483029,0.0000497177,0.0005415735,0.0013098695,0.000069455935,0.000682915,0.000044748936,0.00009436795,0.0011240053,0.0028987345,0.993153,0.000016281117],"about_ca_topic_score_codex":0.0011232283,"about_ca_topic_score_gemma":0.0021882078,"teacher_disagreement_score":0.002286577,"about_ca_system_score_codex":0.00084054214,"about_ca_system_score_gemma":0.0012311894,"threshold_uncertainty_score":0.007649362},"labels":[],"label_agreement":null},{"id":"W2326270405","doi":"10.1158/1538-7445.am2012-lb-517","title":"Abstract LB-517: EIF5A2, A downstream target of PI3K/Akt pathway, Is an adverse prognostic marker of melanoma patient survival by increasing cell invasion","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health Research Institute; Vancouver Coastal Health","funders":"","keywords":"Melanoma; Protein kinase B; Cancer research; Medicine; Tissue microarray; Metastasis; PTEN; PI3K/AKT/mTOR pathway; Immunohistochemistry; Cancer; Pathology; Oncology; Internal medicine; Biology; Signal transduction; Cell biology","score_opus":0.03944835908933938,"score_gpt":0.3089208844004857,"score_spread":0.26947252531114635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326270405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919665,0.0022436073,0.0011726039,0.00011923409,0.00004066288,0.00001844575,0.0028535028,0.00008090235,0.0015045417],"genre_scores_gemma":[0.9958955,0.00023563951,0.00057222845,0.0000430036,0.00002537994,0.00001963508,0.0021538734,0.000006705105,0.0010480435],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99979657,0.00003104067,0.000022090475,0.00004395977,0.00007263809,0.000033851993],"domain_scores_gemma":[0.99970955,0.00004092685,0.000113114904,0.000018237182,0.000065052816,0.000053083582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030799082,0.0002909423,0.00026831677,0.0007240391,0.00019697906,0.00042054834,0.00012786094,0.00020894565,0.003345229],"category_scores_gemma":[0.000438122,0.000101638936,0.00028231682,0.0007081716,0.00013246103,0.00015714965,0.00017277455,0.00040157232,0.00062873965],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037238253,0.00014309556,0.8328833,0.00019337541,0.00028819803,0.00028586612,0.000031890046,0.0004909612,0.14466707,0.00007128832,0.0020976905,0.015123535],"study_design_scores_gemma":[0.000028625254,0.000229213,0.9715622,0.000014451588,0.0001291276,0.00086901925,0.000039773477,0.001857277,0.023545409,0.000089968846,0.001626224,0.000008698902],"about_ca_topic_score_codex":0.0009888512,"about_ca_topic_score_gemma":0.0011601886,"teacher_disagreement_score":0.003345229,"about_ca_system_score_codex":0.0002681669,"about_ca_system_score_gemma":0.00016700003,"threshold_uncertainty_score":0.011190891},"labels":[],"label_agreement":null},{"id":"W2326404665","doi":"10.1167/iovs.12-10553","title":"ERK5 Regulates Glucose-Induced Increased Fibronectin Production in the Endothelial Cells and in the Retina in Diabetes","year":2012,"lang":"en","type":"article","venue":"Investigative Ophthalmology & Visual Science","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Downregulation and upregulation; Fibronectin; MAPK/ERK pathway; Internal medicine; Protein kinase A; Signal transduction; Endocrinology; Retinal; Vascular endothelial growth factor A; Diabetic retinopathy; Cell biology; Kinase; Biology; Vascular endothelial growth factor; Chemistry; Diabetes mellitus; Medicine; Extracellular matrix; Biochemistry","score_opus":0.025906083825517835,"score_gpt":0.28592608524656554,"score_spread":0.2600200014210477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326404665","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99237293,0.004533141,0.0011893315,0.00008378928,0.00003563514,0.000015242248,0.00030592256,0.000039576953,0.0014243785],"genre_scores_gemma":[0.9946002,0.0018692268,0.0010150968,0.00006760019,0.000009968328,0.000024143692,0.00037108856,0.000009318196,0.002033388],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999163,0.00001104981,0.000007941169,0.00001942271,0.000020462303,0.000024689873],"domain_scores_gemma":[0.9999498,0.0000027606886,0.000020053996,0.0000030919718,0.000008868475,0.000015434787],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000106197316,0.00029403396,0.00016341764,0.00021941715,0.00014501855,0.00028564644,0.00011429249,0.00015714396,0.0010170877],"category_scores_gemma":[0.0000630713,0.000100354875,0.00028651708,0.00012346248,0.00014176033,0.00013113792,0.00014668352,0.00034576145,0.00021309937],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058904896,0.00007587651,0.0013411698,0.00013502568,0.000014141119,0.0001465525,0.000020776091,0.00005606646,0.9946074,0.000085135915,0.000080413265,0.0028484887],"study_design_scores_gemma":[0.000073828916,0.0006104174,0.0973116,0.000034874047,0.00012362744,0.0007566608,0.00018914645,0.0019000405,0.893983,0.00012979207,0.00487244,0.000014621786],"about_ca_topic_score_codex":0.00053982966,"about_ca_topic_score_gemma":0.00076389266,"teacher_disagreement_score":0.0010170877,"about_ca_system_score_codex":0.0002912673,"about_ca_system_score_gemma":0.00015569318,"threshold_uncertainty_score":0.0034025311},"labels":[],"label_agreement":null},{"id":"W2332505255","doi":"10.1503/jpn.140062","title":"Increased levels of cerebrospinal fluid JNK3 associated with amyloid pathology: links to cognitive decline","year":2015,"lang":"en","type":"article","venue":"Journal of Psychiatry and Neuroscience","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Institut Servier; Institut National de la Santé et de la Recherche Médicale; Servier; Sanofi","keywords":"Senile plaques; Cerebrospinal fluid; Cognitive decline; Alzheimer's disease; Pathology; Neurodegeneration; Disease; Kinase; Tauopathy; Medicine; Degenerative disease; Internal medicine; Endocrinology; Biology; Dementia; Biochemistry","score_opus":0.02616125229602223,"score_gpt":0.27448501376034357,"score_spread":0.24832376146432134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2332505255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99847597,0.0008282444,0.00014531381,0.000040494477,0.000009309955,0.000008706714,0.00020442951,0.000009841762,0.000277784],"genre_scores_gemma":[0.99889344,0.00031725905,0.00027237073,0.000026804868,0.000023076984,0.000012827627,0.00025589744,0.000002844985,0.00019553985],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999044,0.0000126906,0.000014434689,0.000025816533,0.000023238812,0.000019390349],"domain_scores_gemma":[0.99924904,0.00005512927,0.00038829274,0.000026147658,0.0001546339,0.0001266939],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023736377,0.0005593128,0.00038973836,0.00065690477,0.0004597102,0.0004627061,0.00024542166,0.00033920672,0.0013306482],"category_scores_gemma":[0.0006306896,0.00013287687,0.000311406,0.00046336048,0.00035697015,0.00020958534,0.0003470813,0.00044869012,0.00024308934],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0081658205,0.00045082765,0.86531603,0.00044216606,0.00034058632,0.0039443295,0.0006723815,0.00021413095,0.10205652,0.000102382786,0.0007086328,0.017586168],"study_design_scores_gemma":[0.000043679265,0.0004078875,0.9867807,0.000026659734,0.00011599737,0.0046988283,0.00022032301,0.00029050428,0.0067769005,0.0002665131,0.00035707923,0.0000147804285],"about_ca_topic_score_codex":0.0015153886,"about_ca_topic_score_gemma":0.0011701237,"teacher_disagreement_score":0.0015153886,"about_ca_system_score_codex":0.0003523877,"about_ca_system_score_gemma":0.00029680313,"threshold_uncertainty_score":0.0044514537},"labels":[],"label_agreement":null},{"id":"W2332850103","doi":"10.7554/elife.11414","title":"Registered report: COT drives resistance to RAF inhibition through MAP kinase pathway reactivation","year":2016,"lang":"en","type":"article","venue":"eLife","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Applied Biological Materials (Canada)","funders":"Laura and John Arnold Foundation","keywords":"MAPK/ERK pathway; MEK inhibitor; Kinase; Medicine; Cancer research; Biology; Cell biology","score_opus":0.019402117826239577,"score_gpt":0.2528786237664669,"score_spread":0.23347650594022734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2332850103","genre_codex":"empirical","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"protocol","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7479407,0.00643782,0.06840518,0.010516034,0.011976452,0.0079483045,0.08143703,0.0050506527,0.06028775],"genre_scores_gemma":[0.73061806,0.0063083055,0.058026828,0.0027865353,0.0012807449,0.007202322,0.09901991,0.0021846052,0.09257263],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9950147,0.00088212144,0.00077798596,0.0005838025,0.0024013561,0.00033994124],"domain_scores_gemma":[0.98874646,0.0021194841,0.001386628,0.003607192,0.0030105435,0.0011296388],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0074186292,0.00062361534,0.0007411434,0.0013097977,0.0011249868,0.0019421099,0.0009997163,0.0011490087,0.016637431],"category_scores_gemma":[0.004893296,0.00039442236,0.0011805248,0.0013165722,0.0007300524,0.000803227,0.0012110376,0.0018959362,0.00605229],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029762506,0.0009154973,0.0052046813,0.00093841826,0.0001967276,0.0006921267,0.00031343376,0.0005630802,0.8966055,0.0039100703,0.04816347,0.03952066],"study_design_scores_gemma":[0.0006274115,0.0077284956,0.01675115,0.00014876989,0.0002936115,0.0013558001,0.00035226138,0.001929866,0.80073243,0.00090943417,0.1690625,0.00010829175],"about_ca_topic_score_codex":0.0012634372,"about_ca_topic_score_gemma":0.0016033096,"teacher_disagreement_score":0.016637431,"about_ca_system_score_codex":0.0011485154,"about_ca_system_score_gemma":0.0025133311,"threshold_uncertainty_score":0.055657804},"labels":[],"label_agreement":null},{"id":"W2333651255","doi":"10.1158/1538-7445.am2011-4398","title":"Abstract 4398: MEK inhibitors prevent rebound reactivation of ERK signaling by the RAF inhibitor PLX4032 and enhance its antitumor activity","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Workplace Health, Safety and Compensation Commission","funders":"","keywords":"MAPK/ERK pathway; Melanoma; MEK inhibitor; Cancer research; Kinase; Phosphorylation; Therapeutic index; Medicine; V600E; Signal transduction; Mutant; Pharmacology; Chemistry; Biology; Drug; Cell biology; Biochemistry","score_opus":0.06595565880279666,"score_gpt":0.3472648796411768,"score_spread":0.28130922083838017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333651255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911095,0.002195797,0.0010943031,0.00014879505,0.00007936704,0.000093816656,0.000812789,0.00026290535,0.0042027],"genre_scores_gemma":[0.99034685,0.0009608184,0.0016515942,0.00005122884,0.00002784804,0.00008329103,0.0013152176,0.00004132184,0.0055218325],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998796,0.000017274873,0.000009528671,0.000014038348,0.00003589669,0.000043627],"domain_scores_gemma":[0.99993074,0.000014454756,0.000014749216,0.000009111554,0.0000072411794,0.000023661989],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000101267644,0.0006274996,0.00039336737,0.00025170078,0.00013606527,0.00024540667,0.0002820927,0.000276155,0.0049243746],"category_scores_gemma":[0.00009247244,0.00016644331,0.00026565546,0.00018332094,0.00014745946,0.00018348533,0.00014279441,0.0010887157,0.0011111123],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017088089,0.00058157236,0.00019765229,0.00007587441,0.000016339769,0.000071806724,0.000012434813,0.00021712598,0.9889664,0.00012636506,0.0004311073,0.0075944345],"study_design_scores_gemma":[0.00036183532,0.0056710355,0.0044268034,0.000011277049,0.000025484553,0.0003560398,0.000011109438,0.0009928836,0.9841973,0.000047439407,0.0038928369,0.000005975748],"about_ca_topic_score_codex":0.00038514275,"about_ca_topic_score_gemma":0.00060090626,"teacher_disagreement_score":0.0049243746,"about_ca_system_score_codex":0.00017430584,"about_ca_system_score_gemma":0.00026426505,"threshold_uncertainty_score":0.01647371},"labels":[],"label_agreement":null},{"id":"W2336162936","doi":"10.1200/jco.2013.31.15_suppl.9013","title":"An update on BREAK-3, a phase III, randomized trial: Dabrafenib (DAB) versus dacarbazine (DTIC) in patients with BRAF V600E-positive mutation metastatic melanoma (MM).","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":111,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Dabrafenib; Medicine; Trametinib; Internal medicine; Dacarbazine; Hazard ratio; Progression-free survival; Oncology; Vemurafenib; Melanoma; Clinical endpoint; Adverse effect; Phases of clinical research; Gastroenterology; Chemotherapy; Randomized controlled trial; Confidence interval; Cancer; Cancer research; Metastatic melanoma; Kinase","score_opus":0.03970374677695072,"score_gpt":0.3917280835614726,"score_spread":0.3520243367845219,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2336162936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4585926,0.37883675,0.009636399,0.044013057,0.010823583,0.020026764,0.041752372,0.0012529119,0.03506552],"genre_scores_gemma":[0.7264394,0.12880653,0.016978495,0.046325564,0.0052274456,0.024164543,0.030388018,0.00050891563,0.021161089],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99785006,0.0013760712,0.00019095775,0.00017546848,0.00029215493,0.00011538229],"domain_scores_gemma":[0.9968098,0.0010479244,0.0010807515,0.00014713735,0.00039939285,0.00051494775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0053107063,0.0010362793,0.0026210733,0.00054122694,0.00036983547,0.001904808,0.0012592492,0.0020372034,0.006348564],"category_scores_gemma":[0.0074242456,0.0005135975,0.0031809062,0.0006767585,0.00037773262,0.00132814,0.00061727274,0.0042318045,0.0012519594],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6564174,0.0019695056,0.0039727017,0.009973047,0.009349126,0.0002688171,0.00031958762,0.0009848584,0.0075360276,0.0015863462,0.0551921,0.25243038],"study_design_scores_gemma":[0.8950834,0.028708735,0.010067302,0.0014833453,0.0076910257,0.00040609273,0.000082984334,0.0010040549,0.0010225765,0.0012352179,0.053138826,0.00007654797],"about_ca_topic_score_codex":0.0011960042,"about_ca_topic_score_gemma":0.006039771,"teacher_disagreement_score":0.006348564,"about_ca_system_score_codex":0.0010715318,"about_ca_system_score_gemma":0.0013639403,"threshold_uncertainty_score":0.028086007},"labels":[],"label_agreement":null},{"id":"W2343203314","doi":"10.1016/j.jval.2015.03.1234","title":"Metastatic Melanoma Patient Characteristics as A Determening Factor for Braf Gene Mutation Testing and Treatment In Canada – A Retrospective Cohort Study","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Medicine; Ipilimumab; Metastatic melanoma; Melanoma; Internal medicine; Oncology; Cohort; Retrospective cohort study; Mutation; Cancer; Disease; Stage (stratigraphy); Gene; Cancer research; Immunotherapy; Genetics","score_opus":0.047629491895566256,"score_gpt":0.2770613135548097,"score_spread":0.22943182165924342,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2343203314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928812,0.0005007936,0.00015206725,0.0003163764,0.000025734405,0.000041567328,0.004057713,0.00001586045,0.0020088123],"genre_scores_gemma":[0.99678016,0.0002637455,0.0001324267,0.00020057829,0.000015033347,0.000018726976,0.0015494827,0.000013317677,0.0010265622],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984268,0.00012033438,0.00011668905,0.00036265934,0.00034753195,0.000626097],"domain_scores_gemma":[0.9964394,0.00020117265,0.0007913028,0.00027309163,0.0012433535,0.0010516695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006637103,0.0005037121,0.0006919911,0.0016015284,0.003209513,0.0017227918,0.0016548551,0.0010426025,0.0043544117],"category_scores_gemma":[0.0024897915,0.000853238,0.0013381017,0.005283363,0.0010838913,0.0006744151,0.0011461764,0.0015716089,0.0005141772],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000097623444,0.000031177584,0.99791497,0.0000076145207,0.00008428301,0.00014601697,0.00020130059,0.000053191317,0.00012733093,0.00006520294,0.00060031266,0.0006710761],"study_design_scores_gemma":[0.00001614354,0.000042650918,0.9970197,0.000021287087,0.000079219906,0.00028106797,0.0010726572,0.00030763948,0.00006669389,0.000043457017,0.0010249614,0.000024518491],"about_ca_topic_score_codex":0.96643794,"about_ca_topic_score_gemma":0.9746868,"teacher_disagreement_score":0.033562064,"about_ca_system_score_codex":0.01594234,"about_ca_system_score_gemma":0.024482593,"threshold_uncertainty_score":0.11567032},"labels":[],"label_agreement":null},{"id":"W2344830850","doi":"10.1002/cam4.717","title":"Real‐world treatment practice in patients with advanced melanoma in the era before ipilimumab: results from the <scp>IMAGE</scp> study","year":2016,"lang":"en","type":"article","venue":"Cancer Medicine","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec","funders":"Flatiron Health; Helsinn; Cardinal Health; Celgene; Pfizer; Bristol-Myers Squibb","keywords":"Ipilimumab; Melanoma; Medicine; Internal medicine; Oncology; Clinical Practice; Dermatology; Cancer research; Family medicine; Cancer; Immunotherapy","score_opus":0.009487964172250214,"score_gpt":0.2719503305099874,"score_spread":0.2624623663377372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344830850","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981571,0.0002932985,0.000040507344,0.00010298212,0.0000062430454,0.000027126338,0.00091572665,0.0000034196835,0.00045372042],"genre_scores_gemma":[0.9982936,0.00017313121,0.00005590884,0.00008021322,0.00001419472,0.000034023706,0.0012104079,0.0000024646547,0.0001361052],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99883074,0.0004905878,0.0001615015,0.00022033858,0.00015490371,0.00014197083],"domain_scores_gemma":[0.99296486,0.0013545136,0.004007287,0.00037093073,0.00052090135,0.00078138144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016130374,0.0002088785,0.00032557486,0.0007421701,0.00038173728,0.00096421177,0.0004254263,0.0005992248,0.0014455017],"category_scores_gemma":[0.0059100995,0.0002466285,0.0008710519,0.0014604699,0.00027249736,0.0010572406,0.00082408823,0.0007453802,0.0003746186],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033461954,0.00015587032,0.9970975,0.000022279397,0.000100094534,0.00003909596,0.00021038592,0.000057662564,0.000032510103,0.00002173635,0.00028766796,0.00164053],"study_design_scores_gemma":[0.00008688941,0.00041781223,0.9976459,0.000019798279,0.00006208238,0.00010894331,0.0007178451,0.00031019707,0.000030862087,0.000021809743,0.0005662887,0.00001155846],"about_ca_topic_score_codex":0.010507766,"about_ca_topic_score_gemma":0.0104985135,"teacher_disagreement_score":0.010507766,"about_ca_system_score_codex":0.0007630537,"about_ca_system_score_gemma":0.00077216397,"threshold_uncertainty_score":0.020893216},"labels":[],"label_agreement":null},{"id":"W2353777016","doi":"","title":"Expression of MEK-1 in regulation of αV integrin and E-cadherin of MCF-7 breast cancer cells","year":2003,"lang":"en","type":"article","venue":"Zhongguo aizheng zazhi","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Northeast Cancer Centre","funders":"","keywords":"MEK inhibitor; Integrin; MAPK/ERK pathway; Cadherin; MCF-7; Phosphorylation; Cell biology; Transfection; Chemistry; Cancer research; Molecular biology; Cancer cell; Biology; Cell; Cancer; Gene; Biochemistry; Human breast; Genetics","score_opus":0.0075772778683541086,"score_gpt":0.22189310087476866,"score_spread":0.21431582300641455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2353777016","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99339783,0.0021494573,0.0014942953,0.00012795086,0.00002683096,0.00001710723,0.00021294487,0.00004057362,0.0025329683],"genre_scores_gemma":[0.9936646,0.0011234594,0.0013938808,0.000038674865,0.0000046547043,0.00002005083,0.0003883594,0.00000676668,0.0033596023],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99993396,0.0000086481405,0.000004542046,0.000010626707,0.000019756957,0.000022436318],"domain_scores_gemma":[0.99997556,0.000004204945,0.000005404944,0.0000027597646,0.0000052954415,0.000006918331],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006304268,0.00025670914,0.00010682755,0.00011558853,0.00013246319,0.0001802537,0.00011685681,0.0001362782,0.00088918826],"category_scores_gemma":[0.00005076347,0.000102846425,0.00014901173,0.000057610272,0.00009696263,0.00011093271,0.00009684693,0.0003445016,0.00028749174],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059205748,0.000016833053,0.00015384742,0.000029714953,0.0000018600045,0.000028789298,0.000009044097,0.00003419391,0.9987167,0.00012824875,0.000032304317,0.0007891744],"study_design_scores_gemma":[0.000014069583,0.00012428715,0.0034812246,0.0000054025363,0.000011008474,0.00018582454,0.000023289787,0.0008303303,0.99248123,0.00004381983,0.0027973333,0.0000022686438],"about_ca_topic_score_codex":0.0006815406,"about_ca_topic_score_gemma":0.0010607541,"teacher_disagreement_score":0.00088918826,"about_ca_system_score_codex":0.000307069,"about_ca_system_score_gemma":0.00015739363,"threshold_uncertainty_score":0.0029746294},"labels":[],"label_agreement":null},{"id":"W2409346424","doi":"10.1200/jco.2014.32.15_suppl.3000","title":"Randomized comparison of two doses of the anti-PD-1 monoclonal antibody MK-3475 for ipilimumab-refractory (IPI-R) and IPI-naive (IPI-N) melanoma (MEL).","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Ipilimumab; Refractory (planetary science); Clinical endpoint; Mallinckrodt; Clinical trial; Cancer; Immunotherapy; Family medicine","score_opus":0.07231325230553105,"score_gpt":0.4469057133558252,"score_spread":0.37459246105029415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2409346424","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896466,0.0012542702,0.00079988514,0.00040227827,0.0005433624,0.005066347,0.00051504385,0.00007002962,0.0017021573],"genre_scores_gemma":[0.9899593,0.0006137275,0.0012949859,0.000543847,0.00029989978,0.004900457,0.0004117916,0.000018398669,0.0019575963],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99887663,0.0005970719,0.00007843607,0.00020513995,0.000078905956,0.00016373285],"domain_scores_gemma":[0.9985122,0.00049117743,0.00036501646,0.00014558472,0.00007306705,0.000412844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019618426,0.0014550166,0.0023505767,0.00041024934,0.0003040394,0.0011355154,0.001259519,0.0018526836,0.0077990377],"category_scores_gemma":[0.0025698803,0.0008723501,0.0013153978,0.0003601661,0.0013709611,0.0012207004,0.0006236385,0.0029320312,0.0013499965],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98531383,0.0060061864,0.00029752788,0.00012498714,0.0002577572,0.00001791457,0.000029185987,0.00020541243,0.0014722674,0.00009278057,0.00021713284,0.0059651174],"study_design_scores_gemma":[0.86568296,0.13104966,0.0013141315,0.00001931312,0.0003003922,0.00002126675,0.000021084918,0.00058120076,0.00035286255,0.00022032215,0.0004245023,0.000012343198],"about_ca_topic_score_codex":0.00072842167,"about_ca_topic_score_gemma":0.0014968779,"teacher_disagreement_score":0.0077990377,"about_ca_system_score_codex":0.001098427,"about_ca_system_score_gemma":0.0012883462,"threshold_uncertainty_score":0.026090324},"labels":[],"label_agreement":null},{"id":"W2416476141","doi":"10.1002/dvdy.24421","title":"Raf kinase inhibitor protein1 is a myogenic inhibitor with conserved function in avians and mammals","year":2016,"lang":"en","type":"article","venue":"Developmental Dynamics","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Myogenesis; Biology; C2C12; MAPK/ERK pathway; Cell biology; Kinase; Phosphorylation; MEK inhibitor; Myocyte; Signal transduction; Activator (genetics); Molecular biology; Receptor; Genetics","score_opus":0.005689135811775824,"score_gpt":0.1827615306132875,"score_spread":0.17707239480151168,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2416476141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.948239,0.024612984,0.012257352,0.00026582807,0.00009723545,0.000052268133,0.0019978026,0.0005152425,0.011962395],"genre_scores_gemma":[0.97850275,0.0040729726,0.009363443,0.00007146258,0.000022920392,0.000024352557,0.0021483495,0.00006717342,0.0057267584],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99992144,0.0000043130754,0.0000047867447,0.00003725126,0.000021080086,0.00001114904],"domain_scores_gemma":[0.999913,0.000004851879,0.00004613914,0.0000050562735,0.000012214025,0.000018783934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008060433,0.00035260798,0.00019317283,0.00038735903,0.0003852779,0.0002714738,0.00021963129,0.00022592241,0.0012666386],"category_scores_gemma":[0.0000927118,0.00014074103,0.00021482975,0.0001989123,0.00021209862,0.00020491309,0.00021120119,0.00033465293,0.00086109387],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001639111,0.000016283566,0.0032478909,0.00017252831,0.000019162428,0.0004501692,0.00004633438,0.00018652997,0.9799079,0.0005343613,0.0003698415,0.0148850605],"study_design_scores_gemma":[0.000039488685,0.00068599585,0.20284748,0.00007958522,0.00019732559,0.018858476,0.00022501552,0.0034284655,0.6793887,0.0006521785,0.093535796,0.00006149599],"about_ca_topic_score_codex":0.0014463362,"about_ca_topic_score_gemma":0.0017025734,"teacher_disagreement_score":0.0014463362,"about_ca_system_score_codex":0.0003767966,"about_ca_system_score_gemma":0.0002117775,"threshold_uncertainty_score":0.004237294},"labels":[],"label_agreement":null},{"id":"W2462587944","doi":"10.1038/bjc.2016.195","title":"Molecular characterisation of cutaneous melanoma: creating a framework for targeted and immune therapies","year":2016,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"University of Texas MD Anderson Cancer Center; Curtin University of Technology; Melanoma Research Alliance","keywords":"Melanoma; Immune checkpoint; Immune system; Disease; Computational biology; Medicine; Precision medicine; Biology; Bioinformatics; Cancer research; Immunotherapy; Immunology; Genetics; Internal medicine","score_opus":0.013800042175460794,"score_gpt":0.29672233756004146,"score_spread":0.2829222953845807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2462587944","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017495797,0.9969766,0.00070951186,0.0009190772,0.0002260493,0.0000067497695,0.000020807674,0.000009472318,0.0009567679],"genre_scores_gemma":[0.0019705635,0.9951826,0.0013040907,0.0004457808,0.0004044273,0.000011747341,0.00006017533,0.000004207091,0.00061644363],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995741,0.00009524221,0.00006256868,0.00007471449,0.00015349494,0.000039871335],"domain_scores_gemma":[0.99909365,0.0004496315,0.00009411608,0.00004620446,0.00024452488,0.00007186934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014539998,0.000790477,0.0016556673,0.004066778,0.0002933172,0.0017074205,0.0011052034,0.0018224986,0.0015745447],"category_scores_gemma":[0.0015942468,0.0003562195,0.0006446842,0.0015579195,0.0012592964,0.0022981337,0.0009358569,0.003751211,0.0013233747],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008944298,0.00006850014,0.0008262391,0.010347781,0.00012100861,0.0007804218,0.000117896874,0.0008882581,0.00823859,0.015436261,0.02165191,0.94143355],"study_design_scores_gemma":[0.000016333657,0.000088922905,0.0024886446,0.003931036,0.00012592715,0.006675483,0.0001704693,0.00035533277,0.0023824153,0.011003492,0.97272146,0.000040461135],"about_ca_topic_score_codex":0.0013862468,"about_ca_topic_score_gemma":0.001666158,"teacher_disagreement_score":0.004066778,"about_ca_system_score_codex":0.0013209878,"about_ca_system_score_gemma":0.001347997,"threshold_uncertainty_score":0.0095844865},"labels":[],"label_agreement":null},{"id":"W2466439203","doi":"10.3389/fcell.2016.00067","title":"Redundancy in the World of MAP Kinases: All for One","year":2016,"lang":"en","type":"review","venue":"Frontiers in Cell and Developmental Biology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research","keywords":"Kinase; Mitogen-activated protein kinase; Biology; Cell biology; Effector; Gene isoform; Embryonic stem cell; p38 mitogen-activated protein kinases; Signal transduction; Redundancy (engineering); MAPK/ERK pathway; Genetics; Computer science; Gene","score_opus":0.029380579268283805,"score_gpt":0.28239533029225455,"score_spread":0.25301475102397075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2466439203","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000741801,0.98983485,0.0010686102,0.0030277877,0.0007068594,0.0000028482002,0.000022212089,0.000020656511,0.004574296],"genre_scores_gemma":[0.008334824,0.9839569,0.0011345438,0.0019397924,0.0008357153,0.000009519438,0.0000600014,0.000011669312,0.0037171447],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99973863,0.000053200627,0.000027071192,0.000065385306,0.000086424574,0.000029342711],"domain_scores_gemma":[0.99971324,0.000109015506,0.000027238157,0.000026146561,0.00008545985,0.00003889196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006972383,0.0005832098,0.0008351647,0.00095933134,0.0004770685,0.0017272425,0.00066415005,0.0010466614,0.002663237],"category_scores_gemma":[0.0005779928,0.00019835925,0.00037544343,0.0011432992,0.0013063698,0.003911961,0.0011552365,0.0021360433,0.0019206319],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015335497,0.000040195908,0.00045677446,0.01180115,0.0001570351,0.00083098194,0.0007446509,0.00039308475,0.015997082,0.071256764,0.034500696,0.8636682],"study_design_scores_gemma":[0.0000050769445,0.00004255745,0.00043729992,0.00087247806,0.000040684503,0.0015455836,0.00022409494,0.000056175406,0.0014139996,0.017435497,0.97791046,0.000016083291],"about_ca_topic_score_codex":0.00053353515,"about_ca_topic_score_gemma":0.0005757501,"teacher_disagreement_score":0.002663237,"about_ca_system_score_codex":0.00072010583,"about_ca_system_score_gemma":0.0013252401,"threshold_uncertainty_score":0.008909404},"labels":[],"label_agreement":null},{"id":"W2468294668","doi":"10.1097/cji.0000000000000131","title":"An Association Between Glatiramer Acetate and Malignant Melanoma","year":2016,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Glatiramer acetate; Medicine; Melanoma; Dermatology; Association (psychology); Oncology; Internal medicine; Cancer research; Psychology; Disease","score_opus":0.008823298688931851,"score_gpt":0.24556153186318544,"score_spread":0.23673823317425358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2468294668","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936407,0.0019008641,0.00041459792,0.000545591,0.000048981583,0.00002116301,0.00006762031,0.000052700536,0.0033077477],"genre_scores_gemma":[0.9990772,0.0003788875,0.00012728365,0.00006162958,0.000059506412,0.0000020655682,0.000018955578,0.0000026368978,0.00027176147],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.9998098,0.000034219487,0.000019653051,0.0000395114,0.0000363638,0.00006041674],"domain_scores_gemma":[0.9994199,0.0001954473,0.00016647078,0.000056176148,0.000033003787,0.00012902667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018578717,0.00043077837,0.00030426905,0.0009493881,0.00079672504,0.0003739726,0.0002738005,0.0012251694,0.0020660588],"category_scores_gemma":[0.001111043,0.0002763333,0.00029136369,0.0005928823,0.0004691252,0.0004163724,0.000306279,0.0009024935,0.0003761327],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006343636,0.00027831874,0.21274257,0.000073505515,0.000047462436,0.76726365,0.0003855338,0.00014717522,0.00989832,0.00039024616,0.00059088384,0.0075478745],"study_design_scores_gemma":[0.00003062244,0.00038018185,0.11375374,0.000019748908,0.00006245953,0.8807065,0.00017157766,0.0006521585,0.0020453616,0.00026483662,0.0018966205,0.00001614645],"about_ca_topic_score_codex":0.0009155274,"about_ca_topic_score_gemma":0.00088426046,"teacher_disagreement_score":0.0020660588,"about_ca_system_score_codex":0.00026355172,"about_ca_system_score_gemma":0.00020917229,"threshold_uncertainty_score":0.0069116354},"labels":[],"label_agreement":null},{"id":"W2472992307","doi":"10.1039/c6md00241b","title":"Novel p38α MAP kinase inhibitors identified from yoctoReactor DNA-encoded small molecule library","year":2016,"lang":"en","type":"article","venue":"MedChemComm","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Structural Genomics Consortium","funders":"Engineering and Physical Sciences Research Council","keywords":"Small molecule; Computational biology; DNA; Kinase; Biology; Combinatorial chemistry; Chemistry; Genetics","score_opus":0.015329803184348043,"score_gpt":0.20439455643016935,"score_spread":0.1890647532458213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2472992307","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91362363,0.00471816,0.06676881,0.00041549295,0.00010654522,0.0010277652,0.0053014164,0.0011552593,0.00688307],"genre_scores_gemma":[0.92099917,0.004766838,0.046622287,0.00029008795,0.00003706463,0.00082941784,0.009545681,0.00015839093,0.016750993],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998764,0.000009188475,0.000008294432,0.000027700811,0.0000383778,0.000040034025],"domain_scores_gemma":[0.99993074,0.0000132852165,0.000014935462,0.000006211887,0.000016511578,0.000018286766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015395664,0.00072282914,0.00068035815,0.0004934977,0.00019382594,0.00026115697,0.00041377696,0.00032507986,0.0020281225],"category_scores_gemma":[0.00014381198,0.00028483657,0.0003254892,0.0005156777,0.00016544173,0.00020873875,0.00024073006,0.000708475,0.0009156103],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009335755,0.00004999925,0.000067966364,0.00006108541,0.000008100913,0.000066482215,0.000010840137,0.0002780078,0.99520123,0.00009999321,0.00014178584,0.003921164],"study_design_scores_gemma":[0.00005704876,0.00057824043,0.000601966,0.0000063908183,0.00003182053,0.00022021637,0.000009577848,0.0009547121,0.9932342,0.00003056779,0.0042659435,0.00000926585],"about_ca_topic_score_codex":0.0006088478,"about_ca_topic_score_gemma":0.0017606859,"teacher_disagreement_score":0.0020281225,"about_ca_system_score_codex":0.0005156676,"about_ca_system_score_gemma":0.0003647964,"threshold_uncertainty_score":0.0067847967},"labels":[],"label_agreement":null},{"id":"W2483841276","doi":"10.1007/978-1-59259-994-3","title":"From Melanocytes to Melanoma","year":2006,"lang":"en","type":"book","venue":"Humana Press eBooks","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of California, San Francisco; St. George's, University of London; Feinberg School of Medicine; Universität Regensburg; Deutsches Krebsforschungszentrum; University of Queensland; University of Oklahoma; University of Cincinnati; University of Pittsburgh; National Cancer Institute; College of Medicine, University of Cincinnati; University of Toronto; Cleveland Clinic; Melanoma Research Alliance; Cleveland Clinic Foundation; Lawrence Berkeley National Laboratory; Northwestern University; National Institutes of Health; College of Medicine, University of Oklahoma; Ohio State University; Comprehensive Cancer Center, University of Alabama at Birmingham; Yale University; University of Pennsylvania","keywords":"Melanoma; Biology; Cancer research","score_opus":0.026907465919635047,"score_gpt":0.24221531395537463,"score_spread":0.21530784803573957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2483841276","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013904473,0.58921707,0.0064579905,0.0051896432,0.012563906,0.00005792765,0.00017650794,0.00039897417,0.3845475],"genre_scores_gemma":[0.007831072,0.16990502,0.003042393,0.0040956647,0.0025703828,0.000054606462,0.00018660782,0.000091189955,0.8122231],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999281,0.000007789284,0.0000032028859,0.000016734299,0.000034381508,0.000009787372],"domain_scores_gemma":[0.99994516,0.000014659021,0.000003861362,0.000007305905,0.0000129707605,0.00001609165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013615767,0.0006570228,0.00040562713,0.00111575,0.00037624815,0.0011232375,0.0004813716,0.0007345939,0.023560122],"category_scores_gemma":[0.00020775924,0.00028806023,0.00024340548,0.0005658552,0.0004715446,0.0013090632,0.0008351066,0.0021005725,0.020631744],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005879685,0.00004259532,0.00007722466,0.0005846218,0.000009285622,0.00026022753,0.0001088842,0.00018982805,0.019981453,0.03392331,0.2750873,0.6696765],"study_design_scores_gemma":[0.0000030888068,0.0000138062205,0.00008681832,0.00007888473,0.0000025851054,0.00026197295,0.000012499805,0.00002867793,0.0011380697,0.0045627714,0.9938083,0.0000023687942],"about_ca_topic_score_codex":0.0005580673,"about_ca_topic_score_gemma":0.0019374294,"teacher_disagreement_score":0.023560122,"about_ca_system_score_codex":0.0004912754,"about_ca_system_score_gemma":0.00036787105,"threshold_uncertainty_score":0.07881653},"labels":[],"label_agreement":null},{"id":"W2495037279","doi":"10.1016/b978-0-12-803582-5.00010-3","title":"Diversity and implication of MAPK signal transduction involved in the regulation of chemotherapy-induced DNA damage response","year":2016,"lang":"en","type":"book-chapter","venue":"Elsevier eBooks","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Canadian Institutes of Health Research; Canadian Cancer Society","keywords":"DNA damage; MAPK/ERK pathway; DNA repair; Biology; Cancer research; Signal transduction; Cell biology; DNA; Genetics","score_opus":0.017236534091971692,"score_gpt":0.22307285273864189,"score_spread":0.20583631864667018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2495037279","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.34554353,0.4514439,0.050990418,0.003634112,0.0012116975,0.000107101245,0.0010463527,0.0005038187,0.14551906],"genre_scores_gemma":[0.6646371,0.24627052,0.016584327,0.00079654914,0.0007273401,0.00011272459,0.0012740388,0.00009640567,0.06950101],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991524,0.000009283362,0.000005824012,0.000023860533,0.000025846228,0.00001987557],"domain_scores_gemma":[0.9999732,0.0000063890843,0.000005123449,0.000002844553,0.0000059993627,0.0000064441647],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016900353,0.0004821118,0.000283325,0.00048638196,0.00023864499,0.00081927644,0.000351205,0.00039173506,0.0016388273],"category_scores_gemma":[0.000083277686,0.00017498409,0.00030996444,0.0004153144,0.00033389352,0.0009175832,0.00044094076,0.0010406277,0.0006862885],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030523248,0.000069906026,0.00057236606,0.0007203713,0.00002337478,0.0007802454,0.00022475264,0.0010733849,0.8650919,0.020795176,0.0016518802,0.10869135],"study_design_scores_gemma":[0.000052810195,0.00067358883,0.022138407,0.0004743902,0.00016286556,0.007921693,0.0006207375,0.0053389086,0.58426815,0.066282056,0.31195486,0.00011159829],"about_ca_topic_score_codex":0.00021068146,"about_ca_topic_score_gemma":0.0002448159,"teacher_disagreement_score":0.0016388273,"about_ca_system_score_codex":0.00041863066,"about_ca_system_score_gemma":0.00027932756,"threshold_uncertainty_score":0.005482435},"labels":[],"label_agreement":null},{"id":"W2507950939","doi":"10.1158/1078-0432.ccr-16-1192","title":"MAPK Pathway Inhibitors Sensitize BRAF-Mutant Melanoma to an Antibody-Drug Conjugate Targeting GPNMB","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"National Cancer Institute; Deutsches Krebsforschungszentrum; McGill University","keywords":"Microphthalmia-associated transcription factor; Melanoma; MEK inhibitor; MAPK/ERK pathway; Cancer research; Gene knockdown; Medicine; Antibody-drug conjugate; Trametinib; Dabrafenib; Antibody; Monoclonal antibody; Cell culture; Immunology; Biology; Vemurafenib; Signal transduction; Tyrosinase; Metastatic melanoma; Cell biology","score_opus":0.08395417958845613,"score_gpt":0.44757959507761497,"score_spread":0.36362541548915883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2507950939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99653995,0.0010451224,0.0004522427,0.000050096452,0.000018992214,0.000058274014,0.0008837247,0.00007083379,0.00088080467],"genre_scores_gemma":[0.9951199,0.0007104618,0.0008746758,0.000045871056,0.000005714369,0.00005263513,0.0018527274,0.000015171036,0.0013229689],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998795,0.000012951072,0.000008001846,0.00003198837,0.000044133973,0.000023478975],"domain_scores_gemma":[0.9999467,0.00000798022,0.000016802076,0.000007748975,0.000007970859,0.000012774948],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013405713,0.00024670918,0.00031226073,0.00019743392,0.00012651728,0.0002532266,0.00013333926,0.00018266316,0.0022826304],"category_scores_gemma":[0.0001535564,0.0001262354,0.00028604595,0.00013214904,0.00009248091,0.00012224288,0.00012979175,0.00035865285,0.00038397242],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005070199,0.00013117946,0.0029765104,0.00012318986,0.00003930654,0.000047644266,0.000016050455,0.00032703124,0.98826456,0.00003722807,0.000346771,0.007183382],"study_design_scores_gemma":[0.00012994076,0.0033703076,0.05768664,0.000020619347,0.00010563325,0.0010536074,0.000047255537,0.0023301765,0.9261615,0.00005798899,0.009026828,0.0000094378665],"about_ca_topic_score_codex":0.0009165398,"about_ca_topic_score_gemma":0.0021574383,"teacher_disagreement_score":0.0022826304,"about_ca_system_score_codex":0.00037679463,"about_ca_system_score_gemma":0.00019484694,"threshold_uncertainty_score":0.00763613},"labels":[],"label_agreement":null},{"id":"W2518848423","doi":"10.1177/1203475416670368","title":"Prospective Case Series of Cutaneous Adverse Effects Associated With Dabrafenib and Trametinib","year":2016,"lang":"en","type":"article","venue":"Journal of Cutaneous Medicine and Surgery","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Canadian Dermatology Foundation; McGill University Health Centre; Dermatology Foundation","keywords":"Trametinib; Dabrafenib; Medicine; Vemurafenib; Adverse effect; MEK inhibitor; Dermatology; Melanoma; Keratoacanthoma; Oncology; Rash; Internal medicine; Cancer research; MAPK/ERK pathway; Basal cell; Metastatic melanoma","score_opus":0.008931934955345442,"score_gpt":0.21620470601691855,"score_spread":0.2072727710615731,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2518848423","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98622453,0.004233838,0.0013475198,0.00035376046,0.00014160949,0.00018382097,0.00020473296,0.0000877315,0.0072224457],"genre_scores_gemma":[0.9975516,0.00071811373,0.00042683934,0.00027229972,0.00021980914,0.000033140925,0.00015873607,0.000014143809,0.0006054623],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.99854577,0.00023064607,0.0002191317,0.00037250383,0.00024538639,0.0003866527],"domain_scores_gemma":[0.99494946,0.0010440686,0.0016018039,0.00078070746,0.00043830407,0.0011857584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008023603,0.0015458534,0.0011793195,0.0019622862,0.0021859196,0.0017031983,0.001244778,0.0023276906,0.0044133198],"category_scores_gemma":[0.0040350026,0.001213333,0.001281881,0.0016543469,0.001150933,0.0015016105,0.0014694507,0.0019586028,0.0017622411],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023214874,0.00022914281,0.17367741,0.00007154092,0.00009657347,0.81933504,0.0002977462,0.0001620392,0.0010710531,0.00012126978,0.00058581226,0.004120197],"study_design_scores_gemma":[0.000030444999,0.00016739305,0.026745133,0.000015174227,0.00004401322,0.9714883,0.0001603018,0.00018404845,0.00027294015,0.00005539053,0.0008223435,0.000014483726],"about_ca_topic_score_codex":0.0017795685,"about_ca_topic_score_gemma":0.0023168514,"teacher_disagreement_score":0.0044133198,"about_ca_system_score_codex":0.0010739911,"about_ca_system_score_gemma":0.00093729905,"threshold_uncertainty_score":0.014764011},"labels":[],"label_agreement":null},{"id":"W2520271306","doi":"10.5489/cuaj.3652","title":"Initial response of renal cell carcinoma to vemurafenib in a patient treated for metastatic melanoma","year":2016,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Queen's University; University of Ottawa; Dalhousie University","funders":"","keywords":"Vemurafenib; Renal cell carcinoma; Medicine; Melanoma; Metastatic melanoma; Cancer research; Internal medicine; Oncology; V600E; Mutation; Biology","score_opus":0.012923369004801035,"score_gpt":0.22252219637139706,"score_spread":0.20959882736659602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2520271306","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855273,0.0022708946,0.0009699541,0.0031249486,0.00015501502,0.00012914198,0.00023507277,0.00011376986,0.007473926],"genre_scores_gemma":[0.9979722,0.00037353794,0.000250531,0.0004615852,0.00010911746,0.0000065653926,0.000067174056,0.000011062762,0.0007481525],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9997209,0.00002601305,0.000026464862,0.000066026725,0.00006062722,0.00009997016],"domain_scores_gemma":[0.99911577,0.00017691946,0.000074458425,0.000033003216,0.00009843717,0.00050146895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001770864,0.0005211624,0.0009757594,0.0008414885,0.0013918863,0.00061889505,0.00065744057,0.0023554123,0.0013903109],"category_scores_gemma":[0.0019158333,0.0003522678,0.000698244,0.000519677,0.00052682596,0.00057045266,0.00043408104,0.0020692006,0.0004352066],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027333936,0.000117802316,0.024034806,0.000047379508,0.000025221952,0.9669229,0.00040640112,0.00024065452,0.004200297,0.000100192854,0.00045754304,0.0031735243],"study_design_scores_gemma":[0.000043963253,0.0007885298,0.05430251,0.000028106848,0.000047354126,0.9394101,0.00031195776,0.0012845956,0.0023229297,0.00012949819,0.0012900034,0.00004042047],"about_ca_topic_score_codex":0.0074776746,"about_ca_topic_score_gemma":0.0108071575,"teacher_disagreement_score":0.0074776746,"about_ca_system_score_codex":0.001390389,"about_ca_system_score_gemma":0.0008435433,"threshold_uncertainty_score":0.014868319},"labels":[],"label_agreement":null},{"id":"W2526572293","doi":"10.1007/s40487-016-0030-2","title":"Network Meta-analysis of Progression-Free Survival and Overall Survival in First-Line Treatment of BRAF Mutation-Positive Metastatic Melanoma","year":2016,"lang":"en","type":"article","venue":"Oncology and Therapy","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dabrafenib; Trametinib; Vemurafenib; Ipilimumab; Medicine; Dacarbazine; Internal medicine; Oncology; Hazard ratio; Progression-free survival; Melanoma; Confidence interval; Metastatic melanoma; Cancer research; Chemotherapy; Cancer; Biology; Immunotherapy; MAPK/ERK pathway","score_opus":0.05188755218340509,"score_gpt":0.320069913384466,"score_spread":0.2681823612010609,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2526572293","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10216004,0.87396663,0.010635802,0.0029776033,0.00068050815,0.00048517936,0.005726351,0.00020370445,0.003164174],"genre_scores_gemma":[0.88654774,0.10242046,0.005847198,0.0010200884,0.00029735343,0.0005526141,0.002576546,0.00006468435,0.0006733319],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9848681,0.012115331,0.00083821133,0.0010816255,0.0008484382,0.00024835748],"domain_scores_gemma":[0.9800679,0.015850147,0.0021457686,0.0008597841,0.00081917056,0.00025731814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.023915157,0.0020105946,0.0063521806,0.0035895274,0.0003837241,0.0023422162,0.0014763788,0.001386027,0.0028111662],"category_scores_gemma":[0.036788132,0.0008156523,0.03420115,0.0030971281,0.00038444359,0.00092331076,0.0008098446,0.0017529484,0.00017436019],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060345735,0.000045965477,0.020250008,0.020826804,0.9220338,0.00012998666,0.000035059114,0.014953665,0.00027697106,0.00047607426,0.001105832,0.013831363],"study_design_scores_gemma":[0.0013808552,0.00040335837,0.013464643,0.002541756,0.97143406,0.00012184023,0.000022930486,0.006506418,0.00022029532,0.0013762721,0.0024967494,0.00003094153],"about_ca_topic_score_codex":0.018707126,"about_ca_topic_score_gemma":0.02298327,"teacher_disagreement_score":0.023915157,"about_ca_system_score_codex":0.0033183598,"about_ca_system_score_gemma":0.002561308,"threshold_uncertainty_score":0.12647694},"labels":[],"label_agreement":null},{"id":"W2529261316","doi":"10.1111/cyt.12366","title":"<scp>CSF</scp> cytology diagnosis of <scp>NRAS</scp>‐mutated primary leptomeningeal melanomatosis with neurocutaneous melanosis","year":2016,"lang":"en","type":"article","venue":"Cytopathology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Immunocytochemistry; Neuroblastoma RAS viral oncogene homolog; Pathology; Cytology; Melanoma; Cytopathology; Cancer; Cancer research; Internal medicine","score_opus":0.007383496912232193,"score_gpt":0.20439080346001698,"score_spread":0.19700730654778478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2529261316","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98260903,0.0018369554,0.0028871049,0.0009868325,0.00013729672,0.0001279905,0.00023434922,0.00015115984,0.011029325],"genre_scores_gemma":[0.9981817,0.00040177736,0.00079970545,0.0001339208,0.00007164963,0.000008309755,0.000045976092,0.000010034351,0.00034699758],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9997464,0.000022820637,0.000030565534,0.000046534435,0.00007652173,0.000077215656],"domain_scores_gemma":[0.9993844,0.00013995587,0.000117458454,0.00006139882,0.0000771484,0.0002195068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020814728,0.0009171308,0.0005303103,0.0012823181,0.00080456794,0.0006060555,0.00050457707,0.001295074,0.0021025063],"category_scores_gemma":[0.0012735741,0.0003267864,0.00037354272,0.00050558016,0.000979256,0.0005930173,0.00064824225,0.00074833597,0.0008692983],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000097150696,0.000020277903,0.014028196,0.00007508834,0.000011877495,0.9631363,0.00010699262,0.000102925595,0.018580394,0.0001435382,0.00031291915,0.0033843971],"study_design_scores_gemma":[0.000016933971,0.00007872538,0.02062898,0.00003344881,0.000025545476,0.968884,0.0001435842,0.0009164599,0.0079961745,0.00030247332,0.0009613296,0.000012423137],"about_ca_topic_score_codex":0.0030164304,"about_ca_topic_score_gemma":0.0040357118,"teacher_disagreement_score":0.0030164304,"about_ca_system_score_codex":0.00067457196,"about_ca_system_score_gemma":0.0006375572,"threshold_uncertainty_score":0.007033527},"labels":[],"label_agreement":null},{"id":"W2529971012","doi":"10.1200/jco.2012.30.15_suppl.8517","title":"An open-label, multicenter safety study of vemurafenib (PLX4032, RO5185426) in patients with metastatic melanoma.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Vemurafenib; Medicine; Internal medicine; Clinical endpoint; Rash; Ipilimumab; Adverse effect; Melanoma; Oncology; Metastatic melanoma; Gastroenterology; Dermatology; Surgery; Cancer; Clinical trial; Cancer research; Immunotherapy","score_opus":0.09662255233445871,"score_gpt":0.43254964147480046,"score_spread":0.33592708914034175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2529971012","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953406,0.0014757903,0.00043679148,0.00016515281,0.00004082193,0.00081067905,0.00095446524,0.000050558232,0.0007252296],"genre_scores_gemma":[0.9938261,0.0007500629,0.0008594725,0.00034651495,0.00018948995,0.0010476301,0.0020151383,0.000019070885,0.0009464884],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99918383,0.0004941309,0.000042761276,0.00012029282,0.00009007515,0.00006886524],"domain_scores_gemma":[0.9984693,0.00027541156,0.0004875959,0.000108665125,0.0001010576,0.0005579103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020794065,0.0010274173,0.0016026886,0.0003658712,0.0003938561,0.00065786584,0.0005935441,0.000787062,0.0036712687],"category_scores_gemma":[0.0017765404,0.00044377844,0.0010358726,0.0003712957,0.0006035092,0.0007531357,0.0003215515,0.0016699925,0.0009645228],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7953776,0.041171856,0.03439456,0.00090288295,0.002088951,0.0006505564,0.0003652057,0.0013740106,0.02971062,0.00015643064,0.004096873,0.08971042],"study_design_scores_gemma":[0.5273824,0.39442426,0.06759571,0.00005158685,0.0008117984,0.0010551721,0.00008302507,0.0016880016,0.002923532,0.00015726764,0.0037926142,0.00003470499],"about_ca_topic_score_codex":0.0004649517,"about_ca_topic_score_gemma":0.0008393724,"teacher_disagreement_score":0.0036712687,"about_ca_system_score_codex":0.0007640499,"about_ca_system_score_gemma":0.0009146472,"threshold_uncertainty_score":0.012281597},"labels":[],"label_agreement":null},{"id":"W2540613192","doi":"10.1001/jamaoncol.2016.4877","title":"Systemic Therapy for Previously Untreated Advanced <i>BRAF</i>-Mutated Melanoma","year":2016,"lang":"en","type":"review","venue":"JAMA Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University","funders":"","keywords":"Medicine; Hazard ratio; Oncology; Internal medicine; Melanoma; Randomized controlled trial; Meta-analysis; Odds ratio; Confidence interval; Adverse effect; MEK inhibitor; Progression-free survival; Overall survival; Cancer research; MAPK/ERK pathway","score_opus":0.028164773284773216,"score_gpt":0.3337088176855344,"score_spread":0.30554404440076116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2540613192","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003565024,0.99260956,0.0004404268,0.00096261606,0.00038365173,0.0005138162,0.0004474485,0.000015440093,0.0010619403],"genre_scores_gemma":[0.1266354,0.8632406,0.0032283713,0.003131457,0.0012305552,0.0014590443,0.00052747823,0.000017637238,0.00052942656],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.98988277,0.0059925867,0.0023761217,0.0005981555,0.0010248505,0.00012557376],"domain_scores_gemma":[0.9620815,0.03016008,0.0060050916,0.00038676706,0.0011505095,0.00021599772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010649672,0.0009750605,0.006457215,0.0022463708,0.00026102926,0.002238083,0.00086285645,0.0016769496,0.0042391447],"category_scores_gemma":[0.03772457,0.0004234585,0.007275024,0.0021681169,0.00060083665,0.0014275502,0.0005091208,0.0017771891,0.00033840872],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006304733,0.00011400321,0.0021537635,0.7904836,0.06015549,0.00012213776,0.00009728602,0.00048219296,0.00066534313,0.000663262,0.004377108,0.1343811],"study_design_scores_gemma":[0.023156038,0.0063490155,0.012633293,0.5759154,0.33508885,0.00068077334,0.0003227634,0.0012205861,0.0015156504,0.0038977484,0.039109625,0.00011027996],"about_ca_topic_score_codex":0.0023824638,"about_ca_topic_score_gemma":0.004886287,"teacher_disagreement_score":0.010649672,"about_ca_system_score_codex":0.0016268094,"about_ca_system_score_gemma":0.0025279531,"threshold_uncertainty_score":0.0563215},"labels":[],"label_agreement":null},{"id":"W2553199263","doi":"10.1002/ijc.30508","title":"<scp>G</scp>enetic variants of JNK and p38α pathways and risk of non‐small cell lung cancer in an <scp>E</scp>astern <scp>C</scp>hinese population","year":2016,"lang":"en","type":"article","venue":"International Journal of Cancer","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministry of Health, British Columbia; Fudan University","keywords":"Single-nucleotide polymorphism; Lung cancer; Genotype; Biology; Carcinogenesis; Cancer; Genetics; Oncology; Cart; Gene; Bioinformatics; Internal medicine; Cancer research; Medicine","score_opus":0.008559517738421405,"score_gpt":0.2594573567613309,"score_spread":0.2508978390229095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553199263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996798,0.000032551805,0.00008471979,0.000014437063,0.0000019142742,0.0000041511857,0.00005102748,0.0000014680049,0.00013000015],"genre_scores_gemma":[0.9994031,0.000029646691,0.00009081981,0.000011483683,0.00000523809,0.0000053217755,0.000106759806,0.0000016482129,0.00034599664],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99976724,0.000050004204,0.000022775803,0.00008932945,0.00003735308,0.00003335763],"domain_scores_gemma":[0.99976486,0.000047477974,0.00006264051,0.0000415708,0.000028880233,0.00005456266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048564927,0.00037217297,0.00028024463,0.00052347046,0.00053627125,0.00032787424,0.00017053146,0.0002747432,0.0013809601],"category_scores_gemma":[0.00054452254,0.00019379306,0.0004973159,0.0005240069,0.00030971927,0.00012065941,0.00021236752,0.00035195594,0.0001405297],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062039593,0.00009918664,0.98850304,0.000010876077,0.00020473506,0.00073412125,0.00026073627,0.00012881041,0.0065619173,0.00008392091,0.00012358984,0.0026685137],"study_design_scores_gemma":[0.000021913154,0.00012246783,0.9981351,0.0000027741573,0.00008579027,0.00040338142,0.00009966918,0.0005393808,0.00031851343,0.00006199263,0.00020444744,0.000004578128],"about_ca_topic_score_codex":0.015137167,"about_ca_topic_score_gemma":0.013907203,"teacher_disagreement_score":0.015137167,"about_ca_system_score_codex":0.00029493545,"about_ca_system_score_gemma":0.00025357187,"threshold_uncertainty_score":0.03009814},"labels":[],"label_agreement":null},{"id":"W2560245514","doi":"10.1016/j.bmc.2016.11.034","title":"Studies of TAK1-centered polypharmacology with novel covalent TAK1 inhibitors","year":2016,"lang":"en","type":"article","venue":"Bioorganic & Medicinal Chemistry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of General Medical Sciences; National Heart, Lung, and Blood Institute; National Cancer Institute; National Institutes of Health; Public Health Agency of Canada; Pediatric Low Grade Astrocytoma Foundation; Cancer Prevention and Research Institute of Texas","keywords":"Chemistry; Biotinylation; Kinase; Computational biology; Biochemistry; Biology","score_opus":0.02979926222147639,"score_gpt":0.27576516126940603,"score_spread":0.24596589904792965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560245514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9631028,0.009880538,0.014866239,0.0003475739,0.00012635911,0.00023143942,0.00021325285,0.000079595855,0.011152147],"genre_scores_gemma":[0.98825616,0.0044485796,0.0033472977,0.00014878451,0.000028175313,0.00007060039,0.00016556299,0.00001032722,0.0035244646],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998512,0.000027873475,0.000008243077,0.000027488011,0.00003692967,0.00004826413],"domain_scores_gemma":[0.9999392,0.000017135317,0.00001747493,0.000006361041,0.000008400226,0.00001138247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036947022,0.00051426084,0.0002819233,0.00016455817,0.00020328078,0.00022341745,0.0004711016,0.0003065229,0.0020977915],"category_scores_gemma":[0.00023726332,0.00018103344,0.00035322132,0.00015841733,0.00020831385,0.00047411726,0.00026907967,0.0007895138,0.00036392038],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008111361,0.00073841366,0.00020719721,0.00063871406,0.0001315039,0.0004563896,0.00016792021,0.0057592313,0.9572553,0.00592825,0.00058566383,0.027320271],"study_design_scores_gemma":[0.00026426723,0.0050012995,0.0009714713,0.000029096675,0.00010654028,0.00050017284,0.000038125007,0.004603603,0.97824144,0.00067767093,0.0095336065,0.000032657663],"about_ca_topic_score_codex":0.0003588601,"about_ca_topic_score_gemma":0.00060875877,"teacher_disagreement_score":0.0020977915,"about_ca_system_score_codex":0.00035630545,"about_ca_system_score_gemma":0.00020630186,"threshold_uncertainty_score":0.0070177913},"labels":[],"label_agreement":null},{"id":"W2586486297","doi":"10.1016/j.critrevonc.2017.02.003","title":"Enzastaurin: A lesson in drug development","year":2017,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Canadian Cancer Society","keywords":"Medicine; Drug development; Drug; Clinical trial; Pharmacology; MAPK/ERK pathway; Oncology; Kinase; Internal medicine; Biology","score_opus":0.17130075587845123,"score_gpt":0.466556597083607,"score_spread":0.2952558412051558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586486297","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008721026,0.99525297,0.00018543,0.0021820695,0.0011728957,0.0000034274335,0.0000265331,0.000015536438,0.0010739298],"genre_scores_gemma":[0.0011100821,0.99327326,0.0003214027,0.0023681447,0.0013293016,0.000007449413,0.00004909683,0.000005179596,0.0015360797],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998036,0.000038884198,0.0000275664,0.000034087003,0.000071213195,0.000024760018],"domain_scores_gemma":[0.99961627,0.00018716062,0.000037802096,0.000017412718,0.00009020037,0.000051180094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081519276,0.0007813277,0.0011791195,0.0009845945,0.00028805473,0.0012621051,0.0009241276,0.0015577014,0.004134251],"category_scores_gemma":[0.0011200337,0.0002743788,0.00048764187,0.000981451,0.0008695029,0.0021062372,0.00078022026,0.0048902943,0.002457728],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017203201,0.00007553786,0.0001671303,0.005268843,0.0000722931,0.00023420685,0.00003850649,0.0003402841,0.0012739279,0.0074428697,0.13442631,0.8504882],"study_design_scores_gemma":[0.00004444779,0.000053846954,0.00016894088,0.0010338004,0.000042580974,0.00043895218,0.000018681896,0.00005157366,0.00028099772,0.0024584003,0.99539787,0.000009844273],"about_ca_topic_score_codex":0.0007753603,"about_ca_topic_score_gemma":0.002385334,"teacher_disagreement_score":0.004134251,"about_ca_system_score_codex":0.000717285,"about_ca_system_score_gemma":0.0012959463,"threshold_uncertainty_score":0.013830423},"labels":[],"label_agreement":null},{"id":"W2586724626","doi":"10.1074/mcp.m116.065128","title":"Time-resolved Phosphoproteome Analysis of Paradoxical RAF Activation Reveals Novel Targets of ERK","year":2017,"lang":"en","type":"article","venue":"Molecular & Cellular Proteomics","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Université du Québec à Montréal; Institute for Research in Immunology and Cancer","funders":"Canadian Institutes of Health Research; Canada Research Chairs; Genome Canada","keywords":"Vemurafenib; Phosphoproteomics; MAPK/ERK pathway; Phosphorylation; Kinase; Actin cytoskeleton; Cell biology; Cancer research; V600E; Chemistry; Signal transduction; GTPase; Biology; Melanoma; Protein kinase A; Cell; Protein phosphorylation; Mutant; Cytoskeleton; Biochemistry","score_opus":0.011099547197506577,"score_gpt":0.23583559430668702,"score_spread":0.22473604710918044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586724626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934841,0.00043126545,0.0032633322,0.000039192917,0.000007033762,0.000012292241,0.0023204987,0.00007917934,0.00036317142],"genre_scores_gemma":[0.98771966,0.00047165295,0.005717218,0.000030437786,0.000008200856,0.000034843586,0.005440258,0.00002691723,0.00055084366],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990666,0.000005961414,0.000007439931,0.00003283265,0.00002446262,0.000022743185],"domain_scores_gemma":[0.99989676,0.000025243713,0.000028584258,0.000010792808,0.000020469903,0.00001810386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017554995,0.000301689,0.00039629475,0.0011348553,0.00015608309,0.00037416944,0.00016437264,0.00021305488,0.0009135494],"category_scores_gemma":[0.00024230538,0.000113300695,0.00041475223,0.00093656295,0.00013454017,0.00027047325,0.00024030628,0.00030509752,0.0002477617],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010077653,0.00011507539,0.025862042,0.00027848792,0.00014954225,0.00042933103,0.0001218881,0.0021655785,0.9514065,0.00022156053,0.0005706805,0.017671462],"study_design_scores_gemma":[0.000038199163,0.00038312006,0.6520854,0.000022290982,0.00022708619,0.0018285821,0.0003055465,0.05182911,0.28855103,0.00095785176,0.003706368,0.00006540185],"about_ca_topic_score_codex":0.0007273621,"about_ca_topic_score_gemma":0.0009875308,"teacher_disagreement_score":0.0011348553,"about_ca_system_score_codex":0.00013710627,"about_ca_system_score_gemma":0.00011698235,"threshold_uncertainty_score":0.0030561686},"labels":[],"label_agreement":null},{"id":"W2588722468","doi":"10.1093/annonc/mdw379.17","title":"Impact of ipilimumab on metastatic melanoma: Evaluation using patient registry in Canada","year":2016,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; Princess Margaret Cancer Centre; Sunnybrook Health Science Centre; Western University","funders":"","keywords":"Medicine; Ipilimumab; Internal medicine; Cohort; Metastatic melanoma; Disease registry; Melanoma; Clinical trial; Overall survival; Oncology; Cancer; Disease; Immunotherapy","score_opus":0.09076096803751592,"score_gpt":0.3757494754393978,"score_spread":0.28498850740188186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588722468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98053783,0.0009472403,0.000082971805,0.0010539381,0.000017790013,0.000059294107,0.011899623,0.000016388898,0.0053849993],"genre_scores_gemma":[0.99551374,0.0009482801,0.00012145621,0.00018430268,0.000010358018,0.000016727256,0.0024443874,0.000007966816,0.0007527108],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986877,0.00013663541,0.00007360658,0.00013511571,0.000505207,0.00046177654],"domain_scores_gemma":[0.995824,0.00024991162,0.0009129904,0.00010802042,0.00201021,0.0008947759],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006664574,0.00020755433,0.0004141264,0.0013142463,0.0016057227,0.0011848113,0.00083186146,0.0003617816,0.0020191206],"category_scores_gemma":[0.003517323,0.00024995382,0.00050074264,0.006031406,0.00046610035,0.00035398453,0.0007812421,0.0006380198,0.0002094401],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011571049,0.000033382446,0.99427116,0.000023917592,0.000043983044,0.00010894799,0.0001532298,0.00018073921,0.00008672251,0.00011361278,0.0014716615,0.0033969935],"study_design_scores_gemma":[0.000025247808,0.00004140836,0.9960937,0.0000260086,0.00006287785,0.0001658764,0.0007725601,0.00047910804,0.000101350546,0.000023234497,0.0021984747,0.000010244205],"about_ca_topic_score_codex":0.98673475,"about_ca_topic_score_gemma":0.99273247,"teacher_disagreement_score":0.023518026,"about_ca_system_score_codex":0.023518026,"about_ca_system_score_gemma":0.04253894,"threshold_uncertainty_score":0.170636},"labels":[],"label_agreement":null},{"id":"W2589428111","doi":"10.1200/jco.2005.23.16_suppl.5566","title":"A phase II study of BAY 43–9006 in patients with recurrent and/or metastatic head and neck squamous cell carcinoma (HNSCC) and nasopharyngeal cancer (NPC)","year":2005,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bayer (Canada)","funders":"","keywords":"Medicine; Head and neck squamous-cell carcinoma; Internal medicine; Oncology; Progressive disease; Cancer; KRAS; Head and neck cancer; Chemotherapy; Cancer research","score_opus":0.054887103285731785,"score_gpt":0.3927872439765381,"score_spread":0.3379001406908063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589428111","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99545693,0.0011107818,0.00032501944,0.0001735811,0.000077895915,0.0016326344,0.00034512972,0.00005070621,0.00082737854],"genre_scores_gemma":[0.99177575,0.0015121488,0.0011603017,0.00052572356,0.000114340284,0.0016345207,0.001387088,0.000015772377,0.0018744413],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99970067,0.00011968797,0.000018384315,0.000059386966,0.000029429537,0.00007255137],"domain_scores_gemma":[0.9995796,0.000046207104,0.00006144209,0.00003811074,0.000025547473,0.00024906415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011487347,0.0011391818,0.0019131209,0.00036992555,0.00039207577,0.0006449386,0.00069962715,0.0009036624,0.003171534],"category_scores_gemma":[0.0005332957,0.0006118856,0.00096449885,0.00046437455,0.00085107604,0.00064886996,0.00039694033,0.0024006516,0.000976569],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.62449527,0.13067307,0.02160975,0.0009814579,0.0013962006,0.0005685049,0.0006716177,0.0036831375,0.08278412,0.000385482,0.004302344,0.12844904],"study_design_scores_gemma":[0.42682415,0.5444684,0.020948099,0.000023065983,0.00039309723,0.0004500903,0.00009326892,0.0011823886,0.002991743,0.000114517235,0.0024863803,0.00002480062],"about_ca_topic_score_codex":0.0016052014,"about_ca_topic_score_gemma":0.0030983093,"teacher_disagreement_score":0.003171534,"about_ca_system_score_codex":0.00063228817,"about_ca_system_score_gemma":0.0014692533,"threshold_uncertainty_score":0.010609865},"labels":[],"label_agreement":null},{"id":"W2589762716","doi":"10.71781/29309","title":"Nouveaux modes de régulation des voies MAP kinase eucaryotes par phosphorylation","year":2008,"lang":"fr","type":"dissertation","venue":"Papyrus : Institutional Repository (Université de Montréal)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Phosphorylation; Kinase; Cell biology; Biology","score_opus":0.005589219598864192,"score_gpt":0.17145392808000817,"score_spread":0.16586470848114399,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589762716","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9441273,0.0041955523,0.035116285,0.00024257725,0.00008129901,0.00003266733,0.00077259145,0.0004997956,0.0149320075],"genre_scores_gemma":[0.97293234,0.0017592309,0.013945431,0.0000327069,0.000028592833,0.000045319906,0.00069753424,0.0001237266,0.010435113],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997125,0.0000411762,0.0000243687,0.000100253834,0.00007695031,0.00004476127],"domain_scores_gemma":[0.9997243,0.00009281956,0.000046455676,0.000065934335,0.000035539335,0.000034923112],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031138913,0.00044415952,0.0003424421,0.00034041214,0.0005953166,0.0012736164,0.000384619,0.0003261925,0.0012573746],"category_scores_gemma":[0.00043624354,0.00032822235,0.0003147739,0.0002221976,0.00035125721,0.0006382609,0.00047428042,0.0007753496,0.0005968784],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017993893,0.000011340821,0.00054878666,0.000034075023,0.000007269639,0.00006413345,0.00009677196,0.00031800495,0.98902893,0.0037483955,0.00010868355,0.005853747],"study_design_scores_gemma":[0.00001776959,0.00005551041,0.008000242,0.000005787931,0.000012824932,0.00026023967,0.000053680964,0.0016711638,0.9845835,0.00085772976,0.0044649,0.000016682321],"about_ca_topic_score_codex":0.002183512,"about_ca_topic_score_gemma":0.0039016863,"teacher_disagreement_score":0.002183512,"about_ca_system_score_codex":0.00077529304,"about_ca_system_score_gemma":0.0003175742,"threshold_uncertainty_score":0.0056251884},"labels":[],"label_agreement":null},{"id":"W2592587564","doi":"10.3390/ijms18030585","title":"Strategies for Overcoming Resistance in Tumours Harboring BRAF Mutations","year":2017,"lang":"en","type":"review","venue":"International Journal of Molecular Sciences","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nova Scotia Health Authority; Dalhousie University","funders":"","keywords":"Kinase; Acquired resistance; Targeted therapy; Cancer research; Melanoma; MAPK/ERK pathway; Effector; Cancer; Colorectal cancer; Medicine; Mutation; Drug resistance; Bioinformatics; Biology; Gene; Immunology; Internal medicine; Genetics","score_opus":0.07573742879583725,"score_gpt":0.3929465407020033,"score_spread":0.3172091119061661,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592587564","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004040565,0.9964545,0.00045783466,0.00050438865,0.0002567813,0.0000141942255,0.000024229292,0.000021826536,0.0018623382],"genre_scores_gemma":[0.0024391233,0.99520844,0.0006298458,0.00035494467,0.00017102566,0.000018360059,0.00005718173,0.000003458614,0.0011176082],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99985206,0.000026573753,0.0000198181,0.00002279899,0.000059427974,0.000019274366],"domain_scores_gemma":[0.99985194,0.000063790045,0.000024910312,0.0000062923637,0.00003638143,0.000016718077],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040521284,0.00066455436,0.0009222966,0.0020983666,0.0002614579,0.0007022487,0.000735365,0.0009240435,0.003490894],"category_scores_gemma":[0.0004932858,0.00019541572,0.00067818176,0.00075522385,0.0003875489,0.0009846085,0.0005237415,0.002215132,0.0015387791],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007476224,0.0001938253,0.00029173814,0.016112646,0.0001106897,0.0005186134,0.00009327552,0.00053993205,0.0065701394,0.005088496,0.022356164,0.9480498],"study_design_scores_gemma":[0.000027085145,0.00019052264,0.0009755382,0.0026212423,0.0001100341,0.002732717,0.0000722265,0.00015132995,0.002023834,0.002229881,0.9888439,0.000021628168],"about_ca_topic_score_codex":0.0005194333,"about_ca_topic_score_gemma":0.0012236031,"teacher_disagreement_score":0.003490894,"about_ca_system_score_codex":0.00040310726,"about_ca_system_score_gemma":0.0005230912,"threshold_uncertainty_score":0.011678219},"labels":[],"label_agreement":null},{"id":"W2592846677","doi":"10.71781/32289","title":"Rôle physiologique de la MAP kinase atypique ERK3 : analyse génétique et étude de l'expression génique chez la souris","year":2007,"lang":"fr","type":"dissertation","venue":"Papyrus : Institutional Repository (Université de Montréal)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Medical Research Council; Canadian Institutes of Health Research; Medical Research Council Canada; Heart and Stroke Foundation of Canada","keywords":"Molecular biology; Philosophy; Biology","score_opus":0.003582079347832778,"score_gpt":0.20593475539936817,"score_spread":0.2023526760515354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592846677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912226,0.0014800085,0.0035612446,0.00019329798,0.000016388496,0.000026777212,0.0006795173,0.000051925817,0.0027682083],"genre_scores_gemma":[0.98537606,0.0011075927,0.0030156197,0.0000715573,0.0000075023836,0.000037844475,0.0006960203,0.00004053009,0.009647235],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999113,0.000011402993,0.0000040041477,0.000023316385,0.000025593561,0.00002426931],"domain_scores_gemma":[0.9998884,0.00004123025,0.000016211092,0.000011635982,0.000026815094,0.000015628431],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020905284,0.0002945839,0.00018537733,0.0004313993,0.00050447776,0.0005229015,0.0002943697,0.00041471046,0.002400078],"category_scores_gemma":[0.00016075582,0.00023546921,0.00041932962,0.00027321404,0.00039717616,0.00029314778,0.00023793886,0.0006227084,0.0005424194],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007676099,0.000007667636,0.0010533871,0.000018567303,0.0000035428582,0.00007260587,0.00003771272,0.00006856769,0.99737465,0.00018721953,0.000027453496,0.0010718087],"study_design_scores_gemma":[0.000024930016,0.00011887026,0.10431378,0.0000099844,0.000033619577,0.0007964279,0.00022651775,0.0015166557,0.8872071,0.00022215497,0.0055168266,0.000013135666],"about_ca_topic_score_codex":0.014640325,"about_ca_topic_score_gemma":0.0112040825,"teacher_disagreement_score":0.014640325,"about_ca_system_score_codex":0.0007532964,"about_ca_system_score_gemma":0.0006170157,"threshold_uncertainty_score":0.029110253},"labels":[],"label_agreement":null},{"id":"W2594529508","doi":"10.1016/s1470-2045(17)30180-8","title":"Binimetinib versus dacarbazine in patients with advanced NRAS-mutant melanoma (NEMO): a multicentre, open-label, randomised, phase 3 trial","year":2017,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":491,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Dacarbazine; Medicine; Neuroblastoma RAS viral oncogene homolog; Hazard ratio; Melanoma; Internal medicine; Clinical endpoint; Population; Adverse effect; Oncology; Progression-free survival; Randomized controlled trial; Vemurafenib; Cancer; Confidence interval; Chemotherapy; Metastatic melanoma; Cancer research; Colorectal cancer","score_opus":0.05756250214883237,"score_gpt":0.3665577832550817,"score_spread":0.30899528110624935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594529508","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868499,0.0062151756,0.00054206024,0.0012367037,0.0006123555,0.0013237024,0.0009218091,0.00008536401,0.0022130667],"genre_scores_gemma":[0.9869363,0.003728971,0.00093712483,0.0012893764,0.00028644953,0.0013224629,0.0011487555,0.000028760838,0.0043218345],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9996853,0.00014974098,0.000012967834,0.000054089203,0.00002190712,0.00007601962],"domain_scores_gemma":[0.99958855,0.000094968214,0.000085553074,0.000029691724,0.000021922388,0.00017931231],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010900913,0.0015662229,0.002195093,0.00025783526,0.00033874618,0.0010490093,0.00062124594,0.0011643438,0.0052768295],"category_scores_gemma":[0.0010288924,0.00050826935,0.0017016674,0.00033562168,0.00085117744,0.0011798054,0.00043051218,0.0031542596,0.0008562604],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9669834,0.0030715838,0.00077327417,0.00065932365,0.0011657494,0.000051694107,0.000079425896,0.0007177944,0.003389788,0.00016771349,0.0012903878,0.021649847],"study_design_scores_gemma":[0.942104,0.05258199,0.0024016201,0.000052156433,0.0004144834,0.00006822674,0.000046827154,0.00048566784,0.0003248769,0.00037472678,0.0011260752,0.000019225577],"about_ca_topic_score_codex":0.0010510575,"about_ca_topic_score_gemma":0.0033707332,"teacher_disagreement_score":0.0052768295,"about_ca_system_score_codex":0.00087501865,"about_ca_system_score_gemma":0.00068036275,"threshold_uncertainty_score":0.01765275},"labels":[],"label_agreement":null},{"id":"W2595795225","doi":"10.7150/thno.18238","title":"Design and Development of Fluorescent Vemurafenib Analogs for <i>In Vivo</i> Imaging","year":2017,"lang":"en","type":"article","venue":"Theranostics","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Biomedical Imaging and Bioengineering; National Cancer Institute; National Heart, Lung, and Blood Institute; National Institute of General Medical Sciences; Natural Sciences and Engineering Research Council of Canada; Austrian Science Fund","keywords":"Vemurafenib; In vivo; Fluorescence; Chemistry; Nanotechnology; Biomedical engineering; Biophysics; Medicine; Materials science; Biology; Internal medicine; Biotechnology; Physics; Cancer; Optics","score_opus":0.024428557461649934,"score_gpt":0.2605637515785838,"score_spread":0.23613519411693387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2595795225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9240242,0.002929864,0.063253656,0.00036822958,0.00006285325,0.00081618404,0.0005014218,0.00023775763,0.007805824],"genre_scores_gemma":[0.9613927,0.0015185161,0.03247905,0.00014600746,0.000015629506,0.00032681215,0.00054773455,0.000034127825,0.0035395713],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998983,0.000020838184,0.0000073109923,0.000021423848,0.00002303732,0.000029110075],"domain_scores_gemma":[0.9999105,0.000010535961,0.000029620103,0.0000084527655,0.000015786169,0.000025187283],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023559786,0.0003213771,0.00021788402,0.00011313142,0.00015636015,0.0002790659,0.0004740608,0.0003655428,0.0011287895],"category_scores_gemma":[0.00020656464,0.00017176928,0.00020216875,0.00009234563,0.00015635254,0.00032816664,0.00017524674,0.00055852253,0.00034082326],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028073415,0.00013083269,0.00014369437,0.00009624044,0.000009744099,0.0001271329,0.000039102422,0.002195407,0.9831512,0.001321172,0.00023357039,0.012271113],"study_design_scores_gemma":[0.00011457279,0.0011930603,0.00047043475,0.000007799326,0.000015259146,0.00043109083,0.000017864366,0.0029803491,0.9847815,0.00014492062,0.009824867,0.000018270453],"about_ca_topic_score_codex":0.00054347457,"about_ca_topic_score_gemma":0.0009085923,"teacher_disagreement_score":0.0011287895,"about_ca_system_score_codex":0.00047718905,"about_ca_system_score_gemma":0.00031102358,"threshold_uncertainty_score":0.0037761927},"labels":[],"label_agreement":null},{"id":"W2597369162","doi":"10.1200/jco.2013.31.15_suppl.9046","title":"Open-label, multicenter safety study of vemurafenib in patients with <i>BRAF<sup>V600</sup></i> mutation–positive metastatic melanoma.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Vemurafenib; Rash; Internal medicine; Adverse effect; Metastatic melanoma; Population; Melanoma; Oncology; Surgery; Gastroenterology; Cancer; Cancer research","score_opus":0.05019999233793844,"score_gpt":0.37571206789341166,"score_spread":0.32551207555547323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2597369162","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99588794,0.00095981924,0.00045867404,0.00014270848,0.00004066129,0.00065274024,0.0011212957,0.00003799882,0.0006982684],"genre_scores_gemma":[0.9946696,0.00039472146,0.0007920514,0.0003320403,0.00017658136,0.00071024155,0.0023055365,0.000014691228,0.0006044487],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99901545,0.00055720704,0.00006563033,0.00015948726,0.00010553113,0.00009664429],"domain_scores_gemma":[0.9978047,0.0003580956,0.00078039913,0.00019016075,0.00015742733,0.00070913683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022463356,0.0007915206,0.0013557923,0.00023788578,0.00036241088,0.00084939937,0.00050483906,0.0007570036,0.0029302947],"category_scores_gemma":[0.0020255675,0.00033374585,0.0009763635,0.00033061605,0.0005438347,0.0008337418,0.00034789628,0.0014953286,0.00077797996],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.81658405,0.029517932,0.050849795,0.0005977717,0.0016507132,0.0004838268,0.00037725846,0.00115206,0.026945217,0.0001349327,0.0036038994,0.068102516],"study_design_scores_gemma":[0.39164403,0.47613537,0.11705787,0.000071352275,0.0010267994,0.0013957827,0.00016381596,0.0020132111,0.004859318,0.00022429478,0.005358574,0.000049577942],"about_ca_topic_score_codex":0.00034140554,"about_ca_topic_score_gemma":0.0005763439,"teacher_disagreement_score":0.0029302947,"about_ca_system_score_codex":0.0006069995,"about_ca_system_score_gemma":0.0010000275,"threshold_uncertainty_score":0.011879921},"labels":[],"label_agreement":null},{"id":"W2598875489","doi":"10.1200/jco.2009.27.15_suppl.9054","title":"Long-term survival of patients with metastatic melanoma (MM) treated with dacarbazine (DTIC) or temozolomide (TMZ)","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Dacarbazine; Medicine; Temozolomide; Internal medicine; Chemotherapy; Melanoma; Oncology; Cancer; Surgery; Gastroenterology; Cancer research","score_opus":0.06095066757354006,"score_gpt":0.3711432739701306,"score_spread":0.3101926063965905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2598875489","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99875903,0.00047301716,0.000038788567,0.000054197997,0.000005133955,0.0000064386672,0.00031737314,0.00000290851,0.0003431659],"genre_scores_gemma":[0.99928916,0.000129903,0.00003825378,0.000031833246,0.000010213375,0.000007960346,0.00039893258,6.3583394e-7,0.00009303389],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998481,0.000025213036,0.000017894617,0.000036692516,0.000029500874,0.00004249451],"domain_scores_gemma":[0.99925715,0.000092469054,0.00033815356,0.000018190742,0.000059937207,0.0002340662],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031271388,0.0001085231,0.00023279512,0.000401451,0.0003512127,0.0003613869,0.00016615172,0.00028387902,0.0009000496],"category_scores_gemma":[0.0010033188,0.00007780274,0.00026923313,0.0003838013,0.00014479306,0.00030792708,0.00027111842,0.000409327,0.00016136352],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005225104,0.00006200696,0.9953447,0.000011289831,0.000038560087,0.00013958341,0.00004284056,0.000091213115,0.0003476889,0.0000082691795,0.00015526442,0.003236021],"study_design_scores_gemma":[0.000029978959,0.00064121623,0.9978114,0.0000085957945,0.00005720016,0.00068955723,0.00006321531,0.00017026043,0.00010834961,0.00001545059,0.00040120355,0.0000036339445],"about_ca_topic_score_codex":0.0024735357,"about_ca_topic_score_gemma":0.0040658507,"teacher_disagreement_score":0.0024735357,"about_ca_system_score_codex":0.0004570281,"about_ca_system_score_gemma":0.00032928924,"threshold_uncertainty_score":0.0049182773},"labels":[],"label_agreement":null},{"id":"W2602599927","doi":"10.1200/jco.2013.31.15_suppl.e20045","title":"Outcome and prognostic factors in BRAF mutation positive metastatic melanoma treated with a BRAF inhibitor: A population-based study in British Columbia.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"SKiN Health; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Vemurafenib; Medicine; Internal medicine; Melanoma; Oncology; Metastatic melanoma; Asymptomatic; Population; V600E; Clinical trial; Mutation; Gastroenterology; Cancer; Cancer research","score_opus":0.04258170396466641,"score_gpt":0.35631837989130954,"score_spread":0.3137366759266431,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2602599927","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99779654,0.00025531917,0.000025067295,0.000064995555,0.000005369303,0.000024245757,0.0008909302,0.00000447511,0.0009331683],"genre_scores_gemma":[0.9983077,0.0001867517,0.000029469751,0.00008452189,0.0000063109173,0.000017392213,0.0008078776,0.0000027529238,0.0005572205],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996544,0.000035628203,0.00002155378,0.00007664483,0.000102115504,0.00010956837],"domain_scores_gemma":[0.99935085,0.000052230236,0.00012302706,0.00002901154,0.00017256597,0.00027225984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029040937,0.0004448739,0.0005104632,0.0009645209,0.0014146819,0.00081842317,0.0008493541,0.0006683956,0.002445396],"category_scores_gemma":[0.0007416143,0.00043754897,0.00032939157,0.0022808935,0.000525997,0.00031962994,0.000641051,0.0006700931,0.0005833004],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024800215,0.00010488982,0.9967205,0.000019139656,0.000048972386,0.0003196487,0.00018134296,0.000042054333,0.00029338794,0.000010818961,0.00053622056,0.0014749443],"study_design_scores_gemma":[0.00002660115,0.00007448278,0.9987394,0.000013333589,0.000025661244,0.00020617885,0.00041745903,0.00014790028,0.00002416147,0.000008865168,0.0003088256,0.000007104861],"about_ca_topic_score_codex":0.73694885,"about_ca_topic_score_gemma":0.7672754,"teacher_disagreement_score":0.26305115,"about_ca_system_score_codex":0.0037965074,"about_ca_system_score_gemma":0.0032708177,"threshold_uncertainty_score":0.5292006},"labels":[],"label_agreement":null},{"id":"W2602918057","doi":"10.1200/jco.2013.31.15_suppl.9029","title":"Preliminary results from a phase Ib/II, open-label, dose-escalation study of the oral BRAF inhibitor LGX818 in combination with the oral MEK1/2 inhibitor MEK162 in <i>BRAF</i> V600-dependent advanced solid tumors.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; MEK inhibitor; Internal medicine; Nausea; Adverse effect; Melanoma; Oncology; Cancer; Gastroenterology; Colorectal cancer; Pharmacology; Cancer research; MAPK/ERK pathway; Kinase","score_opus":0.06499674081682533,"score_gpt":0.39974818246612964,"score_spread":0.3347514416493043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2602918057","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.982317,0.0020275728,0.0027844615,0.0010034491,0.00014645343,0.005309488,0.0029209915,0.00023795395,0.0032526234],"genre_scores_gemma":[0.9713846,0.002540914,0.007588239,0.0017811569,0.00016381961,0.0047053113,0.0066758012,0.00013272719,0.0050274367],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9992768,0.0003988124,0.000039524206,0.0000846229,0.00008100658,0.00011918899],"domain_scores_gemma":[0.99875855,0.00034724319,0.00019815646,0.00010298925,0.000086950575,0.0005061579],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023852808,0.0017841223,0.0016981838,0.0003967444,0.0004644547,0.0009523333,0.0010473152,0.0013759892,0.0039725527],"category_scores_gemma":[0.001530388,0.00069197797,0.0011915131,0.00039904928,0.00087337557,0.000989492,0.00032641992,0.0034546233,0.0009578793],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.42775425,0.22673786,0.011500365,0.001597884,0.0023572093,0.0010707151,0.0011228042,0.009200919,0.15163203,0.000509455,0.015252071,0.15126453],"study_design_scores_gemma":[0.26591536,0.68895644,0.020788144,0.00005485363,0.00071688613,0.00091999,0.00012624513,0.0025173135,0.012599611,0.00041079693,0.006934212,0.000060209946],"about_ca_topic_score_codex":0.001726413,"about_ca_topic_score_gemma":0.004160096,"teacher_disagreement_score":0.0039725527,"about_ca_system_score_codex":0.00082259683,"about_ca_system_score_gemma":0.0016603161,"threshold_uncertainty_score":0.013289511},"labels":[],"label_agreement":null},{"id":"W2610260729","doi":"10.1016/j.semcancer.2017.04.016","title":"Defining the role of the RSK isoforms in cancer","year":2017,"lang":"en","type":"review","venue":"Seminars in Cancer Biology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":126,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Cancer Research Society","keywords":"Ribosomal s6 kinase; Kinase; Gene isoform; Biology; MAPK/ERK pathway; Carcinogenesis; Cancer research; Function (biology); Protein kinase A; Cell biology; Cancer; Prostate cancer; Signal transduction; Biochemistry; Genetics; Protein kinase B; Gene; P70-S6 Kinase 1","score_opus":0.03400841041748916,"score_gpt":0.36499854027678286,"score_spread":0.3309901298592937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2610260729","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013677783,0.997974,0.00021605463,0.00047670366,0.00035853602,0.0000026390856,0.000014077356,0.000007329814,0.00081383454],"genre_scores_gemma":[0.0009604551,0.99739385,0.00022799497,0.00034421418,0.0003999973,0.0000048305355,0.000033899545,0.0000020695627,0.0006326493],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997987,0.000029931576,0.00002977164,0.000041037674,0.000066541834,0.000034035154],"domain_scores_gemma":[0.99970067,0.0001209791,0.00004557597,0.000017495955,0.00007792881,0.000037413014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010946165,0.0009672933,0.0012860408,0.0014983916,0.00026806415,0.0015843193,0.0013935546,0.0013756846,0.0023945349],"category_scores_gemma":[0.00083369645,0.00036026997,0.00050885737,0.0016188833,0.0012472675,0.002318137,0.0012275401,0.0033638508,0.0020566923],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016325293,0.000049304443,0.00024579494,0.009466701,0.000106111234,0.0003501028,0.00007160514,0.0005966003,0.0059346333,0.015403014,0.031805597,0.9358072],"study_design_scores_gemma":[0.000025541527,0.000055684493,0.00050803315,0.0011415773,0.00007664669,0.000886525,0.000052162035,0.00010077708,0.0014127686,0.0054097255,0.99030834,0.000022168484],"about_ca_topic_score_codex":0.00063668285,"about_ca_topic_score_gemma":0.0011729107,"teacher_disagreement_score":0.0023945349,"about_ca_system_score_codex":0.00083674624,"about_ca_system_score_gemma":0.0012479257,"threshold_uncertainty_score":0.008010507},"labels":[],"label_agreement":null},{"id":"W2610788188","doi":"10.7554/elife.26947","title":"Size uniformity of animal cells is actively maintained by a p38 MAPK-dependent regulation of G1-length","year":2018,"lang":"en","type":"article","venue":"eLife","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"National Institute of General Medical Sciences; Canadian Institutes of Health Research","keywords":"Cell biology; Cell cycle; Cell size; Cell cycle progression; Cell; Small molecule; Biology; MAPK/ERK pathway; p38 mitogen-activated protein kinases; Biophysics; Chemistry; Signal transduction; Genetics","score_opus":0.007206563809472791,"score_gpt":0.22904273750929793,"score_spread":0.22183617369982514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2610788188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907781,0.0012177749,0.005209702,0.00014151259,0.000017027656,0.000029318973,0.00035407682,0.00015856005,0.002093987],"genre_scores_gemma":[0.99421173,0.000593127,0.0028570092,0.000053279175,0.000006273341,0.000048761103,0.00029534,0.000038569568,0.0018957985],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99985445,0.000013716232,0.000008433258,0.00005305792,0.000035342844,0.000034887344],"domain_scores_gemma":[0.9998449,0.000023255323,0.00006044456,0.000019918285,0.000016207636,0.000035249],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015031308,0.00039302759,0.00024241999,0.00027769877,0.0002497299,0.0003341884,0.00027928123,0.00022004337,0.0012512458],"category_scores_gemma":[0.00022292421,0.00024267436,0.00024322497,0.00017200447,0.00030011236,0.00043461847,0.0004041003,0.000451113,0.00034547396],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052478565,0.000007622863,0.0002078967,0.000013608185,0.0000019095946,0.00002280353,0.000006106019,0.00004398397,0.9986578,0.000093499635,0.000016862621,0.00087535667],"study_design_scores_gemma":[0.000014945884,0.00014925124,0.014547905,0.0000041270546,0.000009568066,0.00013644762,0.000026332704,0.0009250797,0.9819365,0.00018261862,0.0020622646,0.000004893867],"about_ca_topic_score_codex":0.00047412203,"about_ca_topic_score_gemma":0.00084292825,"teacher_disagreement_score":0.0012512458,"about_ca_system_score_codex":0.00041274482,"about_ca_system_score_gemma":0.00017942871,"threshold_uncertainty_score":0.0041858554},"labels":[],"label_agreement":null},{"id":"W2612095536","doi":"10.1016/j.ejca.2017.04.007","title":"Open-label, multicentre safety study of vemurafenib in 3219 patients with BRAF V600 mutation-positive metastatic melanoma: 2-year follow-up data and long-term responders' analysis","year":2017,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Vemurafenib; Medicine; Adverse effect; Internal medicine; Melanoma; Population; Metastatic melanoma; Clinical trial; Oncology; Dermatology; Surgery; Gastroenterology; Cancer; Cancer research","score_opus":0.03186342165667164,"score_gpt":0.3152514821229644,"score_spread":0.2833880604662927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2612095536","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978258,0.00074975187,0.00022872498,0.000049987175,0.00001981411,0.0001071437,0.0007451112,0.000015244426,0.00025834475],"genre_scores_gemma":[0.9958835,0.00031761103,0.0002952912,0.00015226113,0.00005494584,0.0001883011,0.0024180277,0.0000123283,0.0006776671],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9991247,0.00039895673,0.00006841944,0.00020072842,0.00010045839,0.00010679339],"domain_scores_gemma":[0.9984397,0.0004279152,0.00038674904,0.000307892,0.00012304228,0.00031470507],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018760961,0.0008201677,0.002273239,0.0002743291,0.00040149232,0.0009216479,0.0005307576,0.0009214955,0.0016629052],"category_scores_gemma":[0.0016331488,0.00039748775,0.0018658104,0.00047558857,0.0006843494,0.0009688354,0.00036316016,0.0013181174,0.0005990589],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.82211936,0.0075177522,0.09112382,0.0006773331,0.004705517,0.0005435397,0.0003437961,0.0022444003,0.018885188,0.00014302137,0.0017026073,0.04999376],"study_design_scores_gemma":[0.26141512,0.20861055,0.5078371,0.00009780314,0.005164476,0.0017546213,0.00034985325,0.0031360432,0.0048582805,0.00058617,0.006012527,0.0001774919],"about_ca_topic_score_codex":0.0004058749,"about_ca_topic_score_gemma":0.00059997145,"teacher_disagreement_score":0.002273239,"about_ca_system_score_codex":0.00060402276,"about_ca_system_score_gemma":0.0005274505,"threshold_uncertainty_score":0.009921908},"labels":[],"label_agreement":null},{"id":"W2620067227","doi":"10.18632/oncotarget.18264","title":"The p38 pathway, a major pleiotropic cascade that transduces stress and metastatic signals in endothelial cells","year":2017,"lang":"en","type":"review","venue":"Oncotarget","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":197,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval","funders":"","keywords":"Cell biology; Angiogenesis; Biology; p38 mitogen-activated protein kinases; Signal transduction; Inflammation; Endothelial stem cell; MAPK/ERK pathway; Protein kinase A; Homeostasis; Kinase; Cancer research; Immunology; Genetics","score_opus":0.05936227944713657,"score_gpt":0.32146177999053877,"score_spread":0.2620995005434022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2620067227","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00039428013,0.9955413,0.00061954866,0.00062092126,0.00042140175,0.000011349497,0.000042635304,0.000031983083,0.0023165785],"genre_scores_gemma":[0.002594472,0.9945491,0.00040948903,0.0003288442,0.00032659984,0.000017787663,0.00006778969,0.0000043714517,0.0017014921],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999803,0.000024817236,0.000024557974,0.000038192793,0.00008433632,0.000025054112],"domain_scores_gemma":[0.9998728,0.000035442525,0.000023031307,0.0000042026445,0.00004193487,0.000022605343],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036578995,0.000880712,0.0007435757,0.0016415556,0.00031610945,0.0008072155,0.0005451641,0.00083039,0.002313193],"category_scores_gemma":[0.0003044397,0.00021525664,0.00035632614,0.0012212557,0.00053735345,0.0009999012,0.00061951,0.0018147175,0.002069234],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000105490784,0.000074569616,0.0003454051,0.009319225,0.00008164885,0.00053857156,0.00007629766,0.00031675544,0.013388576,0.0049560466,0.03551504,0.9352824],"study_design_scores_gemma":[0.000018686907,0.000098229364,0.0010770553,0.0007324951,0.000052927182,0.0023757908,0.000039943723,0.000099431534,0.004236721,0.0018400785,0.98940533,0.000023180042],"about_ca_topic_score_codex":0.0005021639,"about_ca_topic_score_gemma":0.00087009213,"teacher_disagreement_score":0.002313193,"about_ca_system_score_codex":0.00066062564,"about_ca_system_score_gemma":0.00092204043,"threshold_uncertainty_score":0.0077384114},"labels":[],"label_agreement":null},{"id":"W2620651944","doi":"10.1016/s1470-2045(17)30429-1","title":"Dabrafenib plus trametinib in patients with BRAFV600-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trial","year":2017,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":775,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Bristol-Myers Squibb","keywords":"Dabrafenib; Trametinib; Medicine; Melanoma; Asymptomatic; Clinical endpoint; Oncology; MEK inhibitor; Internal medicine; Brain metastasis; Phases of clinical research; Clinical trial; Metastatic melanoma; Cancer; Metastasis; Vemurafenib; Cancer research; Biology; MAPK/ERK pathway","score_opus":0.06803476530507808,"score_gpt":0.3693754023310494,"score_spread":0.3013406370259713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2620651944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98666346,0.006475767,0.0005005918,0.0011807433,0.00038114883,0.0011706512,0.0015595811,0.00013062042,0.0019373157],"genre_scores_gemma":[0.9860643,0.004207412,0.0011384309,0.001179339,0.0002566124,0.0012121841,0.0022400622,0.000036401205,0.003665228],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9997092,0.00012243155,0.000011925414,0.000051701205,0.000020822563,0.00008385973],"domain_scores_gemma":[0.9996464,0.000062201,0.0000697324,0.000027226337,0.00002484214,0.000169678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010738944,0.0019305135,0.0020839733,0.00030135585,0.0003264059,0.0012321703,0.00062587706,0.0012774707,0.004048687],"category_scores_gemma":[0.0008114746,0.00055796595,0.0017528656,0.00038390647,0.0006614232,0.0011905857,0.00030460255,0.0028703695,0.0009952836],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9135118,0.005962158,0.0020982695,0.0010371037,0.0023846233,0.00013881607,0.00013288867,0.001422704,0.008270795,0.00028523142,0.004287895,0.060467727],"study_design_scores_gemma":[0.9286817,0.06172111,0.004618043,0.000048546168,0.00072482636,0.00019447955,0.00006409946,0.0008643386,0.0006746161,0.00036208585,0.0020109245,0.00003526246],"about_ca_topic_score_codex":0.0013672966,"about_ca_topic_score_gemma":0.004532118,"teacher_disagreement_score":0.004048687,"about_ca_system_score_codex":0.001021348,"about_ca_system_score_gemma":0.0008634322,"threshold_uncertainty_score":0.013544142},"labels":[],"label_agreement":null},{"id":"W263438489","doi":"10.1016/j.bbcan.2015.05.001","title":"Tracing the footprints of the breast cancer oncogene BRK — Past till present","year":2015,"lang":"en","type":"review","venue":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Kinase; Carcinogenesis; Biology; Receptor tyrosine kinase; Cancer research; Tyrosine kinase; Breast cancer; Cancer; Metastasis; Oncogene; Signal transduction; Cell biology; Genetics; Cell cycle","score_opus":0.07008028108793904,"score_gpt":0.35974380642426834,"score_spread":0.28966352533632933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W263438489","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00043331273,0.99758077,0.00035827633,0.00037884727,0.00016200733,0.0000019164188,0.000023584034,0.000010286304,0.0010510552],"genre_scores_gemma":[0.0033843634,0.99480236,0.0003419204,0.0002883889,0.00011919447,0.0000034237587,0.000047777492,0.000004707103,0.0010078406],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998572,0.000024454459,0.000010521283,0.000030178051,0.000054830816,0.000022853766],"domain_scores_gemma":[0.9997391,0.00010068758,0.000043345397,0.000017957182,0.000069449685,0.000029361145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006702205,0.00061351195,0.00091178494,0.0010065051,0.00023542679,0.0010591,0.00086722785,0.0008382246,0.0018655155],"category_scores_gemma":[0.00075681246,0.00039903258,0.00034964154,0.0010525781,0.00082755735,0.0017066086,0.0007490712,0.0018139007,0.0015001899],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023015455,0.0000447429,0.00045968464,0.014220776,0.00009371759,0.00035935102,0.00016978612,0.0006763016,0.048542354,0.015099903,0.02287926,0.89722395],"study_design_scores_gemma":[0.000011603219,0.00006774061,0.0008657907,0.0010812775,0.0000691346,0.0007140196,0.000090172645,0.00009519616,0.015644372,0.0055585452,0.97578037,0.000021872786],"about_ca_topic_score_codex":0.0013141249,"about_ca_topic_score_gemma":0.0025134233,"teacher_disagreement_score":0.0018655155,"about_ca_system_score_codex":0.00091958215,"about_ca_system_score_gemma":0.00094000256,"threshold_uncertainty_score":0.0066720247},"labels":[],"label_agreement":null},{"id":"W2725132187","doi":"10.1161/res.109.suppl_1.ap188","title":"Abstract P188: Suppression of MK2 Signaling Protects Against Pressure Overload-Induced Cardiac Dysfunction","year":2011,"lang":"en","type":"article","venue":"Circulation Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"","keywords":"Pressure overload; Internal medicine; Medicine; p38 mitogen-activated protein kinases; Endocrinology; Diastole; Ventricular remodeling; Blood pressure; Heart failure; Chemistry; Kinase; Cardiology; MAPK/ERK pathway; Biochemistry","score_opus":0.09826054560905076,"score_gpt":0.31573047476317734,"score_spread":0.21746992915412658,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2725132187","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98855597,0.001907956,0.0027065384,0.00036955415,0.00023887907,0.00008142486,0.0028587861,0.00055729935,0.0027236748],"genre_scores_gemma":[0.984665,0.0013049361,0.0020364597,0.00017364105,0.00010282389,0.00017183294,0.0020605181,0.000089598674,0.009395169],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99987984,0.000017385613,0.000012015015,0.00002209672,0.000026728645,0.000041891675],"domain_scores_gemma":[0.9998927,0.00000853646,0.000029582061,0.00000883867,0.000006414896,0.000053849486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010361651,0.00080333196,0.0006599193,0.00020376204,0.00016314363,0.00032862282,0.00025367294,0.0003145822,0.0046567344],"category_scores_gemma":[0.00008871988,0.00016195097,0.00028441218,0.00015139491,0.00035921333,0.00025748322,0.00017693854,0.0012767159,0.0012865161],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022559762,0.00026417954,0.0001673828,0.00012686334,0.000017037211,0.00011744314,0.000024802099,0.00011005807,0.9940948,0.00015616397,0.0005417579,0.0021235978],"study_design_scores_gemma":[0.00055202167,0.005197882,0.0071536857,0.000024150457,0.00005597741,0.0005276442,0.000098431534,0.0010137359,0.9780742,0.00013660418,0.0071490854,0.000016496046],"about_ca_topic_score_codex":0.00038879522,"about_ca_topic_score_gemma":0.0004973187,"teacher_disagreement_score":0.0046567344,"about_ca_system_score_codex":0.00020063977,"about_ca_system_score_gemma":0.00027260493,"threshold_uncertainty_score":0.01557833},"labels":[],"label_agreement":null},{"id":"W2727112076","doi":"10.1200/jco.2017.35.15_suppl.e21060","title":"Non-classical BRAF melanoma: A retrospective review of disease characteristics and prognostic implications.","year":2017,"lang":"en","type":"review","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; V600E; Melanoma; Retrospective cohort study; Internal medicine; Oncology; Cohort; Cancer; Disease; Mutation; Vemurafenib; Cancer research; Metastatic melanoma; Gene; Genetics; Biology","score_opus":0.14645723722527285,"score_gpt":0.4762306594476197,"score_spread":0.32977342222234685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2727112076","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9276474,0.06682056,0.0002685237,0.00015699265,0.000041906947,0.000083401224,0.002820662,0.000019072924,0.0021414266],"genre_scores_gemma":[0.9767046,0.0203655,0.00031187842,0.00016634009,0.000060977025,0.000050225208,0.0018923032,0.0000063630837,0.00044171463],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996654,0.000050535684,0.00009412989,0.00008171387,0.00007360083,0.000034613062],"domain_scores_gemma":[0.9986547,0.00037733515,0.0006421531,0.000059667484,0.0001677492,0.000098396726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005635064,0.00019793058,0.0003693695,0.0017549503,0.00022729461,0.00029497317,0.00032615705,0.00031183683,0.0018535834],"category_scores_gemma":[0.0012232915,0.0002821134,0.00029753038,0.0024754463,0.00022261472,0.00042803315,0.00026731176,0.00018736297,0.0006164214],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020822888,0.000047029105,0.95765895,0.0009731094,0.00011653545,0.0067953235,0.00019742484,0.00004327379,0.0007555362,0.00005965994,0.0019847127,0.03116018],"study_design_scores_gemma":[0.00002427533,0.00020866907,0.9563833,0.00044984446,0.00013297972,0.03647204,0.0004188695,0.00006424448,0.00023858658,0.000038874823,0.0055569173,0.000011410434],"about_ca_topic_score_codex":0.0017415549,"about_ca_topic_score_gemma":0.0025462662,"teacher_disagreement_score":0.0018535834,"about_ca_system_score_codex":0.0002493654,"about_ca_system_score_gemma":0.00044103386,"threshold_uncertainty_score":0.00620085},"labels":[],"label_agreement":null},{"id":"W2731399710","doi":"10.1038/s41598-017-05482-y","title":"GLYAT regulates JNK-mediated cell death in Drosophila","year":2017,"lang":"en","type":"article","venue":"Scientific Reports","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Genetics; National Natural Science Foundation of China; Natural Science Foundation of Shanghai","keywords":"Cell biology; Programmed cell death; Kinase; Ectopic expression; Biology; Signal transduction; Cell; Gene; Cell growth; Function (biology); Apoptosis; Genetics","score_opus":0.01411910575121484,"score_gpt":0.2391566058814915,"score_spread":0.22503750013027668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2731399710","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992834,0.0011336036,0.00237015,0.00012916063,0.00003588485,0.000025097264,0.00083019777,0.00010429148,0.002537601],"genre_scores_gemma":[0.9923423,0.00069997896,0.0019431394,0.000097628574,0.000007221828,0.000033559056,0.000776553,0.000046357316,0.0040533417],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999124,0.000012532949,0.000009578676,0.000025340347,0.00002056528,0.000019633524],"domain_scores_gemma":[0.9999163,0.000008877654,0.00003158467,0.0000062319305,0.000008966469,0.000027989836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000723753,0.0004720712,0.00017489068,0.0003288218,0.00022585693,0.00029069,0.00021306015,0.00021080063,0.0011164679],"category_scores_gemma":[0.000055357534,0.00016390046,0.00026151576,0.000116500116,0.00027398692,0.00017515737,0.00025347638,0.0005655672,0.0005425742],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047846424,0.0000069672824,0.00012337408,0.000015871463,0.0000020528653,0.000039602728,0.000007400539,0.000026601409,0.99932075,0.0000734859,0.000021195956,0.00031485784],"study_design_scores_gemma":[0.000020788584,0.00007559362,0.0073234886,0.0000058104447,0.000017656743,0.00020847142,0.00003871261,0.0009556517,0.9887838,0.00008285495,0.00248135,0.000005967952],"about_ca_topic_score_codex":0.0010258182,"about_ca_topic_score_gemma":0.0018085842,"teacher_disagreement_score":0.0011164679,"about_ca_system_score_codex":0.0005746306,"about_ca_system_score_gemma":0.00022540217,"threshold_uncertainty_score":0.0041692853},"labels":[],"label_agreement":null},{"id":"W2737779999","doi":"10.1016/j.bbadis.2017.07.015","title":"Protecting the heart through MK2 modulation, toward a role in diabetic cardiomyopathy and lipid metabolism","year":2017,"lang":"en","type":"review","venue":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada","keywords":"Lipid metabolism; Diabetic cardiomyopathy; Diabetes mellitus; Medicine; Bioinformatics; Inflammation; Signal transduction; Cardiomyopathy; Biology; Heart failure; Endocrinology; Internal medicine; Cell biology","score_opus":0.03282656073238309,"score_gpt":0.3021240001889688,"score_spread":0.2692974394565857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2737779999","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00041088578,0.99809474,0.00016596745,0.00032692013,0.00021245157,0.000003991259,0.00002548839,0.000007968177,0.0007514369],"genre_scores_gemma":[0.0024824117,0.9960206,0.0002317308,0.00024784319,0.00020699244,0.000006744545,0.000036459725,0.0000015856984,0.0007655666],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999941,0.0000072504304,0.000009782365,0.000013656514,0.000019551684,0.000008788187],"domain_scores_gemma":[0.99993014,0.000020627105,0.000014855943,0.000002714141,0.000021770471,0.000009753772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030060203,0.0006871419,0.0007808897,0.0008843636,0.0001966681,0.0007365356,0.00061330583,0.0006012279,0.0019483124],"category_scores_gemma":[0.00027255426,0.00017638419,0.00025168806,0.0007089907,0.0003940276,0.00086694694,0.00046173745,0.0015654735,0.0009691086],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034477844,0.00016308173,0.00040835008,0.016189706,0.00012898538,0.00044580342,0.00008690959,0.00043509618,0.01545573,0.0060527762,0.029073862,0.931215],"study_design_scores_gemma":[0.00009428775,0.00029123467,0.0021291238,0.001988063,0.00024581762,0.0016553848,0.000100903264,0.00019468208,0.0040357667,0.0042879246,0.98494357,0.000033203454],"about_ca_topic_score_codex":0.00055651675,"about_ca_topic_score_gemma":0.0017580178,"teacher_disagreement_score":0.0019483124,"about_ca_system_score_codex":0.0003177865,"about_ca_system_score_gemma":0.0005940741,"threshold_uncertainty_score":0.0065178275},"labels":[],"label_agreement":null},{"id":"W2740393355","doi":"10.1093/annonc/mdx339","title":"Vemurafenib in patients with BRAFV600 mutation-positive metastatic melanoma: final overall survival results of the randomized BRIM-3 study","year":2017,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":258,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"National Cancer Institute; F. Hoffmann-La Roche; Roche","keywords":"Vemurafenib; Dacarbazine; Medicine; Confidence interval; Hazard ratio; Internal medicine; Metastatic melanoma; Progression-free survival; Melanoma; Gastroenterology; Oncology; Chemotherapy; Cancer; Cancer research","score_opus":0.04370504422132651,"score_gpt":0.32638251676067626,"score_spread":0.2826774725393497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740393355","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906645,0.0065956293,0.00029457547,0.00055526546,0.00017753206,0.000138329,0.00044687928,0.000046835718,0.0010805674],"genre_scores_gemma":[0.99554414,0.0018668541,0.00027534814,0.00043691412,0.00013177536,0.0001781053,0.00063545175,0.000016406617,0.00091501116],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9995809,0.00021380406,0.000020530366,0.000056718283,0.000040216484,0.00008779708],"domain_scores_gemma":[0.99966335,0.000081145794,0.00009732751,0.00003406669,0.000020629412,0.00010346163],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012804345,0.00095197035,0.0016972803,0.00020269665,0.0002320003,0.00092976,0.00052989274,0.0007006317,0.0017838284],"category_scores_gemma":[0.0009903872,0.00041279595,0.002095418,0.00023260232,0.00045691873,0.0007880582,0.00039117024,0.0019594147,0.00034880024],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8918924,0.003499961,0.009892793,0.0011412246,0.0054802583,0.0001506114,0.00010390487,0.003003365,0.009927466,0.00035477444,0.0032731437,0.07128015],"study_design_scores_gemma":[0.8263823,0.086690605,0.068151034,0.00014438789,0.0072912425,0.00031843147,0.0001553063,0.0030550594,0.002354978,0.0010512584,0.0043133725,0.00009215372],"about_ca_topic_score_codex":0.00084318843,"about_ca_topic_score_gemma":0.0023717755,"teacher_disagreement_score":0.0017838284,"about_ca_system_score_codex":0.0007712723,"about_ca_system_score_gemma":0.0005833199,"threshold_uncertainty_score":0.0067716837},"labels":[],"label_agreement":null},{"id":"W2745512715","doi":"10.18632/oncotarget.20534","title":"Combined targeting of Raf and Mek synergistically inhibits tumorigenesis in triple negative breast cancer model systems","year":2017,"lang":"en","type":"article","venue":"Oncotarget","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Terry Fox Foundation","keywords":"Triple-negative breast cancer; MAPK/ERK pathway; Cancer research; Erlotinib; Lapatinib; MEK inhibitor; Epidermal growth factor receptor; Breast cancer; Medicine; Cancer; Receptor tyrosine kinase; Carcinogenesis; EGFR inhibitors; Kinase; Biology; Internal medicine; Receptor; Cell biology","score_opus":0.012358972104898003,"score_gpt":0.2579569937641509,"score_spread":0.24559802165925287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2745512715","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98272264,0.004657697,0.0035984993,0.000399892,0.00014592921,0.00014096005,0.0011071498,0.0002965576,0.0069305697],"genre_scores_gemma":[0.988342,0.0026136355,0.0032293196,0.00008755488,0.0000130854805,0.00013402803,0.00061180984,0.000031363204,0.004937187],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99975115,0.000041476775,0.000020690137,0.000031856893,0.000086604035,0.0000681507],"domain_scores_gemma":[0.9999114,0.000013315021,0.000017216611,0.000011233874,0.000013688813,0.000033185126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023535766,0.0005474336,0.0005225602,0.0005176192,0.00026087475,0.00045158842,0.00032002782,0.00029619847,0.001259786],"category_scores_gemma":[0.00009483022,0.00023926013,0.0004196801,0.0002531151,0.0002068368,0.0002751487,0.00036358438,0.0008814268,0.0005214909],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048434228,0.0003188632,0.00032511717,0.0001369798,0.000047292968,0.00008855753,0.00004689277,0.00056674355,0.9915837,0.00026397328,0.00077978836,0.0053577614],"study_design_scores_gemma":[0.00009283236,0.001893343,0.0024133124,0.000013978348,0.00007831505,0.0003607882,0.000085755244,0.003175033,0.9851327,0.000094167895,0.006645562,0.000014230533],"about_ca_topic_score_codex":0.0014462604,"about_ca_topic_score_gemma":0.0054939,"teacher_disagreement_score":0.0014462604,"about_ca_system_score_codex":0.0004679733,"about_ca_system_score_gemma":0.0005030188,"threshold_uncertainty_score":0.0042143464},"labels":[],"label_agreement":null},{"id":"W2745595414","doi":"10.1016/j.jid.2017.07.832","title":"Associations of MC1R Genotype and Patient Phenotypes with BRAF and NRAS Mutations in Melanoma","year":2017,"lang":"en","type":"article","venue":"Journal of Investigative Dermatology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Institute of Environmental Health Sciences; National Institute of General Medical Sciences; National Cancer Institute","keywords":"Neuroblastoma RAS viral oncogene homolog; Melanoma; Medicine; Phenotype; V600E; Genotype; Population; Dermatology; Oncology; Cancer research; Internal medicine; Cancer; Mutation; Gene; Genetics; Biology","score_opus":0.018180276651612533,"score_gpt":0.25044554508459094,"score_spread":0.2322652684329784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2745595414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987803,0.00032348474,0.00009251038,0.000050687442,0.0000062049116,0.000003436502,0.0001801118,0.000010075841,0.0005532042],"genre_scores_gemma":[0.9996076,0.000055596112,0.00009474948,0.00001483176,0.000009014004,0.0000022565866,0.00007492785,0.000004943423,0.00013613822],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99932265,0.00016531443,0.000118674856,0.00016899058,0.00013027334,0.00009405177],"domain_scores_gemma":[0.9975694,0.0009779857,0.0008701231,0.0001618736,0.00013383571,0.00028677503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054716313,0.00054332515,0.00055308826,0.001605787,0.0004825826,0.0006749359,0.0005073838,0.00094686955,0.004267124],"category_scores_gemma":[0.0029774536,0.0002785016,0.00054885604,0.0010193178,0.0003867305,0.00043638246,0.00036907522,0.00059722917,0.00045382918],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010219321,0.00008609077,0.9810783,0.000024148885,0.0001481905,0.0037816144,0.0001677029,0.00018094521,0.010047941,0.00010019348,0.00015540188,0.0032075262],"study_design_scores_gemma":[0.000015454765,0.00019944423,0.9814926,0.000009994489,0.00010627797,0.015371211,0.00017217104,0.00060078077,0.0015380536,0.00014385788,0.00033067638,0.000019446277],"about_ca_topic_score_codex":0.0007576084,"about_ca_topic_score_gemma":0.000891554,"teacher_disagreement_score":0.004267124,"about_ca_system_score_codex":0.00022833723,"about_ca_system_score_gemma":0.00020044034,"threshold_uncertainty_score":0.014274955},"labels":[],"label_agreement":null},{"id":"W2745671375","doi":"10.1200/jco.2017.35.15_suppl.3063","title":"Atezolizumab (A) + cobimetinib (C) + vemurafenib (V) in BRAF<sup>V600</sup>-mutant metastatic melanoma (mel): Updated safety and clinical activity.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; Vemurafenib; Maculopapular rash; Rash; Nausea; Internal medicine; Melanoma; Atezolizumab; CD8; Adverse effect; Oncology; Gastroenterology; Metastatic melanoma; Pharmacology; Nivolumab; Cancer; Cancer research; Immune system; Immunotherapy; Immunology","score_opus":0.08158401592202198,"score_gpt":0.42470405659330257,"score_spread":0.3431200406712806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2745671375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96327555,0.028641097,0.0009848673,0.0005531353,0.00009977942,0.00029333966,0.0009365255,0.000101103964,0.0051145707],"genre_scores_gemma":[0.9912635,0.0053441254,0.00073122303,0.00030038483,0.000062145125,0.00010457733,0.0011978174,0.000009240291,0.0009869878],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9998635,0.000048486585,0.00001934449,0.000018668801,0.000030779207,0.000019317427],"domain_scores_gemma":[0.99972993,0.000064645166,0.00012311261,0.000015062084,0.000022683218,0.000044622033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055136473,0.00021830866,0.00041914973,0.00019705927,0.00011060855,0.00033208623,0.0002426031,0.00020737076,0.0015947538],"category_scores_gemma":[0.0004502379,0.00010376789,0.00046246027,0.0001940845,0.000109934634,0.0002464386,0.00014399092,0.00085252884,0.0003112416],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11371833,0.005194247,0.033177365,0.0022752725,0.0009808992,0.0004720471,0.0001320145,0.0035474917,0.054546595,0.00046385796,0.007560097,0.7779318],"study_design_scores_gemma":[0.079205684,0.51270795,0.22018722,0.0011185457,0.0040770276,0.011207836,0.00023881748,0.010749201,0.05810049,0.001143201,0.10116552,0.000098519784],"about_ca_topic_score_codex":0.00032811504,"about_ca_topic_score_gemma":0.0013158777,"teacher_disagreement_score":0.0015947538,"about_ca_system_score_codex":0.0003633179,"about_ca_system_score_gemma":0.00033985634,"threshold_uncertainty_score":0.0053349733},"labels":[],"label_agreement":null},{"id":"W2751872432","doi":"10.1016/j.jid.2017.07.807","title":"610 A case of metastatic malignant melanoma of the scalp responding to ipilimumab","year":2017,"lang":"en","type":"article","venue":"Journal of Investigative Dermatology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Regina Qu'Appelle Health Region; University of Saskatchewan","funders":"","keywords":"Ipilimumab; Medicine; Melanoma; Dabrafenib; Oncology; Dermatology; Scalp; Immunotherapy; Vemurafenib; Internal medicine; Surgery; Metastatic melanoma; Cancer; Cancer research","score_opus":0.03018014890233582,"score_gpt":0.29407970882405676,"score_spread":0.2638995599217209,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2751872432","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9740384,0.0035163932,0.0035982959,0.0018464697,0.00031162892,0.00012711076,0.00025185413,0.00027772097,0.01603206],"genre_scores_gemma":[0.99476707,0.00093667634,0.001133906,0.0003636073,0.0004274909,0.000030076522,0.000073762254,0.000024352064,0.0022429929],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99967444,0.000031044397,0.000022667646,0.00006605591,0.00005709427,0.00014876378],"domain_scores_gemma":[0.9992305,0.00018470711,0.00015803841,0.000086009015,0.000055183264,0.00028553623],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023104646,0.001383338,0.00078653265,0.0015913789,0.0019323344,0.0011474978,0.00077359425,0.0028272322,0.0027783134],"category_scores_gemma":[0.0013886753,0.0006994285,0.00094538083,0.0011722182,0.00094310375,0.0010238747,0.0008019739,0.0020423527,0.0010293768],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019794745,0.000011344552,0.0014992751,0.000018652545,0.0000034545058,0.9961701,0.00009071709,0.0000516993,0.0010499794,0.00008369924,0.000121372395,0.000879946],"study_design_scores_gemma":[0.000008010542,0.000041282285,0.0019829704,0.0000067280894,0.000007150841,0.9965313,0.000049136775,0.00023754795,0.00036544199,0.000088019915,0.00067794946,0.000004533853],"about_ca_topic_score_codex":0.0018993584,"about_ca_topic_score_gemma":0.0022612573,"teacher_disagreement_score":0.0028272322,"about_ca_system_score_codex":0.0008504044,"about_ca_system_score_gemma":0.0004655402,"threshold_uncertainty_score":0.009294391},"labels":[],"label_agreement":null},{"id":"W2754563145","doi":"10.1101/189761","title":"Evolution and Engineering of Allosteric Regulation in Protein Kinases","year":2017,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hillsborough Hospital","funders":"National Institutes of Health; Gordon and Betty Moore Foundation","keywords":"Allosteric regulation; Phosphorylation; Kinase; Allosteric enzyme; Function (biology); Protein engineering; Protein kinase A","score_opus":0.009453179132250113,"score_gpt":0.198546507973863,"score_spread":0.1890933288416129,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754563145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9144396,0.0008473773,0.076122686,0.0007950268,0.000170786,0.00004993517,0.000107310036,0.00042790282,0.0070393835],"genre_scores_gemma":[0.97707844,0.00043221447,0.020475857,0.00010683754,0.000017484082,0.000028698583,0.00006661202,0.00009406708,0.0016998979],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99986124,0.00003420033,0.000011404487,0.000030522668,0.00003757164,0.00002504131],"domain_scores_gemma":[0.99987817,0.000043814234,0.000026037545,0.000025829477,0.000010295412,0.000015996535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032205248,0.00021187749,0.00021201854,0.00015351233,0.00020107623,0.00038908498,0.00031888575,0.0003140422,0.00094743626],"category_scores_gemma":[0.00051567104,0.00017797969,0.00024824333,0.00011528,0.00040216174,0.00030482042,0.00049258786,0.0008227598,0.0002589688],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000100411766,0.00005460949,0.00068756356,0.00009668115,0.000017392527,0.00026688463,0.00008133361,0.007327254,0.95417666,0.0243661,0.000424821,0.012400191],"study_design_scores_gemma":[0.00006538355,0.00034880725,0.0014268707,0.000018399764,0.000032816642,0.00082603743,0.000082130355,0.0505021,0.90776616,0.022076521,0.016818536,0.0000362957],"about_ca_topic_score_codex":0.00015157418,"about_ca_topic_score_gemma":0.00020768083,"teacher_disagreement_score":0.00094743626,"about_ca_system_score_codex":0.0003169529,"about_ca_system_score_gemma":0.00013512709,"threshold_uncertainty_score":0.0031695366},"labels":[],"label_agreement":null},{"id":"W2755929010","doi":"10.1038/s41467-017-00452-4","title":"Tumor-associated B-cells induce tumor heterogeneity and therapy resistance","year":2017,"lang":"en","type":"article","venue":"Nature Communications","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":141,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute; National Institutes of Health; Melanoma Institute Australia; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Universität Wien; Medical Research Council; Vienna Science and Technology Fund; Cancer Institute NSW; National Health and Medical Research Council; Medizinische Universität Wien","keywords":"Melanoma; Cancer research; Tumor microenvironment; Drug resistance; CD20; Tumor progression; Medicine; Mechanism (biology); Cancer; Biology; Immunology; Antibody; Tumor cells; Internal medicine","score_opus":0.02567919250786586,"score_gpt":0.29789614995040314,"score_spread":0.27221695744253727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755929010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98899823,0.0046571326,0.003066951,0.00023284284,0.000028271943,0.00006737804,0.000079502635,0.00013903907,0.0027306397],"genre_scores_gemma":[0.9967528,0.0006788928,0.00079282664,0.000114873765,0.000019255567,0.000037646605,0.00009301749,0.000017470102,0.0014932202],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99977535,0.000078671146,0.000012608095,0.000032299664,0.00005296141,0.000048191756],"domain_scores_gemma":[0.9997633,0.000078677396,0.000059956586,0.000037899783,0.00002680246,0.00003340997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028175107,0.00017907457,0.0001983084,0.00025165806,0.00013578271,0.00029042488,0.00016332713,0.00030332804,0.0019468432],"category_scores_gemma":[0.0003046287,0.00012584528,0.00018441211,0.00011115793,0.00015110201,0.00023132507,0.00027120116,0.0005884579,0.0005115199],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002207324,0.00014081287,0.002827016,0.000089537614,0.00003064918,0.00028623495,0.00005155761,0.00016062912,0.9789106,0.000650831,0.0003869547,0.016244363],"study_design_scores_gemma":[0.00026764002,0.0037745216,0.037866965,0.000038629187,0.00010115246,0.0065852655,0.00014502043,0.0028289238,0.9169435,0.0014213121,0.030010527,0.000016709882],"about_ca_topic_score_codex":0.00016011225,"about_ca_topic_score_gemma":0.0001610782,"teacher_disagreement_score":0.0019468432,"about_ca_system_score_codex":0.0002033655,"about_ca_system_score_gemma":0.00009160575,"threshold_uncertainty_score":0.0065128207},"labels":[],"label_agreement":null},{"id":"W2756647112","doi":"10.1158/1535-7163.mct-17-0456","title":"Targeting the MAPK Signaling Pathway in Cancer: Promising Preclinical Activity with the Novel Selective ERK1/2 Inhibitor BVD-523 (Ulixertinib)","year":2017,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":234,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Phenomenome Discoveries (Canada)","funders":"","keywords":"MAPK/ERK pathway; Medicine; In vivo; Melanoma; Cancer research; Cancer; Pharmacology; Phosphorylation; Potency; MEK inhibitor; Targeted therapy; In vitro; Internal medicine; Biology; Cell biology; Biochemistry","score_opus":0.039443511507001754,"score_gpt":0.3106321426094479,"score_spread":0.2711886311024461,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2756647112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97811687,0.009662995,0.004249087,0.0006553855,0.00010170223,0.00038481894,0.0012373454,0.00048677507,0.00510507],"genre_scores_gemma":[0.9880355,0.0053371005,0.002566573,0.00011765951,0.000024849689,0.00015663933,0.0012640683,0.000033227167,0.002464413],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989843,0.000018875531,0.0000066597386,0.000012725379,0.000021750686,0.00004157152],"domain_scores_gemma":[0.9999497,0.000005955533,0.000011252017,0.000004727593,0.000008839031,0.000019606581],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003809346,0.00094353606,0.0005305328,0.00033381776,0.00023041773,0.00047249603,0.0003602382,0.00041839704,0.0011754698],"category_scores_gemma":[0.00010474665,0.00024613403,0.00042222987,0.00021858171,0.00018754207,0.00029006295,0.00014242847,0.00087605644,0.00041966332],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019788889,0.0021218085,0.0005057161,0.0002579084,0.00006229045,0.00015989266,0.000044575518,0.0018513353,0.96250176,0.0002806661,0.0012936166,0.028941533],"study_design_scores_gemma":[0.0019084731,0.030071136,0.0061058444,0.00004141395,0.00018107839,0.001200452,0.00003933995,0.0063434844,0.94498277,0.00016538035,0.0089268135,0.00003382433],"about_ca_topic_score_codex":0.0013178498,"about_ca_topic_score_gemma":0.0028288173,"teacher_disagreement_score":0.0013178498,"about_ca_system_score_codex":0.00056345644,"about_ca_system_score_gemma":0.0005332657,"threshold_uncertainty_score":0.0040881634},"labels":[],"label_agreement":null},{"id":"W2758153481","doi":"10.18632/oncotarget.21352","title":"Eyes absent gene (EYA1) is a pathogenic driver and a therapeutic target for melanoma","year":2017,"lang":"en","type":"article","venue":"Oncotarget","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Welichem Biotech (Canada); University of British Columbia","funders":"","keywords":"Medicine; Melanoma; Cancer research; Gene; Bioinformatics; Oncology; Genetics; Biology","score_opus":0.017114928993907517,"score_gpt":0.266597748511279,"score_spread":0.24948281951737147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2758153481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93623346,0.049949232,0.0052070264,0.001820192,0.00028009736,0.000102183825,0.00069734216,0.00016027247,0.005550121],"genre_scores_gemma":[0.98543394,0.008500429,0.0015694749,0.00034953724,0.000053109135,0.00003889299,0.00038487598,0.000016358852,0.0036533084],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998965,0.0000142699455,0.000008874415,0.000027824857,0.000033328048,0.000019195535],"domain_scores_gemma":[0.9998969,0.000013190501,0.000047610753,0.000005901453,0.00001524645,0.000021207568],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023790188,0.0002897666,0.0002708159,0.00030240952,0.00019267267,0.00041056512,0.00016475913,0.00036548634,0.0017861683],"category_scores_gemma":[0.00020121223,0.00012605474,0.0002396046,0.00017617106,0.00021812432,0.0002848825,0.00024041631,0.0005918855,0.00040573737],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009587242,0.00014853508,0.026626047,0.00039901288,0.000072641385,0.001803184,0.00006041908,0.00024136057,0.90803057,0.0009682263,0.0016368654,0.05905438],"study_design_scores_gemma":[0.00025099414,0.0019551436,0.20426366,0.00025210006,0.00047873688,0.016267711,0.00059098296,0.0052750176,0.70388937,0.0020453813,0.064675026,0.000055906123],"about_ca_topic_score_codex":0.0002682587,"about_ca_topic_score_gemma":0.00045229087,"teacher_disagreement_score":0.0017861683,"about_ca_system_score_codex":0.0003339266,"about_ca_system_score_gemma":0.00020628376,"threshold_uncertainty_score":0.0059753656},"labels":[],"label_agreement":null},{"id":"W2761934863","doi":"10.1093/hmg/ddx368","title":"Rare germline variants in known melanoma susceptibility genes in familial melanoma","year":2017,"lang":"en","type":"article","venue":"Human Molecular Genetics","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; National Institutes of Health; Division of Cancer Epidemiology and Genetics, National Cancer Institute; McMaster University","keywords":"Biology; Genetics; Nonsynonymous substitution; Missense mutation; Germline; Germline mutation; Exome sequencing; Population; Exome; Gene; Melanoma; Mutation; Genome; Medicine","score_opus":0.0205141760911975,"score_gpt":0.27635765070968354,"score_spread":0.25584347461848606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2761934863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991373,0.00029484637,0.00027865756,0.0000093974295,0.000002264232,0.0000031923087,0.000117700845,0.0000070958663,0.00014953078],"genre_scores_gemma":[0.999519,0.00007495194,0.00019202322,0.000009696408,0.0000043344257,0.0000027970375,0.0001370697,0.0000027396857,0.00005748595],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99958235,0.000071362694,0.000051193685,0.00017785523,0.00007807162,0.00003909126],"domain_scores_gemma":[0.99920315,0.00029588383,0.00031663702,0.00006824442,0.000056084587,0.00006006924],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003123882,0.0002625598,0.00032348768,0.0011535293,0.00038515858,0.0003236669,0.00021105364,0.00030313636,0.0016239146],"category_scores_gemma":[0.0016461664,0.00012954323,0.0002734483,0.0009220949,0.00026268724,0.00016064414,0.0002409333,0.00025244197,0.00015192073],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016770752,0.00002352818,0.9795094,0.000030313322,0.00011635399,0.0018945223,0.00019371508,0.00011966294,0.01267016,0.000062568,0.000082095736,0.005129922],"study_design_scores_gemma":[0.000007627802,0.000057115416,0.99214774,0.000008524976,0.00006676202,0.005464525,0.000101291305,0.00027801117,0.0014108337,0.00010678738,0.0003465879,0.000004306508],"about_ca_topic_score_codex":0.0010358795,"about_ca_topic_score_gemma":0.0015338178,"teacher_disagreement_score":0.0016239146,"about_ca_system_score_codex":0.00011964398,"about_ca_system_score_gemma":0.000097408025,"threshold_uncertainty_score":0.0054326057},"labels":[],"label_agreement":null},{"id":"W2762161610","doi":"10.1093/annonc/mdx377.003","title":"KEYNOTE-022 update: phase 1 study of first-line pembrolizumab (pembro) plus dabrafenib (D) and trametinib (T) for BRAF-mutant advanced melanoma","year":2017,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Dabrafenib; Medicine; Trametinib; Pembrolizumab; Neutropenia; Discontinuation; Regimen; Melanoma; Internal medicine; Oncology; Metastatic melanoma; Vemurafenib; Gastroenterology; Cancer research; Cancer; Chemotherapy; Immunotherapy; MAPK/ERK pathway","score_opus":0.06839828692160825,"score_gpt":0.39015154680752706,"score_spread":0.3217532598859188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2762161610","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.32007253,0.28622156,0.011939552,0.059519775,0.017322075,0.0148610305,0.13396497,0.0035456682,0.15255278],"genre_scores_gemma":[0.41698313,0.18390942,0.028324718,0.09153223,0.008027614,0.0095249135,0.15571146,0.0011941907,0.104792334],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.999498,0.00016982164,0.000042569944,0.000061002822,0.0001459553,0.00008264141],"domain_scores_gemma":[0.9986312,0.000291748,0.00024938158,0.00007273244,0.00031184833,0.00044303312],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030429547,0.0011120489,0.0021654717,0.0006623306,0.00038550864,0.0017924801,0.0020359987,0.002115018,0.010479594],"category_scores_gemma":[0.002141976,0.0006173286,0.0018090655,0.0006628737,0.00026986274,0.0011107483,0.0005589081,0.0033078117,0.003583902],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.061155763,0.0052546537,0.004211243,0.005438595,0.0030477787,0.00061531656,0.00017700327,0.0024045357,0.026207825,0.0011191368,0.34175402,0.54861414],"study_design_scores_gemma":[0.18457839,0.06318021,0.03368302,0.001702741,0.007609376,0.0020440035,0.00012155179,0.0025428757,0.008755711,0.0017137169,0.6939149,0.00015352917],"about_ca_topic_score_codex":0.0023147727,"about_ca_topic_score_gemma":0.012337942,"teacher_disagreement_score":0.010479594,"about_ca_system_score_codex":0.00157663,"about_ca_system_score_gemma":0.0016597599,"threshold_uncertainty_score":0.035057724},"labels":[],"label_agreement":null},{"id":"W2762653748","doi":"10.1200/jco.2017.35.15_suppl.9074","title":"Efficacy of vemurafenib in patients (pts) with non-small cell lung cancer (NSCLC) with <i>BRAF</i><sup>V600</sup> mutation.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; Vemurafenib; Internal medicine; Oncology; Cohort; Clinical endpoint; Rash; Lung cancer; Adverse effect; Expanded access; Progression-free survival; non-small cell lung cancer (NSCLC); Nausea; Cancer; Clinical trial; Metastatic melanoma; Overall survival","score_opus":0.029809604321270836,"score_gpt":0.3542964915474961,"score_spread":0.32448688722622526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2762653748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99676836,0.0016132368,0.00010059041,0.00011870059,0.000019553841,0.00022249208,0.00040879144,0.000017835755,0.00073044735],"genre_scores_gemma":[0.99764544,0.0006133286,0.00021184701,0.0001622391,0.000035749115,0.00016663288,0.0007535679,0.0000041101307,0.00040700837],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.999793,0.000100380064,0.000017335264,0.000034199435,0.000024537032,0.000030567833],"domain_scores_gemma":[0.999673,0.00008251302,0.000088594395,0.000013443712,0.000021609958,0.000120951074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064476806,0.0003519744,0.0008650313,0.00020778163,0.00013030328,0.00045753657,0.00022335736,0.00033711395,0.0015898144],"category_scores_gemma":[0.00084428827,0.00019786869,0.0006050354,0.00020631484,0.00018538017,0.00044719412,0.0002501665,0.00082838495,0.00031261105],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.51273507,0.021809867,0.096404806,0.0019646117,0.0021326279,0.0011148475,0.00053626404,0.0034399738,0.036490906,0.00018469068,0.006804701,0.31638163],"study_design_scores_gemma":[0.19063587,0.46811637,0.31213492,0.0001781993,0.001922112,0.002459188,0.00028064378,0.0044965763,0.0066469572,0.0003957376,0.012658761,0.0000746482],"about_ca_topic_score_codex":0.00030207093,"about_ca_topic_score_gemma":0.0011316933,"teacher_disagreement_score":0.0015898144,"about_ca_system_score_codex":0.0004168796,"about_ca_system_score_gemma":0.00040991686,"threshold_uncertainty_score":0.0053184032},"labels":[],"label_agreement":null},{"id":"W2767191415","doi":"10.1038/s41467-017-01274-0","title":"RAF inhibitors promote RAS-RAF interaction by allosterically disrupting RAF autoinhibition","year":2017,"lang":"en","type":"article","venue":"Nature Communications","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":105,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"Canadian Institutes of Health Research","keywords":"Kinase; Chemistry; Allosteric regulation; Enzyme; Effector; MAPK/ERK pathway; Cell biology; Enzyme activator; Biochemistry; Biology; Cancer research","score_opus":0.016481119543406312,"score_gpt":0.3123844973971795,"score_spread":0.2959033778537732,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767191415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99332535,0.00079299347,0.0024906346,0.000041062136,0.000013402179,0.00002785359,0.000101888276,0.000102146194,0.0031046786],"genre_scores_gemma":[0.99661994,0.00044849236,0.0013368725,0.000017631055,0.000005726051,0.000011650837,0.00007729159,0.000013533703,0.0014689219],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991786,0.000011961326,0.000005141461,0.000012625367,0.000026264712,0.000026236996],"domain_scores_gemma":[0.9999577,0.000009750954,0.000011959041,0.000005629915,0.000005018513,0.000010051601],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000073840536,0.0002775566,0.00015209436,0.00014989685,0.00010897555,0.00021958185,0.00016068656,0.00011349393,0.0011577685],"category_scores_gemma":[0.00007068341,0.00009970359,0.0001587756,0.00008228676,0.00012500522,0.0001376297,0.00015258374,0.00034645156,0.0003205546],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050188028,0.0000249503,0.00006649657,0.0000134477705,0.0000021766034,0.00001571478,0.0000057493708,0.00009155732,0.9985758,0.00011672783,0.000026888654,0.001010309],"study_design_scores_gemma":[0.0000047699828,0.000104360486,0.00048598315,8.407083e-7,0.0000028948964,0.00004333977,0.0000029115474,0.0004174626,0.99806434,0.000015463014,0.00085653766,0.0000012016847],"about_ca_topic_score_codex":0.00031918715,"about_ca_topic_score_gemma":0.00087025546,"teacher_disagreement_score":0.0011577685,"about_ca_system_score_codex":0.00019113164,"about_ca_system_score_gemma":0.0001416952,"threshold_uncertainty_score":0.0038731098},"labels":[],"label_agreement":null},{"id":"W2774483419","doi":"10.1158/2159-8290.cd-17-1119","title":"First-in-Class ERK1/2 Inhibitor Ulixertinib (BVD-523) in Patients with MAPK Mutant Advanced Solid Tumors: Results of a Phase I Dose-Escalation and Expansion Study","year":2017,"lang":"en","type":"article","venue":"Cancer Discovery","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":418,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Phenomenome Discoveries (Canada)","funders":"","keywords":"Medicine; Adverse effect; Nausea; Neuroblastoma RAS viral oncogene homolog; Cohort; Response Evaluation Criteria in Solid Tumors; Tolerability; Internal medicine; Cancer; Pharmacokinetics; MEK inhibitor; Oncology; Gastroenterology; MAPK/ERK pathway; Pharmacology; Clinical trial; Phases of clinical research; Kinase; Colorectal cancer; KRAS","score_opus":0.010347313231420165,"score_gpt":0.27351285796243774,"score_spread":0.26316554473101755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2774483419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99684554,0.0011724171,0.00035108067,0.00020386947,0.000026093943,0.00034908735,0.00036945153,0.000051742936,0.0006305982],"genre_scores_gemma":[0.99613035,0.0007493975,0.00094588415,0.00028068016,0.000037473772,0.00017940074,0.001072057,0.00001941327,0.00058527285],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996195,0.00016229477,0.000025419271,0.000054939617,0.000055880948,0.00008202516],"domain_scores_gemma":[0.9996344,0.000060496415,0.00007333923,0.00003800579,0.00003573638,0.00015805328],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001666246,0.0008991328,0.0011274096,0.00020053076,0.00026823184,0.0006652549,0.00047210004,0.0005014639,0.001310685],"category_scores_gemma":[0.0005273176,0.00027673563,0.0011179323,0.00026564128,0.0004309842,0.0005333196,0.00020173895,0.0021570134,0.0003887187],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2447366,0.08737255,0.03063749,0.0010046898,0.0024379762,0.0006830447,0.0008569576,0.008679187,0.2647606,0.00036880263,0.008877063,0.34958506],"study_design_scores_gemma":[0.26205775,0.5740362,0.10964433,0.00008631465,0.0015648052,0.0017568042,0.00017837407,0.0068601416,0.035298,0.00034453417,0.008083727,0.0000890262],"about_ca_topic_score_codex":0.0008230916,"about_ca_topic_score_gemma":0.0019395191,"teacher_disagreement_score":0.001666246,"about_ca_system_score_codex":0.00086263614,"about_ca_system_score_gemma":0.00086579996,"threshold_uncertainty_score":0.00881207},"labels":[],"label_agreement":null},{"id":"W2774981435","doi":"10.1007/s00280-017-3486-3","title":"Model based analysis of the heterogeneity in the tumour size dynamics differentiates vemurafenib, dabrafenib and trametinib in metastatic melanoma","year":2017,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CBC (Canada)","funders":"","keywords":"Dabrafenib; Vemurafenib; Trametinib; Tumour heterogeneity; Melanoma; Medicine; Oncology; Cancer research; Metastatic melanoma; Pathology; Internal medicine; Biology; Cancer; MAPK/ERK pathway; Kinase","score_opus":0.024330399213969414,"score_gpt":0.3176762638160448,"score_spread":0.2933458646020754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2774981435","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9676142,0.00017761166,0.03146482,0.00011865544,0.0000044039657,0.000020810194,0.00021261183,0.00005927549,0.0003277019],"genre_scores_gemma":[0.9978726,0.000045612003,0.0017302405,0.0000063763746,0.0000024966052,0.000013912361,0.00015817456,0.0000048942356,0.0001656546],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9997851,0.000079827565,0.000012950961,0.000066562505,0.000027882214,0.000027592905],"domain_scores_gemma":[0.9984353,0.0011417955,0.00024969532,0.00006616854,0.00006442257,0.000042658725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013520103,0.00031577633,0.00048359038,0.00049004745,0.0001079366,0.00053627125,0.00030869132,0.00037648372,0.00028888282],"category_scores_gemma":[0.0037048196,0.000175557,0.000596772,0.00027235603,0.00026704045,0.0003466483,0.00024044885,0.0003675526,0.00005482634],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022365077,0.00007079015,0.03180881,0.00005116906,0.00013697089,0.00011194046,0.000056582026,0.9480092,0.009281341,0.0012661843,0.00013945147,0.008843987],"study_design_scores_gemma":[0.0000047149715,0.00005965984,0.01177359,0.0000020859602,0.000014134109,0.000048996233,0.000012077224,0.9865464,0.0008556769,0.0006046905,0.00007133657,0.0000066604284],"about_ca_topic_score_codex":0.005960108,"about_ca_topic_score_gemma":0.0039650053,"teacher_disagreement_score":0.005960108,"about_ca_system_score_codex":0.0007908462,"about_ca_system_score_gemma":0.00051445473,"threshold_uncertainty_score":0.011850834},"labels":[],"label_agreement":null},{"id":"W2775591256","doi":"10.1097/dad.0000000000001066","title":"Granulomatous Tumoral Melanosis Associated With Pembrolizumab Therapy: A Mimicker of Disease Progression in Metastatic Melanoma","year":2017,"lang":"en","type":"article","venue":"American Journal of Dermatopathology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of Calgary","funders":"","keywords":"Pembrolizumab; Medicine; Melanoma; Sarcoidosis; Immunotherapy; Adverse effect; Concomitant; Metastatic melanoma; Disease; Dermatology; Nivolumab; Oncology; Internal medicine; Pathology; Cancer; Cancer research","score_opus":0.012401068507559062,"score_gpt":0.27244376360585154,"score_spread":0.2600426950982925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2775591256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96654075,0.01708026,0.004543623,0.00082742993,0.0001282811,0.00013790683,0.00012144995,0.00019638852,0.0104240095],"genre_scores_gemma":[0.99679345,0.001860565,0.00076177594,0.00010822885,0.000072339695,0.0000083296745,0.00003465935,0.000007478759,0.00035317472],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99965847,0.000092100294,0.00004314683,0.00006353015,0.00007304392,0.000069767564],"domain_scores_gemma":[0.99942774,0.00018673296,0.00019557282,0.00007037634,0.000034399745,0.000085037456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028985256,0.0005459985,0.00043564657,0.0011454441,0.00045666378,0.00067548803,0.000276946,0.001102283,0.0015209276],"category_scores_gemma":[0.0017514837,0.00032125518,0.00033856684,0.00047694508,0.00055943575,0.00068838365,0.0004956153,0.0006822002,0.00052115123],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036567976,0.00008556577,0.06859095,0.00035626642,0.000042345284,0.87836677,0.00041241638,0.00023436405,0.030476129,0.0008725735,0.00068475533,0.019512229],"study_design_scores_gemma":[0.000017297616,0.000062913445,0.022058895,0.00004673239,0.0000272347,0.97177315,0.00012907216,0.00053619593,0.0032574914,0.00042955502,0.0016535736,0.000007857474],"about_ca_topic_score_codex":0.000430443,"about_ca_topic_score_gemma":0.0006066206,"teacher_disagreement_score":0.0015209276,"about_ca_system_score_codex":0.0002579432,"about_ca_system_score_gemma":0.00019986935,"threshold_uncertainty_score":0.0050880313},"labels":[],"label_agreement":null},{"id":"W2780350829","doi":"10.1200/jco.2016.34.15_suppl.2578","title":"Phase I pharmacokinetic study of single agent trametinib in advanced cancer patients with hepatic dysfunction: An NCI Organ Dysfunction Working Group (ODWG) study.","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; BC Cancer Agency; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Rash; Pharmacokinetics; Internal medicine; Cancer; Melanoma; Gastroenterology; Refractory (planetary science); Cmax; Toxicity; Cohort; Oncology; Urology","score_opus":0.0724240469470236,"score_gpt":0.40042437631507255,"score_spread":0.32800032936804896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2780350829","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958092,0.000643475,0.00041794084,0.00016447277,0.000034376877,0.0010021875,0.000941569,0.000052721538,0.00093400554],"genre_scores_gemma":[0.9921922,0.00072955264,0.0009536446,0.0003392201,0.00006167373,0.0012505297,0.002789029,0.000033160755,0.0016510502],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997476,0.0000895556,0.000011798471,0.000052428368,0.000033299384,0.000065437845],"domain_scores_gemma":[0.99949753,0.000042176893,0.000079040656,0.000049564092,0.000034523193,0.00029720395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000886842,0.0012329269,0.0016978064,0.0003117824,0.00047326094,0.0007725603,0.0006082924,0.0007426636,0.0021715548],"category_scores_gemma":[0.0005839321,0.0005135028,0.0008046876,0.0005067345,0.0005992582,0.0005500336,0.00032793553,0.0019475188,0.0008515287],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5908514,0.11943265,0.04517249,0.00063594145,0.001563202,0.0009110779,0.0006410961,0.00519598,0.11692989,0.0003150631,0.008808841,0.10954236],"study_design_scores_gemma":[0.30227822,0.5810339,0.09311312,0.00003796134,0.00083457236,0.0014124414,0.00015327922,0.0033457347,0.010423996,0.00021425089,0.0070844446,0.000068153335],"about_ca_topic_score_codex":0.0016338129,"about_ca_topic_score_gemma":0.0025374708,"teacher_disagreement_score":0.0021715548,"about_ca_system_score_codex":0.0009344901,"about_ca_system_score_gemma":0.0017637847,"threshold_uncertainty_score":0.0072645545},"labels":[],"label_agreement":null},{"id":"W2784831101","doi":"10.1172/jci94840","title":"COP1/DET1/ETS axis regulates ERK transcriptome and sensitivity to MAPK inhibitors","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Investigation","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"York University; U.S. Department of Defense; University of Minnesota; Geoffrey Beene Cancer Research Center; Gerstner Family Foundation; Memorial Sloan-Kettering Cancer Center; National Cancer Institute; Office of Defense Programs; Cancer Research UK; GIST Cancer Research Fund; Prostate Cancer Foundation","keywords":"Transcriptome; MAPK/ERK pathway; Sensitivity (control systems); Cell biology; Biology; Genetics; Signal transduction; Gene; Gene expression; Engineering","score_opus":0.04126453199566905,"score_gpt":0.3278556770233905,"score_spread":0.2865911450277215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2784831101","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976762,0.00066664617,0.0005290884,0.000043893073,0.0000059910585,0.000008918627,0.0003346071,0.000039196813,0.00069548056],"genre_scores_gemma":[0.997999,0.00025872493,0.00032626832,0.000022170212,0.0000020391526,0.000011669407,0.00042502087,0.000010648285,0.0009443994],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991333,0.000008856352,0.0000061778624,0.000023214545,0.000018871204,0.000029545312],"domain_scores_gemma":[0.99993503,0.0000070643264,0.000021321232,0.0000058617848,0.000009615256,0.000021045178],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006794561,0.00020581853,0.00019673187,0.00020374784,0.00014206862,0.00027106647,0.000108979286,0.00016666025,0.0011016001],"category_scores_gemma":[0.00008982278,0.00011045751,0.00017029389,0.00010427277,0.00013210217,0.00013510893,0.00015226602,0.00034379438,0.00027191598],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012882604,0.00001868462,0.00049595913,0.000010213362,0.0000028229283,0.000023055667,0.0000050457593,0.0000405795,0.99845624,0.000021334356,0.000030622105,0.00076652574],"study_design_scores_gemma":[0.000011148116,0.00014638888,0.039462935,0.0000029577564,0.000011040114,0.00020655974,0.00003649252,0.0011215421,0.9579666,0.00004956904,0.0009798383,0.0000048393927],"about_ca_topic_score_codex":0.00041698094,"about_ca_topic_score_gemma":0.00069115317,"teacher_disagreement_score":0.0011016001,"about_ca_system_score_codex":0.00028786063,"about_ca_system_score_gemma":0.00013196583,"threshold_uncertainty_score":0.003685236},"labels":[],"label_agreement":null},{"id":"W2784833105","doi":"10.2174/1381612824666180125093357","title":"The Emerging Therapeutic Landscape of Advanced Melanoma","year":2018,"lang":"en","type":"review","venue":"Current Pharmaceutical Design","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Oncolytics Biotech; Amgen","keywords":"Medicine; Therapeutic modalities; Melanoma; Modalities; Intensive care medicine; Cancer; Immunotherapy; Treatment modality; Skin cancer; Metastatic melanoma; Internal medicine; Cancer research","score_opus":0.12135652071522658,"score_gpt":0.406393798695927,"score_spread":0.28503727798070044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2784833105","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002460809,0.9964049,0.00026377445,0.0008195557,0.00033810234,0.000005911105,0.00001751289,0.000010939519,0.0018931823],"genre_scores_gemma":[0.0018104712,0.99605477,0.00033574886,0.00048171863,0.00031151428,0.000009212468,0.000028448667,0.000002211431,0.0009657706],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99985266,0.000031133284,0.000015508387,0.000023045981,0.00005936768,0.00001830591],"domain_scores_gemma":[0.999851,0.000060499257,0.000018872692,0.000005120361,0.000044659493,0.0000197889],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047401674,0.0005157971,0.000725483,0.0012254087,0.00030615873,0.0009855311,0.0005021088,0.0010459766,0.0034772127],"category_scores_gemma":[0.0004538478,0.00017494621,0.00035540134,0.0007914101,0.00039885458,0.0013841235,0.000662062,0.002034234,0.0013802075],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000078156416,0.00009481028,0.00014385875,0.013842409,0.000048208938,0.00041948032,0.000109585155,0.00039593864,0.0068407757,0.012779819,0.032856256,0.9323907],"study_design_scores_gemma":[0.000011910439,0.00009564361,0.00030646118,0.00151442,0.000031222185,0.0012175846,0.000056162902,0.00010398564,0.0007460427,0.0031418514,0.9927644,0.000010227722],"about_ca_topic_score_codex":0.00039188072,"about_ca_topic_score_gemma":0.0009595032,"teacher_disagreement_score":0.0034772127,"about_ca_system_score_codex":0.000466253,"about_ca_system_score_gemma":0.0007197319,"threshold_uncertainty_score":0.0116324425},"labels":[],"label_agreement":null},{"id":"W2785160602","doi":"10.14740/jocmr3248w","title":"Validation of the Graded Prognostic Assessment for Melanoma Using Molecular Markers (Melanoma-molGPA)","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Medicine Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Melanoma; Confidence interval; Log-rank test; Oncology; Internal medicine; Survival analysis; Overall survival; Retrospective cohort study; Nodular melanoma; Cancer research","score_opus":0.18404346310155423,"score_gpt":0.5125204512913224,"score_spread":0.32847698818976817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2785160602","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99142426,0.00095210073,0.005266054,0.00020453116,0.000056531084,0.00013565292,0.0007773636,0.00005284489,0.0011308439],"genre_scores_gemma":[0.9960567,0.000064061715,0.0032105634,0.000036965605,0.000019017287,0.000034111814,0.0005094185,0.0000047820554,0.00006451086],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979448,0.0010459452,0.000178811,0.00026153616,0.0004384826,0.00013047218],"domain_scores_gemma":[0.9936534,0.0021771253,0.0017084826,0.0008221793,0.0012804184,0.0003583352],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0055466336,0.00049276516,0.000253041,0.0012690526,0.00026359042,0.0007317568,0.0006460869,0.00044594624,0.00088800327],"category_scores_gemma":[0.012302113,0.00011217194,0.00044326787,0.0006322712,0.0003761352,0.0005046023,0.00080206216,0.0005104987,0.0004150059],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044650174,0.000053932275,0.9731495,0.000049617876,0.00011468108,0.000053032873,0.000033274402,0.00079251535,0.0022801044,0.000113601265,0.00032794825,0.022585325],"study_design_scores_gemma":[0.000100463265,0.001734085,0.9781594,0.000058271133,0.00025803625,0.0015285269,0.00009058978,0.008620132,0.006309713,0.00072615413,0.002387266,0.000027331087],"about_ca_topic_score_codex":0.0008756079,"about_ca_topic_score_gemma":0.0009251614,"teacher_disagreement_score":0.0055466336,"about_ca_system_score_codex":0.0004611507,"about_ca_system_score_gemma":0.0006168593,"threshold_uncertainty_score":0.02933371},"labels":[],"label_agreement":null},{"id":"W2787439801","doi":"10.1101/cshperspect.a031492","title":"Targeting the MAPK Pathway in RAS Mutant Cancers","year":2018,"lang":"en","type":"review","venue":"Cold Spring Harbor Perspectives in Medicine","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Discovery Centre","funders":"","keywords":"KRAS; MAPK/ERK pathway; Cancer research; Protein kinase A; Mutant; Kinase; Carcinogenesis; c-Raf; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Biology; Cell biology; Mutation; Cancer; Biochemistry; Genetics","score_opus":0.028950949646896738,"score_gpt":0.3038557426473558,"score_spread":0.27490479300045906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2787439801","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019201965,0.99542713,0.00032024537,0.0006900499,0.0006143269,0.0000069454263,0.000021398704,0.000020597623,0.0027071326],"genre_scores_gemma":[0.00084839336,0.99618345,0.0002658871,0.00042331207,0.0002828799,0.0000075792523,0.00002836283,0.0000030997635,0.0019568983],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998884,0.000014441205,0.000012576638,0.00001942539,0.00005157587,0.000013431217],"domain_scores_gemma":[0.9998808,0.000036954574,0.000016267326,0.0000058140117,0.000041194326,0.000019032203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040394146,0.0006812068,0.00066206645,0.0015508359,0.00027812825,0.0006685676,0.00055735896,0.00084986334,0.0030157964],"category_scores_gemma":[0.00037044167,0.00025509493,0.0003298463,0.00087200897,0.0004073082,0.0011687061,0.0007462753,0.0021762198,0.0029711076],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000065472545,0.000064310916,0.00011177219,0.008083874,0.00005404837,0.0003007853,0.00006553401,0.00042634364,0.007020405,0.00915567,0.064398475,0.9102534],"study_design_scores_gemma":[0.0000064964233,0.000035113808,0.00018979647,0.0006934106,0.00002076248,0.00067628693,0.000014851526,0.00004698706,0.0005687021,0.001248088,0.99649185,0.0000076131887],"about_ca_topic_score_codex":0.0006212703,"about_ca_topic_score_gemma":0.0014770502,"teacher_disagreement_score":0.0030157964,"about_ca_system_score_codex":0.0006119743,"about_ca_system_score_gemma":0.0007297578,"threshold_uncertainty_score":0.010088801},"labels":[],"label_agreement":null},{"id":"W2787519262","doi":"10.1038/nature25478","title":"MEK drives BRAF activation through allosteric control of KSR proteins","year":2018,"lang":"en","type":"article","venue":"Nature","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":156,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sinai Health System; Lunenfeld-Tanenbaum Research Institute; Université de Montréal; Institute for Research in Immunology and Cancer","funders":"National Center for Research Resources; National Institute of General Medical Sciences; Canadian Institutes of Health Research","keywords":"Kinase; Allosteric regulation; Cell biology; Protein kinase domain; Chemistry; Protein kinase A; MAPK/ERK pathway; Scaffold protein; c-Raf; Mitogen-activated protein kinase kinase; Biochemistry; Biology; Enzyme; Signal transduction; Mutant; Gene","score_opus":0.006254970096759588,"score_gpt":0.24424895081812326,"score_spread":0.23799398072136366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2787519262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98908114,0.0003462235,0.0042337603,0.00033871745,0.000058847745,0.000014668171,0.000120603414,0.0002410692,0.00556496],"genre_scores_gemma":[0.9971494,0.00011245055,0.0009897522,0.00003257623,0.000006212724,0.000004908379,0.00004563645,0.000029322087,0.0016298193],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99982613,0.000021790389,0.000012261163,0.000044334185,0.000048172562,0.000047378835],"domain_scores_gemma":[0.9998858,0.000026002657,0.000026780597,0.00002103455,0.000012969149,0.000027298018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021039443,0.00025835203,0.00011642893,0.00015876333,0.00022395511,0.00057382305,0.0004472308,0.00023156386,0.0038230687],"category_scores_gemma":[0.0002579191,0.00021203836,0.00021163741,0.000075685035,0.00038868628,0.0003296687,0.00044721205,0.00063977134,0.0009062375],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009365731,0.000027340155,0.00019614602,0.000021966085,0.0000024232468,0.000048439288,0.000014976198,0.00011900772,0.99622726,0.0018599986,0.000088865985,0.001299959],"study_design_scores_gemma":[0.000013459745,0.000043614735,0.0010519549,0.0000030126869,0.0000039633514,0.00012382878,0.000020408757,0.003176773,0.99336535,0.0004193194,0.0017724101,0.0000058898254],"about_ca_topic_score_codex":0.00054548663,"about_ca_topic_score_gemma":0.0012779752,"teacher_disagreement_score":0.0038230687,"about_ca_system_score_codex":0.00054253935,"about_ca_system_score_gemma":0.00019893923,"threshold_uncertainty_score":0.012789428},"labels":[],"label_agreement":null},{"id":"W2788163753","doi":"10.1016/j.ejmech.2018.01.053","title":"Effects of rigidity on the selectivity of protein kinase inhibitors","year":2018,"lang":"en","type":"article","venue":"European Journal of Medicinal Chemistry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"Division of Chemistry; National Institute of Dental and Craniofacial Research; National Center for Research Resources; National Institute of General Medical Sciences; Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; TD Bank; National Institutes of Health; National Science Foundation","keywords":"Kinase; Chemistry; Selectivity; Isoquinoline; Biochemistry; Structure–activity relationship; Stereochemistry; Combinatorial chemistry; Catalysis; In vitro","score_opus":0.006772026038693152,"score_gpt":0.20595523823113157,"score_spread":0.19918321219243842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2788163753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98789924,0.0022407703,0.0012729125,0.00031142967,0.000100651356,0.000026991898,0.00030953702,0.00011019853,0.007728258],"genre_scores_gemma":[0.9972683,0.0009734342,0.00039610427,0.000094331146,0.00002628267,0.000008853132,0.00013175332,0.000022844888,0.0010781462],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99976975,0.00007033278,0.000014294067,0.000032759755,0.000041602296,0.000071229595],"domain_scores_gemma":[0.99966097,0.00017843225,0.000058280566,0.000029395858,0.00002771059,0.000045128683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031197243,0.00039607176,0.00030566173,0.00020988949,0.00024231439,0.00034149698,0.00042576282,0.0003608903,0.006735936],"category_scores_gemma":[0.00064796704,0.00023106343,0.0001760599,0.00021053008,0.00030198658,0.00040852907,0.00030882438,0.0006346929,0.00078661955],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006994525,0.00016215368,0.00040713637,0.00020837788,0.000072159964,0.00031504055,0.00006818924,0.0025896619,0.9719063,0.0023017174,0.0007532692,0.014221458],"study_design_scores_gemma":[0.0003095102,0.0024066751,0.0025573098,0.000026362462,0.00009023061,0.00044478595,0.000051579274,0.003480177,0.98401976,0.0005209342,0.0060375277,0.000055107237],"about_ca_topic_score_codex":0.00064783986,"about_ca_topic_score_gemma":0.00081513135,"teacher_disagreement_score":0.006735936,"about_ca_system_score_codex":0.00022550081,"about_ca_system_score_gemma":0.00023224863,"threshold_uncertainty_score":0.022534013},"labels":[],"label_agreement":null},{"id":"W2789665281","doi":"10.1038/s41388-018-0171-x","title":"Classifying BRAF alterations in cancer: new rational therapeutic strategies for actionable mutations","year":2018,"lang":"en","type":"review","venue":"Oncogene","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":559,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McGill University; McGill University Health Centre","funders":"","keywords":"Biology; Druggability; Melanoma; V600E; Cancer research; Mutation; Mutant; MAPK/ERK pathway; Cancer; Kinase; Colorectal cancer; Targeted therapy; Genetics; Gene","score_opus":0.1142483572554173,"score_gpt":0.39143045460058423,"score_spread":0.27718209734516697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789665281","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023590878,0.9971885,0.0006075531,0.00064111885,0.00030099187,0.000006489549,0.000030225623,0.000018782555,0.0009703959],"genre_scores_gemma":[0.0021802278,0.9953062,0.00070472877,0.0005355757,0.00030030025,0.0000103745415,0.00006775542,0.0000038483226,0.00089105434],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99980706,0.00002889754,0.000020575628,0.000039850132,0.00007447023,0.000029124216],"domain_scores_gemma":[0.9997229,0.00012278049,0.000033474225,0.000010651339,0.00008333406,0.000026914384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000767341,0.00084624626,0.0012192085,0.0015062583,0.00022392755,0.0010384485,0.0009705423,0.0010960094,0.0023370476],"category_scores_gemma":[0.0008966416,0.0002471867,0.00047916156,0.0010744485,0.0006381244,0.001273557,0.000654896,0.002466442,0.0012088543],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011568355,0.000080048325,0.00032931584,0.0069430983,0.00007711714,0.00026247287,0.00004308365,0.0005045114,0.0047647436,0.0056818984,0.037461057,0.9437371],"study_design_scores_gemma":[0.000030456024,0.00011572569,0.0006295619,0.0016321357,0.00017202854,0.0015316792,0.000054085875,0.0002695005,0.002479195,0.0044578467,0.9886008,0.0000269265],"about_ca_topic_score_codex":0.0007493715,"about_ca_topic_score_gemma":0.001963578,"teacher_disagreement_score":0.0023370476,"about_ca_system_score_codex":0.00078832713,"about_ca_system_score_gemma":0.001014979,"threshold_uncertainty_score":0.007818162},"labels":[],"label_agreement":null},{"id":"W2802693169","doi":"10.1016/j.jid.2018.04.025","title":"Inherited Genetic Variants Associated with Melanoma BRAF/NRAS Subtypes","year":2018,"lang":"en","type":"article","venue":"Journal of Investigative Dermatology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute of Environmental Health Sciences; National Institute of General Medical Sciences; National Cancer Institute","keywords":"Neuroblastoma RAS viral oncogene homolog; Melanoma; Penetrance; Single-nucleotide polymorphism; Genotype; Odds ratio; V600E; Genetics; Cancer research; Biology; Medicine; Oncology; Phenotype; Mutation; Gene; Internal medicine","score_opus":0.015656443054754294,"score_gpt":0.2306325358010614,"score_spread":0.2149760927463071,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2802693169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97059274,0.0035014434,0.006033065,0.0013679608,0.0007861462,0.000048429367,0.0068403035,0.0003470443,0.010482814],"genre_scores_gemma":[0.99104416,0.00018025744,0.0012762999,0.00012695897,0.00011067689,0.000022666352,0.0009812188,0.0000482092,0.006209468],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99841416,0.0004719271,0.00014258992,0.00043683892,0.00023636706,0.00029812538],"domain_scores_gemma":[0.9987363,0.0005042614,0.0002661227,0.000166627,0.000088863155,0.00023783983],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013725831,0.0009823448,0.00042246538,0.0009167984,0.0006068043,0.0007720653,0.00076687936,0.0011232872,0.0327797],"category_scores_gemma":[0.0032609317,0.00040496452,0.0019511889,0.0007010461,0.00044444477,0.00048532904,0.0007360819,0.0020168494,0.0016682873],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0074766297,0.0005304417,0.8873555,0.0002808375,0.0068801325,0.0057994844,0.00032766914,0.0021507766,0.034185518,0.0027971342,0.009069961,0.043145835],"study_design_scores_gemma":[0.0002601587,0.000519617,0.9571089,0.00012004924,0.0021148524,0.009389341,0.00034121703,0.00710449,0.0037078587,0.0035718814,0.015712922,0.00004879239],"about_ca_topic_score_codex":0.0058426275,"about_ca_topic_score_gemma":0.005650081,"teacher_disagreement_score":0.0327797,"about_ca_system_score_codex":0.00027475078,"about_ca_system_score_gemma":0.00052965817,"threshold_uncertainty_score":0.109659016},"labels":[],"label_agreement":null},{"id":"W2806753114","doi":"10.1084/jem.20171960","title":"Loss of USP28-mediated BRAF degradation drives resistance to RAF cancer therapies","year":2018,"lang":"en","type":"article","venue":"The Journal of Experimental Medicine","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Terry Fox Foundation; Ministry of Education - Singapore; National Research Foundation Singapore","keywords":"Deubiquitinating enzyme; Cancer research; Melanoma; MAPK/ERK pathway; Kinase; In vivo; Cancer; V600E; Mutant; Biology; Medicine; Ubiquitin; Gene; Cell biology; Genetics","score_opus":0.016076339825746626,"score_gpt":0.29935870867977943,"score_spread":0.2832823688540328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2806753114","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986896,0.00027729574,0.0003804352,0.00006474859,0.000004318646,0.000005512444,0.000071679046,0.0000256843,0.0004806914],"genre_scores_gemma":[0.9993105,0.000098336626,0.0001534505,0.000011865603,0.0000020260702,0.0000031375123,0.000056135614,0.000003665962,0.00036098395],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998642,0.000027041253,0.00001536097,0.000023817078,0.000040666262,0.000028830376],"domain_scores_gemma":[0.9998541,0.000037136695,0.000041879928,0.000020433532,0.0000113757615,0.000035153647],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015779184,0.00013653563,0.00022324325,0.00019979523,0.00012301053,0.0003470716,0.00013052812,0.00027082054,0.0011811643],"category_scores_gemma":[0.00019705045,0.00012611545,0.00017370208,0.00009274568,0.0002702317,0.00017375094,0.00016943821,0.00061065145,0.00029733076],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019342217,0.00006252155,0.0014380133,0.000012641599,0.000007099976,0.0001966205,0.000013078558,0.000079122416,0.9957567,0.00014750639,0.0000628772,0.00203046],"study_design_scores_gemma":[0.000044798537,0.0009285259,0.030704677,0.00000644876,0.000030342577,0.0044096205,0.00007401317,0.003198484,0.9577708,0.00027942858,0.002545163,0.000007691078],"about_ca_topic_score_codex":0.00021399322,"about_ca_topic_score_gemma":0.00023753493,"teacher_disagreement_score":0.0011811643,"about_ca_system_score_codex":0.00023171601,"about_ca_system_score_gemma":0.0001267043,"threshold_uncertainty_score":0.0039513707},"labels":[],"label_agreement":null},{"id":"W2808608845","doi":"10.1158/1078-0432.ccr-17-3384","title":"Dual MAPK Inhibition Is an Effective Therapeutic Strategy for a Subset of Class II BRAF Mutant Melanomas","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Nickel Institute; Montreal General Hospital; McGill University; McGill University Health Centre","funders":"Melanoma Research Alliance; Canadian Institutes of Health Research; V Foundation for Cancer Research; U.S. Department of Defense","keywords":"Mutant; Melanoma; Cancer research; Class (philosophy); MAPK/ERK pathway; Medicine; Biology; Genetics; Computer science; Gene; Kinase","score_opus":0.21338425190616878,"score_gpt":0.49637302213594536,"score_spread":0.2829887702297766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808608845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99393785,0.0015131347,0.0016214743,0.00015656471,0.000021586618,0.00006912977,0.00018396635,0.00007756002,0.002418695],"genre_scores_gemma":[0.996806,0.0004878618,0.0010468281,0.000059135888,0.000011199947,0.00003527463,0.00028030248,0.0000075603466,0.0012659298],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99995446,0.0000052802015,0.0000032459382,0.000010201439,0.000011295593,0.00001556424],"domain_scores_gemma":[0.9999683,0.0000030554959,0.000007719211,0.0000036451356,0.0000036132385,0.000013662463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006817856,0.00035875954,0.00023668242,0.00012397827,0.00014741292,0.00027757327,0.00013845725,0.00016930288,0.0012557588],"category_scores_gemma":[0.000055257588,0.00007068718,0.00020519698,0.000069312526,0.000104877385,0.00011929413,0.00010619125,0.00046618414,0.00033689995],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046704127,0.0002247877,0.0030679365,0.00005454996,0.000013962172,0.00028143573,0.000013715434,0.000118000185,0.97987515,0.000091780305,0.00037841836,0.015413291],"study_design_scores_gemma":[0.00034632138,0.007690763,0.049829632,0.000024566143,0.00011313106,0.010634245,0.00008937702,0.0022521438,0.91131496,0.00018166503,0.01750968,0.000013459878],"about_ca_topic_score_codex":0.00021306078,"about_ca_topic_score_gemma":0.0005785195,"teacher_disagreement_score":0.0012557588,"about_ca_system_score_codex":0.00023141706,"about_ca_system_score_gemma":0.00013455788,"threshold_uncertainty_score":0.0042008758},"labels":[],"label_agreement":null},{"id":"W2808796425","doi":"10.1158/0008-5472.can-18-0027","title":"CD271+ Cells Are Diagnostic and Prognostic and Exhibit Elevated MAPK Activity in SHH Medulloblastoma","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Hospital for Sick Children; University of Toronto; Calgary Laboratory Services; University of Manitoba; Ottawa Hospital; Children's Hospital Research Institute of Manitoba","funders":"Canadian Institutes of Health Research; Canada Research Chairs; Government of Canada","keywords":"Medulloblastoma; Vismodegib; Selumetinib; Sonic hedgehog; Cancer research; Smoothened; Progenitor cell; Biology; MEK inhibitor; Population; MAPK/ERK pathway; Medicine; Stem cell; Hedgehog signaling pathway; Signal transduction; Cell biology","score_opus":0.034729770139126225,"score_gpt":0.33415707932083216,"score_spread":0.29942730918170596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808796425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974795,0.0005955031,0.0006871786,0.0000390904,0.0000035139642,0.000011922715,0.00029635592,0.000045807377,0.00084112014],"genre_scores_gemma":[0.9985033,0.00023932182,0.0005151666,0.000011784281,0.0000039860784,0.000008253229,0.00023366469,0.0000056145373,0.00047903223],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999317,0.0000079321935,0.0000051459274,0.000015370375,0.000021876313,0.000017937222],"domain_scores_gemma":[0.9999193,0.000012479509,0.000028976929,0.000005389168,0.000012557036,0.000021396692],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010949313,0.00013936896,0.00013148827,0.0005776847,0.00016250071,0.0002507702,0.00010417469,0.00011024578,0.0016692319],"category_scores_gemma":[0.00013648433,0.00009379419,0.00008121594,0.0002678434,0.00018780369,0.00009951798,0.00015743612,0.00019669754,0.0002882017],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00085289835,0.00003578645,0.14783259,0.00009363991,0.00003057024,0.00028585223,0.00006824491,0.0002488335,0.8375246,0.00009740381,0.0003757901,0.012553699],"study_design_scores_gemma":[0.000021016065,0.00026440356,0.6861401,0.000011516029,0.00007804135,0.0029019048,0.00026146372,0.0019981414,0.30345613,0.00023698437,0.004621716,0.000008502432],"about_ca_topic_score_codex":0.0011574809,"about_ca_topic_score_gemma":0.001838324,"teacher_disagreement_score":0.0016692319,"about_ca_system_score_codex":0.00032876222,"about_ca_system_score_gemma":0.0001553856,"threshold_uncertainty_score":0.0055841208},"labels":[],"label_agreement":null},{"id":"W2809197883","doi":"10.2217/mmt-2017-0026","title":"Combination Therapy for Metastatic Melanoma: A Pharmacist’s Role, Drug Interactions &amp; Complementary Alternative Therapies","year":2018,"lang":"en","type":"review","venue":"Melanoma Management","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Royal Victoria Hospital","funders":"","keywords":"Medicine; Pharmacist; Vemurafenib; Metastatic melanoma; Drug; Intensive care medicine; Dabrafenib; Oncology; Trametinib; Melanoma; Internal medicine; Pharmacology; Cancer; Pharmacy; Cancer research; Nursing","score_opus":0.08007154233816013,"score_gpt":0.3657265639335599,"score_spread":0.2856550215953998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809197883","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007361237,0.9962843,0.00010878716,0.001298289,0.00046324267,0.0000047277704,0.000013480101,0.0000060824977,0.0017474187],"genre_scores_gemma":[0.0008761922,0.9961817,0.00024247864,0.0009025252,0.0005602247,0.0000070293518,0.000020942323,0.0000017791164,0.0012071589],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997671,0.000058982256,0.000030283529,0.000030393301,0.00009558958,0.000017641954],"domain_scores_gemma":[0.9995541,0.00025020624,0.000054629665,0.0000102795775,0.000095106974,0.000035688558],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005094546,0.00057649444,0.0008692971,0.0014855172,0.00029754173,0.0008770194,0.00064728566,0.0012435497,0.0046805562],"category_scores_gemma":[0.00086556026,0.00017260597,0.0005010241,0.0012463032,0.00043729082,0.0014711622,0.0005403313,0.0025465786,0.0016423428],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041051353,0.0000556161,0.00013314713,0.009565092,0.00007158179,0.00026756618,0.000053862677,0.00016982776,0.00050010136,0.0038425152,0.063956015,0.9213436],"study_design_scores_gemma":[0.000014493999,0.000047126912,0.0003862533,0.003313387,0.000054270786,0.0017985083,0.000042896532,0.00005458118,0.00010145115,0.0015814983,0.99259585,0.000009587406],"about_ca_topic_score_codex":0.00071038125,"about_ca_topic_score_gemma":0.0026134157,"teacher_disagreement_score":0.0046805562,"about_ca_system_score_codex":0.0006365199,"about_ca_system_score_gemma":0.00068748544,"threshold_uncertainty_score":0.015657961},"labels":[],"label_agreement":null},{"id":"W2877242924","doi":"10.1186/s13046-018-0812-5","title":"(Arg)9-SH2 superbinder: a novel promising anticancer therapy to melanoma by blocking phosphotyrosine signaling","year":2018,"lang":"en","type":"article","venue":"Journal of Experimental & Clinical Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Fundamental Research Funds for the Central Universities; Natural Science Foundation of Hubei Province; National Natural Science Foundation of China","keywords":"Blocking (statistics); Cancer research; Melanoma; Chemistry; Medicine; Pharmacology; Computer science","score_opus":0.16310925027198273,"score_gpt":0.49484477852532266,"score_spread":0.33173552825333996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2877242924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9545723,0.017370172,0.020799061,0.0006074806,0.0001688144,0.00013856092,0.0004062309,0.00030407927,0.0056332066],"genre_scores_gemma":[0.9777309,0.0070079444,0.008078231,0.0002351833,0.000041404066,0.000058513953,0.00035370712,0.000017270764,0.0064769886],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99996686,0.0000040940804,0.0000016521193,0.000009603823,0.000009784913,0.0000079634365],"domain_scores_gemma":[0.99998796,0.0000010082084,0.000003947111,8.1427e-7,0.00000131136,0.000004968064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000072734525,0.00028498517,0.00020254384,0.00015087826,0.0001049309,0.00012408046,0.00020329337,0.00031651958,0.00083603617],"category_scores_gemma":[0.000028059469,0.00008348912,0.00020451997,0.00010168015,0.00010702709,0.00020427909,0.0001877824,0.00039138662,0.00021291699],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013013351,0.00009607989,0.000092386,0.0001092296,0.000008767889,0.00015927712,0.0000115249195,0.00022346871,0.99107224,0.00025115657,0.00028376566,0.007562092],"study_design_scores_gemma":[0.00018032001,0.0016946632,0.0028038246,0.000012479192,0.000047153364,0.0016617934,0.000018229415,0.0036105453,0.96920156,0.00018813202,0.020555548,0.000025758887],"about_ca_topic_score_codex":0.00020867308,"about_ca_topic_score_gemma":0.00035646494,"teacher_disagreement_score":0.00083603617,"about_ca_system_score_codex":0.00013752947,"about_ca_system_score_gemma":0.000095849085,"threshold_uncertainty_score":0.0027968287},"labels":[],"label_agreement":null},{"id":"W2884253050","doi":"10.3747/co.25.3936","title":"Overcoming Resistance in a BRAF V600e–Mutant Adenocarcinoma of the Lung","year":2018,"lang":"en","type":"article","venue":"Current Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Dabrafenib; Trametinib; Vemurafenib; Medicine; Adenocarcinoma; V600E; Mutation; Cancer research; Melanoma; Mutant; Oncology; Internal medicine; Cancer; Metastatic melanoma; Biology; MAPK/ERK pathway; Gene; Genetics; Kinase","score_opus":0.04052335778572433,"score_gpt":0.3319546082158654,"score_spread":0.29143125043014106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884253050","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892259,0.0035830392,0.0015450795,0.00151312,0.000096225485,0.000060738395,0.00007352451,0.00007593791,0.003826474],"genre_scores_gemma":[0.9959196,0.0014457172,0.0011615114,0.00032933976,0.00007472256,0.000010066691,0.00008360209,0.000010766581,0.00096457876],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9998677,0.000023500292,0.000013835005,0.000027277616,0.000020873387,0.000046836525],"domain_scores_gemma":[0.9998574,0.000041699812,0.000017879209,0.000010892143,0.000010131788,0.00006194534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012592175,0.0004240527,0.00057673187,0.00036272145,0.0004595444,0.00043596147,0.00023873101,0.0010189561,0.00066185166],"category_scores_gemma":[0.00042124352,0.00017301789,0.00055795506,0.00020175685,0.00019228394,0.00030763395,0.00027161336,0.00083719124,0.00034764],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016985561,0.0009191112,0.043154582,0.0003183883,0.00014180946,0.586925,0.00047114486,0.0019989712,0.25164765,0.00062108703,0.0023157003,0.10978796],"study_design_scores_gemma":[0.00033170858,0.005938222,0.03538181,0.000030691706,0.00019440555,0.8827458,0.00018385019,0.0043343427,0.05684317,0.0004856143,0.01347601,0.000054354517],"about_ca_topic_score_codex":0.0005272623,"about_ca_topic_score_gemma":0.0013048763,"teacher_disagreement_score":0.0010189561,"about_ca_system_score_codex":0.00026168211,"about_ca_system_score_gemma":0.00019029625,"threshold_uncertainty_score":0.0022141337},"labels":[],"label_agreement":null},{"id":"W2884269426","doi":"10.1017/cjn.2018.294","title":"15 CD271/p75NTR is a novel diagnostic marker, prognostic indicator and therapeutic target for SHH medulloblastoma","year":2018,"lang":"en","type":"article","venue":"Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Selumetinib; Low-affinity nerve growth factor receptor; Cancer research; Progenitor cell; MAPK/ERK pathway; Downregulation and upregulation; Biology; Population; MEK inhibitor; Stem cell; Neurotrophin; Cell biology; Medicine; Signal transduction; Receptor; Genetics","score_opus":0.02237524677293073,"score_gpt":0.25329413615216695,"score_spread":0.23091888937923621,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884269426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97894245,0.013534621,0.002221594,0.00063357194,0.000029603772,0.000038665723,0.00046711654,0.000107068015,0.0040251417],"genre_scores_gemma":[0.99368423,0.003045653,0.001789475,0.000061867286,0.00001768637,0.000013418137,0.00026682878,0.000007642515,0.0011132454],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999262,0.000009871127,0.0000049758514,0.000014000816,0.000026426864,0.000018404182],"domain_scores_gemma":[0.99994767,0.00000847413,0.000017196853,0.0000034758364,0.000009954256,0.000013149421],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018187276,0.00017757877,0.00022128153,0.00043136437,0.0001775187,0.00042129666,0.0001625675,0.00014207972,0.0008149213],"category_scores_gemma":[0.00014333954,0.000096334545,0.0001308253,0.000259592,0.00019209612,0.00016042171,0.00014188963,0.0003291025,0.00022945506],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00093754416,0.000081454426,0.059268147,0.00025385577,0.0000595514,0.0006391057,0.00007267861,0.00082927797,0.84234583,0.00046372952,0.0011342819,0.09391449],"study_design_scores_gemma":[0.000070788024,0.0008880209,0.33400422,0.000058312442,0.0003340874,0.005513939,0.00030895724,0.0063593616,0.62093174,0.0008826468,0.030618029,0.000029878494],"about_ca_topic_score_codex":0.002513739,"about_ca_topic_score_gemma":0.0069127004,"teacher_disagreement_score":0.002513739,"about_ca_system_score_codex":0.0008501776,"about_ca_system_score_gemma":0.0004929244,"threshold_uncertainty_score":0.006168425},"labels":[],"label_agreement":null},{"id":"W2886364267","doi":"10.1158/1538-7445.am2018-2515","title":"Abstract 2515: Aberrant expression of CSF1R in melanoma is driven through an endogenous viral promoter and it contributes to malignant growth and BRAF-inhibitor resistance","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Workplace Health, Safety and Compensation Commission","funders":"","keywords":"Melanoma; Cancer research; Biology; Autocrine signalling; Small hairpin RNA; Cancer; Gene knockdown; Carcinogenesis; Metastasis; Cell culture; Molecular biology; Genetics","score_opus":0.053638940093703444,"score_gpt":0.3392327324144388,"score_spread":0.28559379232073534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886364267","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979563,0.00045005648,0.00067027146,0.000029804987,0.000007587051,0.000010005705,0.00021748092,0.000024401916,0.0006341444],"genre_scores_gemma":[0.9983633,0.00011520123,0.0005715307,0.000014036777,0.0000032824253,0.0000065740633,0.00021514541,0.000007001098,0.0007038283],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999194,0.000009746936,0.000009214082,0.000017544133,0.00002717786,0.0000169545],"domain_scores_gemma":[0.99991715,0.000015597167,0.000026294741,0.00001358112,0.000010659648,0.000016742797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009002386,0.00014418409,0.00012740261,0.00018161957,0.00009445262,0.000121529134,0.00006432985,0.00016165782,0.00145165],"category_scores_gemma":[0.00012733362,0.000068129615,0.00014470126,0.00010207193,0.00011141284,0.00005889157,0.00009681849,0.00020946247,0.0003104838],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006436602,0.000010003245,0.0030798062,0.000017277185,0.000004236085,0.00028283958,0.000011896254,0.000021808959,0.9950996,0.000029933117,0.0000388578,0.0013392908],"study_design_scores_gemma":[0.000017356817,0.0005370076,0.123847105,0.000012727628,0.00004042113,0.008748818,0.00006231057,0.0014365182,0.86103654,0.000117774594,0.004137567,0.0000058659953],"about_ca_topic_score_codex":0.00057107175,"about_ca_topic_score_gemma":0.00050141657,"teacher_disagreement_score":0.00145165,"about_ca_system_score_codex":0.00018594258,"about_ca_system_score_gemma":0.00008556611,"threshold_uncertainty_score":0.004856229},"labels":[],"label_agreement":null},{"id":"W2887121914","doi":"10.1158/1538-7445.am2018-1206","title":"Abstract 1206: Patterns of BRAF testing and treatment in patients with metastatic melanoma presumed BRAF positive","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Melanoma; Metastatic melanoma; Internal medicine; Mutation; Oncology; Cancer research; Biology","score_opus":0.05028103803597944,"score_gpt":0.3394714339502016,"score_spread":0.28919039591422213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887121914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995131,0.00026544565,0.00007229705,0.0001477346,0.0000044622147,0.000014749322,0.00334494,0.000006067165,0.0010133683],"genre_scores_gemma":[0.9978327,0.00009659746,0.00009528487,0.00006341756,0.000008070032,0.0000100775105,0.0017574938,0.0000029211442,0.00013346822],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99917287,0.00014050028,0.00015460413,0.00024041042,0.0001884665,0.000103159786],"domain_scores_gemma":[0.996176,0.00042784208,0.0027137941,0.0001172388,0.00026658995,0.00029848743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061166636,0.00013537807,0.00022459231,0.0009634758,0.00034292694,0.0006405947,0.00050927594,0.00031798347,0.0031084984],"category_scores_gemma":[0.003870882,0.00016302761,0.0003491289,0.0018831338,0.00020031426,0.00044180534,0.0005023166,0.00044919833,0.00046761546],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008390358,0.000021279147,0.99806315,0.000014738004,0.00001577106,0.00007367365,0.000048887767,0.000028690723,0.000101682825,0.000023088585,0.00036184592,0.0011633005],"study_design_scores_gemma":[0.000008922663,0.00005890688,0.9982134,0.000020955276,0.000011101618,0.00062638905,0.00022442134,0.0002659311,0.00010204088,0.00003341039,0.0004302652,0.0000042316187],"about_ca_topic_score_codex":0.009126582,"about_ca_topic_score_gemma":0.011059485,"teacher_disagreement_score":0.009126582,"about_ca_system_score_codex":0.0006776203,"about_ca_system_score_gemma":0.0005359253,"threshold_uncertainty_score":0.018146932},"labels":[],"label_agreement":null},{"id":"W2887451076","doi":"10.1158/1535-7163.targ-17-b056","title":"Abstract B056: Non-V600 BRAF mutations in melanoma: actionable targets for rational drug combinations","year":2018,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University; University of Toronto","funders":"","keywords":"Trametinib; Dabrafenib; Vemurafenib; Melanoma; Cancer research; MAPK/ERK pathway; MEK inhibitor; Medicine; Kinase; Targeted therapy; Mutant; V600E; In vivo; Cell culture; Cell growth; Metastatic melanoma; Cancer; Biology; Internal medicine; Cell biology; Biochemistry; Genetics","score_opus":0.017198359884491442,"score_gpt":0.28795492942818246,"score_spread":0.27075656954369104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887451076","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8628037,0.066339396,0.016686177,0.004426397,0.00068223604,0.001416745,0.0023145596,0.00061065436,0.044720102],"genre_scores_gemma":[0.9671738,0.01572299,0.0073562344,0.00069064874,0.00011543186,0.00021159432,0.0011694523,0.000044717963,0.0075151175],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999012,0.00002534521,0.00000805909,0.0000143984835,0.000026916436,0.000024029088],"domain_scores_gemma":[0.9999336,0.000009579465,0.000013147731,0.0000055411138,0.0000132069845,0.000024983154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027840683,0.00048629922,0.00045229407,0.0004367124,0.00017971825,0.0004640907,0.00043007592,0.00039490397,0.0043408484],"category_scores_gemma":[0.00014992972,0.00015975312,0.00031630447,0.00022303284,0.0002143469,0.00026208136,0.0002622846,0.0009971125,0.0011128834],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004708792,0.0028917328,0.0020923156,0.0011676728,0.00021288339,0.0017305819,0.00012620419,0.0056196842,0.776816,0.0049682613,0.0115253525,0.18814038],"study_design_scores_gemma":[0.008558138,0.031657122,0.013212893,0.0005294831,0.0005620073,0.008277983,0.00021149499,0.017529583,0.7137689,0.0049017677,0.20067264,0.000118012336],"about_ca_topic_score_codex":0.00041029663,"about_ca_topic_score_gemma":0.0011958224,"teacher_disagreement_score":0.0043408484,"about_ca_system_score_codex":0.00036146838,"about_ca_system_score_gemma":0.00027825212,"threshold_uncertainty_score":0.014521599},"labels":[],"label_agreement":null},{"id":"W2888332715","doi":"10.1172/jci.insight.121144","title":"The TAB1-p38α complex aggravates myocardial injury and can be targeted by small molecules","year":2018,"lang":"en","type":"article","venue":"JCI Insight","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"Menzies Centre for Australian Studies, King's College London, University of London; Biotechnology and Biological Sciences Research Council; Medical Research Council; National Institutes of Health; King's College London; National Institute for Health and Care Research; King's College Hospital NHS Foundation Trust; Francis Crick Institute; British Heart Foundation; Wellcome Trust","keywords":"Medicine; Internal medicine; Chemistry","score_opus":0.013898057202651082,"score_gpt":0.22419419619844433,"score_spread":0.21029613899579325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888332715","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99528354,0.0016456645,0.002027112,0.00010066611,0.000040263585,0.000026995882,0.00023537167,0.000089933164,0.00055053877],"genre_scores_gemma":[0.9929334,0.0013113427,0.0025922474,0.000058780945,0.000015286487,0.000062072446,0.00066105364,0.000027573495,0.0023382204],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99985886,0.000023765173,0.000014061692,0.000024419449,0.000032012947,0.000046778754],"domain_scores_gemma":[0.9999255,0.000007812535,0.00002696992,0.000006454116,0.0000042472857,0.00002895639],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013214312,0.000626613,0.0003889837,0.00023356549,0.00017122702,0.00023760788,0.00026094887,0.00028413735,0.0017544198],"category_scores_gemma":[0.000079240446,0.00022533062,0.00030154007,0.0001371162,0.00025744052,0.00019730501,0.00019428114,0.0010211768,0.00036759992],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017734847,0.000043535943,0.00005943716,0.00003391899,0.000008108859,0.000023784558,0.0000055763485,0.00005568008,0.9990896,0.000041961524,0.000018751309,0.0004423263],"study_design_scores_gemma":[0.000043788852,0.0004874968,0.0016075295,0.000005317908,0.00002360234,0.00016055896,0.000011836409,0.00054232497,0.9959187,0.000028791086,0.0011671644,0.000002917986],"about_ca_topic_score_codex":0.00028669962,"about_ca_topic_score_gemma":0.000392187,"teacher_disagreement_score":0.0017544198,"about_ca_system_score_codex":0.00022496675,"about_ca_system_score_gemma":0.00016541255,"threshold_uncertainty_score":0.00586915},"labels":[],"label_agreement":null},{"id":"W2890051143","doi":"10.1016/j.jbior.2018.09.010","title":"Mitogen and stress- activated protein kinase regulated gene expression in cancer cells","year":2018,"lang":"en","type":"review","venue":"Advances in Biological Regulation","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"CancerCare Manitoba Foundation","keywords":"ASK1; Protein kinase A; Mitogen-activated protein kinase; Kinase; Cell biology; c-Raf; Biology; MAP kinase kinase kinase; Cyclin-dependent kinase 2; Mitogen-activated protein kinase kinase; MAP2K7; p38 mitogen-activated protein kinases; Transcription factor; Cancer research; Gene; Genetics","score_opus":0.03389226257274681,"score_gpt":0.3238834349372045,"score_spread":0.2899911723644577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890051143","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022935434,0.99785846,0.00028332366,0.00031192604,0.00025723854,0.0000032029943,0.000023778957,0.000009206417,0.0010234985],"genre_scores_gemma":[0.0013379282,0.99724114,0.00023874978,0.0001788716,0.00018616635,0.0000043664286,0.000031214764,0.0000017058022,0.0007798334],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99991834,0.0000109541015,0.000010873232,0.000016923545,0.000031779255,0.000011136849],"domain_scores_gemma":[0.9999045,0.000034244928,0.000018247716,0.000004017684,0.000027491418,0.000011419652],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031384375,0.00053776207,0.0006827078,0.0010217727,0.00015141614,0.0006546473,0.0004707109,0.0005046557,0.0016576059],"category_scores_gemma":[0.00031583896,0.00017147211,0.00022933696,0.0012732228,0.00034281024,0.0006725883,0.000447748,0.0011259838,0.00092847814],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009914232,0.00004280731,0.00020991772,0.010888966,0.00005454432,0.00023676327,0.000045619105,0.00035876542,0.011081051,0.004846212,0.02223319,0.949903],"study_design_scores_gemma":[0.00001312992,0.00005586294,0.00087474973,0.0011397294,0.000076700424,0.0008364447,0.000045485252,0.00011865725,0.0032408568,0.0023407263,0.99124277,0.000014765379],"about_ca_topic_score_codex":0.00053119415,"about_ca_topic_score_gemma":0.0011321817,"teacher_disagreement_score":0.0016576059,"about_ca_system_score_codex":0.0004647561,"about_ca_system_score_gemma":0.0007207223,"threshold_uncertainty_score":0.0055452585},"labels":[],"label_agreement":null},{"id":"W2891803344","doi":"10.1016/j.pupt.2018.09.004","title":"Differential regulation of cytokine and chemokine expression by MK2 and MK3 in airway smooth muscle cells","year":2018,"lang":"en","type":"article","venue":"Pulmonary Pharmacology & Therapeutics","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research; National Institutes of Health; Canada Research Chairs; GlaxoSmithKline","keywords":"Chemokine; Cytokine; Cell biology; Airway; Immunology; Chemistry; Neuroscience; Medicine; Biology; Inflammation; Anesthesia","score_opus":0.010494352039516283,"score_gpt":0.2507076953803528,"score_spread":0.24021334334083652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891803344","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972938,0.00072312227,0.00075083,0.000082718914,0.00002095235,0.000007656896,0.00020894135,0.000015855625,0.00089617475],"genre_scores_gemma":[0.99777824,0.00035826152,0.00047947085,0.00004747844,0.000009568538,0.000025082929,0.00020116093,0.0000046081072,0.0010962405],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999861,0.000019781437,0.0000113477645,0.000015655214,0.000029840066,0.00006242825],"domain_scores_gemma":[0.99995565,0.0000072548523,0.000007783513,0.000005508847,0.000008960052,0.000014921666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000113210306,0.00014584186,0.00016511252,0.0001187497,0.00021935086,0.00032171767,0.00009287232,0.00017256745,0.0009943126],"category_scores_gemma":[0.0001067529,0.00011049017,0.00029510705,0.00014027747,0.00017574526,0.00022481491,0.00021738914,0.00042753218,0.0002598659],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040547553,0.000019500763,0.0005066806,0.000022016338,0.0000035318978,0.00004507041,0.0000339862,0.000036053676,0.9980484,0.00013346536,0.000041888623,0.0007039063],"study_design_scores_gemma":[0.00005747236,0.0005122358,0.049715254,0.000007183034,0.000035639892,0.0002863545,0.00026868135,0.0013379218,0.9450233,0.0001848969,0.002560881,0.0000102071635],"about_ca_topic_score_codex":0.00084754074,"about_ca_topic_score_gemma":0.0013729093,"teacher_disagreement_score":0.0009943126,"about_ca_system_score_codex":0.0002388822,"about_ca_system_score_gemma":0.0002536959,"threshold_uncertainty_score":0.0033263564},"labels":[],"label_agreement":null},{"id":"W2892144284","doi":"10.1200/jco.2016.34.15_suppl.e21054","title":"Second-line drug regimens in metastatic melanoma patients based on BRAF mutation status: A Canadian real-world retrospective study.","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Canada; Merck Canada Inc. (Canada)","funders":"","keywords":"Medicine; Metastatic melanoma; Oncology; Melanoma; Internal medicine; Retrospective cohort study; Targeted therapy; Metastasis; Mutation; Immunotherapy; Cancer; Cancer research; Gene","score_opus":0.042917849054351455,"score_gpt":0.374787704850302,"score_spread":0.3318698557959505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2892144284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891214,0.0013015933,0.00010334236,0.00019203435,0.000010595718,0.00014588765,0.007589123,0.0000071047875,0.0015288211],"genre_scores_gemma":[0.9949056,0.0010330315,0.00019922099,0.00022962385,0.00001323114,0.000057078913,0.003204461,0.0000062000627,0.0003515784],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988128,0.00007496937,0.00011874911,0.00024560795,0.00044911218,0.00029884087],"domain_scores_gemma":[0.9967726,0.00022739536,0.0014057413,0.00014467974,0.00089215743,0.00055753614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007570685,0.00045811155,0.0005493127,0.0016199766,0.0018254494,0.0011879818,0.0008684046,0.00055715186,0.002215757],"category_scores_gemma":[0.00252434,0.0006041172,0.0008217009,0.0054937853,0.0005336417,0.00049600616,0.0008018249,0.00088817975,0.0003301395],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010045515,0.000038655,0.9970907,0.000062433355,0.00004682129,0.00014420596,0.00025193967,0.000034375807,0.00009781361,0.00003710809,0.00061598385,0.0014794761],"study_design_scores_gemma":[0.00002501477,0.00008961542,0.99628997,0.00006685049,0.00006344361,0.00045449054,0.0010820845,0.00021141196,0.00006623278,0.000021824972,0.0016114963,0.000017610986],"about_ca_topic_score_codex":0.91299635,"about_ca_topic_score_gemma":0.9386747,"teacher_disagreement_score":0.08700365,"about_ca_system_score_codex":0.013225112,"about_ca_system_score_gemma":0.015537899,"threshold_uncertainty_score":0.17503202},"labels":[],"label_agreement":null},{"id":"W2898547742","doi":"10.1093/annonc/mdy289","title":"KEYNOTE-022 Part 3: Phase II randomized study of 1L dabrafenib (D) and trametinib (T) plus pembrolizumab (Pembro) or placebo (PBO) for BRAF-mutant advanced melanoma","year":2018,"lang":"fr","type":"article","venue":"Annals of Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec","funders":"","keywords":"Dabrafenib; Medicine; Tolerability; Discontinuation; Pembrolizumab; Internal medicine; Placebo; Clinical endpoint; Gastroenterology; Nuclear medicine; Clinical trial; Adverse effect; Metastatic melanoma; Immunotherapy; Cancer; Pathology; Vemurafenib","score_opus":0.0654847845609551,"score_gpt":0.3826286166165271,"score_spread":0.31714383205557195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2898547742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9253044,0.0041711065,0.0025948733,0.0017934215,0.000650017,0.042448707,0.0139611615,0.00062277133,0.0084535945],"genre_scores_gemma":[0.9227446,0.0029546681,0.005883371,0.003102827,0.0007142435,0.040038962,0.010096406,0.00016464498,0.014300314],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99931335,0.00034205933,0.000038784714,0.0001276835,0.00006595829,0.00011203491],"domain_scores_gemma":[0.9991942,0.00011409194,0.00022074419,0.00007388774,0.00004762269,0.00034942746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002400367,0.0025982514,0.0021752312,0.0005382495,0.00065806217,0.0013274065,0.0017966861,0.0019382649,0.0204631],"category_scores_gemma":[0.001497518,0.0010822219,0.0013187752,0.0005676616,0.0011899343,0.0013382961,0.0006777524,0.0037979793,0.0038204745],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9345756,0.025401894,0.00087143504,0.0010152982,0.000552648,0.00008713893,0.00008513042,0.00071849045,0.01376621,0.00026054407,0.0048032524,0.017862394],"study_design_scores_gemma":[0.93887323,0.05706195,0.0010535712,0.000021450362,0.00017712625,0.000068873676,0.000013484046,0.00029432587,0.00087419496,0.00011159201,0.0014361469,0.000013902751],"about_ca_topic_score_codex":0.0007120533,"about_ca_topic_score_gemma":0.0019190173,"teacher_disagreement_score":0.0204631,"about_ca_system_score_codex":0.0014323696,"about_ca_system_score_gemma":0.002900077,"threshold_uncertainty_score":0.068455935},"labels":[],"label_agreement":null},{"id":"W2899103245","doi":"10.4049/jimmunol.1800284","title":"TAOK3 Regulates Canonical TCR Signaling by Preventing Early SHP-1–Mediated Inactivation of LCK","year":2018,"lang":"en","type":"article","venue":"The Journal of Immunology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Canadian Institutes of Health Research; McGill University","keywords":"T-cell receptor; Cell biology; Regulator; Signal transduction; Jurkat cells; Src family kinase; T cell; Superantigen; Phosphorylation; Biology; Phosphatase; Proto-oncogene tyrosine-protein kinase Src; Immunology; Immune system; Biochemistry","score_opus":0.007967681467150555,"score_gpt":0.22424725135693654,"score_spread":0.216279569889786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899103245","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948999,0.00081073213,0.002729165,0.00012568737,0.000030370174,0.000016470172,0.00023188435,0.00014876646,0.0010070478],"genre_scores_gemma":[0.9978033,0.00028002955,0.00085436204,0.00002369079,0.0000057829675,0.000014279945,0.00016670422,0.000025071839,0.00082680123],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989367,0.00001110624,0.000011987369,0.00001837682,0.000023563696,0.000041207782],"domain_scores_gemma":[0.9998816,0.000013706981,0.000048539005,0.000012338783,0.000011336176,0.00003247279],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000113067465,0.00033415432,0.00018041911,0.00017761588,0.0002721196,0.00033146626,0.00032512387,0.0002647394,0.00092371734],"category_scores_gemma":[0.00012096551,0.00012454382,0.0002739629,0.00013354042,0.00031149603,0.00026436208,0.00023106497,0.0006410653,0.00034974655],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009581667,0.000010618959,0.00016758555,0.000017319597,0.0000025230827,0.000040247083,0.000007930073,0.000050292783,0.99896,0.00013515784,0.000029064237,0.0004834076],"study_design_scores_gemma":[0.000023711174,0.000057650723,0.0026233895,0.0000029675411,0.000011569367,0.00021791128,0.000019029529,0.0009361907,0.99465066,0.000102711405,0.0013497331,0.0000044531166],"about_ca_topic_score_codex":0.0007046195,"about_ca_topic_score_gemma":0.00112938,"teacher_disagreement_score":0.00092371734,"about_ca_system_score_codex":0.0005113861,"about_ca_system_score_gemma":0.00038018613,"threshold_uncertainty_score":0.0037104487},"labels":[],"label_agreement":null},{"id":"W2899366572","doi":"10.1097/md.0000000000012751","title":"Cardiac tamponade induced by dabrafenib and trametinib combination therapy for melanoma","year":2018,"lang":"en","type":"article","venue":"Medicine","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatoon Medical Imaging","funders":"","keywords":"Medicine; Dabrafenib; Trametinib; Pericardiocentesis; Pericardial effusion; Cardiac tamponade; Discontinuation; Peripheral edema; Melanoma; Adverse effect; Edema; Surgery; Internal medicine; Cancer research; Vemurafenib; MAPK/ERK pathway","score_opus":0.017701767454888523,"score_gpt":0.2710314692834071,"score_spread":0.25332970182851855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899366572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8570104,0.09145779,0.008574886,0.010243912,0.0009799304,0.00037605007,0.00037967254,0.0006153541,0.030361956],"genre_scores_gemma":[0.98980963,0.005697283,0.0008549063,0.0013789535,0.00064171315,0.00002364028,0.00010196275,0.000018608453,0.001473243],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9995857,0.000120215256,0.000046803274,0.00006284863,0.00009900055,0.00008543729],"domain_scores_gemma":[0.9989184,0.00032498935,0.0004728121,0.00007525159,0.000058811755,0.00014963296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002896299,0.00042927865,0.0004006573,0.00035567218,0.00036984516,0.0005127105,0.00034788335,0.0010445392,0.0022516812],"category_scores_gemma":[0.0019727882,0.00017104672,0.0004582087,0.00024408895,0.00042747552,0.00058813125,0.00039024267,0.0013446715,0.00048521298],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006456245,0.00010927087,0.040077228,0.0006610302,0.00009773833,0.899904,0.00032024356,0.0004250431,0.013662404,0.00079326157,0.0051234406,0.038180664],"study_design_scores_gemma":[0.00007477903,0.0004774302,0.015461106,0.00016657928,0.000059032678,0.9675679,0.0001249387,0.00060671876,0.0049195616,0.00036388804,0.010161349,0.000016715032],"about_ca_topic_score_codex":0.0003408327,"about_ca_topic_score_gemma":0.000761921,"teacher_disagreement_score":0.0022516812,"about_ca_system_score_codex":0.00039837387,"about_ca_system_score_gemma":0.00027663566,"threshold_uncertainty_score":0.007532656},"labels":[],"label_agreement":null},{"id":"W2899797865","doi":"10.1101/467605","title":"Reevaluation of the Role of ERK3 in Perinatal Survival and Post-Natal Growth Using New Genetically-Engineered Mouse Models","year":2018,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Phenotype; Biology; Mutant; Gene; Allele; Genetics; Locus (genetics)","score_opus":0.014501900717828134,"score_gpt":0.21227047300809737,"score_spread":0.19776857229026923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899797865","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9393127,0.0077658645,0.046659976,0.0010451657,0.00018318796,0.00018241393,0.0012371275,0.0005329821,0.0030805627],"genre_scores_gemma":[0.93436944,0.012953222,0.04120292,0.00031536075,0.0000748781,0.00036882877,0.0016097417,0.00018286177,0.008922794],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997274,0.000054436343,0.000039981558,0.00005161903,0.000081323924,0.000045260298],"domain_scores_gemma":[0.99969256,0.00006592375,0.000094716605,0.000042863012,0.00003158104,0.0000723511],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000805162,0.0011899904,0.00035013055,0.000981812,0.00030243114,0.00052312954,0.0009427201,0.000556772,0.0010514485],"category_scores_gemma":[0.00020014415,0.00033404666,0.00044526724,0.00023690841,0.0006840348,0.00060077396,0.00042027546,0.0018544004,0.00040912651],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018152107,0.000069538335,0.00033092755,0.000086265645,0.0000136075505,0.00013115046,0.000028646975,0.00019157112,0.99517834,0.0010146515,0.000076701006,0.0026970769],"study_design_scores_gemma":[0.000057856592,0.00077467243,0.0034026883,0.00005100181,0.0000898075,0.0010975595,0.0000788306,0.0027198284,0.98126686,0.00043299687,0.0100114215,0.000016358952],"about_ca_topic_score_codex":0.00052024174,"about_ca_topic_score_gemma":0.0010713582,"teacher_disagreement_score":0.0011899904,"about_ca_system_score_codex":0.0005063381,"about_ca_system_score_gemma":0.00033558198,"threshold_uncertainty_score":0.0042582154},"labels":[],"label_agreement":null},{"id":"W2905822848","doi":"10.1016/j.ejca.2018.11.018","title":"An open-label, multicentre safety study of vemurafenib in patients with BRAFV600-mutant metastatic melanoma: final analysis and a validated prognostic scoring system","year":2018,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Merck Sharp and Dohme; EUSA Pharma; Eisai; Genentech; Les Laboratories Pierre Fabre; Regeneron Pharmaceuticals; Chugai Pharmaceutical; Amgen; Pfizer; Bristol-Myers Squibb; F. Hoffmann-La Roche","keywords":"Vemurafenib; Medicine; Internal medicine; Tolerability; Melanoma; Metastatic melanoma; Dacarbazine; Oncology; Clinical trial; Population; Surgery; Adverse effect; Chemotherapy; Cancer research; Cancer","score_opus":0.022977513247716175,"score_gpt":0.2802544449555863,"score_spread":0.25727693170787014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905822848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980457,0.0005363545,0.0004540221,0.000049116876,0.000025896356,0.00016444619,0.00043885995,0.000019474857,0.00026601323],"genre_scores_gemma":[0.9976757,0.00012981376,0.0004318891,0.00009627622,0.000042500917,0.00017000156,0.0011235855,0.000011607609,0.00031866724],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9987018,0.0006490825,0.000068063324,0.0002666836,0.00017112916,0.00014323322],"domain_scores_gemma":[0.9973743,0.00072682224,0.0006842315,0.0004656185,0.00027867247,0.00047028426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003102008,0.0012331206,0.001804456,0.0003608968,0.00038240582,0.0011649672,0.00064373715,0.0009387275,0.0012866901],"category_scores_gemma":[0.0035911177,0.00047255703,0.002000876,0.00040285394,0.0007760408,0.0013304612,0.0004912728,0.0015072842,0.00036334508],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.85862577,0.004562401,0.078932576,0.00037261992,0.0043055722,0.00019752448,0.0002260674,0.0023744602,0.0143136,0.00017330461,0.0008153594,0.035100672],"study_design_scores_gemma":[0.30506212,0.23020358,0.44053853,0.00006504071,0.0049638744,0.0012274751,0.00027972326,0.007900544,0.005477003,0.0007647843,0.0033102692,0.00020713278],"about_ca_topic_score_codex":0.0003961563,"about_ca_topic_score_gemma":0.0006845679,"teacher_disagreement_score":0.003102008,"about_ca_system_score_codex":0.0008268515,"about_ca_system_score_gemma":0.00064187136,"threshold_uncertainty_score":0.016405165},"labels":[],"label_agreement":null},{"id":"W2906348647","doi":"10.1002/cpdd.643","title":"Effect of Rifampicin on the Pharmacokinetics of a Single Dose of Vemurafenib in Patients With <i>BRAF</i> <sup>V600</sup> Mutation–Positive Metastatic Malignancy","year":2018,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"F. Hoffmann-La Roche","keywords":"Vemurafenib; Medicine; Pharmacokinetics; Pharmacology; Area under the curve; Dosing; Rifampicin; Confidence interval; Internal medicine; Gastroenterology; Urology; Metastatic melanoma; Cancer; Pathology; Tuberculosis","score_opus":0.01646367025858358,"score_gpt":0.3114050173212828,"score_spread":0.2949413470626992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906348647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99893767,0.00051573577,0.0001596791,0.00007364095,0.00001595729,0.000026799511,0.000036035282,0.000017729011,0.00021672636],"genre_scores_gemma":[0.9996227,0.00007683406,0.00012304154,0.000035348574,0.000018953253,0.00001093544,0.00004503757,0.0000027184399,0.000064484855],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99957603,0.00022048218,0.000026206175,0.00007475661,0.000053200445,0.00004938378],"domain_scores_gemma":[0.99889165,0.00036502507,0.00031516564,0.00006704398,0.00005636717,0.00030477732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008033128,0.0003819535,0.00094792334,0.00015479318,0.00021860194,0.00039160904,0.00015524446,0.00030553792,0.0007084764],"category_scores_gemma":[0.0021504406,0.00022466235,0.0006276608,0.000119497236,0.0002755493,0.0002946853,0.00014848947,0.0009873478,0.00015502301],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.39846098,0.012821134,0.16728286,0.00028441285,0.0019853476,0.001331119,0.0005591789,0.006161936,0.19928584,0.00016371052,0.0024079257,0.20925556],"study_design_scores_gemma":[0.030912649,0.4417844,0.47458845,0.000045715118,0.0010278804,0.0027740872,0.00022581569,0.010360552,0.035070185,0.00018789031,0.0029430173,0.00007940912],"about_ca_topic_score_codex":0.0004279701,"about_ca_topic_score_gemma":0.0006842672,"teacher_disagreement_score":0.00094792334,"about_ca_system_score_codex":0.0004569795,"about_ca_system_score_gemma":0.00036549472,"threshold_uncertainty_score":0.004248321},"labels":[],"label_agreement":null},{"id":"W2908482697","doi":"10.4196/kjpp.2019.23.1.29","title":"Decursin induces apoptosis in glioblastoma cells, but not in glial cells <i>via</i> a mitochondria-related caspase pathway","year":2019,"lang":"en","type":"article","venue":"Korean Journal of Physiology and Pharmacology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child, Adolescent and Family Mental Health","funders":"","keywords":"Apoptosis; U87; Glioma; Cancer research; Cell culture; Cyclin D1; Glioblastoma; Cytotoxic T cell; Cell biology; Chemistry; Cell cycle; Pharmacology; Medicine; Biology; In vitro; Biochemistry","score_opus":0.006112934864680502,"score_gpt":0.22724757757235925,"score_spread":0.22113464270767874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908482697","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99311686,0.003058188,0.00081160513,0.00012848809,0.00003378297,0.000030260513,0.00024914625,0.000040639432,0.0025309913],"genre_scores_gemma":[0.9933768,0.0025436976,0.0008021423,0.00007383324,0.000009131985,0.0000294986,0.0005368389,0.0000074125214,0.0026206418],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999553,0.0000058354094,0.000005983143,0.000006568628,0.000012056947,0.000014285559],"domain_scores_gemma":[0.99997365,0.0000028716283,0.0000082896395,0.000003095648,0.0000046903197,0.000007415522],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000040612118,0.00033374268,0.00021149218,0.00024539218,0.00014499892,0.000137017,0.000069278096,0.00013796252,0.0008362234],"category_scores_gemma":[0.00004415162,0.0000645443,0.00019797117,0.0001252337,0.00009865513,0.000132562,0.00010901609,0.000294113,0.00015987823],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001473572,0.000047522168,0.00034001307,0.00009156391,0.000010305636,0.00014464797,0.000017228664,0.000051170995,0.9953484,0.00007324218,0.000061891515,0.0036667206],"study_design_scores_gemma":[0.00001505035,0.0004129603,0.004152115,0.000007374247,0.000016315484,0.00034449578,0.000036236994,0.00023450746,0.9925564,0.000064528744,0.0021578318,0.0000021715732],"about_ca_topic_score_codex":0.00058325264,"about_ca_topic_score_gemma":0.0017122298,"teacher_disagreement_score":0.0008362234,"about_ca_system_score_codex":0.00023782068,"about_ca_system_score_gemma":0.00017112894,"threshold_uncertainty_score":0.0027974248},"labels":[],"label_agreement":null},{"id":"W2911354154","doi":"10.1016/j.jid.2019.01.027","title":"Dynamic Evolution of Clonal Composition and Neoantigen Landscape in Recurrent Metastatic Melanoma with a Rare Combination of Driver Mutations","year":2019,"lang":"en","type":"article","venue":"Journal of Investigative Dermatology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Genetics; Ligue Contre le Cancer; Agence Nationale de la Recherche; Institute of Cancer Research; Institut National Du Cancer; Centre National de la Recherche Scientifique; Association pour la Recherche sur le Cancer","keywords":"Neuroblastoma RAS viral oncogene homolog; Somatic evolution in cancer; Biology; Melanoma; Missense mutation; Exome sequencing; Cancer research; Exome; Genome instability; Mutation; Phenotype; Chromosome instability; V600E; Genetics; Cancer; Gene; KRAS; Chromosome; DNA; DNA damage","score_opus":0.006976649683310307,"score_gpt":0.2265958688252995,"score_spread":0.2196192191419892,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911354154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99928844,0.00012960195,0.00021435267,0.000011830663,0.0000017451712,0.0000021777141,0.00003572858,0.000013131243,0.00030299052],"genre_scores_gemma":[0.9995364,0.000046880883,0.00018630853,0.000006279391,0.0000024206256,0.0000018711067,0.000038985898,0.0000050755643,0.00017590284],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998957,0.000013026024,0.000008081057,0.0000252151,0.00003113946,0.000026862588],"domain_scores_gemma":[0.99985564,0.000027907592,0.000051685853,0.000014774277,0.000018330944,0.00003152423],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013906868,0.00013590824,0.00014878598,0.0005722869,0.0001859167,0.00033845165,0.00015597016,0.00028255593,0.0012393326],"category_scores_gemma":[0.0004328912,0.00012594048,0.00014310709,0.00027774458,0.00012548688,0.00018072646,0.00017856187,0.0001903017,0.00023655451],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059044565,0.000061854604,0.14970747,0.00003894868,0.00005696928,0.011617515,0.00029722106,0.00075781834,0.8185884,0.00042107963,0.00026626114,0.017596014],"study_design_scores_gemma":[0.00003165247,0.00049444847,0.7852854,0.000014654649,0.00017742252,0.096756525,0.0005128439,0.010284049,0.10206566,0.0008186857,0.0035273999,0.00003131968],"about_ca_topic_score_codex":0.00045283636,"about_ca_topic_score_gemma":0.0006900303,"teacher_disagreement_score":0.0012393326,"about_ca_system_score_codex":0.00017347035,"about_ca_system_score_gemma":0.00008608443,"threshold_uncertainty_score":0.00414598},"labels":[],"label_agreement":null},{"id":"W2913370005","doi":"10.1186/s12885-018-5186-8","title":"Estrogen receptor signaling regulates the expression of the breast tumor kinase in breast cancer cells","year":2019,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency; University of Saskatchewan","funders":"Canadian Institutes of Health Research; Cure Brain Cancer Foundation; Saskatchewan Cancer Agency","keywords":"Fulvestrant; Breast cancer; Estrogen receptor; Tamoxifen; Medicine; Cancer research; Cancer; Immunohistochemistry; Surgical oncology; Estrogen; Estrogen receptor alpha; Internal medicine; Oncology","score_opus":0.006887831661311291,"score_gpt":0.21859619018600723,"score_spread":0.21170835852469594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913370005","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9649801,0.02187894,0.0041972883,0.0004356806,0.00011069459,0.000035831017,0.0018471422,0.00014322951,0.006371146],"genre_scores_gemma":[0.9852931,0.007000676,0.0018213333,0.00008792156,0.0000138103005,0.00002721237,0.0013010593,0.000016369604,0.0044385567],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999205,0.000012202229,0.000007166401,0.000017417702,0.000024070263,0.000018693187],"domain_scores_gemma":[0.9999603,0.000004910578,0.00001325291,0.0000051022503,0.0000097523,0.000006718183],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010995633,0.00022686721,0.00013284507,0.00015416113,0.00014312033,0.00027193414,0.00010858863,0.00014941736,0.0013691416],"category_scores_gemma":[0.000087405264,0.00007988839,0.000196455,0.00020236142,0.0000933517,0.00016659446,0.00016337198,0.00025103788,0.0007819642],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000120682336,0.000027800355,0.00092068856,0.000100343386,0.0000068398263,0.00005685352,0.000017411227,0.00005671613,0.99498075,0.00016499158,0.00018491932,0.0033620107],"study_design_scores_gemma":[0.000034102148,0.00024062044,0.04572886,0.00002997008,0.000037472888,0.0007601672,0.0000825611,0.00096825324,0.9316954,0.000298739,0.020114247,0.000009707254],"about_ca_topic_score_codex":0.00025976877,"about_ca_topic_score_gemma":0.00037731134,"teacher_disagreement_score":0.0013691416,"about_ca_system_score_codex":0.0002686964,"about_ca_system_score_gemma":0.00013733185,"threshold_uncertainty_score":0.0045802593},"labels":[],"label_agreement":null},{"id":"W2913586357","doi":"10.1038/s41419-019-1350-6","title":"MKK3 modulates JNK-dependent cell migration and invasion","year":2019,"lang":"en","type":"article","venue":"Cell Death and Disease","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Genetics; National Natural Science Foundation of China","keywords":"Cell biology; Cell migration; Cell; Chemistry; Biology; Biochemistry","score_opus":0.006426854840862928,"score_gpt":0.19003002857505338,"score_spread":0.18360317373419047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913586357","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933169,0.0018846252,0.0017316492,0.00013336004,0.000047275706,0.00002899358,0.00055173296,0.00009021294,0.0022152555],"genre_scores_gemma":[0.99659365,0.0005007432,0.0007251976,0.000042549265,0.000009107304,0.000035970515,0.00045673456,0.000012670675,0.0016233171],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998654,0.000018230652,0.000012900251,0.000017980974,0.000031772754,0.000053685937],"domain_scores_gemma":[0.9999447,0.000004232293,0.000016903312,0.000004281202,0.000009045793,0.000020844955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011211258,0.00037090038,0.00019020846,0.00017209683,0.00029408722,0.00023649362,0.00018155239,0.00016722869,0.0017487936],"category_scores_gemma":[0.00009047465,0.00011678218,0.0002316451,0.00012540589,0.0001956618,0.00013496909,0.00022028017,0.00058888516,0.0004605451],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016962067,0.000026700669,0.0001731946,0.00006926993,0.000003874791,0.0000271017,0.00001550675,0.000037938302,0.99875426,0.00010092432,0.00008295548,0.00053852587],"study_design_scores_gemma":[0.000025708967,0.00012882036,0.0047567044,0.0000057478696,0.000015118899,0.00013069384,0.00003331074,0.001078896,0.9915999,0.000048663023,0.002172449,0.00000409682],"about_ca_topic_score_codex":0.000717895,"about_ca_topic_score_gemma":0.001014687,"teacher_disagreement_score":0.0017487936,"about_ca_system_score_codex":0.00047726228,"about_ca_system_score_gemma":0.00026732704,"threshold_uncertainty_score":0.005850315},"labels":[],"label_agreement":null},{"id":"W2914108875","doi":"10.1016/j.ctrv.2019.02.001","title":"Network meta-analysis of therapies for previously untreated advanced BRAF-mutated melanoma","year":2019,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; McMaster University; Impact","funders":"","keywords":"Medicine; Dabrafenib; Vemurafenib; Trametinib; Dacarbazine; Oncology; Internal medicine; Ipilimumab; Melanoma; Hazard ratio; Nivolumab; Randomized controlled trial; Population; Progression-free survival; Metastatic melanoma; Cancer; Immunotherapy; Chemotherapy; Cancer research; Overall survival; Confidence interval","score_opus":0.20660714001164493,"score_gpt":0.3974582458880378,"score_spread":0.19085110587639287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914108875","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0029441123,0.9940461,0.0008071962,0.00054305507,0.00023871975,0.000023218709,0.0009081113,0.000024763684,0.00046471934],"genre_scores_gemma":[0.121936016,0.870844,0.0021843119,0.0013220147,0.00076737197,0.00013851034,0.002160602,0.00004421702,0.0006029361],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99820757,0.001131258,0.00018753517,0.0002444292,0.00016696576,0.00006222084],"domain_scores_gemma":[0.99591917,0.0032889391,0.00041636222,0.00013351571,0.0001752977,0.00006672683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003248981,0.0012633764,0.004352498,0.0009895354,0.000115235714,0.00080062205,0.0008657574,0.00059361366,0.0033273406],"category_scores_gemma":[0.007516473,0.0003414374,0.009451126,0.0017220785,0.0001373714,0.00048204223,0.00058675,0.0011906628,0.00024395518],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007042921,0.00007515756,0.0107260225,0.11938472,0.4963322,0.00013629369,0.000056850455,0.006398163,0.0008507258,0.0012758514,0.019350505,0.33837053],"study_design_scores_gemma":[0.0022578721,0.00085691595,0.040084213,0.019533824,0.87580335,0.00036566283,0.00006700597,0.003906976,0.00061426975,0.0067474535,0.049660698,0.0001018124],"about_ca_topic_score_codex":0.0037125119,"about_ca_topic_score_gemma":0.010800838,"teacher_disagreement_score":0.004352498,"about_ca_system_score_codex":0.00085889647,"about_ca_system_score_gemma":0.0009906669,"threshold_uncertainty_score":0.01718241},"labels":[],"label_agreement":null},{"id":"W2915353133","doi":"10.3389/fimmu.2019.00326","title":"Editorial: TRAF Proteins in Health and Disease","year":2019,"lang":"en","type":"editorial","venue":"Frontiers in Immunology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; York University","funders":"National Institute of Environmental Health Sciences; National Institute of Allergy and Infectious Diseases","keywords":"Innate immune system; Immunity; Disease; Immunology; Medicine; Biology; Computational biology; Immune system; Internal medicine","score_opus":0.0038752051202077978,"score_gpt":0.22246115829687532,"score_spread":0.2185859531766675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2915353133","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000039461775,0.0045136916,0.00008991618,0.030908337,0.96190226,0.000018013465,0.00009216566,0.00008395198,0.002352174],"genre_scores_gemma":[0.00061123713,0.004117799,0.00009988693,0.018076453,0.95567286,0.000022987844,0.000082419254,0.000045689718,0.021270692],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99764985,0.0003502878,0.00023960232,0.00029381478,0.0012153675,0.0002510635],"domain_scores_gemma":[0.9917101,0.001905678,0.0006515964,0.0002282198,0.0032352635,0.0022690878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038186926,0.0036737304,0.0023855418,0.002929302,0.0025789998,0.005626313,0.0025214122,0.009487564,0.038501974],"category_scores_gemma":[0.012416474,0.0008098762,0.002020522,0.00085050653,0.0014654777,0.0036692407,0.0015139666,0.011207035,0.02779255],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043468022,0.0000071748955,0.000013201877,0.000090854366,0.000006887827,0.000060897633,0.0000039547317,0.000014684197,0.00006576878,0.00017449819,0.995764,0.0037546186],"study_design_scores_gemma":[0.00006416451,0.000029458799,0.00016990548,0.00020760576,0.000026822641,0.0002374942,0.000022697728,0.00009573276,0.00015638955,0.0010003047,0.99797374,0.000015704003],"about_ca_topic_score_codex":0.000986581,"about_ca_topic_score_gemma":0.002987383,"teacher_disagreement_score":0.038501974,"about_ca_system_score_codex":0.002644934,"about_ca_system_score_gemma":0.0022089363,"threshold_uncertainty_score":0.12880194},"labels":[],"label_agreement":null},{"id":"W2915924826","doi":"","title":"The Mechanisms of ERK1/2 Involvement in Neuron Death after Ischemic Injury and Axotomy","year":2018,"lang":"en","type":"article","venue":"Investigative Ophthalmology & Visual Science","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Rehabilitation Institute; University of Toronto","funders":"","keywords":"Axotomy; Ischemic injury; Medicine; Neuroscience; Ischemia; Cardiology; Internal medicine; Biology; Central nervous system","score_opus":0.02246056207473737,"score_gpt":0.3003845064423126,"score_spread":0.2779239443675753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2915924826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98319626,0.010082508,0.0023461846,0.00042345253,0.00005043531,0.000033106167,0.00015777735,0.00003767946,0.00367255],"genre_scores_gemma":[0.99171066,0.0043694233,0.00079173653,0.000058659592,0.000020806421,0.00005332258,0.00010202539,0.000003663327,0.002889697],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998832,0.00001754276,0.000009035158,0.000012661741,0.000022201986,0.000055343837],"domain_scores_gemma":[0.9999471,0.000005557642,0.000020229312,0.000005175695,0.000008911213,0.000012948637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002815545,0.00057287054,0.00022911097,0.00050163356,0.00053968304,0.0004200527,0.0004018737,0.00046872112,0.0012040525],"category_scores_gemma":[0.00013174002,0.00019410392,0.0004830776,0.00021413997,0.00039732747,0.0008767796,0.0003335919,0.00069166906,0.00018092612],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034024569,0.00029248747,0.0031740086,0.00048637533,0.00007209848,0.0016041555,0.00022779468,0.0005734671,0.96943116,0.0067795827,0.00032980694,0.013626541],"study_design_scores_gemma":[0.00016719665,0.0014493702,0.10757598,0.00011589614,0.00023598863,0.0034300112,0.00081296207,0.0037814758,0.87041295,0.006494124,0.0054808264,0.00004340982],"about_ca_topic_score_codex":0.0005727979,"about_ca_topic_score_gemma":0.00078663306,"teacher_disagreement_score":0.0012040525,"about_ca_system_score_codex":0.00050374836,"about_ca_system_score_gemma":0.0004570309,"threshold_uncertainty_score":0.004027903},"labels":[],"label_agreement":null},{"id":"W2916721669","doi":"10.1038/s41391-019-0134-5","title":"MEK-ERK signaling is a therapeutic target in metastatic castration resistant prostate cancer","year":2019,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":96,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"U.S. National Library of Medicine; National Cancer Institute; Stand Up To Cancer; Prostate Cancer Foundation","keywords":"Medicine; Prostate cancer; Castration; Oncology; MAPK/ERK pathway; Prostate; Cancer research; Cancer; Internal medicine; Orchiectomy; Signal transduction; Hormone","score_opus":0.012716193190937043,"score_gpt":0.26943046605789966,"score_spread":0.25671427286696263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2916721669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98924583,0.007257534,0.0006340679,0.00024678023,0.000014161014,0.000038101916,0.00051887095,0.00005812503,0.001986517],"genre_scores_gemma":[0.99636734,0.0018848577,0.0005459907,0.00006800104,0.000010768834,0.000014592425,0.0005646126,0.0000051544175,0.0005387067],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999126,0.000011007814,0.000005345481,0.000016717579,0.000037895723,0.000016416821],"domain_scores_gemma":[0.99992216,0.000011829443,0.000030218089,0.00000562103,0.000012868984,0.000017254997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017925481,0.00026772954,0.00020403537,0.00023099888,0.00016448615,0.00031054093,0.00013691357,0.00012981254,0.0011504501],"category_scores_gemma":[0.00016217194,0.000088020446,0.0001840887,0.00022776276,0.0001566988,0.000103030674,0.0001372232,0.00037206014,0.00018791422],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016136448,0.00020344768,0.050166186,0.0008527007,0.000107077074,0.0005906744,0.00008609335,0.0019468224,0.8839284,0.00037166354,0.0012533972,0.058879923],"study_design_scores_gemma":[0.00020404751,0.0034773152,0.587657,0.00014448963,0.00031761552,0.009202784,0.00022825318,0.0076678577,0.3675697,0.0007722125,0.022724263,0.00003437219],"about_ca_topic_score_codex":0.0005818714,"about_ca_topic_score_gemma":0.0018117616,"teacher_disagreement_score":0.0011504501,"about_ca_system_score_codex":0.00041090688,"about_ca_system_score_gemma":0.00026767876,"threshold_uncertainty_score":0.003848672},"labels":[],"label_agreement":null},{"id":"W2917321490","doi":"10.1016/j.ejca.2019.01.017","title":"Neurotoxicity induced by targeted therapies in patients treated for metastatic melanoma","year":2019,"lang":"en","type":"letter","venue":"European Journal of Cancer","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Vemurafenib; Dabrafenib; Trametinib; Medicine; Melanoma; Internal medicine; Oncology; Rash; Dermatology; Cancer research; Metastatic melanoma; MAPK/ERK pathway; Chemistry","score_opus":0.017833210656384584,"score_gpt":0.24688768634669964,"score_spread":0.22905447569031506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2917321490","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8715435,0.023521906,0.00094271044,0.0774531,0.0021622777,0.00011598915,0.0007884363,0.00011348763,0.023358598],"genre_scores_gemma":[0.97584087,0.0042274804,0.00023566175,0.015204567,0.0025398526,0.000033886572,0.00018055257,0.000015131343,0.0017220309],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997712,0.00007967631,0.000032739877,0.000023885737,0.000038967355,0.000053555137],"domain_scores_gemma":[0.99909115,0.00033418267,0.00024270189,0.00004485096,0.00013694858,0.00015015533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033125334,0.00021574854,0.00072953495,0.00034274554,0.0006206867,0.00056284806,0.00027134444,0.0014986935,0.0014074256],"category_scores_gemma":[0.002369767,0.00012577498,0.0006156863,0.0007069178,0.00022731129,0.00026630363,0.00024200037,0.0015376185,0.0002434911],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017651893,0.00054190704,0.54187125,0.001081297,0.00091357954,0.2154442,0.00089212885,0.00153417,0.014597581,0.0021140154,0.03891122,0.16444674],"study_design_scores_gemma":[0.00095461117,0.0042119785,0.7585041,0.0004664545,0.0012784054,0.1706709,0.00060734706,0.0022725582,0.004522656,0.004342207,0.05206696,0.00010171038],"about_ca_topic_score_codex":0.0018579484,"about_ca_topic_score_gemma":0.00405874,"teacher_disagreement_score":0.0018579484,"about_ca_system_score_codex":0.0013663599,"about_ca_system_score_gemma":0.00052851136,"threshold_uncertainty_score":0.009913683},"labels":[],"label_agreement":null},{"id":"W2939988319","doi":"10.1200/jco.2015.33.15_suppl.e20094","title":"Evolution of BRAF gene mutation testing and treatment options in BRAF mutation carriers in Canada.","year":2015,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dabrafenib; Vemurafenib; Trametinib; Medicine; Ipilimumab; Oncology; Internal medicine; Melanoma; Mutation; Cancer; Metastatic melanoma; Immunotherapy; Cancer research; Gene; MAPK/ERK pathway; Genetics","score_opus":0.09995703269657306,"score_gpt":0.37960054990944736,"score_spread":0.2796435172128743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2939988319","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9830582,0.0018065064,0.000088613415,0.0009693671,0.000018615203,0.00005728912,0.011089244,0.000013175869,0.0028989583],"genre_scores_gemma":[0.99519145,0.00096642965,0.00016042736,0.00025705426,0.000009774034,0.00001582051,0.00265478,0.000007024983,0.00073735975],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99904054,0.000042722495,0.000062227475,0.0001682122,0.0003397636,0.00034638555],"domain_scores_gemma":[0.9972391,0.00014063831,0.0009830631,0.00003841979,0.0009331923,0.0006656383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000467216,0.0002689791,0.000319022,0.0016500502,0.0016995838,0.001030674,0.00078518095,0.0005699639,0.0023614482],"category_scores_gemma":[0.0023276052,0.00034732066,0.0005504802,0.004990093,0.00061679457,0.00040334967,0.0006576982,0.00071109756,0.00025531443],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009123773,0.000027049233,0.9938962,0.000048424212,0.000024028188,0.00028224362,0.000318495,0.00010635921,0.00017889735,0.00008952723,0.0013335545,0.0036040118],"study_design_scores_gemma":[0.00000914494,0.0000327491,0.99521303,0.000060624454,0.000026588494,0.0004977457,0.001387707,0.00037035986,0.00010935175,0.000032908585,0.002242041,0.000017759945],"about_ca_topic_score_codex":0.9860898,"about_ca_topic_score_gemma":0.9896622,"teacher_disagreement_score":0.027080437,"about_ca_system_score_codex":0.027080437,"about_ca_system_score_gemma":0.03914795,"threshold_uncertainty_score":0.19648325},"labels":[],"label_agreement":null},{"id":"W2942062551","doi":"10.1358/dot.2019.55.4.2958476","title":"Encorafenib and binimetinib for the treatment of BRAFV600E/K-mutated melanoma","year":2019,"lang":"en","type":"review","venue":"Drugs of today","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Melanoma; MAPK/ERK pathway; Metastatic melanoma; V600E; Cancer research; Oncology; Kinase; Pharmacology; Mutation; Internal medicine; Biology; Genetics","score_opus":0.04074034639323368,"score_gpt":0.3182639523817377,"score_spread":0.277523605988504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2942062551","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00028495432,0.99660563,0.00014299805,0.00025735254,0.0002481832,0.000009359041,0.000044831504,0.00001316623,0.0023935202],"genre_scores_gemma":[0.001192986,0.996086,0.00020015152,0.00029960292,0.00013199037,0.000011061605,0.00008576901,0.0000022477345,0.0019902224],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999064,0.000012302604,0.0000122422125,0.000016744278,0.000041262894,0.000010979427],"domain_scores_gemma":[0.99991775,0.0000286588,0.000015141136,0.000002434205,0.000024132647,0.000011991934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024816385,0.000605996,0.0007171097,0.0018839237,0.0001956706,0.00052213523,0.0005480084,0.000652875,0.0047165737],"category_scores_gemma":[0.000325389,0.00016606,0.0004178761,0.0012070179,0.00019475685,0.00071888283,0.00039551427,0.0014560325,0.0023411436],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008522425,0.00007563192,0.00011568633,0.0081812795,0.00007345725,0.00019151463,0.000035497156,0.00027732208,0.002285357,0.0019600121,0.033762332,0.9529568],"study_design_scores_gemma":[0.000024894809,0.00009980304,0.00052995066,0.0012788826,0.00006886985,0.0013289445,0.000018119375,0.00006627305,0.0005066556,0.0006992474,0.99536824,0.000010163671],"about_ca_topic_score_codex":0.0007050188,"about_ca_topic_score_gemma":0.0023236023,"teacher_disagreement_score":0.0047165737,"about_ca_system_score_codex":0.0003901703,"about_ca_system_score_gemma":0.0005359141,"threshold_uncertainty_score":0.015778542},"labels":[],"label_agreement":null},{"id":"W2945161193","doi":"10.1177/2050313x19847358","title":"Cobimetinib- and vemurafenib-induced granulomatous dermatitis and erythema induratum: A case report","year":2019,"lang":"en","type":"article","venue":"SAGE Open Medical Case Reports","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Hospital; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Vemurafenib; Dermatology; Internal medicine; Metastatic melanoma; Cancer","score_opus":0.01063546363307694,"score_gpt":0.26792881881206115,"score_spread":0.2572933551789842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945161193","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94862133,0.015815984,0.007195858,0.0061834306,0.00094588933,0.00049916387,0.00050784677,0.00051488064,0.019715749],"genre_scores_gemma":[0.989755,0.0032004996,0.0019073411,0.0010644296,0.0011861024,0.000051643146,0.000100864854,0.00003233342,0.0027018113],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99898213,0.00011304133,0.00011828285,0.00029289976,0.00015919248,0.00033441588],"domain_scores_gemma":[0.9984401,0.00034391126,0.000407145,0.00016427506,0.0000948991,0.00054968795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050831394,0.0027160652,0.0014344348,0.003504406,0.003184313,0.0026568652,0.0014178818,0.0062105907,0.0032134939],"category_scores_gemma":[0.002224787,0.001880652,0.0017112219,0.0018115203,0.0020203826,0.002932989,0.0020611088,0.004310292,0.0015279439],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014026381,0.000049753926,0.001977785,0.000023694216,0.0000092159435,0.99648947,0.000105115025,0.000028299204,0.00034397654,0.000115866394,0.00020585647,0.0006369636],"study_design_scores_gemma":[0.0000042215356,0.00001800468,0.0008963085,0.000006536909,0.0000075502007,0.99849,0.000051774492,0.0000734085,0.0001365474,0.000053543306,0.00025709442,0.0000050545796],"about_ca_topic_score_codex":0.0021001727,"about_ca_topic_score_gemma":0.002656145,"teacher_disagreement_score":0.0062105907,"about_ca_system_score_codex":0.0014114717,"about_ca_system_score_gemma":0.00077057653,"threshold_uncertainty_score":0.010750234},"labels":[],"label_agreement":null},{"id":"W2945717805","doi":"10.1097/cmr.0000000000000608","title":"Effectiveness of dabrafenib in the treatment of patients with BRAF V600–mutated metastatic melanoma in a Named Patient Program","year":2019,"lang":"en","type":"article","venue":"Melanoma Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital","funders":"","keywords":"Dabrafenib; Metastatic melanoma; Melanoma; Medicine; Cancer research; Oncology; Internal medicine; Vemurafenib","score_opus":0.019890890050654916,"score_gpt":0.310129275355793,"score_spread":0.29023838530513807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945717805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99884915,0.0004841666,0.000059200273,0.00003728975,0.0000038070848,0.000021953729,0.000077976125,0.0000043703003,0.00046206662],"genre_scores_gemma":[0.99942267,0.00023239129,0.00009787757,0.000044900382,0.000007222372,0.000010573329,0.000120954115,0.0000017163295,0.000061588245],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.999519,0.00028776604,0.000032635588,0.000059249127,0.000061089915,0.0000401967],"domain_scores_gemma":[0.99916303,0.00017833691,0.00039394238,0.00004620538,0.000042644035,0.00017589299],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068077847,0.00010631496,0.0003816603,0.00018473524,0.00017607685,0.00036645884,0.00016830495,0.00016405103,0.0006850104],"category_scores_gemma":[0.0014979765,0.000097786615,0.00041846925,0.00029268587,0.00018928737,0.00024349157,0.00022556295,0.00026538636,0.00009701229],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.036741115,0.001680582,0.77205694,0.0003615098,0.0006023135,0.0019599278,0.00031374997,0.0027816186,0.014640987,0.0001707377,0.0017365514,0.16695392],"study_design_scores_gemma":[0.0017500585,0.023846779,0.9604903,0.000058314028,0.00032830294,0.0030249404,0.00027105425,0.0025563214,0.004102653,0.00011159085,0.0034288017,0.000030998715],"about_ca_topic_score_codex":0.0009858138,"about_ca_topic_score_gemma":0.0031460375,"teacher_disagreement_score":0.0009858138,"about_ca_system_score_codex":0.0005176063,"about_ca_system_score_gemma":0.00045192929,"threshold_uncertainty_score":0.0037555099},"labels":[],"label_agreement":null},{"id":"W2945906071","doi":"10.1016/j.bmcl.2019.05.032","title":"Tool inhibitors and assays to interrogate the biology of the TRAF2 and NCK interacting kinase","year":2019,"lang":"en","type":"article","venue":"Bioorganic & Medicinal Chemistry Letters","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"TC Scientific (Canada)","funders":"National Institutes of Health; Ministry of Education, India; National Institute of Neurological Disorders and Stroke; National Institute of Mental Health; Ministry of Earth Sciences","keywords":"TRAF2; Kinase; Context (archaeology); Small molecule; In silico; Chemistry; Cell biology; Computational biology; Cancer research; Biology; Biochemistry; Gene; Receptor","score_opus":0.005079186828949344,"score_gpt":0.20980534846051058,"score_spread":0.20472616163156124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945906071","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6244295,0.04100335,0.2729679,0.0034675044,0.0010011959,0.0019573565,0.0073258136,0.0034054476,0.044441953],"genre_scores_gemma":[0.87514484,0.01852095,0.07957985,0.001130091,0.00015325643,0.0014132796,0.005895703,0.00019038052,0.017971583],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991223,0.00012900053,0.000047710993,0.00012435841,0.0004118874,0.0001647478],"domain_scores_gemma":[0.99953127,0.000119384305,0.00009381106,0.00007325451,0.00010400112,0.00007829212],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012346391,0.001705794,0.00064153713,0.00091104035,0.00060440425,0.0012427777,0.0011857371,0.0010771028,0.003569254],"category_scores_gemma":[0.0007945233,0.00046571487,0.0005646408,0.0007088995,0.0006242284,0.00083427026,0.0007691562,0.0021593014,0.0012797907],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002837112,0.00020394419,0.00043023462,0.00026155007,0.000046846228,0.00009787141,0.000038439226,0.0009282177,0.985407,0.002615053,0.0009093503,0.008777778],"study_design_scores_gemma":[0.000081575854,0.00042035346,0.0005136355,0.00001715352,0.000036181358,0.00030409312,0.000026170364,0.0016927196,0.9861667,0.0006864713,0.010035006,0.000019896115],"about_ca_topic_score_codex":0.00092783576,"about_ca_topic_score_gemma":0.0022452148,"teacher_disagreement_score":0.003569254,"about_ca_system_score_codex":0.0013099799,"about_ca_system_score_gemma":0.00096030073,"threshold_uncertainty_score":0.0119403},"labels":[],"label_agreement":null},{"id":"W2948740360","doi":"10.1038/s41591-019-0448-9","title":"Dabrafenib, trametinib and pembrolizumab or placebo in BRAF-mutant melanoma","year":2019,"lang":"en","type":"article","venue":"Nature Medicine","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":323,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec","funders":"Merck Sharp and Dohme","keywords":"Dabrafenib; Trametinib; Pembrolizumab; Melanoma; Medicine; Mutant; Cancer research; Oncology; Internal medicine; Vemurafenib; Biology; Immunotherapy; Metastatic melanoma; Genetics; MAPK/ERK pathway; Cancer; Phosphorylation; Gene","score_opus":0.005862682673053842,"score_gpt":0.2530370359029938,"score_spread":0.24717435322993997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2948740360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9840342,0.011732112,0.0001243403,0.00070402207,0.0006864867,0.00012873916,0.00043450878,0.000046524074,0.0021091034],"genre_scores_gemma":[0.9912642,0.004671343,0.00023566297,0.00022719536,0.00028021508,0.00015555469,0.00027597815,0.0000065543704,0.002883324],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99968493,0.0001541951,0.000021131813,0.000034228626,0.000016953949,0.00008863019],"domain_scores_gemma":[0.9996232,0.00012874766,0.000048447986,0.000022306602,0.000014383119,0.00016278954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008483264,0.00062934967,0.0022688631,0.00029681218,0.00027736987,0.00052060484,0.0004340798,0.0007718318,0.004805785],"category_scores_gemma":[0.0009898683,0.00031382492,0.0008639482,0.00030635114,0.00041947392,0.0008855728,0.00022457626,0.0015585797,0.000397853],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94366306,0.0040626978,0.0004547462,0.0003710003,0.00037806568,0.000088651796,0.000045805955,0.00038415348,0.011860462,0.00016803753,0.0009705776,0.037552644],"study_design_scores_gemma":[0.47949013,0.4729005,0.023516243,0.00017364611,0.0019185042,0.00044092073,0.0002840681,0.0017218451,0.010892859,0.00091643713,0.007663972,0.00008084795],"about_ca_topic_score_codex":0.0010783097,"about_ca_topic_score_gemma":0.0025649092,"teacher_disagreement_score":0.004805785,"about_ca_system_score_codex":0.00039109364,"about_ca_system_score_gemma":0.0007733362,"threshold_uncertainty_score":0.016076922},"labels":[],"label_agreement":null},{"id":"W2948866156","doi":"10.1371/journal.pcbi.1007034","title":"Phenotypic heterogeneity and evolution of melanoma cells associated with targeted therapy resistance","year":2019,"lang":"en","type":"article","venue":"PLoS Computational Biology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Banting Research Foundation; Jean Perkins Foundation; V Foundation for Cancer Research","keywords":"Biology; Epigenetics; Phenotype; Population; Reprogramming; Transcriptome; Phenotypic plasticity; Computational biology; Systems biology; Somatic evolution in cancer; Genetics; Cell; Cancer; Gene expression; Gene","score_opus":0.009154825070728376,"score_gpt":0.20808523803071896,"score_spread":0.1989304129599906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2948866156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99233246,0.000038689854,0.0071664895,0.00003292279,0.0000019847466,0.00000361845,0.00004938433,0.000026719545,0.0003476443],"genre_scores_gemma":[0.99855775,0.00002246882,0.0012267431,0.0000045573097,7.9570043e-7,0.0000055398095,0.000050017356,0.0000065728796,0.00012542299],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9999291,0.000015813328,0.0000034666186,0.00002614971,0.000013292304,0.000012198483],"domain_scores_gemma":[0.99978226,0.00009636171,0.000053927255,0.000031090593,0.000016864213,0.000019632427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023854217,0.000112915215,0.00020900881,0.00024633194,0.00016398815,0.0003852924,0.0001876281,0.00023180904,0.00047481604],"category_scores_gemma":[0.0008431182,0.00012919941,0.00027384592,0.00020025697,0.00032471653,0.00027479872,0.00024982446,0.00028004913,0.000047939935],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021793715,0.000068389265,0.05140262,0.00008507991,0.000062052284,0.0005668537,0.00025901044,0.33162653,0.59060585,0.014527968,0.00024957667,0.010328229],"study_design_scores_gemma":[0.000010966117,0.00007692934,0.058273975,0.0000042016154,0.000019964204,0.00021590188,0.00010478936,0.8899621,0.044530533,0.0063656503,0.00040785022,0.000027095957],"about_ca_topic_score_codex":0.0008911633,"about_ca_topic_score_gemma":0.0008131446,"teacher_disagreement_score":0.0008911633,"about_ca_system_score_codex":0.00041581097,"about_ca_system_score_gemma":0.00015803547,"threshold_uncertainty_score":0.0030169487},"labels":[],"label_agreement":null},{"id":"W2948884915","doi":"10.1038/s41591-019-0476-5","title":"Combined BRAF and MEK inhibition with PD-1 blockade immunotherapy in BRAF-mutant melanoma","year":2019,"lang":"en","type":"article","venue":"Nature Medicine","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":326,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"National Cancer Institute; National Institutes of Health; Nature","keywords":"Medicine; Dabrafenib; Melanoma; Trametinib; Pembrolizumab; MEK inhibitor; Immunotherapy; Discontinuation; Blockade; Internal medicine; Oncology; Adverse effect; Combination therapy; Targeted therapy; MAPK/ERK pathway; Vemurafenib; Immunology; Pharmacology; Cancer research; Cancer; Kinase; Metastatic melanoma; Biology; Receptor","score_opus":0.0024313152308695026,"score_gpt":0.20831390238842046,"score_spread":0.20588258715755095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2948884915","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873733,0.007237405,0.0007034624,0.00037496618,0.00019292357,0.000070401635,0.00011358624,0.000079589634,0.003854393],"genre_scores_gemma":[0.9963798,0.0014658318,0.0004916603,0.00006988951,0.000036253845,0.000036887675,0.000080954735,0.0000061403284,0.0014325558],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99991035,0.000016305408,0.000005178309,0.000013264905,0.000020094038,0.000034799006],"domain_scores_gemma":[0.99997294,0.000004616799,0.0000043360637,0.0000031477946,0.0000024635797,0.0000125151955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017457346,0.00026600496,0.0004259272,0.00020431473,0.00016613111,0.00032823798,0.00024687342,0.00022036943,0.0011287326],"category_scores_gemma":[0.00009381028,0.00012376106,0.0003084545,0.00015412379,0.00013752225,0.0002897495,0.00017836958,0.00087032514,0.00022214571],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029753562,0.008071122,0.0031759283,0.0005255238,0.00047707412,0.0004745892,0.00010127722,0.00655163,0.59519595,0.0014915323,0.004314034,0.34986776],"study_design_scores_gemma":[0.016636113,0.16907851,0.072690986,0.000168673,0.0018238743,0.004379998,0.00027621942,0.03160855,0.6410629,0.003051793,0.059077337,0.00014503143],"about_ca_topic_score_codex":0.0005120226,"about_ca_topic_score_gemma":0.0019743182,"teacher_disagreement_score":0.0011287326,"about_ca_system_score_codex":0.00034923395,"about_ca_system_score_gemma":0.0003701439,"threshold_uncertainty_score":0.0037760139},"labels":[],"label_agreement":null},{"id":"W2950933169","doi":"10.1002/chin.201544271","title":"ChemInform Abstract: Recent Progress on MAP Kinase Pathway Inhibitors","year":2015,"lang":"en","type":"article","venue":"ChemInform","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Chemistry; Nanotechnology; Computational biology","score_opus":0.021048559248135597,"score_gpt":0.24485972743238557,"score_spread":0.22381116818424998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2950933169","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00046286656,0.9749526,0.0005455615,0.0027195204,0.0046640504,0.000036507197,0.00033467982,0.000118374046,0.016165812],"genre_scores_gemma":[0.0030688539,0.97796553,0.00045372001,0.0026128802,0.0025692785,0.000041744544,0.00081219536,0.0000261153,0.012449761],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997004,0.000038957238,0.000027871185,0.000058890302,0.0001299743,0.000043905857],"domain_scores_gemma":[0.9993106,0.00019905812,0.0000898711,0.000021339052,0.00026481276,0.000114405215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007984993,0.0013047819,0.0012716667,0.0022874617,0.00040052878,0.0016272322,0.0011322475,0.0015876779,0.02101774],"category_scores_gemma":[0.0012474023,0.000353857,0.0005504946,0.0024957268,0.00046649977,0.0016339662,0.0009772019,0.00296144,0.016144866],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002607196,0.00010827699,0.0000929361,0.008768309,0.0000952754,0.0001602897,0.000025435877,0.00031782992,0.0034495704,0.0031229143,0.3443508,0.6392476],"study_design_scores_gemma":[0.000055939836,0.00012869813,0.00023462105,0.0009909187,0.00009669852,0.0003255819,0.0000125573715,0.000065695975,0.0020842268,0.0007468902,0.99524045,0.000017627144],"about_ca_topic_score_codex":0.00075726485,"about_ca_topic_score_gemma":0.0018380912,"teacher_disagreement_score":0.02101774,"about_ca_system_score_codex":0.0009756753,"about_ca_system_score_gemma":0.0012103013,"threshold_uncertainty_score":0.07031131},"labels":[],"label_agreement":null},{"id":"W2953511998","doi":"10.1200/po.18.00266","title":"Efficacy of Vemurafenib in Patients With Non–Small-Cell Lung Cancer With <i>BRAF</i> V600 Mutation: An Open-Label, Single-Arm Cohort of the Histology-Independent VE-BASKET Study","year":2019,"lang":"en","type":"article","venue":"JCO Precision Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"National Cancer Institute","keywords":"Medicine; Vemurafenib; Internal medicine; Cohort; Lung cancer; Clinical endpoint; Oncology; Adverse effect; Progression-free survival; Cancer; Surgery; Clinical trial; Overall survival; Metastatic melanoma","score_opus":0.01430066329293688,"score_gpt":0.27751511090114606,"score_spread":0.26321444760820917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953511998","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99852186,0.00040491723,0.00014511081,0.00004556979,0.000024770547,0.00031298562,0.00032428402,0.000010516515,0.00021013903],"genre_scores_gemma":[0.99745315,0.00026283893,0.0002837612,0.00015553118,0.00008922601,0.00034092073,0.0011266598,0.0000068353943,0.00028109227],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9990085,0.00043111062,0.00007475265,0.0001996825,0.00011928273,0.00016664602],"domain_scores_gemma":[0.9985141,0.00023008292,0.0003221113,0.00019536124,0.00011707905,0.00062118954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025381844,0.0015581917,0.0029148033,0.00033058738,0.00046585407,0.0011854814,0.0006749228,0.0008793737,0.0010801423],"category_scores_gemma":[0.001629779,0.0005619148,0.0016363381,0.00029075594,0.0008290364,0.0011586645,0.0005323995,0.001932544,0.000335213],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.75470203,0.024644371,0.12441629,0.00037742255,0.0024570718,0.0007595526,0.0003986525,0.0020574438,0.03923932,0.00018905617,0.001973713,0.048785098],"study_design_scores_gemma":[0.34277898,0.39015463,0.24801539,0.000054707147,0.0021035182,0.0013108664,0.0002930133,0.0039161006,0.007865633,0.00042967335,0.00291423,0.00016319007],"about_ca_topic_score_codex":0.00044087222,"about_ca_topic_score_gemma":0.00092743576,"teacher_disagreement_score":0.0029148033,"about_ca_system_score_codex":0.00061574584,"about_ca_system_score_gemma":0.0008525419,"threshold_uncertainty_score":0.013423383},"labels":[],"label_agreement":null},{"id":"W295353521","doi":"","title":"Role of mitogen-activated protein kinase in cardiac hypertrophy and heart failure.","year":2003,"lang":"en","type":"article","venue":"PubMed","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":128,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; St. Boniface Hospital","funders":"","keywords":"p38 mitogen-activated protein kinases; Kinase; Mitogen-activated protein kinase; Cell biology; Signal transduction; MAPK/ERK pathway; Protein kinase A; Biology","score_opus":0.00654977939369372,"score_gpt":0.17670737311966978,"score_spread":0.17015759372597605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W295353521","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.028539192,0.9533884,0.0010160303,0.0029936288,0.0015192966,0.00004731137,0.00025363144,0.00007630532,0.012166219],"genre_scores_gemma":[0.314336,0.66577625,0.00178256,0.0021493586,0.004166728,0.00016287042,0.00060285657,0.000021167676,0.011002302],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998766,0.00003112438,0.000010968489,0.000018139286,0.000034979203,0.000028209264],"domain_scores_gemma":[0.999881,0.000026436508,0.000033647593,0.0000032190258,0.000020464036,0.00003514199],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035330318,0.000896132,0.00034201815,0.000534752,0.00026764735,0.00037749016,0.00030095017,0.0006898876,0.0025472292],"category_scores_gemma":[0.00019346757,0.000100195575,0.0002668155,0.00033738773,0.00033039422,0.00039038275,0.0003889945,0.001013711,0.00095808593],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034413997,0.0009678074,0.01858037,0.01990016,0.00031222694,0.012362619,0.0006922778,0.0014152937,0.20472214,0.015647788,0.048472807,0.6734851],"study_design_scores_gemma":[0.000385769,0.0033942023,0.2006211,0.003472405,0.00067947677,0.04924473,0.0006606547,0.0021009701,0.04590252,0.01993691,0.67347914,0.00012222036],"about_ca_topic_score_codex":0.00031790315,"about_ca_topic_score_gemma":0.00034886325,"teacher_disagreement_score":0.0025472292,"about_ca_system_score_codex":0.00031701275,"about_ca_system_score_gemma":0.00038883914,"threshold_uncertainty_score":0.008521318},"labels":[],"label_agreement":null},{"id":"W2955525741","doi":"10.1038/s41591-019-0535-y","title":"Publisher Correction: Combined BRAF and MEK inhibition with PD-1 blockade immunotherapy in BRAF-mutant melanoma","year":2019,"lang":"en","type":"erratum","venue":"Nature Medicine","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Blockade; Melanoma; Immunotherapy; Mutant; Cancer research; Medicine; Biology; Immunology; Internal medicine; Immune system; Receptor; Biochemistry","score_opus":0.0035787299736039827,"score_gpt":0.2152071796316137,"score_spread":0.21162844965800973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955525741","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000102171194,0.0012069443,0.00035652937,0.027452733,0.967191,0.000012239497,0.00035568647,0.00015846618,0.003164173],"genre_scores_gemma":[0.010369416,0.010126481,0.0037250747,0.077680364,0.512635,0.00015058488,0.001309217,0.0012210159,0.38278288],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99759346,0.00031221102,0.00040707798,0.00030726308,0.0011828691,0.00019705723],"domain_scores_gemma":[0.9856996,0.003893302,0.0006511389,0.0007730305,0.0082474165,0.00073560135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002641952,0.0018722732,0.0016984418,0.003514341,0.0023262457,0.0035792396,0.0031777644,0.006881515,0.035973143],"category_scores_gemma":[0.028537044,0.0009850162,0.0016904885,0.0015449146,0.0016462111,0.0016740025,0.0011646659,0.010422144,0.022119518],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030238398,0.000005680869,0.00003772425,0.00008641509,0.000011385964,0.0004179909,0.000011356597,0.0000448467,0.000047467358,0.00042940828,0.99309266,0.005784669],"study_design_scores_gemma":[0.00004097922,0.000019660321,0.000435485,0.00022567523,0.000051032064,0.00092563423,0.000028376193,0.00022658723,0.00041303362,0.00092074746,0.996687,0.000025804586],"about_ca_topic_score_codex":0.013203195,"about_ca_topic_score_gemma":0.01980175,"teacher_disagreement_score":0.035973143,"about_ca_system_score_codex":0.0037799554,"about_ca_system_score_gemma":0.003324328,"threshold_uncertainty_score":0.120342135},"labels":[],"label_agreement":null},{"id":"W2969359604","doi":"10.1002/cmdc.201900428","title":"Targeting an EGFR Water Network with 4‐Anilinoquin(az)oline Inhibitors for Chordoma","year":2019,"lang":"en","type":"article","venue":"ChemMedChem","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill; China Scholarship Council; Novartis Pharma; University of North Carolina at Chapel Hill; Ministero dello Sviluppo Economico; Genome Canada; Fundação de Amparo à Pesquisa do Estado de São Paulo; European Federation of Pharmaceutical Industries and Associations; Merck KGaA; Ontario Ministry of Economic Development and Innovation; Engineering and Physical Sciences Research Council; Pfizer","keywords":"EGFR inhibitors; Epidermal growth factor receptor; Quinazoline; Chemistry; IC50; Cancer research; Amine gas treating; Chordoma; Stereochemistry; Biology; Biochemistry; Receptor; In vitro; Medicine","score_opus":0.006594312264942149,"score_gpt":0.21167948003727927,"score_spread":0.20508516777233712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2969359604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927763,0.0011355497,0.004336822,0.000065265,0.000013995466,0.000058913847,0.0001693769,0.000075418386,0.0013683733],"genre_scores_gemma":[0.996463,0.00041222156,0.0022773973,0.000019707406,0.0000027738924,0.000017089433,0.000118325544,0.0000055088262,0.0006841079],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999615,0.000007054953,0.0000025972442,0.000006933016,0.000010097632,0.000011757274],"domain_scores_gemma":[0.999969,0.0000053045856,0.00000938665,0.0000020800571,0.0000051095694,0.000009089267],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000087851644,0.00025883477,0.00015597818,0.00012607421,0.000085093365,0.00013731208,0.00023989104,0.00012581133,0.0006196582],"category_scores_gemma":[0.00005578089,0.00006764254,0.000115796705,0.000055411194,0.000119923134,0.00011568746,0.00013619794,0.00019591945,0.0001594699],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009974958,0.000024181172,0.00015064754,0.000037339305,0.0000049149057,0.000047336627,0.000009243288,0.000517271,0.99715173,0.000084071704,0.000042264914,0.0018312687],"study_design_scores_gemma":[0.00005920655,0.0009403771,0.0011042637,0.0000036597967,0.000010706816,0.00018036232,0.000010658444,0.0017527766,0.99385035,0.000035420533,0.0020476573,0.0000045022834],"about_ca_topic_score_codex":0.0006130458,"about_ca_topic_score_gemma":0.0014433566,"teacher_disagreement_score":0.0006196582,"about_ca_system_score_codex":0.00030815144,"about_ca_system_score_gemma":0.00013144915,"threshold_uncertainty_score":0.0022358298},"labels":[],"label_agreement":null},{"id":"W2970448152","doi":"10.3747/co.26.4779","title":"Reconsidering the Turnaround Times for BRAF V600 Mutation Analysis in Non-Small-Cell Lung Cancer: A Molecular Diagnosis in One Day Is Achievable for Rapid Treatment Choices","year":2019,"lang":"en","type":"letter","venue":"Current Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Lung cancer; Mutation; Oncology; Lung; Internal medicine; Cancer research; Bioinformatics; Pathology; Genetics; Gene; Biology","score_opus":0.09037548139081107,"score_gpt":0.33502748723717585,"score_spread":0.24465200584636476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2970448152","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010851256,0.0027212913,0.00032376515,0.9815058,0.012078086,0.0000094271945,0.000025297915,0.000052758027,0.0021984065],"genre_scores_gemma":[0.022217588,0.006028825,0.0011063825,0.86033547,0.1053553,0.00004898234,0.000059710877,0.000055833418,0.0047919685],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99834347,0.0004756261,0.00025829076,0.00020486861,0.0004584603,0.00025928684],"domain_scores_gemma":[0.9899498,0.005519829,0.0006169206,0.0004169541,0.002097852,0.0013985359],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022477126,0.00047800282,0.000836525,0.00037860108,0.0019134406,0.0020745706,0.0011862377,0.020077834,0.003772296],"category_scores_gemma":[0.019708853,0.00038970134,0.00070568966,0.00042097733,0.0021084063,0.0035334458,0.0006865305,0.02183705,0.005652477],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015384266,0.00006568199,0.0016074779,0.000100590034,0.000016317808,0.008120511,0.00014216849,0.00020267046,0.0010177372,0.003504252,0.93971056,0.0453582],"study_design_scores_gemma":[0.00025457115,0.00046108707,0.003364157,0.0005560871,0.000053842654,0.027185585,0.0008485059,0.0015412534,0.0013351787,0.037797056,0.92644167,0.00016105013],"about_ca_topic_score_codex":0.002950887,"about_ca_topic_score_gemma":0.0048655863,"teacher_disagreement_score":0.020077834,"about_ca_system_score_codex":0.0036123267,"about_ca_system_score_gemma":0.002280953,"threshold_uncertainty_score":0.026209354},"labels":[],"label_agreement":null},{"id":"W2972559932","doi":"10.1158/1078-0432.ccr-17-3572","title":"A Phase I and Pharmacokinetic Study of Oral Dabrafenib in Children and Adolescent Patients with Recurrent or Refractory <i>BRAF</i> V600 Mutation–Positive Solid Tumors","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":96,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Institutes of Health; Brain Tumour Charity; National Cancer Institute; KWF Kankerbestrijding; National Institute for Health and Care Research","keywords":"Refractory (planetary science); Pharmacokinetics; Medicine; Dabrafenib; Solid tumor; Mutation; Oncology; Internal medicine; Cancer; Genetics; Biology; Gene","score_opus":0.05948289162910631,"score_gpt":0.45527820933167135,"score_spread":0.39579531770256504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972559932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980646,0.00058661005,0.00022180646,0.00009372496,0.000010828551,0.0002858345,0.0002544705,0.000010318909,0.00047182222],"genre_scores_gemma":[0.99630296,0.00092226814,0.0009835125,0.00018838164,0.00002357178,0.0003163189,0.00077054714,0.000008091016,0.00048433154],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99978477,0.000105115905,0.000011575608,0.00002997841,0.000035487974,0.000033105884],"domain_scores_gemma":[0.9996251,0.00005634302,0.000098277465,0.000021673066,0.000035191544,0.00016335517],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051988655,0.00055524835,0.0007688671,0.000149725,0.00022910617,0.00038538882,0.00024792925,0.0003231295,0.001338755],"category_scores_gemma":[0.0005488968,0.0002989136,0.00047691597,0.00021790377,0.00037881013,0.00029698823,0.00014088483,0.001542816,0.00033405813],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22252588,0.06247271,0.30008757,0.0010724423,0.0023814,0.002786758,0.0018464103,0.005113409,0.16861495,0.00069684826,0.0069605806,0.22544107],"study_design_scores_gemma":[0.1685905,0.4391935,0.34301358,0.000093097464,0.00087107957,0.005936696,0.000617203,0.0037829692,0.021224212,0.00022432306,0.016391458,0.000061314524],"about_ca_topic_score_codex":0.0016940694,"about_ca_topic_score_gemma":0.004026027,"teacher_disagreement_score":0.0016940694,"about_ca_system_score_codex":0.00067705096,"about_ca_system_score_gemma":0.001202827,"threshold_uncertainty_score":0.0049123764},"labels":[],"label_agreement":null},{"id":"W2983389082","doi":"10.7554/elife.33718.022","title":"Author response: Hyperactivation of ERK by multiple mechanisms is toxic to RTK-RAS mutation-driven lung adenocarcinoma cells","year":2018,"lang":"en","type":"peer-review","venue":"","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Hyperactivation; MAPK/ERK pathway; Cancer research; Adenocarcinoma; Mutation; Cell biology; Lung cancer; Biology; Lung; Genetics; Medicine; Cancer; Signal transduction; Internal medicine; Gene","score_opus":0.021771971340108488,"score_gpt":0.297361096386786,"score_spread":0.2755891250466775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983389082","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.47433275,0.012251615,0.015832769,0.10536161,0.05323401,0.0010501043,0.013324663,0.0062134326,0.318399],"genre_scores_gemma":[0.34264183,0.0035456386,0.0042335736,0.0039323294,0.0016146621,0.0001062297,0.005132142,0.00057734776,0.63821626],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99884367,0.00017469717,0.00007179615,0.00013938983,0.00063665916,0.00013375489],"domain_scores_gemma":[0.99832183,0.0003528115,0.00015269638,0.00019272833,0.00076139363,0.00021848583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008375068,0.00045337866,0.0003677066,0.00050176674,0.000468623,0.0008950641,0.00052111945,0.001244058,0.11179161],"category_scores_gemma":[0.0022856384,0.00016928514,0.00038874426,0.00026842218,0.00044554617,0.00044704985,0.0006341865,0.0008879183,0.036436],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022834772,0.00039426814,0.0047556227,0.0010657124,0.00012992683,0.0035166985,0.00032070896,0.0009274447,0.6040397,0.0032379834,0.2936323,0.08569604],"study_design_scores_gemma":[0.00017211333,0.0005852218,0.016509928,0.00010388352,0.000047835183,0.002860471,0.00067391526,0.001001921,0.4117952,0.001618123,0.5645821,0.000049357874],"about_ca_topic_score_codex":0.0005857532,"about_ca_topic_score_gemma":0.0011770878,"teacher_disagreement_score":0.11179161,"about_ca_system_score_codex":0.000443232,"about_ca_system_score_gemma":0.00067626714,"threshold_uncertainty_score":0.37398022},"labels":[],"label_agreement":null},{"id":"W2985852902","doi":"10.1021/acs.jmedchem.9b01227","title":"Fast Iterative Synthetic Approach toward Identification of Novel Highly Selective p38 MAP Kinase Inhibitors","year":2019,"lang":"en","type":"article","venue":"Journal of Medicinal Chemistry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Eshelman Institute for Innovation, University of North Carolina at Chapel Hill; Merck Sharp and Dohme; Ontario Ministry of Research, Innovation and Science; Fundação de Amparo à Pesquisa do Estado de São Paulo; Deutsche Forschungsgemeinschaft; Deutschen Konsortium für Translationale Krebsforschung; Novartis; Ontario Genomics Institute; Canada Foundation for Innovation; Wellcome Trust; AbbVie; Takeda Pharmaceutical Company; Janssen Pharmaceuticals; Merck KGaA; Innovative Medicines Initiative; Wellcome; Bayer; Pfizer; Boehringer Ingelheim","keywords":"Chemistry; p38 mitogen-activated protein kinases; Kinase; Mitogen-activated protein kinase; Drug discovery; Potency; Small molecule; Gene isoform; Selectivity; Protein kinase A; Biochemistry; Combinatorial chemistry; Computational biology; In vitro; Pharmacology; Biology; Gene","score_opus":0.009223267021268149,"score_gpt":0.230152640214313,"score_spread":0.22092937319304484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985852902","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6526129,0.0063379006,0.30448532,0.0006728401,0.00023310793,0.0032609315,0.0022761931,0.0013138283,0.028807057],"genre_scores_gemma":[0.8250611,0.006315883,0.16002308,0.00030565023,0.000055177174,0.001358382,0.0012278474,0.00015433584,0.005498581],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996296,0.000050610513,0.0000288235,0.00007519709,0.00011723824,0.00009847719],"domain_scores_gemma":[0.99986994,0.000018072516,0.000030483488,0.000019361778,0.000032982425,0.000029079836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004074453,0.00079105346,0.00075263955,0.0006596872,0.00034473554,0.0005414723,0.00081211195,0.0004261571,0.0017237525],"category_scores_gemma":[0.00041877833,0.00035360138,0.00051148044,0.00069801515,0.0003680703,0.00046352015,0.0009763542,0.0009319636,0.0010467223],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049616856,0.0008110168,0.0006091813,0.00084692676,0.000101014186,0.0012116346,0.00023004068,0.02016952,0.9068743,0.0074846596,0.0020238378,0.059141718],"study_design_scores_gemma":[0.00065482594,0.004857439,0.0009790643,0.00006705848,0.000144843,0.0012692274,0.0001410617,0.03703167,0.91677505,0.0035834548,0.034379773,0.000116488896],"about_ca_topic_score_codex":0.00041435342,"about_ca_topic_score_gemma":0.0011355744,"teacher_disagreement_score":0.0017237525,"about_ca_system_score_codex":0.00037243028,"about_ca_system_score_gemma":0.0008821527,"threshold_uncertainty_score":0.0057665706},"labels":[],"label_agreement":null},{"id":"W2999136960","doi":"10.1016/j.annonc.2019.10.022","title":"Vemurafenib in non-small-cell lung cancer patients with BRAFV600 and BRAFnonV600 mutations","year":2020,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":189,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"PharmaMar; Direction Générale de l’offre de Soins; Institut National Du Cancer; Chugai Pharmaceutical; Roche; Fondation ARC pour la Recherche sur le Cancer; Agence Nationale de la Recherche; Novartis; Amgen; Pfizer; CNIB; AbbVie; Merck","keywords":"Vemurafenib; Medicine; Internal medicine; Oncology; Cohort; Lung cancer; Trametinib; Dabrafenib; Cancer; Metastatic melanoma","score_opus":0.02275642131417564,"score_gpt":0.29257216364256583,"score_spread":0.2698157423283902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2999136960","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98297244,0.012201095,0.0001784389,0.0007858335,0.0001698858,0.000028170309,0.00018471658,0.000016915643,0.003462586],"genre_scores_gemma":[0.99805605,0.0010845811,0.00006817135,0.00013010151,0.000049926235,0.000009996299,0.00013719355,0.000001675016,0.00046231656],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998499,0.000038897313,0.000016304548,0.000023100885,0.000026038126,0.000045697114],"domain_scores_gemma":[0.9998479,0.000045060307,0.000032715143,0.000004664849,0.000013300748,0.00005633489],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021293426,0.00017303292,0.0004244982,0.00017003235,0.00018992917,0.0004327612,0.00016444759,0.00029154983,0.0012402454],"category_scores_gemma":[0.00067429524,0.00011287539,0.00047212545,0.00017606963,0.0001003455,0.00037263928,0.00020570612,0.0005974142,0.000104203595],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.050958067,0.0010176392,0.577501,0.001067761,0.0016555369,0.003400069,0.00021575074,0.0019601912,0.016636143,0.00075573445,0.0064556682,0.33837643],"study_design_scores_gemma":[0.0038594524,0.009158689,0.9465662,0.00022148718,0.0017378638,0.007924647,0.0006465715,0.0048164544,0.0043934984,0.0012764708,0.019333394,0.000065293534],"about_ca_topic_score_codex":0.0007395053,"about_ca_topic_score_gemma":0.0030269083,"teacher_disagreement_score":0.0012402454,"about_ca_system_score_codex":0.0003396128,"about_ca_system_score_gemma":0.00032950967,"threshold_uncertainty_score":0.0041490793},"labels":[],"label_agreement":null},{"id":"W2999167819","doi":"10.3390/molecules25020325","title":"In Depth Analysis of Kinase Cross Screening Data to Identify CAMKK2 Inhibitory Scaffolds","year":2020,"lang":"en","type":"article","venue":"Molecules","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; National Health and Medical Research Council; Novartis Pharma; National Institutes of Health; Medical Research Council; Ministero dello Sviluppo Economico; Genome Canada; Fundação de Amparo à Pesquisa do Estado de São Paulo; National Cancer Institute; European Federation of Pharmaceutical Industries and Associations; Merck KGaA; Conselho Nacional de Desenvolvimento Científico e Tecnológico; Ontario Ministry of Economic Development and Innovation; Pfizer","keywords":"AMPK; Kinase; Protein kinase A; Enzyme; Biochemistry; Chemistry; Biology; Cell biology","score_opus":0.05823401505428979,"score_gpt":0.34140516456448783,"score_spread":0.28317114951019806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2999167819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8937844,0.021461576,0.02718886,0.0003632587,0.00014180865,0.00045012278,0.041102502,0.0015342088,0.013973306],"genre_scores_gemma":[0.86608267,0.015802428,0.038573053,0.00027769987,0.00007642677,0.0003628316,0.0722663,0.0003695315,0.0061890343],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994035,0.000055631004,0.000084453255,0.00010861339,0.00025910733,0.00008868183],"domain_scores_gemma":[0.9990246,0.0002838396,0.00024592446,0.00009351186,0.00028552368,0.00006667999],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008080459,0.00095842604,0.001116622,0.0036148813,0.000508471,0.0006705297,0.0005316214,0.0003488498,0.0060925703],"category_scores_gemma":[0.0013594786,0.00021927472,0.0011193276,0.0036627916,0.00019029988,0.00066062843,0.00030764245,0.00064303353,0.001928217],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067285827,0.00025009934,0.0032726931,0.0011885696,0.00020954556,0.0004588195,0.00008195739,0.0016121309,0.9659282,0.00029172533,0.0009629379,0.02507052],"study_design_scores_gemma":[0.00006786536,0.00115958,0.03715636,0.000078844445,0.0007916092,0.0024206697,0.00017931458,0.008012755,0.9304139,0.00042628634,0.019209933,0.00008288801],"about_ca_topic_score_codex":0.0012572933,"about_ca_topic_score_gemma":0.001902169,"teacher_disagreement_score":0.0060925703,"about_ca_system_score_codex":0.0004454606,"about_ca_system_score_gemma":0.0007627895,"threshold_uncertainty_score":0.02038169},"labels":[],"label_agreement":null},{"id":"W2999417880","doi":"10.1007/s11538-019-00691-0","title":"Overcoming Drug Resistance to BRAF Inhibitor","year":2020,"lang":"en","type":"article","venue":"Bulletin of Mathematical Biology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia, Okanagan Campus; University of British Columbia","funders":"","keywords":"Drug resistance; Cancer research; Drug; Melanoma; MEK inhibitor; Chemokine; Medicine; Cancer; Pharmacology; Immunology; Biology; Inflammation; Internal medicine; MAPK/ERK pathway; Signal transduction; Genetics","score_opus":0.013392137442881353,"score_gpt":0.2355541636642941,"score_spread":0.22216202622141276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2999417880","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.28975064,0.105478846,0.4423558,0.06431355,0.004810256,0.00012847266,0.00044149914,0.0011000201,0.09162092],"genre_scores_gemma":[0.8817518,0.045654852,0.045121226,0.0017089883,0.0014872402,0.00009343934,0.00018637901,0.0001179842,0.023878148],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99986327,0.000033178938,0.00000833656,0.000020702564,0.000056110563,0.000018346527],"domain_scores_gemma":[0.9998305,0.00006123461,0.000032779903,0.000025042307,0.00003312398,0.000017353943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034135117,0.00028933736,0.00034867757,0.00038160154,0.00025449198,0.0007409546,0.000371246,0.00035913082,0.0013150137],"category_scores_gemma":[0.0008522093,0.0001264929,0.0003299007,0.00026130688,0.0005473572,0.0009441543,0.00067351555,0.0011012864,0.00031162432],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015868837,0.0001547874,0.0014716544,0.0008736497,0.00013878122,0.00019819125,0.00025633012,0.040556446,0.08896325,0.49271038,0.023582561,0.35093534],"study_design_scores_gemma":[0.000088692235,0.00039480734,0.0021680398,0.00015549801,0.00016333126,0.0009760293,0.00023033972,0.19177687,0.06019633,0.4974563,0.24633329,0.000060409868],"about_ca_topic_score_codex":0.00041624662,"about_ca_topic_score_gemma":0.0004442351,"teacher_disagreement_score":0.0013150137,"about_ca_system_score_codex":0.00058411574,"about_ca_system_score_gemma":0.0005154777,"threshold_uncertainty_score":0.0043991804},"labels":[],"label_agreement":null},{"id":"W3000205532","doi":"10.1158/1078-0432.ccr-19-1606","title":"A Combinatorial Strategy for Targeting <i>BRAF</i> V600E-Mutant Cancers with BRAFV600E Inhibitor (PLX4720) and Tyrosine Kinase Inhibitor (Ponatinib)","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Aging","funders":"Intramural Research Program; National Institutes of Health","keywords":"Ponatinib; Tyrosine-kinase inhibitor; Cancer research; Tyrosine kinase; MEK inhibitor; Medicine; Mutant; Kinase; Dasatinib; Cancer; Pharmacology; Biology; Imatinib; Internal medicine; Myeloid leukemia; Genetics; Receptor; MAPK/ERK pathway","score_opus":0.11930498942149106,"score_gpt":0.41560940435192795,"score_spread":0.2963044149304369,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3000205532","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9694066,0.0032482694,0.019205462,0.00019145344,0.00009433429,0.00062962476,0.0005253476,0.000423341,0.006275649],"genre_scores_gemma":[0.98697484,0.0011027453,0.009532505,0.000080216894,0.000011992743,0.00014789563,0.00025596973,0.000020651802,0.001873223],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998876,0.000012625731,0.000008145971,0.000026478943,0.000037119953,0.000028112836],"domain_scores_gemma":[0.9999641,0.0000037183506,0.000009412943,0.0000036877643,0.0000049089767,0.000014121756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011945805,0.00044269973,0.0004648128,0.0004205576,0.00014238447,0.0003729812,0.0003105202,0.0002134933,0.0009258787],"category_scores_gemma":[0.00007460402,0.00020254673,0.00032831717,0.00028049323,0.00015279674,0.00021809583,0.0003542271,0.0003524136,0.00031604405],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032994905,0.00031345218,0.0002756925,0.00015865483,0.00005224213,0.00012055764,0.000014988103,0.0012122929,0.9775524,0.00027602975,0.00032664256,0.019367212],"study_design_scores_gemma":[0.00022644502,0.0035980786,0.0024341557,0.000009973676,0.00015477209,0.0007720706,0.000024068224,0.005386505,0.98108,0.00008743448,0.006203981,0.000022619235],"about_ca_topic_score_codex":0.00042572405,"about_ca_topic_score_gemma":0.0016006733,"teacher_disagreement_score":0.0009258787,"about_ca_system_score_codex":0.00028415874,"about_ca_system_score_gemma":0.00026890836,"threshold_uncertainty_score":0.0030973554},"labels":[],"label_agreement":null},{"id":"W3004870356","doi":"10.1200/jco.2020.38.5_suppl.60","title":"Immune adverse events (irAEs) with adjuvant ipilimumab in melanoma, use of hormone replacement and immunosuppressants, and association with outcome: E1609 study analysis.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"National Institutes of Health","keywords":"Medicine; Ipilimumab; Internal medicine; Rash; Adverse effect; Adjuvant; Melanoma; Cancer; Gastroenterology; Oncology; Immunotherapy","score_opus":0.06398664518698148,"score_gpt":0.36053636204142514,"score_spread":0.29654971685444365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3004870356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951538,0.0031257984,0.00014755577,0.000027340246,0.000010950903,0.000032216496,0.00094833557,0.0000043037253,0.00054973515],"genre_scores_gemma":[0.99834526,0.00037303666,0.00007631267,0.0000392603,0.000020789674,0.000030609972,0.0008400205,0.0000019688794,0.00027261773],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99949205,0.00017354962,0.00008338318,0.000097180164,0.00009435046,0.00005947443],"domain_scores_gemma":[0.9984181,0.00034995895,0.0009306762,0.000092210335,0.00006478978,0.00014430955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015129246,0.00026082102,0.00042317578,0.00031191026,0.00010289086,0.0004044632,0.0002610641,0.00024196623,0.0012929215],"category_scores_gemma":[0.0010801645,0.00014829209,0.0011213035,0.0005561064,0.00012494612,0.0002795596,0.00033528075,0.0005495331,0.0001428121],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02349925,0.00017560887,0.96141994,0.00048474962,0.0026870247,0.00014605754,0.00002859661,0.00042488615,0.0011148629,0.000052206517,0.0003756422,0.009591028],"study_design_scores_gemma":[0.00097020745,0.0048211236,0.9888532,0.00007570376,0.002032032,0.0004980129,0.00004513848,0.000688517,0.00045765127,0.00007562295,0.0014723578,0.000010397099],"about_ca_topic_score_codex":0.00031818124,"about_ca_topic_score_gemma":0.0006688948,"teacher_disagreement_score":0.0015129246,"about_ca_system_score_codex":0.00019397645,"about_ca_system_score_gemma":0.00018368909,"threshold_uncertainty_score":0.008001208},"labels":[],"label_agreement":null},{"id":"W3005155748","doi":"10.1158/2159-8290.cd-19-1265","title":"Pan-Cancer Efficacy of Vemurafenib in <i>BRAF</i> V600-Mutant Non-Melanoma Cancers","year":2020,"lang":"en","type":"article","venue":"Cancer Discovery","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":125,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"National Cancer Institute; National Institutes of Health; Roche","keywords":"Vemurafenib; Melanoma; Cancer research; Cancer; Mutant; Medicine; Mutation; Metastatic melanoma; Oncology; Biology; Internal medicine; Genetics; Gene","score_opus":0.014753547116940652,"score_gpt":0.25478500527250764,"score_spread":0.24003145815556698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005155748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94261163,0.042677138,0.00095074455,0.006475747,0.0008254573,0.00013137232,0.000686675,0.00011414554,0.005527172],"genre_scores_gemma":[0.98552567,0.0088503,0.00063956366,0.0015749359,0.0004189292,0.00006505966,0.00042002034,0.000024471825,0.0024809777],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99984574,0.00007099683,0.000010586696,0.000026691892,0.000023913457,0.000021937063],"domain_scores_gemma":[0.99976593,0.00008733353,0.000041968873,0.000021106534,0.000041333733,0.00004232011],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068472704,0.00016837446,0.000582224,0.00012685347,0.00013611614,0.0005194972,0.0001571492,0.00028761622,0.001377246],"category_scores_gemma":[0.0005087228,0.00007940148,0.00031115647,0.00014741617,0.0001626227,0.00026225357,0.000187685,0.00077516126,0.00016188303],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031688314,0.0025591056,0.024431095,0.0016231148,0.00077200984,0.00088690285,0.00020347052,0.0015787721,0.30682927,0.001661208,0.04227938,0.5854875],"study_design_scores_gemma":[0.0142119955,0.11811365,0.3664668,0.00055740133,0.0021490792,0.009360948,0.0008523723,0.0068980097,0.26424223,0.003959734,0.21304373,0.00014407013],"about_ca_topic_score_codex":0.00043453916,"about_ca_topic_score_gemma":0.0028168543,"teacher_disagreement_score":0.001377246,"about_ca_system_score_codex":0.0005028589,"about_ca_system_score_gemma":0.00023290279,"threshold_uncertainty_score":0.0046073794},"labels":[],"label_agreement":null},{"id":"W3006140059","doi":"10.1007/s00280-020-04038-8","title":"Phase I dose-escalation trial of the oral AKT inhibitor uprosertib in combination with the oral MEK1/MEK2 inhibitor trametinib in patients with solid tumors","year":2020,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nexen (Canada)","funders":"Novartis Pharmaceuticals Corporation","keywords":"Tolerability; Trametinib; Dosing; Medicine; Rash; Adverse effect; Internal medicine; Mucositis; Oncology; Pharmacology; Toxicity; MAPK/ERK pathway","score_opus":0.014149507990633454,"score_gpt":0.2872376165837309,"score_spread":0.27308810859309746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006140059","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972365,0.0006350664,0.0002268285,0.00014565102,0.000038563066,0.0008923645,0.00020554784,0.000038521386,0.0005809776],"genre_scores_gemma":[0.99576926,0.00050128973,0.0010513486,0.00028171044,0.00006687113,0.00074256037,0.0006798885,0.000010565103,0.0008965803],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9995333,0.00022158085,0.00003117803,0.00008144145,0.00005174286,0.00008081631],"domain_scores_gemma":[0.9993874,0.00010867432,0.00017570262,0.00006546271,0.00003742716,0.00022528949],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015157394,0.0012156647,0.0017400301,0.00032332243,0.00035217142,0.0006372929,0.0007331678,0.00069779163,0.0022561497],"category_scores_gemma":[0.00083408423,0.00049411715,0.0010662946,0.0003841591,0.0006116585,0.0006789824,0.00033034792,0.0035460806,0.0004901198],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.62886864,0.107568644,0.011627974,0.0010159868,0.0016499202,0.00040809406,0.00051843177,0.0052635064,0.068903126,0.00021200826,0.0033102627,0.17065342],"study_design_scores_gemma":[0.45759752,0.51219493,0.017822245,0.000041559022,0.0005349897,0.00039604062,0.000059388218,0.002273317,0.0070454334,0.00014849426,0.0018561042,0.000030029682],"about_ca_topic_score_codex":0.000534242,"about_ca_topic_score_gemma":0.002201883,"teacher_disagreement_score":0.0022561497,"about_ca_system_score_codex":0.00097549264,"about_ca_system_score_gemma":0.0013008583,"threshold_uncertainty_score":0.0080161095},"labels":[],"label_agreement":null},{"id":"W3008560653","doi":"10.1016/j.jid.2020.01.027","title":"TERT, BRAF, and NRAS Mutational Heterogeneity between Paired Primary and Metastatic Melanoma Tumors","year":2020,"lang":"en","type":"article","venue":"Journal of Investigative Dermatology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; U.S. Food and Drug Administration; National Institute of Arthritis and Musculoskeletal and Skin Diseases; York University","keywords":"Neuroblastoma RAS viral oncogene homolog; Sanger sequencing; Melanoma; Tumor heterogeneity; Cancer research; Genetic heterogeneity; Tumour heterogeneity; Primary tumor; Biology; Mutation; Digital polymerase chain reaction; V600E; Gene; Medicine; Oncology; Cancer; Metastasis; Genetics; Polymerase chain reaction; Phenotype; KRAS","score_opus":0.03592270650365747,"score_gpt":0.2475793456700025,"score_spread":0.21165663916634503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3008560653","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987489,0.00016809285,0.00012795441,0.000009719355,0.000005995533,0.0000051713864,0.00010730696,0.0000114008535,0.0008154321],"genre_scores_gemma":[0.99947006,0.000051003834,0.00008453906,0.000007651454,0.000005936667,0.000003732743,0.0001131151,0.000004529525,0.00025935873],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997186,0.000034023473,0.000030351592,0.00008345833,0.00006161043,0.00007190422],"domain_scores_gemma":[0.9995522,0.0001272769,0.00008040331,0.0000649049,0.00006816041,0.00010702356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027611552,0.0001593723,0.0002486828,0.0009794272,0.000279794,0.00052666175,0.00019952944,0.00026384715,0.0038566932],"category_scores_gemma":[0.0009552225,0.00019169267,0.00022623302,0.00027519095,0.00020969566,0.00023962333,0.0003327819,0.00024750008,0.0005471149],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034187024,0.0001471447,0.3431972,0.00008915879,0.00012377871,0.0095420685,0.00051801506,0.00018755789,0.6294572,0.0003538841,0.00031408088,0.012651179],"study_design_scores_gemma":[0.000050198953,0.0005870803,0.8976284,0.000015723343,0.00014785027,0.04910435,0.00081002363,0.00093595946,0.048908036,0.0003654816,0.0014349764,0.000011926708],"about_ca_topic_score_codex":0.00042610732,"about_ca_topic_score_gemma":0.0005745148,"teacher_disagreement_score":0.0038566932,"about_ca_system_score_codex":0.00020995554,"about_ca_system_score_gemma":0.000117486634,"threshold_uncertainty_score":0.012901902},"labels":[],"label_agreement":null},{"id":"W3008901859","doi":"10.1002/cpdd.773","title":"Absolute Bioavailability of Vemurafenib in Patients With <i>BRAF</i><sup>V600</sup> Mutation–Positive Malignancies","year":2020,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Vemurafenib; Medicine; Bioavailability; Mutation; Internal medicine; Cancer research; Oncology; Pharmacology; Cancer; Genetics; Metastatic melanoma; Gene","score_opus":0.018109760222120016,"score_gpt":0.28101741849757805,"score_spread":0.26290765827545803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3008901859","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990934,0.00035503553,0.00024107545,0.000026261554,0.0000040203677,0.00002316339,0.00005693867,0.000015327467,0.00018478537],"genre_scores_gemma":[0.9994041,0.00007420687,0.00018184076,0.000041472143,0.000010016284,0.000018930576,0.00011806104,0.0000034349741,0.00014794155],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9998367,0.000058274523,0.000010022761,0.000042795502,0.000026474641,0.000025692598],"domain_scores_gemma":[0.999686,0.00009615094,0.00010830509,0.000016431834,0.000025144647,0.00006794431],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042125053,0.00028364122,0.00074201415,0.000146304,0.00021361098,0.0003299957,0.0001261436,0.00029347467,0.00079532736],"category_scores_gemma":[0.0007670475,0.00019966153,0.00028235262,0.000090977905,0.00015269159,0.00035323665,0.0001463876,0.0005784933,0.00018794108],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16023341,0.0050740056,0.36115885,0.00027847185,0.0006235663,0.0013166876,0.00050764956,0.004577148,0.35028547,0.0001996797,0.00186648,0.1138786],"study_design_scores_gemma":[0.010565607,0.17584161,0.73059964,0.00003345158,0.00079957594,0.0038119126,0.00025294285,0.01251976,0.060341988,0.000294458,0.0048567946,0.00008227774],"about_ca_topic_score_codex":0.00043667978,"about_ca_topic_score_gemma":0.00039099876,"teacher_disagreement_score":0.00079532736,"about_ca_system_score_codex":0.0003006304,"about_ca_system_score_gemma":0.00024522564,"threshold_uncertainty_score":0.0026606321},"labels":[],"label_agreement":null},{"id":"W3010215117","doi":"10.1016/j.ajpath.2020.01.012","title":"Oxidative Phosphorylation Promotes Primary Melanoma Invasion","year":2020,"lang":"en","type":"article","venue":"American Journal Of Pathology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health; York University; National Cancer Institute; NYU Langone Medical Center","keywords":"Melanoma; Biology; Cancer research; Tumor progression; Cancer; Genetics","score_opus":0.01244661518154512,"score_gpt":0.22810321966214384,"score_spread":0.2156566044805987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010215117","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933988,0.0015964211,0.00061231316,0.0002506564,0.00009856885,0.000031900283,0.00028768304,0.000068797526,0.0036548998],"genre_scores_gemma":[0.99500954,0.000774661,0.00022531455,0.00004835443,0.000015438389,0.000018695244,0.00020663429,0.0000049735095,0.003696399],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989045,0.000016831667,0.000004785861,0.00001310208,0.000022710674,0.000052107553],"domain_scores_gemma":[0.999918,0.000010088395,0.0000114159075,0.000009829272,0.0000076901215,0.000042878888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013150182,0.0003391687,0.00016046868,0.0002676716,0.0002414049,0.00038425543,0.00011441474,0.00024576072,0.0040657446],"category_scores_gemma":[0.000086023785,0.00019159913,0.00025258545,0.00013399067,0.00014028816,0.00022055946,0.0003049652,0.00087942695,0.0006578477],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077227305,0.00032166552,0.00092454324,0.00005601021,0.000008137015,0.00014777512,0.000020827223,0.00006840337,0.9946866,0.000220191,0.00041707314,0.0023564377],"study_design_scores_gemma":[0.00010157172,0.0021785405,0.056128252,0.000020499128,0.000039203704,0.0006980553,0.00020979719,0.0013451698,0.9326643,0.0003291128,0.0062772697,0.0000082385495],"about_ca_topic_score_codex":0.0007792933,"about_ca_topic_score_gemma":0.0016441646,"teacher_disagreement_score":0.0040657446,"about_ca_system_score_codex":0.00029012433,"about_ca_system_score_gemma":0.00028578754,"threshold_uncertainty_score":0.013601303},"labels":[],"label_agreement":null},{"id":"W3010422213","doi":"10.1038/s41388-020-1240-5","title":"MNK1 signaling induces an ANGPTL4-mediated gene signature to drive melanoma progression","year":2020,"lang":"en","type":"article","venue":"Oncogene","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University; Jewish General Hospital","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Government of Canada","keywords":"Biology; MAPK/ERK pathway; Cancer research; Kinase; Signal transduction; Translation (biology); Protein kinase A; Gene; Cell biology; Messenger RNA; Genetics","score_opus":0.018842612516687108,"score_gpt":0.2675009502663078,"score_spread":0.2486583377496207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010422213","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886728,0.0008737716,0.004184741,0.00034072285,0.00007256581,0.000049275834,0.0010508909,0.00020580941,0.0045494144],"genre_scores_gemma":[0.9902913,0.0003100886,0.0020949324,0.000087283435,0.000006661024,0.000034502555,0.0006051124,0.000028290879,0.006541874],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99985886,0.000016907956,0.000007996707,0.000028590752,0.00003723287,0.000050411778],"domain_scores_gemma":[0.99991715,0.0000069853363,0.000023557195,0.000009923905,0.000010491333,0.00003180869],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009357621,0.00028027614,0.00011337202,0.0002874114,0.00022809376,0.00031315125,0.0001536182,0.00020097235,0.0020431983],"category_scores_gemma":[0.00007873502,0.00016035244,0.0002147628,0.00012069544,0.00017903275,0.00015188422,0.00023978676,0.0009604238,0.00066971034],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053410982,0.000015042175,0.00020635637,0.000010508353,0.0000026517964,0.000028101087,0.0000047053395,0.000053080814,0.9988808,0.00016118893,0.00006494722,0.0005192065],"study_design_scores_gemma":[0.00000963665,0.00006683715,0.005002536,0.0000032241446,0.0000064945357,0.00014187285,0.00002538803,0.00095812284,0.9910692,0.000080994214,0.002632944,0.0000026973364],"about_ca_topic_score_codex":0.0016018912,"about_ca_topic_score_gemma":0.004411512,"teacher_disagreement_score":0.0020431983,"about_ca_system_score_codex":0.00087337306,"about_ca_system_score_gemma":0.00037197824,"threshold_uncertainty_score":0.0068351626},"labels":[],"label_agreement":null},{"id":"W3011435761","doi":"10.1016/j.ejca.2020.02.021","title":"Survival of patients with advanced metastatic melanoma: The impact of MAP kinase pathway inhibition and immune checkpoint inhibition - Update 2019","year":2020,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":110,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Sandoz; Merck Sharp and Dohme; Bristol-Myers Squibb Canada; InflaRx; Les Laboratories Pierre Fabre; Helsinn; OncoSec Medical; Roche; CureVac; Regeneron Pharmaceuticals; Novartis; Alcedis; Bristol-Myers Squibb; Sanofi; Merck; Boehringer Ingelheim; Amgen; Array BioPharma","keywords":"Medicine; Oncology; Melanoma; Blockade; Clinical trial; Internal medicine; Survival analysis; Progression-free survival; MEK inhibitor; Kinase; Cancer research; Overall survival; MAPK/ERK pathway; Biology; Receptor","score_opus":0.009071601066493962,"score_gpt":0.22957760785355402,"score_spread":0.22050600678706006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011435761","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013523784,0.98004663,0.00025785764,0.0020920562,0.0008925952,0.000011687094,0.00039080952,0.0000146384755,0.0027700164],"genre_scores_gemma":[0.08149244,0.90787715,0.00087524636,0.0036845736,0.0027679286,0.000039052553,0.0011440219,0.000012314463,0.002107135],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9998857,0.000024212071,0.000021506483,0.000019674477,0.000031935226,0.000017077613],"domain_scores_gemma":[0.9994679,0.00031250753,0.000091382004,0.000011216273,0.00007713174,0.000039859944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078605977,0.0005446045,0.0013837406,0.00041555456,0.00011113133,0.00070110324,0.00042941637,0.0005904858,0.0012217073],"category_scores_gemma":[0.0009895505,0.000099480036,0.0010378264,0.0008182224,0.00018401183,0.000502444,0.000258111,0.0012821838,0.00025464853],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004337714,0.00013591466,0.00782114,0.007296914,0.001298008,0.00028960858,0.00006505895,0.0009829755,0.0019858177,0.0009899972,0.025893278,0.9489035],"study_design_scores_gemma":[0.0017999402,0.00812283,0.14838505,0.011944592,0.013179525,0.0044832905,0.00030339597,0.0016186805,0.0023582592,0.0034919414,0.80418175,0.00013071168],"about_ca_topic_score_codex":0.0011165251,"about_ca_topic_score_gemma":0.0042124884,"teacher_disagreement_score":0.0013837406,"about_ca_system_score_codex":0.000501294,"about_ca_system_score_gemma":0.0004807509,"threshold_uncertainty_score":0.0041571856},"labels":[],"label_agreement":null},{"id":"W3013420908","doi":"10.1158/2326-6074.tumimm19-a53","title":"Abstract A53: Phosphorylation of eIF4E promotes phenotype switching and MDSC-mediated immunosuppression in melanoma","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Melanoma; Cancer research; Immunotherapy; EIF4E; Cytokine; Immune system; Microphthalmia-associated transcription factor; Immunology; Biology; Medicine; Transcription factor; Gene","score_opus":0.04469111608526693,"score_gpt":0.3249136380126815,"score_spread":0.2802225219274146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013420908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965306,0.0007470144,0.0011287233,0.000088381545,0.000040804025,0.00002239333,0.00042083106,0.00007038916,0.0009509613],"genre_scores_gemma":[0.99755484,0.00022781942,0.00037326693,0.00003175019,0.000011723095,0.000023268401,0.00029614125,0.000010172698,0.0014710551],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990094,0.000013248901,0.000010701021,0.000022528651,0.000023807777,0.000028743854],"domain_scores_gemma":[0.9998996,0.000007948834,0.000041041152,0.000011477528,0.000007777453,0.00003215602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009856459,0.00031687613,0.0001861725,0.0002693828,0.00010884968,0.00020439248,0.00009834836,0.00023616689,0.0023163268],"category_scores_gemma":[0.00009072285,0.00010157431,0.00018504992,0.0001023219,0.00019994825,0.0001333128,0.0001676876,0.00062359066,0.0004952031],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029614667,0.000047057336,0.000556566,0.000025631689,0.00000425976,0.000093149545,0.0000058022138,0.000036872272,0.99768245,0.000055093726,0.00007332962,0.0011236055],"study_design_scores_gemma":[0.000096218806,0.0014901069,0.04311058,0.000016678056,0.000028835928,0.0014612989,0.000076324686,0.0014192221,0.94861615,0.00020979354,0.003466597,0.000008168613],"about_ca_topic_score_codex":0.00009500355,"about_ca_topic_score_gemma":0.000113574904,"teacher_disagreement_score":0.0023163268,"about_ca_system_score_codex":0.00016276883,"about_ca_system_score_gemma":0.0000792827,"threshold_uncertainty_score":0.007748902},"labels":[],"label_agreement":null},{"id":"W3015889104","doi":"10.1186/s12885-020-06798-1","title":"Real-world comparative effectiveness of second-line ipilimumab for metastatic melanoma: a population-based cohort study in Ontario, Canada","year":2020,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; St. Michael's Hospital; Health Sciences Centre; Canadian Centre for Applied Research in Cancer Control; Institute for Clinical Evaluative Sciences; Queen's University; Cancer Care Ontario","funders":"Canadian Institutes of Health Research; Canadian Cancer Society; Government of Ontario; Canadian Centre for Applied Research in Cancer Control; Ontario Ministry of Health and Long-Term Care; Ontario Institute for Cancer Research; Cancer Care Ontario","keywords":"Ipilimumab; Medicine; Internal medicine; Cohort; Population; Oncology; Propensity score matching; Clinical trial; Surgical oncology; Proportional hazards model; Cancer registry; Cancer; Immunotherapy","score_opus":0.04038648890419611,"score_gpt":0.30261044230070044,"score_spread":0.26222395339650434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3015889104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927452,0.0010728043,0.00014217215,0.0002959863,0.0000107422175,0.000105175444,0.004780185,0.0000061557957,0.0008415208],"genre_scores_gemma":[0.997775,0.00035891111,0.00014371355,0.00011077515,0.000008693991,0.000037669906,0.0013098085,0.0000030151689,0.00025244843],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99804366,0.00030845153,0.0001665289,0.00043745423,0.0005838469,0.0004600232],"domain_scores_gemma":[0.995915,0.0003572344,0.0016261522,0.0002917455,0.0010749061,0.00073492614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018038445,0.00037407814,0.0006902684,0.00075011846,0.0017650198,0.0010275787,0.0012220261,0.0004952708,0.0013890378],"category_scores_gemma":[0.0036404063,0.00037854895,0.0010943474,0.002923622,0.0008276346,0.00032738107,0.00066168606,0.0006292783,0.00012778367],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003799702,0.000044170665,0.9958763,0.000064383756,0.0002914194,0.00009356425,0.00034301184,0.00014170705,0.00014926735,0.00009483704,0.0007849137,0.001736376],"study_design_scores_gemma":[0.00008583237,0.00009237635,0.99802506,0.000031919604,0.00015242334,0.000080044934,0.00034049738,0.00035139854,0.00003858311,0.000024603536,0.0007654308,0.000011847899],"about_ca_topic_score_codex":0.979297,"about_ca_topic_score_gemma":0.9823711,"teacher_disagreement_score":0.03254371,"about_ca_system_score_codex":0.03254371,"about_ca_system_score_gemma":0.023969261,"threshold_uncertainty_score":0.23612225},"labels":[],"label_agreement":null},{"id":"W3017244061","doi":"10.1002/cpdd.788","title":"Effect of Vemurafenib on the Pharmacokinetics of a Single Dose of Tizanidine (a CYP1A2 Substrate) in Patients With <i>BRAF</i><sup>V600</sup> Mutation–Positive Malignancies","year":2020,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"F. Hoffmann-La Roche","keywords":"Medicine; Pharmacokinetics; Vemurafenib; Pharmacology; Mutation; Oncology; Internal medicine; Cancer research; Genetics; Cancer; Gene","score_opus":0.018069228122625944,"score_gpt":0.2851740033891128,"score_spread":0.26710477526648685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3017244061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992199,0.00039635593,0.00015857026,0.000033452754,0.000013226524,0.000032715427,0.00003858001,0.000011058575,0.00009612765],"genre_scores_gemma":[0.999374,0.00012238955,0.0002731246,0.000032961256,0.000021643005,0.00003615621,0.000054090924,0.0000036825138,0.00008190543],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9993851,0.0003398529,0.000031394007,0.0001035889,0.00006832654,0.00007156389],"domain_scores_gemma":[0.9990163,0.00036126902,0.00030752996,0.00008014636,0.000038223752,0.00019657343],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011889974,0.0006086488,0.0013063212,0.0001733637,0.0001833748,0.0005070816,0.0002956238,0.000441695,0.0006648109],"category_scores_gemma":[0.0017860245,0.00037449884,0.001105206,0.00018775373,0.0003973718,0.0005154914,0.00017555413,0.0014069002,0.00011285601],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.663625,0.018710861,0.036349908,0.00030011495,0.0026898952,0.0002747547,0.00025603056,0.009564163,0.11758916,0.00014407908,0.0008927703,0.14960326],"study_design_scores_gemma":[0.08254845,0.74300325,0.13401641,0.00002519327,0.001326345,0.00061206636,0.00009320005,0.0121337855,0.024295779,0.00019333113,0.0016805207,0.00007165153],"about_ca_topic_score_codex":0.00043212285,"about_ca_topic_score_gemma":0.0007350056,"teacher_disagreement_score":0.0013063212,"about_ca_system_score_codex":0.00056573114,"about_ca_system_score_gemma":0.0005318421,"threshold_uncertainty_score":0.0062880516},"labels":[],"label_agreement":null},{"id":"W3020083376","doi":"10.1096/fasebj.2020.34.s1.09579","title":"Transcriptional, Post‐transcriptional, and Post‐translational Regulation of MK5 in Cardiac Cells","year":2020,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Montreal Heart Institute","funders":"","keywords":"Myocyte; Messenger RNA; Kinase; Protein kinase A; Internal medicine; Endocrinology; Biology; Cell biology; Molecular biology; Chemistry; Medicine; Biochemistry; Gene","score_opus":0.014439529142087003,"score_gpt":0.21092862851244956,"score_spread":0.19648909937036255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3020083376","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98426694,0.006760278,0.005649525,0.000115954506,0.00007106073,0.000024130777,0.0014387651,0.00006044227,0.001612871],"genre_scores_gemma":[0.9916789,0.0014873883,0.0030626492,0.00009280047,0.000022201431,0.000031515105,0.0014185695,0.000025014857,0.002180855],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998129,0.000018496334,0.000020684964,0.00006354457,0.00004592255,0.000038503113],"domain_scores_gemma":[0.9998809,0.000017106417,0.00003716827,0.000013647101,0.000025325344,0.000025871826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014350514,0.00023216648,0.00019065203,0.00019395148,0.00021990409,0.00037319743,0.00013909985,0.0001848043,0.00088254455],"category_scores_gemma":[0.00015941472,0.000117799056,0.00032511115,0.00015662769,0.00023003994,0.00021696152,0.00023867933,0.00031447693,0.00042788856],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019497237,0.000013354295,0.0012425714,0.00011491736,0.000007704661,0.000045267912,0.000045952063,0.00006283845,0.9964876,0.00017753843,0.00006268647,0.0015445413],"study_design_scores_gemma":[0.000022293041,0.0002919351,0.106316455,0.000035578276,0.00007407544,0.00037139872,0.00020097077,0.0022962673,0.8841017,0.00018719197,0.006083133,0.000018914372],"about_ca_topic_score_codex":0.0010119211,"about_ca_topic_score_gemma":0.0015172303,"teacher_disagreement_score":0.0010119211,"about_ca_system_score_codex":0.00047556253,"about_ca_system_score_gemma":0.00019345761,"threshold_uncertainty_score":0.0034503937},"labels":[],"label_agreement":null},{"id":"W3022006578","doi":"10.1038/s41598-020-64305-9","title":"Anti-inflammatory effects of α-MSH through p-CREB expression in sarcoidosis like granuloma model","year":2020,"lang":"en","type":"article","venue":"Scientific Reports","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Health Resources and Services Administration; Mallinckrodt Pharmaceuticals; Edward Mallinckrodt, Jr. Foundation; U.S. Department of Health and Human Services","keywords":"Sarcoidosis; Granuloma; CREB; Expression (computer science); Medicine; Immunology; Internal medicine; Computer science; Biology; Transcription factor; Genetics; Gene","score_opus":0.01042503504471102,"score_gpt":0.22244372782020397,"score_spread":0.21201869277549296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3022006578","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866127,0.004311437,0.003793849,0.0004404036,0.0003245537,0.00013078397,0.0013788809,0.00029435544,0.0027131278],"genre_scores_gemma":[0.9880043,0.0022316559,0.00334017,0.0002535954,0.0000615633,0.00026151468,0.0013219361,0.000039964078,0.004485216],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99972874,0.00003306825,0.00002299814,0.000060699433,0.00007283501,0.00008167378],"domain_scores_gemma":[0.9998714,0.000018602246,0.00003393964,0.000014382094,0.000018570803,0.00004304873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021746686,0.00035609386,0.00058900105,0.0003171385,0.00018569348,0.0003377594,0.0002394911,0.00044552513,0.0020719643],"category_scores_gemma":[0.00012501286,0.000161386,0.00045468158,0.00018488767,0.00035164054,0.00024715767,0.00017911932,0.0014590687,0.0005436839],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005569298,0.00019904814,0.00014533232,0.00014731073,0.000009268642,0.00008308678,0.000028152013,0.00008208356,0.99727744,0.00004007742,0.00016982581,0.0012613812],"study_design_scores_gemma":[0.00013151785,0.002026706,0.0035630162,0.000025399044,0.00005105922,0.00034744779,0.00012172952,0.0012950407,0.9889042,0.00011427483,0.0034060427,0.000013608074],"about_ca_topic_score_codex":0.00026151875,"about_ca_topic_score_gemma":0.00058192,"teacher_disagreement_score":0.0020719643,"about_ca_system_score_codex":0.0001977525,"about_ca_system_score_gemma":0.0002247097,"threshold_uncertainty_score":0.006931424},"labels":[],"label_agreement":null},{"id":"W3025475588","doi":"10.1136/lba2019.16","title":"P863 KEYNOTE-022 parts 4 and 5: pembrolizumab plus trametinib for patients with solid tumors or BRAF wild-type melanoma","year":2020,"lang":"en","type":"article","venue":"Poster presentations","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital; McMaster University; Juravinski Cancer Centre","funders":"Pfizer","keywords":"Trametinib; Pembrolizumab; Dabrafenib; Medicine; Tolerability; Melanoma; Internal medicine; Oncology; Adverse effect; Vemurafenib; Cancer research; Immunotherapy; MAPK/ERK pathway; Biology; Cancer; Metastatic melanoma; Kinase","score_opus":0.023898150230606634,"score_gpt":0.2698003080044721,"score_spread":0.24590215777386545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3025475588","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9221229,0.00863482,0.003843536,0.0022319595,0.00061021576,0.013988916,0.012233268,0.00097339903,0.035361018],"genre_scores_gemma":[0.9629087,0.0025517603,0.004413375,0.0018833929,0.00020123989,0.0049533253,0.009092219,0.0000867258,0.01390939],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9998369,0.00004684746,0.000011582983,0.000027025151,0.000022137596,0.000055432603],"domain_scores_gemma":[0.99980396,0.000019658804,0.000047675025,0.000017812443,0.000014950168,0.000096068696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058585085,0.0005408216,0.0005791934,0.00025009137,0.00033538017,0.00058584614,0.0007165782,0.00080128567,0.016866367],"category_scores_gemma":[0.0003432095,0.00026434494,0.000854125,0.0002239585,0.00028742786,0.0006724166,0.00036372163,0.001688863,0.0022055432],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3928938,0.028987817,0.005575504,0.0022485133,0.0013525754,0.00051529467,0.00018427848,0.0022565215,0.13448659,0.0013402927,0.053619154,0.3765396],"study_design_scores_gemma":[0.56270015,0.2858581,0.033540726,0.0002577537,0.0009156718,0.0011187927,0.000102627804,0.0021934896,0.03205771,0.00092313165,0.08025979,0.000072009774],"about_ca_topic_score_codex":0.0011718777,"about_ca_topic_score_gemma":0.00491681,"teacher_disagreement_score":0.016866367,"about_ca_system_score_codex":0.0009314345,"about_ca_system_score_gemma":0.0012446672,"threshold_uncertainty_score":0.056423604},"labels":[],"label_agreement":null},{"id":"W3028009597","doi":"10.1038/s43018-020-0064-0","title":"Activation of p38α stress-activated protein kinase drives the formation of the pre-metastatic niche in the lungs","year":2020,"lang":"en","type":"article","venue":"Nature Cancer","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":81,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"National Cancer Institute; U.S. Department of Health and Human Services","keywords":"p38 mitogen-activated protein kinases; Niche; Cell biology; Protein kinase A; Stress (linguistics); Kinase; Medicine; Chemistry; Biology; Biochemistry","score_opus":0.010624996229818832,"score_gpt":0.2596324474144047,"score_spread":0.2490074511845859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3028009597","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925303,0.0008995781,0.00276206,0.00021581896,0.000039061782,0.000023478984,0.00035445113,0.000111934976,0.003063265],"genre_scores_gemma":[0.9931124,0.00031715527,0.0009736571,0.0000400659,0.0000101962405,0.00001828027,0.00023147125,0.00002594258,0.005270852],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99981123,0.00001928027,0.000009256431,0.000035198165,0.000053456857,0.000071538845],"domain_scores_gemma":[0.99981576,0.000021756648,0.000029464012,0.000020423631,0.000021903212,0.00009070251],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011490806,0.0002019006,0.0001890172,0.0002247487,0.00023619639,0.00045970123,0.00020527272,0.0003287983,0.002194191],"category_scores_gemma":[0.00012528076,0.0002441718,0.0002053706,0.00010554887,0.00019156588,0.00029322604,0.00033112045,0.0011267456,0.0010314343],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007054179,0.000017891025,0.0002063393,0.000012795811,0.0000012727237,0.000060822716,0.000011277283,0.000055365406,0.9985877,0.00024259674,0.000074529366,0.0006588227],"study_design_scores_gemma":[0.000014137955,0.0001187523,0.008883752,0.000006453904,0.000003991366,0.0002502996,0.00010444463,0.002032153,0.98555565,0.00016976074,0.0028565791,0.0000041307862],"about_ca_topic_score_codex":0.001002862,"about_ca_topic_score_gemma":0.0015798594,"teacher_disagreement_score":0.002194191,"about_ca_system_score_codex":0.0004429249,"about_ca_system_score_gemma":0.0002689717,"threshold_uncertainty_score":0.007340312},"labels":[],"label_agreement":null},{"id":"W3028971888","doi":"10.1200/jco.2020.38.15_suppl.10023","title":"Time to central nervous system (CNS) metastases (mets) with atezolizumab (A) or placebo (P) combined with cobimetinib (C) + vemurafenib (V) in the phase III IMspire150 study.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"Roche","keywords":"Medicine; Vemurafenib; Internal medicine; Gastroenterology; Magnetic resonance imaging; Placebo; Nuclear medicine; Pathology; Metastatic melanoma; Cancer; Radiology","score_opus":0.06613375915990369,"score_gpt":0.37508031753054516,"score_spread":0.30894655837064144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3028971888","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974534,0.0009080044,0.00020218943,0.00008074903,0.000043785454,0.0002482705,0.0004649441,0.00002135205,0.0005773273],"genre_scores_gemma":[0.9975744,0.00044806133,0.00028080944,0.00011469346,0.000041943942,0.00032208292,0.0006250264,0.000005895387,0.0005871577],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9996183,0.00020187025,0.000024832536,0.000070430455,0.000033514512,0.000051136194],"domain_scores_gemma":[0.9994318,0.0001443985,0.00017853669,0.000038728063,0.000024193165,0.00018233323],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013928395,0.0006046918,0.0010904081,0.00018342552,0.00013701545,0.00045946424,0.00044608887,0.0005131916,0.0022069162],"category_scores_gemma":[0.0010192663,0.00029362357,0.0011195969,0.0001717498,0.000316669,0.00037202451,0.000245446,0.0012579892,0.00029326743],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.91980886,0.007458865,0.010997965,0.00043631074,0.0018893868,0.00011551672,0.00006011945,0.0014412268,0.013835263,0.00010991726,0.0018422087,0.042004358],"study_design_scores_gemma":[0.33597413,0.59239376,0.05685364,0.000079843856,0.0028967669,0.0005223607,0.00007063716,0.0032193805,0.005371422,0.0002394182,0.0023308797,0.000047736226],"about_ca_topic_score_codex":0.00047651678,"about_ca_topic_score_gemma":0.0016722343,"teacher_disagreement_score":0.0022069162,"about_ca_system_score_codex":0.0005297311,"about_ca_system_score_gemma":0.0007785985,"threshold_uncertainty_score":0.0073828697},"labels":[],"label_agreement":null},{"id":"W3029372856","doi":"10.1200/jco.2020.38.15_suppl.e22102","title":"Management of pyrexia in metastatic melanoma patients: A real-world clinical experience survey study.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"Novartis","keywords":"Medicine; Dabrafenib; Trametinib; Adverse effect; Internal medicine; Melanoma; Metastatic melanoma; Vemurafenib; Oncology; Cancer","score_opus":0.20203369067340887,"score_gpt":0.4764066622415882,"score_spread":0.2743729715681793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3029372856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99909616,0.00014238243,0.000045308654,0.00017832515,0.0000047478147,0.000031166954,0.00018255174,0.0000015141129,0.00031791622],"genre_scores_gemma":[0.99887294,0.00027179433,0.00011451946,0.0002776682,0.000006161836,0.000053978853,0.00020474456,0.0000020323782,0.00019608934],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99903995,0.00046457982,0.00012610632,0.00008769502,0.000123683,0.00015786277],"domain_scores_gemma":[0.99698526,0.00073114125,0.001110145,0.00006910341,0.00043658123,0.0006678024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018172028,0.00020270092,0.0003475608,0.00051904604,0.0005844438,0.00076876604,0.00030435406,0.0006060881,0.001775019],"category_scores_gemma":[0.004364874,0.0003326997,0.00043139767,0.00072948105,0.00038360103,0.0013144466,0.00092051097,0.0007314483,0.00039406793],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009269157,0.00034664827,0.97838265,0.00021760273,0.00004500939,0.0005137976,0.013077124,0.000050832125,0.00022927538,0.000046744997,0.0011656331,0.005831949],"study_design_scores_gemma":[0.000026672145,0.0010777445,0.9386609,0.00016312077,0.000027700173,0.0011911163,0.055778284,0.00041688644,0.00008760042,0.00003511147,0.0025002812,0.000034584787],"about_ca_topic_score_codex":0.004633684,"about_ca_topic_score_gemma":0.008665162,"teacher_disagreement_score":0.004633684,"about_ca_system_score_codex":0.00076541264,"about_ca_system_score_gemma":0.0007564822,"threshold_uncertainty_score":0.009610355},"labels":[],"label_agreement":null},{"id":"W3029728451","doi":"10.1200/jco.2020.38.15_suppl.10013","title":"Long-term survival from pembrolizumab (pembro) completion and pembro retreatment: Phase III KEYNOTE-006 in advanced melanoma.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Family medicine","score_opus":0.08588612701183446,"score_gpt":0.40634895926037484,"score_spread":0.3204628322485404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3029728451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99368,0.001611726,0.0004439434,0.00022640463,0.0000660031,0.0010650379,0.0015577921,0.000046357298,0.0013026401],"genre_scores_gemma":[0.9892307,0.0011395724,0.0009980395,0.0004953176,0.000098146105,0.0014199786,0.00429706,0.000023423883,0.0022978047],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995515,0.0002035298,0.000025055408,0.00006854378,0.000054863005,0.00009656556],"domain_scores_gemma":[0.9991196,0.0001420188,0.00021150106,0.00006972157,0.000036961355,0.00042025044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026318617,0.00067814783,0.0010658986,0.00024988782,0.00027540931,0.00066708936,0.000734083,0.00087905204,0.002569081],"category_scores_gemma":[0.0010202476,0.00033398968,0.0010852271,0.00032545722,0.00048620143,0.0005305439,0.00043953068,0.0029557324,0.00068611716],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.77937925,0.052301977,0.01339489,0.00083027204,0.0012533488,0.00014190536,0.00019720067,0.0036809226,0.02869156,0.00019433843,0.0054986123,0.11443568],"study_design_scores_gemma":[0.37463373,0.56435287,0.050232157,0.00007568515,0.0008244826,0.0003220755,0.00004529783,0.0020434572,0.0044015595,0.00016761565,0.0028729474,0.000028266051],"about_ca_topic_score_codex":0.0008778668,"about_ca_topic_score_gemma":0.002288476,"teacher_disagreement_score":0.0026318617,"about_ca_system_score_codex":0.0010204858,"about_ca_system_score_gemma":0.0013774852,"threshold_uncertainty_score":0.013918757},"labels":[],"label_agreement":null},{"id":"W3031004830","doi":"10.1200/jco.2020.38.15_suppl.10022","title":"A phase II, multicenter study of encorafenib/binimetinib followed by a rational triple-combination after progression in patients with advanced BRAF V600-mutated melanoma (LOGIC2).","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Internal medicine; Oncology; Logistic regression","score_opus":0.03068166014931388,"score_gpt":0.37951458013537354,"score_spread":0.34883291998605964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3031004830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927368,0.0008729553,0.00040083707,0.0003217258,0.000111289424,0.0024898334,0.001186536,0.00008300702,0.0017971073],"genre_scores_gemma":[0.98650646,0.0009618979,0.0016506155,0.00075711205,0.0001619521,0.00271742,0.003163064,0.000048328646,0.004033197],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995371,0.00022118964,0.000015053306,0.00009492947,0.000035868652,0.000095910334],"domain_scores_gemma":[0.99927706,0.00007518418,0.00010751884,0.00006363856,0.000042239513,0.00043425985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017664816,0.0022264768,0.001860473,0.0004720283,0.00047140213,0.0013481189,0.0009250177,0.0011199969,0.0056775645],"category_scores_gemma":[0.0008586105,0.0006803724,0.0011276219,0.00047875385,0.00079182803,0.0011145864,0.0004578138,0.002964042,0.0015421192],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.83382475,0.08499163,0.0061153206,0.00038760193,0.00097019493,0.00021719866,0.00027262777,0.0021341268,0.018335538,0.00022793422,0.0035736335,0.048949398],"study_design_scores_gemma":[0.5757476,0.4104956,0.008405678,0.000019774681,0.00032070043,0.0002152426,0.0000774092,0.0010968812,0.0014988551,0.00016169675,0.0019279434,0.000032556207],"about_ca_topic_score_codex":0.0014960008,"about_ca_topic_score_gemma":0.0034505478,"teacher_disagreement_score":0.0056775645,"about_ca_system_score_codex":0.0014008591,"about_ca_system_score_gemma":0.0017288103,"threshold_uncertainty_score":0.018993318},"labels":[],"label_agreement":null},{"id":"W3031975191","doi":"10.1007/s00401-020-02167-1","title":"An optimized workflow to improve reliability of detection of KIAA1549:BRAF fusions from RNA sequencing data","year":2020,"lang":"en","type":"article","venue":"Acta Neuropathologica","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"Deutsches Krebsforschungszentrum; Fondation Charles-Bruneau; Nationales Centrum für Tumorerkrankungen Heidelberg; Brain Tumour Charity; Pediatric Brain Tumor Foundation","keywords":"Workflow; Reliability (semiconductor); Computational biology; RNA; Computer science; Biology; Medicine; Bioinformatics; Pathology; Genetics; Gene; Database","score_opus":0.03664230203625043,"score_gpt":0.25754302520665556,"score_spread":0.22090072317040513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3031975191","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.030649515,0.0010406473,0.8750683,0.0006300379,0.00076732447,0.0026991977,0.013728256,0.07170401,0.003712714],"genre_scores_gemma":[0.04405296,0.00029431703,0.9356398,0.0007594595,0.00014249883,0.00368469,0.008090844,0.004696134,0.002639191],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9910074,0.0018544784,0.0009515629,0.004413475,0.0011931261,0.00058000674],"domain_scores_gemma":[0.98804307,0.0056407345,0.0008650161,0.0017698996,0.0032034686,0.00047779383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012530173,0.0032578167,0.0018384403,0.0051362184,0.0015889079,0.003490267,0.0016451215,0.002273215,0.02022516],"category_scores_gemma":[0.029499516,0.0016458569,0.002446449,0.0024296644,0.0009965673,0.0013986282,0.0020544836,0.0037327542,0.016922694],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004137843,0.0007587782,0.034516066,0.004012777,0.0012921755,0.001973139,0.0029365302,0.010013608,0.4541491,0.005855876,0.055445813,0.4249083],"study_design_scores_gemma":[0.0007450277,0.0010959775,0.054809242,0.0010631903,0.0008167076,0.0029735286,0.0014299367,0.2770232,0.48361322,0.016550967,0.15885794,0.00102105],"about_ca_topic_score_codex":0.0035584117,"about_ca_topic_score_gemma":0.005548504,"teacher_disagreement_score":0.02022516,"about_ca_system_score_codex":0.001112291,"about_ca_system_score_gemma":0.003367414,"threshold_uncertainty_score":0.067659914},"labels":[],"label_agreement":null},{"id":"W3033214396","doi":"10.3390/ijms21114055","title":"The MNK1/2-eIF4E Axis as a Potential Therapeutic Target in Melanoma","year":2020,"lang":"en","type":"review","venue":"International Journal of Molecular Sciences","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University; Jewish General Hospital","funders":"Fonds de Recherche du Québec - Santé; Terry Fox Research Institute; Canadian Cancer Society; Canadian Institutes of Health Research; Réseau de cancérologie Rossy","keywords":"EIF4E; Melanoma; Cancer research; PI3K/AKT/mTOR pathway; Targeted therapy; Medicine; MAPK/ERK pathway; Translation (biology); Kinase; Signal transduction; Protein kinase A; Cancer; Biology; Bioinformatics; Messenger RNA; Internal medicine; Cell biology; Gene; Genetics","score_opus":0.02101689350704776,"score_gpt":0.31828228895370075,"score_spread":0.297265395446653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033214396","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014523364,0.9979603,0.00012185936,0.0002827997,0.00037374377,0.0000039802994,0.000013380768,0.000009536257,0.0010891922],"genre_scores_gemma":[0.00079459074,0.9977639,0.00017672287,0.00025228894,0.00020578523,0.0000061673572,0.00003001492,0.0000018480293,0.00076861173],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99991655,0.000014353161,0.000010394881,0.0000149636635,0.00003188931,0.00001176306],"domain_scores_gemma":[0.99989116,0.000044259083,0.000015047656,0.0000033564397,0.000028815868,0.000017319186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033422536,0.0007355476,0.0008325846,0.0014499043,0.00023487165,0.00063954724,0.0005870224,0.000938754,0.0027362797],"category_scores_gemma":[0.00035719888,0.00020482753,0.0003512162,0.0012772651,0.00028637698,0.0009526469,0.00048407997,0.0019686476,0.0017628645],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000110917426,0.000089189954,0.00013319221,0.01309352,0.000067677065,0.00030925646,0.00005038276,0.0005397449,0.0035632376,0.0038716218,0.04863221,0.9295391],"study_design_scores_gemma":[0.000022013424,0.00011386706,0.00058770186,0.0016530385,0.00007045686,0.0013345452,0.00003235504,0.00009671628,0.0005025981,0.0016002374,0.9939746,0.000011905571],"about_ca_topic_score_codex":0.0005101125,"about_ca_topic_score_gemma":0.001250989,"teacher_disagreement_score":0.0027362797,"about_ca_system_score_codex":0.00050280784,"about_ca_system_score_gemma":0.00067350786,"threshold_uncertainty_score":0.009153724},"labels":[],"label_agreement":null},{"id":"W3034215768","doi":"10.1101/2020.06.11.145995","title":"Catalytic domain plasticity of MKK7 reveals structural mechanisms of allosteric activation and new targeting opportunities","year":2020,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Novartis Pharma; Ontario Ministry of Economic Development and Innovation; Deutschen Konsortium für Translationale Krebsforschung; European Federation of Pharmaceutical Industries and Associations; Merck KGaA; Ministero dello Sviluppo Economico; Fundação de Amparo à Pesquisa do Estado de São Paulo; Diamond Light Source; Genome Canada; Pfizer","keywords":"Allosteric regulation; Regulator; Transferase; Chemistry; Kinase; Structural biology; Helix (gastropod); Protein kinase domain; Structural plasticity; Cell biology; Computational biology; Enzyme; Biochemistry; Biology; Neuroscience; Gene; Ecology","score_opus":0.02937375849624991,"score_gpt":0.21955337550586998,"score_spread":0.19017961700962008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034215768","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9769909,0.002647198,0.012740351,0.0005010626,0.000038970415,0.000024088604,0.00015689238,0.00029078676,0.0066097043],"genre_scores_gemma":[0.9970029,0.0005634089,0.0015081746,0.000055548953,0.0000068450786,0.00000753266,0.000113469956,0.000013801775,0.0007282877],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999504,0.000008504084,0.0000024587387,0.000009623082,0.000016090627,0.000012814653],"domain_scores_gemma":[0.9999678,0.0000092977425,0.0000060380057,0.0000045908355,0.0000039349334,0.000008238112],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016538921,0.00023412265,0.0002083991,0.00007616673,0.00013725134,0.00035802496,0.00032438882,0.00025193967,0.002287836],"category_scores_gemma":[0.000116798656,0.00013171251,0.00018164277,0.00006873383,0.00033491434,0.00027414033,0.00026509986,0.0005542527,0.00044108342],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029282898,0.00007952112,0.0010523929,0.00019989398,0.000028622038,0.00049692416,0.0000851635,0.004771671,0.97374684,0.0066192644,0.0006701899,0.011956678],"study_design_scores_gemma":[0.00016828919,0.00041590212,0.005425119,0.00003693454,0.00006759812,0.0014003445,0.00020391677,0.05533985,0.91376233,0.00862557,0.014510729,0.000043335476],"about_ca_topic_score_codex":0.00028036034,"about_ca_topic_score_gemma":0.0003974868,"teacher_disagreement_score":0.002287836,"about_ca_system_score_codex":0.0002198695,"about_ca_system_score_gemma":0.00018168885,"threshold_uncertainty_score":0.007653594},"labels":[],"label_agreement":null},{"id":"W3034783173","doi":"10.1016/j.trecan.2020.05.009","title":"Clinical Development of BRAF plus MEK Inhibitor Combinations","year":2020,"lang":"en","type":"review","venue":"Trends in cancer","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":352,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Daiichi Sankyo Company; Bristol-Myers Squibb Canada; Genentech; European Society for Medical Oncology; Exelixis; Prometheus; Roche; Pfizer; Novartis Pharmaceuticals Corporation; Celgene; American Society of Clinical Oncology; AstraZeneca; Novartis; Spectrum Pharmaceuticals; Amgen; GlaxoSmithKline","keywords":"MEK inhibitor; Cancer research; Chemistry; Pharmacology; Medicine; MAPK/ERK pathway; Phosphorylation; Biochemistry","score_opus":0.13543415085614935,"score_gpt":0.44001653710992666,"score_spread":0.3045823862537773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034783173","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006459283,0.9947895,0.000502563,0.0007363305,0.00045416926,0.000032482523,0.000060464663,0.00002650767,0.0027520698],"genre_scores_gemma":[0.0068904925,0.9859489,0.0010657166,0.0020642497,0.00056114886,0.00007525422,0.0002420707,0.000011807426,0.003140415],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998004,0.00004595229,0.000022527567,0.000043470754,0.00005934918,0.000028338045],"domain_scores_gemma":[0.999724,0.00012794322,0.000045398734,0.0000082228335,0.00005333548,0.000041075797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083483325,0.0010571807,0.0017234178,0.0010003366,0.0001845437,0.0011191788,0.0012214641,0.0010891047,0.005557346],"category_scores_gemma":[0.0010043432,0.0002806069,0.00078310026,0.0007744572,0.0003897588,0.0009122512,0.00050683686,0.0034347968,0.0018164425],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004566463,0.00019887225,0.00015435368,0.00454149,0.00012298452,0.00017409054,0.000024294859,0.00052208215,0.0016495346,0.0016457579,0.027802212,0.96270764],"study_design_scores_gemma":[0.0013150168,0.0013373747,0.0018986613,0.0040071188,0.00048531612,0.0017133789,0.000051551902,0.0005276144,0.0014804101,0.0028817405,0.98425955,0.00004230373],"about_ca_topic_score_codex":0.0006651468,"about_ca_topic_score_gemma":0.0026401093,"teacher_disagreement_score":0.005557346,"about_ca_system_score_codex":0.00055534363,"about_ca_system_score_gemma":0.00069455,"threshold_uncertainty_score":0.018591225},"labels":[],"label_agreement":null},{"id":"W3036759197","doi":"10.1038/s41580-020-0255-7","title":"ERK signalling: a master regulator of cell behaviour, life and fate","year":2020,"lang":"en","type":"review","venue":"Nature Reviews Molecular Cell Biology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1202,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"Canadian Institutes of Health Research","keywords":"Cell biology; MAPK/ERK pathway; Kinase; Biology; Cell growth; Cell fate determination; Extracellular; Cell; Signal transduction; Intracellular; Protein kinase A; Cell signaling; Regulator; Cell metabolism; Biochemistry; Transcription factor","score_opus":0.024231471057119387,"score_gpt":0.28033844892549703,"score_spread":0.25610697786837766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036759197","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011825748,0.99689984,0.000266703,0.00070168485,0.0005488617,0.0000045862453,0.00003211714,0.000014316246,0.0014136084],"genre_scores_gemma":[0.00072012265,0.9971386,0.00017234973,0.00036250986,0.00033849946,0.0000061045444,0.00004520328,0.0000020575571,0.0012146295],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99984205,0.000017808094,0.000016447239,0.000027514196,0.000072541014,0.000023611472],"domain_scores_gemma":[0.99976593,0.000079523306,0.000031871285,0.0000070555916,0.000072618684,0.00004306899],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067791744,0.0011587031,0.0011957136,0.0013431675,0.0002215938,0.001446518,0.00085100345,0.0013603442,0.0030983842],"category_scores_gemma":[0.000569267,0.0003219217,0.00025392097,0.0016849866,0.0007393989,0.0015691806,0.00091547327,0.0025911,0.0026527706],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015195242,0.00003853077,0.00009641658,0.00696549,0.000059311034,0.00012237711,0.000029411594,0.0005648852,0.0042901114,0.005990103,0.057897974,0.9237933],"study_design_scores_gemma":[0.000025958801,0.000040136398,0.00046210043,0.0009878427,0.000053604916,0.0003647911,0.000032265172,0.0001232762,0.000817084,0.0028955766,0.99418265,0.000014725994],"about_ca_topic_score_codex":0.00090189604,"about_ca_topic_score_gemma":0.0023249723,"teacher_disagreement_score":0.0030983842,"about_ca_system_score_codex":0.0009971728,"about_ca_system_score_gemma":0.0012731185,"threshold_uncertainty_score":0.010365188},"labels":[],"label_agreement":null},{"id":"W3038254578","doi":"10.1002/cpdd.822","title":"Effect of Itraconazole, a Potent CYP3A4 Inhibitor, on the Steady‐State Pharmacokinetics of Vemurafenib in Patients With <i>BRAF</i><sup>V600</sup> Mutation–Positive Malignancies","year":2020,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Vemurafenib; Itraconazole; Medicine; Pharmacokinetics; Dosing; Pharmacology; Crossover study; Confidence interval; Area under the curve; Internal medicine; Adverse effect; Urology; Gastroenterology; Cancer; Dermatology; Pathology; Metastatic melanoma","score_opus":0.012223719638403855,"score_gpt":0.2778418450221536,"score_spread":0.26561812538374974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3038254578","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992187,0.00027014918,0.00010623234,0.00003366413,0.000009181433,0.00001738605,0.00004206845,0.000010944152,0.00029167836],"genre_scores_gemma":[0.999413,0.00009329964,0.00014671487,0.0000255985,0.000015357422,0.000018101715,0.00008158744,0.0000025923512,0.00020377776],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99966276,0.00014226291,0.000024049077,0.000058734517,0.000043884695,0.00006830043],"domain_scores_gemma":[0.9993755,0.00023370981,0.00014842105,0.000046976664,0.000032464744,0.00016286211],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057325204,0.0002694067,0.0006497716,0.00013457186,0.00012818066,0.00032381905,0.00012705455,0.00023968276,0.0008935453],"category_scores_gemma":[0.0013236577,0.00020613316,0.0005806236,0.00020041685,0.0001976445,0.00035430578,0.00014878725,0.00079945975,0.00013107529],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.30035317,0.017090535,0.09210833,0.0002558295,0.0020032404,0.00088616804,0.000458847,0.010560349,0.28821024,0.00022357513,0.001780956,0.28606883],"study_design_scores_gemma":[0.0120323375,0.3327371,0.5794472,0.000024527564,0.0013085362,0.0013178756,0.00012950419,0.013510448,0.056008704,0.00018480854,0.0032134976,0.0000854319],"about_ca_topic_score_codex":0.000555387,"about_ca_topic_score_gemma":0.0011982624,"teacher_disagreement_score":0.0008935453,"about_ca_system_score_codex":0.00036698818,"about_ca_system_score_gemma":0.0003931908,"threshold_uncertainty_score":0.003031671},"labels":[],"label_agreement":null},{"id":"W3043280112","doi":"10.1016/j.jaad.2020.07.044","title":"Cutaneous reactions in children treated with MEK inhibitors, BRAF inhibitors, or combination therapy: A multicenter study","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institutes of Health","keywords":"Medicine; Multicenter study; Oncology; Dermatology; Internal medicine; Randomized controlled trial","score_opus":0.012379842251330356,"score_gpt":0.2599215950624793,"score_spread":0.24754175281114896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3043280112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99922764,0.00033021127,0.000047557292,0.000014074999,0.0000039576407,0.00004525131,0.00008441376,0.0000019787155,0.0002448545],"genre_scores_gemma":[0.9990569,0.0003276068,0.00014072857,0.000069758295,0.000024928753,0.000058928665,0.00018873939,0.0000031353673,0.00012928272],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992124,0.00030978085,0.000062157145,0.00018321713,0.000102511876,0.00012983778],"domain_scores_gemma":[0.9986687,0.00027551068,0.00057230314,0.000068709196,0.00010372968,0.00031109512],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079221296,0.0006229411,0.0009741417,0.00041606688,0.0005798275,0.0005059844,0.00032256226,0.00058652746,0.0014697124],"category_scores_gemma":[0.0012360975,0.0003207435,0.00089170894,0.0006570685,0.00055278995,0.0005293228,0.00034643637,0.0008306005,0.00020965328],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00951467,0.0028716105,0.9721953,0.00011980178,0.00045042872,0.0012766643,0.0003161297,0.0001875847,0.003320314,0.000068566274,0.00028899073,0.009389859],"study_design_scores_gemma":[0.0023347577,0.026691657,0.96064776,0.000047009755,0.0006779377,0.0055353255,0.0010529164,0.00030863538,0.0010609255,0.000044138294,0.0015742813,0.000024596902],"about_ca_topic_score_codex":0.0013883685,"about_ca_topic_score_gemma":0.0012836575,"teacher_disagreement_score":0.0014697124,"about_ca_system_score_codex":0.000660371,"about_ca_system_score_gemma":0.00053786585,"threshold_uncertainty_score":0.004916668},"labels":[],"label_agreement":null},{"id":"W3044551578","doi":"10.1016/j.jdcr.2020.07.021","title":"Isotretinoin for the treatment of severe acneiform eruptions associated with the MEK inhibitor trametinib","year":2020,"lang":"en","type":"article","venue":"JAAD Case Reports","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal","funders":"","keywords":"Trametinib; Medicine; MEK inhibitor; Selumetinib; Vemurafenib; Dabrafenib; Protein kinase A; Cancer research; Internal medicine; Oncology; Melanoma; MAPK/ERK pathway; Cancer; Kinase; Biology","score_opus":0.02314795344111546,"score_gpt":0.2455809543987585,"score_spread":0.22243300095764304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3044551578","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.32892257,0.4862465,0.013701229,0.018689431,0.0028962228,0.0009811082,0.000787676,0.0014489292,0.14632632],"genre_scores_gemma":[0.9118157,0.05802902,0.0038886492,0.006241015,0.0010045484,0.00010081209,0.00046199988,0.00011220764,0.018346],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99979514,0.00005682368,0.000023386896,0.000018009467,0.00007445847,0.000032140455],"domain_scores_gemma":[0.9998067,0.000052244894,0.000051009192,0.000010811636,0.000031157273,0.00004815881],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002233167,0.00031773563,0.00049070956,0.00054662983,0.00029797808,0.00027370313,0.00020484532,0.0006915171,0.003813423],"category_scores_gemma":[0.0007315173,0.00008604848,0.00060233916,0.00028614665,0.00014032562,0.0003043175,0.00022806482,0.0014059707,0.0013646577],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002843117,0.00079086534,0.0067770956,0.0024883286,0.00038345056,0.08345502,0.00028135348,0.00042831618,0.03961907,0.0013447852,0.0527582,0.80883044],"study_design_scores_gemma":[0.0016926605,0.0043177623,0.04290152,0.001807847,0.00061366305,0.46373755,0.00027853026,0.0028511747,0.029555546,0.0018653151,0.4503026,0.000075838725],"about_ca_topic_score_codex":0.0008793129,"about_ca_topic_score_gemma":0.0028127385,"teacher_disagreement_score":0.003813423,"about_ca_system_score_codex":0.00029645584,"about_ca_system_score_gemma":0.00021139419,"threshold_uncertainty_score":0.0127571225},"labels":[],"label_agreement":null},{"id":"W3045758154","doi":"10.1016/j.ophtha.2020.05.043","title":"Re: Francis et al.: Immune checkpoint inhibitor associated optic neuritis (Ophthalmology. 2020;127:1585-1589)","year":2020,"lang":"en","type":"letter","venue":"Ophthalmology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kensington Health; University of Toronto","funders":"","keywords":"Medicine; Optic neuritis; Ophthalmology; Immunology; Multiple sclerosis","score_opus":0.018155429263734313,"score_gpt":0.25912125608346587,"score_spread":0.24096582681973155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3045758154","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012090941,0.0067123356,0.00021766487,0.88912016,0.08637039,0.00003912727,0.000194366,0.0001439333,0.015992954],"genre_scores_gemma":[0.017033067,0.0077136927,0.000524152,0.73411727,0.1797764,0.00007946969,0.00017633007,0.0000847876,0.060494907],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995043,0.00008528219,0.00005970179,0.00008415994,0.00017782711,0.0000887478],"domain_scores_gemma":[0.99889755,0.00044136765,0.00006604695,0.000046731417,0.00030410034,0.00024411135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066057744,0.00085728616,0.0011096442,0.0008508502,0.0018481321,0.0018813522,0.00091792934,0.016956042,0.01692026],"category_scores_gemma":[0.006032799,0.000492717,0.00080095243,0.00042540155,0.0012127975,0.0018958434,0.00063061476,0.015699523,0.019016573],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000061977014,0.000031452426,0.0004115936,0.000038702827,0.000011229283,0.0068332436,0.000018976623,0.000037406677,0.0001544266,0.00059591606,0.9832471,0.008557863],"study_design_scores_gemma":[0.00030659715,0.00011975721,0.002898104,0.000565887,0.000054966742,0.024580788,0.00025061943,0.00078791176,0.0005871888,0.006043829,0.96371275,0.000091587004],"about_ca_topic_score_codex":0.006537494,"about_ca_topic_score_gemma":0.008268677,"teacher_disagreement_score":0.016956042,"about_ca_system_score_codex":0.0023665505,"about_ca_system_score_gemma":0.0011589983,"threshold_uncertainty_score":0.05660391},"labels":[],"label_agreement":null},{"id":"W3048853605","doi":"10.1016/j.chembiol.2020.07.014","title":"Catalytic Domain Plasticity of MKK7 Reveals Structural Mechanisms of Allosteric Activation and Diverse Targeting Opportunities","year":2020,"lang":"en","type":"article","venue":"Cell chemical biology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Eshelman Institute for Innovation, University of North Carolina at Chapel Hill; Shenzhen Gas Corporation; Innovative Medicines Initiative; Deutsche Forschungsgemeinschaft; Ontario Ministry of Economic Development and Innovation; European Federation of Pharmaceutical Industries and Associations; Takeda Pharmaceutical Company; Boehringer Ingelheim; Janssen Pharmaceuticals; Merck KGaA; European Commission; Meso Scale Diagnostics; Sanofi; Wellcome Trust; Astellas Pharma US; Genome Canada; Novartis Pharma; Deutschen Konsortium für Translationale Krebsforschung; Canada Foundation for Innovation; Novartis; Pfizer","keywords":"Allosteric regulation; Regulator; Transferase; Chemistry; Protein kinase domain; Helix (gastropod); Kinase; Structural biology; Cell biology; Enzyme; Computational biology; Biochemistry; Biology; Gene","score_opus":0.0262139424188548,"score_gpt":0.22298158617900635,"score_spread":0.19676764376015154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048853605","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97457325,0.0013067884,0.016112624,0.0006785425,0.00007911595,0.000020013986,0.00011534314,0.0002418375,0.0068724123],"genre_scores_gemma":[0.99695516,0.00030550404,0.001478271,0.00010646957,0.000008330596,0.0000070462506,0.00008528124,0.000019408084,0.0010345448],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998982,0.0000140381535,0.0000059860886,0.000024063116,0.00002918451,0.000028514924],"domain_scores_gemma":[0.99992,0.000020987341,0.000013682431,0.00001373441,0.000011254924,0.000020318012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023017904,0.0003002795,0.00021748968,0.00010255927,0.00023391783,0.00046503416,0.00064191694,0.00034866325,0.0027037659],"category_scores_gemma":[0.00028277072,0.00019140958,0.0002463047,0.00009406764,0.00041301677,0.0004890113,0.0003536442,0.0008670791,0.00081097404],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041780894,0.00006496835,0.0008497541,0.00009474463,0.000020416974,0.00036269455,0.000079298945,0.002346816,0.97423834,0.011656557,0.00046630652,0.009402149],"study_design_scores_gemma":[0.00008934453,0.00021026794,0.0038572953,0.000019006027,0.00004263082,0.0013999047,0.0001624171,0.02241052,0.9572116,0.0058967615,0.008660924,0.000039327133],"about_ca_topic_score_codex":0.0003717184,"about_ca_topic_score_gemma":0.00054056855,"teacher_disagreement_score":0.0027037659,"about_ca_system_score_codex":0.0003609711,"about_ca_system_score_gemma":0.00022590497,"threshold_uncertainty_score":0.009044945},"labels":[],"label_agreement":null},{"id":"W3049717158","doi":"10.1021/acsomega.0c02419","title":"Synthesis of a <sup>11</sup>C-Isotopologue of the B-Raf-Selective Inhibitor Encorafenib Using In-Loop [<sup>11</sup>C]CO<sub>2</sub> Fixation","year":2020,"lang":"en","type":"article","venue":"ACS Omega","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Centre Hospitalier de l’Université de Montréal","funders":"Dana-Farber Cancer Institute","keywords":"Chemistry","score_opus":0.015347437260393683,"score_gpt":0.2303034083146331,"score_spread":0.21495597105423944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3049717158","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90144545,0.0029888658,0.070936866,0.00024508403,0.00017591266,0.0010024954,0.0031735792,0.0006760221,0.019355748],"genre_scores_gemma":[0.93788767,0.0024102214,0.039148588,0.00014857725,0.000035752146,0.00038502942,0.003619439,0.00031059943,0.016054088],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99986064,0.00001668161,0.000010954316,0.00003391333,0.000036411493,0.000041399984],"domain_scores_gemma":[0.99987566,0.000017977352,0.000024227698,0.000018781513,0.000029864275,0.000033482946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019889088,0.00065095705,0.00032938906,0.00024427986,0.0002803788,0.00020720474,0.00047910496,0.00043633228,0.0034959638],"category_scores_gemma":[0.00018591953,0.00022823799,0.00031049238,0.0004085415,0.00017379568,0.00031209915,0.00028167962,0.0005876071,0.0020161192],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023689745,0.000073360745,0.00009515484,0.0001215503,0.000016674647,0.00020971744,0.00004519413,0.0006924231,0.99093574,0.0004999151,0.00024789496,0.0068255463],"study_design_scores_gemma":[0.00003223627,0.00029221765,0.00038542232,0.000005034504,0.000016960854,0.00017376295,0.000011202756,0.0005396089,0.99006325,0.000044238008,0.008422722,0.000013244281],"about_ca_topic_score_codex":0.0014728935,"about_ca_topic_score_gemma":0.0019703403,"teacher_disagreement_score":0.0034959638,"about_ca_system_score_codex":0.0004344267,"about_ca_system_score_gemma":0.00056951423,"threshold_uncertainty_score":0.011695147},"labels":[],"label_agreement":null},{"id":"W3068892982","doi":"10.1016/j.ejmech.2020.112721","title":"Selective targeting of the αC and DFG-out pocket in p38 MAPK","year":2020,"lang":"en","type":"article","venue":"European Journal of Medicinal Chemistry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Eshelman Institute for Innovation, University of North Carolina at Chapel Hill; Pfizer Canada; Merck Sharp and Dohme; AbbVie Deutschland; Innovative Medicines Initiative; Novartis Pharma; Canada Foundation for Innovation; Ontario Ministry of Economic Development and Innovation; Fundação de Amparo à Pesquisa do Estado de São Paulo; Genome Canada; Merck KGaA; Boehringer Ingelheim; Wellcome Trust; Bayer","keywords":"Chemistry; Allosteric regulation; MAPK/ERK pathway; p38 mitogen-activated protein kinases; Binding pocket; Drug discovery; Combinatorial chemistry; Binding site; Computational biology; Signal transduction; Biochemistry; Receptor; Biology","score_opus":0.01038204048651175,"score_gpt":0.2036884798109804,"score_spread":0.19330643932446864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3068892982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97956973,0.0020520894,0.011284313,0.0004119401,0.000104930026,0.0001095902,0.00044397177,0.00016143089,0.0058619035],"genre_scores_gemma":[0.9904055,0.0011947349,0.0045713736,0.00014412153,0.000012993793,0.000046598285,0.00023276714,0.000019814794,0.0033722033],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998913,0.000016365824,0.0000061081646,0.000020566396,0.000020964073,0.000044744003],"domain_scores_gemma":[0.99996126,0.0000074956893,0.000009105586,0.0000059117633,0.000004391227,0.0000118873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022772954,0.00039281114,0.00021246678,0.000111107816,0.00017734864,0.00016351536,0.00040317222,0.0003022801,0.0019945246],"category_scores_gemma":[0.00013364972,0.00013709348,0.00018128703,0.00012953063,0.00019002374,0.00023821194,0.00030576464,0.0005267491,0.00046636836],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048183254,0.000045121942,0.0001038209,0.00008606686,0.00000790716,0.00018808307,0.000031624448,0.00040553074,0.9913892,0.0011874039,0.0003148492,0.0057585235],"study_design_scores_gemma":[0.00010478909,0.00027522887,0.0005648556,0.000012377407,0.000014906854,0.0004004895,0.000023984734,0.0011375616,0.98920876,0.00021915973,0.008024442,0.000013379224],"about_ca_topic_score_codex":0.0008021283,"about_ca_topic_score_gemma":0.0007848633,"teacher_disagreement_score":0.0019945246,"about_ca_system_score_codex":0.00039995002,"about_ca_system_score_gemma":0.0002637571,"threshold_uncertainty_score":0.0066723228},"labels":[],"label_agreement":null},{"id":"W3082347199","doi":"10.1097/cad.0000000000000951","title":"The positive correlation between drug addiction and drug dosage in vemurafenib-resistant melanoma cells is underpinned by activation of ERK1/2-FRA-1 pathway","year":2020,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Aging","funders":"","keywords":"Vemurafenib; Melanoma; Cancer research; Downregulation and upregulation; Medicine; Drug resistance; Pharmacology; clone (Java method); Drug; Addiction; Biology; Metastatic melanoma; Psychiatry; Genetics; Gene","score_opus":0.006785868286619531,"score_gpt":0.21391821300337346,"score_spread":0.20713234471675393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082347199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995227,0.0014828404,0.0014659709,0.00008560683,0.000020445192,0.000028522481,0.000566799,0.00005072332,0.0010721222],"genre_scores_gemma":[0.9947352,0.0006697271,0.0013390047,0.000048171558,0.000008243264,0.00006472185,0.0007356776,0.000008971109,0.0023902105],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99968386,0.000051758943,0.000046949055,0.00006718853,0.00010188534,0.00004834712],"domain_scores_gemma":[0.9996107,0.00007820574,0.00012499923,0.000046095953,0.00007483967,0.00006514659],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001290908,0.00026162897,0.00032421973,0.00034667243,0.000117929434,0.00025976804,0.00013452696,0.00025473133,0.0015081039],"category_scores_gemma":[0.00026954725,0.00020866234,0.00024415832,0.00033830066,0.0001459519,0.00025738677,0.00018694202,0.0005966915,0.0002862285],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023385062,0.00008240955,0.0029120822,0.000047019355,0.000014263563,0.000068616035,0.00003767594,0.00007543166,0.9943838,0.00003725086,0.000058273337,0.0020493043],"study_design_scores_gemma":[0.000021539343,0.0013595179,0.12060513,0.000010166221,0.000030661,0.0006716493,0.0001730366,0.001970408,0.8726041,0.0000898341,0.0024405052,0.000023544435],"about_ca_topic_score_codex":0.0005781334,"about_ca_topic_score_gemma":0.00072948146,"teacher_disagreement_score":0.0015081039,"about_ca_system_score_codex":0.00015339526,"about_ca_system_score_gemma":0.00011303285,"threshold_uncertainty_score":0.0050451756},"labels":[],"label_agreement":null},{"id":"W3083445513","doi":"10.1158/1538-7445.am2020-3491","title":"Abstract 3491: COX-2 inhibitor use and risk of skin cancer: three prospective cohort studies","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Proportional hazards model; Hazard ratio; Skin cancer; Internal medicine; Prospective cohort study; Cancer; Confidence interval; Oncology; Melanoma; Relative risk; Cohort; Basal cell carcinoma; Incidence (geometry); Basal cell; Cancer research","score_opus":0.08770271116284245,"score_gpt":0.37661962489656703,"score_spread":0.2889169137337246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083445513","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99118984,0.003522899,0.0012895461,0.00013234219,0.0000603335,0.00011387185,0.003180309,0.000017431583,0.00049339863],"genre_scores_gemma":[0.9965708,0.00077160855,0.0006679015,0.00008028269,0.00002810249,0.000109258835,0.0014695073,0.000008534031,0.00029395949],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997391,0.0010803868,0.00036204612,0.0005822416,0.00038028983,0.00020404326],"domain_scores_gemma":[0.9945187,0.0014535191,0.0015816028,0.0012476216,0.00079275604,0.00040576392],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045404336,0.00066357496,0.00058605167,0.0010721392,0.00078249414,0.0011733404,0.00084879826,0.000961983,0.0028307268],"category_scores_gemma":[0.006289443,0.00071819057,0.0036576614,0.0021482785,0.00029969547,0.000531406,0.0010119803,0.0012753463,0.00028911428],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013536031,0.00008926623,0.9925327,0.00011788402,0.003443419,0.00013779633,0.000113670656,0.00012302607,0.00032060797,0.00004514823,0.00029428946,0.001428566],"study_design_scores_gemma":[0.0002377352,0.0003159582,0.99367976,0.000061711966,0.0038598613,0.0003254507,0.00021294235,0.00045465166,0.00014890588,0.000070070884,0.0006099996,0.000022847373],"about_ca_topic_score_codex":0.0156112565,"about_ca_topic_score_gemma":0.011985806,"teacher_disagreement_score":0.0156112565,"about_ca_system_score_codex":0.0003891226,"about_ca_system_score_gemma":0.0008526336,"threshold_uncertainty_score":0.031040788},"labels":[],"label_agreement":null},{"id":"W3085796913","doi":"10.1016/j.jaad.2020.09.027","title":"Stevens-Johnson syndrome and toxic epidermal necrolysis reactions to BRAF and MEK inhibitors in patients with melanoma: A systematic review","year":2020,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Psoriasis Association","keywords":"Vemurafenib; Medicine; Toxic epidermal necrolysis; Adverse effect; Melanoma; MEK inhibitor; Dermatology; Internal medicine; MEDLINE; Oncology; Pediatrics; Metastatic melanoma; Cancer research","score_opus":0.010522160189657064,"score_gpt":0.2689324435796214,"score_spread":0.25841028338996436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3085796913","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00042321178,0.9991654,0.000032609296,0.0000757022,0.00004293886,0.000021921762,0.00011079924,0.000002636932,0.00012470975],"genre_scores_gemma":[0.0041885995,0.9951997,0.00013499429,0.00025917063,0.000041422514,0.000023451288,0.00008115211,0.000001197203,0.00007017826],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9991572,0.00015327224,0.00036658908,0.000116377734,0.00016772449,0.000038900773],"domain_scores_gemma":[0.99706596,0.0017043743,0.00089451997,0.00003909327,0.00023571675,0.000060398612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012313918,0.00075095275,0.0035092062,0.003781879,0.0002242164,0.0011276095,0.0009844205,0.001038776,0.0038197485],"category_scores_gemma":[0.0046687084,0.00048547596,0.0034353605,0.0036573224,0.0003623057,0.0011096357,0.0008208972,0.0007332814,0.00023392205],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046234715,0.000044331915,0.0021548774,0.7478384,0.009070063,0.00027442686,0.00014762908,0.00018909168,0.00058675575,0.00032786635,0.008239364,0.23066488],"study_design_scores_gemma":[0.0009187124,0.00059535797,0.021986777,0.66865396,0.13227822,0.003164212,0.00047036432,0.00018028707,0.0005627368,0.00079682784,0.17024575,0.00014684713],"about_ca_topic_score_codex":0.0033375414,"about_ca_topic_score_gemma":0.012148292,"teacher_disagreement_score":0.0038197485,"about_ca_system_score_codex":0.0006993768,"about_ca_system_score_gemma":0.0019425211,"threshold_uncertainty_score":0.012778282},"labels":[],"label_agreement":null},{"id":"W3086268953","doi":"10.1007/s10875-020-00860-0","title":"Correction to: A Nonsense N –Terminus NFKB2 Mutation Leading to Haploinsufficiency in a Patient with a Predominantly Antibody Deficiency","year":2020,"lang":"en","type":"erratum","venue":"Journal of Clinical Immunology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Institute of Allergy and Infectious Diseases","keywords":"Haploinsufficiency; Nonsense; Nonsense mutation; Medicine; Medical microbiology; Genetics; Mutation; Biology; Immunology; Missense mutation; Gene; Phenotype","score_opus":0.0214848113097823,"score_gpt":0.33713476711934814,"score_spread":0.31564995580956584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3086268953","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015013423,0.0015637685,0.001276585,0.048026312,0.9427414,0.00003906516,0.0010102983,0.00037693107,0.0034643349],"genre_scores_gemma":[0.08762966,0.011218638,0.01621475,0.082977906,0.5409952,0.00030888783,0.0035104088,0.0023946033,0.25474992],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.99872005,0.00019645052,0.00027382272,0.00023498014,0.00038926778,0.00018540304],"domain_scores_gemma":[0.9934726,0.002731036,0.00049586955,0.00041993777,0.0022314675,0.00064907386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013291972,0.0022900312,0.0015305082,0.0021054628,0.0016644574,0.0019763298,0.0030572684,0.007311224,0.025929898],"category_scores_gemma":[0.01583216,0.00096909987,0.0013841301,0.00085948716,0.0014302003,0.0010927562,0.00093484897,0.007336542,0.0132102035],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023244398,0.000030378387,0.00042064805,0.00038011323,0.00006045084,0.024087643,0.000058683676,0.00015883837,0.0007547341,0.0010380426,0.961832,0.010946023],"study_design_scores_gemma":[0.00023628803,0.0000825094,0.0025812758,0.00037701454,0.00015560284,0.03982797,0.00010680668,0.0008325664,0.0020561586,0.0015334598,0.9521352,0.00007521986],"about_ca_topic_score_codex":0.005538549,"about_ca_topic_score_gemma":0.0054358477,"teacher_disagreement_score":0.025929898,"about_ca_system_score_codex":0.0017425043,"about_ca_system_score_gemma":0.0013816936,"threshold_uncertainty_score":0.08674413},"labels":[],"label_agreement":null},{"id":"W3088566771","doi":"10.1016/j.annonc.2020.08.1260","title":"1137P Incidence and time course of adverse events (AEs) with atezolizumab (A) in combination with vemurafenib (V) and cobimetinib (C) in the phase III IMspire150 study","year":2020,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"F. Hoffmann-La Roche","keywords":"Medicine; Rash; Internal medicine; Gastroenterology; Adverse effect; Diarrhea; Incidence (geometry); Population; Asymptomatic; Placebo; Pathology","score_opus":0.03152753028955441,"score_gpt":0.331205111221538,"score_spread":0.2996775809319836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3088566771","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99008244,0.003823423,0.0005222086,0.00017307121,0.000077745055,0.000101310616,0.002561927,0.000054641463,0.0026032436],"genre_scores_gemma":[0.9950782,0.0007908684,0.00024817226,0.00016918406,0.00004693186,0.00009777634,0.0022715465,0.00001446187,0.001282735],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99956757,0.00016681166,0.000035338806,0.00008838109,0.00007129042,0.000070576134],"domain_scores_gemma":[0.999395,0.00020988459,0.00020447627,0.00004113683,0.00005080515,0.00009873437],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012118102,0.00041613256,0.000976215,0.00016821446,0.00014988914,0.00058003503,0.00024942152,0.00052194914,0.0023637793],"category_scores_gemma":[0.0010159633,0.00025950762,0.0016638293,0.00031575825,0.00016787974,0.00035395974,0.000196282,0.0014645869,0.000371071],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.60251266,0.003070806,0.16863926,0.0014573721,0.012764048,0.0009585708,0.00012166573,0.006911735,0.04655882,0.00054205087,0.01032972,0.14613332],"study_design_scores_gemma":[0.05957231,0.122455314,0.77834034,0.00014991987,0.008797954,0.0022869657,0.00015905782,0.0070173284,0.0075098136,0.00079806073,0.01279814,0.0001147932],"about_ca_topic_score_codex":0.00051411084,"about_ca_topic_score_gemma":0.0012542127,"teacher_disagreement_score":0.0023637793,"about_ca_system_score_codex":0.00032504514,"about_ca_system_score_gemma":0.00032234614,"threshold_uncertainty_score":0.007907629},"labels":[],"label_agreement":null},{"id":"W3088872436","doi":"10.1016/j.annonc.2020.08.1225","title":"1102P Clinical benefit in BRAFV600 mutation-positive melanoma defined by programmed death ligand 1 (PD-L1) and/or lactate dehydrogenase (LDH) status: Exploratory analyses from the IMspire150 study","year":2020,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"F. Hoffmann-La Roche","keywords":"Medicine; Hazard ratio; Internal medicine; Vemurafenib; Lactate dehydrogenase; Gastroenterology; Oncology; Melanoma; Cancer; Confidence interval; Metastatic melanoma; Cancer research","score_opus":0.16536285663747388,"score_gpt":0.4136882348580487,"score_spread":0.2483253782205748,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3088872436","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903155,0.0034763422,0.00020273475,0.00049026805,0.0000588208,0.0000813681,0.0017190942,0.00004435008,0.0036115556],"genre_scores_gemma":[0.99360424,0.0012173433,0.0002779831,0.00044155968,0.000093048766,0.00008765957,0.0031984313,0.000018865714,0.0010608054],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9997241,0.000109274835,0.000012718405,0.0000680151,0.000027777376,0.000058083486],"domain_scores_gemma":[0.9997116,0.00008877137,0.00006310449,0.000024963318,0.00002001445,0.00009149534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089455594,0.00077451,0.00094397087,0.00023956646,0.00015747665,0.0009211948,0.00031155391,0.0005086913,0.0021992496],"category_scores_gemma":[0.00069605716,0.0002334408,0.0012005634,0.00033441343,0.00035853317,0.0004900708,0.00030739675,0.0012188182,0.00053875276],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5370858,0.003416315,0.13793582,0.0016045026,0.009612841,0.0010867696,0.0002181654,0.0062058414,0.04192613,0.001684459,0.013276785,0.24594665],"study_design_scores_gemma":[0.14301647,0.08665995,0.7143935,0.0003651784,0.01266333,0.0024120414,0.00038593158,0.0049960236,0.00552768,0.005394137,0.024011312,0.00017437238],"about_ca_topic_score_codex":0.000416401,"about_ca_topic_score_gemma":0.0017407807,"teacher_disagreement_score":0.0021992496,"about_ca_system_score_codex":0.0004663026,"about_ca_system_score_gemma":0.00039274257,"threshold_uncertainty_score":0.0073572397},"labels":[],"label_agreement":null},{"id":"W3090469545","doi":"10.1200/jco.20.00995","title":"Five-Year Outcomes With Nivolumab in Patients With Wild-Type <i>BRAF</i> Advanced Melanoma","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":227,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; McGill University; University of British Columbia; BC Cancer Agency","funders":"Ono Pharmaceutical; Bristol-Myers Squibb","keywords":"Medicine; Nivolumab; Melanoma; Oncology; Internal medicine; Metastatic melanoma; Ipilimumab; Cancer research; Cancer; Immunotherapy","score_opus":0.029349432258848444,"score_gpt":0.3323646425640745,"score_spread":0.30301521030522605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3090469545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99447244,0.004008486,0.00017471284,0.00015666116,0.00007009682,0.00010938569,0.00021783172,0.000017847733,0.0007726076],"genre_scores_gemma":[0.99790215,0.0007426638,0.00015517602,0.0002988453,0.00008555498,0.000075019896,0.00041645998,0.0000023077298,0.0003219154],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9997154,0.00013631245,0.000018697981,0.000042209427,0.000033133525,0.0000542411],"domain_scores_gemma":[0.99955994,0.0000748393,0.00013755473,0.000021472717,0.000026343594,0.0001798885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014098824,0.00035547267,0.0007294021,0.00016450012,0.00024702153,0.00046454062,0.00022879249,0.00054266735,0.00073599815],"category_scores_gemma":[0.000708806,0.00009167093,0.00092480885,0.00014092178,0.00028570282,0.0003004181,0.00016510685,0.0007846368,0.00011970378],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.57815516,0.010946731,0.15012482,0.0009763404,0.002908408,0.00042690325,0.0002080607,0.009112482,0.023559371,0.00030121033,0.0047001974,0.21858037],"study_design_scores_gemma":[0.12168873,0.5810955,0.2769516,0.00022243355,0.0023370672,0.0007627003,0.00010643387,0.004900011,0.005323123,0.0004013269,0.0061540576,0.000056933557],"about_ca_topic_score_codex":0.0005761162,"about_ca_topic_score_gemma":0.0014295555,"teacher_disagreement_score":0.0014098824,"about_ca_system_score_codex":0.00047622502,"about_ca_system_score_gemma":0.00039757832,"threshold_uncertainty_score":0.0074563026},"labels":[],"label_agreement":null},{"id":"W3097226470","doi":"10.1186/s12915-020-00895-0","title":"TRIM25 promotes Capicua degradation independently of ERK in the absence of ATXN1L","year":2020,"lang":"en","type":"article","venue":"BMC Biology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; Canada's Michael Smith Genome Sciences Centre; Simon Fraser University; University of British Columbia; BC Cancer Agency","funders":"Canadian Institutes of Health Research; BC Cancer Foundation","keywords":"Biology; MAPK/ERK pathway; Ubiquitin ligase; Transcription factor; Cell biology; Ubiquitin; Protein kinase A; Protein degradation; Proteasome; Cancer research; Downregulation and upregulation; Signal transduction; Kinase; Genetics; Gene","score_opus":0.03512778592242114,"score_gpt":0.26047648144950186,"score_spread":0.22534869552708073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097226470","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947615,0.001633018,0.0010101452,0.00012009071,0.000046292913,0.000017447826,0.0003761465,0.000085895794,0.0019495473],"genre_scores_gemma":[0.99612147,0.00029509538,0.00054310163,0.00004962175,0.0000063352377,0.000020240403,0.00047136596,0.000012809217,0.002480066],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998877,0.00002062979,0.000010895445,0.000022841436,0.000025963776,0.000032017353],"domain_scores_gemma":[0.9998591,0.000017965023,0.00004080124,0.000020012172,0.000012942116,0.00004917469],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018266142,0.00018926877,0.00016043932,0.00017011311,0.00015233268,0.00024684094,0.00025676936,0.00023386118,0.002574676],"category_scores_gemma":[0.00013635244,0.000092400776,0.00021532377,0.00008786111,0.00020716562,0.00013343757,0.00022531577,0.00037926034,0.00077623787],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003665519,0.00004628096,0.0002818726,0.000074778036,0.000008379357,0.00012997059,0.00001346149,0.00007098983,0.99777263,0.00009149606,0.00019290944,0.0009506743],"study_design_scores_gemma":[0.000027409558,0.00031396115,0.010852618,0.000011697667,0.000014419339,0.0004536805,0.000051943865,0.0013222765,0.98398584,0.000052914744,0.0029077963,0.0000054451625],"about_ca_topic_score_codex":0.00080222887,"about_ca_topic_score_gemma":0.0014782703,"teacher_disagreement_score":0.002574676,"about_ca_system_score_codex":0.00034827838,"about_ca_system_score_gemma":0.0002102739,"threshold_uncertainty_score":0.008613169},"labels":[],"label_agreement":null},{"id":"W3103606205","doi":"10.1136/jitc-2020-sitc2020.0307","title":"307 Atezolizumab plus vemurafenib and cobimetinib provides favorable survival outcomes in patients with high tumor mutation burden and proinflammatory gene signature in the phase 3 IMspire150 study","year":2020,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"Pritzker School of Medicine; American Society of Hematology","keywords":"Vemurafenib; Internal medicine; Medicine; Atezolizumab; Hazard ratio; Oncology; Progression-free survival; Melanoma; Pembrolizumab; Immunotherapy; Cancer research; Cancer; Overall survival; Metastatic melanoma; Confidence interval","score_opus":0.00991258563327047,"score_gpt":0.21943228970482428,"score_spread":0.20951970407155382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3103606205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968809,0.0009569397,0.00013084506,0.00022013317,0.00006855277,0.00019081523,0.0007319091,0.000018586381,0.0008013661],"genre_scores_gemma":[0.99660265,0.00036145272,0.00028433264,0.00044525234,0.00012013424,0.0002189029,0.0014757871,0.000007107031,0.000484353],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99965084,0.00017217633,0.000022782035,0.000057169033,0.000030846295,0.000066138935],"domain_scores_gemma":[0.9995758,0.00007084593,0.00010103287,0.000052511426,0.00002916022,0.00017057794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013747036,0.0005611978,0.001259735,0.00015478344,0.00026217607,0.0007117881,0.00036102723,0.0005106766,0.0021762995],"category_scores_gemma":[0.00060010294,0.0002846688,0.0015209009,0.00021266377,0.00030918996,0.00034135295,0.00025245664,0.001092993,0.00046896175],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8315962,0.010299853,0.061841816,0.00044212234,0.00303867,0.0002495746,0.00009447566,0.0015487641,0.027269462,0.00022423177,0.0077970386,0.055597764],"study_design_scores_gemma":[0.45998493,0.19768913,0.31768113,0.00013614832,0.005201667,0.0007746153,0.00015164721,0.005009988,0.006068602,0.0008308642,0.0063340426,0.00013730646],"about_ca_topic_score_codex":0.0005968795,"about_ca_topic_score_gemma":0.001994019,"teacher_disagreement_score":0.0021762995,"about_ca_system_score_codex":0.00043969663,"about_ca_system_score_gemma":0.000724222,"threshold_uncertainty_score":0.0072804093},"labels":[],"label_agreement":null},{"id":"W3107364439","doi":"10.1097/der.0000000000000670","title":"Treatment of Checkpoint Inhibitor–Induced Vitiligo in a Patient with Metastatic Renal Cell Cancer","year":2020,"lang":"en","type":"article","venue":"Dermatitis","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Vitiligo; Dermatology; Skin cancer; Medical school; Cancer; Family medicine; Internal medicine; Medical education","score_opus":0.01574324815981502,"score_gpt":0.22528239601845876,"score_spread":0.20953914785864375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3107364439","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95326436,0.005619739,0.0013725989,0.010453441,0.00037551258,0.00022938385,0.0003133841,0.00015110681,0.02822066],"genre_scores_gemma":[0.9948565,0.0009205555,0.0003772271,0.0012977513,0.00014836284,0.000009846025,0.00007075002,0.0000076055526,0.0023113869],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99984634,0.000023183346,0.000013446338,0.000027552493,0.000030941577,0.00005846407],"domain_scores_gemma":[0.9997451,0.00007119973,0.000033508884,0.000012087843,0.000014940508,0.00012319269],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022691155,0.00041676537,0.0004611021,0.00062624994,0.0011637321,0.0006125158,0.00048335237,0.0023871288,0.0018404584],"category_scores_gemma":[0.0007177089,0.00029065422,0.00070291053,0.00039251242,0.00040592984,0.0004724818,0.00027959133,0.0018303485,0.00040512191],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044414328,0.00040588286,0.021359542,0.00007122556,0.000051291518,0.9592742,0.00019570382,0.000582864,0.003967718,0.00066645956,0.0017635818,0.011217456],"study_design_scores_gemma":[0.00018995439,0.0011673323,0.060304534,0.00006970419,0.00007641926,0.929047,0.00023523754,0.0027241635,0.0019107495,0.0005857279,0.0036622663,0.00002686962],"about_ca_topic_score_codex":0.0036944672,"about_ca_topic_score_gemma":0.007850335,"teacher_disagreement_score":0.0036944672,"about_ca_system_score_codex":0.0014719891,"about_ca_system_score_gemma":0.00074957503,"threshold_uncertainty_score":0.010680139},"labels":[],"label_agreement":null},{"id":"W3112196266","doi":"10.1093/neuonc/noaa222.624","title":"NURS-04. COMBINATION OF NEURO-ONCOLOGY AND DERMATOLOGY CLINICS IMPROVE THE MANAGEMENT AND KNOWLEDGE OF SKIN-RELATED TOXICITIES WITH MEK AND BRAF TARGETED THERAPY","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Dermatology; Oncology nursing; Oncology; Internal medicine; Nursing; Nurse education","score_opus":0.012253833091315423,"score_gpt":0.2562277906902607,"score_spread":0.24397395759894527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112196266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.44318488,0.0030418786,0.010059211,0.20165733,0.014719171,0.007922557,0.0028924854,0.0018792263,0.31464317],"genre_scores_gemma":[0.6926308,0.00505989,0.05411222,0.084259875,0.0013176478,0.010295101,0.0021590728,0.0005242986,0.14964108],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99709296,0.0015229194,0.0001353133,0.00019447131,0.00054186775,0.0005125049],"domain_scores_gemma":[0.9785169,0.0008080127,0.0007319814,0.00031270518,0.0032255459,0.016404849],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038150807,0.0002588893,0.00029189556,0.00040504406,0.003639018,0.0018999134,0.0010425404,0.00089407456,0.038122308],"category_scores_gemma":[0.008850262,0.00040589503,0.0005423837,0.00025333505,0.0007547418,0.0014277657,0.004173311,0.0032843158,0.007971047],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016884506,0.007338731,0.038920682,0.0008728783,0.00003975283,0.000502329,0.010580695,0.0002486529,0.0008241763,0.0016179265,0.5080636,0.43082175],"study_design_scores_gemma":[0.00077057345,0.0044605155,0.09391895,0.002534287,0.000091750124,0.001787951,0.06287166,0.0015603629,0.0022016766,0.004860634,0.8247499,0.00019175584],"about_ca_topic_score_codex":0.004051474,"about_ca_topic_score_gemma":0.014439056,"teacher_disagreement_score":0.038122308,"about_ca_system_score_codex":0.0034776868,"about_ca_system_score_gemma":0.017920475,"threshold_uncertainty_score":0.12753177},"labels":[],"label_agreement":null},{"id":"W3113132520","doi":"10.1016/j.annonc.2020.12.004","title":"Cobimetinib plus atezolizumab in BRAFV600 wild-type melanoma: primary results from the randomized phase III IMspire170 study","year":2020,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":99,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"Genentech; F. Hoffmann-La Roche","keywords":"Atezolizumab; Medicine; Internal medicine; Oncology; Cancer; Pembrolizumab; Immunotherapy","score_opus":0.06816358705992281,"score_gpt":0.3451095596220558,"score_spread":0.276945972562133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113132520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9807488,0.009430953,0.0006919258,0.0011351897,0.00045440893,0.00082307827,0.0019199654,0.00014826751,0.0046474156],"genre_scores_gemma":[0.9834396,0.005114849,0.001026345,0.0015114736,0.00035503105,0.00086881267,0.0034181774,0.000056691533,0.004209106],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9997228,0.000113695336,0.000010796272,0.000046380574,0.000026311802,0.00007997536],"domain_scores_gemma":[0.9996786,0.00006985811,0.00007151639,0.000028428622,0.000024766912,0.00012678996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012109875,0.0013461252,0.0019101723,0.00024740383,0.00026452067,0.0011310606,0.00060322107,0.00075825915,0.0035651897],"category_scores_gemma":[0.00074648275,0.00043626287,0.0018124112,0.00029503982,0.00051336776,0.0009252107,0.00027921784,0.0029441016,0.0010106032],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8560134,0.007704627,0.0034552384,0.0015316445,0.0036024866,0.00011424765,0.00009089439,0.0024127103,0.012091805,0.0005499103,0.00830747,0.10412553],"study_design_scores_gemma":[0.856226,0.11522109,0.014928111,0.00014486596,0.0030880638,0.00028883628,0.00010566849,0.0020389669,0.0020048802,0.00074980047,0.0051507894,0.000052936906],"about_ca_topic_score_codex":0.0009009779,"about_ca_topic_score_gemma":0.0033342582,"teacher_disagreement_score":0.0035651897,"about_ca_system_score_codex":0.00087612827,"about_ca_system_score_gemma":0.0008367347,"threshold_uncertainty_score":0.01192677},"labels":[],"label_agreement":null},{"id":"W3114062763","doi":"10.3390/curroncol28010021","title":"A Rare p.T599dup BRAF Mutant NSCLC in a Non-Smoker","year":2020,"lang":"en","type":"article","venue":"Current Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Kinase; Cancer research; Mutation; Lung cancer; Targeted therapy; Fibrosarcoma; MAPK/ERK pathway; Mutant; non-small cell lung cancer (NSCLC); Cancer; Oncogene; MEK inhibitor; Oncology; Biology; Internal medicine; Genetics; Gene; Pathology; Cell cycle; A549 cell","score_opus":0.058268392822122296,"score_gpt":0.3323510831691569,"score_spread":0.2740826903470346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3114062763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9852328,0.00252371,0.0022262095,0.0021149372,0.00029244562,0.00014417969,0.0003391414,0.0001845881,0.0069420068],"genre_scores_gemma":[0.9962543,0.0007071378,0.000733507,0.0004960332,0.00023454915,0.00001560112,0.00009444604,0.000026462129,0.0014379597],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9995665,0.000030255254,0.000052718016,0.00014794317,0.0000866347,0.0001159849],"domain_scores_gemma":[0.9990895,0.00019951996,0.0001995051,0.000058004338,0.00006916557,0.00038428706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022325049,0.0012414644,0.001063753,0.0015990554,0.0015704191,0.00078397687,0.0010134358,0.003776976,0.0023974788],"category_scores_gemma":[0.0016111057,0.0006739262,0.0011299084,0.0007885198,0.0010334157,0.0010964851,0.0009183174,0.0020943435,0.00094484014],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023418284,0.000014041989,0.0033868365,0.000014314641,0.000003371781,0.9947796,0.000055254084,0.000024313664,0.0010164852,0.000044679684,0.00010088772,0.00053683517],"study_design_scores_gemma":[0.0000029254084,0.000055758064,0.004526727,0.0000069639077,0.000005414252,0.994695,0.00004359297,0.00009950401,0.00031315212,0.00005337965,0.0001920712,0.0000055360592],"about_ca_topic_score_codex":0.002635221,"about_ca_topic_score_gemma":0.0037893453,"teacher_disagreement_score":0.003776976,"about_ca_system_score_codex":0.0007321038,"about_ca_system_score_gemma":0.0005328656,"threshold_uncertainty_score":0.008020341},"labels":[],"label_agreement":null},{"id":"W3115651269","doi":"10.1158/1078-0432.ccr-20-2563","title":"LXH254, a Potent and Selective ARAF-Sparing Inhibitor of BRAF and CRAF for the Treatment of MAPK-Driven Tumors","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":88,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mood Disorders Association of British Columbia; Aegera Therapeutics (Canada)","funders":"","keywords":"Neuroblastoma RAS viral oncogene homolog; KRAS; In vivo; Biology; Cancer research; Mutant; MAPK/ERK pathway; Kinase; Cell culture; Mutation; Cell biology; Genetics; Gene","score_opus":0.19876116464915,"score_gpt":0.45473027212063105,"score_spread":0.25596910747148105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3115651269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9831467,0.0064404425,0.0045759557,0.00025153792,0.000051781804,0.00021928441,0.00061491446,0.0002347735,0.0044644647],"genre_scores_gemma":[0.9901164,0.0021290954,0.0032318933,0.00008479742,0.000021345013,0.00008223113,0.000708873,0.00001713539,0.0036081101],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99992216,0.00001412177,0.000006117097,0.00001442556,0.000025204468,0.000018038452],"domain_scores_gemma":[0.9999633,0.000004160378,0.00000908043,0.0000051500865,0.000004271123,0.000014042844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018125557,0.00047974332,0.00025994718,0.00023367573,0.00012687464,0.00021289282,0.00029994844,0.00028750955,0.0013741925],"category_scores_gemma":[0.00006103341,0.0001353498,0.0002896396,0.00011154539,0.00016677295,0.00015153906,0.00014123482,0.00060552,0.00045195187],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034193284,0.00013695953,0.00031919172,0.00007856775,0.00001781968,0.000120614524,0.000010452128,0.00027598464,0.99012357,0.00014656426,0.00019809653,0.008230277],"study_design_scores_gemma":[0.00029344033,0.00338637,0.0029955502,0.000008385295,0.00004386396,0.0013013126,0.000013772691,0.00085704617,0.9847131,0.000058507176,0.0063156397,0.0000129848595],"about_ca_topic_score_codex":0.00029564014,"about_ca_topic_score_gemma":0.000935262,"teacher_disagreement_score":0.0013741925,"about_ca_system_score_codex":0.00029798827,"about_ca_system_score_gemma":0.00033660268,"threshold_uncertainty_score":0.0045971274},"labels":[],"label_agreement":null},{"id":"W3117376274","doi":"10.2147/jir.s284471","title":"Repurposing FDA Approved Drugs as JNK3 Inhibitor for Prevention of Neuroinflammation Induced by MCAO in Rats","year":2020,"lang":"en","type":"article","venue":"Journal of Inflammation Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":31,"is_retracted":true,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Riphah International University","keywords":"Medicine; Pharmacology; Neuroprotection; Drug repositioning; Neuroinflammation; Dabigatran; Pitavastatin; Brain ischemia; Ischemia; Anesthesia; Drug; Internal medicine; Inflammation; Atorvastatin; Warfarin","score_opus":0.05871791790637751,"score_gpt":0.35316671300971425,"score_spread":0.29444879510333677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3117376274","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888108,0.0046770754,0.0027579435,0.0002667122,0.0000928604,0.0000983905,0.0009581729,0.00016403242,0.0021739379],"genre_scores_gemma":[0.982323,0.006827902,0.0058094678,0.00023747934,0.000024722915,0.00016396727,0.0013493962,0.00003655406,0.0032274819],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999348,0.0000058099913,0.0000051996103,0.000012420952,0.000019506213,0.000022201057],"domain_scores_gemma":[0.99994946,0.000003846721,0.000019299423,0.000003690606,0.000007793998,0.000015925521],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012117389,0.00048924884,0.0006286507,0.00045189308,0.00019263281,0.00018997012,0.0002843406,0.00023387768,0.002977285],"category_scores_gemma":[0.000107817265,0.00014380884,0.00058766815,0.000258078,0.00017658208,0.00026162548,0.0001623991,0.00069073203,0.00035305973],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037266726,0.0023913688,0.0012237394,0.000724971,0.00010314824,0.00032185126,0.000042355292,0.0016917795,0.96054024,0.00048711585,0.0010958518,0.02765094],"study_design_scores_gemma":[0.00060880114,0.015011334,0.006306109,0.00008246672,0.00033689846,0.00048138553,0.00008826395,0.006484333,0.9601113,0.00032177474,0.010124759,0.00004247501],"about_ca_topic_score_codex":0.0005612262,"about_ca_topic_score_gemma":0.0010977738,"teacher_disagreement_score":0.002977285,"about_ca_system_score_codex":0.00017458179,"about_ca_system_score_gemma":0.0003765693,"threshold_uncertainty_score":0.009959996},"labels":[],"label_agreement":null},{"id":"W3126538193","doi":"10.1007/s00432-021-03545-2","title":"Personalized oncology and BRAFK601N melanoma: model development, drug discovery, and clinical correlation","year":2021,"lang":"en","type":"article","venue":"Journal of Cancer Research and Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Ottawa Regional Cancer Foundation; University of Ottawa","funders":"Natural Sciences and Engineering Research Council of Canada; Institute of Cancer Research; Terry Fox Research Institute","keywords":"Melanoma; Medicine; Cancer research; Trametinib; Oncology; Internal medicine; MEK inhibitor; Hematology; Drug development; Drug; Pharmacology; Biology; MAPK/ERK pathway; Genetics","score_opus":0.13277753751436236,"score_gpt":0.49654022204450077,"score_spread":0.3637626845301384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3126538193","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.78062,0.05019576,0.11070956,0.030521454,0.00046179412,0.0007227093,0.0031584878,0.0007350311,0.022875259],"genre_scores_gemma":[0.96934164,0.011503632,0.015916433,0.00091424887,0.00010942152,0.00015073709,0.00065406127,0.000023717927,0.001386062],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988795,0.0006684407,0.000037653313,0.00016440709,0.00017992109,0.00007007093],"domain_scores_gemma":[0.9982608,0.0010188168,0.0003127412,0.00018360648,0.00011964113,0.0001045149],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002883981,0.0007810065,0.0010356954,0.0007023749,0.0003149669,0.0024454007,0.00087633735,0.0010953727,0.0021219098],"category_scores_gemma":[0.004119995,0.00035656267,0.0007155283,0.0007834313,0.00084551645,0.0013815607,0.00086119806,0.0018966293,0.000371551],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007549263,0.005250926,0.13164642,0.0025891704,0.0020029673,0.0020026695,0.00029532856,0.2513608,0.05934063,0.116587915,0.01453844,0.40683544],"study_design_scores_gemma":[0.0015149268,0.008659162,0.054234285,0.00054211967,0.0017856789,0.004428014,0.00042327965,0.63557845,0.040160667,0.21064575,0.04179701,0.00023062069],"about_ca_topic_score_codex":0.0022812963,"about_ca_topic_score_gemma":0.0038508007,"teacher_disagreement_score":0.002883981,"about_ca_system_score_codex":0.0022594386,"about_ca_system_score_gemma":0.003088115,"threshold_uncertainty_score":0.016393423},"labels":[],"label_agreement":null},{"id":"W3126869189","doi":"10.1016/j.hoc.2020.09.005","title":"Advanced Melanoma","year":2020,"lang":"en","type":"review","venue":"Hematology/Oncology Clinics of North America","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Bristol-Myers Squibb Canada; National Heart, Lung, and Blood Institute; National Cancer Institute; National Institutes of Health; Merck; Bristol-Myers Squibb","keywords":"Melanoma; Acquired resistance; Medicine; Innate immune system; Metastatic melanoma; Cancer research; Immunology; Cancer; Immune system; Internal medicine","score_opus":0.031864286746907264,"score_gpt":0.3485917963956079,"score_spread":0.3167275096487006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3126869189","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00044898887,0.97331434,0.0005737181,0.0009123281,0.001946049,0.000031698397,0.00011107458,0.00008090957,0.022580914],"genre_scores_gemma":[0.005630039,0.9561014,0.00092739944,0.0022962803,0.0016398042,0.000040733703,0.00044944626,0.000013748222,0.032901123],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999298,0.000009568444,0.000005065732,0.00001791903,0.000024279456,0.000013387997],"domain_scores_gemma":[0.9999082,0.000021707485,0.000014182009,0.0000061016012,0.000025312756,0.000024474746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016350445,0.00068023335,0.0005529836,0.001077072,0.00025019463,0.0006227342,0.0004085193,0.00066086935,0.015446574],"category_scores_gemma":[0.0003609909,0.00014785651,0.00029635298,0.0006414357,0.00018442444,0.0005102458,0.0005468011,0.0013362227,0.008910024],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049340262,0.000035080568,0.00016793305,0.0017175528,0.00001818634,0.00023307724,0.00001077472,0.00009889802,0.0011936035,0.0012782076,0.111827366,0.88337004],"study_design_scores_gemma":[0.00002877633,0.000060920363,0.0007599303,0.0011545884,0.000040207422,0.002229588,0.00001530226,0.00006901964,0.00043343028,0.00068857154,0.9945135,0.000006111854],"about_ca_topic_score_codex":0.0009327871,"about_ca_topic_score_gemma":0.003390618,"teacher_disagreement_score":0.015446574,"about_ca_system_score_codex":0.00033585948,"about_ca_system_score_gemma":0.00049509236,"threshold_uncertainty_score":0.05167395},"labels":[],"label_agreement":null},{"id":"W3127097750","doi":"10.1158/2159-8290.cd-20-1050","title":"Mutations in the RAS/MAPK Pathway Drive Replication Repair–Deficient Hypermutated Tumors and Confer Sensitivity to MEK Inhibition","year":2021,"lang":"en","type":"article","venue":"Cancer Discovery","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Mount Sinai Hospital; University Health Network; University of Toronto; Alberta Cancer Foundation; Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"Stand Up To Cancer; Ontario Genomics Institute; Government of Canada; Canadian Institutes of Health Research; Ontario Genomics; Genome Canada; National Cancer Institute; Entertainment Industry Foundation; Garron Family Cancer Centre; American Association for Cancer Research; Bristol-Myers Squibb; Government of Ontario","keywords":"Mutation; MAPK/ERK pathway; Genetics; Cancer research; Biology; Replication (statistics); Cell biology; Signal transduction; Gene; Virology","score_opus":0.013850318711776386,"score_gpt":0.25563188791150726,"score_spread":0.24178156919973087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3127097750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99731463,0.00034770244,0.0006071277,0.000054084325,0.000010927225,0.000018644045,0.00025370158,0.000059365804,0.001333684],"genre_scores_gemma":[0.9973242,0.00018985325,0.0009399317,0.00002867993,0.0000038782205,0.00001331194,0.00029012727,0.000017055436,0.0011927827],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998248,0.000028528117,0.00002074224,0.00002369245,0.000062693325,0.000039602233],"domain_scores_gemma":[0.99986434,0.000034590452,0.000031071562,0.00001651858,0.0000101772575,0.000043234148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010986933,0.00023332352,0.00018081212,0.00029136892,0.000109408065,0.00023989035,0.00018344492,0.00022647755,0.0017100403],"category_scores_gemma":[0.00012734516,0.00014979954,0.000149721,0.00015679716,0.0001570617,0.000103037055,0.00023384043,0.00048892974,0.00043107022],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049910646,0.000036002806,0.00030483754,0.000010321138,0.00000411344,0.0000651291,0.000006392236,0.0000842854,0.9984487,0.00009158268,0.000047349677,0.00085128285],"study_design_scores_gemma":[0.000018082306,0.00045588613,0.0070924065,0.0000047142585,0.000009264411,0.0011734763,0.000025068597,0.0016880172,0.98818797,0.00005901228,0.0012814531,0.0000047670683],"about_ca_topic_score_codex":0.0006979017,"about_ca_topic_score_gemma":0.00093361485,"teacher_disagreement_score":0.0017100403,"about_ca_system_score_codex":0.00031032605,"about_ca_system_score_gemma":0.00016138969,"threshold_uncertainty_score":0.0057206154},"labels":[],"label_agreement":null},{"id":"W3128792891","doi":"10.1016/j.annonc.2021.01.065","title":"A phase II randomized trial of cobimetinib plus chemotherapy, with or without atezolizumab, as first-line treatment for patients with locally advanced or metastatic triple-negative breast cancer (COLET): primary analysis","year":2021,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":88,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"Exelixis; Genentech; F. Hoffmann-La Roche","keywords":"Atezolizumab; Medicine; Triple-negative breast cancer; Internal medicine; Tolerability; Oncology; Taxane; Cohort; Breast cancer; Cancer; Adverse effect; Immunotherapy; Pembrolizumab","score_opus":0.035305087332164566,"score_gpt":0.3644163185437791,"score_spread":0.3291112312116145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3128792891","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870728,0.0023656308,0.00041718248,0.0006696218,0.00032238595,0.0055476977,0.0017147092,0.000085669664,0.0018041984],"genre_scores_gemma":[0.9856031,0.0019255119,0.0012268652,0.0010897053,0.00031987546,0.0044604437,0.0023269805,0.000023145769,0.0030243637],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99957067,0.00020529678,0.000021129477,0.00009524697,0.000029961499,0.00007774735],"domain_scores_gemma":[0.99888533,0.0001888975,0.0002523994,0.000092330425,0.00006207106,0.0005189618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014891111,0.0018301203,0.0023607463,0.00041891728,0.0004083114,0.0012379999,0.000784275,0.0013512321,0.00416399],"category_scores_gemma":[0.0013757253,0.0007625111,0.0025478362,0.0003676458,0.0011003803,0.0007928518,0.00045074633,0.0032120005,0.0006765211],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97707593,0.007801384,0.0013887795,0.00036165753,0.0011113468,0.000051026625,0.00004392524,0.0003116479,0.003915208,0.000069128684,0.00089421857,0.0069757374],"study_design_scores_gemma":[0.93008614,0.064385064,0.0033435312,0.000018328175,0.0007535342,0.000055062428,0.000019778947,0.0003163408,0.0004790031,0.00008868935,0.0004399998,0.000014504451],"about_ca_topic_score_codex":0.001707587,"about_ca_topic_score_gemma":0.005367752,"teacher_disagreement_score":0.00416399,"about_ca_system_score_codex":0.0011277744,"about_ca_system_score_gemma":0.0015455929,"threshold_uncertainty_score":0.0139299035},"labels":[],"label_agreement":null},{"id":"W3134877629","doi":"10.1177/1534735421990078","title":"Current Advancements and Novel Strategies in the Treatment of Metastatic Melanoma","year":2021,"lang":"en","type":"review","venue":"Integrative Cancer Therapies","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Windsor","funders":"","keywords":"Medicine; Melanoma; Ipilimumab; Vemurafenib; Cancer; Oncology; Radiation therapy; Targeted therapy; Clinical trial; Skin cancer; Internal medicine; Intensive care medicine; Metastatic melanoma; Immunotherapy; Cancer research","score_opus":0.07854031110835175,"score_gpt":0.3955977993313937,"score_spread":0.31705748822304197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134877629","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017619677,0.997758,0.00021895966,0.00026758638,0.00017836828,0.000007472443,0.000020508802,0.000010848167,0.0013620926],"genre_scores_gemma":[0.0008702783,0.99798656,0.00027776623,0.00016668272,0.00011128289,0.0000080236005,0.000030753028,0.0000016751758,0.00054704834],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998405,0.000028327995,0.000021670543,0.000031698994,0.000059152768,0.000018627343],"domain_scores_gemma":[0.9998555,0.00006501072,0.000019740415,0.000005455337,0.000038708025,0.000015525951],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046000502,0.00067767524,0.00088400935,0.0018864225,0.0002873076,0.0007997025,0.0007280261,0.00078596995,0.004182522],"category_scores_gemma":[0.00044399887,0.00021809501,0.000565921,0.0013195387,0.00038472682,0.0011798183,0.00053598307,0.0020677713,0.0018185645],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000092591334,0.00014296052,0.00014663152,0.020794956,0.0000746741,0.00027194544,0.00008910266,0.000549392,0.005354168,0.0062265946,0.01849091,0.94776607],"study_design_scores_gemma":[0.000018869947,0.00016742347,0.00057677453,0.002679229,0.00009680093,0.0011700952,0.0000622226,0.00012643755,0.0010908026,0.002397396,0.99159676,0.000017294024],"about_ca_topic_score_codex":0.0006762101,"about_ca_topic_score_gemma":0.0016646739,"teacher_disagreement_score":0.004182522,"about_ca_system_score_codex":0.00051028177,"about_ca_system_score_gemma":0.00079312496,"threshold_uncertainty_score":0.013991892},"labels":[],"label_agreement":null},{"id":"W3156993746","doi":"10.1097/md9.0000000000000080","title":"Acute liver failure caused by metastatic malignant melanoma of liver","year":2021,"lang":"en","type":"article","venue":"Medicine Case Reports and Study Protocols","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CAE (Canada)","funders":"","keywords":"Medicine; Liver transplantation; Malignancy; Melanoma; Liver biopsy; Jaundice; Transplantation; Contraindication; Biopsy; Radiology; Surgery; Pathology","score_opus":0.024654315077299746,"score_gpt":0.29679260924580775,"score_spread":0.272138294168508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3156993746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9604821,0.012847627,0.0022702324,0.0014812531,0.00026505292,0.0003097589,0.0002733274,0.00021833622,0.021852234],"genre_scores_gemma":[0.9968849,0.0014997966,0.00033306173,0.00019241679,0.00016649062,0.000023019798,0.00007068539,0.000006849381,0.0008227829],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99971694,0.00007553832,0.000027679283,0.0000419946,0.000053014865,0.00008487132],"domain_scores_gemma":[0.999342,0.00011970837,0.0002260355,0.000075082884,0.000046245223,0.00019093601],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027095174,0.0005998156,0.00043403945,0.0007319783,0.00096606096,0.00060386676,0.00032870928,0.0007968977,0.0027771879],"category_scores_gemma":[0.00133105,0.00020894405,0.00031486753,0.00049061415,0.00052209495,0.0006370358,0.00066944235,0.0008421535,0.0006112022],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002240649,0.00007827741,0.045256708,0.0003216019,0.00002195716,0.9372835,0.00028203675,0.00011173055,0.0044002756,0.0007227798,0.0016419968,0.009655034],"study_design_scores_gemma":[0.000023572451,0.0001400378,0.016523082,0.00007572245,0.000023068378,0.97779125,0.0001652606,0.00022847018,0.0014457245,0.0003147853,0.0032596004,0.000009459715],"about_ca_topic_score_codex":0.00074941,"about_ca_topic_score_gemma":0.0007444797,"teacher_disagreement_score":0.0027771879,"about_ca_system_score_codex":0.0004921875,"about_ca_system_score_gemma":0.00033465802,"threshold_uncertainty_score":0.009290636},"labels":[],"label_agreement":null},{"id":"W3160335069","doi":"10.3390/cancers13092282","title":"Defining the Criteria for Reflex Testing for BRAF Mutations in Cutaneous Melanoma Patients","year":2021,"lang":"en","type":"review","venue":"Cancers","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto; Princess Margaret Cancer Centre; University of Alberta; Université Laval; McGill University","funders":"Canadian Institutes of Health Research; Cancer Research Society; Canadian Dermatology Foundation","keywords":"Melanoma; Medicine; Pathogenesis; Mutation; Cancer research; Oncology; Bioinformatics; Dermatology; Internal medicine; Biology; Genetics; Gene","score_opus":0.05549257327763334,"score_gpt":0.35491248685543847,"score_spread":0.2994199135778051,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3160335069","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00028226105,0.991707,0.0007018158,0.0031451555,0.00094885606,0.000031730848,0.0000813613,0.000025848565,0.003075945],"genre_scores_gemma":[0.0034454826,0.98734844,0.0024675268,0.0037220544,0.0007392771,0.0000623773,0.00027189974,0.000011476034,0.001931472],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993575,0.00017267559,0.00015923863,0.0000706607,0.00019993066,0.0000399391],"domain_scores_gemma":[0.998635,0.00072143204,0.00012891069,0.000028509607,0.00042496633,0.000061177845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017453309,0.00059187674,0.0011132557,0.0016273833,0.00024290655,0.0008625655,0.0010921941,0.0014178528,0.0021303713],"category_scores_gemma":[0.0035724724,0.00023245245,0.00071263616,0.00091340014,0.0005685491,0.0012728113,0.0005700627,0.0029496513,0.0015959],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007832738,0.00004667975,0.0008596039,0.012315161,0.000066626315,0.00051585876,0.000103740196,0.00018675123,0.001013071,0.0039394177,0.08346483,0.89740986],"study_design_scores_gemma":[0.000033454187,0.00007373414,0.0030784546,0.019263063,0.00017886554,0.004524802,0.00012332585,0.00012199746,0.00078887615,0.0028379816,0.9689399,0.00003544983],"about_ca_topic_score_codex":0.0015774019,"about_ca_topic_score_gemma":0.0031250669,"teacher_disagreement_score":0.0021303713,"about_ca_system_score_codex":0.0007194853,"about_ca_system_score_gemma":0.0015147063,"threshold_uncertainty_score":0.009230316},"labels":[],"label_agreement":null},{"id":"W3163104866","doi":"10.1503/cmaj.78702","title":"To act or not to act","year":2021,"lang":"en","type":"letter","venue":"Canadian Medical Association Journal","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Sorafenib; Psoriasis; Angiogenesis; Medicine; Vascular endothelial growth factor; Cancer research; Hepatocellular carcinoma; Platelet-derived growth factor receptor; Growth factor; Immunology; Receptor; Internal medicine; VEGF receptors","score_opus":0.01196275540531416,"score_gpt":0.24371330590064616,"score_spread":0.231750550495332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3163104866","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01827718,0.00803783,0.0015844627,0.64580244,0.042105366,0.00016894744,0.0003124524,0.00024740887,0.28346395],"genre_scores_gemma":[0.1955063,0.005431332,0.0012191809,0.48355347,0.031169562,0.00015445534,0.00023329021,0.00010741471,0.282625],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991658,0.00022712692,0.000043825246,0.000105118685,0.00020031232,0.0002577714],"domain_scores_gemma":[0.99905294,0.00025336212,0.000091543334,0.000076175755,0.0002037776,0.00032213237],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000645705,0.0004061096,0.00032362094,0.00024294756,0.0013051741,0.0009599472,0.00051902723,0.005063531,0.03029983],"category_scores_gemma":[0.0049974117,0.000105421226,0.00034734845,0.00016839051,0.0011353937,0.0009409233,0.0006205128,0.0047346274,0.01792337],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035578772,0.00020569518,0.0056895236,0.0002627777,0.000038896727,0.035076585,0.00070807565,0.00023616289,0.0026080539,0.020707266,0.83989143,0.09421977],"study_design_scores_gemma":[0.000064361535,0.000086672524,0.0022496544,0.00020939387,0.000016250424,0.04476142,0.00045932087,0.0004369936,0.0009100496,0.009185068,0.9415854,0.00003540278],"about_ca_topic_score_codex":0.0021246194,"about_ca_topic_score_gemma":0.0025773775,"teacher_disagreement_score":0.03029983,"about_ca_system_score_codex":0.0012330925,"about_ca_system_score_gemma":0.0012005566,"threshold_uncertainty_score":0.10136306},"labels":[],"label_agreement":null},{"id":"W3163843574","doi":"10.1002/cam4.3938","title":"Cardiovascular adverse events associated with BRAF versus BRAF/MEK inhibitor: Cross‐sectional and longitudinal analysis using two large national registries","year":2021,"lang":"en","type":"article","venue":"Cancer Medicine","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Metropolitan University","funders":"","keywords":"Vemurafenib; Medicine; Dabrafenib; Adverse effect; Trametinib; Internal medicine; Odds ratio; Oncology; Cancer; MAPK/ERK pathway; Metastatic melanoma","score_opus":0.037405770399443636,"score_gpt":0.32047314155232587,"score_spread":0.2830673711528822,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3163843574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935328,0.00058620743,0.0006650359,0.00008831994,0.000012267477,0.000061292594,0.0046808305,0.000011559793,0.0003617279],"genre_scores_gemma":[0.99334455,0.0002955964,0.0006627824,0.00007937468,0.00001766455,0.00012821102,0.0053612445,0.000007630626,0.000102889266],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9943467,0.0024755313,0.000855018,0.0012014502,0.0006562299,0.00046516364],"domain_scores_gemma":[0.9858614,0.002596456,0.007434344,0.0016716135,0.0016247409,0.000811415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0075415396,0.00046583478,0.0005820855,0.0019097561,0.0005787682,0.0011395226,0.0007663987,0.00053818844,0.0011793043],"category_scores_gemma":[0.011136991,0.0005480411,0.0017897469,0.0033955988,0.00032488123,0.0010797097,0.0015594006,0.0010371257,0.00027317627],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010499278,0.000029482806,0.9987594,0.000017789947,0.00030994118,0.000018522678,0.000039034912,0.000052202908,0.000030133077,0.000020053383,0.00014322755,0.00047525467],"study_design_scores_gemma":[0.00003766302,0.00012253394,0.998137,0.000025761368,0.00040398855,0.00017519032,0.00020167956,0.00046511457,0.00005735377,0.000025631218,0.00033921617,0.000008848902],"about_ca_topic_score_codex":0.0125108715,"about_ca_topic_score_gemma":0.016300559,"teacher_disagreement_score":0.0125108715,"about_ca_system_score_codex":0.0007836154,"about_ca_system_score_gemma":0.0012129962,"threshold_uncertainty_score":0.03988391},"labels":[],"label_agreement":null},{"id":"W3167698157","doi":"10.1200/jco.2021.39.15_suppl.tps10056","title":"FIREFLY-1: A phase 2 study of the pan-RAF inhibitor DAY101 in pediatric patients with low-grade glioma.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; MAPK/ERK pathway; Cancer; MEK inhibitor; Glioma; Oncology; Internal medicine; Kinase; Adverse effect; Cancer research; Biology; Genetics","score_opus":0.039711479461763115,"score_gpt":0.3844723848679845,"score_spread":0.3447609054062214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3167698157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854183,0.004363317,0.001100792,0.00093803776,0.00018741887,0.0021454378,0.002060907,0.00031009907,0.0034757534],"genre_scores_gemma":[0.9741357,0.0075771175,0.0039039813,0.0013463849,0.00013023122,0.0025412124,0.005515894,0.00010369025,0.0047458555],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99978405,0.00006531155,0.000009272216,0.000039879018,0.00003313195,0.000068397894],"domain_scores_gemma":[0.999754,0.000025724576,0.000037696125,0.000019387138,0.000017364388,0.00014578579],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074996764,0.0019331689,0.0016071927,0.00045349772,0.00030139548,0.0008172367,0.0011685977,0.0012094853,0.0035777655],"category_scores_gemma":[0.0003021222,0.0005821746,0.0012164754,0.00044489212,0.0007511084,0.00085630285,0.0004116183,0.0038695529,0.0012083908],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.29622334,0.12735316,0.0121227,0.002644573,0.0026948443,0.0023897341,0.0009953913,0.0074326536,0.1676232,0.0016002887,0.022297077,0.35662302],"study_design_scores_gemma":[0.33876538,0.60127467,0.017476609,0.00010228044,0.0008697005,0.0027657247,0.0002138752,0.0030828514,0.020414714,0.00042634574,0.014525217,0.00008255605],"about_ca_topic_score_codex":0.0028032905,"about_ca_topic_score_gemma":0.007969399,"teacher_disagreement_score":0.0035777655,"about_ca_system_score_codex":0.0015352892,"about_ca_system_score_gemma":0.002050044,"threshold_uncertainty_score":0.011968851},"labels":[],"label_agreement":null},{"id":"W3168328251","doi":"10.1200/jco.2021.39.15_suppl.e21575","title":"BRAF testing timelines and impact on the starting of systemic treatment.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Vemurafenib; Melanoma; Stage (stratigraphy); Internal medicine; Oncology; Turnaround time; Cancer; Timeline; Retrospective cohort study; Disease; Log-rank test; Metastatic melanoma; Survival analysis; Cancer research","score_opus":0.15285928230950835,"score_gpt":0.4414122225085154,"score_spread":0.28855294019900707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3168328251","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99788195,0.0003924491,0.00013365786,0.00010469007,0.000009499392,0.0000103123275,0.0006824775,0.000009077393,0.0007758119],"genre_scores_gemma":[0.99924314,0.00007951789,0.00008916281,0.000019329982,0.000007840466,0.000009185283,0.00040218447,0.0000042785905,0.00014531925],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998679,0.00035152756,0.00022393686,0.00024515783,0.00025295225,0.00024737013],"domain_scores_gemma":[0.981489,0.0074007995,0.00922194,0.00029329944,0.00083479076,0.00076021353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014354952,0.00015685144,0.00017177337,0.0007472183,0.0002297515,0.00070178375,0.0003579077,0.0003484262,0.004489953],"category_scores_gemma":[0.012468974,0.0001470144,0.00049258035,0.0008966723,0.0002133649,0.0006622889,0.00044792623,0.00048283985,0.0006076664],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004044077,0.000031598902,0.9948013,0.00002534942,0.000026825237,0.0001255192,0.00007089563,0.00013926807,0.000119043936,0.000018358936,0.00019202082,0.004045485],"study_design_scores_gemma":[0.000008190127,0.00035607725,0.99731195,0.000018115137,0.000035447327,0.0005320399,0.00030315845,0.00062566553,0.00024887171,0.000025694064,0.00052816264,0.000006780115],"about_ca_topic_score_codex":0.0026383582,"about_ca_topic_score_gemma":0.0024918078,"teacher_disagreement_score":0.004489953,"about_ca_system_score_codex":0.00058211054,"about_ca_system_score_gemma":0.0005087613,"threshold_uncertainty_score":0.01502043},"labels":[],"label_agreement":null},{"id":"W3170480273","doi":"10.1200/jco.2021.39.15_suppl.tps9596","title":"Multicenter phase I/II trial of encorafenib with and without binimetinib in combination with nivolumab and low-dose ipilimumab in metastatic BRAF-mutant melanoma.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Bristol-Myers Squibb Canada","keywords":"Medicine; Ipilimumab; Nivolumab; Melanoma; Oncology; Internal medicine; Regimen; Immunotherapy; Targeted therapy; Vemurafenib; Cancer research; Metastatic melanoma; Cancer","score_opus":0.046277413154985965,"score_gpt":0.3880112685749552,"score_spread":0.34173385541996926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3170480273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98945695,0.00299533,0.0004472462,0.0007041144,0.0002624858,0.0019745221,0.0018174041,0.000101945865,0.0022399994],"genre_scores_gemma":[0.98623383,0.0019761228,0.0014617356,0.0008679067,0.00017416402,0.001994085,0.0029369786,0.000034305463,0.0043209502],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9996203,0.00017667472,0.00001521316,0.00006990756,0.00002949629,0.0000882224],"domain_scores_gemma":[0.9994276,0.00006883043,0.0001034036,0.000041186926,0.000032647822,0.0003263271],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017331261,0.0016683986,0.0014677759,0.00032909622,0.0004211122,0.001058214,0.00087795506,0.0012707387,0.0045138495],"category_scores_gemma":[0.00071004045,0.00067559007,0.0012978498,0.0003709578,0.0009020288,0.0010433,0.00033549612,0.0028794075,0.00086824526],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.90985286,0.028827213,0.003058882,0.00046534743,0.0012298812,0.00012841311,0.00012451722,0.0013182588,0.016052773,0.00019886014,0.0030531273,0.035689883],"study_design_scores_gemma":[0.73505586,0.25047,0.008841935,0.000032221196,0.0004307526,0.0002018251,0.00006119631,0.0007767283,0.0016794349,0.00016958108,0.0022550265,0.00002546018],"about_ca_topic_score_codex":0.0019215862,"about_ca_topic_score_gemma":0.005290739,"teacher_disagreement_score":0.0045138495,"about_ca_system_score_codex":0.0012809444,"about_ca_system_score_gemma":0.0013296525,"threshold_uncertainty_score":0.01510036},"labels":[],"label_agreement":null},{"id":"W3172501354","doi":"10.1007/978-3-030-71155-9_17","title":"Dual Therapy BRAF Inhibitor Chemotherapy (Dabrafenib + Trametinib Chemotherapy) Induced Peripheral Edema","year":2021,"lang":"en","type":"book-chapter","venue":"Clinical cases in cardiology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University","funders":"","keywords":"Dabrafenib; Trametinib; Medicine; Chemotherapy; Edema; Peripheral edema; Melanoma; Peripheral; Surgery; Internal medicine; Adverse effect; Cancer research; Vemurafenib; Metastatic melanoma; MAPK/ERK pathway","score_opus":0.0670888251642819,"score_gpt":0.3355022469181752,"score_spread":0.2684134217538933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3172501354","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07633154,0.199027,0.03551088,0.02144883,0.014166775,0.00024587262,0.0006388286,0.0011518111,0.6514785],"genre_scores_gemma":[0.22668155,0.06926899,0.01803556,0.010515439,0.004406822,0.00012270942,0.00041383578,0.00022060412,0.67033446],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9999629,0.0000054096204,0.0000027305657,0.000006012922,0.0000162532,0.000006735508],"domain_scores_gemma":[0.9999664,0.000014528976,0.0000044809176,0.0000020558496,0.0000039014144,0.000008562912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007124875,0.0002643525,0.00014569645,0.0002336294,0.00021593171,0.00047185732,0.00025981164,0.0005679747,0.009289545],"category_scores_gemma":[0.0001633966,0.000085661806,0.00021302867,0.00015667804,0.00018401463,0.00036359753,0.00027181776,0.0010537736,0.0026292882],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022525869,0.0002986197,0.0014029086,0.0007413753,0.00003245255,0.106357254,0.00031245363,0.0006164667,0.023910016,0.029754559,0.20545135,0.6308973],"study_design_scores_gemma":[0.000029603721,0.0001739665,0.0027360017,0.0003213504,0.000025269102,0.30097148,0.000109287896,0.0007694051,0.005579301,0.008663026,0.6806036,0.000017594977],"about_ca_topic_score_codex":0.0002777411,"about_ca_topic_score_gemma":0.0007596423,"teacher_disagreement_score":0.009289545,"about_ca_system_score_codex":0.0002636623,"about_ca_system_score_gemma":0.00016143154,"threshold_uncertainty_score":0.03107661},"labels":[],"label_agreement":null},{"id":"W3173018072","doi":"10.1200/jco.2021.39.15_suppl.9523","title":"Effects of baseline lactate dehydrogenase (LDH), interferon gamma (IFN-g) expression, and tumor mutational burden (TMB) on treatment response to first-line atezolizumab (A) + vemurafenib (V) and cobimetinib (C) in <i>BRAF</i><sup>V600</sup> mutation–positive advanced melanoma.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"F. Hoffmann-La Roche","keywords":"Medicine; Hazard ratio; Internal medicine; Lactate dehydrogenase; Atezolizumab; Vemurafenib; Oncology; Cancer; Metastatic melanoma; Pembrolizumab; Immunotherapy; Confidence interval; Enzyme; Biology","score_opus":0.021735436523024704,"score_gpt":0.3452379577453137,"score_spread":0.32350252122228895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3173018072","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990515,0.00023522899,0.00015544945,0.00003500711,0.000005848161,0.000016559703,0.000321173,0.000007572638,0.00017162437],"genre_scores_gemma":[0.9994696,0.000033948076,0.000108872795,0.000015292564,0.0000034747545,0.000017446113,0.00023350678,0.0000015601778,0.00011624682],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993568,0.0003921857,0.000024891164,0.00009351378,0.0000416138,0.00009099974],"domain_scores_gemma":[0.9970847,0.0018717564,0.00046678982,0.00016149342,0.000056624845,0.00035876184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026913339,0.00041395176,0.00046026334,0.0001926633,0.0001092119,0.00046172424,0.00040190358,0.00038326439,0.0017132717],"category_scores_gemma":[0.0027329493,0.00015630365,0.0011542719,0.0001516012,0.0002598208,0.00029405358,0.00023306784,0.00080952904,0.00023205428],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.24399418,0.003086487,0.675228,0.00016660745,0.003562532,0.00014397813,0.00013121217,0.011871869,0.007406058,0.00015244905,0.0010462857,0.053210363],"study_design_scores_gemma":[0.003251565,0.049440425,0.89876646,0.000048288686,0.002327123,0.00037827675,0.000100380006,0.039426856,0.0046828226,0.00048684058,0.0010482855,0.000042732227],"about_ca_topic_score_codex":0.0013843094,"about_ca_topic_score_gemma":0.0015275677,"teacher_disagreement_score":0.0026913339,"about_ca_system_score_codex":0.0005261101,"about_ca_system_score_gemma":0.0004854739,"threshold_uncertainty_score":0.014233291},"labels":[],"label_agreement":null},{"id":"W3173362811","doi":"10.1016/j.celrep.2021.109291","title":"Targeting p130Cas- and microtubule-dependent MYC regulation sensitizes pancreatic cancer to ERK MAPK inhibition","year":2021,"lang":"en","type":"article","venue":"Cell Reports","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute of General Medical Sciences; National Cancer Institute; University of North Carolina; Merck; Deutsche Forschungsgemeinschaft; American Association for Cancer Research; Eli Lilly and Company; American Cancer Society; Doris Duke Charitable Foundation; Pancreatic Cancer Action Network; Lustgarten Foundation; U.S. Department of Defense","keywords":"Pancreatic cancer; KRAS; Synthetic lethality; MAPK/ERK pathway; Cancer research; Biology; Small interfering RNA; Cancer cell; Cell biology; Kinase; Cancer; Mutant; Transfection; Cell culture; Biochemistry; Genetics","score_opus":0.006662341930106495,"score_gpt":0.21556977388780185,"score_spread":0.20890743195769534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3173362811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920169,0.0008101845,0.0028803826,0.00016475556,0.000028608003,0.00003666526,0.00039312046,0.00013968202,0.0035297177],"genre_scores_gemma":[0.994118,0.0006916588,0.002350688,0.000041959967,0.0000052147093,0.000033174932,0.00034130574,0.00001975553,0.0023982162],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999089,0.000010574025,0.00000891503,0.00001851673,0.00003334983,0.000019662273],"domain_scores_gemma":[0.9999597,0.0000068862178,0.000012307661,0.000005735188,0.0000046485475,0.00001076877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008134026,0.00030818113,0.00018878125,0.00017172309,0.00013036554,0.0002646776,0.0001684061,0.00017600635,0.0012167066],"category_scores_gemma":[0.00006440996,0.000110745634,0.0001914939,0.00011516683,0.00013979594,0.00014257412,0.00014159743,0.00057802093,0.00029308264],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004424688,0.000031991152,0.00015797677,0.000018148705,0.0000033069532,0.000026932983,0.000004592047,0.00009039527,0.99832374,0.00007468275,0.00004483964,0.0011790423],"study_design_scores_gemma":[0.0000075524686,0.00011844282,0.0014111632,0.0000015382465,0.0000066117755,0.00015751064,0.0000075246458,0.00059151533,0.9964057,0.000024332328,0.0012664361,0.0000015249299],"about_ca_topic_score_codex":0.00033162592,"about_ca_topic_score_gemma":0.0011451708,"teacher_disagreement_score":0.0012167066,"about_ca_system_score_codex":0.00025449853,"about_ca_system_score_gemma":0.0001969368,"threshold_uncertainty_score":0.004070282},"labels":[],"label_agreement":null},{"id":"W3173401695","doi":"10.1158/1078-0432.ccr-21-0809","title":"5-Year Outcomes with Cobimetinib plus Vemurafenib in <i>BRAF</i> V600 Mutation–Positive Advanced Melanoma: Extended Follow-up of the coBRIM Study","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":182,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"F. Hoffmann-La Roche; Roche","keywords":"Vemurafenib; Medicine; Placebo; Internal medicine; Melanoma; Gastroenterology; Surgery; Metastatic melanoma; Pathology; Cancer research; Cancer","score_opus":0.0778736949624746,"score_gpt":0.4348568937526744,"score_spread":0.3569831987901998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3173401695","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99115527,0.0053061717,0.00026133363,0.00023495467,0.00008907547,0.00022952202,0.0017632679,0.000018827723,0.0009415654],"genre_scores_gemma":[0.9951874,0.0008045188,0.00017586874,0.00028145773,0.00014074155,0.00018479586,0.002647927,0.0000057598854,0.0005716005],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9988715,0.0005640742,0.00008229022,0.00019883749,0.00012932533,0.00015400164],"domain_scores_gemma":[0.9970872,0.00047690366,0.0011582378,0.0002711651,0.0001865047,0.0008200582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044732043,0.0007909725,0.0014563404,0.0003195178,0.00055893604,0.0011724884,0.00058917707,0.0013649474,0.002123832],"category_scores_gemma":[0.0026099277,0.00029785422,0.0031297018,0.00043610422,0.0004000083,0.0007556356,0.00057839736,0.0018502595,0.000379168],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.78103775,0.00576015,0.14883363,0.0008591524,0.011086506,0.0003124931,0.00018444621,0.00263818,0.003812097,0.0001278682,0.0042516147,0.041096136],"study_design_scores_gemma":[0.16109063,0.14084597,0.67390364,0.00034169457,0.013358212,0.0007149058,0.00012437942,0.002681444,0.0020669675,0.00038953344,0.004359004,0.00012361587],"about_ca_topic_score_codex":0.0010181512,"about_ca_topic_score_gemma":0.001755988,"teacher_disagreement_score":0.0044732043,"about_ca_system_score_codex":0.00073355366,"about_ca_system_score_gemma":0.00067499315,"threshold_uncertainty_score":0.023656905},"labels":[],"label_agreement":null},{"id":"W3175668895","doi":"10.1096/fasebj.2018.32.1_supplement.662.21","title":"MK5 and ERK3 play overlapping but distinct roles in regulating cardiac fibroblast function","year":2018,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Montreal Heart Institute","funders":"Heart and Stroke Foundation of Canada","keywords":"Fibroblast; Kinase; Protein kinase A; Cell biology; Chemistry; Molecular biology; Biology; Biochemistry; In vitro","score_opus":0.008919299021695706,"score_gpt":0.2123710715336645,"score_spread":0.20345177251196878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3175668895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98693603,0.0058366377,0.00416833,0.00011329766,0.000026523378,0.000022683531,0.0005053439,0.00003653349,0.0023545797],"genre_scores_gemma":[0.9944443,0.0013024268,0.0021704112,0.000049701175,0.0000127087715,0.000025938309,0.00042514896,0.0000059860827,0.0015633989],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99985945,0.000015333382,0.000016059212,0.000029370698,0.000038440885,0.00004117911],"domain_scores_gemma":[0.99990594,0.000010366043,0.000041014024,0.000006030801,0.0000130733,0.000023518727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016329583,0.0004481622,0.00019637318,0.00018082884,0.00023207729,0.0003889055,0.00025544906,0.00022069682,0.0014528587],"category_scores_gemma":[0.00010545199,0.00012893236,0.00040500122,0.00009632922,0.00019228873,0.0002366057,0.00029590662,0.0002994367,0.00032724347],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062892766,0.000045244302,0.0027112793,0.00022531464,0.000023453551,0.00019620119,0.000046723806,0.00019277917,0.99027574,0.0006888348,0.00010403287,0.004861357],"study_design_scores_gemma":[0.000076532626,0.00055718643,0.09751775,0.00005125032,0.0001420486,0.0013941596,0.00023806025,0.0036593892,0.8879144,0.00040298622,0.008021519,0.000024628802],"about_ca_topic_score_codex":0.0004757153,"about_ca_topic_score_gemma":0.0009089061,"teacher_disagreement_score":0.0014528587,"about_ca_system_score_codex":0.00034578156,"about_ca_system_score_gemma":0.00023114718,"threshold_uncertainty_score":0.004860282},"labels":[],"label_agreement":null},{"id":"W3177280881","doi":"10.1096/fasebj.2019.33.1_supplement.478.9","title":"ERK3‐MK5 Signaling in Murine Ventricular Fibroblasts and its Role in Fibroblast Migration","year":2019,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"Heart and Stroke Foundation of Canada","keywords":"Cell biology; Actin; Fibroblast; Protein kinase A; Kinase; Cytoplasm; Cytoskeleton; Chemistry; Molecular biology; Medicine; Biology; Cell; Biochemistry; In vitro","score_opus":0.00548516689490861,"score_gpt":0.19870412606958124,"score_spread":0.19321895917467263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3177280881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893797,0.0032910744,0.0037345113,0.00008353448,0.000023580596,0.000021561073,0.00086319866,0.000042628475,0.0025602807],"genre_scores_gemma":[0.9922156,0.001097034,0.002538812,0.0000479173,0.000008291981,0.00004032663,0.0005423282,0.000010518226,0.0034992346],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999044,0.000009325471,0.0000110077135,0.000019517565,0.00003028558,0.000025459882],"domain_scores_gemma":[0.9999472,0.0000059964495,0.000020180989,0.000004754524,0.0000057268967,0.000016167887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009636946,0.00025577514,0.00008868815,0.00017632112,0.00015126145,0.00016818287,0.00016741344,0.00020559886,0.0013281209],"category_scores_gemma":[0.00005316839,0.00012114085,0.00016934825,0.00007927029,0.00014937863,0.00011866728,0.00014294767,0.00031515976,0.0003900067],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011114512,0.000015793119,0.00025628982,0.000050400995,0.0000021291085,0.00005946634,0.000018171926,0.000048933736,0.99841785,0.00018568203,0.00003453431,0.000799529],"study_design_scores_gemma":[0.000022519635,0.00031822425,0.012804574,0.000016376369,0.000017583929,0.00045361335,0.000070182614,0.00083537726,0.98134995,0.00010817747,0.003998643,0.0000049277714],"about_ca_topic_score_codex":0.000617738,"about_ca_topic_score_gemma":0.00088011136,"teacher_disagreement_score":0.0013281209,"about_ca_system_score_codex":0.00026479596,"about_ca_system_score_gemma":0.00013193324,"threshold_uncertainty_score":0.00444299},"labels":[],"label_agreement":null},{"id":"W3177660183","doi":"10.1038/s41388-021-01917-z","title":"The newly identified MEK1 tyrosine phosphorylation target MACC1 is druggable by approved MEK1 inhibitors to restrict colorectal cancer metastasis","year":2021,"lang":"en","type":"article","venue":"Oncogene","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Partenariat Canadien Contre Le Cancer; Deutschen Konsortium für Translationale Krebsforschung","keywords":"Metastasis; Phosphorylation; Cancer research; Biology; Colorectal cancer; Tyrosine phosphorylation; Cancer; Cell biology; Genetics","score_opus":0.008646537518098555,"score_gpt":0.24667389127483258,"score_spread":0.23802735375673403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3177660183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92285055,0.056130603,0.00808246,0.0012024208,0.00016844744,0.00014386683,0.001119591,0.0003211756,0.0099809],"genre_scores_gemma":[0.98058367,0.011525978,0.002653398,0.00015947939,0.00003168574,0.00005127857,0.0008233542,0.000024385014,0.0041466705],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99993026,0.000010214422,0.0000044255385,0.000013941928,0.000023551056,0.000017587712],"domain_scores_gemma":[0.99995685,0.0000054133543,0.000012005746,0.000005056678,0.000010004674,0.0000106199195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001282797,0.0003211976,0.0002540481,0.00020946885,0.00014559286,0.00028581618,0.0001702163,0.00017057684,0.0018728675],"category_scores_gemma":[0.000101518635,0.000105368264,0.00019862119,0.00011032214,0.00014808253,0.00016192456,0.0001984739,0.00063621305,0.0003964414],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006193457,0.00013362603,0.0014748193,0.0005089917,0.000058524114,0.00017662255,0.00002774758,0.00094484433,0.95415497,0.001053559,0.0013495346,0.039497357],"study_design_scores_gemma":[0.00018059244,0.0012594454,0.010212625,0.000038652113,0.0001143174,0.001278633,0.00002466381,0.0030842046,0.9369729,0.00031770646,0.046495255,0.000020989874],"about_ca_topic_score_codex":0.000649295,"about_ca_topic_score_gemma":0.0017273098,"teacher_disagreement_score":0.0018728675,"about_ca_system_score_codex":0.00040616654,"about_ca_system_score_gemma":0.000278448,"threshold_uncertainty_score":0.0062653422},"labels":[],"label_agreement":null},{"id":"W3180572238","doi":"10.1158/1538-7445.am2021-1218","title":"Abstract 1218: Targeting B-RAF and checkpoint inhibitor resistant melanoma with RSK inhibitor PMD-026 in pre-clinical models","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Institute of Public Health Inspectors","funders":"","keywords":"Melanoma; Cancer research; Cancer; Kinase; Medicine; MEK inhibitor; Metastasis; Targeted therapy; MAPK/ERK pathway; Mucosal melanoma; Vemurafenib; Immunotherapy; Biology; Internal medicine; Metastatic melanoma","score_opus":0.06307485076322,"score_gpt":0.3681155071778808,"score_spread":0.30504065641466077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3180572238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9699121,0.006371475,0.005541856,0.0010923082,0.00057198806,0.0008735966,0.0048582763,0.00077253714,0.010005853],"genre_scores_gemma":[0.9730003,0.0036882225,0.0054689967,0.00030235894,0.000058591926,0.000758833,0.005271967,0.000065153654,0.011385612],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997675,0.000051547853,0.00001658444,0.000038037284,0.000070171685,0.00005613949],"domain_scores_gemma":[0.9998661,0.000018645364,0.000020232326,0.000021943997,0.000019487266,0.000053575903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038223798,0.0006133231,0.0005190913,0.0003632625,0.0002159966,0.00041509356,0.0006609994,0.000644836,0.0032959308],"category_scores_gemma":[0.00019252485,0.00019782831,0.0005305947,0.00021307134,0.00023366215,0.0004075966,0.00017520848,0.002150809,0.001511851],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026795296,0.00344223,0.00025559618,0.00030724297,0.000043824162,0.00019396374,0.000045432967,0.00091627013,0.97670734,0.0003601287,0.0031683575,0.011880105],"study_design_scores_gemma":[0.0011651006,0.030508451,0.003304785,0.000035723686,0.00008489874,0.00097360695,0.000053526226,0.00394115,0.9413375,0.00020961561,0.018358769,0.000026800442],"about_ca_topic_score_codex":0.0008640853,"about_ca_topic_score_gemma":0.0011588869,"teacher_disagreement_score":0.0032959308,"about_ca_system_score_codex":0.00045505687,"about_ca_system_score_gemma":0.0004412027,"threshold_uncertainty_score":0.011025965},"labels":[],"label_agreement":null},{"id":"W3183659755","doi":"10.1101/2021.07.26.453858","title":"Crosstalk with keratinocytes causes GNAQ oncogene specificity in melanoma","year":2021,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"GNAQ; Melanoma; Cancer research; Melanocyte; Oncogene; Biology; Crosstalk; Signal transduction; Epidermis (zoology); Cell cycle; Cell biology; Cell; Genetics; Mutation; Gene","score_opus":0.012932976784231023,"score_gpt":0.21420643201746833,"score_spread":0.2012734552332373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3183659755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968929,0.00031606798,0.0013747099,0.000056073135,0.000010762426,0.000015249504,0.00008481378,0.000056822257,0.0011924282],"genre_scores_gemma":[0.9978351,0.0001067623,0.0006711159,0.000028983537,0.0000017443307,0.000008660303,0.00006305564,0.00000741273,0.0012771294],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999843,0.000029914154,0.000010010292,0.000036164485,0.000041717863,0.000039123424],"domain_scores_gemma":[0.9999324,0.000007998691,0.00002071553,0.0000119446395,0.0000060780594,0.000020764106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000090595946,0.00025152878,0.00011224801,0.00017988677,0.0001261821,0.00022538024,0.00012290677,0.00023978311,0.001504046],"category_scores_gemma":[0.0000581858,0.00011175491,0.00014486721,0.000076250886,0.00018213358,0.00012456579,0.00028400385,0.00036947321,0.00044082617],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017787324,0.000005277707,0.00012498385,0.0000049665023,0.0000010233662,0.000041476684,0.0000027022165,0.000010252541,0.9995783,0.000036790174,0.000006105746,0.00017030108],"study_design_scores_gemma":[0.0000057345887,0.00014625928,0.0048215557,0.0000025589864,0.000007779659,0.0008532957,0.00003302953,0.00047543723,0.992465,0.00008123028,0.0011056572,0.0000024888368],"about_ca_topic_score_codex":0.0002116027,"about_ca_topic_score_gemma":0.00027049874,"teacher_disagreement_score":0.001504046,"about_ca_system_score_codex":0.00022872638,"about_ca_system_score_gemma":0.00009808921,"threshold_uncertainty_score":0.0050314665},"labels":[],"label_agreement":null},{"id":"W3183839551","doi":"10.1038/s41388-021-01911-5","title":"Targeting mTOR signaling overcomes acquired resistance to combined BRAF and MEK inhibition in BRAF-mutant melanoma","year":2021,"lang":"en","type":"article","venue":"Oncogene","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"National Institute of General Medical Sciences; DOD Peer Reviewed Cancer Research Program; U.S. Department of Health and Human Services; National Cancer Institute; National Institutes of Health; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; U.S. Department of Defense","keywords":"mTORC1; PI3K/AKT/mTOR pathway; Melanoma; Cancer research; PTEN; MAPK/ERK pathway; MEK inhibitor; Biology; Protein kinase B; Signal transduction; Targeted therapy; Cell growth; Cancer; Cell biology; Biochemistry; Genetics","score_opus":0.009287203089561663,"score_gpt":0.2286472552873164,"score_spread":0.21936005219775473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3183839551","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99656373,0.0010248112,0.00091163116,0.000058518443,0.000027852526,0.000044946573,0.00008556066,0.00008132078,0.0012016261],"genre_scores_gemma":[0.9974498,0.0005918839,0.00076512975,0.000023014554,0.000010149119,0.000021699803,0.0001317191,0.0000124806165,0.000994096],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991274,0.000014090413,0.0000078709545,0.000015047536,0.00002155495,0.000028704091],"domain_scores_gemma":[0.9999689,0.000003999348,0.0000072201133,0.000004357071,0.000004104041,0.000011427774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010488918,0.00026768513,0.000432374,0.00025026334,0.00012390393,0.00026550255,0.00022488803,0.00017396545,0.0008482618],"category_scores_gemma":[0.00007777419,0.00011967661,0.00023792389,0.00012817394,0.000124153,0.00015200156,0.0001489941,0.00055626646,0.00018406552],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027308494,0.0002449837,0.00020624623,0.00006114071,0.000015268657,0.00009742912,0.000016621503,0.00023003339,0.9907986,0.00015002629,0.00012966544,0.007776918],"study_design_scores_gemma":[0.00014168417,0.0057682465,0.0056366003,0.000012467736,0.00006547721,0.0009658635,0.0000373164,0.002756152,0.97918713,0.00008934724,0.0053302096,0.000009526347],"about_ca_topic_score_codex":0.00052523677,"about_ca_topic_score_gemma":0.0015612586,"teacher_disagreement_score":0.0008482618,"about_ca_system_score_codex":0.00019022841,"about_ca_system_score_gemma":0.00021087482,"threshold_uncertainty_score":0.0028377175},"labels":[],"label_agreement":null},{"id":"W3185536495","doi":"10.1111/cas.15075","title":"Tumor suppressor miR‐193a‐3p enhances efficacy of BRAF/MEK inhibitors in <i>BRAF</i>‐mutated colorectal cancer","year":2021,"lang":"en","type":"article","venue":"Cancer Science","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Aging","funders":"","keywords":"Cancer research; Trametinib; MCL1; Dabrafenib; MAPK/ERK pathway; MEK inhibitor; Cetuximab; Colorectal cancer; EGFR inhibitors; Epidermal growth factor receptor; Cancer; microRNA; KRAS; Cyclin-dependent kinase 6; Biology; Cell cycle; Medicine; Kinase; Vemurafenib; Downregulation and upregulation; Internal medicine; Melanoma; Cell biology; Cyclin-dependent kinase; Gene","score_opus":0.00941443090138921,"score_gpt":0.273504839717919,"score_spread":0.2640904088165298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3185536495","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945898,0.0021633154,0.0011924262,0.00015717142,0.00007894263,0.000040417424,0.00022353907,0.00014323852,0.0014110788],"genre_scores_gemma":[0.997538,0.0006801335,0.0008760047,0.000081887534,0.000013098731,0.000030102427,0.00019006785,0.000017087585,0.000573672],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998658,0.00002194943,0.000015419366,0.000021030959,0.000045443212,0.00003049653],"domain_scores_gemma":[0.9999155,0.000020955405,0.000022598852,0.0000064404444,0.0000113561355,0.000023201315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021418366,0.0002996489,0.00045600935,0.00022485224,0.00017633256,0.0003368497,0.00016946181,0.000231113,0.001003351],"category_scores_gemma":[0.0002490983,0.00018487075,0.0004217176,0.00012616056,0.00020032455,0.00019274249,0.00017558997,0.0005875265,0.00032002814],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009849622,0.0001678871,0.0007546531,0.00007094429,0.00002526094,0.00007950182,0.000021070366,0.00018350412,0.99118716,0.00007229086,0.00022946572,0.0062233447],"study_design_scores_gemma":[0.00016380905,0.0024502245,0.010747974,0.000008947402,0.00012262414,0.0005050888,0.000032045424,0.0023325698,0.97989,0.00008444729,0.0036483076,0.000013867567],"about_ca_topic_score_codex":0.0006533291,"about_ca_topic_score_gemma":0.00091718324,"teacher_disagreement_score":0.001003351,"about_ca_system_score_codex":0.00031234056,"about_ca_system_score_gemma":0.00030233167,"threshold_uncertainty_score":0.003356576},"labels":[],"label_agreement":null},{"id":"W3196331378","doi":"10.3390/cancers13174362","title":"Skin Cancers and the Contribution of Rho GTPase Signaling Networks to Their Progression","year":2021,"lang":"en","type":"review","venue":"Cancers","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Cancer Research Society","keywords":"Skin cancer; Basal cell carcinoma; Cancer research; Cancer; GTPase; Melanoma; Biology; Signal transduction; Carcinogenesis; Tumor progression; Medicine; Basal cell; Bioinformatics; Pathology; Cell biology; Genetics","score_opus":0.016520006515555127,"score_gpt":0.2967562630684083,"score_spread":0.28023625655285317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3196331378","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014196,0.9986564,0.00008439528,0.0002142361,0.00012352956,0.0000026551886,0.000010739053,0.0000059250942,0.00076027284],"genre_scores_gemma":[0.00069662835,0.9986511,0.00008465084,0.00008045105,0.00009683854,0.0000031703057,0.000018574585,7.961354e-7,0.0003678575],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99989104,0.000017720056,0.000015583733,0.000021677302,0.000039078506,0.000014838483],"domain_scores_gemma":[0.99987507,0.000046632253,0.000020612617,0.000003872837,0.000037852293,0.000015909249],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027731908,0.00058961665,0.0007437358,0.0014435422,0.0002131268,0.0007496754,0.00049374194,0.0006630588,0.002594943],"category_scores_gemma":[0.00035771378,0.00018921195,0.00035887823,0.00089840067,0.00031562493,0.00079701695,0.0004715383,0.0014644134,0.0014810235],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009815041,0.00006795057,0.0002738975,0.014573712,0.000080619146,0.00034132763,0.00006182953,0.00043157404,0.004224361,0.0045734947,0.024113338,0.95115966],"study_design_scores_gemma":[0.000012809225,0.00010861458,0.0012671717,0.0020710279,0.00009343938,0.0019347755,0.000049111208,0.00011249732,0.0010999298,0.002023814,0.9912095,0.000017278613],"about_ca_topic_score_codex":0.0008052668,"about_ca_topic_score_gemma":0.0016227631,"teacher_disagreement_score":0.002594943,"about_ca_system_score_codex":0.0004575891,"about_ca_system_score_gemma":0.0008183565,"threshold_uncertainty_score":0.00868094},"labels":[],"label_agreement":null},{"id":"W3197946942","doi":"10.1177/12034754211045380","title":"Reflex Molecular Testing in Melanoma Diagnosis: When Should <i>BRAF</i> Mutation Testing Be Ordered and Who Should Order It?","year":2021,"lang":"en","type":"letter","venue":"Journal of Cutaneous Medicine and Surgery","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Université Laval; McGill University","funders":"","keywords":"Medicine; Melanoma; Mutation; Reflex; Melanoma diagnosis; Diagnostic test; Dermatology; Cancer research; Internal medicine; Genetics; Pediatrics; Gene","score_opus":0.08945554226016338,"score_gpt":0.29274899018997197,"score_spread":0.20329344792980858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3197946942","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0061005605,0.001766838,0.00037486703,0.975377,0.008491956,0.000033334443,0.000059231854,0.00004619748,0.0077500255],"genre_scores_gemma":[0.10404498,0.0044649034,0.0020285342,0.79178596,0.08399224,0.00007745639,0.000101803234,0.000052272295,0.013451799],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99903846,0.0003209799,0.00015714142,0.00010301969,0.00021788645,0.00016256838],"domain_scores_gemma":[0.9966563,0.0018113953,0.00023676461,0.00010065058,0.00047220816,0.0007226903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011265369,0.00040110573,0.0007383842,0.00052848464,0.0015191264,0.0014414863,0.00087191176,0.019621,0.0032024847],"category_scores_gemma":[0.010187871,0.00033945596,0.0007653054,0.00036836992,0.0014379114,0.0017220057,0.00044472874,0.01641644,0.0019721095],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044885144,0.00030020284,0.0186156,0.00017900663,0.00004568974,0.13452716,0.00039954126,0.00040983933,0.0022412245,0.004640839,0.8044522,0.033739842],"study_design_scores_gemma":[0.00064863416,0.0008127443,0.0210926,0.0013236793,0.00014276704,0.2555106,0.0023089242,0.0062314444,0.0019470117,0.026271507,0.6835147,0.00019539097],"about_ca_topic_score_codex":0.003445102,"about_ca_topic_score_gemma":0.00550831,"teacher_disagreement_score":0.019621,"about_ca_system_score_codex":0.0025653813,"about_ca_system_score_gemma":0.0019293003,"threshold_uncertainty_score":0.018613279},"labels":[],"label_agreement":null},{"id":"W3199125645","doi":"10.2139/ssrn.3188455","title":"The Dynamics of ERK Signaling in Melanoma, and the Response to BRAF or MEK Inhibition, Are Cell Cycle Dependent","year":2018,"lang":"en","type":"article","venue":"SSRN Electronic Journal","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"MAPK/ERK pathway; Melanoma; Dynamics (music); Cell cycle; Cell cycle progression; Cancer research; Cell biology; Chemistry; Signal transduction; Cell; Biology; Psychology; Biochemistry","score_opus":0.003852610130388821,"score_gpt":0.2135390917261883,"score_spread":0.20968648159579947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3199125645","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872628,0.0021769195,0.0017534336,0.000223639,0.000035453537,0.000013849541,0.001033245,0.00011340371,0.007387366],"genre_scores_gemma":[0.99099743,0.0012536456,0.0007179948,0.00005075759,0.0000089674,0.000020011792,0.00093513523,0.000028919616,0.0059871916],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999347,0.0000060366883,0.000003882028,0.000016584208,0.000021099268,0.000017696982],"domain_scores_gemma":[0.9999325,0.000012228798,0.000019608882,0.0000069918556,0.000014642712,0.000013896666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000069224276,0.00016237913,0.00015562194,0.00023115159,0.00018276785,0.00039008568,0.00013007733,0.00016344989,0.0037429533],"category_scores_gemma":[0.00016165104,0.00017081674,0.00017403763,0.00015878603,0.0001527574,0.00034990814,0.0001457786,0.0004277819,0.0010879806],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003037443,0.000040165378,0.0009859325,0.000031777276,0.00000602204,0.00004974598,0.000023536399,0.00026887603,0.99264294,0.0006403128,0.0002323316,0.004774672],"study_design_scores_gemma":[0.0000235092,0.00022682382,0.061890773,0.0000092019545,0.000018492712,0.00050453196,0.00009553752,0.0035234774,0.92627573,0.0008512666,0.006562617,0.000017999173],"about_ca_topic_score_codex":0.0009452448,"about_ca_topic_score_gemma":0.0023431377,"teacher_disagreement_score":0.0037429533,"about_ca_system_score_codex":0.00038900616,"about_ca_system_score_gemma":0.0001927627,"threshold_uncertainty_score":0.012521446},"labels":[],"label_agreement":null},{"id":"W3200475404","doi":"10.3389/fonc.2021.756001","title":"Melanoma Plasticity: Promoter of Metastasis and Resistance to Therapy","year":2021,"lang":"en","type":"review","venue":"Frontiers in Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Melanoma; Phenotype; Metastasis; Targeted therapy; Medicine; Cancer research; Immunotherapy; Cancer; Acquired resistance; Metastatic melanoma; Phenotypic plasticity; Immunology; Biology; Gene; Internal medicine; Genetics","score_opus":0.03250405160715081,"score_gpt":0.3179603603004406,"score_spread":0.2854563086932898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3200475404","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015146547,0.9970868,0.00018519661,0.00039441072,0.00026593287,0.0000060824764,0.000036123864,0.000012052219,0.0018618884],"genre_scores_gemma":[0.0010455636,0.99735236,0.00013468704,0.00019637203,0.0001437985,0.000008359029,0.000049578703,0.0000023068103,0.0010670283],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99989533,0.000020476473,0.00001147761,0.000019613986,0.000039097013,0.000014063466],"domain_scores_gemma":[0.99987626,0.000047900012,0.000019109593,0.0000042919955,0.000036987054,0.000015557964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002824684,0.00060031173,0.0008126577,0.0013730511,0.00020675063,0.0009225831,0.000528253,0.00088001066,0.0043021385],"category_scores_gemma":[0.0004173317,0.0002060903,0.00032133542,0.0010408008,0.0003390158,0.0008224902,0.00058031484,0.0014995164,0.002705398],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010110175,0.000052800053,0.00016030745,0.014610157,0.00006655871,0.00025243606,0.000054006206,0.0003391006,0.0040703444,0.007868427,0.041615028,0.9308098],"study_design_scores_gemma":[0.000014733682,0.000064278516,0.00057509885,0.0019338389,0.000054314813,0.0012690168,0.000031799667,0.00007310007,0.00086784805,0.0020806438,0.99302214,0.000013188624],"about_ca_topic_score_codex":0.0005843468,"about_ca_topic_score_gemma":0.001115249,"teacher_disagreement_score":0.0043021385,"about_ca_system_score_codex":0.0005880265,"about_ca_system_score_gemma":0.0007708839,"threshold_uncertainty_score":0.014392078},"labels":[],"label_agreement":null},{"id":"W3200916137","doi":"10.2196/30270","title":"From the Cochrane Library: Systemic Treatments for Metastatic Cutaneous Melanoma","year":2021,"lang":"en","type":"article","venue":"JMIR Dermatology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Cochrane Library; Melanoma; Systemic therapy; Dermatology; Oncology; Internal medicine; Cancer; Meta-analysis; Cancer research","score_opus":0.012197214202803654,"score_gpt":0.2632564708871007,"score_spread":0.251059256684297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3200916137","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012513879,0.87610555,0.00061282405,0.016984876,0.0069308626,0.0028052034,0.044992827,0.00077171787,0.04954487],"genre_scores_gemma":[0.01623788,0.8914212,0.0020845952,0.034073167,0.00730586,0.0043096934,0.012147119,0.00024979856,0.032170612],"study_design_codex":"not_applicable","study_design_gemma":"systematic_review","domain_scores_codex":[0.99785906,0.0006726384,0.0005707612,0.00020878283,0.0005626653,0.00012615668],"domain_scores_gemma":[0.9881612,0.006588573,0.0028161888,0.00020622481,0.0014150846,0.0008127255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019749072,0.0017518346,0.006251361,0.010810736,0.00068413257,0.0030961463,0.0014228508,0.004027637,0.15970224],"category_scores_gemma":[0.02110913,0.0009205635,0.003077966,0.012034381,0.00062231265,0.0023386301,0.0016715076,0.0030987496,0.0123988455],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012595553,0.000050716888,0.0003425224,0.3705752,0.0017146752,0.00013713764,0.000056105404,0.00022533479,0.0002552708,0.0010396634,0.50750333,0.1168405],"study_design_scores_gemma":[0.00791627,0.000686662,0.0069462596,0.37572652,0.013748388,0.00054865045,0.00025227247,0.00043116792,0.0004179545,0.003948114,0.5891595,0.0002182233],"about_ca_topic_score_codex":0.016991647,"about_ca_topic_score_gemma":0.040195987,"teacher_disagreement_score":0.15970224,"about_ca_system_score_codex":0.0034674841,"about_ca_system_score_gemma":0.006015647,"threshold_uncertainty_score":0.53425723},"labels":[],"label_agreement":null},{"id":"W3201018429","doi":"10.3390/curroncol28050304","title":"Management of Pyrexia Associated with the Combination of Dabrafenib and Trametinib: Canadian Consensus Statements","year":2021,"lang":"en","type":"article","venue":"Current Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of Toronto; University of Ottawa; University of British Columbia; Health Sciences Centre; Credit Valley Hospital; Université Laval; Ottawa Hospital; Princess Margaret Cancer Centre; McGill University; Sunnybrook Health Science Centre","funders":"Novartis Pharmaceuticals Canada","keywords":"Dabrafenib; Trametinib; Medicine; Discontinuation; Melanoma; Delphi method; Intensive care medicine; Oncology; Internal medicine; Vemurafenib; Metastatic melanoma; Cancer research","score_opus":0.048106139953511845,"score_gpt":0.3433593410423441,"score_spread":0.29525320108883224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3201018429","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.025899922,0.033114117,0.028710805,0.8113593,0.0139196655,0.011124423,0.0032102407,0.00028588373,0.07237565],"genre_scores_gemma":[0.50160795,0.06625714,0.2580883,0.110739335,0.004584239,0.009135634,0.0073372023,0.0002660985,0.041984074],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9662469,0.011641363,0.006250248,0.001143248,0.011155371,0.003562935],"domain_scores_gemma":[0.88042235,0.012589367,0.0055077295,0.0012420118,0.08974683,0.01049169],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.05943888,0.0010764996,0.0010361929,0.00430221,0.005836565,0.0029284563,0.0043991585,0.005626705,0.0028111595],"category_scores_gemma":[0.081210785,0.00068459334,0.002157694,0.0030405817,0.003072313,0.0018467165,0.004971325,0.0054289666,0.0008543823],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026632857,0.00016865745,0.008464059,0.007130593,0.00022991771,0.0029312342,0.017805245,0.0031726554,0.004098078,0.017101448,0.67849386,0.26013795],"study_design_scores_gemma":[0.00011485941,0.00012932229,0.0077752313,0.00897162,0.00014109959,0.0018536556,0.008991437,0.001722446,0.001019026,0.009057965,0.95993906,0.00028435673],"about_ca_topic_score_codex":0.40678838,"about_ca_topic_score_gemma":0.48801795,"teacher_disagreement_score":0.59321165,"about_ca_system_score_codex":0.03832453,"about_ca_system_score_gemma":0.20501108,"threshold_uncertainty_score":0.8088412},"labels":[],"label_agreement":null},{"id":"W3201749259","doi":"10.51731/cjht.2021.150","title":"Encorafenib in Combination With Binimetinib (Braftovi and Mektovi)","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Metastatic melanoma; Medicine; Business; Test (biology); Marketing; Melanoma; Economic growth; Economics; Cancer research; Health care","score_opus":0.012647135161659275,"score_gpt":0.23328943117980475,"score_spread":0.22064229601814547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3201749259","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09059951,0.6513574,0.002355198,0.008007199,0.0012802889,0.0004588488,0.0050663045,0.00027857488,0.24059667],"genre_scores_gemma":[0.514043,0.3410143,0.00564162,0.004909323,0.00043045823,0.0001881096,0.005331307,0.00004922041,0.12839259],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99977094,0.00005069646,0.000022848419,0.00002998663,0.000091845934,0.00003363241],"domain_scores_gemma":[0.9998235,0.000032850465,0.00004926635,0.000006931669,0.00006236272,0.000025130747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004210755,0.00022769978,0.00023396222,0.00057618675,0.00017428855,0.0005302355,0.000237395,0.0003042775,0.011744136],"category_scores_gemma":[0.0004979126,0.00006913232,0.00040526208,0.0004705792,0.00017603573,0.00031442838,0.00018932058,0.00031844733,0.001308544],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015000092,0.00013671402,0.0034044269,0.003186401,0.00032586697,0.00034182693,0.0000445759,0.0004774376,0.015437823,0.0029048156,0.048316862,0.92392325],"study_design_scores_gemma":[0.00076853525,0.002610393,0.032103423,0.0019980585,0.00053484837,0.002605009,0.00013006662,0.0006176455,0.02734565,0.00089043984,0.9303514,0.000044529123],"about_ca_topic_score_codex":0.023898266,"about_ca_topic_score_gemma":0.12565438,"teacher_disagreement_score":0.023898266,"about_ca_system_score_codex":0.0018167244,"about_ca_system_score_gemma":0.0017089801,"threshold_uncertainty_score":0.047518313},"labels":[],"label_agreement":null},{"id":"W3201926698","doi":"10.1016/j.annonc.2021.08.1428","title":"1043P NF1 mutations and immune checkpoint inhibitor outcomes in patients with BRAF wildtype melanoma","year":2021,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; McGill University; Princess Margaret Cancer Centre","funders":"GlaxoSmithKline","keywords":"Medicine; Melanoma; Oncology; Immune checkpoint; Cancer research; Wild type; Mutation; Internal medicine; Immunotherapy; Genetics; Cancer; Mutant; Gene","score_opus":0.018644000686201933,"score_gpt":0.28473757577301784,"score_spread":0.2660935750868159,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3201926698","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99772567,0.00039049418,0.000038413174,0.00011110907,0.000013290971,0.0000021687583,0.00022326678,0.0000043095224,0.0014912712],"genre_scores_gemma":[0.9991115,0.00009271243,0.000017028284,0.000040446976,0.000018149469,0.0000022521997,0.00025954892,0.0000014658012,0.00045705342],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998946,0.000011551978,0.000008841722,0.000026931975,0.00001798349,0.00004004862],"domain_scores_gemma":[0.99967754,0.00006479528,0.00012427749,0.000016470854,0.000027982405,0.00008889016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017098166,0.0001523472,0.0001864996,0.00030759172,0.00026281425,0.00056402414,0.0002267113,0.00036436718,0.0025435148],"category_scores_gemma":[0.0007144987,0.00011692335,0.00023290812,0.0003679612,0.0001860442,0.00045539922,0.00023752383,0.00051180256,0.0003087858],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014001491,0.000098500386,0.9868837,0.000014386792,0.00007262235,0.00042329254,0.0000435019,0.00024062264,0.0019118249,0.00009652237,0.0005077568,0.008307198],"study_design_scores_gemma":[0.000028579596,0.00029810573,0.99669504,0.000007282631,0.00007083097,0.0011124492,0.00012261684,0.000396968,0.0002983219,0.00020865984,0.0007546302,0.0000066049965],"about_ca_topic_score_codex":0.0012655027,"about_ca_topic_score_gemma":0.0022573844,"teacher_disagreement_score":0.0025435148,"about_ca_system_score_codex":0.00034678614,"about_ca_system_score_gemma":0.000208133,"threshold_uncertainty_score":0.008508861},"labels":[],"label_agreement":null},{"id":"W3203575639","doi":"10.1016/j.annonc.2021.08.1053","title":"531P Binimetinib and encorafenib for the treatment of advanced solid tumors with non-V600E BRAF mutations (mts): Preliminary results of the investigator initiated phase II BEAVER trial","year":2021,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto; Jewish General Hospital","funders":"Servier; Pfizer; American Association for Cancer Research","keywords":"Medicine; Clinical trial; Oncology; Internal medicine; Cancer research","score_opus":0.0708436817400616,"score_gpt":0.3694569890258601,"score_spread":0.2986133072857985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3203575639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97930324,0.006220147,0.00063834834,0.0019898766,0.00022967196,0.00053436885,0.0022837971,0.00014540592,0.008655158],"genre_scores_gemma":[0.97672606,0.0051883343,0.0016211048,0.0018966882,0.000149282,0.0006509528,0.004174249,0.00003939478,0.009553889],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99984515,0.000057712878,0.000005521202,0.000021220632,0.000021009197,0.000049400798],"domain_scores_gemma":[0.9997397,0.000057623256,0.000044849865,0.000015136391,0.000017020997,0.00012571513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072461134,0.000792544,0.00091373,0.00016931548,0.00020158284,0.00083895016,0.00029687132,0.0005369329,0.0032610432],"category_scores_gemma":[0.00059273676,0.00016840722,0.0006874334,0.00023272875,0.00032469424,0.00061538327,0.00028716493,0.002055302,0.0006447008],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.47546086,0.009637076,0.010202682,0.0014758897,0.00222983,0.00063638913,0.00020236848,0.0058691553,0.034155376,0.0018999913,0.026723307,0.43150708],"study_design_scores_gemma":[0.7211111,0.15338054,0.05958971,0.00026647197,0.0017538771,0.0018085574,0.00019818576,0.005928736,0.007632793,0.0035591475,0.044668265,0.000102554084],"about_ca_topic_score_codex":0.0010274255,"about_ca_topic_score_gemma":0.0063779326,"teacher_disagreement_score":0.0032610432,"about_ca_system_score_codex":0.0007095568,"about_ca_system_score_gemma":0.0006498233,"threshold_uncertainty_score":0.010909259},"labels":[],"label_agreement":null},{"id":"W3204422403","doi":"10.30683/1929-2279.2020.09.03","title":"The Role of BRAF Gene in Cancer: Literature Review and Future Directions","year":2020,"lang":"en","type":"article","venue":"Journal of cancer research updates","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Vemurafenib; Cancer research; Cancer; Melanoma; Targeted therapy; Thyroid cancer; Dabrafenib; Colorectal cancer; Medicine; Kinase; Lung cancer; Mutation; Metastasis; Biology; Oncology; Internal medicine; Gene; Genetics","score_opus":0.018332240925627668,"score_gpt":0.34667016034944154,"score_spread":0.32833791942381385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3204422403","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00028630762,0.9979658,0.00008865473,0.0007600971,0.00028028543,0.000004917427,0.000054133576,0.000006147452,0.00055374345],"genre_scores_gemma":[0.0017135876,0.9967693,0.00017142559,0.00047551628,0.00055742724,0.0000065802446,0.00009635181,0.0000020272666,0.00020781724],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99956125,0.00006326521,0.0001419368,0.00008679054,0.0001118753,0.000034830548],"domain_scores_gemma":[0.99789137,0.0011965287,0.00030388354,0.0000443478,0.00047662645,0.00008716022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009332479,0.0007115798,0.0014801191,0.0059317974,0.0005016104,0.0013582064,0.0010351671,0.0012214215,0.005033629],"category_scores_gemma":[0.0026815212,0.00030281948,0.0011353921,0.0055169286,0.00076988694,0.002413625,0.00071370625,0.001374946,0.000947045],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002520463,0.00008293442,0.002837553,0.07137431,0.00030025715,0.0016520633,0.00029224,0.00034990394,0.0012245526,0.0032514215,0.05242917,0.86595345],"study_design_scores_gemma":[0.000046930065,0.00019654704,0.007705571,0.046443358,0.0025814022,0.016733581,0.0007208361,0.00029125993,0.00078929984,0.005181872,0.9192266,0.000082837316],"about_ca_topic_score_codex":0.0027194745,"about_ca_topic_score_gemma":0.0040677437,"teacher_disagreement_score":0.0059317974,"about_ca_system_score_codex":0.0008369424,"about_ca_system_score_gemma":0.0026980028,"threshold_uncertainty_score":0.016839206},"labels":[],"label_agreement":null},{"id":"W3207342838","doi":"10.1016/j.jid.2021.08.292","title":"286 HORMAD1 Contributes to the Development of Squamous Cell Carcinomas in Melanoma Patients","year":2021,"lang":"en","type":"article","venue":"Journal of Investigative Dermatology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Trametinib; Vemurafenib; HaCaT; Cancer research; Melanoma; MAPK/ERK pathway; Cell growth; Medicine; MEK inhibitor; Cell culture; Biology; Signal transduction; Cell biology; Metastatic melanoma","score_opus":0.01307378266497812,"score_gpt":0.22431127542538232,"score_spread":0.2112374927604042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3207342838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957743,0.0011358534,0.0002011473,0.00014234372,0.000023469327,0.000012415812,0.00054268143,0.00002632986,0.002141494],"genre_scores_gemma":[0.9968934,0.0004495242,0.000118775955,0.000052893425,0.000020726406,0.000006155422,0.00035323962,0.00000776047,0.002097455],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990666,0.000016605552,0.0000074561967,0.00001960542,0.000023887194,0.000025795403],"domain_scores_gemma":[0.9997682,0.000035447134,0.000089546855,0.000021128051,0.000028033024,0.000057734196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001472362,0.0002647707,0.00022977557,0.00072273205,0.0003287328,0.00057679176,0.00021279685,0.00032955178,0.0042489422],"category_scores_gemma":[0.00043229217,0.00024769368,0.00032562762,0.0004122391,0.0001425884,0.00016278669,0.00023118242,0.0004531049,0.0006447226],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004906071,0.00040941764,0.6843343,0.00023411559,0.00020000081,0.010896849,0.00029544224,0.00027046187,0.2592057,0.0008093894,0.001706061,0.03673216],"study_design_scores_gemma":[0.000057740694,0.00026555298,0.97109467,0.000032371743,0.00015385702,0.008874132,0.00028349878,0.0005243533,0.013846176,0.00035172873,0.0045024757,0.000013501875],"about_ca_topic_score_codex":0.0011400328,"about_ca_topic_score_gemma":0.0008336116,"teacher_disagreement_score":0.0042489422,"about_ca_system_score_codex":0.00022994257,"about_ca_system_score_gemma":0.00020254984,"threshold_uncertainty_score":0.014214158},"labels":[],"label_agreement":null},{"id":"W3207422538","doi":"10.3390/curroncol28050338","title":"Real World Outcomes in Patients with Advanced Melanoma Treated in Alberta, Canada: A Time-Era Based Analysis","year":2021,"lang":"en","type":"article","venue":"Current Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Occupational Cancer Research Centre; Cambridge Memorial Hospital; University of Calgary; Alberta Health Services","funders":"","keywords":"Medicine; Ipilimumab; Nivolumab; Melanoma; Oncology; Internal medicine; Proportional hazards model; Immunotherapy; Targeted therapy; Metastatic melanoma; Survival analysis; Cancer; Cancer research","score_opus":0.012003939860057506,"score_gpt":0.2725845505070179,"score_spread":0.2605806106469604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3207422538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99415636,0.000601414,0.000108158296,0.00012507409,0.000007547127,0.000030953666,0.0036472268,0.000007458333,0.0013156715],"genre_scores_gemma":[0.99589914,0.00025908183,0.000115637624,0.00008138226,0.00001078813,0.000013977142,0.003290952,0.0000035472417,0.0003255163],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993956,0.000062672996,0.000046513625,0.000082096296,0.00020556289,0.00020763424],"domain_scores_gemma":[0.9984646,0.00013459251,0.0004549724,0.000078079276,0.0005135898,0.00035423762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006029923,0.000353301,0.00039221282,0.0012024197,0.0008952347,0.00093853887,0.0007183227,0.00042046962,0.0010410675],"category_scores_gemma":[0.001333375,0.00018355744,0.0004931157,0.00348147,0.000533631,0.00029911916,0.0006713869,0.00050091516,0.00013472362],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037835495,0.000036603076,0.9951875,0.000028910605,0.0001265792,0.00013351717,0.00012317623,0.00047225592,0.00016794547,0.00007675784,0.0005415205,0.0027268173],"study_design_scores_gemma":[0.00002424219,0.000075798445,0.9978896,0.000014149437,0.00006833929,0.00011073378,0.00032944628,0.00053221657,0.000060592563,0.000029022627,0.00085394876,0.000011909341],"about_ca_topic_score_codex":0.93096656,"about_ca_topic_score_gemma":0.9536379,"teacher_disagreement_score":0.069033444,"about_ca_system_score_codex":0.015920505,"about_ca_system_score_gemma":0.009696175,"threshold_uncertainty_score":0.13887995},"labels":[],"label_agreement":null},{"id":"W3212667942","doi":"10.21203/rs.3.rs-1041332/v1","title":"Phase I Pharmacokinetic Study of Single Agent Trametinib in Patients With Advanced Cancer and Hepatic Dysfunction","year":2021,"lang":"en","type":"preprint","venue":"Research Square","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; University of Toronto; BC Cancer Agency; Princess Margaret Cancer Centre","funders":"National Cancer Institute; Genentech; Ipsen; Eisai; Bristol-Myers Squibb; Eli Lilly and Company; Symphogen; Exelixis; Iterion Therapeutics; Karyopharm Therapeutics; Celgene; Servier; Amgen","keywords":"Pharmacokinetics; Trametinib; Medicine; Cancer; Oncology; Hepatic dysfunction; Internal medicine; Pharmacology; Chemistry","score_opus":0.040257514435766105,"score_gpt":0.37023546769469734,"score_spread":0.32997795325893126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212667942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99533784,0.0008492495,0.0006534662,0.00039499096,0.00006365982,0.0006188068,0.0009547003,0.000088600806,0.001038751],"genre_scores_gemma":[0.9933509,0.00078723364,0.001057068,0.0003558754,0.000061138475,0.0007710904,0.0014546807,0.000047226495,0.002114842],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9998179,0.00005844468,0.000005194854,0.00004374533,0.00001553609,0.000059139584],"domain_scores_gemma":[0.9997056,0.00004200987,0.000050915827,0.000037874182,0.00001866249,0.00014482923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004980082,0.0011399292,0.0017336304,0.00028815883,0.00036744887,0.00089612696,0.0004633463,0.000873557,0.003290847],"category_scores_gemma":[0.0006440286,0.00051834155,0.0010891883,0.00034003265,0.0006372341,0.0008358609,0.00028906245,0.0028454643,0.00087983126],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7680227,0.045952827,0.0074200407,0.00034531183,0.0013859883,0.00035904525,0.00027568638,0.007000402,0.057446916,0.0005236747,0.0064783036,0.10478915],"study_design_scores_gemma":[0.4606184,0.4889712,0.025513113,0.00004214173,0.00090137636,0.00082008936,0.0001586486,0.0063002687,0.00973018,0.0006443211,0.0062086163,0.00009166539],"about_ca_topic_score_codex":0.0012646327,"about_ca_topic_score_gemma":0.0017959636,"teacher_disagreement_score":0.003290847,"about_ca_system_score_codex":0.0010245865,"about_ca_system_score_gemma":0.0014969648,"threshold_uncertainty_score":0.0110090375},"labels":[],"label_agreement":null},{"id":"W3215111763","doi":"10.1016/j.ejca.2021.09.024","title":"KEYNOTE-022: Pembrolizumab with trametinib in patients with BRAF wild-type melanoma or advanced solid tumours irrespective of BRAF mutation","year":2021,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McGill University; University of Toronto; Jewish General Hospital; McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Trametinib; Pembrolizumab; Dosing; Medicine; Adverse effect; Internal medicine; Melanoma; Oncology; Immunotherapy; MAPK/ERK pathway; Cancer; Cancer research; Biology; Kinase","score_opus":0.00713408438545517,"score_gpt":0.24500162893397942,"score_spread":0.23786754454852424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215111763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.897873,0.0291368,0.0006042327,0.009548478,0.0017088265,0.0005601597,0.004035818,0.00023965113,0.05629304],"genre_scores_gemma":[0.9753321,0.004882889,0.0008575431,0.0024183812,0.0006427688,0.00023180008,0.0031730942,0.00002603313,0.012435381],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9998721,0.00003156828,0.000012195648,0.000025933503,0.000016579754,0.00004161009],"domain_scores_gemma":[0.9998834,0.000020636826,0.000020825299,0.000005220096,0.000010891709,0.000059047536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032222387,0.00034461642,0.00046035176,0.00019434429,0.00027335342,0.0005016063,0.000305904,0.0005779546,0.011527471],"category_scores_gemma":[0.00040975062,0.00013215737,0.00040961662,0.00025549828,0.00012137719,0.00045821024,0.00020105112,0.00092960015,0.0017965749],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20893069,0.0027768211,0.058471665,0.0020815583,0.0018159588,0.003331888,0.00016964404,0.0015529513,0.04346767,0.0014608103,0.10990197,0.5660384],"study_design_scores_gemma":[0.092794776,0.058675252,0.4972465,0.0012627604,0.0039773947,0.013709635,0.00038375042,0.0046869786,0.019928027,0.0023552522,0.30478847,0.00019117136],"about_ca_topic_score_codex":0.00052174943,"about_ca_topic_score_gemma":0.0021646123,"teacher_disagreement_score":0.011527471,"about_ca_system_score_codex":0.0004580873,"about_ca_system_score_gemma":0.00044621667,"threshold_uncertainty_score":0.03856325},"labels":[],"label_agreement":null},{"id":"W3215169578","doi":"10.1101/2021.11.30.470372","title":"Replication Study: RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth","year":2021,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kinexus Bioinformatics Corporation (Canada); University of British Columbia","funders":"Medical Research Council; Genentech; University of Dundee","keywords":"MAPK/ERK pathway; Mutant; Gene knockdown; Replication (statistics); Biology; Wild type; V600E; Cancer research; Kinase; Molecular biology; Cell culture; Cell biology; Genetics; Gene; Virology","score_opus":0.010002097264704315,"score_gpt":0.2253415694101344,"score_spread":0.2153394721454301,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215169578","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reproducibility","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"reproducibility","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88649476,0.007968768,0.06594953,0.0034845234,0.004629543,0.0061913626,0.011274142,0.0025532409,0.011454147],"genre_scores_gemma":[0.87615955,0.0044190655,0.06084755,0.0025916272,0.0009358337,0.006691299,0.0142897945,0.0012264147,0.03283883],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969837,0.0007553045,0.00046937706,0.00062832,0.0008691517,0.00029423274],"domain_scores_gemma":[0.99523395,0.00096306665,0.00036284176,0.0017050052,0.0013427329,0.00039240767],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0043887803,0.0013502288,0.0013413682,0.0004442154,0.00074044423,0.0010079229,0.0012705118,0.0014127991,0.006422328],"category_scores_gemma":[0.0028939974,0.0005345122,0.0021881922,0.00040093833,0.0006575402,0.0005911644,0.00067980884,0.0042987796,0.0029983202],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027589835,0.0020166163,0.0009610595,0.00048536577,0.00016727162,0.00016901385,0.00016157649,0.00027759047,0.9781195,0.00053368753,0.0058959657,0.008453377],"study_design_scores_gemma":[0.00059757463,0.011859735,0.0023128593,0.000022344184,0.00022925153,0.00041707684,0.000051544444,0.0006742641,0.9664521,0.00013441948,0.017200943,0.00004784914],"about_ca_topic_score_codex":0.001983318,"about_ca_topic_score_gemma":0.0014584332,"teacher_disagreement_score":0.9956112,"about_ca_system_score_codex":0.00071158184,"about_ca_system_score_gemma":0.0011851405,"threshold_uncertainty_score":0.023210347},"labels":[],"label_agreement":null},{"id":"W4200029899","doi":"10.3390/cancers13246388","title":"Insights of RKIP-Derived Suppression of Prostate Cancer","year":2021,"lang":"en","type":"review","venue":"Cancers","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University; St. Joseph's Hospital","funders":"Canadian Institutes of Health Research","keywords":"Prostate cancer; Cancer research; Metastasis; MAPK/ERK pathway; Medicine; Metastasis suppressor; Cancer; Androgen deprivation therapy; Androgen receptor; Tumor progression; Signal transduction; Biology; Internal medicine; Cell biology","score_opus":0.028794948096742407,"score_gpt":0.30850954569623346,"score_spread":0.279714597599491,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200029899","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002565706,0.9972229,0.00020801376,0.0002616425,0.00026184844,0.0000048531488,0.00002862835,0.000013631841,0.0017418057],"genre_scores_gemma":[0.001619363,0.99652016,0.00022334712,0.00026844474,0.00015838468,0.00000875823,0.000054731165,0.0000028949305,0.0011438966],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999099,0.0000137121915,0.000009866551,0.000017909588,0.000035193883,0.000013461718],"domain_scores_gemma":[0.99991417,0.000028898514,0.000011677358,0.0000035979895,0.000026271953,0.000015431278],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034064022,0.00070103037,0.0007136273,0.0013250326,0.00019223466,0.0007404502,0.00058610697,0.00064265425,0.0023742013],"category_scores_gemma":[0.0002948525,0.00022534435,0.00033481183,0.00095202436,0.00031169326,0.0008633561,0.0005466106,0.0017568276,0.001980763],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013616626,0.00011892113,0.00019282309,0.013194245,0.00008582364,0.00039391956,0.00005997183,0.0004910398,0.009755812,0.0080548255,0.036772702,0.93074375],"study_design_scores_gemma":[0.000020086693,0.00013518227,0.00062626926,0.00096185884,0.000060919345,0.0011298074,0.000023813327,0.000108730215,0.0015340513,0.0016184733,0.99376583,0.000015084189],"about_ca_topic_score_codex":0.0004958315,"about_ca_topic_score_gemma":0.0010014414,"teacher_disagreement_score":0.0023742013,"about_ca_system_score_codex":0.0005072443,"about_ca_system_score_gemma":0.0005715226,"threshold_uncertainty_score":0.007942498},"labels":[],"label_agreement":null},{"id":"W4200303884","doi":"10.51731/cjht.2021.152","title":"Encorafenib (Braftovi)","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Cetuximab; Drug class; Drug; Family medicine; Business; Pharmacology; Economic growth; Internal medicine; Economics; Cancer; Health care","score_opus":0.01682635852450084,"score_gpt":0.24471893124743535,"score_spread":0.2278925727229345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200303884","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.061401617,0.8622086,0.0012555693,0.002862123,0.00038943603,0.00020087633,0.0030690145,0.00015924472,0.068453506],"genre_scores_gemma":[0.41139954,0.523621,0.0030247974,0.0024775413,0.00018844214,0.00013017528,0.003839671,0.00002283535,0.0552961],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998399,0.000024894292,0.000012396958,0.000020416997,0.00007983262,0.000022471273],"domain_scores_gemma":[0.9998666,0.000021856686,0.0000369697,0.0000040165514,0.000052223313,0.000018336654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028276883,0.0002534689,0.00023511227,0.0007257025,0.00019437191,0.00046556888,0.00017042272,0.00024595574,0.0056449748],"category_scores_gemma":[0.00037069654,0.00005468369,0.000263504,0.00059059303,0.00012689654,0.00023119962,0.00014704623,0.00029801243,0.0007795358],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007208248,0.000102605474,0.002593715,0.003114514,0.00022204904,0.00029791103,0.000032647982,0.0004676023,0.014563826,0.0017179358,0.022203,0.95396346],"study_design_scores_gemma":[0.00035473998,0.0017040352,0.024829237,0.0015891317,0.00042752526,0.0032748145,0.000110084744,0.00037028315,0.021972373,0.0005499132,0.9447883,0.000029733159],"about_ca_topic_score_codex":0.016251719,"about_ca_topic_score_gemma":0.1021363,"teacher_disagreement_score":0.016251719,"about_ca_system_score_codex":0.0015853794,"about_ca_system_score_gemma":0.0012878856,"threshold_uncertainty_score":0.03231424},"labels":[],"label_agreement":null},{"id":"W4205235372","doi":"10.1007/978-1-4419-0461-4_382","title":"RSK (p90 Ribosomal S6 Kinase)","year":2012,"lang":"en","type":"book-chapter","venue":"","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Ribosomal s6 kinase; Biology; Cell biology; P70-S6 Kinase 1; Phosphorylation","score_opus":0.014844498128020349,"score_gpt":0.2108818129668865,"score_spread":0.19603731483886613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205235372","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008073758,0.32889423,0.035053086,0.003124569,0.006062591,0.00011820385,0.0020517334,0.0028375755,0.6137842],"genre_scores_gemma":[0.020500502,0.11856692,0.014744547,0.00081322703,0.0007387306,0.00008552512,0.0016521079,0.0002669971,0.8426314],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99993396,0.000003353531,0.000003096792,0.000019057079,0.000032348347,0.000008253624],"domain_scores_gemma":[0.9999815,0.000003856468,0.000002957404,0.0000023727084,0.000005555237,0.0000036549586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010850334,0.00088970235,0.00037837305,0.0006193252,0.00021671117,0.00087938295,0.00048723436,0.0004547986,0.017021142],"category_scores_gemma":[0.000094892726,0.00019575754,0.00028636004,0.0007319852,0.00024294406,0.00092785957,0.0004419509,0.0011333163,0.03202599],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000117145275,0.000060027476,0.000065253545,0.0006908168,0.000012465833,0.0002103764,0.000045995657,0.0006737292,0.066696994,0.02315446,0.13365124,0.7746214],"study_design_scores_gemma":[0.0000051760035,0.000025503437,0.00014606539,0.000031873522,0.0000060465095,0.00038433867,0.000007375657,0.00010940637,0.011581478,0.0025417982,0.9851549,0.0000060039833],"about_ca_topic_score_codex":0.0005067644,"about_ca_topic_score_gemma":0.0011317892,"teacher_disagreement_score":0.017021142,"about_ca_system_score_codex":0.0004738288,"about_ca_system_score_gemma":0.0002998178,"threshold_uncertainty_score":0.05694139},"labels":[],"label_agreement":null},{"id":"W4205496667","doi":"10.1200/po.21.00303","title":"Sustained Response to the Mitogen-Activated Extracellular Kinase Inhibitor Trametinib in a Spindle Cell Sarcoma Harboring a QKI-RAF1 Gene Fusion","year":2022,"lang":"en","type":"article","venue":"JCO Precision Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Trametinib; Fusion gene; Kinase; Extracellular; Fusion protein; Sarcoma; Cell culture; Gene","score_opus":0.014707803517898384,"score_gpt":0.26693388961498593,"score_spread":0.2522260860970875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205496667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998752,0.00020198616,0.00020540191,0.00013510302,0.000027237671,0.000011754931,0.0001505541,0.000021449057,0.0004944237],"genre_scores_gemma":[0.99902177,0.000078755016,0.00014341978,0.00003181569,0.000004518203,0.0000057404964,0.00020108306,0.000002420658,0.0005104637],"study_design_codex":"bench_or_experimental","study_design_gemma":"case_report","domain_scores_codex":[0.99992776,0.000007114862,0.0000059434933,0.000012293636,0.000014028104,0.00003276059],"domain_scores_gemma":[0.99993265,0.000021185524,0.000011497451,0.0000063613757,0.000005660504,0.000022771057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008824139,0.00014712379,0.0002564371,0.0001245633,0.00015374714,0.00021168726,0.0001515892,0.00037143254,0.0007467093],"category_scores_gemma":[0.00016042539,0.00007889466,0.00023167979,0.00012224824,0.00013157066,0.00011732654,0.00008449855,0.0006247679,0.000177676],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019703768,0.00028787856,0.0010817191,0.000023629067,0.000017885843,0.0030244614,0.000040299143,0.0004060764,0.98882616,0.00008358988,0.00030482074,0.003933218],"study_design_scores_gemma":[0.00037544325,0.008398538,0.04547517,0.00000619661,0.00010604841,0.012792595,0.00018800121,0.010631027,0.91808605,0.00014882746,0.003763346,0.000028874858],"about_ca_topic_score_codex":0.0019282813,"about_ca_topic_score_gemma":0.002281598,"teacher_disagreement_score":0.0019282813,"about_ca_system_score_codex":0.0003047896,"about_ca_system_score_gemma":0.00019901853,"threshold_uncertainty_score":0.0038340688},"labels":[],"label_agreement":null},{"id":"W4206568596","doi":"10.1038/s12276-021-00721-9","title":"FBXW7-mediated ERK3 degradation regulates the proliferation of lung cancer cells","year":2022,"lang":"en","type":"article","venue":"Experimental & Molecular Medicine","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Korea Basic Science Institute; Sidney Kimmel Comprehensive Cancer Center; Ministry of Education; Ministry of Science, ICT and Future Planning; School of Medicine, New York University; Catholic University of Korea; York University; Johns Hopkins University","keywords":"Ubiquitin ligase; Ubiquitin; Cell biology; Cullin; F-box protein; Protein kinase A; MAPK/ERK pathway; Kinase; Cancer research; Cell cycle; Biology; Chemistry; Cell; Biochemistry","score_opus":0.007396185953717162,"score_gpt":0.26628059258692216,"score_spread":0.258884406633205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206568596","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946121,0.0021354256,0.0011900727,0.00007743777,0.00003259234,0.000020514233,0.00040493856,0.00010351089,0.0014235417],"genre_scores_gemma":[0.9944993,0.0007870584,0.00068506045,0.00005226398,0.000006263742,0.00004617015,0.0007094928,0.000011077328,0.0032032563],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998878,0.000014216195,0.000010396527,0.000018860792,0.000032469616,0.000036250018],"domain_scores_gemma":[0.99996185,0.0000049086843,0.0000085972315,0.000003840332,0.000008000101,0.000012794064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000093508854,0.0003263085,0.00023075564,0.000250785,0.00022410013,0.00022979618,0.00014947694,0.00024108472,0.0012732635],"category_scores_gemma":[0.000052467876,0.0001407687,0.00032212032,0.00017521149,0.00017168497,0.00012030959,0.00016643871,0.00046842094,0.0004535135],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014307514,0.000060351464,0.0004168234,0.00005137759,0.0000092551,0.00007356391,0.000011473613,0.00006110155,0.9976501,0.00009514259,0.000110966066,0.0013168496],"study_design_scores_gemma":[0.000020670197,0.00012918688,0.008531153,0.000004689647,0.000012953744,0.0001784919,0.000026268019,0.0020744677,0.98727757,0.00004694438,0.0016939444,0.0000036874042],"about_ca_topic_score_codex":0.000742006,"about_ca_topic_score_gemma":0.0008528059,"teacher_disagreement_score":0.0012732635,"about_ca_system_score_codex":0.00027670345,"about_ca_system_score_gemma":0.000200953,"threshold_uncertainty_score":0.0042595267},"labels":[],"label_agreement":null},{"id":"W4206618846","doi":"10.1016/j.celrep.2021.110223","title":"Fine-tuning of MEK signaling is pivotal for limiting B and T cell activation","year":2022,"lang":"en","type":"article","venue":"Cell Reports","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôtel-Dieu de Québec","funders":"Canadian Institutes of Health Research; Agence Nationale de la Recherche","keywords":"MAPK/ERK pathway; Cell biology; Biology; T cell; Cell growth; Immune system; Mutant; Signal transduction; Cancer research; Genetics; Gene","score_opus":0.013544772937852494,"score_gpt":0.21663507103853014,"score_spread":0.20309029810067764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206618846","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99095625,0.002295181,0.004045413,0.00011387607,0.000016630205,0.000015798949,0.00012733183,0.00009460892,0.0023348914],"genre_scores_gemma":[0.9959974,0.0008066197,0.0020673608,0.000026216305,0.000009142622,0.000010142105,0.000055986708,0.000013735516,0.0010133052],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998574,0.000019290212,0.000012380445,0.000034051795,0.000034947487,0.000041890937],"domain_scores_gemma":[0.9998779,0.000017312614,0.000045290257,0.000012384928,0.000013340948,0.000033679273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013851112,0.00031321935,0.00017977583,0.00024242878,0.00019062367,0.00040237207,0.00020949262,0.00020105112,0.0009313138],"category_scores_gemma":[0.00014412498,0.00016873768,0.00013185148,0.00009652305,0.0002639352,0.00025833107,0.00027866496,0.0004717638,0.00038997136],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044313063,0.000007398919,0.00027924732,0.000016485565,0.0000017337619,0.000029087641,0.000005647523,0.000058631973,0.99806017,0.00021820265,0.000018793831,0.0012603226],"study_design_scores_gemma":[0.000014781041,0.00016090953,0.0103386985,0.000007677903,0.000009990808,0.0005167431,0.000034203073,0.00074501906,0.98448944,0.0003296543,0.0033455654,0.000007304512],"about_ca_topic_score_codex":0.0003339817,"about_ca_topic_score_gemma":0.00080508535,"teacher_disagreement_score":0.0009313138,"about_ca_system_score_codex":0.00022317875,"about_ca_system_score_gemma":0.00019446628,"threshold_uncertainty_score":0.0031155944},"labels":[],"label_agreement":null},{"id":"W4210357560","doi":"10.5742/mewfm.2021.94167","title":"Malignant Melanoma","year":2021,"lang":"en","type":"article","venue":"World Family Medicine Journal /Middle East Journal of Family Medicine","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Grand Challenges Canada; King Saud University","keywords":"Melanoma; Medicine; Dermatology; Cancer research","score_opus":0.07280346032310021,"score_gpt":0.2858853146514904,"score_spread":0.21308185432839022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210357560","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000941411,0.99066585,0.0004781356,0.0007606683,0.0012181926,0.0000116070605,0.00006522098,0.00003518026,0.005823712],"genre_scores_gemma":[0.008026735,0.9786729,0.00096705084,0.0012713008,0.0017999191,0.000018567827,0.00024325952,0.0000106474345,0.008989598],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998235,0.000035313893,0.000036916703,0.000029824552,0.000058140475,0.000016312828],"domain_scores_gemma":[0.9998055,0.0000651619,0.000036561225,0.000011259304,0.000057988476,0.000023475759],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023175095,0.00049464824,0.00051110587,0.0022281033,0.00023812315,0.0005757987,0.00034435384,0.00048044216,0.005221312],"category_scores_gemma":[0.00053799996,0.00015518836,0.00037770343,0.0013727301,0.00019920003,0.000873198,0.00037226718,0.0006448554,0.003105611],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000062743995,0.000043541608,0.001266189,0.0057054684,0.00007567533,0.0013961386,0.000082641876,0.00012969886,0.002250614,0.0012378123,0.0902216,0.8975279],"study_design_scores_gemma":[0.000008648147,0.00007897154,0.0036293247,0.0025689374,0.00008344024,0.022567531,0.000102976104,0.000069371854,0.0004930071,0.0009821075,0.9694029,0.000012722127],"about_ca_topic_score_codex":0.0005522233,"about_ca_topic_score_gemma":0.0013137138,"teacher_disagreement_score":0.005221312,"about_ca_system_score_codex":0.0002566991,"about_ca_system_score_gemma":0.00045128094,"threshold_uncertainty_score":0.017467022},"labels":[],"label_agreement":null},{"id":"W4210750855","doi":"10.1016/j.annonc.2022.01.076","title":"Biomarkers of treatment benefit with atezolizumab plus vemurafenib plus cobimetinib in BRAFV600 mutation–positive melanoma","year":2022,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"Roche","keywords":"Atezolizumab; Medicine; Vemurafenib; Internal medicine; Hazard ratio; Oncology; Confidence interval; Cancer; Pembrolizumab; Immunotherapy; Metastatic melanoma","score_opus":0.03356083637505654,"score_gpt":0.30657651588933427,"score_spread":0.27301567951427774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210750855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999263,0.00029758766,0.00014029203,0.00003344166,0.0000067106107,0.000026235395,0.00013179102,0.000004399919,0.00009656191],"genre_scores_gemma":[0.9995339,0.000052407417,0.0001445891,0.000019920752,0.000006040389,0.000027624406,0.00014805322,6.138569e-7,0.00006681178],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99962795,0.00017588405,0.00003107026,0.00007810341,0.00003444147,0.000052473915],"domain_scores_gemma":[0.9993425,0.00025208015,0.00021782724,0.000039346392,0.000018569037,0.0001297272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009269548,0.00031271865,0.00085943966,0.00021648419,0.00015004042,0.000438046,0.00020971967,0.00032867512,0.0015986931],"category_scores_gemma":[0.0015246673,0.00024579774,0.0012869855,0.00016186251,0.00021760084,0.00035952905,0.00027173795,0.000617343,0.00012206024],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4325898,0.0020297128,0.45124075,0.00028882473,0.00208553,0.00016594541,0.0001383331,0.006487132,0.0148754865,0.00022041088,0.0007418825,0.0891362],"study_design_scores_gemma":[0.029623263,0.08905786,0.84531826,0.000083893014,0.0028802152,0.00059993926,0.00019654722,0.02175846,0.007146864,0.0013067987,0.0019445617,0.0000832963],"about_ca_topic_score_codex":0.00029515178,"about_ca_topic_score_gemma":0.00061068253,"teacher_disagreement_score":0.0015986931,"about_ca_system_score_codex":0.000410959,"about_ca_system_score_gemma":0.00031814814,"threshold_uncertainty_score":0.005348146},"labels":[],"label_agreement":null},{"id":"W4211049750","doi":"10.1007/978-3-319-48066-4_4","title":"Melanoma—Treatment","year":2016,"lang":"en","type":"book-chapter","venue":"","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Melanoma; Dabrafenib; Vemurafenib; Trametinib; Sentinel lymph node; Adjuvant therapy; Oncology; Radiation therapy; Immunotherapy; Sentinel node; Internal medicine; Adjuvant; Stage (stratigraphy); Ipilimumab; Cancer; Dermatology; Surgery; Metastatic melanoma; Breast cancer; Cancer research","score_opus":0.015611525560762991,"score_gpt":0.21833499398967784,"score_spread":0.20272346842891487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211049750","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019057093,0.26512992,0.004500866,0.019669326,0.008794076,0.000111718895,0.00051266653,0.00043924837,0.6989365],"genre_scores_gemma":[0.017074013,0.15481602,0.0029199691,0.014624484,0.004493916,0.0001269949,0.0006091196,0.00014559065,0.80518985],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999188,0.000015154963,0.00000345002,0.000013020116,0.000038275764,0.000011227659],"domain_scores_gemma":[0.99995947,0.0000091457505,0.0000043302903,0.000004383658,0.000009245611,0.0000133971425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015572006,0.00046337547,0.00026322427,0.00041376238,0.00029672674,0.0007233446,0.0003441758,0.00066941296,0.04118316],"category_scores_gemma":[0.00028473284,0.000109726214,0.00021139398,0.00025331863,0.0002197333,0.00070310885,0.0005849782,0.0015108581,0.022887057],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037306756,0.000052423842,0.00008637817,0.0003186067,0.0000067487067,0.00016674727,0.00002381717,0.000121136414,0.0013319609,0.0094906315,0.43124264,0.55712163],"study_design_scores_gemma":[0.0000065851577,0.000016373358,0.00016840175,0.00016213088,0.0000029848086,0.0006101202,0.000008418401,0.000032057385,0.00018443425,0.0024880085,0.99631846,0.0000020269858],"about_ca_topic_score_codex":0.0006548136,"about_ca_topic_score_gemma":0.0024713168,"teacher_disagreement_score":0.04118316,"about_ca_system_score_codex":0.00040350578,"about_ca_system_score_gemma":0.00042230857,"threshold_uncertainty_score":0.13777137},"labels":[],"label_agreement":null},{"id":"W4211123988","doi":"10.1016/s0140-6736(13)60802-8","title":"Cutaneous melanoma","year":2013,"lang":"en","type":"review","venue":"The Lancet","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":532,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Melanoma; Medicine; Immunotherapy; Oncology; Targeted therapy; Lymph node; Sentinel lymph node; Immunology; Cancer research; Internal medicine; Cancer","score_opus":0.053280273530099134,"score_gpt":0.30253506249533585,"score_spread":0.24925478896523673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211123988","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009765228,0.99102825,0.00020236723,0.0012097991,0.002238167,0.0000055999412,0.000030100611,0.000023311313,0.0051647783],"genre_scores_gemma":[0.0015846975,0.9873942,0.00026266102,0.0018833561,0.0020383552,0.00000929024,0.00006985871,0.0000053844497,0.006752171],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998821,0.000017312406,0.000011045778,0.000024458895,0.000048405753,0.00001663123],"domain_scores_gemma":[0.9998198,0.00006217448,0.000025997468,0.000009931346,0.00004914369,0.000033009215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002668145,0.00069140084,0.0008139997,0.0012117126,0.0002476502,0.0008892539,0.0006013188,0.0010746921,0.009285525],"category_scores_gemma":[0.0007577622,0.00020904647,0.00029213887,0.00083456613,0.00045250947,0.00094732473,0.000673913,0.0019509204,0.005134457],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000066692686,0.0000265995,0.00010866747,0.0035758468,0.000025629302,0.00028556428,0.000015826268,0.00015414112,0.0009209964,0.0026467121,0.16934049,0.8228328],"study_design_scores_gemma":[0.000019049183,0.000023262217,0.00031680433,0.0014278879,0.000032434604,0.0014920167,0.000022251854,0.000045669774,0.00015919976,0.0011197337,0.9953342,0.000007360725],"about_ca_topic_score_codex":0.0013059493,"about_ca_topic_score_gemma":0.0038614501,"teacher_disagreement_score":0.009285525,"about_ca_system_score_codex":0.00056042516,"about_ca_system_score_gemma":0.0007637743,"threshold_uncertainty_score":0.031063199},"labels":[],"label_agreement":null},{"id":"W4211260689","doi":"10.3390/molecules27041172","title":"3, 3′- (3, 5-DCPBC) Down-Regulates Multiple Phosphokinase Dependent Signal Transduction Pathways in Malignant Melanoma Cells through Specific Diminution of EGFRY1086 Phosphorylation","year":2022,"lang":"en","type":"article","venue":"Molecules","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Universität Ulm; International Union of Biochemistry and Molecular Biology; University of Karachi","keywords":"Phosphorylation; Cancer research; Melanoma; Signal transduction; Proto-oncogene tyrosine-protein kinase Src; Kinase; Tyrosine kinase; Receptor tyrosine kinase; Tyrosine phosphorylation; Cell growth; Epidermal growth factor receptor; Cell biology; Biology; Chemistry; Receptor; Biochemistry","score_opus":0.013840483644331568,"score_gpt":0.2007239063609254,"score_spread":0.18688342271659383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211260689","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99624985,0.0011915271,0.0006028377,0.00006330894,0.000020140298,0.000016453578,0.00016454369,0.0000526007,0.0016387617],"genre_scores_gemma":[0.99666387,0.00066462497,0.00045110288,0.000027247268,0.000004330643,0.000014092207,0.00022625571,0.000007433043,0.0019411902],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99996233,0.000006195039,0.0000027094748,0.000006804925,0.000010426095,0.000011535354],"domain_scores_gemma":[0.9999802,0.0000030553488,0.000004074146,0.0000024792334,0.000002845498,0.000007376833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000447791,0.00021742022,0.00012156194,0.00012474897,0.000093533556,0.000110559085,0.000097299504,0.00012781585,0.0010042284],"category_scores_gemma":[0.00003557148,0.00006819683,0.00011122367,0.00008513874,0.00010160571,0.00007653557,0.000061016595,0.00030630236,0.00018905397],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060526225,0.000028696633,0.00004454173,0.000017084552,0.0000017211445,0.000021444466,0.000004955301,0.00003461544,0.9991259,0.000043153625,0.000024906043,0.0005925275],"study_design_scores_gemma":[0.000010704573,0.00026395448,0.0014346334,0.0000016621162,0.00000477445,0.00007350514,0.0000074732593,0.0003032294,0.9967513,0.000012312089,0.0011354631,0.0000010222798],"about_ca_topic_score_codex":0.001072791,"about_ca_topic_score_gemma":0.0013621994,"teacher_disagreement_score":0.001072791,"about_ca_system_score_codex":0.00013505277,"about_ca_system_score_gemma":0.00015172297,"threshold_uncertainty_score":0.003359437},"labels":[],"label_agreement":null},{"id":"W4214507203","doi":"10.3390/curroncol29030126","title":"Real-World Evidence of Systemic Therapy Sequencing on Overall Survival for Patients with Metastatic BRAF-Mutated Cutaneous Melanoma","year":2022,"lang":"en","type":"article","venue":"Current Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Western University; Queen's University","funders":"","keywords":"Metastatic melanoma; Medicine; Systemic therapy; Melanoma; Overall survival; Oncology; Targeted therapy; Vemurafenib; Cancer research; Internal medicine; Bioinformatics; Cancer; Biology","score_opus":0.08902090121553219,"score_gpt":0.3500544874061776,"score_spread":0.26103358619064543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214507203","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9705375,0.0247261,0.00038044123,0.0010840407,0.000062285515,0.000028905242,0.0011481987,0.000011151012,0.0020214487],"genre_scores_gemma":[0.99723,0.0014962862,0.00025771302,0.0002679035,0.000036076133,0.000012266305,0.00062452856,0.0000029713942,0.00007243925],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981553,0.0010472409,0.00015739346,0.00025414655,0.0002895939,0.00009625363],"domain_scores_gemma":[0.99058026,0.0053817164,0.0028546832,0.00036349357,0.0004789495,0.00034082186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036264495,0.00017221422,0.0003271801,0.0002702021,0.00020298772,0.00065332936,0.0003311959,0.00039983712,0.001692292],"category_scores_gemma":[0.009752623,0.000103280225,0.0007562739,0.0004748036,0.00037932003,0.00039782946,0.0002895264,0.00041598285,0.00009286249],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011817801,0.00020352157,0.8998874,0.0010466361,0.002521192,0.000078168196,0.00012504616,0.0019452214,0.00080364256,0.00017783289,0.0014208354,0.07997265],"study_design_scores_gemma":[0.0005570264,0.0024661082,0.98820937,0.00039284356,0.0025613953,0.00024395794,0.00018977534,0.0016031791,0.0003390747,0.00021888716,0.003196759,0.000021598875],"about_ca_topic_score_codex":0.0077202064,"about_ca_topic_score_gemma":0.019395994,"teacher_disagreement_score":0.0077202064,"about_ca_system_score_codex":0.0011663324,"about_ca_system_score_gemma":0.00145847,"threshold_uncertainty_score":0.019178748},"labels":[],"label_agreement":null},{"id":"W4214602468","doi":"10.1002/hep.26804","title":"NASH: Diagnosis and Treatment","year":2013,"lang":"en","type":"article","venue":"Hepatology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Assistance publique-Hôpitaux de Paris; Universitat de Barcelona; National Institute for Health and Care Research; Università degli Studi di Milano; University of Alberta; University of Texas Southwestern Medical Center; Università degli Studi di Padova; Arizona State University","keywords":"Medicine; Intensive care medicine; Computer science","score_opus":0.015932113447580297,"score_gpt":0.22817976251818992,"score_spread":0.2122476490706096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214602468","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.032847952,0.58833426,0.03265299,0.1426325,0.014878177,0.00082249055,0.002089792,0.00125952,0.18448234],"genre_scores_gemma":[0.38285118,0.3641358,0.0436022,0.04768646,0.032848585,0.00081563165,0.0040560653,0.00030975044,0.12369421],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99963367,0.00009061147,0.00003711842,0.000058645834,0.00011341416,0.00006657928],"domain_scores_gemma":[0.9996158,0.00004522625,0.000058648588,0.000023653702,0.00012599441,0.00013073416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069583795,0.00071063987,0.0008473094,0.0011547981,0.00072383037,0.0012813812,0.0004958518,0.0011596207,0.009135698],"category_scores_gemma":[0.0010669099,0.00022578178,0.00042637446,0.0005285474,0.0004762645,0.0009956786,0.001047163,0.0020313738,0.0040394682],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055663736,0.00032448684,0.0135554215,0.0012071871,0.00011444971,0.0062306346,0.00008712174,0.00041186594,0.003080675,0.013245725,0.118102066,0.84308374],"study_design_scores_gemma":[0.00036959528,0.00063687004,0.022490272,0.00785527,0.00027877637,0.06418618,0.0006626747,0.0035604083,0.0029421593,0.041240066,0.8556439,0.00013388316],"about_ca_topic_score_codex":0.0016702532,"about_ca_topic_score_gemma":0.0024723846,"teacher_disagreement_score":0.009135698,"about_ca_system_score_codex":0.001069889,"about_ca_system_score_gemma":0.0014425402,"threshold_uncertainty_score":0.030561924},"labels":[],"label_agreement":null},{"id":"W4220865860","doi":"10.1200/op.21.00810","title":"Turnaround Times in Melanoma BRAF Testing and the Impact on the Initiation of Systemic Therapy at a Single Tertiary Care Cancer Center","year":2022,"lang":"en","type":"article","venue":"JCO Oncology Practice","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Melanoma; Internal medicine; Cancer; Oncology; Biopsy; Retrospective cohort study; Disease; Cancer research","score_opus":0.025367693740765477,"score_gpt":0.3065768639556606,"score_spread":0.2812091702148951,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220865860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99838877,0.0006480194,0.00018396709,0.00012367785,0.000011774246,0.000012870663,0.00017139003,0.000011557738,0.00044794322],"genre_scores_gemma":[0.99964666,0.000082575156,0.00007799939,0.000030455121,0.0000074709396,0.000007904533,0.000088756125,0.000004550304,0.000053622258],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99668807,0.00089209067,0.00049011,0.00055093714,0.0007211539,0.000657629],"domain_scores_gemma":[0.97154266,0.0077703753,0.015955687,0.0005635109,0.0020284606,0.0021394594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00237329,0.00023845801,0.00027551464,0.0010051955,0.0005548344,0.0011265856,0.0005877037,0.00031807504,0.0028847437],"category_scores_gemma":[0.015869591,0.0002727084,0.00041531262,0.0013020482,0.00034545042,0.00060600607,0.00069922686,0.000684144,0.00033202325],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022284997,0.00003891255,0.9936593,0.00004570293,0.000049517515,0.00016915724,0.00036531032,0.00028940648,0.00022173952,0.00002997566,0.0002895724,0.0046184855],"study_design_scores_gemma":[0.0000070220335,0.00033617078,0.9960551,0.000053052656,0.00004623422,0.0005438781,0.0010742276,0.0008540315,0.00044088508,0.000026229329,0.0005513908,0.000011668723],"about_ca_topic_score_codex":0.014541482,"about_ca_topic_score_gemma":0.012012057,"teacher_disagreement_score":0.014541482,"about_ca_system_score_codex":0.002407749,"about_ca_system_score_gemma":0.001807892,"threshold_uncertainty_score":0.028913677},"labels":[],"label_agreement":null},{"id":"W4221120669","doi":"10.1111/jcmm.17260","title":"Novel chloroquine derivative suppresses melanoma cell growth by DNA damage through increasing ROS levels","year":2022,"lang":"en","type":"article","venue":"Journal of Cellular and Molecular Medicine","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"Project 211; National Natural Science Foundation of China","keywords":"Melanoma; Apoptosis; Cancer research; Chloroquine; DNA damage; Flow cytometry; Cell growth; Mutant; Chemistry; Biology; Molecular biology; Immunology; DNA; Biochemistry; Gene","score_opus":0.011514993698753037,"score_gpt":0.2278742348919947,"score_spread":0.21635924119324168,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221120669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97882277,0.013993028,0.003423416,0.00020978214,0.000057723937,0.00009682321,0.00036700265,0.000119156495,0.0029103172],"genre_scores_gemma":[0.9917595,0.0033775347,0.002932709,0.00009285617,0.000011861345,0.00003382223,0.00027973094,0.000006763227,0.0015052925],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99996746,0.000007193991,0.0000029893733,0.0000064345354,0.000008315265,0.000007565008],"domain_scores_gemma":[0.99997246,0.0000029877665,0.0000076233828,0.0000019711053,0.0000059186505,0.000008931357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000054275242,0.00029698116,0.00014069621,0.00020381603,0.00009330693,0.00009478899,0.0001531674,0.00019618882,0.00057984906],"category_scores_gemma":[0.000045909113,0.00007160642,0.00015717438,0.000078022815,0.000102902246,0.00012291918,0.000097862554,0.00026947554,0.00010584398],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015616967,0.000044335,0.00013101609,0.00016240998,0.0000050377535,0.00010919382,0.000009300356,0.00010469389,0.9970299,0.000060866172,0.00006500716,0.0021220348],"study_design_scores_gemma":[0.000080271726,0.0014822645,0.0023850473,0.0000142191975,0.000018478315,0.00041061686,0.000015200485,0.000548565,0.9897775,0.000030122947,0.005229387,0.000008288781],"about_ca_topic_score_codex":0.00030320542,"about_ca_topic_score_gemma":0.0008450236,"teacher_disagreement_score":0.00057984906,"about_ca_system_score_codex":0.00012621928,"about_ca_system_score_gemma":0.00014971843,"threshold_uncertainty_score":0.0019398332},"labels":[],"label_agreement":null},{"id":"W4223492952","doi":"10.1016/j.celrep.2022.110634","title":"Melanomas with concurrent BRAF non-p.V600 and NF1 loss-of-function mutations are targetable by BRAF/MEK inhibitor combination therapy","year":2022,"lang":"en","type":"article","venue":"Cell Reports","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University Health Centre; Sunnybrook Health Science Centre; Health Sciences Centre; University of British Columbia; McGill University","funders":"Canadian Institutes of Health Research","keywords":"Neuroblastoma RAS viral oncogene homolog; Melanoma; Mutant; Cancer research; MEK inhibitor; Mutation; Combination therapy; Trametinib; Context (archaeology); In vivo; Targeted therapy; Medicine; MAPK/ERK pathway; Biology; Kinase; Cancer; KRAS; Pharmacology; Genetics; Internal medicine; Gene","score_opus":0.006085928717589404,"score_gpt":0.20014177039258874,"score_spread":0.19405584167499934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4223492952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990961,0.0024998179,0.00097539084,0.00010339622,0.000025945574,0.000047267054,0.00006718856,0.00007203895,0.005247878],"genre_scores_gemma":[0.99811614,0.00045336707,0.00040499406,0.000036087982,0.000011121124,0.000010682288,0.00008421812,0.0000048779116,0.0008786424],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999099,0.0000152145185,0.000006394977,0.00001762631,0.000028376795,0.000022423414],"domain_scores_gemma":[0.99992657,0.000011952102,0.000021608617,0.0000090257745,0.000004934377,0.000025986066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012014117,0.00022941285,0.00029789767,0.00019530172,0.00018158286,0.00028069734,0.00010224221,0.00016691328,0.001213199],"category_scores_gemma":[0.00017862828,0.000116158786,0.00021294845,0.00011515277,0.00013900903,0.00014862235,0.00013230438,0.00039586076,0.00028333635],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012543804,0.0004268836,0.019546285,0.00008671414,0.000066442175,0.0062820762,0.000041236475,0.00026804992,0.93860024,0.00033087152,0.0005734347,0.03252339],"study_design_scores_gemma":[0.00044091063,0.008051787,0.3372891,0.000038187754,0.00028425903,0.12567371,0.00020082612,0.0047214357,0.50258374,0.00080191676,0.019880224,0.000033900433],"about_ca_topic_score_codex":0.0004198558,"about_ca_topic_score_gemma":0.0012476274,"teacher_disagreement_score":0.001213199,"about_ca_system_score_codex":0.00019429871,"about_ca_system_score_gemma":0.00015043624,"threshold_uncertainty_score":0.00405854},"labels":[],"label_agreement":null},{"id":"W4225272646","doi":"10.1101/2022.04.29.490009","title":"MEK inhibitor resistance in lung cancer cells associated with addiction to sustained ERK suppression","year":2022,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research; BC Cancer Foundation; Loxo Oncology; Japanese Respiratory Society; Michael Smith Health Research BC; Memorial Sloan-Kettering Cancer Center; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Trametinib; KRAS; MAPK/ERK pathway; MEK inhibitor; Cancer research; Mutant; Drug resistance; Mutation; Biology; Medicine; Kinase; Gene; Cell biology; Genetics","score_opus":0.0060579338931166056,"score_gpt":0.21419827142526218,"score_spread":0.2081403375321456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225272646","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918321,0.0005857976,0.0021584213,0.00016305684,0.000029835797,0.000028074737,0.0008686203,0.00014908952,0.0041850214],"genre_scores_gemma":[0.9921029,0.0002501736,0.0016175997,0.0000418615,0.0000063101497,0.000018629826,0.00096831145,0.000025814532,0.0049683847],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999249,0.000014554334,0.000008027279,0.000011249699,0.000025089326,0.000016284046],"domain_scores_gemma":[0.999956,0.000012692283,0.0000062433733,0.000010498196,0.000005790687,0.000008743326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010908408,0.00016724608,0.00015769048,0.00021790771,0.00015357572,0.00029903845,0.00011371275,0.00018664885,0.0019410296],"category_scores_gemma":[0.00010786416,0.00009177563,0.0001304369,0.0001304613,0.00012178866,0.00009692519,0.00018586547,0.00039197563,0.00084415526],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014827949,0.00003656306,0.0012906652,0.000018503386,0.000005417552,0.00029366088,0.000016235004,0.0001700949,0.99517894,0.00029355678,0.0002792768,0.0022687542],"study_design_scores_gemma":[0.00002153159,0.00020140965,0.009453134,0.0000032067949,0.00000709315,0.0018425975,0.000036845362,0.0025893769,0.9806615,0.00015778416,0.0050208704,0.000004643694],"about_ca_topic_score_codex":0.0006462323,"about_ca_topic_score_gemma":0.0005334912,"teacher_disagreement_score":0.0019410296,"about_ca_system_score_codex":0.00019902023,"about_ca_system_score_gemma":0.00008420993,"threshold_uncertainty_score":0.0064933896},"labels":[],"label_agreement":null},{"id":"W4225315024","doi":"10.2217/mmt-2021-0005","title":"Improved Overall Survival in Dual Compared to Single Immune Checkpoint Inhibitors in <i>BRAF</i> V600-Negative Advanced Melanoma","year":2022,"lang":"en","type":"article","venue":"Melanoma Management","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston Health Sciences Centre; Queen's University","funders":"","keywords":"Melanoma; Medicine; Hazard ratio; Retrospective cohort study; Adverse effect; Internal medicine; Oncology; Immune system; Immune checkpoint; Gastroenterology; Immunotherapy; Cancer; Cancer research; Immunology; Confidence interval","score_opus":0.010721805563873874,"score_gpt":0.22081334006982017,"score_spread":0.2100915345059463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225315024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961378,0.0031260378,0.00009290169,0.000051578987,0.000019129326,0.000008515765,0.00011134762,0.0000031848444,0.00044945665],"genre_scores_gemma":[0.99919325,0.00042774368,0.00007458608,0.00003562468,0.000017074854,0.0000061674937,0.00010153908,9.0236426e-7,0.00014308139],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99983644,0.000043254222,0.000015056767,0.000050102568,0.00002521969,0.000029863191],"domain_scores_gemma":[0.9996692,0.00006667149,0.0001528303,0.000015184797,0.000021732638,0.00007445642],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004355905,0.00015194419,0.00035447977,0.00022646868,0.00010093696,0.00039769354,0.00014065369,0.0001734874,0.000960578],"category_scores_gemma":[0.0006720437,0.0000669784,0.00040619925,0.00016359225,0.0001302993,0.0002632855,0.0002136458,0.00032537224,0.000097311095],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.048453115,0.001190457,0.7886461,0.00074883644,0.0012430967,0.00044186006,0.00010797528,0.0009615731,0.018459897,0.00015996885,0.00099511,0.13859196],"study_design_scores_gemma":[0.0013516417,0.023736252,0.9604721,0.00012302255,0.0013794932,0.0023448006,0.00019474493,0.0015064424,0.0050561717,0.00023260107,0.0035839663,0.00001872984],"about_ca_topic_score_codex":0.00020957734,"about_ca_topic_score_gemma":0.00051373267,"teacher_disagreement_score":0.000960578,"about_ca_system_score_codex":0.00023211604,"about_ca_system_score_gemma":0.00016907477,"threshold_uncertainty_score":0.0032134652},"labels":[],"label_agreement":null},{"id":"W4225533145","doi":"10.1186/s13046-021-02236-7","title":"Phase I pharmacokinetic study of single agent trametinib in patients with advanced cancer and hepatic dysfunction","year":2022,"lang":"en","type":"article","venue":"Journal of Experimental & Clinical Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute","keywords":"Pharmacokinetics; Medicine; Trametinib; Oncology; Internal medicine; Cancer; Pharmacology; Chemistry; MAPK/ERK pathway; Signal transduction","score_opus":0.10032305673022786,"score_gpt":0.47567527607257537,"score_spread":0.3753522193423475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225533145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974438,0.0005376829,0.00045724516,0.00012616134,0.000020796191,0.00050802965,0.00030630216,0.0000483997,0.00055143016],"genre_scores_gemma":[0.99679935,0.00031637694,0.00090008345,0.00015746141,0.00003268168,0.0005426335,0.0006513021,0.000011554469,0.00058858655],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99976,0.00008407204,0.0000134042075,0.000044766464,0.00004023662,0.000057549238],"domain_scores_gemma":[0.99952114,0.0000619577,0.00012835595,0.0000446088,0.000034203604,0.00020978038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065403804,0.0006179815,0.0011718973,0.00020064627,0.00031145618,0.00044792602,0.00036269502,0.00039416432,0.0017141837],"category_scores_gemma":[0.00061812607,0.00032275173,0.0005527952,0.00029552376,0.0003862403,0.0003922939,0.00021271082,0.0016205504,0.00040792802],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4111036,0.08480553,0.06389293,0.0007979348,0.0018758221,0.0010600134,0.0007997498,0.011426781,0.19586639,0.0004769355,0.008553697,0.21934061],"study_design_scores_gemma":[0.19699539,0.6757478,0.088559724,0.00004328688,0.00059552887,0.002558224,0.00012061345,0.007449661,0.020682026,0.00029337863,0.006889817,0.00006454391],"about_ca_topic_score_codex":0.00056667667,"about_ca_topic_score_gemma":0.0014601739,"teacher_disagreement_score":0.0017141837,"about_ca_system_score_codex":0.0007474828,"about_ca_system_score_gemma":0.0014371147,"threshold_uncertainty_score":0.0057344437},"labels":[],"label_agreement":null},{"id":"W4225994592","doi":"10.1016/j.jtocrr.2022.100324","title":"Clinical Outcomes With Dabrafenib Plus Trametinib in a Clinical Trial Versus Real-World Standard of Care in Patients With BRAF-Mutated Advanced NSCLC","year":2022,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Merck Sharp and Dohme; Roche; Novartis; Amgen; Pfizer; Les Laboratories Pierre Fabre; Novartis Pharmaceuticals Corporation; AstraZeneca; Takeda Pharmaceutical Company; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Dabrafenib; Hazard ratio; Medicine; Trametinib; Internal medicine; Oncology; Confidence interval; Proportional hazards model; Vemurafenib; Cancer","score_opus":0.07276526832441786,"score_gpt":0.4439244341244604,"score_spread":0.37115916580004255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225994592","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942684,0.0031873921,0.00025324064,0.00048278325,0.00024190494,0.00060014793,0.00024949867,0.00001844055,0.00069808983],"genre_scores_gemma":[0.9975,0.0006628746,0.00034255572,0.0001995246,0.000120897355,0.0005583772,0.0002927247,0.0000027343735,0.00032037776],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9980591,0.0012710242,0.0001558697,0.00024595403,0.000120410696,0.0001475829],"domain_scores_gemma":[0.99840504,0.0004021381,0.00053109066,0.00011117466,0.00011239293,0.00043826437],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00411096,0.0009735868,0.0016047766,0.0003416367,0.00028629426,0.0012745198,0.00061137177,0.0010555293,0.001982264],"category_scores_gemma":[0.0038704588,0.00030970716,0.0024919286,0.00031560205,0.00076858036,0.0009575297,0.0004324791,0.0018603198,0.00027262935],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9648887,0.004338646,0.004037527,0.00051621965,0.0024537859,0.000035974605,0.000051700717,0.001751348,0.0011843842,0.000116667594,0.00038357545,0.020241411],"study_design_scores_gemma":[0.72979045,0.23757094,0.024080561,0.00012492202,0.0026422811,0.00014619147,0.000068558824,0.003025631,0.0008672936,0.0004007738,0.0012398629,0.000042501684],"about_ca_topic_score_codex":0.00052304106,"about_ca_topic_score_gemma":0.0012848979,"teacher_disagreement_score":0.00411096,"about_ca_system_score_codex":0.0013768394,"about_ca_system_score_gemma":0.001064805,"threshold_uncertainty_score":0.021741092},"labels":[],"label_agreement":null},{"id":"W4231437775","doi":"10.3410/f.1123822.580910","title":"Faculty Opinions recommendation of The human ERG1 channel polymorphism, K897T, creates a phosphorylation site that inhibits channel activity.","year":2008,"lang":"en","type":"dataset","venue":"Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Channel (broadcasting); Phosphorylation; Psychology; Chemistry; Computer science; Telecommunications; Biochemistry","score_opus":0.03479540733954763,"score_gpt":0.3132672033714569,"score_spread":0.2784717960319093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4231437775","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011731243,0.00010869811,0.00008148312,0.00012167227,0.000019708783,0.00001119365,0.9973826,0.00021922322,0.0008823039],"genre_scores_gemma":[0.002035184,0.00008040188,0.00029166,0.000070394446,0.000008513087,0.00004046374,0.9962681,0.000035596207,0.001169667],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994305,0.00008887099,0.00006015503,0.00017531433,0.00016552,0.0000797139],"domain_scores_gemma":[0.99831533,0.0005292229,0.00031076567,0.0003229372,0.00033381872,0.00018799522],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007818927,0.0016618883,0.0012282295,0.0017932745,0.00045994623,0.0012386899,0.0020416987,0.0016262727,0.031582586],"category_scores_gemma":[0.0041130707,0.0004446719,0.0011465898,0.002744787,0.00021783376,0.000548312,0.00070083834,0.0011494532,0.025817472],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047801752,0.00006736764,0.0064319815,0.00096111913,0.00015549336,0.00008271021,0.000015695048,0.0006114634,0.00047661847,0.00024611267,0.98378223,0.00669116],"study_design_scores_gemma":[0.0015380507,0.00009510687,0.053400185,0.00038068098,0.0004048253,0.000344505,0.00007148921,0.0024481039,0.0027751143,0.0012359964,0.93723965,0.000066121494],"about_ca_topic_score_codex":0.018109491,"about_ca_topic_score_gemma":0.041479677,"teacher_disagreement_score":0.031582586,"about_ca_system_score_codex":0.0008055899,"about_ca_system_score_gemma":0.0017438403,"threshold_uncertainty_score":0.1056543},"labels":[],"label_agreement":null},{"id":"W4232359937","doi":"10.1515/iupac.88.1490","title":"Vimentin","year":2017,"lang":"it","type":"dataset","venue":"IUPAC Standards Online","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University of Toronto","funders":"","keywords":"Glossary; Terminology; Relation (database); Computer science; Linguistics; Data mining; Philosophy","score_opus":0.014453146301263787,"score_gpt":0.3957062548108621,"score_spread":0.3812531085095983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4232359937","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016948032,0.00021141424,0.00025362137,0.00018132885,0.000075562086,0.00004688764,0.9946148,0.000541864,0.0039050651],"genre_scores_gemma":[0.00048136184,0.0001763301,0.00056769635,0.00024402457,0.000018482557,0.00016202978,0.99606955,0.00014139486,0.0021391094],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972855,0.0004513272,0.0005310808,0.00089502113,0.00055715954,0.00027990958],"domain_scores_gemma":[0.99447167,0.0015383732,0.0005952478,0.0014235036,0.0016460887,0.00032514118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015834896,0.0013817659,0.0012321379,0.0038833383,0.0010539085,0.00375968,0.0023609025,0.0016973701,0.18443823],"category_scores_gemma":[0.015066739,0.0005992853,0.0017037424,0.0064515094,0.0004484355,0.0031580313,0.0024928036,0.0018265828,0.20492814],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011075964,0.000015356358,0.0014721233,0.0013658396,0.000035060122,0.000027476048,0.00003857621,0.00015069357,0.00015375165,0.0014517375,0.9849036,0.010274975],"study_design_scores_gemma":[0.000072740644,0.0000120017085,0.0024055932,0.0005987932,0.000021756092,0.000056830715,0.000071483526,0.00013871181,0.00019242201,0.0014287105,0.99498296,0.000017929862],"about_ca_topic_score_codex":0.013549384,"about_ca_topic_score_gemma":0.025561247,"teacher_disagreement_score":0.18443823,"about_ca_system_score_codex":0.0016593452,"about_ca_system_score_gemma":0.002946129,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W4232840593","doi":"10.1515/iupac.88.1255","title":"Protein Kinase","year":2017,"lang":"en","type":"dataset","venue":"IUPAC Standards Online","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University of Toronto","funders":"","keywords":"Glossary; Terminology; Relation (database); Computer science; Linguistics; Data mining; Philosophy","score_opus":0.013921763962676383,"score_gpt":0.3801489457770687,"score_spread":0.36622718181439234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4232840593","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023651206,0.0007658626,0.00015055489,0.00009746396,0.000042676907,0.000019446874,0.9963122,0.00028937028,0.0020858638],"genre_scores_gemma":[0.0007797508,0.0007183854,0.00043022854,0.00013157443,0.0000109215125,0.00009893444,0.9964036,0.00006554426,0.0013611584],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988368,0.00013854439,0.00024672243,0.00040565035,0.0002291354,0.00014321858],"domain_scores_gemma":[0.99851793,0.00039526128,0.0002794058,0.00036801246,0.00032576092,0.00011362548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007755273,0.0019003231,0.0016422677,0.0036809982,0.000926102,0.0029518325,0.0018636537,0.0016543745,0.08515434],"category_scores_gemma":[0.0045361356,0.00065816403,0.001829319,0.006680224,0.00035346707,0.0019818877,0.0015760658,0.00197722,0.11097842],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045771195,0.00003406112,0.0031983035,0.0057719788,0.00012723154,0.00008906911,0.000054879223,0.00058827625,0.0008669164,0.0016246244,0.96963227,0.017554574],"study_design_scores_gemma":[0.00015682132,0.00002473267,0.006684404,0.000911191,0.000088444154,0.0001826807,0.000055379143,0.00025569208,0.00065565255,0.001764659,0.9891806,0.000039730734],"about_ca_topic_score_codex":0.011953797,"about_ca_topic_score_gemma":0.019647237,"teacher_disagreement_score":0.08515434,"about_ca_system_score_codex":0.0014336174,"about_ca_system_score_gemma":0.0026469987,"threshold_uncertainty_score":0.28486967},"labels":[],"label_agreement":null},{"id":"W4234030450","doi":"10.2113/gscanmin.43.2.847","title":"ERRATA","year":2005,"lang":"en","type":"article","venue":"The Canadian Mineralogist","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Geology","score_opus":0.014865137677562241,"score_gpt":0.22357956046888375,"score_spread":0.20871442279132152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4234030450","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00029272717,0.0019739629,0.00063949084,0.09816888,0.8633507,0.000068752524,0.0026283462,0.00049439166,0.03238275],"genre_scores_gemma":[0.0085822465,0.005058885,0.0032916565,0.10042533,0.098345906,0.00021478157,0.0049960148,0.0017857673,0.7772994],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.994696,0.00070874067,0.00060857355,0.00065410195,0.002919716,0.00041282544],"domain_scores_gemma":[0.9630234,0.0042638276,0.0011509634,0.0022310347,0.027666397,0.0016643326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038384956,0.0010916246,0.0011469102,0.0037968215,0.005421017,0.004819337,0.0018462981,0.0032693818,0.15321244],"category_scores_gemma":[0.061910592,0.0006221478,0.0010487045,0.0023719931,0.0017501211,0.0020861865,0.0020522587,0.007977297,0.08687314],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010401102,0.0000017686015,0.000045318724,0.000024629659,0.0000019864942,0.000037666545,0.00001629785,0.000005890825,0.000010314601,0.00044561247,0.99626464,0.0031355221],"study_design_scores_gemma":[0.000009064521,0.000003745568,0.00026108633,0.000104400926,0.000009961583,0.00010456344,0.000087017615,0.000018220151,0.000089,0.00034369266,0.9989588,0.000010391186],"about_ca_topic_score_codex":0.108275436,"about_ca_topic_score_gemma":0.13109519,"teacher_disagreement_score":0.15321244,"about_ca_system_score_codex":0.007216891,"about_ca_system_score_gemma":0.01153979,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W4234696818","doi":"10.3410/f.732647410.793546173","title":"Faculty Opinions recommendation of MEK drives BRAF activation through allosteric control of KSR proteins.","year":2018,"lang":"en","type":"dataset","venue":"Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; National Institutes of Health; Canada Research Chairs","keywords":"Allosteric regulation; Kinase; Gene isoform; GTP'; Chemistry; Enzyme; Cell biology; Enzyme activator; Protein kinase domain; Domain (mathematical analysis); Computational biology; Biochemistry; Biology; Gene","score_opus":0.024391906352065805,"score_gpt":0.32756743757347645,"score_spread":0.30317553122141067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4234696818","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017710679,0.00042940502,0.000095090625,0.00016051755,0.000031790158,0.0000122149495,0.99511874,0.00041776578,0.0019632746],"genre_scores_gemma":[0.0038598485,0.0002695089,0.00037231317,0.000055747627,0.000011108091,0.000038481474,0.99430686,0.000059659447,0.0010264429],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993673,0.000085011314,0.000068666166,0.0002390339,0.00015895341,0.00008113074],"domain_scores_gemma":[0.99883956,0.00038629866,0.00022332704,0.00016780585,0.00023037687,0.00015254144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005356113,0.0012092659,0.0007682523,0.0020728519,0.00044422114,0.0013057727,0.0014439786,0.00091043505,0.038935646],"category_scores_gemma":[0.003584047,0.00026016287,0.0009983268,0.0032591156,0.00020880882,0.00067295186,0.0007465507,0.0009755791,0.028840186],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004066742,0.00005292715,0.018930724,0.004475868,0.0004005293,0.00014540837,0.00006422565,0.001126001,0.0013238781,0.00092475367,0.9571576,0.014991428],"study_design_scores_gemma":[0.00031568765,0.000041925785,0.026362708,0.00039070687,0.00020830645,0.00016716629,0.00006718257,0.001108159,0.0016996347,0.0007077861,0.96890646,0.000024250738],"about_ca_topic_score_codex":0.01542107,"about_ca_topic_score_gemma":0.0383176,"teacher_disagreement_score":0.038935646,"about_ca_system_score_codex":0.0010851016,"about_ca_system_score_gemma":0.0017210305,"threshold_uncertainty_score":0.13025266},"labels":[],"label_agreement":null},{"id":"W4236592345","doi":"10.3410/f.7127958.7358060","title":"Faculty Opinions recommendation of ERK1/2 MAP kinases promote cell cycle entry by rapid, kinase-independent disruption of retinoblastoma-lamin A complexes.","year":2010,"lang":"en","type":"dataset","venue":"Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Kinase; Retinoblastoma; Lamin; Mitogen-activated protein kinase; Cell biology; Chemistry; Cancer research; Biochemistry; Biology; Nucleus; Gene","score_opus":0.013630118544551971,"score_gpt":0.30005259364004166,"score_spread":0.2864224750954897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4236592345","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012110494,0.00033927153,0.000054425367,0.00012703368,0.000028202056,0.000010013721,0.9970752,0.00025668583,0.0008980524],"genre_scores_gemma":[0.002188468,0.00017359002,0.0002413382,0.00005491716,0.000009847335,0.000033845,0.9963476,0.000032870874,0.00091751944],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99911636,0.00014122836,0.00009238586,0.000293026,0.0002339634,0.00012300606],"domain_scores_gemma":[0.99831593,0.0005443601,0.0002798041,0.00029077576,0.00033626132,0.00023288364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087205507,0.002016927,0.0012098656,0.0024008774,0.0005507211,0.0019323619,0.0018022517,0.0015446411,0.029567236],"category_scores_gemma":[0.0048093214,0.00043539456,0.0014721776,0.0035653673,0.00026905813,0.0007894397,0.0010762485,0.001187238,0.026626468],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057964283,0.00008079699,0.0066035846,0.002035221,0.00027298546,0.00006820785,0.00002461177,0.0009016888,0.0006865966,0.00036526585,0.9801533,0.008227963],"study_design_scores_gemma":[0.001413848,0.000104075036,0.04527065,0.0005620489,0.0004640246,0.00021075828,0.00009727578,0.0023432088,0.002896284,0.0011977828,0.9453756,0.00006450086],"about_ca_topic_score_codex":0.025456207,"about_ca_topic_score_gemma":0.0651965,"teacher_disagreement_score":0.029567236,"about_ca_system_score_codex":0.0013767305,"about_ca_system_score_gemma":0.0023374788,"threshold_uncertainty_score":0.0989123},"labels":[],"label_agreement":null},{"id":"W4237501644","doi":"10.1016/s1701-2163(15)30225-5","title":"ERRATA","year":2015,"lang":"en","type":"article","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Gynecology","score_opus":0.016453142509333683,"score_gpt":0.21714037484115087,"score_spread":0.20068723233181718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237501644","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020109839,0.001458153,0.00033654334,0.06578088,0.9215382,0.000041986335,0.0014732793,0.00022653547,0.008943278],"genre_scores_gemma":[0.012351497,0.008907492,0.0039698286,0.18305379,0.2761716,0.0003881181,0.006758305,0.0022888936,0.5061105],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99462366,0.00081241183,0.0009168884,0.0006983063,0.0025253901,0.00042336792],"domain_scores_gemma":[0.95362973,0.006869542,0.0018363302,0.0026629223,0.03273718,0.0022642415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003920713,0.0012661796,0.0012710656,0.004141348,0.004193995,0.004583346,0.0019717228,0.0035255437,0.1159196],"category_scores_gemma":[0.07465131,0.00069828297,0.0012136931,0.002222436,0.0016977531,0.0018615297,0.0019995158,0.009525806,0.0726617],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017081842,0.0000028693141,0.00007410737,0.00004798879,0.000003711207,0.00008278114,0.000016528287,0.0000073833125,0.00001474534,0.0002449316,0.9962884,0.0031995045],"study_design_scores_gemma":[0.000016111744,0.000007711694,0.0004932101,0.0002257893,0.000017786295,0.00025491146,0.000108300395,0.000023491531,0.00013122556,0.0003634524,0.99834216,0.000015948583],"about_ca_topic_score_codex":0.045987092,"about_ca_topic_score_gemma":0.052753516,"teacher_disagreement_score":0.1159196,"about_ca_system_score_codex":0.005440854,"about_ca_system_score_gemma":0.01018341,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W4238150434","doi":"10.3410/f.718281745.793492031","title":"Faculty Opinions recommendation of Mapping the molecular determinants of BRAF oncogene dependence in human lung cancer.","year":2014,"lang":"en","type":"dataset","venue":"Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Oncogene; Lung cancer; Computational biology; Cancer; Human lung; Cancer research; Oncology; Biology; Internal medicine; Medicine; Lung","score_opus":0.03207066754461356,"score_gpt":0.36094466241952294,"score_spread":0.32887399487490937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4238150434","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002036213,0.00010876863,0.00006371461,0.00011443491,0.00002227865,0.000010621888,0.9986981,0.00023978866,0.00053870014],"genre_scores_gemma":[0.0009161959,0.00011408893,0.00029951127,0.00011172158,0.000013874682,0.000060633334,0.997633,0.000062596235,0.00078836957],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99884677,0.0001796772,0.00014277038,0.00037490678,0.000292976,0.00016289784],"domain_scores_gemma":[0.99613035,0.0012247002,0.0005328574,0.0007614246,0.0008021382,0.00054851203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001463986,0.0017243046,0.0018270749,0.0033189466,0.0005722471,0.0025664372,0.0028007552,0.0023408227,0.08321366],"category_scores_gemma":[0.010508788,0.00070558913,0.0017464851,0.004839644,0.00034608613,0.0012569514,0.0018262828,0.001581116,0.06097233],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015875595,0.000025290752,0.0028310514,0.001118242,0.000114240036,0.000029600047,0.000012192148,0.0002685152,0.0001762935,0.00023144366,0.9911548,0.0038794542],"study_design_scores_gemma":[0.0010273672,0.000043731885,0.022412932,0.0006994029,0.0002762915,0.00015484587,0.000056056968,0.00088964525,0.0007742511,0.0017059668,0.9719088,0.00005072039],"about_ca_topic_score_codex":0.020081418,"about_ca_topic_score_gemma":0.04538908,"teacher_disagreement_score":0.08321366,"about_ca_system_score_codex":0.001350852,"about_ca_system_score_gemma":0.0031733448,"threshold_uncertainty_score":0.2783774},"labels":[],"label_agreement":null},{"id":"W4238605545","doi":"10.1161/res.121.suppl_1.111","title":"Abstract 111: Reduced MK5 Expression Alters Migration, Proliferation, and Collagen Biosynthesis in Murine Ventricular Fibroblasts","year":2017,"lang":"en","type":"article","venue":"Circulation Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"","keywords":"Cytoplasm; Fibroblast; Cell biology; Kinase; Protein kinase A; Biology; Molecular biology; Chemistry; Endocrinology; Internal medicine; Medicine; Biochemistry; In vitro","score_opus":0.0480049123205058,"score_gpt":0.3347805609489195,"score_spread":0.2867756486284137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4238605545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935662,0.001291684,0.0017511762,0.00012008067,0.000063474195,0.000019932699,0.0010970386,0.00009734292,0.0019929747],"genre_scores_gemma":[0.98954064,0.0006709605,0.0017427733,0.00010505954,0.0000139914355,0.000048681784,0.0014010398,0.00004981486,0.00642694],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99983037,0.000018871833,0.000028862329,0.00004057509,0.000044944238,0.000036393343],"domain_scores_gemma":[0.9998747,0.000014569185,0.000040385832,0.000012981998,0.000010434034,0.00004681743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008305087,0.00033893663,0.00022240725,0.00017923379,0.0001524626,0.00028375888,0.00019820253,0.00031425306,0.0028423974],"category_scores_gemma":[0.00007355121,0.00016514951,0.00023745363,0.00012389247,0.00020631091,0.00018265707,0.00020905504,0.0005868881,0.0007379189],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010145507,0.000020708294,0.00008290913,0.000035566496,0.0000027144727,0.000039589297,0.000009082538,0.000016079319,0.99921715,0.000034371024,0.00003289956,0.00040743814],"study_design_scores_gemma":[0.000018181327,0.00029864415,0.005893096,0.000009290693,0.000018795765,0.00022130704,0.000027831742,0.00038588094,0.9911841,0.00002822873,0.0019110272,0.0000035930411],"about_ca_topic_score_codex":0.0006485491,"about_ca_topic_score_gemma":0.0007750966,"teacher_disagreement_score":0.0028423974,"about_ca_system_score_codex":0.0002574383,"about_ca_system_score_gemma":0.0001586863,"threshold_uncertainty_score":0.009508789},"labels":[],"label_agreement":null},{"id":"W4239344658","doi":"10.1002/9780471420194.tnmm52","title":"Melanoma","year":2017,"lang":"en","type":"other","venue":"TNM Online","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Melanoma; Immunotherapy; Targeted therapy; Metastatic melanoma; Disease; Oncology; Chemotherapy; Internal medicine; Dermatology; Surgery; Cancer; Cancer research","score_opus":0.01503629735674408,"score_gpt":0.27086701819224546,"score_spread":0.2558307208355014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239344658","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01079776,0.034993295,0.0031460663,0.004771509,0.003962633,0.00024256828,0.009453639,0.0011892418,0.9314433],"genre_scores_gemma":[0.05614051,0.02084342,0.002771724,0.0019292457,0.0008768391,0.00011593891,0.011341657,0.00028420496,0.9056965],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99985087,0.000017664948,0.000010187929,0.000027490678,0.00006632716,0.000027505677],"domain_scores_gemma":[0.9998375,0.000010851583,0.000019738423,0.000019976693,0.000054093776,0.000057706766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019019049,0.00066253135,0.00023442398,0.0008484817,0.00053982297,0.0011263513,0.0003972765,0.0005083043,0.15778574],"category_scores_gemma":[0.00043909976,0.00013509837,0.0002730893,0.00053243124,0.00019555887,0.00044075958,0.0007525965,0.00083360757,0.110004574],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017880466,0.00010441636,0.001979191,0.0008876905,0.000023466777,0.0013028982,0.0000838625,0.00021226716,0.017883109,0.017513223,0.4319403,0.5278908],"study_design_scores_gemma":[0.0000107992955,0.000024054527,0.0012074222,0.000100556645,0.0000063701505,0.0013216479,0.00002342079,0.000060091057,0.0018757435,0.0011159468,0.99425054,0.0000034013751],"about_ca_topic_score_codex":0.0011504852,"about_ca_topic_score_gemma":0.0017799523,"teacher_disagreement_score":0.15778574,"about_ca_system_score_codex":0.00053611206,"about_ca_system_score_gemma":0.0005521723,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W4240418344","doi":"10.3410/f.737102223.793579864","title":"Faculty Opinions recommendation of Metabolic heterogeneity confers differences in melanoma metastatic potential.","year":2020,"lang":"en","type":"dataset","venue":"Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Metastatic melanoma; Melanoma; Computational biology; Medicine; Internal medicine; Oncology; Cancer research; Biology","score_opus":0.03795361420794748,"score_gpt":0.3287469055302956,"score_spread":0.29079329132234816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4240418344","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00026682948,0.000142334,0.000053992684,0.00023277674,0.00004480041,0.000010004286,0.9978795,0.00020568116,0.0011641196],"genre_scores_gemma":[0.0016117302,0.00015286115,0.00034072725,0.00023741575,0.000028146438,0.000052864845,0.99532336,0.00009171717,0.002161099],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9987249,0.00021497389,0.00013456059,0.0004132747,0.0003240664,0.0001882028],"domain_scores_gemma":[0.9952461,0.0015795283,0.0006092624,0.00083698845,0.0010783874,0.00064982445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014882917,0.0014267409,0.0014210518,0.0024927692,0.00069105794,0.0029530665,0.0021994798,0.0024869768,0.12797631],"category_scores_gemma":[0.013110989,0.0005532591,0.0016592424,0.003589739,0.00030956222,0.0013952565,0.0018169363,0.0016074268,0.094056815],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013021658,0.00001914183,0.0025721868,0.00069688517,0.00006857516,0.000020976566,0.000012270694,0.00011293826,0.00014107836,0.00022129853,0.99309796,0.002906485],"study_design_scores_gemma":[0.0005707908,0.000032376593,0.015494076,0.00066596625,0.00018639068,0.00014814753,0.00006532982,0.00058064034,0.0005671876,0.0016659877,0.9799841,0.000039054743],"about_ca_topic_score_codex":0.017573655,"about_ca_topic_score_gemma":0.050446443,"teacher_disagreement_score":0.12797631,"about_ca_system_score_codex":0.0012188427,"about_ca_system_score_gemma":0.002548173,"threshold_uncertainty_score":0.4281234},"labels":[],"label_agreement":null},{"id":"W4241605155","doi":"10.1016/j.ejca.2012.06.013","title":"Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline – Update 2012","year":2012,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":229,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Cancer Research UK","keywords":"Medicine; Ipilimumab; Melanoma; Guideline; Oncology; Vemurafenib; Internal medicine; Stage (stratigraphy); Systemic therapy; Adjuvant therapy; Skin cancer; Cancer; Surgery; Dermatology; Breast cancer; Immunotherapy; Pathology; Cancer research; Metastatic melanoma","score_opus":0.02186877716028896,"score_gpt":0.2939923508756755,"score_spread":0.27212357371538654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241605155","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010222288,0.7900345,0.012147832,0.11732774,0.014807692,0.00083874405,0.011629099,0.00070646644,0.042285718],"genre_scores_gemma":[0.08906148,0.656047,0.053885754,0.1002351,0.008220542,0.0023080509,0.058452748,0.00043153204,0.03135774],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99841833,0.00034505164,0.00040139322,0.00010744386,0.0005722625,0.00015562333],"domain_scores_gemma":[0.99782383,0.0003927497,0.00038269316,0.000045513232,0.0011326947,0.00022257969],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023220775,0.001296302,0.0023978313,0.0026977307,0.00049406773,0.000953445,0.0023753943,0.0038125974,0.0016312865],"category_scores_gemma":[0.0036521656,0.0005326147,0.0020314297,0.0022210227,0.00033360076,0.0008749061,0.0009091747,0.0041402937,0.0016123895],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032641378,0.00019623865,0.0025188904,0.0029371022,0.00027172282,0.00046762012,0.00005121051,0.0013816046,0.0010708831,0.0005868692,0.6701149,0.32007658],"study_design_scores_gemma":[0.0008736979,0.00030592707,0.036452215,0.014570245,0.0015941659,0.0054252837,0.00020864225,0.0023737752,0.0017785062,0.0022990573,0.9339981,0.00012036287],"about_ca_topic_score_codex":0.014857527,"about_ca_topic_score_gemma":0.03246199,"teacher_disagreement_score":0.014857527,"about_ca_system_score_codex":0.002056615,"about_ca_system_score_gemma":0.0034786984,"threshold_uncertainty_score":0.029542089},"labels":[],"label_agreement":null},{"id":"W4242515395","doi":"10.1007/978-1-4419-0461-4_193","title":"Mitogen-Activated Protein Kinases","year":2012,"lang":"en","type":"book-chapter","venue":"","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Mitogen-activated protein kinase; Kinase; Cell biology; Biology","score_opus":0.018690065625357133,"score_gpt":0.2155802233983124,"score_spread":0.19689015777295527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242515395","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0024539086,0.14076625,0.024478713,0.0021288802,0.004043644,0.00010143512,0.0007277812,0.00087731355,0.82442206],"genre_scores_gemma":[0.006406011,0.05021985,0.006327953,0.0006683771,0.00051057566,0.000082155864,0.0005791398,0.000079401085,0.93512666],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999168,0.0000051673906,0.0000026971497,0.000019138162,0.00004621652,0.000009921706],"domain_scores_gemma":[0.99997747,0.0000048770958,0.000002045675,0.00000371066,0.00000681191,0.0000051269167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011496615,0.0011944859,0.00041332125,0.00079322327,0.0003700552,0.0010539106,0.00061622495,0.0004674918,0.041565415],"category_scores_gemma":[0.0001230706,0.00023490343,0.0002691859,0.0008376178,0.000321957,0.001092649,0.00071998296,0.0014137606,0.050736707],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006898457,0.00010022983,0.000051416573,0.0005750801,0.000011740306,0.00015586619,0.0000875166,0.00041411276,0.046678025,0.051401656,0.2019198,0.6985356],"study_design_scores_gemma":[0.0000033736392,0.000014212195,0.00008353107,0.00004658249,0.00000362285,0.00016782407,0.0000100518655,0.00006884084,0.004931815,0.005338702,0.98932785,0.0000036370743],"about_ca_topic_score_codex":0.00031802533,"about_ca_topic_score_gemma":0.0010050097,"teacher_disagreement_score":0.041565415,"about_ca_system_score_codex":0.0004867959,"about_ca_system_score_gemma":0.0003548194,"threshold_uncertainty_score":0.13905019},"labels":[],"label_agreement":null},{"id":"W4242647017","doi":"10.3410/f.725372069.793506833","title":"Faculty Opinions recommendation of Structural assembly of the signaling competent ERK2-RSK1 heterodimeric protein kinase complex.","year":2015,"lang":"en","type":"dataset","venue":"Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Protein kinase A; Cell biology; Kinase; Chemistry; Computational biology; Biology","score_opus":0.044033456622931774,"score_gpt":0.3392537000004153,"score_spread":0.29522024337748354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242647017","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000494881,0.00034950304,0.00009592942,0.00009500559,0.000023178309,0.000010363727,0.9976406,0.00047840935,0.00081218436],"genre_scores_gemma":[0.0010838518,0.00013261294,0.00026383693,0.00006286298,0.000005276968,0.00002539032,0.99791926,0.000043275773,0.00046365103],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99899226,0.00012926439,0.0000928593,0.00034514582,0.00029966887,0.00014086379],"domain_scores_gemma":[0.9982681,0.0005183954,0.0002798804,0.00033430214,0.00033760484,0.0002616608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010548135,0.0026493352,0.0016640677,0.002313796,0.00073390047,0.0021234318,0.002723103,0.0030150728,0.049000967],"category_scores_gemma":[0.004935973,0.0007194157,0.0019108824,0.003346186,0.00032816976,0.0013122327,0.0014730507,0.0017375544,0.047111988],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043688194,0.00006436964,0.0037258698,0.0027107233,0.00019475393,0.00006828139,0.000026316287,0.00079446146,0.0009477994,0.000615456,0.9857328,0.0046823053],"study_design_scores_gemma":[0.0009093862,0.00007735284,0.01662274,0.00068696303,0.00029066452,0.0001959549,0.000063759435,0.0021464953,0.00256662,0.002128837,0.97425735,0.000053945136],"about_ca_topic_score_codex":0.020235656,"about_ca_topic_score_gemma":0.052486204,"teacher_disagreement_score":0.049000967,"about_ca_system_score_codex":0.0016400527,"about_ca_system_score_gemma":0.002766747,"threshold_uncertainty_score":0.16392457},"labels":[],"label_agreement":null},{"id":"W4243158089","doi":"10.5858/2007-131-1361-bmimla","title":"BRAF Mutations in Melanocytic Lesions and Papillary Thyroid Carcinoma Samples Identified Using Melting Curve Analysis of Polymerase Chain Reaction Products","year":2007,"lang":"en","type":"article","venue":"Archives of Pathology & Laboratory Medicine","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of Calgary","funders":"","keywords":"Polymerase chain reaction; Thyroid carcinoma; V600E; Mutation; Pathology; Context (archaeology); Molecular biology; Melanoma; Concordance; Digital polymerase chain reaction; Melting curve analysis; Carcinoma; Biology; Cancer research; Medicine; Gene; Thyroid; Genetics","score_opus":0.02144916971540927,"score_gpt":0.2794666409867749,"score_spread":0.2580174712713656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243158089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917889,0.00055721897,0.0063755796,0.00003309393,0.000016589822,0.000098095974,0.0003766068,0.00010879536,0.0006452308],"genre_scores_gemma":[0.9789114,0.0002891194,0.018288074,0.000048965238,0.000011443436,0.00015745421,0.0014224809,0.000030481944,0.0008405686],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99910396,0.00012712146,0.00010840929,0.00030009254,0.00026760795,0.00009278152],"domain_scores_gemma":[0.99915683,0.0004174599,0.0001283443,0.000068013476,0.00017112825,0.000058084534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073599286,0.00037005256,0.00015804527,0.0012637693,0.00019364215,0.00031597688,0.00024454456,0.00040047764,0.0007153494],"category_scores_gemma":[0.0018797732,0.00029385963,0.0002847687,0.0004038552,0.0004067491,0.00013721078,0.00014770954,0.00024257766,0.0003035369],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003841142,0.000119755205,0.03725391,0.00010031423,0.000042785712,0.0003717736,0.00038568815,0.00027279236,0.9548903,0.000101142665,0.000077256685,0.006000328],"study_design_scores_gemma":[0.000030972496,0.0009860172,0.14752164,0.00004828965,0.00013023206,0.0042426335,0.00033150477,0.0076679904,0.83676344,0.00015789806,0.0020896601,0.000029530105],"about_ca_topic_score_codex":0.0010972499,"about_ca_topic_score_gemma":0.0014448776,"teacher_disagreement_score":0.0012637693,"about_ca_system_score_codex":0.00033617983,"about_ca_system_score_gemma":0.00021711818,"threshold_uncertainty_score":0.0038923621},"labels":[],"label_agreement":null},{"id":"W4244027507","doi":"10.1128/.20.10.3442-3448.2000","title":"Deficient Gene Expression in Protein Kinase Inhibitor α Null Mutant Mice","year":2000,"lang":"en","type":"article","venue":"Molecular and Cellular Biology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Nutrition, Metabolism and Diabetes","funders":"","keywords":"Biology; Mutant; Gene; Molecular biology; Gene expression; Protein kinase A; Kinase; Genetics; Cell biology","score_opus":0.0048735671419802085,"score_gpt":0.19712885734831215,"score_spread":0.19225529020633195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244027507","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96936595,0.0021884437,0.015353897,0.0006384122,0.00028930616,0.000173578,0.0041608214,0.0011563255,0.0066732652],"genre_scores_gemma":[0.9515898,0.0028238047,0.01221496,0.00022262486,0.00009460022,0.00027224747,0.0022002545,0.0007082098,0.029873574],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99931383,0.000065188695,0.0000828073,0.00020337413,0.000202158,0.00013270785],"domain_scores_gemma":[0.9985594,0.00017666974,0.00060606736,0.00013730045,0.000089700145,0.00043083262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037811432,0.0015890646,0.0006925605,0.002941993,0.00052031514,0.0012274466,0.0009983573,0.0011632589,0.005219908],"category_scores_gemma":[0.00042278867,0.0009460156,0.0006838037,0.00067010045,0.0011855875,0.0007389256,0.0005792356,0.0024704777,0.0019490237],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019562448,0.000033165245,0.00012216977,0.000021778504,0.0000081947055,0.00017908063,0.000017357757,0.000058364898,0.99821126,0.0005857532,0.00005950339,0.000507667],"study_design_scores_gemma":[0.00008867833,0.00015616551,0.0020146458,0.000020319038,0.000058002857,0.0013803518,0.00005426151,0.00087469263,0.9917856,0.0003428135,0.0032097907,0.000014584148],"about_ca_topic_score_codex":0.0009896184,"about_ca_topic_score_gemma":0.0008952884,"teacher_disagreement_score":0.005219908,"about_ca_system_score_codex":0.00079871895,"about_ca_system_score_gemma":0.00051309913,"threshold_uncertainty_score":0.017462313},"labels":[],"label_agreement":null},{"id":"W4245477498","doi":"10.1007/978-1-4614-6438-9_382-1","title":"RSK (p90 Ribosomal S6 Kinase)","year":2016,"lang":"en","type":"book-chapter","venue":"","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Ribosomal s6 kinase; Chemistry; Biochemistry; P70-S6 Kinase 1; Phosphorylation; Protein kinase B","score_opus":0.011135923531443534,"score_gpt":0.20667481781722633,"score_spread":0.1955388942857828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4245477498","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005015885,0.27055252,0.027498836,0.0031405375,0.0066438275,0.00009411181,0.0015589071,0.002017722,0.68347776],"genre_scores_gemma":[0.013367196,0.09642712,0.009641206,0.0007486331,0.00079271116,0.000062283565,0.0011867218,0.00023272727,0.8775414],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999925,0.0000038878707,0.0000035110452,0.000021091942,0.000038470032,0.000008061696],"domain_scores_gemma":[0.99997663,0.0000049272694,0.000003538168,0.0000029849593,0.0000071533514,0.000004767787],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001290556,0.0008853986,0.00035337327,0.00065767905,0.00022395318,0.0009952214,0.00048540934,0.00047442358,0.021774985],"category_scores_gemma":[0.0001235263,0.00019984895,0.00028086922,0.0007389079,0.00028525808,0.0011358324,0.00055144564,0.0012310441,0.036405277],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009368046,0.000052785894,0.00006187998,0.0006596944,0.000010285209,0.00016128286,0.000051155694,0.00065111584,0.040385522,0.029699227,0.16586909,0.7623043],"study_design_scores_gemma":[0.000003773455,0.000016590715,0.000099126606,0.00003469816,0.0000038568883,0.00025206606,0.0000068989248,0.00008750112,0.005829993,0.0029098613,0.9907512,0.0000044860913],"about_ca_topic_score_codex":0.00055062055,"about_ca_topic_score_gemma":0.0012199739,"teacher_disagreement_score":0.021774985,"about_ca_system_score_codex":0.0005615456,"about_ca_system_score_gemma":0.0003607403,"threshold_uncertainty_score":0.072844565},"labels":[],"label_agreement":null},{"id":"W4246100262","doi":"10.1007/978-1-4419-0461-4_542","title":"Erk3 and Erk4","year":2012,"lang":"en","type":"book-chapter","venue":"","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"History","score_opus":0.012906163130893879,"score_gpt":0.2016056041995225,"score_spread":0.18869944106862863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4246100262","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010748825,0.13750128,0.030698359,0.0040184334,0.004187585,0.00010289858,0.0009893334,0.0006766533,0.81107664],"genre_scores_gemma":[0.020556597,0.05115434,0.008557826,0.0007922987,0.00035668915,0.000078655925,0.0007220019,0.00012415083,0.9176574],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999232,0.0000050924264,0.0000030886981,0.000019061708,0.000035316636,0.000014192599],"domain_scores_gemma":[0.9999782,0.000003874689,0.0000024249864,0.000002881336,0.000008230346,0.0000043966984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011894564,0.000910842,0.00029323806,0.0006096311,0.00040360118,0.001123375,0.00053994235,0.0005395318,0.027007623],"category_scores_gemma":[0.00010427208,0.00027713669,0.00033296912,0.0006447619,0.00036574565,0.0010606131,0.0005488225,0.0016401034,0.020048369],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017788059,0.000121107165,0.00012899895,0.0008883187,0.000023995035,0.00033744506,0.0001491079,0.0009135161,0.11252055,0.1160834,0.122368135,0.6462876],"study_design_scores_gemma":[0.0000057416673,0.000022937711,0.00028009005,0.00006126998,0.000008432391,0.0004302671,0.000031877764,0.00020163781,0.026981859,0.012384865,0.9595813,0.000009642251],"about_ca_topic_score_codex":0.00057724025,"about_ca_topic_score_gemma":0.0014495689,"teacher_disagreement_score":0.027007623,"about_ca_system_score_codex":0.00060681585,"about_ca_system_score_gemma":0.00051979534,"threshold_uncertainty_score":0.090349436},"labels":[],"label_agreement":null},{"id":"W4246498996","doi":"10.1128/mmbr.00013-12","title":"Activation and Function of the MAPKs and Their Substrates, the MAPK-Activated Protein Kinases","year":2012,"lang":"en","type":"article","venue":"Microbiology and Molecular Biology Reviews","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":182,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Biology; Kinase; MAPK/ERK pathway; Function (biology); Cell biology; Mitogen-activated protein kinase; Protein-Serine-Threonine Kinases; p38 mitogen-activated protein kinases; Protein kinase A; Computational biology","score_opus":0.013875150653033878,"score_gpt":0.22869412866250177,"score_spread":0.2148189780094679,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4246498996","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.058640674,0.8921496,0.019421754,0.0063063037,0.0011747209,0.00004572464,0.00022609632,0.00011729499,0.02191785],"genre_scores_gemma":[0.305659,0.6652139,0.009890402,0.0010286514,0.0012174663,0.00006945235,0.00026843775,0.000038690647,0.01661392],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99976915,0.00004064154,0.000016652648,0.00004585787,0.00008820532,0.00003950211],"domain_scores_gemma":[0.9998673,0.000032410633,0.000028770943,0.000010220659,0.00003675626,0.000024603343],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063557306,0.0007501688,0.00031090173,0.00050611125,0.0003608665,0.0012109529,0.00042761496,0.00088121183,0.0012616761],"category_scores_gemma":[0.0005365724,0.000301168,0.00029898685,0.00045355284,0.0009500636,0.0013775897,0.00052192225,0.0017744799,0.00083641184],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044476034,0.00010476876,0.0006283723,0.0023549572,0.00004201313,0.00058582023,0.00022098221,0.0012513926,0.7794641,0.051438347,0.006277042,0.15718739],"study_design_scores_gemma":[0.000052439424,0.00038212232,0.009236912,0.0004659549,0.00006192944,0.0047912197,0.0004240456,0.0015481077,0.463658,0.04524672,0.4740369,0.000095686315],"about_ca_topic_score_codex":0.00033787603,"about_ca_topic_score_gemma":0.00035151414,"teacher_disagreement_score":0.0012616761,"about_ca_system_score_codex":0.00084787636,"about_ca_system_score_gemma":0.0005276491,"threshold_uncertainty_score":0.0061517954},"labels":[],"label_agreement":null},{"id":"W4247001916","doi":"10.1007/978-3-662-48986-4_310576","title":"BÄK","year":2019,"lang":"de","type":"book-chapter","venue":"Springer Reference Medizin","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Mathematics","score_opus":0.030438737332141114,"score_gpt":0.24122985714062195,"score_spread":0.21079111980848084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247001916","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008272908,0.005392829,0.0020802966,0.0020328802,0.0025087835,0.00003981606,0.0012806978,0.0007327315,0.98510474],"genre_scores_gemma":[0.0032846394,0.0020823337,0.00092206564,0.00055228785,0.00025775147,0.000035862307,0.0009576752,0.0002619553,0.9916455],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996049,0.000042235442,0.000022415443,0.00012304427,0.0001476289,0.000059861053],"domain_scores_gemma":[0.99976104,0.00003443049,0.000018647263,0.000052274307,0.00008827395,0.00004533068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035003707,0.0011915353,0.0005129571,0.0016315962,0.001226097,0.004064339,0.0007728865,0.0013279781,0.5592649],"category_scores_gemma":[0.0009973609,0.0003039959,0.00034651434,0.0013402432,0.0005501062,0.0026459491,0.0022640475,0.002210365,0.5298292],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008764718,0.000047213667,0.00027642478,0.00028147787,0.000007700373,0.00022897992,0.0002739031,0.00014125621,0.0026736595,0.08122976,0.52001804,0.39473397],"study_design_scores_gemma":[0.0000023057548,0.000004907889,0.00010377104,0.000038453407,0.0000012962613,0.00011537975,0.00004188625,0.000027202383,0.00025859408,0.0029864379,0.9964169,0.0000028033603],"about_ca_topic_score_codex":0.0014880162,"about_ca_topic_score_gemma":0.0022082028,"teacher_disagreement_score":0.5592649,"about_ca_system_score_codex":0.0009035062,"about_ca_system_score_gemma":0.00078037934,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W4249533637","doi":"10.15562/bdv.v3i2.38","title":"Focus on the dabrafenib, vemurafenib, and trametinib in clinical outcome of melanoma: a systematic review and meta-analysis","year":2020,"lang":"en","type":"review","venue":"Bali Dermatology and Venereology Journal","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Trametinib; Dabrafenib; Vemurafenib; Medicine; Oncology; Internal medicine; Melanoma; MEK inhibitor; Targeted therapy; Randomized controlled trial; Meta-analysis; Cancer; Cancer research; Metastatic melanoma; MAPK/ERK pathway","score_opus":0.10863957499082004,"score_gpt":0.3745808384374596,"score_spread":0.26594126344663954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249533637","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019900831,0.9967186,0.00024999687,0.00020406446,0.00008430424,0.00015583976,0.00041376485,0.000012334944,0.00017097639],"genre_scores_gemma":[0.10560778,0.88982743,0.0012434149,0.0010216996,0.00021759798,0.0009206916,0.00081541995,0.000029662675,0.0003162477],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9892196,0.004658224,0.0033507382,0.001086374,0.0012945601,0.00039049238],"domain_scores_gemma":[0.976824,0.017078053,0.003487553,0.00049392885,0.0018186517,0.00029774473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01575955,0.0030187268,0.019431654,0.008432922,0.0006782024,0.0035990176,0.002214914,0.0021953615,0.0045168563],"category_scores_gemma":[0.03489322,0.0011745726,0.040180527,0.009596531,0.0007122267,0.0020930753,0.0016945138,0.0018024851,0.00032355494],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009205907,0.000020303605,0.003389616,0.5946163,0.38998246,0.00012828346,0.00008856005,0.00034222464,0.00015150152,0.0001732804,0.00067808025,0.009508756],"study_design_scores_gemma":[0.0002822956,0.00012398101,0.0032811777,0.05478493,0.93884456,0.0001195072,0.00006290372,0.00012447563,0.000084867046,0.00019360859,0.0020761597,0.000021470807],"about_ca_topic_score_codex":0.009239283,"about_ca_topic_score_gemma":0.022200624,"teacher_disagreement_score":0.019431654,"about_ca_system_score_codex":0.0032813733,"about_ca_system_score_gemma":0.0056493985,"threshold_uncertainty_score":0.08334541},"labels":[],"label_agreement":null},{"id":"W4252336504","doi":"10.3410/f.725693254.793509614","title":"Faculty Opinions recommendation of Functional Redundancy of ERK1 and ERK2 MAP Kinases during Development.","year":2015,"lang":"en","type":"dataset","venue":"Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Redundancy (engineering); Kinase; Mitogen-activated protein kinase; Computer science; Information retrieval; Biology; Cell biology","score_opus":0.032858658023750875,"score_gpt":0.31604434362280376,"score_spread":0.2831856855990529,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4252336504","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004003649,0.0002505576,0.000094092626,0.00009981208,0.000028238504,0.000008871634,0.9978422,0.0003277488,0.00094820024],"genre_scores_gemma":[0.0012623942,0.00015388227,0.000308971,0.00008796785,0.000009563679,0.000030999825,0.997203,0.000052534564,0.0008907539],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99890125,0.000140873,0.000119046745,0.0003785212,0.00030176024,0.00015854783],"domain_scores_gemma":[0.9972277,0.00083996245,0.0004084858,0.00050489267,0.0006210849,0.00039783222],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011867988,0.0019836966,0.0015108364,0.0027278727,0.000562094,0.0021702265,0.002176227,0.002114729,0.054539472],"category_scores_gemma":[0.00680119,0.0005541351,0.0016985532,0.0034933912,0.00027866362,0.0011428795,0.0014560173,0.001297455,0.04487517],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003025171,0.000034912588,0.004254488,0.0018986117,0.00015647542,0.000055115685,0.000019453919,0.0004393755,0.0006019008,0.00037432867,0.9865057,0.0053572804],"study_design_scores_gemma":[0.0006221617,0.00005120631,0.02273838,0.0006972654,0.00027413273,0.00019168764,0.000052734922,0.0010693176,0.001473577,0.0014716494,0.9713083,0.000049619783],"about_ca_topic_score_codex":0.016562114,"about_ca_topic_score_gemma":0.046507843,"teacher_disagreement_score":0.054539472,"about_ca_system_score_codex":0.0011880164,"about_ca_system_score_gemma":0.0026075072,"threshold_uncertainty_score":0.18245274},"labels":[],"label_agreement":null},{"id":"W4253022805","doi":"10.21203/rs.3.rs-59611/v1","title":"Conformation and Dynamics of the Kinase Domain Drive Subcellular Location and Activation of LRRK2.","year":2020,"lang":"en","type":"preprint","venue":"Research Square","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Novartis Pharma; National Cancer Institute; National Institutes of Health; Ministero dello Sviluppo Economico; Fundação de Amparo à Pesquisa do Estado de São Paulo; Deutsche Forschungsgemeinschaft; Merck KGaA; Ontario Ministry of Economic Development and Innovation; Genome Canada","keywords":"Dynamics (music); Domain (mathematical analysis); LRRK2; Subcellular localization; Cell biology; Kinase; Computer science; Chemistry; Physics; Biochemistry; Biology; Mathematics; Cytoplasm; Gene","score_opus":0.02588846582245569,"score_gpt":0.3045738191004528,"score_spread":0.2786853532779971,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253022805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981906,0.00013317756,0.0011316828,0.000032766176,0.0000049363584,0.0000035988783,0.00008990763,0.000026466974,0.00038690906],"genre_scores_gemma":[0.99908316,0.00006834382,0.0004677301,0.0000074359446,0.0000010793466,0.0000051594297,0.00010156198,0.000006255134,0.00025923384],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99997497,0.0000027608949,0.0000015459386,0.000008311546,0.0000062831173,0.0000060890284],"domain_scores_gemma":[0.999967,0.000006614241,0.000012811163,0.000003196011,0.0000042269985,0.00000627794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000050625113,0.00014281823,0.00009831554,0.000045039098,0.000091773356,0.00017445048,0.00018502046,0.0001510667,0.0010400257],"category_scores_gemma":[0.000104627565,0.00009671727,0.000099211546,0.000061280625,0.00016037536,0.00019734564,0.00011358129,0.00021656099,0.00018262153],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010966527,0.000018294531,0.00070013496,0.000034099536,0.000008589804,0.000047697493,0.0000154057,0.0020387266,0.99586344,0.0002887981,0.00008300159,0.00079215394],"study_design_scores_gemma":[0.00004938623,0.00019349049,0.017624527,0.000008700718,0.000026635396,0.00033386852,0.00006342147,0.08536011,0.89410305,0.0004215743,0.0017965233,0.000018737055],"about_ca_topic_score_codex":0.0005998985,"about_ca_topic_score_gemma":0.00067548646,"teacher_disagreement_score":0.0010400257,"about_ca_system_score_codex":0.00031939262,"about_ca_system_score_gemma":0.00009623649,"threshold_uncertainty_score":0.0034791827},"labels":[],"label_agreement":null},{"id":"W4254037848","doi":"10.1007/978-3-319-67199-4_193","title":"Mitogen-Activated Protein Kinases","year":2017,"lang":"en","type":"book-chapter","venue":"","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Mitogen-activated protein kinase; Kinase; Cell biology; Chemistry; Biology","score_opus":0.021580523433992176,"score_gpt":0.23458300397695808,"score_spread":0.21300248054296592,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4254037848","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013796076,0.115876794,0.015494846,0.0023553297,0.0046931286,0.00007108407,0.0005122812,0.0006289306,0.8589879],"genre_scores_gemma":[0.004385636,0.045792546,0.0037779124,0.00071008696,0.00069740065,0.00006399156,0.00045629786,0.00008504137,0.94403106],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998933,0.0000074784866,0.0000031012116,0.00002261551,0.0000619881,0.00001151204],"domain_scores_gemma":[0.99996614,0.0000076009833,0.0000029209534,0.000005174278,0.00001042532,0.00000776389],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014755665,0.001262799,0.00039980226,0.000882136,0.0004156883,0.0014297598,0.00065920077,0.00053095067,0.055783983],"category_scores_gemma":[0.00018342884,0.0002513454,0.00026805187,0.0009189506,0.00041307113,0.001462545,0.0009979579,0.0016871339,0.06363167],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005216954,0.00008365029,0.00004605351,0.00053173717,0.000009251549,0.00010916184,0.00009141477,0.00038536548,0.02235804,0.06571186,0.2871808,0.6234405],"study_design_scores_gemma":[0.0000025403444,0.000009044329,0.000057135,0.000054936758,0.0000022413585,0.00010189321,0.000011381365,0.00005659994,0.002109824,0.0069466615,0.99064493,0.0000028207628],"about_ca_topic_score_codex":0.00038713645,"about_ca_topic_score_gemma":0.0011644247,"teacher_disagreement_score":0.055783983,"about_ca_system_score_codex":0.0006627827,"about_ca_system_score_gemma":0.0005001256,"threshold_uncertainty_score":0.186616},"labels":[],"label_agreement":null},{"id":"W4255458617","doi":"10.3390/books978-3-03842-413-0","title":"An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2","year":2017,"lang":"en","type":"book","venue":"","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of General Medical Sciences; Natural Sciences and Engineering Research Council of Canada; Schulich School of Medicine and Dentistry, Western University; Schulich School of Medicine and Dentistry; Universität des Saarlandes; City University of New York; School of Medicine, Boston University; Collegio Ghislieri di Pavia; Deutsche Forschungsgemeinschaft; Associazione Italiana per la Ricerca sul Cancro; Canadian Institutes of Health Research; Universität Ulm","keywords":"Computer science; Political science","score_opus":0.020602863577209682,"score_gpt":0.2671349620025971,"score_spread":0.24653209842538742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4255458617","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00025519764,0.7699658,0.001284029,0.03488124,0.14405274,0.000041856398,0.0008092568,0.00026173377,0.048448216],"genre_scores_gemma":[0.0015110405,0.5608888,0.0018614427,0.02980643,0.08260036,0.00007034771,0.0014114605,0.00031107944,0.3215391],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995322,0.00004254591,0.000033267203,0.000067384375,0.0002731413,0.00005149072],"domain_scores_gemma":[0.9991405,0.0002405611,0.00005273964,0.000024740199,0.00031481785,0.0002265637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008052234,0.0013033499,0.0012117616,0.002381674,0.00071373006,0.0040493924,0.0011180653,0.0022256614,0.052158877],"category_scores_gemma":[0.0016310938,0.00058952055,0.00078866864,0.0028902928,0.00059525867,0.0041742744,0.0014922753,0.004379508,0.038639527],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032370415,0.000013367398,0.00001880141,0.0005553485,0.000007724587,0.000056948655,0.000017767386,0.00006795573,0.0007950514,0.0011907938,0.93118274,0.06606122],"study_design_scores_gemma":[0.000004300804,0.000009037886,0.000055749057,0.00014277204,0.0000050534163,0.00009910112,0.000008271664,0.000010527464,0.00010173045,0.00051389716,0.99904495,0.000004670705],"about_ca_topic_score_codex":0.0015259511,"about_ca_topic_score_gemma":0.0064703953,"teacher_disagreement_score":0.052158877,"about_ca_system_score_codex":0.0015691568,"about_ca_system_score_gemma":0.0013048167,"threshold_uncertainty_score":0.17448884},"labels":[],"label_agreement":null},{"id":"W4256429561","doi":"10.3109/9781420020588-14","title":"Apoptosis Modulators: p53 Targeting","year":2007,"lang":"en","type":"book-chapter","venue":"","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Apoptosis; Chemistry; Biochemistry","score_opus":0.019979597610203296,"score_gpt":0.23497497308322624,"score_spread":0.21499537547302294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4256429561","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1493912,0.6260712,0.051788684,0.015591814,0.0055972165,0.0015381913,0.002762673,0.003614569,0.14364438],"genre_scores_gemma":[0.6406019,0.24797846,0.012674296,0.005772353,0.00156119,0.00071036787,0.0019713857,0.00017986125,0.088550135],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99985516,0.00001845863,0.0000061982632,0.000040490824,0.000039435494,0.00004026298],"domain_scores_gemma":[0.9999509,0.0000059318695,0.00001332092,0.0000036026745,0.000010707315,0.000015528794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020425768,0.00092364254,0.00050517404,0.0005325163,0.00024073926,0.00061939075,0.00052988564,0.00070333976,0.009526772],"category_scores_gemma":[0.00014661292,0.00016350725,0.00030377688,0.00035229986,0.00022220545,0.00050929846,0.0004608593,0.001524369,0.0034367254],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021552427,0.0014377221,0.000698004,0.0026259285,0.00013192235,0.0012517476,0.00007423081,0.0014538784,0.46050242,0.010639307,0.06491627,0.45411333],"study_design_scores_gemma":[0.0016384186,0.00511946,0.0032087765,0.00049959176,0.00018370702,0.006177233,0.000049221202,0.0028699662,0.336796,0.005625025,0.63778377,0.000048902242],"about_ca_topic_score_codex":0.00023550424,"about_ca_topic_score_gemma":0.0006101793,"teacher_disagreement_score":0.009526772,"about_ca_system_score_codex":0.00057800114,"about_ca_system_score_gemma":0.00024163723,"threshold_uncertainty_score":0.031870186},"labels":[],"label_agreement":null},{"id":"W4256628608","doi":"10.3410/f.725773107.793511270","title":"Faculty Opinions recommendation of BRAF Mutants Evade ERK-Dependent Feedback by Different Mechanisms that Determine Their Sensitivity to Pharmacologic Inhibition.","year":2015,"lang":"en","type":"dataset","venue":"Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Sensitivity (control systems); MAPK/ERK pathway; Mutant; Process (computing); Pharmacology; Computational biology; Biology; Computer science; Cell biology; Genetics; Kinase; Gene; Engineering","score_opus":0.03932157064087754,"score_gpt":0.3301473169275142,"score_spread":0.29082574628663665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4256628608","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005602196,0.00039550892,0.00008358292,0.00014887752,0.00003410882,0.000013082113,0.99743503,0.00026778434,0.0010617973],"genre_scores_gemma":[0.0020998304,0.00023913206,0.0003623097,0.0001517089,0.000014974458,0.00005610693,0.9958722,0.0000514444,0.0011522791],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987453,0.00019228453,0.00016616353,0.00039439215,0.00034259763,0.00015910617],"domain_scores_gemma":[0.9972007,0.00096688315,0.00049372285,0.0005100167,0.0005547492,0.000273861],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013182918,0.0016212334,0.0014612498,0.0020532745,0.00052952615,0.0021358551,0.0021323783,0.0020755215,0.048914336],"category_scores_gemma":[0.008716665,0.00048771902,0.0018793294,0.0030470004,0.00028655285,0.001087086,0.0012737007,0.0013582355,0.041522104],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004544316,0.00004686436,0.0056678522,0.0023188957,0.00027390238,0.000045169352,0.000018228606,0.0005325906,0.00045088382,0.00043690676,0.9824453,0.0073088994],"study_design_scores_gemma":[0.0010903329,0.00007375279,0.023737684,0.0010197944,0.00044190316,0.00018964121,0.000061098384,0.0011517453,0.0016027193,0.0018893403,0.96868694,0.000055091976],"about_ca_topic_score_codex":0.014864438,"about_ca_topic_score_gemma":0.041771658,"teacher_disagreement_score":0.048914336,"about_ca_system_score_codex":0.0012860157,"about_ca_system_score_gemma":0.00227628,"threshold_uncertainty_score":0.16363478},"labels":[],"label_agreement":null},{"id":"W4281393985","doi":"10.1021/acs.jmedchem.2c00173","title":"Illuminating the Dark: Highly Selective Inhibition of Serine/Threonine Kinase 17A with Pyrazolo[1,5- <i>a</i> ]pyrimidine-Based Macrocycles","year":2022,"lang":"en","type":"article","venue":"Journal of Medicinal Chemistry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Structural Genomics Consortium; Deutsche Forschungsgemeinschaft","keywords":"Kinome; Chemistry; Serine; Pyrimidine; Kinase; Programmed cell death; Protein kinase A; Threonine; Biochemistry; Cell growth; In vitro; Drug discovery; Apoptosis; Cell biology; Cancer research; Phosphorylation; Biology","score_opus":0.0054145322059472485,"score_gpt":0.2062778087777506,"score_spread":0.20086327657180333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281393985","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9812056,0.0057436256,0.0065307794,0.00018886822,0.0000747608,0.000078291436,0.0004165705,0.00025186862,0.005509704],"genre_scores_gemma":[0.9927684,0.0025221186,0.002652144,0.00007587958,0.00001150916,0.00003438947,0.0001922563,0.000014094983,0.0017292518],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999517,0.000008873949,0.0000036730964,0.000012942302,0.000009269774,0.000013500568],"domain_scores_gemma":[0.9999701,0.000004313688,0.00001001441,0.0000025048657,0.0000031964476,0.000009849358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000101400794,0.0002827734,0.00020435955,0.00013542494,0.00008246625,0.00017482616,0.0001950996,0.00014594437,0.00089828373],"category_scores_gemma":[0.00008993111,0.00009588181,0.00014000379,0.00008825805,0.00013167874,0.00018644359,0.00021660994,0.0002598867,0.00025337443],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034601073,0.00006120475,0.00013647274,0.00013090266,0.000013617247,0.00016302832,0.000039296796,0.0010546232,0.9875975,0.00075023645,0.00037617094,0.009330858],"study_design_scores_gemma":[0.0001432145,0.0018162844,0.0013788354,0.000017051278,0.000023044911,0.00029918292,0.000020465866,0.0023314604,0.9849311,0.0002253261,0.008794745,0.000019249988],"about_ca_topic_score_codex":0.00035699515,"about_ca_topic_score_gemma":0.00093112176,"teacher_disagreement_score":0.00089828373,"about_ca_system_score_codex":0.00019250502,"about_ca_system_score_gemma":0.000128984,"threshold_uncertainty_score":0.0030050278},"labels":[],"label_agreement":null},{"id":"W4281786110","doi":"10.1200/jco.2022.40.16_suppl.9547","title":"Overall survival (OS) with first-line atezolizumab (A) or placebo (P) in combination with vemurafenib (V) and cobimetinib (C) in <i>BRAF</i><sup>V600</sup> mutation-positive advanced melanoma: Second interim OS analysis of the phase 3 IMspire150 study.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; Hazard ratio; Vemurafenib; Interim analysis; Internal medicine; Melanoma; Gastroenterology; Oncology; Metastatic melanoma; Cancer; Confidence interval; Randomized controlled trial; Cancer research","score_opus":0.037436212219799016,"score_gpt":0.37055697196171805,"score_spread":0.333120759741919,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281786110","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949639,0.0010722678,0.0003349757,0.00011286066,0.00007695908,0.00044718082,0.0015799623,0.000053802385,0.001358117],"genre_scores_gemma":[0.99457526,0.00046602462,0.00044895432,0.00023639061,0.00008391551,0.00077427493,0.0024287156,0.000012100422,0.00097439653],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9996152,0.00014403231,0.000028655404,0.00008953367,0.00003852514,0.00008412578],"domain_scores_gemma":[0.9994986,0.00010324126,0.00016078659,0.000052571708,0.000027894566,0.00015699188],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016480145,0.00083534216,0.0013358631,0.00032058882,0.00019865774,0.00070921134,0.00053187786,0.000769054,0.003184104],"category_scores_gemma":[0.0008965603,0.0003283688,0.0018272566,0.00024760063,0.00046318248,0.00071573054,0.000381047,0.0018378926,0.00053803716],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9099008,0.01122402,0.011777128,0.00040620242,0.0018503884,0.000069441165,0.00008067409,0.0016138675,0.010287297,0.00014148958,0.0030205336,0.049628314],"study_design_scores_gemma":[0.27288267,0.66199654,0.05098925,0.00007083542,0.003077879,0.00025714058,0.00005212448,0.002078404,0.005550662,0.0002390796,0.002760712,0.000044770964],"about_ca_topic_score_codex":0.0003055312,"about_ca_topic_score_gemma":0.0007542432,"teacher_disagreement_score":0.003184104,"about_ca_system_score_codex":0.0005964016,"about_ca_system_score_gemma":0.0007200722,"threshold_uncertainty_score":0.010651886},"labels":[],"label_agreement":null},{"id":"W4281861539","doi":"10.1200/jco.2022.40.16_suppl.9516","title":"Pembrolizumab (pembro) plus dabrafenib (dab) and trametinib (tram) in <i>BRAF</i><sup>V600E/K</sup>-mutant melanoma: Long-term follow-up of KEYNOTE-022 parts 1, 2, and 3.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Dabrafenib; Medicine; Tolerability; Trametinib; Pembrolizumab; Melanoma; Placebo; Internal medicine; Adverse effect; Metastatic melanoma; Oncology; Dermatology; Vemurafenib; Cancer; Cancer research; Pathology; Immunotherapy; MAPK/ERK pathway; Chemistry","score_opus":0.05212084778346847,"score_gpt":0.35385471353698156,"score_spread":0.3017338657535131,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281861539","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904891,0.0023461736,0.00039864396,0.00015788137,0.000058967387,0.0017419776,0.0019562703,0.00007099663,0.0027799394],"genre_scores_gemma":[0.99135876,0.0009401327,0.0006368127,0.00032560775,0.000044406795,0.0012115572,0.0034081514,0.000011166971,0.0020634267],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997974,0.000058579746,0.000015560743,0.000045285487,0.000024627116,0.00005849612],"domain_scores_gemma":[0.9997471,0.000022052274,0.00006285884,0.000022246013,0.000014441918,0.00013138555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007203233,0.0005055404,0.0009489164,0.00026211483,0.0003243947,0.00049049186,0.0004416786,0.0004965457,0.0037150104],"category_scores_gemma":[0.00039304298,0.00029159684,0.00080437254,0.00038037138,0.00022635687,0.0005582258,0.00033882097,0.0015301009,0.000799781],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.66881084,0.029882057,0.02723933,0.0010957235,0.0018928947,0.00039137725,0.00016224373,0.0027961794,0.05258123,0.00022686721,0.0071220985,0.20779914],"study_design_scores_gemma":[0.2382108,0.60295653,0.13255088,0.00011232355,0.0016579358,0.0008912576,0.000081858845,0.0013073568,0.010320382,0.00020286109,0.011667628,0.00004026189],"about_ca_topic_score_codex":0.0008148044,"about_ca_topic_score_gemma":0.0021523335,"teacher_disagreement_score":0.0037150104,"about_ca_system_score_codex":0.0010447995,"about_ca_system_score_gemma":0.000942673,"threshold_uncertainty_score":0.012427926},"labels":[],"label_agreement":null},{"id":"W4282022545","doi":"10.1200/jco.2022.40.16_suppl.9522","title":"Long-term survival in advanced melanoma for patients treated with nivolumab plus ipilimumab in CheckMate 067.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Ipilimumab; Nivolumab; Internal medicine; Placebo; Oncology; Gastroenterology; Cancer; Immunotherapy; Pathology","score_opus":0.043367404318560704,"score_gpt":0.3662485159631802,"score_spread":0.3228811116446195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282022545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986186,0.00045874016,0.000048034468,0.000074917276,0.000026913436,0.0000464464,0.00023025651,0.0000062944937,0.00048979034],"genre_scores_gemma":[0.99834776,0.00019956908,0.00009347631,0.00013179872,0.00003463978,0.000058389975,0.0005807194,0.0000014263117,0.00055217027],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99989474,0.000030322684,0.000006346555,0.00002297348,0.000018713235,0.000026920781],"domain_scores_gemma":[0.99973947,0.00003225864,0.000048260852,0.000012275999,0.000011803619,0.00015597972],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046088808,0.00024413015,0.00044240104,0.00015632616,0.00029153787,0.00033746733,0.00023087909,0.00035145017,0.001743597],"category_scores_gemma":[0.0003858583,0.0000994457,0.00042030585,0.00013332616,0.00014096372,0.00018370275,0.00017009834,0.0005795485,0.00028166082],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2689107,0.010090945,0.50298077,0.00035794554,0.001017422,0.0009912158,0.00021113784,0.0022908733,0.056779154,0.0001520412,0.0049977754,0.15122004],"study_design_scores_gemma":[0.02667891,0.13495538,0.82420534,0.00006818671,0.00093254546,0.0010079221,0.000077459554,0.0024159136,0.0039212722,0.00014060533,0.0055675413,0.000028979766],"about_ca_topic_score_codex":0.0010440721,"about_ca_topic_score_gemma":0.0021590395,"teacher_disagreement_score":0.001743597,"about_ca_system_score_codex":0.00044902877,"about_ca_system_score_gemma":0.00047764208,"threshold_uncertainty_score":0.005832851},"labels":[],"label_agreement":null},{"id":"W4282946667","doi":"10.1158/1538-7445.am2022-98","title":"Abstract 98: The role of HORMAD1 in transformation of keratinocytes following vemurafenib treatment","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Business Development Bank of Canada; McGill University Health Centre","funders":"","keywords":"Vemurafenib; Trametinib; HaCaT; Cancer research; MAPK/ERK pathway; MEK inhibitor; Medicine; Melanoma; Cell growth; Kinase; Cell culture; Pharmacology; Biology; Metastatic melanoma; Cell biology","score_opus":0.04021768466794612,"score_gpt":0.3462389301832301,"score_spread":0.306021245515284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282946667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941421,0.0015917986,0.00079980266,0.000085048465,0.00005018721,0.000033890556,0.00064177776,0.00004794317,0.0026074655],"genre_scores_gemma":[0.99557185,0.00038708508,0.0003906283,0.000026954276,0.0000058996666,0.000016319449,0.0005928691,0.0000051681777,0.0030031651],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991786,0.000010194063,0.0000072395533,0.000015129735,0.000026026315,0.000023596966],"domain_scores_gemma":[0.9999354,0.000010420767,0.000012975855,0.000008372418,0.000014431352,0.000018357654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008482342,0.0001546837,0.00015537982,0.00026262866,0.00018077489,0.00024594966,0.00011116473,0.0002404539,0.0032862925],"category_scores_gemma":[0.0000954911,0.00007555084,0.00025969298,0.00011587912,0.00009784715,0.00011876373,0.00011358921,0.00037437747,0.0007978532],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028197584,0.000067211884,0.0010865442,0.0000509834,0.000005005556,0.00028866658,0.000019374935,0.000035788198,0.9955504,0.000051504838,0.000076560544,0.0024859754],"study_design_scores_gemma":[0.000022458546,0.00061951607,0.04975716,0.000011180411,0.000021795153,0.0016915343,0.00015408227,0.00073839223,0.94348115,0.00007357591,0.003421105,0.000008045979],"about_ca_topic_score_codex":0.00065456715,"about_ca_topic_score_gemma":0.0005053906,"teacher_disagreement_score":0.0032862925,"about_ca_system_score_codex":0.00020806552,"about_ca_system_score_gemma":0.00015163126,"threshold_uncertainty_score":0.010993779},"labels":[],"label_agreement":null},{"id":"W4282959988","doi":"10.1158/1538-7445.am2022-404","title":"Abstract 404: Identification of combination partners to combat acquired resistance to ulixertinib (ERK1/2 inhibitor) using transcriptomics","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Phenomenome Discoveries (Canada)","funders":"","keywords":"MAPK/ERK pathway; Transcriptome; PI3K/AKT/mTOR pathway; Cancer research; Drug resistance; Melanoma; Signal transduction; Biology; Phenotype; Gene; Protein kinase B; Acquired resistance; Gene expression; Cell biology; Genetics","score_opus":0.08828580308583767,"score_gpt":0.39857790460185183,"score_spread":0.31029210151601416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282959988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94915265,0.0034023975,0.021067405,0.00045913577,0.00011636381,0.00024721792,0.02009759,0.0009546966,0.0045026285],"genre_scores_gemma":[0.92428255,0.003340091,0.03684623,0.0005555593,0.000049785885,0.00041671278,0.025738437,0.0003143624,0.008456294],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99976736,0.000016547754,0.00001276943,0.00006870991,0.00010305563,0.00003150858],"domain_scores_gemma":[0.9998969,0.00002175277,0.000027021873,0.0000074440027,0.000033116037,0.000013698029],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023109271,0.0004171847,0.0005633512,0.0004155144,0.00026040978,0.000611333,0.00020093174,0.00040710386,0.0019351395],"category_scores_gemma":[0.00022722852,0.00016958288,0.00048417386,0.00047030856,0.00017464705,0.00025451748,0.00020395621,0.0005219986,0.00082068174],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013413098,0.00002692028,0.000922748,0.000119437915,0.000013647219,0.000044218716,0.000018849476,0.00043273022,0.9912855,0.00007060493,0.000364618,0.006566559],"study_design_scores_gemma":[0.000030035671,0.00055434124,0.025676273,0.000036186113,0.0001268421,0.00041076922,0.0001194189,0.012934479,0.946449,0.00030744032,0.013328249,0.000027110678],"about_ca_topic_score_codex":0.0007050188,"about_ca_topic_score_gemma":0.0010340633,"teacher_disagreement_score":0.0019351395,"about_ca_system_score_codex":0.00042787,"about_ca_system_score_gemma":0.0003801209,"threshold_uncertainty_score":0.00647372},"labels":[],"label_agreement":null},{"id":"W4283016030","doi":"10.1200/po.21.00561","title":"Locoregionally Advanced, BRAF V600L–Positive, Mucosal Melanoma of the Hypopharynx Treated With a Combination of <i>BRAF</i> and <i>MEK</i> Inhibitors","year":2022,"lang":"en","type":"article","venue":"JCO Precision Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Université de Montréal; Hôpital Maisonneuve-Rosemont; Université de Sherbrooke","funders":"","keywords":"Mucosal melanoma; Medicine; Melanoma; Cancer research; MEK inhibitor; Trametinib; Dermatology; Oncology; Internal medicine; Biology; Genetics; MAPK/ERK pathway","score_opus":0.005415797021471048,"score_gpt":0.21854370826433173,"score_spread":0.21312791124286068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283016030","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9400515,0.03556762,0.000705174,0.0020435606,0.000567767,0.00032298197,0.000514921,0.000206592,0.020019794],"genre_scores_gemma":[0.9820877,0.008984372,0.0008417196,0.0010822467,0.0002821083,0.00007363244,0.0008009929,0.000019454652,0.0058278334],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99994826,0.000006703056,0.00000371133,0.000008325302,0.00001820037,0.000014785357],"domain_scores_gemma":[0.9999372,0.00000864487,0.000010096772,0.0000052320197,0.0000067228725,0.000032085238],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015744483,0.0003273489,0.000692548,0.00026748766,0.00033440418,0.00028944275,0.00022301178,0.0003169423,0.0023688055],"category_scores_gemma":[0.00016174001,0.00016045707,0.0005990894,0.0002456717,0.00017894963,0.0003158236,0.0001658769,0.00064511044,0.00042544777],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0683504,0.006626637,0.065109074,0.0017744254,0.0016690285,0.05653277,0.00056400266,0.0030991999,0.21537499,0.00053605397,0.039026868,0.54133654],"study_design_scores_gemma":[0.015037679,0.11608991,0.7020094,0.0010281035,0.0030931563,0.059942793,0.00063871354,0.0064682798,0.024701543,0.00060734455,0.07025685,0.00012631949],"about_ca_topic_score_codex":0.0033736003,"about_ca_topic_score_gemma":0.014008494,"teacher_disagreement_score":0.0033736003,"about_ca_system_score_codex":0.0005138541,"about_ca_system_score_gemma":0.00037827442,"threshold_uncertainty_score":0.0079244375},"labels":[],"label_agreement":null},{"id":"W4283026383","doi":"10.1007/s11523-022-00888-9","title":"Cobimetinib in Pediatric and Young Adult Patients with Relapsed or Refractory Solid Tumors (iMATRIX-cobi): A Multicenter, Phase I/II Study","year":2022,"lang":"en","type":"article","venue":"Targeted Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"National Cancer Institute; Genentech; F. Hoffmann-La Roche","keywords":"Medicine; Refractory (planetary science); Multicenter study; Phases of clinical research; Internal medicine; Oncology; Clinical trial; Randomized controlled trial","score_opus":0.008484783094617332,"score_gpt":0.27110953133376103,"score_spread":0.2626247482391437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283026383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960134,0.0021687646,0.00017343035,0.00018835528,0.000024224597,0.0005120433,0.00036258975,0.000032523385,0.00052469166],"genre_scores_gemma":[0.9916163,0.0034371554,0.0012935875,0.00049764465,0.00009179586,0.000903154,0.0015037624,0.00001576157,0.0006408363],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99977404,0.00009623088,0.000018934152,0.00003268204,0.000030927542,0.000047183385],"domain_scores_gemma":[0.9995516,0.000038288574,0.00012502224,0.000025739291,0.00003396715,0.00022536583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012303859,0.00088257267,0.0013484758,0.00023481165,0.0002500215,0.0005309952,0.00040752298,0.0004591137,0.00089665304],"category_scores_gemma":[0.0005034858,0.00030906973,0.000696842,0.0003409209,0.0003341776,0.0004271804,0.00022021338,0.0016091741,0.0003535744],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3652004,0.07223995,0.07875925,0.0016322805,0.0028259885,0.0017085739,0.001051242,0.005158389,0.1396117,0.0005275343,0.0102602905,0.3210243],"study_design_scores_gemma":[0.2631934,0.569565,0.13292606,0.00012204976,0.0014261316,0.0028452987,0.00024019401,0.004021308,0.014295671,0.00019404758,0.011113216,0.000057593646],"about_ca_topic_score_codex":0.0009891071,"about_ca_topic_score_gemma":0.0028097858,"teacher_disagreement_score":0.0013484758,"about_ca_system_score_codex":0.0007170174,"about_ca_system_score_gemma":0.0014077894,"threshold_uncertainty_score":0.0065069795},"labels":[],"label_agreement":null},{"id":"W4283373229","doi":"10.1101/2022.02.17.22271120","title":"Clinical activity of MAPK targeted therapies in patients with non-V600 BRAF mutant tumors","year":2022,"lang":"en","type":"preprint","venue":"medRxiv","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McGill University; University of Toronto; University Health Network; McGill University Health Centre; Jewish General Hospital","funders":"Daiichi Sankyo Europe; National Cancer Institute; Fonds de Recherche du Québec - Santé; Foundation Medicine; Bayer Yakuhin; Chugai Pharmaceutical; EMD Serono; PharmaMar; Eisai; University of Texas MD Anderson Cancer Center; Insmed; BeiGene; Helsinn; Les Laboratories Pierre Fabre; AstraZeneca; Novocure; Array BioPharma; Jazz Pharmaceuticals; Conquer Cancer Foundation; Merck KGaA; Taiho Pharmaceutical; Karyopharm Therapeutics; Exelixis; Sanofi; National Institutes of Health; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; GlaxoSmithKline; Yakult Honsha; American Society of Clinical Oncology; Ono Pharmaceutical; Eli Lilly and Company; Bristol-Myers Squibb; Symphogen; Moderna; Incyte; Pfizer; Genentech; Aeglea BioTherapeutics; Helsinn Therapeutics; Amgen; Clovis Oncology; Melanoma Research Alliance; AIM at Melanoma; Daiichi Sankyo Company; American Cancer Society","keywords":"Medicine; Targeted therapy; MAPK/ERK pathway; Oncology; Lung cancer; Cancer; Melanoma; Internal medicine; Cancer research; Kinase; Biology; Genetics","score_opus":0.013277811220506495,"score_gpt":0.2615942006891303,"score_spread":0.2483163894686238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283373229","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013376842,0.9850874,0.00022821155,0.00016885328,0.000072159855,0.00008805071,0.0005357512,0.00001072535,0.00043207358],"genre_scores_gemma":[0.5332373,0.4629734,0.0010727273,0.0008987898,0.00029804968,0.00028630308,0.00096372736,0.000023176699,0.00024666914],"study_design_codex":"meta_analysis","study_design_gemma":"observational","domain_scores_codex":[0.9943516,0.0025663525,0.0017317263,0.0006504901,0.0005648911,0.0001348552],"domain_scores_gemma":[0.9798244,0.015523415,0.0033296617,0.00037957795,0.00079969666,0.000143378],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0077375807,0.0009801652,0.0065998742,0.002987633,0.00024425957,0.0017785237,0.0008865606,0.0010293758,0.0017887113],"category_scores_gemma":[0.017898493,0.0005505746,0.016073648,0.0033040536,0.00036308577,0.0009833374,0.00055029866,0.0009983686,0.00016180263],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069251545,0.000056999517,0.023688793,0.3041642,0.6133321,0.00016453501,0.00010035077,0.0011890096,0.0008584443,0.00019673603,0.0011074506,0.048216287],"study_design_scores_gemma":[0.0013693232,0.0011248603,0.03238335,0.031197706,0.9270056,0.000390646,0.00010375989,0.0004073036,0.0007342181,0.00043661473,0.0048093507,0.000037324968],"about_ca_topic_score_codex":0.0020051808,"about_ca_topic_score_gemma":0.0046290965,"teacher_disagreement_score":0.0077375807,"about_ca_system_score_codex":0.0011558463,"about_ca_system_score_gemma":0.0009874584,"threshold_uncertainty_score":0.040920734},"labels":[],"label_agreement":null},{"id":"W4283459037","doi":"10.1186/s12575-022-00170-2","title":"A novel 7 RNA-based signature for prediction of prognosis and therapeutic responses of wild-type BRAF cutaneous melanoma","year":2022,"lang":"en","type":"article","venue":"Biological Procedures Online","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Melanoma; Signature (topology); Computational biology; RNA; Cancer research; Biology; Bioinformatics; Medicine; Gene; Genetics; Mathematics","score_opus":0.03382879992296209,"score_gpt":0.26695094034701516,"score_spread":0.23312214042405308,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283459037","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9395152,0.0025386522,0.045558922,0.00044220273,0.0001241137,0.00022442926,0.00658632,0.0007900905,0.0042201397],"genre_scores_gemma":[0.97232246,0.00033207895,0.022134159,0.00016686469,0.000073123796,0.00011666554,0.004060264,0.00002872831,0.0007656073],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99955326,0.00008530897,0.000058534064,0.0001044775,0.00013872271,0.000059764643],"domain_scores_gemma":[0.99879956,0.00039078668,0.00036049483,0.00006692442,0.00027187908,0.000110398236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071506784,0.00054993946,0.0005407471,0.0020749834,0.00020867249,0.0006862689,0.0003041867,0.0005265777,0.001477108],"category_scores_gemma":[0.0018270193,0.000106986176,0.0005185026,0.0007807178,0.00020174685,0.00032815352,0.0003192739,0.0003417287,0.0006233702],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032216792,0.0005421217,0.582353,0.00060740113,0.00055993674,0.001280247,0.00014971066,0.023455067,0.15674844,0.0011380347,0.0042467075,0.22569764],"study_design_scores_gemma":[0.00022175327,0.0027858135,0.4513152,0.00023190149,0.0012354094,0.0057864934,0.00028442743,0.41581762,0.10451628,0.005778459,0.011851622,0.00017499468],"about_ca_topic_score_codex":0.000624484,"about_ca_topic_score_gemma":0.0012172045,"teacher_disagreement_score":0.0020749834,"about_ca_system_score_codex":0.00037147998,"about_ca_system_score_gemma":0.00048604433,"threshold_uncertainty_score":0.0049414635},"labels":[],"label_agreement":null},{"id":"W4283727421","doi":"10.1051/medsci/2022083","title":"La résistance aux inhibiteurs de BRAF","year":2022,"lang":"fr","type":"review","venue":"médecine/sciences","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Ligue Contre le Cancer; Agence Nationale de la Recherche","keywords":"Molecular biology; Biology","score_opus":0.06437820404074798,"score_gpt":0.33454828691499844,"score_spread":0.2701700828742505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283727421","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00056744117,0.9960524,0.0003480417,0.000436206,0.00027987186,0.000008422143,0.000038202234,0.000019485275,0.0022498535],"genre_scores_gemma":[0.0032507903,0.994381,0.000209036,0.0003287344,0.00016528384,0.000011808762,0.00007358821,0.0000039495367,0.0015757649],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99979085,0.000033871787,0.000019580355,0.00004100535,0.0000859425,0.000028779694],"domain_scores_gemma":[0.9998241,0.00008253477,0.000026326166,0.000008375136,0.000044927416,0.000013718472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004423977,0.0006405447,0.00082837825,0.0013491438,0.00021467435,0.00073013385,0.0005964669,0.00086883537,0.0024950586],"category_scores_gemma":[0.00058878976,0.00020628671,0.0006224514,0.00078637863,0.00041569344,0.0006891832,0.00044750757,0.0018391213,0.0012197858],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016497259,0.00006466718,0.00036005533,0.013112283,0.00015871025,0.00045343087,0.00008353143,0.000567823,0.01472942,0.006747238,0.031052688,0.9325052],"study_design_scores_gemma":[0.000035894536,0.0001754537,0.0012347447,0.0016856096,0.00014997736,0.0029235396,0.000034676166,0.00011701934,0.005469277,0.0017269137,0.98642576,0.000021066444],"about_ca_topic_score_codex":0.0009811335,"about_ca_topic_score_gemma":0.0015591178,"teacher_disagreement_score":0.0024950586,"about_ca_system_score_codex":0.00066886295,"about_ca_system_score_gemma":0.00071057794,"threshold_uncertainty_score":0.008346796},"labels":[],"label_agreement":null},{"id":"W4283740577","doi":"10.1111/pcmr.13053","title":"The <scp>MITF</scp> regulatory network in melanoma","year":2022,"lang":"en","type":"article","venue":"Pigment Cell & Melanoma Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec","funders":"Deutsche Krebshilfe; Cancer Research UK; Ludwig Institute for Cancer Research","keywords":"Microphthalmia-associated transcription factor; Biology; Melanoma; Transcription factor; Phenotype; Immune system; IRF4; Cancer research; Cell biology; Gene; Genetics","score_opus":0.025625129441628976,"score_gpt":0.27978217988864623,"score_spread":0.25415705044701725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283740577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9790536,0.004099089,0.0070624673,0.0004121949,0.000059351223,0.000036669222,0.0016344812,0.0004276309,0.0072144284],"genre_scores_gemma":[0.9932755,0.0004660403,0.0016981015,0.00008924711,0.0000210156,0.000025528525,0.0010907393,0.000024827172,0.003308989],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998944,0.000010376764,0.000003447022,0.000039138948,0.000026645324,0.000025962043],"domain_scores_gemma":[0.99987006,0.000017083878,0.000042336065,0.000007169382,0.00001832878,0.000044975262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000103575025,0.00028710687,0.00013733827,0.00040576985,0.00030290495,0.0003569322,0.00017079004,0.0002858167,0.0026556095],"category_scores_gemma":[0.00013024602,0.00011578986,0.00014245466,0.00019699692,0.00020776619,0.00021809728,0.00025253466,0.00027250408,0.0006192588],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021101176,0.000022947343,0.0030794695,0.0000728966,0.000011861417,0.00026551727,0.00002744921,0.0005530792,0.9853012,0.0011878025,0.00083437754,0.008432373],"study_design_scores_gemma":[0.000083866136,0.00048322423,0.28117275,0.00009767557,0.000055735763,0.002603548,0.0002668961,0.022099635,0.6477547,0.0040784236,0.041252945,0.00005055776],"about_ca_topic_score_codex":0.0012546184,"about_ca_topic_score_gemma":0.0017593221,"teacher_disagreement_score":0.0026556095,"about_ca_system_score_codex":0.0004485477,"about_ca_system_score_gemma":0.00021603859,"threshold_uncertainty_score":0.008883834},"labels":[],"label_agreement":null},{"id":"W4285392780","doi":"10.1038/s41467-022-31690-w","title":"Qualitative differences in disease-associated MEK mutants reveal molecular signatures and aberrant signaling-crosstalk in cancer","year":2022,"lang":"en","type":"article","venue":"Nature Communications","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Core Research for Evolutional Science and Technology; University of Tokyo; Mitsubishi Foundation; Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology; Princess Takamatsu Cancer Research Fund; Université Laval","keywords":"Crosstalk; Mutant; Disease; Biology; Signal transduction; Genetics; Cancer research; Computational biology; Cell biology; Gene; Medicine; Internal medicine; Physics","score_opus":0.03331426079489453,"score_gpt":0.3463030226673061,"score_spread":0.3129887618724116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285392780","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972078,0.00025171184,0.0017080732,0.000031025145,0.0000052547966,0.0000066517696,0.00016960614,0.00005303772,0.0005667617],"genre_scores_gemma":[0.99826705,0.000102690006,0.0010416395,0.000011446446,0.0000011145108,0.000006136408,0.00011625709,0.000009892441,0.00044370187],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991775,0.000012757315,0.000008163451,0.000019211804,0.000021934167,0.00002025279],"domain_scores_gemma":[0.9999113,0.000015131597,0.000025652034,0.000009901725,0.000009318013,0.00002869086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008170805,0.00018294848,0.00009788084,0.00037011146,0.000092999755,0.00020472074,0.00011273544,0.00016946196,0.0010032859],"category_scores_gemma":[0.000101827245,0.00011113346,0.00013114167,0.00010412771,0.00020016875,0.00012825022,0.00015910977,0.0001989271,0.00017625206],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006558304,0.000005443678,0.00044191146,0.0000073776905,0.0000026975185,0.000049289618,0.000006950947,0.00003218186,0.9988973,0.00009067011,0.0000076233327,0.00039284315],"study_design_scores_gemma":[0.000008991128,0.00015020125,0.020326592,0.000002944488,0.000016103526,0.0013702221,0.000048196154,0.0008788966,0.97608644,0.0002418384,0.0008631105,0.0000065941167],"about_ca_topic_score_codex":0.0002649091,"about_ca_topic_score_gemma":0.00040791012,"teacher_disagreement_score":0.0010032859,"about_ca_system_score_codex":0.00017020169,"about_ca_system_score_gemma":0.00009361753,"threshold_uncertainty_score":0.0033563375},"labels":[],"label_agreement":null},{"id":"W4288855843","doi":"10.5281/zenodo.6941499","title":"Antibody Characterization Report for Mitogenactivated protein kinase 1 (MAPK1)","year":2022,"lang":"en","type":"article","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"","keywords":"Antibody; Characterization (materials science); Protein kinase A; Chemistry; Kinase; Medicine; Immunology; Biochemistry; Materials science; Nanotechnology","score_opus":0.0215495625673884,"score_gpt":0.2462846470707449,"score_spread":0.2247350845033565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4288855843","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.32250887,0.03769412,0.4767438,0.004083481,0.0044617876,0.0046238923,0.08203005,0.004733667,0.063120365],"genre_scores_gemma":[0.20126444,0.03831293,0.19586621,0.0017888044,0.0013918421,0.0047523505,0.47605544,0.0014080964,0.079159856],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99930036,0.00008898171,0.00010064887,0.00018319779,0.0001682678,0.00015845559],"domain_scores_gemma":[0.99885416,0.00021286987,0.0001122,0.00021131405,0.0004341427,0.00017533074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082895707,0.002279533,0.0009351938,0.002363114,0.0012789675,0.00082955847,0.0017051079,0.0008297909,0.028149622],"category_scores_gemma":[0.0012001666,0.00081842,0.0013844953,0.0016238473,0.00025751148,0.0009889662,0.00057242735,0.0019248556,0.023236074],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024248844,0.00019188253,0.00030990443,0.0004845816,0.000052104017,0.00023322711,0.00006738665,0.000098917735,0.9827985,0.00072317227,0.006281747,0.008515917],"study_design_scores_gemma":[0.00020158397,0.0012015064,0.010603338,0.00018226173,0.00032919718,0.0060300753,0.0001839154,0.0016395751,0.6083355,0.00082053215,0.3703867,0.00008584018],"about_ca_topic_score_codex":0.0014830988,"about_ca_topic_score_gemma":0.0022300824,"teacher_disagreement_score":0.028149622,"about_ca_system_score_codex":0.00071176497,"about_ca_system_score_gemma":0.0011400778,"threshold_uncertainty_score":0.094169915},"labels":[],"label_agreement":null},{"id":"W4291782573","doi":"10.3899/jrheum.220367","title":"A Retrospective Analysis of Outcome in Melanoma Differentiation–Associated Gene 5–Related Interstitial Lung Disease Treated with Tofacitinib or Tacrolimus","year":2022,"lang":"en","type":"article","venue":"The Journal of Rheumatology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine; Tacrolimus; Interstitial lung disease; Hazard ratio; Gastroenterology; Tocilizumab; Mortality rate; Proportional hazards model; Retrospective cohort study; Surgery; Lung; Disease; Transplantation; Confidence interval","score_opus":0.00900281164908297,"score_gpt":0.23844536508486508,"score_spread":0.2294425534357821,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4291782573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993863,0.00023811926,0.00006675791,0.000011826272,0.000004832464,0.000004849925,0.00013912906,0.0000016941622,0.00014643405],"genre_scores_gemma":[0.9996306,0.00007343603,0.000025201229,0.000011259772,0.0000108143295,0.0000043473174,0.00021404032,0.0000010123488,0.000029230228],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993056,0.00017811795,0.00008805208,0.00018612524,0.00009974878,0.00014240183],"domain_scores_gemma":[0.9987256,0.00024365653,0.00060795096,0.00009142872,0.00009082638,0.00024053185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000600784,0.00022582184,0.00043735214,0.00058067,0.00040384752,0.00043564508,0.00026190575,0.00032725747,0.0009406225],"category_scores_gemma":[0.0012924339,0.000238655,0.0005632655,0.0007562833,0.00027277417,0.00036030207,0.00035388704,0.0003984238,0.00014966591],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002330396,0.000025057963,0.99841774,0.0000066580624,0.00005101339,0.0002630224,0.000022726717,0.000042796964,0.00015383158,0.000011583253,0.000051227362,0.00072138995],"study_design_scores_gemma":[0.000021464852,0.0003020237,0.9975885,0.0000059247504,0.00004925081,0.0013568236,0.0001249938,0.0002707501,0.00009006359,0.000020828447,0.00016452014,0.000004928989],"about_ca_topic_score_codex":0.0018517933,"about_ca_topic_score_gemma":0.0017215934,"teacher_disagreement_score":0.0018517933,"about_ca_system_score_codex":0.0003437228,"about_ca_system_score_gemma":0.00033403872,"threshold_uncertainty_score":0.0036820173},"labels":[],"label_agreement":null},{"id":"W4292182315","doi":"10.1101/2022.08.16.504086","title":"Kinase Suppressor of RAS 1 (KSR1) maintains the transformed phenotype of BRAFV600E mutant human melanoma cells","year":2022,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Children's Health Foundation; Science Foundation Ireland","keywords":"MAPK/ERK pathway; Biology; Kinase; Phenotype; Cell biology; Mutant; Cell growth; Cell cycle; Melanoma; Protein kinase A; Cancer research; Apoptosis; Genetics; Gene","score_opus":0.01124051392551464,"score_gpt":0.2180414584811038,"score_spread":0.20680094455558914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292182315","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9848828,0.0011521062,0.0057987203,0.00019299438,0.000056021203,0.000030822495,0.0029753544,0.00048085136,0.004430353],"genre_scores_gemma":[0.97953415,0.00056381884,0.0040934486,0.000041187777,0.000008862894,0.000025300824,0.0034390911,0.00012249558,0.012171575],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99992263,0.000008516817,0.000006284131,0.000017701192,0.000029633686,0.000015166515],"domain_scores_gemma":[0.99995625,0.000005545775,0.00001053967,0.0000107758015,0.000007039895,0.000009893572],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000095844785,0.00026165193,0.00015647872,0.00027849575,0.00016891652,0.00019410743,0.00015681075,0.00017935157,0.0018652369],"category_scores_gemma":[0.00006936146,0.000104666564,0.00016103828,0.00015276382,0.0001176989,0.00009741174,0.00016922234,0.00038211318,0.0012851555],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026403788,0.000009081567,0.00010299567,0.000009425701,0.0000015803809,0.000032947624,0.0000062133704,0.000039022867,0.99893504,0.000063790525,0.000062933395,0.00071047485],"study_design_scores_gemma":[0.0000063725943,0.000045884386,0.003258112,0.000002658307,0.000004263377,0.00026206754,0.000014265013,0.00078866957,0.9916437,0.00005565821,0.003915365,0.0000029409796],"about_ca_topic_score_codex":0.0007016965,"about_ca_topic_score_gemma":0.0010024665,"teacher_disagreement_score":0.0018652369,"about_ca_system_score_codex":0.00019099902,"about_ca_system_score_gemma":0.00014759028,"threshold_uncertainty_score":0.0062398314},"labels":[],"label_agreement":null},{"id":"W4292265616","doi":"10.1200/po.22.00107","title":"Clinical Activity of Mitogen-Activated Protein Kinase–Targeted Therapies in Patients With Non–V600 BRAF-Mutant Tumors","year":2022,"lang":"en","type":"review","venue":"JCO Precision Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McGill University Health Centre; University of Toronto; University Health Network; McGill University; Jewish General Hospital","funders":"National Cancer Institute; Fonds de Recherche du Québec - Santé; Association Neurofibromatoses et Recklinghause; American Society of Clinical Oncology; Conquer Cancer Foundation","keywords":"Medicine; MAPK/ERK pathway; Lung cancer; Melanoma; Targeted therapy; Oncology; Cancer; Cancer research; Internal medicine; Protein kinase A; Mutant; Kinase; Biology; Gene; Genetics","score_opus":0.038454183383332424,"score_gpt":0.34254752105524694,"score_spread":0.3040933376719145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292265616","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017345876,0.9812383,0.00021037707,0.00018084912,0.00007344797,0.00007135889,0.00042413402,0.00001061155,0.0004450443],"genre_scores_gemma":[0.58906543,0.407667,0.00095314893,0.000802501,0.00027456105,0.00022977384,0.0007689681,0.000016709071,0.00022192732],"study_design_codex":"meta_analysis","study_design_gemma":"not_applicable","domain_scores_codex":[0.9949067,0.0024101185,0.0015309253,0.0005382863,0.00050447666,0.00010935939],"domain_scores_gemma":[0.98214424,0.013426923,0.003260035,0.00033934854,0.0006905892,0.00013894228],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007046282,0.00089337205,0.0051647364,0.0027144833,0.00023881752,0.0015249476,0.0008078834,0.0009525148,0.0012838605],"category_scores_gemma":[0.017255316,0.00056215696,0.015271558,0.0029848646,0.00033630116,0.00089929,0.00047998282,0.00090452173,0.00012217832],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061406204,0.000056603287,0.034942128,0.28044608,0.6286482,0.0001459472,0.0001271283,0.0012441276,0.00086020876,0.00018177737,0.0011693204,0.04603783],"study_design_scores_gemma":[0.0013669955,0.0010683788,0.04507586,0.031479724,0.91433513,0.000360484,0.00011647775,0.00050824124,0.00069225003,0.00036969487,0.0045862882,0.00004049988],"about_ca_topic_score_codex":0.0019074396,"about_ca_topic_score_gemma":0.0047941273,"teacher_disagreement_score":0.007046282,"about_ca_system_score_codex":0.0010676775,"about_ca_system_score_gemma":0.0008893209,"threshold_uncertainty_score":0.037264764},"labels":[],"label_agreement":null},{"id":"W4293199696","doi":"10.1101/2022.08.24.505130","title":"On the therapeutic potential of MAPK4 in triple-negative breast cancer","year":2022,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"Helse Nord RHF; Deutsche Forschungsgemeinschaft; Cancer Research Society; Kreftforeningen","keywords":"Triple-negative breast cancer; PI3K/AKT/mTOR pathway; Cancer research; Protein kinase B; Kinase; Subfamily; Cell growth; Biology; Cancer; Breast cancer; Signal transduction; Cell biology; Gene; Genetics","score_opus":0.011440819637779218,"score_gpt":0.22296386856018097,"score_spread":0.21152304892240176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293199696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7648996,0.11347386,0.023538599,0.011587082,0.0013853546,0.0001761269,0.0012977751,0.00088675285,0.082754865],"genre_scores_gemma":[0.8984306,0.0503935,0.01167742,0.00082378235,0.0004510586,0.00008885631,0.0010589798,0.00014352784,0.03693223],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99993634,0.000017017688,0.0000030597982,0.0000072601392,0.000024962024,0.000011416835],"domain_scores_gemma":[0.9999702,0.000010773064,0.0000032960402,0.0000036504791,0.0000057580255,0.000006268854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032411065,0.000308621,0.00022214107,0.00035342327,0.00020410854,0.00033924615,0.0001591477,0.0002452137,0.004247944],"category_scores_gemma":[0.0001638936,0.00007841411,0.00019668872,0.0002036791,0.00022828324,0.00025818063,0.00018940761,0.00043321025,0.0010721684],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021138282,0.00028651525,0.001080587,0.0005985202,0.000062136765,0.0009654644,0.00011219393,0.0024919917,0.8567658,0.011080935,0.007895338,0.11654666],"study_design_scores_gemma":[0.00017344604,0.000859004,0.0046543963,0.00007134951,0.00009965917,0.0018948193,0.00008172175,0.004093149,0.86948746,0.0071936003,0.11137188,0.00001968315],"about_ca_topic_score_codex":0.00026891296,"about_ca_topic_score_gemma":0.00038389553,"teacher_disagreement_score":0.004247944,"about_ca_system_score_codex":0.00031999766,"about_ca_system_score_gemma":0.00021848085,"threshold_uncertainty_score":0.014210761},"labels":[],"label_agreement":null},{"id":"W4295817741","doi":"10.1016/j.annonc.2022.07.925","title":"799P A pilot study of the neo-adjuvant use of vemurafenib plus cobimetinib in patients with BRAF mutant melanoma with palpable lymph node metastases","year":2022,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital; Sunnybrook Health Science Centre; McGill University Health Centre; Ottawa Hospital; Health Sciences Centre","funders":"","keywords":"Medicine; Vemurafenib; Melanoma; Internal medicine; Surgery; Oncology; Metastatic melanoma; Cancer; Cancer research","score_opus":0.0520053171506117,"score_gpt":0.27798662691980586,"score_spread":0.22598130976919417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295817741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998298,0.0003259387,0.000111311245,0.00012900442,0.000055129396,0.00017738885,0.00024647833,0.000009669168,0.00064710056],"genre_scores_gemma":[0.99782854,0.0002492427,0.00021254242,0.00014122251,0.00009192995,0.00019508398,0.00047089145,0.0000054275383,0.00080507883],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996437,0.0001314558,0.00001900832,0.00008638035,0.000029732864,0.00008960968],"domain_scores_gemma":[0.9994286,0.00015358737,0.000070714734,0.000047281294,0.00004004049,0.00025975463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006858792,0.0007463347,0.0012757527,0.00020338372,0.00032543676,0.00057196844,0.00033299992,0.0006571556,0.0030078415],"category_scores_gemma":[0.0010381019,0.00034413347,0.0014181128,0.00031379022,0.0004437215,0.0007783218,0.000304674,0.0018083097,0.00059755857],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8926429,0.019769754,0.021997714,0.00015703104,0.001173908,0.0002596276,0.000107389096,0.0005751017,0.014646022,0.000074112715,0.00070495566,0.047891468],"study_design_scores_gemma":[0.20578766,0.6600315,0.12493778,0.00003398072,0.0020645976,0.00028295265,0.000116967414,0.0015703853,0.0023680697,0.00017833905,0.0025782636,0.00004955415],"about_ca_topic_score_codex":0.0012495779,"about_ca_topic_score_gemma":0.0022146704,"teacher_disagreement_score":0.0030078415,"about_ca_system_score_codex":0.0004997908,"about_ca_system_score_gemma":0.0009450134,"threshold_uncertainty_score":0.010062218},"labels":[],"label_agreement":null},{"id":"W4295820891","doi":"10.1016/j.annonc.2022.07.939","title":"813P Time to development of central nervous system (CNS) metastases (mets) with atezolizumab (A) or placebo (P) combined with vemurafenib (V) + cobimetinib (C): Updated results from the phase III IMspire150 study","year":2022,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; Atezolizumab; Vemurafenib; Placebo; Internal medicine; Oncology; Pembrolizumab; Pathology; Cancer; Immunotherapy; Metastatic melanoma","score_opus":0.03804869258544963,"score_gpt":0.3045034102998207,"score_spread":0.26645471771437107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295820891","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93992513,0.031962752,0.0021612996,0.0012465557,0.0007343924,0.00025685914,0.013266391,0.00021562279,0.010231105],"genre_scores_gemma":[0.9780628,0.005997297,0.0007831119,0.001003508,0.0002710208,0.0002748457,0.008727709,0.00004806034,0.0048317173],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9997409,0.00007564091,0.000021225747,0.00006540559,0.00004854865,0.00004828546],"domain_scores_gemma":[0.9994343,0.00016851841,0.00021457623,0.000035412726,0.000058779704,0.00008842774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081285334,0.00056716485,0.0011735114,0.00017999264,0.00014927995,0.0007258858,0.0002883284,0.0005011148,0.0038997964],"category_scores_gemma":[0.0012083626,0.00022046843,0.0016951818,0.00030314503,0.0001400954,0.00054964656,0.00024574946,0.0015240831,0.00062701775],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4764213,0.001784281,0.06832365,0.0032968523,0.014322498,0.00048305394,0.00010909727,0.0056266943,0.02032839,0.00074796483,0.022924861,0.38563135],"study_design_scores_gemma":[0.10409854,0.09883485,0.6744271,0.0007748222,0.032468922,0.0024649054,0.0002278428,0.0062684002,0.013826867,0.0036742485,0.06273394,0.00019951342],"about_ca_topic_score_codex":0.0008265292,"about_ca_topic_score_gemma":0.0021381553,"teacher_disagreement_score":0.0038997964,"about_ca_system_score_codex":0.00043266406,"about_ca_system_score_gemma":0.0004150067,"threshold_uncertainty_score":0.013046086},"labels":[],"label_agreement":null},{"id":"W4295837169","doi":"10.1016/j.annonc.2022.07.1765","title":"1686P Evaluating the relationship between BRAF mutation class and patient demographics in an international cancer cohort","year":2022,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital; McGill University Health Centre","funders":"","keywords":"Medicine; Demographics; Cohort; Oncology; Cancer; Mutation; Internal medicine; Family medicine; Demography; Genetics; Gene","score_opus":0.15137463734243106,"score_gpt":0.4302997214824439,"score_spread":0.2789250841400128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295837169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954209,0.00016515431,0.00029753416,0.0003128172,0.000033696026,0.000011042765,0.0018781503,0.000016318127,0.0018643315],"genre_scores_gemma":[0.99643815,0.00015041661,0.00030445523,0.00014996227,0.000048755643,0.00002205357,0.0014421408,0.00001773887,0.0014263781],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99974257,0.000051845374,0.000021416243,0.00007096845,0.000047150686,0.00006602236],"domain_scores_gemma":[0.99904364,0.00022206047,0.00027244337,0.00008760056,0.00013367838,0.0002405527],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005713154,0.00026327872,0.00020396047,0.00083274534,0.0005152868,0.0006607056,0.00032753154,0.00044708353,0.0046825693],"category_scores_gemma":[0.002610268,0.00017927446,0.00040366407,0.001124398,0.0001654004,0.00048755584,0.0005183756,0.0007269522,0.0008194127],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027962157,0.000047868372,0.9912649,0.000009031194,0.000065506654,0.00021532954,0.00006536693,0.00006476429,0.0008812422,0.000054801912,0.0010990946,0.005952488],"study_design_scores_gemma":[0.000018065804,0.00015355245,0.9952792,0.0000075377234,0.000121753204,0.0008536136,0.0002419881,0.00033013988,0.00044308446,0.0001420663,0.0024028718,0.0000060878806],"about_ca_topic_score_codex":0.0034281132,"about_ca_topic_score_gemma":0.004180721,"teacher_disagreement_score":0.0046825693,"about_ca_system_score_codex":0.0002626532,"about_ca_system_score_gemma":0.00041616944,"threshold_uncertainty_score":0.015664756},"labels":[],"label_agreement":null},{"id":"W4296929566","doi":"10.1016/j.ejca.2022.09.002","title":"Corrigendum to ‘p53 Reactivation by PRIMA-1Met (APR-246) sensitises V600E/KBRAF melanoma to vemurafenib’[Eur J of Cancer 55 (2016) 98–110]","year":2022,"lang":"en","type":"erratum","venue":"European Journal of Cancer","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Vemurafenib; Melanoma; Medicine; Cancer research; Protein kinase B; PI3K/AKT/mTOR pathway; MAPK/ERK pathway; Metastatic melanoma; Phosphorylation; Chemistry; Signal transduction","score_opus":0.015286994784977513,"score_gpt":0.2587760244581139,"score_spread":0.24348902967313635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296929566","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013914349,0.0034401382,0.00055392605,0.0385872,0.9516276,0.000028610337,0.0006372914,0.0003142721,0.0046717413],"genre_scores_gemma":[0.00811367,0.016155802,0.004085646,0.13911083,0.357444,0.00017441434,0.0043304944,0.00089777267,0.46968743],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99775946,0.0002267733,0.00033681377,0.0004400209,0.00096119853,0.00027569622],"domain_scores_gemma":[0.9944054,0.0012837705,0.00040336105,0.00041975803,0.003008832,0.00047888613],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001897005,0.0027845255,0.0028507635,0.0032145754,0.0028584471,0.0026987405,0.0040938184,0.009007114,0.07866708],"category_scores_gemma":[0.013400841,0.0014300593,0.0028833614,0.0018254017,0.0017191594,0.0017205873,0.0021196322,0.006833605,0.05026326],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003824741,0.00001411009,0.000043510325,0.00012636103,0.000014677951,0.00031266038,0.00001212287,0.000051914878,0.0002268323,0.00022515595,0.99396884,0.004965601],"study_design_scores_gemma":[0.00004214551,0.00003730803,0.0010883325,0.00011700357,0.000057643952,0.00047454282,0.000024401445,0.0002101612,0.0007209323,0.0006887984,0.9965048,0.00003399372],"about_ca_topic_score_codex":0.023211757,"about_ca_topic_score_gemma":0.038235415,"teacher_disagreement_score":0.07866708,"about_ca_system_score_codex":0.0033810136,"about_ca_system_score_gemma":0.0031076076,"threshold_uncertainty_score":0.26316756},"labels":[],"label_agreement":null},{"id":"W4297752154","doi":"","title":"Cutaneous mosaic syndromes associated with early postzygotic activating BRAF mutations","year":2017,"lang":"en","type":"preprint","venue":"HAL (Le Centre pour la Communication Scientifique Directe)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Mosaic; Genetics; Mutation; Biology; Medicine; Gene","score_opus":0.014294349959851276,"score_gpt":0.2264035959307994,"score_spread":0.21210924597094813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297752154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98827773,0.00065491913,0.0014501194,0.00015914688,0.000023549706,0.000027883145,0.00029089896,0.00010269573,0.009013056],"genre_scores_gemma":[0.99617213,0.00026825146,0.00076362654,0.000028428936,0.000028882907,0.000008039378,0.00007497695,0.00001964591,0.00263611],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.9998784,0.000018506262,0.000007984349,0.000030434305,0.000031746607,0.00003290096],"domain_scores_gemma":[0.99977916,0.000043964963,0.00009143645,0.000024097613,0.000008549447,0.00005277104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000083675215,0.000727929,0.0003159907,0.0007509656,0.00030829778,0.0004010159,0.00022286468,0.0006954992,0.006122981],"category_scores_gemma":[0.00041869128,0.000248218,0.00020748626,0.00051511417,0.00044998838,0.00023603675,0.0004732294,0.00046854105,0.00074351614],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014868312,0.00009002838,0.029342586,0.00026169102,0.00016083631,0.5681595,0.00045385506,0.00088937907,0.36066797,0.0074632955,0.0017032969,0.02932076],"study_design_scores_gemma":[0.00016194985,0.00022842229,0.10861096,0.000043070457,0.00014673486,0.8447622,0.00017973103,0.0013249319,0.035539586,0.0024737704,0.0064904927,0.000038135786],"about_ca_topic_score_codex":0.0007167185,"about_ca_topic_score_gemma":0.0010344913,"teacher_disagreement_score":0.006122981,"about_ca_system_score_codex":0.00021374931,"about_ca_system_score_gemma":0.0001762033,"threshold_uncertainty_score":0.020483375},"labels":[],"label_agreement":null},{"id":"W4307492590","doi":"10.15252/emmm.202215677","title":"The AhR‐SRC axis as a therapeutic vulnerability in BRAFi‐resistant melanoma","year":2022,"lang":"en","type":"article","venue":"EMBO Molecular Medicine","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"College of Natural Resources and Sciences, Humboldt State University; Centre Hospitalier Universitaire de Rennes; Université de Rennes 1; Institut National Du Cancer; Ligue Contre le Cancer; Institut National de la Santé et de la Recherche Médicale; CNIB; Centre National de la Recherche Scientifique; Stichting Tegen Kanker; Alliance Nationale pour les Sciences de la Vie et de la Santé","keywords":"Melanoma; Cancer research; Downregulation and upregulation; Proto-oncogene tyrosine-protein kinase Src; Dasatinib; Aryl hydrocarbon receptor; Biology; Medicine; Transcription factor; Immunology; Signal transduction; Cell biology; Gene; Genetics","score_opus":0.010478176335757492,"score_gpt":0.2579483852212526,"score_spread":0.2474702088854951,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307492590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9823161,0.0063309628,0.0041115563,0.0006227272,0.00004679317,0.00004643912,0.0001921151,0.00020590548,0.006127317],"genre_scores_gemma":[0.996618,0.0012921797,0.00048354856,0.00006127565,0.000012211775,0.0000088777515,0.00007170999,0.000008123935,0.0014440618],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989426,0.00002059207,0.0000051959105,0.000018455972,0.000034034023,0.000027366568],"domain_scores_gemma":[0.9999535,0.0000067807987,0.000015862079,0.000006421921,0.0000062592158,0.000011168894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018221505,0.0002290175,0.00027163202,0.00019707019,0.00016301672,0.0004006113,0.00015276528,0.0002558432,0.0016878335],"category_scores_gemma":[0.00008636588,0.00008186146,0.0001917969,0.0000914108,0.00022677486,0.00025109388,0.00022255571,0.00055395585,0.00028429722],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016407693,0.00004924538,0.0010763712,0.00005492949,0.0000085831625,0.00029768664,0.000025521575,0.00021077762,0.98905736,0.000901146,0.00014560108,0.008008542],"study_design_scores_gemma":[0.000080681464,0.003341076,0.034186933,0.000024817427,0.00008800069,0.0071509546,0.0002489695,0.004477734,0.9270401,0.0024109767,0.020919992,0.000029828268],"about_ca_topic_score_codex":0.00019537771,"about_ca_topic_score_gemma":0.00048382647,"teacher_disagreement_score":0.0016878335,"about_ca_system_score_codex":0.00031763536,"about_ca_system_score_gemma":0.00016377267,"threshold_uncertainty_score":0.005646348},"labels":[],"label_agreement":null},{"id":"W4307642528","doi":"10.1007/s40264-022-01248-2","title":"Characterization of Serous Retinopathy Associated with Cobimetinib: Integrated Safety Analysis of Four Studies","year":2022,"lang":"en","type":"article","venue":"Drug Safety","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"Genentech; F. Hoffmann-La Roche; Roche","keywords":"Medicine; Serous fluid; Retinopathy; Ophthalmology; Internal medicine; Endocrinology","score_opus":0.013423989524145823,"score_gpt":0.22816094373591547,"score_spread":0.21473695421176964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307642528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9092876,0.07103195,0.0052523636,0.00034463685,0.00003914408,0.0026761799,0.0057756915,0.00011626148,0.0054762186],"genre_scores_gemma":[0.9893182,0.0040520355,0.0028202257,0.0002238372,0.000047218768,0.00066938787,0.0026286442,0.000016601165,0.00022380176],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98580325,0.0062655243,0.0033755805,0.0009982941,0.0031135005,0.00044393365],"domain_scores_gemma":[0.94462776,0.017805466,0.027106114,0.0028754699,0.0066108694,0.0009743563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.028135184,0.0008108056,0.0016261247,0.0045277397,0.0004648859,0.0023165068,0.00075706746,0.00074727344,0.001402153],"category_scores_gemma":[0.017995967,0.0002793201,0.00446535,0.003918576,0.0005353515,0.00081696844,0.0011797374,0.0006764234,0.00016971034],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03202992,0.0007897637,0.73048073,0.010279798,0.05479211,0.0003777172,0.00046244907,0.0015546586,0.017208181,0.00022456246,0.0009714546,0.15082859],"study_design_scores_gemma":[0.0037973006,0.021562533,0.88422537,0.0021760112,0.05878721,0.0019529484,0.00033110238,0.0015204356,0.013248885,0.00043401375,0.01186256,0.000101640515],"about_ca_topic_score_codex":0.0006237987,"about_ca_topic_score_gemma":0.0016166292,"teacher_disagreement_score":0.028135184,"about_ca_system_score_codex":0.0012552823,"about_ca_system_score_gemma":0.0016215707,"threshold_uncertainty_score":0.14879483},"labels":[],"label_agreement":null},{"id":"W4307844453","doi":"10.1038/s41467-022-34179-8","title":"CDK12 is hyperactivated and a synthetic-lethal target in BRAF-mutated melanoma","year":2022,"lang":"en","type":"article","venue":"Nature Communications","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Université du Québec à Montréal; Université de Montréal; Institute for Research in Immunology and Cancer","funders":"CIHR Skin Research Training Centre; University of Colorado School of Medicine, Anschutz Medical Campus; University of Toronto; Cancer Research Society; Natural Sciences and Engineering Research Council of Canada; Government of Canada; McGill University","keywords":"Melanoma; Cancer research; Mutation; Medicine; Biology; Computational biology; Genetics; Gene","score_opus":0.011272290712120582,"score_gpt":0.26318901355589375,"score_spread":0.25191672284377314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307844453","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9835476,0.007918349,0.0026155422,0.00021589182,0.000090939495,0.00003734161,0.0005886648,0.0002175552,0.0047681304],"genre_scores_gemma":[0.9951042,0.0014167626,0.00075750716,0.000032893502,0.000010797195,0.000022435142,0.0002967343,0.000016446806,0.0023422788],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990845,0.000014098942,0.0000072634894,0.0000187733,0.00002982447,0.000021584992],"domain_scores_gemma":[0.999948,0.00000711502,0.000010825937,0.0000064513074,0.0000055928936,0.000021956703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000080713246,0.00029123286,0.00024411594,0.00028414303,0.00016988908,0.00021596815,0.00013388148,0.0002086687,0.0019709377],"category_scores_gemma":[0.00009628495,0.00012941581,0.00016571517,0.00015468222,0.00016328135,0.00011969338,0.00013709295,0.00042197554,0.000453138],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013598152,0.000024798039,0.00024147696,0.000038158298,0.0000046378855,0.00009050275,0.000005468205,0.00008282331,0.9975938,0.00012116845,0.000084960695,0.001576196],"study_design_scores_gemma":[0.000017644626,0.00026234152,0.00454949,0.0000051268885,0.000010320956,0.00075597456,0.000017079248,0.00059444056,0.9885765,0.000077436925,0.0051296004,0.0000040053415],"about_ca_topic_score_codex":0.0007676548,"about_ca_topic_score_gemma":0.0011076744,"teacher_disagreement_score":0.0019709377,"about_ca_system_score_codex":0.00028846285,"about_ca_system_score_gemma":0.00017227793,"threshold_uncertainty_score":0.006593466},"labels":[],"label_agreement":null},{"id":"W4307911011","doi":"10.1016/s0959-8049(22)00972-8","title":"Characterizing mechanisms of resistance to BRAF and MEK inhibitors in cancers with Class 2 BRAF mutations: uncovering novel therapeutic opportunities","year":2022,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McGill University Health Centre; University of Toronto; University Health Network; McGill University; Jewish General Hospital","funders":"","keywords":"Melanoma; Cancer research; Vemurafenib; Medicine; Mutant; Targeted therapy; Cancer; MEK inhibitor; Biology; MAPK/ERK pathway; Gene; Internal medicine; Signal transduction; Genetics; Metastatic melanoma","score_opus":0.02404520859833804,"score_gpt":0.23654860479195203,"score_spread":0.212503396193614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307911011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94221836,0.042959075,0.0074586477,0.0019227724,0.0000627658,0.00009560616,0.00047294798,0.00013646633,0.00467337],"genre_scores_gemma":[0.98271126,0.01350359,0.0020714598,0.00026578255,0.000052977604,0.000047455225,0.0002812454,0.000014002783,0.0010522711],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998498,0.000029781226,0.000010573481,0.000026299991,0.000037663875,0.000045882654],"domain_scores_gemma":[0.9998901,0.000024134099,0.000040045,0.000012771691,0.000016558197,0.000016427086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062681996,0.0004325729,0.0004831287,0.00070282957,0.00018080522,0.0010305552,0.0004704444,0.0005358265,0.00106081],"category_scores_gemma":[0.00037320898,0.0002381438,0.0003910927,0.00039944093,0.00037208587,0.0008971355,0.00026194897,0.00077066314,0.00021572057],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015581711,0.00033733132,0.027501388,0.00053265365,0.00016475838,0.00064570014,0.00020793214,0.0019603688,0.85307455,0.0058236094,0.0012366469,0.106956884],"study_design_scores_gemma":[0.0004454847,0.0046844496,0.20925514,0.00019686275,0.00078854215,0.01256506,0.0012082305,0.018938327,0.6756338,0.020084798,0.056069963,0.0001294165],"about_ca_topic_score_codex":0.00046527493,"about_ca_topic_score_gemma":0.0008275566,"teacher_disagreement_score":0.00106081,"about_ca_system_score_codex":0.0006073366,"about_ca_system_score_gemma":0.0004207328,"threshold_uncertainty_score":0.0044065714},"labels":[],"label_agreement":null},{"id":"W4309889913","doi":"10.1038/s41698-022-00328-x","title":"MEK inhibitor resistance in lung adenocarcinoma is associated with addiction to sustained ERK suppression","year":2022,"lang":"en","type":"article","venue":"npj Precision Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Canadian Institutes of Health Research; Japanese Respiratory Society; National Cancer Institute; BC Cancer Foundation; Government of Canada; Michael Smith Health Research BC; Memorial Sloan-Kettering Cancer Center; Eli Lilly and Company","keywords":"Trametinib; KRAS; MEK inhibitor; MAPK/ERK pathway; Cancer research; Drug resistance; Mutant; Adenocarcinoma; Medicine; Cancer; Biology; Kinase; Internal medicine; Gene; Genetics; Colorectal cancer","score_opus":0.00917306857849693,"score_gpt":0.2587210472632028,"score_spread":0.24954797868470585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309889913","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992354,0.00015866,0.00022336973,0.000018374707,0.000001317076,0.0000050481176,0.000043652268,0.000016757589,0.00029742453],"genre_scores_gemma":[0.99962115,0.000052133473,0.00013614811,0.000007494712,0.0000011101132,0.0000018014999,0.00005050613,0.0000019644763,0.00012778264],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991095,0.000015490607,0.000012850739,0.000016719652,0.0000248377,0.00001916713],"domain_scores_gemma":[0.9998099,0.000033125,0.0000712489,0.000021969232,0.000019743751,0.000043968157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010861722,0.00015501799,0.00018157074,0.00038289608,0.00013993212,0.00026486034,0.00012711914,0.00019954183,0.0010237376],"category_scores_gemma":[0.00018652271,0.00011105803,0.00018789897,0.00021246435,0.00016539157,0.000099483164,0.00019268553,0.00030393334,0.00022412938],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069351005,0.0001452237,0.11095333,0.00004028834,0.000027301197,0.0032005862,0.00003871234,0.00022446614,0.87731546,0.00018907138,0.00012123253,0.0070508798],"study_design_scores_gemma":[0.000035587633,0.0020533628,0.6833306,0.000010135262,0.0000701332,0.04695414,0.00016408856,0.0044547804,0.26046237,0.0003123076,0.0021314018,0.000021115],"about_ca_topic_score_codex":0.00033387222,"about_ca_topic_score_gemma":0.00050723413,"teacher_disagreement_score":0.0010237376,"about_ca_system_score_codex":0.00016090536,"about_ca_system_score_gemma":0.000092401046,"threshold_uncertainty_score":0.0034247637},"labels":[],"label_agreement":null},{"id":"W4310554573","doi":"10.1016/s1470-2045(22)00687-8","title":"Overall survival with first-line atezolizumab in combination with vemurafenib and cobimetinib in BRAFV600 mutation-positive advanced melanoma (IMspire150): second interim analysis of a multicentre, randomised, phase 3 study","year":2022,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":104,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"F. Hoffmann-La Roche; Roche","keywords":"Medicine; Vemurafenib; Atezolizumab; Interim analysis; Placebo; Internal medicine; Tolerability; Oncology; Adverse effect; Surgery; Randomized controlled trial; Metastatic melanoma; Pembrolizumab; Cancer; Immunotherapy; Pathology","score_opus":0.017250538822363423,"score_gpt":0.2996574736859282,"score_spread":0.2824069348635648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310554573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99141484,0.0031694453,0.00053117156,0.00065380847,0.0002893747,0.0004904216,0.0020292432,0.00009760702,0.0013241738],"genre_scores_gemma":[0.98725224,0.0015294278,0.0009812092,0.0010888431,0.00025691738,0.0009666019,0.0049534137,0.000058395206,0.0029129658],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9989215,0.00048342795,0.000041178086,0.00018269016,0.00008228022,0.000288897],"domain_scores_gemma":[0.9988275,0.00024241352,0.000230533,0.00014028534,0.00007099923,0.00048826457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041050334,0.0020926103,0.0040409495,0.0004045912,0.00037409095,0.0018446196,0.0011756249,0.0017568677,0.00327141],"category_scores_gemma":[0.0016331488,0.0007734328,0.005019004,0.00037990863,0.0009149283,0.0016404134,0.00065030874,0.004613081,0.0009403778],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9626947,0.003310014,0.002225103,0.00034312168,0.0023754167,0.000048659105,0.000060738155,0.0016203122,0.0041108234,0.000090468086,0.0019171777,0.021203427],"study_design_scores_gemma":[0.7764504,0.19416119,0.02168575,0.0000600119,0.0029804872,0.00015906781,0.00005256892,0.0011899639,0.001351712,0.00028249956,0.0015701953,0.000056067285],"about_ca_topic_score_codex":0.0012207424,"about_ca_topic_score_gemma":0.0031529253,"teacher_disagreement_score":0.0041050334,"about_ca_system_score_codex":0.001532682,"about_ca_system_score_gemma":0.0013921658,"threshold_uncertainty_score":0.02170974},"labels":[],"label_agreement":null},{"id":"W4312060640","doi":"10.1101/2022.12.09.519777","title":"p38γ and p38δ modulate innate immune response by regulating MEF2D activation","year":2022,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University; Institute for Research in Immunology and Cancer","funders":"Medical Research Council; Agencia Estatal de Investigación; Ministerio de Educación y Formación Profesional; Universidad Autónoma de Madrid; Cancer Research UK; Wellcome Trust; Francis Crick Institute; Centro Nacional de Biotecnología; University of Dundee","keywords":"p38 mitogen-activated protein kinases; Innate immune system; Cell biology; Biology; MEF2C; Inflammation; Transcription factor; Immune system; Kinase; Protein kinase A; Immunology; Gene; Biochemistry","score_opus":0.009305685861567265,"score_gpt":0.21207144322676835,"score_spread":0.20276575736520108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312060640","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99171525,0.001825835,0.003999077,0.00017809754,0.000039131493,0.000036471887,0.000649217,0.00009291545,0.0014640987],"genre_scores_gemma":[0.9942577,0.0006413369,0.0021989287,0.000053875166,0.00001240963,0.00006930122,0.000325199,0.000014322694,0.0024269377],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998535,0.00002045446,0.000013398968,0.00003738845,0.0000314655,0.000043771346],"domain_scores_gemma":[0.9999057,0.000009734689,0.00003388169,0.000009520528,0.000009600672,0.000031555617],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016731769,0.0004935878,0.00014722203,0.00034442524,0.00017550008,0.00023436431,0.00022213152,0.00023446533,0.001980973],"category_scores_gemma":[0.00009700221,0.000159661,0.00023660887,0.00012322914,0.00028368126,0.00020428687,0.00023249876,0.0005302717,0.0004002694],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016191641,0.000023758364,0.0002465702,0.000031874293,0.0000030703368,0.000039308143,0.000008729585,0.000035244666,0.998591,0.000062380655,0.000027828573,0.00076831336],"study_design_scores_gemma":[0.000039662526,0.00015135725,0.0074509783,0.000009582472,0.000009254901,0.00018399696,0.000032434957,0.0006139069,0.990119,0.00012296799,0.0012629421,0.000003944778],"about_ca_topic_score_codex":0.00017526964,"about_ca_topic_score_gemma":0.00023098038,"teacher_disagreement_score":0.001980973,"about_ca_system_score_codex":0.00023081154,"about_ca_system_score_gemma":0.00012407702,"threshold_uncertainty_score":0.0066269636},"labels":[],"label_agreement":null},{"id":"W4312224396","doi":"10.1186/s13046-022-02559-z","title":"The traditional chinese medicine monomer Ailanthone improves the therapeutic efficacy of anti-PD-L1 in melanoma cells by targeting c-Jun","year":2022,"lang":"en","type":"article","venue":"Journal of Experimental & Clinical Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"Science and Technology Innovative Research Team in Higher Educational Institutions of Hunan Province; Project 211; Higher Education Discipline Innovation Project; National Natural Science Foundation of China","keywords":"Melanoma; Cancer research; Flow cytometry; Medicine; In vitro; Apoptosis; Combination therapy; Tumor microenvironment; Pharmacology; Immunology; Chemistry; Tumor cells","score_opus":0.09284339632606865,"score_gpt":0.4406179071527125,"score_spread":0.34777451082664385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312224396","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887061,0.004453732,0.0024158065,0.00019139203,0.000044507764,0.00008913441,0.0003995693,0.00009985095,0.003599768],"genre_scores_gemma":[0.9925437,0.002038238,0.002881122,0.00010639372,0.000011172697,0.000037754708,0.00025251732,0.000011373464,0.0021177696],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999651,0.0000036803406,0.0000022623656,0.000008515539,0.00001218203,0.000008309387],"domain_scores_gemma":[0.9999796,0.0000038215226,0.000005755894,0.0000017243904,0.0000027048125,0.0000063588477],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007519462,0.0003363786,0.00028516076,0.00034605397,0.00011841047,0.00015847958,0.00017203909,0.00014568924,0.0022813678],"category_scores_gemma":[0.00006228716,0.00008660761,0.00027330653,0.00017348772,0.0001297623,0.00019801912,0.00017613899,0.00041582342,0.00022619721],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036641155,0.00018936732,0.00048607908,0.00043754917,0.000028056436,0.00012143619,0.000022263323,0.0011192824,0.98098594,0.00017932033,0.00028300835,0.015781296],"study_design_scores_gemma":[0.00016058733,0.0030614187,0.005273453,0.0000269365,0.00012307114,0.00029164867,0.000036949874,0.0054742177,0.97752064,0.00012409735,0.007886009,0.00002098617],"about_ca_topic_score_codex":0.00051339855,"about_ca_topic_score_gemma":0.0012908833,"teacher_disagreement_score":0.0022813678,"about_ca_system_score_codex":0.00017757082,"about_ca_system_score_gemma":0.00023408895,"threshold_uncertainty_score":0.0076319575},"labels":[],"label_agreement":null},{"id":"W4313126052","doi":"10.22374/cjgim.v17i2.578","title":"Small-Cell Lung Cancer Presenting with Ocular and Scalp Metastases","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of General Internal Medicine","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Lung cancer; Dermatology; Scalp; Malignancy; Gynecology; Presentation (obstetrics); Cancer; Pathology; Internal medicine; Surgery","score_opus":0.013736591902029891,"score_gpt":0.23865913792013949,"score_spread":0.2249225460181096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313126052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9690831,0.005740397,0.0029436569,0.0019431944,0.00033908643,0.00015724338,0.00044617767,0.00019356747,0.019153617],"genre_scores_gemma":[0.9962763,0.0012801549,0.00060342345,0.00035657166,0.000310654,0.000012015727,0.000091227645,0.0000146663715,0.00105493],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99973696,0.000020499761,0.00002241009,0.00004913568,0.000052770523,0.00011815117],"domain_scores_gemma":[0.9995247,0.00009169607,0.00010534293,0.00003081959,0.00003777773,0.00020972312],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000118898126,0.0011663891,0.00061824743,0.0017748482,0.0014734743,0.0008726128,0.00042592417,0.0017036314,0.0028011375],"category_scores_gemma":[0.0014660961,0.0003730735,0.00046801302,0.0011290993,0.00066769647,0.00070655474,0.00081285904,0.0014120357,0.0006689538],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020552126,0.00001880009,0.013422546,0.00001812386,0.0000058703463,0.98311377,0.00007306549,0.000040200182,0.0014887501,0.00011857199,0.00027469243,0.0014050901],"study_design_scores_gemma":[0.000003387485,0.000020501577,0.006071376,0.000005604926,0.000005842615,0.9930823,0.00007979182,0.00006692433,0.00023650895,0.00010064954,0.00032142305,0.000005668379],"about_ca_topic_score_codex":0.0053509097,"about_ca_topic_score_gemma":0.00896042,"teacher_disagreement_score":0.0053509097,"about_ca_system_score_codex":0.0007689701,"about_ca_system_score_gemma":0.0007446574,"threshold_uncertainty_score":0.010639548},"labels":[],"label_agreement":null},{"id":"W4313503211","doi":"10.3390/cancers15010025","title":"On the Therapeutic Potential of ERK4 in Triple-Negative Breast Cancer","year":2022,"lang":"en","type":"article","venue":"Cancers","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"Helse Nord RHF; Deutsche Forschungsgemeinschaft; Canadian Institutes of Health Research; Cancer Research Society; Kreftforeningen","keywords":"Triple-negative breast cancer; Cancer research; PI3K/AKT/mTOR pathway; Kinase; Breast cancer; Cell growth; Protein kinase B; Cancer; Mitogen-activated protein kinase; Medicine; Biology; Signal transduction; Cell biology; Internal medicine; Biochemistry","score_opus":0.010923095163950874,"score_gpt":0.23875614717970448,"score_spread":0.2278330520157536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313503211","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7072954,0.2453488,0.004208954,0.0083154375,0.00077162933,0.00012367123,0.00031900094,0.00011287369,0.033504184],"genre_scores_gemma":[0.877931,0.11148536,0.0022877855,0.001329185,0.00027680476,0.00007034258,0.00022322575,0.000024589126,0.006371624],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999076,0.00003257845,0.000006678919,0.000009098719,0.000021491045,0.00002253628],"domain_scores_gemma":[0.99994874,0.000018985236,0.000007793123,0.0000052625765,0.000010493747,0.000008776135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005003318,0.00022206483,0.00023583185,0.0003438293,0.00018765815,0.0004269512,0.0002364341,0.0002993588,0.0014227424],"category_scores_gemma":[0.00016667724,0.00006934234,0.00026982365,0.00022721791,0.00027268654,0.00037539352,0.00020812088,0.00075195637,0.00031713638],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050515775,0.001205775,0.0017425214,0.0016478961,0.0001286848,0.0012061682,0.00020467435,0.0017680187,0.63831806,0.011435328,0.0044445824,0.3328468],"study_design_scores_gemma":[0.0009155666,0.0146743795,0.015058235,0.00064157497,0.0004477967,0.004588576,0.00053243444,0.003395945,0.6690066,0.008179682,0.28249672,0.00006254199],"about_ca_topic_score_codex":0.0002049084,"about_ca_topic_score_gemma":0.0006408707,"teacher_disagreement_score":0.0014227424,"about_ca_system_score_codex":0.00023494221,"about_ca_system_score_gemma":0.00026055655,"threshold_uncertainty_score":0.0047594905},"labels":[],"label_agreement":null},{"id":"W4313556534","doi":"10.18433/jpps33020","title":"Post-Marketing Safety of Vemurafenib: A Real-World Pharmacovigilance Study of the FDA Adverse Event Reporting System","year":2022,"lang":"en","type":"article","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Vemurafenib; Adverse Event Reporting System; Medicine; Pharmacovigilance; Adverse effect; Internal medicine; Pharmacology; Metastatic melanoma; Cancer","score_opus":0.0480715049185764,"score_gpt":0.37734010287839204,"score_spread":0.3292685979598156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313556534","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99726343,0.0004934168,0.00092432456,0.000197837,0.000013015642,0.00008775615,0.00055986125,0.000020958907,0.0004395101],"genre_scores_gemma":[0.99918836,0.000046707013,0.00023329131,0.000060614228,0.000014062787,0.00002311446,0.00037783824,0.000004390939,0.000051598876],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9773147,0.011740123,0.0033592947,0.0026503482,0.00433895,0.00059648533],"domain_scores_gemma":[0.92364484,0.023438662,0.0424691,0.0042474894,0.0052272645,0.00097269024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016685173,0.0003031736,0.000386332,0.0012615871,0.0002827753,0.0014633803,0.0005163985,0.00074552896,0.0015572988],"category_scores_gemma":[0.0541006,0.00022689319,0.000963927,0.0014316263,0.00041239124,0.0011264692,0.0008294086,0.00068893825,0.00030357076],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015723628,0.00026242048,0.98749906,0.00007914341,0.00045973615,0.00012144996,0.00020290006,0.0002045437,0.00045974122,0.00008296547,0.00028536512,0.008770186],"study_design_scores_gemma":[0.00010413347,0.00079992577,0.9920561,0.00003240396,0.00032104072,0.0006158737,0.00020565778,0.0040769842,0.0007477779,0.00008343112,0.0009350359,0.000021761693],"about_ca_topic_score_codex":0.0014314416,"about_ca_topic_score_gemma":0.0010307467,"teacher_disagreement_score":0.016685173,"about_ca_system_score_codex":0.0009899362,"about_ca_system_score_gemma":0.0006795644,"threshold_uncertainty_score":0.08824068},"labels":[],"label_agreement":null},{"id":"W4313856340","doi":"10.1016/j.jtocrr.2022.100460","title":"Real-World Treatment Patterns and Effectiveness of Targeted and Immune Checkpoint Inhibitor-Based Systemic Therapy in BRAF Mutation-Positive NSCLC","year":2023,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; University of Calgary","funders":"AstraZeneca; Pfizer; Bristol-Myers Squibb","keywords":"Systemic therapy; Targeted therapy; Medicine; Oncology; Immune checkpoint; Mutation; Immune system; Cancer research; Internal medicine; Immunotherapy; Immunology; Biology; Cancer; Genetics; Gene","score_opus":0.050758505383652536,"score_gpt":0.391417087290026,"score_spread":0.34065858190637344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313856340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971111,0.0013140241,0.00018273368,0.00010694745,0.0000041765647,0.000013375286,0.00079392665,0.0000042593833,0.00046935823],"genre_scores_gemma":[0.9990055,0.00017839845,0.000106805295,0.000023425946,0.000005158227,0.000009494953,0.0006316871,0.0000017155606,0.000037838712],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978582,0.00089569145,0.0004185856,0.00040100413,0.0003075959,0.0001188883],"domain_scores_gemma":[0.9935679,0.0017735611,0.0038101312,0.00026078298,0.000338319,0.00024928694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018548984,0.00009259085,0.00029568438,0.0006440418,0.0001440045,0.0005348091,0.00024449118,0.00029523706,0.00078643666],"category_scores_gemma":[0.0059407367,0.00009387168,0.00039590546,0.000907152,0.0002101432,0.00048097366,0.00029697042,0.00023854559,0.0001212718],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008485495,0.000048406855,0.9865023,0.000053477874,0.00020559468,0.00007282777,0.00005052485,0.0006168729,0.00036653783,0.00004454229,0.00018500866,0.011005321],"study_design_scores_gemma":[0.000026980504,0.00026825242,0.99736017,0.00002106591,0.000055280525,0.00041833098,0.00011714064,0.0008840389,0.00026244854,0.00007563262,0.0005032005,0.000007527703],"about_ca_topic_score_codex":0.0014946102,"about_ca_topic_score_gemma":0.0031785502,"teacher_disagreement_score":0.0018548984,"about_ca_system_score_codex":0.000762129,"about_ca_system_score_gemma":0.0003970337,"threshold_uncertainty_score":0.009809732},"labels":[],"label_agreement":null},{"id":"W4317437925","doi":"10.1073/pnas.2218373120","title":"HER2-driven breast cancer suppression by the JNK signaling pathway","year":2023,"lang":"en","type":"article","venue":"Proceedings of the National Academy of Sciences","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Canadian Institutes of Health Research; National Institutes of Health; Government of Canada","keywords":"Cancer research; Biology; Signal transduction; Breast cancer; Kinase; Cancer; MAPK/ERK pathway; Cell biology; Genetics","score_opus":0.027348133353117636,"score_gpt":0.2895597089851433,"score_spread":0.2622115756320257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317437925","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98721826,0.0020381357,0.0044393474,0.0002499016,0.00006902094,0.000056648034,0.0011739996,0.00016142325,0.0045933076],"genre_scores_gemma":[0.9856776,0.0013770113,0.0031657035,0.000111930094,0.000010316672,0.00006267127,0.0014604767,0.00002874279,0.008105484],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998878,0.000016407712,0.00000902157,0.000019434274,0.0000411568,0.0000261635],"domain_scores_gemma":[0.99994993,0.0000058698834,0.000015625832,0.000005970155,0.00000607382,0.000016522798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013569625,0.00037194652,0.00018822623,0.00017515237,0.00015681735,0.000303252,0.00017320212,0.00019018361,0.0016021766],"category_scores_gemma":[0.00006515324,0.00012226596,0.00025779102,0.00011230165,0.00015040037,0.0001355195,0.00023988464,0.0004979769,0.00044240718],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045029516,0.000017647708,0.00007644154,0.00002677101,0.0000036116712,0.000028865647,0.0000049276323,0.00004053852,0.9988293,0.000064189764,0.000045631707,0.0008170212],"study_design_scores_gemma":[0.000014628558,0.00013007678,0.0035041291,0.0000058703404,0.000011199741,0.0004147977,0.00002123919,0.0011377685,0.98977226,0.00007055761,0.004912999,0.000004350705],"about_ca_topic_score_codex":0.00043481865,"about_ca_topic_score_gemma":0.0008525354,"teacher_disagreement_score":0.0016021766,"about_ca_system_score_codex":0.00036968407,"about_ca_system_score_gemma":0.00023817035,"threshold_uncertainty_score":0.0053598285},"labels":[],"label_agreement":null},{"id":"W4319071946","doi":"10.1007/s11684-022-0935-0","title":"NETO2 promotes melanoma progression via activation of the Ca2+/CaMKII signaling pathway","year":2023,"lang":"en","type":"article","venue":"Frontiers of Medicine","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Melanoma; Cancer research; CREB; Carcinogenesis; Signal transduction; Metastasis; Cancer; Biology; Chemistry; Medicine; Cell biology; Internal medicine; Gene; Transcription factor; Genetics","score_opus":0.011193098576051934,"score_gpt":0.23978654342470793,"score_spread":0.22859344484865599,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319071946","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9799059,0.0070047206,0.0024652984,0.0008373193,0.00035624302,0.000048165144,0.00058886874,0.00017467342,0.0086187525],"genre_scores_gemma":[0.9935502,0.0016100961,0.00055515504,0.00011070519,0.000027048382,0.00003651314,0.0002447404,0.000009662616,0.003855793],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999948,0.0000071447066,0.0000024258106,0.000008730167,0.000012601473,0.000021049906],"domain_scores_gemma":[0.99996793,0.0000022976117,0.0000073217725,0.0000017224439,0.0000034596424,0.000017327588],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000064440545,0.0002504851,0.00014183106,0.00015278858,0.00017228417,0.0002291597,0.00014668437,0.00019451282,0.0018303964],"category_scores_gemma":[0.00006006271,0.000084479936,0.00018826374,0.00007905228,0.00012741002,0.000165224,0.00017679941,0.00061158853,0.0002649846],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008948806,0.00012512541,0.0005757959,0.00013705665,0.000014119052,0.000091814036,0.000013261826,0.00008814358,0.99358964,0.00033859402,0.0003788357,0.0037527976],"study_design_scores_gemma":[0.0002513741,0.0011261852,0.034535274,0.00003403955,0.000073871575,0.00043103518,0.00014761688,0.0027126402,0.94590306,0.0006436091,0.014122025,0.0000192791],"about_ca_topic_score_codex":0.0008046984,"about_ca_topic_score_gemma":0.0020552755,"teacher_disagreement_score":0.0018303964,"about_ca_system_score_codex":0.000269836,"about_ca_system_score_gemma":0.0002473602,"threshold_uncertainty_score":0.0061233044},"labels":[],"label_agreement":null},{"id":"W4321480727","doi":"10.1139/bcb-2022-0371","title":"Mitogen- and stress-activated protein kinase (MSK1/2) regulated gene expression in normal and disease states","year":2023,"lang":"en","type":"review","venue":"Biochemistry and Cell Biology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Canadian Institutes of Health Research; University of Manitoba; Natural Sciences and Engineering Research Council of Canada; CancerCare Manitoba Foundation","keywords":"Signal transduction; Biology; Regulation of gene expression; Gene expression; Cell biology; Kinase; Transcription factor; Epigenetics; Histone; Mitogen-activated protein kinase; Gene; Cancer research; Genetics","score_opus":0.01611058602091132,"score_gpt":0.255082661481922,"score_spread":0.23897207546101068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321480727","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018765009,0.9979272,0.00014665177,0.00014715122,0.0001845857,0.0000035427763,0.000021617547,0.000010959076,0.0013705752],"genre_scores_gemma":[0.00072349695,0.9979785,0.00017105901,0.00010713097,0.00011020696,0.0000055780624,0.000033890836,0.0000015678377,0.00086852594],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999137,0.000011881136,0.000012611499,0.000019216599,0.000032063195,0.000010460745],"domain_scores_gemma":[0.99992526,0.000025984495,0.0000131201405,0.0000030881477,0.000021657423,0.0000109011335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020301173,0.0007489392,0.00088104024,0.0017928607,0.00022783902,0.0006725765,0.00051940634,0.0007147769,0.0025619918],"category_scores_gemma":[0.0002325174,0.00019969218,0.00025458398,0.0021330705,0.00034741568,0.00088221073,0.00052843126,0.001157703,0.0023908585],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000084969295,0.00006223908,0.00019623312,0.012958984,0.00006000814,0.000256706,0.0000638519,0.00034729138,0.0053062635,0.0034557537,0.02931107,0.9478967],"study_design_scores_gemma":[0.000010095898,0.00006916851,0.0011317033,0.0013636335,0.000060745126,0.0016358764,0.000049393253,0.00007247008,0.001011967,0.0018850544,0.99269354,0.00001643954],"about_ca_topic_score_codex":0.0006079366,"about_ca_topic_score_gemma":0.0010921407,"teacher_disagreement_score":0.0025619918,"about_ca_system_score_codex":0.0005148263,"about_ca_system_score_gemma":0.0006082104,"threshold_uncertainty_score":0.008570671},"labels":[],"label_agreement":null},{"id":"W4321601768","doi":"10.3389/fnmol.2023.1022364","title":"The clinicopathological features of ganglioglioma with CD34 expression and BRAF mutation in patients with epilepsy","year":2023,"lang":"en","type":"article","venue":"Frontiers in Molecular Neuroscience","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Capital Health","keywords":"Ganglioglioma; Epilepsy; Medicine; Mutation; Pathology; Biology; Genetics; Gene; Psychiatry","score_opus":0.004740434434397551,"score_gpt":0.2154295113190737,"score_spread":0.21068907688467614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321601768","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994673,0.0001893646,0.00005743169,0.000021104013,0.0000029116666,0.000003192629,0.000056980025,0.000002246743,0.00019961614],"genre_scores_gemma":[0.9997849,0.000050225368,0.00005005323,0.0000068955405,0.000008288249,0.0000025441268,0.00005379246,5.0977536e-7,0.000042753385],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99983203,0.00003363414,0.000026216561,0.0000392714,0.000032190605,0.000036678528],"domain_scores_gemma":[0.9994172,0.00013081904,0.0002616801,0.00003230059,0.00005073883,0.00010734129],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022585952,0.00024318624,0.00020484453,0.0007079334,0.00031050423,0.00025985623,0.0001623251,0.00029765468,0.0010375234],"category_scores_gemma":[0.0011570365,0.00017338336,0.00022287425,0.00050321734,0.00027748465,0.0003145126,0.00025934388,0.00019876556,0.00019952281],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000099072204,0.000008072511,0.9972012,0.000004394745,0.000014821066,0.0010634362,0.000020055062,0.000041064653,0.0006162628,0.000011128384,0.000037834827,0.0008827094],"study_design_scores_gemma":[0.000011630059,0.000080748476,0.9887382,0.0000041687013,0.000027941105,0.010141042,0.00014578777,0.0003195142,0.00021301534,0.00007039986,0.00024271315,0.0000048267243],"about_ca_topic_score_codex":0.00072867615,"about_ca_topic_score_gemma":0.0010204434,"teacher_disagreement_score":0.0010375234,"about_ca_system_score_codex":0.00014235446,"about_ca_system_score_gemma":0.00020655242,"threshold_uncertainty_score":0.0034708977},"labels":[],"label_agreement":null},{"id":"W4322011930","doi":"10.1016/j.ejmech.2023.115231","title":"Design, synthesis and characterisation of a novel type II B-RAF paradox breaker inhibitor","year":2023,"lang":"en","type":"article","venue":"European Journal of Medicinal Chemistry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Genentech; Vlaamse regering; Innovative Medicines Initiative; Ontario Genomics Institute; European Federation of Pharmaceutical Industries and Associations; Merck KGaA; McGill University; Innovative Health Initiative; Ontario Genomics; Genome Canada; Fundação de Amparo à Pesquisa do Estado de São Paulo; Bayer; Pfizer","keywords":"Chemistry; Kinase; Vemurafenib; Protein kinase domain; MAPK/ERK pathway; Protein kinase A; V600E; Moiety; Allosteric regulation; Mutant; Stereochemistry; Cell biology; Biochemistry; Enzyme; Cancer research; Biology","score_opus":0.02658339831722194,"score_gpt":0.23327497006591655,"score_spread":0.2066915717486946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322011930","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8630779,0.014367395,0.10259986,0.0010364911,0.00028795828,0.0018505879,0.0022166274,0.0008593465,0.013703812],"genre_scores_gemma":[0.93925875,0.0072333384,0.03803691,0.00033307073,0.000035179593,0.0003736157,0.0021450475,0.00006650547,0.012517645],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990404,0.0000090046115,0.0000069960183,0.000021141364,0.000026420681,0.000032262964],"domain_scores_gemma":[0.9999534,0.0000044511817,0.000011371044,0.000004796709,0.000009687844,0.00001635726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021723745,0.00049041474,0.00035597474,0.00026536942,0.00022535361,0.00048481926,0.00063717423,0.00038302568,0.0016620457],"category_scores_gemma":[0.00015655215,0.00019372525,0.00033195168,0.00019053029,0.00013770006,0.000318714,0.0002681058,0.0007922212,0.0007907569],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003536855,0.0002271179,0.00019856199,0.0001973797,0.00005178065,0.00025688845,0.00005048646,0.0019322298,0.9717907,0.00083610637,0.0006330944,0.023471987],"study_design_scores_gemma":[0.00035383416,0.0021288896,0.00077665335,0.000021848915,0.00010432794,0.0009038238,0.000032740045,0.0034134719,0.9550427,0.00023945121,0.03694677,0.000035498808],"about_ca_topic_score_codex":0.0005478831,"about_ca_topic_score_gemma":0.0011270414,"teacher_disagreement_score":0.0016620457,"about_ca_system_score_codex":0.00043096073,"about_ca_system_score_gemma":0.00043305504,"threshold_uncertainty_score":0.0055601},"labels":[],"label_agreement":null},{"id":"W4328050936","doi":"10.1101/2023.03.17.533211","title":"Multiple cancer types rapidly escape from multiple MAPK inhibitors to generate mutagenesis-prone subpopulations","year":2023,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health; Université Laval; Damon Runyon Cancer Research Foundation","keywords":"MAPK/ERK pathway; KRAS; Cancer research; Biology; Cancer; Melanoma; Cell cycle; Neuroblastoma RAS viral oncogene homolog; DNA damage; Kinase; Mutation; Genetics; DNA; Gene","score_opus":0.02282854965967724,"score_gpt":0.2334979828291233,"score_spread":0.21066943316944606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4328050936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96167475,0.0016570869,0.029192446,0.00035309116,0.000048005124,0.000088727036,0.00050048804,0.0005602493,0.0059250924],"genre_scores_gemma":[0.97697306,0.00087872613,0.010883885,0.000248609,0.000024408555,0.000082467624,0.0008984675,0.00017273902,0.009837643],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99987864,0.000012442164,0.000008286971,0.000034933335,0.00004072829,0.000024902141],"domain_scores_gemma":[0.99991584,0.000010528847,0.00002215717,0.000022495044,0.0000099662875,0.000018945635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017464656,0.00024673788,0.0003045581,0.00028002722,0.00016020557,0.00037384906,0.00017201235,0.00028353822,0.0014631916],"category_scores_gemma":[0.00013926973,0.00017677817,0.000285488,0.000170728,0.00015465332,0.0002383446,0.00047329118,0.0005506914,0.0008643484],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056411765,0.000016724005,0.0016056254,0.000024703728,0.000010638517,0.00013768139,0.000028775488,0.00026980726,0.9901596,0.0007266593,0.00020955039,0.0067538074],"study_design_scores_gemma":[0.000024787723,0.00027227768,0.02158799,0.00001113767,0.000027550333,0.003562031,0.00007151719,0.0049535567,0.94917375,0.0013125774,0.018989589,0.000013237339],"about_ca_topic_score_codex":0.0002815121,"about_ca_topic_score_gemma":0.00062287814,"teacher_disagreement_score":0.0014631916,"about_ca_system_score_codex":0.00026683457,"about_ca_system_score_gemma":0.00014940668,"threshold_uncertainty_score":0.0048949122},"labels":[],"label_agreement":null},{"id":"W4361246377","doi":"10.1158/0008-5472.c.6497147.v1","title":"Data from Modeling Genomic Diversity and Tumor Dependency in Malignant Melanoma","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"National Cancer Institute; Genentech; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; National Science Foundation","keywords":"PTEN; Tensin; Cancer research; Biology; Melanoma; MAPK/ERK pathway; Kinase; Comparative genomic hybridization; Cancer; Effector; Gene; Computational biology; Genetics; PI3K/AKT/mTOR pathway; Signal transduction; Chromosome; Cell biology","score_opus":0.0985299461382925,"score_gpt":0.269137022450537,"score_spread":0.1706070763122445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361246377","genre_codex":"empirical","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9448231,0.0004558435,0.0442837,0.00025683292,0.000017434051,0.000055553865,0.0076118456,0.0005474114,0.0019483138],"genre_scores_gemma":[0.9808913,0.00013980658,0.010062681,0.000028169974,0.000009855489,0.0000471381,0.008204908,0.000059097812,0.0005570614],"study_design_codex":"simulation_or_modeling","study_design_gemma":"not_applicable","domain_scores_codex":[0.99952435,0.00021017295,0.000018310984,0.00015636225,0.00005515119,0.00003563492],"domain_scores_gemma":[0.9957769,0.003316068,0.00018458097,0.00041112417,0.00021776101,0.00009364873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013500956,0.00043939645,0.00041516457,0.0007973444,0.00024928458,0.0005624935,0.00061455223,0.00047123435,0.0023126625],"category_scores_gemma":[0.007075976,0.00024814537,0.0009680123,0.0008492517,0.00034411674,0.00040695525,0.00047489503,0.00043513978,0.00040523638],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041548457,0.00008046236,0.06586652,0.00008084634,0.00016439402,0.00017306748,0.000086774184,0.9088474,0.0032594425,0.0018103094,0.0010124744,0.018202787],"study_design_scores_gemma":[0.00002821787,0.00008125038,0.018136567,0.000006959997,0.000049488022,0.00009674465,0.000051061477,0.9726115,0.0023412118,0.00517103,0.0014147897,0.0000112537255],"about_ca_topic_score_codex":0.009829174,"about_ca_topic_score_gemma":0.0075343545,"teacher_disagreement_score":0.009829174,"about_ca_system_score_codex":0.00065504987,"about_ca_system_score_gemma":0.0003474079,"threshold_uncertainty_score":0.019543886},"labels":[],"label_agreement":null},{"id":"W4361247448","doi":"10.1158/0008-5472.c.6497147","title":"Data from Modeling Genomic Diversity and Tumor Dependency in Malignant Melanoma","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"National Cancer Institute; Genentech; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; National Science Foundation","keywords":"PTEN; Tensin; Cancer research; Biology; Melanoma; MAPK/ERK pathway; Kinase; Effector; Cancer; Comparative genomic hybridization; Gene; Computational biology; Genetics; PI3K/AKT/mTOR pathway; Signal transduction; Chromosome; Cell biology","score_opus":0.0985299461382925,"score_gpt":0.269137022450537,"score_spread":0.1706070763122445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361247448","genre_codex":"empirical","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9448231,0.0004558435,0.0442837,0.00025683292,0.000017434051,0.000055553865,0.0076118456,0.0005474114,0.0019483138],"genre_scores_gemma":[0.9808913,0.00013980658,0.010062681,0.000028169974,0.000009855489,0.0000471381,0.008204908,0.000059097812,0.0005570614],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99952435,0.00021017295,0.000018310984,0.00015636225,0.00005515119,0.00003563492],"domain_scores_gemma":[0.9957769,0.003316068,0.00018458097,0.00041112417,0.00021776101,0.00009364873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013500956,0.00043939645,0.00041516457,0.0007973444,0.00024928458,0.0005624935,0.00061455223,0.00047123435,0.0023126625],"category_scores_gemma":[0.007075976,0.00024814537,0.0009680123,0.0008492517,0.00034411674,0.00040695525,0.00047489503,0.00043513978,0.00040523638],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041548457,0.00008046236,0.06586652,0.00008084634,0.00016439402,0.00017306748,0.000086774184,0.9088474,0.0032594425,0.0018103094,0.0010124744,0.018202787],"study_design_scores_gemma":[0.00002821787,0.00008125038,0.018136567,0.000006959997,0.000049488022,0.00009674465,0.000051061477,0.9726115,0.0023412118,0.00517103,0.0014147897,0.0000112537255],"about_ca_topic_score_codex":0.009829174,"about_ca_topic_score_gemma":0.0075343545,"teacher_disagreement_score":0.009829174,"about_ca_system_score_codex":0.00065504987,"about_ca_system_score_gemma":0.0003474079,"threshold_uncertainty_score":0.019543886},"labels":[],"label_agreement":null},{"id":"W4361816124","doi":"10.1158/1078-0432.c.6529128.v1","title":"Data from ERK Mutations and Amplification Confer Resistance to ERK-Inhibitor Therapy","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Discovery Centre","funders":"Genentech","keywords":"MAPK/ERK pathway; Cancer research; Mutant; MEK inhibitor; Acquired resistance; Kinase; Biology; Chemistry; Cancer; Cell biology; Genetics; Gene","score_opus":0.11274219032447373,"score_gpt":0.32470702541379165,"score_spread":0.2119648350893179,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361816124","genre_codex":"empirical","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97985935,0.0005864489,0.002601762,0.00033297678,0.000050786115,0.00010980664,0.004302158,0.00017685283,0.011979873],"genre_scores_gemma":[0.9900676,0.00034252234,0.0018070233,0.00016080345,0.000005208506,0.0000822991,0.0033994918,0.000046951947,0.0040880595],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997136,0.000041654068,0.000031615273,0.00004029604,0.00012969569,0.000043128555],"domain_scores_gemma":[0.99975413,0.00006933776,0.00005229693,0.000039155708,0.00004332943,0.000041628755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027057974,0.00040279768,0.0003495079,0.00032060593,0.00019573553,0.0002811929,0.00032651017,0.0004864777,0.0107827],"category_scores_gemma":[0.00040387042,0.00020290917,0.00051544275,0.00025753208,0.00022068292,0.00022528484,0.00015712957,0.00065843883,0.0015717249],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002504172,0.0006687555,0.0063933497,0.0002224444,0.00007922934,0.0009375447,0.0000485032,0.0019557055,0.9674501,0.00095983694,0.002804914,0.015975505],"study_design_scores_gemma":[0.00025142732,0.0021334575,0.02819821,0.000020641817,0.00012429807,0.0039374433,0.00009976472,0.005904253,0.9443825,0.00046776136,0.014448043,0.000032302087],"about_ca_topic_score_codex":0.0012426836,"about_ca_topic_score_gemma":0.0013747318,"teacher_disagreement_score":0.0107827,"about_ca_system_score_codex":0.00047170915,"about_ca_system_score_gemma":0.00033657058,"threshold_uncertainty_score":0.036071658},"labels":[],"label_agreement":null},{"id":"W4361819285","doi":"10.1158/1078-0432.c.6529128","title":"Data from ERK Mutations and Amplification Confer Resistance to ERK-Inhibitor Therapy","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Discovery Centre","funders":"Genentech","keywords":"MAPK/ERK pathway; Cancer research; Mutant; MEK inhibitor; Acquired resistance; Kinase; Biology; Chemistry; Cancer; Cell biology; Genetics; Gene","score_opus":0.11274219032447373,"score_gpt":0.32470702541379165,"score_spread":0.2119648350893179,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361819285","genre_codex":"empirical","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97985935,0.0005864489,0.002601762,0.00033297678,0.000050786115,0.00010980664,0.004302158,0.00017685283,0.011979873],"genre_scores_gemma":[0.9900676,0.00034252234,0.0018070233,0.00016080345,0.000005208506,0.0000822991,0.0033994918,0.000046951947,0.0040880595],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997136,0.000041654068,0.000031615273,0.00004029604,0.00012969569,0.000043128555],"domain_scores_gemma":[0.99975413,0.00006933776,0.00005229693,0.000039155708,0.00004332943,0.000041628755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027057974,0.00040279768,0.0003495079,0.00032060593,0.00019573553,0.0002811929,0.00032651017,0.0004864777,0.0107827],"category_scores_gemma":[0.00040387042,0.00020290917,0.00051544275,0.00025753208,0.00022068292,0.00022528484,0.00015712957,0.00065843883,0.0015717249],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002504172,0.0006687555,0.0063933497,0.0002224444,0.00007922934,0.0009375447,0.0000485032,0.0019557055,0.9674501,0.00095983694,0.002804914,0.015975505],"study_design_scores_gemma":[0.00025142732,0.0021334575,0.02819821,0.000020641817,0.00012429807,0.0039374433,0.00009976472,0.005904253,0.9443825,0.00046776136,0.014448043,0.000032302087],"about_ca_topic_score_codex":0.0012426836,"about_ca_topic_score_gemma":0.0013747318,"teacher_disagreement_score":0.0107827,"about_ca_system_score_codex":0.00047170915,"about_ca_system_score_gemma":0.00033657058,"threshold_uncertainty_score":0.036071658},"labels":[],"label_agreement":null},{"id":"W4361943399","doi":"10.1158/1078-0432.c.6517965","title":"Data from Phosphorylated 4E-BP1 Is Associated with Poor Survival in Melanoma","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health; York University; American Skin Association","keywords":"PTEN; Melanoma; Cancer research; Protein kinase B; Phosphorylation; Protein kinase A; PI3K/AKT/mTOR pathway; Kinase; Biology; Signal transduction; Medicine; Internal medicine; Molecular biology; Cell biology","score_opus":0.06088095513259808,"score_gpt":0.27480969225632385,"score_spread":0.21392873712372576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361943399","genre_codex":"empirical","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99850804,0.00019849482,0.00009337664,0.000038339167,0.0000046569985,0.000003184477,0.0007177388,0.000007080909,0.00042905821],"genre_scores_gemma":[0.99854445,0.000070968286,0.00005771431,0.000021994387,0.000007209622,0.000005760793,0.0008590403,0.000004393117,0.00042846688],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99993,0.000011984707,0.0000069290036,0.000021804293,0.000018042723,0.000011227967],"domain_scores_gemma":[0.9996364,0.000067084366,0.00013123051,0.000028986446,0.000040112347,0.00009609649],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013922631,0.00014426028,0.00021222039,0.00036777393,0.00016504514,0.0001983742,0.00011313196,0.0002073482,0.0031473076],"category_scores_gemma":[0.00044521716,0.00009690735,0.00017428456,0.00033444085,0.0001200182,0.00012215269,0.00011257602,0.00025341767,0.00038686933],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027188805,0.00008688974,0.9620388,0.00004850637,0.0000765468,0.00036332727,0.000081118844,0.00017426451,0.026303438,0.000033147186,0.0006943444,0.0073807524],"study_design_scores_gemma":[0.00002357487,0.000186838,0.9966312,0.00000423391,0.000025777217,0.00087165786,0.000031795877,0.0002094545,0.0014067993,0.000032227483,0.0005731224,0.0000033098456],"about_ca_topic_score_codex":0.0008727579,"about_ca_topic_score_gemma":0.0011895649,"teacher_disagreement_score":0.0031473076,"about_ca_system_score_codex":0.00012849455,"about_ca_system_score_gemma":0.000084164014,"threshold_uncertainty_score":0.010528803},"labels":[],"label_agreement":null},{"id":"W4361949475","doi":"10.1158/1078-0432.c.6517965.v1","title":"Data from Phosphorylated 4E-BP1 Is Associated with Poor Survival in Melanoma","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health; York University; American Skin Association","keywords":"PTEN; Melanoma; Cancer research; Protein kinase B; Phosphorylation; Protein kinase A; Kinase; Biology; PI3K/AKT/mTOR pathway; Signal transduction; Medicine; Internal medicine; Molecular biology; Cell biology","score_opus":0.06088095513259808,"score_gpt":0.27480969225632385,"score_spread":0.21392873712372576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361949475","genre_codex":"empirical","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99850804,0.00019849482,0.00009337664,0.000038339167,0.0000046569985,0.000003184477,0.0007177388,0.000007080909,0.00042905821],"genre_scores_gemma":[0.99854445,0.000070968286,0.00005771431,0.000021994387,0.000007209622,0.000005760793,0.0008590403,0.000004393117,0.00042846688],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99993,0.000011984707,0.0000069290036,0.000021804293,0.000018042723,0.000011227967],"domain_scores_gemma":[0.9996364,0.000067084366,0.00013123051,0.000028986446,0.000040112347,0.00009609649],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013922631,0.00014426028,0.00021222039,0.00036777393,0.00016504514,0.0001983742,0.00011313196,0.0002073482,0.0031473076],"category_scores_gemma":[0.00044521716,0.00009690735,0.00017428456,0.00033444085,0.0001200182,0.00012215269,0.00011257602,0.00025341767,0.00038686933],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027188805,0.00008688974,0.9620388,0.00004850637,0.0000765468,0.00036332727,0.000081118844,0.00017426451,0.026303438,0.000033147186,0.0006943444,0.0073807524],"study_design_scores_gemma":[0.00002357487,0.000186838,0.9966312,0.00000423391,0.000025777217,0.00087165786,0.000031795877,0.0002094545,0.0014067993,0.000032227483,0.0005731224,0.0000033098456],"about_ca_topic_score_codex":0.0008727579,"about_ca_topic_score_gemma":0.0011895649,"teacher_disagreement_score":0.0031473076,"about_ca_system_score_codex":0.00012849455,"about_ca_system_score_gemma":0.000084164014,"threshold_uncertainty_score":0.010528803},"labels":[],"label_agreement":null},{"id":"W4364353540","doi":"10.1007/s10637-022-01326-3","title":"Results of an open-label phase 1b study of the ERK inhibitor MK-8353 plus the MEK inhibitor selumetinib in patients with advanced or metastatic solid tumors","year":2023,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Tolerability; Adverse effect; Selumetinib; Nausea; Discontinuation; Vomiting; MEK inhibitor; Internal medicine; Response Evaluation Criteria in Solid Tumors; Gastroenterology; Population; Cancer; Phases of clinical research; Surgery; Oncology; Chemotherapy; MAPK/ERK pathway; Kinase; Colorectal cancer","score_opus":0.034795656958310404,"score_gpt":0.3114770306345717,"score_spread":0.27668137367626133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4364353540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993948,0.0020287393,0.0004985998,0.00024514727,0.0000709051,0.0012282802,0.00082008133,0.000046532023,0.0011138213],"genre_scores_gemma":[0.9931069,0.0012196592,0.0013385088,0.00045713154,0.00010545737,0.0007821923,0.0017647553,0.000022666141,0.0012027466],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99941564,0.0003020216,0.00004105827,0.000090517446,0.00007309579,0.00007757096],"domain_scores_gemma":[0.99932444,0.00013629837,0.00014971805,0.000043285123,0.0000621544,0.000284064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020625708,0.001161114,0.0016429597,0.0003254799,0.00037190877,0.0006498245,0.00051342574,0.00071179145,0.0027024162],"category_scores_gemma":[0.00084755005,0.00044641364,0.00096993725,0.00027019205,0.0005987358,0.0008332974,0.00025028767,0.002205942,0.0006064328],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5940633,0.13634801,0.01595664,0.0012948283,0.0030381822,0.0004433645,0.000423766,0.0037846162,0.11501646,0.00019627814,0.0048052305,0.12462937],"study_design_scores_gemma":[0.2688163,0.6849177,0.03263955,0.000043947737,0.001104225,0.00043152965,0.00007881713,0.0013714377,0.00740368,0.00013552912,0.0030231525,0.000034242792],"about_ca_topic_score_codex":0.0005342476,"about_ca_topic_score_gemma":0.0019278399,"teacher_disagreement_score":0.0027024162,"about_ca_system_score_codex":0.0006683911,"about_ca_system_score_gemma":0.0010622669,"threshold_uncertainty_score":0.010908067},"labels":[],"label_agreement":null},{"id":"W4367059606","doi":"10.1126/sciadv.ade0631","title":"Abrogation of MAP4K4 protein function causes congenital anomalies in humans and zebrafish","year":2023,"lang":"en","type":"article","venue":"Science Advances","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre; McMaster University; Trillium Health Centre","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Child Health and Human Development; National Institute of Mental Health; National Institute of General Medical Sciences; National Center for Advancing Translational Sciences; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Human Genome Research Institute","keywords":"Zebrafish; Biology; Kinase; Protein kinase A; Genetics; Signal transduction; Cell biology; Gene","score_opus":0.010896861559003938,"score_gpt":0.25496915998211905,"score_spread":0.24407229842311512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367059606","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99531674,0.000613577,0.0022106085,0.00011187827,0.000015675805,0.000026241398,0.00044289755,0.00010766978,0.0011547036],"genre_scores_gemma":[0.99515426,0.00057222013,0.0024326013,0.00004419011,0.0000063679804,0.000030114783,0.00029374743,0.000037827154,0.001428528],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996897,0.000037091268,0.000029911478,0.00009618358,0.00009857322,0.000048589423],"domain_scores_gemma":[0.9998635,0.000029027116,0.00005985005,0.0000141066475,0.000007061343,0.000026520487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016023613,0.0009775683,0.00037018594,0.0008625297,0.00041788546,0.00023725494,0.00037851193,0.00052283495,0.002500776],"category_scores_gemma":[0.0003155133,0.00029194064,0.00047503223,0.0003125437,0.0009661921,0.00016476982,0.0006790688,0.00041049995,0.00024354241],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044416747,0.000044911034,0.0074350615,0.00010805834,0.00012650117,0.008742716,0.00014179491,0.00084011065,0.9719991,0.0011543803,0.00032032267,0.008642813],"study_design_scores_gemma":[0.00021655542,0.0013826205,0.19460759,0.000090549715,0.0006637037,0.075085446,0.00037768853,0.0041883867,0.7045937,0.0014911501,0.01715193,0.00015071276],"about_ca_topic_score_codex":0.0035574718,"about_ca_topic_score_gemma":0.00539836,"teacher_disagreement_score":0.0035574718,"about_ca_system_score_codex":0.00064250117,"about_ca_system_score_gemma":0.00053970155,"threshold_uncertainty_score":0.008365929},"labels":[],"label_agreement":null},{"id":"W4376604468","doi":"10.1021/acschemneuro.3c00205","title":"Synthesis and Preclinical Positron Emission Tomography Imaging of the p38 MAPK Inhibitor [<sup>11</sup>C]Talmapimod: Effects of Drug Efflux and Sex Differences","year":2023,"lang":"en","type":"article","venue":"ACS Chemical Neuroscience","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research; Azrieli Foundation; Canada Research Chairs; Canada Foundation for Innovation; Ontario Research Foundation","keywords":"Radiosynthesis; Positron emission tomography; Chemistry; In vivo; Blood–brain barrier; Pharmacology; Ex vivo; p38 mitogen-activated protein kinases; Nuclear medicine; Kinase; MAPK/ERK pathway; In vitro; Medicine; Biochemistry; Biology; Internal medicine; Central nervous system","score_opus":0.007631859850970237,"score_gpt":0.22907015645282564,"score_spread":0.2214382966018554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376604468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96052295,0.0034626126,0.026923707,0.00021949984,0.000038492664,0.00041307413,0.0018254856,0.00026183773,0.006332272],"genre_scores_gemma":[0.9605701,0.0030371724,0.026422068,0.0001273352,0.000025081705,0.00040219806,0.0021898285,0.00014357454,0.0070825657],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999076,0.00001942695,0.0000060683174,0.00002092253,0.000020027253,0.000025970436],"domain_scores_gemma":[0.99989784,0.000017652135,0.000027346996,0.000016480846,0.00002096815,0.000019700889],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002944396,0.0005438013,0.00024416507,0.00017285004,0.0001493846,0.00020607401,0.00048561525,0.00038915433,0.0016588682],"category_scores_gemma":[0.00017388005,0.00022044887,0.00017049765,0.00019583876,0.00024008256,0.00023834551,0.00015957058,0.00042495952,0.00067031826],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005219148,0.000054219337,0.00013279173,0.000061403705,0.000010528484,0.00013042701,0.00003164912,0.00042308978,0.99433005,0.0003366008,0.00015037878,0.0038169012],"study_design_scores_gemma":[0.000032996417,0.000729909,0.0005763229,0.0000034943164,0.00001614063,0.0002856257,0.000010640779,0.00052495167,0.99364245,0.0000388563,0.004130884,0.000007681102],"about_ca_topic_score_codex":0.00076871767,"about_ca_topic_score_gemma":0.0008100001,"teacher_disagreement_score":0.0016588682,"about_ca_system_score_codex":0.00033101218,"about_ca_system_score_gemma":0.00027533187,"threshold_uncertainty_score":0.005549431},"labels":[],"label_agreement":null},{"id":"W4376641322","doi":"10.1158/2159-8290.c.6649132.v1","title":"Data from Late-Stage Metastatic Melanoma Emerges through a Diversity of Evolutionary Pathways","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"Medical Research Council; Genentech; Ipsen; Ono Pharmaceutical; Cancer Research UK; Gordon and Rose McAlpine Foundation for Neuroscience Research; Francis Crick Institute; Wellcome Trust; National Institute for Health and Care Research; Melanoma Research Alliance; Invitae; Bristol-Myers Squibb; AstraZeneca; Pfizer; Rosetrees Trust; U.S. Department of Defense","keywords":"Biology; Melanoma; Cancer research; Loss of heterozygosity; Amplicon; Genetics; Gene; Allele; Polymerase chain reaction","score_opus":0.1500584193282261,"score_gpt":0.3023461955995019,"score_spread":0.15228777627127577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376641322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8628453,0.01345266,0.027526006,0.0036468082,0.00026069113,0.0001499518,0.07937284,0.0007138909,0.012031834],"genre_scores_gemma":[0.82535845,0.0046361545,0.01842345,0.0016593306,0.0002022999,0.00022417298,0.14479557,0.0006135013,0.00408702],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989697,0.00023999505,0.000091567395,0.000367589,0.00022280765,0.00010831246],"domain_scores_gemma":[0.9977501,0.0006535489,0.0003243552,0.00044008624,0.0006006664,0.00023120458],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016296229,0.00039024226,0.00057036977,0.0017567228,0.00075319456,0.001516636,0.0004231637,0.0004662788,0.00292838],"category_scores_gemma":[0.0040269126,0.00021378114,0.00069615274,0.0016508412,0.00045891115,0.0007678838,0.0016648212,0.0010017315,0.0016238999],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011602255,0.00015947984,0.5486425,0.0020334143,0.0016429381,0.0018721725,0.0016026794,0.0029547035,0.27643585,0.0029454182,0.02553827,0.13501231],"study_design_scores_gemma":[0.00003270449,0.00021204812,0.8713543,0.00034067553,0.00046502386,0.0027236142,0.001043217,0.004438343,0.016485125,0.007062797,0.095770426,0.00007160943],"about_ca_topic_score_codex":0.001396286,"about_ca_topic_score_gemma":0.0050734016,"teacher_disagreement_score":0.00292838,"about_ca_system_score_codex":0.00042261425,"about_ca_system_score_gemma":0.00060489646,"threshold_uncertainty_score":0.009796381},"labels":[],"label_agreement":null},{"id":"W4377691942","doi":"10.1016/j.jcjo.2023.04.013","title":"Utility of systemic brigatinib therapy in tumour recurrence of choroid metastasis from non-small cell lung carcinoma","year":2023,"lang":"en","type":"letter","venue":"Canadian Journal of Ophthalmology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Metastasis; Carcinoma; Lung; Oncology; Choroid; Systemic therapy; Internal medicine; Cancer; Psychology; Retina; Neuroscience","score_opus":0.03329928215595812,"score_gpt":0.24880242088775223,"score_spread":0.2155031387317941,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377691942","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.42311192,0.040633027,0.002416757,0.48584008,0.013035716,0.00020912831,0.0005505821,0.00040286174,0.033800017],"genre_scores_gemma":[0.87533814,0.008283915,0.0017452175,0.08395855,0.021923305,0.00008404567,0.00024450253,0.000067009605,0.00835533],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.99981886,0.000034016986,0.000029798828,0.000022494536,0.000041935607,0.00005294054],"domain_scores_gemma":[0.99899715,0.0005351245,0.000079403384,0.000055819,0.00009400598,0.00023847689],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004335606,0.00032446926,0.00082545687,0.0004695468,0.00094501645,0.00096829276,0.0006326362,0.004291416,0.0011205273],"category_scores_gemma":[0.0032260427,0.00024279933,0.00079198426,0.0003928853,0.00068645924,0.00064583175,0.00023822305,0.003915949,0.00054715975],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035777777,0.00034058758,0.036094725,0.00047787072,0.00020707013,0.6956717,0.0004007488,0.0013789419,0.009706251,0.001997909,0.124984846,0.12516163],"study_design_scores_gemma":[0.002013788,0.0032699185,0.10297733,0.0005044469,0.00096946035,0.68304425,0.0009121323,0.016176676,0.013916694,0.0068365084,0.16914831,0.00023048805],"about_ca_topic_score_codex":0.0077027003,"about_ca_topic_score_gemma":0.016366629,"teacher_disagreement_score":0.0077027003,"about_ca_system_score_codex":0.0028311159,"about_ca_system_score_gemma":0.0011262993,"threshold_uncertainty_score":0.02054131},"labels":[],"label_agreement":null},{"id":"W4378078276","doi":"10.3389/fcell.2023.1192221","title":"ERK3 and DGKζ interact to modulate cell motility in lung cancer cells","year":2023,"lang":"en","type":"article","venue":"Frontiers in Cell and Developmental Biology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"National Cancer Institute; National Institutes of Health","keywords":"Extracellular; Kinase; Cell biology; Cancer cell; Biology; Cell migration; Cancer research; Cell; Chemistry; Biochemistry; Cancer","score_opus":0.006770923796486746,"score_gpt":0.23272096913110638,"score_spread":0.22595004533461963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378078276","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99532735,0.001975971,0.0009222551,0.0000994128,0.000030123467,0.000011585014,0.0003093053,0.00004382947,0.0012801106],"genre_scores_gemma":[0.99611026,0.0008597363,0.00048705,0.000062089,0.0000038706567,0.000020695394,0.00056698127,0.000007239708,0.001882155],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998753,0.000013097033,0.000007984279,0.000020769277,0.00003025713,0.000052534677],"domain_scores_gemma":[0.9999722,0.0000026342484,0.000006290835,0.0000030225408,0.000004634476,0.00001116857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007951362,0.00026455775,0.00022586017,0.00015822123,0.00020857144,0.00024166421,0.00013425067,0.00019583447,0.0009265816],"category_scores_gemma":[0.000069672766,0.00011629921,0.00029571878,0.00019863748,0.00011490938,0.00013701609,0.00024146105,0.00040336387,0.00042287476],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018040201,0.00002815081,0.00045198828,0.00005451845,0.000008400676,0.00004544244,0.00001405643,0.000092344766,0.9976695,0.00009929565,0.00009207313,0.0012637193],"study_design_scores_gemma":[0.000052431325,0.00016618047,0.02534076,0.0000095293135,0.00003253229,0.00029478775,0.00008790833,0.0039354805,0.9650554,0.00012988331,0.004884495,0.000010543484],"about_ca_topic_score_codex":0.001148744,"about_ca_topic_score_gemma":0.0016575522,"teacher_disagreement_score":0.001148744,"about_ca_system_score_codex":0.0004777719,"about_ca_system_score_gemma":0.00019727452,"threshold_uncertainty_score":0.0034665465},"labels":[],"label_agreement":null},{"id":"W4378528003","doi":"10.3390/cancers15112938","title":"Mutation in the Common Docking Domain Affects MAP Kinase ERK2 Catalysis and Stability","year":2023,"lang":"en","type":"article","venue":"Cancers","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ontario Genomics Institute; European Federation of Pharmaceutical Industries and Associations; Merck KGaA; Ministero dell’Istruzione, dell’Università e della Ricerca; Ontario Genomics; Genome Canada; McGill University; Genentech; Bayer; Pfizer; Bristol-Myers Squibb","keywords":"MAPK/ERK pathway; Phosphorylation; Signal transduction; Kinase; Cell biology; Mutant; Effector; Docking (animal); Chemistry; Protein kinase A; Biology; Missense mutation; Mutation; Biochemistry; Gene; Medicine","score_opus":0.014041745965945833,"score_gpt":0.25502261268155413,"score_spread":0.24098086671560828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378528003","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989297,0.00016162769,0.00055612455,0.000016771019,0.000010650868,0.0000068992154,0.00010597387,0.000014305203,0.0001980321],"genre_scores_gemma":[0.9990896,0.000081334845,0.00038461966,0.000014814634,0.000003264271,0.0000051810994,0.0001461887,0.000013103377,0.00026192784],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998442,0.000034499153,0.000023515366,0.00003602983,0.000035350506,0.00002643049],"domain_scores_gemma":[0.99982077,0.000042834792,0.000057225505,0.000018226987,0.000016701826,0.000044250566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011680535,0.00046657468,0.00028643102,0.00015779065,0.0001486079,0.00019503542,0.0002761653,0.00032320747,0.0010150219],"category_scores_gemma":[0.00026668326,0.00013984847,0.0003894022,0.00019060896,0.00027424592,0.00015481695,0.00022718651,0.0003623342,0.00028087053],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042902702,0.000071323135,0.00082171184,0.000030754232,0.000030016694,0.00031014497,0.000022575805,0.0003428964,0.99650097,0.0001072367,0.000035729736,0.0012975468],"study_design_scores_gemma":[0.000064138,0.00058651343,0.013294443,0.00001145922,0.00007601859,0.0026605895,0.00006455928,0.003957377,0.97747874,0.000114609844,0.0016622343,0.00002952125],"about_ca_topic_score_codex":0.0007177821,"about_ca_topic_score_gemma":0.0005065657,"teacher_disagreement_score":0.0010150219,"about_ca_system_score_codex":0.00025080962,"about_ca_system_score_gemma":0.00013479931,"threshold_uncertainty_score":0.0033955574},"labels":[],"label_agreement":null},{"id":"W4379280787","doi":"10.1200/jco.2023.41.16_suppl.9579","title":"A pilot study of the neoadjuvant use of vemurafenib plus cobimetinib in patients with BRAF-mutant melanoma with palpable lymph node metastases: Survival results.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; McGill University; Ottawa Hospital; Jewish General Hospital; University of Ottawa; Royal Victoria Hospital; Health Sciences Centre; Sunnybrook Hospital","funders":"","keywords":"Medicine; Vemurafenib; Melanoma; Internal medicine; Neoadjuvant therapy; Lymph node; Surgery; Oncology; Cancer; Metastatic melanoma; Breast cancer; Cancer research","score_opus":0.09954392322007363,"score_gpt":0.35462500954589155,"score_spread":0.25508108632581794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379280787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998711,0.00028347652,0.000107196625,0.000053737498,0.000022615324,0.00032572355,0.0002106054,0.0000089531495,0.0002766395],"genre_scores_gemma":[0.99758446,0.0002489611,0.00044010612,0.00013657627,0.00009859216,0.0004990448,0.0005290842,0.00000522208,0.0004579536],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9992286,0.00041157193,0.000041288673,0.00013427071,0.000053798223,0.00013034607],"domain_scores_gemma":[0.99836665,0.0003642428,0.00029270953,0.00012342885,0.00008988087,0.0007632279],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017415218,0.0010189887,0.0014900714,0.0003233187,0.00042786487,0.00065021426,0.0004902135,0.00077891274,0.0021655797],"category_scores_gemma":[0.0014442069,0.00047050673,0.0013058473,0.00036946387,0.0007171627,0.0008321441,0.0003894414,0.0014805582,0.00058355316],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.77944887,0.07732164,0.077888414,0.0002746416,0.0009097799,0.00041140238,0.00039660357,0.0011251975,0.020190146,0.000064814216,0.0006400143,0.041328486],"study_design_scores_gemma":[0.061596557,0.84047216,0.09436857,0.000016432361,0.00043168524,0.00023487091,0.00011343272,0.0006649924,0.0012460857,0.000043559885,0.0007812987,0.000030310333],"about_ca_topic_score_codex":0.0011005737,"about_ca_topic_score_gemma":0.0018335999,"teacher_disagreement_score":0.0021655797,"about_ca_system_score_codex":0.00077076163,"about_ca_system_score_gemma":0.0010980149,"threshold_uncertainty_score":0.009210169},"labels":[],"label_agreement":null},{"id":"W4379282676","doi":"10.1200/jco.2023.41.16_suppl.e21535","title":"Efficacy and safety of BRAF/MEK inhibitor rechallenge in patients with advanced melanoma: Systematic review and meta-analysis.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Oncology; Meta-analysis; Melanoma; Adverse effect; Cochrane Library; Confidence interval; Targeted therapy; Randomized controlled trial; Cancer; Cancer research","score_opus":0.08060896918441193,"score_gpt":0.3887397324274803,"score_spread":0.3081307632430683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379282676","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002691515,0.99558496,0.00031760635,0.00018988215,0.000100111836,0.0002623284,0.00059476815,0.000019295541,0.00023958871],"genre_scores_gemma":[0.12660155,0.86825055,0.001547206,0.0010626006,0.0001679365,0.0010176236,0.000951307,0.000029118935,0.00037200857],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9939109,0.0025807647,0.0020768652,0.00057975657,0.0006608257,0.0001908435],"domain_scores_gemma":[0.9873281,0.008808787,0.0024259398,0.00029265138,0.00096278166,0.00018182024],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.010122368,0.002209422,0.016046235,0.0058673793,0.0004868978,0.0026333279,0.0020009074,0.0020448256,0.004100597],"category_scores_gemma":[0.0230222,0.0013238689,0.028699933,0.006616349,0.00065963314,0.0018117228,0.0013174063,0.0015898523,0.00039263215],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013204103,0.000020029755,0.0017935022,0.6272551,0.35754353,0.00010198962,0.00007276923,0.0003432411,0.00017879432,0.00011491085,0.0006485455,0.010607125],"study_design_scores_gemma":[0.00066243677,0.00021428223,0.003132768,0.05950701,0.9330541,0.00012843215,0.000056943176,0.00016973913,0.00012165546,0.00020884005,0.0027156086,0.000028139764],"about_ca_topic_score_codex":0.0070381863,"about_ca_topic_score_gemma":0.01686153,"teacher_disagreement_score":0.9839538,"about_ca_system_score_codex":0.002360123,"about_ca_system_score_gemma":0.00333836,"threshold_uncertainty_score":0.05353284},"labels":[],"label_agreement":null},{"id":"W4379283236","doi":"10.1200/jco.2023.41.16_suppl.3125","title":"Clinical activity of mitogen-activated protein kinase (MAPK) inhibitors in patients with MAP2K1 (MEK1)-mutated metastatic cancers: A systematic review and meta-analysis.","year":2023,"lang":"en","type":"review","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"KRAS; Neuroblastoma RAS viral oncogene homolog; Medicine; HRAS; MAPK/ERK pathway; Cancer research; Cancer; Colorectal cancer; Mutation; Mutant; Melanoma; Lung cancer; Kinase; Oncology; Internal medicine; Biology; Gene; Genetics","score_opus":0.2124749365452833,"score_gpt":0.4693900631818412,"score_spread":0.2569151266365579,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379283236","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00700822,0.98936486,0.00025596368,0.00020749695,0.000072918905,0.000137982,0.0025908554,0.00001624507,0.00034547257],"genre_scores_gemma":[0.21504258,0.7783155,0.0014681574,0.0008618391,0.00018985159,0.00067297445,0.0031306816,0.000025863395,0.00029255115],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9952468,0.0018718715,0.0014931048,0.0006480363,0.0005494207,0.00019074004],"domain_scores_gemma":[0.98934525,0.0073651467,0.0020247656,0.0002732878,0.0008351856,0.00015639768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006599227,0.0013626484,0.009761353,0.005655375,0.0003552147,0.0015070237,0.0013485285,0.0011164539,0.0023121631],"category_scores_gemma":[0.01361755,0.00077760045,0.016824458,0.009114326,0.00039920816,0.00094770984,0.00091750926,0.0008330441,0.0002592],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002068057,0.000024488143,0.011691665,0.58981127,0.37076014,0.00015402358,0.0000949627,0.0007037032,0.00056973164,0.00015749612,0.0025302889,0.02143425],"study_design_scores_gemma":[0.000816802,0.00031176498,0.018103547,0.05508815,0.918503,0.00026047474,0.00007165091,0.00026285686,0.0002814245,0.00022928773,0.006031216,0.000039882936],"about_ca_topic_score_codex":0.0064019794,"about_ca_topic_score_gemma":0.018249854,"teacher_disagreement_score":0.009761353,"about_ca_system_score_codex":0.0017321092,"about_ca_system_score_gemma":0.0027203683,"threshold_uncertainty_score":0.034900486},"labels":[],"label_agreement":null},{"id":"W4379339637","doi":"10.1200/jco.2023.41.16_suppl.e21506","title":"Patient characteristics and treatment patterns in BRAF-mutated unresectable or metastatic melanoma in the United States: A snapshot from real-world data.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"Pfizer","keywords":"Medicine; Ipilimumab; Melanoma; Dabrafenib; Trametinib; Internal medicine; Nivolumab; Oncology; Metastatic melanoma; Targeted therapy; Retrospective cohort study; Gastroenterology; Vemurafenib; Cancer; Cancer research; Immunotherapy; Kinase","score_opus":0.2015642610219666,"score_gpt":0.44122866727246157,"score_spread":0.23966440625049498,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379339637","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9824332,0.0014275509,0.00011285014,0.00026409782,0.000010579539,0.0000279663,0.014888933,0.000011997704,0.00082284905],"genre_scores_gemma":[0.99017745,0.0006895752,0.0001697248,0.0001466802,0.000013566443,0.000032351483,0.008600038,0.0000043460896,0.00016619427],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99936444,0.00013521036,0.00014887119,0.00015678036,0.00009289549,0.00010175987],"domain_scores_gemma":[0.99752957,0.000345678,0.0015307255,0.00008014808,0.00025992384,0.000254049],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064983446,0.00014476918,0.00027385217,0.0012787586,0.00025997814,0.0005274211,0.0002831314,0.000317639,0.0016288892],"category_scores_gemma":[0.0018161245,0.00018571987,0.00039224158,0.0024476105,0.0001629204,0.00058808585,0.00044054812,0.0004493825,0.00029763082],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007785854,0.000025395555,0.99722785,0.000031503718,0.000034185745,0.000050112874,0.000057563007,0.000044772692,0.000056710258,0.000017267173,0.00071549905,0.0016612442],"study_design_scores_gemma":[0.000005803513,0.000058638398,0.99812764,0.00003091718,0.000019872512,0.00027689696,0.000418973,0.00016550426,0.000045331904,0.000013134503,0.000832563,0.0000047523495],"about_ca_topic_score_codex":0.012433595,"about_ca_topic_score_gemma":0.021438098,"teacher_disagreement_score":0.012433595,"about_ca_system_score_codex":0.00061285886,"about_ca_system_score_gemma":0.0005466619,"threshold_uncertainty_score":0.024722457},"labels":[],"label_agreement":null},{"id":"W4379341627","doi":"10.1200/jco.2023.41.16_suppl.9542","title":"Durable clinical outcomes in patients (pts) with advanced melanoma and progression-free survival (PFS) ≥3y on nivolumab (NIVO) ± ipilimumab (IPI) or IPI in checkmate 067.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Nivolumab; Ipilimumab; Internal medicine; Oncology; Progression-free survival; Placebo; Melanoma; Overall survival; Cancer; Immunotherapy; Pathology; Cancer research","score_opus":0.06243232627494016,"score_gpt":0.41519514953864695,"score_spread":0.3527628232637068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379341627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989053,0.00030371692,0.000067741654,0.000027896811,0.0000055381715,0.00003098858,0.00028826838,0.0000049915493,0.00036548538],"genre_scores_gemma":[0.99909234,0.00009123084,0.000061683495,0.000039819748,0.00001065625,0.00003418583,0.00048432124,0.0000010177419,0.00018485903],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.999803,0.00007091117,0.000013941083,0.00003998519,0.00002866128,0.00004353181],"domain_scores_gemma":[0.9994211,0.00012600796,0.00024265499,0.000028182272,0.000020164218,0.00016188157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079443585,0.00016462503,0.00036754785,0.00013465312,0.00014645154,0.0003344912,0.00018104656,0.00027423105,0.0017677743],"category_scores_gemma":[0.00075310917,0.00010320964,0.0004889957,0.000224831,0.00018205422,0.0002730523,0.00024397424,0.00051553245,0.00018841532],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.24041359,0.0041830223,0.6432587,0.0004295834,0.001088852,0.0005700415,0.00022887003,0.0023507318,0.019326761,0.00014472353,0.0024280273,0.08557703],"study_design_scores_gemma":[0.008788875,0.07672418,0.90747565,0.00003436658,0.0006074972,0.0007063383,0.00008715811,0.001427155,0.0020615782,0.000116233925,0.001957663,0.000013344095],"about_ca_topic_score_codex":0.00061458326,"about_ca_topic_score_gemma":0.0011918487,"teacher_disagreement_score":0.0017677743,"about_ca_system_score_codex":0.00034720724,"about_ca_system_score_gemma":0.00034714787,"threshold_uncertainty_score":0.0059138536},"labels":[],"label_agreement":null},{"id":"W4380362186","doi":"10.1016/b978-0-12-817134-9.00015-5","title":"Integrated pharmacokinetic/pharmacodynamic/efficacy analysis in oncology: importance of pharmacodynamic/efficacy relationships","year":2023,"lang":"en","type":"book-chapter","venue":"Elsevier eBooks","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Pharmacodynamics; Pharmacokinetics; Context (archaeology); Pharmacology; Medicine; Biomarker; Oncology; Drug; Clinical efficacy; Efficacy; Computational biology; Internal medicine; Biology","score_opus":0.03322566239138656,"score_gpt":0.30059597343123423,"score_spread":0.26737031103984765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380362186","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017716631,0.18587674,0.6968765,0.009875966,0.0012374083,0.00023097402,0.0021665175,0.0014700776,0.08454921],"genre_scores_gemma":[0.3644576,0.16954839,0.3711229,0.0062054815,0.0033466308,0.00043906536,0.0018315321,0.0012651384,0.08178329],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99920243,0.0003654203,0.000039621726,0.00009954794,0.00026480577,0.00002812011],"domain_scores_gemma":[0.99787235,0.0017944295,0.00011406865,0.00007359826,0.00010829817,0.0000372932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027438032,0.0010554639,0.001552969,0.0008053688,0.00013686945,0.0029287504,0.00060769735,0.00095170015,0.0074101235],"category_scores_gemma":[0.0046703774,0.00049768906,0.0011129525,0.0007560628,0.0004833733,0.0015217591,0.0005634626,0.0024951417,0.0025510048],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042217184,0.00030057473,0.0040771095,0.0016447117,0.00094206905,0.00046584525,0.000073807234,0.057005078,0.019554349,0.060980503,0.029977256,0.8245565],"study_design_scores_gemma":[0.00011739047,0.0012647074,0.012102861,0.0010419127,0.0013182041,0.003632348,0.00015047539,0.29668924,0.021930983,0.45281118,0.20871507,0.00022558094],"about_ca_topic_score_codex":0.00077191234,"about_ca_topic_score_gemma":0.0013711753,"teacher_disagreement_score":0.0074101235,"about_ca_system_score_codex":0.0008191691,"about_ca_system_score_gemma":0.0008915897,"threshold_uncertainty_score":0.024789274},"labels":[],"label_agreement":null},{"id":"W4384029604","doi":"10.1093/noajnl/vdad071.016","title":"ACQUIRED PTEN LOSS MAY MEDIATE DABRAFENIB AND TRAMETINIB RESISTANCE IN BRAF V600E–MUTATED EPITHELIOID GLIOBLASTOMA: A CASE REPORT","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology Advances","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Trametinib; Dabrafenib; PTEN; Temozolomide; Medicine; Cancer research; Vemurafenib; Melanoma; MEK inhibitor; Oncology; PI3K/AKT/mTOR pathway; Glioma; Internal medicine; Biology; MAPK/ERK pathway; Metastatic melanoma; Signal transduction","score_opus":0.010870951514336478,"score_gpt":0.2837415345649626,"score_spread":0.2728705830506261,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384029604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.984397,0.0032769397,0.0029982505,0.001178974,0.00011341299,0.0001547795,0.00015374162,0.00016389764,0.00756307],"genre_scores_gemma":[0.9970853,0.00080864277,0.0008593477,0.00020494848,0.00023555054,0.000015941027,0.00005440282,0.000013611982,0.00072218204],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99943,0.00006411185,0.00006188733,0.00009989171,0.000081513695,0.0002625912],"domain_scores_gemma":[0.9991258,0.00017334528,0.00026321394,0.00011962278,0.00007216898,0.0002458431],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040289693,0.001389839,0.0010352136,0.0019011444,0.0017104361,0.0018961519,0.0009316164,0.003342772,0.0026622557],"category_scores_gemma":[0.0016469056,0.0009373075,0.00090166024,0.001100688,0.0013154799,0.0017279374,0.0011498196,0.0018228672,0.0012406784],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028151639,0.000021238426,0.0050391993,0.000020585165,0.000006194471,0.99322754,0.00006150209,0.000028430724,0.0006953522,0.00010172329,0.000106211875,0.0006638439],"study_design_scores_gemma":[0.000007627409,0.000027843635,0.0022499727,0.000007385108,0.000016086069,0.99627316,0.00009813586,0.00024326879,0.0006089206,0.000106003965,0.0003557971,0.0000057039506],"about_ca_topic_score_codex":0.0018595849,"about_ca_topic_score_gemma":0.0020963047,"teacher_disagreement_score":0.003342772,"about_ca_system_score_codex":0.0011102457,"about_ca_system_score_gemma":0.00060301844,"threshold_uncertainty_score":0.008906066},"labels":[],"label_agreement":null},{"id":"W4385241321","doi":"10.3390/cancers15153754","title":"Efficacy and Safety of Rechallenge with BRAF/MEK Inhibitors in Advanced Melanoma Patients: A Systematic Review and Meta-Analysis","year":2023,"lang":"en","type":"review","venue":"Cancers","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Melanoma; Oncology; Internal medicine; Overall survival; Meta-analysis; Refractory (planetary science); Immunotherapy; Disease; Clinical Practice; Cancer research; Cancer; Physical therapy","score_opus":0.045585849554262654,"score_gpt":0.30551939764361535,"score_spread":0.2599335480893527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385241321","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022200989,0.99669373,0.00022664884,0.000119549055,0.00007077989,0.000084500716,0.00039435277,0.000011047884,0.00017936173],"genre_scores_gemma":[0.068672754,0.9287557,0.0008504796,0.00049351825,0.00013585415,0.00028882694,0.000601631,0.000013520435,0.00018761592],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9967854,0.0013455676,0.0010372535,0.00035691212,0.0003510657,0.00012386998],"domain_scores_gemma":[0.99132276,0.006453099,0.0012867097,0.00020197325,0.00063234946,0.00010308546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005973602,0.0019474928,0.011362068,0.0044724164,0.0003929246,0.0019599285,0.0013464597,0.0013955621,0.0030338073],"category_scores_gemma":[0.015279378,0.0009960429,0.020509694,0.0052348743,0.00038894368,0.001083324,0.00089381984,0.0011388889,0.00028143884],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012832884,0.000023944513,0.003154352,0.5952471,0.37078544,0.00013978136,0.000061793144,0.0005028843,0.00032660842,0.00015624463,0.0011162419,0.027202364],"study_design_scores_gemma":[0.00040793404,0.00019591939,0.004335004,0.046013843,0.943989,0.00017680203,0.000044088272,0.00016547545,0.00017854049,0.00024089466,0.00422643,0.000025947762],"about_ca_topic_score_codex":0.0045184195,"about_ca_topic_score_gemma":0.012002062,"teacher_disagreement_score":0.011362068,"about_ca_system_score_codex":0.0014821473,"about_ca_system_score_gemma":0.0024046048,"threshold_uncertainty_score":0.031591833},"labels":[],"label_agreement":null},{"id":"W4385450961","doi":"10.1126/scisignal.ade8744","title":"Multiple cancers escape from multiple MAPK pathway inhibitors and use DNA replication stress signaling to tolerate aberrant cell cycles","year":2023,"lang":"en","type":"article","venue":"Science Signaling","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Anschutz Medical Campus, University of Colorado; National Cancer Institute; National Institutes of Health; National Institute of Standards and Technology; Université Laval; Damon Runyon Cancer Research Foundation","keywords":"MAPK/ERK pathway; Biology; Cancer research; Cell growth; DNA damage; DNA replication; KRAS; DNA repair; Kinase; Cancer cell; Cancer; Cell biology; Mutation; DNA; Genetics; Gene","score_opus":0.021194317219238996,"score_gpt":0.2445866611679958,"score_spread":0.2233923439487568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385450961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918263,0.0029338617,0.0033703875,0.00012994706,0.000014907195,0.000056641504,0.00018563835,0.000120656594,0.0013617316],"genre_scores_gemma":[0.99493873,0.0008605693,0.0018482574,0.00006558562,0.000005442797,0.00004266187,0.00029847515,0.000014955644,0.0019253416],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998871,0.000011745182,0.000011692666,0.000029696004,0.00003255539,0.00002726335],"domain_scores_gemma":[0.9999262,0.000006945026,0.00002064511,0.000013591894,0.000011934785,0.0000207541],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015648545,0.0003020551,0.00033887263,0.00023363697,0.00018800776,0.00034531922,0.00016224493,0.0002239301,0.0008020787],"category_scores_gemma":[0.00010700708,0.00011482448,0.0002652548,0.00013812061,0.00014999865,0.00023654255,0.00029713125,0.0006143765,0.00023841416],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007321388,0.00003926978,0.0013329824,0.00003126292,0.000007934594,0.00007271087,0.000015109805,0.000119878125,0.9922631,0.00013482553,0.00004471204,0.0058649913],"study_design_scores_gemma":[0.000026821495,0.00083255774,0.0259492,0.0000094922425,0.000022449643,0.0018451962,0.000060648617,0.0016249656,0.9636289,0.00020807711,0.0057822657,0.000009483926],"about_ca_topic_score_codex":0.00042618898,"about_ca_topic_score_gemma":0.000902334,"teacher_disagreement_score":0.0008020787,"about_ca_system_score_codex":0.00033634334,"about_ca_system_score_gemma":0.00020780382,"threshold_uncertainty_score":0.0026831627},"labels":[],"label_agreement":null},{"id":"W4385481458","doi":"10.3390/biom13081212","title":"A Combination of Conformation-Specific RAF Inhibitors Overcome Drug Resistance Brought about by RAF Overexpression","year":2023,"lang":"en","type":"article","venue":"Biomolecules","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Core Research for Evolutional Science and Technology; National Cancer Institute; National Institutes of Health; Queen's University; European Commission; Irish Research Council; Albert-Ludwigs-Universität Freiburg; Japan Society for the Promotion of Science; Queen's University Belfast; Uehara Memorial Foundation","keywords":"Downregulation and upregulation; Gene isoform; MAPK/ERK pathway; Chemistry; Phenotype; Cell biology; Signal transduction; Cancer research; Biology; Biochemistry; Gene","score_opus":0.006780478765837725,"score_gpt":0.22388524567376852,"score_spread":0.2171047669079308,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385481458","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98854977,0.0013724547,0.007940065,0.00009730806,0.000021371627,0.000029185263,0.00012072477,0.00012786001,0.0017412839],"genre_scores_gemma":[0.995806,0.0007505025,0.0027446665,0.000017033874,0.0000048854035,0.000019413614,0.00007061886,0.000016813648,0.0005700991],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999472,0.0000062772533,0.000003870753,0.00001668372,0.000014618203,0.000011374683],"domain_scores_gemma":[0.99996936,0.000005992615,0.000010255095,0.0000049600803,0.000002490814,0.0000068881236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000080213125,0.00032848935,0.00035117316,0.00013877699,0.00008094463,0.0002502185,0.00022242696,0.00016084968,0.00071367936],"category_scores_gemma":[0.00008986236,0.00011854671,0.00025920742,0.000117965756,0.000106338885,0.00022751078,0.00019788831,0.0003432779,0.00018575529],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017751764,0.000089810776,0.00028502365,0.00007862512,0.000038412858,0.000053776424,0.000007983278,0.005356166,0.9861858,0.0004010227,0.00008216669,0.007243655],"study_design_scores_gemma":[0.00004999009,0.00055660063,0.001135802,0.000004551608,0.00007286386,0.00014500595,0.00001107838,0.022260023,0.9727482,0.00019149258,0.0028120112,0.000012406877],"about_ca_topic_score_codex":0.00019167275,"about_ca_topic_score_gemma":0.00048785642,"teacher_disagreement_score":0.00071367936,"about_ca_system_score_codex":0.00014834499,"about_ca_system_score_gemma":0.00013786403,"threshold_uncertainty_score":0.002387464},"labels":[],"label_agreement":null},{"id":"W4385515906","doi":"10.1016/j.jcjo.2023.07.008","title":"BRAF and MEK inhibitor-associated optic neuropathy in stage IIIC BRAF+ melanoma","year":2023,"lang":"en","type":"letter","venue":"Canadian Journal of Ophthalmology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"MEK inhibitor; Melanoma; Medicine; Stage (stratigraphy); Cancer research; Melanoma diagnosis; Optic neuropathy; Oncology; Internal medicine; Optic nerve; Biology; MAPK/ERK pathway; Ophthalmology; Genetics; Signal transduction","score_opus":0.020235514592606675,"score_gpt":0.23465095754453869,"score_spread":0.21441544295193202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385515906","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.57893145,0.023608316,0.0018309578,0.24884667,0.009902931,0.0004259214,0.0009561249,0.00037111135,0.13512655],"genre_scores_gemma":[0.9271364,0.0047203954,0.0009426594,0.039766893,0.015947135,0.00005195191,0.00018096459,0.000039665585,0.011213942],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9996408,0.000036231457,0.00003662227,0.000038311973,0.000093267074,0.00015473303],"domain_scores_gemma":[0.9990771,0.00029265115,0.00011799438,0.00005276688,0.00011082549,0.00034853522],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004577859,0.00066561636,0.0009300169,0.00091540616,0.0017461203,0.001200878,0.0009090235,0.006669513,0.0025948924],"category_scores_gemma":[0.0024510499,0.00043486053,0.0010410899,0.00077371066,0.0012405106,0.0008476006,0.00041664205,0.0044941343,0.00062837335],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069138437,0.00010984885,0.017121054,0.00011501132,0.00004634945,0.9500103,0.00011972523,0.00019792492,0.0013920014,0.0009490018,0.020333068,0.008914372],"study_design_scores_gemma":[0.00030371934,0.00045127343,0.06355987,0.00016179452,0.00016951312,0.90837145,0.00040244454,0.0024348232,0.00096881756,0.0033959723,0.019723535,0.000056776207],"about_ca_topic_score_codex":0.025539242,"about_ca_topic_score_gemma":0.04098166,"teacher_disagreement_score":0.025539242,"about_ca_system_score_codex":0.003759605,"about_ca_system_score_gemma":0.0022783969,"threshold_uncertainty_score":0.05078119},"labels":[],"label_agreement":null},{"id":"W4385635813","doi":"10.33590/emjoncol/10305035","title":"Acquired PTEN Loss May Mediate Dabrafenib and Trametinib Resistance in BRAF V600E-Mutated Epithelioid Glioblastoma: A Case Report and Literature Review","year":2023,"lang":"en","type":"article","venue":"EMJ Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Hospital for Sick Children; SickKids Foundation; Western University","funders":"","keywords":"Trametinib; Dabrafenib; Temozolomide; PTEN; Medicine; Cancer research; MEK inhibitor; Vemurafenib; Melanoma; Oncology; Glioma; MAPK/ERK pathway; Internal medicine; Kinase; PI3K/AKT/mTOR pathway; Biology; Signal transduction; Metastatic melanoma","score_opus":0.010798618170922066,"score_gpt":0.2937090708532966,"score_spread":0.2829104526823745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385635813","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.44816586,0.49431375,0.0088433605,0.0055851536,0.0013294976,0.00037662516,0.0006341416,0.0005018646,0.04024985],"genre_scores_gemma":[0.8191466,0.17000224,0.0023104008,0.0017330162,0.002390593,0.000056731846,0.00041634496,0.000053452222,0.0038906299],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9995969,0.00004239887,0.00010573665,0.000075916905,0.00007178447,0.000107351174],"domain_scores_gemma":[0.9994148,0.00015595375,0.00025531364,0.000045907327,0.000056129913,0.00007189828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030361908,0.001048279,0.0010104,0.003143653,0.0010292439,0.0018447804,0.00092454674,0.0025655997,0.0026299725],"category_scores_gemma":[0.0010284485,0.0006136099,0.0007516361,0.0022642005,0.0012098628,0.0024378528,0.0009566032,0.0012508432,0.0016151383],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003864425,0.000028520693,0.0055699334,0.0006870731,0.000033148062,0.974815,0.0001914976,0.00008015909,0.0016020584,0.0003582257,0.0015313497,0.015064385],"study_design_scores_gemma":[0.000004836957,0.000011290031,0.0019725368,0.00013957138,0.000054626664,0.99150544,0.00018766361,0.00010961417,0.0006194574,0.00020866143,0.0051747854,0.000011546232],"about_ca_topic_score_codex":0.0010935736,"about_ca_topic_score_gemma":0.0014164513,"teacher_disagreement_score":0.003143653,"about_ca_system_score_codex":0.0007008504,"about_ca_system_score_gemma":0.0006739859,"threshold_uncertainty_score":0.008798122},"labels":[],"label_agreement":null},{"id":"W4385807698","doi":"10.7717/peerj.15873","title":"Prognostic and clinicopathological role of RACK1 for cancer patients: a systematic review and meta-analysis","year":2023,"lang":"en","type":"review","venue":"PeerJ","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"West China Hospital, Sichuan University; Sichuan University; China Postdoctoral Science Foundation; National Natural Science Foundation of China","keywords":"Internal medicine; Medicine; Meta-analysis; Hazard ratio; Cochrane Library; Confidence interval; Oncology; Lymphovascular invasion; Odds ratio; Cancer; Metastasis","score_opus":0.10998793342270693,"score_gpt":0.38418002799342343,"score_spread":0.27419209457071647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385807698","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004132758,0.99429375,0.00039984865,0.0001644571,0.00009483084,0.00021788856,0.0005284328,0.000016620274,0.00015136274],"genre_scores_gemma":[0.15297574,0.84163105,0.0020095503,0.0007414992,0.00021394946,0.0012273348,0.0008819699,0.00002785411,0.00029107588],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99227166,0.00322659,0.0025097777,0.00089864543,0.0007975023,0.00029577655],"domain_scores_gemma":[0.9806192,0.014240213,0.0029910842,0.00053583324,0.0013843116,0.00022933011],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012080628,0.0027010248,0.017853897,0.008122618,0.00072545116,0.002890631,0.002165824,0.002209895,0.0032316719],"category_scores_gemma":[0.028021453,0.0015037361,0.03479844,0.009439731,0.0007720359,0.0016398982,0.0015137936,0.0015014982,0.00029925263],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010978519,0.000020976551,0.005586454,0.5183144,0.4645345,0.00015500239,0.00009442946,0.00047087003,0.0002297499,0.000107083346,0.00055343146,0.008835249],"study_design_scores_gemma":[0.00024175274,0.00011451381,0.0038689012,0.028093155,0.9659562,0.00010667236,0.000046136985,0.0001455804,0.00008943351,0.00011936522,0.001196559,0.000021766067],"about_ca_topic_score_codex":0.007749213,"about_ca_topic_score_gemma":0.018269705,"teacher_disagreement_score":0.017853897,"about_ca_system_score_codex":0.002522528,"about_ca_system_score_gemma":0.0042602248,"threshold_uncertainty_score":0.063889205},"labels":[],"label_agreement":null},{"id":"W4386012742","doi":"10.1016/j.pediatrneurol.2023.08.019","title":"Treatment of Refractory Epilepsy With MEK Inhibitor in Patients With RASopathy","year":2023,"lang":"en","type":"article","venue":"Pediatric Neurology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Trametinib; Discontinuation; Medicine; Epilepsy; Levetiracetam; Pediatrics; Refractory (planetary science); Internal medicine; Oncology; MAPK/ERK pathway; Biology; Psychiatry","score_opus":0.005595701158758129,"score_gpt":0.19526764394857712,"score_spread":0.189671942789819,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386012742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9690402,0.01871496,0.00096275646,0.0020022616,0.00018811272,0.000066988374,0.00027727647,0.00009599184,0.008651489],"genre_scores_gemma":[0.99421096,0.00358979,0.00044122906,0.00047883362,0.00007074863,0.00002899301,0.00026141357,0.0000068904114,0.00091108313],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9999409,0.000012028841,0.000009830078,0.000007800982,0.000008787758,0.000020750029],"domain_scores_gemma":[0.9999182,0.000019240782,0.000019164529,0.0000046829177,0.0000072727166,0.000031326865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011708212,0.0003287986,0.0004873677,0.00022501414,0.00026254903,0.00024483923,0.00020496937,0.00031002148,0.00085494213],"category_scores_gemma":[0.0003621779,0.00006157346,0.0003945049,0.0001882878,0.00013798001,0.00022130349,0.00011780974,0.00058224035,0.00020191082],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029488573,0.0018135912,0.20959498,0.0012548399,0.0013679616,0.12192849,0.00057062437,0.002531422,0.08538874,0.0021661797,0.014494473,0.5294001],"study_design_scores_gemma":[0.0052478593,0.017975587,0.5909372,0.0007370673,0.0021477567,0.2758018,0.0010954343,0.005357234,0.03822142,0.0055695022,0.056741517,0.00016759169],"about_ca_topic_score_codex":0.0007239428,"about_ca_topic_score_gemma":0.0022455566,"teacher_disagreement_score":0.00085494213,"about_ca_system_score_codex":0.00031112914,"about_ca_system_score_gemma":0.00041756147,"threshold_uncertainty_score":0.0028600693},"labels":[],"label_agreement":null},{"id":"W4386281917","doi":"10.1016/j.ygyno.2023.08.007","title":"The spectrum of MAPK-ERK pathway genomic alterations in gynecologic malignancies: Opportunities for novel therapeutic approaches","year":2023,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"KRAS; Neuroblastoma RAS viral oncogene homolog; HRAS; Medicine; MAPK/ERK pathway; Cancer research; Serous fluid; Gynecologic oncology; Ovarian cancer; Oncology; Cervix; Cancer; Internal medicine; Biology; Signal transduction; Colorectal cancer; Genetics","score_opus":0.14032292412891686,"score_gpt":0.28610429681241273,"score_spread":0.14578137268349586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386281917","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7615124,0.1938443,0.014409012,0.00778103,0.0001891165,0.0001001302,0.00083186396,0.0002506699,0.021081517],"genre_scores_gemma":[0.94739485,0.04531629,0.004794217,0.0005023604,0.00011982816,0.00005027613,0.00027928615,0.00001869135,0.0015241775],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.999926,0.000013882945,0.0000050290523,0.000015592275,0.000019156307,0.00002038735],"domain_scores_gemma":[0.9999306,0.000021814145,0.000018450939,0.0000059328245,0.000009925497,0.000013218525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023917711,0.0003228807,0.0003265581,0.00054317346,0.00017060693,0.0004855229,0.00022312939,0.00026637703,0.0013116491],"category_scores_gemma":[0.00024434694,0.00011768308,0.00023226898,0.00041092178,0.00023901115,0.000369535,0.00034162495,0.00047491447,0.00017760012],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015344495,0.00030398314,0.04734121,0.0007822693,0.00014748334,0.0047581,0.00020403833,0.002052919,0.55358034,0.008828964,0.0022055274,0.3782607],"study_design_scores_gemma":[0.00045466935,0.0032906565,0.43932515,0.000712756,0.0011071687,0.054487642,0.0019658837,0.009244871,0.2917318,0.042706806,0.15485425,0.00011837877],"about_ca_topic_score_codex":0.000277304,"about_ca_topic_score_gemma":0.0008272112,"teacher_disagreement_score":0.0013116491,"about_ca_system_score_codex":0.00028530977,"about_ca_system_score_gemma":0.00031187278,"threshold_uncertainty_score":0.004387915},"labels":[],"label_agreement":null},{"id":"W4386356684","doi":"10.1126/sciadv.ade7486","title":"BRAF <sup>Δβ3-αC</sup> in-frame deletion mutants differ in their dimerization propensity, HSP90 dependence, and druggability","year":2023,"lang":"en","type":"article","venue":"Science Advances","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Ontario Institute for Cancer Research","funders":"Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Deutsche Forschungsgemeinschaft","keywords":"Druggability; Mutant; Linker; Amino acid; Mutation; Exon; Dabrafenib; Alanine; Cancer research; Chemistry; Biology; Molecular biology; Genetics; Gene; Vemurafenib; Melanoma","score_opus":0.01324951791092464,"score_gpt":0.25451904860327607,"score_spread":0.24126953069235144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386356684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959188,0.00033965308,0.0014695902,0.000072059214,0.000013937791,0.000016983066,0.000691118,0.000055433862,0.0014224257],"genre_scores_gemma":[0.9947273,0.00023716655,0.001686495,0.00005438525,0.0000033380422,0.000017881239,0.0012408455,0.000035875702,0.0019968322],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998666,0.000017848488,0.000018306775,0.000023475493,0.00004574641,0.000027909653],"domain_scores_gemma":[0.99991524,0.000011791528,0.000025565241,0.000012370845,0.000010377178,0.000024699268],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008951957,0.0002862765,0.00015429156,0.0001326361,0.00014205507,0.0002598805,0.0001601176,0.00018961253,0.001447375],"category_scores_gemma":[0.00011104786,0.00010624807,0.00025596004,0.00013683148,0.00014911334,0.00013795121,0.00011724457,0.00039010207,0.00067634543],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043965047,0.000010825803,0.00030991106,0.000008279653,0.0000038827575,0.000046553585,0.000006949531,0.00005068552,0.99876523,0.000058510454,0.000043788674,0.00065144274],"study_design_scores_gemma":[0.000008553352,0.00012454274,0.010154913,0.000003088886,0.000017313181,0.0014765033,0.000039529674,0.0006705276,0.9826189,0.00005820141,0.004821373,0.000006507202],"about_ca_topic_score_codex":0.001280557,"about_ca_topic_score_gemma":0.001567788,"teacher_disagreement_score":0.001447375,"about_ca_system_score_codex":0.0002382769,"about_ca_system_score_gemma":0.00015507327,"threshold_uncertainty_score":0.0048419833},"labels":[],"label_agreement":null},{"id":"W4386863242","doi":"10.1101/2023.09.15.557847","title":"The clinical, genomic, and transcriptomic landscape of BRAF mutant cancers","year":2023,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McGill University Health Centre; McGill University; Jewish General Hospital","funders":"Fonds de Recherche du Québec - Santé; EMD Serono; Fondation de l'Hôpital général juif; Jewish General Hospital; Advanced Accelerator Applications; Canadian Institutes of Health Research; Genome Canada; AstraZeneca Canada; AstraZeneca; American Society of Clinical Oncology; Pfizer; Conquer Cancer Foundation","keywords":"Wnt signaling pathway; Transcriptome; Cancer; Melanoma; Cancer research; Biology; Mutant; Mutation; Medicine; Gene; Genetics; Oncology; Internal medicine; Gene expression","score_opus":0.02277451477685394,"score_gpt":0.24925717703166586,"score_spread":0.22648266225481192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386863242","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966884,0.0006825114,0.00015168852,0.000055407643,0.0000031868085,0.000004396869,0.0019996415,0.0000092241235,0.00040556648],"genre_scores_gemma":[0.9980323,0.00021516682,0.00015865921,0.00003036114,0.0000061599044,0.000006734279,0.0013762265,0.0000037444963,0.00017063272],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998485,0.000025727253,0.000013559184,0.00005144869,0.000025064475,0.000035652592],"domain_scores_gemma":[0.99981576,0.00004279436,0.00007224142,0.000009606182,0.00002602356,0.000033613323],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014976256,0.00010224874,0.0001726387,0.00070568494,0.00015384512,0.00040752318,0.00010639375,0.00016116194,0.0014640132],"category_scores_gemma":[0.00048405715,0.0000750409,0.00013745001,0.0007795614,0.00013143323,0.0001341405,0.00018566621,0.0001210382,0.00022361607],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005847289,0.000021129857,0.9606598,0.000051386873,0.00006991734,0.00037890847,0.00007940198,0.00012699308,0.027086671,0.00006658808,0.00058240147,0.010292023],"study_design_scores_gemma":[0.0000028352183,0.00004505866,0.99749136,0.0000041883636,0.000017145254,0.0007731149,0.000096345124,0.00015318023,0.00081742724,0.000059810984,0.00053738605,0.0000022732766],"about_ca_topic_score_codex":0.0010525224,"about_ca_topic_score_gemma":0.001686335,"teacher_disagreement_score":0.0014640132,"about_ca_system_score_codex":0.0001645475,"about_ca_system_score_gemma":0.00011222779,"threshold_uncertainty_score":0.0048975945},"labels":[],"label_agreement":null},{"id":"W4386863695","doi":"10.1007/s12265-023-10431-4","title":"The Role of p90 Ribosomal S6 Kinase (RSK) in Tyrosine Kinase Inhibitor (TKI)-Induced Cardiotoxicity","year":2023,"lang":"en","type":"review","venue":"Journal of Cardiovascular Translational Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Cardiotoxicity; Ribosomal s6 kinase; Tyrosine kinase; Kinase; Tyrosine-kinase inhibitor; Biology; Protein kinase A; Effector; Cancer research; Cell biology; Pharmacology; Cancer; Phosphorylation; Signal transduction; P70-S6 Kinase 1; Protein kinase B; Genetics; Chemotherapy","score_opus":0.09482116411547385,"score_gpt":0.3732754609136442,"score_spread":0.27845429679817035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386863695","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015340546,0.99864465,0.00012842895,0.00022730678,0.00021869868,0.000003649905,0.000018550603,0.0000063330494,0.0005989079],"genre_scores_gemma":[0.0008958758,0.9980013,0.00014591627,0.00019674526,0.00019695476,0.0000062680974,0.000029503895,0.00000124349,0.0005262023],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99987817,0.000016072489,0.00001954082,0.000025202015,0.00004474512,0.00001632172],"domain_scores_gemma":[0.9997987,0.00008376724,0.00003846506,0.000007082844,0.000050697286,0.00002132404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056228717,0.0009203557,0.0013535061,0.0010875448,0.000195527,0.0009852228,0.00088620506,0.0010967312,0.0025701565],"category_scores_gemma":[0.0005340272,0.00025561568,0.00047675782,0.0011975619,0.00050471805,0.0009769975,0.0005996078,0.002306615,0.0019921483],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022949012,0.00013219166,0.00018736118,0.010059888,0.000109049855,0.000248406,0.000031689284,0.0005271147,0.0044383514,0.003104495,0.028313158,0.9526187],"study_design_scores_gemma":[0.00009842602,0.00034059546,0.0013875226,0.0022192094,0.00023872417,0.0012000599,0.0000447143,0.00021267342,0.0020712044,0.0024683448,0.98968863,0.000029885103],"about_ca_topic_score_codex":0.0006320339,"about_ca_topic_score_gemma":0.0016101052,"teacher_disagreement_score":0.0025701565,"about_ca_system_score_codex":0.0005218882,"about_ca_system_score_gemma":0.00080041453,"threshold_uncertainty_score":0.00859803},"labels":[],"label_agreement":null},{"id":"W4387158006","doi":"10.1097/pas.0000000000002131","title":"Clinical, Morphologic, and Molecular Features of Benign and Intermediate-grade Melanocytic Tumors With Activating Mutations in MAP2K1","year":2023,"lang":"en","type":"article","venue":"The American Journal of Surgical Pathology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; William Osler Health System","funders":"","keywords":"HRAS; Pathology; Missense mutation; Pleomorphism (cytology); V600E; Biology; Spitz nevus; Nevus; Medicine; Dermatology; Melanoma; Mutation; KRAS; Cancer research; Genetics; Immunohistochemistry; Gene","score_opus":0.015221080423406915,"score_gpt":0.28988806644840565,"score_spread":0.2746669860249987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387158006","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993069,0.00013196272,0.00012698998,0.000008388361,0.0000016571892,0.000008026044,0.000029947996,0.000004674524,0.00038142913],"genre_scores_gemma":[0.9996774,0.000047141544,0.00013188693,0.0000066905186,0.0000049582018,0.00000616266,0.000058228965,0.0000012241027,0.00006621922],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99965644,0.00004753049,0.00006253327,0.0000732439,0.00007318567,0.000087110944],"domain_scores_gemma":[0.9990877,0.00025976833,0.00025144426,0.000072116694,0.00008320839,0.0002457958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038526946,0.0004350004,0.00024989995,0.0013992719,0.00041439966,0.00037165216,0.0002628872,0.00039651847,0.0014975914],"category_scores_gemma":[0.0021544471,0.00034070824,0.00023126951,0.00040163836,0.0006504838,0.00044947973,0.0005696111,0.00018881312,0.00030244814],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031757067,0.000049345177,0.9716204,0.000029114544,0.000030396739,0.015090584,0.00015604231,0.00012189892,0.008703163,0.000055901495,0.00006565439,0.003759994],"study_design_scores_gemma":[0.000032024964,0.00031786488,0.8651493,0.000015473948,0.000047000034,0.13146545,0.0003726486,0.00048899365,0.0016030658,0.0001338609,0.0003595782,0.000014693059],"about_ca_topic_score_codex":0.00050342485,"about_ca_topic_score_gemma":0.0009817053,"teacher_disagreement_score":0.0014975914,"about_ca_system_score_codex":0.00019955305,"about_ca_system_score_gemma":0.00019800513,"threshold_uncertainty_score":0.005009949},"labels":[],"label_agreement":null},{"id":"W4388656122","doi":"10.1101/2023.11.13.566904","title":"Impaired migration and metastatic spread of human melanoma by a novel small molecule targeting the transmembrane domain of death receptor p75 <sup>NTR</sup>","year":2023,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital; University of Calgary","funders":"National Medical Research Council; Medical Research Council; Vetenskapsrådet; Cancerfonden","keywords":"Small molecule; Intracellular; Melanoma; Receptor; Cancer research; Cell biology; Extracellular; Transmembrane protein; Biology; Low-affinity nerve growth factor receptor; Nerve growth factor; Ligand (biochemistry); Pharmacology; Biochemistry","score_opus":0.018221027005160092,"score_gpt":0.22024053574720714,"score_spread":0.20201950874204705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388656122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99587727,0.0012134111,0.0010460851,0.00007324896,0.000027170463,0.000044939523,0.0001984145,0.000032367243,0.0014870393],"genre_scores_gemma":[0.9936945,0.00085926976,0.0015092064,0.000041842377,0.000008651205,0.00003823579,0.00029578543,0.000006023403,0.0035465204],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99996054,0.0000069899047,0.0000025543527,0.000006204287,0.00001192483,0.0000118497255],"domain_scores_gemma":[0.99998486,0.000003839329,0.0000025317192,0.0000017565563,0.0000022812576,0.0000047215008],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008204301,0.00036433554,0.0001739935,0.00014649218,0.00010220148,0.000116984134,0.0000910463,0.00016144523,0.001210257],"category_scores_gemma":[0.000060242026,0.000074060204,0.00014496256,0.000060782666,0.0001049303,0.000061126775,0.00008443178,0.00025910907,0.0002592062],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000107907494,0.00006011521,0.000087483466,0.00001720893,0.000004269473,0.00005243387,0.00000562635,0.00010175977,0.99757797,0.000048034595,0.000051617364,0.0018856258],"study_design_scores_gemma":[0.000055626027,0.0013018795,0.0016417428,0.0000028316872,0.000016242715,0.00020518732,0.000007589799,0.00075592723,0.99440855,0.000028731834,0.0015732468,0.000002477974],"about_ca_topic_score_codex":0.0011193004,"about_ca_topic_score_gemma":0.001290807,"teacher_disagreement_score":0.001210257,"about_ca_system_score_codex":0.00017919636,"about_ca_system_score_gemma":0.00019382207,"threshold_uncertainty_score":0.0040486455},"labels":[],"label_agreement":null},{"id":"W4388781591","doi":"10.1016/j.fander.2023.09.267","title":"Recherche de la mutation BRAF sur les mélanomes au CHU de Québec : sept ans de données","year":2023,"lang":"fr","type":"article","venue":"Annales de Dermatologie et de Vénéréologie - FMC","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Hôtel-Dieu de Québec","funders":"","keywords":"Molecular biology; Biology; Mutation; Philosophy; Genetics; Gene","score_opus":0.14152347085577557,"score_gpt":0.3602038730258062,"score_spread":0.21868040217003062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388781591","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.79138917,0.12999976,0.0070167836,0.019368408,0.0018881022,0.00037398544,0.006225152,0.00030077095,0.043437753],"genre_scores_gemma":[0.87432665,0.04269085,0.007118108,0.00385695,0.00040191333,0.0001709401,0.0036041318,0.0001385702,0.06769193],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9976665,0.00030110395,0.00018843306,0.00031158302,0.0011972411,0.0003352452],"domain_scores_gemma":[0.9940586,0.0012567232,0.00028599286,0.0001335714,0.0038591553,0.00040603365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003325736,0.000759604,0.0007438521,0.0027601751,0.0021787735,0.002973852,0.0006908153,0.0011962833,0.003687464],"category_scores_gemma":[0.006529527,0.0004489498,0.0010575136,0.0023272808,0.0013027863,0.0006608041,0.00062040513,0.0019546417,0.0006784995],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023330147,0.00045903344,0.3171683,0.002349776,0.001935126,0.02671559,0.018919459,0.0067955395,0.11506274,0.006484958,0.052517608,0.4492589],"study_design_scores_gemma":[0.00012212624,0.00041100322,0.66789097,0.001096638,0.000866191,0.0065347715,0.0064952807,0.0023229304,0.021995604,0.0006195827,0.29138687,0.00025802682],"about_ca_topic_score_codex":0.9407009,"about_ca_topic_score_gemma":0.94815,"teacher_disagreement_score":0.05929911,"about_ca_system_score_codex":0.020681461,"about_ca_system_score_gemma":0.015617486,"threshold_uncertainty_score":0.15005523},"labels":[],"label_agreement":null},{"id":"W4388848431","doi":"10.1016/j.ejca.2023.113458","title":"First-in-human study of naporafenib (LXH254) with or without spartalizumab in adult patients with advanced solid tumors harboring MAPK signaling pathway alterations","year":2023,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"National Cancer Institute; Novartis Pharmaceuticals UK Limited; Chugai Pharmaceutical; Italfarmaco; Bristol-Myers Squibb; AstraZeneca; Symphogen; Sun Pharma; Eisai; Sanofi; Genentech; Pfizer; Novartis Pharmaceuticals Corporation; Daiichi-Sankyo","keywords":"Medicine; Rash; Nausea; KRAS; Adverse effect; Internal medicine; Gastroenterology; Dysgeusia; Pharmacology; Oncology; Cancer; Colorectal cancer","score_opus":0.013822229583305158,"score_gpt":0.26503973175402923,"score_spread":0.2512175021707241,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388848431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994249,0.002058477,0.00041912723,0.000119471304,0.00007900736,0.00020939691,0.0010918542,0.000037193768,0.0017364391],"genre_scores_gemma":[0.9946109,0.0009234987,0.0003038048,0.00026893496,0.00007362355,0.0001392786,0.0017096446,0.000013391616,0.0019568142],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996581,0.000092235365,0.000015647363,0.0000835851,0.00003298761,0.000117463176],"domain_scores_gemma":[0.9995882,0.00007931908,0.00006067701,0.00006770301,0.000032851945,0.00017127693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008890514,0.0008284694,0.0014850907,0.0002108905,0.00046802705,0.00083221745,0.00030462956,0.000762198,0.0034674087],"category_scores_gemma":[0.0006496509,0.00033704436,0.0013461072,0.00020616341,0.00069809164,0.0007279838,0.00022885794,0.0018442378,0.0007134927],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6866522,0.03594603,0.09741629,0.00063695177,0.004391456,0.0016892452,0.0003546202,0.0015817174,0.057165567,0.00036346016,0.0048483387,0.10895417],"study_design_scores_gemma":[0.052982118,0.6952991,0.20103595,0.000091020076,0.004132852,0.0026640445,0.00051504606,0.002094746,0.023302285,0.00049880333,0.01727009,0.00011397515],"about_ca_topic_score_codex":0.0016244426,"about_ca_topic_score_gemma":0.00289554,"teacher_disagreement_score":0.0034674087,"about_ca_system_score_codex":0.0007622017,"about_ca_system_score_gemma":0.00090583577,"threshold_uncertainty_score":0.01159966},"labels":[],"label_agreement":null},{"id":"W4388879933","doi":"10.1101/2023.11.21.568071","title":"Tumorigenesis driven by the BRAF <sup>V600E</sup> oncoprotein requires secondary mutations that overcome its feedback inhibition of migration and invasion","year":2023,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Fonds de Recherche du Québec - Santé; Emerson Collective; Geoffrey Beene Cancer Research Center; Memorial Sloan-Kettering Cancer Center; National Institutes of Health; Yale University; Canadian Institutes of Health Research; Melanoma Research Alliance","keywords":"Carcinogenesis; Cancer research; Mutation; V600E; Biology; Genetics; Cancer; Gene","score_opus":0.019692991710014804,"score_gpt":0.2185973495610697,"score_spread":0.19890435785105487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388879933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991601,0.0006191273,0.003398561,0.00011067372,0.000028454795,0.000027375983,0.00031143552,0.00009595318,0.0038075182],"genre_scores_gemma":[0.993933,0.0002712245,0.0015623893,0.000028634711,0.000006477962,0.000017698323,0.0004571692,0.00002189935,0.0037014394],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999386,0.00000982567,0.000004713185,0.000011463644,0.000017323673,0.000017995451],"domain_scores_gemma":[0.9999467,0.0000074490463,0.000011857677,0.0000060183493,0.000005424307,0.000022530197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000082684135,0.00027883265,0.00013096147,0.0001665292,0.00011243324,0.00015410542,0.000104036,0.00015474462,0.0015670991],"category_scores_gemma":[0.00006675293,0.00008217776,0.00013295177,0.00005210349,0.00013050981,0.00008435436,0.00021194151,0.00034090775,0.0005124242],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034773053,0.000015383826,0.000107629014,0.000009329134,0.0000014593833,0.00004909753,0.0000023113435,0.00003814905,0.99901974,0.00018485847,0.000040370276,0.0004969601],"study_design_scores_gemma":[0.000010915285,0.0001362291,0.0035034986,0.0000040697805,0.000004569519,0.0007560264,0.000009804696,0.0011616631,0.99055207,0.000120058576,0.003738851,0.000002224011],"about_ca_topic_score_codex":0.00038223815,"about_ca_topic_score_gemma":0.0006345668,"teacher_disagreement_score":0.0015670991,"about_ca_system_score_codex":0.00022984965,"about_ca_system_score_gemma":0.00013059571,"threshold_uncertainty_score":0.005242467},"labels":[],"label_agreement":null},{"id":"W4389007994","doi":"10.1096/fasebj.30.1_supplement.1115.1","title":"Differential Expression and Subcellular Localization of MK5, ERK3 and ERK4 in Cardiac Fibroblasts and Myocytes","year":2016,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Myocyte; Cell biology; Protein kinase A; Kinase; Biology; Medicine; Chemistry","score_opus":0.0059942445050817595,"score_gpt":0.19539153467754367,"score_spread":0.1893972901724619,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389007994","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99367636,0.0019685798,0.002437263,0.000025864845,0.000014150589,0.000014675437,0.0004458953,0.000015780312,0.0014013995],"genre_scores_gemma":[0.99306446,0.001019713,0.0029774504,0.000037270645,0.000010525468,0.00003933836,0.00067387085,0.000007716924,0.00216974],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998678,0.000010338991,0.000016101088,0.000036230595,0.000039759245,0.000029719115],"domain_scores_gemma":[0.9999285,0.000014179293,0.000022081089,0.0000064848978,0.000011382371,0.000017465729],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010855902,0.00020490529,0.0001283815,0.00022561867,0.00018853499,0.00020113242,0.00013022464,0.0001655413,0.0008359346],"category_scores_gemma":[0.00008055054,0.00010516058,0.0001990675,0.00012950173,0.00017718284,0.00013102905,0.00016610957,0.00018431421,0.00024246852],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013031208,0.000008145112,0.0008875811,0.00004460751,0.000004184419,0.00007211123,0.00004027083,0.000019187994,0.9980558,0.000079393874,0.000014135163,0.00064432033],"study_design_scores_gemma":[0.000026118121,0.00037699568,0.075538136,0.000017668968,0.0000559465,0.0012123344,0.00026475574,0.00086751103,0.9182015,0.00014762982,0.0032776701,0.0000136905755],"about_ca_topic_score_codex":0.00045779286,"about_ca_topic_score_gemma":0.00083127274,"teacher_disagreement_score":0.0008359346,"about_ca_system_score_codex":0.00017501213,"about_ca_system_score_gemma":0.00010845524,"threshold_uncertainty_score":0.0027964711},"labels":[],"label_agreement":null},{"id":"W4389149792","doi":"10.20944/preprints202311.1711.v1","title":"Extracellular Signal-Regulated Kinases: One Pathway, Multiple Fates","year":2023,"lang":"en","type":"preprint","venue":"Preprints.org","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Université de Montréal; Montreal Clinical Research Institute","funders":"Canadian Institutes of Health Research","keywords":"MAPK/ERK pathway; Cell biology; Cell fate determination; Kinase; Cell growth; Signal transduction; Context (archaeology); Biology; Extracellular; Transcription factor; Genetics","score_opus":0.12530728223178414,"score_gpt":0.30264643438751676,"score_spread":0.17733915215573262,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389149792","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0024664707,0.9753576,0.0037752101,0.0037849888,0.0026412457,0.000017809154,0.00016766002,0.00007849731,0.011710498],"genre_scores_gemma":[0.01456328,0.9707813,0.0017745963,0.0017718888,0.0019190359,0.00003006534,0.00017767341,0.000029631161,0.008952449],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996309,0.00006203179,0.000039808398,0.0000830093,0.00013791498,0.000046311474],"domain_scores_gemma":[0.9997925,0.000080753816,0.000026162077,0.00001796585,0.000052820233,0.000029775147],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004884625,0.0009708548,0.0014424882,0.0009662612,0.00043014277,0.0028940565,0.00052677223,0.0011686321,0.003382333],"category_scores_gemma":[0.00044117597,0.00023258991,0.00054382405,0.0011575182,0.0008714612,0.0028435152,0.0010631992,0.0023984988,0.0020809765],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029937428,0.00009187918,0.00078540633,0.017936528,0.00030556554,0.0013310493,0.0006324507,0.00088578876,0.03163736,0.092756696,0.057496227,0.79584163],"study_design_scores_gemma":[0.000014427241,0.00008633195,0.0007364654,0.0019111352,0.0001298692,0.002412153,0.00024200344,0.00018448298,0.004606312,0.023032064,0.966614,0.000030821055],"about_ca_topic_score_codex":0.00023040127,"about_ca_topic_score_gemma":0.00033234563,"teacher_disagreement_score":0.003382333,"about_ca_system_score_codex":0.00061986496,"about_ca_system_score_gemma":0.0011853775,"threshold_uncertainty_score":0.011314988},"labels":[],"label_agreement":null},{"id":"W4389992286","doi":"10.3390/cells13010019","title":"Promising and Minimally Invasive Biomarkers: Targeting Melanoma","year":2023,"lang":"en","type":"article","venue":"Cells","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Melanoma; Tumour heterogeneity; Biomarker; Medicine; Targeted therapy; Liquid biopsy; Immunotherapy; Cancer; Bioinformatics; Computational biology; Biology; Cancer research; Internal medicine","score_opus":0.011481993520989749,"score_gpt":0.2214415800887308,"score_spread":0.20995958656774105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389992286","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011979239,0.9307927,0.03357605,0.011537732,0.0017984152,0.00010334562,0.00030423526,0.00024841545,0.009659899],"genre_scores_gemma":[0.1948384,0.73048717,0.04857569,0.011277454,0.0032143225,0.00030820363,0.00076050655,0.00009903331,0.010439205],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9992793,0.00025186356,0.000038766237,0.00012043197,0.00024295141,0.00006684325],"domain_scores_gemma":[0.9992204,0.00038206813,0.00011365164,0.000039858667,0.00017419596,0.00006986933],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015269243,0.00077705755,0.0009125342,0.0014267904,0.00025869833,0.0019772602,0.0006495896,0.0016419792,0.0026602815],"category_scores_gemma":[0.0019308948,0.00034882748,0.0007026286,0.0006161377,0.0010023783,0.0023665843,0.0009292215,0.0021775072,0.001264089],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068656844,0.00020608785,0.0046777036,0.010080481,0.0002957866,0.0016402238,0.00030770068,0.0016588209,0.15081997,0.029668722,0.027842876,0.772115],"study_design_scores_gemma":[0.00011658353,0.0015538587,0.0055056647,0.0031539607,0.00042678174,0.009482388,0.00052312337,0.0040468182,0.11674714,0.043181952,0.81506276,0.00019902046],"about_ca_topic_score_codex":0.00031877175,"about_ca_topic_score_gemma":0.00074667163,"teacher_disagreement_score":0.0026602815,"about_ca_system_score_codex":0.0005838074,"about_ca_system_score_gemma":0.00054102443,"threshold_uncertainty_score":0.00889951},"labels":[],"label_agreement":null},{"id":"W4390174857","doi":"10.3390/cancers16010095","title":"Extracellular Signal-Regulated Kinases: One Pathway, Multiple Fates","year":2023,"lang":"en","type":"article","venue":"Cancers","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute; Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"MAPK/ERK pathway; Cell biology; Cell fate determination; Cell growth; Kinase; Signal transduction; Context (archaeology); Extracellular; Biology; Transcription factor; Genetics","score_opus":0.021110256261635228,"score_gpt":0.22854535866931927,"score_spread":0.20743510240768404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390174857","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0027601053,0.9805504,0.0028136913,0.0034679782,0.0018723796,0.000018161132,0.00008761567,0.000050447547,0.00837926],"genre_scores_gemma":[0.01246039,0.97738963,0.0015461583,0.0012768435,0.00099116,0.000021386059,0.000086792475,0.000012262115,0.00621527],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999708,0.00005534638,0.000035339828,0.000059030313,0.000102682716,0.00003953406],"domain_scores_gemma":[0.9998437,0.000058047906,0.000024065408,0.0000098755945,0.000039447754,0.000024805042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041747952,0.0009435279,0.0011851009,0.00076833944,0.00041907188,0.0022845622,0.00053785637,0.0008456236,0.0023928552],"category_scores_gemma":[0.00030739207,0.00018583341,0.00043606327,0.00092141435,0.0006708544,0.00274259,0.00090272876,0.0019010657,0.0012852516],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002920125,0.000109693465,0.00080376194,0.013948106,0.00023457396,0.0013150736,0.00051569106,0.00081898225,0.035899997,0.052540854,0.04186886,0.8516524],"study_design_scores_gemma":[0.000016470962,0.00012934096,0.00082553964,0.0015427753,0.00013726727,0.0025595804,0.0003111434,0.00019752335,0.0051001753,0.012786111,0.97636545,0.000028558155],"about_ca_topic_score_codex":0.00023232614,"about_ca_topic_score_gemma":0.00048334245,"teacher_disagreement_score":0.0023928552,"about_ca_system_score_codex":0.0005331399,"about_ca_system_score_gemma":0.0010936715,"threshold_uncertainty_score":0.008004904},"labels":[],"label_agreement":null},{"id":"W4390512567","doi":"10.1126/scisignal.adg4422","title":"The induction of SHP-1 degradation by TAOK3 ensures the responsiveness of T cells to TCR stimulation","year":2024,"lang":"en","type":"article","venue":"Science Signaling","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital; McGill University","funders":"","keywords":"T-cell receptor; Cell biology; Protein tyrosine phosphatase; Phosphorylation; Biology; Phosphatase; Signal transduction; T cell; Kinase; Tyrosine kinase; Cytotoxic T cell; Molecular biology; Chemistry; Biochemistry; Immunology; Immune system","score_opus":0.0135716060954329,"score_gpt":0.26972808616762917,"score_spread":0.25615648007219627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390512567","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967765,0.00080295553,0.001330128,0.00007335336,0.000022587108,0.000018027722,0.00025005767,0.00007186682,0.0006545924],"genre_scores_gemma":[0.99756026,0.00031738725,0.00075196166,0.000032255495,0.00000894082,0.000037349186,0.00028181824,0.00001877283,0.0009913439],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998266,0.00001921357,0.00001872785,0.000030984815,0.000033811804,0.000070667586],"domain_scores_gemma":[0.9998814,0.000012625821,0.000040727977,0.000015707876,0.000011528372,0.000037924325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013618884,0.0003556779,0.00030660094,0.00018542915,0.00025511585,0.000320462,0.00022580527,0.0002728928,0.0009957895],"category_scores_gemma":[0.00011394557,0.00015319121,0.0003048091,0.00020125232,0.0002905254,0.0002154735,0.0003168387,0.0008141238,0.0003295405],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000861298,0.000011692474,0.0000801854,0.0000143256175,0.0000019741121,0.000019713681,0.0000051798716,0.00002748771,0.9994493,0.00003471235,0.00001485418,0.00025438308],"study_design_scores_gemma":[0.000027437703,0.00016432708,0.0031562073,0.0000039644833,0.000011656954,0.00016770915,0.000019172167,0.00073494815,0.9943721,0.000046357083,0.0012915975,0.0000045361953],"about_ca_topic_score_codex":0.0005969114,"about_ca_topic_score_gemma":0.00074164016,"teacher_disagreement_score":0.0009957895,"about_ca_system_score_codex":0.00037117698,"about_ca_system_score_gemma":0.00027164756,"threshold_uncertainty_score":0.003331244},"labels":[],"label_agreement":null},{"id":"W4390706303","doi":"10.1038/s41568-023-00650-x","title":"The role of CRAF in cancer progression: from molecular mechanisms to precision therapies","year":2024,"lang":"en","type":"review","venue":"Nature reviews. Cancer","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; McGill University; Jewish General Hospital","funders":"","keywords":"Kinase; Cancer research; Biology; Cancer; Melanoma; Protein kinase A; Bioinformatics; Genetics","score_opus":0.01771481328387154,"score_gpt":0.37752539805915375,"score_spread":0.3598105847752822,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390706303","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000042809384,0.998221,0.00012190306,0.00066874875,0.000357861,0.0000026348491,0.000016519652,0.000009390065,0.0005590966],"genre_scores_gemma":[0.0004166965,0.99811614,0.000105217456,0.00042270566,0.00033478052,0.0000057675493,0.000026825932,0.0000016520603,0.0005703526],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997807,0.000035192188,0.00001860198,0.000033401182,0.0000931173,0.00003897899],"domain_scores_gemma":[0.99954,0.00021012934,0.000050026843,0.000016697104,0.00010958634,0.00007359328],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091025035,0.0012659325,0.0019330824,0.0017288374,0.00030102045,0.0014762748,0.0014467604,0.0020598322,0.00435625],"category_scores_gemma":[0.0007714494,0.00043253336,0.00069773546,0.0017469982,0.0010727242,0.0016109655,0.0010905374,0.00496821,0.0035925526],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020408253,0.00007382503,0.00012326258,0.008303293,0.000082674276,0.00016086195,0.000026359452,0.0007499927,0.0025774743,0.009617771,0.12029731,0.85778326],"study_design_scores_gemma":[0.00005100082,0.000090380905,0.00045016332,0.0017461429,0.000072902825,0.00063129474,0.000025450157,0.00018966118,0.00038581478,0.003970084,0.99236673,0.000020328538],"about_ca_topic_score_codex":0.0014193268,"about_ca_topic_score_gemma":0.0033352978,"teacher_disagreement_score":0.00435625,"about_ca_system_score_codex":0.0014332284,"about_ca_system_score_gemma":0.001174604,"threshold_uncertainty_score":0.014573038},"labels":[],"label_agreement":null},{"id":"W4391023398","doi":"10.3390/cancers16020445","title":"The Clinical, Genomic, and Transcriptomic Landscape of BRAF Mutant Cancers","year":2024,"lang":"en","type":"article","venue":"Cancers","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McGill University Health Centre; McGill University; Jewish General Hospital","funders":"Fonds de Recherche du Québec - Santé; Institut TransMedTech; Association Neurofibromatoses et Recklinghause; American Society of Clinical Oncology; Conquer Cancer Foundation","keywords":"Transcriptome; Mutant; Biology; Computational biology; Cancer research; Medicine; Genetics; Gene; Gene expression","score_opus":0.016992680293118866,"score_gpt":0.278747568436457,"score_spread":0.26175488814333814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391023398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99677974,0.0008007436,0.00016899047,0.00006488642,0.0000027143224,0.000005515461,0.001689572,0.000009225744,0.0004786285],"genre_scores_gemma":[0.99794716,0.00028722032,0.000196695,0.000031785738,0.000006114932,0.000009006053,0.0013708881,0.000004314423,0.0001468683],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998456,0.000024411558,0.000014011655,0.000053503783,0.000028735387,0.000033700806],"domain_scores_gemma":[0.99979633,0.000043400905,0.00009008834,0.00000899928,0.000027595714,0.000033580505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017411912,0.000112008616,0.00014990928,0.00072977797,0.00015557016,0.00036871052,0.00012238926,0.00016722071,0.0013102426],"category_scores_gemma":[0.0005371597,0.00007616012,0.00013739028,0.0007836277,0.00014575289,0.00014257073,0.00019259148,0.00013124914,0.00021808356],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052330166,0.000019229845,0.966301,0.000055815224,0.000065051056,0.0003707689,0.000086670785,0.00014288806,0.02120669,0.0000705755,0.00054495217,0.010613103],"study_design_scores_gemma":[0.0000028181319,0.000045684705,0.99723047,0.0000048306556,0.000018435718,0.000999146,0.00008348189,0.00013422489,0.0007976397,0.000065486835,0.0006155229,0.00000230679],"about_ca_topic_score_codex":0.0009557683,"about_ca_topic_score_gemma":0.0017171148,"teacher_disagreement_score":0.0013102426,"about_ca_system_score_codex":0.00018917424,"about_ca_system_score_gemma":0.00012983779,"threshold_uncertainty_score":0.0043831468},"labels":[],"label_agreement":null},{"id":"W4391792274","doi":"10.1016/j.jbc.2024.105739","title":"Identification of RSK substrates using an analog-sensitive kinase approach","year":2024,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"Fonds pour la Formation à la Recherche dans l’Industrie et dans l’Agriculture; Fonds Wetenschappelijk Onderzoek; Vlaamse regering; Fonds De La Recherche Scientifique - FNRS; Canadian Institutes of Health Research; Cancer Research Society","keywords":"Gene isoform; Kinase; Biology; Ribosomal s6 kinase; Cell biology; Molecular biology; Biochemistry; Phosphorylation; Gene; P70-S6 Kinase 1; Protein kinase B","score_opus":0.038998189072817935,"score_gpt":0.2783685005082478,"score_spread":0.23937031143542986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391792274","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9830489,0.0018666385,0.011932686,0.00014008283,0.000044828706,0.00012358282,0.0008056668,0.00012425728,0.0019131821],"genre_scores_gemma":[0.96566755,0.0020187222,0.025598548,0.00012069703,0.000022232598,0.00016930285,0.0034074157,0.00004648468,0.0029491638],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99973756,0.0000397447,0.000032164608,0.000075227734,0.00006817675,0.00004706446],"domain_scores_gemma":[0.99986494,0.000021828422,0.000044376175,0.000020652116,0.000025130375,0.000023118026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002682651,0.000665388,0.00045633267,0.0005855374,0.00031198372,0.00048071422,0.00045546718,0.00038681718,0.0016877169],"category_scores_gemma":[0.00026811374,0.0002548409,0.0005221417,0.0004060061,0.00018056936,0.00040733482,0.00030113038,0.00068506686,0.00063535385],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020934986,0.0000505466,0.00076653203,0.00007473874,0.000025689727,0.00010322143,0.00001676727,0.00036102557,0.99465525,0.00023382233,0.000071916336,0.0034310084],"study_design_scores_gemma":[0.000021435322,0.00018083303,0.0035202622,0.0000043468995,0.000038983737,0.0005932652,0.000027387368,0.002627349,0.9891255,0.0001024589,0.003742962,0.00001519705],"about_ca_topic_score_codex":0.00031701816,"about_ca_topic_score_gemma":0.0005398294,"teacher_disagreement_score":0.0016877169,"about_ca_system_score_codex":0.00057617226,"about_ca_system_score_gemma":0.00023640771,"threshold_uncertainty_score":0.0056459308},"labels":[],"label_agreement":null},{"id":"W4392058118","doi":"10.1038/s41594-024-01233-6","title":"The CNK–HYP scaffolding complex promotes RAF activation by enhancing KSR–MEK interaction","year":2024,"lang":"en","type":"article","venue":"Nature Structural & Molecular Biology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University of Toronto; Sinai Health System; Institute for Research in Immunology and Cancer; Université de Montréal; Lunenfeld-Tanenbaum Research Institute","funders":"Argonne National Laboratory; National Institute of General Medical Sciences; Office of Research Infrastructure Programs, National Institutes of Health; Canadian Institutes of Health Research; Canada Research Chairs; Office of Science; National Institutes of Health; Fondation pour la Recherche Médicale; U.S. Department of Energy","keywords":"MAPK/ERK pathway; Scaffold protein; Cell biology; Allosteric regulation; Kinase; MEK inhibitor; Small GTPase; Chemistry; Phosphorylation; Biology; Signal transduction; Biochemistry; Receptor","score_opus":0.005813699272387353,"score_gpt":0.30016669159552783,"score_spread":0.2943529923231405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392058118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955526,0.00030142054,0.0019635586,0.00008490913,0.0000111879435,0.000008476523,0.00010494441,0.00006183937,0.0019110806],"genre_scores_gemma":[0.9974349,0.00012971982,0.001228946,0.000024710474,0.0000029534867,0.000004929898,0.00012024591,0.00001411526,0.0010395094],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99992585,0.0000070154265,0.000002826606,0.000017609871,0.000028606142,0.000018027236],"domain_scores_gemma":[0.99993014,0.000007662879,0.000019546884,0.0000071853174,0.0000060985412,0.000029405373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006924408,0.00022298563,0.00009460504,0.000094022085,0.00016941818,0.00018718904,0.00022653284,0.00016326751,0.0016017038],"category_scores_gemma":[0.000075720185,0.00010361186,0.00010549685,0.00005475695,0.00017761994,0.0001696665,0.00027566677,0.0003641569,0.00034535758],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033607605,0.0000057599837,0.00009183249,0.000014208184,0.0000026081225,0.000040761264,0.000005994961,0.0000894031,0.9992205,0.00016533319,0.0000360709,0.0002938948],"study_design_scores_gemma":[0.000013513371,0.0000478165,0.0055698217,0.00000440055,0.000004171637,0.0002635798,0.000018938601,0.002426985,0.9893128,0.00007362493,0.0022581122,0.0000062327813],"about_ca_topic_score_codex":0.0014341787,"about_ca_topic_score_gemma":0.0023694432,"teacher_disagreement_score":0.0016017038,"about_ca_system_score_codex":0.0004838034,"about_ca_system_score_gemma":0.00019991242,"threshold_uncertainty_score":0.005358219},"labels":[],"label_agreement":null},{"id":"W4392805481","doi":"10.1007/s10637-024-01428-0","title":"A phase 1 trial of the MEK inhibitor selumetinib in combination with pembrolizumab for advanced or metastatic solid tumors","year":2024,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Université Laval","funders":"","keywords":"Selumetinib; Medicine; Pembrolizumab; Adverse effect; Internal medicine; MEK inhibitor; Gastroenterology; Pharmacology; Urology; Oncology; Cancer; Colorectal cancer; MAPK/ERK pathway; Immunotherapy; Chemistry; Kinase","score_opus":0.02116369759197948,"score_gpt":0.29944718956827593,"score_spread":0.2782834919762964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392805481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99199986,0.0024212268,0.00051754824,0.00045648022,0.00012976595,0.001972877,0.0006723551,0.000070302536,0.0017595852],"genre_scores_gemma":[0.9872875,0.0024670642,0.0020993447,0.0008764178,0.00017087648,0.0022700205,0.002049023,0.00002523463,0.0027544592],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9996964,0.00015376383,0.000012069503,0.000053720745,0.000029346927,0.00005477303],"domain_scores_gemma":[0.9996737,0.000053745047,0.00006249905,0.000018275947,0.000021851198,0.00016996881],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012454333,0.001519028,0.0015116329,0.00039472684,0.0003378702,0.0006720037,0.0005487355,0.00094783166,0.002536543],"category_scores_gemma":[0.000579935,0.00053266116,0.0009047488,0.0002620024,0.0005698761,0.00056656427,0.00028101038,0.0025741938,0.00061294704],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6547149,0.08463463,0.005651883,0.0015165267,0.0017971444,0.0006398732,0.00045116676,0.0041526146,0.099808864,0.0005765681,0.007701109,0.13835481],"study_design_scores_gemma":[0.5030928,0.47876632,0.0073269857,0.000045267745,0.00039261303,0.00035813576,0.00004328864,0.001784083,0.0048037507,0.00022865582,0.0031327358,0.000025352445],"about_ca_topic_score_codex":0.00063596567,"about_ca_topic_score_gemma":0.0016600128,"teacher_disagreement_score":0.002536543,"about_ca_system_score_codex":0.0005887681,"about_ca_system_score_gemma":0.0009728437,"threshold_uncertainty_score":0.008485556},"labels":[],"label_agreement":null},{"id":"W4393071322","doi":"10.1158/1538-7445.am2024-3484","title":"Abstract 3484: Mechanism of BRAF V600E resistance revealed by cell panel screening and bioinformatics","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Micropharma (Canada)","funders":"","keywords":"Mechanism (biology); Medicine; Computational biology; Bioinformatics; Biology; Physics","score_opus":0.05578470948236121,"score_gpt":0.33464701982419764,"score_spread":0.27886231034183645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393071322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8007096,0.0060508833,0.066925146,0.004979068,0.00057240855,0.000678077,0.09063012,0.010024238,0.019430432],"genre_scores_gemma":[0.83228856,0.0033156052,0.058597412,0.0009372161,0.00012010731,0.00038404806,0.09515638,0.000363373,0.0088372985],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99950576,0.00007637297,0.00003187308,0.00009633552,0.00023232352,0.000057193945],"domain_scores_gemma":[0.9995061,0.00016829988,0.000067671885,0.00004289341,0.00016701613,0.00004797287],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007657975,0.000564058,0.0008181865,0.0013676924,0.00047177234,0.0009769533,0.0005841071,0.00051636825,0.0035692726],"category_scores_gemma":[0.0011253362,0.00024441708,0.00063048466,0.0014596657,0.00021922436,0.00035420142,0.0004120788,0.0005925769,0.0021608234],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001964854,0.0005326647,0.10370611,0.0010636862,0.00029536895,0.0015422028,0.00020532057,0.02053464,0.6527114,0.0028366481,0.0683699,0.14623725],"study_design_scores_gemma":[0.00016790658,0.0009991673,0.25136334,0.00013180746,0.00040957885,0.0019831872,0.00041639872,0.27133805,0.4020419,0.0052152644,0.065728545,0.00020480201],"about_ca_topic_score_codex":0.0032515717,"about_ca_topic_score_gemma":0.004519374,"teacher_disagreement_score":0.0035692726,"about_ca_system_score_codex":0.0007678527,"about_ca_system_score_gemma":0.0009982846,"threshold_uncertainty_score":0.01194042},"labels":[],"label_agreement":null},{"id":"W4393092741","doi":"10.1158/1538-7445.am2024-5661","title":"Abstract 5661: Identifying and intervening rare resistant subclones to BRAF/MEK inhibitors in metastatic melanoma","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada)","funders":"","keywords":"Metastatic melanoma; Melanoma; Cancer research; Medicine; Oncology; Internal medicine; Biology","score_opus":0.08646921128498422,"score_gpt":0.4047472445627559,"score_spread":0.3182780332777717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393092741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972562,0.0007796359,0.0011064556,0.000030151608,0.0000045986253,0.000020975593,0.00026124308,0.00002846628,0.0005121535],"genre_scores_gemma":[0.9975636,0.0002362878,0.0013353763,0.000016148404,0.0000030824085,0.000008983679,0.00020962847,0.000008098837,0.000618899],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998553,0.00002333935,0.000009744479,0.00004371665,0.000047955913,0.000019911162],"domain_scores_gemma":[0.9998479,0.000047706773,0.000036714704,0.000012481616,0.00003147655,0.000023700724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018391166,0.00017498042,0.00023830893,0.00054064766,0.00017679232,0.00025805415,0.00012114246,0.0002248192,0.0016709317],"category_scores_gemma":[0.0004229455,0.00011161998,0.00017468286,0.00020869795,0.00013067269,0.00011607054,0.00013221863,0.00022549265,0.0003752924],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047789552,0.00008721968,0.109561786,0.00012939055,0.000026108972,0.0004599888,0.00013090702,0.00033995428,0.86094373,0.00008086721,0.00013554013,0.02762662],"study_design_scores_gemma":[0.000029520228,0.0016774986,0.5900031,0.000025084164,0.000081232014,0.005889568,0.00022757999,0.002328835,0.39674416,0.00017477608,0.0028039883,0.000014589439],"about_ca_topic_score_codex":0.0013928039,"about_ca_topic_score_gemma":0.0017056868,"teacher_disagreement_score":0.0016709317,"about_ca_system_score_codex":0.0002096335,"about_ca_system_score_gemma":0.00015120361,"threshold_uncertainty_score":0.005589783},"labels":[],"label_agreement":null},{"id":"W4393095547","doi":"10.1158/1538-7445.am2024-5063","title":"Abstract 5063: Exploring the mutational landscape of <i>KRAS</i> and <i>NRAS</i> in tumors with non-V600 <i>BRAF</i> mutations","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Neuroblastoma RAS viral oncogene homolog; KRAS; Biology; Cancer research; Cancer; Computational biology; Genetics; Colorectal cancer","score_opus":0.049181328696039195,"score_gpt":0.33532084791382694,"score_spread":0.28613951921778774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393095547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96768624,0.0009828804,0.0006693109,0.00012068825,0.000009109901,0.00002342381,0.029092986,0.00007139231,0.0013439725],"genre_scores_gemma":[0.94630045,0.00040176112,0.0011253816,0.000095618474,0.00001973545,0.00003729754,0.051142026,0.000039584538,0.00083810015],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997062,0.000039134455,0.000026912727,0.00013938133,0.000040553226,0.000047816196],"domain_scores_gemma":[0.99944013,0.00017544413,0.00013294023,0.000082979044,0.00007049301,0.00009793961],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035212896,0.00020013785,0.00042892154,0.00094076357,0.00027622742,0.0006214858,0.0002816694,0.00030800636,0.0033998631],"category_scores_gemma":[0.0008657434,0.00015999582,0.00034776394,0.0012726276,0.00014589276,0.00016576558,0.00039768065,0.00024693253,0.0014120257],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016613215,0.00007247778,0.9369114,0.00028599167,0.00020279826,0.0009172572,0.00017465555,0.00085110735,0.026951155,0.00014282102,0.0064250715,0.025403837],"study_design_scores_gemma":[0.000059362083,0.0001867217,0.9822725,0.000035840276,0.0001571518,0.0026653076,0.00023466899,0.001228197,0.0038562429,0.00029128537,0.009001215,0.000011649935],"about_ca_topic_score_codex":0.002637094,"about_ca_topic_score_gemma":0.0049386835,"teacher_disagreement_score":0.0033998631,"about_ca_system_score_codex":0.00022859342,"about_ca_system_score_gemma":0.0002712945,"threshold_uncertainty_score":0.011373639},"labels":[],"label_agreement":null},{"id":"W4393155298","doi":"10.1101/2024.03.23.24304779","title":"Clinical activity of Mitogen-Activated Protein Kinase (MAPK) inhibitors in patients with MAP2K1 (MEK1)-mutated metastatic cancers","year":2024,"lang":"en","type":"preprint","venue":"medRxiv","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay–Lac-Saint-Jean; Jewish General Hospital; Institute for Research in Immunology and Cancer; McGill University; McGill University Health Centre","funders":"Fonds de Recherche du Québec - Santé","keywords":"MAPK/ERK pathway; Protein kinase A; Mitogen-activated protein kinase; Cancer research; Mitogen-activated protein kinase kinase; Kinase; Medicine; Internal medicine; Biology; Cell biology","score_opus":0.018004168532599327,"score_gpt":0.27794224844238125,"score_spread":0.2599380799097819,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393155298","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.022285908,0.9749885,0.00019514622,0.00020702642,0.000060783455,0.00006185829,0.0017251675,0.000012507397,0.00046306953],"genre_scores_gemma":[0.571839,0.42344102,0.00078752456,0.00086031144,0.00023974685,0.00021313544,0.0024053673,0.000025629224,0.00018838272],"study_design_codex":"meta_analysis","study_design_gemma":"observational","domain_scores_codex":[0.9961074,0.0014944894,0.0012129261,0.0006144252,0.0004599088,0.000110842666],"domain_scores_gemma":[0.99039465,0.0061988714,0.0023406066,0.00028278766,0.0006654443,0.00011762997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0056959414,0.0007460627,0.0052975235,0.0034732725,0.000215611,0.0013269667,0.00078319176,0.00077825837,0.0012647416],"category_scores_gemma":[0.011038733,0.0005516904,0.010849436,0.0055615483,0.00034373245,0.0007105982,0.0005575035,0.00075701124,0.00014681743],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007547132,0.00006769064,0.062204164,0.33065698,0.52992857,0.00021676338,0.0001370569,0.0015610327,0.001410498,0.00024616267,0.0029300968,0.063093856],"study_design_scores_gemma":[0.0019437486,0.0008481314,0.09850236,0.036892835,0.8501667,0.00055235776,0.00012618347,0.0005714155,0.00086757966,0.00051466335,0.008947594,0.00006657746],"about_ca_topic_score_codex":0.003036354,"about_ca_topic_score_gemma":0.007030582,"teacher_disagreement_score":0.0056959414,"about_ca_system_score_codex":0.0011308241,"about_ca_system_score_gemma":0.0009937354,"threshold_uncertainty_score":0.030123353},"labels":[],"label_agreement":null},{"id":"W4393227360","doi":"10.51559/myphje28","title":"Focus on the dabrafenib, vemurafenib, and trametinib in the clinical outcome of melanoma: A systematic review and meta-analysis","year":2020,"lang":"en","type":"review","venue":"Bali Dermatology Venereology and Aesthetic Journal","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dabrafenib; Vemurafenib; Trametinib; Meta-analysis; Medicine; Melanoma; Oncology; Internal medicine; Metastatic melanoma; Cancer research; Biology; MAPK/ERK pathway; Genetics","score_opus":0.11116023517452486,"score_gpt":0.3703861669011715,"score_spread":0.25922593172664665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393227360","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018223358,0.9969716,0.00022384457,0.00021668838,0.000083747254,0.0001380735,0.0003791115,0.0000111144645,0.00015336872],"genre_scores_gemma":[0.08662835,0.9091969,0.0011276753,0.0010282724,0.00021619764,0.0007527585,0.00075544,0.000025778709,0.0002686877],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9898656,0.0043069655,0.0032065692,0.0010358616,0.0012335327,0.00035141368],"domain_scores_gemma":[0.97646993,0.017471138,0.0033464462,0.0004750153,0.0019404922,0.00029707956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015597619,0.0029128387,0.020026417,0.0080344835,0.0006702317,0.0035101122,0.0021907487,0.0021585554,0.0043028435],"category_scores_gemma":[0.034190565,0.0011758668,0.03947091,0.00891515,0.0006989098,0.0020754624,0.0016752102,0.0018227233,0.00032796615],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088522217,0.00002070789,0.0030756206,0.592536,0.39203563,0.00011707855,0.00009091517,0.0003318632,0.0001572222,0.00017221285,0.00070938125,0.009868183],"study_design_scores_gemma":[0.0002562541,0.00012574755,0.0030649498,0.056013413,0.93778795,0.00011542249,0.00006220167,0.00012102265,0.00008315053,0.00019444557,0.0021530103,0.000022396933],"about_ca_topic_score_codex":0.008606316,"about_ca_topic_score_gemma":0.020763734,"teacher_disagreement_score":0.020026417,"about_ca_system_score_codex":0.0031676348,"about_ca_system_score_gemma":0.005451053,"threshold_uncertainty_score":0.08248913},"labels":[],"label_agreement":null},{"id":"W4393987697","doi":"10.1158/1538-7445.am2024-ct178","title":"Abstract CT178: Phase 1 trial of PF-07799933 (ARRY-440), a next-generation BRAF inhibitor, for BRAF-mutant cancers","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Mutant; Medicine; Cancer research; Internal medicine; Cancer; Oncology; Biology; Genetics; Gene","score_opus":0.16352622464378694,"score_gpt":0.43476064472679554,"score_spread":0.2712344200830086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393987697","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9706971,0.002938409,0.000960063,0.0016714217,0.00029099407,0.0045144525,0.0072596637,0.00043382723,0.011233906],"genre_scores_gemma":[0.970731,0.001841585,0.0019989647,0.0015903952,0.00025158128,0.0033084373,0.010160762,0.000084630214,0.010032573],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997397,0.000087878965,0.000011403124,0.00004597273,0.000035855126,0.00007916287],"domain_scores_gemma":[0.9997749,0.000027412301,0.00002890681,0.00001714365,0.000016341524,0.00013534409],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063857704,0.0014995929,0.0012508461,0.0004172543,0.0004383973,0.0008040054,0.00070371386,0.0011568663,0.008720741],"category_scores_gemma":[0.00048339035,0.00041189225,0.00074713706,0.00035075628,0.0007262747,0.0007283422,0.00028223876,0.003063497,0.0019341976],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.55062234,0.04665842,0.007373219,0.0012611893,0.001389305,0.0010705576,0.00025849967,0.0065702745,0.1622226,0.0018998894,0.053707927,0.16696578],"study_design_scores_gemma":[0.5451642,0.40302712,0.014055474,0.0000791968,0.00049438886,0.0010394524,0.0000642538,0.0028542175,0.01573825,0.0007800395,0.016657114,0.00004632885],"about_ca_topic_score_codex":0.0015038678,"about_ca_topic_score_gemma":0.0033943213,"teacher_disagreement_score":0.008720741,"about_ca_system_score_codex":0.0012993545,"about_ca_system_score_gemma":0.0018221645,"threshold_uncertainty_score":0.029173732},"labels":[],"label_agreement":null},{"id":"W4394099245","doi":"10.6084/m9.figshare.15015807","title":"Human-BB-EALH-10080","year":2022,"lang":"en","type":"dataset","venue":"Figshare","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Geography","score_opus":0.03156695583384264,"score_gpt":0.2753141566316339,"score_spread":0.24374720079779125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394099245","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004383127,0.0003691421,0.00010011181,0.0000557532,0.000020376787,0.000009422719,0.9977604,0.0004774191,0.00076902076],"genre_scores_gemma":[0.0013032673,0.00018880519,0.00032857317,0.00009129134,0.000008163711,0.00007271006,0.99709845,0.00014485836,0.00076394965],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990729,0.00013931788,0.00007530264,0.00035449534,0.0001872188,0.00017073669],"domain_scores_gemma":[0.99837744,0.00068441103,0.00017055651,0.00032585554,0.00020161562,0.0002400617],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000902573,0.0033352408,0.0021537615,0.0036821598,0.0010135039,0.002607553,0.0028453062,0.003550209,0.10637284],"category_scores_gemma":[0.0049812677,0.00091506995,0.0018274289,0.005918367,0.0005307953,0.0010077693,0.0018354938,0.0015574181,0.1181776],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004908314,0.00005599441,0.0023661503,0.0030633812,0.0002275395,0.00011038984,0.00005554891,0.0008768849,0.00079604035,0.0005961589,0.9863815,0.0049796235],"study_design_scores_gemma":[0.0014062588,0.000081028855,0.009450179,0.0008002243,0.00041588838,0.00027615164,0.00009922306,0.001028682,0.0017913852,0.002292424,0.9822875,0.00007107639],"about_ca_topic_score_codex":0.012656974,"about_ca_topic_score_gemma":0.022510841,"teacher_disagreement_score":0.10637284,"about_ca_system_score_codex":0.0010400697,"about_ca_system_score_gemma":0.0020766794,"threshold_uncertainty_score":0.3558526},"labels":[],"label_agreement":null},{"id":"W4394223942","doi":"10.6084/m9.figshare.15015813","title":"Human-BB-EALH-10120","year":2022,"lang":"en","type":"dataset","venue":"Figshare","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Computer science","score_opus":0.03179092619975781,"score_gpt":0.2752377814709838,"score_spread":0.243446855271226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394223942","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004230341,0.00037032532,0.00009869923,0.000054691896,0.00002116149,0.000009458383,0.9976968,0.0005145718,0.0008111286],"genre_scores_gemma":[0.0012444841,0.00018246428,0.0003075606,0.00009132699,0.0000079204465,0.00006621982,0.99721473,0.00015043466,0.00073490624],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99910116,0.00013598155,0.000073661635,0.00034157242,0.00018017739,0.00016750887],"domain_scores_gemma":[0.9983925,0.00068159704,0.00016514356,0.00031679226,0.0001935122,0.00025028564],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008932486,0.003398358,0.002182998,0.0037548412,0.001009371,0.0026173687,0.0028520976,0.0036000041,0.11508411],"category_scores_gemma":[0.0049687475,0.0009252002,0.0018134,0.005964944,0.00054078497,0.0010084296,0.0018955301,0.001524379,0.123491764],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047793917,0.000052886673,0.0022107544,0.0030100371,0.00021793848,0.000111818525,0.00005572532,0.000839169,0.0007874363,0.00060250657,0.98685735,0.0047764233],"study_design_scores_gemma":[0.0013799313,0.000080486876,0.008794428,0.00074502826,0.00038352085,0.0002703286,0.0000926948,0.000959965,0.0016659895,0.0021478147,0.98341125,0.00006852508],"about_ca_topic_score_codex":0.012944511,"about_ca_topic_score_gemma":0.022519637,"teacher_disagreement_score":0.8849159,"about_ca_system_score_codex":0.0010599727,"about_ca_system_score_gemma":0.0021117688,"threshold_uncertainty_score":0.3849947},"labels":[],"label_agreement":null},{"id":"W4394298753","doi":"10.6084/m9.figshare.15015831","title":"Human-BB-EALH-11323","year":2022,"lang":"en","type":"dataset","venue":"Figshare","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Business; Computer science","score_opus":0.03252014426929625,"score_gpt":0.2765554766786453,"score_spread":0.24403533240934902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394298753","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00041500587,0.00039240232,0.000100918776,0.000052593277,0.000020954183,0.000009118857,0.997736,0.0005058133,0.0007672562],"genre_scores_gemma":[0.001311261,0.00019999662,0.00032030372,0.00008952509,0.000008237773,0.00006945622,0.9971174,0.00016636276,0.0007173967],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99906963,0.00013900157,0.000076150594,0.00035031541,0.00018898101,0.00017597],"domain_scores_gemma":[0.99830127,0.00073182886,0.00017165388,0.00033387323,0.00020478768,0.00025662404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008883965,0.0033925213,0.0023545935,0.0038088593,0.0010662224,0.0028375834,0.0029349113,0.0036470694,0.11499048],"category_scores_gemma":[0.0052731163,0.00095434743,0.001887722,0.006371858,0.00056348764,0.0010398543,0.00198004,0.0015830074,0.12499902],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049719703,0.000048760594,0.0021757067,0.0031581803,0.00024371067,0.0001217562,0.00005856776,0.0008729672,0.0007914343,0.0006387641,0.98658574,0.0048072115],"study_design_scores_gemma":[0.0014574911,0.00007942668,0.008984816,0.0007977037,0.00042011507,0.0002902981,0.00009893242,0.00095940405,0.0016040922,0.0022726674,0.9829594,0.00007564087],"about_ca_topic_score_codex":0.013756766,"about_ca_topic_score_gemma":0.02306506,"teacher_disagreement_score":0.11499048,"about_ca_system_score_codex":0.0010706511,"about_ca_system_score_gemma":0.0021725139,"threshold_uncertainty_score":0.38468146},"labels":[],"label_agreement":null},{"id":"W4394440783","doi":"10.6084/m9.figshare.15015801","title":"Human-BB-EALH-2702","year":2022,"lang":"en","type":"dataset","venue":"Figshare","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Computer science","score_opus":0.03238490869043247,"score_gpt":0.2752502536298163,"score_spread":0.24286534493938383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394440783","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00045782304,0.00038416055,0.000097311655,0.00005126243,0.000019789171,0.0000090113945,0.99773765,0.00045785995,0.0007852046],"genre_scores_gemma":[0.0013965103,0.00020405216,0.0003358462,0.000087829314,0.00000824555,0.00007102487,0.9969894,0.00014987892,0.0007570927],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991541,0.00012277854,0.00006848504,0.00032315278,0.00017274125,0.00015873926],"domain_scores_gemma":[0.9984463,0.0006859422,0.00015998166,0.00029451578,0.00017985799,0.00023348852],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008185741,0.0032767118,0.002111613,0.0036035345,0.000977648,0.0026182514,0.0026016887,0.0032528376,0.10492357],"category_scores_gemma":[0.004738502,0.0008914333,0.0018160786,0.0059672114,0.0005062686,0.00095410965,0.0017640212,0.0015078785,0.11271055],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005261618,0.000055631324,0.002590125,0.0032599142,0.00025366695,0.00012985358,0.000058799367,0.0009557888,0.00090444554,0.00063074875,0.9853196,0.005315293],"study_design_scores_gemma":[0.0013526696,0.00007949587,0.009697746,0.0007430961,0.00041256766,0.00029083816,0.00009798678,0.0009791825,0.001754115,0.0021451272,0.9823774,0.000069696456],"about_ca_topic_score_codex":0.012225533,"about_ca_topic_score_gemma":0.02110842,"teacher_disagreement_score":0.10492357,"about_ca_system_score_codex":0.00096380996,"about_ca_system_score_gemma":0.0019580147,"threshold_uncertainty_score":0.3510043},"labels":[],"label_agreement":null},{"id":"W4395001749","doi":"10.21037/tlcr-24-117","title":"The evolving treatment landscape for BRAF-mutated non-small cell lung cancer","year":2024,"lang":"en","type":"editorial","venue":"Translational Lung Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Fonds de Recherche du Québec - Santé","keywords":"Medicine; Lung cancer; Computational biology; Bioinformatics; Cancer research; Oncology; Biology","score_opus":0.023759278697591632,"score_gpt":0.3710229324003498,"score_spread":0.34726365370275813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395001749","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000046502926,0.017848516,0.0001757196,0.063701786,0.91687727,0.00001572372,0.000035306715,0.000052099786,0.0012470533],"genre_scores_gemma":[0.00044411,0.008181859,0.00010820151,0.0270271,0.9599261,0.000016598146,0.00001811812,0.00002090062,0.0042569875],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966175,0.0007732203,0.0004085702,0.00039835655,0.0015056863,0.0002966982],"domain_scores_gemma":[0.98549056,0.0070640375,0.00071482564,0.00028396322,0.0037118918,0.0027346541],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008771564,0.0027908245,0.0029846078,0.0020880646,0.0020974083,0.0055731535,0.0031330925,0.014922491,0.0076615657],"category_scores_gemma":[0.017781124,0.0009934532,0.00220027,0.00089158665,0.0023529811,0.0042477604,0.0016661563,0.027665833,0.0045043095],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053859847,0.000012704289,0.000020801846,0.00022241155,0.000019314946,0.00011847704,0.000008359102,0.000026658312,0.0000753537,0.00043500474,0.9909793,0.0080278125],"study_design_scores_gemma":[0.00012755604,0.000072911054,0.00029781502,0.00048731692,0.00009175076,0.00040840034,0.000040270876,0.00026520164,0.00015594786,0.0018757001,0.9961514,0.000025664505],"about_ca_topic_score_codex":0.0016330751,"about_ca_topic_score_gemma":0.005196448,"teacher_disagreement_score":0.014922491,"about_ca_system_score_codex":0.0035795285,"about_ca_system_score_gemma":0.0029694268,"threshold_uncertainty_score":0.046389043},"labels":[],"label_agreement":null},{"id":"W4395039339","doi":"10.1161/circ.128.suppl_22.a19146","title":"Abstract 19146: Disruption of TRAF2-TAK1-IKKB Signaling Triggers Mitochondrial Perturbations and Necrotic Cell Death in Doxorubicin Cardiotoxicity","year":2013,"lang":"en","type":"article","venue":"Circulation","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Cardiotoxicity; Medicine; TRAF2; Doxorubicin; Programmed cell death; Apoptosis; Cancer research; Pharmacology; Cell biology; Tumor necrosis factor alpha; Internal medicine; Chemotherapy; Tumor necrosis factor receptor; Biology; Biochemistry","score_opus":0.014022354746231614,"score_gpt":0.22579377784202032,"score_spread":0.2117714230957887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395039339","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98313373,0.0040891627,0.004043354,0.0006027692,0.0003398936,0.000111203,0.0022183124,0.00022858866,0.0052330033],"genre_scores_gemma":[0.9831444,0.0019534768,0.0019086641,0.00022200971,0.00005473013,0.000120981174,0.001898145,0.000043330045,0.010654297],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99983,0.00003262731,0.000025936815,0.000028744558,0.000039509752,0.000043117125],"domain_scores_gemma":[0.9999031,0.000011858901,0.00002784665,0.000009461371,0.000007377903,0.000040325747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016808075,0.00049356284,0.0003680484,0.00019525722,0.00020892013,0.00028435225,0.00023493683,0.00047603124,0.006469436],"category_scores_gemma":[0.00009328638,0.0001993372,0.0003310889,0.00015958428,0.0002719484,0.00027131673,0.00022520323,0.00087934267,0.0018106987],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003850116,0.00006141819,0.000056421482,0.00006376786,0.0000070752094,0.00014737209,0.000010815767,0.00004225758,0.9983553,0.000106726526,0.0001424073,0.00062140153],"study_design_scores_gemma":[0.00011822324,0.0010389546,0.0036718594,0.0000269188,0.000023705834,0.0010323201,0.000036930673,0.0006057167,0.98855376,0.00007985253,0.0048051337,0.0000066566845],"about_ca_topic_score_codex":0.00033418427,"about_ca_topic_score_gemma":0.00031405062,"teacher_disagreement_score":0.006469436,"about_ca_system_score_codex":0.00027184602,"about_ca_system_score_gemma":0.00020005353,"threshold_uncertainty_score":0.021642387},"labels":[],"label_agreement":null},{"id":"W4396229481","doi":"10.4103/joco.joco_21_23","title":"Hypotony and Anterior Uveitis following Dual Therapy with Nivolumab and Ipilimumab for Metastatic Melanoma: A Case Report","year":2023,"lang":"en","type":"article","venue":"Journal of Current Ophthalmology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Ipilimumab; Nivolumab; Metastatic melanoma; Melanoma; Uveitis; Dermatology; Oncology; Internal medicine; Ophthalmology; Immunotherapy; Cancer research; Cancer","score_opus":0.04593346516438089,"score_gpt":0.32841571685621895,"score_spread":0.28248225169183805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396229481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9567661,0.021445448,0.0052686334,0.003822871,0.00055384485,0.00021125602,0.0002271631,0.00031664208,0.011387944],"genre_scores_gemma":[0.99401516,0.0022101402,0.001052752,0.0008024351,0.00064672687,0.000022443997,0.000053638018,0.000020360967,0.0011763483],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9988808,0.00015034093,0.00013889976,0.000244581,0.00019150825,0.00039396292],"domain_scores_gemma":[0.9978702,0.00055340055,0.00070163776,0.00020188,0.00010221955,0.0005707512],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045370377,0.0017883673,0.0013037018,0.0026923313,0.0027800906,0.001982115,0.0009439884,0.004825747,0.0020797718],"category_scores_gemma":[0.002289444,0.0012501773,0.0017152932,0.0015602183,0.002070408,0.0022202705,0.002043954,0.0036330323,0.00070921576],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023429544,0.000021313686,0.003935864,0.000022048149,0.00001163163,0.9944893,0.00007947298,0.000023076731,0.0005394199,0.00006000085,0.00012740324,0.00066704635],"study_design_scores_gemma":[0.000006405013,0.000035757697,0.0019103056,0.000009104957,0.000011426657,0.99732363,0.00006432005,0.000087149594,0.00023623253,0.00005475252,0.00025503957,0.000005907799],"about_ca_topic_score_codex":0.0025691178,"about_ca_topic_score_gemma":0.003646609,"teacher_disagreement_score":0.004825747,"about_ca_system_score_codex":0.001508963,"about_ca_system_score_gemma":0.0010881268,"threshold_uncertainty_score":0.01094836},"labels":[],"label_agreement":null},{"id":"W4396541840","doi":"10.1158/2159-8290.cd-24-0024","title":"A Next-Generation BRAF Inhibitor Overcomes Resistance to BRAF Inhibition in Patients with <i>BRAF</i> -Mutant Cancers Using Pharmacokinetics-Informed Dose Escalation","year":2024,"lang":"en","type":"article","venue":"Cancer Discovery","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"National Cancer Institute","keywords":"Pharmacokinetics; Mutant; Cancer research; Vemurafenib; Medicine; Pharmacology; Oncology; Internal medicine; Biology; Melanoma; Genetics; Metastatic melanoma; Gene","score_opus":0.020333717682602878,"score_gpt":0.2673368469978584,"score_spread":0.24700312931525553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396541840","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98899555,0.0015808886,0.003958117,0.0005139835,0.00005711706,0.00045962675,0.00027103603,0.00026938834,0.0038944285],"genre_scores_gemma":[0.9940597,0.00065044925,0.0034983621,0.00020313595,0.000025003847,0.00014855494,0.00029472678,0.000031531712,0.001088606],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9998648,0.000022470806,0.000008751764,0.000027064849,0.000036978166,0.000040036426],"domain_scores_gemma":[0.99993134,0.000009100375,0.000021289234,0.000009136934,0.0000073719575,0.000021721615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034324077,0.0003163443,0.00037384464,0.0002290435,0.00018949901,0.00046225026,0.00036407984,0.0003423132,0.0014414164],"category_scores_gemma":[0.00022314662,0.00016220535,0.0003502714,0.00016143093,0.00020500923,0.00038327152,0.0002363978,0.0012662623,0.00029956806],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066026407,0.0040656533,0.0043376214,0.00018965491,0.00015003054,0.0002463298,0.00018197062,0.0059691006,0.7446541,0.0013829597,0.0028665632,0.22935343],"study_design_scores_gemma":[0.02237583,0.09923792,0.036882475,0.00008254213,0.00072413916,0.0055016284,0.0001534469,0.029293297,0.744161,0.0023093682,0.059127774,0.00015054888],"about_ca_topic_score_codex":0.0006182757,"about_ca_topic_score_gemma":0.0027666036,"teacher_disagreement_score":0.0014414164,"about_ca_system_score_codex":0.00059513445,"about_ca_system_score_gemma":0.0005847711,"threshold_uncertainty_score":0.0048220158},"labels":[],"label_agreement":null},{"id":"W4396705239","doi":"10.3390/curroncol31050199","title":"Incidence of Ophthalmological Complications in NF-1 Patients Treated with MEK Inhibitors","year":2024,"lang":"en","type":"article","venue":"Current Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"University of Texas MD Anderson Cancer Center","keywords":"Medicine; Incidence (geometry); Pediatrics; Internal medicine","score_opus":0.05485758313077425,"score_gpt":0.353153969199409,"score_spread":0.29829638606863473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396705239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986583,0.0006972473,0.00005373533,0.000012978304,0.0000025104632,0.000004859518,0.00008507294,0.0000034838843,0.0004817702],"genre_scores_gemma":[0.9995454,0.0002290595,0.000042223986,0.000011350547,0.000007810891,0.000003999233,0.00009817502,0.0000014203433,0.000060516013],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994822,0.00010997721,0.00007529909,0.00010765009,0.00013161419,0.000093171744],"domain_scores_gemma":[0.997834,0.00031961667,0.0013859769,0.00009175764,0.00013382858,0.00023476026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039833022,0.00018503933,0.00033108194,0.00088563905,0.00041730562,0.00058515696,0.0002170598,0.00040742318,0.00094241847],"category_scores_gemma":[0.0019643034,0.00017343,0.00033321968,0.00087142875,0.0002524781,0.00037921517,0.00035308517,0.0004959591,0.00017429504],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001291503,0.000023931518,0.99685776,0.0000073142387,0.000020515834,0.0004922946,0.000035014553,0.00002523996,0.00019073473,0.00001241295,0.000033868855,0.0021717264],"study_design_scores_gemma":[0.0000072220023,0.00021821904,0.993404,0.000008151983,0.000029842526,0.005686442,0.00014013714,0.00010527917,0.00014198972,0.000021385213,0.00023248025,0.0000049830646],"about_ca_topic_score_codex":0.0010756165,"about_ca_topic_score_gemma":0.0011734354,"teacher_disagreement_score":0.0010756165,"about_ca_system_score_codex":0.00027242952,"about_ca_system_score_gemma":0.0002872772,"threshold_uncertainty_score":0.0031526685},"labels":[],"label_agreement":null},{"id":"W4397026662","doi":"10.52768/2993-1142/1096","title":"Regulation of Stem Cell Proliferation by p38 MAPK Signaling","year":2023,"lang":"en","type":"article","venue":"Med Discoveries","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Trois-Rivières; Innovation and Economic Development Trois Rivières","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Cell biology; Cell growth; p38 mitogen-activated protein kinases; Effector; Biology; MAPK/ERK pathway; Stem cell; Protein kinase A; Proinflammatory cytokine; Signal transduction; Kinase; Secretion; Immunology; Inflammation; Genetics; Biochemistry","score_opus":0.009281786729640935,"score_gpt":0.2109968121283673,"score_spread":0.20171502539872635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4397026662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9146459,0.04492928,0.020842774,0.0011504235,0.0003848115,0.00013315723,0.00095042784,0.00035573824,0.016607601],"genre_scores_gemma":[0.97980875,0.012204153,0.0038919866,0.00015130543,0.00009096607,0.00009252238,0.00031977333,0.000017040393,0.003423454],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99983084,0.000035451518,0.000012041405,0.00003459632,0.000046490768,0.00004051989],"domain_scores_gemma":[0.99993336,0.000012720825,0.00001677737,0.000006009763,0.000013866666,0.000017260323],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018521126,0.00041087499,0.00014861696,0.0004074024,0.0003014064,0.00031701487,0.00015880904,0.00021533115,0.001403278],"category_scores_gemma":[0.000156042,0.00009816678,0.0002399411,0.00018206828,0.0002875578,0.00039140173,0.0003853578,0.0005851586,0.0003681289],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020595918,0.00005120226,0.0006764796,0.00030325184,0.0000115147695,0.00031684103,0.000107420645,0.00013555356,0.98002213,0.0014870025,0.00042401033,0.016258612],"study_design_scores_gemma":[0.00004581412,0.00048094155,0.011774526,0.00005838735,0.0000349582,0.00080600096,0.00022367416,0.001884669,0.95614237,0.0023346758,0.026198959,0.000014984891],"about_ca_topic_score_codex":0.00019017291,"about_ca_topic_score_gemma":0.00025167415,"teacher_disagreement_score":0.001403278,"about_ca_system_score_codex":0.00024346371,"about_ca_system_score_gemma":0.00028480645,"threshold_uncertainty_score":0.004694402},"labels":[],"label_agreement":null},{"id":"W4397041612","doi":"10.1681/asn.20233411s1482a","title":"A Case of Acute Interstitial Nephritis Associated with Belvarafenib, a Novel pan-RAF Kinase Inhibitor for Metastatic NRAS Mutant Melanoma","year":2023,"lang":"en","type":"article","venue":"Journal of the American Society of Nephrology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Neuroblastoma RAS viral oncogene homolog; Cancer research; Mutant; Medicine; Melanoma; Metastatic melanoma; Kinase; Interstitial nephritis; Internal medicine; Cancer; Biology; Colorectal cancer; Kidney; Cell biology; Gene; Genetics","score_opus":0.018594787320048496,"score_gpt":0.26523894046757,"score_spread":0.24664415314752153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4397041612","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95308864,0.013707659,0.009379441,0.0031613118,0.00055616145,0.00040745328,0.00032613144,0.00060126046,0.018771918],"genre_scores_gemma":[0.99530303,0.0012241424,0.0012100942,0.00055735005,0.00047121092,0.000024405206,0.000087318265,0.000021955964,0.0011004875],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9989561,0.00012599958,0.000101670004,0.00028139318,0.00017696137,0.00035785383],"domain_scores_gemma":[0.99784875,0.0004763094,0.00052374403,0.00023152311,0.00016687838,0.0007527417],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005535307,0.0017036857,0.0011262847,0.0023470917,0.0021297855,0.0014610118,0.0015568429,0.0041033905,0.002460232],"category_scores_gemma":[0.0025964812,0.0013430811,0.0013677223,0.0013412673,0.00130215,0.0021364214,0.00141713,0.0032328777,0.0007034731],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057985308,0.00003709177,0.0038270634,0.0000445356,0.000011400358,0.9941755,0.000113807015,0.00004228042,0.0008055055,0.0000949466,0.00012640287,0.0006634782],"study_design_scores_gemma":[0.000017345643,0.000063438936,0.0025541051,0.000010990109,0.000013848472,0.9962794,0.000064302294,0.00020965491,0.0003654228,0.000052945405,0.0003620003,0.0000065830786],"about_ca_topic_score_codex":0.0026464085,"about_ca_topic_score_gemma":0.0033805142,"teacher_disagreement_score":0.0041033905,"about_ca_system_score_codex":0.0014582202,"about_ca_system_score_gemma":0.0010522061,"threshold_uncertainty_score":0.0105801225},"labels":[],"label_agreement":null},{"id":"W4398160457","doi":"10.1038/s41388-024-03060-x","title":"Recent insights into the therapeutic strategies targeting the pseudokinase PTK7 in cancer","year":2024,"lang":"en","type":"article","venue":"Oncogene","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"FPInnovations","funders":"Institut National Du Cancer; Institut Universitaire de France; Ministère de l'Education Nationale, de l'Enseignement Supérieur et de la Recherche; Ligue Contre le Cancer; Fondation ARC pour la Recherche sur le Cancer","keywords":"Kinome; Biology; Kinase; Receptor tyrosine kinase; Cancer research; Cancer; Tyrosine kinase; Cancer cell; Trastuzumab; Signal transduction; Cell biology; Breast cancer","score_opus":0.018334259795092487,"score_gpt":0.2875386479947466,"score_spread":0.2692043881996541,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4398160457","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0036525081,0.98720306,0.0025013739,0.0021917454,0.00040599215,0.000024710334,0.0000494937,0.000040974475,0.0039301827],"genre_scores_gemma":[0.017035218,0.97802275,0.0016851729,0.00095334434,0.00057717727,0.000025877724,0.000091870315,0.0000069616945,0.0016014975],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998832,0.000026443422,0.000013583469,0.000018138333,0.000033088938,0.000025504054],"domain_scores_gemma":[0.99985445,0.00005142559,0.000028681596,0.000006504348,0.000035367495,0.000023499937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051397487,0.00056325004,0.00051033404,0.00078864564,0.00017863407,0.00086550583,0.00036549053,0.00068469445,0.0017454679],"category_scores_gemma":[0.00028966193,0.00022878266,0.00039236087,0.00065967435,0.00042061132,0.001129657,0.00040297685,0.0015721521,0.00086086546],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005215354,0.0003002381,0.0007099242,0.012883031,0.0001523426,0.0011674426,0.00022810174,0.0024516725,0.0773834,0.01850589,0.022417963,0.86327857],"study_design_scores_gemma":[0.00008369294,0.0010168765,0.002348252,0.0010950145,0.0002633145,0.0039195,0.00017199163,0.0012338661,0.025862556,0.009636174,0.95431715,0.000051575942],"about_ca_topic_score_codex":0.00034125568,"about_ca_topic_score_gemma":0.0008613868,"teacher_disagreement_score":0.0017454679,"about_ca_system_score_codex":0.00056078983,"about_ca_system_score_gemma":0.0005521549,"threshold_uncertainty_score":0.005839169},"labels":[],"label_agreement":null},{"id":"W4399323608","doi":"10.3390/cells13110973","title":"Multiple Endocrine Neoplasia Type 1 Regulates TGFβ-Mediated Suppression of Tumor Formation and Metastasis in Melanoma","year":2024,"lang":"en","type":"article","venue":"Cells","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Canadian Institutes of Health Research","keywords":"Cancer research; MEN1; Melanoma; Carcinogenesis; Metastasis; Medicine; Cancer; Multiple endocrine neoplasia; Biology; Internal medicine; Gene","score_opus":0.008493583349461173,"score_gpt":0.22069814101719062,"score_spread":0.21220455766772944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399323608","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98705006,0.008010698,0.0021456368,0.00017242666,0.00007146583,0.000026419748,0.00035770284,0.00010687261,0.0020587745],"genre_scores_gemma":[0.992871,0.0035457972,0.0007915924,0.000039649985,0.000008383673,0.000014967651,0.00020789653,0.000008541227,0.0025122303],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99995327,0.000011354464,0.0000045165966,0.00001008551,0.0000121996745,0.000008638135],"domain_scores_gemma":[0.9999566,0.0000051545526,0.000018672159,0.0000032821438,0.0000052398814,0.000010991462],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011094002,0.0003744119,0.00015123101,0.0002101418,0.00011857668,0.0002214033,0.00008906802,0.00011639885,0.00092791836],"category_scores_gemma":[0.00005914613,0.00007722648,0.00017582101,0.000080101294,0.00012106568,0.00009459963,0.00011352444,0.00030300458,0.00024396517],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005234047,0.000015779826,0.0002876281,0.00002750841,0.000004392238,0.00010177001,0.0000087665785,0.000055161643,0.9981495,0.00006317026,0.000038372287,0.0011956821],"study_design_scores_gemma":[0.000022779734,0.00023208442,0.01776074,0.000009836425,0.000023800689,0.00084431964,0.000064981425,0.0010335413,0.97432566,0.000101960715,0.005573908,0.0000062989993],"about_ca_topic_score_codex":0.00043568786,"about_ca_topic_score_gemma":0.000829607,"teacher_disagreement_score":0.00092791836,"about_ca_system_score_codex":0.00020786704,"about_ca_system_score_gemma":0.00014935213,"threshold_uncertainty_score":0.00310421},"labels":[],"label_agreement":null},{"id":"W4399667123","doi":"10.1200/jco.2024.42.16_suppl.3104","title":"Binimetinib and encorafenib for the treatment of advanced solid tumors with non-V600E BRAF mutations (mts): Final results of the investigator-initiated phase II BEAVER trial.","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Princess Margaret Cancer Centre; University of Toronto; University Health Network; McGill University; Jewish General Hospital","funders":"Jewish General Hospital; Pfizer; Conquer Cancer Foundation","keywords":"Medicine; Internal medicine; Oncology; Mutation; Clinical trial; Solid tumor; Cancer research; Cancer; Genetics; Gene","score_opus":0.12547345969595325,"score_gpt":0.44443399536287137,"score_spread":0.3189605356669181,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399667123","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9634313,0.013424498,0.0013579606,0.001337753,0.00032807552,0.0028622544,0.006161991,0.00019724105,0.010898926],"genre_scores_gemma":[0.9585152,0.005963839,0.0033582128,0.0020066875,0.00017505143,0.0029496676,0.013588906,0.00006384362,0.013378446],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997019,0.00013217828,0.000014188984,0.000039609677,0.00004515201,0.000066887595],"domain_scores_gemma":[0.99969375,0.000054082957,0.00007166598,0.000018695027,0.000024326795,0.00013751806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012746467,0.0007057882,0.0008365745,0.0002797225,0.00021460927,0.000901211,0.00039411662,0.0006736593,0.004167152],"category_scores_gemma":[0.00088149565,0.00024907006,0.00067698286,0.00028942814,0.00033200806,0.00073114625,0.00036567225,0.0016901997,0.00057366665],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.72037774,0.012140014,0.01002721,0.0021460608,0.0026682992,0.00044361773,0.00025602547,0.0036098901,0.021154119,0.0014463824,0.02532488,0.20040575],"study_design_scores_gemma":[0.76398975,0.1568963,0.027415244,0.00037648878,0.0023957836,0.001128195,0.00017469576,0.0035274392,0.00708173,0.0019297735,0.035010196,0.00007439979],"about_ca_topic_score_codex":0.0007849457,"about_ca_topic_score_gemma":0.003701989,"teacher_disagreement_score":0.004167152,"about_ca_system_score_codex":0.0005768646,"about_ca_system_score_gemma":0.000850795,"threshold_uncertainty_score":0.0139404535},"labels":[],"label_agreement":null},{"id":"W4399724959","doi":"10.1101/2024.06.14.599035","title":"Mitochondrial Signatures Shape Phenotype Switching and Apoptosis in Response to PLK1 and RSK Inhibitors in Melanoma","year":2024,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Phenotype; Apoptosis; Melanoma; Cancer research; Mitochondrion; Biology; Cell biology; Genetics; Gene","score_opus":0.007209653173887765,"score_gpt":0.21342225151442834,"score_spread":0.20621259834054056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399724959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99569196,0.0014161192,0.0011526293,0.00016664015,0.000020258203,0.00001154586,0.0004996612,0.000055449993,0.0009857528],"genre_scores_gemma":[0.9973508,0.0005600905,0.0005536437,0.00003526951,0.0000037487544,0.000010940876,0.0002856184,0.000014593462,0.0011852357],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999379,0.000009255098,0.0000050135204,0.000016024182,0.000017821454,0.0000139760195],"domain_scores_gemma":[0.99994016,0.000008961202,0.000019708472,0.0000065575127,0.000009427315,0.000015222207],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000114404254,0.0001267681,0.00018381525,0.0002181239,0.00010117903,0.00030730417,0.00007928942,0.00020427149,0.0015221693],"category_scores_gemma":[0.00013845475,0.0000946406,0.0001877335,0.00012903135,0.00014176426,0.00017552887,0.00016219437,0.00038006765,0.00042073638],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041567622,0.0000210642,0.0019171127,0.000034722965,0.000008281809,0.000051264047,0.000025721683,0.00029956416,0.99389726,0.00011664567,0.00015429965,0.0030584726],"study_design_scores_gemma":[0.000044144716,0.00032107744,0.0514034,0.0000093487915,0.000022796161,0.00049161795,0.000119655866,0.0029629844,0.94080704,0.00039662689,0.0034110802,0.000010194005],"about_ca_topic_score_codex":0.0004892614,"about_ca_topic_score_gemma":0.00059661386,"teacher_disagreement_score":0.0015221693,"about_ca_system_score_codex":0.0003268574,"about_ca_system_score_gemma":0.00011296993,"threshold_uncertainty_score":0.0050922036},"labels":[],"label_agreement":null},{"id":"W4399737375","doi":"10.1200/jco.2024.42.16_suppl.tps3180","title":"A phase 1, open-label, dose escalation and dose expansion study to evaluate the safety, tolerability, pharmacokinetics, and antitumor activity of PF-07799544 (ARRY-134) as a single agent and in combination with PF-07799933 BRAF dimer inhibitor, in participants 16 years and older with advanced solid tumors.","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Ottawa Hospital; McGill University; Health Sciences Centre; McGill University Health Centre; Sunnybrook Health Science Centre","funders":"Pfizer","keywords":"Medicine; Tolerability; Pharmacokinetics; Maximum tolerated dose; Pharmacology; Open label; Oncology; Adverse effect","score_opus":0.09363379947207903,"score_gpt":0.45930803875461584,"score_spread":0.36567423928253684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399737375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99186456,0.0006343287,0.0010151446,0.00023915344,0.00009991232,0.0038781487,0.0011056724,0.00009629234,0.0010667631],"genre_scores_gemma":[0.9801877,0.00089179835,0.0041280994,0.00090522895,0.00018806422,0.0068249158,0.002396567,0.000063369545,0.0044143414],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99947506,0.0001725907,0.00001876139,0.00013541168,0.00007469126,0.0001235078],"domain_scores_gemma":[0.9990345,0.00011985874,0.00020670664,0.00010603503,0.000088394976,0.0004445455],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001744638,0.0016150922,0.0020685152,0.00045849994,0.00064356875,0.00082147785,0.0010967567,0.0015186714,0.0043947226],"category_scores_gemma":[0.001027427,0.0007422097,0.001078531,0.0004596217,0.0012217253,0.001473188,0.0004011287,0.0046450812,0.0013234818],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4868301,0.30506483,0.006466994,0.0006382928,0.00079785456,0.00039278765,0.000514,0.0027587125,0.12207179,0.00029567562,0.0042015766,0.06996736],"study_design_scores_gemma":[0.14573944,0.83770585,0.007861506,0.000014199734,0.00022834461,0.00024234707,0.00006895157,0.0006262992,0.0049776165,0.00020104447,0.002304386,0.000030004128],"about_ca_topic_score_codex":0.0008203369,"about_ca_topic_score_gemma":0.0020214221,"teacher_disagreement_score":0.0043947226,"about_ca_system_score_codex":0.0011150079,"about_ca_system_score_gemma":0.0020656304,"threshold_uncertainty_score":0.014701784},"labels":[],"label_agreement":null},{"id":"W4400272226","doi":"10.1200/jco.2024.42.16_suppl.e21533","title":"Prospective real-world evidence for the use of immune-checkpoint inhibitors and BRAF-targeted therapy in advanced melanoma from a large Canadian cohort.","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Credit Valley Hospital; Niagara Health System; University of Alberta; Princess Margaret Cancer Centre; University of Calgary; Health Sciences Centre; Ottawa Hospital; Dalhousie University; University of Toronto; Sunnybrook Health Science Centre; Queen's University; Cancer Care Ontario","funders":"","keywords":"Medicine; Melanoma; Oncology; Targeted therapy; Immune checkpoint; Cohort; Ipilimumab; Prospective cohort study; Internal medicine; Immunotherapy; Cancer; Cancer research","score_opus":0.10461052156559818,"score_gpt":0.4095387828409206,"score_spread":0.3049282612753224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400272226","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9240097,0.02043626,0.0004692436,0.0027023726,0.00014733305,0.00039296647,0.04387235,0.00003254442,0.007937191],"genre_scores_gemma":[0.98596674,0.0038307959,0.0006688303,0.00084227166,0.000057389392,0.000120288685,0.007874211,0.000011112547,0.000628524],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99570966,0.0008432862,0.0004409087,0.00062267523,0.001756198,0.00062716345],"domain_scores_gemma":[0.9778977,0.0033566123,0.009416465,0.0014202886,0.006110016,0.0017989101],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0051825643,0.00052684883,0.00062654406,0.0012702624,0.0017434799,0.0014565324,0.0014636395,0.00088939583,0.0038775338],"category_scores_gemma":[0.016899759,0.00046359526,0.0015896359,0.0043670423,0.00090089894,0.00043985972,0.00102881,0.0007133598,0.0002977035],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011861012,0.000052950625,0.9868434,0.00042720328,0.0007756743,0.00007991105,0.00021822489,0.00012650575,0.000116869545,0.00015471141,0.0028032712,0.0072152084],"study_design_scores_gemma":[0.0002575472,0.00013627423,0.9940853,0.0002565938,0.0007936346,0.00011204815,0.0002832636,0.0002100366,0.0000515458,0.000042962252,0.0037427095,0.000028127195],"about_ca_topic_score_codex":0.9501324,"about_ca_topic_score_gemma":0.96587735,"teacher_disagreement_score":0.04986757,"about_ca_system_score_codex":0.015608502,"about_ca_system_score_gemma":0.03572132,"threshold_uncertainty_score":0.11324817},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":true,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":true,"confidence":"high"}],"label_agreement":"agree"},{"id":"W4401159118","doi":"10.1101/2024.07.28.24311101","title":"CDK4/6 and SHP2 mediate BRAF/MEK inhibitor resistance in Class 2 and 3 BRAF mutant cancers","year":2024,"lang":"en","type":"preprint","venue":"medRxiv","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; McGill University Health Centre; Princess Margaret Cancer Centre; Jewish General Hospital; McGill University; University of Toronto; University Health Network","funders":"","keywords":"Neuroblastoma RAS viral oncogene homolog; Cancer research; MEK inhibitor; MAPK/ERK pathway; Mutant; Cancer; Mutation; Medicine; Biology; Kinase; Gene; KRAS; Internal medicine; Genetics","score_opus":0.009096468143398267,"score_gpt":0.23354354613141465,"score_spread":0.22444707798801639,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401159118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986689,0.0003900871,0.00015014572,0.000030183091,0.0000044444596,0.000011800564,0.00010617713,0.000011648299,0.0006267032],"genre_scores_gemma":[0.99922526,0.00011842407,0.000118299904,0.00001962911,0.0000021096596,0.000008957674,0.000102001606,0.0000024507258,0.0004028896],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999305,0.000009700269,0.0000034095472,0.000010976844,0.000019987106,0.000025282825],"domain_scores_gemma":[0.9999448,0.000010671609,0.000015031138,0.000006006108,0.000005128563,0.000018402787],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000112078495,0.00013163152,0.00015505702,0.00019575065,0.00013284457,0.00024364483,0.00013060629,0.0001948135,0.0017643414],"category_scores_gemma":[0.00013385364,0.00008462184,0.00019302737,0.000103273036,0.00013700721,0.000111378096,0.00014419825,0.00040335557,0.0002188088],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016454005,0.00031894032,0.026441915,0.000052720723,0.00003252034,0.00052284735,0.000056090365,0.0005199434,0.9576875,0.00030781608,0.0005187993,0.011895542],"study_design_scores_gemma":[0.0003141311,0.0035924541,0.43548018,0.00001958732,0.00006523903,0.0069831717,0.00025158422,0.005499577,0.54117984,0.0006509662,0.0059450483,0.000018319095],"about_ca_topic_score_codex":0.00073183526,"about_ca_topic_score_gemma":0.0009591888,"teacher_disagreement_score":0.0017643414,"about_ca_system_score_codex":0.00027147098,"about_ca_system_score_gemma":0.0001787893,"threshold_uncertainty_score":0.0059022903},"labels":[],"label_agreement":null},{"id":"W4401475093","doi":"10.1101/2024.08.08.607128","title":"The “DDVF” motif used by viral and bacterial proteins to hijack RSK kinases evolved as a mimic of a short linear motif (SLiM) found in proteins related to the RAS-ERK MAP kinase pathway","year":2024,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National de la Recherche Scientifique","funders":"","keywords":"Biology; Kinase; MAPK/ERK pathway; Cell biology; Phosphorylation; Structural motif; Sequence motif; Genetics; Computational biology; Biochemistry; Gene","score_opus":0.008859051855275125,"score_gpt":0.2194177831227795,"score_spread":0.21055873126750435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401475093","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99602926,0.00035709012,0.0028155632,0.000038178838,0.0000113019705,0.000012513244,0.00022673527,0.00006226604,0.00044718603],"genre_scores_gemma":[0.99503857,0.00012091169,0.0033512176,0.000045303717,0.000003274703,0.000009638022,0.0006815318,0.000014007682,0.00073537754],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989665,0.000024310464,0.000010057968,0.000022878374,0.000022190516,0.000024031131],"domain_scores_gemma":[0.99992347,0.000012858918,0.000025990817,0.0000085450965,0.0000071646386,0.000021986776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012088548,0.00030840863,0.00021113313,0.00018064753,0.00013357111,0.00021541331,0.00017339477,0.00020426216,0.0010122552],"category_scores_gemma":[0.00011826592,0.00009132568,0.0005017082,0.0001497023,0.00013043641,0.000151952,0.00023056364,0.00026147984,0.000369909],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015067245,0.000017231054,0.0010413248,0.000029142464,0.000016798207,0.00010992652,0.000008901072,0.00018198729,0.99735755,0.00011019858,0.000049613114,0.00092659716],"study_design_scores_gemma":[0.000015875949,0.00023587163,0.010078556,0.0000073786796,0.000030246729,0.00071938324,0.00003358644,0.0036405795,0.9827139,0.000057569792,0.0024584003,0.000008591116],"about_ca_topic_score_codex":0.00031229766,"about_ca_topic_score_gemma":0.00043424516,"teacher_disagreement_score":0.0010122552,"about_ca_system_score_codex":0.00026652435,"about_ca_system_score_gemma":0.0000842754,"threshold_uncertainty_score":0.0033863783},"labels":[],"label_agreement":null},{"id":"W4401805242","doi":"10.1007/s00520-024-08810-x","title":"Mucocutaneous toxicities from MEK inhibitors: a scoping review of the literature","year":2024,"lang":"en","type":"review","venue":"Supportive Care in Cancer","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Mucocutaneous zone; Nursing research; Dermatology; Pain medicine; Intensive care medicine; Internal medicine; Pathology; Disease","score_opus":0.021352138554916397,"score_gpt":0.34933402696338633,"score_spread":0.3279818884084699,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401805242","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012607033,0.9995524,0.000026452657,0.00008160099,0.00002758493,0.000008302775,0.00004294808,0.0000013753178,0.00013323124],"genre_scores_gemma":[0.0008731918,0.99884075,0.00007576802,0.0001052306,0.00002623494,0.0000098865985,0.000028675397,5.682646e-7,0.00003968758],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9991641,0.0001789465,0.0003187749,0.00010550477,0.00018720873,0.00004548856],"domain_scores_gemma":[0.996372,0.0026501082,0.0006279653,0.000039633047,0.000263179,0.000047162954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018208676,0.00095009344,0.003216466,0.004562017,0.00036524425,0.0017941728,0.0011040505,0.0011976822,0.0032194436],"category_scores_gemma":[0.005369906,0.00043099053,0.0022913313,0.0059312633,0.00046983495,0.0014526927,0.0010094879,0.0009744189,0.0003612429],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024367546,0.000039200975,0.00057909964,0.4962123,0.001597266,0.00038450942,0.00016256506,0.0003209562,0.00076432887,0.0007696557,0.00867517,0.49025118],"study_design_scores_gemma":[0.00013245102,0.00027709323,0.004641397,0.6489196,0.018320953,0.003711142,0.00051654974,0.00017605055,0.00089087413,0.0014587069,0.32088396,0.00007115224],"about_ca_topic_score_codex":0.003058789,"about_ca_topic_score_gemma":0.0072654565,"teacher_disagreement_score":0.004562017,"about_ca_system_score_codex":0.0011561001,"about_ca_system_score_gemma":0.0032733479,"threshold_uncertainty_score":0.010770142},"labels":[],"label_agreement":null},{"id":"W4402560067","doi":"10.1016/j.annonc.2024.08.681","title":"614MO Type II RAF inhibitor tovorafenib in recurrent/refractory (R/R) melanoma or other solid tumors with RAF fusions and/or RAF1 amplification","year":2024,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Refractory (planetary science); Cancer research; Melanoma; Solid tumor; Oncology; Internal medicine; Cancer","score_opus":0.06356548457946962,"score_gpt":0.3571273992258349,"score_spread":0.2935619146463653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402560067","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98901165,0.0051397737,0.00035355394,0.00045858583,0.00017643363,0.00007216797,0.00023691055,0.00009517836,0.004455765],"genre_scores_gemma":[0.9962005,0.001031179,0.00026698937,0.0000967966,0.000027399976,0.0000266663,0.00027432674,0.000007588857,0.0020685005],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99993,0.00001503513,0.000005749201,0.000007631461,0.000009544687,0.000032032975],"domain_scores_gemma":[0.9999405,0.000008424594,0.000008719052,0.000004845946,0.0000044826056,0.00003300552],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021136094,0.000266932,0.0004998787,0.00018922042,0.00020107088,0.0003343927,0.00023595824,0.00026171256,0.002099817],"category_scores_gemma":[0.00020723359,0.000102918144,0.00033940712,0.0001245127,0.0001060422,0.00020529602,0.00014306302,0.0006106997,0.0003187298],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.117902815,0.005318012,0.027570995,0.0010777647,0.0012031042,0.005906815,0.00033618085,0.0043261987,0.3050991,0.0019207645,0.017733805,0.5116044],"study_design_scores_gemma":[0.06211088,0.18070912,0.26475403,0.00034535435,0.00249293,0.03493149,0.00085135875,0.028382376,0.26157522,0.0027552017,0.16086768,0.00022430657],"about_ca_topic_score_codex":0.00083288463,"about_ca_topic_score_gemma":0.0038872396,"teacher_disagreement_score":0.002099817,"about_ca_system_score_codex":0.000411449,"about_ca_system_score_gemma":0.00040569928,"threshold_uncertainty_score":0.007024586},"labels":[],"label_agreement":null},{"id":"W4402560083","doi":"10.1016/j.annonc.2024.08.691","title":"624P Belvarafenib in patients (pts) with BRAF class II or III alteration-positive tumours: TAPISTRY study","year":2024,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; Internal medicine; Oncology","score_opus":0.026726967471272407,"score_gpt":0.32412004431273234,"score_spread":0.29739307684145994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402560083","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99925655,0.00017374038,0.00005154047,0.000022484073,0.000006792882,0.00000939262,0.000108544926,0.0000022233858,0.00036871553],"genre_scores_gemma":[0.99912256,0.00010438419,0.000041622177,0.00003731091,0.00001659234,0.000010429985,0.0002398741,0.0000021749763,0.0004252523],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99984705,0.000029882938,0.000010100666,0.000055421166,0.000019646737,0.000037849175],"domain_scores_gemma":[0.9998306,0.000021495538,0.00005158376,0.000012909253,0.000015605752,0.00006771846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022718996,0.00042070373,0.00041896777,0.00027587896,0.00030478789,0.00070186565,0.00020032706,0.00044348615,0.0018456393],"category_scores_gemma":[0.00048985594,0.0003421804,0.00056631357,0.0004044489,0.00023532132,0.00051066664,0.00034226602,0.00061484106,0.0005210911],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030435065,0.0013242516,0.9390186,0.000115695366,0.0006877705,0.0014089468,0.00023168873,0.00024721515,0.011169794,0.00013917501,0.0005132436,0.014708555],"study_design_scores_gemma":[0.0012636617,0.008885134,0.9823673,0.000016037344,0.00082617835,0.0023813413,0.00034152382,0.00060389825,0.00096593355,0.00019966498,0.002127611,0.00002174667],"about_ca_topic_score_codex":0.00075412245,"about_ca_topic_score_gemma":0.00080627523,"teacher_disagreement_score":0.0018456393,"about_ca_system_score_codex":0.00027925248,"about_ca_system_score_gemma":0.00021361934,"threshold_uncertainty_score":0.0061742663},"labels":[],"label_agreement":null},{"id":"W4402775563","doi":"10.1007/s11912-024-01599-2","title":"Risk Stratification, Screening and Treatment of BRAF/MEK Inhibitors-Associated Cardiotoxicity","year":2024,"lang":"en","type":"review","venue":"Current Oncology Reports","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Cardiotoxicity; Risk stratification; Oncology; Internal medicine; Stratification (seeds); Chemotherapy","score_opus":0.07883167995989944,"score_gpt":0.38152584444017396,"score_spread":0.30269416448027453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402775563","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013986244,0.99895644,0.00016548346,0.00028202514,0.0001146744,0.0000032034038,0.000015201722,0.0000045514576,0.00031857158],"genre_scores_gemma":[0.002013532,0.99650997,0.00035618147,0.00032583528,0.0004380399,0.000008057612,0.00004666825,0.0000015869193,0.0003000825],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99980265,0.000043924927,0.000030798943,0.000042312742,0.000063075095,0.000017276709],"domain_scores_gemma":[0.99956924,0.00023344548,0.00007728963,0.000009588128,0.00008106715,0.000029392402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071522593,0.00065423036,0.0014542942,0.001111009,0.00011989157,0.0008075844,0.0007034628,0.0008595855,0.0013242415],"category_scores_gemma":[0.0013572223,0.00019266183,0.0006431757,0.0008034774,0.0002674874,0.000485382,0.00037312417,0.0016926547,0.00055842457],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014328926,0.00006363008,0.00074768317,0.0062157228,0.00021333918,0.00018994296,0.000016118365,0.00043002627,0.0006201855,0.0010283076,0.018734701,0.97159684],"study_design_scores_gemma":[0.00027867986,0.0006298952,0.012908203,0.01622748,0.0022583865,0.0056086318,0.00011409087,0.0011335886,0.0014751755,0.007780619,0.9514995,0.00008568383],"about_ca_topic_score_codex":0.0008766668,"about_ca_topic_score_gemma":0.0020753627,"teacher_disagreement_score":0.0014542942,"about_ca_system_score_codex":0.0004135045,"about_ca_system_score_gemma":0.0007467413,"threshold_uncertainty_score":0.004429996},"labels":[],"label_agreement":null},{"id":"W4403215038","doi":"10.1093/toxsci/kfae129","title":"Development and safety of investigational and approved drugs targeting the RAS function regulation in RAS mutant cancers","year":2024,"lang":"en","type":"review","venue":"Toxicological Sciences","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Artificial Intelligence in Medicine (Canada)","funders":"National Natural Science Foundation of China","keywords":"Adverse effect; Medicine; Dosing; Investigational Drugs; Cancer; Food and drug administration; Pharmacology; Drug development; Drug; Adverse Outcome Pathway; Bioinformatics; Intensive care medicine; Clinical trial; Biology; Internal medicine; Computational biology","score_opus":0.049508986519040475,"score_gpt":0.29634851079449914,"score_spread":0.24683952427545866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403215038","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00048647527,0.9969216,0.0002919805,0.00023486186,0.0001645096,0.000011235813,0.000047945112,0.000013322666,0.0018280013],"genre_scores_gemma":[0.0023303488,0.9959293,0.00029396894,0.00020271237,0.00010416027,0.000012905074,0.00006262578,0.000002336797,0.001061584],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99982977,0.000030884257,0.00002368511,0.00002441762,0.000074790136,0.000016489663],"domain_scores_gemma":[0.9998136,0.00007284293,0.000035937268,0.0000060767748,0.0000558812,0.000015553427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050018926,0.00050875236,0.0009362824,0.0013872241,0.00020150501,0.00066974293,0.0005698267,0.0007727757,0.0029839112],"category_scores_gemma":[0.00047556974,0.0002068366,0.0005083275,0.0009958062,0.0002377844,0.0007447185,0.00040097098,0.001169947,0.0013531575],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009303227,0.00010971262,0.00019167077,0.016603732,0.00010323594,0.0002909712,0.000055295437,0.0004679159,0.0067373468,0.0035118419,0.018955145,0.95288],"study_design_scores_gemma":[0.000024312334,0.00022836657,0.0008776262,0.0021437234,0.0001616433,0.0014408622,0.00004013843,0.00014820723,0.002368538,0.0013092153,0.9912384,0.000018960123],"about_ca_topic_score_codex":0.00047720273,"about_ca_topic_score_gemma":0.001082158,"teacher_disagreement_score":0.0029839112,"about_ca_system_score_codex":0.0003482636,"about_ca_system_score_gemma":0.000653207,"threshold_uncertainty_score":0.009982109},"labels":[],"label_agreement":null},{"id":"W4403663525","doi":"","title":"Post Proceedings of the STAF 2023 Workshops","year":2024,"lang":"en","type":"other","venue":"HAL (Le Centre pour la Communication Scientifique Directe)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Environmental science","score_opus":0.006748592815243814,"score_gpt":0.20456993393816728,"score_spread":0.19782134112292346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403663525","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004556167,0.0036781675,0.002908255,0.035938855,0.15099226,0.0007301089,0.011273937,0.001605222,0.78831697],"genre_scores_gemma":[0.0033213228,0.00048514374,0.00050736114,0.0017012293,0.0040972847,0.0001170312,0.0023838144,0.0003170752,0.9870697],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.998823,0.00015094997,0.000033421293,0.0001079745,0.0005739584,0.0003107138],"domain_scores_gemma":[0.99630725,0.00027509025,0.000104369865,0.00016250381,0.0013805805,0.00177018],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0025979474,0.0011884997,0.00055199175,0.0015889836,0.0021190906,0.0060220542,0.0013142988,0.0033319565,0.50828266],"category_scores_gemma":[0.0032105716,0.00028450682,0.0010615516,0.0009655098,0.0004191296,0.0015817997,0.0022253287,0.0023937263,0.31141788],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000084628184,0.000032608717,0.000056565168,0.0000507552,0.0000028816075,0.00004037687,0.000024144943,0.000049088037,0.000258233,0.0008940999,0.98509556,0.013410937],"study_design_scores_gemma":[0.000024114748,0.000037620488,0.0007246226,0.00004609178,0.0000028784295,0.000025794165,0.0000798946,0.00010779339,0.0002366095,0.00074167916,0.9979658,0.0000070235706],"about_ca_topic_score_codex":0.0042898003,"about_ca_topic_score_gemma":0.014706246,"teacher_disagreement_score":0.49171734,"about_ca_system_score_codex":0.0019379457,"about_ca_system_score_gemma":0.0033323315,"threshold_uncertainty_score":0.7013751},"labels":[],"label_agreement":null},{"id":"W4403823250","doi":"10.2139/ssrn.4999742","title":"Extracellular Matrix Signals Promote Actin-Dependent Mitochondrial Elongation and Activity","year":2024,"lang":"en","type":"preprint","venue":"SSRN Electronic Journal","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal; Université du Québec à Trois-Rivières","funders":"","keywords":"Extracellular matrix; Elongation; Actin; Cell biology; Extracellular; Chemistry; Mitochondrion; Matrix (chemical analysis); Biophysics; Biology; Materials science; Ultimate tensile strength","score_opus":0.008248094821110146,"score_gpt":0.25511395611132226,"score_spread":0.24686586129021212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403823250","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98143125,0.0030394373,0.00472417,0.00048451545,0.00012210007,0.0000200742,0.0007738939,0.00014803742,0.009256417],"genre_scores_gemma":[0.9888403,0.0008817707,0.001658276,0.00005821312,0.000026766102,0.00001182262,0.0007616653,0.00004062226,0.0077205743],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990165,0.0000129188165,0.000007680718,0.000022422675,0.000023853634,0.000031518855],"domain_scores_gemma":[0.99985886,0.000029270885,0.000035712033,0.0000187068,0.000021328211,0.000036092875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013749958,0.00027364757,0.0001392797,0.00017680952,0.00016157584,0.0003965514,0.00010485558,0.0003155837,0.004096286],"category_scores_gemma":[0.00019990193,0.00012618439,0.00021166849,0.00012633139,0.00010478801,0.0003117438,0.00032918094,0.0005665929,0.0015695475],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013913325,0.000013205883,0.000083892846,0.000025905376,0.0000025252782,0.000039248673,0.0000059096196,0.00004068156,0.9978669,0.00025121705,0.00009172401,0.0014396028],"study_design_scores_gemma":[0.00002373055,0.00010396303,0.008322823,0.000009148392,0.0000070769793,0.00016931299,0.000027459093,0.0009799112,0.9873117,0.00033329707,0.0027069408,0.0000045811485],"about_ca_topic_score_codex":0.00024748239,"about_ca_topic_score_gemma":0.0005358605,"teacher_disagreement_score":0.004096286,"about_ca_system_score_codex":0.00028678955,"about_ca_system_score_gemma":0.00012716447,"threshold_uncertainty_score":0.013703465},"labels":[],"label_agreement":null},{"id":"W4405070410","doi":"10.3390/curroncol31120568","title":"Braf-Mutant Melanomas: Biology and Therapy","year":2024,"lang":"en","type":"review","venue":"Current Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Melanoma; Medicine; Adjuvant; Targeted therapy; Cancer research; Mutant; Adjuvant therapy; Disease; Mutation; Oncology; Cancer; Internal medicine; Gene; Immunology; Biology; Genetics","score_opus":0.14769301815361696,"score_gpt":0.44821491817125264,"score_spread":0.3005219000176357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405070410","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011089874,0.9985511,0.00006770233,0.0002914048,0.00025706136,0.00000400609,0.000009762202,0.0000063195334,0.00070176605],"genre_scores_gemma":[0.0006362319,0.99819714,0.00008902836,0.00019985742,0.00020786996,0.00000467698,0.00002365311,0.0000010932393,0.0006404601],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998605,0.000023067974,0.000014993992,0.000021182645,0.0000624764,0.000017766626],"domain_scores_gemma":[0.999858,0.00004911661,0.00001959411,0.0000058963183,0.00004527217,0.000022065786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000423125,0.0008236859,0.001172794,0.0014525295,0.00023042783,0.00079975196,0.0009112335,0.0009457231,0.0023599793],"category_scores_gemma":[0.0004326618,0.00026271178,0.0004480187,0.0010382812,0.00041541734,0.0010563175,0.0005466148,0.0026772222,0.0014950822],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000105408864,0.00011012915,0.00015704423,0.008365785,0.00006488753,0.00020049191,0.000041600397,0.0004838668,0.00211219,0.0026610468,0.0481385,0.9375591],"study_design_scores_gemma":[0.000024368173,0.0001277717,0.0006174407,0.0020395597,0.00005488097,0.0013064607,0.000027562586,0.00010552537,0.00040402502,0.0020298255,0.9932498,0.0000127659705],"about_ca_topic_score_codex":0.00075162825,"about_ca_topic_score_gemma":0.0016643314,"teacher_disagreement_score":0.0023599793,"about_ca_system_score_codex":0.00062255317,"about_ca_system_score_gemma":0.0006112322,"threshold_uncertainty_score":0.007894933},"labels":[],"label_agreement":null},{"id":"W4405181476","doi":"10.1158/1538-8514.cancerchem24-ia020","title":"Abstract IA020: Discovery of brain-penetrant inhibitors for the treatment of BRAF mutant tumors","year":2024,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Penetrant (biochemical); Cancer research; Mutant; Cancer; Kinase; Neuroblastoma RAS viral oncogene homolog; Medicine; Pharmacology; Biology; Gene; Genetics; Internal medicine","score_opus":0.020412385785389217,"score_gpt":0.28341883247375693,"score_spread":0.2630064466883677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405181476","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6699448,0.09708267,0.04922945,0.008519621,0.003528817,0.0028787334,0.009175372,0.002603116,0.1570373],"genre_scores_gemma":[0.7981963,0.05161496,0.036238972,0.0044393656,0.0008088564,0.00074031425,0.006623308,0.00022297073,0.101114966],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99992347,0.000014424396,0.000004294196,0.000012310596,0.00002364483,0.000021905778],"domain_scores_gemma":[0.9999255,0.0000050829617,0.000008526089,0.0000028605518,0.00001942274,0.000038537248],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028121754,0.00058731815,0.0003573605,0.0005980392,0.00016071185,0.00052369304,0.0004014399,0.00051615835,0.0035257884],"category_scores_gemma":[0.00016033271,0.00019991641,0.0003499565,0.00022360432,0.00016537422,0.00019993205,0.0002754529,0.0009799107,0.0015083561],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00096289377,0.00085111894,0.0007325149,0.0005327543,0.00008629435,0.0008741837,0.00008504362,0.0022679681,0.744804,0.0053233407,0.033839554,0.20964034],"study_design_scores_gemma":[0.0032442731,0.016961535,0.008140107,0.00023708769,0.00026059544,0.0033222528,0.000062370316,0.009328233,0.5939455,0.002223823,0.3621361,0.0001380851],"about_ca_topic_score_codex":0.0012547199,"about_ca_topic_score_gemma":0.0027289714,"teacher_disagreement_score":0.0035257884,"about_ca_system_score_codex":0.00043146673,"about_ca_system_score_gemma":0.0007608758,"threshold_uncertainty_score":0.011794925},"labels":[],"label_agreement":null},{"id":"W4405181970","doi":"10.1158/1538-8514.cancerchem24-ia018","title":"Abstract IA018: Pan-RAF-MEK molecular glue NST-628 is a potent and brain-penetrant inhibitor of the RAS-MAPK pathway","year":2024,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"MAPK/ERK pathway; Cancer research; MEK inhibitor; Tolerability; Phosphorylation; Medicine; Kinase; Cancer; Chemistry; Pharmacology; Internal medicine; Biochemistry; Adverse effect","score_opus":0.012600471978043988,"score_gpt":0.2521511944222847,"score_spread":0.2395507224442407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405181970","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.42790097,0.072914,0.027956123,0.003798275,0.0037762648,0.0017421043,0.012215971,0.0058870874,0.44380918],"genre_scores_gemma":[0.6370134,0.03491423,0.014452103,0.0008897125,0.0004564429,0.00054529804,0.013967813,0.00026607455,0.29749498],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99987566,0.000008671784,0.0000073415827,0.00001701156,0.000058617752,0.000032645734],"domain_scores_gemma":[0.99993324,0.0000040907184,0.0000071623035,0.000005728106,0.00001647183,0.000033366483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016429633,0.0008559426,0.00034371723,0.0006286076,0.0002989612,0.00044173354,0.0004594916,0.0005886895,0.018796027],"category_scores_gemma":[0.00009958235,0.00026694295,0.0002529952,0.0003819096,0.0001845634,0.0003067284,0.0003395314,0.0009055807,0.0069945026],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010918883,0.0003407592,0.00036557775,0.00038523364,0.00002965805,0.00042167946,0.000042568405,0.00043341017,0.8797034,0.0023838733,0.033485886,0.08131607],"study_design_scores_gemma":[0.0006130146,0.0039635403,0.005127777,0.000078675526,0.00007543593,0.00204035,0.00004616361,0.0012030744,0.638427,0.000442089,0.34794623,0.00003662134],"about_ca_topic_score_codex":0.0018903391,"about_ca_topic_score_gemma":0.004130342,"teacher_disagreement_score":0.018796027,"about_ca_system_score_codex":0.00054599904,"about_ca_system_score_gemma":0.00071847986,"threshold_uncertainty_score":0.06287897},"labels":[],"label_agreement":null},{"id":"W4405289324","doi":"10.14740/wjon1945","title":"Loss of MK2 Enhances Radiation-Mediated Apoptosis in Bladder Cancer","year":2024,"lang":"en","type":"article","venue":"World Journal of Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of General Medical Sciences; National Cancer Institute; National Institutes of Health","keywords":"Medicine; Apoptosis; Bladder cancer; Cancer research; Cancer; Radiation therapy; Oncology; Internal medicine; Genetics","score_opus":0.010965381108806129,"score_gpt":0.2963152185490005,"score_spread":0.2853498374401944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405289324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944975,0.002080159,0.0015489175,0.00017422938,0.000052431216,0.00002462199,0.0004076439,0.00009728653,0.0011172289],"genre_scores_gemma":[0.9969784,0.0007873359,0.00063831283,0.000052209005,0.0000077830255,0.000032599793,0.00032953618,0.000011529035,0.0011623609],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998685,0.000020843467,0.000016534284,0.000020081683,0.000038619964,0.000035375142],"domain_scores_gemma":[0.99991035,0.000013434048,0.000027300744,0.000009796106,0.000011334006,0.000027779215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014938887,0.0002875057,0.00029924436,0.00022457197,0.00020230026,0.00030542316,0.00018582506,0.00022885446,0.0019040945],"category_scores_gemma":[0.000121145466,0.00013560816,0.0002771428,0.00016247174,0.00023281021,0.00019531028,0.0001939354,0.0006373716,0.00035622154],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028283533,0.000113027534,0.0005647996,0.00012870031,0.000013336257,0.000050011753,0.000020347818,0.00012640786,0.997051,0.00007156526,0.00015023121,0.0014277097],"study_design_scores_gemma":[0.00004436599,0.0012257077,0.011661781,0.000017168055,0.000048246122,0.00053908175,0.000054536504,0.0015155199,0.9818848,0.00006427613,0.0029368168,0.000007756357],"about_ca_topic_score_codex":0.00043881248,"about_ca_topic_score_gemma":0.0007621312,"teacher_disagreement_score":0.0019040945,"about_ca_system_score_codex":0.00032697027,"about_ca_system_score_gemma":0.00023919718,"threshold_uncertainty_score":0.006369829},"labels":[],"label_agreement":null},{"id":"W4405437295","doi":"10.1021/acs.jmedchem.4c02552","title":"Design, Synthesis, and Biochemical Evaluation of Novel MLK3 Inhibitors: A Target Hopping Example","year":2024,"lang":"en","type":"article","venue":"Journal of Medicinal Chemistry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Structural Genomics Consortium; Deutsche Forschungsgemeinschaft","keywords":"Kinome; Druggability; Chemistry; Kinase; Computational biology; Focal adhesion; Lineage (genetic); MAP kinase kinase kinase; Protein kinase A; Cell biology; Signal transduction; Biochemistry; Biology","score_opus":0.043370069545414947,"score_gpt":0.2840475989558541,"score_spread":0.24067752941043913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405437295","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9192352,0.015834162,0.0469496,0.0011386703,0.000156637,0.0021641846,0.0023390986,0.00047396525,0.011708483],"genre_scores_gemma":[0.9516638,0.013303386,0.026437668,0.00033712515,0.000041985142,0.0004312908,0.0012366475,0.00005422912,0.006493943],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998222,0.000032652897,0.000016841228,0.000027686634,0.000059215403,0.000041411502],"domain_scores_gemma":[0.99991465,0.000011005559,0.000012765162,0.000009006477,0.000024662959,0.0000278695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042810783,0.0005790689,0.0005325609,0.0003358417,0.00028058284,0.00035118122,0.0003741796,0.0004017186,0.0015066909],"category_scores_gemma":[0.00023338829,0.00020693603,0.00034766103,0.00029381484,0.00021805237,0.00033121704,0.00022747218,0.0006159111,0.0005013678],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003845899,0.0006660052,0.00024373921,0.00039745422,0.000045408924,0.00027253514,0.00010157753,0.004402269,0.97260714,0.0010147466,0.00067483785,0.01918959],"study_design_scores_gemma":[0.00038926597,0.007004183,0.0010782175,0.000034486067,0.000082254024,0.00046721965,0.000040677634,0.0032169393,0.97486645,0.00035985548,0.012412629,0.000047718797],"about_ca_topic_score_codex":0.0009832873,"about_ca_topic_score_gemma":0.0021156722,"teacher_disagreement_score":0.0015066909,"about_ca_system_score_codex":0.0005954794,"about_ca_system_score_gemma":0.0006035808,"threshold_uncertainty_score":0.0050403476},"labels":[],"label_agreement":null},{"id":"W4405516329","doi":"10.21203/rs.3.rs-5632942/v1","title":"FRAME: A phase I trial of defactinib (FAK inhibitor) in combination with avutometinib (RAF-MEK clamp) in patients with solid tumours including low grade serous ovarian cancer","year":2024,"lang":"en","type":"preprint","venue":"Research Square","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Ottawa Mental Health Centre; Institute of Cancer Research","funders":"Royal Marsden NHS Foundation Trust","keywords":"Medicine; Tolerability; Pharmacokinetics; MEK inhibitor; Pharmacodynamics; Ovarian cancer; Internal medicine; Clinical endpoint; Oncology; Serous fluid; Confidence interval; Dosing; Clinical trial; Cancer; MAPK/ERK pathway; Pharmacology; Adverse effect; Kinase; Chemistry","score_opus":0.04171688311191956,"score_gpt":0.3854444483205771,"score_spread":0.34372756520865755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405516329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96266943,0.007881694,0.0016837071,0.004362727,0.0010216633,0.0021342065,0.0070795547,0.00060943724,0.0125575615],"genre_scores_gemma":[0.9560151,0.0054814937,0.0034942953,0.0033234558,0.00057783,0.0022389374,0.009912052,0.0001575332,0.018799378],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9998716,0.00004303302,0.000003944101,0.000025210984,0.000012228135,0.000043913882],"domain_scores_gemma":[0.999828,0.000027070411,0.000025525982,0.000013826159,0.000009467935,0.00009617534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063865434,0.0010723717,0.0009815136,0.0002785773,0.0002517044,0.0008116095,0.0005282928,0.0010935814,0.0124758035],"category_scores_gemma":[0.0005582003,0.00034094075,0.001105812,0.00022189549,0.0004702077,0.0006398424,0.00036107216,0.0020900618,0.0021529049],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.63758576,0.017834527,0.0028720743,0.0013187737,0.0017613592,0.00048160137,0.0001978071,0.0034852736,0.039921585,0.0011330441,0.04370419,0.249704],"study_design_scores_gemma":[0.7928475,0.16748495,0.009888119,0.0001247086,0.0008480573,0.0005371864,0.000094597024,0.0016080611,0.0046866857,0.000935253,0.020888263,0.00005655783],"about_ca_topic_score_codex":0.0009965223,"about_ca_topic_score_gemma":0.0032363152,"teacher_disagreement_score":0.0124758035,"about_ca_system_score_codex":0.0005467797,"about_ca_system_score_gemma":0.0008535262,"threshold_uncertainty_score":0.04173577},"labels":[],"label_agreement":null},{"id":"W4406463200","doi":"10.1007/s11060-024-04930-w","title":"It’s all downstream from here: RTK/Raf/MEK/ERK pathway resistance mechanisms in glioblastoma","year":2025,"lang":"en","type":"review","venue":"Journal of Neuro-Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Glioblastoma; MAPK/ERK pathway; Downstream (manufacturing); Resistance (ecology); Cancer research; Cell biology; Biology; Signal transduction; Business; Ecology","score_opus":0.024110785795744393,"score_gpt":0.30871339111734475,"score_spread":0.28460260532160037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406463200","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002956804,0.99593496,0.00018915406,0.0011743801,0.00069649797,0.000005627882,0.000032083484,0.000014637875,0.0016570246],"genre_scores_gemma":[0.0016627935,0.99577326,0.00018913994,0.00054859684,0.00029961797,0.0000054689385,0.00004474061,0.0000026620658,0.0014737563],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999281,0.000012346678,0.000009621619,0.000013731339,0.000025018446,0.000011063934],"domain_scores_gemma":[0.99988866,0.00003375507,0.000015569349,0.0000037280292,0.00004537968,0.0000127635885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024723195,0.00046549476,0.0005468758,0.0010555087,0.00022555608,0.00079181517,0.00039915086,0.00076700246,0.0029865964],"category_scores_gemma":[0.00038565972,0.00010968185,0.00042224553,0.0009241192,0.00024552018,0.00110147,0.00034587306,0.0011903747,0.0014820345],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010723776,0.000046468747,0.00026562592,0.013683909,0.00008319164,0.00028169312,0.000095874704,0.00029304746,0.0039408924,0.004846456,0.0588722,0.91748345],"study_design_scores_gemma":[0.000012819532,0.00010052819,0.00090675044,0.0030914142,0.00009071412,0.0016493258,0.00008537992,0.00008221249,0.0011643704,0.002655561,0.9901451,0.000015908068],"about_ca_topic_score_codex":0.00088867923,"about_ca_topic_score_gemma":0.001587618,"teacher_disagreement_score":0.0029865964,"about_ca_system_score_codex":0.00042886514,"about_ca_system_score_gemma":0.00095401244,"threshold_uncertainty_score":0.009991229},"labels":[],"label_agreement":null},{"id":"W4406638397","doi":"10.1016/b978-0-7506-3993-4.50292-2","title":"10.1016/b978-0-7506-3993-4.50292-2","year":2000,"lang":"en","type":"book-chapter","venue":"Time to knit","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Geology","score_opus":0.006951697914268973,"score_gpt":0.1687909199803848,"score_spread":0.16183922206611584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406638397","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002407142,0.0007094513,0.001291952,0.00034648928,0.00019860294,0.00005518466,0.0007092014,0.0011242372,0.9953241],"genre_scores_gemma":[0.00054428825,0.00033922787,0.0005037049,0.00012995656,0.00004382541,0.00004100766,0.0004734711,0.0002072666,0.9977174],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99960226,0.000021349637,0.000023874958,0.0001487353,0.00012727454,0.00007654733],"domain_scores_gemma":[0.9985481,0.00049004686,0.00010303238,0.00018593273,0.00023126772,0.00044158177],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0008062023,0.0022631157,0.0015009814,0.00181862,0.0011770732,0.0036195556,0.0029719989,0.0038095305,0.9802816],"category_scores_gemma":[0.0012946954,0.0007374138,0.0009777066,0.001542191,0.0010611856,0.0038374728,0.002883083,0.0022073446,0.9899448],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020244776,0.00014376438,0.00032203615,0.000448283,0.00002043716,0.00016076083,0.000073042975,0.00038949822,0.0036972156,0.005583858,0.29632583,0.692633],"study_design_scores_gemma":[0.000025712445,0.0000566761,0.0005046123,0.00028239875,0.000009264286,0.0002956772,0.00006917583,0.00014173494,0.00047706184,0.0012895621,0.9968335,0.000014750565],"about_ca_topic_score_codex":0.0019641388,"about_ca_topic_score_gemma":0.0017879988,"teacher_disagreement_score":0.019718409,"about_ca_system_score_codex":0.0007898799,"about_ca_system_score_gemma":0.00069465855,"threshold_uncertainty_score":0.028125823},"labels":[],"label_agreement":null},{"id":"W4406649743","doi":"10.1016/b978-2-294-73068-9.00508-9","title":"10.1016/b978-2-294-73068-9.00508-9","year":2000,"lang":"en","type":"book-chapter","venue":"Time to knit","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Geology","score_opus":0.00683809002744843,"score_gpt":0.16842494315321083,"score_spread":0.1615868531257624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406649743","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00025700565,0.00090072793,0.0012674474,0.00042442512,0.00025215183,0.00005001229,0.00084415183,0.0012095493,0.99479455],"genre_scores_gemma":[0.000540096,0.00037168342,0.00045692164,0.000121303216,0.00004942115,0.00003588583,0.00048784324,0.0002034735,0.99773335],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996785,0.000017835484,0.000021461055,0.00011381962,0.00010378784,0.00006456859],"domain_scores_gemma":[0.99877745,0.00041343246,0.000086666594,0.00015528873,0.00018795923,0.00037919957],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00076158234,0.002303506,0.0014908669,0.0016147946,0.0011868961,0.0038948709,0.002677864,0.0038898662,0.97731906],"category_scores_gemma":[0.0011414465,0.0008075059,0.0009425136,0.0015965003,0.0010983193,0.003882298,0.0027690635,0.0024608606,0.98921853],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001850376,0.00012871,0.00029913962,0.0004729117,0.00002188071,0.0001548588,0.000069334856,0.00039140868,0.0033044848,0.005929309,0.34352607,0.6455169],"study_design_scores_gemma":[0.000027205577,0.000051567822,0.00049554516,0.00029397104,0.000008916237,0.00030663103,0.00006264845,0.00013901567,0.0005192129,0.0013761705,0.9967051,0.000014007397],"about_ca_topic_score_codex":0.0017203711,"about_ca_topic_score_gemma":0.0017694235,"teacher_disagreement_score":0.022680938,"about_ca_system_score_codex":0.00077246566,"about_ca_system_score_gemma":0.0006771048,"threshold_uncertainty_score":0.032351613},"labels":[],"label_agreement":null},{"id":"W4406854679","doi":"10.1200/po.24.00199","title":"Clinical Activity of Mitogen-Activated Protein Kinase Inhibitors in Patients With MAP2K1 (MEK1)-Mutated Metastatic Cancers","year":2025,"lang":"en","type":"review","venue":"JCO Precision Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; McGill University; Jewish General Hospital","funders":"National Cancer Institute; Conquer Cancer Foundation","keywords":"MAPK/ERK pathway; Mutant; Cancer; Mutation; Cancer research; Medicine; Kinase; Protein kinase A; Internal medicine; Oncology; Biology; Gene; Genetics","score_opus":0.033493044826011814,"score_gpt":0.3678672657524481,"score_spread":0.3343742209264363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406854679","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010820363,0.98759764,0.00014491027,0.00019448069,0.000056894103,0.000056881516,0.00076959404,0.000006915525,0.00035231863],"genre_scores_gemma":[0.44190666,0.5539083,0.0008711693,0.0010643062,0.00037530073,0.00026900755,0.0014168335,0.000017405175,0.0001709457],"study_design_codex":"meta_analysis","study_design_gemma":"not_applicable","domain_scores_codex":[0.99450535,0.0021633166,0.0018401656,0.0007583816,0.00060496735,0.00012781321],"domain_scores_gemma":[0.9850603,0.009870066,0.0036816169,0.00031346612,0.0009206228,0.0001538973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0075624357,0.0007675491,0.006149663,0.003189997,0.00022386435,0.0013997016,0.00079207326,0.00087660295,0.001243326],"category_scores_gemma":[0.016986344,0.00058134063,0.011358516,0.0047100713,0.00037045332,0.0007572326,0.00055397436,0.0008681539,0.00013159036],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0073605045,0.00007144244,0.05019973,0.37103644,0.4994627,0.00018085222,0.0001449034,0.001047304,0.0011075246,0.00024477707,0.0021391278,0.06700462],"study_design_scores_gemma":[0.0020284972,0.0010072956,0.0820253,0.043606523,0.86039186,0.0005567376,0.00014655519,0.0005129235,0.0007567166,0.00052188605,0.008388813,0.000056899447],"about_ca_topic_score_codex":0.002840255,"about_ca_topic_score_gemma":0.006238373,"teacher_disagreement_score":0.0075624357,"about_ca_system_score_codex":0.0011382023,"about_ca_system_score_gemma":0.0010319022,"threshold_uncertainty_score":0.03999442},"labels":[],"label_agreement":null},{"id":"W4408592042","doi":"10.1158/1078-0432.ccr-24-0254","title":"Longitudinal Genomic Analysis to Fine-tune Targeted Therapy: Results of the Phase II LOGIC 2 Trial in Patients with <i>BRAF</i> V600-Mutant Metastatic Melanoma","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; McGill University; University of Toronto; Jewish General Hospital","funders":"Memorial Sloan-Kettering Cancer Center; Pfizer; National Cancer Institute; Foundation for the National Institutes of Health","keywords":"Medicine; Metastatic melanoma; Melanoma; Adverse effect; MEK inhibitor; Clinical endpoint; Internal medicine; Oncology; Phases of clinical research; Clinical trial; Cancer research; MAPK/ERK pathway; Kinase","score_opus":0.10792660299837883,"score_gpt":0.4474522176663169,"score_spread":0.33952561466793807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408592042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957074,0.0015302962,0.0004213079,0.0004323058,0.000042285883,0.00025284477,0.0006976024,0.000047026522,0.000868878],"genre_scores_gemma":[0.99533254,0.00064851163,0.00096220954,0.0005032044,0.00006235882,0.00032693913,0.0014534114,0.000011584644,0.0006991383],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995882,0.0002628034,0.00001586445,0.000066640976,0.000029739747,0.000036700825],"domain_scores_gemma":[0.99936706,0.0001452468,0.00019554546,0.000047431753,0.000042709897,0.00020204675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017330172,0.00065389,0.0005944391,0.00014351733,0.00018956877,0.00053410174,0.00029079587,0.00042547574,0.0017833954],"category_scores_gemma":[0.0012274547,0.00021682895,0.00063343265,0.00016506939,0.00032241375,0.00042839668,0.00026752413,0.0010056591,0.00022209127],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.72681785,0.015041235,0.06823248,0.00042288378,0.002695816,0.000112914604,0.00021382782,0.0038051067,0.022207843,0.00028770964,0.005298393,0.15486403],"study_design_scores_gemma":[0.42444342,0.3859653,0.1659691,0.000081083606,0.003053072,0.00042478734,0.00014931703,0.0067597074,0.005788046,0.00063144905,0.0066560376,0.00007876225],"about_ca_topic_score_codex":0.0007006808,"about_ca_topic_score_gemma":0.0020113986,"teacher_disagreement_score":0.0017833954,"about_ca_system_score_codex":0.0006632699,"about_ca_system_score_gemma":0.0007759487,"threshold_uncertainty_score":0.009165168},"labels":[],"label_agreement":null},{"id":"W4408853818","doi":"10.1038/s44276-025-00133-6","title":"A phase Ia study of the MEK1/2 inhibitor PD-0325901 with the c-MET inhibitor crizotinib in patients with advanced solid cancers","year":2025,"lang":"en","type":"article","venue":"BJC Reports","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"FP7 Health; RECETOX Přírodovědecké Fakulty Masarykovy Univerzity; Takeda Oncology; Chugai Pharmaceutical; Bristol-Myers Squibb; Samsung; University of Oxford; Genentech; Cancer Research UK; Aptitude Health; Daiichi Sankyo Europe; Gilead Sciences; Servier; Queen's University; Merck KGaA; Ministerstvo Školství, Mládeže a Tělovýchovy; National Institute for Health and Care Research; Queen's University Belfast; Seagen; European Commission; Sanofi; GlaxoSmithKline; Amgen; Pfizer; Eli Lilly and Company; Associazione Italiana per la Ricerca sul Cancro; Les Laboratories Pierre Fabre; AstraZeneca","keywords":"Crizotinib; Tolerability; Medicine; Adverse effect; Internal medicine; Pharmacokinetics; Toxicity; Clinical trial; Oncology; Pharmacology; Colorectal cancer; ALK inhibitor; MEK inhibitor; Cancer; Lung cancer; Kinase; MAPK/ERK pathway; Chemistry","score_opus":0.004268398584754407,"score_gpt":0.2552967227798368,"score_spread":0.25102832419508236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408853818","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99328,0.00132877,0.0005774126,0.00025618257,0.0000703695,0.0023981708,0.00056362664,0.0000994881,0.0014261468],"genre_scores_gemma":[0.99361354,0.0008074631,0.0013765708,0.0003311852,0.00007828514,0.0012947624,0.0012140047,0.000018367418,0.0012658063],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99928445,0.0002693869,0.000041227355,0.00014294319,0.00008972505,0.00017228516],"domain_scores_gemma":[0.99935883,0.000044638964,0.00010588773,0.000059739228,0.000040743744,0.0003900963],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014717032,0.0019148153,0.0021607596,0.00057999714,0.0005346431,0.0011304456,0.0009265088,0.00094858377,0.0024355077],"category_scores_gemma":[0.00070360256,0.00072094076,0.0012938215,0.0005784961,0.0011445273,0.00078130537,0.0004202384,0.0032533633,0.00094970514],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.54916143,0.15373816,0.010722615,0.00083619123,0.001628934,0.0007547639,0.00064926676,0.0041402997,0.15545249,0.00039544931,0.004560347,0.11796002],"study_design_scores_gemma":[0.31819394,0.6501323,0.015584219,0.00002873776,0.0004950572,0.00073076534,0.000084866835,0.0014099962,0.010591575,0.00013364013,0.002576937,0.000038037633],"about_ca_topic_score_codex":0.0020333051,"about_ca_topic_score_gemma":0.004099458,"teacher_disagreement_score":0.0024355077,"about_ca_system_score_codex":0.001423576,"about_ca_system_score_gemma":0.0020127648,"threshold_uncertainty_score":0.010328889},"labels":[],"label_agreement":null},{"id":"W4409039258","doi":"10.1016/j.jcjo.2025.03.003","title":"Disproportionality analysis of BRAF and MEK inhibitors demonstrate risk of retinal detachment: an analysis of the FDA Adverse Event Reporting System","year":2025,"lang":"en","type":"letter","venue":"Canadian Journal of Ophthalmology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; University of British Columbia","funders":"","keywords":"Adverse effect; Medicine; Event (particle physics); Adverse Event Reporting System; Oncology; Pharmacology","score_opus":0.013670933649898555,"score_gpt":0.26224896115549584,"score_spread":0.2485780275055973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409039258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.53474116,0.003028811,0.003839927,0.4119166,0.004960454,0.0002420388,0.008544784,0.0002053755,0.032520838],"genre_scores_gemma":[0.8577539,0.00092512474,0.0023660266,0.12916368,0.0048987195,0.00009429884,0.0013884709,0.0000519874,0.0033578267],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98893636,0.0039422247,0.001712488,0.0010214057,0.003469649,0.0009178792],"domain_scores_gemma":[0.9110377,0.056041203,0.012445105,0.003814079,0.014138429,0.0025235827],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008868676,0.0001886659,0.0006083176,0.0020005477,0.001019886,0.0018826419,0.0007202767,0.00402605,0.0016653094],"category_scores_gemma":[0.05886552,0.00026787253,0.0010653326,0.0028616686,0.0005974965,0.00066733133,0.0006488764,0.0030485103,0.0005559026],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017334438,0.00021846125,0.80486774,0.000100292986,0.00066471845,0.005770715,0.00045188805,0.00056741305,0.0016418953,0.003614775,0.14526334,0.035105255],"study_design_scores_gemma":[0.00046515075,0.0007739102,0.8599914,0.0002872165,0.0013132918,0.014685766,0.0011450802,0.009749541,0.0036614987,0.006187701,0.101514205,0.0002253191],"about_ca_topic_score_codex":0.017391302,"about_ca_topic_score_gemma":0.026229732,"teacher_disagreement_score":0.017391302,"about_ca_system_score_codex":0.0024368705,"about_ca_system_score_gemma":0.0024327324,"threshold_uncertainty_score":0.046902597},"labels":[],"label_agreement":null},{"id":"W4409283259","doi":"10.1016/j.molcel.2025.03.015","title":"MLKL activity requires a splicing-regulated, druggable intramolecular interaction","year":2025,"lang":"en","type":"article","venue":"Molecular Cell","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"European Research Council; Medical Research Council; Natural Sciences and Engineering Research Council of Canada; Bundesministerium für Bildung und Forschung; Max-Planck-Gesellschaft; Deutsche Forschungsgemeinschaft; Canada Research Chairs; Wellcome Trust; Alexander von Humboldt-Stiftung","keywords":"Biology; Druggability; Intramolecular force; RNA splicing; Alternative splicing; Computational biology; Cell biology; Genetics; Gene; Gene isoform; Stereochemistry; RNA","score_opus":0.00469308000108386,"score_gpt":0.23257445785790754,"score_spread":0.22788137785682366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409283259","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99110293,0.0004084815,0.0069918176,0.000071534465,0.000023424256,0.000025648047,0.00007836769,0.00008054757,0.0012173044],"genre_scores_gemma":[0.9969921,0.00011068178,0.0020351352,0.000030965206,0.0000067979117,0.000010474099,0.00013091469,0.000017733979,0.00066521263],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99983156,0.00003950028,0.000017450551,0.000042524898,0.000047416517,0.00002159682],"domain_scores_gemma":[0.999828,0.00004020706,0.00006164132,0.00002930439,0.000012075998,0.000028775547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017859797,0.00017737014,0.00013180346,0.000059890957,0.00009906295,0.00022392155,0.00013034962,0.00017381756,0.0009696849],"category_scores_gemma":[0.00016945825,0.00007468097,0.00015137052,0.00006180559,0.00023087976,0.00015640547,0.00017873358,0.00043216758,0.00044625517],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002365133,0.000007306939,0.000102094215,0.0000051622587,0.0000013642368,0.000031669686,0.0000041920302,0.000025227326,0.9991467,0.000115376635,0.000007597297,0.00052961434],"study_design_scores_gemma":[0.000007752213,0.00010417879,0.0010286667,0.0000019667211,0.0000032041132,0.0002614605,0.000006392774,0.00047737802,0.9969284,0.00004204682,0.0011367013,0.0000018869289],"about_ca_topic_score_codex":0.0000841032,"about_ca_topic_score_gemma":0.00019631868,"teacher_disagreement_score":0.0009696849,"about_ca_system_score_codex":0.00017983875,"about_ca_system_score_gemma":0.00010898781,"threshold_uncertainty_score":0.0032439232},"labels":[],"label_agreement":null},{"id":"W4409403709","doi":"10.1093/mtomcs/mfag019","title":"The PBAF chromatin remodeling complex contributes to metal homeostasis through MTF1 regulation","year":2025,"lang":"en","type":"preprint","venue":"Metallomics","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; Center for Research Computing, University of Pittsburgh; National Institutes of Health; University of Pittsburgh; Canadian Institute for Advanced Research","keywords":"Chromatin remodeling; Chromatin; Cell biology; Homeostasis; Biology; Genetics; DNA","score_opus":0.03456263041632805,"score_gpt":0.2897207606766446,"score_spread":0.25515813026031653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409403709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9801651,0.0045011775,0.0098370565,0.00032094817,0.00006354401,0.000028642675,0.0010909506,0.00046186397,0.0035306423],"genre_scores_gemma":[0.9903751,0.00061603397,0.0023050439,0.00006352511,0.000019033503,0.000022466122,0.0010332259,0.00004467061,0.005520769],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99988914,0.000008061314,0.000006002315,0.000046936664,0.000026500054,0.000023486547],"domain_scores_gemma":[0.99990475,0.000008169622,0.000029528328,0.000009142155,0.00001761852,0.0000306933],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012089263,0.0004822973,0.00020326025,0.00025740985,0.0003200376,0.00042368541,0.00025913108,0.00032353488,0.0021840525],"category_scores_gemma":[0.00010303107,0.00022257185,0.00027631328,0.00013939329,0.00022653565,0.0001991347,0.0003267982,0.00035191636,0.0009906538],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000078454,0.000010169926,0.0010160039,0.000027178343,0.00000454327,0.00004162363,0.000011188265,0.00003256997,0.9970643,0.00013008731,0.00012406829,0.0014597968],"study_design_scores_gemma":[0.00002036262,0.000101807076,0.05316016,0.000013333668,0.000021297248,0.00049849425,0.000047859576,0.0027240065,0.9350117,0.00029937833,0.008091048,0.000010523886],"about_ca_topic_score_codex":0.0010296425,"about_ca_topic_score_gemma":0.0012770547,"teacher_disagreement_score":0.0021840525,"about_ca_system_score_codex":0.00035611272,"about_ca_system_score_gemma":0.0001786942,"threshold_uncertainty_score":0.007306397},"labels":[],"label_agreement":null},{"id":"W4410347733","doi":"10.21203/rs.3.rs-6635662/v1","title":"Adenosine kinase role in melanoma progression and resistance","year":2025,"lang":"en","type":"preprint","venue":"Research Square","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"Conselho Nacional de Desenvolvimento Científico e Tecnológico; Coordenação de Aperfeiçoamento de Pessoal de Nível Superior; Fundação de Amparo à Pesquisa do Estado de São Paulo","keywords":"Cancer research; Biology; Melanoma; Epigenetics; Neuroblastoma RAS viral oncogene homolog; Cell growth; Tumor microenvironment; Tumor progression; Cancer; Gene; Mutation; Genetics","score_opus":0.02505236830304632,"score_gpt":0.3624558500968223,"score_spread":0.337403481793776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410347733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5686171,0.18126647,0.039126553,0.02078093,0.002520017,0.000088989545,0.002993926,0.0007515901,0.1838544],"genre_scores_gemma":[0.94120234,0.020368993,0.0054007755,0.00026494323,0.00038036786,0.000023712793,0.0004493347,0.00005823416,0.031851366],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99993145,0.000016449902,0.0000028323534,0.000016490285,0.000018407369,0.000014338092],"domain_scores_gemma":[0.9999583,0.000010187585,0.000007634065,0.0000056659856,0.000006582017,0.000011724072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016325458,0.00032008917,0.00025646915,0.00031201614,0.00023676186,0.00090563286,0.00021013439,0.00058247626,0.004240848],"category_scores_gemma":[0.00020459096,0.00012386554,0.00017455882,0.00024206175,0.0002826268,0.0004926853,0.0002432862,0.0006665536,0.00090284226],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019717386,0.000196688,0.0030092073,0.000796771,0.00010449517,0.002143737,0.00018456749,0.005853836,0.65198326,0.20599896,0.016521288,0.11123555],"study_design_scores_gemma":[0.00036265585,0.00054743316,0.035700593,0.0002492281,0.00020783648,0.005467458,0.00044658422,0.031217583,0.32055983,0.39227957,0.21287462,0.000086641456],"about_ca_topic_score_codex":0.0007777094,"about_ca_topic_score_gemma":0.00054566347,"teacher_disagreement_score":0.004240848,"about_ca_system_score_codex":0.00053870166,"about_ca_system_score_gemma":0.00028769052,"threshold_uncertainty_score":0.014187038},"labels":[],"label_agreement":null},{"id":"W4410804792","doi":"10.1200/jco.2025.43.16_suppl.10037","title":"Post hoc analysis of rashes reported in patients (pts) with <i>BRAF</i> -altered relapsed/refractory (r/r) pediatric low-grade glioma (pLGG) treated with the type II RAF inhibitor tovorafenib in FIREFLY-1.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Post-hoc analysis; Refractory (planetary science); Post hoc; Glioma; Internal medicine; Oncology; Cancer research","score_opus":0.023774918182884755,"score_gpt":0.3318645945096321,"score_spread":0.3080896763267474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410804792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948809,0.00032782834,0.0002838788,0.00004198048,0.00006872534,0.00048565032,0.0030542717,0.000020355918,0.0008363881],"genre_scores_gemma":[0.9942827,0.00009347825,0.0003135335,0.00008151708,0.000054783388,0.0006930558,0.0036261273,0.000012647202,0.0008422126],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99798226,0.0008803848,0.00016442302,0.0004711763,0.00025412478,0.00024763434],"domain_scores_gemma":[0.9961196,0.0018496889,0.0009699771,0.00033968964,0.00038800397,0.00033320146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002374931,0.0005858411,0.0013070282,0.00046438366,0.0002544624,0.0006501287,0.000454656,0.00047829314,0.0058627087],"category_scores_gemma":[0.0039841034,0.00022007042,0.0030462272,0.000519269,0.00035122255,0.00054436683,0.0004820408,0.0011477967,0.000439875],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6561721,0.0038870971,0.2939561,0.0010851508,0.013481996,0.00044063534,0.00024624678,0.0018732244,0.0060569886,0.00013573798,0.004372234,0.018292481],"study_design_scores_gemma":[0.027133785,0.13642761,0.8126805,0.000067699206,0.009113118,0.00072626595,0.0004009569,0.0050328043,0.0037856307,0.00020211692,0.004361161,0.00006829084],"about_ca_topic_score_codex":0.0011228316,"about_ca_topic_score_gemma":0.0018861486,"teacher_disagreement_score":0.0058627087,"about_ca_system_score_codex":0.0007371633,"about_ca_system_score_gemma":0.00077469193,"threshold_uncertainty_score":0.01961273},"labels":[],"label_agreement":null},{"id":"W4410822612","doi":"10.1200/jco.2025.43.16_suppl.3117","title":"Exploring the efficacy and mechanism of action of combined pan-Raf and MEK inhibition in halting the growth of non-V600 BRAF mutated tumors.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; McGill University; University of Toronto; Jewish General Hospital","funders":"Conquer Cancer Foundation","keywords":"Medicine; Mechanism of action; Cancer research; Mechanism (biology); Trametinib; Pharmacology; MAPK/ERK pathway; Phosphorylation; In vitro; Cell biology; Biology; Genetics","score_opus":0.11044413258769474,"score_gpt":0.38591487342573005,"score_spread":0.2754707408380353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410822612","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915481,0.0044722026,0.0006461088,0.00015328043,0.00005213224,0.000188035,0.00048086353,0.00005239426,0.0024069492],"genre_scores_gemma":[0.99501795,0.0018081641,0.001151367,0.000054474396,0.00001777773,0.00007899175,0.00039929172,0.0000069848156,0.0014649936],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998529,0.000034684195,0.00000915009,0.000023992206,0.00003391213,0.000045289595],"domain_scores_gemma":[0.99990094,0.000024613933,0.000017556396,0.00000977801,0.000010192141,0.000036941048],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034290503,0.00038768802,0.00048213295,0.0002872597,0.00014631613,0.0003425734,0.00043220402,0.00032472395,0.002269242],"category_scores_gemma":[0.00013074973,0.00020063616,0.00044309022,0.00021610102,0.00023669572,0.0004142632,0.00018321488,0.0008110231,0.00039320788],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009025741,0.005898455,0.0029332181,0.0005799116,0.00016537751,0.00018422681,0.00009645898,0.0018388673,0.93378544,0.00027605757,0.00083344843,0.044382863],"study_design_scores_gemma":[0.0021278989,0.12674439,0.026708711,0.000045147524,0.00038460176,0.0011112574,0.00015010632,0.004501556,0.8292396,0.00014479375,0.008799782,0.00004204325],"about_ca_topic_score_codex":0.0010605818,"about_ca_topic_score_gemma":0.004213385,"teacher_disagreement_score":0.002269242,"about_ca_system_score_codex":0.00042466656,"about_ca_system_score_gemma":0.00045807988,"threshold_uncertainty_score":0.007591367},"labels":[],"label_agreement":null},{"id":"W4410850949","doi":"10.1126/science.adp2742","title":"BRAF oncogenic mutants evade autoinhibition through a common mechanism","year":2025,"lang":"en","type":"article","venue":"Science","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; University of Calgary; Institute for Research in Immunology and Cancer","funders":"National Cancer Institute","keywords":"Mutant; Kinase; Protein kinase domain; Mutation; Cell biology; Helix (gastropod); MAPK/ERK pathway; V600E; HEK 293 cells; Extracellular; Biology; Protein kinase A; Signal transduction; Point mutation; Chemistry; Biochemistry; Receptor; Gene","score_opus":0.009250420946475735,"score_gpt":0.2858589757979586,"score_spread":0.2766085548514829,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410850949","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99330455,0.0010306548,0.002864129,0.00008019673,0.000013686562,0.000020515243,0.00008248922,0.0001458991,0.002457757],"genre_scores_gemma":[0.9973465,0.00033195614,0.0013307789,0.000042490545,0.0000027227613,0.000012764863,0.00006539141,0.00001193332,0.00085545116],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998841,0.000010835326,0.00000668024,0.000020587931,0.00005465927,0.000023071821],"domain_scores_gemma":[0.9999294,0.000007422057,0.000023712717,0.000011763076,0.000010265605,0.000017437667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008797093,0.00034279865,0.0003014294,0.00017027766,0.00016390157,0.000283482,0.0002617083,0.0002787904,0.0005487543],"category_scores_gemma":[0.00009143163,0.00021457265,0.00033801826,0.000078407975,0.00030813765,0.00023780164,0.00031184455,0.00054405816,0.00022850711],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044655506,0.000012994874,0.00018610596,0.000024313511,0.000010250364,0.00008414276,0.000010159505,0.00021104081,0.9974874,0.0006031125,0.000035511595,0.0012902444],"study_design_scores_gemma":[0.00005058337,0.00020158195,0.0051605985,0.000007683232,0.000019545194,0.0011466537,0.000023482098,0.00286069,0.9870781,0.0003640864,0.0030741417,0.000012853501],"about_ca_topic_score_codex":0.0005154155,"about_ca_topic_score_gemma":0.001121865,"teacher_disagreement_score":0.0005487543,"about_ca_system_score_codex":0.0003578344,"about_ca_system_score_gemma":0.00023950661,"threshold_uncertainty_score":0.0025963187},"labels":[],"label_agreement":null},{"id":"W4410923604","doi":"10.14738/bjhr.1202.18696","title":"Case Report: Malignant Melanoma Treated with Ipilimumab and Nivolumab in Patient with Multiple Sclerosis","year":2025,"lang":"en","type":"article","venue":"British journal of healthcare and medical research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency","funders":"","keywords":"Nivolumab; Ipilimumab; Melanoma; Medicine; Multiple sclerosis; Dermatology; Oncology; Metastatic melanoma; Internal medicine; Immunotherapy; Cancer research; Cancer; Immunology","score_opus":0.035081720030283293,"score_gpt":0.313850099638557,"score_spread":0.27876837960827366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410923604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93352705,0.013553513,0.006705634,0.013958145,0.0014791418,0.00041200587,0.0005176368,0.000423936,0.029423008],"genre_scores_gemma":[0.98721355,0.0023876557,0.0021754256,0.0022097763,0.001804977,0.000054443757,0.00010586285,0.000038321756,0.0040100426],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99930155,0.00008631012,0.0000662389,0.00020980672,0.00009332937,0.00024286068],"domain_scores_gemma":[0.99899393,0.00019580698,0.00026530455,0.00009510373,0.00008487864,0.00036497126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033541935,0.002045531,0.0013478794,0.0021389367,0.0041835033,0.0018543855,0.0011667146,0.006941744,0.003992183],"category_scores_gemma":[0.0020402642,0.0010535843,0.0016324967,0.0014963377,0.0015675753,0.0023992884,0.0016358919,0.004462631,0.0013372272],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024837995,0.00004304048,0.0021588004,0.000018522851,0.000007306432,0.99618125,0.0001482093,0.000034096043,0.0002631668,0.0001065699,0.00029881854,0.0007153707],"study_design_scores_gemma":[0.0000046319897,0.00002583408,0.0007682556,0.0000070414467,0.000006901013,0.99846786,0.00006512053,0.000060992792,0.00011794257,0.00007234831,0.00039821395,0.000004821792],"about_ca_topic_score_codex":0.00271234,"about_ca_topic_score_gemma":0.0030716308,"teacher_disagreement_score":0.006941744,"about_ca_system_score_codex":0.0012430672,"about_ca_system_score_gemma":0.0008816221,"threshold_uncertainty_score":0.013355136},"labels":[],"label_agreement":null},{"id":"W4411027220","doi":"10.1200/jco.2025.43.17_suppl.lba9500","title":"Nivolumab plus relatlimab vs nivolumab alone for the adjuvant treatment of completely resected stage III–IV melanoma: Primary results from RELATIVITY-098.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Nivolumab; Adjuvant; Stage (stratigraphy); Oncology; Internal medicine; Immunotherapy; Cancer","score_opus":0.09703807293845568,"score_gpt":0.39292538388310383,"score_spread":0.29588731094464815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411027220","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99011,0.0038665326,0.00037273424,0.0003236034,0.0003016068,0.0020061648,0.0011854193,0.00007195258,0.001762083],"genre_scores_gemma":[0.9895465,0.0023482265,0.001144331,0.00061760267,0.00033614857,0.0017931736,0.0014132706,0.000028749471,0.002772044],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9994593,0.00028685236,0.00003320247,0.0000865937,0.000046126475,0.00008792774],"domain_scores_gemma":[0.99911577,0.00020224287,0.0002398958,0.00007408034,0.00004990252,0.00031807472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024577675,0.0013874843,0.0020804459,0.00042667578,0.0003309074,0.00081029703,0.0011180105,0.000953197,0.0048111314],"category_scores_gemma":[0.001206899,0.00065446546,0.002403666,0.0003478666,0.0008263726,0.00077462586,0.0004800265,0.0033424718,0.00088604714],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.92877525,0.026096858,0.0012921416,0.0008451877,0.0014383901,0.000044902605,0.00007637884,0.00066666637,0.008752483,0.000083845836,0.0012347287,0.030693185],"study_design_scores_gemma":[0.46955854,0.5170568,0.0075307046,0.00007392312,0.001717305,0.00010092526,0.000041596388,0.0005965142,0.0017877774,0.00013954913,0.0013697308,0.000026711867],"about_ca_topic_score_codex":0.0012767902,"about_ca_topic_score_gemma":0.0044749924,"teacher_disagreement_score":0.0048111314,"about_ca_system_score_codex":0.0010330933,"about_ca_system_score_gemma":0.0013948891,"threshold_uncertainty_score":0.016094863},"labels":[],"label_agreement":null},{"id":"W4411253612","doi":"10.1016/j.xcrm.2025.102183","title":"BRAF/MEK inhibition induces cell state transitions boosting immune checkpoint sensitivity in BRAFV600E-mutant glioma","year":2025,"lang":"en","type":"article","venue":"Cell Reports Medicine","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Stanford Cancer Institute; Baton Rouge Area Foundation; National Institutes of Health; National Cancer Institute; National Institute of Neurological Disorders and Stroke; University of California, San Francisco","keywords":"Boosting (machine learning); Mutant; Glioma; Cancer research; Immune checkpoint; Sensitivity (control systems); Immune system; Melanoma; Chemistry; Biology; Immunotherapy; Immunology; Computer science; Genetics; Gene; Artificial intelligence","score_opus":0.008069683595600147,"score_gpt":0.23174627332294867,"score_spread":0.22367658972734852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411253612","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966799,0.00068230357,0.0009842361,0.000093127666,0.00003627936,0.000020456146,0.00013964542,0.00012731108,0.0012368266],"genre_scores_gemma":[0.9977737,0.00036093927,0.00044278213,0.000038071976,0.000006008776,0.000015949021,0.00009850832,0.000012381041,0.001251486],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999387,0.0000066599305,0.0000041102703,0.000011389784,0.000011461143,0.000027758235],"domain_scores_gemma":[0.99997747,0.0000028044974,0.0000061439446,0.0000030171536,0.00000224085,0.000008186924],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006406459,0.00024985112,0.00017120238,0.00013680434,0.000099193014,0.00021524105,0.00014964436,0.0001720263,0.0012612999],"category_scores_gemma":[0.000055359702,0.00012628116,0.00024950856,0.00007691002,0.00013384638,0.00013115555,0.00012423673,0.00049235503,0.000208209],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029828912,0.0000879138,0.00012465494,0.000025212552,0.0000063831203,0.00002571863,0.000011881783,0.00007182243,0.9962017,0.00010831107,0.00009580504,0.0029423577],"study_design_scores_gemma":[0.000049468676,0.0009979609,0.0030462737,0.0000031741322,0.000022807637,0.000094306575,0.000017131335,0.0011821929,0.99238306,0.00007854775,0.0021189032,0.000006218206],"about_ca_topic_score_codex":0.0006772265,"about_ca_topic_score_gemma":0.0013999562,"teacher_disagreement_score":0.0012612999,"about_ca_system_score_codex":0.0001876215,"about_ca_system_score_gemma":0.00012903013,"threshold_uncertainty_score":0.0042194724},"labels":[],"label_agreement":null},{"id":"W4412073469","doi":"10.1038/s41698-025-01025-1","title":"Exceptional response to the ATR inhibitor, camonsertib, in a patient with ALT+ metastatic melanoma","year":2025,"lang":"en","type":"article","venue":"npj Precision Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Telesta Therapeutics (Canada)","funders":"National Cancer Institute; University of Texas MD Anderson Cancer Center; National Institutes of Health; U.S. Department of Defense","keywords":"Metastatic melanoma; Melanoma; Medicine; Dermatology; Internal medicine; Oncology; Cancer research","score_opus":0.01024201955165141,"score_gpt":0.28245354135337647,"score_spread":0.27221152180172503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412073469","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98096496,0.001845368,0.0018030225,0.0037684424,0.00013795614,0.00010109598,0.00038190864,0.00018763517,0.01080958],"genre_scores_gemma":[0.9963529,0.00041497638,0.00057240255,0.00062572677,0.00005691412,0.0000075211765,0.000094743176,0.0000154183,0.0018593987],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9998692,0.00001353728,0.000013448928,0.000046547342,0.000025234762,0.000031905874],"domain_scores_gemma":[0.9996062,0.00007040059,0.00006177694,0.000021966513,0.000034234286,0.00020558365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013524956,0.0005288548,0.00042760902,0.0006300083,0.00076489453,0.0004093087,0.0003369849,0.001281643,0.0011141001],"category_scores_gemma":[0.000762671,0.00018831204,0.0003860978,0.00033356296,0.00039309205,0.0004231784,0.00031266263,0.0012663696,0.00027046292],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029581753,0.00011536554,0.023202252,0.000063317675,0.000031403673,0.9505999,0.00034166628,0.0004586227,0.013551311,0.0003451278,0.0011476864,0.009847395],"study_design_scores_gemma":[0.000023289618,0.0006225494,0.04127669,0.000021710217,0.0000485765,0.951189,0.00015062261,0.0013201648,0.0035166396,0.0002746886,0.0015354623,0.000020579082],"about_ca_topic_score_codex":0.0022116737,"about_ca_topic_score_gemma":0.005095149,"teacher_disagreement_score":0.0022116737,"about_ca_system_score_codex":0.00059815205,"about_ca_system_score_gemma":0.0003481242,"threshold_uncertainty_score":0.0043976307},"labels":[],"label_agreement":null},{"id":"W4412516480","doi":"10.3390/ijms26146957","title":"Hydroxytyrosol Reprograms the Tumor Microenvironment in 3D Melanoma Models by Suppressing ERBB Family and Kinase Pathways","year":2025,"lang":"en","type":"article","venue":"International Journal of Molecular Sciences","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National de la Recherche Scientifique","funders":"Malta Council for Science and Technology","keywords":"Hydroxytyrosol; ErbB; Melanoma; Cancer research; MAPK/ERK pathway; Cell cycle; Protein kinase B; PI3K/AKT/mTOR pathway; Oncogene; Biology; Signal transduction; Apoptosis; Cell; Kinase; Chemistry; Cell biology; Biochemistry","score_opus":0.01090314123258337,"score_gpt":0.2428423201403975,"score_spread":0.23193917890781413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412516480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99182,0.0020380078,0.0042903917,0.0000985732,0.00003496942,0.000032883392,0.00040729463,0.00007889986,0.001199014],"genre_scores_gemma":[0.993404,0.0014799725,0.003165546,0.000058580816,0.0000074007303,0.00005394896,0.0003604084,0.000015491358,0.001454879],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99994147,0.000011816074,0.000004326522,0.000011074564,0.000017768129,0.000013612364],"domain_scores_gemma":[0.9999695,0.0000042703555,0.000009943921,0.0000042075753,0.000004372066,0.000007761429],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010443766,0.0002784554,0.00018531337,0.00018824435,0.00012723447,0.00020305859,0.0001069878,0.00018455672,0.0004913871],"category_scores_gemma":[0.000047536992,0.00009504668,0.00024185644,0.00009761492,0.00013833256,0.0001702749,0.00012621447,0.00040001803,0.00011356007],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007133441,0.000024778567,0.00009829261,0.00003531929,0.00000430385,0.000031645308,0.000009721071,0.00009118034,0.9987251,0.00004976621,0.000029011493,0.00082955876],"study_design_scores_gemma":[0.000012827207,0.0002371944,0.0022096776,0.0000038228354,0.000017881703,0.00013378997,0.000021978514,0.0010573468,0.9941584,0.00003813221,0.0021049653,0.000003966066],"about_ca_topic_score_codex":0.00061443326,"about_ca_topic_score_gemma":0.0012970639,"teacher_disagreement_score":0.00061443326,"about_ca_system_score_codex":0.00014394864,"about_ca_system_score_gemma":0.00016333445,"threshold_uncertainty_score":0.0016438365},"labels":[],"label_agreement":null},{"id":"W4412975036","doi":"10.3390/ph18081161","title":"Design, Synthesis, and Bioactivity Assessment of Modified Vemurafenib Analog","year":2025,"lang":"en","type":"article","venue":"Pharmaceuticals","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro; Conselho Nacional de Desenvolvimento Científico e Tecnológico","keywords":"Vemurafenib; Medicine; Melanoma; Cancer research; Metastasis; Matrix metalloproteinase; Drug resistance; Malignancy; V600E; Pharmacology; Oncology; Internal medicine; Metastatic melanoma; Cancer; Mutation; Chemistry; Biology; Biochemistry","score_opus":0.04929140372200529,"score_gpt":0.37330805511450804,"score_spread":0.32401665139250274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412975036","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97317976,0.0037005427,0.017415185,0.00010488256,0.000047147485,0.0002897414,0.00058150623,0.000057383928,0.0046238727],"genre_scores_gemma":[0.98926264,0.0013721228,0.006868218,0.00003694947,0.000008159314,0.000072162744,0.0004185355,0.000009269516,0.0019519344],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99994004,0.000010747649,0.000005491362,0.000012497609,0.000017051998,0.000014161268],"domain_scores_gemma":[0.99995875,0.000004267891,0.000013546926,0.000003879931,0.00001027477,0.000009253393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011269126,0.00026836307,0.00015358847,0.00014616358,0.0000860827,0.00013169857,0.00020543995,0.0001730565,0.0011156035],"category_scores_gemma":[0.00012143322,0.00006885828,0.00020403576,0.00012451259,0.00007983181,0.00014289899,0.000116357114,0.00021911277,0.00027542218],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022458844,0.00015798517,0.00015861636,0.00023148904,0.000018018474,0.00018227613,0.000034655484,0.0019314142,0.9859918,0.00030126574,0.000119275406,0.010648704],"study_design_scores_gemma":[0.00012158735,0.003632371,0.0013191922,0.00001882653,0.00003614061,0.0005187443,0.00002395323,0.0024111797,0.9811211,0.00010273639,0.0106732715,0.000020777472],"about_ca_topic_score_codex":0.00025690428,"about_ca_topic_score_gemma":0.00037555298,"teacher_disagreement_score":0.0011156035,"about_ca_system_score_codex":0.00017110854,"about_ca_system_score_gemma":0.00016580116,"threshold_uncertainty_score":0.0037320256},"labels":[],"label_agreement":null},{"id":"W4413057852","doi":"10.21203/rs.3.rs-6857127/v1","title":"mTOR inhibition enhances the antitumor efficacy of RAF dimer-MEK blockade by inhibiting the ATF4-MTHFD2 pathway","year":2025,"lang":"en","type":"preprint","venue":"Research Square","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Cancer research; MEK inhibitor; Vemurafenib; Mutant; Melanoma; Neuroblastoma RAS viral oncogene homolog; Biology; Mutation; MAPK/ERK pathway; Gene; KRAS; Kinase; Genetics; Metastatic melanoma","score_opus":0.028942815259880534,"score_gpt":0.3385003813407827,"score_spread":0.3095575660809022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413057852","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98853755,0.0021912018,0.001364326,0.00037685857,0.00011389438,0.000033302276,0.00079786027,0.0002135198,0.006371518],"genre_scores_gemma":[0.99494815,0.00061906525,0.0008064233,0.000041628165,0.000015003199,0.000017688746,0.00048406975,0.000020339168,0.0030477114],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999374,0.000007847546,0.0000030253655,0.000009116186,0.000013244609,0.00002936316],"domain_scores_gemma":[0.99997926,0.000003682703,0.0000034046411,0.0000028163329,0.000002162533,0.000008616524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000078072895,0.00031809052,0.0002908943,0.00018728082,0.00013549946,0.00019148881,0.00018169924,0.00024584134,0.004852803],"category_scores_gemma":[0.00007895879,0.00009378282,0.00020960892,0.000105158986,0.00011226974,0.00018989205,0.00013500654,0.00075235596,0.00069208606],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003667863,0.00051463395,0.00027798847,0.00012438142,0.00003870994,0.00010392367,0.000014867131,0.0006742512,0.97299725,0.000455815,0.0014190675,0.019711303],"study_design_scores_gemma":[0.00019597111,0.0012899885,0.0024756705,0.0000065635118,0.00003796831,0.00028177325,0.00001873469,0.0014527777,0.9883648,0.00014717126,0.005721784,0.0000068543054],"about_ca_topic_score_codex":0.0005645655,"about_ca_topic_score_gemma":0.0009611419,"teacher_disagreement_score":0.004852803,"about_ca_system_score_codex":0.00019684766,"about_ca_system_score_gemma":0.00026077603,"threshold_uncertainty_score":0.01623422},"labels":[],"label_agreement":null},{"id":"W4413094252","doi":"10.1080/07391102.2025.2543358","title":"Mutation-specific structural changes in BRAF: understanding dimerization and drug binding for targeted therapy","year":2025,"lang":"en","type":"article","venue":"Journal of Biomolecular Structure and Dynamics","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pancreas Centre (Canada)","funders":"","keywords":"Allosteric regulation; Sorafenib; Mutation; Mutant; MAPK/ERK pathway; Cancer research; Kinase; Carcinogenesis; HEK 293 cells; V600E; Plasma protein binding; Protein structure; Biology; Chemistry; Cell biology; Biochemistry; Enzyme; Gene","score_opus":0.008845506066400517,"score_gpt":0.24243876862815797,"score_spread":0.23359326256175744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413094252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9209033,0.0076256813,0.0614644,0.0017894635,0.000071911636,0.000082545834,0.00022832536,0.0003573683,0.0074769044],"genre_scores_gemma":[0.9886419,0.0029989767,0.0075417073,0.00013129252,0.000015991194,0.000042754433,0.00011523151,0.00004179108,0.00047020012],"study_design_codex":"simulation_or_modeling","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999194,0.000017654942,0.0000027705744,0.000013476027,0.000028125156,0.000018546296],"domain_scores_gemma":[0.9999443,0.000022290245,0.000011869359,0.0000048181173,0.0000069123516,0.0000097778275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002177808,0.00054368726,0.0005511425,0.00013890276,0.00038752749,0.00037097372,0.0005493797,0.0006275324,0.0009321483],"category_scores_gemma":[0.00036284735,0.0002967287,0.00043661275,0.00013701792,0.00039940895,0.0009209245,0.0004046095,0.00076987414,0.00018994694],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030961214,0.00023812785,0.0033299702,0.00046383645,0.000116479256,0.0006484417,0.00024347728,0.6524891,0.2891116,0.020251265,0.0013183551,0.03147958],"study_design_scores_gemma":[0.00006035398,0.0003064166,0.001897485,0.00003178024,0.000046094592,0.00018440193,0.00013200613,0.95054895,0.030270103,0.011963642,0.004516129,0.000042595988],"about_ca_topic_score_codex":0.003525733,"about_ca_topic_score_gemma":0.0032932614,"teacher_disagreement_score":0.003525733,"about_ca_system_score_codex":0.00082519074,"about_ca_system_score_gemma":0.0007220133,"threshold_uncertainty_score":0.0070104003},"labels":[],"label_agreement":null},{"id":"W4413306536","doi":"10.4204/eptcs.426.12","title":"Dagger-Drazin Inverses","year":2025,"lang":"en","type":"article","venue":"Electronic Proceedings in Theoretical Computer Science","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Natural Sciences and Engineering Research Council of Canada; Eesti Teadusagentuur","keywords":"Dagger; Mathematics; Computer science; Algebra over a field; Pure mathematics; Philosophy; Theology","score_opus":0.0031368408452571005,"score_gpt":0.23388263556294983,"score_spread":0.23074579471769274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413306536","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15964898,0.0019525333,0.6713759,0.0012019324,0.00083176536,0.00011730952,0.0004615,0.00096703967,0.163443],"genre_scores_gemma":[0.803797,0.001149371,0.13047175,0.0011129754,0.0004041542,0.00018640741,0.0004149195,0.00053232483,0.061931055],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99773574,0.00047677578,0.00023427553,0.00063283235,0.00058691035,0.0003333784],"domain_scores_gemma":[0.9976433,0.0007361303,0.0002709595,0.00054045045,0.0005976892,0.00021148563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016693638,0.0007404524,0.00057506753,0.002154364,0.0014520427,0.002905439,0.00061634067,0.0011198636,0.007332705],"category_scores_gemma":[0.0031222086,0.00046803063,0.0015179651,0.00094470545,0.0044545988,0.005891798,0.0036563308,0.0027192275,0.0019064985],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017741379,0.000011480111,0.00026457364,0.00005187568,0.000009949867,0.00015673482,0.00043317038,0.0003023642,0.0026046538,0.9850211,0.000537138,0.010589144],"study_design_scores_gemma":[0.000007798339,0.000052241434,0.0004675009,0.00003614985,0.000014378661,0.0008461337,0.00028682497,0.0016387282,0.0038396253,0.9561112,0.03665583,0.000043507087],"about_ca_topic_score_codex":0.00036849777,"about_ca_topic_score_gemma":0.0005248352,"teacher_disagreement_score":0.007332705,"about_ca_system_score_codex":0.00075814466,"about_ca_system_score_gemma":0.00042220834,"threshold_uncertainty_score":0.024530351},"labels":[],"label_agreement":null},{"id":"W4413450173","doi":"10.1101/2025.08.18.670743","title":"O-mannosylation and protein maturation check-points represent therapeutic opportunities in BRAF fusion protein oncogenesis","year":2025,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Carcinogenesis; Fusion protein; Fusion; Cancer research; Computational biology; Biology; Genetics; Cancer; Philosophy; Gene; Recombinant DNA","score_opus":0.024032494674530586,"score_gpt":0.2322331060019839,"score_spread":0.20820061132745332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413450173","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9151754,0.020410186,0.042847883,0.003081648,0.00029918455,0.00015112896,0.0005758497,0.0007260378,0.016732793],"genre_scores_gemma":[0.9749937,0.0069396608,0.011736248,0.00017716516,0.00006919959,0.00004244335,0.0002811493,0.00006625559,0.0056941723],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998981,0.000018211125,0.00000520314,0.000019539959,0.000034964043,0.00002396562],"domain_scores_gemma":[0.99995553,0.000008683914,0.000012020796,0.0000082260785,0.000004348482,0.000011247835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002620891,0.00041928585,0.00028799076,0.00022227835,0.00022302114,0.00063520274,0.00019086502,0.00050720177,0.0012744763],"category_scores_gemma":[0.00015860944,0.00018637658,0.00023416306,0.00015846235,0.00038343173,0.0004929721,0.00036058592,0.00093196274,0.00041071777],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002707408,0.00004603438,0.00026929358,0.000070227994,0.000007877829,0.00017262391,0.000022792845,0.0004845603,0.9859577,0.0033406226,0.00028700457,0.009070597],"study_design_scores_gemma":[0.0000400275,0.0002432318,0.0010618423,0.000009893622,0.000017236905,0.0006851393,0.000025743408,0.0015092707,0.9790813,0.0019045783,0.015412764,0.0000090163585],"about_ca_topic_score_codex":0.00020194892,"about_ca_topic_score_gemma":0.00035320586,"teacher_disagreement_score":0.0012744763,"about_ca_system_score_codex":0.0003979713,"about_ca_system_score_gemma":0.0002601991,"threshold_uncertainty_score":0.0042635202},"labels":[],"label_agreement":null},{"id":"W4413843120","doi":"10.1101/2025.08.26.672105","title":"Metabolic rewiring of cancer cells induces metastasis via ERK5 but triggers recognition by NK cells","year":2025,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Nautical Research Society","funders":"Direction Générale de l’offre de Soins; Région Occitanie Pyrénées-Méditerranée; Université de Montpellier; Institut National Du Cancer; Centre Hospitalier Régional Universitaire de Montpellier; Agence Nationale de la Recherche","keywords":"Cancer cell; Metastasis; Cancer; Cancer research; Cancer metastasis; Cell biology; Chemistry; Biology; Genetics","score_opus":0.014844090479305462,"score_gpt":0.22857418518903128,"score_spread":0.21373009470972582,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413843120","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899408,0.0017881278,0.0037662506,0.00030016544,0.000059476784,0.00003037751,0.0005328138,0.00011736254,0.0034645933],"genre_scores_gemma":[0.99340904,0.00065356476,0.0019369988,0.000066812914,0.0000068778577,0.000030937867,0.00041342212,0.0000139354015,0.0034683412],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999101,0.000013647981,0.000007989943,0.000018938752,0.000020059646,0.00002923302],"domain_scores_gemma":[0.99997354,0.0000028924178,0.000008647409,0.0000040268424,0.0000026086893,0.000008170497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008206209,0.00026817227,0.00013650594,0.00012291686,0.000120880984,0.00019190316,0.00014218,0.0001693061,0.0017265701],"category_scores_gemma":[0.000041057294,0.0001014959,0.00023394391,0.00007692763,0.00014232271,0.00015003857,0.00016713225,0.00054184214,0.00036851692],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007665814,0.000021459413,0.0000810022,0.000028326076,0.000002681607,0.000023743485,0.0000036235047,0.000051330506,0.9987531,0.00016187507,0.00004809943,0.00074801885],"study_design_scores_gemma":[0.000016157861,0.00012415495,0.0021170173,0.0000048017855,0.0000065966715,0.00010270166,0.000014068175,0.000873002,0.99445194,0.00006921937,0.002217936,0.0000023599976],"about_ca_topic_score_codex":0.00044124242,"about_ca_topic_score_gemma":0.0006853532,"teacher_disagreement_score":0.0017265701,"about_ca_system_score_codex":0.00027387202,"about_ca_system_score_gemma":0.0001664922,"threshold_uncertainty_score":0.0057759285},"labels":[],"label_agreement":null},{"id":"W4414292789","doi":"10.1038/s44321-025-00297-1","title":"Impaired migration and lung invasion of human melanoma by a novel small molecule targeting the transmembrane domain of death receptor p75NTR","year":2025,"lang":"en","type":"article","venue":"EMBO Molecular Medicine","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital; University of Calgary","funders":"Peking University; Vetenskapsrådet; National Natural Science Foundation of China; Cancerfonden; Canadian Cancer Society","keywords":"Fascin; Melanoma; Small molecule; Filopodia; Transmembrane protein; Receptor; Extracellular; Intracellular; Low-affinity nerve growth factor receptor","score_opus":0.008880508441601851,"score_gpt":0.23456900386811294,"score_spread":0.2256884954265111,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414292789","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99630296,0.0012591757,0.0010318324,0.000053368436,0.000024020104,0.00005578948,0.00013126963,0.000030131867,0.0011114158],"genre_scores_gemma":[0.99586284,0.0008225581,0.0012696147,0.00003736772,0.0000069558855,0.000048955917,0.00018943641,0.0000038132991,0.0017583914],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99995327,0.000008956868,0.0000034813793,0.000007707618,0.000011778568,0.000014778905],"domain_scores_gemma":[0.9999759,0.000005311958,0.0000045633205,0.0000028472587,0.0000031709349,0.000008130811],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008247041,0.00042034977,0.00019115116,0.00016450247,0.00011329973,0.00011916747,0.00012524612,0.0001740544,0.0010050696],"category_scores_gemma":[0.000067134424,0.0000894003,0.00018690834,0.00007602769,0.000112879585,0.00008518551,0.0001059498,0.0002857734,0.00018990618],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010182642,0.00009136021,0.00007528974,0.000027187487,0.00000627206,0.000059777147,0.0000069544526,0.000113062095,0.99763465,0.00004196504,0.00003625809,0.0018054699],"study_design_scores_gemma":[0.000077514596,0.0027474328,0.0017721571,0.0000048837633,0.000026190572,0.0002624692,0.000011704673,0.0009904809,0.9923701,0.000025077716,0.0017074156,0.00000460314],"about_ca_topic_score_codex":0.00077022566,"about_ca_topic_score_gemma":0.0012679199,"teacher_disagreement_score":0.0010050696,"about_ca_system_score_codex":0.00019774026,"about_ca_system_score_gemma":0.00020341262,"threshold_uncertainty_score":0.0033623576},"labels":[],"label_agreement":null},{"id":"W4414565348","doi":"10.51731/cjht.2025.1232","title":"Mirikizumab (Omvoh)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Drug; Public health; Disease; Pharmacotherapy","score_opus":0.010457072088659793,"score_gpt":0.2574572150895341,"score_spread":0.24700014300087433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414565348","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.39357027,0.35597548,0.0100796595,0.013028222,0.0041170116,0.0014665656,0.0051086685,0.0045917938,0.2120623],"genre_scores_gemma":[0.85817635,0.049268275,0.009357771,0.0053244736,0.0005547128,0.00045098306,0.0062065762,0.000119004464,0.07054184],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999845,0.00001798277,0.000009997566,0.000026494032,0.00006127816,0.000039165465],"domain_scores_gemma":[0.9999331,0.000005936229,0.0000145802105,0.0000055336122,0.00001419343,0.000026672544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001993678,0.0002773352,0.00040913784,0.0005155661,0.00030361736,0.00042465606,0.0002988512,0.0005283809,0.006077168],"category_scores_gemma":[0.00020357851,0.00012033872,0.00035364318,0.00025989264,0.00021198195,0.0002704142,0.00031129323,0.0013315609,0.002862632],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036867764,0.0010626921,0.0026385116,0.0016182445,0.00020126168,0.0010904879,0.00006829779,0.00037318093,0.15960401,0.0038814691,0.0679624,0.7578126],"study_design_scores_gemma":[0.0058369627,0.0066198464,0.031027263,0.00058845937,0.00030422062,0.01056692,0.00007471839,0.0013915562,0.09304188,0.0022209825,0.8482391,0.000088094785],"about_ca_topic_score_codex":0.0017767332,"about_ca_topic_score_gemma":0.004080457,"teacher_disagreement_score":0.006077168,"about_ca_system_score_codex":0.0006071346,"about_ca_system_score_gemma":0.00053648296,"threshold_uncertainty_score":0.020330131},"labels":[],"label_agreement":null},{"id":"W4415067350","doi":"10.1038/s41416-025-03216-w","title":"Modeling response to the KRAS-G12C inhibitor AZD4625 in KRASG12C NSCLC patient-derived xenografts reveals insights into primary resistance mechanisms","year":2025,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Princess Margaret Cancer Centre; Public Health Ontario; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research; Genome British Columbia; Genome Canada; Scheme for Promotion of Academic and Research Collaboration; AstraZeneca","keywords":"Acquired resistance; Drug resistance; Primary (astronomy); Cancer; Resistance (ecology)","score_opus":0.005566039474640553,"score_gpt":0.23504852688843866,"score_spread":0.22948248741379812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415067350","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973562,0.00027795925,0.0015657197,0.000024572304,0.0000033964002,0.000011491737,0.0004484816,0.000031316707,0.0002808546],"genre_scores_gemma":[0.99646336,0.00039339424,0.001836059,0.000011181073,0.0000011082952,0.00001623964,0.00065800257,0.000010140425,0.0006105719],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99994564,0.000006837513,0.0000035253004,0.000016040636,0.000016480786,0.000011503973],"domain_scores_gemma":[0.9999647,0.000008383962,0.000009696218,0.0000044372628,0.000004782758,0.000008097755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007927074,0.00022917085,0.00026444023,0.00013399783,0.00008394776,0.00025315493,0.00016325114,0.00023232904,0.0007355613],"category_scores_gemma":[0.00007702166,0.00010223559,0.00026297744,0.0001600216,0.00009932013,0.00013650542,0.00010450979,0.0003708148,0.00019923042],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020195066,0.000050360573,0.00279918,0.000027030135,0.000014063696,0.0000593332,0.000022298149,0.0064393175,0.98846215,0.000051721687,0.000056345576,0.0018162107],"study_design_scores_gemma":[0.000020073243,0.0016766795,0.022819035,0.000003825266,0.00003976466,0.0003466484,0.000084936924,0.04068347,0.9328889,0.00009384577,0.0013318873,0.000010765799],"about_ca_topic_score_codex":0.0020802042,"about_ca_topic_score_gemma":0.002218162,"teacher_disagreement_score":0.0020802042,"about_ca_system_score_codex":0.0003732065,"about_ca_system_score_gemma":0.00017538432,"threshold_uncertainty_score":0.0041362047},"labels":[],"label_agreement":null},{"id":"W4415762739","doi":"10.1016/j.celrep.2025.116495","title":"CDK12 inhibition reveals melanoma dependence on the RUNX1/CBFβ complex for genomic stability","year":2025,"lang":"en","type":"article","venue":"Cell Reports","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Université de Montréal; Institute for Research in Immunology and Cancer","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research; Cancer Research Society","keywords":"Melanoma; Effector; Transcription factor; Kinase; DNA damage; Proto-Oncogene Proteins c-myc; MAPK/ERK pathway; Transcription (linguistics)","score_opus":0.025471571092833125,"score_gpt":0.248679615308324,"score_spread":0.22320804421549087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415762739","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931767,0.0007465102,0.002486836,0.00009222923,0.000021931177,0.000019965135,0.0004701491,0.00013209187,0.0028536334],"genre_scores_gemma":[0.9952739,0.0002694743,0.0009091696,0.000021561653,0.000002001419,0.0000119796905,0.00022760824,0.000029627576,0.0032546758],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999094,0.000008649882,0.0000061433975,0.00002224869,0.00003195822,0.00002152156],"domain_scores_gemma":[0.9999417,0.000008824633,0.000013742805,0.000007986973,0.0000050320295,0.00002276985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007605895,0.00021106591,0.00014800068,0.00017508106,0.0001221011,0.00021157831,0.00016977654,0.000154418,0.0018860865],"category_scores_gemma":[0.00006218111,0.00010172224,0.00014565229,0.00008128227,0.00013415508,0.00008280786,0.0001312027,0.00042734048,0.00044898404],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037327423,0.000011705795,0.0000702979,0.000006623982,0.0000016460475,0.000020054513,0.0000042526544,0.000040031166,0.99923396,0.000081316655,0.00002727385,0.0004655021],"study_design_scores_gemma":[0.0000075173534,0.00008507022,0.001377233,0.0000018530609,0.000004902264,0.000099071025,0.000009581833,0.00083405006,0.99606305,0.00003041481,0.0014856233,0.0000017525012],"about_ca_topic_score_codex":0.001316885,"about_ca_topic_score_gemma":0.0023663705,"teacher_disagreement_score":0.0018860865,"about_ca_system_score_codex":0.00029230493,"about_ca_system_score_gemma":0.00019561387,"threshold_uncertainty_score":0.0063096285},"labels":[],"label_agreement":null},{"id":"W4415940943","doi":"10.1016/j.annonc.2025.08.1239","title":"664MO Long-term efficacy and safety of larotrectinib in TRK fusion primary central nervous system tumours: An updated analysis","year":2025,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Trk receptor; Central nervous system; Nervous system; Fusion; Neurotrophin","score_opus":0.020674499688767927,"score_gpt":0.31606979547465125,"score_spread":0.2953952957858833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415940943","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.38978615,0.5741278,0.0028148482,0.004161441,0.0007911421,0.00027266407,0.009197732,0.00030554464,0.018542683],"genre_scores_gemma":[0.7220533,0.23992777,0.0034571486,0.004959798,0.0010869098,0.00028037038,0.018846009,0.00013702187,0.009251667],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9995943,0.00007458023,0.00007568191,0.0000573734,0.00013727167,0.000060830916],"domain_scores_gemma":[0.9990097,0.00031829398,0.0003359432,0.00006248697,0.00021803276,0.000055476765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001765625,0.00043656593,0.0013938792,0.0007889433,0.00015494335,0.0011744368,0.0005156327,0.00033028022,0.0020171797],"category_scores_gemma":[0.0013859802,0.00017483016,0.0017226591,0.0010870803,0.00020411125,0.00090291107,0.0002940219,0.00092024833,0.0006756303],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009116699,0.00029670532,0.0419045,0.003959241,0.0055089165,0.0003305274,0.00007186399,0.0016038392,0.014553265,0.00038556047,0.014334588,0.90793437],"study_design_scores_gemma":[0.0056472817,0.017597333,0.54949933,0.0034901127,0.037293598,0.0063573313,0.0002655967,0.0037088264,0.021976821,0.001932682,0.35195574,0.0002753134],"about_ca_topic_score_codex":0.0010340973,"about_ca_topic_score_gemma":0.0037919995,"teacher_disagreement_score":0.0020171797,"about_ca_system_score_codex":0.0011141793,"about_ca_system_score_gemma":0.00068040384,"threshold_uncertainty_score":0.009337604},"labels":[],"label_agreement":null},{"id":"W4415941719","doi":"10.1016/j.annonc.2025.08.933","title":"510P Clinical and molecular characteristics of cancers that switch phenotype from ER+ primary to triple negative in metastatic disease","year":2025,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Phenotype; Disease; Breast cancer; Clinical phenotype; Cancer; Metastasis","score_opus":0.053523999403280266,"score_gpt":0.3713198270787527,"score_spread":0.31779582767547243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415941719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98956525,0.00023083507,0.00023573877,0.00014677864,0.000015778549,0.000026577223,0.0011454604,0.000028835138,0.008604643],"genre_scores_gemma":[0.99703276,0.000080683036,0.00015821835,0.000050067916,0.000015011338,0.000016628577,0.0008914848,0.000009306292,0.0017459085],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998971,0.000009720393,0.000008263559,0.000025631814,0.000018237108,0.0000410978],"domain_scores_gemma":[0.999617,0.00008044918,0.00007862456,0.000022402912,0.000049773473,0.00015171606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013334941,0.00017332716,0.00017537797,0.0006488149,0.0003306807,0.00033926687,0.00017224655,0.00031903625,0.008530604],"category_scores_gemma":[0.0005453346,0.00012383035,0.0001357334,0.00042819887,0.00026251998,0.00020644354,0.00019250979,0.0003349335,0.0011158383],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060182833,0.00032847573,0.7605358,0.00007613012,0.0000675309,0.018099938,0.00017388158,0.00044504643,0.18384014,0.0009280086,0.0038404095,0.025646364],"study_design_scores_gemma":[0.00004333032,0.00059843244,0.96634597,0.000008175808,0.00003222309,0.021797178,0.00015742256,0.00049919647,0.0070180637,0.0002817385,0.0032080256,0.00001013067],"about_ca_topic_score_codex":0.0011083785,"about_ca_topic_score_gemma":0.0012471837,"teacher_disagreement_score":0.008530604,"about_ca_system_score_codex":0.00024733544,"about_ca_system_score_gemma":0.00016145094,"threshold_uncertainty_score":0.02853775},"labels":[],"label_agreement":null},{"id":"W4415942559","doi":"10.1016/j.annonc.2025.08.607","title":"173TiP DyNAMIc trial: Circulating tumour DNA guided adaptive BRAF and MEK inhibitor therapy - A phase II randomised proof of concept study","year":2025,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; St. Thomas Hospital","funders":"","keywords":"MEK inhibitor; Population; Mutation; Acquired resistance; Mutant; Phases of clinical research","score_opus":0.06634267648748954,"score_gpt":0.38295494382005774,"score_spread":0.3166122673325682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415942559","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95802677,0.009451056,0.0038801834,0.0033539834,0.0018410924,0.0054036495,0.005913189,0.0007446698,0.011385373],"genre_scores_gemma":[0.949919,0.006047517,0.006762278,0.005131068,0.000983014,0.0063021197,0.004979906,0.00020473934,0.019670306],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99963,0.00011408795,0.000009934234,0.000088557055,0.000041200372,0.00011623853],"domain_scores_gemma":[0.9995784,0.00009073842,0.00007282899,0.000032703145,0.00002383835,0.00020148908],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010961081,0.0017740906,0.002556406,0.0003138354,0.00027781926,0.0017959542,0.00095446885,0.0015214477,0.01355766],"category_scores_gemma":[0.0008855247,0.00050199806,0.0015843402,0.00031681455,0.0010659518,0.0010174724,0.0004242296,0.0043185307,0.0025039692],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8367748,0.013114385,0.00074414734,0.0015848611,0.0016084769,0.00014055766,0.00010490163,0.002011322,0.019426912,0.0011845509,0.01283912,0.11046603],"study_design_scores_gemma":[0.8680977,0.12350269,0.001678437,0.00006459747,0.00044531998,0.00009446053,0.000030697567,0.00074137584,0.0008675046,0.0006133919,0.0038338075,0.00002995782],"about_ca_topic_score_codex":0.00076626835,"about_ca_topic_score_gemma":0.0016622965,"teacher_disagreement_score":0.01355766,"about_ca_system_score_codex":0.001057214,"about_ca_system_score_gemma":0.0013788103,"threshold_uncertainty_score":0.045354962},"labels":[],"label_agreement":null},{"id":"W4416140904","doi":"10.1093/neuonc/noaf201.0359","title":"CSIG-25. EXPLORING THE ROLE OF THE CIC/YY1 COMPLEX IN MODULATING SENSITIVITY OF MEK INHIBITORS IN GLIOBLASTOMA","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"MAPK/ERK pathway; Effector; Transcription factor; Suppressor; Kinase; Transcription (linguistics); Downregulation and upregulation; Cell growth; Signal transduction","score_opus":0.019920383563121712,"score_gpt":0.25587932083091514,"score_spread":0.23595893726779343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416140904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98423475,0.009331517,0.0011363274,0.00026814116,0.00008987182,0.00019550782,0.0018883,0.00015597591,0.0026996783],"genre_scores_gemma":[0.992152,0.0028509514,0.0011048006,0.00010411741,0.000014679359,0.000102485435,0.0016441075,0.000019096988,0.0020077697],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998981,0.000012309649,0.000007545649,0.000016488917,0.00002275477,0.000042816417],"domain_scores_gemma":[0.99994886,0.0000044562244,0.000008589319,0.0000048320408,0.000006533861,0.000026734184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023108348,0.0003773502,0.00047264193,0.0003405871,0.00018678949,0.00037825314,0.000390675,0.00027760823,0.0024539419],"category_scores_gemma":[0.000106821535,0.00017335908,0.00034258742,0.0002833531,0.00021081751,0.00021029574,0.00019580833,0.00054180244,0.0005911024],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021564455,0.0004509361,0.001635603,0.00037450073,0.0000674528,0.00013432628,0.000028787901,0.00096490135,0.97253937,0.00025689104,0.001083631,0.020307226],"study_design_scores_gemma":[0.00051580195,0.008190958,0.029953212,0.000044793156,0.00019498424,0.00041162275,0.00009289753,0.00512448,0.9415678,0.00017340505,0.013691832,0.000038290753],"about_ca_topic_score_codex":0.0024966362,"about_ca_topic_score_gemma":0.0047527202,"teacher_disagreement_score":0.0024966362,"about_ca_system_score_codex":0.00066281494,"about_ca_system_score_gemma":0.00062329444,"threshold_uncertainty_score":0.008209288},"labels":[],"label_agreement":null},{"id":"W4416140972","doi":"10.1093/neuonc/noaf201.0589","title":"CTP-17. Clinical stability following tovorafenib treatment in relapsed/refractory pediatric low-grade glioma: updated results from the phase 2 FIREFLY-1 trial","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Clinical trial; Radiography; Drug; Retrospective cohort study; Phases of clinical research; Drug holiday","score_opus":0.041871743802711574,"score_gpt":0.35258401359150787,"score_spread":0.3107122697887963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416140972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9709302,0.016289439,0.0005261558,0.00076008047,0.00014373494,0.00038496804,0.0072024213,0.00008899649,0.0036739584],"genre_scores_gemma":[0.97833383,0.005181185,0.0009182407,0.0006312559,0.0001921073,0.00046070263,0.01312337,0.000042356496,0.0011169496],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9993168,0.00034154777,0.000048233553,0.000085207415,0.000118959135,0.00008915986],"domain_scores_gemma":[0.9980476,0.00044770434,0.0009025933,0.00011870193,0.00013982173,0.00034365038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023103226,0.0004941162,0.001221175,0.00034817847,0.00019126345,0.001128324,0.00046789725,0.0004442696,0.0021862835],"category_scores_gemma":[0.0022180174,0.00018324633,0.00091505685,0.00069488405,0.00033543597,0.0006189289,0.00029231998,0.0011122709,0.0004883456],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3206243,0.004518607,0.1571376,0.0026560482,0.0057184948,0.0006522553,0.00043344658,0.0048031867,0.01832509,0.0005222503,0.025122019,0.4594868],"study_design_scores_gemma":[0.18511926,0.1642792,0.5782834,0.0006670683,0.0075002615,0.0033977276,0.00042103036,0.0042220266,0.010098876,0.0011243672,0.044722576,0.00016422699],"about_ca_topic_score_codex":0.001166229,"about_ca_topic_score_gemma":0.003386465,"teacher_disagreement_score":0.0023103226,"about_ca_system_score_codex":0.00075191306,"about_ca_system_score_gemma":0.0009825475,"threshold_uncertainty_score":0.0122182965},"labels":[],"label_agreement":null},{"id":"W4417465128","doi":"10.1080/17576180.2025.2601855","title":"Accelerating the discovery of MET inhibitors powered by high-throughput hit identification","year":2025,"lang":"en","type":"editorial","venue":"Bioanalysis","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Onex (Canada)","funders":"","keywords":"Identification (biology); Drug discovery; Key (lock); Drug industry","score_opus":0.005987982221905168,"score_gpt":0.2411850595054003,"score_spread":0.23519707728349515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417465128","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005783388,0.05464528,0.0018521681,0.08331256,0.85305965,0.00010855643,0.00023585487,0.000370859,0.0058367383],"genre_scores_gemma":[0.0051580532,0.056835607,0.0012872409,0.0810393,0.8133194,0.00012115764,0.0002444081,0.00014791549,0.04184698],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99715316,0.00041470412,0.0002635776,0.0002913312,0.0016297437,0.0002475237],"domain_scores_gemma":[0.9929871,0.002279109,0.0003820506,0.00016409288,0.0028159649,0.0013716575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007150033,0.0022030333,0.0017762453,0.0015547659,0.0011461972,0.004437193,0.0026568829,0.008244948,0.0070614214],"category_scores_gemma":[0.01022405,0.0010202938,0.0013635013,0.0008446886,0.0013036478,0.004064011,0.0016887875,0.015334892,0.005737847],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014252894,0.000025005582,0.000036648085,0.00031826555,0.000047421443,0.00013842127,0.0000145337235,0.00006827419,0.0006257831,0.0012714902,0.97973585,0.017575815],"study_design_scores_gemma":[0.0002616782,0.00013227847,0.000234629,0.00018565604,0.000110275796,0.00021664958,0.000023498404,0.00046844402,0.0011559813,0.0020864217,0.9950996,0.000024976494],"about_ca_topic_score_codex":0.00080455455,"about_ca_topic_score_gemma":0.0033831885,"teacher_disagreement_score":0.008244948,"about_ca_system_score_codex":0.0022892284,"about_ca_system_score_gemma":0.002270179,"threshold_uncertainty_score":0.037813485},"labels":[],"label_agreement":null},{"id":"W571830263","doi":"10.71781/29189","title":"Étude du rôle de la MAP Kinase non-conventionnelle ERK3 dans le développement thymique et l'activation des lymphocytes T","year":2009,"lang":"fr","type":"dissertation","venue":"Open MIND","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Molecular biology; Humanities; Philosophy; Biology","score_opus":0.016164046712867496,"score_gpt":0.2809208107904095,"score_spread":0.264756764077542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W571830263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98989594,0.0021104668,0.0058210925,0.00008954654,0.000025535128,0.000019345916,0.00024194428,0.000036905378,0.0017591853],"genre_scores_gemma":[0.9850839,0.001987606,0.004977168,0.00006530744,0.000009620959,0.000052449985,0.00046888183,0.000027274658,0.007327701],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998406,0.000017746357,0.000011078116,0.000034517467,0.000060783277,0.000035170608],"domain_scores_gemma":[0.9998752,0.000024405414,0.000029478271,0.000017140626,0.00002484816,0.000028977889],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026310585,0.00026409078,0.00018142416,0.00020413462,0.00028342227,0.0005149257,0.00032356355,0.00037160306,0.0014618539],"category_scores_gemma":[0.0001464606,0.00015416068,0.00037225813,0.0001721331,0.0003096289,0.00035810517,0.0002325409,0.00082132174,0.00033195107],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011361794,0.0000133189715,0.00028291307,0.000029126759,0.0000033982733,0.000043184635,0.000027146278,0.000075235876,0.9980071,0.0002685729,0.000012058707,0.0011242429],"study_design_scores_gemma":[0.000021128613,0.0002331072,0.0068737194,0.000009316679,0.000024973133,0.00029345127,0.0001017408,0.0011668795,0.9865639,0.00015876864,0.004543908,0.000009140863],"about_ca_topic_score_codex":0.0009978979,"about_ca_topic_score_gemma":0.0011194987,"teacher_disagreement_score":0.0014618539,"about_ca_system_score_codex":0.00045195705,"about_ca_system_score_gemma":0.00035536085,"threshold_uncertainty_score":0.004890442},"labels":[],"label_agreement":null},{"id":"W6885990720","doi":"10.14288/1.0402940","title":"Management of Pyrexia Associated with the Combination of Dabrafenib and Trametinib: Canadian Consensus Statements","year":2021,"lang":"en","type":"article","venue":"Open Collections","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dabrafenib; Discontinuation; Delphi method; Trametinib; Quality of life (healthcare); Adverse effect","score_opus":0.015268687383697018,"score_gpt":0.26159927816296846,"score_spread":0.24633059077927144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6885990720","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.022880064,0.032401577,0.026893001,0.8205659,0.015009937,0.010099713,0.003312936,0.00029383853,0.06854304],"genre_scores_gemma":[0.4795811,0.07059261,0.25576583,0.12306464,0.005644382,0.00922761,0.008440018,0.00030581074,0.047377944],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.96503633,0.011930706,0.006341078,0.0011949164,0.0117682805,0.003728723],"domain_scores_gemma":[0.86696035,0.014324264,0.005930683,0.0014500289,0.09934605,0.011988584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0619323,0.0010675066,0.0010529893,0.00438767,0.0060603763,0.0031759175,0.004529541,0.005917651,0.0031696984],"category_scores_gemma":[0.08950208,0.00068185304,0.0022008587,0.0029898428,0.0032579373,0.0019652066,0.0054053897,0.005748532,0.00094903447],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023692685,0.0001582875,0.0073277485,0.006581701,0.00019980031,0.0027302643,0.01659511,0.0026519839,0.0034951232,0.016224168,0.7012569,0.24254203],"study_design_scores_gemma":[0.00010458382,0.00011314637,0.0068753045,0.008818932,0.0001258574,0.001721358,0.008448055,0.0014852618,0.0009005545,0.00923104,0.9619062,0.00026977243],"about_ca_topic_score_codex":0.40338907,"about_ca_topic_score_gemma":0.47970703,"teacher_disagreement_score":0.5966109,"about_ca_system_score_codex":0.036998004,"about_ca_system_score_gemma":0.20882775,"threshold_uncertainty_score":0.8020822},"labels":[],"label_agreement":null},{"id":"W6888975055","doi":"10.25345/c5s46hj34","title":"MassIVE MSV000096432 - MEF2A, MEF2C, and MEF2D Interactomes in Mouse MA-10 Leydig Cells","year":2024,"lang":"en","type":"dataset","venue":"California Digital Library","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Cell culture; HEK 293 cells; Mutation; Reprogramming; Saccharomyces cerevisiae","score_opus":0.005095941209822667,"score_gpt":0.19742357420841986,"score_spread":0.19232763299859718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6888975055","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013119347,0.00030295053,0.000093444585,0.000049187252,0.00001572416,0.000005748848,0.99699485,0.0006274476,0.0005987524],"genre_scores_gemma":[0.0025544334,0.0001569235,0.00035842299,0.000059254537,0.0000055009914,0.000042004493,0.99605405,0.00008171981,0.00068758556],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995372,0.000041207633,0.000035201003,0.00017575442,0.00011286558,0.000097790915],"domain_scores_gemma":[0.9994611,0.00017725897,0.000059585676,0.000098663055,0.000093331895,0.000110131696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005046266,0.0019686804,0.0016867121,0.002897745,0.00083860446,0.0020870892,0.0021325366,0.0020388414,0.04033285],"category_scores_gemma":[0.001776351,0.0004955003,0.001401844,0.0037023704,0.0002946429,0.0006332452,0.0016083989,0.0009922936,0.032487508],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057460397,0.00004988731,0.0059692804,0.003028958,0.00039851564,0.00024576715,0.000106173626,0.0014081962,0.0040588607,0.001001339,0.9738072,0.009351164],"study_design_scores_gemma":[0.0009948937,0.00008611314,0.037035935,0.0005787403,0.000595384,0.0006398912,0.00015123072,0.0024173101,0.0053412877,0.0029317415,0.9491292,0.000098140416],"about_ca_topic_score_codex":0.0157808,"about_ca_topic_score_gemma":0.036025606,"teacher_disagreement_score":0.04033285,"about_ca_system_score_codex":0.00080414873,"about_ca_system_score_gemma":0.001566023,"threshold_uncertainty_score":0.13492686},"labels":[],"label_agreement":null},{"id":"W6920955846","doi":"10.6084/m9.figshare.13161576.v1","title":"Additional file 7 of TRIM25 promotes Capicua degradation independently of ERK in the absence of ATXN1L","year":2020,"lang":"en","type":"article","venue":"Figshare","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; Canada's Michael Smith Genome Sciences Centre; Simon Fraser University; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Gene knockdown; Western blot; Cell culture; Blot; Northern blot; Messenger RNA; Small interfering RNA; Cell","score_opus":0.029590144715436018,"score_gpt":0.2229487473642402,"score_spread":0.19335860264880417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6920955846","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00029701102,0.00005426405,0.0004600249,0.00016954014,0.00010423711,0.00011855105,0.9967219,0.0010808499,0.0009935751],"genre_scores_gemma":[0.008351933,0.00032845562,0.0054608053,0.0009746415,0.00017834966,0.0020978423,0.9696982,0.0025749868,0.010334813],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989073,0.00009154256,0.0001701978,0.00027724594,0.0003739643,0.00017985096],"domain_scores_gemma":[0.99198395,0.0049740537,0.00060362817,0.00055800285,0.0015369033,0.0003434176],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015805042,0.0022239813,0.0023948378,0.0018341359,0.0014866224,0.0029551645,0.0024874026,0.0020424635,0.8777368],"category_scores_gemma":[0.016698549,0.0011723003,0.0016677363,0.0026477443,0.00039043577,0.0025626498,0.0014220367,0.0014598471,0.24384241],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011584207,0.00016783175,0.0022000747,0.007797578,0.00010407393,0.00021990824,0.00010734002,0.0005866438,0.0020590865,0.00083296833,0.9751413,0.009624826],"study_design_scores_gemma":[0.011992161,0.0011379168,0.03376991,0.006787626,0.00034079832,0.0012935351,0.00056321727,0.0052874717,0.0097359745,0.011605362,0.9170654,0.00042055975],"about_ca_topic_score_codex":0.0072584916,"about_ca_topic_score_gemma":0.013541681,"teacher_disagreement_score":0.8777368,"about_ca_system_score_codex":0.0014576175,"about_ca_system_score_gemma":0.0022411412,"threshold_uncertainty_score":0.17439353},"labels":[],"label_agreement":null},{"id":"W6928684693","doi":"10.4224/40001876","title":"Canadair CT-133 aircraft low speed large sideslip angle flight characteristics","year":2002,"lang":"en","type":"report","venue":"NPARC","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Angle of attack; Control system; Stability (learning theory); Noise (video); Work (physics); Acceleration","score_opus":0.016574321116959726,"score_gpt":0.2370394712802922,"score_spread":0.22046515016333249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6928684693","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5609856,0.0003405755,0.0039145625,0.0009029725,0.00056366017,0.00075536885,0.013321043,0.001150728,0.41806546],"genre_scores_gemma":[0.7704247,0.00018029692,0.002337989,0.00010246306,0.000045158602,0.000085610845,0.007799475,0.00019739539,0.21882683],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99946004,0.000021223103,0.000009496457,0.000048363225,0.00037279315,0.0000880447],"domain_scores_gemma":[0.99819833,0.00010162088,0.00006549015,0.00008286796,0.0013319707,0.00021978327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029145367,0.0003641982,0.00025059044,0.0009216145,0.001955106,0.0006913372,0.00042282094,0.0004904863,0.037763093],"category_scores_gemma":[0.0007393549,0.000117081116,0.00015233443,0.0004526933,0.00021037876,0.0002946266,0.0003379619,0.00044052064,0.0088887],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023044439,0.00067458436,0.17923832,0.0005087743,0.00007163429,0.0027810966,0.00084740465,0.009509874,0.33573845,0.0027870056,0.2044577,0.26108065],"study_design_scores_gemma":[0.00017335199,0.0016914239,0.5826891,0.000106599124,0.000071835246,0.0014553854,0.0011439471,0.014937683,0.09437223,0.0003545689,0.3028765,0.0001273805],"about_ca_topic_score_codex":0.1258835,"about_ca_topic_score_gemma":0.29210603,"teacher_disagreement_score":0.1258835,"about_ca_system_score_codex":0.0018628538,"about_ca_system_score_gemma":0.0030900592,"threshold_uncertainty_score":0.2503016},"labels":[],"label_agreement":null},{"id":"W6928997765","doi":"10.4224/crm.2023.bfly-1","title":"BFLY-1: Black Soldier Fly Meal Certified Reference Material","year":2023,"lang":"en","type":"other","venue":"NRC Digital Repository","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"National Research Council Canada","funders":"","keywords":"Meal; Certification; Certified reference materials; Larva; Research council; Fly ash","score_opus":0.015285640654572892,"score_gpt":0.22101571234159725,"score_spread":0.20573007168702437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6928997765","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.057347283,0.006954841,0.06800708,0.0011267932,0.0008128455,0.0018097097,0.51275283,0.012439664,0.33874887],"genre_scores_gemma":[0.07046918,0.0042094477,0.0710404,0.0007378787,0.000106600884,0.0009789873,0.59704584,0.0035404568,0.25187123],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986652,0.00013953116,0.000061977065,0.0002291096,0.0008038236,0.000100295234],"domain_scores_gemma":[0.99858546,0.00007601808,0.00012704555,0.00023987162,0.00087342574,0.00009827418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018521943,0.0012694256,0.0005448298,0.0027961738,0.0008227285,0.0009468983,0.0025050545,0.0009534259,0.061816864],"category_scores_gemma":[0.002256448,0.00038465054,0.00030090252,0.0018171731,0.0003497779,0.00075847126,0.0008036071,0.00060442963,0.06264383],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018451716,0.00056761154,0.0050490364,0.0018758435,0.00008838201,0.00042915516,0.00016441639,0.0008754234,0.3495741,0.0074655586,0.42573148,0.2063339],"study_design_scores_gemma":[0.00005905635,0.00021936053,0.006708019,0.00019037482,0.000040806655,0.00028986452,0.000062565814,0.00053495454,0.13027433,0.0009520089,0.860624,0.00004460976],"about_ca_topic_score_codex":0.013926371,"about_ca_topic_score_gemma":0.032960672,"teacher_disagreement_score":0.061816864,"about_ca_system_score_codex":0.0011568547,"about_ca_system_score_gemma":0.0017478481,"threshold_uncertainty_score":0.20679802},"labels":[],"label_agreement":null},{"id":"W6929228637","doi":"10.48550/arxiv.1711.03093","title":"Milky Way Globular Cluster Metallicity and Low-Mass X-ray Binaries: The Red Giant Influence","year":2017,"lang":"en","type":"preprint","venue":"arXiv (Cornell University)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Globular cluster; Metallicity; Milky Way; Galaxy; Red-giant branch; Star cluster; Stellar density; Stars","score_opus":0.02981949781744656,"score_gpt":0.18291808655779443,"score_spread":0.15309858874034787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6929228637","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988673,0.00039542463,0.000042648982,0.00008086727,0.0000032565492,0.0000012762624,0.000041001356,0.000005295806,0.000563006],"genre_scores_gemma":[0.99946266,0.000089327186,0.00002797084,0.000029545687,0.000008743638,6.337702e-7,0.00005314629,0.0000056851577,0.00032226357],"study_design_codex":"observational","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99976677,0.000057240806,0.000018375258,0.0000719686,0.000037471622,0.000048263],"domain_scores_gemma":[0.9970099,0.0008253004,0.0009732153,0.0003071076,0.00017893282,0.00070569606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007087789,0.00027286026,0.000392064,0.00097068836,0.00033108288,0.0014920705,0.0003998823,0.00047199838,0.0030579984],"category_scores_gemma":[0.002677385,0.00015476662,0.00043555128,0.00097296934,0.000880701,0.00066309544,0.0008191656,0.0003205017,0.00040610167],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017249152,0.0000137053175,0.99647635,0.0000074508334,0.00009112369,0.00010374695,0.000112037465,0.000064102824,0.0008263371,0.00010934113,0.000049720922,0.0019734376],"study_design_scores_gemma":[0.0000029038765,0.000021655142,0.99928516,0.0000044391722,0.000036472495,0.000080865626,0.00013406502,0.00011651503,0.000091915186,0.0001071973,0.00011621075,0.000002646144],"about_ca_topic_score_codex":0.007542878,"about_ca_topic_score_gemma":0.0076400004,"teacher_disagreement_score":0.007542878,"about_ca_system_score_codex":0.00042572286,"about_ca_system_score_gemma":0.00030199235,"threshold_uncertainty_score":0.014997959},"labels":[],"label_agreement":null},{"id":"W6929437301","doi":"10.5061/dryad.hh76j","title":"Data from: Taxonomic and functional diversity in Mediterranean pastures: Insights on the biodiversity-productivity trade-off","year":2016,"lang":"en","type":"dataset","venue":"Data Archiving and Networked Services (DANS)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec en Outaouais","funders":"","keywords":"Species richness; Biodiversity; Vegetation (pathology); Woody plant; Biomass (ecology); Productivity; Species diversity; Herbaceous plant","score_opus":0.05747742101261689,"score_gpt":0.23448804519597377,"score_spread":0.1770106241833569,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6929437301","genre_codex":"empirical","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97186625,0.0010174676,0.00091600424,0.000067934525,0.000019943762,0.000028858189,0.023006242,0.00006363449,0.0030137082],"genre_scores_gemma":[0.9764097,0.00034727127,0.0017198776,0.000060851737,0.000029528192,0.000075887816,0.020514542,0.000017368233,0.0008249648],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99961144,0.000103769686,0.00006039323,0.0000942511,0.00009531883,0.000034783658],"domain_scores_gemma":[0.99780494,0.0005774303,0.0006847405,0.00031814913,0.00045101397,0.00016368764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009718609,0.0002499338,0.00032990388,0.0021532152,0.00020254577,0.000592237,0.00039457486,0.0003199406,0.00396157],"category_scores_gemma":[0.0018388097,0.0001109908,0.00031218724,0.0018821724,0.00020517077,0.00031132915,0.00045496968,0.00018580187,0.0012000627],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004193554,0.000057648398,0.9571655,0.00030826032,0.00020663456,0.00008187662,0.00037719985,0.00040766556,0.0039750016,0.00006241939,0.0022913853,0.034647048],"study_design_scores_gemma":[0.0000060721045,0.00001884391,0.99849474,0.00001234399,0.000017024686,0.000027179569,0.00009203915,0.00014168127,0.00012715983,0.000031771833,0.0010285708,0.0000027074962],"about_ca_topic_score_codex":0.0048514144,"about_ca_topic_score_gemma":0.010218069,"teacher_disagreement_score":0.0048514144,"about_ca_system_score_codex":0.00027009854,"about_ca_system_score_gemma":0.0001727876,"threshold_uncertainty_score":0.013252735},"labels":[],"label_agreement":null},{"id":"W6929727411","doi":"10.5064/f6z31wj1/pstv7q","title":"0_README_Johnson.txt","year":2018,"lang":"el","type":"dataset","venue":"Syracuse University Qualitative Data Repository","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University","funders":"","keywords":"Process (computing); Identification (biology); Product (mathematics)","score_opus":0.051447091421987556,"score_gpt":0.3217349744076935,"score_spread":0.27028788298570594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6929727411","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000088817986,0.000024539493,0.000087868066,0.00006263344,0.0000143788,0.000008713685,0.99746454,0.0012863029,0.00096216926],"genre_scores_gemma":[0.00041643815,0.00004180856,0.00031113144,0.000060134545,0.000008428105,0.00005099971,0.9975915,0.00030607972,0.0012135349],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99912506,0.00015744095,0.0000851416,0.0002810256,0.00019265615,0.00015856443],"domain_scores_gemma":[0.99763477,0.0007416372,0.0001926947,0.0006991487,0.00042476953,0.00030692786],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013445339,0.0016996387,0.0010813026,0.0031053452,0.00068270817,0.003196631,0.0027278909,0.0014943108,0.20975174],"category_scores_gemma":[0.0061582224,0.0008270646,0.0011163497,0.0044787666,0.00045191546,0.0018158979,0.0025716152,0.0015145376,0.25420225],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007598446,0.000016704915,0.0004470572,0.00035297088,0.000023677036,0.000013857052,0.00002543673,0.00016307563,0.0001097286,0.000504168,0.9959265,0.0023407573],"study_design_scores_gemma":[0.00024278567,0.000020991569,0.0021298747,0.00014578016,0.000018761853,0.000035494104,0.00006435758,0.00041207587,0.00053618196,0.0017354229,0.99463516,0.000023043714],"about_ca_topic_score_codex":0.011300843,"about_ca_topic_score_gemma":0.022246255,"teacher_disagreement_score":0.7902483,"about_ca_system_score_codex":0.001216771,"about_ca_system_score_gemma":0.0016391566,"threshold_uncertainty_score":0.7016895},"labels":[],"label_agreement":null},{"id":"W6930093850","doi":"10.5281/zenodo.11955896","title":"cervical dystonia pdf","year":2024,"lang":"en","type":"other","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Spasmodic Torticollis; Brachial Plexopathy; Hyporeflexia; Dystonia; Paralysis","score_opus":0.017384316441048913,"score_gpt":0.23234698456982494,"score_spread":0.21496266812877604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6930093850","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005264227,0.0020788198,0.0005978405,0.0018867126,0.0030194959,0.000187509,0.008305658,0.0021626225,0.98123497],"genre_scores_gemma":[0.0022767272,0.0019667258,0.00065062323,0.0009687567,0.0005571815,0.00007557168,0.0055433353,0.0007454291,0.9872155],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99963963,0.000023117336,0.000018925071,0.000043682758,0.00020314883,0.00007141907],"domain_scores_gemma":[0.9987852,0.00015464028,0.00004233803,0.00008186241,0.0006153262,0.00032057153],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00029844916,0.0011326143,0.0009729424,0.0020201383,0.0013269855,0.0032779395,0.0011556669,0.0019015527,0.89733714],"category_scores_gemma":[0.0021334675,0.00037450416,0.0008249364,0.001398256,0.00043621255,0.0021613005,0.0021884243,0.0019851613,0.7725778],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031727566,0.00001627447,0.00003329587,0.00014166035,0.0000019330403,0.00010373813,0.000018263134,0.000020297239,0.0003162584,0.0004542955,0.9574641,0.041398074],"study_design_scores_gemma":[0.00001903779,0.00002558582,0.00076711795,0.00016519234,0.000003710697,0.00049632555,0.00005555829,0.00003334774,0.00026236958,0.00042758687,0.9977336,0.000010510057],"about_ca_topic_score_codex":0.0067525846,"about_ca_topic_score_gemma":0.014109713,"teacher_disagreement_score":0.10266286,"about_ca_system_score_codex":0.0011893372,"about_ca_system_score_gemma":0.0012814202,"threshold_uncertainty_score":0.1464361},"labels":[],"label_agreement":null},{"id":"W6930130010","doi":"10.5281/zenodo.11796480","title":"Thomas international gia test pdf","year":2024,"lang":"en","type":"other","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Test (biology); Sample (material); Multiple choice; Cognition; International comparisons; Test score; Work (physics); Section (typography)","score_opus":0.017326469146929327,"score_gpt":0.23630322072275942,"score_spread":0.21897675157583008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6930130010","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004310657,0.00050925196,0.0011066077,0.0016953822,0.002079882,0.00021579314,0.0055246544,0.006503134,0.9819343],"genre_scores_gemma":[0.0021300612,0.00044935456,0.00072286377,0.0007279964,0.0002883457,0.000090580696,0.003906736,0.0021832834,0.9895008],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99781334,0.00010971173,0.00009561108,0.00018274994,0.0015652801,0.00023333626],"domain_scores_gemma":[0.99485296,0.0004119488,0.00011719917,0.00063606875,0.0033024931,0.000679351],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0014180399,0.0019549793,0.0012119383,0.0038579614,0.0023118695,0.0099769505,0.0031608725,0.004258532,0.8836705],"category_scores_gemma":[0.007063127,0.0009970441,0.0013446843,0.002902694,0.0013192358,0.006646183,0.0032679555,0.0030545043,0.8727444],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004674588,0.000029358162,0.000070390306,0.00011206815,0.0000023211253,0.00006613131,0.000028175315,0.000053794276,0.00037519343,0.0022275443,0.9621455,0.034842685],"study_design_scores_gemma":[0.000011848469,0.000028912173,0.00037644734,0.000086260916,0.0000038926014,0.000118655946,0.00006390858,0.00007338008,0.0005591397,0.00091954356,0.9977456,0.000012520492],"about_ca_topic_score_codex":0.009759463,"about_ca_topic_score_gemma":0.01507624,"teacher_disagreement_score":0.11632949,"about_ca_system_score_codex":0.0025853638,"about_ca_system_score_gemma":0.0034467934,"threshold_uncertainty_score":0.16592991},"labels":[],"label_agreement":null},{"id":"W6930155680","doi":"10.5281/zenodo.11884942","title":"the war of art book pdf free download","year":2024,"lang":"en","type":"other","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Spanish Civil War; Download; World War II; Face (sociological concept); Period (music); First world war; Event (particle physics); Decolonization","score_opus":0.012511240167585088,"score_gpt":0.21679373379586447,"score_spread":0.20428249362827938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6930155680","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017629944,0.0005425138,0.0002529181,0.00031519964,0.0011043263,0.000040073282,0.0005124784,0.00057939976,0.9964768],"genre_scores_gemma":[0.0007005808,0.00054362515,0.00019024391,0.00015388976,0.00014844921,0.000013166787,0.00037211698,0.0003278676,0.9975502],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996295,0.000020698199,0.000011992182,0.000050188068,0.00022588586,0.00006158032],"domain_scores_gemma":[0.9996283,0.00003614948,0.00001319623,0.00004669203,0.00014982387,0.0001258651],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00021467435,0.0010770434,0.00073238154,0.0014889275,0.0019642801,0.006545668,0.00084024854,0.0012612351,0.8670975],"category_scores_gemma":[0.0010581067,0.0004771661,0.0008566386,0.0013268257,0.000634402,0.003141956,0.0031549975,0.0022272028,0.81667876],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002118682,0.000021374975,0.000052230964,0.000115108225,0.0000022749148,0.000056913508,0.000049388545,0.000048473026,0.00042065847,0.0031652877,0.9321617,0.06388538],"study_design_scores_gemma":[0.0000020168438,0.00000618733,0.00014304662,0.000047992315,9.2916093e-7,0.000038932547,0.00005314946,0.000015393296,0.000102925274,0.00033266886,0.99925345,0.0000032230118],"about_ca_topic_score_codex":0.002896924,"about_ca_topic_score_gemma":0.008142754,"teacher_disagreement_score":0.1329025,"about_ca_system_score_codex":0.0010518944,"about_ca_system_score_gemma":0.0009888668,"threshold_uncertainty_score":0.18956923},"labels":[],"label_agreement":null},{"id":"W6930294228","doi":"10.5281/zenodo.11351238","title":"+27723039124, I NEED POWERFUL REVENGE INSTANT DEATH SPELL CASTER IN LIECHTENSTEIN, LITHUANIA, LUXEMBOURG, BAHRAIN, ALASKA, USA, UK, CANADA, AUSTRALIA.","year":2024,"lang":"en","type":"other","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Spell; Psychic; Face (sociological concept); Anger; Instant; Wish; Notice; Need to know; Mistake; Recklessness","score_opus":0.029806894418486593,"score_gpt":0.24350503531932452,"score_spread":0.21369814090083794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6930294228","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010021716,0.0061956765,0.0006099953,0.017888,0.0063039907,0.00022040092,0.0020599982,0.0012498267,0.9554504],"genre_scores_gemma":[0.00597203,0.00059856405,0.00018155029,0.0006328502,0.00010075658,0.000020036834,0.00021884865,0.00011453641,0.99216086],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997273,0.000036752237,0.000010199598,0.00006323145,0.000059205213,0.00010325622],"domain_scores_gemma":[0.9994287,0.000037169004,0.000029666486,0.000017647017,0.00008342609,0.00040337472],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00041003822,0.00066882983,0.0005914335,0.0006111871,0.0037836418,0.0031381606,0.00064593484,0.0012639307,0.8275835],"category_scores_gemma":[0.00084524223,0.00023954682,0.00028722407,0.00058248517,0.0006835516,0.0012484014,0.0031056805,0.0010765571,0.5623108],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018675225,0.00007175024,0.0019218912,0.0003490978,0.000006940752,0.00073746586,0.0012780335,0.00007082795,0.001518471,0.0034304278,0.8075519,0.18287647],"study_design_scores_gemma":[0.0000071209765,0.00004964409,0.0024753988,0.00010137134,0.0000018500616,0.00023431888,0.0012975086,0.000020674042,0.0001449548,0.00019388941,0.995468,0.0000052440237],"about_ca_topic_score_codex":0.0041858144,"about_ca_topic_score_gemma":0.014856905,"teacher_disagreement_score":0.17241651,"about_ca_system_score_codex":0.0011187253,"about_ca_system_score_gemma":0.001738774,"threshold_uncertainty_score":0.24593121},"labels":[],"label_agreement":null},{"id":"W6930398408","doi":"10.5281/zenodo.11200905","title":"HeuDiConv: flexible DICOM conversion into structured directory layouts","year":2024,"lang":"en","type":"other","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill Genome Centre","funders":"","keywords":"Documentation; Directory; Container (type theory); DICOM","score_opus":0.0178797308174471,"score_gpt":0.2419833400854723,"score_spread":0.2241036092680252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6930398408","genre_codex":"software","genre_gemma":"software","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"software","genre_consensus":"software","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0023523488,0.00049818953,0.20165356,0.00060837914,0.0010278444,0.0008258922,0.052961856,0.635442,0.10463003],"genre_scores_gemma":[0.036573756,0.0014191791,0.20172884,0.0010827484,0.0005201509,0.002251199,0.12692624,0.38590008,0.24359778],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99872845,0.00013602419,0.00015026842,0.00015270845,0.00063683774,0.00019573273],"domain_scores_gemma":[0.99676704,0.00076472264,0.00012004146,0.0011031193,0.0009938941,0.00025124353],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001912126,0.0021411525,0.0010112798,0.004124454,0.00096254353,0.0041214996,0.004033671,0.0015282946,0.5459777],"category_scores_gemma":[0.0070053446,0.0019836568,0.0011162078,0.0031406123,0.0004806194,0.003314511,0.0039984244,0.0016715713,0.31209558],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022065894,0.000039572005,0.00021313982,0.00036382035,0.000025580961,0.00013350903,0.000080182814,0.000384861,0.004361544,0.003034495,0.87882394,0.112318754],"study_design_scores_gemma":[0.00022825104,0.0000535494,0.0011953826,0.00020296672,0.000021957856,0.000506426,0.000080820406,0.008517998,0.029530782,0.0070050173,0.95251346,0.00014329141],"about_ca_topic_score_codex":0.002314974,"about_ca_topic_score_gemma":0.003634289,"teacher_disagreement_score":0.5459777,"about_ca_system_score_codex":0.0010912695,"about_ca_system_score_gemma":0.0009851927,"threshold_uncertainty_score":0.6476077},"labels":[],"label_agreement":null},{"id":"W6930477615","doi":"10.5281/zenodo.11679523","title":"Medecine interne pdf","year":2024,"lang":"fr","type":"other","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Publishing; Reading (process); Open university; Face (sociological concept); Healthcare system","score_opus":0.019600414817425964,"score_gpt":0.23411785632846605,"score_spread":0.21451744151104007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6930477615","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00049976737,0.008260109,0.0004698226,0.022239396,0.02547383,0.00033344256,0.007419045,0.001689683,0.9336151],"genre_scores_gemma":[0.0027065433,0.005929586,0.0006038324,0.008503774,0.0069235843,0.0002362834,0.00347157,0.00062771584,0.9709972],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981451,0.00026750032,0.00012252432,0.00031882085,0.00086473936,0.00028130822],"domain_scores_gemma":[0.9954803,0.0005014023,0.00028232785,0.00035692716,0.0014371892,0.0019417984],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0013294417,0.0011145949,0.0010713863,0.0021226995,0.0013096955,0.0053934464,0.001080257,0.0028296341,0.865784],"category_scores_gemma":[0.00801138,0.0005963038,0.0008622195,0.0017709639,0.000617927,0.0024923044,0.0037772413,0.003539672,0.8176132],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018000206,0.000020355517,0.000079404665,0.00009999549,0.0000024136664,0.000022918888,0.0000098715345,0.000010859361,0.00006483094,0.00032618127,0.9669554,0.03238967],"study_design_scores_gemma":[0.000013045143,0.000013580919,0.0003161387,0.00011081088,0.0000011976656,0.000062952524,0.000017295608,0.00001099208,0.000033596974,0.00014614264,0.9992712,0.0000030481085],"about_ca_topic_score_codex":0.0018719049,"about_ca_topic_score_gemma":0.0030494465,"teacher_disagreement_score":0.13421601,"about_ca_system_score_codex":0.001527885,"about_ca_system_score_gemma":0.002447749,"threshold_uncertainty_score":0.19144285},"labels":[],"label_agreement":null},{"id":"W6930544418","doi":"10.5281/zenodo.12217428","title":"Sae j300 pdf","year":2024,"lang":"en","type":"other","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lubricant; Viscosity; Viscosity index; Diesel fuel; Motor oil; Oil viscosity","score_opus":0.01881929531598979,"score_gpt":0.23166779270642812,"score_spread":0.21284849739043832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6930544418","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011404854,0.0007443991,0.008217244,0.00079021713,0.002174673,0.00042999454,0.022063594,0.0070450907,0.95739436],"genre_scores_gemma":[0.005298116,0.0014476508,0.0062352745,0.0006075666,0.00032826283,0.00017293583,0.038730953,0.0028995944,0.94427973],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99853575,0.000050445946,0.000059967206,0.0000795362,0.0011639879,0.00011024011],"domain_scores_gemma":[0.9983688,0.00005212763,0.000042453532,0.00018592167,0.0012588863,0.00009170663],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0007182895,0.0015612586,0.0006448664,0.0031268366,0.0011232017,0.0036876341,0.0022262807,0.0019065927,0.5577859],"category_scores_gemma":[0.0019944042,0.000777914,0.0011175094,0.0022625993,0.00029814374,0.0026189988,0.0016347956,0.0016310082,0.56055164],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059563456,0.000042283362,0.000114979106,0.00018148641,0.0000065579093,0.00004604178,0.000014374916,0.0004004706,0.0021678647,0.0026293953,0.90625566,0.0880813],"study_design_scores_gemma":[0.000008790151,0.00001940237,0.00033438893,0.000044749704,0.000002894259,0.000053271277,0.000014241206,0.00025021727,0.001072185,0.0005518486,0.9976373,0.0000106046455],"about_ca_topic_score_codex":0.007861774,"about_ca_topic_score_gemma":0.007080799,"teacher_disagreement_score":0.44221407,"about_ca_system_score_codex":0.0013507657,"about_ca_system_score_gemma":0.0016404829,"threshold_uncertainty_score":0.6307647},"labels":[],"label_agreement":null},{"id":"W6930673055","doi":"10.5281/zenodo.15577723","title":"The Role of Upskilling and Reskilling Initiatives in Downsizing: A Strategic HR Approach","year":2025,"lang":"en","type":"article","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Seneca Polytechnic","funders":"","keywords":"Strategic planning; Government (linguistics); Work (physics); Context (archaeology)","score_opus":0.02091440354431256,"score_gpt":0.23744462089682714,"score_spread":0.21653021735251457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6930673055","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15606612,0.0035745178,0.08314746,0.07657932,0.00091518165,0.00024466703,0.00017315787,0.00032597157,0.67897356],"genre_scores_gemma":[0.9732001,0.0005387123,0.0057144454,0.002147851,0.00012923406,0.000056573197,0.000031590054,0.000041982174,0.018139446],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99484766,0.0016401402,0.00012254911,0.0005817098,0.0008066134,0.0020014504],"domain_scores_gemma":[0.9936028,0.0014190043,0.0006038128,0.0003741972,0.0007538941,0.0032462717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0056201937,0.00061730214,0.00047881686,0.001708278,0.0027379366,0.009365459,0.0016625458,0.0035687333,0.013789995],"category_scores_gemma":[0.0042092334,0.00026324685,0.00052436464,0.0012024931,0.004947798,0.005944241,0.005388722,0.003566455,0.0013315408],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015155211,0.00028317064,0.00551761,0.00020332143,0.000050154293,0.0004703506,0.0034000496,0.0025547156,0.0016658361,0.89902383,0.008652305,0.07802711],"study_design_scores_gemma":[0.00007722282,0.00041983742,0.01425205,0.0004725052,0.000088732944,0.00050789095,0.028886333,0.009497896,0.0033752345,0.81835425,0.123922065,0.00014596546],"about_ca_topic_score_codex":0.0031861314,"about_ca_topic_score_gemma":0.005333546,"teacher_disagreement_score":0.013789995,"about_ca_system_score_codex":0.004173202,"about_ca_system_score_gemma":0.011262946,"threshold_uncertainty_score":0.046132088},"labels":[],"label_agreement":null},{"id":"W6930882358","doi":"10.5281/zenodo.227088","title":"Irrigation System In Thanjavur District Under The Cholas","year":2017,"lang":"en","type":"article","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Bay; Irrigation; Quarter (Canadian coin); Population; BENGAL; West bengal; Delta","score_opus":0.03173363134769063,"score_gpt":0.2453925231150591,"score_spread":0.21365889176736846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6930882358","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96860844,0.0008013028,0.000328843,0.00063493353,0.00006425629,0.00009875579,0.00039513994,0.0000712986,0.02899718],"genre_scores_gemma":[0.9902291,0.00049238856,0.00034832582,0.00013850204,0.000019673804,0.000032424156,0.00036834722,0.0000132906125,0.008357874],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99967587,0.000051453935,0.000023190138,0.000055671113,0.000044883414,0.0001488747],"domain_scores_gemma":[0.9997838,0.00002663887,0.00004909779,0.00001812453,0.000043004587,0.00007931531],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017906194,0.0002389847,0.00021158496,0.0005605996,0.0021296772,0.0016222787,0.0005313073,0.00036148337,0.0070136813],"category_scores_gemma":[0.00028632293,0.00025788098,0.00016698857,0.001458318,0.00086431537,0.00043238225,0.0013903367,0.00039595453,0.00064546993],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005829121,0.00093747705,0.678653,0.0012032657,0.00011160958,0.025724024,0.025791612,0.0034097582,0.042719845,0.0334641,0.018635202,0.16876712],"study_design_scores_gemma":[0.00012154466,0.0004530854,0.7979325,0.0002434667,0.000063979205,0.00869928,0.03274466,0.0018838067,0.002427459,0.0014778639,0.15385364,0.00009871847],"about_ca_topic_score_codex":0.0429749,"about_ca_topic_score_gemma":0.08404568,"teacher_disagreement_score":0.0429749,"about_ca_system_score_codex":0.0022914775,"about_ca_system_score_gemma":0.0047923555,"threshold_uncertainty_score":0.08544952},"labels":[],"label_agreement":null},{"id":"W6930959661","doi":"10.5281/zenodo.14968371","title":"Plagiothecium denticulatum var. denticulatum Schimp.","year":2025,"lang":"en","type":"article","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Apex (geometry); Phytogeography; Taxonomy (biology); Subject (documents)","score_opus":0.014171856971355264,"score_gpt":0.23882063954793,"score_spread":0.22464878257657475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6930959661","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.48653778,0.03861622,0.006348417,0.002669678,0.0019044179,0.0007976292,0.06102304,0.0018059493,0.40029687],"genre_scores_gemma":[0.85043085,0.010751343,0.004677188,0.0009785752,0.00033779745,0.00016596928,0.030635066,0.00018780418,0.1018355],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998653,0.000008278551,0.000009335169,0.000039900366,0.00004973359,0.000027523916],"domain_scores_gemma":[0.99981695,0.000032538177,0.000050435006,0.000015952062,0.000061323146,0.00002273375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001441302,0.0010678134,0.00035505186,0.0019464764,0.00122857,0.00051257585,0.0005241687,0.0003856404,0.01820986],"category_scores_gemma":[0.00027959852,0.00034501334,0.0003089884,0.001312355,0.00018898874,0.0006770142,0.0006247977,0.00059479673,0.008796059],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054089533,0.0001399299,0.03523335,0.001613069,0.00008845744,0.0042873835,0.0008228668,0.0005364239,0.2589104,0.0014808334,0.04899754,0.6473489],"study_design_scores_gemma":[0.000055584816,0.00022722497,0.43600902,0.00015676212,0.00007738309,0.0032493595,0.0007513861,0.00028592275,0.011608201,0.00039354034,0.5471597,0.00002591831],"about_ca_topic_score_codex":0.029385889,"about_ca_topic_score_gemma":0.06323101,"teacher_disagreement_score":0.029385889,"about_ca_system_score_codex":0.0009350597,"about_ca_system_score_gemma":0.0005820231,"threshold_uncertainty_score":0.060917974},"labels":[],"label_agreement":null},{"id":"W6931438848","doi":"10.5281/zenodo.6941498","title":"Antibody Characterization Report for Mitogenactivated protein kinase 1 (MAPK1)","year":2022,"lang":"en","type":"article","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"","keywords":"Immunoprecipitation; Antibody; Protein kinase A; Mitogen-activated protein kinase kinase; Kinase; MAP2K7; Cyclin-dependent kinase 9; c-Raf","score_opus":0.0215495625673884,"score_gpt":0.2462846470707449,"score_spread":0.2247350845033565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6931438848","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.32250887,0.03769412,0.4767438,0.004083481,0.0044617876,0.0046238923,0.08203005,0.004733667,0.063120365],"genre_scores_gemma":[0.20126444,0.03831293,0.19586621,0.0017888044,0.0013918421,0.0047523505,0.47605544,0.0014080964,0.079159856],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99930036,0.00008898171,0.00010064887,0.00018319779,0.0001682678,0.00015845559],"domain_scores_gemma":[0.99885416,0.00021286987,0.0001122,0.00021131405,0.0004341427,0.00017533074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082895707,0.002279533,0.0009351938,0.002363114,0.0012789675,0.00082955847,0.0017051079,0.0008297909,0.028149622],"category_scores_gemma":[0.0012001666,0.00081842,0.0013844953,0.0016238473,0.00025751148,0.0009889662,0.00057242735,0.0019248556,0.023236074],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024248844,0.00019188253,0.00030990443,0.0004845816,0.000052104017,0.00023322711,0.00006738665,0.000098917735,0.9827985,0.00072317227,0.006281747,0.008515917],"study_design_scores_gemma":[0.00020158397,0.0012015064,0.010603338,0.00018226173,0.00032919718,0.0060300753,0.0001839154,0.0016395751,0.6083355,0.00082053215,0.3703867,0.00008584018],"about_ca_topic_score_codex":0.0014830988,"about_ca_topic_score_gemma":0.0022300824,"teacher_disagreement_score":0.028149622,"about_ca_system_score_codex":0.00071176497,"about_ca_system_score_gemma":0.0011400778,"threshold_uncertainty_score":0.094169915},"labels":[],"label_agreement":null},{"id":"W6931550473","doi":"10.5479/si.097884601x.10\"&gt;10.5479/si.097884601x.10&lt;/a&gt","title":"From Tent to Trading Post and Back Again - Smithsonian Anthropology in Nunavut, Nunavik, Nitassinan, and Nunatsiavut: The Changing IPY Agenda, 1882 2007","year":2009,"lang":"en","type":"other","venue":"DSpace Repository (Smithsonian)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Field (mathematics); Ethnography; Term (time); History of anthropology","score_opus":0.007453054626166857,"score_gpt":0.23620933734459656,"score_spread":0.2287562827184297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6931550473","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.053142298,0.025893765,0.00043149324,0.022792865,0.0013561633,0.000041687963,0.0042640194,0.00009526811,0.89198244],"genre_scores_gemma":[0.1667725,0.006342483,0.00054947805,0.0007665316,0.00009211587,0.000026331727,0.00063673337,0.00008002754,0.8247338],"study_design_codex":"not_applicable","study_design_gemma":"qualitative","domain_scores_codex":[0.99985313,0.000022962122,0.000005682044,0.000029423249,0.000037564707,0.00005117787],"domain_scores_gemma":[0.9998659,0.000020763478,0.000011406694,0.000014081599,0.00004773066,0.000040104722],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.00033127927,0.0002273423,0.00013782669,0.0006636278,0.0050296956,0.0025859834,0.0005715139,0.00064122083,0.043632105],"category_scores_gemma":[0.00072351453,0.00020522517,0.00007014422,0.002569868,0.0021190837,0.0016667347,0.0015627815,0.0013184751,0.0033390853],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008729821,0.000051468778,0.014116174,0.00026364735,0.000008131957,0.0007213679,0.06426619,0.00020951981,0.0005525236,0.21314494,0.49913052,0.2074482],"study_design_scores_gemma":[0.0000025447457,0.0000039755514,0.014079359,0.00011343175,0.0000020138662,0.0001010408,0.012856672,0.00002390174,0.00017110018,0.0023102413,0.9703287,0.000007007337],"about_ca_topic_score_codex":0.58441013,"about_ca_topic_score_gemma":0.8597842,"teacher_disagreement_score":0.9949703,"about_ca_system_score_codex":0.007479919,"about_ca_system_score_gemma":0.01319976,"threshold_uncertainty_score":0.8360747},"labels":[],"label_agreement":null},{"id":"W6931590913","doi":"10.5281/zenodo.8320154","title":"Lasioglossum (Dialictus) helianthi","year":2023,"lang":"en","type":"article","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba","funders":"","keywords":"Margin (machine learning); Dorsum; Thermokarst","score_opus":0.03132129813550377,"score_gpt":0.2464983750202048,"score_spread":0.21517707688470103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6931590913","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8713667,0.0051266733,0.0019211097,0.0004751442,0.00009618161,0.00014873591,0.0034902277,0.0005847621,0.11679037],"genre_scores_gemma":[0.98545545,0.0013365488,0.0010360526,0.00028368214,0.000037934977,0.00007237949,0.0016757963,0.00003077017,0.010071401],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99995816,0.0000044303915,0.0000041021895,0.000016898091,0.000008875691,0.000007638703],"domain_scores_gemma":[0.9999403,0.000008953131,0.000025907288,0.0000049497858,0.00001153145,0.000008367853],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000058950845,0.00042568488,0.00014487123,0.0010871167,0.0005937362,0.00020926763,0.00029379185,0.000188314,0.008575977],"category_scores_gemma":[0.000102940125,0.00012343224,0.00007868721,0.00067661004,0.00035064446,0.00049318076,0.0007236024,0.00028569493,0.002687262],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011183171,0.00013114212,0.112850375,0.001199441,0.000101718426,0.0041497163,0.007098011,0.00065485074,0.20653121,0.0036608896,0.018799052,0.64370525],"study_design_scores_gemma":[0.00010692564,0.00029777153,0.82058865,0.0002541336,0.00010680589,0.0043879165,0.002954096,0.00025306825,0.004752725,0.0007717009,0.16548324,0.000042925516],"about_ca_topic_score_codex":0.008639791,"about_ca_topic_score_gemma":0.017720373,"teacher_disagreement_score":0.008639791,"about_ca_system_score_codex":0.00046027737,"about_ca_system_score_gemma":0.00015336603,"threshold_uncertainty_score":0.028689504},"labels":[],"label_agreement":null},{"id":"W6939113131","doi":"10.60692/necx6-1sh61","title":"MK3 Modulation Affects BMI1-Dependent and Independent Cell Cycle Check-Points","year":2015,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Cell cycle; Fibroblast; Cell growth; Cell; Carcinogenesis; Senescence; Epigenetics","score_opus":0.02042482514501518,"score_gpt":0.19746634159446497,"score_spread":0.1770415164494498,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6939113131","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99452424,0.0011248958,0.0013698769,0.000058332505,0.000038557748,0.000019633193,0.0007286169,0.00010975065,0.0020261663],"genre_scores_gemma":[0.9972288,0.000367236,0.0006053962,0.000020700798,0.0000045456836,0.00002005665,0.00037579046,0.000020122174,0.0013573461],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990594,0.000010750398,0.000010260079,0.000022714923,0.000019711932,0.000030618376],"domain_scores_gemma":[0.9999126,0.000013221085,0.000023685267,0.0000113129945,0.000010333087,0.000028707262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008697018,0.00027638784,0.00020379835,0.00019222219,0.00015023598,0.00021056118,0.00014996933,0.00015131799,0.0015757461],"category_scores_gemma":[0.000098468954,0.00008541522,0.00022847486,0.00014900918,0.00019801287,0.00012688612,0.0002151157,0.00040160332,0.00036995378],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030907925,0.000017570785,0.00019995222,0.00002872213,0.000003676369,0.000023675666,0.000011691692,0.000046826746,0.9983908,0.00007782611,0.000028642313,0.0008615834],"study_design_scores_gemma":[0.000014611889,0.00014248102,0.0038318217,0.0000022949669,0.000011485005,0.000079266196,0.000014128468,0.0005740833,0.99391854,0.00003636325,0.0013714837,0.0000034632876],"about_ca_topic_score_codex":0.0010222085,"about_ca_topic_score_gemma":0.0016544423,"teacher_disagreement_score":0.0015757461,"about_ca_system_score_codex":0.00034928156,"about_ca_system_score_gemma":0.00023628018,"threshold_uncertainty_score":0.005271375},"labels":[],"label_agreement":null},{"id":"W6939236861","doi":"10.60692/p6tn8-w0m15","title":"MK3 Modulation Affects BMI1-Dependent and Independent Cell Cycle Check-Points","year":2015,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Cell cycle; Fibroblast; Cell growth; Cell; Carcinogenesis; Senescence; Epigenetics","score_opus":0.02042482514501518,"score_gpt":0.19746634159446497,"score_spread":0.1770415164494498,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6939236861","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99452424,0.0011248958,0.0013698769,0.000058332505,0.000038557748,0.000019633193,0.0007286169,0.00010975065,0.0020261663],"genre_scores_gemma":[0.9972288,0.000367236,0.0006053962,0.000020700798,0.0000045456836,0.00002005665,0.00037579046,0.000020122174,0.0013573461],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990594,0.000010750398,0.000010260079,0.000022714923,0.000019711932,0.000030618376],"domain_scores_gemma":[0.9999126,0.000013221085,0.000023685267,0.0000113129945,0.000010333087,0.000028707262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008697018,0.00027638784,0.00020379835,0.00019222219,0.00015023598,0.00021056118,0.00014996933,0.00015131799,0.0015757461],"category_scores_gemma":[0.000098468954,0.00008541522,0.00022847486,0.00014900918,0.00019801287,0.00012688612,0.0002151157,0.00040160332,0.00036995378],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030907925,0.000017570785,0.00019995222,0.00002872213,0.000003676369,0.000023675666,0.000011691692,0.000046826746,0.9983908,0.00007782611,0.000028642313,0.0008615834],"study_design_scores_gemma":[0.000014611889,0.00014248102,0.0038318217,0.0000022949669,0.000011485005,0.000079266196,0.000014128468,0.0005740833,0.99391854,0.00003636325,0.0013714837,0.0000034632876],"about_ca_topic_score_codex":0.0010222085,"about_ca_topic_score_gemma":0.0016544423,"teacher_disagreement_score":0.0015757461,"about_ca_system_score_codex":0.00034928156,"about_ca_system_score_gemma":0.00023628018,"threshold_uncertainty_score":0.005271375},"labels":[],"label_agreement":null},{"id":"W6957908865","doi":"10.6084/m9.figshare.12873323.v1","title":"Additional file 8 of Genome-wide gene expression analysis supports a developmental model of low temperature tolerance gene regulation in wheat (Triticum aestivum L.)","year":2020,"lang":"en","type":"article","venue":"Figshare","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Gene expression; Gene; Regulation of gene expression; Expression (computer science); Gene expression profiling; Regulator gene","score_opus":0.013896541151029323,"score_gpt":0.19941329271452685,"score_spread":0.18551675156349753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6957908865","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001820692,0.000014889994,0.00042503228,0.000079451136,0.00003461819,0.000024193612,0.9973489,0.0010698469,0.0008210365],"genre_scores_gemma":[0.0061595086,0.00010215093,0.0049467916,0.00031479768,0.00007813607,0.00069016655,0.9770225,0.0031749143,0.00751097],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994742,0.000074171185,0.00007137267,0.00016044569,0.00012602995,0.000093734605],"domain_scores_gemma":[0.98923475,0.007819204,0.00044434777,0.0007967374,0.0013770919,0.00032781495],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001306129,0.0012840946,0.0013112513,0.0024109844,0.0010468184,0.0016421833,0.001969013,0.0012871957,0.8460617],"category_scores_gemma":[0.011653697,0.0007491926,0.0014396878,0.0032423106,0.0002934965,0.001696077,0.0011556239,0.0011446701,0.23316787],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003288795,0.000058190304,0.0017113304,0.001919631,0.00006344674,0.00010297037,0.000077623445,0.00045031705,0.0006162887,0.00060196244,0.9874972,0.006572261],"study_design_scores_gemma":[0.0039864755,0.0001900456,0.030403672,0.0018496043,0.00023355549,0.00045430067,0.00031597976,0.0020756212,0.0030072792,0.009883631,0.9474027,0.0001970217],"about_ca_topic_score_codex":0.00682689,"about_ca_topic_score_gemma":0.010324507,"teacher_disagreement_score":0.8460617,"about_ca_system_score_codex":0.00085154816,"about_ca_system_score_gemma":0.0012790705,"threshold_uncertainty_score":0.21957421},"labels":[],"label_agreement":null},{"id":"W6967290733","doi":"10.5281/zenodo.10581731","title":"ATR: SCAF1 immunoprecipitation","year":2023,"lang":"en","type":"article","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Immunoprecipitation; Spectral line; Antibody; Monoclonal antibody","score_opus":0.02756479338311642,"score_gpt":0.24374128268047318,"score_spread":0.21617648929735675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6967290733","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009011859,0.0014632696,0.2118995,0.0006126244,0.0006345999,0.0016958656,0.5665505,0.19838262,0.009749196],"genre_scores_gemma":[0.019122893,0.0012644153,0.31270626,0.001453862,0.00021188798,0.009764454,0.51425976,0.11119657,0.030019911],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969633,0.00045660036,0.000390114,0.0011849696,0.0006395102,0.00036546428],"domain_scores_gemma":[0.9981421,0.0006551836,0.00018126595,0.00054282503,0.00028596277,0.00019270317],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041483627,0.005217546,0.0048075803,0.004655123,0.0024245393,0.003569244,0.0038889905,0.0019847655,0.20318756],"category_scores_gemma":[0.003879113,0.0031203746,0.0025485877,0.0031372744,0.0010088917,0.002121322,0.0023962473,0.006158745,0.1579231],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038127697,0.0004333325,0.0029405872,0.004770105,0.0008140082,0.000700649,0.00044844998,0.0014081576,0.24905616,0.0039222846,0.67717004,0.054523505],"study_design_scores_gemma":[0.0016628369,0.0006622074,0.011671919,0.0005990593,0.000607102,0.0022678887,0.00021161254,0.013578134,0.32145634,0.008025253,0.63866585,0.000591756],"about_ca_topic_score_codex":0.0022312764,"about_ca_topic_score_gemma":0.004170361,"teacher_disagreement_score":0.20318756,"about_ca_system_score_codex":0.0014574802,"about_ca_system_score_gemma":0.0020010571,"threshold_uncertainty_score":0.67973006},"labels":[],"label_agreement":null},{"id":"W6969086089","doi":"10.5281/zenodo.7308668","title":"atmos-cloud-sim-uj/PySDM-examples: PySDM-examples v2.14","year":2022,"lang":"en","type":"other","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Semtech (Canada)","funders":"","keywords":"Breakup; Product (mathematics); Plot (graphics); Current (fluid); Event (particle physics)","score_opus":0.028208722359177034,"score_gpt":0.23248044913913116,"score_spread":0.20427172677995412,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6969086089","genre_codex":"software","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0036188448,0.0001567423,0.060971364,0.0005330641,0.0004428849,0.00012464784,0.052697223,0.84732205,0.034133207],"genre_scores_gemma":[0.04777034,0.00030456774,0.06446845,0.00084156345,0.00018290951,0.0005997432,0.10820885,0.7420603,0.03556331],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992849,0.000095072384,0.00004413466,0.00014192206,0.00031395783,0.00011998806],"domain_scores_gemma":[0.99823594,0.0004295683,0.000072401286,0.00063794875,0.00043111635,0.00019307635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015048942,0.0021636155,0.0009604027,0.0010382225,0.0008319399,0.0019370466,0.0036449202,0.0017981952,0.27001238],"category_scores_gemma":[0.006366143,0.0018763989,0.0014340524,0.0010544804,0.0005661489,0.003551542,0.0029976133,0.0035305691,0.16249937],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043245713,0.00006904173,0.0012347569,0.00034855015,0.00004395504,0.00011165103,0.00011507717,0.0022777428,0.00230229,0.004407768,0.9640742,0.024582539],"study_design_scores_gemma":[0.00045400704,0.000036600002,0.0021107683,0.00013475287,0.000030981548,0.00017470011,0.00005155819,0.0236555,0.022782931,0.0095843095,0.94086504,0.00011882128],"about_ca_topic_score_codex":0.0038035004,"about_ca_topic_score_gemma":0.0032915603,"teacher_disagreement_score":0.27001238,"about_ca_system_score_codex":0.0011023355,"about_ca_system_score_gemma":0.0007523531,"threshold_uncertainty_score":0.9032814},"labels":[],"label_agreement":null},{"id":"W6976900606","doi":"10.6084/m9.figshare.13161576","title":"Additional file 7 of TRIM25 promotes Capicua degradation independently of ERK in the absence of ATXN1L","year":2020,"lang":"en","type":"article","venue":"Figshare","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; Canada's Michael Smith Genome Sciences Centre; Simon Fraser University; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Gene knockdown; Western blot; Cell culture; Blot; Northern blot; Messenger RNA; Small interfering RNA; Cell","score_opus":0.029590144715436018,"score_gpt":0.2229487473642402,"score_spread":0.19335860264880417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6976900606","genre_codex":"dataset","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00029701102,0.00005426405,0.0004600249,0.00016954014,0.00010423711,0.00011855105,0.9967219,0.0010808499,0.0009935751],"genre_scores_gemma":[0.008351933,0.00032845562,0.0054608053,0.0009746415,0.00017834966,0.0020978423,0.9696982,0.0025749868,0.010334813],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989073,0.00009154256,0.0001701978,0.00027724594,0.0003739643,0.00017985096],"domain_scores_gemma":[0.99198395,0.0049740537,0.00060362817,0.00055800285,0.0015369033,0.0003434176],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015805042,0.0022239813,0.0023948378,0.0018341359,0.0014866224,0.0029551645,0.0024874026,0.0020424635,0.8777368],"category_scores_gemma":[0.016698549,0.0011723003,0.0016677363,0.0026477443,0.00039043577,0.0025626498,0.0014220367,0.0014598471,0.24384241],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011584207,0.00016783175,0.0022000747,0.007797578,0.00010407393,0.00021990824,0.00010734002,0.0005866438,0.0020590865,0.00083296833,0.9751413,0.009624826],"study_design_scores_gemma":[0.011992161,0.0011379168,0.03376991,0.006787626,0.00034079832,0.0012935351,0.00056321727,0.0052874717,0.0097359745,0.011605362,0.9170654,0.00042055975],"about_ca_topic_score_codex":0.0072584916,"about_ca_topic_score_gemma":0.013541681,"teacher_disagreement_score":0.8777368,"about_ca_system_score_codex":0.0014576175,"about_ca_system_score_gemma":0.0022411412,"threshold_uncertainty_score":0.17439353},"labels":[],"label_agreement":null},{"id":"W6977622042","doi":"10.6084/m9.figshare.3578379","title":"Trends in Relative Abundance and Early Life Survival of Atlantic Menhaden during 1977–2013 from Long-Term Ichthyoplankton Programs","year":2016,"lang":"en","type":"article","venue":"Figshare","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ichthyoplankton; Larva; Abundance (ecology); Juvenile; Chesapeake bay; Relative species abundance; North Atlantic oscillation","score_opus":0.02358459435305714,"score_gpt":0.24027648955098554,"score_spread":0.21669189519792842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6977622042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99832267,0.00014490528,0.000023058012,0.000022988408,0.0000038952535,0.0000027985936,0.0011240988,0.0000029678042,0.00035263455],"genre_scores_gemma":[0.9959274,0.00020940803,0.00007144188,0.00003714406,0.00000882731,0.000010935402,0.002977699,0.0000023971818,0.00075470906],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99985063,0.000008576541,0.000014029536,0.00004639301,0.000034954683,0.00004544408],"domain_scores_gemma":[0.99934095,0.000030896223,0.00028863322,0.00001978152,0.00015699198,0.00016271487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021673327,0.00019476838,0.00012167779,0.0008876248,0.00034741883,0.00040108472,0.00033305073,0.00017723472,0.0009063114],"category_scores_gemma":[0.0004999659,0.00014693508,0.00026660418,0.0007311315,0.00021321054,0.00023522774,0.0005034529,0.00028036113,0.00018444516],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002945724,0.0000045337156,0.99800473,0.000007669306,0.000021675214,0.000031017145,0.00012990378,0.000025740028,0.00042035876,0.0000076044143,0.00014255049,0.0011747312],"study_design_scores_gemma":[4.175767e-7,0.0000055079745,0.9996753,0.000002914256,0.000003702929,0.000013046398,0.00011189329,0.000025302681,0.00003355387,9.588956e-7,0.00012671227,8.311096e-7],"about_ca_topic_score_codex":0.19712271,"about_ca_topic_score_gemma":0.5374904,"teacher_disagreement_score":0.19712271,"about_ca_system_score_codex":0.0011269421,"about_ca_system_score_gemma":0.0006479115,"threshold_uncertainty_score":0.3919506},"labels":[],"label_agreement":null},{"id":"W6981700026","doi":"","title":"Extracción de características morfológicas y análisis estadístico de imágenes digitales de microscopía de biomateriales con aplicaciones en ingeniería tisular","year":2016,"lang":"es","type":"dissertation","venue":"RiuNet (Politechnical University of Valencia)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Head and neck; 3d printer; Glottis; Mallinckrodt","score_opus":0.007197873256983863,"score_gpt":0.24443650812399917,"score_spread":0.2372386348670153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6981700026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8026569,0.009145174,0.15622726,0.0009778502,0.00054681156,0.00023974903,0.0019598815,0.0024194107,0.025826963],"genre_scores_gemma":[0.80343276,0.006148493,0.14345121,0.00056818075,0.00011243683,0.00033510904,0.001506638,0.0006577236,0.043787315],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992459,0.000098390396,0.000038279162,0.0002016027,0.00033682294,0.00007906463],"domain_scores_gemma":[0.9988643,0.0003187446,0.0001257015,0.00013722848,0.0005030736,0.000050961407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010685209,0.0005651841,0.00045555684,0.0014744429,0.0004384698,0.0012311959,0.00042147687,0.0008695103,0.006950845],"category_scores_gemma":[0.0011639346,0.00042283363,0.0005803467,0.00094776676,0.000635388,0.0007942167,0.00058860035,0.0008098932,0.0015821002],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007780287,0.000041314175,0.0009771988,0.00020024666,0.000015577336,0.000060349113,0.00012303695,0.00020822261,0.97763765,0.00023679945,0.0003483393,0.02007345],"study_design_scores_gemma":[0.00001100133,0.00015943346,0.015521769,0.00004557281,0.00007097247,0.0002688451,0.00030867633,0.0023460004,0.96828294,0.00031292488,0.012636179,0.000035773133],"about_ca_topic_score_codex":0.0018427584,"about_ca_topic_score_gemma":0.003850781,"teacher_disagreement_score":0.006950845,"about_ca_system_score_codex":0.00074549945,"about_ca_system_score_gemma":0.00063657423,"threshold_uncertainty_score":0.023252904},"labels":[],"label_agreement":null},{"id":"W6983739028","doi":"","title":"The Novel Roles of MAP Kinase-Interacting Serine/Threonine- Protein Kinase 1 (MNK1) in Melanoma Progression","year":2020,"lang":"en","type":"dissertation","venue":"eScholarship@McGill (McGill)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"McGill University","keywords":"EIF4E; MAPK/ERK pathway; Melanoma; PI3K/AKT/mTOR pathway; Kinase; Downregulation and upregulation; Translation (biology); Phosphorylation; Protein kinase A; EIF4EBP1","score_opus":0.012412843075706321,"score_gpt":0.2516364096251161,"score_spread":0.23922356654940977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6983739028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82525516,0.14758344,0.009881056,0.0036213163,0.0010798872,0.00008183722,0.00078392413,0.00038193993,0.011331497],"genre_scores_gemma":[0.9615242,0.029204492,0.0032669595,0.00035666977,0.00016614626,0.000031295283,0.0003977698,0.000023609204,0.0050288453],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998907,0.00001234956,0.00000776283,0.000034963814,0.000027755737,0.000026410431],"domain_scores_gemma":[0.9999075,0.000009197352,0.00003171143,0.0000061318256,0.00001572903,0.000029720974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020751139,0.00056938233,0.0002458008,0.00046077956,0.00035351087,0.0007421966,0.00027777103,0.00047790963,0.0007859992],"category_scores_gemma":[0.00017934405,0.00015046608,0.00039613238,0.00016810223,0.00033106518,0.0005770378,0.00042058385,0.0009853754,0.00026842757],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008120611,0.00013009479,0.0068725604,0.0010351669,0.000055013992,0.002642134,0.00022660219,0.0010072403,0.9215089,0.006375366,0.0020881805,0.0572466],"study_design_scores_gemma":[0.00015773372,0.0011769545,0.10689471,0.00040539552,0.0003225761,0.021398248,0.0007063181,0.008224389,0.6917307,0.010854035,0.15798824,0.00014075202],"about_ca_topic_score_codex":0.0005065403,"about_ca_topic_score_gemma":0.00081020704,"teacher_disagreement_score":0.0007859992,"about_ca_system_score_codex":0.0005550468,"about_ca_system_score_gemma":0.00038532252,"threshold_uncertainty_score":0.004027188},"labels":[],"label_agreement":null},{"id":"W6990619212","doi":"","title":"Effectiveness of dabrafenib in the treatment of patients with &lt;i&gt;BRAF &lt;/i&gt;V600-mutated metastatic melanoma in a Named Patient Program","year":2019,"lang":"en","type":"article","venue":"UWA Profiles and Research Repository (UWA)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Metastatic melanoma; Dabrafenib; Melanoma; Radiation therapy; Chemotherapy","score_opus":0.01135371363391633,"score_gpt":0.2704309587925473,"score_spread":0.25907724515863095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6990619212","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871345,0.005664415,0.00007941126,0.0011926069,0.000080909274,0.000053171265,0.000977937,0.000025932864,0.004791022],"genre_scores_gemma":[0.99597687,0.0015457408,0.00013674503,0.0003478111,0.000047816113,0.000021661086,0.0009494472,0.00000430368,0.00096965645],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9998338,0.00007399302,0.0000105151785,0.000021572105,0.000021271897,0.000038878814],"domain_scores_gemma":[0.9997197,0.00005323494,0.000050779312,0.0000134600805,0.00001823622,0.00014460977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032455992,0.00016751181,0.00049220276,0.00018885074,0.00020186038,0.00047078717,0.00016568863,0.00025015287,0.002196585],"category_scores_gemma":[0.0006526352,0.000069423455,0.00057890697,0.00018271332,0.00011907058,0.00027727097,0.00012632525,0.00054980244,0.00025318775],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17518748,0.0057028104,0.13698465,0.00040370584,0.0015565702,0.00088474,0.00015178717,0.004524414,0.009900387,0.0011385933,0.017769521,0.64579546],"study_design_scores_gemma":[0.05251281,0.13976718,0.7454906,0.0003663104,0.002516154,0.0036860805,0.0005470944,0.006668642,0.0070934137,0.0013769667,0.039861318,0.0001134279],"about_ca_topic_score_codex":0.0015417198,"about_ca_topic_score_gemma":0.0060060066,"teacher_disagreement_score":0.002196585,"about_ca_system_score_codex":0.0006138866,"about_ca_system_score_gemma":0.0004767176,"threshold_uncertainty_score":0.007348299},"labels":[],"label_agreement":null},{"id":"W6997474366","doi":"","title":"The αNAC transcriptional coregulator is a substrate of p38α MAP kinase","year":2016,"lang":"en","type":"dissertation","venue":"eScholarship@McGill (McGill)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Kinase; Substrate (aquarium); Enzyme; MAP kinase kinase kinase; Protein kinase A; Substrate specificity; Signal transduction; Drosophila melanogaster","score_opus":0.011456803248181296,"score_gpt":0.2240894065185231,"score_spread":0.2126326032703418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6997474366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9497558,0.0070313634,0.015198814,0.001006145,0.0002636336,0.00006832226,0.00054820714,0.00024063869,0.025887005],"genre_scores_gemma":[0.9618173,0.0030562754,0.004194751,0.00014588442,0.000099940225,0.000017918892,0.0015595279,0.000047207737,0.029061127],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99988663,0.000011021047,0.000004128961,0.000028475544,0.00003540538,0.000034308745],"domain_scores_gemma":[0.9998716,0.0000093245335,0.000035237033,0.0000111657755,0.000032285032,0.000040279123],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016273532,0.00036723405,0.0001419619,0.00016639793,0.0002618583,0.00036455184,0.00016281867,0.00016940138,0.0060229106],"category_scores_gemma":[0.00016069514,0.00014044529,0.00022865205,0.0001794342,0.00013107504,0.00025125482,0.00026229108,0.00044719243,0.002559131],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019764485,0.000020661539,0.0004537801,0.000034842134,0.0000039092497,0.0001239469,0.00001895883,0.000058668484,0.99127847,0.0003804759,0.00025431524,0.007174225],"study_design_scores_gemma":[0.000014137887,0.0002889631,0.015219061,0.00001098402,0.000009637708,0.00071280426,0.00007419034,0.0004649176,0.969413,0.00028798264,0.013498607,0.0000058470705],"about_ca_topic_score_codex":0.0008234038,"about_ca_topic_score_gemma":0.0009612179,"teacher_disagreement_score":0.0060229106,"about_ca_system_score_codex":0.00045170207,"about_ca_system_score_gemma":0.00023065884,"threshold_uncertainty_score":0.020148635},"labels":[],"label_agreement":null},{"id":"W7000280021","doi":"","title":"Étude de l'hétérogénéité de la réponse immunitaires aux inhibiteurs des kinases RSK et PLK dans le mélanome","year":2024,"lang":"fr","type":"dissertation","venue":"Papyrus : Institutional Repository (Université de Montréal)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Université de Montréal; Cancer Research Society","keywords":"Kinase; SAMHD1; Gain of function; Human immunodeficiency virus (HIV)","score_opus":0.005445796602505507,"score_gpt":0.19738224149766478,"score_spread":0.19193644489515926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7000280021","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9726491,0.014423968,0.005893583,0.00035620524,0.00012102109,0.00006197096,0.0005871454,0.00011455469,0.0057924087],"genre_scores_gemma":[0.98160166,0.0063522635,0.0017884356,0.0001997407,0.000046478915,0.00018802825,0.00057637645,0.00004908122,0.009197979],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99947685,0.00008954015,0.000035858455,0.0001336606,0.0002018519,0.00006226901],"domain_scores_gemma":[0.99959475,0.00014655177,0.00007509571,0.00006184986,0.00008400116,0.000037775404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006300825,0.0002755669,0.0006054793,0.00038802874,0.00028344686,0.0006537386,0.00026939515,0.0004441847,0.0029178497],"category_scores_gemma":[0.0005699147,0.0002035494,0.00064641674,0.00031884166,0.00030510564,0.0005018098,0.00017078727,0.0011737356,0.00059497985],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011174422,0.0001267353,0.0027969016,0.0003285695,0.000095604635,0.00012194294,0.00010290526,0.0011007978,0.9782893,0.0004269223,0.0002717882,0.015220941],"study_design_scores_gemma":[0.00014038518,0.0027658592,0.045262054,0.000046999743,0.00023873083,0.00060902204,0.00027742772,0.004476517,0.9268283,0.00040597827,0.018908236,0.000040438645],"about_ca_topic_score_codex":0.0009941444,"about_ca_topic_score_gemma":0.0010127892,"teacher_disagreement_score":0.0029178497,"about_ca_system_score_codex":0.00048498478,"about_ca_system_score_gemma":0.0003279349,"threshold_uncertainty_score":0.009761214},"labels":[],"label_agreement":null},{"id":"W70018851","doi":"10.1016/b978-012124546-7/50444-7","title":"MAP Kinases","year":2003,"lang":"en","type":"book-chapter","venue":"Elsevier eBooks","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"p38 mitogen-activated protein kinases; Kinase; MAPK/ERK pathway; Mitogen-activated protein kinase; Tyrosine kinase; Small molecule; Protein-Serine-Threonine Kinases; Biology; Computational biology; Protein kinase A; Signal transduction; Medicine; Bioinformatics; Cell biology; Biochemistry","score_opus":0.012202823450679006,"score_gpt":0.21848790712278376,"score_spread":0.20628508367210477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W70018851","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005335945,0.032139912,0.018131588,0.0014123644,0.0017187721,0.00009917949,0.002779936,0.0023933428,0.935989],"genre_scores_gemma":[0.0082946755,0.010485772,0.0035174259,0.00031954327,0.00015086398,0.00008827278,0.0024412957,0.000094113326,0.9746079],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999305,0.0000022649322,0.0000022847871,0.00002305503,0.00003111306,0.000010795632],"domain_scores_gemma":[0.99996865,0.000004227639,0.0000027198475,0.000005538106,0.000009719967,0.000009119967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000086274835,0.0015397172,0.00049550383,0.00087540474,0.00048568562,0.001086008,0.0005776492,0.00063242286,0.11274516],"category_scores_gemma":[0.00011472631,0.00031411136,0.00034673142,0.00066401844,0.00024922896,0.00096542377,0.00073225977,0.0013219934,0.15412477],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015700908,0.0001025379,0.00021170116,0.00075255195,0.000023806298,0.0004728275,0.00011897202,0.00051208114,0.14821988,0.029414468,0.2066377,0.61337656],"study_design_scores_gemma":[0.000013846506,0.000032376767,0.0004994178,0.00008270575,0.000011153974,0.00045522102,0.00002410327,0.0001674524,0.015850022,0.0041539557,0.9787023,0.0000074384006],"about_ca_topic_score_codex":0.000941315,"about_ca_topic_score_gemma":0.001585669,"teacher_disagreement_score":0.11274516,"about_ca_system_score_codex":0.000448686,"about_ca_system_score_gemma":0.0003835407,"threshold_uncertainty_score":0.37717015},"labels":[],"label_agreement":null},{"id":"W7006065617","doi":"","title":"Synthèse et optimisation d'inhibiteurs spécifiques de ERK3 pour le développement d'une thérapie ciblée au cancer du sein triple-négatif","year":2022,"lang":"fr","type":"dissertation","venue":"Papyrus : Institutional Repository (Université de Montréal)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; Breast cancer; Immunosurveillance; Wilms' tumor","score_opus":0.01067306005750071,"score_gpt":0.2114415922600376,"score_spread":0.20076853220253688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7006065617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.66555655,0.16928162,0.088067785,0.0059860274,0.0029944684,0.002287593,0.00762615,0.0012674626,0.056932356],"genre_scores_gemma":[0.8032058,0.08775626,0.05008855,0.0024948586,0.00029411467,0.0014675612,0.0076011294,0.00039302168,0.046698738],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99962735,0.00006590405,0.000034724555,0.00008147942,0.00012539556,0.00006524199],"domain_scores_gemma":[0.99979764,0.00004375934,0.000040478033,0.000021615828,0.00006671205,0.000029693572],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070735754,0.0005597051,0.0009205022,0.00045254527,0.00038281997,0.0010986269,0.00073513377,0.00079782895,0.008736473],"category_scores_gemma":[0.00053576083,0.00035800907,0.0011123817,0.00042190836,0.00034195243,0.0007229656,0.00043650265,0.0019354195,0.0021946442],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014948006,0.0007639549,0.00054552004,0.0026046722,0.00020359262,0.00027312536,0.00017762303,0.003830043,0.8939579,0.0030128479,0.0049732667,0.088162675],"study_design_scores_gemma":[0.00065118074,0.003422876,0.0016576834,0.00032488984,0.00041334407,0.00057003414,0.00014774052,0.0027497967,0.81236964,0.0008364576,0.17677379,0.000082614664],"about_ca_topic_score_codex":0.0014861609,"about_ca_topic_score_gemma":0.003731798,"teacher_disagreement_score":0.008736473,"about_ca_system_score_codex":0.00074497005,"about_ca_system_score_gemma":0.0011804703,"threshold_uncertainty_score":0.029226363},"labels":[],"label_agreement":null},{"id":"W7011524568","doi":"","title":"New insights into MKK7 regulation in mammalian cells","year":2005,"lang":"en","type":"dissertation","venue":"eScholarship@McGill (McGill)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Phosphorylation; Kinase; p38 mitogen-activated protein kinases; MAPK/ERK pathway; Protein kinase A; Mitogen-activated protein kinase; Mutant; Signal transduction","score_opus":0.008784869998845559,"score_gpt":0.2236614782020792,"score_spread":0.21487660820323365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7011524568","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4827918,0.2629592,0.05675317,0.016401514,0.0021465984,0.00019478776,0.0049248487,0.0013035638,0.17252444],"genre_scores_gemma":[0.7072604,0.15753247,0.02157292,0.0019487329,0.0004969072,0.00019521918,0.004937039,0.00021929663,0.10583699],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99985874,0.000015238164,0.000013992023,0.00002927423,0.000055626155,0.0000271399],"domain_scores_gemma":[0.99996114,0.000007068015,0.0000056941803,0.0000049294304,0.000009275221,0.0000118333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021814033,0.0003429642,0.0002677806,0.0005360671,0.0003697403,0.0012644732,0.0003859418,0.00040029536,0.0062461346],"category_scores_gemma":[0.00008793269,0.00022185614,0.000517215,0.0003537302,0.00034148415,0.0007600558,0.00042090128,0.0010662214,0.0025941],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033211958,0.00005892461,0.0005650511,0.00070102146,0.000026799973,0.0004274683,0.00028452385,0.00023062549,0.9373159,0.01130092,0.002377618,0.046379037],"study_design_scores_gemma":[0.00008980902,0.00029245458,0.016631344,0.00024745232,0.00009471539,0.001482533,0.0005857624,0.002172852,0.62373096,0.0061195767,0.34851494,0.000037601523],"about_ca_topic_score_codex":0.0011093165,"about_ca_topic_score_gemma":0.0028373057,"teacher_disagreement_score":0.0062461346,"about_ca_system_score_codex":0.00090600265,"about_ca_system_score_gemma":0.00052324525,"threshold_uncertainty_score":0.020895362},"labels":[],"label_agreement":null},{"id":"W7024313345","doi":"","title":"Rhamm-/- mice are defective in skin wound repair due to aberrant ERK1,2 signaling in \\nfibroblast migration","year":2006,"lang":"en","type":"article","venue":"eScholarship (California Digital Library)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Congressionally Directed Medical Research Programs; Biological and Environmental Research; Canadian Institutes of Health Research; Breast Cancer Society of Canada; U.S. Department of Energy; U.S. Department of Defense","keywords":"Wound healing; Signal transduction; Immune system; Fibroblast; Tissue repair; Disease; Inflammation; Cell migration","score_opus":0.006880987525309037,"score_gpt":0.19331985505314986,"score_spread":0.18643886752784083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7024313345","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9723846,0.002375776,0.009449981,0.0011370943,0.00030329154,0.0001571989,0.0052913474,0.0017693783,0.0071314145],"genre_scores_gemma":[0.95193356,0.0011958728,0.00999906,0.00032307248,0.0001323503,0.00025062793,0.0024342223,0.001214111,0.032517176],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99877685,0.0001739215,0.00020503868,0.0002752267,0.00034058184,0.00022833353],"domain_scores_gemma":[0.9984654,0.00018747397,0.0006812221,0.00014405375,0.00005132135,0.00047064837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005308077,0.0021559289,0.0009115587,0.0023254568,0.00076251075,0.0013511755,0.0015208683,0.0022179286,0.013261684],"category_scores_gemma":[0.00035105317,0.0012788099,0.0008948543,0.00054566946,0.0015295611,0.00087317795,0.0011161148,0.0034033416,0.0056431447],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040026894,0.00008493738,0.00016335037,0.00004650192,0.00001716351,0.0006413233,0.000024565952,0.00011266034,0.99714124,0.0005319216,0.00017365621,0.00066246587],"study_design_scores_gemma":[0.00020775966,0.00018816387,0.0055812798,0.000034561745,0.00007241245,0.0041164868,0.000104341474,0.0016748447,0.9832947,0.00034404505,0.004356186,0.000025278825],"about_ca_topic_score_codex":0.0011875831,"about_ca_topic_score_gemma":0.001680909,"teacher_disagreement_score":0.013261684,"about_ca_system_score_codex":0.00069567584,"about_ca_system_score_gemma":0.0003511966,"threshold_uncertainty_score":0.04436475},"labels":[],"label_agreement":null},{"id":"W7028458492","doi":"","title":"ERK4, a new tumor suppressor gene candidate implicated in prostate cancer progression","year":2005,"lang":"en","type":"dissertation","venue":"eScholarship@McGill (McGill)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Prostate cancer; Tumor suppressor gene; Candidate gene; Locus (genetics); Metastasis; Allele; Cancer; Microarray analysis techniques; Gene; Genotyping","score_opus":0.010162663386806702,"score_gpt":0.26521674450347604,"score_spread":0.25505408111666933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7028458492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9836559,0.0043999553,0.0024603028,0.00027952614,0.000082911785,0.000042994052,0.006624759,0.00017815713,0.0022753996],"genre_scores_gemma":[0.9704348,0.0029501293,0.0039347443,0.00019030289,0.00003896483,0.000033505865,0.014464089,0.00003614472,0.0079172775],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999918,0.0000052923397,0.0000049228142,0.000024677061,0.000034254896,0.000012943248],"domain_scores_gemma":[0.9999149,0.000012247513,0.00003134559,0.000004168994,0.00001788897,0.000019517416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008348497,0.0003681189,0.00023485889,0.0006134643,0.0002485344,0.00034958488,0.00021963254,0.00024795593,0.0018989977],"category_scores_gemma":[0.00014074292,0.000113163565,0.000312951,0.00050988037,0.00014952042,0.000092942304,0.00017044644,0.00030048453,0.00042061994],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009062283,0.00010497254,0.027101839,0.00028950753,0.00009289317,0.002422248,0.000052344185,0.0006420697,0.9446941,0.00031851875,0.0009296107,0.022445574],"study_design_scores_gemma":[0.00010068795,0.00054960046,0.49483347,0.00004775733,0.00039221236,0.010524693,0.00019735261,0.0053353934,0.44701725,0.0006874918,0.040259108,0.00005500107],"about_ca_topic_score_codex":0.0024592795,"about_ca_topic_score_gemma":0.003940034,"teacher_disagreement_score":0.0024592795,"about_ca_system_score_codex":0.00038873593,"about_ca_system_score_gemma":0.00039514157,"threshold_uncertainty_score":0.0063527822},"labels":[],"label_agreement":null},{"id":"W7034750744","doi":"","title":"Transplant Glomerulopathy, Late Antibody-Mediated Rejection and the ABCD Tetrad in Kidney Allograft Biopses for Cause","year":2007,"lang":"en","type":"article","venue":"NPARC","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Kidney; Tetrad; Kidney transplant; Kidney transplantation; Transplantation","score_opus":0.008621300434230967,"score_gpt":0.24756249071980677,"score_spread":0.2389411902855758,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7034750744","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.921401,0.003792473,0.002414928,0.008654667,0.001938436,0.00014079033,0.0003794931,0.00028166806,0.060996585],"genre_scores_gemma":[0.9796076,0.00085358217,0.0013686174,0.00074539916,0.00097559614,0.000016781816,0.00021655064,0.000060546132,0.016155332],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.9996257,0.000067928675,0.000046825327,0.000038882772,0.0001424151,0.00007821556],"domain_scores_gemma":[0.9987588,0.00035976936,0.00016349666,0.00010782977,0.0003338527,0.00027634343],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007472994,0.0002440978,0.00034097015,0.0011964833,0.0009680059,0.0007903463,0.0004900846,0.0011615693,0.014421843],"category_scores_gemma":[0.0025017348,0.00016451925,0.00031599042,0.00028975448,0.00042542082,0.00056789647,0.0003312158,0.000725062,0.002339724],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022165303,0.0005855117,0.37705484,0.00055920717,0.00017552213,0.43552873,0.0009305248,0.0002333611,0.034525983,0.0031752763,0.03925785,0.10575666],"study_design_scores_gemma":[0.00021505181,0.00054011325,0.3136649,0.00024465504,0.0002168615,0.5639186,0.0010618758,0.0026227534,0.029482998,0.0019818645,0.085971534,0.00007883771],"about_ca_topic_score_codex":0.0005782182,"about_ca_topic_score_gemma":0.0013402554,"teacher_disagreement_score":0.014421843,"about_ca_system_score_codex":0.0003818843,"about_ca_system_score_gemma":0.00037418675,"threshold_uncertainty_score":0.048245907},"labels":[],"label_agreement":null},{"id":"W7039633588","doi":"","title":"Mountains to climb – healthcare challenges in rural British Columbia","year":2023,"lang":"en","type":"article","venue":"Figshare","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Health care; Rural area; Population; Referral; Rural health; Service (business); Relocation; Quality (philosophy)","score_opus":0.05599379876591076,"score_gpt":0.27625425906694784,"score_spread":0.22026046030103708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7039633588","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.61574644,0.020605356,0.0005120589,0.21474408,0.0020116281,0.00032801757,0.0029323734,0.0001818171,0.14293826],"genre_scores_gemma":[0.9173625,0.015346052,0.0011053398,0.03308768,0.0002725039,0.00023849228,0.0012502229,0.00013033536,0.031206809],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9986343,0.00022475996,0.00006388515,0.000085625354,0.00023988014,0.0007514948],"domain_scores_gemma":[0.996512,0.00018946157,0.00017466489,0.000046813482,0.00075062504,0.0023264757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007803348,0.0002874114,0.0004286816,0.000850701,0.015413562,0.0037275671,0.0017832444,0.0009334147,0.015034563],"category_scores_gemma":[0.0024412724,0.00035734943,0.0002963569,0.0027911842,0.0019526371,0.0008542593,0.0040327804,0.00282089,0.0009140896],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018184727,0.00035821498,0.22431058,0.0018147264,0.00015522007,0.0140065765,0.07238819,0.0006282844,0.0012964008,0.011322401,0.49370518,0.17983238],"study_design_scores_gemma":[0.0000638693,0.00011962904,0.33216393,0.0029142795,0.000056488876,0.0036588428,0.3333439,0.00047816447,0.000117376534,0.0030050068,0.32392853,0.00014999422],"about_ca_topic_score_codex":0.96239036,"about_ca_topic_score_gemma":0.9875695,"teacher_disagreement_score":0.037609637,"about_ca_system_score_codex":0.028226534,"about_ca_system_score_gemma":0.062764995,"threshold_uncertainty_score":0.20479876},"labels":[],"label_agreement":null},{"id":"W7043179990","doi":"","title":"Rôle de la signalisation par ERK et de la sénescence cellulaire dans la progression du cancer pancréatique","year":2022,"lang":"fr","type":"dissertation","venue":"Papyrus : Institutional Repository (Université de Montréal)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"MAPK/ERK pathway; Extracellular signal-regulated kinases; Kinase; Cancer","score_opus":0.0030215408433268967,"score_gpt":0.20196235655652456,"score_spread":0.19894081571319766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7043179990","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82167965,0.12080658,0.015180424,0.004984097,0.00075503153,0.000115567585,0.00063945213,0.00018679528,0.03565238],"genre_scores_gemma":[0.8941387,0.06970414,0.005940967,0.0007770596,0.0002210424,0.00008441268,0.00048345796,0.000038725044,0.028611483],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99970526,0.000057068755,0.000022733833,0.0000614111,0.00009176906,0.00006168997],"domain_scores_gemma":[0.99970335,0.000063365515,0.00006658252,0.000024350078,0.000096198935,0.000046119967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006423983,0.00033650993,0.00034446793,0.0005143559,0.000533701,0.001475714,0.0002639712,0.00051199115,0.0031274057],"category_scores_gemma":[0.00041522647,0.0002018011,0.0004767742,0.0003308216,0.0006321236,0.00082083035,0.0005172131,0.0009834573,0.0007052782],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013205212,0.00025457024,0.015296304,0.0017196076,0.00007647012,0.00091086334,0.0007997646,0.0016054037,0.83038425,0.01338068,0.0016611927,0.13259035],"study_design_scores_gemma":[0.00007903073,0.0016042046,0.102294765,0.00039231902,0.0001659429,0.0028381306,0.0017474929,0.004267493,0.72932386,0.0054800496,0.1516784,0.00012821874],"about_ca_topic_score_codex":0.0016621597,"about_ca_topic_score_gemma":0.0029647183,"teacher_disagreement_score":0.0031274057,"about_ca_system_score_codex":0.00087563164,"about_ca_system_score_gemma":0.0008624566,"threshold_uncertainty_score":0.010462165},"labels":[],"label_agreement":null},{"id":"W7066542686","doi":"","title":"Interaction of combined administration of multi-targeted kinase inhibitors with ionizing radiation","year":2014,"lang":"en","type":"dissertation","venue":"eScholarship@McGill (McGill)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; McGill University","keywords":"Ionizing radiation; Radiation therapy; Cancer; Sorafenib; In vivo; Breast cancer; Radiation sensitivity; Cancer cell; Kinase","score_opus":0.01181685063901404,"score_gpt":0.23916196535394693,"score_spread":0.2273451147149329,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7066542686","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98813534,0.007383093,0.0010395409,0.0002093818,0.00018224503,0.000109124034,0.00027942145,0.000084750274,0.0025771149],"genre_scores_gemma":[0.9915782,0.004628392,0.0012725164,0.00006949656,0.000043484317,0.000075140895,0.00034563558,0.0000109451785,0.001976199],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998715,0.000025268195,0.000008481812,0.00002191329,0.000029047756,0.000043764536],"domain_scores_gemma":[0.99993014,0.000017192879,0.000014723024,0.000008159909,0.0000061200285,0.000023623736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016700114,0.00027508708,0.0005587174,0.00033599546,0.0000969032,0.00045007828,0.00031126,0.0002521247,0.001539558],"category_scores_gemma":[0.00014308922,0.00013985274,0.00048244995,0.00022774583,0.00010522528,0.00020084037,0.00022860822,0.00064251246,0.00029105964],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066619995,0.0029184183,0.0019758071,0.0007605884,0.00039069846,0.00030122732,0.0001395223,0.0038805415,0.9038658,0.00060733035,0.0022080066,0.07629003],"study_design_scores_gemma":[0.00070023106,0.01605379,0.0075256913,0.00004101295,0.00030138856,0.00049994414,0.00007898949,0.0049154987,0.95412564,0.0000937527,0.01562932,0.00003470012],"about_ca_topic_score_codex":0.00069906935,"about_ca_topic_score_gemma":0.0016311209,"teacher_disagreement_score":0.001539558,"about_ca_system_score_codex":0.00022189932,"about_ca_system_score_gemma":0.000345178,"threshold_uncertainty_score":0.005150318},"labels":[],"label_agreement":null},{"id":"W7071460085","doi":"","title":"An shRNA expression system to interrogate the role of PTEN proximal genes in BRAFV600E-driven melanoma in vitro","year":2015,"lang":"en","type":"dissertation","venue":"eScholarship@McGill (McGill)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"PTEN; Melanoma; Gene silencing; Neuroblastoma RAS viral oncogene homolog; Gene knockdown; Cancer; MAPK/ERK pathway; Small hairpin RNA; Suppressor","score_opus":0.009787350508491537,"score_gpt":0.24070911103934592,"score_spread":0.2309217605308544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7071460085","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80603385,0.006752304,0.14766186,0.0008507533,0.000941394,0.0017318147,0.011389642,0.0017651122,0.022873385],"genre_scores_gemma":[0.84192306,0.0062712696,0.09970945,0.0005073534,0.000086484935,0.0021605631,0.017235802,0.0003475644,0.0317584],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994103,0.00007927033,0.000095554824,0.00011408941,0.00022351048,0.000077328135],"domain_scores_gemma":[0.99984527,0.000040825744,0.0000361292,0.000029960216,0.00002919605,0.000018608116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000667818,0.0005260921,0.00044914393,0.0004804417,0.00043393107,0.00044196247,0.00049904984,0.00052373676,0.001781289],"category_scores_gemma":[0.00021271915,0.00037053332,0.0004772193,0.0003804635,0.00030794792,0.00027878585,0.00038635594,0.001495273,0.00095171964],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016931292,0.000059891576,0.0000713376,0.00007604037,0.000005832478,0.000029988816,0.00003851705,0.00012528166,0.9976683,0.00030985277,0.00017910599,0.0014188726],"study_design_scores_gemma":[0.00002236579,0.00038522563,0.0010895861,0.000018007682,0.000032021995,0.00015174168,0.000026373125,0.0027915807,0.98419535,0.00011676143,0.011160096,0.0000108255845],"about_ca_topic_score_codex":0.0016392362,"about_ca_topic_score_gemma":0.004222329,"teacher_disagreement_score":0.001781289,"about_ca_system_score_codex":0.00056269567,"about_ca_system_score_gemma":0.00055391365,"threshold_uncertainty_score":0.0059589744},"labels":[],"label_agreement":null},{"id":"W7071734702","doi":"","title":"Uncovering the role of mutant RAC1 in cutaneous melanoma","year":2018,"lang":"en","type":"dissertation","venue":"eScholarship@McGill (McGill)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Université de Montréal; McGill University","keywords":"Transcriptome; Melanoma; Mutant; RAC1; Signal transduction; Proteomics; Microphthalmia-associated transcription factor; Carcinogenesis","score_opus":0.006690504937081659,"score_gpt":0.21545414854402964,"score_spread":0.208763643606948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7071734702","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98286325,0.005751428,0.0073089586,0.00027457872,0.00003855034,0.00005407755,0.002230394,0.0002523021,0.0012264659],"genre_scores_gemma":[0.9846971,0.0034046415,0.008855603,0.00016614867,0.000017732162,0.000032443568,0.0018188625,0.00004425992,0.00096330524],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999124,0.0000074316695,0.00000485923,0.000030560608,0.000030624327,0.000014038755],"domain_scores_gemma":[0.9999479,0.000006824883,0.000017611992,0.000006473592,0.000008574359,0.0000126131345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000121533536,0.00028592438,0.00022214912,0.0005231675,0.0001916004,0.00027866417,0.00024188758,0.0002687374,0.00068636343],"category_scores_gemma":[0.00012781499,0.00017363716,0.00029389467,0.00027952497,0.00012290559,0.00016951369,0.0002033306,0.0003821161,0.0002681572],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000068865,0.000019618758,0.0031907423,0.00009715347,0.00001797251,0.0001827422,0.0000150327005,0.0001756942,0.99113524,0.000110219255,0.00013123607,0.0048555247],"study_design_scores_gemma":[0.000028640396,0.00041684808,0.18529776,0.00009302748,0.00022996454,0.0055735903,0.00024029255,0.016983805,0.7719653,0.00089654076,0.018236667,0.000037586105],"about_ca_topic_score_codex":0.00054107036,"about_ca_topic_score_gemma":0.00087462313,"teacher_disagreement_score":0.00068636343,"about_ca_system_score_codex":0.00025873655,"about_ca_system_score_gemma":0.00015525304,"threshold_uncertainty_score":0.0022961497},"labels":[],"label_agreement":null},{"id":"W7084141838","doi":"10.5194/wes-2025-152-rc1","title":"Comment on wes-2025-152","year":2025,"lang":"en","type":"peer-review","venue":"","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"North Island College","funders":"","keywords":"Mesoscale meteorology; Wake; Turbine; Wind power; Offshore wind power; Wind speed","score_opus":0.02559297736461563,"score_gpt":0.3016156857295934,"score_spread":0.2760227083649778,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7084141838","genre_codex":"other","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009792515,0.0011605013,0.00081562233,0.21932273,0.16248573,0.0004509764,0.008083472,0.0037953951,0.6029063],"genre_scores_gemma":[0.003419117,0.00041699116,0.0002563641,0.15985717,0.01125771,0.00022345463,0.0018102787,0.000735315,0.8220235],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99895513,0.0000957497,0.00007781531,0.00011924587,0.0005059694,0.00024610676],"domain_scores_gemma":[0.9976654,0.00049542147,0.00008498925,0.00020745116,0.0011861083,0.00036055985],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013033001,0.00074407965,0.00061060453,0.00079438894,0.0024376728,0.0034912042,0.0016280636,0.013050268,0.4426392],"category_scores_gemma":[0.008677081,0.0003534209,0.00094258547,0.0007877613,0.00090277824,0.0023681363,0.0017503109,0.007115251,0.31344208],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000208372,0.000007270397,0.000052492534,0.000019580732,8.8734566e-7,0.000060831568,0.000008709388,0.000008432046,0.00004752338,0.00071911997,0.99582857,0.0032258856],"study_design_scores_gemma":[0.000007808282,0.0000072112607,0.00022210988,0.000037955746,8.610217e-7,0.000014302461,0.000030880296,0.000021176184,0.000063885826,0.00032972862,0.9992593,0.000004731142],"about_ca_topic_score_codex":0.01963647,"about_ca_topic_score_gemma":0.025005674,"teacher_disagreement_score":0.4426392,"about_ca_system_score_codex":0.0018648959,"about_ca_system_score_gemma":0.002301912,"threshold_uncertainty_score":0.7950075},"labels":[],"label_agreement":null},{"id":"W7105162640","doi":"10.71781/30271","title":"Rôle de la signalisation par ERK et de la sénescence cellulaire dans la progression du cancer pancréatique","year":2022,"lang":"fr","type":"dissertation","venue":"Papyrus : Institutional Repository (Université de Montréal)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"MAPK/ERK pathway; Extracellular signal-regulated kinases; Kinase; Cancer","score_opus":0.0030215408433268967,"score_gpt":0.20196235655652456,"score_spread":0.19894081571319766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7105162640","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83407897,0.12886742,0.011917562,0.0027533292,0.0004607345,0.000091450784,0.00043473562,0.00012865131,0.02126715],"genre_scores_gemma":[0.923884,0.05859351,0.0034157683,0.0003842382,0.00014087786,0.000057996687,0.00030735333,0.00002091871,0.013195311],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996425,0.00007895538,0.00002820239,0.00007114423,0.00010612153,0.000073016985],"domain_scores_gemma":[0.9996549,0.00007200366,0.00008471742,0.000028819226,0.00010328744,0.000056266683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000785508,0.00034408146,0.00035219072,0.00063299964,0.00053373864,0.0013806951,0.00024814325,0.0005513676,0.0020032513],"category_scores_gemma":[0.0005533749,0.00021972992,0.0005656015,0.00035773736,0.0006443804,0.0008524887,0.00052664167,0.0011344246,0.00049172324],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001723869,0.00027653383,0.022008605,0.002435101,0.00011785079,0.0010808869,0.0010246532,0.0018742104,0.8239476,0.01303668,0.0011225017,0.13135144],"study_design_scores_gemma":[0.00010785824,0.002291024,0.18105115,0.00058734056,0.00028122702,0.004645839,0.0024985396,0.004679498,0.646464,0.006999607,0.150229,0.00016494845],"about_ca_topic_score_codex":0.0013071103,"about_ca_topic_score_gemma":0.0020432966,"teacher_disagreement_score":0.0020032513,"about_ca_system_score_codex":0.0007858834,"about_ca_system_score_gemma":0.0008697622,"threshold_uncertainty_score":0.006701529},"labels":[],"label_agreement":null},{"id":"W7105234012","doi":"10.71781/29577","title":"Synthèse et optimisation d'inhibiteurs spécifiques de ERK3 pour le développement d'une thérapie ciblée au cancer du sein triple-négatif","year":2022,"lang":"fr","type":"dissertation","venue":"Papyrus : Institutional Repository (Université de Montréal)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; Breast cancer; Immunosurveillance; Childhood cancer","score_opus":0.01067306005750071,"score_gpt":0.2114415922600376,"score_spread":0.20076853220253688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7105234012","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7262696,0.13089615,0.093815416,0.0039320006,0.0018451425,0.00171862,0.0048712622,0.00076756533,0.035884183],"genre_scores_gemma":[0.84898686,0.0678424,0.04863189,0.0016080682,0.00022371426,0.0010827482,0.0048419824,0.0002099734,0.026572473],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99966204,0.000059770806,0.000032426487,0.00006844775,0.00011900988,0.00005822385],"domain_scores_gemma":[0.9998306,0.000038717477,0.00003614759,0.000018225288,0.000052817002,0.000023521978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006323596,0.0004977541,0.0007824062,0.0003989582,0.000314605,0.00088084204,0.0005781937,0.00073580776,0.005121216],"category_scores_gemma":[0.00044080266,0.0003087905,0.0010640027,0.0003624432,0.00030809417,0.00065331074,0.00035737533,0.0017433463,0.0014072726],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010761308,0.0004514686,0.00039167196,0.0017223707,0.00013007951,0.00020500967,0.00010232692,0.0030424634,0.9403625,0.0020516487,0.0018536294,0.048610725],"study_design_scores_gemma":[0.0003993402,0.002395792,0.0012912212,0.00017548069,0.00026510743,0.00049641565,0.00009066977,0.0025587,0.90853804,0.00061531377,0.08311495,0.000059054655],"about_ca_topic_score_codex":0.0011341214,"about_ca_topic_score_gemma":0.0023956867,"teacher_disagreement_score":0.005121216,"about_ca_system_score_codex":0.00060820865,"about_ca_system_score_gemma":0.000998082,"threshold_uncertainty_score":0.017132103},"labels":[],"label_agreement":null},{"id":"W7112163010","doi":"","title":"Outcomes with Postrecurrence Systemic Therapy Following Adjuvant Checkpoint Inhibitor Treatment for Resected Melanoma in CheckMate 238","year":2024,"lang":"en","type":"article","venue":"UWA Profiles and Research Repository (University of Western Australia)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Systemic therapy; Melanoma; Adjuvant; Adjuvant therapy; Nivolumab; Ipilimumab; Programmed cell death 1","score_opus":0.06648043261754608,"score_gpt":0.32505338550426205,"score_spread":0.258572952886716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7112163010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974618,0.0006364256,0.00006182886,0.0001709279,0.000037903086,0.000014064659,0.00049702835,0.000005463957,0.001114499],"genre_scores_gemma":[0.9981426,0.00022082355,0.000022299535,0.00006449484,0.000033611814,0.000008463238,0.0010491108,0.0000021480778,0.00045650397],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99978703,0.000029328407,0.000018433973,0.000040837815,0.000036281708,0.00008811962],"domain_scores_gemma":[0.99895656,0.00014834623,0.00040254218,0.0000500422,0.00008688971,0.00035554013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027853402,0.00016774597,0.00033948087,0.00031143217,0.00040783916,0.00074609474,0.00037742738,0.00037657865,0.0019273437],"category_scores_gemma":[0.0013681275,0.00009959468,0.0007860921,0.0003814533,0.00021274043,0.0004863602,0.00046307256,0.00080719433,0.00024207168],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003502765,0.00047707703,0.97686106,0.00005956756,0.00022712955,0.00082850683,0.00011015439,0.00031264854,0.0005103377,0.000079495214,0.0011169829,0.015914215],"study_design_scores_gemma":[0.00006129716,0.0012329424,0.99675876,0.000028649647,0.0001598516,0.00060347415,0.00020896015,0.00024486738,0.000146753,0.000072913426,0.00047138377,0.000010196523],"about_ca_topic_score_codex":0.005273744,"about_ca_topic_score_gemma":0.0110823205,"teacher_disagreement_score":0.005273744,"about_ca_system_score_codex":0.00077607925,"about_ca_system_score_gemma":0.00053056114,"threshold_uncertainty_score":0.010486066},"labels":[],"label_agreement":null},{"id":"W7113146127","doi":"","title":"Updated overall survival (OS) data from the phase 1b study of tebentafusp (tebe) as monotherapy or combination therapy with durvalumab (durva) and/or tremelimumab (treme) in metastatic cutaneous melanoma (mCM).","year":2022,"lang":"en","type":"article","venue":"Research Explorer (The University of Manchester)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Particle Physics","funders":"","keywords":"Tremelimumab; Durvalumab; Combination therapy; Overall survival; Immunotherapy; Melanoma; Ipilimumab; Metastatic melanoma","score_opus":0.14737765955495585,"score_gpt":0.33922039090865874,"score_spread":0.1918427313537029,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7113146127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5216537,0.07311579,0.0038187203,0.0025713264,0.00064121454,0.0011531559,0.37417272,0.0004688603,0.022404559],"genre_scores_gemma":[0.57182586,0.015615123,0.0028080416,0.0024031259,0.00033205783,0.0018816986,0.39775917,0.00019058386,0.0071843197],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99931395,0.00027063655,0.000073979805,0.00007903127,0.00017352977,0.00008885809],"domain_scores_gemma":[0.9977755,0.0005644768,0.00081004185,0.00019563122,0.00031064148,0.00034368254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027084358,0.00076216384,0.0012807033,0.0006100903,0.00023048365,0.0008845583,0.0006429909,0.0005023101,0.0052699107],"category_scores_gemma":[0.0027095915,0.00028184915,0.0011816043,0.0012751567,0.00014932736,0.0008143313,0.0004625628,0.0013975744,0.0012797138],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.31348023,0.0020355799,0.12176705,0.00895852,0.015180297,0.00039311723,0.00030768645,0.009660396,0.017389188,0.0010315966,0.17184319,0.33795315],"study_design_scores_gemma":[0.05114234,0.027528346,0.6922986,0.0011067588,0.018445956,0.0013234982,0.00017801728,0.0019699745,0.005704046,0.0018046402,0.1983642,0.00013360701],"about_ca_topic_score_codex":0.002164945,"about_ca_topic_score_gemma":0.0074541033,"teacher_disagreement_score":0.0052699107,"about_ca_system_score_codex":0.00075214665,"about_ca_system_score_gemma":0.0006986594,"threshold_uncertainty_score":0.017629623},"labels":[],"label_agreement":null},{"id":"W7118075936","doi":"10.47743/jpd.2025.32.1.976","title":"PREDICTION OF 3D STRUCTURE OF MITOGEN-ACTIVATED PROTEIN KINASE KINASE 2 USING ALPHAFOLD 2 AND SIMULATION OF ITS INTERACTION WITH MITOGEN-ACTIVATED PROTEIN KINASE 6 IN ARABIDOPSIS THALIANA","year":2025,"lang":"","type":"article","venue":"Journal of Plant Development","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Carleton University","funders":"","keywords":"Mitogen-activated protein kinase kinase; MAP kinase kinase kinase; MAP2K7; Cyclin-dependent kinase 9; Protein kinase A; c-Raf; Docking (animal); Cyclin-dependent kinase 2; ASK1","score_opus":0.01961443145398404,"score_gpt":0.24467038891252194,"score_spread":0.2250559574585379,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7118075936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987059,0.00019901844,0.008465695,0.00013627636,0.000023083669,0.000021354137,0.00082133675,0.0004489644,0.002825143],"genre_scores_gemma":[0.98763996,0.00019599423,0.009971922,0.000024519486,0.000004749857,0.000038615934,0.0013816468,0.00007531559,0.00066719594],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9999559,0.000009234061,0.0000018052183,0.000009529317,0.0000122714455,0.000011266239],"domain_scores_gemma":[0.9999193,0.000026789747,0.000011759962,0.0000046744544,0.000016409042,0.0000209431],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015405635,0.00059028354,0.00040411495,0.00031206463,0.00052676094,0.0003649641,0.0004979999,0.0005533271,0.0020081755],"category_scores_gemma":[0.00022065602,0.00035037828,0.0005565677,0.00027778774,0.00017855693,0.00031074736,0.00016754247,0.0003763147,0.00024627394],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043222393,0.00021594878,0.0065851933,0.00018234689,0.00009334852,0.0008599222,0.00010525076,0.92051476,0.061222807,0.002988053,0.0016558182,0.00514432],"study_design_scores_gemma":[0.00004915418,0.00007180273,0.001790798,0.0000067174683,0.000010898038,0.00004141223,0.000042346368,0.9931039,0.0040320843,0.00042382668,0.00041555066,0.000011515958],"about_ca_topic_score_codex":0.008895294,"about_ca_topic_score_gemma":0.008705404,"teacher_disagreement_score":0.008895294,"about_ca_system_score_codex":0.0007938981,"about_ca_system_score_gemma":0.0007704139,"threshold_uncertainty_score":0.017687082},"labels":[],"label_agreement":null},{"id":"W7125212277","doi":"10.1098/rsbm.2025.0021","title":"Christopher John Marshall","year":2025,"lang":"en","type":"article","venue":"Biographical Memoirs of Fellows of the Royal Society","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"Francis Crick Institute","keywords":"Rigour; Passion; Biography; Rest (music); Bench to bedside; Cancer; Identification (biology)","score_opus":0.00519449700143627,"score_gpt":0.217008585054037,"score_spread":0.21181408805260074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7125212277","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016590774,0.020180594,0.0033314514,0.27280164,0.10533857,0.000110356435,0.00079311884,0.0009788445,0.5948064],"genre_scores_gemma":[0.00873902,0.007714005,0.0010492511,0.026322683,0.0070368582,0.00004446986,0.00021756512,0.00034581445,0.9485304],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99844295,0.00017093294,0.00005636921,0.00033188873,0.00077569525,0.00022219823],"domain_scores_gemma":[0.9961892,0.00038004824,0.00014202706,0.00021908688,0.0015673157,0.0015023261],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012257688,0.00067782996,0.00038080462,0.0011890206,0.0025071502,0.0045076543,0.001148635,0.002240672,0.2097777],"category_scores_gemma":[0.007209317,0.00029292316,0.00033972145,0.0005655438,0.0012511738,0.0029446965,0.002915833,0.0046175867,0.09413631],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000070124893,0.000007365781,0.00008525218,0.000027212449,0.0000010655831,0.00008281417,0.0000854024,0.000023195556,0.00011146596,0.00847121,0.9690235,0.022074534],"study_design_scores_gemma":[0.0000010015913,0.0000020187447,0.000057400768,0.00003167077,4.7186916e-7,0.000106383915,0.00006432364,0.000016290154,0.00005031464,0.00097063446,0.99869674,0.000002772599],"about_ca_topic_score_codex":0.007955783,"about_ca_topic_score_gemma":0.011150395,"teacher_disagreement_score":0.2097777,"about_ca_system_score_codex":0.002755158,"about_ca_system_score_gemma":0.0048493636,"threshold_uncertainty_score":0.7017763},"labels":[],"label_agreement":null},{"id":"W7133073096","doi":"","title":"Genetic variants of the MAPK pathways: In silico characterization to breast cancer association","year":2007,"lang":"","type":"dissertation","venue":"TSpace","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Heritage; Library and Archives Canada","funders":"","keywords":"Breast cancer; In silico; Single-nucleotide polymorphism; Heterozygote advantage; Cancer; Genotype; MAPK/ERK pathway","score_opus":0.010039658556636213,"score_gpt":0.2819842480923982,"score_spread":0.271944589535762,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7133073096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97275305,0.00038460904,0.022353226,0.00032227574,0.000033680273,0.00009284959,0.0026480788,0.00030353406,0.0011087361],"genre_scores_gemma":[0.9856036,0.00016169189,0.009926746,0.000054687687,0.000020308684,0.00006322267,0.003425217,0.000055356137,0.00068924355],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9986778,0.0008774302,0.00005900267,0.0002129003,0.000104190156,0.00006865087],"domain_scores_gemma":[0.9959443,0.0033928428,0.0002313666,0.00019112126,0.00011234496,0.00012803648],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024381238,0.00065021607,0.0006431843,0.0012944402,0.00039918363,0.0006538732,0.0004760682,0.0004487404,0.005227733],"category_scores_gemma":[0.005927275,0.0003345668,0.0022240195,0.0010074482,0.00024303695,0.00016023353,0.00046295495,0.00060482585,0.00071083393],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031426763,0.00032618383,0.91084784,0.0003019538,0.0047754943,0.001526579,0.00023802761,0.030065386,0.022168288,0.0010140789,0.0019656697,0.023627901],"study_design_scores_gemma":[0.00055778644,0.0007891767,0.6566364,0.00008008127,0.004625339,0.0040943194,0.00026352514,0.31579095,0.008767199,0.003945317,0.0043918868,0.000057886693],"about_ca_topic_score_codex":0.0020446067,"about_ca_topic_score_gemma":0.0024530757,"teacher_disagreement_score":0.005227733,"about_ca_system_score_codex":0.00024050823,"about_ca_system_score_gemma":0.0005396954,"threshold_uncertainty_score":0.01748854},"labels":[],"label_agreement":null},{"id":"W7161803099","doi":"10.82308/18628","title":"ERK4, a new tumor suppressor gene candidate implicated in prostate cancer progression","year":2005,"lang":"en","type":"dissertation","venue":"","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Prostate cancer; Tumor suppressor gene; Candidate gene; Locus (genetics); Metastasis; Allele; Cancer; Microarray analysis techniques; Gene; Genotyping","score_opus":0.007563608998492463,"score_gpt":0.2876354614230219,"score_spread":0.2800718524245294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7161803099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9836559,0.0043999553,0.0024603028,0.00027952614,0.000082911785,0.000042994052,0.006624759,0.00017815713,0.0022753996],"genre_scores_gemma":[0.9704348,0.0029501293,0.0039347443,0.00019030289,0.00003896483,0.000033505865,0.014464089,0.00003614472,0.0079172775],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999918,0.0000052923397,0.0000049228142,0.000024677061,0.000034254896,0.000012943248],"domain_scores_gemma":[0.9999149,0.000012247513,0.00003134559,0.000004168994,0.00001788897,0.000019517416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008348497,0.0003681189,0.00023485889,0.0006134643,0.0002485344,0.00034958488,0.00021963254,0.00024795593,0.0018989977],"category_scores_gemma":[0.00014074292,0.000113163565,0.000312951,0.00050988037,0.00014952042,0.000092942304,0.00017044644,0.00030048453,0.00042061994],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009062283,0.00010497254,0.027101839,0.00028950753,0.00009289317,0.002422248,0.000052344185,0.0006420697,0.9446941,0.00031851875,0.0009296107,0.022445574],"study_design_scores_gemma":[0.00010068795,0.00054960046,0.49483347,0.00004775733,0.00039221236,0.010524693,0.00019735261,0.0053353934,0.44701725,0.0006874918,0.040259108,0.00005500107],"about_ca_topic_score_codex":0.0024592795,"about_ca_topic_score_gemma":0.003940034,"teacher_disagreement_score":0.0024592795,"about_ca_system_score_codex":0.00038873593,"about_ca_system_score_gemma":0.00039514157,"threshold_uncertainty_score":0.0063527822},"labels":[],"label_agreement":null},{"id":"W7161992983","doi":"10.82308/27573","title":"Investigation of the co-operativity of mutations in the mitogen-activated protein kinase (MAPK) pathway in cutaneous melanomas","year":2022,"lang":"en","type":"dissertation","venue":"","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Kinase; MAPK/ERK pathway; Protein kinase A; Mutation; Neuroblastoma RAS viral oncogene homolog; Mutant","score_opus":0.014331388421173112,"score_gpt":0.24753158482972867,"score_spread":0.23320019640855555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7161992983","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998588,0.00060479937,0.00012697927,0.00001665739,0.000004988993,0.000007856546,0.000055592824,0.0000036440117,0.00059136056],"genre_scores_gemma":[0.99919647,0.00020682928,0.00013528204,0.000009205268,0.000005742727,0.000005776508,0.00006923607,0.000001909197,0.00036965348],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99977094,0.00004925746,0.000022961021,0.000058257297,0.00005397197,0.00004459536],"domain_scores_gemma":[0.99948776,0.00014143185,0.00014196278,0.000028180659,0.000083967185,0.00011672462],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027965746,0.00015738644,0.00017032021,0.00096055376,0.00025829315,0.0003086816,0.00011655268,0.00028849667,0.001647664],"category_scores_gemma":[0.0006880882,0.00012988312,0.00023065928,0.00050143135,0.00015816271,0.00021944393,0.00016842794,0.00024285003,0.00028155127],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016571225,0.0002531167,0.8669687,0.00012006285,0.00008410675,0.0057895468,0.00038359608,0.00010322001,0.10777427,0.00010106228,0.00014303207,0.016622152],"study_design_scores_gemma":[0.000014276037,0.00077108474,0.97345644,0.000010627621,0.000071260685,0.014902775,0.00046960634,0.00023963892,0.008614702,0.00006268483,0.0013801957,0.0000065982617],"about_ca_topic_score_codex":0.00055387587,"about_ca_topic_score_gemma":0.0005471806,"teacher_disagreement_score":0.001647664,"about_ca_system_score_codex":0.00013728393,"about_ca_system_score_gemma":0.00013503962,"threshold_uncertainty_score":0.0055119395},"labels":[],"label_agreement":null},{"id":"W761145466","doi":"","title":"Activation of mammalian target of rapamycin complex 1 (mTORC1) and 2 (mTORC2) is required for retinal ganglion cell dendrite regeneration after axonal injury.","year":2015,"lang":"en","type":"article","venue":"Investigative Ophthalmology & Visual Science","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"mTORC1; mTORC2; Regeneration (biology); Retinal ganglion cell; Neuroscience; Dendrite (mathematics); Cell biology; PI3K/AKT/mTOR pathway; Retina; Biology; Signal transduction","score_opus":0.04691283773313831,"score_gpt":0.3125197278770259,"score_spread":0.2656068901438876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W761145466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9785231,0.0083112875,0.0031543323,0.0006748647,0.00014587681,0.000036717956,0.0010349656,0.00025981554,0.007859032],"genre_scores_gemma":[0.9917394,0.0018479661,0.0012010372,0.00008574099,0.000016956466,0.000033813707,0.00059397705,0.000030014276,0.004451168],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99980706,0.000025125493,0.000015391312,0.000033751803,0.00006465059,0.00005413976],"domain_scores_gemma":[0.99985814,0.000008043709,0.000052293144,0.000009981482,0.000027520622,0.00004394567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015649543,0.00035666703,0.00020313312,0.00042911194,0.0005195797,0.00057102664,0.00019942789,0.000324421,0.0015236993],"category_scores_gemma":[0.0001712045,0.00021352261,0.00022758347,0.00017336303,0.00029034624,0.00036037114,0.00030692734,0.00058979564,0.0005674574],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002918381,0.000042336582,0.0007148061,0.0000615687,0.00001051557,0.000121369885,0.000016731712,0.00007851302,0.99515057,0.0006588718,0.00047315372,0.0023795997],"study_design_scores_gemma":[0.00004178753,0.00025241898,0.06307237,0.000029698618,0.00005093422,0.00090072444,0.00016587527,0.0022527059,0.92266923,0.00072278536,0.009823579,0.00001793643],"about_ca_topic_score_codex":0.0015362062,"about_ca_topic_score_gemma":0.003583984,"teacher_disagreement_score":0.0015362062,"about_ca_system_score_codex":0.00074008026,"about_ca_system_score_gemma":0.00065621303,"threshold_uncertainty_score":0.0053696632},"labels":[],"label_agreement":null},{"id":"W84962494","doi":"10.1096/fasebj.21.5.a258-a","title":"Involvement of ERK in the Regulation of Apoptosis of Breast Cancer Cells","year":2007,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; Laurentian University","funders":"","keywords":"Apoptosis; MAPK/ERK pathway; Annexin; Kinase; Cell cycle; Cancer research; Cell growth; Cell biology; Signal transduction; Programmed cell death; Breast cancer; Biology; Cancer; Chemistry; Biochemistry","score_opus":0.013321051210858924,"score_gpt":0.2402353329071722,"score_spread":0.22691428169631328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W84962494","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877628,0.0066109677,0.0016799821,0.000260353,0.000029549656,0.00002089948,0.0002747857,0.00003997298,0.0033206912],"genre_scores_gemma":[0.99384695,0.0029513491,0.000900698,0.00005821089,0.0000080062755,0.000016003552,0.00031064128,0.0000047692724,0.0019032694],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99992454,0.000017041068,0.0000071766617,0.000008265125,0.00002097455,0.000021979484],"domain_scores_gemma":[0.9999602,0.0000075701637,0.00000994256,0.0000054481557,0.000009481964,0.0000074178765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000098891076,0.00020615202,0.0001375119,0.00018552376,0.00015490007,0.00022769916,0.00014144521,0.0001490491,0.0009263001],"category_scores_gemma":[0.000107964384,0.00008235984,0.00015669373,0.00010954817,0.00010491478,0.00016393595,0.00015511306,0.00031933235,0.0002766528],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060780224,0.000093486626,0.0009945552,0.00012890554,0.000007953959,0.0002264195,0.000020734873,0.00021962245,0.98657334,0.0005091833,0.00011023708,0.010507777],"study_design_scores_gemma":[0.00004598964,0.00034495452,0.017157728,0.000015618265,0.000019972122,0.0011902936,0.00005170488,0.0017794279,0.9737067,0.0004037106,0.005277928,0.0000060214807],"about_ca_topic_score_codex":0.00017017589,"about_ca_topic_score_gemma":0.0003004204,"teacher_disagreement_score":0.0009263001,"about_ca_system_score_codex":0.00020016266,"about_ca_system_score_gemma":0.00014533098,"threshold_uncertainty_score":0.0030987263},"labels":[],"label_agreement":null},{"id":"W937127559","doi":"10.1016/j.bmcl.2015.07.093","title":"Recent progress on MAP kinase pathway inhibitors","year":2015,"lang":"en","type":"review","venue":"Bioorganic & Medicinal Chemistry Letters","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":60,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"MAPK/ERK pathway; Signal transduction; Kinase; Anti-apoptotic Ras signalling cascade; Chemistry; Mitogen-activated protein kinase; Intracellular; Cancer research; Cell biology; Computational biology; Biology; Biochemistry","score_opus":0.03257826275852975,"score_gpt":0.2847047729781015,"score_spread":0.2521265102195717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W937127559","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006399501,0.99530184,0.00064917817,0.0003582235,0.00036284697,0.000012466372,0.00004569574,0.000025318557,0.0026044506],"genre_scores_gemma":[0.003810271,0.9927301,0.00051180436,0.0005275615,0.0002658183,0.000021463802,0.00008304019,0.0000046203772,0.0020453774],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99986434,0.000019972162,0.000016840268,0.000027587328,0.00004421495,0.000027010019],"domain_scores_gemma":[0.99985385,0.00006440413,0.00002707821,0.0000057650473,0.000030164341,0.000018786477],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047037893,0.00093040965,0.0011404662,0.0012620853,0.00021431687,0.0007924187,0.00071874826,0.0006243022,0.0033655502],"category_scores_gemma":[0.0005438161,0.000356994,0.00042344455,0.0013755615,0.00037738116,0.0010909479,0.0006718625,0.0018187023,0.0014531929],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002337875,0.00014996613,0.00018106458,0.010396806,0.0001079972,0.0002748099,0.000049407812,0.00072166586,0.0068618795,0.0038647703,0.029410655,0.9477472],"study_design_scores_gemma":[0.00009583719,0.00027176604,0.00058441446,0.0009716884,0.0002416501,0.0007925313,0.000032858534,0.000329422,0.0035931186,0.0020281847,0.9910343,0.00002420813],"about_ca_topic_score_codex":0.00047905423,"about_ca_topic_score_gemma":0.0013467214,"teacher_disagreement_score":0.0033655502,"about_ca_system_score_codex":0.00047547912,"about_ca_system_score_gemma":0.0006917327,"threshold_uncertainty_score":0.0112589},"labels":[],"label_agreement":null}]}